Citrus Sinensis ID: 002160
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 958 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FPR3 | 933 | Serine/threonine-protein | yes | no | 0.947 | 0.973 | 0.584 | 0.0 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.280 | 0.327 | 0.643 | 2e-99 | |
| Q54TM7 | 1288 | Probable serine/threonine | yes | no | 0.286 | 0.212 | 0.431 | 9e-65 | |
| Q54H46 | 642 | Probable serine/threonine | no | no | 0.262 | 0.390 | 0.468 | 5e-63 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.271 | 0.376 | 0.441 | 4e-61 | |
| Q54TA1 | 749 | Probable serine/threonine | no | no | 0.263 | 0.336 | 0.450 | 2e-59 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.280 | 0.293 | 0.431 | 4e-59 | |
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.270 | 0.156 | 0.361 | 4e-56 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.314 | 0.185 | 0.354 | 3e-55 | |
| Q5UQG7 | 1651 | Putative serine/threonine | N/A | no | 0.271 | 0.157 | 0.383 | 6e-53 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1023 bits (2644), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 562/962 (58%), Positives = 692/962 (71%), Gaps = 54/962 (5%)
Query: 1 MRNIFKKLHIGSNHES-NRTNETLASTTSCATDHNRTSSSSS--NAAPPS-----PSASA 52
M++IFKKLH G N E NRTN+ + +D NR S++ A P S P A A
Sbjct: 1 MKHIFKKLHRGGNQEQQNRTNDA-----APPSDQNRIHVSANPPQATPSSVTETLPVAGA 55
Query: 53 ATAASSPAPVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSL-N 111
++ +SPAP +S +R DYM+SEEE+QVQLA+AISAS+S + EK QIRAATLLSL +
Sbjct: 56 TSSMASPAPTAAS-NRADYMSSEEEYQVQLALAISASNSQSSEDPEKHQIRAATLLSLGS 114
Query: 112 NRRSDLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLAHL 171
++R D RD ++V A+ LSRQYWEY VLDYEE+VVD FYD+Y LSTD + QG++PSL L
Sbjct: 115 HQRMDSRRDSSEVVAQRLSRQYWEYGVLDYEEKVVDSFYDVYSLSTDSAKQGEMPSLEDL 174
Query: 172 ESNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPV 231
ESN G GFE V+VNR ID +L EL+++A+CIAL T V +LVQ+LA+LV HMGG
Sbjct: 175 ESNHGTPGFEAVVVNRPIDSSLHELLEIAECIALGCSTTSVSVLVQRLAELVTEHMGGSA 234
Query: 232 KDANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGS 291
+D++I+LARW E+S+E + +L T V PIG + IG+SRHRALLFKVLADS+RLPCRLVKGS
Sbjct: 235 EDSSIVLARWTEKSSEFKAALNTCVFPIGFVKIGISRHRALLFKVLADSVRLPCRLVKGS 294
Query: 292 HYTGVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRT 351
HYTG EDDAVN I+LE+ERE+LVDLM PGTLIPAD SA + +P N +K P +
Sbjct: 295 HYTGNEDDAVNTIRLEDEREYLVDLMTDPGTLIPADFASASNNTVEPCNSNGNKFPTAQF 354
Query: 352 SNDSGAVYSKPKPLHAEGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSGI 411
SND PK EGSS +S + S L+ + +E+ +S S+P S
Sbjct: 355 SNDV------PKLSEGEGSSHSSMANYSSSLDRRTEAERTDS--SYPKVGPLRNIDYSSP 406
Query: 412 SSRVTPNQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADLN 471
SS + Q + SS+ IG KG RG A+ + +R N+N+VPY Q +ED K+LFADLN
Sbjct: 407 SSVTSSTQLENNSSTAIG----KGSRG--AIIECSRTNMNIVPYNQNSEEDPKNLFADLN 460
Query: 472 PFQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYM 531
PFQ KGA K + + V++F + NP+ GR P PMM KN + NE P++KE SY+
Sbjct: 461 PFQNKGADKLYMPTKSGLNNVDDFHQQKNNPLVGRSPAPMMWKN-YSCNEAPKRKENSYI 519
Query: 532 EGILPKINREPN-NNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGPSL 590
E +LPK++R+P N +S +TSS++ + +N+ +D+ + + S
Sbjct: 520 ENLLPKLHRDPRYGNTQSSYATSSSNGAIS---------SNVHGRDNVTFVSPVAVPSSF 570
Query: 591 ASSTSQLNGPPLVEDLSSNSKDE---NPKNV------EDHEIGYHDRRKCTHDRF-MGTN 640
S+ +Q P +VED++ N+ +E P ++ E HD RK T D G +
Sbjct: 571 TSTENQFR-PSIVEDMNRNTNNELDLQPHTAAVVHGQQNDESHIHDHRKYTSDDISTGCD 629
Query: 641 LKLRDLESPSSSVDSSTSKVD-QIFDD-DVCECEIPWEDLVLGERIGLGSYGEVYHADWN 698
+L+D ES SSS+DS++ + D Q+ DD DV ECEIPW DLV+ ERIGLGSYGEVYHADW+
Sbjct: 630 PRLKDHESTSSSLDSTSYRNDPQVLDDADVGECEIPWNDLVIAERIGLGSYGEVYHADWH 689
Query: 699 GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758
GTEVAVKKFLDQDFSGAAL EF+ EV+IMRRLRHPNVV F+GAVTRPPNLSI+TEFLPRG
Sbjct: 690 GTEVAVKKFLDQDFSGAALAEFRSEVRIMRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRG 749
Query: 759 SLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVS 817
SL+RILHRP +DE+RRIKMALD A GMNCLHTSTPTIVHRDLK+PNLLVD NWNVKV
Sbjct: 750 SLYRILHRPKSHIDERRRIKMALDVAMGMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVG 809
Query: 818 DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG 877
DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL+LPW G
Sbjct: 810 DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWRG 869
Query: 878 MNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVI 937
MNPMQVVGAVGFQNRRLEIPKELDP+V RII ECWQTDP+LRPSFAQLT LKPL RLV+
Sbjct: 870 MNPMQVVGAVGFQNRRLEIPKELDPVVGRIILECWQTDPNLRPSFAQLTEVLKPLNRLVL 929
Query: 938 PS 939
P+
Sbjct: 930 PT 931
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 364 bits (934), Expect = 2e-99, Method: Compositional matrix adjust.
Identities = 175/272 (64%), Positives = 214/272 (78%), Gaps = 3/272 (1%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRR 729
+ +IPW DL + E+IG GS+G V+ A+W+G++VAVK ++QDF + EF REV IM+R
Sbjct: 543 DMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKR 602
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHC--QVDEKRRIKMALD-ARGM 786
LRHPN+VLFMGAVT+PPNLSI+TE+L RGSL+R+LH+ Q+DE+RR+ MA D A+GM
Sbjct: 603 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 662
Query: 787 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 846
N LH P IVHRDLKSPNLLVDK + VKV DFGLSRLK +TFLSSKS AGTPEWMAPEV
Sbjct: 663 NYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEV 722
Query: 847 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 906
LR+EPSNEK DVYSFGVILWELATL+ PW +NP QVV AVGF+ +RLEIP+ L+P VA
Sbjct: 723 LRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAA 782
Query: 907 IIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 938
II CW +P RPSFA + L+PL + +P
Sbjct: 783 IIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 814
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 249 bits (635), Expect = 9e-65, Method: Compositional matrix adjust.
Identities = 122/283 (43%), Positives = 181/283 (63%), Gaps = 9/283 (3%)
Query: 644 RDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVA 703
+D + P ++ + +V++ F E E+P ++ +G RIG G YG+V+ W GTEVA
Sbjct: 822 KDHQFPVPTIPAKIIEVEKPF-----EWEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVA 876
Query: 704 VKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRI 763
VK + + + + + ++EV ++ +LRHPN+VLFMGA T P + I+TE+L RGSL I
Sbjct: 877 VKMLFNDNVNLKLISDLRKEVDLLCKLRHPNIVLFMGACTEPSSPCIVTEYLSRGSLANI 936
Query: 764 LHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 822
L ++D R+++ D ARGM LH+ P I+HRDLK+ NLLVD +W VKV+DFGL+
Sbjct: 937 LLDESIEMDWGLRLQLGFDCARGMTYLHSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLA 996
Query: 823 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ 882
+K +TF +K+ GT W+APEVL E EK DVYS+ ++LWEL T +P+ G N MQ
Sbjct: 997 TVKSHTF--AKTMCGTTGWVAPEVLAEEGYTEKADVYSYAIVLWELLTRLIPYAGKNTMQ 1054
Query: 883 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 925
VV ++ + RL +P P A ++ CW+TDP+ RPSF ++
Sbjct: 1055 VVRSID-RGERLPMPAWCPPKYAALMNRCWETDPTHRPSFPEI 1096
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 243 bits (620), Expect = 5e-63, Method: Compositional matrix adjust.
Identities = 119/254 (46%), Positives = 167/254 (65%), Gaps = 3/254 (1%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
+I + +G RIG G+YGEVY W G++VAVKK + + L EF RE+ +M+ LR
Sbjct: 368 DIDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMKNLR 427
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLH 790
HPNV+ F+G+ PP++ I TE++PRGSL+ ILH Q+ IKM +D A+G+ LH
Sbjct: 428 HPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAKGVIYLH 487
Query: 791 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 850
STP I+HRDLKS NLLVD+NW VKV+DFGLS ++ ++ + GTP W +PEVLR++
Sbjct: 488 NSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQG--ATMTACGTPCWTSPEVLRSQ 545
Query: 851 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 910
EK DVYSFG+ILWE AT + P+ G+ P QV+ AVG + R +P+ P +++ +
Sbjct: 546 RYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPVPQNGPPKYIQLLID 605
Query: 911 CWQTDPSLRPSFAQ 924
C +PS RP+ Q
Sbjct: 606 CLNENPSHRPTMEQ 619
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 237 bits (604), Expect = 4e-61, Method: Compositional matrix adjust.
Identities = 116/263 (44%), Positives = 169/263 (64%), Gaps = 3/263 (1%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
+I + + +G RIG G++GEVY W G++VAVKK + + L EF RE+ +M+ LR
Sbjct: 385 DIDTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMKNLR 444
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLH 790
HPNV+ F+G+ P++ I TE++PRGSL+ ILH ++ +M +D A+G+ LH
Sbjct: 445 HPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAKGIIYLH 504
Query: 791 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 850
STP I+HRDLKS NLLVD+NW VKV+DFGLS ++ ++ + GTP W +PEVLR++
Sbjct: 505 GSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQG--ATMTACGTPCWTSPEVLRSQ 562
Query: 851 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 910
EK DVYSFG+ILWE AT + P+ G+ P QV+ AVG + R PK P +++ +
Sbjct: 563 RYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPTPKYGPPKYIQLLKD 622
Query: 911 CWQTDPSLRPSFAQLTVALKPLQ 933
C +PS RP+ Q L+ ++
Sbjct: 623 CLNENPSQRPTMEQCLEILESIE 645
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TA1|DRKC_DICDI Probable serine/threonine-protein kinase drkC OS=Dictyostelium discoideum GN=drkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 231 bits (590), Expect = 2e-59, Method: Compositional matrix adjust.
Identities = 119/264 (45%), Positives = 162/264 (61%), Gaps = 12/264 (4%)
Query: 677 DLVLGERIGLGSYGEVYHADWNGTEVAVKKFL-----DQDFSGAALLEFKREVKIMRRLR 731
++V+ RIG GS EV+ W G VA+KK D+DF L E +E IM +LR
Sbjct: 490 EIVVQNRIGRGSCAEVFTGTWRGIIVAIKKAKLLNEDDEDF----LNELAQEATIMSQLR 545
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLH 790
HPN+ F+G PP + I+ E++P GSL+RILH P +D R MALD A+GMN LH
Sbjct: 546 HPNICQFLGTCNNPPEILIVMEYMPLGSLYRILHDPSISLDWPRMKSMALDIAKGMNYLH 605
Query: 791 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVLR 848
P ++HRDLKS NLLVD+++ VK+SDFGLS KH ++ + GTP W APEVLR
Sbjct: 606 CCDPIVIHRDLKSHNLLVDEHYRVKISDFGLSTRFKKHLDKKTAMTPVGTPCWTAPEVLR 665
Query: 849 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 908
N+P EK DV+SF ++LWE+ T + P+ GM Q+V +VG R +P ++ R+I
Sbjct: 666 NDPYTEKADVFSFAIVLWEIVTREDPYQGMPTFQIVISVGQHKLRPIVPPQVSAPFTRLI 725
Query: 909 WECWQTDPSLRPSFAQLTVALKPL 932
ECW DP RPSF ++ L+ +
Sbjct: 726 TECWSEDPQQRPSFQEIVKRLEAM 749
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 230 bits (587), Expect = 4e-59, Method: Compositional matrix adjust.
Identities = 120/278 (43%), Positives = 177/278 (63%), Gaps = 9/278 (3%)
Query: 650 SSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKF-L 708
S SV S+ Q F D EI + +L + ++G G++G VY W G+ VA+K+ +
Sbjct: 638 SGSVVEPPSQQQQYFSD----IEISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKI 693
Query: 709 DQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH 768
++D + L EF++E+ I+ RLRHPN+VL M A T PPNL ITE+LP GSL+ LH
Sbjct: 694 NEDVNNQVLEEFRKELTILSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKK 753
Query: 769 CQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827
+++ + K+A+ A+GMN LH S ++HRD+KS NLL+D++ NVK+ DFGLS+LK
Sbjct: 754 IKMNMQLYKKLAIQIAQGMNYLHLSG--VIHRDIKSLNLLLDEHMNVKICDFGLSKLKSK 811
Query: 828 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV 887
+ +KS G+P WM+PE+L E EK DVY+FG+ILWEL T +LP+ G++ +Q+ AV
Sbjct: 812 STEMTKSI-GSPIWMSPELLMGEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAV 870
Query: 888 GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 925
++ R IP ++ +I CW DP RPSF ++
Sbjct: 871 TTKSLRPPIPNAWPYQLSHLIQACWHQDPLKRPSFTEI 908
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 220 bits (560), Expect = 4e-56, Method: Compositional matrix adjust.
Identities = 95/263 (36%), Positives = 171/263 (65%), Gaps = 4/263 (1%)
Query: 668 VCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIM 727
+C I ++++ +GE+IGLGSYG VY W +VA+KKF+ Q LL + E+ +
Sbjct: 1389 LCSWVINYDEIKMGEQIGLGSYGVVYRGKWKNVDVAIKKFIKQKIDENHLLGIREEIAFL 1448
Query: 728 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGM 786
++L HPN++ +GA + PN+ I+TE++ +G+L + +++ ++IK+ ++ A+G+
Sbjct: 1449 KKLHHPNIITMVGASLKKPNICIVTEYMAKGNLRDAMRTCTPKLEWHQKIKILVNIAKGI 1508
Query: 787 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 846
+ LH+ P I+HRD+K N+L+D+NWNVK++DFG +R+K + ++ GTP W APE+
Sbjct: 1509 SYLHSFDPPIIHRDIKPSNILIDENWNVKIADFGFARIKEENAIMTR--CGTPCWTAPEI 1566
Query: 847 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 906
+RN+ +EK DV+SFG+++WE+ T K P+IG N M++ + ++ R +IP++ A+
Sbjct: 1567 IRNDIYDEKVDVFSFGIVMWEVLTCKEPFIGANFMKITMDI-LEDVRPKIPQDCPEEFAK 1625
Query: 907 IIWECWQTDPSLRPSFAQLTVAL 929
++ +CW + RP+ + + L
Sbjct: 1626 LMRKCWHAKSTKRPTMDDVIIVL 1648
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 217 bits (553), Expect = 3e-55, Method: Compositional matrix adjust.
Identities = 115/324 (35%), Positives = 185/324 (57%), Gaps = 23/324 (7%)
Query: 625 YHDRRKCTHDRFMG--TNLKLRDLESPSSSVDSSTSKVDQIFDDD--------------- 667
Y + + +RF G T + D ++ S + D S +I D D
Sbjct: 1294 YEIKFEILKNRFFGGITYVNYND-DTDSGTADDSNYDSGKIIDIDYMADIDKEDSFLTSA 1352
Query: 668 -VCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKI 726
+C I ++++ +G++IGLGSYG V++ W G +VAVKKF+ Q S LLEF+ E+
Sbjct: 1353 NMCRWIINYDEISIGKQIGLGSYGIVFNGKWKGVDVAVKKFVKQKLSETQLLEFRAEMAF 1412
Query: 727 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARG 785
+ L+H N+V F+GA + PN+ I+TE++ G+L +L P ++ ++K+ A G
Sbjct: 1413 LSELKHSNIVTFIGACIKKPNICIVTEYMRMGNLRDVLKNPDIKITFANKLKLLYGAAMG 1472
Query: 786 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 845
++ LH+S P IVHRD+K N+LVD+++NVK++DFG +R+K + ++ + GTP W APE
Sbjct: 1473 IDYLHSSNPMIVHRDIKPANILVDEHFNVKIADFGFARIKEDN--TTMTRCGTPCWTAPE 1530
Query: 846 VLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 905
V+R E EK DV+SFGV++WE+ T K P+ N M+V + + R IP + A
Sbjct: 1531 VIRGEKYCEKADVFSFGVVMWEVLTGKEPFAECNFMKVSLDI-LEGGRPIIPSDCPHEFA 1589
Query: 906 RIIWECWQTDPSLRPSFAQLTVAL 929
++I +CW RP+ ++ L
Sbjct: 1590 KLIKKCWHAKAHKRPTMTEVVQQL 1613
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5UQG7|YR818_MIMIV Putative serine/threonine-protein kinase/receptor R818 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R818 PE=4 SV=1 | Back alignment and function description |
|---|
Score = 210 bits (534), Expect = 6e-53, Method: Compositional matrix adjust.
Identities = 102/266 (38%), Positives = 159/266 (59%), Gaps = 6/266 (2%)
Query: 668 VCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIM 727
+C I ++D+ +G++IG+GSYG V W VAVKKF+ Q +LEF+ E+ +
Sbjct: 1384 LCRWIINYDDIQIGKQIGVGSYGIVNMGKWKNINVAVKKFVKQKIDEKQMLEFRAEIAFL 1443
Query: 728 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGM 786
+LRHP+++L +GA + PN+ I+TEF+ GSL ++ + + K +IKM A G+
Sbjct: 1444 SQLRHPHIILMIGACLKRPNICIVTEFMGNGSLRNVIKTT--KPEWKLKIKMLYQTALGI 1501
Query: 787 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 846
LH S P I+HRD+K N+LVD + NVK++DFG +R+K S + GTP W APE+
Sbjct: 1502 GYLHNSDPIIIHRDIKPSNILVDDSMNVKIADFGFARIKEEN--SVMTRCGTPCWTAPEI 1559
Query: 847 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 906
+R E EK DV+SFG+++WE+ T K P+ G N M+V + + R +IP + +
Sbjct: 1560 IRGEKYTEKVDVFSFGIVMWEVLTCKEPFSGCNFMKVSMDI-LEGARPQIPSDCPIDFTK 1618
Query: 907 IIWECWQTDPSLRPSFAQLTVALKPL 932
++ +CW P RPS + + L +
Sbjct: 1619 LMKQCWHAKPDKRPSMEDVIMGLNDM 1644
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 958 | ||||||
| 224125544 | 967 | predicted protein [Populus trichocarpa] | 0.983 | 0.974 | 0.682 | 0.0 | |
| 224130772 | 955 | predicted protein [Populus trichocarpa] | 0.964 | 0.967 | 0.684 | 0.0 | |
| 359487849 | 955 | PREDICTED: serine/threonine-protein kina | 0.970 | 0.973 | 0.679 | 0.0 | |
| 255542402 | 958 | map3k delta-1 protein kinase, putative [ | 0.966 | 0.966 | 0.675 | 0.0 | |
| 356535135 | 930 | PREDICTED: serine/threonine-protein kina | 0.938 | 0.966 | 0.654 | 0.0 | |
| 229335619 | 913 | EDR1 [Glycine max] | 0.938 | 0.984 | 0.654 | 0.0 | |
| 356576743 | 932 | PREDICTED: serine/threonine-protein kina | 0.938 | 0.964 | 0.650 | 0.0 | |
| 262213688 | 871 | EDR1 [Glycine max] | 0.885 | 0.973 | 0.650 | 0.0 | |
| 449435758 | 935 | PREDICTED: LOW QUALITY PROTEIN: serine/t | 0.951 | 0.975 | 0.634 | 0.0 | |
| 298204924 | 876 | unnamed protein product [Vitis vinifera] | 0.893 | 0.977 | 0.640 | 0.0 |
| >gi|224125544|ref|XP_002319612.1| predicted protein [Populus trichocarpa] gi|222857988|gb|EEE95535.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1310 bits (3389), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 671/983 (68%), Positives = 780/983 (79%), Gaps = 41/983 (4%)
Query: 1 MRNIFKKLHIGSNHES--NRTNETLASTTSCAT-----DHNRTSSSSSNAAPPSPSASAA 53
M++IFKKLHIGSNHES NRT+ A++ S D +++ +S A+PP S S A
Sbjct: 1 MKHIFKKLHIGSNHESSPNRTSNETATSASSPPPSGSSDQRASATINSPASPPLTSPSPA 60
Query: 54 TAASSPAPVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSLN-- 111
T A + TDY TSEEEFQVQLA+AISAS+S D +EKDQIRAATLLSL
Sbjct: 61 TTVQPSA----ISNLTDYFTSEEEFQVQLALAISASNSEFRDDTEKDQIRAATLLSLGGG 116
Query: 112 NRRSDLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLAHL 171
N R D+ R+K + E +SR YWEYNVLDY E+V+DGFYD+ L T + QGK+PSL L
Sbjct: 117 NNRVDVDREKGEEKVEDMSRYYWEYNVLDYGEKVMDGFYDV--LCTSSAVQGKMPSLTDL 174
Query: 172 ESNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPV 231
E+N +SGFE VIVNR ID LEEL+Q+AQCIALD PAT+V +LVQQLA+LV GHMGGPV
Sbjct: 175 ETNASSSGFEAVIVNRKIDPTLEELMQIAQCIALDCPATNVAVLVQQLAELVTGHMGGPV 234
Query: 232 KDANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGS 291
KDAN++LA+W+ERS+ELR SLQTSVLPIGSINIGLSRHRALLFKVLAD+I+LPCRLVKGS
Sbjct: 235 KDANLILAKWIERSSELRTSLQTSVLPIGSINIGLSRHRALLFKVLADTIKLPCRLVKGS 294
Query: 292 HYTGVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRT 351
HYTG+EDDAVNIIKL++EREFLVDLMAAPGTLIPAD+ SAKD+ FK IP LR+
Sbjct: 295 HYTGIEDDAVNIIKLKDEREFLVDLMAAPGTLIPADVPSAKDSTFK--------IPSLRS 346
Query: 352 SNDSGAVYSKPKPLHAEGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSGI 411
+ND+G V+++P PL EG+SQ+S+VDG P N SE AESLP F S + G SSG+
Sbjct: 347 TNDTGVVFTRPNPLPGEGTSQSSSVDGISPFNSRLNSENAESLPFFSGSSSDAGVGSSGV 406
Query: 412 SSRVTP-NQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADL 470
+++ P NQ +SS+ IGTS+YKG RG +AVGDG RMNVNVVPYG EDSK+LF+DL
Sbjct: 407 ANKAAPTNQFGNISSTAIGTSVYKGSRGGHAVGDGVRMNVNVVPYGPNSPEDSKNLFSDL 466
Query: 471 NPFQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSY 530
NPFQIKG GK+ +H P E+K+ EF + NPV G PP P++ KN++ YNEVPR+KE
Sbjct: 467 NPFQIKGTGKSFMHHKPVENKINEFPGRKNNPVPG-PPAPLVWKNRYAYNEVPRRKENEL 525
Query: 531 MEGILPKINREPNNNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGPSL 590
+EG+ P+INREPNN + ASTSS SE P FK S++ N S+K+S++R+ S +L
Sbjct: 526 VEGLYPRINREPNNYNQSLASTSS-SEKVYPQGFKSSSNFNPSNKESDTRNYASSVSSAL 584
Query: 591 ASSTSQLNGPPLVEDLSSNSKDE---NPKNV-----------EDHEIGYHDRRKCTHDRF 636
+S SQ P VE+ +SN K+ + KN+ ED+EI +HDRRKCT+DRF
Sbjct: 585 SSDPSQCYSFPSVEEANSNFKENKLWDAKNLQNDSEAMAKEHEDNEIDFHDRRKCTYDRF 644
Query: 637 MGTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHAD 696
MGTNLKL+D ESPS+SVD + +VDQI DD EI WEDL++GERIGLGSYGEVYHAD
Sbjct: 645 MGTNLKLKDPESPSASVDPISHRVDQIMDDVDVGDEICWEDLIIGERIGLGSYGEVYHAD 704
Query: 697 WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 756
WNGTEVAVKKFLDQDFSGAAL EFKREV+IMRRLRHPNVVLFMGAVTRPPNLSIITEFLP
Sbjct: 705 WNGTEVAVKKFLDQDFSGAALDEFKREVRIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 764
Query: 757 RGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVK 815
RGSL+RILHRP CQ+DEKRRI+MALD ARGMNCLH S PTIVHRDLKSPNLLVDKNW VK
Sbjct: 765 RGSLYRILHRPQCQIDEKRRIRMALDVARGMNCLHASIPTIVHRDLKSPNLLVDKNWTVK 824
Query: 816 VSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 875
V DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFG+ILWELAT++LPW
Sbjct: 825 VCDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGIILWELATIRLPW 884
Query: 876 IGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935
GMNPMQVVGAVGFQNRRLEIPKE+DPLVARIIWECWQTDP+LRPSFAQLTVALKPLQRL
Sbjct: 885 SGMNPMQVVGAVGFQNRRLEIPKEVDPLVARIIWECWQTDPNLRPSFAQLTVALKPLQRL 944
Query: 936 VIPSHPDQPSSALPQEISVNSTP 958
VIPSH DQPS L QEI+VNSTP
Sbjct: 945 VIPSHLDQPSPPLQQEIAVNSTP 967
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224130772|ref|XP_002328373.1| predicted protein [Populus trichocarpa] gi|222838088|gb|EEE76453.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1286 bits (3328), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 662/967 (68%), Positives = 767/967 (79%), Gaps = 43/967 (4%)
Query: 1 MRNIFKKLHIGSNHES--NRTNE--------TLASTTSCATDHNRTSSSSSNAAPPSPSA 50
M++IFKKLHIGSN+ES NRT+ SC++DH + +S A PPS S
Sbjct: 1 MKHIFKKLHIGSNNESSPNRTSNDTATSASTPPPPPPSCSSDHRAAGTGNSPANPPSTSP 60
Query: 51 SAATAASSPAPVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSL 110
S AT A ++ G+RTDY SEE+FQVQLA+AISAS+S D +EKDQIRAATLLSL
Sbjct: 61 SPATTAQP----LAFGNRTDYFASEEDFQVQLALAISASNSEFRDDTEKDQIRAATLLSL 116
Query: 111 N--NRRSDLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSL 168
N R D+GR+K + E LSR YWEYNVLDY ERV+DGFYD++ T + QGK+PSL
Sbjct: 117 GGGNNRIDVGREKGEGKVEDLSRYYWEYNVLDYGERVMDGFYDVF--CTSSAVQGKMPSL 174
Query: 169 AHLESNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMG 228
LE+N G SGFE VIVNR +D ALEEL+Q+AQCIALD ATDV ILVQQLA+LV GHMG
Sbjct: 175 MDLETNAGGSGFEAVIVNRKVDPALEELMQIAQCIALDWLATDVTILVQQLAELVTGHMG 234
Query: 229 GPVKDANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLV 288
GPVKDAN++LA+WM+RSTELR SLQTSVLPIGSINIGLSRHRALLFKVLAD+I+LPCRLV
Sbjct: 235 GPVKDANLILAKWMDRSTELRTSLQTSVLPIGSINIGLSRHRALLFKVLADTIKLPCRLV 294
Query: 289 KGSHYTGVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPI 348
KGSHYTG+EDDAVNIIKLE+EREFLVDLMAAPGTLIPAD+ SAKDT FK IP
Sbjct: 295 KGSHYTGIEDDAVNIIKLEDEREFLVDLMAAPGTLIPADVPSAKDTTFK--------IPA 346
Query: 349 LRTSNDSGAVYSKPKPLHAEGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAAS 408
R SN++G V+++ KPL EG+SQNS+VDG PL+ SE AESLPSF S G S
Sbjct: 347 PR-SNETGVVFARSKPLTGEGTSQNSSVDGISPLDRILCSENAESLPSFSGSSNNAGVGS 405
Query: 409 SGISSRVTP-NQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLF 467
SG+S++ P NQ ++S+ GTS+YKG RG +A+GDG RMNVNVVPY EDSK+LF
Sbjct: 406 SGVSNKTAPTNQLGNIASTAFGTSVYKGSRGVHAIGDGLRMNVNVVPYVPNTSEDSKNLF 465
Query: 468 ADLNPFQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKE 527
ADLNPFQIKG GK+ +H P E+K+ EFQ + NPV PP P+M KN+ YNEVPR+K+
Sbjct: 466 ADLNPFQIKGTGKSFMHNKPAENKINEFQGRKNNPVPS-PPAPLMWKNRFAYNEVPRRKD 524
Query: 528 YSYMEGILPKINREPNNNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSG 587
+EG+ P+INREPNN +S +++S SE P FK S++ N S+++S++R++ S +
Sbjct: 525 NDNVEGLYPRINREPNNYNHSSLASTSLSEKVYPQGFKSSSNLNTSNRESDTRNSASSAS 584
Query: 588 PSLASSTSQLNGPPLVEDLSSNSKDE--NPKNV-----------EDHEIGYHDRRKCTHD 634
L+S T+Q P VE+++SN +++ + KN+ ED+EIG+HDRRKC HD
Sbjct: 585 SELSSYTNQGYSLPSVEEVNSNFEEKLWDAKNLQNDMEASVKESEDNEIGFHDRRKCIHD 644
Query: 635 RFMGTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYH 694
RFMGTNLKL+ ESPS+SVDSST +VD+I DD EI WEDLV GERIGLGSYGEVYH
Sbjct: 645 RFMGTNLKLKGPESPSTSVDSSTHRVDRILDDVDVGDEICWEDLVFGERIGLGSYGEVYH 704
Query: 695 ADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754
ADWNGTEVAVKKFLDQDFSGAAL EFKREV+IMRRLRHPNVVLFMGAVTRPPNLSIITEF
Sbjct: 705 ADWNGTEVAVKKFLDQDFSGAALDEFKREVRIMRRLRHPNVVLFMGAVTRPPNLSIITEF 764
Query: 755 LPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN 813
LPRGSL+RILHRP CQ+DEKRRIKMALD ARGMNCLH STPTIVHRDLKSPNLLVD+NW
Sbjct: 765 LPRGSLYRILHRPQCQIDEKRRIKMALDVARGMNCLHASTPTIVHRDLKSPNLLVDENWT 824
Query: 814 VKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL 873
VKV DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLK
Sbjct: 825 VKVCDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKS 884
Query: 874 PWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 933
PW GMNPMQVVGAVGFQNRRLEIPKE+DPLVARIIWECWQTDP+LRPSFA+L VAL PLQ
Sbjct: 885 PWSGMNPMQVVGAVGFQNRRLEIPKEVDPLVARIIWECWQTDPNLRPSFAELAVALMPLQ 944
Query: 934 RLVIPSH 940
RLV+PSH
Sbjct: 945 RLVVPSH 951
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359487849|ref|XP_002271755.2| PREDICTED: serine/threonine-protein kinase CTR1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1283 bits (3321), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 668/983 (67%), Positives = 775/983 (78%), Gaps = 53/983 (5%)
Query: 1 MRNIFKKLHIGSN-HESNRTNETLASTTS----CATDHNRTSSSSSNAAPPSPSASAATA 55
M++IFKKLHIGS+ H+ NR+NETL+S T+ CA+DH RTSS+ S+ +PPS S T
Sbjct: 1 MKHIFKKLHIGSSSHDPNRSNETLSSATTSSPACASDH-RTSSAQSSVSPPSSYPSPTT- 58
Query: 56 ASSPAPVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSLNNRRS 115
FQVQLA+AISAS+S+ D SEKDQIRAATLLSL R+
Sbjct: 59 ----------------------FQVQLALAISASNSDFRDDSEKDQIRAATLLSLGRHRT 96
Query: 116 DLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLAHLESNL 175
D RDK D +AE +SR+YW+YNVLDYEE+VVDGFYD+YGLSTDP QGK+PSL LE+NL
Sbjct: 97 DSVRDK-DESAESMSRRYWDYNVLDYEEKVVDGFYDVYGLSTDPVIQGKMPSLTDLETNL 155
Query: 176 GNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPVKDAN 235
GNSGFEV++VNR ID ALEELVQVA CIALD PA +VG+LVQ+LA++V HMGGPV+DAN
Sbjct: 156 GNSGFEVIVVNRRIDPALEELVQVAHCIALDCPAAEVGVLVQRLAEIVTDHMGGPVRDAN 215
Query: 236 IMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSHYTG 295
IML +WME +LR SL TS+LP+GS++IGLSRHRALLFK+LAD++ +PCRLVKGSHYTG
Sbjct: 216 IMLVKWMESRKDLRTSLHTSILPVGSLSIGLSRHRALLFKILADNVGVPCRLVKGSHYTG 275
Query: 296 VEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRTSNDS 355
VEDDAVNIIKL+ EREFLVDLM APGTLIPADILSAKD++ K YNP +SKIP L+ S D
Sbjct: 276 VEDDAVNIIKLDNEREFLVDLMGAPGTLIPADILSAKDSSLKSYNPKLSKIPTLQASKDP 335
Query: 356 GAVYSKPKPLHA--EGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSGISS 413
G VYS+PKPL EGSSQ ST++ SLP + ++SEK ESL SF S S + G +S IS
Sbjct: 336 GGVYSRPKPLLGDYEGSSQTSTIENSLPQDRKASSEKIESLDSFSSSSGDTGVGTSRISK 395
Query: 414 RVTP-NQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADLNP 472
RVTP NQSD S IG S+YKG RG NAVGDG+RMNVN+VPY Q ED K+LFADLNP
Sbjct: 396 RVTPVNQSDLRPSLAIGASVYKGSRGANAVGDGSRMNVNIVPYNQNSTEDPKNLFADLNP 455
Query: 473 FQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYME 532
FQ+ G+ K S P E+KV+EFQ + + GRPP+P+M KN++ NEVPRKKE ++E
Sbjct: 456 FQMIGSSKASAQSKPMENKVDEFQREKNSAAPGRPPLPLMWKNRYANNEVPRKKENDFVE 515
Query: 533 GILPKINREPNN-NL-STSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGPSL 590
G+ PKINRE N+ NL S +++ ++TSE FK S +A +++K ++ +++ + L
Sbjct: 516 GLFPKINRETNDYNLPSLTSNNATTSEKVYSGVFKLSGNAYMNNKVNDDQNSSCNTTSML 575
Query: 591 ASSTSQLNGPPLVEDLSSNSKDENPKN-----------VEDH---EIGYHDRRKCTHDRF 636
A STSQ N L ED+++N ++ K+ ++H E G HD RK HD F
Sbjct: 576 APSTSQFNRLSLDEDVNANYNEKYHKDGKVFQSDMVDAAKEHDKNETGLHDHRKFRHDSF 635
Query: 637 MGTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHAD 696
M N LR+ ESP SSVDS KVDQ+F +DV ECEIPWEDLVLGERIGLGSYGEVYH D
Sbjct: 636 MENN--LREAESPCSSVDSDAGKVDQMF-EDVGECEIPWEDLVLGERIGLGSYGEVYHGD 692
Query: 697 WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 756
WNGTEVAVKKFLDQDFSGAAL EFKREV+IMRRLRHPNVVLFMGAVTRPPNLSIITEFLP
Sbjct: 693 WNGTEVAVKKFLDQDFSGAALAEFKREVRIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 752
Query: 757 RGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVK 815
RGSL+RILHRP CQ+DEKRRIKMALD A+GMNCLHTS PTIVHRDLKSPNLLVDKNWNVK
Sbjct: 753 RGSLYRILHRPSCQIDEKRRIKMALDVAKGMNCLHTSLPTIVHRDLKSPNLLVDKNWNVK 812
Query: 816 VSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 875
V DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE SNEKCDVYSFG+ILWELATL+LPW
Sbjct: 813 VCDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNENSNEKCDVYSFGIILWELATLRLPW 872
Query: 876 IGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935
GMNPMQVVGAVGFQNRRL+IPKE+DPLVARIIWECWQTDP+LRPSFAQLTVALKPLQRL
Sbjct: 873 SGMNPMQVVGAVGFQNRRLDIPKEVDPLVARIIWECWQTDPNLRPSFAQLTVALKPLQRL 932
Query: 936 VIPSHPDQPSSALPQEISVNSTP 958
VIP H DQ S L QEISVNSTP
Sbjct: 933 VIPQHLDQQSLTLQQEISVNSTP 955
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542402|ref|XP_002512264.1| map3k delta-1 protein kinase, putative [Ricinus communis] gi|223548225|gb|EEF49716.1| map3k delta-1 protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1268 bits (3282), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 669/990 (67%), Positives = 779/990 (78%), Gaps = 64/990 (6%)
Query: 1 MRNIFKKLHIGSNHESN-RTNETLASTTSCATDHNRTSSSSSNAAPPSPSASAATAASSP 59
M++IFKKLHIGS HE N R NET + + SC++DH RTSS
Sbjct: 1 MKHIFKKLHIGSGHEPNHRPNETPSPSQSCSSDH-RTSS--------------------- 38
Query: 60 APVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPE--DFSEKDQIRAATLLSL----NNR 113
V + S +S E++Q+QLA+A+SAS+SN E + E DQIRAATLLSL NN
Sbjct: 39 --VNAPASPPSTSSSPEDYQIQLALALSASASNSEFREDHENDQIRAATLLSLGGNHNNH 96
Query: 114 ------RSDLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPS 167
R D+ R+K ++AAE LSRQYWEYNVLDYEE+V+DGFYD++ S P Q K+PS
Sbjct: 97 THNPTHRIDMPRNKGELAAEALSRQYWEYNVLDYEEKVMDGFYDVF--SRSPVVQAKMPS 154
Query: 168 LAHLESNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHM 227
L LE+N G+S FE V++NR +DHALEELVQVAQCIALD PATDVGILVQ+LA++V GHM
Sbjct: 155 LTELETNPGSSSFEAVVINRAMDHALEELVQVAQCIALDCPATDVGILVQRLAEVVTGHM 214
Query: 228 GGPVKDANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRL 287
GGPVKDANIMLARWMERST+LR+SL TS LPIGSI+IGLSRHRALLFKVLAD+IR PCRL
Sbjct: 215 GGPVKDANIMLARWMERSTDLRKSLHTSALPIGSIDIGLSRHRALLFKVLADNIRFPCRL 274
Query: 288 VKGSHYTGVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIP 347
VKGSHYTG+EDDA+NIIKLE+EREFLVDLMA PGTLIPAD+LSAKDT FK YNP I+ I
Sbjct: 275 VKGSHYTGIEDDAINIIKLEDEREFLVDLMADPGTLIPADVLSAKDTTFKSYNPNINIIA 334
Query: 348 ILRTSNDSGAVYSKPKPLHAEGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAA 407
L++ N+S +Y++ P EGSSQNS++DGSLPL+ S++E AESL SF S G
Sbjct: 335 GLQSPNESEIIYTRSSPSFGEGSSQNSSMDGSLPLDRRSSNETAESLASFSGASSNVGVG 394
Query: 408 SSGISSRV-TPNQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSL 466
SSG S+V + NQ +SS IG YKGGRG +AV D RMNVNV+PYGQ EDS++L
Sbjct: 395 SSGGPSKVASSNQHGNISSLAIG---YKGGRGTHAVADAVRMNVNVIPYGQNSLEDSRNL 451
Query: 467 FADLNPFQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKK 526
F+DLNPFQIKG GK+ +H P E+KVE+F + N + GRPP P+ KN++ YNEVPRKK
Sbjct: 452 FSDLNPFQIKGTGKSFMHNKPAENKVEDFHGQKDNLLPGRPPAPLKWKNRYAYNEVPRKK 511
Query: 527 EYSYMEGILPKINREPN--NNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALS 584
EY Y+EG+ P I+REPN N S ++S+S+ SE P S+ +N SS+D ++ ++ S
Sbjct: 512 EYDYIEGLFPGISREPNGYNQSSLASSSSTMSEKVYPQGLNSSSSSNTSSRDGDAWNSSS 571
Query: 585 GSGPSLASSTSQLNGPPLVEDLSSNSKDENPKNV--------------EDHEIGYHDRRK 630
G+ +LAS +Q LVE+ +S+ K E+P++ E++EIG+ DRRK
Sbjct: 572 GTNSALASGMNQCYKSSLVEEANSDFK-ESPRDAKNFQNDAEVTIRDDENNEIGFQDRRK 630
Query: 631 CTHDRFMGTNLKLRDLESPSSSVDSSTSKVDQIFDD-DVCECEIPWEDLVLGERIGLGSY 689
CTHDRFMG NLKL+ ES SSS+DS +KVDQIFDD DV ECEIPWEDL LGERIGLGSY
Sbjct: 631 CTHDRFMGINLKLK--ESSSSSIDSGKNKVDQIFDDVDVGECEIPWEDLDLGERIGLGSY 688
Query: 690 GEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749
GEVYHADWNGTEVAVKKFLDQDFSGAAL EFKREV+IMRRLRHPNVVLFMGAVTRPPNLS
Sbjct: 689 GEVYHADWNGTEVAVKKFLDQDFSGAALAEFKREVRIMRRLRHPNVVLFMGAVTRPPNLS 748
Query: 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLV 808
II+EFLPRGSL+RILHRPHCQ+DEKRRIKMALD ARGMNCLH+S PTIVHRDLKSPNLLV
Sbjct: 749 IISEFLPRGSLYRILHRPHCQIDEKRRIKMALDVARGMNCLHSSIPTIVHRDLKSPNLLV 808
Query: 809 DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWEL 868
DKNWNVKV DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWEL
Sbjct: 809 DKNWNVKVCDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWEL 868
Query: 869 ATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928
ATL+LPW GMNPMQVVGAVGFQNRRLEIPK++DP VA IIW+CWQ+DP+ RPSFA+LT A
Sbjct: 869 ATLRLPWSGMNPMQVVGAVGFQNRRLEIPKDIDPKVAMIIWQCWQSDPNARPSFAELTTA 928
Query: 929 LKPLQRLVIPSHPDQPSSALPQEISVNSTP 958
LKPLQRLVIPSH DQPSS L QEISVNSTP
Sbjct: 929 LKPLQRLVIPSHLDQPSSPLQQEISVNSTP 958
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356535135|ref|XP_003536104.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1196 bits (3095), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 636/972 (65%), Positives = 738/972 (75%), Gaps = 73/972 (7%)
Query: 1 MRNIFKKLHIGSNHESNRTNETLAS--TTSCATDHNRTSSSSSNAAPPSPSASAATAAS- 57
M+NIFKKLHIGS+H+ +R+NE S + SC D +++S+++ + + ++++ +
Sbjct: 18 MKNIFKKLHIGSSHDPHRSNEASPSVPSPSCVADQSQSSAATPASPSSASASASTVVVTP 77
Query: 58 -----SPAPVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSLNN 112
+PV++ R D+ +SEEEFQVQLA+AISAS+S + EKDQI AATLLSL
Sbjct: 78 GGGGGGASPVMN---RQDFFSSEEEFQVQLALAISASNSEFREDPEKDQIHAATLLSLGG 134
Query: 113 RRSDLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLAHLE 172
R D R+K DVA E LSRQYWEYNVLDYEE+VVDGFYD+YG D QGK+PS LE
Sbjct: 135 HRIDSARNKDDVA-EALSRQYWEYNVLDYEEKVVDGFYDVYGPYNDSVMQGKMPSRTDLE 193
Query: 173 SNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPVK 232
+N G G E+VIVNRTID +LEEL+Q+AQCIALD P V LVQ+LA+LV HMGGPVK
Sbjct: 194 ANPG--GSELVIVNRTIDPSLEELIQIAQCIALDCP---VSSLVQRLAELVTSHMGGPVK 248
Query: 233 DANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSH 292
DA+IMLARW E EL+ SL T VLP+GS+NIGLSRHRALLFKVLAD+I +PCRLVKGSH
Sbjct: 249 DASIMLARWTETRAELKTSLHTIVLPLGSLNIGLSRHRALLFKVLADNINMPCRLVKGSH 308
Query: 293 YTGVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRTS 352
YTGVEDDAVNIIKLE+EREFLVDLMAAPGTLIPADILS KD+AFKPYNP I P L ++
Sbjct: 309 YTGVEDDAVNIIKLEDEREFLVDLMAAPGTLIPADILSTKDSAFKPYNPKI--WPSLPST 366
Query: 353 NDSGAVYSKP-KPLHAEGSSQNSTV-DGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSG 410
D+ YS+P +P H EGSSQNS V D SLP NG EK+E PS S + G S
Sbjct: 367 KDNEFSYSRPIQPSHGEGSSQNSVVKDYSLPWNGKPYFEKSE--PSNLGLSRDSGVGPSK 424
Query: 411 ISSRVTPNQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADL 470
I ++ TPNQ + L + + GTSLYKG G N VGDG R+NVNVVPY DS++LFADL
Sbjct: 425 IPNKGTPNQLENLPALS-GTSLYKGTLGMNTVGDGTRLNVNVVPYTNNSPNDSRNLFADL 483
Query: 471 NPFQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSY 530
NPFQIKG GK +H P E+K E +S + N VSGRPP+P+M KN+H YNE PRK
Sbjct: 484 NPFQIKGMGKAPVHNKPVENKPPELKSTKNNAVSGRPPVPLMWKNRHAYNEDPRK----- 538
Query: 531 MEGILPKINREPN--NNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGP 588
N PN N ++ SS SE + S KP ++NI++ +
Sbjct: 539 -------TNHNPNEYNPPLFVSNGSSMSEIIDLSSSKPLYNSNINN---------DVNAQ 582
Query: 589 SLASSTSQLNGPPLVEDLSSNSKDENPKNVEDHEIGYHDRRKCTHDRFMGTNLKLRDLES 648
+LA T ++ P HD+R CT+DRFMG+NLKL+D ES
Sbjct: 583 TLAQVTGSVSPP------------------------NHDQRNCTYDRFMGSNLKLKDPES 618
Query: 649 PSSSVDSSTSKVDQIFDD-DVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKF 707
PSSS+DS T++VDQI DD DV ECEIPWEDLVLGERIG+GSYGEVYHADWNGTEVAVKKF
Sbjct: 619 PSSSIDSITNRVDQILDDVDVGECEIPWEDLVLGERIGIGSYGEVYHADWNGTEVAVKKF 678
Query: 708 LDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRP 767
LDQDFSGAAL EFKREV+IMRRLRHPN+VLFMGAVTRPPNLSII+E+LPRGSL+RILHRP
Sbjct: 679 LDQDFSGAALSEFKREVRIMRRLRHPNIVLFMGAVTRPPNLSIISEYLPRGSLYRILHRP 738
Query: 768 HCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826
+CQ+DEKRRIKMALD ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV DFGLSRLKH
Sbjct: 739 NCQIDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVCDFGLSRLKH 798
Query: 827 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGA 886
NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL+LPW GMNPMQVVGA
Sbjct: 799 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWSGMNPMQVVGA 858
Query: 887 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSS 946
VGFQNRRL+IPKE+DP+VARIIWECWQ DP+LRPSFAQLTVALKPLQRLVIPS+ DQ +
Sbjct: 859 VGFQNRRLDIPKEVDPIVARIIWECWQQDPNLRPSFAQLTVALKPLQRLVIPSYQDQLAP 918
Query: 947 ALPQEISVNSTP 958
+PQEISVNSTP
Sbjct: 919 PMPQEISVNSTP 930
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|229335619|gb|ACQ57002.1| EDR1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1195 bits (3092), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 636/972 (65%), Positives = 737/972 (75%), Gaps = 73/972 (7%)
Query: 1 MRNIFKKLHIGSNHESNRTNETLAS--TTSCATDHNRTSSSSSNAAPPSPSASAATAAS- 57
M+NIFKKLHIGS+H+ +R+NE S + SC D +++S+++ + + ++++ +
Sbjct: 1 MKNIFKKLHIGSSHDPHRSNEASPSVPSPSCVADQSQSSAATPASPSSASASASTVVVTP 60
Query: 58 -----SPAPVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSLNN 112
+PV++ R D+ +SEEEFQVQLA+AISAS+S + EKDQI AATLLSL
Sbjct: 61 GGGGGGASPVMN---RQDFFSSEEEFQVQLALAISASNSEFREDPEKDQIHAATLLSLGG 117
Query: 113 RRSDLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLAHLE 172
R D R+K DVA E LSRQYWEYNVLDYEE+VVDGFYD+YG D QGK+PS LE
Sbjct: 118 HRIDSARNKDDVA-EALSRQYWEYNVLDYEEKVVDGFYDVYGPYNDSVMQGKMPSRTDLE 176
Query: 173 SNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPVK 232
+N G G E+VIVNRTID +LEEL+Q+AQCIALD P V LVQ+LA+LV HMGGPVK
Sbjct: 177 ANPG--GSELVIVNRTIDPSLEELIQIAQCIALDCP---VSSLVQRLAELVTSHMGGPVK 231
Query: 233 DANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSH 292
DA+IMLARW E EL+ SL T VLP+GS+NIGLSRHRALLFKVLAD+I +PCRLVKGSH
Sbjct: 232 DASIMLARWTETRAELKTSLHTIVLPLGSLNIGLSRHRALLFKVLADNINMPCRLVKGSH 291
Query: 293 YTGVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRTS 352
YTGVEDDAVNIIKLE+EREFLVDLMAAPGTLIPADILS KD+AFKPYNP I P L ++
Sbjct: 292 YTGVEDDAVNIIKLEDEREFLVDLMAAPGTLIPADILSTKDSAFKPYNPKI--WPSLPST 349
Query: 353 NDSGAVYSKP-KPLHAEGSSQNSTV-DGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSG 410
D+ YS+P +P H EGSSQNS V D SLP NG EK+E PS S + G S
Sbjct: 350 KDNEFSYSRPIQPSHGEGSSQNSVVKDYSLPWNGKPYFEKSE--PSNLGLSRDSGVGPSK 407
Query: 411 ISSRVTPNQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADL 470
I ++ TPNQ + L + + GTSLYKG G N VGDG R+NVNVVPY DS++LFADL
Sbjct: 408 IPNKGTPNQLENLPALS-GTSLYKGTLGMNTVGDGTRLNVNVVPYTNNSPNDSRNLFADL 466
Query: 471 NPFQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSY 530
NPFQIKG GK +H P E+K E +S + VSGRPP+P+M KN+H YNE PRK
Sbjct: 467 NPFQIKGMGKAPVHNKPVENKPPELKSTKNYAVSGRPPVPLMWKNRHAYNEDPRK----- 521
Query: 531 MEGILPKINREPN--NNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGP 588
N PN N ++ SS SE + S KP ++NI++ +
Sbjct: 522 -------TNHNPNEYNPPLFVSNGSSMSEIIDLSSSKPLYNSNINN---------DVNAQ 565
Query: 589 SLASSTSQLNGPPLVEDLSSNSKDENPKNVEDHEIGYHDRRKCTHDRFMGTNLKLRDLES 648
+LA T ++ P HD+R CT+DRFMG+NLKL+D ES
Sbjct: 566 TLAQVTGSVSPP------------------------NHDQRNCTYDRFMGSNLKLKDPES 601
Query: 649 PSSSVDSSTSKVDQIFDD-DVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKF 707
PSSS+DS T++VDQI DD DV ECEIPWEDLVLGERIG+GSYGEVYHADWNGTEVAVKKF
Sbjct: 602 PSSSIDSITNRVDQILDDVDVGECEIPWEDLVLGERIGIGSYGEVYHADWNGTEVAVKKF 661
Query: 708 LDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRP 767
LDQDFSGAAL EFKREV+IMRRLRHPN+VLFMGAVTRPPNLSII+E+LPRGSL+RILHRP
Sbjct: 662 LDQDFSGAALSEFKREVRIMRRLRHPNIVLFMGAVTRPPNLSIISEYLPRGSLYRILHRP 721
Query: 768 HCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826
+CQ+DEKRRIKMALD ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV DFGLSRLKH
Sbjct: 722 NCQIDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVCDFGLSRLKH 781
Query: 827 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGA 886
NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL+LPW GMNPMQVVGA
Sbjct: 782 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWSGMNPMQVVGA 841
Query: 887 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSS 946
VGFQNRRL+IPKE+DP+VARIIWECWQ DP+LRPSFAQLTVALKPLQRLVIPSH DQ +
Sbjct: 842 VGFQNRRLDIPKEVDPIVARIIWECWQQDPNLRPSFAQLTVALKPLQRLVIPSHHDQVAP 901
Query: 947 ALPQEISVNSTP 958
+PQEISVNSTP
Sbjct: 902 PMPQEISVNSTP 913
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356576743|ref|XP_003556489.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1186 bits (3067), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 634/974 (65%), Positives = 729/974 (74%), Gaps = 75/974 (7%)
Query: 1 MRNIFKKLHIGSNHESNRTNETLASTTS--CATDHNRTSSSSSNAAPPSPS--------A 50
M+NIFKKLHIGS+H+ +R+NE S CATD +++S+++ + +
Sbjct: 18 MKNIFKKLHIGSSHDPHRSNEPSPPVPSPSCATDQSQSSAATPPSPSSASPSPSPSTLVV 77
Query: 51 SAATAASSPAPVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSL 110
+ + +PVV+ R D+ +SEEEFQVQLA+AISAS+S + EKDQI AATLLSL
Sbjct: 78 TPSCGGGGASPVVN---RQDFFSSEEEFQVQLALAISASNSEFREDPEKDQIHAATLLSL 134
Query: 111 NNRRSDLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLAH 170
R D R+K DVA E LSRQYWEYNVLDYEE+VVDGFYD+YG D QGK+PS
Sbjct: 135 GGHRIDSTRNKDDVA-EALSRQYWEYNVLDYEEKVVDGFYDVYGPYNDSVMQGKMPSRTD 193
Query: 171 LESNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGP 230
LE+N G G E+VIVN+TID ALEEL+Q+AQCIALD P V LVQ+LA+LV HMGGP
Sbjct: 194 LEANPG--GSELVIVNQTIDPALEELIQIAQCIALDCP---VSSLVQRLAELVTSHMGGP 248
Query: 231 VKDANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKG 290
VKDA IMLARW E ELR SL T VLP+GS+NIGLSRHRALLFKVLAD+I +PCRL+KG
Sbjct: 249 VKDAGIMLARWTETRAELRTSLHTIVLPLGSLNIGLSRHRALLFKVLADNINMPCRLLKG 308
Query: 291 SHYTGVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILR 350
SHYTGVEDDAVNIIKLE EREFLVDLMAAPGTLIPADILS KD+AFK YNP I +P L
Sbjct: 309 SHYTGVEDDAVNIIKLEGEREFLVDLMAAPGTLIPADILSTKDSAFKSYNPKI--LPSLP 366
Query: 351 TSNDSGAVYSKP-KPLHAEGSSQNSTV-DGSLPLNGGSTSEKAESLPSFPSPSYEPGAAS 408
++ D+ YS+P +P H EGSSQNS + D SLP NG EK+E PS S E G
Sbjct: 367 STKDNEFSYSRPIQPFHGEGSSQNSVIKDYSLPWNGKPYFEKSE--PSNLGLSRESGTGP 424
Query: 409 SGISSRVTPNQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFA 468
S I ++ TPNQ D L + + G SLYKG G N VGDG R+NVNVVPY DS++LFA
Sbjct: 425 SKIPNKGTPNQLDNLPALS-GASLYKGTLGMNTVGDGTRLNVNVVPYTNISPNDSRNLFA 483
Query: 469 DLNPFQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEY 528
DLNPFQIKG GK +H P E+K E +S + N VSGRPP+P+M KN+ YNE PRK
Sbjct: 484 DLNPFQIKGMGKAPVHNKPVENKPPELKSTKNNTVSGRPPVPLMWKNRPAYNEDPRK--- 540
Query: 529 SYMEGILPKINREPN--NNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGS 586
N PN N ++ SSTSEN + S KP ++NI++ +
Sbjct: 541 ---------TNHNPNDYNPPLFVSNGSSTSENIDLSSSKPLYNSNINN---------DVN 582
Query: 587 GPSLASSTSQLNGPPLVEDLSSNSKDENPKNVEDHEIGYHDRRKCTHDRFMGTNLKLRDL 646
+LA T ++ P HD+RKCT+DRFMG+NLKL+D
Sbjct: 583 AQTLAQVTGSVSPP------------------------NHDQRKCTYDRFMGSNLKLKDP 618
Query: 647 ESPSSSVDSSTSKVDQIFDD-DVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVK 705
ESPSSS+DS T+++D I DD DV ECEIPWEDLVLGERIG+GSYGEVYHADWNGTEVAVK
Sbjct: 619 ESPSSSIDSITNRIDPILDDVDVGECEIPWEDLVLGERIGIGSYGEVYHADWNGTEVAVK 678
Query: 706 KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH 765
KFLDQDFSGAAL EFKREV+IMRRLRHPN+VLFMGAVTRPPNLSII+E+LPRGSL+RILH
Sbjct: 679 KFLDQDFSGAALSEFKREVRIMRRLRHPNIVLFMGAVTRPPNLSIISEYLPRGSLYRILH 738
Query: 766 RPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824
R + Q+DEKRRIKMALD ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV DFGLSRL
Sbjct: 739 RSNYQIDEKRRIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVCDFGLSRL 798
Query: 825 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV 884
KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL+LPW MN MQVV
Sbjct: 799 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWSEMNTMQVV 858
Query: 885 GAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQP 944
GAVGFQNRRL+IPKE+DP+VARIIWECWQ DP+LRPSFAQLTVALKPLQRLVIPSH DQ
Sbjct: 859 GAVGFQNRRLDIPKEVDPIVARIIWECWQQDPNLRPSFAQLTVALKPLQRLVIPSHHDQV 918
Query: 945 SSALPQEISVNSTP 958
+ +PQEISVNSTP
Sbjct: 919 APPMPQEISVNSTP 932
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|262213688|gb|ACY36006.1| EDR1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1178 bits (3047), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 627/964 (65%), Positives = 711/964 (73%), Gaps = 116/964 (12%)
Query: 1 MRNIFKKLHIGSNHESNRTNETLASTTSCATDHNRTSSSSSNAAPPSPSASAATAASSPA 60
M+NIFKKLHIGS+H+ +R+NE SPS
Sbjct: 18 MKNIFKKLHIGSSHDPHRSNEA------------------------SPS----------- 42
Query: 61 PVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSLNNRRSDLGRD 120
D+ +SEEEFQVQLA+AISAS+S + EKDQI AATLLSL R D R+
Sbjct: 43 ---------DFFSSEEEFQVQLALAISASNSEFREDPEKDQIHAATLLSLGGHRIDSARN 93
Query: 121 KADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLAHLESNLGNSGF 180
K DVA E LSRQYWEYNVLDYEE+VVDGFYD+YG D QGK+PS LE+N G G
Sbjct: 94 KDDVA-EALSRQYWEYNVLDYEEKVVDGFYDVYGPYNDSVMQGKMPSRTDLEANPG--GS 150
Query: 181 EVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPVKDANIMLAR 240
E+VIVNRTID +LEEL+Q+AQCIALD P V LVQ+LA+LV HMGGPVKDA+IMLAR
Sbjct: 151 ELVIVNRTIDPSLEELIQIAQCIALDCP---VSSLVQRLAELVTSHMGGPVKDASIMLAR 207
Query: 241 WMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDDA 300
W E EL+ SL T VLP+GS+NIGLSRHRALLFKVLAD+I +PCRLVKGSHYTGVEDDA
Sbjct: 208 WTETRAELKTSLHTIVLPLGSLNIGLSRHRALLFKVLADNINMPCRLVKGSHYTGVEDDA 267
Query: 301 VNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRTSNDSGAVYS 360
VNIIKLE+EREFLVDLMAAPGTLIPADILS KD+AFKPYNP I P L ++ D+ YS
Sbjct: 268 VNIIKLEDEREFLVDLMAAPGTLIPADILSTKDSAFKPYNPKI--WPSLPSTKDNEFSYS 325
Query: 361 KP-KPLHAEGSSQNSTV-DGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSGISSRVTPN 418
+P +P H EGSSQNS V D SLP NG EK + G S I ++ TPN
Sbjct: 326 RPIQPSHGEGSSQNSVVKDYSLPWNGKPYFEK------------DSGVGPSKIPNKGTPN 373
Query: 419 QSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADLNPFQIKGA 478
Q + L + + GTSLYKG G N VGDG R+NVNVVPY DS++LFADLNPFQIKG
Sbjct: 374 QLENLPALS-GTSLYKGTLGMNTVGDGTRLNVNVVPYTNNSPNDSRNLFADLNPFQIKGM 432
Query: 479 GKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYMEGILPKI 538
GK +H P E+K E +S + N VSGRPP+P+M KN+H YNE PRK
Sbjct: 433 GKAPVHNKPVENKPPELKSTKNNAVSGRPPVPLMWKNRHAYNEDPRK------------T 480
Query: 539 NREPN--NNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGPSLASSTSQ 596
N PN N ++ SS SE + S KP ++NI++ + +LA T
Sbjct: 481 NHNPNEYNPPLFVSNGSSMSEIIDLSSSKPLYNSNINN---------DVNAQTLAQVTGS 531
Query: 597 LNGPPLVEDLSSNSKDENPKNVEDHEIGYHDRRKCTHDRFMGTNLKLRDLESPSSSVDSS 656
++ P HD+R CT+DRFMG+NLKL+D ESPSSS+DS
Sbjct: 532 VSPP------------------------NHDQRNCTYDRFMGSNLKLKDPESPSSSIDSI 567
Query: 657 TSKVDQIFDD-DVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGA 715
T++VDQI DD DV ECEIPWEDLVLGERIG+GSYGEVYHADWNGTEVAVKKFLDQDFSGA
Sbjct: 568 TNRVDQILDDVDVGECEIPWEDLVLGERIGIGSYGEVYHADWNGTEVAVKKFLDQDFSGA 627
Query: 716 ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR 775
AL EFKREV+IMRRLRHPN+VLFMGAVTRPPNLSII+E+LPRGSL+RILHRP+CQ+DEKR
Sbjct: 628 ALSEFKREVRIMRRLRHPNIVLFMGAVTRPPNLSIISEYLPRGSLYRILHRPNCQIDEKR 687
Query: 776 RIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 834
RIKMALD ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV DFGLSRLKHNTFLSSKS
Sbjct: 688 RIKMALDVARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVCDFGLSRLKHNTFLSSKS 747
Query: 835 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL 894
TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL+LPW GMNPMQVVGAVGFQNRRL
Sbjct: 748 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWSGMNPMQVVGAVGFQNRRL 807
Query: 895 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQEISV 954
+IPKE+DP+VARIIWECWQ DP+LRPSFAQLTVALKPLQRLVIPS+ DQ + +PQEISV
Sbjct: 808 DIPKEVDPIVARIIWECWQQDPNLRPSFAQLTVALKPLQRLVIPSYQDQLAPPMPQEISV 867
Query: 955 NSTP 958
NSTP
Sbjct: 868 NSTP 871
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449435758|ref|XP_004135661.1| PREDICTED: LOW QUALITY PROTEIN: serine/threonine-protein kinase CTR1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1176 bits (3041), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 622/981 (63%), Positives = 740/981 (75%), Gaps = 69/981 (7%)
Query: 1 MRNIFKKLHIGSNHESNRTNE-----TLASTTSCATDHNRTSSSSSNAAPPSPSASAATA 55
M++IFKK HIGSNHE NR+NE AS++ C +D NR + + + PP+
Sbjct: 1 MKHIFKKFHIGSNHEPNRSNENPSPVAAASSSPCVSD-NRGGNVTQVSVPPN-------- 51
Query: 56 ASSPAPVVSSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSLNNRRS 115
R+DY +SEEEFQVQLA+AISAS+S+ D EKDQIRAATLLSL N R
Sbjct: 52 ------------RSDYFSSEEEFQVQLALAISASNSDFRDDPEKDQIRAATLLSLGNHRI 99
Query: 116 D-LGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLAHLESN 174
D RD+ D AAEVLSRQYWEYNVLDYEE+VV+GFYD+ LSTD + QGK+PSL+ +E++
Sbjct: 100 DSTARDQGD-AAEVLSRQYWEYNVLDYEEKVVNGFYDV--LSTDSAVQGKIPSLSDIEAS 156
Query: 175 LGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPVKDA 234
G+SGFEVV+VN TID ALEELVQ+AQCIA D P T+V +LVQ+LA+LV GHMGGPVKDA
Sbjct: 157 FGSSGFEVVMVNMTIDPALEELVQIAQCIA-DCPGTEVRVLVQRLAELVMGHMGGPVKDA 215
Query: 235 NIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSHYT 294
+ MLARWMERSTELR SL TSVLPIGSINIGLSRHRALLFKVLADSI++PCRLVKGSHYT
Sbjct: 216 HFMLARWMERSTELRTSLHTSVLPIGSINIGLSRHRALLFKVLADSIKMPCRLVKGSHYT 275
Query: 295 GVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTA-FKPYNPLISKIPILRTSN 353
GVE+DAVNIIKLE+EREFLVDLMAAPGTL+PADI +AKDT FKPYNP +S+IP L SN
Sbjct: 276 GVEEDAVNIIKLEDEREFLVDLMAAPGTLLPADIFNAKDTTNFKPYNPKVSRIPSLHHSN 335
Query: 354 DSGAVYSKPKPLHAEGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSGISS 413
D G +KP EGSSQN + ++G + ES+PS SSG++
Sbjct: 336 DVGISSAKPTSGLEEGSSQNFGAEAISLMDGKLGYGRTESVPS-----------SSGVTC 384
Query: 414 RVTPNQSDYLSSSTIGTSLYKGGRGPNAVGDG-ARMNVNVVPYGQTGQEDSKSLFADLNP 472
+ + LS GTS YKG GDG R+NVNVVP+GQ+ EDSK+LFADLNP
Sbjct: 385 XINSRLMENLSLLGTGTSRYKGAH----FGDGNVRLNVNVVPFGQS-SEDSKNLFADLNP 439
Query: 473 FQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYME 532
F I+G GK+ + +++K EE Q P G PP+P+ KN+ +N VP K EY YME
Sbjct: 440 FLIRGTGKSFIPNKFSDNKSEELQK----PTIGHPPVPLW-KNRFAFNAVPNKNEYDYME 494
Query: 533 GILPKINREPNN-NLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGPSLA 591
G P+I+R PN+ N++ S+S S+ SE+ P SND + S + +E S+ S A
Sbjct: 495 GRFPRISRGPNDQNMALSSSNSTGSESVKPGGSGTSNDLSASVRSAEVGSSSSNMYAQPA 554
Query: 592 SSTSQLNGPPLVEDLSSNSKDENPKNVE------------DHEIGYHDRRKCTHDRFMGT 639
+ N P +++ + S E+ N + D+ I + +RRK T++R +GT
Sbjct: 555 FGMMEPNILPFIDEQNRKSNGEHSGNTDMEDEKVDAVDGRDNLIRFDNRRKFTYERSVGT 614
Query: 640 NLKLRDLESPSSSVDSSTSKVDQIFDD-DVCECEIPWEDLVLGERIGLGSYGEVYHADWN 698
NL L+D +P V+ S+++ +Q++DD DV +CEI WEDLV+GERIGLGSYGEVYHADWN
Sbjct: 615 NLILKDSGNPGLLVNPSSNRFEQVYDDVDVGQCEIQWEDLVIGERIGLGSYGEVYHADWN 674
Query: 699 GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758
TEVAVKKFLDQDFSGAAL EFKREV IMR+LRHPN+VLFMGAVTRPPNLSI+TEFLPRG
Sbjct: 675 DTEVAVKKFLDQDFSGAALAEFKREVLIMRQLRHPNIVLFMGAVTRPPNLSIVTEFLPRG 734
Query: 759 SLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVS 817
SL+RI+HRP+CQ+DEKRRIKMALD ARGMNCLHTS PTIVHRDLKSPNLLVDKNWNVKVS
Sbjct: 735 SLYRIIHRPNCQIDEKRRIKMALDVARGMNCLHTSNPTIVHRDLKSPNLLVDKNWNVKVS 794
Query: 818 DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG 877
DFGLSRLKHNTFLSSKST GTPEWMAPEVLRNEPSNEKCDVYSFG+ILWELATL+LPW G
Sbjct: 795 DFGLSRLKHNTFLSSKSTGGTPEWMAPEVLRNEPSNEKCDVYSFGIILWELATLRLPWSG 854
Query: 878 MNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVI 937
MNPMQVVGAVGF+N+RLEIPKE+DP VARIIWECWQTDP+LRPSF+QL LKPLQRLV+
Sbjct: 855 MNPMQVVGAVGFRNQRLEIPKEVDPTVARIIWECWQTDPNLRPSFSQLANILKPLQRLVL 914
Query: 938 PSHPDQPSSALPQEISVNSTP 958
P H DQPSS++ QEISVNSTP
Sbjct: 915 PPHSDQPSSSVLQEISVNSTP 935
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|298204924|emb|CBI34231.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1161 bits (3004), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 619/966 (64%), Positives = 713/966 (73%), Gaps = 110/966 (11%)
Query: 1 MRNIFKKLHIGSN-HESNRTNETLASTTS----CATDHNRTSSSSSNAAPPSPSASAATA 55
M++IFKKLHIGS+ H+ NR+NETL+S T+ CA+DH RTSS+ S+ +PPS S T
Sbjct: 1 MKHIFKKLHIGSSSHDPNRSNETLSSATTSSPACASDH-RTSSAQSSVSPPSSYPSPTTV 59
Query: 56 ASSPAPVV------SSGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLS 109
+S+ A + ++ +R+DY SEEEFQVQLA+AISAS+S+ D SEKDQIRAATLLS
Sbjct: 60 SSTAASTLPTATSPAASNRSDYFLSEEEFQVQLALAISASNSDFRDDSEKDQIRAATLLS 119
Query: 110 LNNRRSDLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLA 169
L R+D RDK D +AE +SR+YW+YNVLDYEE+VVDGFYD+YGLSTDP QGK+PSL
Sbjct: 120 LGRHRTDSVRDK-DESAESMSRRYWDYNVLDYEEKVVDGFYDVYGLSTDPVIQGKMPSLT 178
Query: 170 HLESNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGG 229
LE+NLGNSGFEV++VNR ID ALEELVQVA CIALD PA +VG+LVQ+LA++V HMGG
Sbjct: 179 DLETNLGNSGFEVIVVNRRIDPALEELVQVAHCIALDCPAAEVGVLVQRLAEIVTDHMGG 238
Query: 230 PVKDANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVK 289
PV+DANIML +WME +LR SL TS+LP+GS++IGLSRHRALLFK+LAD++ +PCRLVK
Sbjct: 239 PVRDANIMLVKWMESRKDLRTSLHTSILPVGSLSIGLSRHRALLFKILADNVGVPCRLVK 298
Query: 290 GSHYTGVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPIL 349
GSHYTGVEDDAVNIIKL+ EREFLVDLM APGTLIPADILSAKD+
Sbjct: 299 GSHYTGVEDDAVNIIKLDNEREFLVDLMGAPGTLIPADILSAKDS--------------- 343
Query: 350 RTSNDSGAVYSKPKPLHAEGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAASS 409
SSQ ST++ SLP + ++SEK ESL SF S S + G +S
Sbjct: 344 --------------------SSQTSTIENSLPQDRKASSEKIESLDSFSSSSGDTGVGTS 383
Query: 410 GISSRVTP-NQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFA 468
IS RVTP NQSD S IG S+YKG RG NAVGDG+RMNVN+VPY Q ED K+LFA
Sbjct: 384 RISKRVTPVNQSDLRPSLAIGASVYKGSRGANAVGDGSRMNVNIVPYNQNSTEDPKNLFA 443
Query: 469 DLNPFQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEY 528
DLNPFQ+ G+ K S P E+KV+EFQ + S P
Sbjct: 444 DLNPFQMIGSSKASAQSKPMENKVDEFQREK---NSAAP--------------------- 479
Query: 529 SYMEGILPKINREPNNNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGP 588
+N + N++ +T++ + ++ FN S +AN + K
Sbjct: 480 ---------VNDDQNSSCNTTSMLAPSTSQFNRLSLDEDVNANYNEK------------- 517
Query: 589 SLASSTSQLNGPPLVEDLSSNSKDENPKNVEDHEIGYHDRRKCTHDRFMGTNLKLRDLES 648
+G D+ +K E+ KN E G HD RK HD FM N LR+ ES
Sbjct: 518 ------YHKDGKVFQSDMVDAAK-EHDKN----ETGLHDHRKFRHDSFMENN--LREAES 564
Query: 649 PSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFL 708
P SSVDS KVDQ+F +DV ECEIPWEDLVLGERIGLGSYGEVYH DWNGTEVAVKKFL
Sbjct: 565 PCSSVDSDAGKVDQMF-EDVGECEIPWEDLVLGERIGLGSYGEVYHGDWNGTEVAVKKFL 623
Query: 709 DQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH 768
DQDFSGAAL EFKREV+IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL+RILHRP
Sbjct: 624 DQDFSGAALAEFKREVRIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLYRILHRPS 683
Query: 769 CQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827
CQ+DEKRRIKMALD A+GMNCLHTS PTIVHRDLKSPNLLVDKNWNVKV DFGLSRLKHN
Sbjct: 684 CQIDEKRRIKMALDVAKGMNCLHTSLPTIVHRDLKSPNLLVDKNWNVKVCDFGLSRLKHN 743
Query: 828 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV 887
TFLSSKSTAGTPEWMAPEVLRNE SNEKCDVYSFG+ILWELATL+LPW GMNPMQVVGAV
Sbjct: 744 TFLSSKSTAGTPEWMAPEVLRNENSNEKCDVYSFGIILWELATLRLPWSGMNPMQVVGAV 803
Query: 888 GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSA 947
GFQNRRL+IPKE+DPLVARIIWECWQTDP+LRPSFAQLTVALKPLQRLVIP H DQ S
Sbjct: 804 GFQNRRLDIPKEVDPLVARIIWECWQTDPNLRPSFAQLTVALKPLQRLVIPQHLDQQSLT 863
Query: 948 LPQEIS 953
L QEIS
Sbjct: 864 LQQEIS 869
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 958 | ||||||
| TAIR|locus:2025515 | 933 | EDR1 "ENHANCED DISEASE RESISTA | 0.949 | 0.975 | 0.562 | 3e-266 | |
| TAIR|locus:2143009 | 880 | AT5G11850 [Arabidopsis thalian | 0.294 | 0.320 | 0.756 | 6.3e-179 | |
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.298 | 0.277 | 0.717 | 1e-170 | |
| TAIR|locus:2194055 | 992 | AT1G18160 [Arabidopsis thalian | 0.286 | 0.276 | 0.720 | 7.6e-161 | |
| TAIR|locus:2144613 | 821 | CTR1 "CONSTITUTIVE TRIPLE RESP | 0.280 | 0.327 | 0.643 | 8.1e-125 | |
| TAIR|locus:2084314 | 773 | AT3G06620 [Arabidopsis thalian | 0.286 | 0.354 | 0.602 | 3.2e-88 | |
| TAIR|locus:2127228 | 736 | AT4G23050 [Arabidopsis thalian | 0.275 | 0.358 | 0.611 | 2.9e-87 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.284 | 0.356 | 0.595 | 7.7e-87 | |
| TAIR|locus:2084304 | 671 | AT3G06630 [Arabidopsis thalian | 0.263 | 0.375 | 0.623 | 2.7e-84 | |
| TAIR|locus:2052786 | 775 | AT2G31010 [Arabidopsis thalian | 0.260 | 0.322 | 0.482 | 6.6e-83 |
| TAIR|locus:2025515 EDR1 "ENHANCED DISEASE RESISTANCE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2561 (906.6 bits), Expect = 3.0e-266, P = 3.0e-266
Identities = 540/960 (56%), Positives = 653/960 (68%)
Query: 1 MRNIFKKLHIGSNHES-NRTNETLASTTSCATDHNRXXXXXX------XXXXXXXXXXXX 53
M++IFKKLH G N E NRTN+ A+ S D NR
Sbjct: 1 MKHIFKKLHRGGNQEQQNRTND--AAPPS---DQNRIHVSANPPQATPSSVTETLPVAGA 55
Query: 54 XXXXXXXXXXXXGSRTDYMTSEEEFQVQLAMAISASSSNPEDFSEKDQIRAATLLSL-NN 112
+R DYM+SEEE+QVQLA+AISAS+S + EK QIRAATLLSL ++
Sbjct: 56 TSSMASPAPTAASNRADYMSSEEEYQVQLALAISASNSQSSEDPEKHQIRAATLLSLGSH 115
Query: 113 RRSDLGRDKADVAAEVLSRQYWEYNVLDYEERVVDGFYDIYGLSTDPSTQGKLPSLAHLE 172
+R D RD ++V A+ LSRQYWEY VLDYEE+VVD FYD+Y LSTD + QG++PSL LE
Sbjct: 116 QRMDSRRDSSEVVAQRLSRQYWEYGVLDYEEKVVDSFYDVYSLSTDSAKQGEMPSLEDLE 175
Query: 173 SNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPVK 232
SN G GFE V+VNR ID +L EL+++A+CIAL T V +LVQ+LA+LV HMGG +
Sbjct: 176 SNHGTPGFEAVVVNRPIDSSLHELLEIAECIALGCSTTSVSVLVQRLAELVTEHMGGSAE 235
Query: 233 DANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSH 292
D++I+LARW E+S+E + +L T V PIG + IG+SRHRALLFKVLADS+RLPCRLVKGSH
Sbjct: 236 DSSIVLARWTEKSSEFKAALNTCVFPIGFVKIGISRHRALLFKVLADSVRLPCRLVKGSH 295
Query: 293 YTGVEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRTS 352
YTG EDDAVN I+LE+ERE+LVDLM PGTLIPAD SA + +P N +K P + S
Sbjct: 296 YTGNEDDAVNTIRLEDEREYLVDLMTDPGTLIPADFASASNNTVEPCNSNGNKFPTAQFS 355
Query: 353 NDSGAVYSKPKPLHAEGSSQNSTVDGSLPLNGGSTSEKAESLPSFPSPSYEPGAASSGIS 412
ND PK EGSS +S + S L+ + +E+ +S S+P S S
Sbjct: 356 NDV------PKLSEGEGSSHSSMANYSSSLDRRTEAERTDS--SYPKVGPLRNIDYSSPS 407
Query: 413 SRVTPNQSDYLSSSTIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQEDSKSLFADLNP 472
S + Q + SS+ IG KG RG A+ + +R N+N+VPY Q +ED K+LFADLNP
Sbjct: 408 SVTSSTQLENNSSTAIG----KGSRG--AIIECSRTNMNIVPYNQNSEEDPKNLFADLNP 461
Query: 473 FQIKGAGKTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYME 532
FQ KGA K + + V++F + NP+ GR P PMM KN + NE P++KE SY+E
Sbjct: 462 FQNKGADKLYMPTKSGLNNVDDFHQQKNNPLVGRSPAPMMWKN-YSCNEAPKRKENSYIE 520
Query: 533 GILPKINREPNNNLXXXXXXXXXXENFNPHSFKPSNDANISSKDXXXXXXXXXXXXXXXX 592
+LPK++R+P ++ S + +N+ +D
Sbjct: 521 NLLPKLHRDPRYG--------NTQSSYATSSSNGAISSNVHGRDNVTFVSPVAVPSSFTS 572
Query: 593 XXXQLNGPPLVEDLSSNSKDE---NPKNV------EDHEIGYHDRRKCTHDRFM-GTNLK 642
Q P +VED++ N+ +E P ++ E HD RK T D G + +
Sbjct: 573 TENQFR-PSIVEDMNRNTNNELDLQPHTAAVVHGQQNDESHIHDHRKYTSDDISTGCDPR 631
Query: 643 LRDLEXXXXXXXXXXXKVD-QIFDD-DVCECEIPWEDLVLGERIGLGSYGEVYHADWNGT 700
L+D E + D Q+ DD DV ECEIPW DLV+ ERIGLGSYGEVYHADW+GT
Sbjct: 632 LKDHESTSSSLDSTSYRNDPQVLDDADVGECEIPWNDLVIAERIGLGSYGEVYHADWHGT 691
Query: 701 EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 760
EVAVKKFLDQDFSGAAL EF+ EV+IMRRLRHPNVV F+GAVTRPPNLSI+TEFLPRGSL
Sbjct: 692 EVAVKKFLDQDFSGAALAEFRSEVRIMRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGSL 751
Query: 761 FRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 819
+RILHRP +DE+RRIKMALD A GMNCLHTSTPTIVHRDLK+PNLLVD NWNVKV DF
Sbjct: 752 YRILHRPKSHIDERRRIKMALDVAMGMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDF 811
Query: 820 GLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN 879
GLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL+LPW GMN
Sbjct: 812 GLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWRGMN 871
Query: 880 PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPS 939
PMQVVGAVGFQNRRLEIPKELDP+V RII ECWQTDP+LRPSFAQLT LKPL RLV+P+
Sbjct: 872 PMQVVGAVGFQNRRLEIPKELDPVVGRIILECWQTDPNLRPSFAQLTEVLKPLNRLVLPT 931
|
|
| TAIR|locus:2143009 AT5G11850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1136 (405.0 bits), Expect = 6.3e-179, Sum P(2) = 6.3e-179
Identities = 214/283 (75%), Positives = 246/283 (86%)
Query: 667 DVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKI 726
+ + EI WEDL +GERIG+GSYGEVY A+WNGTEVAVKKFLDQDFSG AL +FK E++I
Sbjct: 598 EAAKWEIMWEDLQIGERIGIGSYGEVYRAEWNGTEVAVKKFLDQDFSGDALTQFKSEIEI 657
Query: 727 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARG 785
M RLRHPNVVLFMGAVTRPPN SI+TEFLPRGSL+R+LHRP+ Q+DEKRR++MALD A+G
Sbjct: 658 MLRLRHPNVVLFMGAVTRPPNFSILTEFLPRGSLYRLLHRPNHQLDEKRRMRMALDVAKG 717
Query: 786 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 845
MN LHTS PT+VHRDLKSPNLLVDKNW VKV DFGLSR+KH+T+LSSKSTAGTPEWMAPE
Sbjct: 718 MNYLHTSHPTVVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHHTYLSSKSTAGTPEWMAPE 777
Query: 846 VLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 905
VLRNEP+NEKCDVYSFGVILWELAT ++PW G+NPMQVVGAVGFQNRRLEIP ++D VA
Sbjct: 778 VLRNEPANEKCDVYSFGVILWELATSRVPWKGLNPMQVVGAVGFQNRRLEIPDDIDLTVA 837
Query: 906 RIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSAL 948
+II ECWQT+P LRPSF QL +LK LQ L I + + S +
Sbjct: 838 QIIRECWQTEPHLRPSFTQLMQSLKRLQGLNISNRANTSESLM 880
|
|
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1108 (395.1 bits), Expect = 1.0e-170, Sum P(4) = 1.0e-170
Identities = 208/290 (71%), Positives = 249/290 (85%)
Query: 666 DDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVK 725
DDV +CEI WE++ +GERIGLGSYGEVY DW+GTEVAVKKFLDQD +G AL EF+ EV+
Sbjct: 736 DDVSDCEILWEEITVGERIGLGSYGEVYRGDWHGTEVAVKKFLDQDLTGEALEEFRSEVR 795
Query: 726 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDA-R 784
IM++LRHPN+VLFMGAVTRPPNLSI+TEFLPRGSL+R++HRP+ Q+DE+RR++MALDA R
Sbjct: 796 IMKKLRHPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQLDERRRLRMALDAAR 855
Query: 785 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 844
GMN LH+ P IVHRDLKSPNLLVDKNW VKV DFGLSR+KH+T+LSSKSTAGT EWMAP
Sbjct: 856 GMNYLHSCNPMIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHSTYLSSKSTAGTAEWMAP 915
Query: 845 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 904
EVLRNEP++EKCDVYS+GVILWEL TL+ PW MNPMQVVGAVGFQ+RRL+IP +DP +
Sbjct: 916 EVLRNEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPDFVDPAI 975
Query: 905 ARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQP---SSALPQE 951
A +I +CWQTD LRPSFA++ +LK LQ+ V S+ +P SS+LP E
Sbjct: 976 ADLISKCWQTDSKLRPSFAEIMASLKRLQKPVTGSNIPRPVPSSSSLPTE 1025
|
|
| TAIR|locus:2194055 AT1G18160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1079 (384.9 bits), Expect = 7.6e-161, Sum P(2) = 7.6e-161
Identities = 201/279 (72%), Positives = 240/279 (86%)
Query: 666 DDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVK 725
DDV ECEI WE++ + ERIGLGSYGEVY DW+GT VAVKKF+DQD +G AL EF+ EV+
Sbjct: 703 DDVAECEILWEEITVAERIGLGSYGEVYRGDWHGTAVAVKKFIDQDITGEALEEFRSEVR 762
Query: 726 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDA-R 784
+MRRLRHPN+VLFMGAVTRPPNLSI+TEFLPRGSL+R++HRP+ Q+DE++R++MALDA R
Sbjct: 763 MMRRLRHPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQLDERKRLRMALDAAR 822
Query: 785 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 844
GMN LH+ P IVHRDLKSPNLLVDKNW VKV DFGLSR+K +T+LSSKSTAGT EWMAP
Sbjct: 823 GMNYLHSCNPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKVSTYLSSKSTAGTAEWMAP 882
Query: 845 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 904
EVLRNEP++EKCDVYS+GVILWEL TL+ PW MNPMQVVGAVGFQ+RRL+IP+ +DP +
Sbjct: 883 EVLRNEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPEFVDPGI 942
Query: 905 ARIIWECWQTDPSLRPSFAQLTVALK----PLQRLVIPS 939
A II +CWQTDP LRPSF ++ +LK P+QR +PS
Sbjct: 943 ADIIRKCWQTDPRLRPSFGEIMDSLKQLQKPIQRAAVPS 981
|
|
| TAIR|locus:2144613 CTR1 "CONSTITUTIVE TRIPLE RESPONSE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 908 (324.7 bits), Expect = 8.1e-125, Sum P(2) = 8.1e-125
Identities = 175/272 (64%), Positives = 214/272 (78%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRR 729
+ +IPW DL + E+IG GS+G V+ A+W+G++VAVK ++QDF + EF REV IM+R
Sbjct: 543 DMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKR 602
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHC--QVDEKRRIKMALD-ARGM 786
LRHPN+VLFMGAVT+PPNLSI+TE+L RGSL+R+LH+ Q+DE+RR+ MA D A+GM
Sbjct: 603 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 662
Query: 787 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 846
N LH P IVHRDLKSPNLLVDK + VKV DFGLSRLK +TFLSSKS AGTPEWMAPEV
Sbjct: 663 NYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEV 722
Query: 847 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 906
LR+EPSNEK DVYSFGVILWELATL+ PW +NP QVV AVGF+ +RLEIP+ L+P VA
Sbjct: 723 LRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAA 782
Query: 907 IIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 938
II CW +P RPSFA + L+PL + +P
Sbjct: 783 IIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 814
|
|
| TAIR|locus:2084314 AT3G06620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 881 (315.2 bits), Expect = 3.2e-88, P = 3.2e-88
Identities = 167/277 (60%), Positives = 212/277 (76%)
Query: 659 KVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALL 718
KVD D + E EI W+DL +GE++G GS G VYH W G++VAVK F Q++S +
Sbjct: 477 KVDT--DSEGLEYEILWDDLTIGEQVGQGSCGTVYHGLWFGSDVAVKVFSKQEYSAEVIE 534
Query: 719 EFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK 778
FK+EV +M+RLRHPNV+LFMGAVT P L I++EFLPRGSLFR+L + ++D +RRI
Sbjct: 535 SFKQEVLLMKRLRHPNVLLFMGAVTSPQRLCIVSEFLPRGSLFRLLQKSTSKLDWRRRIH 594
Query: 779 MALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 837
MALD ARGMN LH +P I+HRDLKS NLLVDKNW VKV+DFGLSR+KH T+L+SKS G
Sbjct: 595 MALDIARGMNYLHHCSPPIIHRDLKSSNLLVDKNWTVKVADFGLSRIKHETYLTSKSGKG 654
Query: 838 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 897
TP+WMAPEVLRNE ++EK D+YSFGV+LWELAT K+PW +N MQV+GAVGF ++RLEIP
Sbjct: 655 TPQWMAPEVLRNESADEKSDIYSFGVVLWELATEKIPWETLNSMQVIGAVGFMDQRLEIP 714
Query: 898 KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934
K++DP ++ CW +D LRP+F +L L+ LQR
Sbjct: 715 KDIDPRWISLMESCWHSDTKLRPTFQELMDKLRDLQR 751
|
|
| TAIR|locus:2127228 AT4G23050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 872 (312.0 bits), Expect = 2.9e-87, P = 2.9e-87
Identities = 162/265 (61%), Positives = 204/265 (76%)
Query: 671 CEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
CEI WEDL LGE +G GS+ V+ WNG++VA+K + D D++ L E K+E+ IM++L
Sbjct: 461 CEIRWEDLQLGEEVGRGSFAAVHRGVWNGSDVAIKVYFDGDYNAMTLTECKKEINIMKKL 520
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCL 789
RHPNV+LFMGAV +II E++PRGSLF+ILH + +D+KRR++MALD ARGMN L
Sbjct: 521 RHPNVLLFMGAVCTEEKSAIIMEYMPRGSLFKILHNTNQPLDKKRRLRMALDVARGMNYL 580
Query: 790 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 849
H P IVHRDLKS NLLVDKNWNVKV DFGLS+ K+ TFLS+KS GTP+WMAPEVLR+
Sbjct: 581 HRRNPPIVHRDLKSSNLLVDKNWNVKVGDFGLSKWKNATFLSTKSGKGTPQWMAPEVLRS 640
Query: 850 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 909
EPSNEKCDV+SFGVILWEL T +PW +N +QVVG VGF +RRL++P+ L+P +A II
Sbjct: 641 EPSNEKCDVFSFGVILWELMTTLVPWDRLNSIQVVGVVGFMDRRLDLPEGLNPRIASIIQ 700
Query: 910 ECWQTDPSLRPSFAQLTVALKPLQR 934
+CWQTDP+ RPSF +L + L R
Sbjct: 701 DCWQTDPAKRPSFEELISQMMSLFR 725
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 868 (310.6 bits), Expect = 7.7e-87, P = 7.7e-87
Identities = 165/277 (59%), Positives = 207/277 (74%)
Query: 659 KVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALL 718
KVD D D + EI WEDL +GE+IG GS G VYH W G++VAVK F Q++S +
Sbjct: 470 KVDM--DSDCLDYEILWEDLTIGEQIGQGSCGTVYHGLWFGSDVAVKVFSKQEYSEEIIT 527
Query: 719 EFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK 778
FK+EV +M+RLRHPNV+LFMGAV P L I+TEFLPRGSLFR+L R ++D +RRI
Sbjct: 528 SFKQEVSLMKRLRHPNVLLFMGAVASPQRLCIVTEFLPRGSLFRLLQRNKSKLDLRRRIH 587
Query: 779 MALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 837
MA D ARGMN LH +P I+HRDLKS NLLVD+NW VKV+DFGLSR+KH T+L++ G
Sbjct: 588 MASDIARGMNYLHHCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHETYLTTNGR-G 646
Query: 838 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 897
TP+WMAPEVLRNE ++EK DVYSFGV+LWEL T K+PW +N MQV+GAVGF N+RLE+P
Sbjct: 647 TPQWMAPEVLRNEAADEKSDVYSFGVVLWELVTEKIPWENLNAMQVIGAVGFMNQRLEVP 706
Query: 898 KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934
K++DP ++ CW ++P RPSF +L L+ LQR
Sbjct: 707 KDVDPQWIALMESCWHSEPQCRPSFQELMDKLRELQR 743
|
|
| TAIR|locus:2084304 AT3G06630 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 844 (302.2 bits), Expect = 2.7e-84, P = 2.7e-84
Identities = 159/255 (62%), Positives = 198/255 (77%)
Query: 659 KVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALL 718
KVD D D E EI W+DL +GE+IG GS G VYH W G++VAVK F Q++S + +
Sbjct: 417 KVD--IDSDPLEHEILWDDLTIGEQIGRGSCGTVYHGIWFGSDVAVKVFSKQEYSESVIK 474
Query: 719 EFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK 778
F++EV +M+RLRHPNV+LFMGAVT P L I++EF+PRGSLFR+L R ++D +RRI
Sbjct: 475 SFEKEVSLMKRLRHPNVLLFMGAVTSPQRLCIVSEFVPRGSLFRLLQRSMSKLDWRRRIN 534
Query: 779 MALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 837
MALD ARGMN LH +P I+HRDLKS NLLVD+NW VKV+DFGLSR+KH T+L+SKS G
Sbjct: 535 MALDIARGMNYLHCCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHQTYLTSKSGKG 594
Query: 838 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 897
TP+WMAPEVLRNE ++EK D+YSFGV+LWELAT K+PW +N MQV+GAVGF N+RLEIP
Sbjct: 595 TPQWMAPEVLRNESADEKSDIYSFGVVLWELATEKIPWENLNSMQVIGAVGFMNQRLEIP 654
Query: 898 KELDPLVARIIWECW 912
K+ DP +I CW
Sbjct: 655 KDTDPDWISLIESCW 669
|
|
| TAIR|locus:2052786 AT2G31010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 655 (235.6 bits), Expect = 6.6e-83, Sum P(3) = 6.6e-83
Identities = 125/259 (48%), Positives = 180/259 (69%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRR 729
E +I + +L +G R+G+G +GEV+ WNGT+VA+K FL+QD + + +F E+ I+ R
Sbjct: 511 EWDIDFSELTVGTRVGIGFFGEVFRGVWNGTDVAIKLFLEQDLTAENMEDFCNEISILSR 570
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRP--HCQVDEKRRIKMALD-ARGM 786
+RHPNVVLF+GA T+PP LS+ITE++ GSL+ ++H ++ RR++M D RG+
Sbjct: 571 VRHPNVVLFLGACTKPPRLSMITEYMELGSLYYLIHMSGQKKKLSWHRRLRMLRDICRGL 630
Query: 787 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 846
C+H IVHRDLKS N LVDK+W VK+ DFGLSR+ + + S+AGTPEWMAPE+
Sbjct: 631 MCIHRMK--IVHRDLKSANCLVDKHWTVKICDFGLSRIMTDENMKDTSSAGTPEWMAPEL 688
Query: 847 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 906
+RN P EKCD++S GVI+WEL+TL+ PW G+ P +VV AV + RLEIP PL ++
Sbjct: 689 IRNRPFTEKCDIFSLGVIMWELSTLRKPWEGVPPEKVVFAVAHEGSRLEIPD--GPL-SK 745
Query: 907 IIWECWQTDPSLRPSFAQL 925
+I +CW +P RP+ ++
Sbjct: 746 LIADCW-AEPEERPNCEEI 763
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9FPR3 | EDR1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5841 | 0.9478 | 0.9732 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.00130329 | SubName- Full=Putative uncharacterized protein; (967 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 958 | |||
| pfam14381 | 203 | pfam14381, EDR1, Ethylene-responsive protein kinas | 4e-99 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-71 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-69 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-68 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-62 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-61 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-59 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-58 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-55 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-48 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-46 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-46 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-45 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-45 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-43 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-43 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-42 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-42 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-41 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-41 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-39 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-39 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-39 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-39 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-39 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-39 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-39 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-38 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-38 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-38 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-38 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-37 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-37 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-37 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-36 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-36 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-35 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-35 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-35 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-35 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-35 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-34 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-34 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-34 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-33 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-33 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-33 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-33 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-33 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-32 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-32 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-32 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-32 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-32 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-31 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-31 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-31 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-31 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-31 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-31 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-30 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-30 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-30 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-30 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-30 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-30 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-30 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-30 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-29 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-29 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-29 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-29 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-29 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-29 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-29 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-29 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-29 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-29 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-28 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-28 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-28 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-28 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-28 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-28 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-28 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-28 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-28 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-27 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-27 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-27 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-27 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-27 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-27 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-27 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-26 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-26 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-26 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-26 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-26 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-26 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-26 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-25 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-25 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-25 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-25 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-25 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-25 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-25 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-25 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-24 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-24 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-24 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-24 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-23 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-23 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-23 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-23 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-23 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-22 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-22 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-22 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-22 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-22 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-21 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-21 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-21 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-21 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-21 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-20 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-20 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-20 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-20 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-20 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-20 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-20 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-20 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-19 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-19 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-19 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-19 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-19 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-19 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-19 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-18 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-18 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-18 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-18 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-18 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-18 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-18 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-18 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-18 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-17 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-17 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-17 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-17 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-17 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-17 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-16 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-16 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-16 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-16 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-16 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-16 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-15 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-15 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-15 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-15 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-15 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-15 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-15 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 9e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-14 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-14 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-14 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-14 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-14 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-13 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-12 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-12 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-11 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-11 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-10 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 9e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 9e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.002 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.002 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.002 |
| >gnl|CDD|222722 pfam14381, EDR1, Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Score = 309 bits (793), Expect = 4e-99
Identities = 114/206 (55%), Positives = 146/206 (70%), Gaps = 6/206 (2%)
Query: 123 DVAAEVLSRQYWEYNVLDYEERVVDGFYDIYG--LSTDPSTQGKLPSLAHLES-NLGNSG 179
+AE LS +YW Y L Y++++ DGFYDIYG +D G++PSL L++ G+S
Sbjct: 1 RSSAEALSHRYWVYGCLSYDDKIPDGFYDIYGMDPCSDLKEFGRIPSLEDLQAVPPGDSS 60
Query: 180 FEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPVKDANIMLA 239
FEVV+V+R D L+EL Q+A+C+ T+ LVQ+LA LV+ HMGGPVKDA MLA
Sbjct: 61 FEVVLVDRRTDPKLKELEQLARCLVSGCG-TNTAALVQKLAGLVSDHMGGPVKDAESMLA 119
Query: 240 RWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDD 299
RW E S EL+ + V+P+GS+ IGL RHRALLFKVLADSI LPCRLVKG Y G +DD
Sbjct: 120 RWKECSNELKE--NSGVVPLGSLKIGLCRHRALLFKVLADSIGLPCRLVKGCKYCGSDDD 177
Query: 300 AVNIIKLEEEREFLVDLMAAPGTLIP 325
A N++K ++ RE+LVDLM APGTLIP
Sbjct: 178 ASNLVKFDDGREYLVDLMGAPGTLIP 203
|
EDR1 regulates disease resistance and ethylene-induced senescence, and is also involved in stress response signalling and cell death regulation. Length = 203 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 236 bits (604), Expect = 3e-71
Identities = 99/258 (38%), Positives = 145/258 (56%), Gaps = 14/258 (5%)
Query: 678 LVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
L LG+++G G++GEVY G T+VAVK L + S EF E IM++L
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKT-LKEGASEEEREEFLEEASIMKKLS 59
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLH 790
HPN+V +G T+ L I+TE++P G L L + ++ K ++MAL A+GM L
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 791 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG-TP-EWMAPEVLR 848
+ VHRDL + N LV +N VK+SDFGLSR + K G P +WMAPE L+
Sbjct: 120 SK--NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 849 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 907
+ K DV+SFGV+LWE+ TL + P+ GM+ +V+ + RL P+ + +
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL-EDGYRLPRPENCPDELYEL 236
Query: 908 IWECWQTDPSLRPSFAQL 925
+ +CW DP RP+F++L
Sbjct: 237 MLQCWAYDPEDRPTFSEL 254
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 230 bits (590), Expect = 2e-69
Identities = 100/263 (38%), Positives = 140/263 (53%), Gaps = 17/263 (6%)
Query: 678 LVLGERIGLGSYGEVYHADWNGT------EVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
L LG+++G G++GEVY G EVAVK L +D S + EF RE +IMR+L
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKT-LKEDASEQQIEEFLREARIMRKLD 59
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLH 790
HPNVV +G T L I+ E++ G L L + ++ + AL ARGM L
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 791 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE---WMAPEVL 847
S +HRDL + N LV +N VK+SDFGLSR ++ G WMAPE L
Sbjct: 120 -SKN-FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD--DYYRKRGGKLPIRWMAPESL 175
Query: 848 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 906
+ K DV+SFGV+LWE+ TL + P+ GM+ +V+ + RL P P +
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLK-NGYRLPQPPNCPPELYD 234
Query: 907 IIWECWQTDPSLRPSFAQLTVAL 929
++ +CW DP RP+F++L L
Sbjct: 235 LMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 226 bits (579), Expect = 8e-68
Identities = 99/258 (38%), Positives = 142/258 (55%), Gaps = 14/258 (5%)
Query: 678 LVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
L LG+++G G++GEVY G EVAVK L +D S + EF RE +IMR+L
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKT-LKEDASEQQIEEFLREARIMRKLD 59
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ-VDEKRRIKMALD-ARGMNCL 789
HPN+V +G T L I+ E++P G L L + + + + AL ARGM L
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 790 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVLR 848
S +HRDL + N LV +N VK+SDFGLSR ++ P WMAPE L+
Sbjct: 120 E-SKN-FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 849 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 907
K DV+SFGV+LWE+ TL + P+ GM+ +V+ + + RL P P + ++
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLK-KGYRLPKPPNCPPELYKL 236
Query: 908 IWECWQTDPSLRPSFAQL 925
+ +CW DP RP+F++L
Sbjct: 237 MLQCWAEDPEDRPTFSEL 254
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 212 bits (542), Expect = 1e-62
Identities = 76/255 (29%), Positives = 123/255 (48%), Gaps = 18/255 (7%)
Query: 680 LGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ E++G GS+G+VY A T VA+K + + RE+KI+++L+HPN+V
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKV-IKKKKIKKDRERILREIKILKKLKHPNIVR 61
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTI 796
L ++ E+ G LF +L + ++ E + LH+ I
Sbjct: 62 LYDVFEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLHSKG--I 118
Query: 797 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKC 856
VHRDLK N+L+D++ +VK++DFGL+R + GTPE+MAPEVL + +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL-TTFVGTPEYMAPEVLLGKGYGKAV 177
Query: 857 DVYSFGVILWELATLKLPWIGMNPMQVV------GAVGFQNRRLEIPKELDPLVARIIWE 910
D++S GVIL+EL T K P+ G + + + F +I E L+ +
Sbjct: 178 DIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRK---- 233
Query: 911 CWQTDPSLRPSFAQL 925
DP R + +
Sbjct: 234 LLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 207 bits (530), Expect = 7e-61
Identities = 92/267 (34%), Positives = 139/267 (52%), Gaps = 23/267 (8%)
Query: 682 ERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+++G G++GEVY G TEVAVK L +D S +F +E ++M++L HPNVV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT-LKEDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQ------VDEKRRIKMALD-ARGMN 787
+G T L ++ E++ G L L RP + K + A+ A+GM
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 788 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE---WMAP 844
L + VHRDL + N LV ++ VK+SDFGLSR + G WMAP
Sbjct: 120 YLASK--KFVHRDLAARNCLVGEDLVVKISDFGLSR-DVYDDDYYRKKTGGKLPIRWMAP 176
Query: 845 EVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 903
E L++ K DV+SFGV+LWE+ TL P+ G++ +V+ + + RL P+
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR-KGYRLPKPEYCPDE 235
Query: 904 VARIIWECWQTDPSLRPSFAQLTVALK 930
+ ++ CWQ DP RP+F++L L+
Sbjct: 236 LYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 204 bits (521), Expect = 1e-59
Identities = 89/259 (34%), Positives = 135/259 (52%), Gaps = 16/259 (6%)
Query: 678 LVLGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 735
L ++G GS+G VY A GT VAVK + +RE++I+RRL HPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTP 794
V + A +L ++ E+ G LF L R + E K+AL RG+ LH++
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR-GGPLSEDEAKKIALQILRGLEYLHSNG- 118
Query: 795 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR-NEPSN 853
I+HRDLK N+L+D+N VK++DFGL++ + S + GTP +MAPEVL
Sbjct: 119 -IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 854 EKCDVYSFGVILWELATLKLPW---IGMNPMQVVGAVGFQNRRLEIPKELDPLVAR---- 906
K DV+S GVIL+EL T K P+ ++ +Q++ + LE + +
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRIL--GPPLEFDEPKWSSGSEEAKD 235
Query: 907 IIWECWQTDPSLRPSFAQL 925
+I +C DPS RP+ ++
Sbjct: 236 LIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 199 bits (509), Expect = 1e-58
Identities = 81/247 (32%), Positives = 123/247 (49%), Gaps = 41/247 (16%)
Query: 684 IGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 741
+G G +G VY A G +VA+K ++ S + L E RE++I+++L HPN+V G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKII-KKEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 742 VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRD 800
+L ++ E+ GSL +L ++ E +++ L G+ LH S I+HRD
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH-SNG-IIHRD 117
Query: 801 LKSPNLLVDK-NWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDV 858
LK N+L+D N VK++DFGLS+L + K+ GTP +MAPEVL + +EK D+
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177
Query: 859 YSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSL 918
+S GVIL+EL LK +I + Q DP
Sbjct: 178 WSLGVILYELPELK---------------------------------DLIRKMLQKDPEK 204
Query: 919 RPSFAQL 925
RPS ++
Sbjct: 205 RPSAKEI 211
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 192 bits (491), Expect = 1e-55
Identities = 86/258 (33%), Positives = 132/258 (51%), Gaps = 13/258 (5%)
Query: 677 DLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 734
+ GE +G GS+G VY A G +AVK S L +RE++I+ L+HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 735 VVLFMGA-VTRPPN-LSIITEFLPRGSLFRILHR-PHCQVDE-KRRIKMALDARGMNCLH 790
+V + G+ N L+I E++ GSL +L + ++ + L G+ LH
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQIL--EGLAYLH 118
Query: 791 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS--SKSTAGTPEWMAPEVLR 848
++ IVHRD+K N+LVD + VK++DFG ++ + + S GTP WMAPEV+R
Sbjct: 119 SNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 849 NEPSNEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKELDPLVARI 907
E D++S G + E+AT K PW + NPM + +G EIP+ L
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDF 236
Query: 908 IWECWQTDPSLRPSFAQL 925
+ +C + DP RP+ +L
Sbjct: 237 LRKCLRRDPKKRPTADEL 254
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 2e-48
Identities = 95/262 (36%), Positives = 141/262 (53%), Gaps = 14/262 (5%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
I ++L LG IG G +G+V D+ G +VAVK D A F E +M LR
Sbjct: 2 AINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDD---STAAQAFLAEASVMTTLR 58
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALD-ARGMNCL 789
HPN+V +G V + L I+TE++ +GSL L R + +++ ALD GM L
Sbjct: 59 HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL 118
Query: 790 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVLR 848
VHRDL + N+LV ++ KVSDFGL++ S K P +W APE LR
Sbjct: 119 EEK--NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGK----LPVKWTAPEALR 172
Query: 849 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 907
+ + K DV+SFG++LWE+ + ++P+ + VV V + R+E P+ P V ++
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-KGYRMEAPEGCPPEVYKV 231
Query: 908 IWECWQTDPSLRPSFAQLTVAL 929
+ +CW+ DP+ RP+F QL L
Sbjct: 232 MKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 4e-46
Identities = 88/264 (33%), Positives = 134/264 (50%), Gaps = 21/264 (7%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
EIP E L L ++G G +GEV+ WNG T+VAVK S A L+ E +IM++L
Sbjct: 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQ---EAQIMKKL 58
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH-------CQVDEKRRIKMALDA 783
RH +V + + I+TE++ +GSL L VD +I A
Sbjct: 59 RHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQI-----A 113
Query: 784 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWM 842
GM L + +HRDL + N+LV +N K++DFGL+RL + +++ A P +W
Sbjct: 114 EGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT 171
Query: 843 APEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELD 901
APE K DV+SFG++L E+ T ++P+ GM +V+ V + R+ P
Sbjct: 172 APEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRMPRPPNCP 230
Query: 902 PLVARIIWECWQTDPSLRPSFAQL 925
+ ++ +CW DP RP+F L
Sbjct: 231 EELYDLMLQCWDKDPEERPTFEYL 254
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 5e-46
Identities = 80/253 (31%), Positives = 138/253 (54%), Gaps = 15/253 (5%)
Query: 680 LGERIGLGSYGEVYHA-DWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
LG+ IG G++G VY + G VA+K+ + AL +E+ +++ L+HPN+V
Sbjct: 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHR----PHCQVDEKRRIKMALDARGMNCLHTST 793
++G++ +L II E+ GSL +I+ + P V + L +G+ LH
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLV--AVYVYQVL--QGLAYLHEQ- 118
Query: 794 PTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 852
++HRD+K+ N+L K+ VK++DFG++ +L + S GTP WMAPEV+ +
Sbjct: 119 -GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS-KDDASVVGTPYWMAPEVIEMSGA 176
Query: 853 NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 912
+ D++S G + EL T P+ +NPM + + Q+ +P+ + P + + +C+
Sbjct: 177 STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDFLMQCF 235
Query: 913 QTDPSLRPSFAQL 925
Q DP+LRP+ QL
Sbjct: 236 QKDPNLRPTAKQL 248
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 4e-45
Identities = 98/267 (36%), Positives = 146/267 (54%), Gaps = 12/267 (4%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRR 729
E+ D+ + ++G G YGEVY W VAVK L +D + EF +E +M+
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKED--TMEVEEFLKEAAVMKE 58
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ-VDEKRRIKMALD-ARGMN 787
++HPN+V +G TR P IITEF+ G+L L + Q V+ + MA + M
Sbjct: 59 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 118
Query: 788 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEV 846
L +HRDL + N LV +N VKV+DFGLSRL ++ + A P +W APE
Sbjct: 119 YLEKK--NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 176
Query: 847 LRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 905
L + K DV++FGV+LWE+AT + P+ G++ QV + + R+E P+ P V
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYRMERPEGCPPKVY 235
Query: 906 RIIWECWQTDPSLRPSFAQLTVALKPL 932
++ CWQ +PS RPSFA++ A + +
Sbjct: 236 ELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 5e-45
Identities = 76/255 (29%), Positives = 129/255 (50%), Gaps = 23/255 (9%)
Query: 684 IGLGSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
IG GS+G+VY +G +K+ + + AL EVKI+++L HPN++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDAL----NEVKILKKLNHPNIIK 63
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK--MALD-----ARGMNCLH 790
+ + L I+ E+ G L + + + Q E + LD + LH
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKK---QKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 791 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 850
+ I+HRD+K N+ + N VK+ DFG+S++ +T +K+ GTP +++PE+ +N+
Sbjct: 121 SRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNK 178
Query: 851 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 910
P N K D++S G +L+EL TLK P+ G N +++ + IP + + ++
Sbjct: 179 PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYP-PIPSQYSSELRNLVSS 237
Query: 911 CWQTDPSLRPSFAQL 925
Q DP RPS AQ+
Sbjct: 238 LLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 4e-43
Identities = 86/268 (32%), Positives = 133/268 (49%), Gaps = 29/268 (10%)
Query: 684 IGLGSYGEVYHADWN------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+G G +G+V ++ G +VAVK L+ +F+RE++I+R L H N+V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKS-LNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 738 FMGAVTRP--PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTP 794
+ G +P +L +I E+LP GSL L R Q++ KR + + +GM+ L +
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR- 129
Query: 795 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTP-EWMAPEVLRNEP 851
+HRDL + N+LV+ VK+SDFGL+++ + + K +P W APE LR
Sbjct: 130 -YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSK 188
Query: 852 SNEKCDVYSFGVILWELAT------------LKLPWIGMNPMQVVGAVGF--QNRRLEIP 897
+ DV+SFGV L+EL T L++ I M V + + RL P
Sbjct: 189 FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRP 248
Query: 898 KELDPLVARIIWECWQTDPSLRPSFAQL 925
V ++ CW+ +P RPSFA L
Sbjct: 249 PSCPDEVYDLMKLCWEAEPQDRPSFADL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 5e-43
Identities = 84/266 (31%), Positives = 134/266 (50%), Gaps = 34/266 (12%)
Query: 675 WEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH 732
+E L E+IG G +GEVY A G EVA+K + S + E++I+++ +H
Sbjct: 2 FEIL---EKIGKGGFGEVYKARHKRTGKEVAIKVIKLE--SKEKKEKIINEIQILKKCKH 56
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK-------MALDARG 785
PN+V + G+ + L I+ EF GSL +L + Q + +I L+
Sbjct: 57 PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLL-KSTNQTLTESQIAYVCKELLKGLEY-- 113
Query: 786 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 845
LH++ I+HRD+K+ N+L+ + VK+ DFGLS +T + + GTP WMAPE
Sbjct: 114 ---LHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK-ARNTMVGTPYWMAPE 167
Query: 846 VLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV------VGAVGFQNRRLEIPKE 899
V+ +P + K D++S G+ ELA K P+ + PM+ G G +N P++
Sbjct: 168 VINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRN-----PEK 222
Query: 900 LDPLVARIIWECWQTDPSLRPSFAQL 925
+ +C Q +P RP+ QL
Sbjct: 223 WSDEFKDFLKKCLQKNPEKRPTAEQL 248
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 156 bits (395), Expect = 1e-42
Identities = 88/253 (34%), Positives = 130/253 (51%), Gaps = 13/253 (5%)
Query: 681 GERIGLGSYGEVYHADWN---GTEVAVK--KFLDQDFSG-AALLEFKREVKIMRRLRHPN 734
GE +G GS+G VY N G AVK D +G A+ + ++E+ ++ +L+HPN
Sbjct: 5 GELLGSGSFGSVYEG-LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN 63
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTP 794
+V ++G NL I E +P GSL ++L + + R+ G+ LH
Sbjct: 64 IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR-- 121
Query: 795 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS-SKSTAGTPEWMAPEVLRNE-PS 852
VHRD+K N+LVD N VK++DFG++ K S +KS G+P WMAPEV+ +
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMA--KQVVEFSFAKSFKGSPYWMAPEVIAQQGGY 179
Query: 853 NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 912
D++S G + E+AT K PW + + V +G IP L I +C
Sbjct: 180 GLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCL 239
Query: 913 QTDPSLRPSFAQL 925
Q DPSLRP+ A+L
Sbjct: 240 QRDPSLRPTAAEL 252
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 5e-42
Identities = 87/262 (33%), Positives = 132/262 (50%), Gaps = 9/262 (3%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
E P E+ L ++G G +GEV+ W VA+K L D +F++EV+ ++RL
Sbjct: 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIK-ILKSD-DLLKQQDFQKEVQALKRL 59
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV-DEKRRIKMALD-ARGMNC 788
RH +++ + + IITE + +GSL L P QV I MA A GM
Sbjct: 60 RHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAY 119
Query: 789 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 848
L +HRDL + N+LV ++ KV+DFGL+RL S +W APE
Sbjct: 120 LEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAAS 177
Query: 849 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 907
+ + K DV+SFG++L+E+ T ++P+ GMN +V + R+ P + + +I
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIYKI 236
Query: 908 IWECWQTDPSLRPSFAQLTVAL 929
+ ECW +P RPSF L L
Sbjct: 237 MLECWAAEPEDRPSFKALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 84/264 (31%), Positives = 128/264 (48%), Gaps = 21/264 (7%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
EI + L ++G G +GEV+ WN T VAVK +F E +IM++L
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK---DFLAEAQIMKKL 58
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKM-------ALDA 783
RHP ++ T + I+TE + GSL L R +K+ A A
Sbjct: 59 RHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQG-----GAGRALKLPQLIDMAAQVA 113
Query: 784 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWM 842
GM L +HRDL + N+LV +N KV+DFGL+R +K + + + + +W
Sbjct: 114 SGMAYLEAQ--NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT 171
Query: 843 APEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELD 901
APE + K DV+SFG++L E+ T ++P+ GM +V+ V Q R+ P
Sbjct: 172 APEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCP 230
Query: 902 PLVARIIWECWQTDPSLRPSFAQL 925
+ I+ +CW+ DP RP+F L
Sbjct: 231 KELYDIMLDCWKEDPDDRPTFETL 254
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 3e-41
Identities = 88/280 (31%), Positives = 143/280 (51%), Gaps = 24/280 (8%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
E+P E + L +G GS+G VY G T VA+K ++++ S +EF E
Sbjct: 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKT-VNENASMRERIEFLNEA 60
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRP---HCQV----DEKR 775
+M+ +VV +G V+ ++ E + +G L L RP + ++
Sbjct: 61 SVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQK 120
Query: 776 RIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 834
I+MA + A GM L VHRDL + N +V ++ VK+ DFG++R + T K
Sbjct: 121 FIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKG 178
Query: 835 TAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 891
G P WMAPE L++ K DV+SFGV+LWE+ATL + P+ G++ +V+ V
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-DG 237
Query: 892 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 931
L++P+ + ++ CWQ +P +RP+F ++ +LK
Sbjct: 238 GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 1e-39
Identities = 81/275 (29%), Positives = 135/275 (49%), Gaps = 31/275 (11%)
Query: 666 DDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKRE 723
D+ P E E+IG G+ GEVY A T EVA+KK E
Sbjct: 9 KDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM---RLRKQNKELIINE 65
Query: 724 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDA 783
+ IM+ +HPN+V + + L ++ E++ GSL I+ + +++E + +A
Sbjct: 66 ILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQ---IAYVC 122
Query: 784 R----GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG----LSRLKHNTFLSSKST 835
R G+ LH+ ++HRD+KS N+L+ K+ +VK++DFG L++ K S
Sbjct: 123 REVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK----RNSV 176
Query: 836 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--- 892
GTP WMAPEV++ + K D++S G++ E+A + P++ P++ + F
Sbjct: 177 VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL----FLITTKG 232
Query: 893 --RLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 925
L+ P++ P + +C DP RPS +L
Sbjct: 233 IPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 77/257 (29%), Positives = 131/257 (50%), Gaps = 12/257 (4%)
Query: 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
P E + E++G GSYG VY A G VA+K L E +E+ I+++
Sbjct: 1 PEEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP----VEEDLQEIIKEISILKQCD 56
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDA--RGMNCL 789
P +V + G+ + +L I+ E+ GS+ I+ + + E+ I L +G+ L
Sbjct: 57 SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEE-IAAILYQTLKGLEYL 115
Query: 790 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 849
H++ +HRD+K+ N+L+++ K++DFG+S +T + GTP WMAPEV++
Sbjct: 116 HSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE 173
Query: 850 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLVARII 908
N K D++S G+ E+A K P+ ++PM+ + + + L P++ P +
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFV 233
Query: 909 WECWQTDPSLRPSFAQL 925
+C DP RPS QL
Sbjct: 234 KKCLVKDPEERPSAIQL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 3e-39
Identities = 82/254 (32%), Positives = 134/254 (52%), Gaps = 9/254 (3%)
Query: 682 ERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740
E+IG G++G+VY TEVAVK +F +E +I+++ HPN+V +G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKR-KFLQEAEILKQYDHPNIVKLIG 59
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDA-RGMNCLHTSTPTIVHR 799
+ + I+ E +P GSL L + ++ K+ ++M+LDA GM L + +HR
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK--NCIHR 117
Query: 800 DLKSPNLLVDKNWNVKVSDFGLSRLKHNT-FLSSKSTAGTP-EWMAPEVLRNEPSNEKCD 857
DL + N LV +N +K+SDFG+SR + + S P +W APE L + D
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESD 177
Query: 858 VYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 916
V+S+G++LWE +L P+ GM+ Q + R+ P+ + R++ +CW DP
Sbjct: 178 VWSYGILLWETFSLGDTPYPGMSNQQTRERIE-SGYRMPAPQLCPEEIYRLMLQCWAYDP 236
Query: 917 SLRPSFAQLTVALK 930
RPSF+++ L+
Sbjct: 237 ENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 3e-39
Identities = 80/256 (31%), Positives = 124/256 (48%), Gaps = 15/256 (5%)
Query: 682 ERIGLGSYGEVYHADW---NGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+++G GS+G V +W G VAVK L D + +F +E IM L H N++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVK-CLKSDKLSDIMDDFLKEAAIMHSLDHENLI 59
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI-KMALD-ARGMNCLHTSTP 794
G V P L ++TE P GSL L + + A+ A GM L +
Sbjct: 60 RLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR- 117
Query: 795 TIVHRDLKSPNLLVDKNWNVKVSDFGLSR---LKHNTFLSSKSTAGTPEWMAPEVLRNEP 851
+HRDL + N+L+ + VK+ DFGL R + ++ + W APE LR
Sbjct: 118 -FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 852 SNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 910
+ DV+ FGV LWE+ T + PW G++ Q++ + + RLE P+ + ++ +
Sbjct: 177 FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236
Query: 911 CWQTDPSLRPSFAQLT 926
CW +P+ RP+FA L
Sbjct: 237 CWAHNPADRPTFAALR 252
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 3e-39
Identities = 87/262 (33%), Positives = 137/262 (52%), Gaps = 23/262 (8%)
Query: 680 LGERIGLGSYGEVYHA---DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
G +IG G++G+VY A D G +AVK+ QD + E E+K++ L+HPN+V
Sbjct: 4 RGNKIGGGTFGKVYTAVNLD-TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV-DEK--RRIKMALDARGMNCLHTST 793
+ G + I E+ G+L +L H ++ DE R + L G+ LH+
Sbjct: 63 KYYGVEVHREKVYIFMEYCSGGTLEELLE--HGRILDEHVIRVYTLQL-LEGLAYLHSH- 118
Query: 794 PTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNT---FLSSKSTAGTPEWMAPEVLRN 849
IVHRD+K N+ +D N +K+ DFG + +LK+NT +S AGTP +MAPEV+
Sbjct: 119 -GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 850 EPSNEK---CDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPK--ELDPL 903
D++S G ++ E+AT K PW + N Q++ VG ++ IP +L P
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKP-PIPDSLQLSPE 236
Query: 904 VARIIWECWQTDPSLRPSFAQL 925
+ C ++DP RP+ ++L
Sbjct: 237 GKDFLDRCLESDPKKRPTASEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 4e-39
Identities = 88/258 (34%), Positives = 141/258 (54%), Gaps = 14/258 (5%)
Query: 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 735
+ L LGE IG G +G V ++ G +VAVK + D + A LE E +M +L H N+
Sbjct: 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKN-IKCDVTAQAFLE---ETAVMTKLHHKNL 61
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALD-ARGMNCLHTST 793
V +G + L I+ E + +G+L L R V + ++ +LD A GM + +
Sbjct: 62 VRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGME--YLES 118
Query: 794 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN 853
+VHRDL + N+LV ++ KVSDFGL+R+ +SK +W APE L+++ +
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV---KWTAPEALKHKKFS 175
Query: 854 EKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 912
K DV+S+GV+LWE+ + + P+ M+ +V V + R+E P+ V ++ CW
Sbjct: 176 SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-KGYRMEPPEGCPADVYVLMTSCW 234
Query: 913 QTDPSLRPSFAQLTVALK 930
+T+P RPSF +L L+
Sbjct: 235 ETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 6e-39
Identities = 84/259 (32%), Positives = 133/259 (51%), Gaps = 14/259 (5%)
Query: 677 DLVLGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 735
+L + +G G +G V+ W G +VA+K + S +F E K+M +L HPN+
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPNL 61
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTP 794
V G T+ + I+TE++ G L L ++ + + M D M L ++
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN-- 119
Query: 795 TIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEPSN 853
+HRDL + N LV ++ VKVSDFGL+R + + + SS+ T +W PEV +
Sbjct: 120 GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179
Query: 854 EKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAV--GFQNRRLEIPKELDPLVARIIWE 910
K DV+SFGV++WE+ + K+P+ + +VV +V G+ RL PK V I++
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY---RLYRPKLAPTEVYTIMYS 236
Query: 911 CWQTDPSLRPSFAQLTVAL 929
CW P RP+F +L L
Sbjct: 237 CWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 4e-38
Identities = 92/264 (34%), Positives = 142/264 (53%), Gaps = 22/264 (8%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
EIP E L L +++G G +GEV+ WNG T+VAVK S + LE E +IM++L
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLE---EAQIMKKL 58
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKM-------ALDA 783
RH +V V+ P + I+TE++ +GSL L + E R +K+ A A
Sbjct: 59 RHDKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-----KDGEGRALKLPNLVDMAAQVA 112
Query: 784 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWM 842
GM + +HRDL+S N+LV K++DFGL+RL + +++ A P +W
Sbjct: 113 AGM--AYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWT 170
Query: 843 APEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELD 901
APE K DV+SFG++L EL T ++P+ GMN +V+ V + R+ P++
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRMPCPQDCP 229
Query: 902 PLVARIIWECWQTDPSLRPSFAQL 925
+ ++ +CW+ DP RP+F L
Sbjct: 230 ISLHELMLQCWKKDPEERPTFEYL 253
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 6e-38
Identities = 84/264 (31%), Positives = 134/264 (50%), Gaps = 17/264 (6%)
Query: 674 PWEDLVLGERIGLGSYGEVYHAD--WNGTEVAVK--KFLDQDFSGAALLEFKREVKIMRR 729
P ED L +RIG G+YG+VY A G VA+K K D ++E+ +++
Sbjct: 1 PQEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD----DFEIIQQEISMLKE 56
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDA-RGMNC 788
RHPN+V + G+ R L I+ E+ GSL I + E + + + +G+
Sbjct: 57 CRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAY 116
Query: 789 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL- 847
LH + +HRD+K N+L+ ++ +VK++DFG+S T KS GTP WMAPEV
Sbjct: 117 LHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAA 174
Query: 848 --RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV---GAVGFQNRRLEIPKELDP 902
R + KCD+++ G+ ELA L+ P ++PM+ + F +L+ ++ P
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSP 234
Query: 903 LVARIIWECWQTDPSLRPSFAQLT 926
+ I +C DP RP+ +L
Sbjct: 235 VFHDFIKKCLTKDPKKRPTATKLL 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 8e-38
Identities = 87/256 (33%), Positives = 126/256 (49%), Gaps = 14/256 (5%)
Query: 676 EDLVLGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 734
+DL + +G G +G V + W G +VA+K + S EF E K+M +L H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEK 60
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALD-ARGMNCLHT 791
+V G T+ + I+TE++ G L L H Q + ++M D GM L +
Sbjct: 61 LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQ--LLEMCKDVCEGMAYLES 118
Query: 792 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNE 850
+HRDL + N LVD VKVSDFGLSR + + + SS + W PEVL
Sbjct: 119 KQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYS 176
Query: 851 PSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 909
+ K DV++FGV++WE+ +L K+P+ N + V V Q RL P V I++
Sbjct: 177 KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLASEKVYAIMY 235
Query: 910 ECWQTDPSLRPSFAQL 925
CW RP+F QL
Sbjct: 236 SCWHEKAEERPTFQQL 251
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 8e-38
Identities = 82/268 (30%), Positives = 131/268 (48%), Gaps = 38/268 (14%)
Query: 676 EDLVLGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
E L E IG GS+GEVY A T VA+K +D + + + + ++E++ + + R P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKV-IDLEEAEDEIEDIQQEIQFLSQCRSP 59
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDA-RGMNCLHTS 792
+ + G+ + L II E+ GS +L +P ++DE + + G+ LH
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KP-GKLDETYIAFILREVLLGLEYLHEE 117
Query: 793 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNTFLSSKSTAGTPEWMAPEV 846
+HRD+K+ N+L+ + +VK++DFG+S K NTF GTP WMAPEV
Sbjct: 118 GK--IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF------VGTPFWMAPEV 169
Query: 847 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 906
++ +EK D++S G+ ELA + P ++PM+V+ IPK P +
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL---------FLIPKNNPPSLEG 220
Query: 907 IIWE---------CWQTDPSLRPSFAQL 925
+ C DP RPS +L
Sbjct: 221 NKFSKPFKDFVSLCLNKDPKERPSAKEL 248
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 89/288 (30%), Positives = 144/288 (50%), Gaps = 32/288 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
EIP + E +G G++G+VY + G T VA+K L ++ EF++E
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKT-LKENAEPKVQQEFRQEA 59
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL--FRILHRPHCQV---DEKRRIKM 779
++M L+HPN+V +G T+ ++ E+L G L F + + PH V +K
Sbjct: 60 ELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119
Query: 780 ALD-----------ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828
+LD A GM L S+ VHRDL + N LV + VK+SDFGLSR ++
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYL--SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSA 177
Query: 829 -FLSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQVVG 885
+ +S + P WM PE + + D++SFGV+LWE+ + L P+ G + +V+
Sbjct: 178 DYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE 237
Query: 886 AVGFQNRR-LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932
+ ++R+ L P++ V ++ ECW P+ RP F + L+
Sbjct: 238 MI--RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 90/285 (31%), Positives = 151/285 (52%), Gaps = 31/285 (10%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE-------VAVKKFLDQDFSGAALLEFKREV 724
E+P + L LG+ +G G++G+V A+ G + VAVK L D + L + E+
Sbjct: 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKM-LKDDATEKDLSDLVSEM 66
Query: 725 KIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRP---HCQVDEKRRIK 778
++M+ + +H N++ +G T+ L ++ E+ G+L L RP + D+ R +
Sbjct: 67 EMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPE 126
Query: 779 MALD-----------ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827
L ARGM L ++ +HRDL + N+LV ++ +K++DFGL+R H+
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFL--ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHH 184
Query: 828 TFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATLK-LPWIGMNPMQVV 884
K+T G P +WMAPE L + + DV+SFGV+LWE+ TL P+ G+ P++ +
Sbjct: 185 IDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEEL 243
Query: 885 GAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 929
+ + R+E P+ + ++ +CW PS RP+F QL L
Sbjct: 244 FKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 6e-37
Identities = 88/255 (34%), Positives = 138/255 (54%), Gaps = 16/255 (6%)
Query: 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 735
++L L + IG G +G+V D+ G +VAVK + D + A F E +M +LRH N+
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVK-CIKNDATAQA---FLAEASVMTQLRHSNL 61
Query: 736 VLFMGA-VTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALD-ARGMNCLHTS 792
V +G V L I+TE++ +GSL L R + +K +LD M L +
Sbjct: 62 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121
Query: 793 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVLRNEP 851
VHRDL + N+LV ++ KVSDFGL++ S++ T P +W APE LR +
Sbjct: 122 N--FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS----STQDTGKLPVKWTAPEALREKK 175
Query: 852 SNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 910
+ K DV+SFG++LWE+ + ++P+ + VV V + +++ P P+V ++ +
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPVVYDVMKQ 234
Query: 911 CWQTDPSLRPSFAQL 925
CW D + RPSF QL
Sbjct: 235 CWHLDAATRPSFLQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 1e-36
Identities = 85/265 (32%), Positives = 133/265 (50%), Gaps = 19/265 (7%)
Query: 673 IPWEDLVLGERIGLGSYGEVYHADWNGT-----EVAVKKFLDQDFSGAALLEFKREVKIM 727
I + + + IG G +GEV +VA+K S L+F E IM
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG-SSDKQRLDFLTEASIM 59
Query: 728 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGM 786
+ HPN++ G VT+ + IITE++ GSL + L + + + M A GM
Sbjct: 60 GQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGM 119
Query: 787 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG--TP-EWMA 843
L S VHRDL + N+LV+ N KVSDFGLSR ++ ++ +T G P W A
Sbjct: 120 KYL--SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS-EATYTTKGGKIPIRWTA 176
Query: 844 PEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAV--GFQNRRLEIPKEL 900
PE + DV+SFG+++WE+ + + P+ M+ V+ AV G+ RL P +
Sbjct: 177 PEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY---RLPPPMDC 233
Query: 901 DPLVARIIWECWQTDPSLRPSFAQL 925
+ +++ +CWQ D + RP+F+Q+
Sbjct: 234 PSALYQLMLDCWQKDRNERPTFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 79/257 (30%), Positives = 122/257 (47%), Gaps = 16/257 (6%)
Query: 680 LGERIGLGSYGEVY---HADWNGTEVAVKKF-LDQDFSGAA--LLEFKREVKIMRRLRHP 733
G+ +G G++G VY D G E+AVK+ D D + + E+++++ L+H
Sbjct: 6 RGKLLGQGAFGRVYLCYDVD-TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHE 64
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTST 793
+V + G + LSI E++P GS+ L + R G+ LH++
Sbjct: 65 RIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM 124
Query: 794 PTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLK----HNTFLSSKSTAGTPEWMAPEVLR 848
IVHRD+K N+L D NVK+ DFG S RL+ T + KS GTP WM+PEV+
Sbjct: 125 --IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGM--KSVTGTPYWMSPEVIS 180
Query: 849 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 908
E K DV+S G + E+ T K PW M + + Q ++P + P +
Sbjct: 181 GEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240
Query: 909 WECWQTDPSLRPSFAQL 925
+ + RPS +L
Sbjct: 241 RRTFVENAKKRPSAEEL 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 1e-35
Identities = 90/267 (33%), Positives = 142/267 (53%), Gaps = 18/267 (6%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
EIP E L L ++G G +GEV+ WNGT VA+K S A L+ E ++M++L
Sbjct: 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKL 58
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-----ARG 785
RH +V V+ P + I+TE++ +GSL L ++ + R+ +D A G
Sbjct: 59 RHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKG---EMGKYLRLPQLVDMAAQIASG 114
Query: 786 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAP 844
M + VHRDL++ N+LV +N KV+DFGL+RL + +++ A P +W AP
Sbjct: 115 M--AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 172
Query: 845 EVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 903
E K DV+SFG++L EL T ++P+ GM +V+ V + R+ P E
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPES 231
Query: 904 VARIIWECWQTDPSLRPSFAQLTVALK 930
+ ++ +CW+ +P RP+F L L+
Sbjct: 232 LHDLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 1e-35
Identities = 84/257 (32%), Positives = 130/257 (50%), Gaps = 10/257 (3%)
Query: 677 DLVLGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 735
+L + +G G +G V+ W +VA+K + S +F E K+M +L HP +
Sbjct: 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLSHPKL 61
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDA-RGMNCLHTSTP 794
V G T+ L I+TEF+ G L L + ++ + + M D GM L +
Sbjct: 62 VQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN-- 119
Query: 795 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVLRNEPSN 853
+ +HRDL + N LV VKVSDFG++R + +S S A P +W PEV +
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS 179
Query: 854 EKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 912
K DV+SFGV++WE+ T K+P+ + +VV + + RL PK V +++ CW
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS-RGFRLYRPKLASMTVYEVMYSCW 238
Query: 913 QTDPSLRPSFAQLTVAL 929
P RP+FA+L A+
Sbjct: 239 HEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 78/247 (31%), Positives = 130/247 (52%), Gaps = 6/247 (2%)
Query: 682 ERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740
E +G G++GEV+ + T VAVK +D ++F E +I+++ HPN+V +G
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKT-CKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRD 800
T+ + I+ E +P G L + ++ K+ +K ALDA + + +HRD
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAA-GMAYLESKNCIHRD 118
Query: 801 LKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVLRNEPSNEKCDVY 859
L + N LV +N +K+SDFG+SR + + SS P +W APE L + + DV+
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVW 178
Query: 860 SFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSL 918
S+G++LWE +L + P+ GM Q V + R+ P++ V +++ CW P
Sbjct: 179 SYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYKVMQRCWDYKPEN 237
Query: 919 RPSFAQL 925
RP F++L
Sbjct: 238 RPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 79/275 (28%), Positives = 132/275 (48%), Gaps = 28/275 (10%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHA-------DWNGTEVAVKKFLDQDFSGAALLEFKREV 724
+ + +VL +G G++G+V+ + + VAVK L + S A +F+RE
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKT-LKETASNDARKDFEREA 59
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR-------------PHCQV 771
+++ +H N+V F G T ++ E++ G L + L P ++
Sbjct: 60 ELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119
Query: 772 DEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT-F 829
+ +++A+ A GM L ++ VHRDL + N LV + VK+ DFG+SR + T +
Sbjct: 120 TLSQLLQIAVQIASGMVYL--ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY 177
Query: 830 LSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAV 887
P WM PE + + DV+SFGV+LWE+ T K PW G++ +V+ +
Sbjct: 178 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237
Query: 888 GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSF 922
Q R L+ P+ V I+ CW+ DP R +
Sbjct: 238 T-QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINI 271
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 9e-35
Identities = 91/272 (33%), Positives = 142/272 (52%), Gaps = 28/272 (10%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
EIP E L L +++G G +GEV+ A +N T+VAVK S A L E +M+ L
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLA---EANVMKTL 58
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKM-------ALDA 783
+H +V VT+ P + IITEF+ +GSL L + DE + + A A
Sbjct: 59 QHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFL-----KSDEGSKQPLPKLIDFSAQIA 112
Query: 784 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWM 842
GM +HRDL++ N+LV + K++DFGL+R+ + +++ A P +W
Sbjct: 113 EGM--AFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT 170
Query: 843 APEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAV--GFQNRRLE-IPK 898
APE + K DV+SFG++L E+ T ++P+ GM+ +V+ A+ G++ R E P+
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPE 230
Query: 899 ELDPLVARIIWECWQTDPSLRPSFAQLTVALK 930
EL I+ CW+ P RP+F + L
Sbjct: 231 EL----YNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 86/264 (32%), Positives = 140/264 (53%), Gaps = 12/264 (4%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
E+P E L L +++G G +GEV+ +NG T+VA+K S A L E +M++L
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLA---EANLMKQL 58
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALD-ARGMNC 788
+HP +V VT+ P + IITE++ GSL L P ++ + I MA A GM
Sbjct: 59 QHPRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAF 117
Query: 789 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVL 847
+ +HRDL++ N+LV + K++DFGL+RL + +++ A P +W APE +
Sbjct: 118 IERKN--YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 175
Query: 848 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 906
K DV+SFG++L E+ T ++P+ GM +V+ + + R+ P +
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRMPRPDNCPEELYE 234
Query: 907 IIWECWQTDPSLRPSFAQLTVALK 930
++ CW+ P RP+F L L+
Sbjct: 235 LMRLCWKEKPEERPTFEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 3e-34
Identities = 77/265 (29%), Positives = 127/265 (47%), Gaps = 32/265 (12%)
Query: 682 ERIGLGSYGEVYHA----DWNGTEVAVKKFLDQDFSGAALLEFKR-----EVKIMRRLRH 732
E IG GS+G V D G + K+ D+ + E ++ EV I+R L+H
Sbjct: 6 ETIGKGSFGTVRKVRRKSD--GKILVWKEI---DYGN--MTEKEKQQLVSEVNILRELKH 58
Query: 733 PNVVLFMGAVTRPPN--LSIITEFLPRGSLFRILHRPHCQVDEKR-------RIKMALDA 783
PN+V + + N L I+ E+ G L +++ + C+ + K RI L
Sbjct: 59 PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQK--CKKERKYIEEEFIWRILTQL-L 115
Query: 784 RGMNCLHT---STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 840
+ H T++HRDLK N+ +D N NVK+ DFGL+++ + +K+ GTP
Sbjct: 116 LALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPY 175
Query: 841 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 900
+M+PE L + +EK D++S G +++EL L P+ N +Q+ + + + IP
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK-EGKFRRIPYRY 234
Query: 901 DPLVARIIWECWQTDPSLRPSFAQL 925
+ +I DP RPS +L
Sbjct: 235 SSELNEVIKSMLNVDPDKRPSTEEL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 79/259 (30%), Positives = 128/259 (49%), Gaps = 16/259 (6%)
Query: 682 ERIGLGSYGEVYHADW---NGTEVAVK-KFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ +G G++G V + +G EV V K L Q+ A EF RE +M +L HP +V
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTI 796
+G V + L ++ E P G L + L + ++ ++A A GM L +
Sbjct: 61 LIG-VCKGEPLMLVMELAPLGPLLKYL-KKRREIPVSDLKELAHQVAMGMAYLESKH--F 116
Query: 797 VHRDLKSPN-LLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTP-EWMAPEVLRNEPS 852
VHRDL + N LLV+++ K+SDFG+SR + + + + P +W APE +
Sbjct: 117 VHRDLAARNVLLVNRH-QAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 853 NEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 911
+ K DV+S+GV LWE + P+ M +V+ + RL P+E + I+ C
Sbjct: 176 SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-SGERLPRPEECPQEIYSIMLSC 234
Query: 912 WQTDPSLRPSFAQLTVALK 930
W+ P RP+F++L +
Sbjct: 235 WKYRPEDRPTFSELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 1e-33
Identities = 87/256 (33%), Positives = 136/256 (53%), Gaps = 12/256 (4%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
EIP E L L ++G G +GEV+ WNGT +VA+K A L+ E +IM++L
Sbjct: 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQ---EAQIMKKL 58
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ-VDEKRRIKMALD-ARGMNC 788
RH +V V+ P + I+TEF+ +GSL L + + + + MA A GM
Sbjct: 59 RHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAY 117
Query: 789 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVL 847
+ +HRDL++ N+LV N K++DFGL+RL + +++ A P +W APE
Sbjct: 118 IERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175
Query: 848 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 906
K DV+SFG++L EL T ++P+ GM +V+ V + R+ P+ +
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRMPCPQGCPESLHE 234
Query: 907 IIWECWQTDPSLRPSF 922
++ CW+ DP RP+F
Sbjct: 235 LMKLCWKKDPDERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 1e-33
Identities = 89/271 (32%), Positives = 143/271 (52%), Gaps = 27/271 (9%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
EIP E + L +++G G +GEV+ + N T+VAVK S A LE E +M+ L
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLE---EANLMKTL 58
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKM-------ALDA 783
+H +V VT+ + IITE++ +GSL L + DE ++ + A A
Sbjct: 59 QHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFL-----KSDEGGKVLLPKLIDFSAQIA 113
Query: 784 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWM 842
GM + +HRDL++ N+LV ++ K++DFGL+R+ + +++ A P +W
Sbjct: 114 EGM--AYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWT 171
Query: 843 APEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAV--GFQNRRLE-IPK 898
APE + K DV+SFG++L+E+ T K+P+ GM+ V+ A+ G++ R+E P
Sbjct: 172 APEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPD 231
Query: 899 ELDPLVARIIWECWQTDPSLRPSFAQLTVAL 929
EL I+ CW+ RP+F L L
Sbjct: 232 EL----YDIMKTCWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 87/285 (30%), Positives = 145/285 (50%), Gaps = 30/285 (10%)
Query: 672 EIPWEDLVLGERIGLGSYGEVY--HADWNGTE----VAVKKFLDQDFSGAALLEFKREVK 725
E+P + E +G ++G++Y H G + VA+K D + + EF++E
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEAS 59
Query: 726 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL--FRILHRPH----CQVDEKRRIKM 779
+M L HPN+V +G VT+ + ++ E+L +G L F I+ PH C DE +K
Sbjct: 60 LMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKS 119
Query: 780 ALD-----------ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828
+LD A GM L S+ VH+DL + N+L+ + +VK+SD GLSR ++
Sbjct: 120 SLDHGDFLHIAIQIAAGMEYL--SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177
Query: 829 -FLSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQVVG 885
+ + + P WM PE + + D++SFGV+LWE+ + L P+ G + +V+
Sbjct: 178 DYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE 237
Query: 886 AVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 930
V + + L ++ P + ++ ECWQ PS RP F + L+
Sbjct: 238 MVR-KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 83/261 (31%), Positives = 123/261 (47%), Gaps = 11/261 (4%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHA---DWNGTEVAVK-KFLDQDFSGAALLEFKREVKIM 727
EI ED+ LG IG G +G+VY ++AV K S + +F +E IM
Sbjct: 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIM 61
Query: 728 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGM 786
R+ HP++V +G +T P + I+ E P G L L +D I + + +
Sbjct: 62 RQFDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTAL 120
Query: 787 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPE 845
L + VHRD+ + N+LV VK+ DFGLSR + S P +WMAPE
Sbjct: 121 AYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178
Query: 846 VLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 904
+ DV+ FGV +WE+ L P+ G+ V+G + RL +P P +
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPPTL 237
Query: 905 ARIIWECWQTDPSLRPSFAQL 925
++ +CW DPS RP F +L
Sbjct: 238 YSLMTKCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 7e-33
Identities = 83/256 (32%), Positives = 129/256 (50%), Gaps = 14/256 (5%)
Query: 676 EDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 734
+L L + IG G +G V+ W +VA+K + S +F E ++M +L HP
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPK 60
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTST 793
+V G T + ++ EF+ G L L + ++ + M LD GM L +S
Sbjct: 61 LVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN 120
Query: 794 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK-HNTFLSSKSTAGTPEWMAPEVLRNEPS 852
++HRDL + N LV +N VKVSDFG++R + + SS T +W +PEV
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKY 178
Query: 853 NEKCDVYSFGVILWEL-ATLKLPWIGMNPMQVVGAV--GFQNRRLEIPKELDPLVARIIW 909
+ K DV+SFGV++WE+ + K P+ + +VV + GF RL P+ V ++
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF---RLYKPRLASQSVYELMQ 235
Query: 910 ECWQTDPSLRPSFAQL 925
CW+ P RPSF+ L
Sbjct: 236 HCWKERPEDRPSFSLL 251
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 78/276 (28%), Positives = 130/276 (47%), Gaps = 20/276 (7%)
Query: 678 LVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
L + +G G++G VY W VA+K + + S A E E +M +
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLRE-ETSPKANKEILDEAYVMASVD 67
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLH 790
HP+VV +G + + +IT+ +P G L + + + + + A+GM+ L
Sbjct: 68 HPHVVRLLG-ICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYL- 125
Query: 791 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG-TP-EWMAPEVLR 848
+VHRDL + N+LV +VK++DFGL++L + G P +WMA E +
Sbjct: 126 -EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 849 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 907
+ K DV+S+GV +WEL T P+ G+ +++ + + RL P V +
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-KGERLPQPPICTIDVYMV 243
Query: 908 IWECWQTDPSLRPSFAQLT-----VALKPLQRLVIP 938
+ +CW D RP+F +L +A P + LVI
Sbjct: 244 LVKCWMIDAESRPTFKELINEFSKMARDPQRYLVIQ 279
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 77/271 (28%), Positives = 137/271 (50%), Gaps = 30/271 (11%)
Query: 679 VLGERIGLGSYGEVYHA--DWNGTEVAVKKF------LDQDFSG-----AALLEFKREVK 725
V GE IG G+YG VY A G +AVK+ + S AL + E++
Sbjct: 4 VKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKAL---RSEIE 60
Query: 726 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDA-- 783
++ L H N+V ++G T LSI E++P GS+ L R + + +E+ ++ +
Sbjct: 61 TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL-RTYGRFEEQL-VRFFTEQVL 118
Query: 784 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEW 841
G+ LH+ I+HRDLK+ NLLVD + K+SDFG+S+ + + + ++ + G+ W
Sbjct: 119 EGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176
Query: 842 MAPEVLRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE 899
MAPEV+ + + K D++S G ++ E+ + PW + + +G + IP +
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPD 236
Query: 900 LDPLVARI----IWECWQTDPSLRPSFAQLT 926
+ ++ + + C+ +P RP+ +L
Sbjct: 237 VSMNLSPVALDFLNACFTINPDNRPTARELL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 90/299 (30%), Positives = 142/299 (47%), Gaps = 54/299 (18%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE------------------VAVKKFLDQDFS 713
E P + L E++G G +GEV+ + +G + VAVK L D S
Sbjct: 1 EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKV-LRPDAS 59
Query: 714 GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE 773
A +F +EVKI+ RL PN+ +G T P L +I E++ G L + L + V E
Sbjct: 60 DNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQK---HVAE 116
Query: 774 KRRIKMALDARGMNCL------------HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 821
+ + + L + + VHRDL + N LV KN+ +K++DFG+
Sbjct: 117 TSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGM 176
Query: 822 SR-LKHNTFLSSKSTAGTP-EWMAPE-VLRNEPSNEKCDVYSFGVILWELATL--KLPWI 876
SR L + + + A P WMA E VL + + K DV++FGV LWE+ TL + P+
Sbjct: 177 SRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFT-TKSDVWAFGVTLWEILTLCREQPYE 235
Query: 877 GMNPMQVVGAVG--FQNRRLEI--------PKELDPLVARIIWECWQTDPSLRPSFAQL 925
+ QV+ G F++ +I PK+ + ++ ECW+ D RP+F ++
Sbjct: 236 HLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKD----IYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 84/263 (31%), Positives = 127/263 (48%), Gaps = 16/263 (6%)
Query: 682 ERIGLGSYGEVY-----HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
E IG G +GEV VA+K L ++ +F E IM + HPN++
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKT-LKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPT 795
G VT+ + IITEF+ G+L L + Q + + M A GM L S
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL--SEMN 126
Query: 796 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN-----TFLSSKSTAGTPEWMAPEVLRNE 850
VHRDL + N+LV+ N KVSDFGLSR + T+ SS W APE +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 851 PSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 909
DV+S+G+++WE+ + + P+ M+ V+ A+ Q+ RL P + + +++
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRLPPPMDCPTALHQLML 245
Query: 910 ECWQTDPSLRPSFAQLTVALKPL 932
+CWQ D + RP F Q+ L +
Sbjct: 246 DCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 7e-32
Identities = 80/264 (30%), Positives = 128/264 (48%), Gaps = 21/264 (7%)
Query: 684 IGLGSYGEVYHADWNGTE-------VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+G G +GEV+ A G E V VK EF+RE+ + R+L H NVV
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVV 71
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE--------KRRIKMALD-ARGMN 787
+G +I E+ G L + L + ++ K+++ + A GM+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 788 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEV 846
H S VHRDL + N LV VKVS LS+ +N+ A P W+APE
Sbjct: 132 --HLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEA 189
Query: 847 LRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 905
++ + + K DV+SFGV++WE+ T +LP+ G++ +V+ + L +P+ +
Sbjct: 190 VQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLY 249
Query: 906 RIIWECWQTDPSLRPSFAQLTVAL 929
+++ CW +P RPSF++L AL
Sbjct: 250 KLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 89/283 (31%), Positives = 150/283 (53%), Gaps = 33/283 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG---------TEVAVKKFLDQDFSGAALLEFKR 722
E+P + LVLG+ +G G +G+V A+ G T+VAVK L D + L +
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVK-MLKSDATEKDLSDLIS 72
Query: 723 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL-----------HRPHCQ 770
E+++M+ + +H N++ +GA T+ L +I E+ +G+L L + P
Sbjct: 73 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQV 132
Query: 771 VDEKRRIKMALD-----ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825
+E+ K + ARGM L ++ +HRDL + N+LV ++ +K++DFGL+R
Sbjct: 133 PEEQLSFKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 826 HNTFLSSKSTAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQ 882
H+ K+T G +WMAPE L + + DV+SFGV+LWE+ TL P+ G+ P++
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVE 249
Query: 883 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 925
+ + + R++ P + ++ +CW PS RP+F QL
Sbjct: 250 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 88/279 (31%), Positives = 144/279 (51%), Gaps = 24/279 (8%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
E+ E + + +G GS+G VY G T VA+K +++ S +EF E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKT-VNEAASMRERIEFLNEA 60
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH--RPHCQVDE-------KR 775
+M+ +VV +G V++ +I E + RG L L RP + + K+
Sbjct: 61 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120
Query: 776 RIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 834
I+MA + A GM L+ + VHRDL + N +V +++ VK+ DFG++R + T K
Sbjct: 121 MIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 835 TAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 891
G WM+PE L++ DV+SFGV+LWE+ATL + P+ GM+ QV+ V +
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV-MEG 237
Query: 892 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 930
L+ P ++ ++ CWQ +P +RPSF ++ ++K
Sbjct: 238 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 88/262 (33%), Positives = 132/262 (50%), Gaps = 24/262 (9%)
Query: 681 GERIGLGSYGEVYHADWN-GTEVAVKKF-LDQDFSGAALLEFKR---EVKIMRRLRHPNV 735
GE +G G+YG VY N G +AVK+ LD AA E+++ EV +++ L+H N+
Sbjct: 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHR--PHCQVDEKRRIKMALDARGMNCLHTST 793
V ++G +SI EF+P GS+ IL+R P + + K LD G+ LH +
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD--GVAYLHNNC 122
Query: 794 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSR--------LKHNTFLSSKSTAGTPEWMAPE 845
+VHRD+K N+++ N +K+ DFG +R H+ L KS GTP WMAPE
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML--KSMHGTPYWMAPE 178
Query: 846 VLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPL 903
V+ K D++S G ++E+AT K P M+ + + +G +R L +P
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG-AHRGLMPRLPDSFSAA 237
Query: 904 VARIIWECWQTDPSLRPSFAQL 925
+ C D RPS QL
Sbjct: 238 AIDFVTSCLTRDQHERPSALQL 259
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 90/283 (31%), Positives = 138/283 (48%), Gaps = 31/283 (10%)
Query: 675 WEDLVLGERIGLGSYGEVYHA----DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
WED+ + IG G++G+V A D A+K L + S +F E++++ +L
Sbjct: 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIK-MLKEFASENDHRDFAGELEVLCKL 59
Query: 731 -RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL---------------HRPHCQVDEK 774
HPN++ +GA L I E+ P G+L L H + +
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119
Query: 775 RRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 833
+ ++ A D A GM L S +HRDL + N+LV +N K++DFGLSR + + K
Sbjct: 120 QLLQFASDVATGMQYL--SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEE---VYVK 174
Query: 834 STAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLK-LPWIGMNPMQVVGAVGFQ 890
T G WMA E L K DV+SFGV+LWE+ +L P+ GM ++ + Q
Sbjct: 175 KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP-Q 233
Query: 891 NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 933
R+E P+ D V ++ +CW+ P RP FAQ++V L +
Sbjct: 234 GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 71/261 (27%), Positives = 126/261 (48%), Gaps = 20/261 (7%)
Query: 681 GERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGA----ALLEFKREVKIMRRLRHPN 734
G+++G G++ Y A GT +AVK+ + + + ++E+++M RL HP+
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDA-RGMNCLHTST 793
++ +GA + ++ E++ GS+ +L + + E I RG++ LH +
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQ 123
Query: 794 PTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHNTFLSSKST-----AGTPEWMAPEVL 847
I+HRD+K NLL+D ++++DFG + + + GT +MAPEVL
Sbjct: 124 --IIHRDVKGANLLIDSTGQRLRIADFG-AAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180
Query: 848 RNEPSNEKCDVYSFGVILWELATLKLPWIG---MNPMQVVGAVGFQNRRLEIPKELDPLV 904
R E CDV+S G ++ E+AT K PW N + ++ + IP+ L P +
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGL 240
Query: 905 ARIIWECWQTDPSLRPSFAQL 925
+ C + P RP +L
Sbjct: 241 RDVTLRCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 4e-31
Identities = 79/264 (29%), Positives = 139/264 (52%), Gaps = 26/264 (9%)
Query: 681 GERIGLGSYGEVY---HADWNGTEVAVKKF------LDQDFSGAALLE-FKREVKIMRRL 730
G IG GS+G VY +A +G +AVK+ ++L+ RE+ +++ L
Sbjct: 5 GALIGSGSFGSVYLGMNAS-SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDARGMN 787
+H N+V ++G+ +L+I E++P GS+ +L+ + +E + ++ L +G+N
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQIL--KGLN 120
Query: 788 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK------STAGTPEW 841
LH I+HRD+K N+LVD +K+SDFG+S+ LS+K S G+ W
Sbjct: 121 YLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 842 MAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 901
MAPEV++ K D++S G ++ E+ T K P+ +Q + +G +N EIP +
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-ENASPEIPSNIS 237
Query: 902 PLVARIIWECWQTDPSLRPSFAQL 925
+ + ++ D + RP+ A+L
Sbjct: 238 SEAIDFLEKTFEIDHNKRPTAAEL 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 89/288 (30%), Positives = 142/288 (49%), Gaps = 45/288 (15%)
Query: 673 IPWEDLVLGERIGLGSYGEVYHA----DWNGTEVAVKKFLD-------QDFSGAALLEFK 721
+ W D+ + IG G++G+V A D + A+K+ + +DF+G
Sbjct: 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG------- 56
Query: 722 REVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSL---------------FRILH 765
E++++ +L HPN++ +GA L + E+ P G+L F I +
Sbjct: 57 -ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 115
Query: 766 RPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824
+ ++ + A D ARGM+ L S +HRDL + N+LV +N+ K++DFGLSR
Sbjct: 116 STASTLSSQQLLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSRG 173
Query: 825 KHNTFLSSKSTAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPM 881
+ + K T G WMA E L DV+S+GV+LWE+ +L P+ GM
Sbjct: 174 QE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 230
Query: 882 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 929
++ + Q RLE P D V ++ +CW+ P RPSFAQ+ V+L
Sbjct: 231 ELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 82/267 (30%), Positives = 127/267 (47%), Gaps = 31/267 (11%)
Query: 676 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKK--FLDQDFSGAALLEFKREVKIMRRLR 731
DL + +G GS G VY G A+KK + LL RE+K +R
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLL---RELKTLRSCE 57
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDAR----GMN 787
P VV GA + +SI+ E++ GSL L + ++ E +A AR G++
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSL-ADLLKKVGKIPEP---VLAYIARQILKGLD 113
Query: 788 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL------KHNTFLSSKSTAGTPEW 841
LHT I+HRD+K NLL++ VK++DFG+S++ + NTF+ GT +
Sbjct: 114 YLHT-KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV------GTVTY 166
Query: 842 MAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI---GMNPMQVVGAVGFQNRRLEIPK 898
M+PE ++ E + D++S G+ L E A K P++ + +++ A+ +
Sbjct: 167 MSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAE 226
Query: 899 ELDPLVARIIWECWQTDPSLRPSFAQL 925
E P I C Q DP RPS A+L
Sbjct: 227 EFSPEFRDFISACLQKDPKKRPSAAEL 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 83/253 (32%), Positives = 131/253 (51%), Gaps = 20/253 (7%)
Query: 682 ERIGLGSYGEVYHADW--NGTEVAVK---KFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
ERIG G++GEV+ + T VAVK + L D +F +E +I+++ HPN+V
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA----KFLQEARILKQYSHPNIV 56
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDAR-GMNCLHTSTPT 795
+G T+ + I+ E + G L ++ K I+M +A GM L +
Sbjct: 57 RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH-- 114
Query: 796 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WMAPEVLRNEP 851
+HRDL + N LV + +K+SDFG+SR + + +S T G + W APE L
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS--TGGMKQIPVKWTAPEALNYGR 172
Query: 852 SNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 910
+ + DV+SFG++LWE +L +P+ ++ Q A+ Q RL P+ V R++
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPDAVYRLMER 231
Query: 911 CWQTDPSLRPSFA 923
CW+ DP RPSF+
Sbjct: 232 CWEYDPGQRPSFS 244
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 85/274 (31%), Positives = 136/274 (49%), Gaps = 44/274 (16%)
Query: 675 WEDLVLGERIGLGSYGEVYHADWNGTEV-AVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
WE ++GE +G G++G+VY A T + A K + + S L +F E+ I+ +HP
Sbjct: 7 WE--IIGE-LGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHP 62
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDARGMNCLHTS 792
N+V A L I+ EF G+L I+ + E + R +N LH+
Sbjct: 63 NIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH 122
Query: 793 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNTFLSSKSTAGTPEWMAPEV 846
++HRDLK+ N+L+ + +VK++DFG+S K +TF+ GTP WMAPEV
Sbjct: 123 K--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI------GTPYWMAPEV 174
Query: 847 L-----RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 901
+ ++ P + K D++S G+ L ELA ++ P +NPM+V+ L+I K
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL---------LKILKSEP 225
Query: 902 PLVAR----------IIWECWQTDPSLRPSFAQL 925
P + + + C DP RP+ A+L
Sbjct: 226 PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAEL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 64/253 (25%), Positives = 123/253 (48%), Gaps = 7/253 (2%)
Query: 677 DLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 734
D + +IG GS+G V+ + A+K+ + E E +++ +L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ-VDEKRRIKMALDAR-GMNCLHTS 792
++ + + L+I+ E+ G L ++L + + E + + + G+ LH+
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 793 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 852
I+HRD+KS NL +D NVK+ D G+++L + + + GTP +++PE+ ++P
Sbjct: 121 K--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPY 178
Query: 853 NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 912
NEK DV++ GV+L+E T K P+ N ++ + + + + +A++I +C
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPFDANNQGALILKI-IRGVFPPVSQMYSQQLAQLIDQCL 237
Query: 913 QTDPSLRPSFAQL 925
D RP QL
Sbjct: 238 TKDYRQRPDTFQL 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 74/249 (29%), Positives = 118/249 (47%), Gaps = 13/249 (5%)
Query: 684 IGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 741
+G GSYG VY A+K+ S + E++I+ + HPN++ + A
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 742 VTRPPNLSIITEFLPRGSLFRILHRPHCQV-----DEKRRIKMALDARGMNCLHTSTPTI 796
L I+ E+ P G L + + + + E RI + L RG+ LH I
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQL-LRGLQALHEQK--I 124
Query: 797 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKC 856
+HRDLKS N+L+ N VK+ D G+S++ K+ GTP +MAPEV + P + K
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGISKVLKKNMA--KTQIGTPHYMAPEVWKGRPYSYKS 182
Query: 857 DVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 916
D++S G +L+E+AT P+ + MQ + + + IP + I Q P
Sbjct: 183 DIWSLGCLLYEMATFAPPFEARS-MQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKP 241
Query: 917 SLRPSFAQL 925
LRP+ ++
Sbjct: 242 KLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 76/279 (27%), Positives = 126/279 (45%), Gaps = 31/279 (11%)
Query: 678 LVLGERIGLGSYGEVYHADWNGTE-----VAVKKFLDQDFSGAALLEFKREVKIMRRLRH 732
L LG+ +G G +G V + + VAVK + + + EF E M+ H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 733 PNVVLFMG------AVTRPPNLSIITEFLPRGSLFRILHRPHCQ-----VDEKRRIKMAL 781
PNV+ +G ++ + P +I F+ G L L + + +K +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 782 D-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN-TFLSSKSTAGTP 839
D A GM L S +HRDL + N ++ ++ V V+DFGLS+ ++ + A P
Sbjct: 121 DIALGMEYL--SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 178
Query: 840 -EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVG-----AVGFQNRR 893
+W+A E L + K DV++FGV +WE+AT G P V R
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATR-----GQTPYPGVENHEIYDYLRHGNR 233
Query: 894 LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932
L+ P++ + +++ CW+ DP RP+F +L L+ +
Sbjct: 234 LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 86/277 (31%), Positives = 138/277 (49%), Gaps = 31/277 (11%)
Query: 684 IGLGSYGEV----YH--ADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+G G++G V Y D G VAVKK Q + L +F+RE++I++ L+H N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKL--QHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 738 FMGAVTRP--PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTP 794
+ G NL ++ E+LP GSL L + ++D ++ + A +GM L +
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL--GSK 127
Query: 795 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPE-WMAPEVLRNEP 851
VHRDL + N+LV+ VK+ DFGL+++ + + + +P W APE L
Sbjct: 128 RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK 187
Query: 852 SNEKCDVYSFGVILWELAT----------LKLPWIGMN---PMQVVGAVGF--QNRRLEI 896
+ DV+SFGV+L+EL T + +G + M V + N RL
Sbjct: 188 FSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPA 247
Query: 897 PKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 933
P + I+ ECW DPS RPSF++L + ++ ++
Sbjct: 248 PPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 83/285 (29%), Positives = 135/285 (47%), Gaps = 28/285 (9%)
Query: 682 ERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRLRH---PNVVL 737
E IG G+YG VY T V K ++ D + + +REV ++ +LR PN+
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEK------RRIKMALDARGMNCLHT 791
+ G+ + P L II E+ GS+ R L + + EK R + +AL +H
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGP-IAEKYISVIIREVLVAL-----KYIHK 119
Query: 792 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 851
++HRD+K+ N+LV NVK+ DFG++ L + + GTP WMAPEV+
Sbjct: 120 VG--VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGK 177
Query: 852 S-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG-FQNRRLEIPKELDPLVARIIW 909
+ K D++S G+ ++E+AT P+ ++ + + + + RLE L+ +
Sbjct: 178 YYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLE-DNGYSKLLREFVA 236
Query: 910 ECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQEISV 954
C +P R S +L L+ I +H P S L + IS
Sbjct: 237 ACLDEEPKERLSAEEL------LKSKWIKAHSKTPVSILKELISR 275
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 81/255 (31%), Positives = 126/255 (49%), Gaps = 18/255 (7%)
Query: 684 IGLGSYGEVYHA-----DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
IG G +G VYH D AVK L++ + +F +E IM+ HPNV+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKS-LNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 739 MGAVTRPPNLS-IITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTI 796
+G ++ ++ G L + K I L A+GM L ++
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL--ASKKF 119
Query: 797 VHRDLKSPNLLVDKNWNVKVSDFGLSR---LKHNTFLSSKSTAGTP-EWMAPEVLRNEPS 852
VHRDL + N ++D+++ VKV+DFGL+R K + + + A P +WMA E L+ +
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKF 179
Query: 853 NEKCDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKEL-DPLVARIIWE 910
K DV+SFGV+LWEL T P+ ++ + + Q RRL P+ DPL ++
Sbjct: 180 TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL-LQGRRLLQPEYCPDPLY-EVMLS 237
Query: 911 CWQTDPSLRPSFAQL 925
CW P +RP+F++L
Sbjct: 238 CWHPKPEMRPTFSEL 252
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 87/272 (31%), Positives = 137/272 (50%), Gaps = 33/272 (12%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
+D L E IG+G+ VY A N +VA+K+ +D + ++ E ++EV+ M + HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKR-IDLEKCQTSVDELRKEVQAMSQCNHP 59
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR--PHCQVDEKRRIKMALDA--RGMNCL 789
NVV + + L ++ +L GSL I+ P +DE I L +G+ L
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAI-IATVLKEVLKGLEYL 118
Query: 790 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS----------RLKHNTFLSSKSTAGTP 839
H++ +HRD+K+ N+L+ ++ +VK++DFG+S R TF GTP
Sbjct: 119 HSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF------VGTP 170
Query: 840 EWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--RLEI 896
WMAPEV+ + K D++SFG+ ELAT P+ PM+V+ + QN LE
Sbjct: 171 CWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL-MLTLQNDPPSLET 229
Query: 897 PKELDP---LVARIIWECWQTDPSLRPSFAQL 925
+ ++I C Q DPS RP+ +L
Sbjct: 230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEEL 261
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 87/290 (30%), Positives = 149/290 (51%), Gaps = 33/290 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE---------VAVKKFLDQDFSGAALLEFKR 722
E P + LVLG+ +G G +G+V A+ G + VAVK L + + L +
Sbjct: 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVK-MLKDNATDKDLADLIS 66
Query: 723 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSL---------------FRILHR 766
E+++M+ + +H N++ +G T+ L +I E+ +G+L F I
Sbjct: 67 EMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKV 126
Query: 767 PHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825
P Q+ K + A ARGM L + +HRDL + N+LV ++ +K++DFGL+R
Sbjct: 127 PEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDNVMKIADFGLARGV 184
Query: 826 HNTFLSSKSTAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQ 882
H+ K++ G +WMAPE L + + DV+SFG+++WE+ TL P+ G+ P++
Sbjct: 185 HDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI-PVE 243
Query: 883 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932
+ + + R++ P + ++ ECW P+ RP+F QL AL +
Sbjct: 244 ELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 87/294 (29%), Positives = 137/294 (46%), Gaps = 42/294 (14%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
E P ++ IG G++G V+ A G T VAVK L ++ S +F+RE
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVK-MLKEEASADMQADFQREA 59
Query: 725 KIMRRLRHPNVVLFMG--AVTRPPNLSIITEFLPRGSLFRILHR---------------- 766
+M HPN+V +G AV +P + ++ E++ G L L
Sbjct: 60 ALMAEFDHPNIVKLLGVCAVGKP--MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSA 117
Query: 767 -----PHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 820
+ ++ +A A GM + S VHRDL + N LV +N VK++DFG
Sbjct: 118 RKCGLNPLPLSCTEQLCIAKQVAAGM--AYLSERKFVHRDLATRNCLVGENMVVKIADFG 175
Query: 821 LSRLKHNT--FLSSKSTAGTPEWMAPE-VLRNEPSNEKCDVYSFGVILWELATLKL-PWI 876
LSR ++ + +S++ A WM PE + N + E DV+++GV+LWE+ + + P+
Sbjct: 176 LSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTES-DVWAYGVVLWEIFSYGMQPYY 234
Query: 877 GMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 930
GM +V+ V N L P + ++ CW PS RPSFA + L+
Sbjct: 235 GMAHEEVIYYVRDGN-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 81/276 (29%), Positives = 131/276 (47%), Gaps = 25/276 (9%)
Query: 678 LVLGERIGLGSYGEVYHA-----DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH 732
LG +G G +G V A D + +VAVK FS + + EF RE M+ H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 733 PNVVLFMG------AVTRPPNLSIITEFLPRGSLF------RILHRPHCQVDEKRRIKMA 780
PNV+ +G A R P +I F+ G L RI P + + ++
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPF-TLPLQTLVRFM 119
Query: 781 LD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGT 838
+D A GM L S+ +HRDL + N ++++N V V+DFGLS+ + + +
Sbjct: 120 IDIASGMEYL--SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 839 P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEI 896
P +W+A E L + DV++FGV +WE+ T + P+ G+ ++ + + RL+
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL-IKGNRLKQ 236
Query: 897 PKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932
P + V ++ +CW +P RPSF L L+ +
Sbjct: 237 PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 77/261 (29%), Positives = 125/261 (47%), Gaps = 39/261 (14%)
Query: 683 RIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGA-ALLEFKREVKIMRRLRHPNVVLFM 739
+IG G + VY A +G VA+KK + A A + +E+ ++++L HPNV+ ++
Sbjct: 9 KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYL 68
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQ---VDEKRRIKMALD-ARGMNCLHTSTPT 795
+ L+I+ E G L R++ Q + E+ K + + +H+
Sbjct: 69 ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR-- 126
Query: 796 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA-----GTPEWMAPEVLRNE 850
I+HRD+K N+ + VK+ D GL R F SSK+TA GTP +M+PE +
Sbjct: 127 IMHRDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVGTPYYMSPERIHEN 181
Query: 851 PSNEKCDVYSFGVILWELATLKLPWIG--MNPMQVVGAVGFQN-RRLEIP--------KE 899
N K D++S G +L+E+A L+ P+ G MN + + + + P +E
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL-----CKKIEKCDYPPLPADHYSEE 236
Query: 900 LDPLVARIIWECWQTDPSLRP 920
L LV+R C DP RP
Sbjct: 237 LRDLVSR----CINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 81/258 (31%), Positives = 127/258 (49%), Gaps = 12/258 (4%)
Query: 684 IGLGSYGEVYHADW---NGTEVAVK-KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
IG G +GEV E+ V K L ++ +F E IM + HPN++
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVH 798
G VT+ + I+TE++ GSL L + Q + + M A GM L S VH
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL--SDMGYVH 129
Query: 799 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP---EWMAPEVLRNEPSNEK 855
RDL + N+LV+ N KVSDFGLSR+ + ++ +T G W APE +
Sbjct: 130 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSA 189
Query: 856 CDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 914
DV+S+G+++WE+ + + P+ M+ V+ A+ + RL P + + +++ +CWQ
Sbjct: 190 SDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-EGYRLPAPMDCPAALHQLMLDCWQK 248
Query: 915 DPSLRPSFAQLTVALKPL 932
D + RP F Q+ L L
Sbjct: 249 DRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 6e-29
Identities = 81/269 (30%), Positives = 133/269 (49%), Gaps = 30/269 (11%)
Query: 676 EDLVLGERIGLGSYGEVYHA-------DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMR 728
D+VL +G G++G+V+ A + + VAVK ++ S +A +F+RE +++
Sbjct: 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLT 62
Query: 729 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRR---------- 776
L+H ++V F G T L ++ E++ G L R L H P ++
Sbjct: 63 VLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLG 122
Query: 777 --IKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--FLS 831
+ +A A GM ++ ++ VHRDL + N LV + VK+ DFG+SR ++T +
Sbjct: 123 QMLAIASQIASGM--VYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 180
Query: 832 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQ 890
T WM PE + + D++SFGV+LWE+ T K PW ++ + + + Q
Sbjct: 181 GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT-Q 239
Query: 891 NRRLEIPKELDPLVARIIWECWQTDPSLR 919
R LE P+ P V I+ CWQ +P R
Sbjct: 240 GRELERPRTCPPEVYAIMQGCWQREPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 7e-29
Identities = 90/296 (30%), Positives = 142/296 (47%), Gaps = 41/296 (13%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE----------------VAVKKFLDQDFSGA 715
E P + L L E++G G +GEV+ + G VAVK L D +
Sbjct: 1 EFPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKM-LRADVTKT 59
Query: 716 ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ----- 770
A +F +E+KIM RL++PN++ +G L +ITE++ G L + L + +
Sbjct: 60 ARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTH 119
Query: 771 ------VDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 823
V + MA+ A GM L ++ VHRDL + N LV ++ +K++DFG+SR
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYL--ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177
Query: 824 -LKHNTFLSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL--KLPWIGMN 879
L + + A P WMA E + DV++FGV LWE+ TL + P+ ++
Sbjct: 178 NLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237
Query: 880 PMQVVGAVG--FQNRRLEIPKELDPL----VARIIWECWQTDPSLRPSFAQLTVAL 929
QV+ G F+N+ +I PL V +++ CW D RP+F ++ L
Sbjct: 238 DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 8e-29
Identities = 72/248 (29%), Positives = 119/248 (47%), Gaps = 25/248 (10%)
Query: 684 IGLGSYGEVY---HADWNGTEVAVKKFLDQD--FSGAALLEFKREVKIMRRLRHPNVV-L 737
+G GS+G+V D G A+K L + + E I+ R+ HP +V L
Sbjct: 1 LGKGSFGKVLLVRKKD-TGKLYAMKV-LKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR------RIKMALDARGMNCLHT 791
T L ++ E+ P G LF L + E+R I +AL+ LH+
Sbjct: 59 HYAFQT-EEKLYLVLEYAPGGELFSHLSKEGR-FSEERARFYAAEIVLALEY-----LHS 111
Query: 792 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 851
I++RDLK N+L+D + ++K++DFGL++ + + + GTPE++APEVL +
Sbjct: 112 LG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKG 169
Query: 852 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 911
+ D +S GV+L+E+ T K P+ + ++ + L P+ L P +I
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI--LKDPLRFPEFLSPEARDLISGL 227
Query: 912 WQTDPSLR 919
Q DP+ R
Sbjct: 228 LQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 9e-29
Identities = 88/285 (30%), Positives = 136/285 (47%), Gaps = 50/285 (17%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSG--AALLEFKR 722
E P +L G+ +G G++G+V A G +VAVK S AL+
Sbjct: 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS--- 87
Query: 723 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL 781
E+KIM L H N+V +GA T + +ITE+ G L L R KR + L
Sbjct: 88 ELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRR-------KRESFLTL 140
Query: 782 D---------ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLS 831
+ A+GM L ++ +HRDL + N+L+ VK+ DFGL+R + +++
Sbjct: 141 EDLLSFSYQVAKGMAFL--ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV 198
Query: 832 SKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGM-------NPMQ 882
K A P +WMAPE + N + DV+S+G++LWE+ +L P+ GM ++
Sbjct: 199 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK 258
Query: 883 VVGAVGFQNRRLE-IPKELDPLVARIIWECWQTDPSLRPSFAQLT 926
G++ + E P E + I+ CW DP RP+F Q+
Sbjct: 259 ----EGYRMAQPEHAPAE----IYDIMKTCWDADPLKRPTFKQIV 295
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 1e-28
Identities = 86/283 (30%), Positives = 145/283 (51%), Gaps = 33/283 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE---------VAVKKFLDQDFSGAALLEFKR 722
E + L LG+ +G G +G+V A+ G + VAVK L D + L +
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVK-MLKDDATEKDLSDLVS 69
Query: 723 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSL---------------FRILHR 766
E+++M+ + +H N++ +GA T+ L +I E+ +G+L + I
Sbjct: 70 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARV 129
Query: 767 PHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825
P Q+ K + ARGM L ++ +HRDL + N+LV +N +K++DFGL+R
Sbjct: 130 PDEQMTFKDLVSCTYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDV 187
Query: 826 HNTFLSSKSTAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQ 882
+N K+T G +WMAPE L + + DV+SFGV++WE+ TL P+ G+ P++
Sbjct: 188 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVE 246
Query: 883 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 925
+ + + R++ P + ++ +CW PS RP+F QL
Sbjct: 247 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQL 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 84/260 (32%), Positives = 128/260 (49%), Gaps = 16/260 (6%)
Query: 684 IGLGSYGEVYHADWN---GTEVAVK-KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
IG G +GEV+ EVAV K L ++ +F E IM + H N++
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVH 798
G VT+ IITE++ G+L + L + + + M A GM L S VH
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL--SDMNYVH 130
Query: 799 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP---EWMAPEVLRNEPSNEK 855
RDL + N+LV+ N KVSDFGLSR+ + + +T+G W APE +
Sbjct: 131 RDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSA 190
Query: 856 CDVYSFGVILWELATL-KLPWIGMNPMQVVGAV--GFQNRRLEIPKELDPLVARIIWECW 912
DV+SFG+++WE+ + + P+ M+ +V+ A+ GF RL P + V +++ +CW
Sbjct: 191 SDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF---RLPAPMDCPSAVYQLMLQCW 247
Query: 913 QTDPSLRPSFAQLTVALKPL 932
Q D + RP F + L L
Sbjct: 248 QQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 90/293 (30%), Positives = 137/293 (46%), Gaps = 46/293 (15%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE-------VAVKKFLDQDFSGAALLEFKREV 724
EI + E +G +G+VY GT VA+K D+ G EFK E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK-AEGPLREEFKHEA 59
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL--FRILHRPHCQV---DEKRRIKM 779
+ RL+HPN+V +G VT+ LS+I + L F ++ PH V D+ + +K
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 780 ALD-----------ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR----- 823
L+ A GM L S+ +VH+DL + N+LV NVK+SD GL R
Sbjct: 120 TLEPADFVHIVTQIAAGMEFL--SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 824 ----LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGM 878
L N+ L + WM+PE + + D++S+GV+LWE+ + L P+ G
Sbjct: 178 DYYKLMGNSLLPIR-------WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230
Query: 879 NPMQVVGAVGFQNRR-LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 930
+ V+ + +NR+ L P + V ++ ECW PS RP F + L+
Sbjct: 231 SNQDVIEMI--RNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 91/283 (32%), Positives = 148/283 (52%), Gaps = 33/283 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE---------VAVKKFLDQDFSGAALLEFKR 722
E+ L LG+ +G G +G+V A+ G + VAVK L D + L +
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVK-MLKDDATDKDLSDLVS 66
Query: 723 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH--RP--------HCQV 771
E+++M+ + +H N++ +GA T+ L ++ E+ +G+L L RP C++
Sbjct: 67 EMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL 126
Query: 772 DE-----KRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825
E K + A ARGM L ++ +HRDL + N+LV ++ +K++DFGL+R
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDV 184
Query: 826 HNTFLSSKSTAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQ 882
HN K+T G +WMAPE L + + DV+SFGV+LWE+ TL P+ G+ P++
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVE 243
Query: 883 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 925
+ + + R++ P + I+ ECW PS RP+F QL
Sbjct: 244 ELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQL 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 73/249 (29%), Positives = 130/249 (52%), Gaps = 8/249 (3%)
Query: 682 ERIGLGSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLE---FKREVKIMRRLRHPNVVL 737
++IG GS+G++Y A + +E V K + D + + E K+EV ++ +++HPN+V
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIK--EIDLTKMPVKEKEASKKEVILLAKMKHPNIVT 63
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIV 797
F + L I+ E+ G L + ++R + + +I + H I+
Sbjct: 64 FFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKIL 123
Query: 798 HRDLKSPNLLVDKNWNV-KVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKC 856
HRD+KS N+ + KN V K+ DFG++R +++ + + GTP +++PE+ +N P N K
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKT 183
Query: 857 DVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 916
D++S G +L+EL TLK P+ G N Q+V + Q I + +I + ++ P
Sbjct: 184 DIWSLGCVLYELCTLKHPFEGNNLHQLVLKI-CQGYFAPISPNFSRDLRSLISQLFKVSP 242
Query: 917 SLRPSFAQL 925
RPS +
Sbjct: 243 RDRPSITSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 86/274 (31%), Positives = 131/274 (47%), Gaps = 24/274 (8%)
Query: 672 EIPWEDLVLGERIGLGSYGEVY-----HADWNGTEVAVK-KFLDQDFSGAALLEFKREVK 725
E+P + + L +G G++GEVY D + E+ V K L + S +F E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 726 IMRRLRHPNVVLFMG-AVTRPPNLSIITEFLPRGSLFRILH--RPH----CQVDEKRRIK 778
IM + H N+V +G + R P I+ E + G L L RP + K +
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRF-ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF 120
Query: 779 MALD-ARGMNCLHTSTPTIVHRDLKSPN-LLVDKNWN--VKVSDFGLSR-LKHNTFLSSK 833
A D A+G L + +HRD+ + N LL K K++DFG++R + ++
Sbjct: 121 CARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178
Query: 834 STAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 891
A P +WM PE + K DV+SFGV+LWE+ +L +P+ G +V+ V
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV-TGG 237
Query: 892 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 925
RL+ PK V RI+ +CWQ P RP+FA +
Sbjct: 238 GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATI 271
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 7e-28
Identities = 94/297 (31%), Positives = 143/297 (48%), Gaps = 42/297 (14%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE------------------VAVKKFLDQDFS 713
E P + L E++G G +GEV+ + G E VAVK L +D +
Sbjct: 1 EFPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVK-MLREDAN 59
Query: 714 GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQ- 770
A +F +E+KIM RL+ PN++ + L +ITE++ G L + L H P
Sbjct: 60 KNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAA 119
Query: 771 VDEKRR-------IKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 822
I MA A GM L S+ VHRDL + N LV KN+ +K++DFG+S
Sbjct: 120 EKADVVTISYSTLIFMATQIASGMKYL--SSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 823 R-LKHNTFLSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL--KLPWIGM 878
R L + + A P WM+ E + DV++FGV LWE+ TL + P+ +
Sbjct: 178 RNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237
Query: 879 NPMQVVGAVG-F---QNRRLEIPKE-LDP-LVARIIWECWQTDPSLRPSFAQLTVAL 929
+ QV+ G F Q R++ +PK L P + +++ CW+ + RPSF ++ L
Sbjct: 238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 8e-28
Identities = 85/290 (29%), Positives = 141/290 (48%), Gaps = 38/290 (13%)
Query: 677 DLVLGERIGLGSYGEVYHA---DWNG----TEVAVKKFLDQDFSGAALLEFKREVKIMRR 729
+LVLG+ +G G +G+V A G T VAVK L ++ S + L + E ++++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVK-MLKENASSSELRDLLSEFNLLKQ 59
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR-----PHCQVDEKRRIKMALDA- 783
+ HP+V+ GA ++ L +I E+ GSL L P + R LD
Sbjct: 60 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 784 ------------------RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-- 823
RGM L + +VHRDL + N+LV + +K+SDFGLSR
Sbjct: 120 DERALTMGDLISFAWQISRGMQYL--AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 824 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQ 882
+ ++++ +WMA E L + + DV+SFGV+LWE+ TL P+ G+ P +
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237
Query: 883 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932
+ + R+E P+ + ++ CW+ +P RP+FA ++ L+ +
Sbjct: 238 LFNLLK-TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 74/215 (34%), Positives = 113/215 (52%), Gaps = 7/215 (3%)
Query: 674 PWEDLVLGERIGLGSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH 732
P ED L +RIG G+YG+VY A + N E+A K + + G ++E+ +M+ +H
Sbjct: 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE-PGEDFAVVQQEIIMMKDCKH 65
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTS 792
N+V + G+ R L I EF GSL I H + + +G+ LH+
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK 125
Query: 793 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL---RN 849
+HRD+K N+L+ N +VK++DFG+S T KS GTP WMAPEV R
Sbjct: 126 GK--MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERK 183
Query: 850 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV 884
N+ CD+++ G+ ELA L+ P ++PM+ +
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 87/273 (31%), Positives = 134/273 (49%), Gaps = 31/273 (11%)
Query: 673 IPWEDLVLGERIGLGSYGEVYHAD-WNGTE------VAVKKFLDQDFSGAALLEFKREVK 725
I D+VL +G G++G+V+ A+ +N + VAVK D AA +F+RE +
Sbjct: 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL--AARKDFQREAE 59
Query: 726 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQV---DEKRRIKMA 780
++ L+H ++V F G L ++ E++ G L + L H P + + R+ K
Sbjct: 60 LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 119
Query: 781 LD-----------ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT- 828
L A GM ++ ++ VHRDL + N LV N VK+ DFG+SR ++T
Sbjct: 120 LGLSQMLHIASQIASGM--VYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 177
Query: 829 -FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGA 886
+ T WM PE + + DV+SFGVILWE+ T K PW ++ +V+
Sbjct: 178 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237
Query: 887 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLR 919
+ Q R LE P+ V I+ CWQ +P R
Sbjct: 238 IT-QGRVLERPRVCPKEVYDIMLGCWQREPQQR 269
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 1e-27
Identities = 81/266 (30%), Positives = 125/266 (46%), Gaps = 35/266 (13%)
Query: 684 IGLGSYGEVYHA-----DWNGTE---VAVKKF----LDQDFSGAALLEFKREVKIMRRLR 731
+G G++GEVY G+ VAVK DQ+ EF +E +M
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK-----EFLKEAHLMSNFN 57
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ------VDEKRRIKMALD-AR 784
HPN+V +G II E + G L L + + K + + LD A+
Sbjct: 58 HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 785 GMNCLHTSTPTIVHRDLKSPNLLV-----DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGT 838
G C++ +HRDL + N LV D + VK+ DFGL+R + + + +
Sbjct: 118 G--CVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175
Query: 839 P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEI 896
P WMAPE L + + DV+SFGV++WE+ TL + P+ +N +V+ V RL+
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-AGGRLQK 234
Query: 897 PKELDPLVARIIWECWQTDPSLRPSF 922
P+ + +++ CW DPS RP+F
Sbjct: 235 PENCPDKIYQLMTNCWAQDPSERPTF 260
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 73/304 (24%), Positives = 125/304 (41%), Gaps = 64/304 (21%)
Query: 676 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVK----KFLDQDFSGAALLEFK-----REV 724
+D G+ IG GS+ V A E A+K + L + E K E
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK--------EKKVKYVKIEK 52
Query: 725 KIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEK------RRI 777
+++ RL HP ++ NL + E+ P G L + + + + +DEK I
Sbjct: 53 EVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK-YGSLDEKCTRFYAAEI 111
Query: 778 KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS----- 832
+AL+ LH+ I+HRDLK N+L+DK+ ++K++DFG +++
Sbjct: 112 LLALEY-----LHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGD 164
Query: 833 ---------------KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG 877
S GT E+++PE+L +P+ + D+++ G I++++ T K P+ G
Sbjct: 165 ATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG 224
Query: 878 MNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVI 937
N + P P +I + DP R + LK
Sbjct: 225 SNEYLTFQKI--LKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK------- 275
Query: 938 PSHP 941
+HP
Sbjct: 276 -AHP 278
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 84/279 (30%), Positives = 136/279 (48%), Gaps = 24/279 (8%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
E+ E + L +G GS+G VY + T VAVK +++ S +EF E
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKT-VNESASLRERIEFLNEA 60
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH--RPHCQVDE-------KR 775
+M+ +VV +G V++ ++ E + G L L RP + + +
Sbjct: 61 SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 120
Query: 776 RIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 834
I+MA + A GM L+ VHRDL + N +V ++ VK+ DFG++R + T K
Sbjct: 121 MIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 835 TAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 891
G WMAPE L++ D++SFGV+LWE+ +L + P+ G++ QV+ V
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-MDG 237
Query: 892 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 930
L+ P V ++ CWQ +P +RP+F ++ LK
Sbjct: 238 GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 86/284 (30%), Positives = 138/284 (48%), Gaps = 34/284 (11%)
Query: 675 WEDLVLGERIGLGSYGEVYHADWNGTEV-AVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
WE ++GE +G G++G+VY A T A K ++ S L ++ E++I+ HP
Sbjct: 14 WE--IIGE-LGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYMVEIEILATCNHP 69
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGS-------LFRILHRPHCQVDEKRRIKMALDARGM 786
+V +GA L I+ EF P G+ L R L P QV ++ ++ +
Sbjct: 70 YIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLE------AL 123
Query: 787 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 846
LH+ I+HRDLK+ N+L+ + ++K++DFG+S T S GTP WMAPEV
Sbjct: 124 QYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEV 181
Query: 847 -----LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKEL 900
+++ P + K D++S G+ L E+A ++ P +NPM+V+ + L P +
Sbjct: 182 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKW 241
Query: 901 DPLVARIIWECWQTDPSLRPSFAQL--------TVALKPLQRLV 936
+ P RPS AQL + +PL+ LV
Sbjct: 242 SMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPLRELV 285
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 84/269 (31%), Positives = 133/269 (49%), Gaps = 29/269 (10%)
Query: 684 IGLGSYGEVYHA--DWNGTEV-AVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFM 739
IG G++G+V A +G + A K + + S +F E++++ +L HPN++ +
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 740 GAVTRPPNLSIITEFLPRGSLFRIL---------------HRPHCQVDEKRRIKMALDA- 783
GA L + E+ P G+L L + + ++ + A D
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 784 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG--TPEW 841
RGM+ L S +HRDL + N+LV +N+ K++DFGLSR + + K T G W
Sbjct: 123 RGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE---VYVKKTMGRLPVRW 177
Query: 842 MAPEVLRNEPSNEKCDVYSFGVILWELATLK-LPWIGMNPMQVVGAVGFQNRRLEIPKEL 900
MA E L DV+S+GV+LWE+ +L P+ GM ++ + Q RLE P
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPLNC 236
Query: 901 DPLVARIIWECWQTDPSLRPSFAQLTVAL 929
D V ++ +CW+ P RPSFAQ+ V+L
Sbjct: 237 DDEVYDLMRQCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 7e-27
Identities = 82/241 (34%), Positives = 128/241 (53%), Gaps = 26/241 (10%)
Query: 675 WEDLVLGERIGLGSYGEVYHADWNGTEV-AVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
WE ++GE +G G++G+VY A T V A K +D S L ++ E+ I+ HP
Sbjct: 7 WE--IIGE-LGDGAFGKVYKAQNKETGVLAAAKVIDTK-SEEELEDYMVEIDILASCDHP 62
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRI---LHRPHCQVDEKRRIKMALDARGMNCLH 790
N+V + A NL I+ EF G++ + L RP + + K L+A +N LH
Sbjct: 63 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEA--LNYLH 120
Query: 791 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL--- 847
+ I+HRDLK+ N+L + ++K++DFG+S T S GTP WMAPEV+
Sbjct: 121 ENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 178
Query: 848 --RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 905
++ P + K DV+S G+ L E+A ++ P +NPM+V+ L+I K P +A
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL---------LKIAKSEPPTLA 229
Query: 906 R 906
+
Sbjct: 230 Q 230
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 9e-27
Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 31/207 (14%)
Query: 682 ERIGLGSYGEVYHADWN---GTEVAVKKF-LDQD---FSGAALLEFKREVKIMRRLRHPN 734
E++G G+YG VY A + G VA+KK LD + AL RE+ +++ L+HPN
Sbjct: 5 EKLGEGTYGVVYKA-RDKKTGEIVALKKIRLDNEEEGIPSTAL----REISLLKELKHPN 59
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDARGMNCLHT 791
+V + + L ++ E+ L + L + + K + L RG+ H+
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLL--RGLAYCHS 116
Query: 792 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEV 846
I+HRDLK N+L++++ +K++DFGL+R T E W APE+
Sbjct: 117 HR--ILHRDLKPQNILINRDGVLKLADFGLAR-----AFGIPLRTYTHEVVTLWYRAPEI 169
Query: 847 LRNEPS-NEKCDVYSFGVILWELATLK 872
L + D++S G I E+ T K
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 1e-26
Identities = 77/254 (30%), Positives = 129/254 (50%), Gaps = 23/254 (9%)
Query: 682 ERIGLGSYGEVYHADWNGTEVAVK-KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740
ERIG GS+GEV+ N T+ V K +D + + + + ++E+ ++ + P V + G
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDARGMNCLHTSTPTIVHR 799
+ + L II E+L GS +L P + +K L +G++ LH+ +HR
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL--KGLDYLHSEKK--IHR 125
Query: 800 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVY 859
D+K+ N+L+ + +VK++DFG++ +T + + GTP WMAPEV++ + K D++
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIW 185
Query: 860 SFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA--------RIIWEC 911
S G+ ELA + P M+PM+V+ IPK P + I C
Sbjct: 186 SLGITAIELAKGEPPNSDMHPMRVL---------FLIPKNNPPTLTGEFSKPFKEFIDAC 236
Query: 912 WQTDPSLRPSFAQL 925
DPS RP+ +L
Sbjct: 237 LNKDPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 2e-26
Identities = 79/285 (27%), Positives = 139/285 (48%), Gaps = 28/285 (9%)
Query: 673 IPWEDLVLGERIGLGSYGEVYHAD-------WNGTEVAVKKFLDQDFSGAALLEFKREVK 725
I ++VL +G G++G+V+ A+ + VAVK +D S A +F RE +
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTL--KDASDNARKDFHREAE 59
Query: 726 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH------------RPHCQVDE 773
++ L+H ++V F G L ++ E++ G L + L ++ +
Sbjct: 60 LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQ 119
Query: 774 KRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--FL 830
+ + +A A GM ++ ++ VHRDL + N LV +N VK+ DFG+SR ++T +
Sbjct: 120 SQMLHIAQQIAAGM--VYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYR 177
Query: 831 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGF 889
T WM PE + + DV+S GV+LWE+ T K PW ++ +V+ +
Sbjct: 178 VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT- 236
Query: 890 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934
Q R L+ P+ V ++ CWQ +P +R + ++ L+ L +
Sbjct: 237 QGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 61/252 (24%), Positives = 121/252 (48%), Gaps = 7/252 (2%)
Query: 684 IGLGSYGE--VYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 741
+G G++GE +Y + + V K+ S + E+ I+ L+HPN++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 742 VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD--ARGMNCLHTSTPTIVHR 799
L I E+ G+L+ + R Q+ E+ + L ++ +H + I+HR
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHR 125
Query: 800 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVY 859
D+K+ N+ + K +K+ DFG+S++ + + +++ GTP +M+PE+ + N K D++
Sbjct: 126 DIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIW 185
Query: 860 SFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLR 919
+ G +L+EL TLK + NP+ +V + Q + + ++ Q DP R
Sbjct: 186 ALGCVLYELLTLKRTFDATNPLNLVVKI-VQGNYTPVVSVYSSELISLVHSLLQQDPEKR 244
Query: 920 PSFAQLTVALKP 931
P+ ++
Sbjct: 245 PTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 75/256 (29%), Positives = 129/256 (50%), Gaps = 27/256 (10%)
Query: 684 IGLGSYGEVY--HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 741
+G G++G V+ + V +K+ + + L + E ++++ L HPN++ +
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 742 VTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKR------RIKMALDARGMNCLHTSTP 794
L I+ E+ P G+L + R + +DE +I +AL H T
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH-------HVHTK 120
Query: 795 TIVHRDLKSPNLLVDKNWNV-KVSDFGLSRLKHNTFLSSKSTA----GTPEWMAPEVLRN 849
I+HRDLK+ N+L+DK+ V K+ DFG+S++ LSSKS A GTP +++PE+
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKI-----LSSKSKAYTVVGTPCYISPELCEG 175
Query: 850 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 909
+P N+K D+++ G +L+ELA+LK + N +V + I P + ++I
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKI-MSGTFAPISDRYSPDLRQLIL 234
Query: 910 ECWQTDPSLRPSFAQL 925
DPS RP +Q+
Sbjct: 235 SMLNLDPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 75/229 (32%), Positives = 115/229 (50%), Gaps = 14/229 (6%)
Query: 680 LGERIGLGSYGEVY---HADWNGTEVAVKKFL---DQDFSGAALLEFKREVKIMRRLRHP 733
LG+ +G G++GEVY AD G E+AVK+ D + + + E+++++ LRH
Sbjct: 6 LGKLLGRGAFGEVYLCYDAD-TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHD 64
Query: 734 NVVLFMGAVTRPPN--LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHT 791
+V + G + P LSI E++P GS+ L + R +G++ LH+
Sbjct: 65 RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS 124
Query: 792 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS---KSTAGTPEWMAPEVLR 848
+ IVHRD+K N+L D NVK+ DFG S+ +S KS GTP WM+PEV+
Sbjct: 125 NM--IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182
Query: 849 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 897
E K DV+S + E+ T K PW M + + Q + +P
Sbjct: 183 GEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLP 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 73/253 (28%), Positives = 127/253 (50%), Gaps = 21/253 (8%)
Query: 682 ERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740
ERIG GS+GEVY N T EV K +D + + + + ++E+ ++ + P + + G
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRD 800
+ + L II E+L GS +L +P + + +G++ LH+ +HRD
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILREILKGLDYLHSERK--IHRD 126
Query: 801 LKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYS 860
+K+ N+L+ + +VK++DFG++ +T + + GTP WMAPEV++ + K D++S
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWS 186
Query: 861 FGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV--------ARIIWECW 912
G+ ELA + P ++PM+V+ IPK P + + C
Sbjct: 187 LGITAIELAKGEPPNSDLHPMRVL---------FLIPKNSPPTLEGQYSKPFKEFVEACL 237
Query: 913 QTDPSLRPSFAQL 925
DP RP+ +L
Sbjct: 238 NKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 57/197 (28%), Positives = 110/197 (55%), Gaps = 10/197 (5%)
Query: 682 ERIGLGSYGE---VYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
++IG GS+G+ V + +G + +K+ S E ++EV ++ ++HPN+V +
Sbjct: 6 KKIGEGSFGKAILVKSKE-DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCL---HTSTPT 795
+ NL I+ ++ G L++ ++ + + +I LD CL H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQI---LDWFVQICLALKHVHDRK 121
Query: 796 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK 855
I+HRD+KS N+ + K+ +K+ DFG++R+ ++T +++ GTP +++PE+ N P N K
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNK 181
Query: 856 CDVYSFGVILWELATLK 872
D+++ G +L+E+ TLK
Sbjct: 182 SDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 66/233 (28%), Positives = 114/233 (48%), Gaps = 21/233 (9%)
Query: 684 IGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLE-FKREVKIMRRLRHPNVVLFMG 740
I G+YG V+ A T A+K D ++ E I+ + + P VV
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRD 800
+ NL ++ E+LP G L +L ++ RI +A + LH++ I+HRD
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--IIHRD 118
Query: 801 LKSPNLLVDKNWNVKVSDFGLSRL--------KHNTFLSSKSTAGTPEWMAPEVLRNEPS 852
LK N+L+D N ++K++DFGLS++ ++ K GTP+++APEV+ +
Sbjct: 119 LKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178
Query: 853 NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---RRLEIPKELDP 902
++ D +S G IL+E P+ G P ++ FQN ++E P++++
Sbjct: 179 SKTVDWWSLGCILYEFLVGIPPFHGETPEEI-----FQNILNGKIEWPEDVEV 226
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 75/272 (27%), Positives = 120/272 (44%), Gaps = 24/272 (8%)
Query: 680 LGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRHP-NVVL 737
+ ++G GS+GEVY A + VA+K + S + +E F RE++I+ L HP N+V
Sbjct: 4 ILRKLGEGSFGEVYLA-RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVK 62
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV----DEKRRIKMALDARGMNCLHTST 793
+L ++ E++ GSL +L + + E I + + LH+
Sbjct: 63 LYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQI-LSALEYLHSKG 121
Query: 794 PTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHNTFLSSKSTA------GTPEWMAPEV 846
I+HRD+K N+L+D++ VK+ DFGL++L + +S A GTP +MAPEV
Sbjct: 122 --IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179
Query: 847 LR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 903
L ++ D++S G+ L+EL T P+ G L P PL
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPL 239
Query: 904 VARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935
+ +A P RL
Sbjct: 240 SPSNPE----LISKAASDLLKKLLAKDPKNRL 267
|
Length = 384 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 2e-25
Identities = 82/272 (30%), Positives = 129/272 (47%), Gaps = 22/272 (8%)
Query: 678 LVLGERIGLGSYGEVYHADWNGTE----VAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
L LG+ +G G +G V N + VAVK + + + +F E M+ HP
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 734 NVVLFMGAVTRP------PNLSIITEFLPRGSLF------RILHRPHCQVDEKRRIKMAL 781
NV+ +G + P+ +I F+ G L R+ P + M
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 782 DARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN-TFLSSKSTAGTP- 839
A GM L S+ + +HRDL + N ++++N NV V+DFGLS+ +N + A P
Sbjct: 121 IASGMEYL--SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178
Query: 840 EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPK 898
+W+A E L + K DV+SFGV +WE+AT + P+ G+ ++ + NR + P
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD 238
Query: 899 ELDPLVARIIWECWQTDPSLRPSFAQLTVALK 930
LD L + ++ CW +P RPSF L L+
Sbjct: 239 CLDGLYS-LMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 78/267 (29%), Positives = 130/267 (48%), Gaps = 26/267 (9%)
Query: 674 PWEDLVLGERIGLGSYGEVYHA-DWNGTEVAVKKFLD----QDFSGAALLEFKREVKIMR 728
P D L +R+G G+YG+VY A + + E+A K + DFS ++E+ +++
Sbjct: 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFS-----LIQQEIFMVK 61
Query: 729 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH----RPHCQVDEKRRIKMALDAR 784
+H N+V + G+ L I E+ GSL I H Q+ R + +
Sbjct: 62 ECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL----Q 117
Query: 785 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 844
G+ LH+ +HRD+K N+L+ N +VK++DFG++ T KS GTP WMAP
Sbjct: 118 GLAYLHSKGK--MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAP 175
Query: 845 EVL---RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ---VVGAVGFQNRRLEIPK 898
EV +N N+ CD+++ G+ ELA L+ P ++PM+ ++ FQ +L+
Sbjct: 176 EVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKT 235
Query: 899 ELDPLVARIIWECWQTDPSLRPSFAQL 925
+ + +P RP+ +L
Sbjct: 236 KWSSTFHNFVKISLTKNPKKRPTAERL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 3e-25
Identities = 81/261 (31%), Positives = 122/261 (46%), Gaps = 23/261 (8%)
Query: 680 LGERIGLGSYGEVY---HADWNGTEVAVKKFL---DQDFSGAALLEFKREVKIMRRLRHP 733
LG+ +G G++G VY AD G E+AVK+ + + + + E+++++ L H
Sbjct: 6 LGKLLGQGAFGRVYLCYDAD-TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHE 64
Query: 734 NVVLFMGAVTRPP--NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHT 791
+V + G + P LSI E +P GS+ L + R G++ LH+
Sbjct: 65 RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHS 124
Query: 792 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS---KSTAGTPEWMAPEVLR 848
+ IVHRD+K N+L D NVK+ DFG S+ LS KS GTP WM+PEV+
Sbjct: 125 NM--IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182
Query: 849 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD----PLV 904
E K D++S G + E+ T K PW M + + Q +P + +
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFL 242
Query: 905 ARIIWECWQTDPSLRPSFAQL 925
RI E LRPS +L
Sbjct: 243 KRIFVEA-----KLRPSADEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 3e-25
Identities = 75/260 (28%), Positives = 124/260 (47%), Gaps = 13/260 (5%)
Query: 684 IGLGSYGEVYHADW--NGTEVAVK---KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
+G G++G VY W G V + K L++ A +EF E IM + HP++V
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIV 797
+G V P + ++T+ +P G L +H + + + + A+GM ++ +V
Sbjct: 75 LG-VCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGM--MYLEERRLV 131
Query: 798 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP--EWMAPEVLRNEPSNEK 855
HRDL + N+LV +VK++DFGL+RL + G +WMA E + +
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQ 191
Query: 856 CDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 914
DV+S+GV +WEL T P+ G+ P + + + + RL P V ++ +CW
Sbjct: 192 SDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMI 250
Query: 915 DPSLRPSFAQLTVALKPLQR 934
D RP F +L + R
Sbjct: 251 DADSRPKFKELAAEFSRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 86/268 (32%), Positives = 132/268 (49%), Gaps = 29/268 (10%)
Query: 684 IGLGSYGEVY------HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+G G +G+V D G +VAVK L + G + + K+E++I+R L H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKS-LKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 738 FMGAVTRPPNLSI--ITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTP 794
+ G T I I EFLP GSL L R +++ K+++K A+ +GM+ L +
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL--GSR 128
Query: 795 TIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNT-FLSSKSTAGTPE-WMAPEVLRNEP 851
VHRDL + N+LV+ VK+ DFGL++ ++ + + + K +P W APE L
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188
Query: 852 SNEKCDVYSFGVILWELAT------------LKLPWIGMNPMQVVGAVGF--QNRRLEIP 897
DV+SFGV L+EL T LK+ M V V + +RL P
Sbjct: 189 FYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRP 248
Query: 898 KELDPLVARIIWECWQTDPSLRPSFAQL 925
V +++ +CW+ PS R +F L
Sbjct: 249 PNCPEEVYQLMRKCWEFQPSKRTTFQNL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 69/264 (26%), Positives = 128/264 (48%), Gaps = 44/264 (16%)
Query: 676 EDLVLGERIGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFK------REVKIM 727
+D + +G GS+G V G+ A+K S A +++ K E +I+
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKIL-----SKAKIVKLKQVEHVLNEKRIL 55
Query: 728 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR------PHCQV--DEKRRIKM 779
+ +RHP +V G+ NL ++ E++P G LF L + P + + + +
Sbjct: 56 QSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQ---VVL 112
Query: 780 ALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGT 838
AL+ LH+ IV+RDLK NLL+D + +K++DFG + R+K T+ + GT
Sbjct: 113 ALEY-----LHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY----TLCGT 161
Query: 839 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLE 895
PE++APE++ ++ + D ++ G++++E+ P+ NP+Q+ ++ ++
Sbjct: 162 PEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI-----YEKILEGKVR 216
Query: 896 IPKELDPLVARIIWECWQTDPSLR 919
P P +I Q D + R
Sbjct: 217 FPSFFSPDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 86/303 (28%), Positives = 137/303 (45%), Gaps = 54/303 (17%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE------------------VAVKKFLDQDFS 713
+ P L+ E++G G +GEV+ + + VAVK L D +
Sbjct: 1 KFPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVK-ILRPDAN 59
Query: 714 GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE 773
A +F +EVKI+ RL+ PN++ +G L +ITE++ G L + L +D+
Sbjct: 60 KNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL--SSHHLDD 117
Query: 774 KRR--------------------IKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNW 812
K + +AL A GM L S+ VHRDL + N LV +N
Sbjct: 118 KEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL--SSLNFVHRDLATRNCLVGENL 175
Query: 813 NVKVSDFGLSR-LKHNTFLSSKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELAT 870
+K++DFG+SR L + + A P WMA E + DV++FGV LWE+
Sbjct: 176 TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
Query: 871 L--KLPWIGMNPMQVVGAVG--FQNRRLEIPKELDPLVARIIWE----CWQTDPSLRPSF 922
L + P+ + QV+ G F+++ ++ P + ++E CW D RPSF
Sbjct: 236 LCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSF 295
Query: 923 AQL 925
+ +
Sbjct: 296 SDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 73/263 (27%), Positives = 123/263 (46%), Gaps = 20/263 (7%)
Query: 676 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSGAALLEFK---REVKIMRR 729
+DL +G G+ G V G +AVK L+ + K RE+ I+ +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-----EAIQKQILRELDILHK 55
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDA-RGMNC 788
P +V F GA ++SI E++ GSL +IL ++ E+ K+A+ +G+
Sbjct: 56 CNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTY 115
Query: 789 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 848
LH I+HRD+K N+LV+ +K+ DFG+S N+ +K+ GT +MAPE ++
Sbjct: 116 LH-EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--AKTFVGTSSYMAPERIQ 172
Query: 849 NEPSNEKCDVYSFGVILWELATLKLPWIG-----MNPMQVVGAVGFQNRRLEIPKELDPL 903
+ K D++S G+ L ELAT + P+ +++ + + + P
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPD 232
Query: 904 VARIIWECWQTDPSLRPSFAQLT 926
+ C DP RPS+ +L
Sbjct: 233 FQDFVNLCLIKDPRERPSYKELL 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 74/258 (28%), Positives = 135/258 (52%), Gaps = 15/258 (5%)
Query: 674 PWEDLVLGERIGLGSYGEVYHADWNGTE-VAVKKFLDQDFSGAALLEFKREVKIMRRLRH 732
P E E+IG GS+GEV+ N T+ V K +D + + + + ++E+ ++ +
Sbjct: 2 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 61
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDA-RGMNCLHT 791
P V + G+ + L II E+L GS +L +DE + + + +G++ LH+
Sbjct: 62 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHS 119
Query: 792 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 851
+HRD+K+ N+L+ ++ VK++DFG++ +T + + GTP WMAPEV++
Sbjct: 120 EKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177
Query: 852 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE- 910
+ K D++S G+ ELA + P ++PM+V+ + N P L+ ++ + E
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN-----PPTLEGNYSKPLKEF 232
Query: 911 ---CWQTDPSLRPSFAQL 925
C +PS RP+ +L
Sbjct: 233 VEACLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 66/233 (28%), Positives = 110/233 (47%), Gaps = 11/233 (4%)
Query: 702 VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF 761
VA+ L S F E + + H N+V G +TR + I+TE++ G+L
Sbjct: 36 VAIHT-LRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALD 94
Query: 762 RILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 820
L + Q+ + + M A GM L S VH+ L + +LV+ + K+S F
Sbjct: 95 SFLRKHEGQLVAGQLMGMLPGLASGMKYL--SEMGYVHKGLAAHKVLVNSDLVCKISGFR 152
Query: 821 -LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGM 878
L K ++ S W APE ++ + DV+SFG+++WE+ + + P+ M
Sbjct: 153 RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212
Query: 879 NPMQVVGAV--GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 929
+ V+ AV GF RL P+ L+ +++ +CWQ + RP F+Q+ L
Sbjct: 213 SGQDVIKAVEDGF---RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 85/278 (30%), Positives = 124/278 (44%), Gaps = 50/278 (17%)
Query: 680 LGERIGLGSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNV 735
L E IG G+YG+VY H G VA+K D E K E I+R+ HPN+
Sbjct: 10 LVEVIGEGTYGKVYKARHKK-TGQLVAIKI---MDIIEDEEEEIKEEYNILRKYSNHPNI 65
Query: 736 VLFMGAVT--RPPN----LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDA------ 783
F GA PP L ++ E GS+ ++ + +R+K A
Sbjct: 66 ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLR---KKGKRLKEEWIAYILRET 122
Query: 784 -RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM 842
RG+ LH + ++HRD+K N+L+ KN VK+ DFG+S +T + GTP WM
Sbjct: 123 LRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWM 180
Query: 843 APEVLRNEPSNE-----KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 897
APEV+ + + + DV+S G+ ELA K P M+PM+ + F+ IP
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL----FK-----IP 231
Query: 898 KELDPLVAR----------IIWECWQTDPSLRPSFAQL 925
+ P + I EC + RP +L
Sbjct: 232 RNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEEL 269
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNV 735
+IG G+YG VY A G VA+KK F + AL RE+K+++ L HPN+
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTAL----REIKLLKELNHPNI 60
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK--MALDARGMNCLHTST 793
+ + +L ++ EF+ L++++ + E IK + +G+ H+
Sbjct: 61 IKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESL-IKSYLYQLLQGLAFCHSHG 118
Query: 794 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEVLR 848
I+HRDLK NLL++ +K++DFGL+R S T W APE+L
Sbjct: 119 --ILHRDLKPENLLINTEGVLKLADFGLARS-----FGSPVRPYTHYVVTRWYRAPELLL 171
Query: 849 NEPS-NEKCDVYSFGVILWELATLKLPWIGMN 879
+ + D++S G I EL + + + G +
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 7e-24
Identities = 80/282 (28%), Positives = 129/282 (45%), Gaps = 22/282 (7%)
Query: 684 IGLGSYGEVYHADWNGTEVAVK-----KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
+G G++G VY W VK K L + S A E E +M + +P+V
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIV 797
+G + + +IT+ +P G L + + + + + A+GMN L +V
Sbjct: 75 LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LV 131
Query: 798 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG-TP-EWMAPEVLRNEPSNEK 855
HRDL + N+LV +VK++DFGL++L + G P +WMA E + + +
Sbjct: 132 HRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQ 191
Query: 856 CDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 914
DV+S+GV +WEL T P+ G+ P + ++ + RL P V I+ +CW
Sbjct: 192 SDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMI 250
Query: 915 DPSLRPSFAQLT-----VALKPLQRLVI----PSHPDQPSSA 947
D RP F +L +A P + LVI H P+ +
Sbjct: 251 DADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDS 292
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 81/258 (31%), Positives = 125/258 (48%), Gaps = 19/258 (7%)
Query: 681 GERI--GLGSYGEVYHADWNGTEV--AVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
GER+ G G+YG VY A T+V A+K+ ++D L E+ + L+H N+V
Sbjct: 11 GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLH--EEIALHSYLKHRNIV 68
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI-----KMALDARGMNCLHT 791
++G+ + I E +P GSL +L + + + K L+ G+ LH
Sbjct: 69 QYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE--GLKYLHD 126
Query: 792 STPTIVHRDLKSPNLLVDKNWNV-KVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 850
+ IVHRD+K N+LV+ V K+SDFG S+ +++ GT ++MAPEV+
Sbjct: 127 N--QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKG 184
Query: 851 PS--NEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKELDPLVARI 907
P D++S G + E+AT K P+I + P + VG EIP+ L
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNF 244
Query: 908 IWECWQTDPSLRPSFAQL 925
I C++ DP R S L
Sbjct: 245 ILRCFEPDPDKRASAHDL 262
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 85/257 (33%), Positives = 123/257 (47%), Gaps = 30/257 (11%)
Query: 684 IGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLE----FKREVKIMRRLRHPNVVL 737
IG GS+G VY A T VA+KK +SG E +EV+ +++LRHPN +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMS---YSGKQSNEKWQDIIKEVRFLQQLRHPNTIE 79
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRI-KMALDARGMNCLHTSTP 794
+ G R ++ E+ GS IL H+ Q E I AL G+ LH+
Sbjct: 80 YKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGALQ--GLAYLHSHE- 135
Query: 795 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH--NTFLSSKSTAGTPEWMAPEVL--RNE 850
+HRD+K+ N+L+ + VK++DFG + L N+F+ GTP WMAPEV+ +E
Sbjct: 136 -RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWMAPEVILAMDE 188
Query: 851 PS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK-ELDPLVARII 908
+ K DV+S G+ ELA K P MN M + + QN + + +
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNDSPTLSSNDWSDYFRNFV 247
Query: 909 WECWQTDPSLRPSFAQL 925
C Q P RPS +L
Sbjct: 248 DSCLQKIPQDRPSSEEL 264
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 78/264 (29%), Positives = 122/264 (46%), Gaps = 23/264 (8%)
Query: 681 GERIGLGSYGEV---YHADWNGTEVAVKKFL---DQDFSGAALLEFKREVKIMRRLRHPN 734
G+ +G G++G V Y D G E+A K+ + + + + E+++++ L+H
Sbjct: 7 GKLLGQGAFGRVYLCYDVD-TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHER 65
Query: 735 VVLFMGAVTR--PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTS 792
+V + G + L+I E++P GS+ L + R GM+ LH++
Sbjct: 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 793 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS---KSTAGTPEWMAPEVLRN 849
IVHRD+K N+L D NVK+ DFG S+ +S +S GTP WM+PEV+
Sbjct: 126 M--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG 183
Query: 850 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP----LVA 905
E K DV+S G + E+ T K PW M + + Q ++P + +
Sbjct: 184 EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFLG 243
Query: 906 RIIWECWQTDPS----LRPSFAQL 925
I E PS LR FAQL
Sbjct: 244 CIFVEARHR-PSAEELLRHPFAQL 266
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 81/278 (29%), Positives = 127/278 (45%), Gaps = 35/278 (12%)
Query: 679 VLGERIGLGSYGEV--YHADWN----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH 732
VLGE G +G+V Y D G VAVK L ++ +K+E+ I++ L H
Sbjct: 11 VLGE----GHFGKVSLYCYDPANDGTGEMVAVKT-LKRECGQQNTSGWKKEINILKTLYH 65
Query: 733 PNVVLFMGAVTRP--PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCL 789
N+V + G + L +I E++P GSL L P +++ + + A GM L
Sbjct: 66 ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNLAQLLLFAQQICEGMAYL 123
Query: 790 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL---KHNTFLSSKSTAGTPEWMAPEV 846
H+ +HRDL + N+L+D + VK+ DFGL++ H + + W A E
Sbjct: 124 HSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVEC 181
Query: 847 LRNEPSNEKCDVYSFGVILWELAT------------LKLPWIGMNPMQVVGAVGFQNRRL 894
L+ + DV+SFGV L+EL T ++ M VV + R +
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM 241
Query: 895 EIPKELD-PLVARIIWE-CWQTDPSLRPSFAQLTVALK 930
+P + P I+ + CW+T+ RP+F L LK
Sbjct: 242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 79/280 (28%), Positives = 128/280 (45%), Gaps = 56/280 (20%)
Query: 682 ERIGLGSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKR-----------EVKIM 727
E +G G++G VY + +A+K+ + A + KR EV I+
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEI---NVHNPAFGKDKRERDKSIGDIVSEVTII 62
Query: 728 R-RLRHPNVVLFMGAVTRPPNLSIITEFL---PRGSLFRILHRPHCQVDEKRR----IKM 779
+ +LRHPN+V + L I+ + + P G F L + E+R ++M
Sbjct: 63 KEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQM 122
Query: 780 ALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH-NTFLSSKSTAGT 838
L R LH IVHRDL N+++ ++ V ++DFGL++ K + L+S GT
Sbjct: 123 VLALR---YLHKEK-RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSV--VGT 176
Query: 839 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN----PMQVVGAVGFQNRRL 894
+ PE+++NEP EK DV++FG IL+++ TL+ P+ N ++V AV
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV------- 229
Query: 895 EIPKELDPL--------VARIIWECWQTDPSLRPSFAQLT 926
+PL V +I C D RP Q++
Sbjct: 230 -----YEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 5e-23
Identities = 73/252 (28%), Positives = 123/252 (48%), Gaps = 18/252 (7%)
Query: 684 IGLGSYGEV--YHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 741
+G GSYGEV +G + +KK ++ S ++E +++ +L+HPN+V + +
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 742 VTRPPN-LSIITEFLPRGSLFRILHR------PHCQVDEK-RRIKMALDARGMNCLHTST 793
L I+ F G L+ L P QV E +I MAL LH
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQY-----LHEKH 122
Query: 794 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN 853
I+HRDLK+ N+ + + +KV D G++R+ N + + GTP +M+PE+ N+P N
Sbjct: 123 --ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYN 180
Query: 854 EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 913
K DV++ G ++E+ATLK + + +V + + + +PK+ P + +I
Sbjct: 181 YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI-IEGKLPPMPKDYSPELGELIATMLS 239
Query: 914 TDPSLRPSFAQL 925
P RPS +
Sbjct: 240 KRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 1e-22
Identities = 76/256 (29%), Positives = 125/256 (48%), Gaps = 10/256 (3%)
Query: 674 PWEDLVLGERIGLGSYGEV--YHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
P L +IG GS G V G +VAVKK +D L F EV IMR +
Sbjct: 17 PRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKK-MDLRKQQRRELLFN-EVVIMRDYQ 74
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDA-RGMNCLH 790
HPN+V + L ++ EFL G+L I+ H +++E++ + L + ++ LH
Sbjct: 75 HPNIVEMYSSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLAVLKALSFLH 132
Query: 791 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 850
++HRD+KS ++L+ + VK+SDFG KS GTP WMAPEV+
Sbjct: 133 AQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRL 190
Query: 851 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV-GFQNRRLEIPKELDPLVARIIW 909
P + D++S G+++ E+ + P+ P+Q + + +L+ ++ P + +
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLD 250
Query: 910 ECWQTDPSLRPSFAQL 925
DP+ R + A+L
Sbjct: 251 RMLVRDPAQRATAAEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 1e-22
Identities = 72/249 (28%), Positives = 129/249 (51%), Gaps = 12/249 (4%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
E+IG G+ G VY A G EVA+K+ Q L+ E+ +MR +HPN+V ++
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELI--INEILVMRENKHPNIVNYL 82
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDA-RGMNCLHTSTPTIVH 798
+ L ++ E+L GSL ++ +DE + + + + + LH++ ++H
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQ--VIH 138
Query: 799 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST-AGTPEWMAPEVLRNEPSNEKCD 857
RD+KS N+L+ + +VK++DFG + S +ST GTP WMAPEV+ + K D
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 858 VYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWECWQTDP 916
++S G++ E+ + P++ NP++ + + L+ P++L + + C + D
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDV 257
Query: 917 SLRPSFAQL 925
R S +L
Sbjct: 258 EKRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 1e-22
Identities = 72/256 (28%), Positives = 120/256 (46%), Gaps = 14/256 (5%)
Query: 684 IGLGSYGEV----YHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
+G G++G V Y + VAVK + + A E RE +M++L +P +V +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVH 798
G + + ++ E G L + L + V EK ++ + GM L + VH
Sbjct: 63 G-ICEAESWMLVMELAELGPLNKFLQKNK-HVTEKNITELVHQVSMGMKYLEETN--FVH 118
Query: 799 RDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTP-EWMAPEVLRNEPSNEK 855
RDL + N+L+ K+SDFGLS+ + +K+ P +W APE + + K
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSK 178
Query: 856 CDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 914
DV+SFGV++WE + P+ GM +V + R+E P+ P + ++ CW
Sbjct: 179 SDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SGERMECPQRCPPEMYDLMKLCWTY 237
Query: 915 DPSLRPSFAQLTVALK 930
RP FA + + L+
Sbjct: 238 GVDERPGFAVVELRLR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 3e-22
Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 30/206 (14%)
Query: 682 ERIGLGSYGEVYHADWNGTE--VAVKKF-LDQD---FSGAALLEFKREVKIMRRLRHPNV 735
+IG G+YG+VY A T VA+KK ++ + F A+ RE+K++++LRHPN+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAI----REIKLLQKLRHPNI 60
Query: 736 VLFMGAVTRPPNLSI--ITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDARGMNCLH 790
V VT SI + E++ L +L P + E K +K L G+ LH
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLL--EGLQYLH 117
Query: 791 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APE 845
++ I+HRD+K N+L++ + +K++DFGL+R + S T W PE
Sbjct: 118 SNG--ILHRDIKGSNILINNDGVLKLADFGLAR----PYTKRNSADYTNRVITLWYRPPE 171
Query: 846 VLRNEPS-NEKCDVYSFGVILWELAT 870
+L + D++S G IL EL
Sbjct: 172 LLLGATRYGPEVDMWSVGCILAELFL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 4e-22
Identities = 76/275 (27%), Positives = 125/275 (45%), Gaps = 50/275 (18%)
Query: 687 GSYGEVYHADWNGT------EVAVKKFLDQDFSGAALLE---FKREVKIMRRLRHPNVVL 737
G++G +++ EV VK D A+ ++ +E ++ L H N++
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKD----HASEIQVTLLLQESCLLYGLSHQNILP 72
Query: 738 FMGAVTR---PP-------NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGM 786
+ PP N + FL + L + ++ + MA+ A GM
Sbjct: 73 ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRL--GEANNPQALSTQQLVHMAIQIACGM 130
Query: 787 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE-----W 841
+ LH ++H+D+ + N ++D+ VK++D LSR + F G E W
Sbjct: 131 SYLHKRG--VIHKDIAARNCVIDEELQVKITDNALSR---DLFPMDYHCLGDNENRPVKW 185
Query: 842 MAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAV--GFQNRRLE--- 895
MA E L N+ + DV+SFGV+LWEL TL + P++ ++P ++ + G+ RL
Sbjct: 186 MALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY---RLAQPI 242
Query: 896 -IPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 929
P EL ++A CW DP RPSF+QL L
Sbjct: 243 NCPDELFAVMAC----CWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 9e-22
Identities = 70/248 (28%), Positives = 127/248 (51%), Gaps = 10/248 (4%)
Query: 682 ERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
E+IG G+ G V+ A G EVA+K+ Q L+ E+ +M+ L++PN+V F+
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELI--INEILVMKELKNPNIVNFL 82
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDA-RGMNCLHTSTPTIVH 798
+ L ++ E+L GSL ++ C +DE + + + + + LH + ++H
Sbjct: 83 DSFLVGDELFVVMEYLAGGSLTDVVTET-C-MDEAQIAAVCRECLQALEFLHANQ--VIH 138
Query: 799 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDV 858
RD+KS N+L+ + +VK++DFG + GTP WMAPEV+ + K D+
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 859 YSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWECWQTDPS 917
+S G++ E+ + P++ NP++ + + L+ P++L P+ + C + D
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVE 258
Query: 918 LRPSFAQL 925
R S +L
Sbjct: 259 KRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 66/208 (31%), Positives = 107/208 (51%), Gaps = 19/208 (9%)
Query: 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA-ALLEFKREVKIMRRLRHPNVVLF 738
++IG G + EVY A +G VA+KK D A A + +E+ ++++L HPNV+ +
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 67
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ---VDEKRRIKMALD-ARGMNCLHTSTP 794
+ L+I+ E G L R++ Q + EK K + + +H+
Sbjct: 68 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR- 126
Query: 795 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA-----GTPEWMAPEVLRN 849
++HRD+K N+ + VK+ D GL R F SSK+TA GTP +M+PE +
Sbjct: 127 -VMHRDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 850 EPSNEKCDVYSFGVILWELATLKLPWIG 877
N K D++S G +L+E+A L+ P+ G
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 58/238 (24%), Positives = 115/238 (48%), Gaps = 13/238 (5%)
Query: 692 VYHADWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRHPNVV----LFMGAVTRPP 746
+Y +N EV ++ F L++ + E+K +RR+ N++ + V P
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDA-RGMNCLHTSTPTIVHRDLKSPN 805
LS+I E+ RG L +L + + K ++ MA+D +G+ L+ T +++L S +
Sbjct: 96 RLSLILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKYTNK-PYKNLTSVS 153
Query: 806 LLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGV 863
LV +N+ +K+ GL ++ + K+ + + ++L + K D+YS GV
Sbjct: 154 FLVTENYKLKIICHGLEKILSSP--PFKNV-NFMVYFSYKMLNDIFSEYTIKDDIYSLGV 210
Query: 864 ILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPS 921
+LWE+ T K+P+ + ++ + +N L++P + + I+ C D RP+
Sbjct: 211 VLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPN 268
|
Length = 283 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 2e-21
Identities = 71/270 (26%), Positives = 132/270 (48%), Gaps = 41/270 (15%)
Query: 679 VLGERIGLGSYGEVY-----HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
+L +R+G GS+G VY A +K+ + + ++ +E +++ +L HP
Sbjct: 3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRR--------------IKM 779
+V F + IITE+ L C+++E + I++
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDL-------DCKLEELKHTGKTLSENQVCEWFIQL 115
Query: 780 ALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP 839
L G++ +H I+HRDLK+ N+ + N +K+ DFG+SRL + + + GTP
Sbjct: 116 LL---GVHYMHQRR--ILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTP 169
Query: 840 EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP-- 897
+M+PE L+++ + K D++S G IL+E+ L + G N + VV + + +P
Sbjct: 170 YYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI-VEGPTPSLPET 228
Query: 898 --KELDPLVARIIWECWQTDPSLRPSFAQL 925
++L+ ++ ++ DPSLRPS A++
Sbjct: 229 YSRQLNSIMQSML----NKDPSLRPSAAEI 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-21
Identities = 59/201 (29%), Positives = 102/201 (50%), Gaps = 17/201 (8%)
Query: 684 IGLGSYGE---VYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740
+G GS+G V H N + K + S +A+ + ++E ++ +++HPN+V F
Sbjct: 8 VGEGSFGRALLVQHV--NSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI---KMALDARGMNCL---HTSTP 794
+ +L I+ E+ G L + + ++ ++ L CL H
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIK------LQRGKLFPEDTILQWFVQMCLGVQHIHEK 119
Query: 795 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNE 854
++HRD+KS N+ + +N VK+ DFG +RL + + + GTP ++ PE+ N P N
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNN 179
Query: 855 KCDVYSFGVILWELATLKLPW 875
K D++S G IL+EL TLK P+
Sbjct: 180 KSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 4e-21
Identities = 68/266 (25%), Positives = 123/266 (46%), Gaps = 31/266 (11%)
Query: 680 LGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
LGE G GS + N + K + D + + RE++I + + P +V +
Sbjct: 9 LGEGAG-GSVTKCRLK--NTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYY 65
Query: 740 GAVTRPP--NLSIITEFLPRGSLFRILHRPHCQ---VDEKRRIKMALDA-RGMNCLHTST 793
GA ++ I E+ GSL I + + + EK K+A +G++ LH+
Sbjct: 66 GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125
Query: 794 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN 853
I+HRD+K N+L+ + VK+ DFG+S N+ + + GT +MAPE ++ +P +
Sbjct: 126 --IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL--AGTFTGTSFYMAPERIQGKPYS 181
Query: 854 EKCDVYSFGVILWELATLKLPWI-----GMNPMQVVGAVGFQNRRLEIPKELDPLVARII 908
DV+S G+ L E+A + P+ + P++++ + + P+ D I
Sbjct: 182 ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI----VNMPNPELKDEPGNGIK 237
Query: 909 W---------ECWQTDPSLRPSFAQL 925
W +C + DP+ RP+ +
Sbjct: 238 WSEEFKDFIKQCLEKDPTRRPTPWDM 263
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 7e-21
Identities = 76/280 (27%), Positives = 136/280 (48%), Gaps = 12/280 (4%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
E+IG G+ G VY A G EVA+K+ Q L+ E+ +MR ++PN+V ++
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELI--INEILVMRENKNPNIVNYL 82
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDA-RGMNCLHTSTPTIVH 798
+ L ++ E+L GSL ++ C +DE + + + + ++ LH++ ++H
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTET-C-MDEGQIAAVCRECLQALDFLHSNQ--VIH 138
Query: 799 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDV 858
RD+KS N+L+ + +VK++DFG + GTP WMAPEV+ + K D+
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 859 YSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWECWQTDPS 917
+S G++ E+ + P++ NP++ + + L+ P+ L + + C + D
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVD 258
Query: 918 LRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQEISVNST 957
R S +L P +L P P +E NS+
Sbjct: 259 RRGSAKELL--QHPFLKLAKPLSSLTPLIIAAKEAIKNSS 296
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 9e-21
Identities = 79/265 (29%), Positives = 122/265 (46%), Gaps = 22/265 (8%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLE----FKREVK 725
+ P E V IG GS+G VY A + T VAVKK +SG E +EVK
Sbjct: 17 DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKM---SYSGKQTNEKWQDIIKEVK 73
Query: 726 IMRRLRHPNVVLFMGAVTRPPNLSIITEFL--PRGSLFRILHRPHCQVDEKRRIKMALDA 783
+++L+HPN + + G + ++ E+ L + +P +V+ AL
Sbjct: 74 FLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL-- 131
Query: 784 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 843
+G+ LH+ ++HRD+K+ N+L+ + VK++DFG + + S GTP WMA
Sbjct: 132 QGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSS----PANSFVGTPYWMA 185
Query: 844 PEVLRNEPSNE---KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 900
PEV+ + K DV+S G+ ELA K P MN M + + + E
Sbjct: 186 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEW 245
Query: 901 DPLVARIIWECWQTDPSLRPSFAQL 925
+ C Q P RP+ A+L
Sbjct: 246 TDSFRGFVDYCLQKIPQERPASAEL 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 2e-20
Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 30/207 (14%)
Query: 679 VLGERIGLGSYGEVYHA-DWN-GTEVAVKKFLDQDFSGA-------ALLEFKREVKIMRR 729
G+++G G+Y VY A D G VA+KK + A AL RE+K+++
Sbjct: 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTAL----REIKLLQE 58
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHC---QVDEKRRIKMALDARGM 786
L+HPN++ + N++++ EF+ L +++ D K + M L RG+
Sbjct: 59 LKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTL--RGL 115
Query: 787 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK----STAGTPEWM 842
LH++ I+HRDLK NLL+ + +K++DFGL+R +F S T +
Sbjct: 116 EYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLAR----SFGSPNRKMTHQVVTRWYR 169
Query: 843 APEVLRNEPS-NEKCDVYSFGVILWEL 868
APE+L D++S G I EL
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAEL 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-20
Identities = 83/284 (29%), Positives = 129/284 (45%), Gaps = 25/284 (8%)
Query: 656 STSKVDQIFDDDVCEC---EIPWEDLVLGERIGLGSYGEVYHA-DWNGTEV-AVKKFLDQ 710
STS+ + D ++ E E P + IG GS+G VY A D EV A+KK
Sbjct: 2 STSRAGSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKM--- 58
Query: 711 DFSGAALLE----FKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL--PRGSLFRIL 764
+SG E +EVK ++R++HPN + + G R ++ E+ L +
Sbjct: 59 SYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVH 118
Query: 765 HRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824
+P +V+ AL +G+ LH+ ++HRD+K+ N+L+ + VK++DFG + +
Sbjct: 119 KKPLQEVEIAAITHGAL--QGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASI 174
Query: 825 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNE---KCDVYSFGVILWELATLKLPWIGMNPM 881
+ S GTP WMAPEV+ + K DV+S G+ ELA K P MN M
Sbjct: 175 AS----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 230
Query: 882 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 925
+ + E + C Q P RP+ +L
Sbjct: 231 SALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEEL 274
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 66/250 (26%), Positives = 119/250 (47%), Gaps = 12/250 (4%)
Query: 684 IGLGSYG----EVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
+G G++G VY +VA+K L + + E RE +IM +L +P +V +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIK-VLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHR 799
G V L ++ E G L + L ++ + + M + VHR
Sbjct: 62 G-VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSN-VVELMHQVSMGMKYLEGKNFVHR 119
Query: 800 DLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTP-EWMAPEVLRNEPSNEKC 856
DL + N+L+ K+SDFGLS+ +++ ++S P +W APE + + +
Sbjct: 120 DLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRS 179
Query: 857 DVYSFGVILWE-LATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTD 915
DV+S+G+ +WE + + P+ M +V+ + Q +RL+ P E P + ++ +CW
Sbjct: 180 DVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAECPPEMYALMKDCWIYK 238
Query: 916 PSLRPSFAQL 925
RP+FA++
Sbjct: 239 WEDRPNFAKV 248
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 3e-20
Identities = 64/213 (30%), Positives = 101/213 (47%), Gaps = 40/213 (18%)
Query: 684 IGLGSYGEVYHAD--WNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVV- 736
IG G+YG V A G +VA+KK F D + L RE+K++R LRH N++
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL----REIKLLRHLRHENIIG 63
Query: 737 LFMGAVTRPPNLS------IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLH 790
L + RPP+ I+TE + L +++ P D+ + + RG+ LH
Sbjct: 64 LL--DILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH 120
Query: 791 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM-------- 842
++ ++HRDLK N+LV+ N ++K+ DFGL+R ++
Sbjct: 121 SAN--VIHRDLKPSNILVNSNCDLKICDFGLAR-------GVDPDEDEKGFLTEYVVTRW 171
Query: 843 --APEVLRNEPS-NEKCDVYSFGVILWELATLK 872
APE+L + + D++S G I EL T K
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 68/205 (33%), Positives = 105/205 (51%), Gaps = 9/205 (4%)
Query: 683 RIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740
+IG GS G V A G +VAVKK +D L F EV IMR H NVV
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKK-MDLRKQQRRELLFN-EVVIMRDYHHENVVDMYN 86
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDA-RGMNCLHTSTPTIVHR 799
+ L ++ EFL G+L I+ H +++E++ + L R ++ LH ++HR
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLSVLRALSYLHNQG--VIHR 142
Query: 800 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVY 859
D+KS ++L+ + +K+SDFG KS GTP WMAPEV+ P + D++
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIW 202
Query: 860 SFGVILWELATLKLPWIGMNPMQVV 884
S G+++ E+ + P+ P+Q +
Sbjct: 203 SLGIMVIEMIDGEPPYFNEPPLQAM 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 4e-20
Identities = 69/257 (26%), Positives = 123/257 (47%), Gaps = 19/257 (7%)
Query: 677 DLVLGERIGLGSYGEVYHAD--WNGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRHP 733
+ + ++IG G + EVY A + VA+KK + + A + +E+ ++++L HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILH--RPHCQVDEKRRIKMALDARGMNCLHT 791
NV+ ++ + L+I+ E G L +++ + ++ +R + H
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 792 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA-----GTPEWMAPEV 846
+ ++HRD+K N+ + VK+ D GL R F SSK+TA GTP +M+PE
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGR-----FFSSKTTAAHSLVGTPYYMSPER 177
Query: 847 LRNEPSNEKCDVYSFGVILWELATLKLPWIG--MNPMQVVGAVGFQNRRLEIPKE-LDPL 903
+ N K D++S G +L+E+A L+ P+ G MN + + Q +P E
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIE-QCDYPPLPTEHYSEK 236
Query: 904 VARIIWECWQTDPSLRP 920
+ ++ C DP RP
Sbjct: 237 LRELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 4e-20
Identities = 76/279 (27%), Positives = 133/279 (47%), Gaps = 26/279 (9%)
Query: 677 DLVLGERIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLR 731
+L + +G G +G V+ W + ++ V QD SG E + M L
Sbjct: 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLD 67
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLH 790
H +V +G + +L ++T+ P GSL + + +D +R + + A+GM L
Sbjct: 68 HAYIVRLLG-ICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE 126
Query: 791 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-----KHNTFLSSKSTAGTP-EWMAP 844
+VHR+L + N+L+ + V+++DFG++ L K + S TP +WMA
Sbjct: 127 EHR--MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFY----SEHKTPIKWMAL 180
Query: 845 EVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKELDPL 903
E + + DV+S+GV +WE+ + P+ GM P +V + + RL P+
Sbjct: 181 ESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-KGERLAQPQICTID 239
Query: 904 VARIIWECWQTDPSLRPSFAQLT-----VALKPLQRLVI 937
V ++ +CW D ++RP+F +L +A P + LVI
Sbjct: 240 VYMVMVKCWMIDENVRPTFKELANEFTRMARDPPRYLVI 278
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 4e-20
Identities = 73/260 (28%), Positives = 122/260 (46%), Gaps = 13/260 (5%)
Query: 684 IGLGSYGEVYHADW--NGTEVAVK---KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
+G G++G VY W +G V + K L ++ S A E E +M + P V
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIV 797
+G + + ++T+ +P G L + ++ + + + A+GM+ L +V
Sbjct: 75 LG-ICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LV 131
Query: 798 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG-TP-EWMAPEVLRNEPSNEK 855
HRDL + N+LV +VK++DFGL+RL + G P +WMA E + + +
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQ 191
Query: 856 CDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 914
DV+S+GV +WEL T P+ G+ P + + + + RL P V I+ +CW
Sbjct: 192 SDVWSYGVTVWELMTFGAKPYDGI-PAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMI 250
Query: 915 DPSLRPSFAQLTVALKPLQR 934
D RP F +L + R
Sbjct: 251 DSECRPRFRELVDEFSRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 6e-20
Identities = 65/219 (29%), Positives = 103/219 (47%), Gaps = 20/219 (9%)
Query: 722 REVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR--PHCQVDEKRRIKM 779
RE++IM R P +V F GA N+ + EF+ GSL RI + P V+ +I +
Sbjct: 52 RELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGP-IPVEILGKIAV 110
Query: 780 ALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP 839
A+ G+ L+ + I+HRD+K N+LV+ +K+ DFG+S N+ + + GT
Sbjct: 111 AV-VEGLTYLY-NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--ADTFVGTS 166
Query: 840 EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG----------- 888
+M+PE ++ K DV+S G+ + ELA K P+ + + G
Sbjct: 167 TYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPF-AFSNIDDDGQDDPMGILDLLQQI 225
Query: 889 FQNRRLEIPKELDPLVAR-IIWECWQTDPSLRPSFAQLT 926
Q +P P R + C DP+ RP+ QL
Sbjct: 226 VQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLC 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 8e-20
Identities = 71/252 (28%), Positives = 119/252 (47%), Gaps = 22/252 (8%)
Query: 677 DLVLGERIGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKR------EVKIMR 728
D +GE +G GS+G V A GT A+K ++ +L+ K+ E I+
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKRE-----ILKMKQVQHVAQEKSILM 73
Query: 729 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNC 788
L HP +V M + + + EF+ G LF L + ++ + A
Sbjct: 74 ELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEY 133
Query: 789 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVL 847
LH+ I++RDLK NLL+D +VKV+DFG + ++ TF + GTPE++APEV+
Sbjct: 134 LHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF----TLCGTPEYLAPEVI 187
Query: 848 RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 907
+++ + D ++ GV+L+E P+ P ++ + RL+ P D +
Sbjct: 188 QSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI--LAGRLKFPNWFDGRARDL 245
Query: 908 IWECWQTDPSLR 919
+ QTD + R
Sbjct: 246 VKGLLQTDHTKR 257
|
Length = 329 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 1e-19
Identities = 50/138 (36%), Positives = 80/138 (57%), Gaps = 3/138 (2%)
Query: 790 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS--KSTAGTPEWMAPEVL 847
H + ++HRD+KS N+L+ N VK+ DFG S++ T ++ GTP ++APE+
Sbjct: 158 HVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIW 217
Query: 848 RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 907
R +P ++K D++S GV+L+EL TLK P+ G N M+ V R +P + P + I
Sbjct: 218 RRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-MEEVMHKTLAGRYDPLPPSISPEMQEI 276
Query: 908 IWECWQTDPSLRPSFAQL 925
+ +DP RPS ++L
Sbjct: 277 VTALLSSDPKRRPSSSKL 294
|
Length = 496 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 90.6 bits (224), Expect = 1e-19
Identities = 68/248 (27%), Positives = 125/248 (50%), Gaps = 10/248 (4%)
Query: 682 ERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
E+IG G+ G VY A G EVA+++ Q L+ E+ +MR ++PN+V ++
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNPNIVNYL 83
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDA-RGMNCLHTSTPTIVH 798
+ L ++ E+L GSL ++ C +DE + + + + + LH++ ++H
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTET-C-MDEGQIAAVCRECLQALEFLHSNQ--VIH 139
Query: 799 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDV 858
RD+KS N+L+ + +VK++DFG + GTP WMAPEV+ + K D+
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 859 YSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWECWQTDPS 917
+S G++ E+ + P++ NP++ + + L+ P++L + + C D
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVE 259
Query: 918 LRPSFAQL 925
R S +L
Sbjct: 260 KRGSAKEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 1e-19
Identities = 73/247 (29%), Positives = 123/247 (49%), Gaps = 10/247 (4%)
Query: 683 RIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740
+IG GS G V A +G VAVKK +D L F EV IMR +H NVV
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKK-MDLRKQQRRELLFN-EVVIMRDYQHENVVEMYN 84
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDA-RGMNCLHTSTPTIVHR 799
+ L ++ EFL G+L I+ H +++E++ + L + ++ LH ++HR
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLKALSVLHAQG--VIHR 140
Query: 800 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVY 859
D+KS ++L+ + VK+SDFG KS GTP WMAPE++ P + D++
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 860 SFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRRLEIPKELDPLVARIIWECWQTDPSL 918
S G+++ E+ + P+ P++ + + +L+ ++ P + + DP+
Sbjct: 201 SLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQ 260
Query: 919 RPSFAQL 925
R + A+L
Sbjct: 261 RATAAEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 2e-19
Identities = 82/300 (27%), Positives = 122/300 (40%), Gaps = 41/300 (13%)
Query: 646 LESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGT-EVAV 704
L PSSS SS+S +L RIG G+ G VY T +
Sbjct: 47 LPPPSSSSSSSSSSSAS---GSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYA 103
Query: 705 KKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL--FR 762
K + + + RE++I+R + HPNVV + ++ EF+ GSL
Sbjct: 104 LKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH 163
Query: 763 ILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 822
I D R+I G+ LH IVHRD+K NLL++ NVK++DFG+S
Sbjct: 164 IADEQFLA-DVARQI-----LSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVS 215
Query: 823 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKC-----DVYSFGVILWELATLKLPWIG 877
R+ T S+ GT +M+PE + + ++ D++S GV + E + P+
Sbjct: 216 RILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF-- 273
Query: 878 MNPMQVVGAVGFQ------------NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 925
VG Q ++ E P I C Q +P+ R S QL
Sbjct: 274 --------GVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQL 325
|
Length = 353 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 20/200 (10%)
Query: 682 ERIGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
+G G+YG V T VA+KKF + + REVK++R+LRH N+V
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEK--RRIKMALDARGMNCLHTSTPTIV 797
A R L ++ E++ R +L +L + R L + + H+ I+
Sbjct: 67 EAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQL-LQAIAYCHSHN--II 122
Query: 798 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA------GTPEWMAPEVLRNEP 851
HRD+K N+LV ++ +K+ DFG +R L ++ + T + APE+L +
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFAR-----ALRARPASPLTDYVATRWYRAPELLVGDT 177
Query: 852 SNEK-CDVYSFGVILWELAT 870
+ K DV++ G I+ EL
Sbjct: 178 NYGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-19
Identities = 84/267 (31%), Positives = 118/267 (44%), Gaps = 33/267 (12%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKFLD--QDFSGAALLEFKREVKIMRRL-RHPNVV 736
E IG G+YG+VY +G+ AVK LD D E + E I++ L HPNVV
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDE----EIEAEYNILQSLPNHPNVV 82
Query: 737 LFMGAVTRPPNLS-----IITEFLPRGS---LFRILHRPHCQVDEKRRIKMALDARGMNC 788
F G + L ++ E GS L + L ++DE I L +
Sbjct: 83 KFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAM-ISYILYGALLGL 141
Query: 789 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 848
H I+HRD+K N+L+ VK+ DFG+S +T L ++ GTP WMAPEV+
Sbjct: 142 QHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 201
Query: 849 NEPS-----NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 903
E + +CDV+S G+ EL P M+P++ + F+ R P L P
Sbjct: 202 CEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL----FKIPRNPPPTLLHPE 257
Query: 904 -----VARIIWECWQTDPSLRPSFAQL 925
I +C D RPS L
Sbjct: 258 KWCRSFNHFISQCLIKDFEARPSVTHL 284
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 4e-19
Identities = 60/235 (25%), Positives = 103/235 (43%), Gaps = 56/235 (23%)
Query: 676 EDLVLGERIGLGSYGEVYHADWNGTE--VAVKKF-----LDQDFSGAALLEFKREVKIMR 728
+D + + IG G++GEV+ T A+K + ++ + E I+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH----VRAERDILA 56
Query: 729 RLRHPNVV-LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRR-----IKMALD 782
P +V L+ + +L ++ E++P G L +L R +E R + +ALD
Sbjct: 57 DADSPWIVKLYY-SFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALD 115
Query: 783 A-RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------------------- 822
+ + +HRD+K N+L+D + ++K++DFGL
Sbjct: 116 SVHKLGF--------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNL 167
Query: 823 ----------RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWE 867
R + + ST GTP+++APEVLR P +CD +S GVIL+E
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 5e-19
Identities = 53/157 (33%), Positives = 86/157 (54%), Gaps = 2/157 (1%)
Query: 721 KREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA 780
K E I+ + HP +V A L +I +FL G LF L + +E + +A
Sbjct: 46 KMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA 105
Query: 781 LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 840
A ++ LH+ I++RDLK N+L+D+ ++K++DFGLS+ + + S GT E
Sbjct: 106 ELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE 163
Query: 841 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG 877
+MAPEV+ + D +SFGV+++E+ T LP+ G
Sbjct: 164 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG 200
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 8e-19
Identities = 52/151 (34%), Positives = 84/151 (55%), Gaps = 15/151 (9%)
Query: 783 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTP-E 840
ARGM L ++ +HRDL + N+L+ +N VK+ DFGL+R + + K A P +
Sbjct: 183 ARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240
Query: 841 WMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNR-----RL 894
WMAPE + ++ + DV+SFGV+LWE+ +L P+ G+ + F R R+
Sbjct: 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-----EFCRRLKEGTRM 295
Query: 895 EIPKELDPLVARIIWECWQTDPSLRPSFAQL 925
P+ P + I+ +CW +P RP+F++L
Sbjct: 296 RAPEYATPEIYSIMLDCWHNNPEDRPTFSEL 326
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 9e-19
Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 18/223 (8%)
Query: 684 IGLGSYGEVYHAD--WNGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRH-PNVVLFM 739
I G++G VY A G A+K D + + K E IM P V
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHR 799
+ L ++ E+L G ++ ++ + +A G+ LH I+HR
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHR 121
Query: 800 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVY 859
D+K NLL+D+ ++K++DFGLSR L +K GTP+++APE + ++ D +
Sbjct: 122 DIKPENLLIDQTGHLKLTDFGLSRNG----LENKKFVGTPDYLAPETILGVGDDKMSDWW 177
Query: 860 SFGVILWELATLKLPWIGMNPMQVVGAVGFQN---RRLEIPKE 899
S G +++E P+ P V F N RR+ P+E
Sbjct: 178 SLGCVIFEFLFGYPPFHAETPDAV-----FDNILSRRINWPEE 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 1e-18
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 682 ERIGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKREVK-------IMRRLRH 732
++G G YG+V+ A T VA+K+ LL EV+ I+ +
Sbjct: 7 TQVGQGGYGQVFLAKKKDTGEIVALKRMKKS------LLFKLNEVRHVLTERDILTTTKS 60
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTS 792
+V + A L + E++P G +L+ ++ R MA ++ LH
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL 120
Query: 793 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 852
+HRDLK N L+D + ++K++DFGLS+ + S G+P++MAPEVLR +
Sbjct: 121 G--YIHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANSVVGSPDYMAPEVLRGKGY 175
Query: 853 NEKCDVYSFGVILWELATLKLPWIGMNPMQV 883
+ D +S G +L+E P+ G P +
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFPPFSGSTPNET 206
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 64/237 (27%), Positives = 98/237 (41%), Gaps = 34/237 (14%)
Query: 684 IGLGSYGEVY--HADWNGTEVAVKKFL-DQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740
+G+G +G V A+K E +I+ HP +V
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDAR--------GMNCLHTS 792
+ ++ E+ G L+ IL DE AR LH
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRD-RGLFDEY-------TARFYIACVVLAFEYLHNR 112
Query: 793 TPTIVHRDLKSPNLLVDKNWNVKVSDFGL-----SRLKHNTFLSSKSTAGTPEWMAPEVL 847
I++RDLK NLL+D N VK+ DFG S K TF GTPE++APE++
Sbjct: 113 G--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC------GTPEYVAPEII 164
Query: 848 RNEPSNEKCDVYSFGVILWELATLKLPWIG--MNPMQVVGAVGFQNRRLEIPKELDP 902
N+ + D +S G++L+EL T + P+ +PM++ + N +LE P +D
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDK 221
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 77/288 (26%), Positives = 126/288 (43%), Gaps = 62/288 (21%)
Query: 684 IGLGSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740
+G GSYG V H + G VA+KKFL+ + RE++++++LRH N+V +
Sbjct: 9 VGEGSYGMVMKCKHKE-TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDA-RGMNCLHTSTPTIVHR 799
R L ++ EF+ L + P+ +DE R K RG+ H+ I+HR
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSHN--IIHR 124
Query: 800 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT----PEWM-APEVLRNEPSNE 854
D+K N+LV ++ VK+ DFG +R L++ T W APE+L +
Sbjct: 125 DIKPENILVSQSGVVKLCDFGFAR-----TLAAPGEVYTDYVATRWYRAPELLVGDTKYG 179
Query: 855 K-CDVYSFGVILWELATLKLPWIGMNPM-----------QVVGAVG-------------- 888
+ D+++ G ++ E+ T P+ ++ +G
Sbjct: 180 RAVDIWAVGCLVTEMLT-------GEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232
Query: 889 -FQNRRLEIPKELDPL----------VARIIWECWQTDPSLRPSFAQL 925
F RL KE++PL V + +C + DP RPS +QL
Sbjct: 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQL 280
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 81/278 (29%), Positives = 123/278 (44%), Gaps = 44/278 (15%)
Query: 675 WEDLVLGERIGLGSYGEVY--HADWNGTEVAVKKFLD--QDFSGAALLEFKREVKIMRRL 730
WE + E IG G+YG+V+ NG++ AVK LD D E + E I++ L
Sbjct: 20 WE---IIETIGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDE----EIEAEYNILKAL 71
Query: 731 R-HPNVVLFMGA-----VTRPPNLSIITEFLPRGSLFRILHRPHCQVD--EKRRIKMALD 782
HPNVV F G V L ++ E GS+ ++ + + E+ I L
Sbjct: 72 SDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILH 131
Query: 783 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM 842
M H +HRD+K N+L+ VK+ DFG+S +T L ++ GTP WM
Sbjct: 132 EALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWM 191
Query: 843 APEVLRNEPS-----NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 897
APEV+ E + +CDV+S G+ EL P ++PM+ + +IP
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL---------FKIP 242
Query: 898 KELDPLVAR----------IIWECWQTDPSLRPSFAQL 925
+ P + + I +C D RP+ + L
Sbjct: 243 RNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDL 280
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 679 VLGERIGLGSYGEVYHA-DWN-GTEVAVKKF---LDQDFSGAALLEFKREVKIMRRLR-- 731
IG G+YG VY A D N G VA+KK L ++ + L RE+ ++++L
Sbjct: 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTL---REIALLKQLESF 58
Query: 732 -HPNVVLFMG-----AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK--MALDA 783
HPN+V + R L+++ E + + L L + IK M
Sbjct: 59 EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 784 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM- 842
RG++ LH+ IVHRDLK N+LV + VK++DFGL+R+ +F + ++ W
Sbjct: 118 RGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARIY--SFEMALTSVVVTLWYR 173
Query: 843 APEVLRNEPSNEKCDVYSFGVILWELATLK 872
APEVL D++S G I EL +
Sbjct: 174 APEVLLQSSYATPVDMWSVGCIFAELFRRR 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 2e-18
Identities = 55/153 (35%), Positives = 85/153 (55%), Gaps = 5/153 (3%)
Query: 783 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTP-E 840
ARGM L ++ +HRDL + N+L+ +N VK+ DFGL+R + + K +A P +
Sbjct: 184 ARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241
Query: 841 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKE 899
WMAPE + ++ + DV+SFGV+LWE+ +L P+ G+ + R+ P+
Sbjct: 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPEN 301
Query: 900 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932
P + RI+ CWQ DP RP+F+ L L L
Sbjct: 302 ATPEIYRIMLACWQGDPKERPTFSALVEILGDL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 2e-18
Identities = 60/194 (30%), Positives = 99/194 (51%), Gaps = 16/194 (8%)
Query: 684 IGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIM-------RRLRHPN 734
IG GS+G+V A +G+ AVK + +L+ K + IM + L+HP
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKK-----TILKKKEQNHIMAERNVLLKNLKHPF 57
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTP 794
+V + L + +++ G LF L R C ++ + R A A + LH+
Sbjct: 58 LVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN- 116
Query: 795 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNE 854
I++RDLK N+L+D +V ++DFGL + ++ + GTPE++APEVLR EP +
Sbjct: 117 -IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDR 175
Query: 855 KCDVYSFGVILWEL 868
D + G +L+E+
Sbjct: 176 TVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 3e-18
Identities = 74/270 (27%), Positives = 124/270 (45%), Gaps = 37/270 (13%)
Query: 680 LGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVL 737
L E +G G+YG+VY T ++A K +D +G E K+E+ ++++ H N+
Sbjct: 10 LVELVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 738 FMGAVTR--PPNLS----IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDA--RGMNCL 789
+ GA + PP + ++ EF GS+ ++ ++ I RG++ L
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127
Query: 790 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 849
H ++HRD+K N+L+ +N VK+ DFG+S T + GTP WMAPEV+
Sbjct: 128 HQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185
Query: 850 EPSNE-----KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 904
+ + + K D++S G+ E+A P M+PM+ + IP+ P +
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL---------FLIPRNPAPRL 236
Query: 905 ARIIW---------ECWQTDPSLRPSFAQL 925
W C + S RP+ QL
Sbjct: 237 KSKKWSKKFQSFIESCLVKNHSQRPTTEQL 266
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 3e-18
Identities = 71/263 (26%), Positives = 123/263 (46%), Gaps = 27/263 (10%)
Query: 682 ERIGLGSYGEVYHADWN-GTEVA--VKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
+ IG G +G+V + + G A V K L + L F +EV+ R L HPNV+
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILH--RPHCQVDEKRRI--KMALD-ARGMNCLHTST 793
+G ++ EF P G L L R ++ + +MA + A G+ LH +
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA- 119
Query: 794 PTIVHRDLKSPNLLVDKNWNVKVSDFGL--SRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 851
+H DL N + + +VK+ D+GL + + +++ A W+APE++
Sbjct: 120 -DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 852 SN-------EKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPK-ELD- 901
+ +K +++S GV +WEL T P+ ++ QV+ V + + +++PK +LD
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV-VREQDIKLPKPQLDL 237
Query: 902 PLVAR---IIWECWQTDPSLRPS 921
R ++ CW DP RP+
Sbjct: 238 KYSDRWYEVMQFCW-LDPETRPT 259
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 3e-18
Identities = 73/249 (29%), Positives = 113/249 (45%), Gaps = 22/249 (8%)
Query: 684 IGLGSYGEVYHA-DWNGTEV-AVKKFLDQDFSGAALLE----FKREVKIMRRLRHPNVVL 737
IG GS+G VY A D +EV A+KK +SG E +EV+ +++LRHPN +
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKM---SYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 738 FMGAVTRPPNLSIITEFL--PRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPT 795
+ G R ++ E+ L + +P +V+ AL +G+ LH+
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGAL--QGLAYLHSH--N 135
Query: 796 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNE- 854
++HRD+K+ N+L+ + VK+ DFG + + + GTP WMAPEV+ +
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASI----MAPANXFVGTPYWMAPEVILAMDEGQY 191
Query: 855 --KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 912
K DV+S G+ ELA K P MN M + + + C
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 251
Query: 913 QTDPSLRPS 921
Q P RP+
Sbjct: 252 QKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 4e-18
Identities = 43/155 (27%), Positives = 80/155 (51%), Gaps = 5/155 (3%)
Query: 722 REVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKMA 780
E +I++ L HP +V + N+ ++ + L G L + + + +E+ + +
Sbjct: 49 NERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFS-EEQVKFWIC 107
Query: 781 LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 840
+ LH+ I+HRD+K N+L+D+ +V ++DF ++ L++ ST+GTP
Sbjct: 108 EIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT-STSGTPG 164
Query: 841 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 875
+MAPEVL + + D +S GV +E K P+
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY 199
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 4e-18
Identities = 59/248 (23%), Positives = 118/248 (47%), Gaps = 12/248 (4%)
Query: 676 EDLVLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRH 732
+DL + +G G++G V+ + A+K + + E ++++ + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTS 792
P ++ L ++ E++P G LF L + + + LH+
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 793 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEP 851
IV+RDLK N+L+DK ++K++DFG ++ L+ T+ + GTPE++APEV++++
Sbjct: 121 E--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW----TLCGTPEYLAPEVIQSKG 174
Query: 852 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 911
N+ D ++ G++++E+ P+ NP + + +LE P+ LD +I +
Sbjct: 175 HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI--LAGKLEFPRHLDLYAKDLIKKL 232
Query: 912 WQTDPSLR 919
D + R
Sbjct: 233 LVVDRTRR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 5e-18
Identities = 55/167 (32%), Positives = 85/167 (50%), Gaps = 30/167 (17%)
Query: 676 EDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
D + ++G G++GEVY A G VA+KK L + + RE+KI+++L+HP
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHP 67
Query: 734 NVV-LFMGAVTRPPNLSIITEFLPRGSLFRI-----------LHRP-----HCQVDEKRR 776
NVV L AV RP RGS++ + L P Q+ K
Sbjct: 68 NVVPLIDMAVERPDKSKRK-----RGSVYMVTPYMDHDLSGLLENPSVKLTESQI--KCY 120
Query: 777 IKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 823
+ L+ G+N LH + I+HRD+K+ N+L+D +K++DFGL+R
Sbjct: 121 MLQLLE--GINYLHENH--ILHRDIKAANILIDNQGILKIADFGLAR 163
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 6e-18
Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 20/196 (10%)
Query: 684 IGLGSYGEVYHADWNGTEV--AVKKFLDQDFSGAALLEFKREVKIM-------RRLRHPN 734
IG GS+G+V A E AVK + A+L+ K E IM + ++HP
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKK-----AILKKKEEKHIMSERNVLLKNVKHPF 57
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTP 794
+V + L + +++ G LF L R C ++ + R A A + LH+
Sbjct: 58 LVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN- 116
Query: 795 TIVHRDLKSPNLLVDKNWNVKVSDFGLSR--LKHNTFLSSKSTAGTPEWMAPEVLRNEPS 852
IV+RDLK N+L+D ++ ++DFGL + ++HN ++ + GTPE++APEVL +P
Sbjct: 117 -IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLHKQPY 173
Query: 853 NEKCDVYSFGVILWEL 868
+ D + G +L+E+
Sbjct: 174 DRTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 8e-18
Identities = 53/197 (26%), Positives = 97/197 (49%), Gaps = 3/197 (1%)
Query: 723 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 782
E ++++ RHP + + L + E+ G LF L R +++ R A
Sbjct: 45 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 104
Query: 783 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM 842
++ LH S +V+RDLK NL++DK+ ++K++DFGL + + K+ GTPE++
Sbjct: 105 VSALDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYL 163
Query: 843 APEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 902
APEVL + D + GV+++E+ +LP+ + ++ + + R P+ L P
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF--PRTLSP 221
Query: 903 LVARIIWECWQTDPSLR 919
++ + DP R
Sbjct: 222 EAKSLLSGLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-17
Identities = 46/153 (30%), Positives = 82/153 (53%), Gaps = 2/153 (1%)
Query: 723 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 782
E ++++ RHP + + L + E++ G LF L R +++ R A
Sbjct: 45 ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEI 104
Query: 783 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM 842
++ LH+ IV+RDLK NL++DK+ ++K++DFGL + + K+ GTPE++
Sbjct: 105 VSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYL 162
Query: 843 APEVLRNEPSNEKCDVYSFGVILWELATLKLPW 875
APEVL + D + GV+++E+ +LP+
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 20/200 (10%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ RIG G++G V+ A G VA+KK + G + RE+K ++ +HP VV
Sbjct: 4 ILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVK 63
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALDARGMNCLHTSTP 794
+ ++ E++P L +L RP + K ++M L G+ +H +
Sbjct: 64 LLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLK--GVAYMHANG- 119
Query: 795 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----W-MAPEVLRN 849
I+HRDLK NLL+ + +K++DFGL+RL F + + + W APE+L
Sbjct: 120 -IMHRDLKPANLLISADGVLKIADFGLARL----FSEEEPRLYSHQVATRWYRAPELLYG 174
Query: 850 EPS-NEKCDVYSFGVILWEL 868
+ D+++ G I EL
Sbjct: 175 ARKYDPGVDLWAVGCIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 76/267 (28%), Positives = 119/267 (44%), Gaps = 51/267 (19%)
Query: 684 IGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLE-------FKREVKIMRRLRH-PNV 735
+G G+YG+V+ G A K + + A +++ + E +++ +R P +
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRIL-HRPHCQVDEKR----RIKMALDARGMNCLH 790
V A L +I +++ G LF L R H E R I +ALD LH
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD-----HLH 122
Query: 791 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK-----STAGTPEWMAPE 845
I++RD+K N+L+D +V ++DFGLS+ FL+ + S GT E+MAPE
Sbjct: 123 QLG--IIYRDIKLENILLDSEGHVVLTDFGLSKE----FLAEEEERAYSFCGTIEYMAPE 176
Query: 846 VLRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI------- 896
V+R ++ D +S GV+ +EL T G +P V G QN + EI
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLT------GASPFTVDGE---QNSQSEISRRILKS 227
Query: 897 ----PKELDPLVARIIWECWQTDPSLR 919
PK + I + + DP R
Sbjct: 228 KPPFPKTMSAEARDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-17
Identities = 53/197 (26%), Positives = 97/197 (49%), Gaps = 4/197 (2%)
Query: 723 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 782
E ++++ RHP + A L + E+ G LF L R +E+ R A
Sbjct: 45 ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI 104
Query: 783 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM 842
+ LH+ +V+RD+K NL++DK+ ++K++DFGL + + + K+ GTPE++
Sbjct: 105 VSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYL 162
Query: 843 APEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 902
APEVL + D + GV+++E+ +LP+ + ++ + + R P+ L P
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF--PRTLSP 220
Query: 903 LVARIIWECWQTDPSLR 919
++ + DP R
Sbjct: 221 EAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 34/209 (16%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSG---AALLEFKREVKIMRRLRHPNV 735
E+IG G+YG VY A G VA+KK L+ + G A+ RE+ +++ L HPN+
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI----REISLLKELNHPNI 60
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRIL-HRPHCQVDEKRRIKMALDA--RGMNCLHTS 792
V + V L ++ EFL L + + P +D IK L +G+ H+
Sbjct: 61 VRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDP-PLIKSYLYQLLQGIAYCHSH 118
Query: 793 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR---LKHNTFLSSKSTAGTPE----WM-AP 844
++HRDLK NLL+D+ +K++DFGL+R + T+ T E W AP
Sbjct: 119 R--VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY--------THEVVTLWYRAP 168
Query: 845 EVLRNEPS-NEKCDVYSFGVILWELATLK 872
E+L + D++S G I E+ +
Sbjct: 169 EILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 75/268 (27%), Positives = 129/268 (48%), Gaps = 28/268 (10%)
Query: 676 EDLVLGERIGLGSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKR---EVKIMRR 729
+DL + E +G G+YG V H GT +AVK+ S E KR ++ I R
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVP-TGTIMAVKRIRATVNSQ----EQKRLLMDLDISMR 55
Query: 730 LRH-PNVVLFMGAVTRPPNLSIITEFLPRG--SLFRILHRPHCQVDEKRRIKMALD-ARG 785
P V F GA+ R ++ I E + ++ ++ + E K+A+ +
Sbjct: 56 SVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKA 115
Query: 786 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 845
+ LH S +++HRD+K N+L+++N VK+ DFG+S ++ ++ AG +MAPE
Sbjct: 116 LEYLH-SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS-VAKTIDAGCKPYMAPE 173
Query: 846 VLRNEPS----NEKCDVYSFGVILWELATLKLP---WIGMNPMQVVGAVGFQNRRLEIPK 898
+ E + + K DV+S G+ + ELAT + P W P Q + V + ++P
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW--KTPFQQLKQV-VEEPSPQLPA 230
Query: 899 E-LDPLVARIIWECWQTDPSLRPSFAQL 925
E P + +C + + RP++ +L
Sbjct: 231 EKFSPEFQDFVNKCLKKNYKERPNYPEL 258
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 64/204 (31%), Positives = 104/204 (50%), Gaps = 7/204 (3%)
Query: 683 RIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740
+IG GS G V A +G +VAVK +D L F EV IMR +H NVV
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVK-MMDLRKQQRRELLFN-EVVIMRDYQHQNVVEMYK 85
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRD 800
+ L ++ EFL G+L I+ + ++ + ++ + + LH+ ++HRD
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESV-LQALCYLHSQG--VIHRD 142
Query: 801 LKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYS 860
+KS ++L+ + VK+SDFG KS GTP WMAPEV+ P + D++S
Sbjct: 143 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWS 202
Query: 861 FGVILWELATLKLPWIGMNPMQVV 884
G+++ E+ + P+ +P+Q +
Sbjct: 203 LGIMVIEMVDGEPPYFSDSPVQAM 226
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 3e-17
Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 39/214 (18%)
Query: 683 RIGLGSYGEVYHAD--WNGTEVAVKKFL----DQDFSGAALLEFKREVKIMRRLRHPNVV 736
+IG G++GEV+ A VA+KK L + F AL RE+KI++ L+H NVV
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITAL----REIKILQLLKHENVV 74
Query: 737 LFMGAVTRPPN--------LSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDARG 785
+ ++ EF L +L + + K+ +KM L+ G
Sbjct: 75 NLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLN--G 131
Query: 786 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG-------- 837
+ +H + I+HRD+K+ N+L+ K+ +K++DFGL+R F SK++
Sbjct: 132 LYYIHRNK--ILHRDMKAANILITKDGILKLADFGLAR----AFSLSKNSKPNRYTNRVV 185
Query: 838 TPEWMAPEVLRNEPS-NEKCDVYSFGVILWELAT 870
T + PE+L E D++ G I+ E+ T
Sbjct: 186 TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 80/269 (29%), Positives = 125/269 (46%), Gaps = 27/269 (10%)
Query: 676 EDLV-LGERIGLGSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKREVK-IMRRL 730
EDL LGE IG G++G V H +GT +AVK+ + ++ +MR
Sbjct: 4 EDLKDLGE-IGRGAFGTVNKMLHKP-SGTIMAVKR-IRSTVDEKEQKRLLMDLDVVMRSS 60
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI------KMALDA- 783
P +V F GA+ R + I E L SL + + K I K+A+
Sbjct: 61 DCPYIVKFYGALFREGDCWICME-LMDISLDKFYKYVYEV--LKSVIPEEILGKIAVATV 117
Query: 784 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 843
+ +N L I+HRD+K N+L+D+N N+K+ DFG+S ++ ++ AG +MA
Sbjct: 118 KALNYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD-AGCRPYMA 175
Query: 844 PEVL---RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM--QVVGAVGFQNRRL--EI 896
PE + + + + DV+S G+ L+E+AT K P+ N + Q+ V L
Sbjct: 176 PERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSE 235
Query: 897 PKELDPLVARIIWECWQTDPSLRPSFAQL 925
+E P I C D S RP + +L
Sbjct: 236 EREFSPSFVNFINLCLIKDESKRPKYKEL 264
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 5e-17
Identities = 51/153 (33%), Positives = 84/153 (54%), Gaps = 5/153 (3%)
Query: 783 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTP-E 840
A+GM L ++ +HRDL + N+L+ +N VK+ DFGL+R + + K A P +
Sbjct: 189 AKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246
Query: 841 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKE 899
WMAPE + + + DV+SFGV+LWE+ +L P+ G+ + + R+ P
Sbjct: 247 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY 306
Query: 900 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932
P + + + +CW +PS RP+F++L L L
Sbjct: 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 1e-16
Identities = 59/196 (30%), Positives = 94/196 (47%), Gaps = 20/196 (10%)
Query: 684 IGLGSYGEVYHADWNGTEV--AVKKFLDQDFSGAALLEFKREVKIM-------RRLRHPN 734
IG GS+G+V A AVK A+L+ K + IM + ++HP
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVL-----QKKAILKKKEQKHIMAERNVLLKNVKHPF 57
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTP 794
+V + L + +++ G LF L R + + R A A + LH+
Sbjct: 58 LVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN- 116
Query: 795 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAPEVLRNEPS 852
I++RDLK N+L+D +V ++DFGL K S ++ GTPE++APEVLR +P
Sbjct: 117 -IIYRDLKPENILLDSQGHVVLTDFGLC--KEGIEHSKTTSTFCGTPEYLAPEVLRKQPY 173
Query: 853 NEKCDVYSFGVILWEL 868
+ D + G +L+E+
Sbjct: 174 DRTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 1e-16
Identities = 65/222 (29%), Positives = 111/222 (50%), Gaps = 19/222 (8%)
Query: 684 IGLGSYGEVYHADWNGTEV-----AVKK--FLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+G GS+G+V A+ GT A+KK L+ D ++E R V + HP +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVE--RRVLALA-WEHPFLT 59
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDARGMNCLHTSTPT 795
+L + E+L G L + + DE R R A G+ LH
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKKG-- 116
Query: 796 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK 855
I++RDLK N+L+DK+ ++K++DFG+ + N + + GTP+++APE+L+ + NE
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNES 176
Query: 856 CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 897
D +SFGV+L+E+ + P+ G + ++ F + + P
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGEDEDEL-----FDSILNDRP 213
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-16
Identities = 53/155 (34%), Positives = 83/155 (53%), Gaps = 9/155 (5%)
Query: 783 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR--LKHNTFLSSKSTAGTPE 840
A GM L ++ VHRDL + N+L+ + VK+ DFGL+R ++ + ++S ST +
Sbjct: 249 ANGMEFL--ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLK 306
Query: 841 WMAPEVLRNEPSNEKCDVYSFGVILWELATL---KLPWIGMNPMQVVGAVGFQNRRLEIP 897
WMAPE + N DV+SFG++LWE+ TL P + MN Q A+ + R+ P
Sbjct: 307 WMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE-QFYNAIK-RGYRMAKP 364
Query: 898 KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932
+ I+ +CW+ +RP F+QL + L
Sbjct: 365 AHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 64/196 (32%), Positives = 94/196 (47%), Gaps = 7/196 (3%)
Query: 682 ERIGLGSYGEVYHADWNGTE--VAVKKF-LDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
E+IG G+YG VY T VA+KK L+ + G RE+ +++ L+HPN+V
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAI-REISLLKELQHPNIVCL 64
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDARGMNCLHTSTPTIV 797
+ + L +I EFL L + L P Q + +K L L + ++
Sbjct: 65 QDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVL 123
Query: 798 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKC 856
HRDLK NLL+D +K++DFGL+R T + APEVL P +
Sbjct: 124 HRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPV 183
Query: 857 DVYSFGVILWELATLK 872
D++S G I E+AT K
Sbjct: 184 DIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 67/207 (32%), Positives = 104/207 (50%), Gaps = 38/207 (18%)
Query: 684 IGLGSYGEVYHADWN--GTEVAVKK---FLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
IG G+YG V A G +VA+KK F Q F L RE+KI+RR +H N++
Sbjct: 13 IGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL----REIKILRRFKHENIIGI 68
Query: 739 MGAVTRPPNLS------IITEFLPRGSLFRI-----LHRPHCQVDEKRRIKMALDARGMN 787
+ + RPP+ I+ E + L+++ L H Q + L RG+
Sbjct: 69 L-DIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQY----FLYQIL--RGLK 120
Query: 788 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-----KHNTFLSSKSTAGTPEWM 842
+H++ ++HRDLK NLL++ N ++K+ DFGL+R+ H FL+ T +
Sbjct: 121 YIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLT--EYVATRWYR 176
Query: 843 APEVLRNEPSNEKC-DVYSFGVILWEL 868
APE++ N K D++S G IL E+
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEM 203
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 59/196 (30%), Positives = 97/196 (49%), Gaps = 13/196 (6%)
Query: 684 IGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGA--ALLEFKREVKIMRRLRHPNVVLFMG 740
+G G +GEV T ++ K + + A + F+ E I+ P +
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDARGMNCLHTSTPTIVHR 799
A NL ++ E+ P G L +L+R Q DE + +A ++ +H VHR
Sbjct: 69 AFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHR 126
Query: 800 DLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK--- 855
D+K N+L+D+ ++K++DFG + RL N ++SK GTP+++APEVL + K
Sbjct: 127 DIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTY 186
Query: 856 ---CDVYSFGVILWEL 868
CD +S GVI +E+
Sbjct: 187 GVECDWWSLGVIAYEM 202
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 3e-16
Identities = 72/269 (26%), Positives = 122/269 (45%), Gaps = 28/269 (10%)
Query: 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVK-KFLDQDFSGAALLEFKREVKIMRRLRHPN 734
E VL E +G G+YG VY T V + K + + + + E+ I+ + P
Sbjct: 2 EIEVLDE-LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPY 60
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEK--RRIKMALDARGMNCLH 790
+V F GA + + E++ GSL ++ + E RRI A+ +G+ L
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAV-VKGLKFLK 119
Query: 791 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS-SKSTAGTPEWMAPEVLRN 849
I+HRD+K N+LV+ N VK+ DFG+S N S +K+ G +MAPE +++
Sbjct: 120 EEH-NIIHRDVKPTNVLVNGNGQVKLCDFGVS---GNLVASLAKTNIGCQSYMAPERIKS 175
Query: 850 EPSNE------KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL------EIP 897
N+ + DV+S G+ + E+A + P+ P + + Q + +P
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGRYPY----PPETYANIFAQLSAIVDGDPPTLP 231
Query: 898 KELDPLVARIIWECWQTDPSLRPSFAQLT 926
+ +C P+ RP++AQL
Sbjct: 232 SGYSDDAQDFVAKCLNKIPNRRPTYAQLL 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-16
Identities = 54/158 (34%), Positives = 87/158 (55%), Gaps = 15/158 (9%)
Query: 783 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR--LKHNTFLSSKSTAGTPE 840
ARGM L ++ VHRDL + N+L+ + VK+ DFGL+R + + ++S ST +
Sbjct: 247 ARGMEFL--ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVK 304
Query: 841 WMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNR-----RL 894
WMAPE + + DV+S+G++LWE+ +L P+ GM +V + F N+ R+
Sbjct: 305 WMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM----IVDST-FYNKIKSGYRM 359
Query: 895 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932
P V I+ +CW ++P RPSF L+ ++ L
Sbjct: 360 AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 3e-16
Identities = 69/233 (29%), Positives = 117/233 (50%), Gaps = 41/233 (17%)
Query: 684 IGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIM----------RRL--- 730
+G GS+G+V+ A+ GT +Q F+ AL K++V +M +R+
Sbjct: 3 LGKGSFGKVFLAELKGT--------NQFFAIKAL---KKDVVLMDDDVECTMVEKRVLSL 51
Query: 731 --RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHC-QVDEKRRIKMALD-ARGM 786
HP + NL + E+L G L + H C + D R A + G+
Sbjct: 52 AWEHPFLTHLYCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGL 109
Query: 787 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAP 844
LH+ IV+RDLK N+L+D + ++K++DFG+ K N +K+ GTP+++AP
Sbjct: 110 QFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMC--KENMLGDAKTCTFCGTPDYIAP 165
Query: 845 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 897
E+L + N D +SFGV+L+E+ + P+ G + ++ FQ+ R++ P
Sbjct: 166 EILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL-----FQSIRMDNP 213
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 8e-16
Identities = 62/193 (32%), Positives = 105/193 (54%), Gaps = 19/193 (9%)
Query: 684 IGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFK-REVKIMRRLRHPNVVLFMG 740
+G+G++G V A G VA+KK + + FS L + RE+K+++ LRH N++
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIM-KPFSTPVLAKRTYRELKLLKHLRHENIISLSD 76
Query: 741 AVTRP-PNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALDA--RGMNCLHTSTPTI 796
P ++ +TE L L R+L RP EK+ I+ L RG+ +H++ +
Sbjct: 77 IFISPLEDIYFVTELLGT-DLHRLLTSRPL----EKQFIQYFLYQILRGLKYVHSAG--V 129
Query: 797 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV-LRNEPSNEK 855
VHRDLK N+L+++N ++K+ DFGL+R++ ST + APE+ L + + +
Sbjct: 130 VHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTR---YYRAPEIMLTWQKYDVE 186
Query: 856 CDVYSFGVILWEL 868
D++S G I E+
Sbjct: 187 VDIWSAGCIFAEM 199
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 76/271 (28%), Positives = 115/271 (42%), Gaps = 36/271 (13%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-- 731
DL IG G+ G+VY + G +AVK+ E KR I+ L
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE----ENKR---ILMDLDVV 67
Query: 732 ---H--PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGM 786
H P +V G ++ I E L L ++L R + E KM + +
Sbjct: 68 LKSHDCPYIVKCYGYFITDSDVFICME-LMSTCLDKLLKRIQGPIPEDILGKMTVAI--V 124
Query: 787 NCLH--TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKS---TAGTPE 840
LH ++HRD+K N+L+D + NVK+ DFG+S RL + SK+ +AG
Sbjct: 125 KALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL-----VDSKAKTRSAGCAA 179
Query: 841 WMAPEVLRNEPSNEK----CDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNR-RL 894
+MAPE + N K DV+S G+ L ELAT + P+ +V+ + + L
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL 239
Query: 895 EIPKELDPLVARIIWECWQTDPSLRPSFAQL 925
+ P + C D RP + +L
Sbjct: 240 PPNEGFSPDFCSFVDLCLTKDHRKRPKYREL 270
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (194), Expect = 1e-15
Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 35/212 (16%)
Query: 679 VLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNV 735
+ +++G G++G VY A G VA+KK + +S + REVK +R+L HPN+
Sbjct: 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL-REVKSLRKLNEHPNI 60
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDAR----------- 784
V L + E++ G+L++++ K R
Sbjct: 61 VKLKEVFRENDELYFVFEYM-EGNLYQLM---------KDRKGKPFSESVIRSIIYQILQ 110
Query: 785 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN--TFLSSKSTAGTPEWM 842
G+ +H HRDLK NLLV VK++DFGL+R + + ST W
Sbjct: 111 GLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVST----RWY 164
Query: 843 -APEV-LRNEPSNEKCDVYSFGVILWELATLK 872
APE+ LR+ + D+++ G I+ EL TL+
Sbjct: 165 RAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-15
Identities = 64/244 (26%), Positives = 107/244 (43%), Gaps = 30/244 (12%)
Query: 684 IGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFK-----REVK--------IMRRL 730
IG GS+G+V A K+ LD +L+ K +E K +++ +
Sbjct: 3 IGKGSFGKVLLA---------KRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV 53
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLH 790
+HP +V + L + +F+ G LF L R + + R A A + LH
Sbjct: 54 KHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH 113
Query: 791 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 850
+ IV+RDLK N+L+D +V ++DFGL + ++ + GTPE++APEV+R +
Sbjct: 114 SIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQ 171
Query: 851 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 910
P + D + G +L+E+ G+ P + L P L P + W
Sbjct: 172 PYDNTVDWWCLGAVLYEML------YGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWS 225
Query: 911 CWQT 914
+
Sbjct: 226 ILEE 229
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 68/254 (26%), Positives = 117/254 (46%), Gaps = 16/254 (6%)
Query: 676 EDLVLGERIGLGSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 734
+D+ E +G G+ G VY A + K + D + + E++I+ + P
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPY 60
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTP 794
++ F GA +SI TEF+ GSL P + RI +A+ +G+ L +
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLG---RIAVAV-VKGLTYLWSLK- 115
Query: 795 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNE 854
I+HRD+K N+LV+ VK+ DFG+S N+ +K+ GT +MAPE + E
Sbjct: 116 -ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--AKTYVGTNAYMAPERISGEQYGI 172
Query: 855 KCDVYSFGVILWELATLKLPWI-------GMNPMQVVGAVGFQNRRLEIPKELDPLVARI 907
DV+S G+ ELA + P+ + P+Q++ + ++ + +
Sbjct: 173 HSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHF 232
Query: 908 IWECWQTDPSLRPS 921
I +C + P RP+
Sbjct: 233 ITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 60/238 (25%), Positives = 101/238 (42%), Gaps = 38/238 (15%)
Query: 680 LGERIGLGSYGEVYHA-DWN-GTEVAVKKFLDQDFSGAALLEFK------------REVK 725
G +G G+YG+V A D G VA+KK + S + + RE+K
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 726 IMRRLRHPNVVLFMGAV---TRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 782
IM ++H N+ MG V ++++ + + L +++ R + + + +
Sbjct: 73 IMNEIKHENI---MGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQI 128
Query: 783 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG----- 837
G+N LH +HRDL N+ ++ K++DFGL+R S +
Sbjct: 129 LNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 838 ----TPE----WM-APEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVG 885
T + W APE+L E + D++S G I EL T K + G N + +G
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244
|
Length = 335 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-15
Identities = 60/237 (25%), Positives = 106/237 (44%), Gaps = 47/237 (19%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADW---NGTEVAVKKF----------LDQDFSGAA 716
+ ++ +ED +G GS+G V A + + VA+K+F +D FS
Sbjct: 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS--- 80
Query: 717 LLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRR 776
E KI+ + HP V G+ L ++ EF+ G F L R +R
Sbjct: 81 ------ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR-------NKR 127
Query: 777 IKMALDARGMNCLHTS----------TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826
+ C + + + IV+RDLK NLL+DK+ +K++DFG +++
Sbjct: 128 F-----PNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182
Query: 827 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV 883
+ + GTPE++APE+L N + D ++ G+ ++E+ P+ P+ +
Sbjct: 183 T---RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI 236
|
Length = 340 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-15
Identities = 59/186 (31%), Positives = 82/186 (44%), Gaps = 18/186 (9%)
Query: 699 GTEVAVKKFLDQDFSGAALL-EFKREVKIMRRLRHPNVV-LFMGAVTRPPNLSIITEFLP 756
G EVA+K F+RE + RL HPN+V L P L + E++P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 757 RGSLFRILHR--PHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLV---DKN 811
+L +L + R + LDA + C H IVHRDLK N++V
Sbjct: 63 GRTLREVLAADGALPAGETGRLMLQVLDA--LACAHNQG--IVHRDLKPQNIMVSQTGVR 118
Query: 812 WNVKVSDFGLSRLKHNTFLSSKSTA-------GTPEWMAPEVLRNEPSNEKCDVYSFGVI 864
+ KV DFG+ L + +T GTP + APE LR EP D+Y++G+I
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178
Query: 865 LWELAT 870
E T
Sbjct: 179 FLECLT 184
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 26/199 (13%)
Query: 684 IGLGSYGEVYHADWNGT-EV----AVKK--FLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+G GS+G+V A+ GT E+ +KK L D + E KR + + + HP +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTE-KRVLALAGK--HPFLT 59
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPT 795
L + E++ G L + R + DE R A + G+ LH
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHERG-- 116
Query: 796 IVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNTFLSSKSTAGTPEWMAPEVLRN 849
I++RDLK N+L+D ++K++DFG+ + +TF GTP+++APE+L
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF------CGTPDYIAPEILSY 170
Query: 850 EPSNEKCDVYSFGVILWEL 868
+P D ++ GV+L+E+
Sbjct: 171 QPYGPAVDWWALGVLLYEM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 69/259 (26%), Positives = 110/259 (42%), Gaps = 45/259 (17%)
Query: 684 IGLGSYGEV---YHADWNGTEVAVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFM 739
IG G++GEV D G A+KK + + + E I+ +P VV
Sbjct: 9 IGRGAFGEVRLVQKKD-TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLY 67
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHR 799
+ L +I E+LP G + +L + +E+ R +A ++ +H +HR
Sbjct: 68 YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG--YIHR 125
Query: 800 DLKSPNLLVDKNWNVKVSDFGLS-------------RLKHN----------TFLSSK--- 833
D+K NLL+D ++K+SDFGL L H +SSK
Sbjct: 126 DIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKA 185
Query: 834 ------------STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM 881
ST GTP+++APEV N++CD +S GVI++E+ P+ NP
Sbjct: 186 ETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQ 245
Query: 882 QVVGAVGFQNRRLEIPKEL 900
+ + L+ P E+
Sbjct: 246 ETYRKIINWKETLQFPDEV 264
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 45/155 (29%), Positives = 82/155 (52%), Gaps = 6/155 (3%)
Query: 723 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV--DEKRRIKMA 780
E ++++ RHP + + L + E+ G LF H +V +++ R A
Sbjct: 45 ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA 102
Query: 781 LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 840
+ LH+ +V+RDLK NL++DK+ ++K++DFGL + + + K+ GTPE
Sbjct: 103 EIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160
Query: 841 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 875
++APEVL + D + GV+++E+ +LP+
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 3e-15
Identities = 63/227 (27%), Positives = 108/227 (47%), Gaps = 39/227 (17%)
Query: 684 IGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFK----REVKIMRRLRHPNVVL 737
+G G+YG+V A T +VA+KK L + F A RE+++++ + H NV+
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKK-LSRPFQSA---IHAKRTYRELRLLKHMDHENVIG 78
Query: 738 FMGAVTRPPNLS------IITEFLPRGSLFRILHRPHCQV--DEKRRIKMALDARGMNCL 789
+ T +L ++T + L I+ CQ D+ + + RG+ +
Sbjct: 79 LLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVK---CQKLSDDHIQFLVYQILRGLKYI 134
Query: 790 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAPEVL 847
H++ I+HRDLK N+ V+++ +K+ DFGL+R + T T + APE++
Sbjct: 135 HSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHT-----DDEMTGYVATRWYRAPEIM 187
Query: 848 RNEPS-NEKCDVYSFGVILWELATLKLPWIGMNP-------MQVVGA 886
N N+ D++S G I+ EL T K + G + M +VG
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGT 234
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 63/220 (28%), Positives = 107/220 (48%), Gaps = 19/220 (8%)
Query: 680 LGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVL 737
L E +G G+YG+VY T ++A K +D + E K E+ ++++ H N+
Sbjct: 20 LVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 738 FMGAVTR--PP----NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDA--RGMNCL 789
+ GA + PP L ++ EF GS+ ++ ++ I RG+ L
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137
Query: 790 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 849
H ++HRD+K N+L+ +N VK+ DFG+S T + GTP WMAPEV+
Sbjct: 138 HAHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 195
Query: 850 EPSNE-----KCDVYSFGVILWELATLKLPWIGMNPMQVV 884
+ + + + D++S G+ E+A P M+PM+ +
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL 235
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 61/194 (31%), Positives = 96/194 (49%), Gaps = 15/194 (7%)
Query: 684 IGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 741
+G G+YG V T+ VA+KKF D + + RE+K++R L+ N+V A
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 742 VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDL 801
R L ++ E++ + L + P+ EK R + + ++ H + IVHRD+
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDI 126
Query: 802 KSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA------PEVLRNEPSNEK 855
K NLL+ N +K+ DFG +R LS S A E++A PE+L P +
Sbjct: 127 KPENLLISHNDVLKLCDFGFAR-----NLSEGSNANYTEYVATRWYRSPELLLGAPYGKA 181
Query: 856 CDVYSFGVILWELA 869
D++S G IL EL+
Sbjct: 182 VDMWSVGCILGELS 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 5e-15
Identities = 47/146 (32%), Positives = 80/146 (54%), Gaps = 5/146 (3%)
Query: 783 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTP-E 840
A+GM+ L ++ +HRDL + N+L+ K+ DFGL+R +++++ K A P +
Sbjct: 224 AKGMSFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVK 281
Query: 841 WMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKE 899
WMAPE + N + DV+S+G++LWE+ +L P+ GM + + R+ P+
Sbjct: 282 WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPEC 341
Query: 900 LDPLVARIIWECWQTDPSLRPSFAQL 925
+ I+ CW DP RP+F Q+
Sbjct: 342 APSEMYDIMKSCWDADPLKRPTFKQI 367
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 9e-15
Identities = 74/275 (26%), Positives = 121/275 (44%), Gaps = 35/275 (12%)
Query: 682 ERIGLGSYGEVY----HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ IG G +G+V ++ + +V VK+ L S ++F E + R L+H N++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKE-LRVSASVQEQMKFLEEAQPYRSLQHSNLLQ 59
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARG---MNC------ 788
+G T ++ EF P G L L C+ E M D M C
Sbjct: 60 CLGQCTEVTPYLLVMEFCPLGDLKGYLRS--CRKAEL----MTPDPTTLQRMACEIALGL 113
Query: 789 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH--NTFLSSKSTAGTPEWMAPEV 846
LH +H DL N L+ + VK+ D+GLS K+ + +++ W+APE+
Sbjct: 114 LHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPEL 173
Query: 847 LRNEPSN-------EKCDVYSFGVILWELATL-KLPWIGMNPMQVVG-AVGFQNRRLEIP 897
+ N ++ +V+S GV +WEL L P+ ++ QV+ V Q +L P
Sbjct: 174 VDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP 233
Query: 898 KELDPLVAR---IIWECWQTDPSLRPSFAQLTVAL 929
+ PL R ++ CW P RPS ++ + L
Sbjct: 234 RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 62/194 (31%), Positives = 93/194 (47%), Gaps = 13/194 (6%)
Query: 683 RIGLGSYGEVYHA-DWNGTE-VAVKKF-LDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
RIG G+YG VY A D E VA+KK +D + G + RE+ ++ LRHPN+V
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSL-REITLLLNLRHPNIVELK 72
Query: 740 GAVT--RPPNLSIITEFLPR--GSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPT 795
V ++ ++ E+ + SL + P + K + L RG+ LH +
Sbjct: 73 EVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLL--RGLQYLHENF-- 128
Query: 796 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-EPSNE 854
I+HRDLK NLL+ +K++DFGL+R T + APE+L
Sbjct: 129 IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTT 188
Query: 855 KCDVYSFGVILWEL 868
D+++ G IL EL
Sbjct: 189 AIDMWAVGCILAEL 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 682 ERIGLGSYGEVY---HADWNGTEVAVKKFL----DQDFSGAALLEFKREVKIMRRLRHPN 734
+IG GSYG V+ + + G VA+KKF+ D AL RE++++++L+HPN
Sbjct: 7 SKIGEGSYGVVFKCRNRE-TGQIVAIKKFVESEDDPVIKKIAL----REIRMLKQLKHPN 61
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDARGMNCLHT 791
+V + R L ++ E+ L + P V E K+ I L A +N H
Sbjct: 62 LVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQA--VNFCHK 118
Query: 792 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 851
+HRD+K N+L+ K +K+ DFG +R+ T + APE+L +
Sbjct: 119 HN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT 176
Query: 852 S-NEKCDVYSFGVILWELATLKLPWIG 877
DV++ G + EL T + W G
Sbjct: 177 QYGPPVDVWAIGCVFAELLTGQPLWPG 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-14
Identities = 56/189 (29%), Positives = 86/189 (45%), Gaps = 37/189 (19%)
Query: 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNL 806
NL +I EFLP G + +L + +E+ + +A ++ +H +HRD+K NL
Sbjct: 75 NLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNL 132
Query: 807 LVDKNWNVKVSDFGL-------------SRLKHN-----TF--LSSK------------- 833
L+D +VK+SDFGL L H+ TF ++SK
Sbjct: 133 LLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQL 192
Query: 834 --STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN 891
ST GTP+++APEV N+ CD +S GVI++E+ P+ P + V
Sbjct: 193 AFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWK 252
Query: 892 RRLEIPKEL 900
L P E+
Sbjct: 253 ETLIFPPEV 261
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 46/214 (21%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKR---EVKIMRRLRHPNVV 736
E IG G+YG V A +G +VA+KK + KR E+KI+R +H N++
Sbjct: 11 ENIGSGAYGVVCSAIDTRSGKKVAIKKIPH---AFDVPTLAKRTLRELKILRHFKHDNII 67
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLF---------------RILHRPHCQVDEKRRIKMAL 781
+I P G+ F I+H +E R +
Sbjct: 68 ------------AIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQ 115
Query: 782 DARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL------KHNTFLSSKST 835
RG+ +H++ ++HRDLK NLLV+++ +++ DFG++R +H F++
Sbjct: 116 LLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173
Query: 836 AGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWEL 868
T + APE+L + P D++S G I E+
Sbjct: 174 --TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 5e-14
Identities = 61/220 (27%), Positives = 106/220 (48%), Gaps = 36/220 (16%)
Query: 684 IGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
IG G++G V W +G VA+KK + + + RE+K++ +H NV
Sbjct: 8 IGYGAFGVV----WSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNV-- 61
Query: 738 FMGA--VTRPPNLS------IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCL 789
+ A + +PP++ ++TE + + L +I+ P + ++ + RG+ L
Sbjct: 62 -LSALDILQPPHIDPFEEIYVVTELM-QSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYL 119
Query: 790 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL------KHNTFLSSKSTAGTPEWMA 843
H++ I+HRD+K NLLV+ N +K+ DFGL+R+ KH T T + A
Sbjct: 120 HSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMT-----QEVVTQYYRA 172
Query: 844 PEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQ 882
PE+L D++S G I EL ++ + +P+Q
Sbjct: 173 PEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 5e-14
Identities = 56/189 (29%), Positives = 85/189 (44%), Gaps = 37/189 (19%)
Query: 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNL 806
NL +I EFLP G + +L + +E + +A ++ +H +HRD+K NL
Sbjct: 75 NLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNL 132
Query: 807 LVDKNWNVKVSDFGL-------------SRLKHN-----TF--LSSK------------- 833
L+D +VK+SDFGL L HN +F ++SK
Sbjct: 133 LLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQL 192
Query: 834 --STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN 891
ST GTP+++APEV N+ CD +S GVI++E+ P+ P + V
Sbjct: 193 AYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWK 252
Query: 892 RRLEIPKEL 900
L P E+
Sbjct: 253 ETLVFPPEV 261
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 5e-14
Identities = 61/197 (30%), Positives = 89/197 (45%), Gaps = 22/197 (11%)
Query: 684 IGLGSYGEVY--HADWNGTEVAVKKFLD-------QDFSGAALLEFKREVKIMRRLRHPN 734
+G G +GEV G A KK LD + A E KI+ ++
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKK-LDKKRLKKRKGEQMALN-----EKKILEKVSSRF 54
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKMALD-ARGMNCLHTS 792
+V A +L ++ + G L + I + E R I A G+ LH
Sbjct: 55 IVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR 114
Query: 793 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEP 851
IV+RDLK N+L+D + NV++SD GL+ LK K AGTP +MAPEVL+ E
Sbjct: 115 R--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRAGTPGYMAPEVLQGEV 170
Query: 852 SNEKCDVYSFGVILWEL 868
+ D ++ G L+E+
Sbjct: 171 YDFSVDWFALGCTLYEM 187
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 6e-14
Identities = 65/253 (25%), Positives = 126/253 (49%), Gaps = 22/253 (8%)
Query: 638 GTNLKLRDLESPS----SSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVY 693
G N + DL+ P+ ++D+ ++ ++I + + ++ ED + + IG G++GEV
Sbjct: 2 GLNSLVLDLDFPALRKNKNIDNFLNRYEKIVRK-IRKLQMKAEDYDVVKVIGRGAFGEVQ 60
Query: 694 HADWNGTE-VAVKKFLDQ----DFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748
++ V K L + S +A F E IM P VV A L
Sbjct: 61 LVRHKSSQKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQLFCAFQDDKYL 118
Query: 749 SIITEFLPRGSLFRILHRPHCQVDEK-RRIKMALDARGMNCLHTSTPTIVHRDLKSPNLL 807
++ E++P G L ++ + V EK + A ++ +H+ ++HRD+K N+L
Sbjct: 119 YMVMEYMPGGDLVNLM--SNYDVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNML 174
Query: 808 VDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN----EKCDVYSFG 862
+DK+ ++K++DFG ++ + + GTP++++PEVL+++ + +CD +S G
Sbjct: 175 LDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234
Query: 863 VILWELATLKLPW 875
V L+E+ P+
Sbjct: 235 VFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-14
Identities = 61/238 (25%), Positives = 102/238 (42%), Gaps = 33/238 (13%)
Query: 704 VKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRI 763
V K L D L F +M +L H ++V G R N+ ++ E++ G L
Sbjct: 34 VLKVLGSD--HRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVF 90
Query: 764 LHRP------HCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---- 813
LHR H ++D + L A ++ L +VH ++ N+LV +
Sbjct: 91 LHREKNNVSLHWKLD----VAKQL-ASALHYLEDK--KLVHGNVCGKNILVARYGLNEGY 143
Query: 814 ---VKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN--EKCDVYSFGVILWEL 868
+K+SD G+ T LS + W+APE +RN ++ D +SFG L E+
Sbjct: 144 VPFIKLSDPGIPI----TVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
Query: 869 AT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 925
+ + P ++ + F + +P +A +I +CW DP+ RPSF +
Sbjct: 200 CSNGEEP---LSTLSSSEKERFYQDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAI 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 7e-14
Identities = 60/194 (30%), Positives = 89/194 (45%), Gaps = 15/194 (7%)
Query: 684 IGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGA-----ALLEFKREVKIMRRLRHPNVVL 737
+G G +G+V A++ T E+ K L + A +L+ KR + RHP +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDARGMNCLHTSTPTI 796
++ + E+ G L +H E R A G+ LH + I
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLHENK--I 122
Query: 797 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT-FLSSKST-AGTPEWMAPEVLRNEPSNE 854
V+RDLK NLL+D VK++DFGL K F ST GTPE++APEVL
Sbjct: 123 VYRDLKLDNLLLDTEGFVKIADFGLC--KEGMGFGDRTSTFCGTPEFLAPEVLTETSYTR 180
Query: 855 KCDVYSFGVILWEL 868
D + GV+++E+
Sbjct: 181 AVDWWGLGVLIYEM 194
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-13
Identities = 63/247 (25%), Positives = 120/247 (48%), Gaps = 36/247 (14%)
Query: 644 RDLESPS----SSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVY---HAD 696
D + P+ ++D+ S+ ++ + + + + ED + + IG G++GEV H
Sbjct: 8 YDCDIPALRKNKNIDNFLSRYEKAAEK-ITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKS 66
Query: 697 WNGTEVAVKKFLDQD----FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752
+V K L + S +A F E IM +V A L ++
Sbjct: 67 SK--QVYAMKLLSKFEMIKRSDSAF--FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122
Query: 753 EFLPRGSLFRILHRPHCQVDEK------RRIKMALDARGMNCLHTSTPTIVHRDLKSPNL 806
E++P G L ++ + + EK + +ALDA +H+ +HRD+K N+
Sbjct: 123 EYMPGGDLVNLM--SNYDIPEKWARFYTAEVVLALDA-----IHSMG--FIHRDVKPDNM 173
Query: 807 LVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN----EKCDVYSF 861
L+DK+ ++K++DFG ++ N + + GTP++++PEVL+++ + +CD +S
Sbjct: 174 LLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 233
Query: 862 GVILWEL 868
GV L+E+
Sbjct: 234 GVFLYEM 240
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-13
Identities = 66/242 (27%), Positives = 98/242 (40%), Gaps = 70/242 (28%)
Query: 684 IGLGSYGEVY--HADWNGTEVAVKKFLDQDFSGAALLE--FKREVKIMRRLRHPNVVLFM 739
IG G GEVY + VA+KK + +D S LL+ F RE KI L HP +V
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKK-IREDLSENPLLKKRFLREAKIAADLIHPGIV--- 65
Query: 740 GAVTRPPNLSIITE---------FLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLH 790
P SI ++ ++ +L +L V +K + L +
Sbjct: 66 ------PVYSICSDGDPVYYTMPYIEGYTLKSLLK----SVWQKESLSKELAEK------ 109
Query: 791 TSTPT-------------------IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH----- 826
TS ++HRDLK N+L+ V + D+G + K
Sbjct: 110 TSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEED 169
Query: 827 --------NTFLSSKST-----AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL 873
S T GTP++MAPE L P++E D+Y+ GVIL+++ TL
Sbjct: 170 LLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSF 229
Query: 874 PW 875
P+
Sbjct: 230 PY 231
|
Length = 932 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 684 IGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALL-------EFKREVKIMRRLRHPNVV 736
+G G YG+V+ K F + A ++ K E I+ ++HP +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEK-----RRIKMALDARGMNCLHT 791
+ A L +I E+L G LF L R +++ I +AL+ H
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALE-------HL 116
Query: 792 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAPEVLRN 849
I++RDLK N+L+D +VK++DFGL K + + + GT E+MAPE+L
Sbjct: 117 HQQGIIYRDLKPENILLDAQGHVKLTDFGLC--KESIHEGTVTHTFCGTIEYMAPEILMR 174
Query: 850 EPSNEKCDVYSFGVILWELATLKLPWIGMN 879
+ D +S G +++++ T P+ N
Sbjct: 175 SGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 64/205 (31%), Positives = 102/205 (49%), Gaps = 27/205 (13%)
Query: 683 RIGLGSYGEVYHADWNGTE--VAVKKF-LDQDFSGAALLEFKREVKIMRRLRHPNVV--- 736
RI G+YG VY A T VA+KK ++++ G + RE+ I+ +L+HPN+V
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSL-REINILLKLQHPNIVTVK 70
Query: 737 -LFMGAVTRPPNLSIITEFLPRG--SLFRILHRPHCQVDEKRRIKMALDARGMNCLHTST 793
+ +G + + ++ E++ SL + +P Q + K + L G+ LH +
Sbjct: 71 EVVVG--SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLL--SGVAHLHDNW 126
Query: 794 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-----LKHNTFLSSKSTAGTPEWMAPEVLR 848
I+HRDLK+ NLL++ +K+ DFGL+R LK T T + APE+L
Sbjct: 127 --ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYT-----QLVVTLWYRAPELLL 179
Query: 849 NEPS-NEKCDVYSFGVILWELATLK 872
+ D++S G I EL T K
Sbjct: 180 GAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-13
Identities = 41/148 (27%), Positives = 72/148 (48%), Gaps = 2/148 (1%)
Query: 723 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 782
E ++ ++ P +V + P L ++ F+ G LF L R + R A
Sbjct: 43 ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAEL 102
Query: 783 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM 842
+ LH +++RDLK N+L+D ++ + DFGL +L + + GTPE++
Sbjct: 103 LCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYL 160
Query: 843 APEVLRNEPSNEKCDVYSFGVILWELAT 870
APE+L + D ++ GV+L+E+ T
Sbjct: 161 APELLLGHGYTKAVDWWTLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 66/248 (26%), Positives = 112/248 (45%), Gaps = 15/248 (6%)
Query: 684 IGLGSYGEVYHADWNGTE-----VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
IG GSY +V TE VKK L D ++ ++ V + HP +V
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHV-FEQASNHPFLVGL 61
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVH 798
L + E++ G L + R +E R A + +N LH I++
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIY 119
Query: 799 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDV 858
RDLK N+L+D ++K++D+G+ + ++ + GTP ++APE+LR E D
Sbjct: 120 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179
Query: 859 YSFGVILWELATLKLPW--IGM--NPMQVVGAVGFQ---NRRLEIPKELDPLVARIIWEC 911
++ GV+++E+ + P+ +G NP Q FQ +++ IP+ L A ++
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSF 239
Query: 912 WQTDPSLR 919
DP R
Sbjct: 240 LNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 63/218 (28%), Positives = 97/218 (44%), Gaps = 41/218 (18%)
Query: 684 IGLGSYGEVYHADW----NGTEVAVKKF-----LDQDFSGAALLEFKREVKIMRRLRHPN 734
IG G+YG VY A +G E A+KKF S +A RE+ ++R L+H N
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSAC----REIALLRELKHEN 63
Query: 735 VVLFMGAVTRPPNLSI-----ITEFLPRGSLFRIL--HRPH--CQVDE---KRRIKMALD 782
VV + + S+ E L++I+ HR + K + L+
Sbjct: 64 VVSLVEVFLEHADKSVYLLFDYAEH----DLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119
Query: 783 ARGMNCLHTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSRLKHN---TFLSSKST 835
G++ LH++ ++HRDLK N+LV + VK+ D GL+RL +
Sbjct: 120 --GVHYLHSN--WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175
Query: 836 AGTPEWMAPEVLRNEPSNEKC-DVYSFGVILWELATLK 872
T + APE+L K D+++ G I EL TL+
Sbjct: 176 VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 66/210 (31%), Positives = 98/210 (46%), Gaps = 30/210 (14%)
Query: 684 IGLGSYGEVYHADWN--GTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740
IG G+YG+VY A G VA+KK LD + G + RE+KI+R+L H N+V
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAI-REIKILRQLNHRNIVNLKE 73
Query: 741 AVT----------RPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDARGMN 787
VT ++ E++ L +L E K +K L+ G+N
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLE--GLN 130
Query: 788 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM-APEV 846
H +HRD+K N+L++ +K++DFGL+RL ++ + W PE+
Sbjct: 131 YCHKK--NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPEL 188
Query: 847 LRNE----PSNEKCDVYSFGVILWELATLK 872
L E P+ DV+S G IL EL T K
Sbjct: 189 LLGEERYGPA---IDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 57/197 (28%), Positives = 88/197 (44%), Gaps = 25/197 (12%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
E+IG G+YG VY A G VA+KK LD + G RE+ +++ L HPN+V
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKL 64
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDA-------RGMNCLHT 791
+ + L ++ EFL + + I + L +G+ H+
Sbjct: 65 LDVIHTENKLYLVFEFLHQDL------KKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 792 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 851
++HRDLK NLL++ +K++DFGL+R + T + APE+L
Sbjct: 119 H--RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-- 174
Query: 852 SNEKCDVYSFGVILWEL 868
C YS V +W L
Sbjct: 175 ----CKYYSTAVDIWSL 187
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 7e-13
Identities = 58/200 (29%), Positives = 92/200 (46%), Gaps = 28/200 (14%)
Query: 684 IGLGSYGEVYHADWN--GTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
IG G+ G V A G VA+KK F + + A RE+ +M+ + H N++
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY----RELVLMKLVNHKNIIG 79
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCL-------- 789
+ T +L EF + ++ CQV I+M LD M+ L
Sbjct: 80 LLNVFTPQKSLE---EFQDVYLVMELMDANLCQV-----IQMDLDHERMSYLLYQMLCGI 131
Query: 790 -HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 848
H + I+HRDLK N++V + +K+ DFGL+R +F+ + T + APEV+
Sbjct: 132 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVIL 190
Query: 849 NEPSNEKCDVYSFGVILWEL 868
E D++S G I+ E+
Sbjct: 191 GMGYKENVDIWSVGCIMGEM 210
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 8e-13
Identities = 47/150 (31%), Positives = 85/150 (56%), Gaps = 11/150 (7%)
Query: 783 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTP-E 840
A+GM+ L ++ +HRD+ + N+L+ K+ DFGL+R + +++ K A P +
Sbjct: 222 AQGMDFL--ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVK 279
Query: 841 WMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGM---NPMQVVGAVGFQNRRLEI 896
WMAPE + + + DV+S+G++LWE+ +L K P+ G+ + + G+Q R
Sbjct: 280 WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSR--- 336
Query: 897 PKELDPLVARIIWECWQTDPSLRPSFAQLT 926
P P + I+ CW +P+ RP+F+Q++
Sbjct: 337 PDFAPPEIYSIMKMCWNLEPTERPTFSQIS 366
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 15/197 (7%)
Query: 684 IGLGSYGEVYHA---DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVVL 737
IG G+YG+V+ A G VA+K+ Q L REV ++R L HPNVV
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 738 FMGAVT-----RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDA-RGMNCLHT 791
T R L+++ E + + + P V + M RG++ LH+
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 128
Query: 792 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 851
+VHRDLK N+LV + +K++DFGL+R+ + S T + APEVL
Sbjct: 129 HR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT-SVVVTLWYRAPEVLLQSS 185
Query: 852 SNEKCDVYSFGVILWEL 868
D++S G I E+
Sbjct: 186 YATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 62/198 (31%), Positives = 96/198 (48%), Gaps = 18/198 (9%)
Query: 684 IGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVVLF 738
IG+G+YG VY A +G VA+K Q L REV +++RL HPN+V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 739 MGAVT-----RPPNLSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDARGMNCLH 790
M R ++++ E + + L L + P + + + M RG++ LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDL-MRQFLRGLDFLH 125
Query: 791 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 850
+ IVHRDLK N+LV VK++DFGL+R+ ++ ++ T + APEVL
Sbjct: 126 ANC--IVHRDLKPENILVTSGGQVKLADFGLARI-YSCQMALTPVVVTLWYRAPEVLLQS 182
Query: 851 PSNEKCDVYSFGVILWEL 868
D++S G I E+
Sbjct: 183 TYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 34/91 (37%), Positives = 55/91 (60%), Gaps = 2/91 (2%)
Query: 785 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 844
G+ LH I++RDLK N+L+D + NV++SD GL+ + +K AGTP +MAP
Sbjct: 109 GLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAP 166
Query: 845 EVLRNEPSNEKCDVYSFGVILWELATLKLPW 875
E+L+ E + D ++ GV L+E+ + P+
Sbjct: 167 ELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 56/229 (24%), Positives = 109/229 (47%), Gaps = 24/229 (10%)
Query: 684 IGLGSYGEVYHADWNGTE------VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+G GS+G+V A+ GT+ + K + QD + KR + + + P +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK--PPFLTQ 65
Query: 738 FMGAVTRPPNLSIITEFLPRGSL-FRI-----LHRPHCQVDEKRRIKMALDARGMNCLHT 791
L + E++ G L + I PH A A G+ LH+
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAV------FYAAEIAIGLFFLHS 119
Query: 792 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 851
I++RDLK N+++D ++K++DFG+ + ++++ GTP+++APE++ +P
Sbjct: 120 KG--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQP 177
Query: 852 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 900
+ D ++FGV+L+E+ + P+ G + ++ ++ N + PK L
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--VSYPKSL 224
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 24/213 (11%)
Query: 682 ERIGLGSYGEVYH--ADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
E++G GSY VY + NG VA+K Q+ G RE +++ L+H N+VL
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-REASLLKGLKHANIVLLH 69
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-------RIKMALDA--RGMNCLH 790
+ L+++ E++ H CQ +K +K+ L RG++ +H
Sbjct: 70 DIIHTKETLTLVFEYV---------HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH 120
Query: 791 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 850
I+HRDLK NLL+ +K++DFGL+R K + + T + P+VL
Sbjct: 121 QRY--ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGS 178
Query: 851 PSNEKC-DVYSFGVILWELATLKLPWIGMNPMQ 882
C D++ G I E+ + GM +Q
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ 211
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 63/203 (31%), Positives = 97/203 (47%), Gaps = 23/203 (11%)
Query: 684 IGLGSYGEVYHADWNGT--EVAVKKF---LDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
IG G+YG V A + T +VA+KK D L RE+K++R L H NV+
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL---REIKLLRHLDHENVIA- 68
Query: 739 MGAVTRPPN------LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTS 792
+ + PP+ + I+ E L L +I+ D+ + + RG+ +H++
Sbjct: 69 IKDIMPPPHREAFNDVYIVYE-LMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA 127
Query: 793 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 852
++HRDLK NLL++ N ++K+ DFGL+R T + APE+L N
Sbjct: 128 N--VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLN--C 183
Query: 853 NE---KCDVYSFGVILWELATLK 872
+E DV+S G I EL K
Sbjct: 184 SEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-12
Identities = 72/263 (27%), Positives = 121/263 (46%), Gaps = 44/263 (16%)
Query: 684 IGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH--------PNV 735
+G G+YG+V+ K + + AAL++ + V+ R R+ P +
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKR----RIKMALDARGMNCLH 790
V A L +I +++ G +F L+ R + DE R I +AL+ H
Sbjct: 68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALE-------H 120
Query: 791 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK-----STAGTPEWMAPE 845
IV+RD+K N+L+D +V ++DFGLS+ FLS + S GT E+MAPE
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSK----EFLSEEKERTYSFCGTIEYMAPE 176
Query: 846 VLRNEPSNEKC-DVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRL-----EI 896
++R + + K D +S G++++EL T G +P + G Q +RR+
Sbjct: 177 IIRGKGGHGKAVDWWSLGILIFELLT------GASPFTLEGERNTQSEVSRRILKCDPPF 230
Query: 897 PKELDPLVARIIWECWQTDPSLR 919
P + P ++ + + DP R
Sbjct: 231 PSFIGPEAQDLLHKLLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 65/248 (26%), Positives = 112/248 (45%), Gaps = 15/248 (6%)
Query: 684 IGLGSYGEVYHADWNGTEVA-----VKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
IG GSY +V + T +KK L D ++ ++ V HP +V
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHV-FETASNHPFLVGL 61
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVH 798
L + EF+ G L + R +E R A + +N LH I++
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIY 119
Query: 799 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDV 858
RDLK N+L+D ++K++D+G+ + ++ + GTP ++APE+LR E D
Sbjct: 120 RDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179
Query: 859 YSFGVILWELATLKLPW--IGM--NPMQVVGAVGFQ---NRRLEIPKELDPLVARIIWEC 911
++ GV+++E+ + P+ +GM NP Q FQ +++ IP+ L + ++
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGF 239
Query: 912 WQTDPSLR 919
DP R
Sbjct: 240 LNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-12
Identities = 65/253 (25%), Positives = 122/253 (48%), Gaps = 22/253 (8%)
Query: 638 GTNLKLRDLESPS----SSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVY 693
G + + DL+ P+ ++D+ ++ + + + + ED + + IG G++GEV
Sbjct: 2 GLDALVYDLDFPALRKNKNIDNFLNRYKDTINK-IRDLRMKAEDYEVVKVIGRGAFGEVQ 60
Query: 694 HADWNGT-EVAVKKFLDQ----DFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748
T +V K L + S +A F E IM P VV A L
Sbjct: 61 LVRHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQLFYAFQDDRYL 118
Query: 749 SIITEFLPRGSLFRILHRPHCQVDEK-RRIKMALDARGMNCLHTSTPTIVHRDLKSPNLL 807
++ E++P G L ++ + V EK R A ++ +H+ +HRD+K N+L
Sbjct: 119 YMVMEYMPGGDLVNLM--SNYDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNML 174
Query: 808 VDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN----EKCDVYSFG 862
+DK+ ++K++DFG ++ + + GTP++++PEVL+++ + +CD +S G
Sbjct: 175 LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234
Query: 863 VILWELATLKLPW 875
V L+E+ P+
Sbjct: 235 VFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 27/201 (13%)
Query: 684 IGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKREV-------KIMRR---LR 731
IG G++G+VY T A+K + K+EV I+ R
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL------SKKEIVAKKEVAHTIGERNILVRTLLDE 54
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVD---EKRRIKMALDARGMNC 788
P +V + +L ++T+++ G LF H Q + + R K + +
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGELFW-----HLQKEGRFSEDRAKFYIAELVLAL 109
Query: 789 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 848
H IV+RDLK N+L+D ++ + DFGLS+ ++ + GT E++APEVL
Sbjct: 110 EHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLL 169
Query: 849 NEPSNEK-CDVYSFGVILWEL 868
+E K D +S GV+++E+
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 49/206 (23%), Positives = 93/206 (45%), Gaps = 31/206 (15%)
Query: 683 RIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFM 739
+IG G++ EV A G A+K + + F + RE++ +RRL HPN++ +
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKC-MKKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64
Query: 740 GAVTRPPN--LSIITEFLPRGSLFR-ILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTI 796
+ L+++ E L +L+ I R +++ + M + ++ +H + I
Sbjct: 65 EVLFDRKTGRLALVFE-LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--I 121
Query: 797 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP--------EWM-APEVL 847
HRD+K N+L+ + +K++DFG S + P W APE L
Sbjct: 122 FHRDIKPENILIKDD-ILKLADFG----------SCRGIYSKPPYTEYISTRWYRAPECL 170
Query: 848 RNEPS-NEKCDVYSFGVILWELATLK 872
+ K D+++ G + +E+ +L
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILSLF 196
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 43/142 (30%), Positives = 70/142 (49%), Gaps = 20/142 (14%)
Query: 796 IVHRDLKSPNLLVDKNWNVKVSDFGLSRL---------------KHNTFLSSKSTAGTPE 840
IVHRDLK NLL+ ++K++DFGLS++ K K GTPE
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181
Query: 841 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 900
++APEV+ + + D ++ G+IL+E +P+ G P ++ G V + +E P+
Sbjct: 182 YIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV--ISDDIEWPEGD 239
Query: 901 DPLVAR---IIWECWQTDPSLR 919
+ L A +I + +P R
Sbjct: 240 EALPADAQDLISRLLRQNPLER 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 52/220 (23%), Positives = 94/220 (42%), Gaps = 19/220 (8%)
Query: 677 DLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
++G+ + T VAVKK S L ++E+ R+L+HPN++
Sbjct: 3 LTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNIL 62
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRR-----IKMALDARGMNCLHT 791
++ + L +++ + GS L + H +K L ++ +H+
Sbjct: 63 PYVTSFIVDSELYVVSPLMAYGSC-EDLLKTHFPEGLPELAIAFILKDVL--NALDYIHS 119
Query: 792 STPTIVHRDLKSPNLLVDKNWNVKVSDF--GLSRLKHN-----TFLSSKSTAGTPEWMAP 844
+HR +K+ ++L+ + V +S +S +KH KS+ W++P
Sbjct: 120 K--GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177
Query: 845 EVLRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQ 882
EVL+ NEK D+YS G+ ELA +P+ M Q
Sbjct: 178 EVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-12
Identities = 27/82 (32%), Positives = 56/82 (68%)
Query: 796 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK 855
I++RDLK N+++D ++K++DFG+ + +++K+ GTP+++APE++ +P +
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKS 181
Query: 856 CDVYSFGVILWELATLKLPWIG 877
D ++FGV+L+E+ + P+ G
Sbjct: 182 VDWWAFGVLLYEMLAGQAPFEG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 6e-12
Identities = 48/155 (30%), Positives = 82/155 (52%), Gaps = 7/155 (4%)
Query: 722 REVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEK--RRIKM 779
RE+K++ P +V F GA +SI E + GSL ++L + ++ E +I +
Sbjct: 48 RELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPENILGKISI 106
Query: 780 ALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP 839
A+ RG+ L I+HRD+K N+LV+ +K+ DFG+S ++ + S GT
Sbjct: 107 AV-LRGLTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTR 162
Query: 840 EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP 874
+M+PE L+ + D++S G+ L E+A + P
Sbjct: 163 SYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 7e-12
Identities = 36/115 (31%), Positives = 72/115 (62%), Gaps = 11/115 (9%)
Query: 785 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWM 842
G+ LH+ I++RDLK N+++D++ ++K++DFG+ K N F ++++ GTP+++
Sbjct: 108 GLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMC--KENVFGDNRASTFCGTPDYI 163
Query: 843 APEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 897
APE+L+ D +SFGV+L+E+ + P+ G + ++ F++ R++ P
Sbjct: 164 APEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL-----FESIRVDTP 213
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 7e-12
Identities = 77/298 (25%), Positives = 119/298 (39%), Gaps = 72/298 (24%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKFLD--QDFSGAALLEFKREVKIMRRLRHPNVVL 737
E IG GSYG V A G +VA+KK D + S A RE+K++R LRHP++V
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDAT--RILREIKLLRLLRHPDIVE 63
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV--------DEKRRIKMALDARGMNCL 789
+ + PP+ EF +F ++ QV E + + R + +
Sbjct: 64 -IKHIMLPPSRR---EFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYI 119
Query: 790 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM------- 842
HT+ + HRDLK N+L + + +K+ DFGL+R+ N T W
Sbjct: 120 HTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFN------DTPTAIFWTDYVATRW 171
Query: 843 --APEVL-----RNEPSNEKCDVYSFGVILWELATLKLPWIGMN---------------P 880
APE+ + P+ D++S G I E+ T K + G N
Sbjct: 172 YRAPELCGSFFSKYTPA---IDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPS 228
Query: 881 MQVVGAVG-------FQNRRLEIPKEL-------DPLVARIIWECWQTDPSLRPSFAQ 924
+ + V + R + P DPL R++ DP RP+ +
Sbjct: 229 PETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEE 286
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 8e-12
Identities = 61/246 (24%), Positives = 109/246 (44%), Gaps = 13/246 (5%)
Query: 684 IGLGSYGEVYHADWNGTEV-----AVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
IG GSY +V + VKK L D ++ ++ V + +P +V
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHV-FEQASSNPFLVGL 61
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVH 798
L ++ E++ G L + R +E R A +N LH I++
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIY 119
Query: 799 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDV 858
RDLK N+L+D + ++K++D+G+ + ++ + GTP ++APE+LR E D
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDW 179
Query: 859 YSFGVILWELATLKLPW--IGMNPMQVVGAVGFQ---NRRLEIPKELDPLVARIIWECWQ 913
++ GV+++E+ + P+ I NP FQ + + IP+ L + ++
Sbjct: 180 WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLN 239
Query: 914 TDPSLR 919
DP R
Sbjct: 240 KDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 8e-12
Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 721 KREVKIMRRLRH-PNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKR--- 775
+ E +++ +R P +V A L +I +++ G LF + R + E +
Sbjct: 52 RTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYS 111
Query: 776 -RIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS-SK 833
I +AL+ H I++RD+K N+L+D N +V ++DFGLS+ H + +
Sbjct: 112 GEIVLALE-------HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAY 164
Query: 834 STAGTPEWMAPEVLRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ- 890
S GT E+MAP+++R ++ D +S GV+++EL T G +P V G Q
Sbjct: 165 SFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT------GASPFTVDGEKNSQA 218
Query: 891 --NRRL-----EIPKELDPLVARIIWECWQTDPSLR 919
+RR+ P+E+ L II DP R
Sbjct: 219 EISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 55/235 (23%), Positives = 111/235 (47%), Gaps = 12/235 (5%)
Query: 676 EDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLD--QDFSGAALLEFKREVKIMRRLRH 732
ED + + IG G++GEV N +V K L+ + A F+ E ++ +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDARGMNCLHT 791
+ A NL ++ ++ G L +L + ++ E R +A ++ +H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 792 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNE 850
VHRD+K N+L+D N +++++DFG +L + + S GTP++++PE+L+
Sbjct: 121 LH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 851 PSNE-----KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 900
+ +CD +S GV ++E+ + P+ + ++ G + R + P ++
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQV 233
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 46/213 (21%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
E++G G+Y VY G VA+K+ LD + G RE+ +M+ L+H N+V
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAI-REISLMKELKHENIVRL 63
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKM-----ALDA---------- 783
+ L ++ E+ D K+ + ALD
Sbjct: 64 HDVIHTENKLMLVFEY--------------MDKDLKKYMDTHGVRGALDPNTVKSFTYQL 109
Query: 784 -RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR---LKHNTFLSSKSTAGTP 839
+G+ H + ++HRDLK NLL++K +K++DFGL+R + NTF + T
Sbjct: 110 LKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTL--- 164
Query: 840 EWM-APEVLRNEPS-NEKCDVYSFGVILWELAT 870
W AP+VL + + D++S G I+ E+ T
Sbjct: 165 -WYRAPDVLLGSRTYSTSIDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-11
Identities = 48/160 (30%), Positives = 84/160 (52%), Gaps = 26/160 (16%)
Query: 776 RIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS---S 832
+I +ALD + +HRDLKS N+ + +K+ DFG S+ +++ +S +
Sbjct: 177 QIVLALDEVHSRKM-------MHRDLKSANIFLMPTGIIKLGDFGFSK-QYSDSVSLDVA 228
Query: 833 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR 892
S GTP ++APE+ + ++K D++S GVIL+EL TL P+ G + +++ V +
Sbjct: 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY 288
Query: 893 -------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 925
+ LDPL+++ +P+LRP+ QL
Sbjct: 289 DPFPCPVSSGMKALLDPLLSK--------NPALRPTTQQL 320
|
Length = 478 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 37/207 (17%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSG---AALLEFKREVKIMRRLRHPNV 735
E+IG G+YG V+ A VA+K+ LD D G +AL RE+ +++ L+H N+
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL----REICLLKELKHKNI 61
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-------RIKMALDARGMNC 788
V + L+++ E+ C D K+ I + M
Sbjct: 62 VRLYDVLHSDKKLTLVFEY--------------CDQDLKKYFDSCNGDIDPEIVKSFMFQ 107
Query: 789 L-----HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 843
L + ++HRDLK NLL++KN +K++DFGL+R + T +
Sbjct: 108 LLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRP 167
Query: 844 PEVLRNEP-SNEKCDVYSFGVILWELA 869
P+VL + D++S G I ELA
Sbjct: 168 PDVLFGAKLYSTSIDMWSAGCIFAELA 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 52/192 (27%), Positives = 92/192 (47%), Gaps = 12/192 (6%)
Query: 684 IGLGSYGEVYHADWNGT-EVAVKKFLD-----QDFSGAALLEFKREVKIMRRLRHPNVVL 737
+G GS+G+V A+ GT EV K L QD + KR + + + HP +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAK--HPFLTA 60
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDARGMNCLHTSTPTI 796
L + E++ G L + R + DE R R A + LH +
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLHRHG--V 117
Query: 797 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKC 856
++RDLK N+L+D + K++DFG+ + +++ + GTP+++APE+L+
Sbjct: 118 IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSV 177
Query: 857 DVYSFGVILWEL 868
D ++ GV+++E+
Sbjct: 178 DWWALGVLMYEM 189
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 20/216 (9%)
Query: 723 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKMAL 781
E +I+ ++ VV A L ++ + G L F I H +E R + A
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109
Query: 782 D-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 840
+ G+ LH IV+RDLK N+L+D + ++++SD GL+ + + K GT
Sbjct: 110 EICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRVGTVG 166
Query: 841 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK-E 899
+MAPEV++NE D ++ G +L+E+ + G FQ R+ +I + E
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEM--------------IAGQSPFQQRKKKIKREE 212
Query: 900 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935
++ LV + E + S ++ + P +RL
Sbjct: 213 VERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 4e-11
Identities = 62/234 (26%), Positives = 95/234 (40%), Gaps = 52/234 (22%)
Query: 684 IGLGSYGEV--YHADWNGTEVAVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFMG 740
IG G++GEV G A+K L + F L K E ++ P VV
Sbjct: 9 IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYY 68
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRD 800
+ L +I EFLP G L +L + ++ R MA + +H +HRD
Sbjct: 69 SFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG--FIHRD 126
Query: 801 LKSPNLLVDKNWNVKVSDFGLSRLKHNTF------------------------------- 829
+K N+L+D+ ++K+SDFGLS H
Sbjct: 127 IKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINL 186
Query: 830 -LSSK---------------STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWE 867
+SSK ST GTP+++APE+ + ++CD +S G I++E
Sbjct: 187 TMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 4e-11
Identities = 57/245 (23%), Positives = 97/245 (39%), Gaps = 48/245 (19%)
Query: 684 IGLGSYGEVYHADWNGTEV--AVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFMG 740
IG+G++GEV T A+K D K E I+ + VV
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRD 800
+ NL + +++P G + +L R ++ R +A + +H +HRD
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG--FIHRD 126
Query: 801 LKSPNLLVDKNWNVKVSDFGLS---RLKHN------------------------------ 827
+K N+L+D++ ++K++DFGL R H+
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLK 186
Query: 828 ----------TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG 877
+ S GTP ++APEVL + CD +S GVIL+E+ + P++
Sbjct: 187 PLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLA 246
Query: 878 MNPMQ 882
P +
Sbjct: 247 DTPAE 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 684 IGLGSYGEV--YHADWNGTEVAVKKFLDQDF----SGA--ALLEFKREVKIMRRLRHPNV 735
+G G +GEV G A KK LD+ SG ALLE +I+ ++ P +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKK-LDKKRLKKKSGEKMALLE----KEILEKVNSPFI 55
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKM-ALDARGMNCLHTST 793
V A +L ++ + G L + I + ++ +R I A G+ LH +
Sbjct: 56 VNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGI--LHLHS 113
Query: 794 PTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 852
IV+RD+K N+L+D N ++SD GL+ LK ++ + AGT +MAPE+L+ EP
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR--AGTNGYMAPEILKEEPY 171
Query: 853 NEKCDVYSFGVILWELATLKLPW 875
+ D ++ G ++E+ + P+
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 6e-11
Identities = 49/174 (28%), Positives = 89/174 (51%), Gaps = 5/174 (2%)
Query: 702 VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF 761
+ +K + + A + RE++++ P +V F GA +SI E + GSL
Sbjct: 32 IMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 91
Query: 762 RILHRPHCQVDEKRRIKMALDA-RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 820
++L ++ E+ K+++ RG+ L I+HRD+K N+LV+ +K+ DFG
Sbjct: 92 QVLKEAK-RIPEEILGKVSIAVLRGLAYLREKH-QIMHRDVKPSNILVNSRGEIKLCDFG 149
Query: 821 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP 874
+S ++ + S GT +M+PE L+ + + D++S G+ L ELA + P
Sbjct: 150 VSGQLIDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 6e-11
Identities = 63/202 (31%), Positives = 97/202 (48%), Gaps = 19/202 (9%)
Query: 682 ERIGLGSYGEVYHADWNGTE--VAVKKF-LDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
E+IG G+YG VY A T +A+KK L+Q+ G RE+ +++ ++H N+V
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI-REISLLKEMQHGNIVRL 66
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDA--RGMNCLHTSTPTI 796
V L ++ E+L + P + R IK L RG+ H+ +
Sbjct: 67 QDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNP-RLIKTYLYQILRGIAYCHSHR--V 123
Query: 797 VHRDLKSPNLLVDKNWN-VKVSDFGLSR---LKHNTFLSSKSTAGTPEWM-APEVLRNEP 851
+HRDLK NLL+D+ N +K++DFGL+R + TF T W APE+L
Sbjct: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTL----WYRAPEILLGSR 179
Query: 852 S-NEKCDVYSFGVILWELATLK 872
+ D++S G I E+ K
Sbjct: 180 HYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 7e-11
Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 48/211 (22%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGA--ALLEFKREVKIMRRLR-HPNVV 736
+++G G+YG V+ A VA+KK D F A A F RE+ ++ L HPN+V
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFDA-FRNATDAQRTF-REIMFLQELGDHPNIV 70
Query: 737 LFMGAVTRPPN---LSIITEFLP-------RGSLFRILHRPHCQVDEKRRIKMALDARGM 786
+ V + N + ++ E++ R ++ +H KR I L + +
Sbjct: 71 KLL-NVIKAENDKDIYLVFEYMETDLHAVIRANILEDVH--------KRYIMYQL-LKAL 120
Query: 787 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP------- 839
+H+ ++HRDLK N+L++ + VK++DFGL+R + + P
Sbjct: 121 KYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLAR----SLSELEENPENPVLTDYVA 174
Query: 840 -EWM-APEVLRNEPSNEKCDVYSFGVILWEL 868
W APE+L Y+ GV +W +
Sbjct: 175 TRWYRAPEILLGSTR------YTKGVDMWSV 199
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 7e-11
Identities = 66/242 (27%), Positives = 109/242 (45%), Gaps = 40/242 (16%)
Query: 702 VAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 757
VA+KK F +Q + A RE+ +M+ + H N++ + T +L EF
Sbjct: 45 VAIKKLSRPFQNQTHAKRAY----RELVLMKCVNHKNIISLLNVFTPQKSLE---EFQDV 97
Query: 758 GSLFRILHRPHCQVDEKRRIKMALDARGMNCL---------HTSTPTIVHRDLKSPNLLV 808
+ ++ CQV I+M LD M+ L H + I+HRDLK N++V
Sbjct: 98 YLVMELMDANLCQV-----IQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 152
Query: 809 DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWEL 868
+ +K+ DFGL+R +F+ + T + APEV+ E D++S G I+ E+
Sbjct: 153 KSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211
Query: 869 ATLKLPWIGMNPM----QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQ 924
K+ + G + + +V+ +G E K+L P V + RP +A
Sbjct: 212 VRHKILFPGRDYIDQWNKVIEQLGTPCP--EFMKKLQPTVRNYVEN--------RPKYAG 261
Query: 925 LT 926
LT
Sbjct: 262 LT 263
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 8e-11
Identities = 54/183 (29%), Positives = 84/183 (45%), Gaps = 26/183 (14%)
Query: 699 GTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754
G VAVKK F +Q + A RE+ +++ + H N++ + T +L EF
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAY----RELVLLKCVNHKNIISLLNVFTPQKSLE---EF 98
Query: 755 LPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCL---------HTSTPTIVHRDLKSPN 805
+ ++ CQV I M LD M+ L H + I+HRDLK N
Sbjct: 99 QDVYLVMELMDANLCQV-----IHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 153
Query: 806 LLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVIL 865
++V + +K+ DFGL+R F+ + T + APEV+ E D++S G I+
Sbjct: 154 IVVKSDCTLKILDFGLARTACTNFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIM 212
Query: 866 WEL 868
EL
Sbjct: 213 GEL 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 55/198 (27%), Positives = 96/198 (48%), Gaps = 6/198 (3%)
Query: 676 EDLVLGERIGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
E V +++G G+Y V+ TE VA+K+ + GA REV +++ L+H
Sbjct: 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKNLKHA 63
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTST 793
N+V + L+++ E+L + + + +I M RG++ H
Sbjct: 64 NIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK 123
Query: 794 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS- 852
I+HRDLK NLL+++ +K++DFGL+R K + + T + P+VL
Sbjct: 124 --ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 853 NEKCDVYSFGVILWELAT 870
+ D++ G IL+E+AT
Sbjct: 182 STPIDMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 67/269 (24%), Positives = 115/269 (42%), Gaps = 40/269 (14%)
Query: 682 ERIGLGSYGEVY----HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ IG G +G+V + D V VK+ L + S EF ++ R L+HPN++
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKE-LKANASSKEQNEFLQQGDPYRILQHPNILQ 59
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNC------LHT 791
+G ++ E+ G L L Q RR L + M C H
Sbjct: 60 CLGQCVEAIPYLLVFEYCELGDLKSYL----SQEQWHRRNSQLLLLQRMACEIAAGVTHM 115
Query: 792 STPTIVHRDLKSPNLLVDKNWNVKVSDFGL--SRLKHNTFLSSKSTAGTPEWMAPEVL-- 847
+H DL N + + VKV D+G+ SR K + + W+APE++
Sbjct: 116 HKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGE 175
Query: 848 ---------RNEPSNEKCDVYSFGVILWEL-ATLKLPWIGMNPMQVVGAVGFQNRRLEIP 897
+ +PSN V++ GV LWEL P+ ++ +V+ V +++++++
Sbjct: 176 FHGGLITAEQTKPSN----VWALGVTLWELFENAAQPYSHLSDREVLNHV-IKDQQVKLF 230
Query: 898 K-ELD-PLVAR---IIWECWQTDPSLRPS 921
K +L+ P R ++ CW + P R +
Sbjct: 231 KPQLELPYSERWYEVLQFCWLS-PEKRAT 258
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 63/224 (28%), Positives = 103/224 (45%), Gaps = 35/224 (15%)
Query: 684 IGLGSYGEVYHADWN--GTEVAVKK-FLDQDFSGAALLEFKREVKIMRRLRHPNVV---- 736
+G GS G V+ A + VAVKK L S L RE+KI+RRL H N+V
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHAL---REIKIIRRLDHDNIVKVYE 69
Query: 737 -LFMGAVTRPPNLSIITEF--------LPRGSLFRILHRPHCQV-DEKRRIKMALDARGM 786
L ++ +TE L +L + +E R+ M RG+
Sbjct: 70 VLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLRGL 127
Query: 787 NCLHTSTPTIVHRDLKSPNLLVDKNWNV-KVSDFGLSRL-----KHNTFLSSKSTAGTPE 840
+H++ ++HRDLK N+ ++ V K+ DFGL+R+ H +LS T
Sbjct: 128 KYIHSA--NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV--TKW 183
Query: 841 WMAPEVLRNEPSN--EKCDVYSFGVILWELATLKLPWIGMNPMQ 882
+ +P +L + P+N + D+++ G I E+ T K + G + ++
Sbjct: 184 YRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE 226
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 53/191 (27%), Positives = 89/191 (46%), Gaps = 26/191 (13%)
Query: 702 VAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 757
VA+KK F +Q + A RE+ +M+ + H N++ + T +L EF
Sbjct: 52 VAIKKLSRPFQNQTHAKRAY----RELVLMKCVNHKNIIGLLNVFTPQKSLE---EFQDV 104
Query: 758 GSLFRILHRPHCQVDEKRRIKMALDARGMNCL---------HTSTPTIVHRDLKSPNLLV 808
+ ++ CQV I+M LD M+ L H + I+HRDLK N++V
Sbjct: 105 YIVMELMDANLCQV-----IQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159
Query: 809 DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWEL 868
+ +K+ DFGL+R +F+ + T + APEV+ E D++S G I+ E+
Sbjct: 160 KSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 869 ATLKLPWIGMN 879
+ + G +
Sbjct: 219 IKGGVLFPGTD 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-10
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 30/205 (14%)
Query: 684 IGLGSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+G G+YG V A G +VA+KK F + F+ A RE+++++ ++H NV+
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY----RELRLLKHMKHENVIG 78
Query: 738 FMGAVTRPPNLSIITEF---LP-----RGSLFRILHRPHCQVDEKRRIKMALDA-RGMNC 788
+ T +L +F +P G L + H ++ E R + +G+
Sbjct: 79 LLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKY 133
Query: 789 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 848
+H + I+HRDLK NL V+++ +K+ DFGL+R T T + APEV+
Sbjct: 134 IHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVVTRWYRAPEVIL 188
Query: 849 N-EPSNEKCDVYSFGVILWELATLK 872
N + D++S G I+ E+ T K
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-10
Identities = 53/193 (27%), Positives = 89/193 (46%), Gaps = 14/193 (7%)
Query: 684 IGLGSYGEVYHA------DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+G GS+G+V A +V K + QD + KR + + R HP +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARN--HPFLTQ 60
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ-VDEKR-RIKMALDARGMNCLHTSTPT 795
P L + EF+ G L + H + DE R R A + LH
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITSALMFLHDKG-- 116
Query: 796 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK 855
I++RDLK N+L+D + K++DFG+ + ++ + GTP+++APE+L+
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPS 176
Query: 856 CDVYSFGVILWEL 868
D ++ GV+L+E+
Sbjct: 177 VDWWAMGVLLYEM 189
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 21/205 (10%)
Query: 684 IGLGSYGEVYHADWNGTE----VAVKKFLDQDFSGAALLEFK-REVKIMRRLR-HPNVV- 736
+G G+YG V A T VA+KK + FS L + RE+K++R R H N+
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKK-ITNVFSKKILAKRALRELKLLRHFRGHKNITC 66
Query: 737 LF-MGAVTRPP-NLSIITEFLPRGSLFRILH--RPHCQVDEKRRIKMALDARGMNCLHTS 792
L+ M V N + E L L +I+ +P + I L G+ +H++
Sbjct: 67 LYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQIL--CGLKYIHSA 124
Query: 793 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS----KSTAGTPEWMAPEV-L 847
++HRDLK NLLV+ + +K+ DFGL+R + T + APE+ L
Sbjct: 125 N--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIML 182
Query: 848 RNEPSNEKCDVYSFGVILWELATLK 872
+ + DV+S G IL EL K
Sbjct: 183 SFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 25/82 (30%), Positives = 56/82 (68%)
Query: 796 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK 855
I++RDLK N+++D ++K++DFG+ + +++++ GTP+++APE++ +P +
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKS 181
Query: 856 CDVYSFGVILWELATLKLPWIG 877
D +++GV+L+E+ + P+ G
Sbjct: 182 VDWWAYGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 25/202 (12%)
Query: 684 IGLGSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+G G+YG V A G +VA+KK F + F+ A RE+ +++ ++H NV+
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY----RELTLLKHMQHENVIG 78
Query: 738 FMGAVTRPPNLSIITEF---LP--RGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTS 792
+ T + +F +P + L +I+ P ++K + + G+ +H++
Sbjct: 79 LLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLS--EDKVQYLVYQMLCGLKYIHSA 136
Query: 793 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM-APEVLRN-E 850
I+HRDLK NL V+++ +K+ DFGL+R T W APEV+ N
Sbjct: 137 G--IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVT----RWYRAPEVILNWM 190
Query: 851 PSNEKCDVYSFGVILWELATLK 872
N+ D++S G I+ E+ T K
Sbjct: 191 HYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 53/195 (27%), Positives = 98/195 (50%), Gaps = 12/195 (6%)
Query: 682 ERIGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
+++G G+Y VY T+ VA+K+ + GA REV +++ L+H N+V
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHANIVTLH 70
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHC-QVDEKRRIKMALDA--RGMNCLHTSTPTI 796
+ +L+++ E+L + L + L C +K+ L RG+N H +
Sbjct: 71 DIIHTEKSLTLVFEYLDK-DLKQYLD--DCGNSINMHNVKLFLFQLLRGLNYCHRRK--V 125
Query: 797 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEK 855
+HRDLK NLL+++ +K++DFGL+R K + + T + P++L + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQ 185
Query: 856 CDVYSFGVILWELAT 870
D++ G I +E++T
Sbjct: 186 IDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 51/193 (26%), Positives = 98/193 (50%), Gaps = 6/193 (3%)
Query: 684 IGLGSYGEVYHADWNGTE-VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 742
+G G+ G V+ + + +K + + A + RE++++ P +V F GA
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 743 TRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDA-RGMNCLHTSTPTIVHRDL 801
+SI E + GSL ++L + ++ E+ K+++ +G+ L I+HRD+
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKH-KIMHRDV 130
Query: 802 KSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSF 861
K N+LV+ +K+ DFG+S ++ + S GT +M+PE L+ + + D++S
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSM 188
Query: 862 GVILWELATLKLP 874
G+ L E+A + P
Sbjct: 189 GLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 3e-10
Identities = 50/194 (25%), Positives = 83/194 (42%), Gaps = 33/194 (17%)
Query: 687 GSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746
GS G V+ A G V + Q G L+E +++ + HP+V+ +
Sbjct: 77 GSEGRVFVATKPGQPDPVVLKIGQ--KGTTLIE----AMLLQNVNHPSVIRMKDTLVSGA 130
Query: 747 NLSIITEFLP--RGSLFRILHRPHCQVDEKRRIKMALDA--------RGMNCLHTSTPTI 796
++ LP L+ L + R + + A G+ LH I
Sbjct: 131 ITCMV---LPHYSSDLYTYLTK------RSRPLPID-QALIIEKQILEGLRYLHAQR--I 178
Query: 797 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--FLSSKSTAGTPEWMAPEVLRNEPSNE 854
+HRD+K+ N+ ++ V + D G ++ FL AGT E APEVL + N
Sbjct: 179 IHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG---LAGTVETNAPEVLARDKYNS 235
Query: 855 KCDVYSFGVILWEL 868
K D++S G++L+E+
Sbjct: 236 KADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 24/200 (12%)
Query: 684 IGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKR---EVKIMRRLRHPNVVLF 738
+G G+YG V A G VAVKK L + F +++ KR E+++++ ++H NV+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKK-LSRPFQ--SIIHAKRTYRELRLLKHMKHENVIGL 81
Query: 739 MGAVTRPPNLS-----IITEFLPRGSLFRILHRPHCQ--VDEKRRIKMALDARGMNCLHT 791
+ T +L + L L I+ CQ D+ + + RG+ +H+
Sbjct: 82 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS 138
Query: 792 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-E 850
+ I+HRDLK NL V+++ +K+ DFGL+R +T T + APE++ N
Sbjct: 139 AD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIMLNWM 193
Query: 851 PSNEKCDVYSFGVILWELAT 870
N+ D++S G I+ EL T
Sbjct: 194 HYNQTVDIWSVGCIMAELLT 213
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 24/201 (11%)
Query: 682 ERIGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
E++G G+Y V+ TE VA+K+ + GA REV +++ L+H N+V
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHANIVTLH 70
Query: 740 GAVTRPPNLSIITEFLPR---------GSLFRILHRPHCQVDEKRRIKMALDARGMNCLH 790
V +L+++ E+L + G++ + +I + RG+ H
Sbjct: 71 DIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSM---------HNVKIFLYQILRGLAYCH 121
Query: 791 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 850
++HRDLK NLL+++ +K++DFGL+R K + + T + P+VL
Sbjct: 122 RRK--VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGS 179
Query: 851 PS-NEKCDVYSFGVILWELAT 870
+ + D++ G I +E+A+
Sbjct: 180 SEYSTQIDMWGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 6e-10
Identities = 45/159 (28%), Positives = 79/159 (49%), Gaps = 24/159 (15%)
Query: 723 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK---- 778
E I+R + HP+++ G T +I LPR ++ +C + KR I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPR---YKT--DLYCYLAAKRNIAICDI 184
Query: 779 MALDA---RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS----RLKHNTFLS 831
+A++ R + LH + I+HRD+K+ N+ ++ +V + DFG + + N +
Sbjct: 185 LAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG 242
Query: 832 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT 870
AGT APE+L +P D++S G++L+E+AT
Sbjct: 243 ---WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 7e-10
Identities = 63/218 (28%), Positives = 97/218 (44%), Gaps = 22/218 (10%)
Query: 682 ERIGLGSYGEVYHAD--WNGTEVAVKK-FLDQDFSG---AALLEFKREVKIMRRLRHPNV 735
E+IG G+YG+VY A G VA+KK L+ D G AL RE+ +++ L
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTAL----REISLLQMLSESIY 62
Query: 736 VLFMGAVTR------PPNLSIITEFLPRG-SLFRILHR--PHCQVDEKRRIKMALDARGM 786
++ + V P+L ++ E+L F + P + K IK +
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKT-IKSFMYQLLK 121
Query: 787 NCLHTSTPTIVHRDLKSPNLLVDKNWNV-KVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 845
H ++HRDLK NLLVDK + K++D GL R S T + APE
Sbjct: 122 GVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPE 181
Query: 846 VLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQ 882
VL + D++S G I E++ + + G + +Q
Sbjct: 182 VLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ 219
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-09
Identities = 67/278 (24%), Positives = 114/278 (41%), Gaps = 56/278 (20%)
Query: 684 IGLGSYGEVYHADWNGTEV--AVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFMG 740
+G+G++GEV A T+ A+K +D + K E I+ + VV
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRD 800
+ NL + +++P G + +L R ++ R +A + +H +HRD
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG--FIHRD 126
Query: 801 LKSPNLLVDKNWNVKVSDFGL--------------------------------------- 821
+K N+L+D++ ++K++DFGL
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186
Query: 822 SRLK---------HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLK 872
RLK H L+ S GTP ++APEVL + CD +S GVIL+E+ +
Sbjct: 187 DRLKPLERRAARQHQRCLA-HSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 245
Query: 873 LPWIGMNPMQVVGAVGFQNRRLEIPKE--LDPLVARII 908
P++ P++ V L IP + L P + +I
Sbjct: 246 PPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLI 283
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-09
Identities = 66/277 (23%), Positives = 110/277 (39%), Gaps = 54/277 (19%)
Query: 684 IGLGSYGEVYHADWNGTEV--AVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFMG 740
+G+G++GEV A T A+K +D + + K E I+ + VV
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRD 800
+ NL + +++P G + +L R + R +A + +H +HRD
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG--FIHRD 126
Query: 801 LKSPNLLVDKNWNVKVSDFGLS---RLKHNTFLSSK------------------------ 833
+K N+L+D + ++K++DFGL R HN+ K
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186
Query: 834 --------------------STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL 873
S GTP ++APEVL + + CD +S GVIL+E+ +
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQP 246
Query: 874 PWIGMNPMQVVGAVGFQNRRLEIPKE--LDPLVARII 908
P++ P + V L IP + L P +I
Sbjct: 247 PFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLI 283
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 63/234 (26%), Positives = 99/234 (42%), Gaps = 48/234 (20%)
Query: 684 IGLGSYGEVY--HADWNGTEVAVKKFLDQDFSGAALLEFKR------------EVKIMRR 729
+G G +GEV G A KK LE KR E +I+ +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKK-----------LEKKRIKKRKGEAMALNEKQILEK 56
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKMALDAR-GMN 787
+ VV A L ++ + G L F I + + DE+R + A + G+
Sbjct: 57 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLE 116
Query: 788 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEV 846
LH IV+RDLK N+L+D ++++SD GL+ + + + GT +MAPEV
Sbjct: 117 DLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI--RGRVGTVGYMAPEV 172
Query: 847 LRNEPSNEKCDVYSFGVILWELATLKLPWI-GMNPMQVVGAVGFQNRRLEIPKE 899
++NE Y+F W L L I G +P F+ R+ ++ +E
Sbjct: 173 VKNER-------YTFSPDWWGLGCLIYEMIEGKSP--------FRQRKEKVKRE 211
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 33/111 (29%), Positives = 61/111 (54%), Gaps = 8/111 (7%)
Query: 797 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--FLSSKSTAGTPEWMAPEVLRNEPS-- 852
VHRD+K N+L+D N +++++DFG S LK N + S GTP++++PE+L+
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM 182
Query: 853 ---NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 900
+CD +S GV ++E+ + P+ + ++ G + R + P +
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHI 233
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 9e-09
Identities = 56/221 (25%), Positives = 92/221 (41%), Gaps = 40/221 (18%)
Query: 684 IGLGSYGEVYHADWNGTEV--AVK---KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
+G G G V+ GT A+K K + + ++E I+ L HP +
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQE--ILATLDHPFLPTL 66
Query: 739 MGAVTRPPNLSIITEFLPRGSLFRILHRP--HCQVDEKRRIKMALDARGMNCLHTSTPTI 796
+ L ++ ++ P G LFR+L R C +E R A + LH I
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--I 124
Query: 797 VHRDLKSPNLLVDKNWNVKVSDFGLS------------------------RLKHNTFLS- 831
V+RDLK N+L+ ++ ++ +SDF LS + TF
Sbjct: 125 VYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEE 184
Query: 832 ----SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWEL 868
S S GT E++APEV+ + D ++ G++L+E+
Sbjct: 185 PSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEM 225
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (143), Expect = 9e-09
Identities = 65/231 (28%), Positives = 105/231 (45%), Gaps = 43/231 (18%)
Query: 682 ERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKR-----EVKIMRRLRHPNVV 736
++IG G +GEV+ T+ + F + S L E ++ EV +MR L+H N+V
Sbjct: 19 KKIGNGRFGEVFLVKHKRTQ---EFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIV 75
Query: 737 LFMGAVTRPPN--LSIITEFLPRGSLFRILHR---------PHCQVDEKRRIKMALDARG 785
++ N L I+ EF G L R + + H VD R++ AL
Sbjct: 76 RYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCH 135
Query: 786 MNCLHTSTPTIVHRDLKSPNLLVD-------------KNWN----VKVSDFGLSRLKHNT 828
+ ++HRDLK N+ + N N K+ DFGLS+ N
Sbjct: 136 NLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK---NI 192
Query: 829 FLSS--KSTAGTPEWMAPEVLRNEPS--NEKCDVYSFGVILWELATLKLPW 875
+ S S GTP + +PE+L +E ++K D+++ G I++EL + K P+
Sbjct: 193 GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-09
Identities = 53/190 (27%), Positives = 86/190 (45%), Gaps = 6/190 (3%)
Query: 682 ERIGLGSYGEVYH--ADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
E++G GSY VY + NG VA+K + G RE +++ L+H N+VL
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI-REASLLKGLKHANIVLLH 69
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHR 799
+ L+ + E++ ++ P R+ M RG+ +H I+HR
Sbjct: 70 DIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHR 127
Query: 800 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDV 858
DLK NLL+ +K++DFGL+R K + S T + P+VL + D+
Sbjct: 128 DLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDI 187
Query: 859 YSFGVILWEL 868
+ G I E+
Sbjct: 188 WGAGCIFIEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 31/109 (28%), Positives = 61/109 (55%), Gaps = 6/109 (5%)
Query: 797 VHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNE- 854
VHRD+K N+L+DKN +++++DFG RL + + S GTP++++PE+L+ +
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183
Query: 855 ----KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE 899
+CD +S GV ++E+ + P+ + ++ G + + P +
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPD 232
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 19/200 (9%)
Query: 699 GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758
GT V V+ ++ + L + EV + RHPN++ T L +I+ F+ G
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 759 SLFRILHRPHCQVDEKRRIKMAL--DARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV 816
S +L + + I L RG+N LH + +HR++K+ ++L+ + V +
Sbjct: 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSL 142
Query: 817 SDFGLSRL--------KHNTF--LSSKSTAGTPEWMAPEVLRNEPS--NEKCDVYSFGVI 864
S GLS L K ST+ P W++PE+LR + N K D+YS G+
Sbjct: 143 S--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLP-WLSPELLRQDLYGYNVKSDIYSVGIT 199
Query: 865 LWELATLKLPWIGMNPMQVV 884
ELAT ++P+ M Q++
Sbjct: 200 ACELATGRVPFQDMLRTQML 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 26/199 (13%)
Query: 684 IGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKR---EVKIMRRLRHPNVVLF 738
+G G+YG V A +VAVKK L + F +L+ +R E+++++ ++H NV+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKK-LSRPFQ--SLIHARRTYRELRLLKHMKHENVIGL 79
Query: 739 MGAVTRPPNLSIITEF-----LPRGSLFRILHRPHCQ--VDEKRRIKMALDARGMNCLHT 791
+ T ++ E L L I+ CQ DE + + RG+ +H+
Sbjct: 80 LDVFTPATSIENFNEVYLVTNLMGADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHS 136
Query: 792 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM-APEVLRN- 849
+ I+HRDLK N+ V+++ +++ DFGL+R + +T W APE++ N
Sbjct: 137 AG--IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVAT----RWYRAPEIMLNW 190
Query: 850 EPSNEKCDVYSFGVILWEL 868
N+ D++S G I+ EL
Sbjct: 191 MHYNQTVDIWSVGCIMAEL 209
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 2e-08
Identities = 48/196 (24%), Positives = 92/196 (46%), Gaps = 25/196 (12%)
Query: 687 GSYGEVY---HADWNGTEVAVKKFLD-QDFSGAALLEFKREV-KIMRRLRHPNVVLFMGA 741
G +G+V H ++ V+K + ++F+ +E V ++M+ +PN + +
Sbjct: 27 GKFGKVSVLKHKPTQ--KLFVQKIIKAKNFNA---IEPM--VHQLMKD--NPNFIKLYYS 77
Query: 742 VTRPPNLSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRD 800
VT +I +++ G LF +L + E ++I L +N LH I+H D
Sbjct: 78 VTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQL-VEALNDLHKHN--IIHND 134
Query: 801 LKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSKSTA-GTPEWMAPEVLRNEPSNEKCDV 858
+K N+L D + + D+GL ++ + S GT ++ +PE ++ + D
Sbjct: 135 IKLENVLYDRAKDRIYLCDYGLCKIIG-----TPSCYDGTLDYFSPEKIKGHNYDVSFDW 189
Query: 859 YSFGVILWELATLKLP 874
++ GV+ +EL T K P
Sbjct: 190 WAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 60/198 (30%), Positives = 91/198 (45%), Gaps = 23/198 (11%)
Query: 684 IGLGSYGEVY---HADWNGTEVAVKKFLDQD---FSGAALLEFKREVKIMRRLRH----P 733
IG G +GEVY AD G A+K LD+ L +IM L P
Sbjct: 2 IGRGGFGEVYGCRKAD-TGKMYAMK-CLDKKRIKMKQGETLALNE--RIMLSLVSTGDCP 57
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTST 793
+V A P LS I + + G L L + + + R A G+ +H
Sbjct: 58 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF 117
Query: 794 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK--STAGTPEWMAPEVL-RNE 850
+V+RDLK N+L+D++ +V++SD GL+ F K ++ GT +MAPEVL +
Sbjct: 118 --VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKGV 171
Query: 851 PSNEKCDVYSFGVILWEL 868
+ D +S G +L++L
Sbjct: 172 AYDSSADWFSLGCMLFKL 189
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 5/157 (3%)
Query: 723 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKMAL 781
E +I+ ++ VV A L ++ + G L F I + + +E+R + A
Sbjct: 50 EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109
Query: 782 DAR-GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 840
+ G+ LH V+RDLK N+L+D ++++SD GL+ +K S + GT
Sbjct: 110 EILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESIRGRVGTVG 166
Query: 841 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG 877
+MAPEVL N+ D + G +++E+ + P+ G
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 63/256 (24%), Positives = 115/256 (44%), Gaps = 33/256 (12%)
Query: 681 GERIGLGSYGEVYHADWNGTEVAVKKFLD---QDFSGAALLEFKREVKIMRRLRHPNVVL 737
G R +G YGE++ TEV + K LD +++S + F +M +L H ++VL
Sbjct: 14 GIRREVGDYGELHK-----TEV-LLKVLDKSHRNYSES----FFEAASMMSQLSHKHLVL 63
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTI 796
G ++ E++ GSL L + ++ ++++A A ++ L +
Sbjct: 64 NYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--L 121
Query: 797 VHRDLKSPNLLV-----DKNWN---VKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 848
H ++ + N+L+ K N +K+SD G+S T L + W+ PE +
Sbjct: 122 THGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI----TVLPKEILLERIPWVPPECIE 177
Query: 849 NEPS-NEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 906
N + + D +SFG LWE+ + P ++ + + F R ++P +A
Sbjct: 178 NPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---KLQFYEDRHQLPAPKWTELAN 234
Query: 907 IIWECWQTDPSLRPSF 922
+I +C +P RPSF
Sbjct: 235 LINQCMDYEPDFRPSF 250
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 23/155 (14%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
+++G GSY VY G VA+K+ + GA RE +++ L+H N+V
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI-REASLLKDLKHANIVTLH 69
Query: 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR---------RIKMALDARGMNCLH 790
+ L+++ E+L Q + R+ + RG+ H
Sbjct: 70 DIIHTKKTLTLVFEYL---------DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH 120
Query: 791 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825
++HRDLK NLL+ + +K++DFGL+R K
Sbjct: 121 QRR--VLHRDLKPQNLLISERGELKLADFGLARAK 153
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 55/195 (28%), Positives = 88/195 (45%), Gaps = 17/195 (8%)
Query: 684 IGLGSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH----PNVV 736
IG G +GEVY AD G A+K + +IM L P +V
Sbjct: 2 IGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTI 796
A P L I + + G L L + +++ R G+ +H +
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--V 118
Query: 797 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK--STAGTPEWMAPEVLRNEPS-N 853
V+RDLK N+L+D++ +V++SD GL+ F K ++ GT +MAPEVL+ + +
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKGTAYD 174
Query: 854 EKCDVYSFGVILWEL 868
D +S G +L++L
Sbjct: 175 SSADWFSLGCMLFKL 189
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 43/155 (27%), Positives = 76/155 (49%), Gaps = 5/155 (3%)
Query: 723 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL-FRILHRPHCQVDEKRRIKMAL 781
E +I+ ++ VV A L ++ + G L F I + + DE+R I A
Sbjct: 50 EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAA 109
Query: 782 D-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 840
+ G+ L IV+RDLK N+L+D ++++SD GL+ ++ + + GT
Sbjct: 110 ELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLA-VQIPEGETVRGRVGTVG 166
Query: 841 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW 875
+MAPEV+ NE D + G +++E+ + P+
Sbjct: 167 YMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 58/227 (25%)
Query: 681 GERIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
G ++G G+YG VY A + + A+K+ S +A RE+ ++R L+HPNV+
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC----REIALLRELKHPNVI 61
Query: 737 ----LFMGAVTRP---------PNLSIITEF------------LPRGSLFRILHRPHCQV 771
+F+ R +L I +F LPRG + +L++
Sbjct: 62 SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ----- 116
Query: 772 DEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSRLKHN 827
LD G++ LH + ++HRDLK N+LV + VK++D G +RL ++
Sbjct: 117 --------ILD--GIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164
Query: 828 TF--LSSKSTAGTPEWM-APEVLRNEPSNEKC-DVYSFGVILWELAT 870
L+ W APE+L K D+++ G I EL T
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-06
Identities = 39/105 (37%), Positives = 55/105 (52%), Gaps = 13/105 (12%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVK--KFLDQDFSGAALLEFKR 722
E+P ++LVLG +G G++G V A +G +VAVK K + AL+
Sbjct: 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMS--- 89
Query: 723 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR 766
E+KIM L H N+V +GA T+ + IITE+ G L LHR
Sbjct: 90 ELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHR 134
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 3e-06
Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 36/216 (16%)
Query: 681 GERIGLGSYGEVYHA----DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
G ++G G+YG VY A + E A+K+ S +A RE+ ++R L+HPNV+
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC----REIALLRELKHPNVI 61
Query: 737 LFMGAVTRPPNLSIITEF-LPRGSLFRIL--HR-----------PHCQVDEKRRIKMALD 782
+ + F L+ I+ HR P V K + LD
Sbjct: 62 ALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMV--KSLLYQILD 119
Query: 783 ARGMNCLHTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSRLKHNTF--LSSKSTA 836
G++ LH + ++HRDLK N+LV + VK++D G +RL ++ L+
Sbjct: 120 --GIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 837 GTPEWM-APEVLRNEPSNEKC-DVYSFGVILWELAT 870
W APE+L K D+++ G I EL T
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 7e-06
Identities = 71/279 (25%), Positives = 123/279 (44%), Gaps = 48/279 (17%)
Query: 616 KNVEDHEIGYHDRRKCTHDRFMGTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPW 675
+++ +E H K +F + KL + E ++ +++ D+D+ P
Sbjct: 8 EDINIYEEKNHKANKGGSGKFEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRS--PN 65
Query: 676 EDLVLGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFK-REVKIMRRLRH 732
+ LG IG GS+G VY A T +VA+KK L QD ++K RE+ IM+ L H
Sbjct: 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVL-QD------PQYKNRELLIMKNLNH 118
Query: 733 PNVVL-----FMGAVTRPPN---LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-- 782
N++ + + L+++ EF+P+ H + R AL
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTV--------HKYMKHYARNNHALPLF 170
Query: 783 ---------ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN-VKVSDFGLSRLKHNTFLSS 832
R + +H+ I HRDLK NLL+D N + +K+ DFG ++ N
Sbjct: 171 LVKLYSYQLCRALAYIHSK--FICHRDLKPQNLLIDPNTHTLKLCDFGSAK---NLLAGQ 225
Query: 833 KSTA--GTPEWMAPEVLRNEPS-NEKCDVYSFGVILWEL 868
+S + + + APE++ + D++S G I+ E+
Sbjct: 226 RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEM 264
|
Length = 440 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 44/136 (32%), Positives = 61/136 (44%), Gaps = 11/136 (8%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
E P + LVLG +G G++G+V G +VAVK L + E+
Sbjct: 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVK-MLKPTARSSEKQALMSEL 91
Query: 725 KIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH--RPHCQVDEKRRIKMAL 781
KIM L H N+V +GA T+ + IITE+ G L LH R + + K L
Sbjct: 92 KIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDL 151
Query: 782 DARGMNCLHTSTPTIV 797
D G+N ST + V
Sbjct: 152 DIFGINPADESTRSYV 167
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 60/242 (24%), Positives = 102/242 (42%), Gaps = 33/242 (13%)
Query: 698 NGTEV-AVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 756
NG E+ V K LD AL F +M ++ H ++ G R ++ EF+
Sbjct: 41 NGRELRVVLKVLDPSHRDIAL-AFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVE 99
Query: 757 RGSLFRILHRPHCQVDEKRRIKMALD-------ARGMNCLHTSTPTIVHRDLKSPNLLVD 809
G L L + EK R+ +A A ++ L +VH ++ + N+L+
Sbjct: 100 HGPLDVCLRK------EKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLA 151
Query: 810 KNW-------NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSF 861
+ +K+SD G+S T LS + W+APE + S + D +SF
Sbjct: 152 RLGLAEGTSPFIKLSDPGVSF----TALSREERVERIPWIAPECVPGGNSLSTAADKWSF 207
Query: 862 GVILWELA-TLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRP 920
G L E+ ++P P + F ++ +P+ +A +I +C +P+ RP
Sbjct: 208 GTTLLEICFDGEVPLKERTPSE---KERFYEKKHRLPEPSCKELATLISQCLTYEPTQRP 264
Query: 921 SF 922
SF
Sbjct: 265 SF 266
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 5e-05
Identities = 27/84 (32%), Positives = 48/84 (57%), Gaps = 2/84 (2%)
Query: 796 IVHRDLKSPNLLVDKNWNVKVSDFGLS-RL-KHNTFLSSKSTAGTPEWMAPEVLRNEPSN 853
I+HRD+K+ N+ +D+ N + DFG + +L H +GT E +PE+L +P
Sbjct: 206 IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYC 265
Query: 854 EKCDVYSFGVILWELATLKLPWIG 877
K D++S G++L+E++ + G
Sbjct: 266 AKTDIWSAGLVLFEMSVKNVTLFG 289
|
Length = 392 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 6e-05
Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 22/158 (13%)
Query: 723 EVKIMRRLRHPNVVLFM-----GAVT---RPPNLSIITEFLPRGSLFRILHRPHCQVDE- 773
E +++RRL HP V+ + G +T P S + +L G+ R L QV
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYL--GARLRPLGLA--QVTAV 265
Query: 774 KRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS- 832
R++ A+D + I+HRD+K+ N+LV+ ++ + DFG + ++ +
Sbjct: 266 ARQLLSAID-------YIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318
Query: 833 -KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELA 869
AGT + APEVL +P D++S G++++E A
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356
|
Length = 461 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 7e-05
Identities = 45/156 (28%), Positives = 77/156 (49%), Gaps = 15/156 (9%)
Query: 723 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 782
E+ M +L+HPN+V +G +I E++ +L +L + +RR K+A+
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIG 788
Query: 783 -ARGMNCLHTS-TPTIVHRDLKSPNLLVDKNW--NVKVSDFGLSRLKHNTFLSSKSTAGT 838
A+ + LH +P +V +L +++D ++++S GL F+SS
Sbjct: 789 IAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSA----- 843
Query: 839 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP 874
++APE + EK D+Y FG+IL EL T K P
Sbjct: 844 --YVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 25/85 (29%), Positives = 43/85 (50%), Gaps = 7/85 (8%)
Query: 797 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKC 856
+HR KS N+L+ W+ + G F + + + P +MAPEV++ + EK
Sbjct: 33 LHRQAKSGNILL--TWDGLLKLDGSV-----AFKTPEQSRPDPYFMAPEVIQGQSYTEKA 85
Query: 857 DVYSFGVILWELATLKLPWIGMNPM 881
D+YS G+ L+E +LP+ +
Sbjct: 86 DIYSLGITLYEALDYELPYNEEREL 110
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 41/160 (25%), Positives = 73/160 (45%), Gaps = 15/160 (9%)
Query: 718 LEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI 777
L F +MR++ H ++VL G R ++ EF+ G L +HR + +
Sbjct: 49 LAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKF 108
Query: 778 KMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-------NVKVSDFGLSRLKHNTF 829
K+A A ++ L +VH ++ + N+L+ + +K+SD G+ T
Sbjct: 109 KVAKQLASALSYLEDK--DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI----TV 162
Query: 830 LSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWEL 868
LS + W+APE + + + + D +SFG LWE+
Sbjct: 163 LSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 36/101 (35%), Positives = 52/101 (51%), Gaps = 16/101 (15%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE-------VAVKKFLDQDFSGAALLEFK--- 721
E P + L LG+ +G G++G+V A G E VAVK + GA E+K
Sbjct: 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKE----GATASEYKALM 58
Query: 722 REVKIMRRL-RHPNVVLFMGAVTRPPN-LSIITEFLPRGSL 760
E+KI+ + H NVV +GA T+P L +I E+ G+L
Sbjct: 59 TELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNL 99
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 42/172 (24%), Positives = 71/172 (41%), Gaps = 30/172 (17%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHA-------DWNGTEVAVKKFLDQDFSGA--ALLEFKR 722
E P ++L G+ +G G++G+V A + N VAVK + AL+
Sbjct: 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMS--- 90
Query: 723 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL 781
E+KI+ L +H N+V +GA T + +ITE+ G L L +
Sbjct: 91 ELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRK--------------- 135
Query: 782 DARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 833
A + P I N+ ++K ++ SD G S +T++ +
Sbjct: 136 KAETFLNFVMALPEISETSSDYKNITLEK-KYIR-SDSGFSSQGSDTYVEMR 185
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 34/98 (34%), Positives = 51/98 (52%), Gaps = 10/98 (10%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE-------VAVKKFLDQDFSGAALLEFKREV 724
E P + L LG+ +G G++G+V AD G + VAV K L + + + E+
Sbjct: 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAV-KMLKEGATHSEHRALMSEL 61
Query: 725 KIMRRL-RHPNVVLFMGAVTRPPN-LSIITEFLPRGSL 760
KI+ + H NVV +GA T+P L +I EF G+L
Sbjct: 62 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 99
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 47/202 (23%), Positives = 91/202 (45%), Gaps = 23/202 (11%)
Query: 698 NGTEVAVKKFLDQDFSGAALLEF-KREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 756
G V V++ ++ + ++ F + E+ + + HPN+V + L ++T F+
Sbjct: 24 TGEYVTVRR-INLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82
Query: 757 RGSLFRILHRPHCQ--VDEKRRIKMALDARGM----NCLHTSTPTIVHRDLKSPNLLVDK 810
GS ++ C +D + +A +G+ + +H VHR +K+ ++L+
Sbjct: 83 YGSAKDLI----CTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISV 136
Query: 811 NWNVKVSDF--GLSRLKHNTFLS-----SKSTAGTPEWMAPEVLRN--EPSNEKCDVYSF 861
+ V +S LS + H L K + W++PEVL+ + + K D+YS
Sbjct: 137 DGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 196
Query: 862 GVILWELATLKLPWIGMNPMQV 883
G+ ELA +P+ M Q+
Sbjct: 197 GITACELANGHVPFKDMPATQM 218
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.002
Identities = 48/178 (26%), Positives = 82/178 (46%), Gaps = 17/178 (9%)
Query: 676 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRH 732
E+ V+ + I G++G+VY N AVK D ++ + E + +
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK------MALDARGM 786
P +V ++ N+ ++ E+L G + +LH + DE+ +K +ALD
Sbjct: 64 PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDY--- 119
Query: 787 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 844
LH I+HRDLK N+L+ ++K++DFGLS++ N L+ TP P
Sbjct: 120 --LHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKP 173
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 958 | |||
| PF14381 | 204 | EDR1: Ethylene-responsive protein kinase Le-CTR1 | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.98 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.98 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.98 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.79 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.71 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.66 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.64 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.6 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.58 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.55 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.45 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.36 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.33 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.29 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.23 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.22 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.14 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.13 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.1 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.05 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.98 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.92 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.75 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.74 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.67 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.59 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.53 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.49 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.48 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.26 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.15 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.12 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.11 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.09 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.07 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.02 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.0 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.89 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.78 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.67 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.63 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.6 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.59 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.58 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.5 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.5 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.4 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.38 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.3 | |
| smart00460 | 68 | TGc Transglutaminase/protease-like homologues. Tra | 97.2 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.16 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.15 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.05 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.95 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.87 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.54 | |
| PF01841 | 113 | Transglut_core: Transglutaminase-like superfamily; | 96.46 | |
| COG5279 | 521 | CYK3 Uncharacterized protein involved in cytokines | 96.3 | |
| PLN02236 | 344 | choline kinase | 96.2 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.03 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.98 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.91 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.82 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.74 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.68 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.47 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.46 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.34 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.17 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.07 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.04 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.6 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 93.62 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 93.24 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 92.93 |
| >PF14381 EDR1: Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-68 Score=551.87 Aligned_cols=198 Identities=51% Similarity=0.878 Sum_probs=189.0
Q ss_pred hHHHHHHHhhhcccccCCCcccCceeeeecCCC--CC-CCCCCCCChhhhcc-cCCCCceEEEEEeccCChHHHHHHHHH
Q 002160 125 AAEVLSRQYWEYNVLDYEERVVDGFYDIYGLST--DP-STQGKLPSLAHLES-NLGNSGFEVVIVNRTIDHALEELVQVA 200 (958)
Q Consensus 125 ~~~~~S~r~w~~~~Lsy~d~i~dGFY~i~g~~~--~~-~~~~~iPsl~~L~~-~~~~~~~EVIlVDr~~D~~L~~L~~~a 200 (958)
++|++|||||++|+|+|+|||+||||+|||+.. ++ ++++|||+|++|++ ++.++++|||||||++|++|++|+++|
T Consensus 2 ~~e~lS~r~W~~~~L~y~dki~DGFYdi~g~~~~~~l~~~~~~~Psl~~L~~~~~~~~~~EvIlVDr~~D~~L~~L~~~a 81 (204)
T PF14381_consen 2 SAESLSHRYWVNGCLSYDDKIPDGFYDIYGMDCTNSLKEEFGRMPSLEDLQAVPPDDSSREVILVDRRRDPSLKELEQRA 81 (204)
T ss_pred cHHHHHHHHHHcCCCCCCCcCCCCCcccccCCCccccccccCCCCCHHHHhcCCCCCCCeeEEEEccccCHHHHHHHHHH
Confidence 689999999999999999999999999999963 44 79999999999999 578999999999999999999999999
Q ss_pred HHHHhcCCCCchHHHHHHHHHHHHhhcCCCCCChhHHHHhHHHHHHHHHHHhCCceeEeeecccccchhhHHHHHHhhhc
Q 002160 201 QCIALDLPATDVGILVQQLADLVNGHMGGPVKDANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFKVLADS 280 (958)
Q Consensus 201 ~~l~~~l~~~~~~~~~~~lA~~V~~~mgg~~~~~~~~~~~~~~~~~~l~~~~~s~v~pig~i~~G~~rhRAlLFKvLaD~ 280 (958)
+++++++.. +.++++++||+|||++|||++.+++....+|++++++||. +++|+|||+|++|+|||||||||||||+
T Consensus 82 ~~~~~~~~~-~~~~~v~~LA~lVa~~MGG~~~~~~~~~~~w~~~s~~lk~--~s~~vplG~l~~G~~rhRALLFKvLAD~ 158 (204)
T PF14381_consen 82 HELSKGLST-NTKELVQKLAKLVADRMGGPVSDAEDMLFRWELRSEKLKE--NSGVVPLGSLRIGLCRHRALLFKVLADR 158 (204)
T ss_pred HHHHhcccc-CHHHHHHHHHHHHHHHhCCCCCcchhhhHHHHHHHHHHHh--CCCeEEEeeecccchHHHHHHHHHHHHh
Confidence 999998864 4589999999999999999999999999999999998988 7899999999999999999999999999
Q ss_pred CCCCceeecccCCCCc-cCcceEEEEeCCcceeeeecccCCCcccC
Q 002160 281 IRLPCRLVKGSHYTGV-EDDAVNIIKLEEEREFLVDLMAAPGTLIP 325 (958)
Q Consensus 281 i~l~c~lv~G~~~~g~-~~~a~~~v~~~~~~~~~vDlm~~pg~l~~ 325 (958)
||||||||||+||||+ +++|||+|++++++|||||||++||+|+|
T Consensus 159 iglpCrLvrG~~y~g~~~~~a~~~V~~~~~~eyiVDLm~~PG~L~P 204 (204)
T PF14381_consen 159 IGLPCRLVRGCYYCGWDDDDASNLVKFDDGREYIVDLMGAPGQLIP 204 (204)
T ss_pred cCCCceEEeeccCCccCCCCceEEEEcCCCcEEEEEcCCCCCCcCC
Confidence 9999999999999999 89999999999999999999999999998
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=427.66 Aligned_cols=254 Identities=24% Similarity=0.393 Sum_probs=230.5
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHH-HHHHHHHHHHHHHHcCCCceeEEeccccCCCce
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA-ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~-~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l 748 (958)
.+..++|+++++||+|+||+||+++. +++.||+|++.+..+.+. .....+.|..||.+++||+||+++..|++.+++
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 45678999999999999999999975 788999999988766443 566788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
|||+||+.||+|+.+|++.+.+.+...+++++.++.||.|||+.+ ||||||||+|||+|.+||++|+||||++.....
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 999999999999999999999999999999999999999999999 999999999999999999999999999976665
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHH
Q 002160 829 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 908 (958)
Q Consensus 829 ~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI 908 (958)
.....++|||++|||||++.+..|+..+|||||||++|||++|.+||.+.+..++.+.+... .....|..++.+.++||
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~-k~~~~p~~ls~~ardll 257 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKG-KLPLPPGYLSEEARDLL 257 (357)
T ss_pred CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcC-cCCCCCccCCHHHHHHH
Confidence 55667799999999999999999999999999999999999999999999999999988633 33556677999999999
Q ss_pred HHhhhcCCCCCC----CHHHHHHH
Q 002160 909 WECWQTDPSLRP----SFAQLTVA 928 (958)
Q Consensus 909 ~~CL~kDP~kRP----Sa~EIL~~ 928 (958)
.++|..||++|. ++.+|..|
T Consensus 258 ~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 258 KKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred HHHhccCHHHhcCCCCChHHhhcC
Confidence 999999999996 56665544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-48 Score=432.58 Aligned_cols=272 Identities=47% Similarity=0.786 Sum_probs=247.2
Q ss_pred ccccccCCCCeeEEEEeeccCceEEEEEEECCcE-EEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC
Q 002160 668 VCECEIPWEDLVLGERIGLGSYGEVYHADWNGTE-VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (958)
Q Consensus 668 ~~~~eI~~~dy~i~k~LG~G~fG~Vykak~~g~~-VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~ 746 (958)
...+.|.+.++.+.+.||+|+||+||+|.|.|+. ||||++...........+|.+|+.+|.+++|||||+|+|++.++.
T Consensus 33 ~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~ 112 (362)
T KOG0192|consen 33 LPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP 112 (362)
T ss_pred ccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 3456778888888899999999999999999999 999999888776666889999999999999999999999999987
Q ss_pred -ceEEEEeecCCCCHHHHHhC-CCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCC-cEEEEecccc
Q 002160 747 -NLSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLS 822 (958)
Q Consensus 747 -~l~LVmEy~~gGsL~d~L~k-~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g-~VKL~DFGLA 822 (958)
.+.|||||+++|+|.+++++ ....+....++.++++ +.||.|||.+++ ||||||||+||||+.++ ++||+|||++
T Consensus 113 ~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 113 GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccc
Confidence 79999999999999999988 4677888888888887 999999999886 99999999999999998 9999999999
Q ss_pred ccccCCcccCCCCCCCCCccCccccc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCC
Q 002160 823 RLKHNTFLSSKSTAGTPEWMAPEVLR--NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 900 (958)
Q Consensus 823 k~~~~~~~~~~s~~GT~~Y~APEvl~--g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~l 900 (958)
+.............||+.|||||++. ...|+.|+|||||||+||||++|+.||.+....++...+.....++.+|..+
T Consensus 192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~ 271 (362)
T KOG0192|consen 192 REKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKEC 271 (362)
T ss_pred eeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccC
Confidence 98766544445578999999999999 5689999999999999999999999999999988999998899999999999
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhcCCCC
Q 002160 901 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSH 940 (958)
Q Consensus 901 s~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~~p~~ 940 (958)
++.+..||.+||..||.+||+|.+|+..|+.+........
T Consensus 272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~ 311 (362)
T KOG0192|consen 272 PPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAG 311 (362)
T ss_pred CHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccC
Confidence 9999999999999999999999999999999977655433
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-47 Score=412.37 Aligned_cols=251 Identities=32% Similarity=0.466 Sum_probs=222.2
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc-
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN- 747 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~- 747 (958)
..+...+++.++.||+|..|+||++++ +++.+|+|++. -..+.....++.+|++|++..+|||||.+||+|.....
T Consensus 74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence 346778899999999999999999987 68899999983 44566778899999999999999999999999999995
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHh-cCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~-~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
.+|+||||++|+|.+++.+.+.. .+.....++.. +.||.|||. ++ ||||||||+||||+..|+|||||||.++.+
T Consensus 153 isI~mEYMDgGSLd~~~k~~g~i-~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNskGeVKicDFGVS~~l 229 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRVGRI-PEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSKGEVKICDFGVSGIL 229 (364)
T ss_pred EEeehhhcCCCCHHHHHhhcCCC-CHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccCCCEEeccccccHHh
Confidence 99999999999999999876544 44444444444 899999996 66 999999999999999999999999999988
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----ChhHHHHhhhccccccCCCCC-
Q 002160 826 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM-----NPMQVVGAVGFQNRRLEIPKE- 899 (958)
Q Consensus 826 ~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~-----~~~ei~~~i~~~~~~~~ip~~- 899 (958)
.+. ...++.||..|||||.+.|..|+.++||||||+.++||..|++||... +..+++..|. .+..+.+|..
T Consensus 230 vnS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv-~~ppP~lP~~~ 306 (364)
T KOG0581|consen 230 VNS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV-DEPPPRLPEGE 306 (364)
T ss_pred hhh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh-cCCCCCCCccc
Confidence 776 457899999999999999999999999999999999999999999774 5667777775 5567788886
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 900 LDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 900 ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+++++++||..||++||.+||++.|++.|
T Consensus 307 fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 307 FSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 99999999999999999999999999986
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=422.68 Aligned_cols=250 Identities=28% Similarity=0.436 Sum_probs=233.1
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
.+|+.++.||+|||..||.++. +|+.||+|++.+..+ ......++.+|++|.++|+|||||+++++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999976 899999999987654 3445678999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
|+|..++|..++++.+...+.+.+.++.|++.||.|||+++ |||||||..|||++++.+|||+|||||..+.......
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk 175 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERK 175 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEecccceeeeecCccccc
Confidence 99999999999998888888889999999999999999999 9999999999999999999999999999988777778
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhh
Q 002160 833 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 912 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL 912 (958)
.+.||||-|+|||++.....+..+||||+||+||.||.|++||...+-.+.+..|. .....+|..++.++++||.++|
T Consensus 176 ~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik--~~~Y~~P~~ls~~A~dLI~~lL 253 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK--LNEYSMPSHLSAEAKDLIRKLL 253 (592)
T ss_pred ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH--hcCcccccccCHHHHHHHHHHh
Confidence 88999999999999999999999999999999999999999999999999999884 4567788999999999999999
Q ss_pred hcCCCCCCCHHHHHHHH
Q 002160 913 QTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 913 ~kDP~kRPSa~EIL~~L 929 (958)
+.||.+||++++|+.+=
T Consensus 254 ~~~P~~Rpsl~~vL~h~ 270 (592)
T KOG0575|consen 254 RPNPSERPSLDEVLDHP 270 (592)
T ss_pred cCCcccCCCHHHHhcCH
Confidence 99999999999999874
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=402.60 Aligned_cols=251 Identities=28% Similarity=0.448 Sum_probs=225.3
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
..+|.+.+.||.|+||+||+|++ ++..||||.+.+..+.....+-+..|+.||+.|+|||||+|++++..++.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 36799999999999999999987 6789999999998887878888999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCC------CcEEEEecccccccc
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKN------WNVKVSDFGLSRLKH 826 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~------g~VKL~DFGLAk~~~ 826 (958)
|||+||+|.+|+++.+...+...+.++.+++.||++||.++ ||||||||+||||+.. -.+||+|||+|+.+.
T Consensus 89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 99999999999999888888888888888899999999998 9999999999999864 469999999999987
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccccc-CCCCCCcHHHH
Q 002160 827 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL-EIPKELDPLVA 905 (958)
Q Consensus 827 ~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~-~ip~~ls~eL~ 905 (958)
+.. ...+.||++.|||||++..++|+-|+|+||+|+|+|+|++|+.||...+..++...+....... .++..++..+.
T Consensus 167 ~~~-~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~ 245 (429)
T KOG0595|consen 167 PGS-MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLR 245 (429)
T ss_pred chh-HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchh
Confidence 653 3456899999999999999999999999999999999999999999999999988876554444 34566788888
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 002160 906 RIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 906 dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+|+...|+.++..|-++.+...+
T Consensus 246 ~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 246 ELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred hhhhHHHhcCccccCchHHhhhh
Confidence 99999999999999887766554
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=411.55 Aligned_cols=252 Identities=26% Similarity=0.411 Sum_probs=228.1
Q ss_pred CCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCceE
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~l~ 749 (958)
...||.+++.||.|+|++|++|+. +++.||||++.+.-+ .+...+-+.+|..+|.+| .||.||+||..|+++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 347899999999999999999975 789999999877654 333455678999999999 8999999999999999999
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~ 829 (958)
+|+||+++|+|.+++++.+.+.+...+.+.++++.||+|||.+| ||||||||+|||||++|++||+|||.|+.+....
T Consensus 151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999999999999998888999999999999999999998 9999999999999999999999999999754321
Q ss_pred c-----------c--CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCC
Q 002160 830 L-----------S--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI 896 (958)
Q Consensus 830 ~-----------~--~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~i 896 (958)
. . ..+++||.+|.+||++.....++.+|||+||||||+|+.|++||.+.++.-+++.| ......+
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI--~~l~y~f 306 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKI--QALDYEF 306 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHH--HHhcccC
Confidence 1 1 14589999999999999999999999999999999999999999999999888888 4457788
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002160 897 PKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 897 p~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L 929 (958)
|..+++.+++||+++|..||.+|++..||.+|.
T Consensus 307 p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 307 PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred CCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 999999999999999999999999999998875
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=384.93 Aligned_cols=240 Identities=25% Similarity=0.442 Sum_probs=223.2
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeccccCCCceE
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~ 749 (958)
...++|++++.||.|+||+|.+++. ++.-+|+|++.++..-. ...+...+|..+|+.+.||+++++++.|.+..++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 5678999999999999999999975 78889999988776533 34456789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~ 829 (958)
|||||++||.|+.+|++.+.+.+...+++.++.+.||+|||.++ ||||||||+|||||.+|++||+|||+|+.....
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 99999999999999999999999999999999999999999999 999999999999999999999999999987655
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHH
Q 002160 830 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 909 (958)
Q Consensus 830 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~ 909 (958)
..+.||||.|+|||++...+|++++|||+|||++|||+.|.+||...++.+++++|. .....+|..+++++++||.
T Consensus 198 --T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~--~~~v~fP~~fs~~~kdLl~ 273 (355)
T KOG0616|consen 198 --TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKIL--EGKVKFPSYFSSDAKDLLK 273 (355)
T ss_pred --EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHH--hCcccCCcccCHHHHHHHH
Confidence 346899999999999999999999999999999999999999999999999999995 5578899999999999999
Q ss_pred HhhhcCCCCC
Q 002160 910 ECWQTDPSLR 919 (958)
Q Consensus 910 ~CL~kDP~kR 919 (958)
.+|+.|-.+|
T Consensus 274 ~LL~vD~t~R 283 (355)
T KOG0616|consen 274 KLLQVDLTKR 283 (355)
T ss_pred HHHhhhhHhh
Confidence 9999999999
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=402.66 Aligned_cols=252 Identities=23% Similarity=0.345 Sum_probs=213.3
Q ss_pred CCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHH-----HHHHHHHHHHHHHHcCCCceeEEeccccCCC
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA-----ALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~-----~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~ 746 (958)
..+.|.+.+.||+|+||.|-+|.. +++.||||++.++..... ....+.+|++||++|+|||||+++++|..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 346688999999999999999954 899999999987765331 2234679999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCC---CcEEEEeccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKN---WNVKVSDFGLSR 823 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~---g~VKL~DFGLAk 823 (958)
..||||||++||+|++.+-.++...+..-+.+..|++.|+.|||+.| |+||||||+|||+..+ ..+||+|||+|+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccchhh
Confidence 99999999999999999988888878888888888899999999999 9999999999999755 889999999999
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCC---CchhhHHHHHHHHHHHHhCCCCCCCCChhH-HHHhhhcccc--ccCCC
Q 002160 824 LKHNTFLSSKSTAGTPEWMAPEVLRNEPS---NEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGFQNR--RLEIP 897 (958)
Q Consensus 824 ~~~~~~~~~~s~~GT~~Y~APEvl~g~~~---s~ksDIWSLGiLLyELLtG~~PF~g~~~~e-i~~~i~~~~~--~~~ip 897 (958)
..+.. ....++|||+.|.|||++.+..+ ..++|||||||+||-+++|.+||.+..... ..+.+..... .+...
T Consensus 328 ~~g~~-sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w 406 (475)
T KOG0615|consen 328 VSGEG-SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW 406 (475)
T ss_pred ccccc-eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence 88744 44678999999999999986553 448899999999999999999998765444 4444432211 11223
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 898 KELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 898 ~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
..++.+.++||.+||..||++||++.|+++|
T Consensus 407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 407 DRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred hhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 5689999999999999999999999999875
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=404.59 Aligned_cols=255 Identities=27% Similarity=0.427 Sum_probs=224.9
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~ 747 (958)
..+..++|++++.||+|+||.||+|+. +|..+|+|++++... ....+.-++.|.+||...++|+||+||..|++.++
T Consensus 136 ~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~ 215 (550)
T KOG0605|consen 136 TRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY 215 (550)
T ss_pred ccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe
Confidence 356789999999999999999999965 799999999988764 33456678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
+||||||++||++..+|.+.+...+...+++++..+.|+.-+|++| ||||||||+|+|||..||+||+||||+.-+..
T Consensus 216 LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCEeeccccccchhhh
Confidence 9999999999999999999999999999999999999999999999 99999999999999999999999999853210
Q ss_pred ----------------------C-cc------------------------cCCCCCCCCCccCcccccCCCCCchhhHHH
Q 002160 828 ----------------------T-FL------------------------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYS 860 (958)
Q Consensus 828 ----------------------~-~~------------------------~~~s~~GT~~Y~APEvl~g~~~s~ksDIWS 860 (958)
. .. .....+|||.|||||++.+..|+..+||||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 0 00 011356999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCC--CCcHHHHHHHHHhhhcCCCCCC---CHHHHHHH
Q 002160 861 FGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK--ELDPLVARIIWECWQTDPSLRP---SFAQLTVA 928 (958)
Q Consensus 861 LGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~--~ls~eL~dLI~~CL~kDP~kRP---Sa~EIL~~ 928 (958)
||||+||||.|.+||.+.++.++..+|......+.+|. .++++++|||.+||. ||.+|. +++||.+|
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKH 445 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence 99999999999999999999999999865555566665 468999999999998 999996 47777764
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=386.39 Aligned_cols=258 Identities=28% Similarity=0.487 Sum_probs=222.0
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEec-cccCCCc-
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG-AVTRPPN- 747 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g-~~~~~~~- 747 (958)
.....+|+|.++||+|.||+||++.. ++..||.|.+.-...+.........|+.+|++|+|||||++++ -|.++..
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV 94 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence 44567899999999999999999965 8999999999877777778888999999999999999999999 4555555
Q ss_pred eEEEEeecCCCCHHHHHh---CCCCCccHHHHHHH-HHHHHHHHHHHhcCCc--EeecCCCCCceEEcCCCcEEEEeccc
Q 002160 748 LSIITEFLPRGSLFRILH---RPHCQVDEKRRIKM-ALDARGMNCLHTSTPT--IVHRDLKSPNLLVDKNWNVKVSDFGL 821 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~---k~~~~~~e~~~l~i-a~~a~aL~yLH~~g~g--IIHRDLKPeNILId~~g~VKL~DFGL 821 (958)
++||||||.+|+|..+++ +.+..+++...+.+ ++++.||+++|..-+. |+||||||.||+|+.+|.|||+||||
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL 174 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL 174 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence 899999999999998774 44455555555554 4459999999994444 99999999999999999999999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCC-CCC
Q 002160 822 SRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP-KEL 900 (958)
Q Consensus 822 Ak~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip-~~l 900 (958)
++.+........+++|||.||+||++.+.+|+.++|||||||++|||..-+.||++.+-.++..+|. +..-+.+| ..+
T Consensus 175 ~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~-qgd~~~~p~~~Y 253 (375)
T KOG0591|consen 175 GRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIE-QGDYPPLPDEHY 253 (375)
T ss_pred HhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHH-cCCCCCCcHHHh
Confidence 9998877666778899999999999999999999999999999999999999999998888888885 44445567 678
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002160 901 DPLVARIIWECWQTDPSLRPSFAQLTVALK 930 (958)
Q Consensus 901 s~eL~dLI~~CL~kDP~kRPSa~EIL~~L~ 930 (958)
+.++..||..|+..||+.||+...++..+.
T Consensus 254 S~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 254 STDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred hhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 999999999999999999999655555544
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=405.33 Aligned_cols=253 Identities=25% Similarity=0.392 Sum_probs=226.2
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCC
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP 746 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~ 746 (958)
..+..++|.++++||+|.||+|+++.. +++.+|||.+++..+ ..........|.+|+... +||++++++.+|+..+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 456778999999999999999999976 677899999988764 455677889999999988 5999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
++|+||||+.||++..+ .+.+.+.+...++|.+..+.||.|||.++ |||||||.+|||+|.+|++||+|||+++...
T Consensus 443 ~l~fvmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred eEEEEEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEcccCcEEecccccccccC
Confidence 99999999999995433 34456777888899999999999999999 9999999999999999999999999999876
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHH
Q 002160 827 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 906 (958)
Q Consensus 827 ~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~d 906 (958)
.......++|||+.|||||++.+..|+..+|||+|||+|||||.|+.||.+.+..++.+.|. .....+|..++.+..+
T Consensus 520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~--~d~~~yP~~ls~ea~~ 597 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV--NDEVRYPRFLSKEAIA 597 (694)
T ss_pred CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh--cCCCCCCCcccHHHHH
Confidence 55567788999999999999999999999999999999999999999999999999999995 4577789999999999
Q ss_pred HHHHhhhcCCCCCCCH-----HHHHHH
Q 002160 907 IIWECWQTDPSLRPSF-----AQLTVA 928 (958)
Q Consensus 907 LI~~CL~kDP~kRPSa-----~EIL~~ 928 (958)
+++++|.++|++|..+ .+|.+|
T Consensus 598 il~~ll~k~p~kRLG~~e~d~~~i~~h 624 (694)
T KOG0694|consen 598 IMRRLLRKNPEKRLGSGERDAEDIKKH 624 (694)
T ss_pred HHHHHhccCcccccCCCCCCchhhhhC
Confidence 9999999999999754 555543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=402.41 Aligned_cols=270 Identities=28% Similarity=0.403 Sum_probs=237.4
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecC-CCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQ-DFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~-~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
.-|++++.||+|+-|.|.+|++ +|+.+|||++.+. .........+.+|+-||+.|.||||+++|++|++..++|+|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4588999999999999999987 8999999999877 555566778999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
||++||.|++++.+.+...+.+..-++.+++.|+.|+|..+ |+||||||+|+|||..++|||+|||+|.+.... ...
T Consensus 92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-klL 168 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-KLL 168 (786)
T ss_pred EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeeccceeecccCC-ccc
Confidence 99999999999999888888888888888899999999999 999999999999999999999999999876544 334
Q ss_pred CCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHh
Q 002160 833 KSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 911 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g~~~-s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~C 911 (958)
.+.||++.|.|||++.|.+| +.++||||.|||||.||+|++||.+.+...++.++ +.+..++|.++++++++||.+|
T Consensus 169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV--~~G~f~MPs~Is~eaQdLLr~m 246 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKV--QRGVFEMPSNISSEAQDLLRRM 246 (786)
T ss_pred cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHH--HcCcccCCCcCCHHHHHHHHHH
Confidence 56899999999999999998 67999999999999999999999999999998888 5668889999999999999999
Q ss_pred hhcCCCCCCCHHHHHHHHHhhhhhcCCCCCCCCCCCCCc
Q 002160 912 WQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQ 950 (958)
Q Consensus 912 L~kDP~kRPSa~EIL~~L~kL~k~~~p~~P~~p~~~~~~ 950 (958)
|..||.+|.+++||++|---..--..|...+.+..++++
T Consensus 247 l~VDp~~RiT~~eI~kHP~l~g~~~~~~~~~~~~~~~~~ 285 (786)
T KOG0588|consen 247 LDVDPSTRITTEEILKHPFLSGYTSLPSSKSLRPPVSVP 285 (786)
T ss_pred hccCccccccHHHHhhCchhhcCCCCChhhhcCCCcccc
Confidence 999999999999999985433222333333444444333
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=390.43 Aligned_cols=257 Identities=31% Similarity=0.471 Sum_probs=224.6
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCC---HHHHHHHHHHHHHHHHcC-CCceeEEeccccCCC
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS---GAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPP 746 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~---~~~~~~f~~Ei~ILk~L~-HPNIVkL~g~~~~~~ 746 (958)
.....|.+++.||+|+||+|++|.+ +++.||||.+.+.... ......+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3457899999999999999999976 7899999976654221 123456778999999998 999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCC-CcEEEEeccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLK 825 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~-g~VKL~DFGLAk~~ 825 (958)
++|+||||+.||+|++++.+.+...+...+.++.+++.|++|||.++ |+||||||+|||++.+ +++||+|||++...
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 99999999999999999988666666777778888899999999998 9999999999999998 99999999999877
Q ss_pred cCCcccCCCCCCCCCccCcccccCCC-C-CchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCC-cH
Q 002160 826 HNTFLSSKSTAGTPEWMAPEVLRNEP-S-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL-DP 902 (958)
Q Consensus 826 ~~~~~~~~s~~GT~~Y~APEvl~g~~-~-s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~l-s~ 902 (958)
........+++||+.|+|||++.+.. | +.++||||+||+||.|++|..||...+...+...+ ......+|..+ ++
T Consensus 172 ~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki--~~~~~~~p~~~~S~ 249 (370)
T KOG0583|consen 172 PGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKI--RKGEFKIPSYLLSP 249 (370)
T ss_pred CCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHH--hcCCccCCCCcCCH
Confidence 43335567899999999999999977 7 58899999999999999999999998888888776 55678889999 99
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhh
Q 002160 903 LVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934 (958)
Q Consensus 903 eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k 934 (958)
++++||.+||..||.+|+++.+|+ .-.-++.
T Consensus 250 ~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 250 EARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 999999999999999999999999 5455544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=373.23 Aligned_cols=251 Identities=24% Similarity=0.366 Sum_probs=212.2
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
+.|+.+.++|+|+||.||+|++ +|+.||||+|.....++...+...+|+++|++|+|+|+|.++++|....+++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 5688889999999999999976 78999999998887667667778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCC
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 833 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~ 833 (958)
||+.--|.++-+.......+..+-++++.+.|+.|+|+++ +|||||||+||||+.+|.+||||||+|+.+..+....+
T Consensus 82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YT 159 (396)
T KOG0593|consen 82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYT 159 (396)
T ss_pred ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccchhhHhhcCCcchhh
Confidence 9977555554444445566677777888899999999999 99999999999999999999999999999875555566
Q ss_pred CCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcc-------------------ccc
Q 002160 834 STAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-------------------NRR 893 (958)
Q Consensus 834 s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~-------------------~~~ 893 (958)
.++.|++|.|||.+.| .+|++.+|||++||++.||++|.+-|.+..+.+.+..|... +.+
T Consensus 160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~ 239 (396)
T KOG0593|consen 160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVR 239 (396)
T ss_pred hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeee
Confidence 7889999999999998 77999999999999999999999999998776655444211 111
Q ss_pred cCCCC----------CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 894 LEIPK----------ELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 894 ~~ip~----------~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
++-|. .++..+.+|++.||+.||++|++.+|++.|
T Consensus 240 lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 240 LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 11111 245578899999999999999999999865
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=394.88 Aligned_cols=264 Identities=36% Similarity=0.600 Sum_probs=229.5
Q ss_pred ccccccCCCCeeEEEEeeccCceEEEEEEECCc-EEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC
Q 002160 668 VCECEIPWEDLVLGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (958)
Q Consensus 668 ~~~~eI~~~dy~i~k~LG~G~fG~Vykak~~g~-~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~ 746 (958)
...++|+.+.+.+++.||+|-||.||+|+|++. +||||.++...... ..|.+|+++|++|+|+|||+++++|..++
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~ 274 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQE 274 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence 345677788899999999999999999999877 99999987764443 47889999999999999999999999988
Q ss_pred ceEEEEeecCCCCHHHHHhC-CCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 747 NLSIITEFLPRGSLFRILHR-PHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k-~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
.+|||||||+.|+|.++|+. .+..+.....+.++ +++.||+||.+++ +|||||-..||||++++.+||+|||||+.
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccCceEEEcccccccc
Confidence 99999999999999999987 44444444444444 4499999999999 99999999999999999999999999996
Q ss_pred ccCCcccCC-CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcH
Q 002160 825 KHNTFLSSK-STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 902 (958)
Q Consensus 825 ~~~~~~~~~-s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~ 902 (958)
..+..+... ...-...|.|||.+....++.|+|||||||+||||+| |+.||.+....+++..+. .+.++.-|..+|.
T Consensus 353 ~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le-~GyRlp~P~~CP~ 431 (468)
T KOG0197|consen 353 IGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE-RGYRLPRPEGCPD 431 (468)
T ss_pred cCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-ccCcCCCCCCCCH
Confidence 655544322 2223458999999999999999999999999999998 899999999999998886 7788899999999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhcC
Q 002160 903 LVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVI 937 (958)
Q Consensus 903 eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~~ 937 (958)
++.+++..||+.+|++||||+.+...|+.+.....
T Consensus 432 ~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~ 466 (468)
T KOG0197|consen 432 EVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE 466 (468)
T ss_pred HHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence 99999999999999999999999999998866543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=385.99 Aligned_cols=263 Identities=39% Similarity=0.653 Sum_probs=225.4
Q ss_pred ccccccCCCCeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc
Q 002160 668 VCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 668 ~~~~eI~~~dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~ 747 (958)
..+++|..+++.+++.||+|.||+||+|+|.| .||||++.......+..+.|++|+.+|++-+|.||+-|+|||..+..
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 46788999999999999999999999999987 58999999888888899999999999999999999999999998877
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
.||+-+|+|-+|+.+|+.....++....+.++++ ++||.|||.++ |||||||..|||+.+++.|||+||||+....
T Consensus 463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccCCcEEEecccceeeee
Confidence 9999999999999999987777777777777777 99999999998 9999999999999999999999999987542
Q ss_pred CC--cccCCCCCCCCCccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccC---CCC
Q 002160 827 NT--FLSSKSTAGTPEWMAPEVLRN---EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE---IPK 898 (958)
Q Consensus 827 ~~--~~~~~s~~GT~~Y~APEvl~g---~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~---ip~ 898 (958)
.- ......-.|...|||||+++. .+|++.+|||||||++|||++|.+||...+..+++-.+......+. +..
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s 619 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRS 619 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhc
Confidence 21 111122347789999999874 4589999999999999999999999997776666555533322222 234
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhh
Q 002160 899 ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934 (958)
Q Consensus 899 ~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k 934 (958)
.++.++++|+..||.+++++||.|.+|+..|+.+..
T Consensus 620 ~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 620 NCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 678899999999999999999999999999988866
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=372.71 Aligned_cols=262 Identities=32% Similarity=0.518 Sum_probs=209.8
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEE-------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccc
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAV 742 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~ 742 (958)
+++..++|++.+.||+|+||.||+|.+ .++.||||++.... .......+.+|+.+|+++ +|||||++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 467788999999999999999999974 24579999886432 333456789999999999 899999999988
Q ss_pred cCCC-ceEEEEeecCCCCHHHHHhCCCC----------------------------------------------------
Q 002160 743 TRPP-NLSIITEFLPRGSLFRILHRPHC---------------------------------------------------- 769 (958)
Q Consensus 743 ~~~~-~l~LVmEy~~gGsL~d~L~k~~~---------------------------------------------------- 769 (958)
...+ .+++||||+++|+|.+++.....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 7644 58999999999999999875321
Q ss_pred ---------CccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC--cccCCCCCC
Q 002160 770 ---------QVDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--FLSSKSTAG 837 (958)
Q Consensus 770 ---------~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~--~~~~~s~~G 837 (958)
.+.+...+ +..+++.||+|||..+ |+||||||+|||++.++.+||+|||+++..... ........+
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 12223333 3444599999999988 999999999999999999999999999864322 111223346
Q ss_pred CCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCC
Q 002160 838 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 916 (958)
Q Consensus 838 T~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP 916 (958)
+..|+|||++.+..++.++|||||||++|||++ |..||.+....+..............+..+++.+.+||.+||+.||
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 318 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDP 318 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCh
Confidence 678999999999999999999999999999997 9999987654433333333444556677889999999999999999
Q ss_pred CCCCCHHHHHHHHHhhhhh
Q 002160 917 SLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 917 ~kRPSa~EIL~~L~kL~k~ 935 (958)
.+||++.+|++.|+++...
T Consensus 319 ~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 319 KERPTFSALVEILGDLLQE 337 (338)
T ss_pred hhCcCHHHHHHHHHHHHhc
Confidence 9999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=367.27 Aligned_cols=246 Identities=23% Similarity=0.388 Sum_probs=212.3
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
++|++.+.||+|+||.||+|++ +++.||||++...... ......+.+|+.+|++++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 4689999999999999999987 5889999998754432 234556889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
||+++|+|.+++.+.+.........++.+++.||+|||.++ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---T 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEEecCcchhccCC---c
Confidence 99999999999987655555555555556699999999988 999999999999999999999999999865432 2
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhh
Q 002160 833 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 912 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL 912 (958)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+. .....++..+++.+++||.+||
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l 233 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL--AGKLEFPRHLDLYAKDLIKKLL 233 (291)
T ss_pred ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCcCCCccCCHHHHHHHHHHc
Confidence 34579999999999999999999999999999999999999999988877776663 3356677888999999999999
Q ss_pred hcCCCCCCC-----HHHHHHH
Q 002160 913 QTDPSLRPS-----FAQLTVA 928 (958)
Q Consensus 913 ~kDP~kRPS-----a~EIL~~ 928 (958)
+.||.+||+ +.++++|
T Consensus 234 ~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 234 VVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCCHHHccCCccCCHHHHhcC
Confidence 999999995 8898887
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=391.76 Aligned_cols=253 Identities=37% Similarity=0.609 Sum_probs=228.1
Q ss_pred ccccccCCCCeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc
Q 002160 668 VCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 668 ~~~~eI~~~dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~ 747 (958)
...++|+++.+.-++-||.|+.|.||+|++.++.||||+++... +.+++-|++|+|||||.|.|+|.....
T Consensus 116 ~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCtqsPc 186 (904)
T KOG4721|consen 116 EELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCTQSPC 186 (904)
T ss_pred hhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeecCCce
Confidence 45678899988889999999999999999999999999864321 367889999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
++||||||..|-|..+|+...........-|...++.||.|||.|+ |||||||.-||||..+..|||+|||.++...+
T Consensus 187 yCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~ 264 (904)
T KOG4721|consen 187 YCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKELSD 264 (904)
T ss_pred eEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchHhhhh
Confidence 9999999999999999998877777777777778899999999999 99999999999999999999999999987755
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHH
Q 002160 828 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 907 (958)
Q Consensus 828 ~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dL 907 (958)
. .+.-.|+||..|||||++.+++.++|+|||||||+|||||||..||.+.+...++-.+..+...+..|..++..|+-|
T Consensus 265 ~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL 343 (904)
T KOG4721|consen 265 K-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLL 343 (904)
T ss_pred h-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHH
Confidence 4 445679999999999999999999999999999999999999999998887766666655566778899999999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHhh
Q 002160 908 IWECWQTDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 908 I~~CL~kDP~kRPSa~EIL~~L~kL 932 (958)
|++||+..|..||+|.+|+.||.-.
T Consensus 344 ~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 344 LKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred HHHHHhcCCCCCccHHHHHHHHhhc
Confidence 9999999999999999999999854
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=387.11 Aligned_cols=249 Identities=29% Similarity=0.433 Sum_probs=226.9
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
++|.+.+.||+|.||.||||+. +.+.||||.+.+....+..+..+.+|++|++.|+|||||.++++|+...++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 6788999999999999999965 67789999999888888888999999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCC
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 833 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~ 833 (958)
|+.| +|+.+|...+...++..+......+.||.|||+++ |+|||+||.|||++.+|++|+||||+|+.+.......+
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlt 158 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLT 158 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCCCceeechhhhhhhcccCceeee
Confidence 9977 99999998887777777777777799999999998 99999999999999999999999999998876555556
Q ss_pred CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhh
Q 002160 834 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 913 (958)
Q Consensus 834 s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~ 913 (958)
...|||.|||||++.+++|+..+|+||||||+|||+.|++||+.....+++..|.. .+...|...+..++.|+..+|.
T Consensus 159 sikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~--d~v~~p~~~S~~f~nfl~gLL~ 236 (808)
T KOG0597|consen 159 SIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILK--DPVKPPSTASSSFVNFLQGLLI 236 (808)
T ss_pred eccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhc--CCCCCcccccHHHHHHHHHHhh
Confidence 77899999999999999999999999999999999999999999888888888853 3555567899999999999999
Q ss_pred cCCCCCCCHHHHHHHH
Q 002160 914 TDPSLRPSFAQLTVAL 929 (958)
Q Consensus 914 kDP~kRPSa~EIL~~L 929 (958)
+||.+|.+-.+++.|=
T Consensus 237 kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 237 KDPAQRLTWTDLLGHP 252 (808)
T ss_pred cChhhcccHHHHhcCh
Confidence 9999999999988764
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=371.92 Aligned_cols=249 Identities=27% Similarity=0.424 Sum_probs=215.7
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceE
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~ 749 (958)
...++|++.+.||+|+||.||+|++ +++.||||++..... .......+.+|+.+|++++||||+++++++...+.+|
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 94 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY 94 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence 4457899999999999999999987 578899999876532 2234567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~ 829 (958)
+||||+++|+|.+++.+.+.......+.+..+++.||.|||.++ |+||||||+||||+.++.+||+|||+++......
T Consensus 95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 99999999999999987665555555556666699999999998 9999999999999999999999999998664332
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHH
Q 002160 830 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 909 (958)
Q Consensus 830 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~ 909 (958)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+. .....+|..++..+++||.
T Consensus 173 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~ 247 (329)
T PTZ00263 173 ---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL--AGRLKFPNWFDGRARDLVK 247 (329)
T ss_pred ---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh--cCCcCCCCCCCHHHHHHHH
Confidence 24579999999999999999999999999999999999999999988877776664 3456678889999999999
Q ss_pred HhhhcCCCCCCC-----HHHHHHH
Q 002160 910 ECWQTDPSLRPS-----FAQLTVA 928 (958)
Q Consensus 910 ~CL~kDP~kRPS-----a~EIL~~ 928 (958)
+||+.||.+|++ +++|+.|
T Consensus 248 ~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 248 GLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcC
Confidence 999999999986 7888866
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=373.95 Aligned_cols=257 Identities=32% Similarity=0.504 Sum_probs=215.3
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC--ceEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP--NLSII 751 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~--~l~LV 751 (958)
.+|..++.||+|+||.||++.. +++..|||.+..... .....+.+|+++|.+|+|||||+++|...... .++|.
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccc--hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 4577788999999999999987 479999998876532 22667899999999999999999999744444 69999
Q ss_pred EeecCCCCHHHHHhCCCC-CccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcC-CCcEEEEeccccccccC--
Q 002160 752 TEFLPRGSLFRILHRPHC-QVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRLKHN-- 827 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~-~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~-~g~VKL~DFGLAk~~~~-- 827 (958)
|||+++|+|.+++.+.+. ..+...+.+..+++.||.|||+++ ||||||||+||||+. ++.+||+|||+++....
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 999999999999998774 455666666667799999999988 999999999999999 79999999999987763
Q ss_pred -CcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CChhHHHHhhhccccccCCCCCCcHHH
Q 002160 828 -TFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIG-MNPMQVVGAVGFQNRRLEIPKELDPLV 904 (958)
Q Consensus 828 -~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g-~~~~ei~~~i~~~~~~~~ip~~ls~eL 904 (958)
.......+.||+.|||||++.+ ....+++|||||||++.||+||+.||.. ....+....+......+.+|..++.++
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA 252 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence 1122345789999999999995 3345699999999999999999999988 455555556655555678999999999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhc
Q 002160 905 ARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 936 (958)
Q Consensus 905 ~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~ 936 (958)
++||.+||..||.+||++.+++.|---.....
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 99999999999999999999999987655443
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=360.31 Aligned_cols=246 Identities=23% Similarity=0.377 Sum_probs=209.8
Q ss_pred EEeeccCceEEEEEEECCcEEEEEEeecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeccccC----CCceEEEEeecC
Q 002160 682 ERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTR----PPNLSIITEFLP 756 (958)
Q Consensus 682 k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~----~~~l~LVmEy~~ 756 (958)
..||+|++|.||+|+++++.||||.+....... .....+.+|+.+|++++|||||++++++.+ ...+++||||++
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~ 105 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence 569999999999999999999999987654332 335678899999999999999999999866 346899999999
Q ss_pred CCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhc-CCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCC
Q 002160 757 RGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 834 (958)
Q Consensus 757 gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~-g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s 834 (958)
+|+|.+++.+... ..+...+.++.+ +.||.|||.. + ++||||||+|||+++++.+||+|||+++...... ..
T Consensus 106 ~g~L~~~l~~~~~-~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---~~ 179 (283)
T PHA02988 106 RGYLREVLDKEKD-LSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---FK 179 (283)
T ss_pred CCcHHHHHhhCCC-CChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCCCcEEEcccchHhhhcccc---cc
Confidence 9999999987543 344444544444 8999999974 6 8899999999999999999999999988654322 23
Q ss_pred CCCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhh
Q 002160 835 TAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 912 (958)
Q Consensus 835 ~~GT~~Y~APEvl~g--~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL 912 (958)
..|+..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..++...+.....++.++..+++.+++||.+||
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl 259 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACT 259 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHh
Confidence 568899999999976 678999999999999999999999999988887777765555666777788999999999999
Q ss_pred hcCCCCCCCHHHHHHHHHhhh
Q 002160 913 QTDPSLRPSFAQLTVALKPLQ 933 (958)
Q Consensus 913 ~kDP~kRPSa~EIL~~L~kL~ 933 (958)
+.||.+||++.+|+..|+.++
T Consensus 260 ~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 260 SHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred cCCcccCcCHHHHHHHHHHHH
Confidence 999999999999999999875
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=369.69 Aligned_cols=243 Identities=24% Similarity=0.407 Sum_probs=208.4
Q ss_pred EEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeecCCC
Q 002160 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758 (958)
Q Consensus 682 k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~gG 758 (958)
+.||+|+||.||+|++ +++.||||++..... .......+.+|+.+|++++||||+++++++...+.+||||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999976 688999999876432 2334567789999999999999999999999999999999999999
Q ss_pred CHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCCCC
Q 002160 759 SLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT 838 (958)
Q Consensus 759 sL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~GT 838 (958)
+|.+++.+.........+.+..+++.||+|||.++ |+||||||+||||+.++.+||+|||+++............+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecC
Confidence 99999987665555555555666699999999998 9999999999999999999999999987643333333456799
Q ss_pred CCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCC
Q 002160 839 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSL 918 (958)
Q Consensus 839 ~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~k 918 (958)
+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+. .....+|..+++++.+||.+||+.||.+
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L~~dP~~ 236 (323)
T cd05571 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEEIRFPRTLSPEAKSLLAGLLKKDPKQ 236 (323)
T ss_pred ccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 99999999999999999999999999999999999999887776666553 3356678889999999999999999999
Q ss_pred CC-----CHHHHHHH
Q 002160 919 RP-----SFAQLTVA 928 (958)
Q Consensus 919 RP-----Sa~EIL~~ 928 (958)
|| ++.+|++|
T Consensus 237 R~~~~~~~~~~ll~h 251 (323)
T cd05571 237 RLGGGPEDAKEIMEH 251 (323)
T ss_pred cCCCCCCCHHHHHcC
Confidence 99 79999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=371.11 Aligned_cols=255 Identities=26% Similarity=0.370 Sum_probs=221.5
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEECC--cEEEEEEeecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeccccCCC
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG--TEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~~g--~~VAVK~i~~~~~~-~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~ 746 (958)
...+..++|++++.||+|.-|+||+++..+ ..+|+|++.+..+. ...+.++..|.+||+.++||+++.||..|+.+.
T Consensus 71 ~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~ 150 (459)
T KOG0610|consen 71 DGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK 150 (459)
T ss_pred CCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence 345667889999999999999999998854 78999999887654 455677889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhCCC--CCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPH--CQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~--~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
..||+||||+||+|+.+++++. .+.+...+++.+..+.||+|||..| ||||||||+||||.++|||.|+||.|+..
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcEEeeecccccc
Confidence 9999999999999999887654 4677888999999999999999999 99999999999999999999999998753
Q ss_pred ccC-----------------------------------C---------------------cccCCCCCCCCCccCccccc
Q 002160 825 KHN-----------------------------------T---------------------FLSSKSTAGTPEWMAPEVLR 848 (958)
Q Consensus 825 ~~~-----------------------------------~---------------------~~~~~s~~GT~~Y~APEvl~ 848 (958)
... . ......++||-+|+|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 100 0 01123567999999999999
Q ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCC--CCcHHHHHHHHHhhhcCCCCCCC----H
Q 002160 849 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK--ELDPLVARIIWECWQTDPSLRPS----F 922 (958)
Q Consensus 849 g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~--~ls~eL~dLI~~CL~kDP~kRPS----a 922 (958)
|...+.++|||.|||++||||.|..||.|.+..+.+..+..+ .+.+|. .++..++|||+++|.+||.+|.. +
T Consensus 309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~--~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA 386 (459)
T KOG0610|consen 309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ--PLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGA 386 (459)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC--CCcCCCCCcchhHHHHHHHHHhccChhhhhccccch
Confidence 999999999999999999999999999999999999988655 444443 67899999999999999999987 8
Q ss_pred HHHHHH
Q 002160 923 AQLTVA 928 (958)
Q Consensus 923 ~EIL~~ 928 (958)
.||.+|
T Consensus 387 ~eIK~H 392 (459)
T KOG0610|consen 387 AEIKRH 392 (459)
T ss_pred HHhhcC
Confidence 888775
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=364.21 Aligned_cols=253 Identities=25% Similarity=0.405 Sum_probs=230.4
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCce
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l 748 (958)
.+..++|..+++||+|.||+|.+++. +++.||||++++.-+ .......-..|-++|+..+||++..|...|+..+++
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 45678999999999999999999965 789999999887754 334455567899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
++||||+.||.|+.+|.+...+.+...+++-+.++.||.|||..+ ||+||||.+|+|+|++||+||+|||+++.-...
T Consensus 244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccCCceEeeecccchhcccc
Confidence 999999999999999999888999999999999999999999988 999999999999999999999999999987666
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHH
Q 002160 829 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 908 (958)
Q Consensus 829 ~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI 908 (958)
.....++||||+|+|||++....|+..+|||.+|+++|||++|++||+..+...+...|. ...+.+|..++++++.|+
T Consensus 322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl--~ed~kFPr~ls~eAktLL 399 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL--MEDLKFPRTLSPEAKTLL 399 (516)
T ss_pred cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH--hhhccCCccCCHHHHHHH
Confidence 667788999999999999999999999999999999999999999999999998888884 447788999999999999
Q ss_pred HHhhhcCCCCCC-----CHHHHHHH
Q 002160 909 WECWQTDPSLRP-----SFAQLTVA 928 (958)
Q Consensus 909 ~~CL~kDP~kRP-----Sa~EIL~~ 928 (958)
..+|.+||.+|. ++.||.++
T Consensus 400 sGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 400 SGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred HHHhhcChHhhcCCCchhHHHHHhh
Confidence 999999999995 46777665
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=362.92 Aligned_cols=243 Identities=24% Similarity=0.408 Sum_probs=207.0
Q ss_pred EEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeecCCC
Q 002160 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758 (958)
Q Consensus 682 k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~gG 758 (958)
+.||+|+||.||+++. +++.||+|++..... .......+.+|+++++.++||||++++++|...+.+||||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3699999999999976 688999999876532 2334567788999999999999999999999999999999999999
Q ss_pred CHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCCCC
Q 002160 759 SLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT 838 (958)
Q Consensus 759 sL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~GT 838 (958)
+|..++.+.........+.++.+++.||.|||.++ |+||||||+|||++.++.+||+|||+++.............||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCC
Confidence 99999877665555555555666699999999998 9999999999999999999999999987543332333456799
Q ss_pred CCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCC
Q 002160 839 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSL 918 (958)
Q Consensus 839 ~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~k 918 (958)
+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+. .....+|..+++++++||.+||+.||.+
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L~~dP~~ 236 (323)
T cd05595 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL--MEEIRFPRTLSPEAKSLLAGLLKKDPKQ 236 (323)
T ss_pred cCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 99999999999999999999999999999999999999888777666553 2345677889999999999999999999
Q ss_pred CC-----CHHHHHHH
Q 002160 919 RP-----SFAQLTVA 928 (958)
Q Consensus 919 RP-----Sa~EIL~~ 928 (958)
|+ ++.+++++
T Consensus 237 R~~~~~~~~~~~l~h 251 (323)
T cd05595 237 RLGGGPSDAKEVMEH 251 (323)
T ss_pred hCCCCCCCHHHHHcC
Confidence 98 88998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=362.79 Aligned_cols=248 Identities=25% Similarity=0.374 Sum_probs=210.3
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
++|++.+.||+|+||.||+|++ +++.||||++...... ......+.+|+.++..++||||+++++++...+.+||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 3699999999999999999987 5789999998765332 234557889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
||+++++|.+++...........+.++.+++.||.|||.++ |+||||||+|||++.++.+||+|||+++.... ..
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~~ 155 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YA 155 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEEEeCcCCccccc---cc
Confidence 99999999999987655555555556666699999999998 99999999999999999999999999976543 23
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCC------CCCcHHHHH
Q 002160 833 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP------KELDPLVAR 906 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip------~~ls~eL~d 906 (958)
....||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+.........| ..++.++.+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~ 235 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD 235 (333)
T ss_pred CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHH
Confidence 45679999999999999999999999999999999999999999888777665553222222222 246899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 002160 907 IIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 907 LI~~CL~kDP~kRPSa~EIL~~ 928 (958)
||.+||..+|.+||++.+|+++
T Consensus 236 li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 236 LITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHhhChhhhcCCHHHHHhC
Confidence 9999999999999999999987
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=379.81 Aligned_cols=249 Identities=28% Similarity=0.470 Sum_probs=217.7
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEE
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~L 750 (958)
-....|...++||+|+.|.||.++. +++.||||++...... ...-+.+|+.+|+.++|+|||++++.|...+.+|+
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~--~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV 347 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP--KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV 347 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC--chhhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence 3456788889999999999999975 7888999998765433 23456899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc
Q 002160 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 751 VmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~ 829 (958)
||||++||+|.|.+.... +.+.+...++.. +.||+|||..+ |||||||.+|||++.+|.+||+|||++..+....
T Consensus 348 VMEym~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred EEeecCCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 999999999999987643 455555555554 89999999998 9999999999999999999999999999887766
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccccc--CCCCCCcHHHHHH
Q 002160 830 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVARI 907 (958)
Q Consensus 830 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~--~ip~~ls~eL~dL 907 (958)
....+.+||++|||||++....|++++|||||||+++||+.|++||...++.+.+..+. .+..+ ..+..+++.+++|
T Consensus 424 ~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa-~ng~P~lk~~~klS~~~kdF 502 (550)
T KOG0578|consen 424 SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPKLKNPEKLSPELKDF 502 (550)
T ss_pred CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh-hcCCCCcCCccccCHHHHHH
Confidence 66778899999999999999999999999999999999999999999988887777775 33344 4577899999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 002160 908 IWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 908 I~~CL~kDP~kRPSa~EIL~~ 928 (958)
+.+||+.|+.+|+++.|||+|
T Consensus 503 L~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 503 LDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHHHhhcchhcCCCHHHHhcC
Confidence 999999999999999999986
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=377.15 Aligned_cols=249 Identities=27% Similarity=0.453 Sum_probs=219.7
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
..|...++||+|.||.||+|.+ +++.||||++..... +..+..+.+|+.+|.+++++||.++|+.+..+..++++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 3466778999999999999976 688999999876543 3456778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCC
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 833 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~ 833 (958)
||.||++.+.|.......+....+.+.....||.|||.++ .||||||+.|||+..+|.+||+|||.+..+........
T Consensus 92 y~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~ 169 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRK 169 (467)
T ss_pred HhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecceeeeeechhhccc
Confidence 9999999999987655444444455555589999999998 99999999999999999999999999999887777778
Q ss_pred CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhh
Q 002160 834 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 913 (958)
Q Consensus 834 s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~ 913 (958)
+++||+.|||||++.+..|+.|+|||||||+.|||.+|.+||.+..++.++..|. +..++.+...+++.+++||..||+
T Consensus 170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp-k~~PP~L~~~~S~~~kEFV~~CL~ 248 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP-KSAPPRLDGDFSPPFKEFVEACLD 248 (467)
T ss_pred cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc-CCCCCccccccCHHHHHHHHHHhh
Confidence 9999999999999999899999999999999999999999999999987766664 444555656899999999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 002160 914 TDPSLRPSFAQLTVA 928 (958)
Q Consensus 914 kDP~kRPSa~EIL~~ 928 (958)
+||+.||++.++++|
T Consensus 249 k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 249 KNPEFRPSAKELLKH 263 (467)
T ss_pred cCcccCcCHHHHhhh
Confidence 999999999999876
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=360.21 Aligned_cols=241 Identities=24% Similarity=0.360 Sum_probs=205.5
Q ss_pred eeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeecCCCCH
Q 002160 684 IGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 760 (958)
Q Consensus 684 LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~gGsL 760 (958)
||+|+||.||+|++ +++.||||++..... .......+.+|+.+|++++||||+++++++...+.+|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999987 578899999875432 334456788999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCCCCCC
Q 002160 761 FRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 840 (958)
Q Consensus 761 ~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~GT~~ 840 (958)
.+++.+.+..........+.+++.||.|||.++ |+||||||+|||++.++.+||+|||+++............+||+.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcc
Confidence 999987655555555555666699999999988 999999999999999999999999999864333333345679999
Q ss_pred ccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCC
Q 002160 841 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRP 920 (958)
Q Consensus 841 Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRP 920 (958)
|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+. .....++..+++++++||.+||+.||.+||
T Consensus 159 y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dp~~R~ 236 (312)
T cd05585 159 YLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL--QEPLRFPDGFDRDAKDLLIGLLSRDPTRRL 236 (312)
T ss_pred cCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH--cCCCCCCCcCCHHHHHHHHHHcCCCHHHcC
Confidence 999999999999999999999999999999999999888777766653 345667788999999999999999999997
Q ss_pred C---HHHHHHH
Q 002160 921 S---FAQLTVA 928 (958)
Q Consensus 921 S---a~EIL~~ 928 (958)
+ +.+++.|
T Consensus 237 ~~~~~~e~l~h 247 (312)
T cd05585 237 GYNGAQEIKNH 247 (312)
T ss_pred CCCCHHHHHcC
Confidence 5 6777665
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=344.50 Aligned_cols=256 Identities=25% Similarity=0.442 Sum_probs=212.4
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE-----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~-----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~ 747 (958)
|..++|++.+.||+|+||.||+|.+ .+..||+|.+.... .......+.+|+.++++++||||+++++++...+.
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 5567899999999999999999975 35679999886543 33445678999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHH-HHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
+++||||+++|+|.+++.+......+...+.++. .+.||+|||.++ |+||||||+||||+.++.+||+|||.+....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999999999977544445555544444 489999999988 9999999999999999999999999876543
Q ss_pred CCc-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHH
Q 002160 827 NTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 904 (958)
Q Consensus 827 ~~~-~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL 904 (958)
... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+. .......+..++..+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 237 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-DGFRLPAPRNCPNLL 237 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCCHHH
Confidence 221 11122345678999999999999999999999999999775 999999888777666653 333455677899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 002160 905 ARIIWECWQTDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 905 ~dLI~~CL~kDP~kRPSa~EIL~~L~kL 932 (958)
.+++.+||+.+|.+||++.+|++.|.++
T Consensus 238 ~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 238 HQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 9999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=364.16 Aligned_cols=250 Identities=27% Similarity=0.455 Sum_probs=211.7
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
++|++.+.||+|+||.||+|++ +++.||||++....... .....+.+|++++..++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 4799999999999999999987 48999999987654322 34567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc---
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--- 829 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~--- 829 (958)
||+++++|.+++.+.........+..+.+++.||+|||.++ |+||||||+||||+.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 99999999999987655555555555666699999999988 9999999999999999999999999998654332
Q ss_pred --------------------------ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHH
Q 002160 830 --------------------------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV 883 (958)
Q Consensus 830 --------------------------~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei 883 (958)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 238 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence 123345699999999999999999999999999999999999999999887776
Q ss_pred HHhhhccccccCCCC--CCcHHHHHHHHHhhhcCCCCCCC-HHHHHHH
Q 002160 884 VGAVGFQNRRLEIPK--ELDPLVARIIWECWQTDPSLRPS-FAQLTVA 928 (958)
Q Consensus 884 ~~~i~~~~~~~~ip~--~ls~eL~dLI~~CL~kDP~kRPS-a~EIL~~ 928 (958)
...+........+|. .+++++.+||.+||. ||.+||+ +++|+++
T Consensus 239 ~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 239 YNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 666643223333443 369999999999997 9999999 9999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=362.93 Aligned_cols=243 Identities=24% Similarity=0.405 Sum_probs=207.5
Q ss_pred EEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeecCCC
Q 002160 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758 (958)
Q Consensus 682 k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~gG 758 (958)
+.||+|+||.||+++. +++.||||++..... .......+.+|+++|+.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999976 688999999876532 2344567889999999999999999999999999999999999999
Q ss_pred CHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCCCC
Q 002160 759 SLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT 838 (958)
Q Consensus 759 sL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~GT 838 (958)
+|.+++...........+.++.+++.||+|||.++ |+||||||+||||+.++.+||+|||+++............+||
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCC
Confidence 99998877655555555555566699999999998 9999999999999999999999999987643332333456799
Q ss_pred CCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCC
Q 002160 839 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSL 918 (958)
Q Consensus 839 ~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~k 918 (958)
+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+. .....+|..+++++.+||.+||++||.+
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L~~dP~~ 236 (328)
T cd05593 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEDIKFPRTLSADAKSLLSGLLIKDPNK 236 (328)
T ss_pred cCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc--cCCccCCCCCCHHHHHHHHHHcCCCHHH
Confidence 99999999999999999999999999999999999999887776666553 3355678889999999999999999999
Q ss_pred CC-----CHHHHHHH
Q 002160 919 RP-----SFAQLTVA 928 (958)
Q Consensus 919 RP-----Sa~EIL~~ 928 (958)
|+ ++.+|+++
T Consensus 237 R~~~~~~~~~~il~h 251 (328)
T cd05593 237 RLGGGPDDAKEIMRH 251 (328)
T ss_pred cCCCCCCCHHHHhcC
Confidence 97 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=365.27 Aligned_cols=251 Identities=25% Similarity=0.390 Sum_probs=214.4
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEEC---CcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADWN---GTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~~---g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~ 746 (958)
..+..++|++.+.||+|+||.||+|++. +..||||++..... .......+.+|+.+++.++|||||++++++.+.+
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 4466789999999999999999999763 25799999865432 2334567889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
.+|+||||+++|+|.+++.+...........++.+++.||.|||..+ |+||||||+|||++.++++||+|||+++...
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 99999999999999999987665554555555566699999999998 9999999999999999999999999998654
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHH
Q 002160 827 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 906 (958)
Q Consensus 827 ~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~d 906 (958)
.. .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+. .....+|..+++.+++
T Consensus 183 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~ 257 (340)
T PTZ00426 183 TR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL--EGIIYFPKFLDNNCKH 257 (340)
T ss_pred CC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHH
Confidence 32 234679999999999999889999999999999999999999999888776666663 3345678889999999
Q ss_pred HHHHhhhcCCCCCC-----CHHHHHHH
Q 002160 907 IIWECWQTDPSLRP-----SFAQLTVA 928 (958)
Q Consensus 907 LI~~CL~kDP~kRP-----Sa~EIL~~ 928 (958)
||.+||+.||.+|+ ++++|++|
T Consensus 258 li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 258 LMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 99999999999995 89998876
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=360.93 Aligned_cols=243 Identities=26% Similarity=0.410 Sum_probs=207.4
Q ss_pred EEeeccCceEEEEEEE-----CCcEEEEEEeecCCC--CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEee
Q 002160 682 ERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDF--SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 682 k~LG~G~fG~Vykak~-----~g~~VAVK~i~~~~~--~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
+.||+|+||.||+++. .++.||||++..... .......+.+|+.+|+.++||||++++++|..++.+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 577899999876432 122345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCC
Q 002160 755 LPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 834 (958)
Q Consensus 755 ~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s 834 (958)
+++++|.+++.+.+.........++.+++.||.|||.++ |+||||||+||||+.++.+||+|||+++...........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT 159 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccc
Confidence 999999999987665555666666667799999999988 999999999999999999999999998754333333345
Q ss_pred CCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhc
Q 002160 835 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 914 (958)
Q Consensus 835 ~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~k 914 (958)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+. .....+|..+++.+.+||.+||++
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~ 237 (323)
T cd05584 160 FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL--KGKLNLPPYLTPEARDLLKKLLKR 237 (323)
T ss_pred cCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHccc
Confidence 679999999999999889999999999999999999999999888777666653 335567888999999999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 002160 915 DPSLRP-----SFAQLTVA 928 (958)
Q Consensus 915 DP~kRP-----Sa~EIL~~ 928 (958)
||.+|| ++.+++.+
T Consensus 238 ~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 238 NPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CHhHcCCCCCCCHHHHhcC
Confidence 999999 88888775
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=348.48 Aligned_cols=251 Identities=24% Similarity=0.297 Sum_probs=200.9
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
++|++.+.||+|+||.||+|++ +++.||||++............+.+|+.++++++||||+++++++...+.+|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 4699999999999999999987 57789999987655444455678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc-ccC
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-LSS 832 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~-~~~ 832 (958)
|++++.|..+............+..+.+.+.||.|||..+ |+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence 9998877665544333334444445555699999999988 9999999999999999999999999998754322 122
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccc-----------------ccc-
Q 002160 833 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-----------------RRL- 894 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~-----------------~~~- 894 (958)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.... ...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR 238 (287)
T ss_pred cccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence 34578999999999999889999999999999999999999998766543322111000 000
Q ss_pred ------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 895 ------------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 895 ------------~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.....++.++++||.+||+.||.+||+++++++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0112367889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=363.66 Aligned_cols=251 Identities=27% Similarity=0.389 Sum_probs=208.8
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
++|++.+.||+|+||+||+|++ +++.||||++.+... .......+.+|+.++.+++|+||+++++.+.+...+||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4799999999999999999976 678999999876433 2234457889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc---
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--- 829 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~--- 829 (958)
||+++|+|.+++.+.+.......+.++.+++.||.|||.++ |+||||||+||||+.++++||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 99999999999987766666667777777799999999988 9999999999999999999999999987542210
Q ss_pred --------------------------------ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 002160 830 --------------------------------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG 877 (958)
Q Consensus 830 --------------------------------~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g 877 (958)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 001245799999999999999999999999999999999999999999
Q ss_pred CChhHHHHhhhccccccCCCC--CCcHHHHHHHHHhhh--cCCCCCCCHHHHHHH
Q 002160 878 MNPMQVVGAVGFQNRRLEIPK--ELDPLVARIIWECWQ--TDPSLRPSFAQLTVA 928 (958)
Q Consensus 878 ~~~~ei~~~i~~~~~~~~ip~--~ls~eL~dLI~~CL~--kDP~kRPSa~EIL~~ 928 (958)
.+..+....+........+|. .+++++++||.+|+. .++..||+++||++|
T Consensus 239 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 239 ETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 888777766643333344443 468999999999664 233456899999998
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=366.19 Aligned_cols=250 Identities=26% Similarity=0.373 Sum_probs=207.8
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
.|++++.||+|+||+||+|++ +++.||||++..... .......+.+|+.+|++++|||||++++++.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588999999999999999976 678999999976543 33445678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc----
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF---- 829 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~---- 829 (958)
|+++|+|.+++.+.........+.++.+++.||.|||..+ |+||||||+||||+.++++||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 9999999999987666666666777777799999999988 9999999999999999999999999975321000
Q ss_pred -------------------------------------------ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHH
Q 002160 830 -------------------------------------------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILW 866 (958)
Q Consensus 830 -------------------------------------------~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLy 866 (958)
......+||+.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~ 239 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHH
Confidence 0012357999999999999998999999999999999
Q ss_pred HHHhCCCCCCCCChhHHHHhhhccccccCCCC--CCcHHHHHHHHHhh--hcCCCCCCCHHHHHHH
Q 002160 867 ELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK--ELDPLVARIIWECW--QTDPSLRPSFAQLTVA 928 (958)
Q Consensus 867 ELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~--~ls~eL~dLI~~CL--~kDP~kRPSa~EIL~~ 928 (958)
||++|..||...+..+....+........+|. .+++++++||.+|| ..++..|+++.+|+.|
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 99999999998877665555533233334443 57999999999954 5566669999999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=345.73 Aligned_cols=256 Identities=30% Similarity=0.551 Sum_probs=212.2
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEECC-------cEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~~g-------~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~ 745 (958)
+..++|++.+.||+|+||.||+|.+.+ ..||+|.+.... .......|.+|+.++.+++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 456789999999999999999997632 469999876443 344556789999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhCCCC---------------CccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEc
Q 002160 746 PNLSIITEFLPRGSLFRILHRPHC---------------QVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVD 809 (958)
Q Consensus 746 ~~l~LVmEy~~gGsL~d~L~k~~~---------------~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId 809 (958)
...+++|||+++++|.+++.+... ...+...+. +.+.+.||.|||..+ |+||||||+|||++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~ 158 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVG 158 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEc
Confidence 999999999999999999875421 223333333 444499999999988 99999999999999
Q ss_pred CCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHh
Q 002160 810 KNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGA 886 (958)
Q Consensus 810 ~~g~VKL~DFGLAk~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~ 886 (958)
+++.+||+|||+++...... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....++...
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999997653322 12233456889999999998889999999999999999997 9999999888777766
Q ss_pred hhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 002160 887 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 887 i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL 932 (958)
+. .......+..++.++.+|+.+||+.||.+||++.+|+++|+.+
T Consensus 239 i~-~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 239 IR-SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HH-cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 64 3344556778999999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=357.32 Aligned_cols=248 Identities=21% Similarity=0.324 Sum_probs=208.3
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCC-CceeEEeccccCCCceEEEE
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRH-PNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~H-PNIVkL~g~~~~~~~l~LVm 752 (958)
+|++.+.||+|+||.||+|++ +++.||||++.+... .......+..|++++..+.| ++|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 588999999999999999987 467899999876432 23345677889999999976 56889999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
||+++|+|.+++.............++.+++.||.|||.++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCce
Confidence 99999999999876655444555555556699999999988 9999999999999999999999999987543222333
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhh
Q 002160 833 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 912 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL 912 (958)
...+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+. .....+|..+++++++||.+||
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l 236 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM--EHNVSYPKSLSKEAVSICKGLL 236 (324)
T ss_pred eeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHh
Confidence 45679999999999999999999999999999999999999999888777776663 3456678889999999999999
Q ss_pred hcCCCCCCCH-----HHHHHH
Q 002160 913 QTDPSLRPSF-----AQLTVA 928 (958)
Q Consensus 913 ~kDP~kRPSa-----~EIL~~ 928 (958)
.+||.+|++. .+++++
T Consensus 237 ~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 237 TKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred hcCHHHcCCCCCCCHHHHhcC
Confidence 9999999976 666655
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=347.57 Aligned_cols=252 Identities=23% Similarity=0.390 Sum_probs=224.8
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~ 747 (958)
.....++|++++.||+|-||.||+|+. ++-.||+|++.+..+. .....++.+|++|-..|+||||+++|++|.+..+
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 345668999999999999999999976 5667999998776542 2345689999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHh--CCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 748 LSIITEFLPRGSLFRILH--RPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~--k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
.||++||..+|+|+..|. +...+.+....-++.+.+.||.|+|..+ ||||||||+|+|++..|.+||+|||.+...
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 999999999999999998 5555666777778888899999999988 999999999999999999999999998765
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHH
Q 002160 826 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 905 (958)
Q Consensus 826 ~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~ 905 (958)
. .....+.|||..|.+||+..+..++..+|+|++|++.||++.|.+||......+.+..+. ..+..+|..++.+++
T Consensus 175 p--~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~--k~~~~~p~~is~~a~ 250 (281)
T KOG0580|consen 175 P--SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR--KVDLKFPSTISGGAA 250 (281)
T ss_pred C--CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH--HccccCCcccChhHH
Confidence 4 344567899999999999999999999999999999999999999999988888888874 447778899999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 002160 906 RIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 906 dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
|||.+||.++|.+|....|++.|
T Consensus 251 dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 251 DLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred HHHHHHhccCccccccHHHHhhh
Confidence 99999999999999999999876
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=363.70 Aligned_cols=250 Identities=27% Similarity=0.426 Sum_probs=209.6
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
++|++.+.||+|+||.||+|++ +++.||||++..... .......+.+|+.+|+.++||||++++++|.+.+.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4799999999999999999987 688999999876532 2234456789999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc--
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL-- 830 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~-- 830 (958)
||+++|+|.+++...+.......+.++.+++.||.|||.++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 99999999999987665556666666777799999999998 99999999999999999999999999875421100
Q ss_pred ------------------------------------cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 002160 831 ------------------------------------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP 874 (958)
Q Consensus 831 ------------------------------------~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~P 874 (958)
.....+||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence 11134699999999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccccccCCCC--CCcHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 002160 875 WIGMNPMQVVGAVGFQNRRLEIPK--ELDPLVARIIWECWQTDPSLRPS---FAQLTVA 928 (958)
Q Consensus 875 F~g~~~~ei~~~i~~~~~~~~ip~--~ls~eL~dLI~~CL~kDP~kRPS---a~EIL~~ 928 (958)
|.+.+..+....+........+|. .+++++++||.+||. +|.+|++ +.+++.|
T Consensus 239 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 239 FCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999887776665543333334443 468999999999996 9999997 9998875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=361.23 Aligned_cols=243 Identities=24% Similarity=0.409 Sum_probs=206.2
Q ss_pred EEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeecCCC
Q 002160 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758 (958)
Q Consensus 682 k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~gG 758 (958)
+.||+|+||.||++++ +++.||+|++..... .......+.+|+++++.++||||+++++++...+.+||||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999976 688999999876533 2334567788999999999999999999999999999999999999
Q ss_pred CHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHh-cCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCCC
Q 002160 759 SLFRILHRPHCQVDEKRRIKMALDARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 837 (958)
Q Consensus 759 sL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~-~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~G 837 (958)
+|..++.+.........+.+..+++.||.|||. .+ |+||||||+||||+.++.+||+|||+++.............|
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG 158 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccC
Confidence 999988776555455555555566999999997 56 999999999999999999999999998754332233344679
Q ss_pred CCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCC
Q 002160 838 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPS 917 (958)
Q Consensus 838 T~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~ 917 (958)
|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+. .....+|..+++++.+||.+||+.||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~L~~dP~ 236 (325)
T cd05594 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEEIRFPRTLSPEAKSLLSGLLKKDPK 236 (325)
T ss_pred CcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHhhcCHH
Confidence 999999999999999999999999999999999999999888776666553 335567888999999999999999999
Q ss_pred CCC-----CHHHHHHH
Q 002160 918 LRP-----SFAQLTVA 928 (958)
Q Consensus 918 kRP-----Sa~EIL~~ 928 (958)
+|+ ++.++++|
T Consensus 237 ~R~~~~~~~~~~il~h 252 (325)
T cd05594 237 QRLGGGPDDAKEIMQH 252 (325)
T ss_pred HhCCCCCCCHHHHhcC
Confidence 996 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=348.16 Aligned_cols=248 Identities=23% Similarity=0.266 Sum_probs=202.9
Q ss_pred eeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEee
Q 002160 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
|++.+.||+|+||.||+|.+ +++.||||.+....... .....+.+|+++|++++|+||+++++++.+.+.+++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 78899999999999999976 68999999987654332 2334678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhCCC-CCccHHHHHHH-HHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 755 LPRGSLFRILHRPH-CQVDEKRRIKM-ALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 755 ~~gGsL~d~L~k~~-~~~~e~~~l~i-a~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
+++|+|..++.... ....+.....+ .+.+.||+|||+.+ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 158 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-TV 158 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-ee
Confidence 99999998775432 23444444444 44599999999988 9999999999999999999999999998653321 22
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhh--ccccccCCCCCCcHHHHHHHHH
Q 002160 833 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG--FQNRRLEIPKELDPLVARIIWE 910 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~--~~~~~~~ip~~ls~eL~dLI~~ 910 (958)
....||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+. .......++..++.++.+||.+
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 238 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRM 238 (285)
T ss_pred cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHH
Confidence 34579999999999999999999999999999999999999998765432222111 1233445677899999999999
Q ss_pred hhhcCCCCCCC-----HHHHHHH
Q 002160 911 CWQTDPSLRPS-----FAQLTVA 928 (958)
Q Consensus 911 CL~kDP~kRPS-----a~EIL~~ 928 (958)
||+.||.+||+ +++++++
T Consensus 239 ~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 239 LLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HhhcCHHHhcCCCCCCHHHHhcC
Confidence 99999999997 8899886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=356.26 Aligned_cols=248 Identities=21% Similarity=0.335 Sum_probs=208.5
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCceEEEE
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~l~LVm 752 (958)
+|++.+.||+|+||.||+|++ +++.||||++.+... .......+..|..++..+ +|++|+++++++...+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 588999999999999999987 567899999876532 223345567788888887 5899999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
||+++|+|.+++.+...........++.+++.||.|||.++ |+||||||+|||++.++++||+|||+++.........
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcc
Confidence 99999999999876655444555555556699999999988 9999999999999999999999999997643333334
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhh
Q 002160 833 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 912 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL 912 (958)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+. .....+|..++.++++||.+||
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~~~l 236 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM--EHNVAYPKSMSKEAVAICKGLM 236 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCcCCHHHHHHHHHHc
Confidence 45679999999999999999999999999999999999999999988877776664 3355677889999999999999
Q ss_pred hcCCCCCCCH-----HHHHHH
Q 002160 913 QTDPSLRPSF-----AQLTVA 928 (958)
Q Consensus 913 ~kDP~kRPSa-----~EIL~~ 928 (958)
++||.+|++. .+|+.+
T Consensus 237 ~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 237 TKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred ccCHHhcCCCCCCCHHHHhcC
Confidence 9999999974 666654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=365.91 Aligned_cols=250 Identities=27% Similarity=0.395 Sum_probs=207.6
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
++|.+++.||+|+||.||++++ +++.||||++.+... .......+.+|++++++++|||||+++++|.+...+||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4789999999999999999976 788999999876432 2334567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc--
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL-- 830 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~-- 830 (958)
||+++|+|.+++...........+.++.+++.||+|||..+ |+||||||+||||+.++++||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 99999999999987665555666666677799999999998 99999999999999999999999999863221000
Q ss_pred ---------------------------------------------cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHH
Q 002160 831 ---------------------------------------------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVIL 865 (958)
Q Consensus 831 ---------------------------------------------~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLL 865 (958)
.....+||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 00125699999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChhHHHHhhhccccccCCCC--CCcHHHHHHHHHhhhcCCCCC---CCHHHHHHH
Q 002160 866 WELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK--ELDPLVARIIWECWQTDPSLR---PSFAQLTVA 928 (958)
Q Consensus 866 yELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~--~ls~eL~dLI~~CL~kDP~kR---PSa~EIL~~ 928 (958)
|||++|..||.+.+..+....+........+|. .++.++++||.+||. +|.+| +++.+++.+
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 239 FECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 999999999998877666655543233344444 578999999999997 67765 599999887
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=367.36 Aligned_cols=265 Identities=26% Similarity=0.418 Sum_probs=213.7
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHH------------HHHHHHHHHHHHHHcCCCceeEE
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA------------ALLEFKREVKIMRRLRHPNVVLF 738 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~------------~~~~f~~Ei~ILk~L~HPNIVkL 738 (958)
...++|++++.||+|.||.|-+|+. +++.||||++.+...... .++++.+|+.||++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 4568999999999999999999986 788999999876543211 23578999999999999999999
Q ss_pred eccccCC--CceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEE
Q 002160 739 MGAVTRP--PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVK 815 (958)
Q Consensus 739 ~g~~~~~--~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VK 815 (958)
+++..++ +++|||+|||..|.+.+.=.. ...+.+.+...++.+ +.||+|||.++ ||||||||.|+||+.+|+||
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d-~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPD-KPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCC-cccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCCCcEE
Confidence 9998765 569999999999887654322 221334444444444 99999999999 99999999999999999999
Q ss_pred EEecccccccc-----CCcccCCCCCCCCCccCcccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHh
Q 002160 816 VSDFGLSRLKH-----NTFLSSKSTAGTPEWMAPEVLRNEP----SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGA 886 (958)
Q Consensus 816 L~DFGLAk~~~-----~~~~~~~s~~GT~~Y~APEvl~g~~----~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~ 886 (958)
|+|||.+.... .........+|||.|+|||.+.++. .+.+.|||||||+||.|++|+.||.+....++..+
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K 330 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK 330 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH
Confidence 99999987652 2222223467999999999998733 36789999999999999999999999999999998
Q ss_pred hhccccccCCCCC--CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhh--hcCCCCCC
Q 002160 887 VGFQNRRLEIPKE--LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR--LVIPSHPD 942 (958)
Q Consensus 887 i~~~~~~~~ip~~--ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k--~~~p~~P~ 942 (958)
|. +.++.+|.. +..++++||.+||.+||++|.++.+|..|.-.... ..+++.++
T Consensus 331 Iv--n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~~~s~~~ 388 (576)
T KOG0585|consen 331 IV--NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSPQSSEPS 388 (576)
T ss_pred Hh--cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCCccCCcc
Confidence 84 557777765 78999999999999999999999999998755433 33444443
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=355.82 Aligned_cols=246 Identities=25% Similarity=0.389 Sum_probs=203.7
Q ss_pred eeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHH---HcCCCceeEEeccccCCCceEEE
Q 002160 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMR---RLRHPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk---~L~HPNIVkL~g~~~~~~~l~LV 751 (958)
|++.+.||+|+||.||+|++ +++.||||++.+... .......+.+|++++. .++||||+++++++...+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67899999999999999986 678999999876532 2233456667766654 56799999999999999999999
Q ss_pred EeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc
Q 002160 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~ 831 (958)
|||+++++|..++.+. .........++.+++.||.|||..+ |+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~E~~~~~~L~~~~~~~-~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05589 81 MEYAAGGDLMMHIHTD-VFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR 157 (324)
T ss_pred EcCCCCCcHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCc
Confidence 9999999999888653 2333344444555599999999988 999999999999999999999999998754333333
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHh
Q 002160 832 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 911 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~C 911 (958)
....+|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+. .....+|..+++.+.+||.+|
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~ 235 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV--NDEVRYPRFLSREAISIMRRL 235 (324)
T ss_pred ccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHH
Confidence 345679999999999999999999999999999999999999999888777766653 234557778999999999999
Q ss_pred hhcCCCCCC-----CHHHHHHH
Q 002160 912 WQTDPSLRP-----SFAQLTVA 928 (958)
Q Consensus 912 L~kDP~kRP-----Sa~EIL~~ 928 (958)
|+.||.+|| ++.+|+++
T Consensus 236 L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 236 LRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred hhcCHhHcCCCCCCCHHHHhhC
Confidence 999999999 57777775
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=348.15 Aligned_cols=250 Identities=24% Similarity=0.285 Sum_probs=200.3
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
.++|++.++||.|+||.||+|+. +++.||+|++...... .....+.+|+.++++++||||+++++++......++||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 46799999999999999999976 6789999988654322 22346778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHH-HHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc
Q 002160 753 EFLPRGSLFRILHRPHCQVDEK-RRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~-~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~ 831 (958)
||+++ +|.+++...+....+. .+..+.+++.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT 159 (288)
T ss_pred eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence 99975 8998887655444444 4444455599999999988 999999999999999999999999999765443333
Q ss_pred CCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc-----------------c
Q 002160 832 SKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-----------------R 893 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~-----------------~ 893 (958)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+..... .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 344578999999999876 5688999999999999999999999988776554433211000 0
Q ss_pred cCC-----------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 894 LEI-----------PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 894 ~~i-----------p~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
..+ ...++.++++||.+||+.||.+||+++|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 001 12467889999999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=347.03 Aligned_cols=255 Identities=30% Similarity=0.472 Sum_probs=203.3
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEEC------------------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCc
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADWN------------------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 734 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~~------------------g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPN 734 (958)
++..+|++.++||+|+||.||+|.+. +..||||.+.... .......|.+|+++|.+++|||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCC
Confidence 45678999999999999999999752 2369999876543 3445667999999999999999
Q ss_pred eeEEeccccCCCceEEEEeecCCCCHHHHHhCCCC------------------CccHHHHHHHH-HHHHHHHHHHhcCCc
Q 002160 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHC------------------QVDEKRRIKMA-LDARGMNCLHTSTPT 795 (958)
Q Consensus 735 IVkL~g~~~~~~~l~LVmEy~~gGsL~d~L~k~~~------------------~~~e~~~l~ia-~~a~aL~yLH~~g~g 795 (958)
|+++++++...+..++||||+++|+|.+++..... ...+...+.++ +++.||.|||.++
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-- 158 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN-- 158 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--
Confidence 99999999999999999999999999998864321 12233344444 4489999999998
Q ss_pred EeecCCCCCceEEcCCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh--C
Q 002160 796 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT--L 871 (958)
Q Consensus 796 IIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt--G 871 (958)
|+||||||+|||++.++.+||+|||+++....... ......++..|+|||++.+..++.++||||||+++|+|++ +
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence 99999999999999999999999999976533221 1223345789999999998889999999999999999986 6
Q ss_pred CCCCCCCChhHHHHhhhc---c---ccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002160 872 KLPWIGMNPMQVVGAVGF---Q---NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 930 (958)
Q Consensus 872 ~~PF~g~~~~ei~~~i~~---~---~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~ 930 (958)
..||...+..+....+.. . ......+..++..+.+||.+||+.||.+||++.+|.+.|+
T Consensus 239 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 239 EQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 788988766655443311 0 1112234567899999999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=352.77 Aligned_cols=253 Identities=25% Similarity=0.335 Sum_probs=205.6
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEE
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~L 750 (958)
+..++|++.+.||+|+||.||++++ ++..||+|.+.... .......+.+|+++|++++||||+++++++...+.+++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4567899999999999999999987 57889999886542 34456679999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc
Q 002160 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 830 (958)
Q Consensus 751 VmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~ 830 (958)
||||+++++|.+++.+............+.+.+.||.|||..+ +|+||||||+|||++.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH-QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC-CEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 9999999999999976554444444444445599999999742 3999999999999999999999999998765432
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhc---------------------
Q 002160 831 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF--------------------- 889 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~--------------------- 889 (958)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..++...+..
T Consensus 158 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (331)
T cd06649 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPG 237 (331)
T ss_pred ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccc
Confidence 22346799999999999999999999999999999999999999977655443222110
Q ss_pred ------------------------cccccCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002160 890 ------------------------QNRRLEIP-KELDPLVARIIWECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 890 ------------------------~~~~~~ip-~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L 929 (958)
...++..+ ..+++++++||.+||++||++||++.+|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 238 RPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00111111 24678999999999999999999999999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=341.70 Aligned_cols=270 Identities=23% Similarity=0.340 Sum_probs=219.2
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
.+|...++||+|.||.||+|++ +|+.||||+++..+..+.......+|+++|+.++|+|||.++++|.+.+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4677889999999999999986 79999999998876665555678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCcc-HHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 754 FLPRGSLFRILHRPHCQVD-EKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~-e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
|++ .+|...++.....+. ...+.++.+...|++|||.+. |+||||||.|+||+.+|.+||+|||+|+.+.......
T Consensus 82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 996 489988876655444 445556666699999999999 9999999999999999999999999999987665555
Q ss_pred CCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccccc-----------------
Q 002160 833 KSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL----------------- 894 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~----------------- 894 (958)
...+-|.+|.|||.+.|. .|+..+||||.|||+.||+.|.+-|.|.++.+.+..+......+
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence 555789999999999874 58999999999999999999999999988776655442111100
Q ss_pred -CCC--------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhcCCCCCCCCCCCCC
Q 002160 895 -EIP--------KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALP 949 (958)
Q Consensus 895 -~ip--------~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~~p~~P~~p~~~~~ 949 (958)
.+| ...+.++.||+.+||..||.+|+++.|.+++ .-+.....|..|..-+.+.+
T Consensus 239 ~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~-~yf~~~P~pt~~~~lp~p~~ 301 (318)
T KOG0659|consen 239 QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH-PYFKSLPLPTPPSKLPIPST 301 (318)
T ss_pred hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc-hhhhcCCCCCChhhCcCCcc
Confidence 011 1345678999999999999999999999876 33344566666654444444
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=359.24 Aligned_cols=243 Identities=28% Similarity=0.437 Sum_probs=206.3
Q ss_pred EEeeccCceEEEEEEE-----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeecC
Q 002160 682 ERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 756 (958)
Q Consensus 682 k~LG~G~fG~Vykak~-----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~ 756 (958)
+.||+|+||.||+++. +++.||||++............+.+|+++|++++||||+++++++...+.+|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999864 57899999987655444445567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCC
Q 002160 757 RGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 836 (958)
Q Consensus 757 gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~ 836 (958)
+|+|.+++.+...........++.+++.||.|||.++ |+||||||+|||++.++.+||+|||+++.............
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 159 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC 159 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceeccc
Confidence 9999999977655555555555666699999999998 99999999999999999999999999986544433334567
Q ss_pred CCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCC
Q 002160 837 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 916 (958)
Q Consensus 837 GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP 916 (958)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+. .....+|..+++.+.+||.+||+.||
T Consensus 160 g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~l~~~P 237 (318)
T cd05582 160 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL--KAKLGMPQFLSPEAQSLLRALFKRNP 237 (318)
T ss_pred CChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence 9999999999999889999999999999999999999999888777666653 33456778899999999999999999
Q ss_pred CCCCC-----HHHHHHH
Q 002160 917 SLRPS-----FAQLTVA 928 (958)
Q Consensus 917 ~kRPS-----a~EIL~~ 928 (958)
.+||+ +.+++.+
T Consensus 238 ~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 238 ANRLGAGPDGVEEIKRH 254 (318)
T ss_pred hHcCCCCCCCHHHHhCC
Confidence 99999 4555543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=356.49 Aligned_cols=243 Identities=23% Similarity=0.342 Sum_probs=205.0
Q ss_pred EEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCceEEEEeecCC
Q 002160 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (958)
Q Consensus 682 k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~l~LVmEy~~g 757 (958)
+.||+|+||.||+|++ +++.||||++.+... .......+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999986 578899999876432 223455677888899887 699999999999999999999999999
Q ss_pred CCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCCC
Q 002160 758 GSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 837 (958)
Q Consensus 758 GsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~G 837 (958)
|+|.+++.+...........++.+.+.||.|||.++ |+||||||+|||++.++.+||+|||+++.............|
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCG 158 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccccccc
Confidence 999999887655555555555566699999999988 999999999999999999999999998764333333445679
Q ss_pred CCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCC
Q 002160 838 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPS 917 (958)
Q Consensus 838 T~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~ 917 (958)
|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...+. .....+|..++.++++||.+||+.||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~L~~dP~ 236 (320)
T cd05590 159 TPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL--NDEVVYPTWLSQDAVDILKAFMTKNPT 236 (320)
T ss_pred CccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHcccCHH
Confidence 999999999999999999999999999999999999999988877777663 334566778999999999999999999
Q ss_pred CCCCH------HHHHHH
Q 002160 918 LRPSF------AQLTVA 928 (958)
Q Consensus 918 kRPSa------~EIL~~ 928 (958)
+||++ ++++.|
T Consensus 237 ~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 237 MRLGSLTLGGEEAILRH 253 (320)
T ss_pred HCCCCCCCCCHHHHHcC
Confidence 99998 666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=355.25 Aligned_cols=243 Identities=24% Similarity=0.395 Sum_probs=203.3
Q ss_pred EEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCceEEEEeecCC
Q 002160 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (958)
Q Consensus 682 k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~l~LVmEy~~g 757 (958)
+.||+|+||.||+|++ +++.||||++..... .......+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 567899999876432 223344556677777765 899999999999999999999999999
Q ss_pred CCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCCC
Q 002160 758 GSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 837 (958)
Q Consensus 758 GsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~G 837 (958)
|+|..++.............+..+++.||.|||.++ |+||||||+|||++.++.+||+|||+++............+|
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccC
Confidence 999999877665555555556666699999999988 999999999999999999999999999865433333445679
Q ss_pred CCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCC
Q 002160 838 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPS 917 (958)
Q Consensus 838 T~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~ 917 (958)
|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...+. ...+.+|..++.++.+||.+||+.||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~ll~~~l~~~P~ 236 (316)
T cd05592 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL--NDRPHFPRWISKEAKDCLSKLFERDPT 236 (316)
T ss_pred CccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHccCCHH
Confidence 999999999999999999999999999999999999999988877776663 345667788999999999999999999
Q ss_pred CCCCHH-HHHHH
Q 002160 918 LRPSFA-QLTVA 928 (958)
Q Consensus 918 kRPSa~-EIL~~ 928 (958)
+||++. +++++
T Consensus 237 ~R~~~~~~l~~h 248 (316)
T cd05592 237 KRLGVDGDIRQH 248 (316)
T ss_pred HcCCChHHHHcC
Confidence 999875 56543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.67 Aligned_cols=250 Identities=32% Similarity=0.545 Sum_probs=208.4
Q ss_pred CCCCeeEEEEeeccCceEEEEEEEC-CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~~-g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
+.++|++.+.||+|+||.||++++. +..+|+|.+...... ...+.+|+.+|++++||||+++++++.....+++||
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 4567999999999999999999884 458999987654433 346888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHH-HHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~ 831 (958)
||+++|+|.+++........+.....++. .+.||.|||.++ |+||||||+||+++.++.+||+|||+++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 99999999999876444445555555444 489999999988 999999999999999999999999998765432221
Q ss_pred -CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHH
Q 002160 832 -SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 909 (958)
Q Consensus 832 -~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~ 909 (958)
.....++..|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+.. ......+...+..+.+||.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR-GFRLYRPKLASMTVYEVMY 235 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHHHHHHHH
Confidence 122335668999999998889999999999999999999 8999998887777766643 3344556678899999999
Q ss_pred HhhhcCCCCCCCHHHHHHHH
Q 002160 910 ECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 910 ~CL~kDP~kRPSa~EIL~~L 929 (958)
+||+.+|.+||++.+|++.|
T Consensus 236 ~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 236 SCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHccCCcccCcCHHHHHHhh
Confidence 99999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=355.79 Aligned_cols=243 Identities=21% Similarity=0.314 Sum_probs=205.4
Q ss_pred EEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCceEEEEeecCC
Q 002160 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (958)
Q Consensus 682 k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~l~LVmEy~~g 757 (958)
+.||+|+||.||+|++ +++.||||++..... .......+..|.+++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3599999999999987 467899999876432 233445677899999877 799999999999999999999999999
Q ss_pred CCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCCC
Q 002160 758 GSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 837 (958)
Q Consensus 758 GsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~G 837 (958)
++|..++.+...........++.+++.||.|||.++ |+||||||+|||++.++.+||+|||+++.............|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeecccceecccCCcccccccc
Confidence 999998877655555555555566699999999998 999999999999999999999999998764333333445679
Q ss_pred CCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCC
Q 002160 838 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPS 917 (958)
Q Consensus 838 T~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~ 917 (958)
|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+. .....+|..++.++.+||.+||++||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~ll~~~L~~dp~ 236 (321)
T cd05591 159 TPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL--HDDVLYPVWLSKEAVSILKAFMTKNPN 236 (321)
T ss_pred CccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhccCHH
Confidence 999999999999999999999999999999999999999988887777664 234556777899999999999999999
Q ss_pred CCC-------CHHHHHHH
Q 002160 918 LRP-------SFAQLTVA 928 (958)
Q Consensus 918 kRP-------Sa~EIL~~ 928 (958)
+|| ++.+++++
T Consensus 237 ~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 237 KRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HcCCCCCCCCCHHHHhcC
Confidence 999 78888766
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=364.08 Aligned_cols=250 Identities=25% Similarity=0.365 Sum_probs=206.7
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
.+|++++.||+|+||.||+|+. +++.||||++.+... .......+.+|+.+|++++|+||+++++.|.+++.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3799999999999999999986 678999999865432 2223456789999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC----
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT---- 828 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~---- 828 (958)
||+++|+|.+++.+.+.......+.++.+++.||.|||.++ |+||||||+|||++.++++||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 99999999999987665555556666667799999999988 999999999999999999999999997532100
Q ss_pred ---------------------------------------cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHH
Q 002160 829 ---------------------------------------FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELA 869 (958)
Q Consensus 829 ---------------------------------------~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELL 869 (958)
.......+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 00112357999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhHHHHhhhccccccCCC--CCCcHHHHHHHHHhhhcCCCCCC---CHHHHHHH
Q 002160 870 TLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARIIWECWQTDPSLRP---SFAQLTVA 928 (958)
Q Consensus 870 tG~~PF~g~~~~ei~~~i~~~~~~~~ip--~~ls~eL~dLI~~CL~kDP~kRP---Sa~EIL~~ 928 (958)
+|+.||.+.+..+....+........++ ..+++++.+||.+|+ .+|.+|+ ++.+++.|
T Consensus 239 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 239 VGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999999888776655543222233333 368899999999987 5999999 89999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=363.07 Aligned_cols=249 Identities=26% Similarity=0.399 Sum_probs=206.9
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
.|++++.||+|+||.||+|+. +++.||||++..... .......+.+|+.+|++++|||||+++++|.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588999999999999999986 678899999876533 23345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC-----
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT----- 828 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~----- 828 (958)
|+++|+|.+++.+.+.......+.++.+++.||+|||.++ |+||||||+||||+.+|++||+|||++......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 9999999999987665556666666777799999999998 999999999999999999999999997532100
Q ss_pred ------------------------------------------cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHH
Q 002160 829 ------------------------------------------FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILW 866 (958)
Q Consensus 829 ------------------------------------------~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLy 866 (958)
.......+||+.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHH
Confidence 00012357999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChhHHHHhhhccccccCCC--CCCcHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 002160 867 ELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARIIWECWQTDPSLRPS---FAQLTVA 928 (958)
Q Consensus 867 ELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip--~~ls~eL~dLI~~CL~kDP~kRPS---a~EIL~~ 928 (958)
||++|+.||.+.++.+....+........+| ..+++++.+||.+|+ .+|.+|++ +.+|+.|
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 9999999999888776665554333333343 457999999999986 59999987 8888875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=331.24 Aligned_cols=249 Identities=26% Similarity=0.406 Sum_probs=212.8
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEee
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
+|.+.+.||+|+||.||+|++ +++.|++|.+............+.+|++++++++||||+++++++...+.+|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 588899999999999999987 688999999877666666677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhCC-CCCccHHHHHHHHH-HHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 755 LPRGSLFRILHRP-HCQVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 755 ~~gGsL~d~L~k~-~~~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
+++++|.+++... .....+...+.++. .+.||.|||..+ |+|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~ 158 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA 158 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCCCCEEEcccccceeccCccchh
Confidence 9999999998764 33445555554444 489999999987 9999999999999999999999999988765443333
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhh
Q 002160 833 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 912 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL 912 (958)
....|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+..+....+. ......++..++..+.++|.+||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l 237 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKII-RGVFPPVSQMYSQQLAQLIDQCL 237 (256)
T ss_pred hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-cCCCCCCccccCHHHHHHHHHHc
Confidence 44578999999999999889999999999999999999999998887666555543 33344566678999999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 002160 913 QTDPSLRPSFAQLTVA 928 (958)
Q Consensus 913 ~kDP~kRPSa~EIL~~ 928 (958)
+.+|++||++.+|+++
T Consensus 238 ~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 238 TKDYRQRPDTFQLLRN 253 (256)
T ss_pred cCCcccCcCHHHHhhC
Confidence 9999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=360.13 Aligned_cols=260 Identities=28% Similarity=0.446 Sum_probs=207.3
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEE-------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEecc
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA 741 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~ 741 (958)
...++.++|++++.||+|+||.||+|++ .+..||||++..... ......+.+|+++|..+ +|||||+++++
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~ 107 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGA 107 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence 3456677999999999999999999974 345799998865432 23456788999999999 89999999999
Q ss_pred ccCCCceEEEEeecCCCCHHHHHhCCCC----------------------------------------------------
Q 002160 742 VTRPPNLSIITEFLPRGSLFRILHRPHC---------------------------------------------------- 769 (958)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~d~L~k~~~---------------------------------------------------- 769 (958)
|...+..++||||+++|+|.+++.+...
T Consensus 108 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (375)
T cd05104 108 CTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187 (375)
T ss_pred eccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence 9999999999999999999999864321
Q ss_pred ----------------------CccHHHHHHHHH-HHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 770 ----------------------QVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 770 ----------------------~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
...+...+.++. .+.||.|||.++ |+||||||+|||++.++.+||+|||+++...
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECCCcEEEecCccceecc
Confidence 123333344444 489999999988 9999999999999999999999999998654
Q ss_pred CCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHH
Q 002160 827 NTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 903 (958)
Q Consensus 827 ~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~e 903 (958)
.... ......++..|+|||++.+..++.++|||||||++|||++ |..||.................+...+...+.+
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSE 345 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHH
Confidence 3211 1112335668999999999999999999999999999997 899998765433333332233344556677899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 002160 904 VARIIWECWQTDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 904 L~dLI~~CL~kDP~kRPSa~EIL~~L~kL 932 (958)
+++||.+||+.||.+||++.+|++.|++.
T Consensus 346 l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 346 MYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 99999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=356.48 Aligned_cols=256 Identities=30% Similarity=0.430 Sum_probs=213.2
Q ss_pred cccccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC
Q 002160 669 CECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (958)
Q Consensus 669 ~~~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~ 746 (958)
..+.++.++|++.++||.|.-+.||+|+. +++.||||++..+.+... ...+.+|++.|+.++|||||+++..|..+.
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDS 97 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence 45667789999999999999999999986 789999999988776654 788999999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhCCCC-CccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHC-QVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~-~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
.+|+||.||.+|++.++++..-. .+++.....+... +.||.|||.+| .||||||+.||||+.+|.|||+|||.+..
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~dG~VkLadFgvsa~ 175 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSDGTVKLADFGVSAS 175 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCCCcEEEcCceeeee
Confidence 99999999999999999875332 2444444444333 89999999998 99999999999999999999999997765
Q ss_pred ccCCcc----cCCCCCCCCCccCccccc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccccc----
Q 002160 825 KHNTFL----SSKSTAGTPEWMAPEVLR--NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL---- 894 (958)
Q Consensus 825 ~~~~~~----~~~s~~GT~~Y~APEvl~--g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~---- 894 (958)
+..... ..+++.||+.|||||++. ...|+.|+|||||||+..||.+|+.||....+.+++..-. ++..+
T Consensus 176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL-qn~pp~~~t 254 (516)
T KOG0582|consen 176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL-QNDPPTLLT 254 (516)
T ss_pred ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh-cCCCCCccc
Confidence 432211 115678999999999954 3558999999999999999999999999999888765443 33232
Q ss_pred -CCC----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 895 -EIP----KELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 895 -~ip----~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
-++ +.++..++.+|..||++||.+||++.+++++
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 111 3467789999999999999999999999876
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=360.95 Aligned_cols=261 Identities=28% Similarity=0.463 Sum_probs=209.5
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEE-------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEecc
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA 741 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~ 741 (958)
.+.+..++|++++.||+|+||.||+|++ .+..||||++..... ......+.+|+++|+.+ +|+|||+++++
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~ 110 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGA 110 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeE
Confidence 3456778999999999999999999975 224799999875532 33456788999999999 89999999999
Q ss_pred ccCCCceEEEEeecCCCCHHHHHhCCCC----------------------------------------------------
Q 002160 742 VTRPPNLSIITEFLPRGSLFRILHRPHC---------------------------------------------------- 769 (958)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~d~L~k~~~---------------------------------------------------- 769 (958)
|...+.+++||||+++|+|.+++.+...
T Consensus 111 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 111 CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 9999999999999999999999864211
Q ss_pred -----------------CccHHHHHHH-HHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc-
Q 002160 770 -----------------QVDEKRRIKM-ALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 830 (958)
Q Consensus 770 -----------------~~~e~~~l~i-a~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~- 830 (958)
.+.+...+.+ .+++.||.|||.++ |+||||||+|||+++++++||+|||+++.......
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 1223333443 44489999999988 99999999999999999999999999976533211
Q ss_pred -cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHH
Q 002160 831 -SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 908 (958)
Q Consensus 831 -~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI 908 (958)
......++..|+|||++.+..++.++|||||||++|+|++ |+.||.....................+..++++++++|
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 348 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIM 348 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHH
Confidence 1112235668999999998889999999999999999997 99999876554433333333334556667899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHhhh
Q 002160 909 WECWQTDPSLRPSFAQLTVALKPLQ 933 (958)
Q Consensus 909 ~~CL~kDP~kRPSa~EIL~~L~kL~ 933 (958)
.+||+.||.+||++.+|++.|+++.
T Consensus 349 ~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 349 KMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHcCCChhhCcCHHHHHHHHHHHh
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=334.00 Aligned_cols=256 Identities=31% Similarity=0.533 Sum_probs=211.1
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEE-CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceE
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~ 749 (958)
++|.+++|++.++||+|+||.||+|.. .+..||+|.+..... ....+.+|+.++++++|+||+++++++...+..+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 357788999999999999999999986 567799998765332 3467889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhCCC-CCccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 750 IITEFLPRGSLFRILHRPH-CQVDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~-~~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
++|||+++++|.+++.+.. ........+ ++.+.+.||+|||..+ ++||||||+||+++.++.+||+|||++.....
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCCCcEEECCCccceecCC
Confidence 9999999999999986532 233333333 4445599999999988 99999999999999999999999999987643
Q ss_pred Cccc-CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHH
Q 002160 828 TFLS-SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 905 (958)
Q Consensus 828 ~~~~-~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~ 905 (958)
.... .....++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+. ...+...+..++.++.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (261)
T cd05072 156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ-RGYRMPRMENCPDELY 234 (261)
T ss_pred CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHH
Confidence 3211 122345678999999998889999999999999999998 999998887776665553 2233444456889999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 002160 906 RIIWECWQTDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 906 dLI~~CL~kDP~kRPSa~EIL~~L~kL 932 (958)
+||.+||..+|++||++++|++.|+++
T Consensus 235 ~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 235 DIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=352.85 Aligned_cols=248 Identities=23% Similarity=0.357 Sum_probs=203.2
Q ss_pred CeeEEEEeeccCceEEEEEEE-----CCcEEEEEEeecCCC--CHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCce
Q 002160 677 DLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDF--SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNL 748 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~-----~g~~VAVK~i~~~~~--~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~l 748 (958)
+|++++.||+|+||.||+++. +++.||+|++.+... .......+..|+++|+.+ +|+||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 588999999999999999975 578899999875432 223345678899999999 599999999999999999
Q ss_pred EEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
++||||+++|+|.+++.+.........+.++.+++.||.|||.++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 999999999999999977655555555555666799999999988 999999999999999999999999999764332
Q ss_pred c-ccCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCh----hHHHHhhhccccccCCCCCCcH
Q 002160 829 F-LSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQNRRLEIPKELDP 902 (958)
Q Consensus 829 ~-~~~~s~~GT~~Y~APEvl~g~~-~s~ksDIWSLGiLLyELLtG~~PF~g~~~----~ei~~~i~~~~~~~~ip~~ls~ 902 (958)
. .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ..+...+ ......++..+++
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 236 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI--LKCDPPFPSFIGP 236 (332)
T ss_pred CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH--hcCCCCCCCCCCH
Confidence 2 2223467999999999998754 78899999999999999999999965322 2222222 2334566778999
Q ss_pred HHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 002160 903 LVARIIWECWQTDPSLRP-----SFAQLTVA 928 (958)
Q Consensus 903 eL~dLI~~CL~kDP~kRP-----Sa~EIL~~ 928 (958)
.+++||.+||+.||.+|| ++.+++++
T Consensus 237 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 237 EAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 999999999999999999 78888865
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=353.23 Aligned_cols=242 Identities=22% Similarity=0.334 Sum_probs=202.0
Q ss_pred EEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCceEEEEeecCC
Q 002160 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (958)
Q Consensus 682 k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~l~LVmEy~~g 757 (958)
+.||+|+||.||+|++ +++.||||++..... .......+..|..++..+ +||||+++++++.+.+.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999987 678999999876432 122344567788888765 899999999999999999999999999
Q ss_pred CCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCCC
Q 002160 758 GSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 837 (958)
Q Consensus 758 GsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~G 837 (958)
|+|..++.+...........++.+.+.||+|||.++ |+||||||+|||++.++.+||+|||+++............+|
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCC
Confidence 999999877655444555555566699999999988 999999999999999999999999998754322233345679
Q ss_pred CCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCC
Q 002160 838 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPS 917 (958)
Q Consensus 838 T~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~ 917 (958)
|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+. ...+.+|..++.++++||.+||+.||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~ 236 (316)
T cd05620 159 TPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR--VDTPHYPRWITKESKDILEKLFERDPT 236 (316)
T ss_pred CcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHHccCCHH
Confidence 999999999999999999999999999999999999999888777776663 335566778999999999999999999
Q ss_pred CCCCHH-HHHH
Q 002160 918 LRPSFA-QLTV 927 (958)
Q Consensus 918 kRPSa~-EIL~ 927 (958)
+||++. +|+.
T Consensus 237 ~R~~~~~~~~~ 247 (316)
T cd05620 237 RRLGVVGNIRG 247 (316)
T ss_pred HcCCChHHHHc
Confidence 999974 6653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=334.21 Aligned_cols=255 Identities=32% Similarity=0.528 Sum_probs=212.1
Q ss_pred CCCCeeEEEEeeccCceEEEEEEEC-----CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCce
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~~-----g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l 748 (958)
..++|++.+.||+|+||.||+|++. ...||||.+.... .......|.+|+.++++++||||+++++++...+..
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 4568999999999999999999873 3479999876543 344566788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
++||||+++++|.+++........+...+.++ +.+.||.|||..+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 99999999999999997655445555555444 4489999999988 99999999999999999999999999987642
Q ss_pred Ccc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHH
Q 002160 828 TFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 904 (958)
Q Consensus 828 ~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL 904 (958)
... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+. .......+..++..+
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 237 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-DGYRLPPPMDCPSAL 237 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHH
Confidence 211 1122334678999999998889999999999999999997 999998877776666554 233445566789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 002160 905 ARIIWECWQTDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 905 ~dLI~~CL~kDP~kRPSa~EIL~~L~kL 932 (958)
.+|+.+||+.+|++||++.+|+++|.++
T Consensus 238 ~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 238 YQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 9999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=348.35 Aligned_cols=249 Identities=27% Similarity=0.385 Sum_probs=195.9
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC-----CceE
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-----PNLS 749 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~-----~~l~ 749 (958)
+|++.+.||+|+||.||+|+. +++.||||++............+.+|+++|++++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 589999999999999999976 688999999875433334455788999999999999999999987543 2489
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~ 829 (958)
+||||+. ++|.+++.+............+.+++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDT 157 (338)
T ss_pred EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence 9999995 689988876655444555555555699999999998 9999999999999999999999999998643221
Q ss_pred ---ccCCCCCCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhc---------------
Q 002160 830 ---LSSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF--------------- 889 (958)
Q Consensus 830 ---~~~~s~~GT~~Y~APEvl~g--~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~--------------- 889 (958)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 11234579999999999876 6788999999999999999999999987654332211100
Q ss_pred -----------cccccCC---CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 890 -----------QNRRLEI---PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 890 -----------~~~~~~i---p~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
......+ ...+++.+.+||.+||+.||++||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000 12467889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=357.30 Aligned_cols=249 Identities=25% Similarity=0.443 Sum_probs=222.2
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LV 751 (958)
..+|++.+.||+|.||+|-++.. .|+.||||.+++..+ +++++..+.+|++||..|+||||+++|.+|++.+++.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 35799999999999999999954 799999999988766 456788899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc
Q 002160 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~ 831 (958)
|||..+|+|+||+.+.+...+.+.+-++.+++.|+.|+|.++ ++|||||.+|||+|.++++||+||||+-++... ..
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N~NiKIADFGLSNly~~~-kf 208 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQNNNIKIADFGLSNLYADK-KF 208 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCCCCeeeeccchhhhhccc-cH
Confidence 999999999999999888888888888888899999999998 999999999999999999999999999887665 33
Q ss_pred CCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHH
Q 002160 832 SKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 910 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~g~~~-s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 910 (958)
.++|||++-|.+||++.|.+| ++.+|-||||++||.|+.|..||.|.+...++..|.... ..-| .-+..+.-||++
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~Ga--YrEP-~~PSdA~gLIRw 285 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGA--YREP-ETPSDASGLIRW 285 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccc--ccCC-CCCchHHHHHHH
Confidence 567999999999999999998 778999999999999999999999999988888775322 2122 345677889999
Q ss_pred hhhcCCCCCCCHHHHHHHH
Q 002160 911 CWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 911 CL~kDP~kRPSa~EIL~~L 929 (958)
||..+|++|.++.+|..|-
T Consensus 286 mLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 286 MLMVNPERRATIEDIASHW 304 (668)
T ss_pred HHhcCcccchhHHHHhhhh
Confidence 9999999999999998874
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=360.51 Aligned_cols=257 Identities=22% Similarity=0.340 Sum_probs=212.0
Q ss_pred cccccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeccccCC
Q 002160 669 CECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (958)
Q Consensus 669 ~~~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~ 745 (958)
....+..++|++.+.||+|+||.||++++ +++.||||++.+.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~ 115 (370)
T cd05596 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD 115 (370)
T ss_pred ccCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 34456778999999999999999999986 6889999998654322 22344577899999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 746 ~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
..+|+||||+++|+|.+++.... ........++.+++.||.|||.++ |+||||||+||||+.++.+||+|||++...
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~~-l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSNYD-IPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 99999999999999999987643 233334444555699999999988 999999999999999999999999999765
Q ss_pred cCCc-ccCCCCCCCCCccCcccccCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCC--
Q 002160 826 HNTF-LSSKSTAGTPEWMAPEVLRNE----PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK-- 898 (958)
Q Consensus 826 ~~~~-~~~~s~~GT~~Y~APEvl~g~----~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~-- 898 (958)
.... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+........+|.
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 272 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI 272 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcC
Confidence 4322 223456799999999998754 378899999999999999999999999887777666654333445554
Q ss_pred CCcHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 002160 899 ELDPLVARIIWECWQTDPSL--RPSFAQLTVA 928 (958)
Q Consensus 899 ~ls~eL~dLI~~CL~kDP~k--RPSa~EIL~~ 928 (958)
.++.++++||.+||+.+|.+ |+++.+|+.|
T Consensus 273 ~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 273 EISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 57999999999999999988 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=337.56 Aligned_cols=255 Identities=29% Similarity=0.543 Sum_probs=210.2
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~ 746 (958)
+.+.+|++.+.||+|+||.||+|.+ .+..||+|.+.... .......+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 4668899999999999999999975 45679999886543 3445567889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhCCC----------------CCccHHHHHHHHH-HHHHHHHHHhcCCcEeecCCCCCceEEc
Q 002160 747 NLSIITEFLPRGSLFRILHRPH----------------CQVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDLKSPNLLVD 809 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~----------------~~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDLKPeNILId 809 (958)
..|+||||+++++|.+++.... ....+...+.++. .+.||.|||.++ |+||||||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~ 158 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIG 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEc
Confidence 9999999999999999985322 1233444444444 489999999988 99999999999999
Q ss_pred CCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHh
Q 002160 810 KNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGA 886 (958)
Q Consensus 810 ~~g~VKL~DFGLAk~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~ 886 (958)
.++.+||+|||+++...... .......++..|+|||++.+..++.++||||||+++|||++ |..||.+.....+...
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999997653321 11233446778999999998889999999999999999998 9999988877666555
Q ss_pred hhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 002160 887 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 931 (958)
Q Consensus 887 i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~k 931 (958)
+. .......+..+++.++++|.+||+.||.+||++.+|+++|+.
T Consensus 239 ~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 VR-KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 54 333445677899999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=344.86 Aligned_cols=258 Identities=28% Similarity=0.480 Sum_probs=210.8
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCc----EEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~----~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~ 746 (958)
+...+|++.+.||+|+||.||+|++ +++ .||||.+... .......++.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~- 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence 4457899999999999999999986 333 4899987643 2334556788999999999999999999998764
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
..++|+||+++|+|.+++.+......+...+.++ +.+.||+|||..+ |+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCCCcEEEccccccccc
Confidence 5789999999999999998765555555555544 4489999999988 999999999999999999999999999876
Q ss_pred cCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcH
Q 002160 826 HNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 902 (958)
Q Consensus 826 ~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~ 902 (958)
..... ......++..|+|||++.+..++.++||||||+++|||++ |..||.+....+....+. ....+..+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTI 238 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-CCCCCCCCCCCCH
Confidence 43221 1122334678999999999999999999999999999997 999998877665544332 3344455667889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 903 LVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 903 eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
++.++|.+||..+|.+||++.+|+..|.++.+.
T Consensus 239 ~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 239 DVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=331.55 Aligned_cols=251 Identities=30% Similarity=0.473 Sum_probs=211.0
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCH---HHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG---AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~---~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~L 750 (958)
+.|++.+.||+|+||.||+|.. +++.||+|.+....... .....+.+|++++++++||||+++++++...+.+++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688999999999999999975 68899999887654322 234578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc
Q 002160 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 830 (958)
Q Consensus 751 VmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~ 830 (958)
||||+++++|.+++.+...........++.+.+.||.|||..+ |+||||||+||++++++.++|+|||+++.......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 9999999999999876554444444445555699999999988 99999999999999999999999999876533211
Q ss_pred cC---CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHH
Q 002160 831 SS---KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 907 (958)
Q Consensus 831 ~~---~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dL 907 (958)
.. ....|+..|+|||++.+..++.++||||||+++|+|++|+.||...+.......+........++..++..+.+|
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNF 239 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHH
Confidence 11 235678899999999998899999999999999999999999988776665555544455666788899999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 002160 908 IWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 908 I~~CL~kDP~kRPSa~EIL~~ 928 (958)
|.+||.++|.+||++.+|+.+
T Consensus 240 i~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 240 LRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHhhcCcccCCCHHHHhhC
Confidence 999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=353.99 Aligned_cols=241 Identities=25% Similarity=0.390 Sum_probs=199.5
Q ss_pred EEeeccCceEEEEEEE--CCcEEEEEEeecCCCC-HHHHHHHHHHH-HHHHHcCCCceeEEeccccCCCceEEEEeecCC
Q 002160 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREV-KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 757 (958)
Q Consensus 682 k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei-~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~g 757 (958)
+.||+|+||.||+|++ +++.||+|++...... ......+..|. .+++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 3699999999999987 5678999998754321 12233444444 456788999999999999999999999999999
Q ss_pred CCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCCC
Q 002160 758 GSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 837 (958)
Q Consensus 758 GsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~G 837 (958)
++|.+++.+.........+.++.+++.||.|||.++ |+||||||+||||+.++.+||+|||+++............+|
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccC
Confidence 999999987666666666666667799999999998 999999999999999999999999999764333333445679
Q ss_pred CCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCC
Q 002160 838 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPS 917 (958)
Q Consensus 838 T~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~ 917 (958)
|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+. .....++..+++.+.+||.+||++||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (325)
T cd05602 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL--NKPLQLKPNITNSARHLLEGLLQKDRT 236 (325)
T ss_pred CccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH--hCCcCCCCCCCHHHHHHHHHHcccCHH
Confidence 999999999999999999999999999999999999999888777666653 234455667899999999999999999
Q ss_pred CCCCHHHHH
Q 002160 918 LRPSFAQLT 926 (958)
Q Consensus 918 kRPSa~EIL 926 (958)
+|+++.+.+
T Consensus 237 ~R~~~~~~~ 245 (325)
T cd05602 237 KRLGAKDDF 245 (325)
T ss_pred HCCCCCCCH
Confidence 999876433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=332.87 Aligned_cols=255 Identities=36% Similarity=0.619 Sum_probs=213.1
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceE
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~ 749 (958)
++.+.+|.+.+.||+|+||.||+|.+ +++.||+|.+.... ....++.+|++++++++|+||+++++++.....++
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 56678899999999999999999976 57889999876432 23567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhCCC-CCccHHHHHHH-HHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 750 IITEFLPRGSLFRILHRPH-CQVDEKRRIKM-ALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~-~~~~e~~~l~i-a~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
++|||+++++|.+++.... ....+...+.+ .+.+.+|+|||..+ |+||||||+|||+++++.+||+|||++.....
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 9999999999999986543 23455544444 44499999999987 99999999999999999999999999987644
Q ss_pred CcccC-CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHH
Q 002160 828 TFLSS-KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 905 (958)
Q Consensus 828 ~~~~~-~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~ 905 (958)
..... ....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+. .......+..++.++.
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 235 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYRMERPEGCPPKVY 235 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHH
Confidence 32211 12234568999999999999999999999999999998 999998877766655553 3345567788999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 002160 906 RIIWECWQTDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 906 dLI~~CL~kDP~kRPSa~EIL~~L~kL 932 (958)
+||.+||+.||++||++.++++.|+.+
T Consensus 236 ~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 236 ELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=365.64 Aligned_cols=251 Identities=26% Similarity=0.354 Sum_probs=212.4
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC--CceEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNLSI 750 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~--~~l~L 750 (958)
.+.|+.+++||+|.||.||+|++ +|+.||+|+++.....+.......+|+.||++|+|||||+|.+..... ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 45688899999999999999986 788999999998877777777888999999999999999999998776 67999
Q ss_pred EEeecCCCCHHHHHhCCCC-CccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc
Q 002160 751 ITEFLPRGSLFRILHRPHC-QVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 751 VmEy~~gGsL~d~L~k~~~-~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~ 829 (958)
|+|||+. +|..++...+. +.....+.++.|++.||.|+|..+ |+|||||..|||||.+|.+||+|||||+.+....
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 9999964 88888887655 445667778888899999999998 9999999999999999999999999999765432
Q ss_pred -ccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc--------ccCCC--
Q 002160 830 -LSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--------RLEIP-- 897 (958)
Q Consensus 830 -~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~--------~~~ip-- 897 (958)
...+..+-|.+|.|||.+.|. .|+.++|+||.||||.||+.|++.|.+.+..+.++.|-.... ...+|
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~ 352 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHA 352 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcc
Confidence 224566789999999999985 489999999999999999999999999988877766532110 01111
Q ss_pred -----------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 898 -----------------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 898 -----------------~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
..++....+|+..+|..||.+|.++.+.+.+
T Consensus 353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 2467788999999999999999999988764
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=368.57 Aligned_cols=258 Identities=26% Similarity=0.370 Sum_probs=214.6
Q ss_pred ccccccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC
Q 002160 668 VCECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (958)
Q Consensus 668 ~~~~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~ 745 (958)
....+...++|.+.+.||+|+||.||+|++ +++.||||++............+.+|+.+|..++|+||+++++.+...
T Consensus 24 ~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 24 EATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred cccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence 334445567999999999999999999976 789999999987776677777889999999999999999998876543
Q ss_pred C--------ceEEEEeecCCCCHHHHHhCCC---CCccHH-HHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCc
Q 002160 746 P--------NLSIITEFLPRGSLFRILHRPH---CQVDEK-RRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN 813 (958)
Q Consensus 746 ~--------~l~LVmEy~~gGsL~d~L~k~~---~~~~e~-~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~ 813 (958)
+ .+++||||+++|+|.+++.... ..+.+. ....+.+.+.||.|||..+ |+||||||+||||+.++.
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSNGL 181 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCCCC
Confidence 2 3689999999999999886421 233444 3444455599999999988 999999999999999999
Q ss_pred EEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccc
Q 002160 814 VKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN 891 (958)
Q Consensus 814 VKL~DFGLAk~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~ 891 (958)
+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+. ..
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~-~~ 260 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL-AG 260 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh-cC
Confidence 9999999998654321 22345679999999999999999999999999999999999999999888777766654 23
Q ss_pred cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 892 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 892 ~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
....++..+++++.+||.+||+.||.+||++.+++.+
T Consensus 261 ~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 261 RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 3445677899999999999999999999999999875
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=366.73 Aligned_cols=251 Identities=24% Similarity=0.415 Sum_probs=224.2
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc-eEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN-LSII 751 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~-l~LV 751 (958)
.++|+++++||+|+||.++++++ .++.|++|++......+........|+.++++++|||||.+.+.|..++. ++||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 46799999999999999999976 67789999999888777777788999999999999999999999999988 9999
Q ss_pred EeecCCCCHHHHHhCCC-CCccHHH-HHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc
Q 002160 752 TEFLPRGSLFRILHRPH-CQVDEKR-RIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~-~~~~e~~-~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~ 829 (958)
|+||+||+|.+.+.+.. ..+.++. ..|+.+++.|+.|||+.. |+|||||+.|||+++++.|||.|||+|+.+....
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 99999999999887554 4444444 445555599999999877 9999999999999999999999999999988776
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHH
Q 002160 830 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 909 (958)
Q Consensus 830 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~ 909 (958)
....+..||+.||.||++.+.+|+.|+|||||||++|||++-+++|.+.+...++..+. ...-..+|..++.+++.||+
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~-~~~~~Plp~~ys~el~~lv~ 239 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKIN-RGLYSPLPSMYSSELRSLVK 239 (426)
T ss_pred hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHh-hccCCCCCccccHHHHHHHH
Confidence 45667899999999999999999999999999999999999999999999988888875 33356778899999999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 002160 910 ECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 910 ~CL~kDP~kRPSa~EIL~~ 928 (958)
.||+++|..||++.+|+.+
T Consensus 240 ~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 240 SMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHhhcCCccCCCHHHHhhC
Confidence 9999999999999999987
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=352.66 Aligned_cols=243 Identities=25% Similarity=0.394 Sum_probs=200.5
Q ss_pred EEeeccCceEEEEEEE--CCcEEEEEEeecCCCC-HHHHHHHHHHHH-HHHHcCCCceeEEeccccCCCceEEEEeecCC
Q 002160 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVK-IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 757 (958)
Q Consensus 682 k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~-ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~g 757 (958)
+.||+|+||+||+|++ +++.||||++...... ......+..|.. +++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 3699999999999987 6889999998764322 222344555554 56778999999999999999999999999999
Q ss_pred CCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCCC
Q 002160 758 GSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 837 (958)
Q Consensus 758 GsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~G 837 (958)
|+|..++.+.........+.++.+++.||.|||.++ |+||||||+||||+.++.+||+|||+++............+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccC
Confidence 999999987655555555555566699999999988 999999999999999999999999998764333333445679
Q ss_pred CCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCC
Q 002160 838 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPS 917 (958)
Q Consensus 838 T~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~ 917 (958)
|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+. .....++..++..+.+||.+||++||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (323)
T cd05575 159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL--NKPLRLKPNISVSARHLLEGLLQKDRT 236 (323)
T ss_pred ChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhhcCHH
Confidence 999999999999999999999999999999999999999888777766663 234456667899999999999999999
Q ss_pred CCCCHH----HHHHH
Q 002160 918 LRPSFA----QLTVA 928 (958)
Q Consensus 918 kRPSa~----EIL~~ 928 (958)
+||++. +++.+
T Consensus 237 ~R~~~~~~~~~il~~ 251 (323)
T cd05575 237 KRLGAKDDFLEIKNH 251 (323)
T ss_pred hCCCCCCCHHHHHcC
Confidence 999874 55543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=351.16 Aligned_cols=243 Identities=22% Similarity=0.362 Sum_probs=205.1
Q ss_pred EEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCceEEEEeecCC
Q 002160 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (958)
Q Consensus 682 k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~l~LVmEy~~g 757 (958)
+.||+|+||.||+|++ +++.||||++.+... .......+..|..+++.+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 577899999876532 223455677899999988 799999999999999999999999999
Q ss_pred CCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCCC
Q 002160 758 GSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 837 (958)
Q Consensus 758 GsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~G 837 (958)
|+|.+++.+...........++.+++.||.|||..+ |+||||||+|||+++++.+||+|||+++............+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceec
Confidence 999999877655544555555556699999999988 999999999999999999999999998754332233344679
Q ss_pred CCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCC
Q 002160 838 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPS 917 (958)
Q Consensus 838 T~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~ 917 (958)
|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+. .....+|..++..+++||.+||+.||.
T Consensus 159 ~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~dP~ 236 (318)
T cd05570 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL--EDEVRYPRWLSKEAKSILKSFLTKNPE 236 (318)
T ss_pred CccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH--cCCCCCCCcCCHHHHHHHHHHccCCHH
Confidence 999999999999999999999999999999999999999888777666653 334567778999999999999999999
Q ss_pred CCCCH-----HHHHHH
Q 002160 918 LRPSF-----AQLTVA 928 (958)
Q Consensus 918 kRPSa-----~EIL~~ 928 (958)
+||++ .+++.+
T Consensus 237 ~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 237 KRLGCLPTGEQDIKGH 252 (318)
T ss_pred HcCCCCCCCHHHHhcC
Confidence 99999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=349.66 Aligned_cols=251 Identities=24% Similarity=0.354 Sum_probs=202.5
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEE
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~L 750 (958)
+..++|++.+.||+|+||.||++++ ++..+|+|.+... ........+.+|+++|++++|||||+++++|...+.+++
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 4567899999999999999999987 5778999987654 234455678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhc-CCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc
Q 002160 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 751 VmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~-g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~ 829 (958)
||||+++++|.+++.+.+............+++.||.|||.. + |+||||||+|||++.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 999999999999997655443333344444558999999974 5 999999999999999999999999998765332
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhh---------------------
Q 002160 830 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG--------------------- 888 (958)
Q Consensus 830 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~--------------------- 888 (958)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||......+....+.
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR 236 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence 1234578999999999999889999999999999999999999997654433221110
Q ss_pred ----------------------ccccccCCCC-CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 889 ----------------------FQNRRLEIPK-ELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 889 ----------------------~~~~~~~ip~-~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.....+.++. .++.++++||.+||++||.+||++.||+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0111111221 367889999999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=350.50 Aligned_cols=248 Identities=21% Similarity=0.329 Sum_probs=207.4
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcC-CCceeEEeccccCCCceEEEE
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~-HPNIVkL~g~~~~~~~l~LVm 752 (958)
+|++.+.||+|+||.||+|++ +++.||||++.+... .......+..|..++..+. |++|+++++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 478889999999999999986 688999999876432 2234456778999998885 578889999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
||+++|+|.+++.+...........++.+.+.||.|||.++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeccccccccCCCCccc
Confidence 99999999999977655555555555556699999999988 9999999999999999999999999987643333333
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhh
Q 002160 833 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 912 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL 912 (958)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+. .....+|..++.++++|+.+||
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~l 236 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM--EHNVSYPKSLSKEAVSICKGLM 236 (323)
T ss_pred cCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCccCCHHHHHHHHHHc
Confidence 45679999999999999999999999999999999999999999988777776664 3345677889999999999999
Q ss_pred hcCCCCCCCH-----HHHHHH
Q 002160 913 QTDPSLRPSF-----AQLTVA 928 (958)
Q Consensus 913 ~kDP~kRPSa-----~EIL~~ 928 (958)
+++|.+|++. .++++|
T Consensus 237 ~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 237 TKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred ccCHhhCCCCCCCCHHHHhcC
Confidence 9999999974 555554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=357.59 Aligned_cols=250 Identities=27% Similarity=0.406 Sum_probs=208.5
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
++|++.+.||+|+||.||+++. +++.||||++..... .......+.+|+.++.+++||||+++++.+.+.+.+||||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4789999999999999999976 688999999875432 2334567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc---
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--- 829 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~--- 829 (958)
||+++|+|.+++.+.........+.++.+++.||.|||.++ |+||||||+||||+.++++||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 99999999999987666566666666777799999999988 9999999999999999999999999987542110
Q ss_pred --------------------------------ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 002160 830 --------------------------------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG 877 (958)
Q Consensus 830 --------------------------------~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g 877 (958)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 001245799999999999999999999999999999999999999999
Q ss_pred CChhHHHHhhhccccccCCCC--CCcHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 002160 878 MNPMQVVGAVGFQNRRLEIPK--ELDPLVARIIWECWQTDPSLRPS---FAQLTVA 928 (958)
Q Consensus 878 ~~~~ei~~~i~~~~~~~~ip~--~ls~eL~dLI~~CL~kDP~kRPS---a~EIL~~ 928 (958)
.+..+....+........+|. .++.++++||.+|+ .||.+|++ +.+|+.|
T Consensus 239 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 239 ETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 888777666643333344443 37899999999987 59999984 6777776
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=351.08 Aligned_cols=242 Identities=24% Similarity=0.361 Sum_probs=201.2
Q ss_pred EEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCceEEEEeecCC
Q 002160 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (958)
Q Consensus 682 k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~l~LVmEy~~g 757 (958)
+.||+|+||.||+|++ +++.||||++..... .......+..|..++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999987 567899999876532 122344566788888765 899999999999999999999999999
Q ss_pred CCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCCC
Q 002160 758 GSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 837 (958)
Q Consensus 758 GsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~G 837 (958)
|+|.+++.+...........++.+.+.||.|||..+ |+||||||+|||++.++.+||+|||+++.............|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecC
Confidence 999999976544444455555556699999999988 999999999999999999999999998754332223345679
Q ss_pred CCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCC
Q 002160 838 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPS 917 (958)
Q Consensus 838 T~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~ 917 (958)
|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.. ..+.+|..++.++++||.+||+.||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~~P~ 236 (316)
T cd05619 159 TPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM--DNPCYPRWLTREAKDILVKLFVREPE 236 (316)
T ss_pred CccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHHHHHHHHHhccCHh
Confidence 9999999999999999999999999999999999999999888777766643 24456777899999999999999999
Q ss_pred CCCCHH-HHHH
Q 002160 918 LRPSFA-QLTV 927 (958)
Q Consensus 918 kRPSa~-EIL~ 927 (958)
+||++. +|+.
T Consensus 237 ~R~~~~~~l~~ 247 (316)
T cd05619 237 RRLGVKGDIRQ 247 (316)
T ss_pred hcCCChHHHHc
Confidence 999996 6655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=354.99 Aligned_cols=248 Identities=28% Similarity=0.367 Sum_probs=199.0
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEE
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~L 750 (958)
....+|++++.||+|+||.||+|++ +++.||||++.... .......+.+|+++|+.++|+||+++++++...+.+|+
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 3456788889999999999999987 58899999986543 33445678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc
Q 002160 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 830 (958)
Q Consensus 751 VmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~ 830 (958)
||||+++++|..... .........+.+++.||.|||.++ |+||||||+||||++++.+||+|||+++.......
T Consensus 150 v~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 150 LLEFMDGGSLEGTHI----ADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred EEecCCCCccccccc----CCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 999999999865321 112222334444589999999998 99999999999999999999999999987654433
Q ss_pred cCCCCCCCCCccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhH---HHHhhhccccccCCCCCCcH
Q 002160 831 SSKSTAGTPEWMAPEVLRN-----EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ---VVGAVGFQNRRLEIPKELDP 902 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g-----~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~e---i~~~i~~~~~~~~ip~~ls~ 902 (958)
......||..|+|||++.. ...+.++|||||||++|||++|+.||....... ....+. .......+..++.
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 302 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC-MSQPPEAPATASR 302 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-ccCCCCCCCccCH
Confidence 3345679999999999843 334568999999999999999999997433221 222221 2334455678899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 903 LVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 903 eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
++++||.+||+.||++||++.||++|
T Consensus 303 ~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 303 EFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999999987
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=338.80 Aligned_cols=247 Identities=36% Similarity=0.630 Sum_probs=205.1
Q ss_pred eEEEEeeccCceEEEEEEEC------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 679 VLGERIGLGSYGEVYHADWN------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 679 ~i~k~LG~G~fG~Vykak~~------g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
++.+.||.|.||.||+|++. +..|+||.+.. .........|.+|++++++++||||++++|++...+.+++||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccccccccccc
Confidence 57889999999999999887 67899998844 344556788999999999999999999999999888899999
Q ss_pred eecCCCCHHHHHhCC-CCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC--
Q 002160 753 EFLPRGSLFRILHRP-HCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT-- 828 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~-~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~-- 828 (958)
||+++|+|.++|... .....+..++.++.+ +.||.|||..+ |+|+||+++|||++.++.+||+|||++......
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccc
Confidence 999999999999876 455666666666555 99999999988 999999999999999999999999999876221
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHH
Q 002160 829 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 907 (958)
Q Consensus 829 ~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dL 907 (958)
........+...|+|||.+.+..++.++||||||+++|||++ |+.||.+.+..++...+ ....+..++..++..+.++
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l 237 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIPDNCPKDIYSL 237 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSBTTSBHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccceeccchhHHHHHH
Confidence 112223446778999999998889999999999999999999 78999998888877777 3556677788899999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHH
Q 002160 908 IWECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 908 I~~CL~kDP~kRPSa~EIL~~L 929 (958)
|.+||..||.+||++.+|++.|
T Consensus 238 i~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 238 IQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHhcC
Confidence 9999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=344.19 Aligned_cols=249 Identities=24% Similarity=0.325 Sum_probs=195.0
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
++|++.+.||+|+||.||+|+. +++.||||++...... .....+.+|+.+++.++||||+++++++......++|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 6799999999999999999987 6889999998754322 223456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCC-ccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 754 FLPRGSLFRILHRPHCQ-VDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~-~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
|+. ++|.+++.+.... .....+..+.+.+.||+|||.++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 160 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY 160 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECCCCcceeccCCCccC
Confidence 995 5787777654433 34444555556699999999998 9999999999999999999999999987654333333
Q ss_pred CCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhH-HHHhhhcc--c-----------------
Q 002160 833 KSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGFQ--N----------------- 891 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~e-i~~~i~~~--~----------------- 891 (958)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... ....+... .
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP 240 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence 45678999999999876 457889999999999999999999998764322 11111000 0
Q ss_pred ccc--CCC---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 892 RRL--EIP---------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 892 ~~~--~ip---------~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
... ..+ ..++..+++||.+||+.||.+||++.|++.|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 000 001 1235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=331.75 Aligned_cols=256 Identities=24% Similarity=0.444 Sum_probs=207.5
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
.+|++.+.||+|+||.||+|++ +++.||||.+..... .......+.+|+.+++.++||||+++++++...+..+++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5799999999999999999976 789999998865432 3445567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhC---CCCCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 753 EFLPRGSLFRILHR---PHCQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 753 Ey~~gGsL~d~L~k---~~~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
||+++++|.+++.. ......+..... +.+.+.||.|||.++ |+|+||||+|||++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 99999999988742 223334444444 444599999999988 999999999999999999999999998865443
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--hHHHHhhhccccccCCCCCCcHHHHH
Q 002160 829 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP--MQVVGAVGFQNRRLEIPKELDPLVAR 906 (958)
Q Consensus 829 ~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~--~ei~~~i~~~~~~~~ip~~ls~eL~d 906 (958)
........|+..|+|||.+.+..++.++|+||||+++|+|++|+.||..... ......+.........+..++..+.+
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239 (267)
T ss_pred hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 3222345688999999999988889999999999999999999999976532 33333332222222223457789999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 002160 907 IIWECWQTDPSLRPSFAQLTVALKPLQ 933 (958)
Q Consensus 907 LI~~CL~kDP~kRPSa~EIL~~L~kL~ 933 (958)
||.+||..+|++||++.+|++.|+.+.
T Consensus 240 li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 240 LVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=351.87 Aligned_cols=238 Identities=26% Similarity=0.423 Sum_probs=198.9
Q ss_pred EEeeccCceEEEEEEE--CCcEEEEEEeecCCCC-HHHHHHHHHHHH-HHHHcCCCceeEEeccccCCCceEEEEeecCC
Q 002160 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVK-IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 757 (958)
Q Consensus 682 k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~-ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~g 757 (958)
+.||+|+||.||+|++ +++.||||++.+.... ......+..|.. +++.++||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 6789999998764322 223344555554 67889999999999999999999999999999
Q ss_pred CCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCCC
Q 002160 758 GSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 837 (958)
Q Consensus 758 GsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~G 837 (958)
++|..++.+.........+.++.+++.||.|||.++ |+||||||+||||+.++.+||+|||+++............+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccC
Confidence 999998877665556666666666799999999988 999999999999999999999999998764333333445679
Q ss_pred CCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCC
Q 002160 838 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPS 917 (958)
Q Consensus 838 T~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~ 917 (958)
|+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+. .....++...+..+.++|.+||++||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (321)
T cd05603 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL--HKPLQLPGGKTVAACDLLVGLLHKDQR 236 (321)
T ss_pred CcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHccCCHh
Confidence 999999999999999999999999999999999999999988777666653 335667778899999999999999999
Q ss_pred CCCCHH
Q 002160 918 LRPSFA 923 (958)
Q Consensus 918 kRPSa~ 923 (958)
+||+..
T Consensus 237 ~R~~~~ 242 (321)
T cd05603 237 RRLGAK 242 (321)
T ss_pred hcCCCC
Confidence 998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=353.22 Aligned_cols=250 Identities=25% Similarity=0.375 Sum_probs=206.9
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
++|.+.+.||+|+||.||+++. +++.||||++..... .......+.+|+.+++.++|+||+++++++.+.+.+||||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4689999999999999999976 688999999876543 2334567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHH-HHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc-c
Q 002160 753 EFLPRGSLFRILHRPHCQVDEK-RRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-L 830 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~-~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~-~ 830 (958)
||+++|+|.+++.+....+.+. .+.++.+++.||.|||..+ |+||||||+|||++.++++||+|||++....... .
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 9999999999998764444444 4444555699999999998 9999999999999999999999999998654322 1
Q ss_pred cCCCCCCCCCccCccccc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCC--CCcH
Q 002160 831 SSKSTAGTPEWMAPEVLR------NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK--ELDP 902 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~------g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~--~ls~ 902 (958)
......||+.|+|||++. +..++.++|||||||++|+|++|+.||...+..+....+........+|. .++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSS 238 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCH
Confidence 223356899999999987 45678899999999999999999999998877766665543333333443 5789
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 903 LVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 903 eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.+++||.+||+ +|.+||++.+++.|
T Consensus 239 ~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 239 DFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 99999999997 99999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=352.02 Aligned_cols=243 Identities=23% Similarity=0.366 Sum_probs=200.2
Q ss_pred EEeeccCceEEEEEEE--CCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCceEEEEeecCC
Q 002160 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (958)
Q Consensus 682 k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~l~LVmEy~~g 757 (958)
+.||+|+||.||+|++ +++.||||++.+.... ......+.+|..++.++ +||||++++++|.....+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3699999999999987 6789999998765432 23456688999999999 799999999999999999999999999
Q ss_pred CCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCCC
Q 002160 758 GSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 837 (958)
Q Consensus 758 GsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~G 837 (958)
|+|.+++.+.+.......+.++.+++.||.|||.++ |+||||||+|||++.++.+||+|||+++............+|
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccC
Confidence 999998876655555555555566699999999998 999999999999999999999999998753322233345679
Q ss_pred CCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--------h-HHHHhhhccccccCCCCCCcHHHHHHH
Q 002160 838 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP--------M-QVVGAVGFQNRRLEIPKELDPLVARII 908 (958)
Q Consensus 838 T~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~--------~-ei~~~i~~~~~~~~ip~~ls~eL~dLI 908 (958)
|+.|+|||++.+..++.++|||||||++|+|++|+.||..... . .....+ ......+|..++..+.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~p~~~~~~~~~li 236 (329)
T cd05588 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI--LEKQIRIPRSLSVKASSVL 236 (329)
T ss_pred CccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH--HcCCCCCCCCCCHHHHHHH
Confidence 9999999999999999999999999999999999999963211 1 122222 2345567888999999999
Q ss_pred HHhhhcCCCCCCC------HHHHHHH
Q 002160 909 WECWQTDPSLRPS------FAQLTVA 928 (958)
Q Consensus 909 ~~CL~kDP~kRPS------a~EIL~~ 928 (958)
.+||+.||.+|++ +.++++|
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 237 KGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 9999999999987 6777765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=330.48 Aligned_cols=255 Identities=33% Similarity=0.547 Sum_probs=211.0
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE-CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEE
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~L 750 (958)
++..++|++.+.||+|+||.||+|.+ .++.||||.+...... ..++.+|+.++++++||||+++++++...+.+++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI 78 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence 56678899999999999999999986 5567999988654332 4568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhCCC-CCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 751 ITEFLPRGSLFRILHRPH-CQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 751 VmEy~~gGsL~d~L~k~~-~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
||||+++++|.+++.... ....+.....++ +.+.|+.|||..+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 999999999999987643 334444444444 4489999999988 999999999999999999999999999876532
Q ss_pred ccc-CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHH
Q 002160 829 FLS-SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 906 (958)
Q Consensus 829 ~~~-~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~d 906 (958)
... ......+..|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..+....+. .......+..++..+.+
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 235 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCPKELYD 235 (261)
T ss_pred cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHHH
Confidence 211 111223457999999999889999999999999999999 999999888776666553 33344556678999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHhh
Q 002160 907 IIWECWQTDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 907 LI~~CL~kDP~kRPSa~EIL~~L~kL 932 (958)
++.+||+.+|.+||++.+|++.|+.+
T Consensus 236 li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 236 IMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=337.20 Aligned_cols=258 Identities=31% Similarity=0.535 Sum_probs=213.5
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE-------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~ 745 (958)
|++.+|.+.+.||+|+||.||++.. ++..+|+|.+... .......+.+|+.++++++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 6778999999999999999999974 2345889987543 234456789999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhCCC------------CCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCC
Q 002160 746 PNLSIITEFLPRGSLFRILHRPH------------CQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNW 812 (958)
Q Consensus 746 ~~l~LVmEy~~gGsL~d~L~k~~------------~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g 812 (958)
+.+++||||+++++|.+++...+ ..+.+...+.++ +.+.+|+|||.++ |+||||||+|||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENL 157 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCC
Confidence 99999999999999999986433 124444444444 4499999999988 99999999999999999
Q ss_pred cEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhc
Q 002160 813 NVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGF 889 (958)
Q Consensus 813 ~VKL~DFGLAk~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~ 889 (958)
.+||+|||+++...... .......++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+.
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~- 236 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT- 236 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-
Confidence 99999999997653321 11222345778999999999889999999999999999998 999998887776666654
Q ss_pred cccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 890 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 890 ~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
.......+..++..+.+|+.+||+.||.+||++.++++.|+++.+.
T Consensus 237 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 237 QGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 3334455667899999999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=334.58 Aligned_cols=256 Identities=32% Similarity=0.531 Sum_probs=208.0
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEEC-------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~~-------g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~ 744 (958)
++..++|++.+.||+|+||.||+|.+. ++.||||++.... ......++.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 345678999999999999999999753 3579999875433 23345678899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhCCCC---------CccHHHHHHH-HHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcE
Q 002160 745 PPNLSIITEFLPRGSLFRILHRPHC---------QVDEKRRIKM-ALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNV 814 (958)
Q Consensus 745 ~~~l~LVmEy~~gGsL~d~L~k~~~---------~~~e~~~l~i-a~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~V 814 (958)
....++||||+++++|.+++.+... .......+.+ .+.+.||.|||..+ ++||||||+|||+++++.+
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCCCCE
Confidence 9999999999999999999865322 1233334433 34489999999987 9999999999999999999
Q ss_pred EEEeccccccccCCccc--CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccc
Q 002160 815 KVSDFGLSRLKHNTFLS--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQN 891 (958)
Q Consensus 815 KL~DFGLAk~~~~~~~~--~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~ 891 (958)
||+|||+++........ .....++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+. ..
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~ 237 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM-EG 237 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cC
Confidence 99999998765332211 112345778999999999889999999999999999998 789998887776665543 33
Q ss_pred cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 002160 892 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 931 (958)
Q Consensus 892 ~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~k 931 (958)
....++..++..+++||.+||+.||.+||++.++++.|++
T Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 238 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 3445677889999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=328.43 Aligned_cols=251 Identities=36% Similarity=0.610 Sum_probs=212.2
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
+..++|++.+.||.|+||.||+|...++.||||.+..... ...++.+|+.++++++|+||+++++++......++||
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence 4567899999999999999999999999999999865532 4567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCC-CccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc
Q 002160 753 EFLPRGSLFRILHRPHC-QVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 830 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~-~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~ 830 (958)
||+++++|.+++..... ...+.....++ +.+.||.|||.++ |+||||||+|||++.++.+||+|||+++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~- 156 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ- 156 (256)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence 99999999999876542 34444444444 4489999999988 9999999999999999999999999998763221
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHH
Q 002160 831 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 909 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~ 909 (958)
....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+. .......+..+++.+.+||.
T Consensus 157 --~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~ 233 (256)
T cd05039 157 --DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-KGYRMEAPEGCPPEVYKVMK 233 (256)
T ss_pred --ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-cCCCCCCccCCCHHHHHHHH
Confidence 12345668999999998889999999999999999997 999998887766655543 23345567778999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHhh
Q 002160 910 ECWQTDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 910 ~CL~kDP~kRPSa~EIL~~L~kL 932 (958)
+||..+|.+||++.+++..|+.+
T Consensus 234 ~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 234 DCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHhccChhhCcCHHHHHHHHhcC
Confidence 99999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=330.68 Aligned_cols=245 Identities=28% Similarity=0.467 Sum_probs=204.2
Q ss_pred EeeccCceEEEEEEE----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeecCCC
Q 002160 683 RIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758 (958)
Q Consensus 683 ~LG~G~fG~Vykak~----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~gG 758 (958)
.||+|+||.||+|.+ ++..||||++...........++.+|+.+++.++||||+++++++. .+.+++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999965 4678999988766555556678999999999999999999999875 45678999999999
Q ss_pred CHHHHHhCCCCCccHHHHHHH-HHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc---CCC
Q 002160 759 SLFRILHRPHCQVDEKRRIKM-ALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS---SKS 834 (958)
Q Consensus 759 sL~d~L~k~~~~~~e~~~l~i-a~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~---~~s 834 (958)
+|.+++.+.... .+.....+ .+.+.||.|||.++ |+||||||.|||++.++.+||+|||++......... ...
T Consensus 81 ~L~~~l~~~~~~-~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQKNKHV-TEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 999999765443 44444444 44499999999988 999999999999999999999999999865433211 122
Q ss_pred CCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhh
Q 002160 835 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 913 (958)
Q Consensus 835 ~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~ 913 (958)
..++..|+|||.+.+..++.++|||||||++|||++ |+.||...+..++...+. ....+..|..+++++++||.+||+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~~~ 236 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SGERMECPQRCPPEMYDLMKLCWT 236 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHhc
Confidence 234578999999988888999999999999999997 999999887777766665 344567788899999999999999
Q ss_pred cCCCCCCCHHHHHHHHHhh
Q 002160 914 TDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 914 kDP~kRPSa~EIL~~L~kL 932 (958)
.||.+||++.+|.+.|++.
T Consensus 237 ~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 237 YGVDERPGFAVVELRLRNY 255 (257)
T ss_pred cCchhCcCHHHHHHHHhcc
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=367.58 Aligned_cols=269 Identities=32% Similarity=0.565 Sum_probs=233.5
Q ss_pred CccccccCCCCeeEEEEeeccCceEEEEEEE--C-C--cE-EEEEEeec-CCCCHHHHHHHHHHHHHHHHcCCCceeEEe
Q 002160 667 DVCECEIPWEDLVLGERIGLGSYGEVYHADW--N-G--TE-VAVKKFLD-QDFSGAALLEFKREVKIMRRLRHPNVVLFM 739 (958)
Q Consensus 667 ~~~~~eI~~~dy~i~k~LG~G~fG~Vykak~--~-g--~~-VAVK~i~~-~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~ 739 (958)
....+++.-++..+.++||+|+||.||+|+. . + .. ||||.... .......+.+|.+|+++|++++|||||+||
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y 227 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY 227 (474)
T ss_pred cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 3455677778888899999999999999976 2 2 23 89998876 336677889999999999999999999999
Q ss_pred ccccCCCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEe
Q 002160 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSD 818 (958)
Q Consensus 740 g~~~~~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~D 818 (958)
|++.....+|||||+|.||+|.++|++.+.......++.++.. +.||+|||.++ +|||||-.+|+|++.++.+||+|
T Consensus 228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~~~vKISD 305 (474)
T KOG0194|consen 228 GVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKKGVVKISD 305 (474)
T ss_pred EEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCCCeEEeCc
Confidence 9999999999999999999999999998765666666666665 89999999998 99999999999999999999999
Q ss_pred ccccccccCCcccCCCC-CCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCC
Q 002160 819 FGLSRLKHNTFLSSKST-AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEI 896 (958)
Q Consensus 819 FGLAk~~~~~~~~~~s~-~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~i 896 (958)
||+++.-. .+...... .-..+|+|||.+....|+.++|||||||++||+++ |..||.+....++...+...+.+..+
T Consensus 306 FGLs~~~~-~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~ 384 (474)
T KOG0194|consen 306 FGLSRAGS-QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPI 384 (474)
T ss_pred cccccCCc-ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCC
Confidence 99987653 22211212 23568999999999999999999999999999998 88899999999999999778888899
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhcCC
Q 002160 897 PKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 938 (958)
Q Consensus 897 p~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~~p 938 (958)
|...+.++..++.+||..+|++||+|.++.+.|+.+.+...+
T Consensus 385 ~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 385 PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 999999999999999999999999999999999999776443
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=333.19 Aligned_cols=256 Identities=31% Similarity=0.526 Sum_probs=212.2
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEEC-------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~~-------g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~ 744 (958)
++..++|.+.+.||+|+||.||+|.+. +..||+|.+.... .......+.+|+.+|+.++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 567789999999999999999999763 2679999875443 33345678899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhCCCC---------CccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcE
Q 002160 745 PPNLSIITEFLPRGSLFRILHRPHC---------QVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNV 814 (958)
Q Consensus 745 ~~~l~LVmEy~~gGsL~d~L~k~~~---------~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~V 814 (958)
....++||||+++++|.+++..... ...+...+. +.+.+.||.|||..+ |+||||||+|||++.++.+
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCCCCE
Confidence 9999999999999999999864321 223344443 444489999999988 9999999999999999999
Q ss_pred EEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccc
Q 002160 815 KVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQN 891 (958)
Q Consensus 815 KL~DFGLAk~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~ 891 (958)
||+|||+++....... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||.+.+..+....+. ..
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~ 237 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-DG 237 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-cC
Confidence 9999999876543221 1223456789999999988889999999999999999998 999998888777666654 44
Q ss_pred cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 002160 892 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 931 (958)
Q Consensus 892 ~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~k 931 (958)
....+|..++..+.+||.+||+.+|.+||++.+|+..|++
T Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 238 GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 4566777889999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=363.88 Aligned_cols=252 Identities=26% Similarity=0.364 Sum_probs=208.4
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeccccCCC-ce
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPP-NL 748 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~-HPNIVkL~g~~~~~~-~l 748 (958)
+..++|.++++||.|.||.||+|+. +++.||||++++.....+... -.||++-|++|+ |||||++.+++.+.+ .+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~-nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECM-NLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHH-HHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 4457899999999999999999975 788999999988776654433 358999999998 999999999999988 89
Q ss_pred EEEEeecCCCCHHHHHhCCCCCc-cHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 749 SIITEFLPRGSLFRILHRPHCQV-DEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~~~-~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
|+|||||+ .+|+++++.+...+ +...+-++.|++.||+|+|.+| +.|||||||||||..+..|||+|||+|+....
T Consensus 86 ~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 86 YFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccceeEeccccccccccc
Confidence 99999995 58999997665544 4555666667799999999999 99999999999999888999999999998755
Q ss_pred CcccCCCCCCCCCccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc--------------
Q 002160 828 TFLSSKSTAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-------------- 892 (958)
Q Consensus 828 ~~~~~~s~~GT~~Y~APEvl~-g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~-------------- 892 (958)
.. ..+.++.|++|.|||++. ...|+.+.|||++|||++|+.+-++-|.|.++.+.+.+|....+
T Consensus 163 kp-PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 163 KP-PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred CC-CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence 42 235678999999999975 56789999999999999999999999999887655544321100
Q ss_pred ---ccCCC-----------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002160 893 ---RLEIP-----------KELDPLVARIIWECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 893 ---~~~ip-----------~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L 929 (958)
...+| ...++++.+||.+||..||.+||++.|.+++-
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 00111 23678999999999999999999999999863
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=329.39 Aligned_cols=250 Identities=32% Similarity=0.573 Sum_probs=208.6
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccc-cCCCceEEE
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV-TRPPNLSII 751 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~-~~~~~l~LV 751 (958)
+.+.+|++.+.||+|+||.||+++..++.||+|.+.... ....+.+|+.++++++|+||+++++++ ......+++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 78 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence 566789999999999999999999999999999875432 245688999999999999999999975 455678999
Q ss_pred EeecCCCCHHHHHhCCCC-CccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc
Q 002160 752 TEFLPRGSLFRILHRPHC-QVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~-~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~ 829 (958)
|||+++++|.+++.+... ...+...+.++ +.+.+|+|||.++ |+||||||+||+++.++.+||+|||+++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 999999999999876443 24444444444 4489999999988 9999999999999999999999999987653321
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHH
Q 002160 830 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 908 (958)
Q Consensus 830 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI 908 (958)
....++..|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+. .......+..+++.+.+||
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 232 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPVVYDVM 232 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHH
Confidence 22345678999999999889999999999999999997 999998877766665553 2334456678899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHhh
Q 002160 909 WECWQTDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 909 ~~CL~kDP~kRPSa~EIL~~L~kL 932 (958)
.+||+.+|++||++.++++.|+.+
T Consensus 233 ~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 233 KQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHhcCChhhCcCHHHHHHHHhcC
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=358.81 Aligned_cols=258 Identities=36% Similarity=0.539 Sum_probs=206.7
Q ss_pred CCeeEEEEeeccCceEEEEEEEC-CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc-eEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN-LSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~~-g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~-l~LVmE 753 (958)
++|.-...||+|+||.||+|... ++.||||++....... ..+|.+|+.+|.+++|||+|+|+|||.+.+. .+||+|
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYE 152 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYE 152 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEE
Confidence 66777788999999999999885 4899999776654332 4469999999999999999999999999884 999999
Q ss_pred ecCCCCHHHHHhCCCC-CccHHHHHHHHHH-HHHHHHHHhcC-CcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc
Q 002160 754 FLPRGSLFRILHRPHC-QVDEKRRIKMALD-ARGMNCLHTST-PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 830 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~-~~~e~~~l~ia~~-a~aL~yLH~~g-~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~ 830 (958)
||++|+|.++|+.... .+.|..|+.|+.. |.||+|||... ++|||||||+.|||+|++++.||+|||+|+.......
T Consensus 153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~ 232 (361)
T KOG1187|consen 153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDT 232 (361)
T ss_pred ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcccc
Confidence 9999999999987766 7899999999998 99999999854 4799999999999999999999999999976543111
Q ss_pred cCCCC-CCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---hhHHHHh---hhcc-----ccccCCC-
Q 002160 831 SSKST-AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN---PMQVVGA---VGFQ-----NRRLEIP- 897 (958)
Q Consensus 831 ~~~s~-~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~---~~ei~~~---i~~~-----~~~~~ip- 897 (958)
..... .||..|+|||.+..+..+.|+||||||++|+||++|+.+..... ...+... .... ...+.+.
T Consensus 233 ~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~ 312 (361)
T KOG1187|consen 233 SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKE 312 (361)
T ss_pred ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccC
Confidence 11222 79999999999998889999999999999999999998876432 1112221 1101 1111222
Q ss_pred CCCc-----HHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 898 KELD-----PLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 898 ~~ls-----~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
...+ ..+..+..+|++.+|.+||+|.|+++.|+.+...
T Consensus 313 ~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 313 GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 2223 2356788899999999999999999999766544
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=331.14 Aligned_cols=251 Identities=33% Similarity=0.543 Sum_probs=207.7
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECC-cEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~~g-~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
+.++|++++.||+|+||.||++++.+ ..||||.+...... ...+.+|+.++++++||||+++++++.....+++||
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence 45689999999999999999998754 46999987654432 356889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc-
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 830 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~- 830 (958)
||+.+++|.+++........+...+.++ +.+.||.|||..+ |+|+||||+|||++.++.+||+|||+++.......
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 9999999999997654444555444444 4499999999988 99999999999999999999999999876543221
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHH
Q 002160 831 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 909 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~ 909 (958)
......++..|++||++.+..++.++|||||||++|+|++ |..||...+..+....+. ...+...+...+..+++++.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLASEKVYAIMY 235 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHH
Confidence 1122335678999999998889999999999999999998 999998887766666553 33444456677899999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHH
Q 002160 910 ECWQTDPSLRPSFAQLTVALK 930 (958)
Q Consensus 910 ~CL~kDP~kRPSa~EIL~~L~ 930 (958)
+||+.+|.+||++.+|+..|+
T Consensus 236 ~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 236 SCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHcCCCcccCCCHHHHHHhhC
Confidence 999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=334.32 Aligned_cols=255 Identities=30% Similarity=0.511 Sum_probs=209.6
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEEC-------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~~-------g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~ 745 (958)
+...+|.+.+.||+|+||.||+|++. ++.||||.+.... .......+.+|+++|++++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 34567899999999999999999752 4679999886543 233457889999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhCCCC-------------CccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCC
Q 002160 746 PNLSIITEFLPRGSLFRILHRPHC-------------QVDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKN 811 (958)
Q Consensus 746 ~~l~LVmEy~~gGsL~d~L~k~~~-------------~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~ 811 (958)
...++||||+++++|.+++...+. ...+.... .+.+.+.++.|||.++ |+||||||+|||++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~ 158 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYD 158 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcCC
Confidence 999999999999999999975431 22333333 3444589999999988 9999999999999999
Q ss_pred CcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhh
Q 002160 812 WNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVG 888 (958)
Q Consensus 812 g~VKL~DFGLAk~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~ 888 (958)
+.+||+|||+++....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT 238 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 9999999999875432211 1223346788999999999999999999999999999998 999998888777766664
Q ss_pred ccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 002160 889 FQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 931 (958)
Q Consensus 889 ~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~k 931 (958)
.......+..++..+++||.+||+.||.+||++.||++.|++
T Consensus 239 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 239 -QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 333344566789999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=380.32 Aligned_cols=263 Identities=32% Similarity=0.568 Sum_probs=226.7
Q ss_pred cccccCCCCeeEEEEeeccCceEEEEEEE-------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEecc
Q 002160 669 CECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 741 (958)
Q Consensus 669 ~~~eI~~~dy~i~k~LG~G~fG~Vykak~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~ 741 (958)
...+|+..+.+..+.||+|+||+||+|+. ....||||.++... ..+...+|++|+++|..|+|||||+|+|+
T Consensus 479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGV 557 (774)
T KOG1026|consen 479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGV 557 (774)
T ss_pred ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence 34567888999999999999999999975 34569999876543 45578899999999999999999999999
Q ss_pred ccCCCceEEEEeecCCCCHHHHHhCCC-------------CCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceE
Q 002160 742 VTRPPNLSIITEFLPRGSLFRILHRPH-------------CQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLL 807 (958)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~d~L~k~~-------------~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNIL 807 (958)
|..++.+++|+|||..|+|.+||.... ..+.....+.++.+ +.||.||-++. +|||||-..|+|
T Consensus 558 C~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCL 635 (774)
T KOG1026|consen 558 CREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCL 635 (774)
T ss_pred EccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhce
Confidence 999999999999999999999996322 12455666666666 99999999999 999999999999
Q ss_pred EcCCCcEEEEeccccccccCCcccC-C-CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 002160 808 VDKNWNVKVSDFGLSRLKHNTFLSS-K-STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVV 884 (958)
Q Consensus 808 Id~~g~VKL~DFGLAk~~~~~~~~~-~-s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~ 884 (958)
|.++..|||+|||+++..-...+.. . ...-..+||+||.+...+++.++|||||||+|||+++ |+.||++..+.|++
T Consensus 636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI 715 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI 715 (774)
T ss_pred eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence 9999999999999998754332221 1 2233569999999999999999999999999999998 99999999999999
Q ss_pred HhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 885 GAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 885 ~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
+.+. ++..+..|.++|.++..|+..||+.+|.+||+|+||-..|+.....
T Consensus 716 e~i~-~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 716 ECIR-AGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HHHH-cCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 9997 4444888999999999999999999999999999999999988654
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=350.06 Aligned_cols=243 Identities=23% Similarity=0.367 Sum_probs=199.6
Q ss_pred EEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCceEEEEeecCC
Q 002160 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (958)
Q Consensus 682 k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~l~LVmEy~~g 757 (958)
+.||+|+||.||+|++ +++.||+|++.+... .......+.+|+.++.++ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3699999999999986 678899999876543 233455678899999887 899999999999999999999999999
Q ss_pred CCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCCC
Q 002160 758 GSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 837 (958)
Q Consensus 758 GsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~G 837 (958)
|+|..++.+.........+.+..+++.||.|||.++ |+||||||+||||+.++++||+|||+++.............|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccC
Confidence 999998877655555555555666699999999998 999999999999999999999999998764333333345679
Q ss_pred CCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------hh-HHHHhhhccccccCCCCCCcHHHHHHH
Q 002160 838 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN--------PM-QVVGAVGFQNRRLEIPKELDPLVARII 908 (958)
Q Consensus 838 T~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~--------~~-ei~~~i~~~~~~~~ip~~ls~eL~dLI 908 (958)
|+.|+|||++.+..++.++|||||||++|+|++|+.||.... .. .+...+ ......+|..++..+++||
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~~p~~~~~~~~~ll 236 (329)
T cd05618 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIPRSLSVKAASVL 236 (329)
T ss_pred CccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH--hcCCCCCCCCCCHHHHHHH
Confidence 999999999999999999999999999999999999995311 11 122222 2345567888999999999
Q ss_pred HHhhhcCCCCCCC------HHHHHHH
Q 002160 909 WECWQTDPSLRPS------FAQLTVA 928 (958)
Q Consensus 909 ~~CL~kDP~kRPS------a~EIL~~ 928 (958)
.+||+.||.+||+ +.+++.|
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 237 KSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 9999999999998 4677665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=357.13 Aligned_cols=263 Identities=32% Similarity=0.472 Sum_probs=211.6
Q ss_pred ccccccCCCCeeEEEEeeccCceEEEEEEEC-------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEe
Q 002160 668 VCECEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFM 739 (958)
Q Consensus 668 ~~~~eI~~~dy~i~k~LG~G~fG~Vykak~~-------g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~-HPNIVkL~ 739 (958)
...++++.++|+++++||+|+||.||+|++. +..||||++.... .......+.+|+++|+++. |||||+++
T Consensus 29 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~ 107 (400)
T cd05105 29 DSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLL 107 (400)
T ss_pred CCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEE
Confidence 3567788899999999999999999999762 2369999886543 3344567899999999995 99999999
Q ss_pred ccccCCCceEEEEeecCCCCHHHHHhCCCC--------------------------------------------------
Q 002160 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHC-------------------------------------------------- 769 (958)
Q Consensus 740 g~~~~~~~l~LVmEy~~gGsL~d~L~k~~~-------------------------------------------------- 769 (958)
++|.....+|||||||++|+|.+++.+...
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (400)
T cd05105 108 GACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ 187 (400)
T ss_pred EEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence 999999999999999999999998864311
Q ss_pred ---------------------------------------------CccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCC
Q 002160 770 ---------------------------------------------QVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKS 803 (958)
Q Consensus 770 ---------------------------------------------~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKP 803 (958)
.+.+...+.++ +.+.||.|||..+ |+||||||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp 265 (400)
T cd05105 188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAA 265 (400)
T ss_pred cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCh
Confidence 12223333333 4489999999988 99999999
Q ss_pred CceEEcCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 002160 804 PNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNP 880 (958)
Q Consensus 804 eNILId~~g~VKL~DFGLAk~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~ 880 (958)
+|||++.++.+||+|||+++...... .......++..|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 266 ~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~ 345 (400)
T cd05105 266 RNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV 345 (400)
T ss_pred HhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch
Confidence 99999999999999999998653321 12223456788999999999889999999999999999997 9999987644
Q ss_pred hHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 002160 881 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 933 (958)
Q Consensus 881 ~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~ 933 (958)
............++..+..++.++.+||.+||+.||++||++.+|.+.|+++.
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 346 DSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred hHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 33332222233455566788999999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=338.62 Aligned_cols=262 Identities=32% Similarity=0.536 Sum_probs=214.6
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEEC---------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEe
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFM 739 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~~---------g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~ 739 (958)
.+++..++|.+++.||+|+||.||++++. ...||+|.+.... ......++.+|+.+++++ +||||++++
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLL 90 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 45677789999999999999999999752 2469999887543 344456788999999999 799999999
Q ss_pred ccccCCCceEEEEeecCCCCHHHHHhCCCC---------------CccHHHHHHHHH-HHHHHHHHHhcCCcEeecCCCC
Q 002160 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHC---------------QVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDLKS 803 (958)
Q Consensus 740 g~~~~~~~l~LVmEy~~gGsL~d~L~k~~~---------------~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDLKP 803 (958)
+++...+..|+||||+++|+|.+++.+... ...+...+.++. .+.||+|||.++ |+||||||
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp 168 (307)
T cd05098 91 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAA 168 (307)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccH
Confidence 999999999999999999999999975421 233444444444 489999999987 99999999
Q ss_pred CceEEcCCCcEEEEeccccccccCCccc--CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 002160 804 PNLLVDKNWNVKVSDFGLSRLKHNTFLS--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNP 880 (958)
Q Consensus 804 eNILId~~g~VKL~DFGLAk~~~~~~~~--~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~ 880 (958)
+|||++.++.+||+|||+++........ .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 9999999999999999998765432111 111234568999999999889999999999999999998 8899988776
Q ss_pred hHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 881 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 881 ~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
.+....+. .......+..++.++.+||.+||..+|.+||++.+|++.|.++...
T Consensus 249 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 249 EELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 66655553 3445567778899999999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=332.15 Aligned_cols=255 Identities=32% Similarity=0.580 Sum_probs=212.9
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE-CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEE
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LV 751 (958)
....+|++++.||.|+||.||+|++ .++.+|+|.+..... .....+.+|+.+++.++|+||+++++++.....+++|
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 3446799999999999999999987 567899998765432 2345788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhCCC-CCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc
Q 002160 752 TEFLPRGSLFRILHRPH-CQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~-~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~ 829 (958)
|||+++++|.+++.+.. ....+..... +.+++.||.|||..+ |+||||||+||||+.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 99999999999997633 2334444444 444589999999988 9999999999999999999999999998765443
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHH
Q 002160 830 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 908 (958)
Q Consensus 830 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI 908 (958)
.......++..|++||++.+..++.++||||||+++|+|++ |+.||.+.+..+....+. ...+...+..++..+.++|
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i 237 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIYKIM 237 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-hCCcCCCCCCCCHHHHHHH
Confidence 33333446778999999998889999999999999999998 899998887777666654 3345566678899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHhh
Q 002160 909 WECWQTDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 909 ~~CL~kDP~kRPSa~EIL~~L~kL 932 (958)
.+||+.||.+||++.+|++.|+.+
T Consensus 238 ~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 238 LECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHcCCCchhCcCHHHHHHHHhcC
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=330.03 Aligned_cols=250 Identities=32% Similarity=0.550 Sum_probs=207.7
Q ss_pred CCCCeeEEEEeeccCceEEEEEEE-CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
...+|++.+.||+|+||.||++++ .+..+|||.+...... ...+.+|+.++++++||||+++++++...+..|+||
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 456789999999999999999987 4557999987654433 246778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHH-HHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~ 831 (958)
||+++++|.+++........+...+.++. .+.||+|||..+ |+||||||+|||++.++.+||+|||+++...+....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 99999999999976554555555555544 489999999988 999999999999999999999999998765432211
Q ss_pred -CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHH
Q 002160 832 -SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 909 (958)
Q Consensus 832 -~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~ 909 (958)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+. ...+...+..++.++.+|+.
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYRPKLAPTEVYTIMY 235 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHH
Confidence 111223457999999999889999999999999999998 899998877776666554 33345566778999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHH
Q 002160 910 ECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 910 ~CL~kDP~kRPSa~EIL~~L 929 (958)
+||..+|++||++.++++.|
T Consensus 236 ~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 236 SCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHhcCChhhCcCHHHHHHHh
Confidence 99999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=355.87 Aligned_cols=255 Identities=23% Similarity=0.366 Sum_probs=209.0
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~ 747 (958)
..+..++|++.+.||+|+||.||++++ +++.||+|++.+... .......+.+|+.+++.++||||+++++++.++..
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 445567899999999999999999987 578899999865332 22334567899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
+|+||||+++|+|.+++.... ......+.+..+++.||+|||.++ |+||||||+|||+++++++||+|||++.....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~~-~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 999999999999999987643 333344444555599999999988 99999999999999999999999999987543
Q ss_pred Cc-ccCCCCCCCCCccCcccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCC--CC
Q 002160 828 TF-LSSKSTAGTPEWMAPEVLRNEP----SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK--EL 900 (958)
Q Consensus 828 ~~-~~~~s~~GT~~Y~APEvl~g~~----~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~--~l 900 (958)
.. ......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+........+|. .+
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 274 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEI 274 (370)
T ss_pred CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccC
Confidence 22 2234567999999999997643 67899999999999999999999998887777666654444455554 46
Q ss_pred cHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 002160 901 DPLVARIIWECWQTDPSL--RPSFAQLTVA 928 (958)
Q Consensus 901 s~eL~dLI~~CL~kDP~k--RPSa~EIL~~ 928 (958)
+..+++||.+||..++.+ |+++.++++|
T Consensus 275 s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 275 SKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 899999999999855543 8899999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=336.59 Aligned_cols=249 Identities=23% Similarity=0.290 Sum_probs=203.2
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
.|++.+.||+|+||.||++.. +++.||||++....... .....+.+|+.++++++||||+++++++..++.+++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478899999999999999986 68899999987654332 223457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCC-CCccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc
Q 002160 754 FLPRGSLFRILHRPH-CQVDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 754 y~~gGsL~d~L~k~~-~~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~ 831 (958)
|+++|+|.+++.... ....+.... .+.+.+.||.|||..+ |+||||||+||++++++.++|+|||++....... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-T 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-c
Confidence 999999998876432 234444444 4445599999999988 9999999999999999999999999987654322 2
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhh--ccccccCCCCCCcHHHHHHHH
Q 002160 832 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG--FQNRRLEIPKELDPLVARIIW 909 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~--~~~~~~~ip~~ls~eL~dLI~ 909 (958)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+. .......++..++..+++||.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICR 237 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHH
Confidence 234578999999999999889999999999999999999999998766543322221 122344566778999999999
Q ss_pred HhhhcCCCCCC-----CHHHHHHH
Q 002160 910 ECWQTDPSLRP-----SFAQLTVA 928 (958)
Q Consensus 910 ~CL~kDP~kRP-----Sa~EIL~~ 928 (958)
+||+.||.+|| ++++++.+
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 238 QLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHccCCHHHhcCCCCCCHHHHhcC
Confidence 99999999999 88899876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=328.67 Aligned_cols=252 Identities=28% Similarity=0.494 Sum_probs=207.0
Q ss_pred eeEEEEeeccCceEEEEEEEC-----CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc-----
Q 002160 678 LVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN----- 747 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~~-----g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~----- 747 (958)
|.+++.||+|+||.||+|.+. +..||||++............+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567889999999999999762 3679999987765555667789999999999999999999998766544
Q ss_pred -eEEEEeecCCCCHHHHHhCCC-----CCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecc
Q 002160 748 -LSIITEFLPRGSLFRILHRPH-----CQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 820 (958)
Q Consensus 748 -l~LVmEy~~gGsL~d~L~k~~-----~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFG 820 (958)
.+++|||+++++|..++.... ....+..... +.+.+.||.|||..+ |+||||||+||++++++.+||+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCCCeEEECCcc
Confidence 799999999999998874321 2334444444 444489999999988 9999999999999999999999999
Q ss_pred ccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCC
Q 002160 821 LSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIP 897 (958)
Q Consensus 821 LAk~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip 897 (958)
+++....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+. .......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 237 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR-HGNRLKQP 237 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCC
Confidence 9986543221 1112335678999999998889999999999999999999 899998888777766554 34455677
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 002160 898 KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 898 ~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL 932 (958)
..++..+.++|.+||+.||.+||++.+|++.|+++
T Consensus 238 ~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 238 EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 88999999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=345.84 Aligned_cols=251 Identities=21% Similarity=0.357 Sum_probs=203.9
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
++|++.+.||+|+||.||++++ .++.||+|++.+... .......+..|+.++..++|+||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 4799999999999999999987 567899999865332 2223445788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccH-HHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC-cc
Q 002160 753 EFLPRGSLFRILHRPHCQVDE-KRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT-FL 830 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e-~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~-~~ 830 (958)
||+++|+|.+++.+......+ ..+.++.+++.||.|||.++ |+||||||+|||++.++++||+|||++...... ..
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 999999999999764434444 44445555699999999988 999999999999999999999999998764322 12
Q ss_pred cCCCCCCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCC---CCCcH
Q 002160 831 SSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP---KELDP 902 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~-----g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip---~~ls~ 902 (958)
.....+||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+....+.....+..+| ..+++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~ 238 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSE 238 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCH
Confidence 223457999999999986 3457889999999999999999999999988877777665443334444 35799
Q ss_pred HHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 002160 903 LVARIIWECWQTDPSL--RPSFAQLTVA 928 (958)
Q Consensus 903 eL~dLI~~CL~kDP~k--RPSa~EIL~~ 928 (958)
++++||.+||..++.+ |+++.++++|
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 239 DAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 9999999999655444 6899999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=354.63 Aligned_cols=257 Identities=23% Similarity=0.363 Sum_probs=209.8
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~ 746 (958)
...+..++|++.+.||+|+||.||+|++ +++.||+|++.+... .......+.+|+.+++.++||||+++++++....
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 3456678999999999999999999987 678899999865432 2233456788999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
.+|+||||+++|+|.+++.... ......+.+..+++.||.|||.++ |+||||||+||||+.++++||+|||+++...
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~~-~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 9999999999999999987643 333344445556699999999998 9999999999999999999999999998654
Q ss_pred CCc-ccCCCCCCCCCccCcccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCC--C
Q 002160 827 NTF-LSSKSTAGTPEWMAPEVLRNEP----SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK--E 899 (958)
Q Consensus 827 ~~~-~~~~s~~GT~~Y~APEvl~g~~----~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~--~ 899 (958)
... ......+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+.......+........+|. .
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 273 (371)
T cd05622 194 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 273 (371)
T ss_pred cCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCC
Confidence 322 2234567999999999997643 78899999999999999999999999887777766654433444443 6
Q ss_pred CcHHHHHHHHHhhhcCCCC--CCCHHHHHHHH
Q 002160 900 LDPLVARIIWECWQTDPSL--RPSFAQLTVAL 929 (958)
Q Consensus 900 ls~eL~dLI~~CL~kDP~k--RPSa~EIL~~L 929 (958)
++..+++||.+||..++.+ |+++.+|++|.
T Consensus 274 ~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 274 ISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 8999999999999844433 78999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=362.76 Aligned_cols=248 Identities=23% Similarity=0.347 Sum_probs=206.1
Q ss_pred CCeeEEEEeeccCceEEEEEEE--C-CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--N-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~-g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
..|.+.+.||+|+||.||+|.. + ++.||+|.+.... ......+.+|+.+|+.++|||||+++++|...+.+||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 4599999999999999999975 3 6678888764432 334456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCC---CCCccHH-HHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 753 EFLPRGSLFRILHRP---HCQVDEK-RRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~---~~~~~e~-~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
||+++|+|.+++.+. ...+.+. ....+.+.+.||.|||.++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 999999999887532 2233343 3344455589999999988 999999999999999999999999999876433
Q ss_pred c--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHH
Q 002160 829 F--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 906 (958)
Q Consensus 829 ~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~d 906 (958)
. ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...+... ....++..++.++++
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~ 301 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG-KYDPFPCPVSSGMKA 301 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCccCCHHHHH
Confidence 2 1234567999999999999999999999999999999999999999988877776666432 333466778999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 002160 907 IIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 907 LI~~CL~kDP~kRPSa~EIL~~ 928 (958)
||.+||..||.+||++.+++.+
T Consensus 302 li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 302 LLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred HHHHHhccChhhCcCHHHHHhC
Confidence 9999999999999999998754
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=328.37 Aligned_cols=255 Identities=31% Similarity=0.566 Sum_probs=210.7
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEE-CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceE
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~ 749 (958)
++|..++|+++++||+|+||.||+|.. +++.||+|.+...... ...+.+|+.++++++|+||+++++++. .+.++
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 356778999999999999999999976 6788999988765443 347889999999999999999999874 45789
Q ss_pred EEEeecCCCCHHHHHhCCC-CCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 750 IITEFLPRGSLFRILHRPH-CQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~-~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
++|||+++++|.+++.+.. ....+.....++ +.+.+|+|||..+ |+||||||+||+++.++.++|+|||++.....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 9999999999999886533 334444444444 4489999999988 99999999999999999999999999976652
Q ss_pred Cc-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHH
Q 002160 828 TF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 905 (958)
Q Consensus 828 ~~-~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~ 905 (958)
.. .......++..|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..+....+. .......+..++.++.
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 233 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRMPRPDNCPEELY 233 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-cCCCCCCCCCCCHHHH
Confidence 22 12223346678999999998889999999999999999998 999998887766665553 3334456677889999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 002160 906 RIIWECWQTDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 906 dLI~~CL~kDP~kRPSa~EIL~~L~kL 932 (958)
+||.+||+.+|++||++++|+..|+.+
T Consensus 234 ~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 234 ELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred HHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=336.93 Aligned_cols=249 Identities=29% Similarity=0.374 Sum_probs=194.9
Q ss_pred CCeeEEEEeeccCceEEEEEEE---CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc---CCCceeEEecccc-----C
Q 002160 676 EDLVLGERIGLGSYGEVYHADW---NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL---RHPNVVLFMGAVT-----R 744 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~---~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L---~HPNIVkL~g~~~-----~ 744 (958)
++|++.+.||+|+||.||+|++ .++.||||.+............+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3689999999999999999976 367899998876544333334566777777766 6999999999874 3
Q ss_pred CCceEEEEeecCCCCHHHHHhCCC-CCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccc
Q 002160 745 PPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 822 (958)
Q Consensus 745 ~~~l~LVmEy~~gGsL~d~L~k~~-~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLA 822 (958)
...+++||||++ ++|.+++.+.. ....+..... +.+.+.||.|||..+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCCCCEEEccccce
Confidence 456899999996 58988886532 2334444444 444499999999988 999999999999999999999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccc---------
Q 002160 823 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--------- 893 (958)
Q Consensus 823 k~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~--------- 893 (958)
+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......
T Consensus 158 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 158 RIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred EeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 765433 2234467899999999999988999999999999999999999999987766554443211000
Q ss_pred ----------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 894 ----------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 894 ----------------~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
..+...+++.+++||.+||+.||++||++.++++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00112467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.31 Aligned_cols=248 Identities=25% Similarity=0.409 Sum_probs=208.2
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEee
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
+|++.+.||+|+||.||++++ ++..||+|.+..... ......+.+|+.+++.++|+||+++++.+...+.+|++|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 588999999999999999976 688999998865432 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhCC-CCCccHHHH-HHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 755 LPRGSLFRILHRP-HCQVDEKRR-IKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 755 ~~gGsL~d~L~k~-~~~~~e~~~-l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
+++++|.+++... .....+... .++.+.+.||.|||.++ |+|+||||+|||++.++.++|+|||++..........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 157 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA 157 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCCCcEEEcccCcceeeccccccc
Confidence 9999999988643 223344434 44445599999999988 9999999999999999999999999997665443333
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhh
Q 002160 833 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 912 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL 912 (958)
....|+..|+|||++.+..++.++|+||||+++|+|++|..||...+.......+. ......++..++..+++||.+||
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 236 (255)
T cd08219 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC-QGSYKPLPSHYSYELRSLIKQMF 236 (255)
T ss_pred ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh-cCCCCCCCcccCHHHHHHHHHHH
Confidence 45678999999999999889999999999999999999999998877766655553 33344566778999999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 002160 913 QTDPSLRPSFAQLTVA 928 (958)
Q Consensus 913 ~kDP~kRPSa~EIL~~ 928 (958)
+.||.+||++.+|+..
T Consensus 237 ~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 237 KRNPRSRPSATTILSR 252 (255)
T ss_pred hCCcccCCCHHHHhhc
Confidence 9999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=349.59 Aligned_cols=239 Identities=26% Similarity=0.374 Sum_probs=198.6
Q ss_pred EEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHH-HHHHcCCCceeEEeccccCCCceEEEEeecCC
Q 002160 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVK-IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 757 (958)
Q Consensus 682 k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~-ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~g 757 (958)
+.||+|+||.||+|++ +++.||||++.+... .......+..|.. +++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3699999999999976 688999999876432 2233445556655 46778999999999999999999999999999
Q ss_pred CCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCCC
Q 002160 758 GSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 837 (958)
Q Consensus 758 GsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~G 837 (958)
|+|..++.+.........+.++.+++.||.|||..+ |+||||||+||||+.++.+||+|||+++............+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccC
Confidence 999998877665555555556666699999999988 999999999999999999999999998764333333445679
Q ss_pred CCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCC
Q 002160 838 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPS 917 (958)
Q Consensus 838 T~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~ 917 (958)
|+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.. ....++..++..+.++|.+||+++|.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ll~~ll~~~p~ 236 (325)
T cd05604 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH--KPLVLRPGASLTAWSILEELLEKDRQ 236 (325)
T ss_pred ChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc--CCccCCCCCCHHHHHHHHHHhccCHH
Confidence 9999999999999999999999999999999999999998887777666642 24445567899999999999999999
Q ss_pred CCCCHHH
Q 002160 918 LRPSFAQ 924 (958)
Q Consensus 918 kRPSa~E 924 (958)
+||++.+
T Consensus 237 ~R~~~~~ 243 (325)
T cd05604 237 RRLGAKE 243 (325)
T ss_pred hcCCCCC
Confidence 9998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=328.67 Aligned_cols=252 Identities=31% Similarity=0.511 Sum_probs=202.7
Q ss_pred eeEEEEeeccCceEEEEEEEC--Cc--EEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC------Cc
Q 002160 678 LVLGERIGLGSYGEVYHADWN--GT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------PN 747 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~~--g~--~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~------~~ 747 (958)
|.+++.||+|+||.||+|++. +. .||||.+............+.+|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 346788999999999999873 32 589998876555555677889999999999999999999976432 24
Q ss_pred eEEEEeecCCCCHHHHHhCC-----CCCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccc
Q 002160 748 LSIITEFLPRGSLFRILHRP-----HCQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 821 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~-----~~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGL 821 (958)
.+++|||+++|+|.+++... .....+..... +.+++.||+|||.++ |+||||||+|||+++++.+||+|||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCCCCEEECCCCc
Confidence 78999999999999887421 12234444444 444589999999988 99999999999999999999999999
Q ss_pred cccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCC
Q 002160 822 SRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPK 898 (958)
Q Consensus 822 Ak~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~ 898 (958)
++....... ......+++.|++||.+.+..++.++||||||+++|+|++ |+.||.+....+....+. .......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~ 237 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR-QGNRLKQPP 237 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCCCCCCC
Confidence 987543221 1122346778999999999989999999999999999999 899998877776666554 333445566
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 002160 899 ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 899 ~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL 932 (958)
.++..+.++|.+||+.||++||++.+|++.|+++
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 238 DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 7889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=346.00 Aligned_cols=251 Identities=20% Similarity=0.334 Sum_probs=204.2
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
++|++.+.||+|+||.||++++ +++.||||++.+... .......+..|+.++..++|+||+++++++...+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4799999999999999999986 578899999865322 2233456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCC-ccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc-
Q 002160 753 EFLPRGSLFRILHRPHCQ-VDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 830 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~-~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~- 830 (958)
||++||+|.+++.+.... .....+.++.+++.||.|||.++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 999999999999764333 34444555556699999999988 99999999999999999999999999976543222
Q ss_pred cCCCCCCCCCccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCC---CCcH
Q 002160 831 SSKSTAGTPEWMAPEVLRN-----EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK---ELDP 902 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g-----~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~---~ls~ 902 (958)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+.....+..+|. .++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~ 238 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE 238 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCH
Confidence 2233579999999999876 4578899999999999999999999998887777666654433444443 4689
Q ss_pred HHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 002160 903 LVARIIWECWQTDPSL--RPSFAQLTVA 928 (958)
Q Consensus 903 eL~dLI~~CL~kDP~k--RPSa~EIL~~ 928 (958)
++++||.+||..++.+ |++++++++|
T Consensus 239 ~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 239 EAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 9999999999876554 4688998876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=326.10 Aligned_cols=245 Identities=32% Similarity=0.562 Sum_probs=201.4
Q ss_pred EEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeecCCCC
Q 002160 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGS 759 (958)
Q Consensus 682 k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~gGs 759 (958)
+.||+|+||.||+|++ +++.||+|.+... ........+.+|++++++++||||+++++++.....+++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 3599999999999976 7888999987643 344456678999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCC--CCC
Q 002160 760 LFRILHRPHCQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK--STA 836 (958)
Q Consensus 760 L~d~L~k~~~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~--s~~ 836 (958)
|.+++.+......+...+. +.+.+.||.|||..+ |+||||||+|||++.++.+||+|||++........... ...
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9999976554445554444 444489999999988 99999999999999999999999999876543211111 112
Q ss_pred CCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcC
Q 002160 837 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTD 915 (958)
Q Consensus 837 GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kD 915 (958)
++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+. .......+..++..+.+|+.+||+.+
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPDAVYRLMERCWEYD 236 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCcccCCHHHHHHHHHHcCCC
Confidence 3457999999999889999999999999999997 899998777665554443 33445667788999999999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 002160 916 PSLRPSFAQLTVALK 930 (958)
Q Consensus 916 P~kRPSa~EIL~~L~ 930 (958)
|++||++.+|++.|+
T Consensus 237 p~~Rps~~~~~~~l~ 251 (252)
T cd05084 237 PGQRPSFSTVHQELQ 251 (252)
T ss_pred hhhCcCHHHHHHHHh
Confidence 999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=333.50 Aligned_cols=260 Identities=31% Similarity=0.562 Sum_probs=213.9
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEECC-------cEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEecc
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA 741 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~~g-------~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~ 741 (958)
.+++..++|++.+.||+|+||.||++++.+ ..||+|.+.... .......+.+|+.+++++ +|+||++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 456777899999999999999999997632 568999876543 334456788999999999 89999999999
Q ss_pred ccCCCceEEEEeecCCCCHHHHHhCCC---------------CCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCc
Q 002160 742 VTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPN 805 (958)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~d~L~k~~---------------~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeN 805 (958)
+...+.++++|||+++|+|..++.... ....+...+.++ +++.||.|||..+ |+||||||+|
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~N 162 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARN 162 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceee
Confidence 999999999999999999999986421 233444444444 4489999999988 9999999999
Q ss_pred eEEcCCCcEEEEeccccccccCCccc--CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhH
Q 002160 806 LLVDKNWNVKVSDFGLSRLKHNTFLS--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQ 882 (958)
Q Consensus 806 ILId~~g~VKL~DFGLAk~~~~~~~~--~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~e 882 (958)
||++.++.+||+|||+++........ .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 99999999999999999875432211 122234568999999999889999999999999999997 999998887776
Q ss_pred HHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 002160 883 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 933 (958)
Q Consensus 883 i~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~ 933 (958)
....+. .......+..++..+.+|+.+||+.||.+||++.+|++.|+.+.
T Consensus 243 ~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 LFKLLK-EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 666554 33455667788999999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=334.72 Aligned_cols=257 Identities=32% Similarity=0.561 Sum_probs=208.2
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCc--EEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCceE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~--~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~l~ 749 (958)
|++|++.+.||+|+||.||+|.+ ++. .+++|.+... ........+.+|+.++.++ +||||+++++++.....++
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 57899999999999999999976 333 4688876532 2333456788999999999 7999999999999999999
Q ss_pred EEEeecCCCCHHHHHhCCC---------------CCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCc
Q 002160 750 IITEFLPRGSLFRILHRPH---------------CQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN 813 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~---------------~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~ 813 (958)
++|||+++++|.+++.+.. ....+...+. +.+.+.||+|||.++ |+||||||+|||++.++.
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECCCCe
Confidence 9999999999999996533 1233344443 444589999999988 999999999999999999
Q ss_pred EEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhcccc
Q 002160 814 VKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNR 892 (958)
Q Consensus 814 VKL~DFGLAk~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~ 892 (958)
+||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+. ...
T Consensus 158 ~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~-~~~ 235 (297)
T cd05089 158 SKIADFGLSRGEEVY-VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGY 235 (297)
T ss_pred EEECCcCCCccccce-eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCC
Confidence 999999998643221 11111223557999999999889999999999999999997 999999888777666553 333
Q ss_pred ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhc
Q 002160 893 RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 936 (958)
Q Consensus 893 ~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~ 936 (958)
....+..++..+++||.+||+.+|.+||++.+|++.|+.+....
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 45566788999999999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=346.82 Aligned_cols=261 Identities=30% Similarity=0.495 Sum_probs=207.8
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEE-------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccc
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAV 742 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~ 742 (958)
++++.++|++.+.||+|+||.||+|.+ +++.||+|++.... .......+..|+.++.++ +|+||+++++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 456778999999999999999999964 24679999886543 333456778899999999 899999999987
Q ss_pred cC-CCceEEEEeecCCCCHHHHHhCCCC----------------------------------------------------
Q 002160 743 TR-PPNLSIITEFLPRGSLFRILHRPHC---------------------------------------------------- 769 (958)
Q Consensus 743 ~~-~~~l~LVmEy~~gGsL~d~L~k~~~---------------------------------------------------- 769 (958)
.. ...++++|||+++++|.+++.....
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 64 4568899999999999998854221
Q ss_pred --------CccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc--ccCCCCCCC
Q 002160 770 --------QVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGT 838 (958)
Q Consensus 770 --------~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~--~~~~s~~GT 838 (958)
...+.....++ +++.||+|||..+ |+||||||+|||++.++++||+|||+++.+.... .......++
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 23344444444 4499999999988 9999999999999999999999999998653221 112234456
Q ss_pred CCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCC
Q 002160 839 PEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPS 917 (958)
Q Consensus 839 ~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~ 917 (958)
..|+|||++.+..++.++|||||||++|||++ |..||.+....+..........+...+...++++.+++.+||+.+|+
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 318 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPE 318 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChh
Confidence 78999999999999999999999999999998 99999875544433333223344555677889999999999999999
Q ss_pred CCCCHHHHHHHHHhhhh
Q 002160 918 LRPSFAQLTVALKPLQR 934 (958)
Q Consensus 918 kRPSa~EIL~~L~kL~k 934 (958)
+||++.+|+++|+++..
T Consensus 319 ~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 319 DRPTFSELVEILGDLLQ 335 (337)
T ss_pred hCcCHHHHHHHHHHHHh
Confidence 99999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=332.58 Aligned_cols=258 Identities=33% Similarity=0.524 Sum_probs=211.9
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE-------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~ 745 (958)
+.+.+|.+.+.||+|+||.||+|++ .+..+++|.+.... ......+.+|+.++++++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 4567899999999999999999975 23458888765432 33446788999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhCCCC---------------CccHHHHHHHHH-HHHHHHHHHhcCCcEeecCCCCCceEEc
Q 002160 746 PNLSIITEFLPRGSLFRILHRPHC---------------QVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDLKSPNLLVD 809 (958)
Q Consensus 746 ~~l~LVmEy~~gGsL~d~L~k~~~---------------~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDLKPeNILId 809 (958)
...++||||+++++|.+++..... ...+...+.++. ++.||+|||.++ |+||||||+|||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~ 157 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVG 157 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEc
Confidence 999999999999999999865321 234444444444 489999999988 99999999999999
Q ss_pred CCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHh
Q 002160 810 KNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGA 886 (958)
Q Consensus 810 ~~g~VKL~DFGLAk~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~ 886 (958)
.++.+||+|||+++...... .......++..|+|||++.+..++.++||||||+++|+|++ |..||...+..+....
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999997653321 11223456789999999999999999999999999999998 9999988877766665
Q ss_pred hhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 887 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 887 i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
+. .......+..++..+.+||.+||+++|.+||++.+|++.|..+.+.
T Consensus 238 ~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 238 IT-QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred Hh-CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 53 3333445567889999999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.19 Aligned_cols=256 Identities=25% Similarity=0.455 Sum_probs=207.9
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
.+|++.+.||+|+||.||++++ +++.||||.+..... .......+.+|+.+++.++|+||+++++++...+.++++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 5788899999999999999985 788999998876443 3334567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhC---CCCCccHHHHHHH-HHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 753 EFLPRGSLFRILHR---PHCQVDEKRRIKM-ALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 753 Ey~~gGsL~d~L~k---~~~~~~e~~~l~i-a~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
||+++++|.+++.. ......+...+.+ .+.+.||.|||..+ |+|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 99999999998863 2223444444444 44589999999988 999999999999999999999999998765443
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--hHHHHhhhccccccCCCCCCcHHHHH
Q 002160 829 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP--MQVVGAVGFQNRRLEIPKELDPLVAR 906 (958)
Q Consensus 829 ~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~--~ei~~~i~~~~~~~~ip~~ls~eL~d 906 (958)
........|+..|+|||++.+..++.++|+||||+++|+|++|..||.+... .+....+.........+..++..+++
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239 (267)
T ss_pred CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHH
Confidence 3223345689999999999988899999999999999999999999976543 23333332111122223468899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 002160 907 IIWECWQTDPSLRPSFAQLTVALKPLQ 933 (958)
Q Consensus 907 LI~~CL~kDP~kRPSa~EIL~~L~kL~ 933 (958)
||.+||+.||.+||++.+|++.+++++
T Consensus 240 li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 240 LVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred HHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=329.11 Aligned_cols=258 Identities=28% Similarity=0.470 Sum_probs=209.5
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCc----EEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~----~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~ 746 (958)
+...+|++.+.||+|+||.||+|++ +++ .||||.+.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~ 81 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-S 81 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-C
Confidence 4457899999999999999999986 343 48999876543 34445678899999999999999999999875 4
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
..+++|||+++|+|.+++......+.+...+.++ +.+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcEEECCCCceeec
Confidence 5789999999999999997654444444444444 4499999999988 999999999999999999999999999865
Q ss_pred cCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcH
Q 002160 826 HNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 902 (958)
Q Consensus 826 ~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~ 902 (958)
..... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.......+...+. .......+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE-KGERLPQPPICTI 238 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCcCCCCccCCH
Confidence 43211 1112234678999999999889999999999999999998 999998777665555443 3334455667899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 903 LVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 903 eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
.+.++|.+||+.||.+||++.++++.|+++...
T Consensus 239 ~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 239 DVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 999999999999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=328.16 Aligned_cols=255 Identities=30% Similarity=0.507 Sum_probs=209.0
Q ss_pred CCCCeeEEEEeeccCceEEEEEEEC-----CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCce
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~~-----g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l 748 (958)
...+|++.+.||+|+||.||+|++. +..+|+|.+.... .......+.+|+.++++++||||+++++++...+.+
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3467999999999999999999762 2369999876543 334456889999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
++||||+++++|.+++.+......+...+.++ +.+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 99999999999999997655444555444444 4489999999988 99999999999999999999999999986543
Q ss_pred Cccc---CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHH
Q 002160 828 TFLS---SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 903 (958)
Q Consensus 828 ~~~~---~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~e 903 (958)
.... .....++..|+|||.+.+..++.++|+|+||+++|+|++ |..||.+....+....+. ...+...+..+++.
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 237 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-EGYRLPAPMDCPAA 237 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh-CCCcCCCCCCCCHH
Confidence 2211 111223568999999999889999999999999999886 999998887766665554 22334455678899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 002160 904 VARIIWECWQTDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 904 L~dLI~~CL~kDP~kRPSa~EIL~~L~kL 932 (958)
+++++.+||+++|.+||++.+|++.|.++
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 238 LHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 99999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=322.43 Aligned_cols=249 Identities=27% Similarity=0.439 Sum_probs=206.6
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC-CCceEEEEe
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-PPNLSIITE 753 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~-~~~l~LVmE 753 (958)
.|++.+.||+|+||.||++++ +++.||||++............+.+|++++++++|+||+++++.+.. ...+|++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 488999999999999999976 57889999987665555556678999999999999999999998764 445899999
Q ss_pred ecCCCCHHHHHhCCC-CCccHHHHHHH-HHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc
Q 002160 754 FLPRGSLFRILHRPH-CQVDEKRRIKM-ALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 754 y~~gGsL~d~L~k~~-~~~~e~~~l~i-a~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~ 831 (958)
|+++++|.+++.... ....+...+.+ .+.+.++.+||..+ |+||||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM 158 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecCCcEEEecccceEEecccCCc
Confidence 999999999887532 23444444444 44489999999988 999999999999999999999999999876443333
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHh
Q 002160 832 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 911 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~C 911 (958)
.....+++.|+|||++.+..++.++||||||+++|+|++|+.||...+.......+. .......+..+++.+.+||.+|
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~ 237 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII-EGKLPPMPKDYSPELGELIATM 237 (257)
T ss_pred cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-hcCCCCCccccCHHHHHHHHHH
Confidence 345668999999999999999999999999999999999999998877655544442 2333456677899999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 002160 912 WQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 912 L~kDP~kRPSa~EIL~~ 928 (958)
|+.+|.+||++.+++++
T Consensus 238 l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 238 LSKRPEKRPSVKSILRQ 254 (257)
T ss_pred hccCcccCCCHHHHhcC
Confidence 99999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=323.41 Aligned_cols=255 Identities=25% Similarity=0.472 Sum_probs=208.8
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
++|++.+.||+|+||.||+|.. +++.||+|.+..... .......+.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5799999999999999999987 688999998875433 3334667899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhC---CCCCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 753 EFLPRGSLFRILHR---PHCQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 753 Ey~~gGsL~d~L~k---~~~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
||+++++|..++.. ......+..... +.+.+.||.|||..+ |+||||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 99999999998853 223344444444 444489999999988 999999999999999999999999998765443
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--hhHHHHhhhccccccCCCC-CCcHHHH
Q 002160 829 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN--PMQVVGAVGFQNRRLEIPK-ELDPLVA 905 (958)
Q Consensus 829 ~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~--~~ei~~~i~~~~~~~~ip~-~ls~eL~ 905 (958)
........++..|+|||.+.+..++.++||||||+++|+|++|+.||.... ..+....+. ......++. .++..+.
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 238 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-KCDYPPLPADHYSEELR 238 (267)
T ss_pred CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhh-cCCCCCCChhhcCHHHH
Confidence 333344568899999999999889999999999999999999999996543 223333332 222333444 6788999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 002160 906 RIIWECWQTDPSLRPSFAQLTVALKPLQ 933 (958)
Q Consensus 906 dLI~~CL~kDP~kRPSa~EIL~~L~kL~ 933 (958)
++|.+||..+|.+||++.+|++.|+.++
T Consensus 239 ~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 239 DLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=353.97 Aligned_cols=248 Identities=19% Similarity=0.220 Sum_probs=190.3
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCC------CceeEEecccc
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH------PNVVLFMGAVT 743 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~H------PNIVkL~g~~~ 743 (958)
++...+|++.++||+|+||+||+|.+ +++.||||++.... .....+..|+++++.++| .+|++++++|.
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34557899999999999999999976 67889999986432 223345677888877754 45889999887
Q ss_pred CC-CceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHh-cCCcEeecCCCCCceEEcCCC---------
Q 002160 744 RP-PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHT-STPTIVHRDLKSPNLLVDKNW--------- 812 (958)
Q Consensus 744 ~~-~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~-~g~gIIHRDLKPeNILId~~g--------- 812 (958)
.. ..++||||++ +++|.+++.+.+.......+..+.+++.||.|||. .+ ||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCccccccccc
Confidence 64 4688999988 77899888766554444555555566999999997 46 99999999999998765
Q ss_pred -------cEEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 002160 813 -------NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVG 885 (958)
Q Consensus 813 -------~VKL~DFGLAk~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~ 885 (958)
.+||+|||++..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+...
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 355 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355 (467)
T ss_pred ccCCCCceEEECCCCccccCcc---ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 499999998864322 2345789999999999999999999999999999999999999998877654433
Q ss_pred hhhccccc-------------------------cCC-C--------------CCCcHHHHHHHHHhhhcCCCCCCCHHHH
Q 002160 886 AVGFQNRR-------------------------LEI-P--------------KELDPLVARIIWECWQTDPSLRPSFAQL 925 (958)
Q Consensus 886 ~i~~~~~~-------------------------~~i-p--------------~~ls~eL~dLI~~CL~kDP~kRPSa~EI 925 (958)
.+...... +.. + ...++.+.+||.+||+.||.+||+++|+
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 22110000 000 0 0124567899999999999999999999
Q ss_pred HHH
Q 002160 926 TVA 928 (958)
Q Consensus 926 L~~ 928 (958)
++|
T Consensus 436 L~H 438 (467)
T PTZ00284 436 TTH 438 (467)
T ss_pred hcC
Confidence 985
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=323.45 Aligned_cols=250 Identities=23% Similarity=0.365 Sum_probs=212.3
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEee
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
+|++.+.||.|+||.||.++. +++.+++|.+...........++.+|++++++++|+||+++++++.+.+.++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588999999999999998875 688999999877766666677889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhCC-CCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 755 LPRGSLFRILHRP-HCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 755 ~~gGsL~d~L~k~-~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
+++++|.+++.+. .....+.....++ +.+.+|.|||..+ ++||||||+||++++++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~ 158 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA 158 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCCCCEEECcCcceEEcccccccc
Confidence 9999999999764 3334444444444 4489999999988 9999999999999999999999999998764433233
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhh
Q 002160 833 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 912 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL 912 (958)
....|+..|+|||++.+..++.++||||||+++|+|++|..||...+..+....+.. ......+..++.++.++|.+||
T Consensus 159 ~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l 237 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ-GNYTPVVSVYSSELISLVHSLL 237 (256)
T ss_pred cccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc-CCCCCCccccCHHHHHHHHHHc
Confidence 456789999999999988889999999999999999999999988777776666543 2233445678899999999999
Q ss_pred hcCCCCCCCHHHHHHHH
Q 002160 913 QTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 913 ~kDP~kRPSa~EIL~~L 929 (958)
+.+|.+||++.++++++
T Consensus 238 ~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 238 QQDPEKRPTADEVLDQP 254 (256)
T ss_pred ccCcccCCCHHHHhhCc
Confidence 99999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=330.15 Aligned_cols=251 Identities=29% Similarity=0.431 Sum_probs=201.2
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
..+|++.+.||+|+||.||+|++ +++.||+|++..... .....+.+|+.++++++||||+++++++...+.+++||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 46799999999999999999986 678899998865432 23446788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
||+++++|.+++.+..............+.+.||.|||..+ |+||||||+||+++.++.+||+|||++..........
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06646 86 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR 163 (267)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEECcCccceeeccccccc
Confidence 99999999999876554433444444445589999999988 9999999999999999999999999998664333333
Q ss_pred CCCCCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccc---cCCCCCCcHHHHH
Q 002160 833 KSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR---LEIPKELDPLVAR 906 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~---g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~---~~ip~~ls~eL~d 906 (958)
....|+..|+|||.+. ...++.++|||||||++|+|++|+.||....+.+....+...... ...+..++..+.+
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHN 243 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHH
Confidence 4457889999999985 344678999999999999999999999766544333222111111 1112356889999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHH
Q 002160 907 IIWECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 907 LI~~CL~kDP~kRPSa~EIL~~L 929 (958)
||.+||+.+|++||++++|+++|
T Consensus 244 li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 244 FVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHHHHhhCChhhCcCHHHHhcCC
Confidence 99999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=334.17 Aligned_cols=255 Identities=29% Similarity=0.496 Sum_probs=208.5
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEEC-------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~~-------g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~ 745 (958)
+...+|++.+.||+|+||.||+|++. +..||||++.... .......+.+|+.++..++||||+++++++...
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 45567888999999999999999763 3679999886543 333456788999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhCCC---------------CCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEc
Q 002160 746 PNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVD 809 (958)
Q Consensus 746 ~~l~LVmEy~~gGsL~d~L~k~~---------------~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId 809 (958)
...++++||+.+++|.+++.... ....+..... +.+.+.||.|||.++ |+||||||+|||++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~ 158 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVF 158 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEec
Confidence 99999999999999999885321 1233333333 344489999999988 99999999999999
Q ss_pred CCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHh
Q 002160 810 KNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGA 886 (958)
Q Consensus 810 ~~g~VKL~DFGLAk~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~ 886 (958)
+++.+||+|||+++....... ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+....
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 999999999999886533221 1123345779999999988889999999999999999998 8899998887777766
Q ss_pred hhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 002160 887 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 931 (958)
Q Consensus 887 i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~k 931 (958)
+. ......++..++..+.+|+.+||+.+|.+||++++|+..|+.
T Consensus 239 i~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 239 IR-NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HH-cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 64 333445677899999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=345.29 Aligned_cols=243 Identities=23% Similarity=0.365 Sum_probs=199.8
Q ss_pred EEeeccCceEEEEEEE--CCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCceEEEEeecCC
Q 002160 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (958)
Q Consensus 682 k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~l~LVmEy~~g 757 (958)
+.||+|+||.||+|+. +++.||||++.+.... ......+.+|+.++.++ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999976 6788999998765432 33456688999999998 699999999999999999999999999
Q ss_pred CCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCCC
Q 002160 758 GSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 837 (958)
Q Consensus 758 GsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~G 837 (958)
|+|..++.+.........+.++.+++.||+|||.++ |+||||||+|||++.++.+||+|||+++............+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccC
Confidence 999998876655555555555666699999999988 999999999999999999999999998754332233345679
Q ss_pred CCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------hhH-HHHhhhccccccCCCCCCcHHHHHHHHH
Q 002160 838 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN------PMQ-VVGAVGFQNRRLEIPKELDPLVARIIWE 910 (958)
Q Consensus 838 T~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~------~~e-i~~~i~~~~~~~~ip~~ls~eL~dLI~~ 910 (958)
|+.|+|||++.+..++.++|||||||++|+|++|+.||.... ..+ ....+ ......+|..++..+.++|.+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~p~~~~~~~~~li~~ 236 (327)
T cd05617 159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--LEKPIRIPRFLSVKASHVLKG 236 (327)
T ss_pred CcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH--HhCCCCCCCCCCHHHHHHHHH
Confidence 999999999999999999999999999999999999996421 112 22222 234556788899999999999
Q ss_pred hhhcCCCCCCC------HHHHHHH
Q 002160 911 CWQTDPSLRPS------FAQLTVA 928 (958)
Q Consensus 911 CL~kDP~kRPS------a~EIL~~ 928 (958)
||+.||.+|++ +.+|+.|
T Consensus 237 ~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 237 FLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HhccCHHHcCCCCCCCCHHHHHcC
Confidence 99999999997 4677665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=329.67 Aligned_cols=255 Identities=29% Similarity=0.470 Sum_probs=207.7
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEEC-------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~~-------g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~ 744 (958)
++..++|.+.+.||+|+||.||+|.+. +..||+|.+.... .......+.+|+.++++++|+||+++++++.+
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred CCCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 355678999999999999999999874 3568888765432 33445678899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhCCCC------CccHHHHHHHHH-HHHHHHHHHhcCCcEeecCCCCCceEEcCCC---cE
Q 002160 745 PPNLSIITEFLPRGSLFRILHRPHC------QVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDLKSPNLLVDKNW---NV 814 (958)
Q Consensus 745 ~~~l~LVmEy~~gGsL~d~L~k~~~------~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDLKPeNILId~~g---~V 814 (958)
....++||||+++++|.+++.+... ...+...+.++. ++.||+|||..+ ++||||||+|||++.++ .+
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcce
Confidence 8999999999999999999865432 344455544444 489999999988 99999999999998654 69
Q ss_pred EEEeccccccccCCccc--CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccc
Q 002160 815 KVSDFGLSRLKHNTFLS--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQN 891 (958)
Q Consensus 815 KL~DFGLAk~~~~~~~~--~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~ 891 (958)
||+|||+++........ ......+..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+. ..
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~-~~ 237 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT-GG 237 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cC
Confidence 99999999865332111 112233568999999999889999999999999999997 999999887776665543 34
Q ss_pred cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002160 892 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 930 (958)
Q Consensus 892 ~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~ 930 (958)
.+...+..++..+.+||.+||+.+|++||++.+|+++|.
T Consensus 238 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 238 GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 456667788999999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=329.56 Aligned_cols=249 Identities=34% Similarity=0.472 Sum_probs=200.7
Q ss_pred eeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeec
Q 002160 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~ 755 (958)
|++++.||+|+||.||+++. +++.||+|++..............+|+.++++++||||+++++++.....+++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 78999999999999999988 5667999999887655554445567999999999999999999999999999999999
Q ss_pred CCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCC
Q 002160 756 PRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 835 (958)
Q Consensus 756 ~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~ 835 (958)
++++|.+++.+............+.+.+.||.+||+++ |+|+||||+|||+++++.++|+|||++.............
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 158 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPF 158 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSS
T ss_pred cccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccc
Confidence 99999999984443434444444445599999999998 9999999999999999999999999987543333334556
Q ss_pred CCCCCccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh---HHHHhhhccccccCC--CCCCcHHHHHHHH
Q 002160 836 AGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGFQNRRLEI--PKELDPLVARIIW 909 (958)
Q Consensus 836 ~GT~~Y~APEvl~-g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~---ei~~~i~~~~~~~~i--p~~ls~eL~dLI~ 909 (958)
.++..|+|||++. +..++.++||||||+++|+|++|..||...+.. ............... .......+.+||.
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 238 (260)
T PF00069_consen 159 VGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIK 238 (260)
T ss_dssp SSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHH
Confidence 7899999999998 888899999999999999999999999987322 222222111111111 1223489999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 002160 910 ECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 910 ~CL~kDP~kRPSa~EIL~~ 928 (958)
+||+.||.+||++.+++++
T Consensus 239 ~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 239 KMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHSSSSGGGSTTHHHHHTS
T ss_pred HHccCChhHCcCHHHHhcC
Confidence 9999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=334.57 Aligned_cols=241 Identities=25% Similarity=0.364 Sum_probs=195.8
Q ss_pred eeccCceEEEEEEE--CCcEEEEEEeecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeecCCCCH
Q 002160 684 IGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 760 (958)
Q Consensus 684 LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~gGsL 760 (958)
||+|+||+||++++ +++.||||++....... .....+..|+++++.++|+||+++++++.....+|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999976 68899999987654322 2345678899999999999999999999999999999999999999
Q ss_pred HHHHhC---CCCCccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCC
Q 002160 761 FRILHR---PHCQVDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 836 (958)
Q Consensus 761 ~d~L~k---~~~~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~ 836 (958)
..++.. ......+.... ++.+++.||.|||+++ |+||||||+|||++.++.+||+|||++..............
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence 887743 22233444444 4445599999999988 99999999999999999999999999976544333334567
Q ss_pred CCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh----HHHHhhhccccccCCCCCCcHHHHHHHHHhh
Q 002160 837 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM----QVVGAVGFQNRRLEIPKELDPLVARIIWECW 912 (958)
Q Consensus 837 GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~----ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL 912 (958)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...... +....+ ......++..++..+.+|+.+||
T Consensus 159 g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l 236 (280)
T cd05608 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI--LNDSVTYPDKFSPASKSFCEALL 236 (280)
T ss_pred CCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh--cccCCCCcccCCHHHHHHHHHHh
Confidence 999999999999999999999999999999999999999765432 222222 12234566778999999999999
Q ss_pred hcCCCCCC-----CHHHHHHH
Q 002160 913 QTDPSLRP-----SFAQLTVA 928 (958)
Q Consensus 913 ~kDP~kRP-----Sa~EIL~~ 928 (958)
+.||.+|| ++++++.|
T Consensus 237 ~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 237 AKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHhcCCCCCCHHHHhcC
Confidence 99999999 67888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=341.59 Aligned_cols=251 Identities=21% Similarity=0.348 Sum_probs=203.1
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
++|++.+.||+|+||.||+++. +++.||||++.+... .......+.+|+.+++.++|+||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4799999999999999999986 578999999875332 2334556889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCC-CccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc-
Q 002160 753 EFLPRGSLFRILHRPHC-QVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 830 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~-~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~- 830 (958)
||+++|+|.+++.+... ......+.++.+++.||+|||.++ |+||||||+|||++.++++||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 99999999999976443 334445555556699999999998 99999999999999999999999999876543222
Q ss_pred cCCCCCCCCCccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCC---CCCcH
Q 002160 831 SSKSTAGTPEWMAPEVLRN-----EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP---KELDP 902 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g-----~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip---~~ls~ 902 (958)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+........++ ..++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 238 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSE 238 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCH
Confidence 2223469999999999973 446789999999999999999999999887777666654333333333 34789
Q ss_pred HHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 002160 903 LVARIIWECWQTDPSL--RPSFAQLTVA 928 (958)
Q Consensus 903 eL~dLI~~CL~kDP~k--RPSa~EIL~~ 928 (958)
.+++||.+||..++.+ |+++.+++.|
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 239 EAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9999999988654443 7899999988
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=334.07 Aligned_cols=262 Identities=31% Similarity=0.522 Sum_probs=214.8
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEE---------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEe
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADW---------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFM 739 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~---------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~ 739 (958)
.+++...+|.+.+.||+|+||.||+|++ .+..||+|.+... ........+.+|+.+++.+ +||||++++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchhee
Confidence 4567778999999999999999999974 2346899987643 2334566789999999999 899999999
Q ss_pred ccccCCCceEEEEeecCCCCHHHHHhCCCC---------------CccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCC
Q 002160 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHC---------------QVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKS 803 (958)
Q Consensus 740 g~~~~~~~l~LVmEy~~gGsL~d~L~k~~~---------------~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKP 803 (958)
+++.....+|+||||+++++|.+++.+... .......+.++ +++.||.|||.++ |+||||||
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp 165 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAA 165 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeeccccc
Confidence 999999999999999999999999875421 12233333333 4499999999988 99999999
Q ss_pred CceEEcCCCcEEEEeccccccccCCccc--CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 002160 804 PNLLVDKNWNVKVSDFGLSRLKHNTFLS--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNP 880 (958)
Q Consensus 804 eNILId~~g~VKL~DFGLAk~~~~~~~~--~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~ 880 (958)
+|||++.++.+||+|||+++........ .....++..|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 9999999999999999999866432211 122345678999999999889999999999999999998 8899988877
Q ss_pred hHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 881 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 881 ~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
.++...+. ...+...+..++..+++||.+||+.+|.+||++.+|++.|+++...
T Consensus 246 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 246 EELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 77766653 3344556778899999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=325.67 Aligned_cols=253 Identities=34% Similarity=0.580 Sum_probs=208.4
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE-CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEE
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~L 750 (958)
++..++|++.++||+|+||.||+|.+ .+..||+|.+...... ...+.+|+.++++++|+||+++++++.. ...++
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~l 77 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYI 77 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEE
Confidence 45678899999999999999999986 5667999988765443 3468899999999999999999998854 56899
Q ss_pred EEeecCCCCHHHHHhCCC-CCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 751 ITEFLPRGSLFRILHRPH-CQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 751 VmEy~~gGsL~d~L~k~~-~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
+|||+++++|.+++.... ....+.....++ +.+.||.|||..+ |+||||||+||++++++.+||+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 999999999999987533 234444444444 4489999999988 999999999999999999999999999765432
Q ss_pred cc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHH
Q 002160 829 FL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 906 (958)
Q Consensus 829 ~~-~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~d 906 (958)
.. ......++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+. .......+...+..+++
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRMPCPQDCPISLHE 234 (260)
T ss_pred ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHHH
Confidence 21 1122335668999999998889999999999999999999 899998887776666554 33445567788999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHh
Q 002160 907 IIWECWQTDPSLRPSFAQLTVALKP 931 (958)
Q Consensus 907 LI~~CL~kDP~kRPSa~EIL~~L~k 931 (958)
||.+||.++|.+||++.++...|++
T Consensus 235 li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 235 LMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHcccCcccCcCHHHHHHHHhc
Confidence 9999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=321.76 Aligned_cols=245 Identities=34% Similarity=0.581 Sum_probs=208.3
Q ss_pred EEeeccCceEEEEEEEC-----CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeecC
Q 002160 682 ERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 756 (958)
Q Consensus 682 k~LG~G~fG~Vykak~~-----g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~ 756 (958)
+.||+|+||.||+|.+. +..|+||.+....... ....+.+|+++++.++|+||+++++++.....+++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 36999999999999874 7789999887654333 56788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhCC--------CCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 757 RGSLFRILHRP--------HCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 757 gGsL~d~L~k~--------~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
+++|.+++... .....+.....++ +.+.||.|||.++ |+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999999875 2444555454444 4489999999988 99999999999999999999999999987654
Q ss_pred Cc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHH
Q 002160 828 TF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 904 (958)
Q Consensus 828 ~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL 904 (958)
.. .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.. ......+..++.++
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRLPKPEYCPDEL 236 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCccCChHH
Confidence 32 22334567889999999998889999999999999999999 6999999887777776653 44566778889999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002160 905 ARIIWECWQTDPSLRPSFAQLTVALK 930 (958)
Q Consensus 905 ~dLI~~CL~kDP~kRPSa~EIL~~L~ 930 (958)
.++|.+||+.+|.+||++.+++++|+
T Consensus 237 ~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 237 YELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHHHccCCcccCcCHHHHHHhhC
Confidence 99999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=336.49 Aligned_cols=259 Identities=31% Similarity=0.572 Sum_probs=208.9
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE--CCcE--EEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCC
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTE--VAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP 746 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~--VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~ 746 (958)
.+.+++|++.+.||+|+||.||+|.+ ++.. +|+|.+... ........+.+|+.++.++ +|+||+++++++...+
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 36678999999999999999999986 4443 577765432 2344556788999999999 8999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhCCCC---------------CccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEcC
Q 002160 747 NLSIITEFLPRGSLFRILHRPHC---------------QVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVDK 810 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~---------------~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~ 810 (958)
.+|+||||+++++|.+++.+... .+.+...+. +.+++.||+|||..+ |+||||||+|||++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~~ 159 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGE 159 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEecC
Confidence 99999999999999999975431 233444444 444589999999988 999999999999999
Q ss_pred CCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhc
Q 002160 811 NWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGF 889 (958)
Q Consensus 811 ~g~VKL~DFGLAk~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~ 889 (958)
++.+||+|||++...... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 160 ~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~- 237 (303)
T cd05088 160 NYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP- 237 (303)
T ss_pred CCcEEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh-
Confidence 999999999998643211 11122334668999999988889999999999999999998 999998877766665553
Q ss_pred cccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 890 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 890 ~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
....+..+..+++.+.+||.+||+.+|++||++.+++..|.++...
T Consensus 238 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 238 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 2234455667889999999999999999999999999999887443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=348.19 Aligned_cols=249 Identities=24% Similarity=0.379 Sum_probs=200.9
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC-----ceE
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP-----NLS 749 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~-----~l~ 749 (958)
+|++++.||+|+||.||++.. +++.||||++...........++.+|+.+|+.++|+||+++++++...+ .+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 578899999999999999985 7899999988654434445567889999999999999999999998776 789
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~ 829 (958)
+||||+. ++|.+++...........+.++.+++.||.|||..+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE 157 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence 9999996 578888766555555555555666699999999998 9999999999999999999999999998653321
Q ss_pred -ccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcc-----------------
Q 002160 830 -LSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ----------------- 890 (958)
Q Consensus 830 -~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~----------------- 890 (958)
.......+++.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....+...
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 122334688999999999874 4789999999999999999999999887765544332110
Q ss_pred -------ccc------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 891 -------NRR------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 891 -------~~~------~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
... ..+....++++.+||.+||+.||.+||++.|++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000 02234568899999999999999999999999976
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=329.64 Aligned_cols=258 Identities=26% Similarity=0.461 Sum_probs=208.8
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCc----EEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~----~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~ 746 (958)
+...+|++.+.||+|+||.||+|.+ +++ .|++|.+... .......++..|+.++++++||||+++++++.. .
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~ 81 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-A 81 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-C
Confidence 3446889999999999999999987 444 4777776432 223345678889999999999999999998764 5
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
..++++||+++|+|.+++.+......+.....++ +.+.||.|||..+ ++||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEEcCCccceec
Confidence 6789999999999999997655555555555444 4489999999988 999999999999999999999999999865
Q ss_pred cCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcH
Q 002160 826 HNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 902 (958)
Q Consensus 826 ~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~ 902 (958)
.... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+. .......+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-KGERLAQPQICTI 238 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCcCCCCCCCCH
Confidence 3321 12233456778999999998889999999999999999998 999998887665544442 3444555667888
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 903 LVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 903 eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
.+.+++.+||..||.+||++.|+++.|..+.+.
T Consensus 239 ~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 239 DVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=330.60 Aligned_cols=258 Identities=30% Similarity=0.482 Sum_probs=209.1
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEEC-------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~~-------g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~ 744 (958)
++..++|++.+.||+|+||.||+|... +..||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 466789999999999999999999642 3479999875443 23334567889999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhCCCC---------CccHH-HHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcE
Q 002160 745 PPNLSIITEFLPRGSLFRILHRPHC---------QVDEK-RRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNV 814 (958)
Q Consensus 745 ~~~l~LVmEy~~gGsL~d~L~k~~~---------~~~e~-~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~V 814 (958)
.+..++||||+++|+|.+++.+... ..... ......+.+.||.|||.++ |+||||||+|||++.++.+
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCCCcE
Confidence 9999999999999999999964321 11222 2333445589999999988 9999999999999999999
Q ss_pred EEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccc
Q 002160 815 KVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQN 891 (958)
Q Consensus 815 KL~DFGLAk~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~ 891 (958)
||+|||+++....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+. ..
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~ 237 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM-DG 237 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cC
Confidence 9999999876533221 1122345678999999998889999999999999999998 789998887776665553 33
Q ss_pred cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 002160 892 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 933 (958)
Q Consensus 892 ~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~ 933 (958)
.....+..+++.++++|.+||+.||.+||++.++++.|++..
T Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 238 GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 445566778899999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=344.01 Aligned_cols=249 Identities=24% Similarity=0.293 Sum_probs=195.7
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC------
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------ 746 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~------ 746 (958)
.++|++.+.||+|+||.||++++ +++.||||++............+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 47899999999999999999976 6889999998765444455667889999999999999999999886543
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
.+|+||||+++ +|.+.+... .........+.+.+.||.|||.++ |+||||||+|||++.++.+||+|||+++...
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHME--LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhcc--CCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 47999999965 566665432 223333444455599999999998 9999999999999999999999999997653
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcc----------------
Q 002160 827 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---------------- 890 (958)
Q Consensus 827 ~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~---------------- 890 (958)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 175 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (359)
T cd07876 175 TN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253 (359)
T ss_pred cC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence 32 2233457899999999999999999999999999999999999999876643322111000
Q ss_pred ----cccc--------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002160 891 ----NRRL--------------------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 891 ----~~~~--------------------~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L 929 (958)
.... ......+.++++||.+||+.||++||++.|++.|-
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 0000 01122467899999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=335.37 Aligned_cols=262 Identities=30% Similarity=0.535 Sum_probs=213.7
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEE---------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEe
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADW---------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFM 739 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~---------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~ 739 (958)
.+++.+++|.+++.||+|+||.||+|++ ....||+|.+.... .......+..|+++++++ +||||++++
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLL 84 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence 3567778999999999999999999975 23468999876543 344566788999999999 699999999
Q ss_pred ccccCCCceEEEEeecCCCCHHHHHhCCC---------------CCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCC
Q 002160 740 GAVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKS 803 (958)
Q Consensus 740 g~~~~~~~l~LVmEy~~gGsL~d~L~k~~---------------~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKP 803 (958)
+++.....+|++|||+++|+|.+++.... ....+..... ..+.+.||.|||.++ |+||||||
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp 162 (314)
T cd05099 85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAA 162 (314)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccc
Confidence 99999899999999999999999986532 1233333343 344489999999988 99999999
Q ss_pred CceEEcCCCcEEEEeccccccccCCcccC--CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 002160 804 PNLLVDKNWNVKVSDFGLSRLKHNTFLSS--KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNP 880 (958)
Q Consensus 804 eNILId~~g~VKL~DFGLAk~~~~~~~~~--~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~ 880 (958)
+|||++.++.+||+|||+++......... ....++..|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999998654322111 12234467999999999889999999999999999999 8999988877
Q ss_pred hHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 881 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 881 ~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
.+....+. .......+..++.++++||.+||+.+|.+||++.++++.|.++...
T Consensus 243 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 243 EELFKLLR-EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 76666654 3334556778899999999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=330.50 Aligned_cols=254 Identities=31% Similarity=0.535 Sum_probs=208.0
Q ss_pred CeeEEEEeeccCceEEEEEEEC-------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceE
Q 002160 677 DLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~~-------g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~ 749 (958)
+|++.+.||+|+||.||+|... ...+++|.+.... .......+.+|+.+++.++||||+++++.+...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 4778899999999999999763 2468888776443 3344567899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhCCC-----------------------CCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCc
Q 002160 750 IITEFLPRGSLFRILHRPH-----------------------CQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPN 805 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~-----------------------~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeN 805 (958)
++|||+.+++|.+++.... ....+...+.++.+ +.||.|||.++ |+||||||+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~n 157 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARN 157 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhhhe
Confidence 9999999999999886421 12334444444444 89999999988 9999999999
Q ss_pred eEEcCCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhH
Q 002160 806 LLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQ 882 (958)
Q Consensus 806 ILId~~g~VKL~DFGLAk~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~e 882 (958)
||+++++.+||+|||+++....... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.+..+.+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999876432211 1222345678999999998889999999999999999998 999999888777
Q ss_pred HHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhh
Q 002160 883 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934 (958)
Q Consensus 883 i~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k 934 (958)
+...+. .......+..++.++.+||.+||+.+|.+||++.+|++.|+++..
T Consensus 238 ~~~~~~-~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 LFNLLK-TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHh-CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 666553 233455677889999999999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=336.75 Aligned_cols=250 Identities=22% Similarity=0.290 Sum_probs=198.7
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
.++|.+.+.||+|+||.||+|+. +++.||||++...... .....+.+|+.++++++||||+++++++..++.+++||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 46799999999999999999976 6788999988654322 22345678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~ 831 (958)
||+++ +|..++...+......... .+.+.+.||.|||.++ |+||||||+|||++.++.+||+|||+++........
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 99975 8888876655444444444 4445599999999988 999999999999999999999999999765443333
Q ss_pred CCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccc-----------------cc
Q 002160 832 SKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-----------------RR 893 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~-----------------~~ 893 (958)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.... ..
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 344568999999999875 457899999999999999999999998876544332221000 00
Q ss_pred cC-----------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 894 LE-----------IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 894 ~~-----------ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.. ....+++++++||.+||+.||.+||++.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 00 112468899999999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=324.11 Aligned_cols=256 Identities=30% Similarity=0.493 Sum_probs=209.4
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCc---EEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGT---EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~---~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~ 747 (958)
|..++|+..+.||+|+||.||+|+. ++. .+|||++.... .......+..|++++++++|+||+++++++...+.
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 4456889999999999999999976 233 68999875442 33445678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHH-HHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
.|+||||+++++|.+++.+......+.....++. .+.|+.|||..+ |+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999999999976544445554444444 489999999988 9999999999999999999999999987654
Q ss_pred CCcccC---CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcH
Q 002160 827 NTFLSS---KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 902 (958)
Q Consensus 827 ~~~~~~---~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~ 902 (958)
...... .....+..|+|||++.+..++.++|||||||++|||++ |+.||...+..+....+.. ......+..++.
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~ 237 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND-GFRLPAPMDCPS 237 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc-CCCCCCCCCCCH
Confidence 322111 11223457999999998889999999999999999997 9999988777666666542 234444567889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 002160 903 LVARIIWECWQTDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 903 eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL 932 (958)
.+.+||.+||+.+|.+||++.+|++.|+++
T Consensus 238 ~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 238 AVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=330.49 Aligned_cols=254 Identities=32% Similarity=0.530 Sum_probs=208.7
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE-------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~ 745 (958)
|++.+|.+.++||+|+||.||+++. ++..+|+|.+... .......+.+|+++++.++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 5678899999999999999999963 3557889986543 344456899999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhCCCC--------------CccHHHHHHH-HHHHHHHHHHHhcCCcEeecCCCCCceEEcC
Q 002160 746 PNLSIITEFLPRGSLFRILHRPHC--------------QVDEKRRIKM-ALDARGMNCLHTSTPTIVHRDLKSPNLLVDK 810 (958)
Q Consensus 746 ~~l~LVmEy~~gGsL~d~L~k~~~--------------~~~e~~~l~i-a~~a~aL~yLH~~g~gIIHRDLKPeNILId~ 810 (958)
...+++|||+++++|.+++..... ...+...+.+ .+++.|++|||..+ |+||||||+|||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~~ 157 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQ 157 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEcC
Confidence 999999999999999999875431 2334444444 44489999999988 999999999999999
Q ss_pred CCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhh
Q 002160 811 NWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAV 887 (958)
Q Consensus 811 ~g~VKL~DFGLAk~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i 887 (958)
++.+||+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||......+....+
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 99999999999875532211 1122335678999999999999999999999999999998 99999887776666555
Q ss_pred hccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 002160 888 GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 931 (958)
Q Consensus 888 ~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~k 931 (958)
. .......+..+++.+.+||.+||+.||.+||++.+|++.|++
T Consensus 238 ~-~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 238 T-QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred H-cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 4 333455667889999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=351.81 Aligned_cols=262 Identities=32% Similarity=0.471 Sum_probs=213.2
Q ss_pred cccccCCCCeeEEEEeeccCceEEEEEEEC-------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEec
Q 002160 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMG 740 (958)
Q Consensus 669 ~~~eI~~~dy~i~k~LG~G~fG~Vykak~~-------g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~-HPNIVkL~g 740 (958)
..+++..++|.+++.||+|+||.||+|++. ++.||||++..... ......+.+|+++|.++. |||||++++
T Consensus 30 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 30 SAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred CcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 457788899999999999999999999863 35799999875432 333457889999999997 999999999
Q ss_pred cccCCCceEEEEeecCCCCHHHHHhCCCC---------------------------------------------------
Q 002160 741 AVTRPPNLSIITEFLPRGSLFRILHRPHC--------------------------------------------------- 769 (958)
Q Consensus 741 ~~~~~~~l~LVmEy~~gGsL~d~L~k~~~--------------------------------------------------- 769 (958)
+|......++||||+++|+|.+++++...
T Consensus 109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 99999999999999999999999975421
Q ss_pred ----------------------------------------------CccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCC
Q 002160 770 ----------------------------------------------QVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLK 802 (958)
Q Consensus 770 ----------------------------------------------~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLK 802 (958)
.+.+...+.++ +++.||.|||..+ |+|||||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlk 266 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLA 266 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCC
Confidence 11222223333 4489999999887 9999999
Q ss_pred CCceEEcCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 002160 803 SPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMN 879 (958)
Q Consensus 803 PeNILId~~g~VKL~DFGLAk~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~ 879 (958)
|+|||+++++.+||+|||+++...... .......++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999999999998643221 11223457889999999998889999999999999999998 899998765
Q ss_pred hhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 002160 880 PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 933 (958)
Q Consensus 880 ~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~ 933 (958)
..+..........++..|..++.++.+||.+||..+|.+||++.+|+..|+++.
T Consensus 347 ~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 347 MNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred chHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 555443333344456677788999999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=324.20 Aligned_cols=247 Identities=29% Similarity=0.482 Sum_probs=202.5
Q ss_pred EEeeccCceEEEEEEE--C---CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeecC
Q 002160 682 ERIGLGSYGEVYHADW--N---GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 756 (958)
Q Consensus 682 k~LG~G~fG~Vykak~--~---g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~ 756 (958)
++||+|+||.||+|++ . +..||+|.+...... ....++.+|+++++++.|+|||++++++. ...+++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 3699999999999976 2 267999988765543 44567899999999999999999999876 456899999999
Q ss_pred CCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC---C
Q 002160 757 RGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS---K 833 (958)
Q Consensus 757 gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~---~ 833 (958)
+++|.+++.+............+.+.+.+|.|||..+ |+||||||+|||++.++.+||+|||+++......... .
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 79 LGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 9999999987664433444444445599999999988 9999999999999999999999999998654322111 1
Q ss_pred CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhh
Q 002160 834 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 912 (958)
Q Consensus 834 s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL 912 (958)
...++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+. .......+..++..+++||.+||
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl 235 (257)
T cd05060 157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-SGERLPRPEECPQEIYSIMLSCW 235 (257)
T ss_pred CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHh
Confidence 1223467999999999889999999999999999997 999998887776665553 33445667788999999999999
Q ss_pred hcCCCCCCCHHHHHHHHHhhh
Q 002160 913 QTDPSLRPSFAQLTVALKPLQ 933 (958)
Q Consensus 913 ~kDP~kRPSa~EIL~~L~kL~ 933 (958)
..+|.+||++.+|++.|+++.
T Consensus 236 ~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 236 KYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred cCChhhCcCHHHHHHHHHhcc
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=322.03 Aligned_cols=254 Identities=32% Similarity=0.565 Sum_probs=210.4
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE-CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEE
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~L 750 (958)
++..++|++.+.||+|+||.||+|.+ .+..||||.+...... ..++.+|+.++++++|+||+++++++......++
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 46778999999999999999999976 4567999988765433 3568899999999999999999999998889999
Q ss_pred EEeecCCCCHHHHHhCCC-CCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 751 ITEFLPRGSLFRILHRPH-CQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 751 VmEy~~gGsL~d~L~k~~-~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
||||+++++|.+++.+.. ....+..... +.+.+.|+.|||..+ |+|+||||+||+|+.++.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCCCCEEECccccceeccch
Confidence 999999999999997643 2344444444 444589999999988 999999999999999999999999998765432
Q ss_pred cc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHH
Q 002160 829 FL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 906 (958)
Q Consensus 829 ~~-~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~d 906 (958)
.. ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+.......+. .......+..++.++.+
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 235 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRMPRPPNCPEELYD 235 (261)
T ss_pred hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHH
Confidence 11 1112234568999999999889999999999999999998 999998887766666553 23344556677999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHh
Q 002160 907 IIWECWQTDPSLRPSFAQLTVALKP 931 (958)
Q Consensus 907 LI~~CL~kDP~kRPSa~EIL~~L~k 931 (958)
++.+||+.+|.+||+++++++.|+.
T Consensus 236 ~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 236 LMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHHcccCcccCCCHHHHHHHHhc
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=331.17 Aligned_cols=256 Identities=32% Similarity=0.515 Sum_probs=205.8
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEECC------------------cEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCc
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADWNG------------------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 734 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~~g------------------~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPN 734 (958)
+...+|++++.||+|+||.||+|++.. ..||+|.+.... .......+.+|++++++++|||
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCC
Confidence 356789999999999999999997532 458999876543 3345678899999999999999
Q ss_pred eeEEeccccCCCceEEEEeecCCCCHHHHHhCCCC----------CccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCC
Q 002160 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHC----------QVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKS 803 (958)
Q Consensus 735 IVkL~g~~~~~~~l~LVmEy~~gGsL~d~L~k~~~----------~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKP 803 (958)
|+++++++.....++++|||+++++|.+++.+... ...+...+.++ +.+.||.|||.++ |+||||||
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp 158 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLAT 158 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccch
Confidence 99999999999999999999999999999876541 34444444444 4499999999988 99999999
Q ss_pred CceEEcCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCC
Q 002160 804 PNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT--LKLPWIGMN 879 (958)
Q Consensus 804 eNILId~~g~VKL~DFGLAk~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt--G~~PF~g~~ 879 (958)
+|||++.++.++|+|||+++...... .......++..|+|||++.+..++.++|||||||++|+|++ +..||....
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 99999999999999999987643321 11223446778999999998889999999999999999998 788998776
Q ss_pred hhHHHHhhhcc------ccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 002160 880 PMQVVGAVGFQ------NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 931 (958)
Q Consensus 880 ~~ei~~~i~~~------~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~k 931 (958)
..+........ ......+..++.++.+||.+||+.||.+||++.+|++.|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 66655444211 11122345678999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=324.53 Aligned_cols=259 Identities=31% Similarity=0.530 Sum_probs=212.5
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEEC-----CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~~-----g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~ 746 (958)
++..++|.+.+.||+|+||.||+|.+. ...||||...... .......+.+|+.++++++||||+++++++.+ .
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 456678999999999999999999763 2368999775443 24455688999999999999999999998875 4
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
..++||||+++++|.+++.+......+.....++ +.+.||.|||.++ ++||||||+|||++.++.+||+|||+++..
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecCCCeEEccCceeeec
Confidence 5789999999999999998755445555555554 4499999999988 999999999999999999999999998765
Q ss_pred cCCcc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHH
Q 002160 826 HNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 903 (958)
Q Consensus 826 ~~~~~-~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~e 903 (958)
..... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+. ...+...+..++..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPPT 236 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHH
Confidence 43321 1122334568999999988889999999999999999986 999998887766665553 33455667788999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 904 VARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 904 L~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
+.+||.+||..+|.+||++.++++.|.++...
T Consensus 237 ~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 237 LYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=323.43 Aligned_cols=250 Identities=32% Similarity=0.528 Sum_probs=205.5
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
.++|++.+.||.|+||.||+|.+ +++.+++|.+...... ....+.+|+.++++++||||+++++++.....+|++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 46899999999999999999986 5788999998765432 4578899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~ 831 (958)
||+++++|.+++......+.+.... .+.+.+.||.|||.++ |+|+||||+||+++.++.+||+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK 157 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence 9999999999987763334444444 4444599999999988 999999999999999999999999998876543333
Q ss_pred CCCCCCCCCccCcccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccc---cccCCCCCCcHHHH
Q 002160 832 SKSTAGTPEWMAPEVLRNE---PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---RRLEIPKELDPLVA 905 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~g~---~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~---~~~~ip~~ls~eL~ 905 (958)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+..+....+.... .....+...+.+++
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFH 237 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHH
Confidence 3456788999999999877 78899999999999999999999998877655444332221 11122334678899
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 002160 906 RIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 906 dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+||.+||..+|.+||++.+|+.+
T Consensus 238 ~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 238 DFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred HHHHHHcCCChhhCCCHHHHhcC
Confidence 99999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=325.02 Aligned_cols=255 Identities=32% Similarity=0.534 Sum_probs=208.9
Q ss_pred CCCCeeEEEEeeccCceEEEEEEEC--C---cEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCce
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADWN--G---TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~~--g---~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l 748 (958)
...+|++.+.||+|+||.||+|++. + ..||||.+... .......+|..|+.++++++||||+++++++.....+
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 3467899999999999999999763 3 35999987643 3445567899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
++||||+++++|.+++........+...+.++ +.+.||.|||.++ ++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 99999999999999987654444555444444 4489999999988 99999999999999999999999999876543
Q ss_pred Cccc--CCC-C--CCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCc
Q 002160 828 TFLS--SKS-T--AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 901 (958)
Q Consensus 828 ~~~~--~~s-~--~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls 901 (958)
.... ... . ..+..|+|||.+.+..++.++|||||||++|||++ |..||...+..+....+. .......+..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~ 237 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRLPPPMDCP 237 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCcCCCcccCC
Confidence 2111 011 1 12457999999999889999999999999999886 999998887776666553 333445566789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 002160 902 PLVARIIWECWQTDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 902 ~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL 932 (958)
..+.+++.+||..+|.+||++.+|+..|+++
T Consensus 238 ~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 238 TALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 9999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=324.35 Aligned_cols=245 Identities=26% Similarity=0.462 Sum_probs=201.1
Q ss_pred EeeccCceEEEEEEEC----CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeecCCC
Q 002160 683 RIGLGSYGEVYHADWN----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758 (958)
Q Consensus 683 ~LG~G~fG~Vykak~~----g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~gG 758 (958)
.||+|+||.||+|.+. +..||||++.... .......+.+|+.++++++||||+++++++.. ..+++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence 3899999999999762 4469999876542 34445678999999999999999999998764 5789999999999
Q ss_pred CHHHHHhCCCCCccHHHHHHHHH-HHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc---CCC
Q 002160 759 SLFRILHRPHCQVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS---SKS 834 (958)
Q Consensus 759 sL~d~L~k~~~~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~---~~s 834 (958)
+|.+++........+...+.++. .+.||.|||.++ |+||||||+|||++.++.+||+|||++......... ...
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99999875444455555555444 499999999988 999999999999999999999999999765332211 111
Q ss_pred CCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhh
Q 002160 835 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 913 (958)
Q Consensus 835 ~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~ 913 (958)
..++..|+|||++.+..++.++||||||+++|+|++ |+.||......++...+. ...+..++..+++++.++|.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~c~~ 236 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAECPPEMYALMKDCWI 236 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHcC
Confidence 223578999999998889999999999999999996 999999888776665553 445566778889999999999999
Q ss_pred cCCCCCCCHHHHHHHHHhh
Q 002160 914 TDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 914 kDP~kRPSa~EIL~~L~kL 932 (958)
.+|++||++.+|++.|+.+
T Consensus 237 ~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 237 YKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CChhhCcCHHHHHHHHhhh
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=346.86 Aligned_cols=241 Identities=24% Similarity=0.399 Sum_probs=198.9
Q ss_pred eeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHc---CCCceeEEeccccCCCceEEEEeecCC
Q 002160 684 IGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL---RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (958)
Q Consensus 684 LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L---~HPNIVkL~g~~~~~~~l~LVmEy~~g 757 (958)
||+|+||+||+|++ +++.||||++.+... .......+..|..++.++ +||||+++++++.....+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999976 588999999865432 223344556677777766 699999999999999999999999999
Q ss_pred CCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCCC
Q 002160 758 GSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 837 (958)
Q Consensus 758 GsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~G 837 (958)
|+|.+++.+.+.......+.++.+++.||+|||.++ |+||||||+||||+.++.+||+|||+++............+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccC
Confidence 999999987666666666666667799999999998 999999999999999999999999998764333333445779
Q ss_pred CCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCC-CCcHHHHHHHHHhhhcC
Q 002160 838 TPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK-ELDPLVARIIWECWQTD 915 (958)
Q Consensus 838 T~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~-~ls~eL~dLI~~CL~kD 915 (958)
|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+... ...++. .++.++++||.+||+.|
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~li~~~L~~~ 236 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG--KVRFPKNVLSDEGRQFVKGLLNRN 236 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC--CCCCCCccCCHHHHHHHHHHcCCC
Confidence 9999999999765 4789999999999999999999999998877776666433 233443 57899999999999999
Q ss_pred CCCCC----CHHHHHHH
Q 002160 916 PSLRP----SFAQLTVA 928 (958)
Q Consensus 916 P~kRP----Sa~EIL~~ 928 (958)
|.+|| ++.++++|
T Consensus 237 P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 237 PQHRLGAHRDAVELKEH 253 (330)
T ss_pred HHHCCCCCCCHHHHhcC
Confidence 99998 56777664
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=324.58 Aligned_cols=254 Identities=33% Similarity=0.573 Sum_probs=206.6
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEEC-CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEE
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~~-g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~L 750 (958)
.+..++|++.++||+|+||.||+|++. ...||||++...... ...+.+|++++++++||||+++++++.. ...++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~l 77 (262)
T cd05071 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 77 (262)
T ss_pred CCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEE
Confidence 356678999999999999999999873 457999988754432 3468899999999999999999998754 56899
Q ss_pred EEeecCCCCHHHHHhCCC-CCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 751 ITEFLPRGSLFRILHRPH-CQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 751 VmEy~~gGsL~d~L~k~~-~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
||||+++|+|.+++.+.. ....+.....++ +.+.||+|||..+ |+||||||+||++++++.+||+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 999999999999997532 233444444444 4489999999988 999999999999999999999999999765433
Q ss_pred ccc-CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHH
Q 002160 829 FLS-SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 906 (958)
Q Consensus 829 ~~~-~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~d 906 (958)
... .....++..|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+. .......+..++..+.+
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~ 234 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHD 234 (262)
T ss_pred ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh-cCCCCCCccccCHHHHH
Confidence 221 122345678999999998889999999999999999999 888998877766665553 22334445678999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHhh
Q 002160 907 IIWECWQTDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 907 LI~~CL~kDP~kRPSa~EIL~~L~kL 932 (958)
||.+||+.+|.+||++.+++..|+..
T Consensus 235 li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 235 LMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HHHHHccCCcccCCCHHHHHHHHHHh
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=333.42 Aligned_cols=260 Identities=29% Similarity=0.456 Sum_probs=211.4
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEE-------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEecc
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA 741 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~ 741 (958)
..++.+++|.+.+.||+|+||.||++++ .+..||||++.... .......+.+|+.+++++ +||||++++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 3556778999999999999999999974 23479999876543 233456789999999999 79999999999
Q ss_pred ccCCCceEEEEeecCCCCHHHHHhCCCC-CccHHHHHHHHH-HHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEec
Q 002160 742 VTRPPNLSIITEFLPRGSLFRILHRPHC-QVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 819 (958)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~d~L~k~~~-~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DF 819 (958)
+...+.+|+||||+.+|+|.+++.+... ...+.....++. .+.||.|||..+ |+|+||||+|||++.++.+||+||
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCCCeEEECCC
Confidence 9999999999999999999999875432 245555554444 489999999988 999999999999999999999999
Q ss_pred cccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCC
Q 002160 820 GLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEI 896 (958)
Q Consensus 820 GLAk~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~i 896 (958)
|+++....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.....................
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 265 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ 265 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCC
Confidence 99976533211 1222346778999999999889999999999999999998 99999877655444333323334455
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 002160 897 PKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 897 p~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL 932 (958)
+...++++.+||.+||+.+|++||++.+|++.|+++
T Consensus 266 ~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 266 PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 667889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=319.87 Aligned_cols=249 Identities=28% Similarity=0.470 Sum_probs=208.2
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC--CCceEEEE
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--PPNLSIIT 752 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~--~~~l~LVm 752 (958)
+|++.+.||.|+||.||++.+ +++.||+|.+...........++..|++++++++|+||+++++++.. ...++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 588999999999999999976 67889999987766666667789999999999999999999997753 45589999
Q ss_pred eecCCCCHHHHHhCC---CCCccHHHHHHH-HHHHHHHHHHH-----hcCCcEeecCCCCCceEEcCCCcEEEEeccccc
Q 002160 753 EFLPRGSLFRILHRP---HCQVDEKRRIKM-ALDARGMNCLH-----TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 823 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~---~~~~~e~~~l~i-a~~a~aL~yLH-----~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk 823 (958)
||+++++|.+++... .....+...+.+ .+++.||.||| ..+ |+|+||||+||+++.++.+||+|||++.
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecCCCEEEecccccc
Confidence 999999999988643 234444444444 44589999999 555 9999999999999999999999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHH
Q 002160 824 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 903 (958)
Q Consensus 824 ~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~e 903 (958)
.............++..|+|||++.+..++.++|+|+||+++|+|++|+.||...+..+....+. ......++..++..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 237 (265)
T cd08217 159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK-EGKFRRIPYRYSSE 237 (265)
T ss_pred cccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHh-cCCCCCCccccCHH
Confidence 76544332344578999999999998889999999999999999999999999887666555553 33344567788999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 904 VARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 904 L~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+.+|+.+||+.+|.+||++.+|+++
T Consensus 238 ~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 238 LNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHHHHccCCcccCCCHHHHhhC
Confidence 9999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=321.82 Aligned_cols=253 Identities=33% Similarity=0.561 Sum_probs=206.1
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEEC-CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEE
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~~-g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~L 750 (958)
++..++|++.+.||+|+||.||+|.+. +..+|+|.+...... ...+.+|++++++++|+||+++++++. .+..++
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05069 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM---PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI 77 (260)
T ss_pred cCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc---HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence 355578999999999999999999874 457999987654332 346788999999999999999999875 456889
Q ss_pred EEeecCCCCHHHHHhCCC-CCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 751 ITEFLPRGSLFRILHRPH-CQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 751 VmEy~~gGsL~d~L~k~~-~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
+|||+++++|.+++.+.. ....+.....++ +.+.||.|||..+ |+||||||+||++++++.+||+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 999999999999997543 234444444444 4489999999988 999999999999999999999999999765432
Q ss_pred cc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHH
Q 002160 829 FL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 906 (958)
Q Consensus 829 ~~-~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~d 906 (958)
.. ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+....+....+. ......++..++..+++
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRMPCPQGCPESLHE 234 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHHH
Confidence 21 1122345678999999998889999999999999999999 999998887766665553 23344556778999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHh
Q 002160 907 IIWECWQTDPSLRPSFAQLTVALKP 931 (958)
Q Consensus 907 LI~~CL~kDP~kRPSa~EIL~~L~k 931 (958)
||.+||.+||.+||++++|++.|++
T Consensus 235 li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 235 LMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHccCCcccCcCHHHHHHHHhc
Confidence 9999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=321.11 Aligned_cols=249 Identities=24% Similarity=0.447 Sum_probs=211.2
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEee
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
+|++.+.||+|+||.||+++. +++.||||.+...........++.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 588999999999999999976 688999999876655555567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhCCC-CCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 755 LPRGSLFRILHRPH-CQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 755 ~~gGsL~d~L~k~~-~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
+.+++|.+++.... ....+...+. +.+.+.+|.|||..+ ++|+||+|+|||++.++.++|+|||++..........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 158 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA 158 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhh
Confidence 99999999887543 2344444444 444499999999988 9999999999999999999999999997664433333
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhh
Q 002160 833 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 912 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL 912 (958)
....|+..|+|||++.+..++.++|+|||||++|+|++|+.||...+..+....+. .......+..++.++.++|.+||
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 237 (256)
T cd08218 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII-RGSYPPVSSHYSYDLRNLVSQLF 237 (256)
T ss_pred hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh-cCCCCCCcccCCHHHHHHHHHHh
Confidence 34568899999999999889999999999999999999999998877776666554 33344566788999999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 002160 913 QTDPSLRPSFAQLTVA 928 (958)
Q Consensus 913 ~kDP~kRPSa~EIL~~ 928 (958)
+.+|.+||++.+|+++
T Consensus 238 ~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 238 KRNPRDRPSVNSILEK 253 (256)
T ss_pred hCChhhCcCHHHHhhC
Confidence 9999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=328.90 Aligned_cols=255 Identities=31% Similarity=0.500 Sum_probs=209.0
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE-------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~ 745 (958)
++.++|++.+.||+|+||.||+|++ .++.||||++.... ......++.+|+.++++++||||+++++++..+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 4567899999999999999999975 35789999876443 344456789999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhCCCC---------------------CccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCC
Q 002160 746 PNLSIITEFLPRGSLFRILHRPHC---------------------QVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKS 803 (958)
Q Consensus 746 ~~l~LVmEy~~gGsL~d~L~k~~~---------------------~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKP 803 (958)
..+++||||+++++|.+++..... ...+...+.++.+ +.||.|||..+ ++||||||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p 158 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLAT 158 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccH
Confidence 999999999999999999864321 2334444444444 89999999987 99999999
Q ss_pred CceEEcCCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 002160 804 PNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNP 880 (958)
Q Consensus 804 eNILId~~g~VKL~DFGLAk~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~ 880 (958)
+|||++.++.+||+|||++........ ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+.
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999875432211 1122334668999999999899999999999999999997 8899988887
Q ss_pred hHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 002160 881 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 931 (958)
Q Consensus 881 ~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~k 931 (958)
.+....+. .......+..++.++.+||.+||+.+|.+||++.||++.|++
T Consensus 239 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 EEVIYYVR-DGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 77766654 233344567789999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=351.10 Aligned_cols=249 Identities=29% Similarity=0.438 Sum_probs=216.1
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCH-HHHHHHHHHHHHHHHcC-CCceeEEeccccCCCceEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~ILk~L~-HPNIVkL~g~~~~~~~l~LV 751 (958)
..|++++.||+|.||.||+++. +|+.+|+|.+.+..... .....+.+|+.||+++. |||||+++++|++...+++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 5699999999999999999976 68899999998776533 35678899999999997 99999999999999999999
Q ss_pred EeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcC----CCcEEEEeccccccccC
Q 002160 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDK----NWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~----~g~VKL~DFGLAk~~~~ 827 (958)
||+|.||+|++.+.+. ...+......+.+.+.++.|||..+ |+||||||+|+|+.. ++.+|++|||+++....
T Consensus 115 mEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred EEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 9999999999988766 3445555556666699999999988 999999999999963 35799999999998876
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCC--CCCCcHHHH
Q 002160 828 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI--PKELDPLVA 905 (958)
Q Consensus 828 ~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~i--p~~ls~eL~ 905 (958)
.......+||+.|+|||++....|+..+||||+|+++|.|++|..||.+.+.......+........- ...++..++
T Consensus 192 -~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~ak 270 (382)
T KOG0032|consen 192 -GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAK 270 (382)
T ss_pred -CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHH
Confidence 45566789999999999999999999999999999999999999999999988877777544332222 245789999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 002160 906 RIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 906 dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+||..||..||.+|+++.++++|
T Consensus 271 d~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 271 DFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHHHHhcccCcccCCCHHHHhcC
Confidence 99999999999999999999995
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=335.58 Aligned_cols=263 Identities=31% Similarity=0.516 Sum_probs=213.9
Q ss_pred cccccCCCCeeEEEEeeccCceEEEEEEEC---------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEE
Q 002160 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLF 738 (958)
Q Consensus 669 ~~~eI~~~dy~i~k~LG~G~fG~Vykak~~---------g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL 738 (958)
..+++...+|++++.||+|+||.||+|++. ...||+|.+... .......++.+|+++++++ +||||+++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 345666778999999999999999999752 236899977643 3344567889999999999 89999999
Q ss_pred eccccCCCceEEEEeecCCCCHHHHHhCCCC---------------CccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCC
Q 002160 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPHC---------------QVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLK 802 (958)
Q Consensus 739 ~g~~~~~~~l~LVmEy~~gGsL~d~L~k~~~---------------~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLK 802 (958)
++++...+.++++|||+++|+|.+++.+... .......+.++ +.+.||.|||.++ |+|||||
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlk 161 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLA 161 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccc
Confidence 9999999999999999999999999875321 22333334433 4489999999988 9999999
Q ss_pred CCceEEcCCCcEEEEeccccccccCCccc--CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 002160 803 SPNLLVDKNWNVKVSDFGLSRLKHNTFLS--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMN 879 (958)
Q Consensus 803 PeNILId~~g~VKL~DFGLAk~~~~~~~~--~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~ 879 (958)
|+|||++.++.+||+|||+++........ .....++..|+|||++.+..++.++||||||+++|||++ |..||.+.+
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred cceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999999999999999865432211 122234567999999999989999999999999999998 899998887
Q ss_pred hhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 880 PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 880 ~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
..+....+. .......+..++.++.+||.+||+.+|.+||++.+|+.+|+++...
T Consensus 242 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 242 VEELFKLLK-EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred HHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 777666553 3344556677889999999999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=351.16 Aligned_cols=246 Identities=24% Similarity=0.362 Sum_probs=219.9
Q ss_pred eeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeec
Q 002160 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~ 755 (958)
|.+.+.||+|.|..|-++++ +|++||||++.+..++......+..|+++|+.++|||||+||++...+.++|||+|+-
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 66778899999999999976 9999999999999888877888999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhCCCCC-ccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEc-CCCcEEEEeccccccccCCcccCC
Q 002160 756 PRGSLFRILHRPHCQ-VDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSK 833 (958)
Q Consensus 756 ~gGsL~d~L~k~~~~-~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId-~~g~VKL~DFGLAk~~~~~~~~~~ 833 (958)
++|+|+||+-++... .++..+.|+++++.|+.|+|+.. +|||||||+||.+. +-|-|||+|||++-.+... ....
T Consensus 100 D~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG-~kL~ 176 (864)
T KOG4717|consen 100 DGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG-KKLT 176 (864)
T ss_pred CCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCCCc-chhh
Confidence 999999998766544 44556777888899999999999 99999999999887 5689999999998766543 3456
Q ss_pred CCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhh
Q 002160 834 STAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 912 (958)
Q Consensus 834 s~~GT~~Y~APEvl~g~~~-s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL 912 (958)
+.||+..|.|||++.|..| .+++||||||+|||-|++|++||+..++.+.+..| ......+|..++.++++||..||
T Consensus 177 TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI--mDCKYtvPshvS~eCrdLI~sML 254 (864)
T KOG4717|consen 177 TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI--MDCKYTVPSHVSKECRDLIQSML 254 (864)
T ss_pred cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh--hcccccCchhhhHHHHHHHHHHH
Confidence 7899999999999999887 46789999999999999999999999998888877 45677889999999999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 002160 913 QTDPSLRPSFAQLTVA 928 (958)
Q Consensus 913 ~kDP~kRPSa~EIL~~ 928 (958)
..||.+|.+.++|..+
T Consensus 255 vRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 255 VRDPKKRASLEEIVST 270 (864)
T ss_pred hcCchhhccHHHHhcc
Confidence 9999999998887653
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=353.78 Aligned_cols=246 Identities=24% Similarity=0.324 Sum_probs=190.4
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC-----
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP----- 745 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~----- 745 (958)
....+|++++.||+|+||.||+|.+ +++.||||++.... ....+|+.+|+.++|||||++++++...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 3456899999999999999999986 67899999885432 1234799999999999999998876432
Q ss_pred ---CceEEEEeecCCCCHHHHHhC---CCCCccHH-HHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCC-CcEEEE
Q 002160 746 ---PNLSIITEFLPRGSLFRILHR---PHCQVDEK-RRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVS 817 (958)
Q Consensus 746 ---~~l~LVmEy~~gGsL~d~L~k---~~~~~~e~-~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~-g~VKL~ 817 (958)
..+++||||+++ +|.+++.. ....+.+. .+.+..+++.||.|||.++ ||||||||+||||+.+ +.+||+
T Consensus 137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeee
Confidence 246799999975 67666532 22333333 4444455699999999998 9999999999999965 479999
Q ss_pred eccccccccCCcccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcc------
Q 002160 818 DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ------ 890 (958)
Q Consensus 818 DFGLAk~~~~~~~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~------ 890 (958)
|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+.+..+...
T Consensus 214 DFGla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 214 DFGSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred ccccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 999998764332 23346789999999998764 6899999999999999999999999987655443322110
Q ss_pred ---------------------ccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 891 ---------------------NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 891 ---------------------~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.....+|...+.++++||.+||++||.+||++.|++.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00112344578899999999999999999999999966
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=376.23 Aligned_cols=261 Identities=31% Similarity=0.549 Sum_probs=226.7
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE---CCc----EEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW---NGT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~---~g~----~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~ 744 (958)
+++++..++.+.||+|+||.||.|.. .+. .||||.+.+. .+.+...+|.+|..+|+.++|||||+++|++.+
T Consensus 688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 36678899999999999999999976 333 4899986543 456778899999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhCC------CCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEE
Q 002160 745 PPNLSIITEFLPRGSLFRILHRP------HCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVS 817 (958)
Q Consensus 745 ~~~l~LVmEy~~gGsL~d~L~k~------~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~ 817 (958)
....+|++|||+||+|..+|++. ...+.....+.++++ +.|+.||++++ +|||||..+|+||++...|||+
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecccCcEEEc
Confidence 99999999999999999999877 556666777777777 99999999998 9999999999999999999999
Q ss_pred eccccccccCCcccCCCCCC--CCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhcccccc
Q 002160 818 DFGLSRLKHNTFLSSKSTAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRL 894 (958)
Q Consensus 818 DFGLAk~~~~~~~~~~s~~G--T~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~ 894 (958)
|||+|+.+....+......+ -..|||||.+..+.++.|+|||||||++||+++ |..||.+.++.++...+... .++
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~g-gRL 923 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEG-GRL 923 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhC-Ccc
Confidence 99999955443333222222 358999999999999999999999999999998 89999999999988866544 499
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhc
Q 002160 895 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 936 (958)
Q Consensus 895 ~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~ 936 (958)
+.|..++..+.+++.+||+.+|++||+|..|++.+..+....
T Consensus 924 ~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 924 DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 999999999999999999999999999999999998885543
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=330.82 Aligned_cols=257 Identities=31% Similarity=0.497 Sum_probs=204.0
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEECC----------------cEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCce
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADWNG----------------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 735 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~~g----------------~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNI 735 (958)
++++.+|++.+.||+|+||.||++++.+ ..||||.+... ........|.+|+++|++++|+||
T Consensus 1 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i 79 (295)
T cd05097 1 EFPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNI 79 (295)
T ss_pred CCchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCc
Confidence 3566789999999999999999986532 24899987654 334455678999999999999999
Q ss_pred eEEeccccCCCceEEEEeecCCCCHHHHHhCCCC-----------CccHHHHHHHHH-HHHHHHHHHhcCCcEeecCCCC
Q 002160 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHC-----------QVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDLKS 803 (958)
Q Consensus 736 VkL~g~~~~~~~l~LVmEy~~gGsL~d~L~k~~~-----------~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDLKP 803 (958)
+++++++......++||||+++++|.+++..... ...+...+.++. .+.||+|||.++ |+||||||
T Consensus 80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp 157 (295)
T cd05097 80 IRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLAT 157 (295)
T ss_pred CeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccCh
Confidence 9999999999999999999999999999864321 123344444444 489999999988 99999999
Q ss_pred CceEEcCCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCC
Q 002160 804 PNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT--LKLPWIGMN 879 (958)
Q Consensus 804 eNILId~~g~VKL~DFGLAk~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt--G~~PF~g~~ 879 (958)
+|||++.++.+||+|||++........ ......++..|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 158 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred hhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 999999999999999999876533211 1122345678999999998889999999999999999988 678998776
Q ss_pred hhHHHHhhhc------cccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 002160 880 PMQVVGAVGF------QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 931 (958)
Q Consensus 880 ~~ei~~~i~~------~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~k 931 (958)
..+....+.. .......+..+++.+.+||.+||+.||.+||++.+|++.|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 238 DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 6655443311 111123345678999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=324.33 Aligned_cols=260 Identities=26% Similarity=0.432 Sum_probs=212.3
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEEC------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC-
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADWN------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR- 744 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~~------g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~- 744 (958)
.+..++|++.+.||+|+||.||+|.+. +..|++|.+.. .........+.+|+.++++++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD-HASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC-CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 356788999999999999999999874 47788888653 3344556778999999999999999999998765
Q ss_pred CCceEEEEeecCCCCHHHHHhCCC-------CCccHHHHHHHHH-HHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEE
Q 002160 745 PPNLSIITEFLPRGSLFRILHRPH-------CQVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV 816 (958)
Q Consensus 745 ~~~l~LVmEy~~gGsL~d~L~k~~-------~~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL 816 (958)
+...++++||+++++|.+++.+.. ..+.+...+.++. .+.||+|||.++ |+||||||+|||++.++.+||
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCCCcEEE
Confidence 567899999999999999986532 2344555555554 499999999988 999999999999999999999
Q ss_pred EeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccc
Q 002160 817 SDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRR 893 (958)
Q Consensus 817 ~DFGLAk~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~ 893 (958)
+|||+++.+..... ......++..|+|||++.+..++.++||||||+++|++++ |+.||...+..+....+. ....
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~ 237 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK-DGYR 237 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH-cCCC
Confidence 99999986533211 1122345678999999999889999999999999999998 999999887777665553 2333
Q ss_pred cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 894 LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 894 ~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
+..+..++.++.+++.+||..||++||++.++++.|..+.+.
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 238 LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 444556789999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=340.33 Aligned_cols=261 Identities=31% Similarity=0.489 Sum_probs=206.2
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEE-------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccc
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAV 742 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~ 742 (958)
+.++.++|++++.||+|+||.||+|.+ .++.||||++.... .......+.+|+.+|.++ +||||+++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 456678999999999999999999974 46789999986543 233456788999999999 689999999987
Q ss_pred cCC-CceEEEEeecCCCCHHHHHhCCCC----------------------------------------------------
Q 002160 743 TRP-PNLSIITEFLPRGSLFRILHRPHC---------------------------------------------------- 769 (958)
Q Consensus 743 ~~~-~~l~LVmEy~~gGsL~d~L~k~~~---------------------------------------------------- 769 (958)
... ..++++|||+++|+|.+++.....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 654 458899999999999999864321
Q ss_pred --------------CccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc--cC
Q 002160 770 --------------QVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL--SS 832 (958)
Q Consensus 770 --------------~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~--~~ 832 (958)
...+.....++ +++.||+|||.++ |+||||||+|||++.++++||+|||++........ ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 238 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 238 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence 12222333333 4489999999988 99999999999999999999999999876532211 11
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHh
Q 002160 833 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 911 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~C 911 (958)
....++..|+|||++.+..++.++||||||+++|+|++ |..||......+..............|..+++.+.+++.+|
T Consensus 239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c 318 (343)
T cd05103 239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 318 (343)
T ss_pred CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHH
Confidence 22335678999999999889999999999999999997 99999876543333333333445556677889999999999
Q ss_pred hhcCCCCCCCHHHHHHHHHhhhh
Q 002160 912 WQTDPSLRPSFAQLTVALKPLQR 934 (958)
Q Consensus 912 L~kDP~kRPSa~EIL~~L~kL~k 934 (958)
|+.||.+||++.+|+++|+.+.+
T Consensus 319 l~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 319 WHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred ccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=318.85 Aligned_cols=250 Identities=32% Similarity=0.540 Sum_probs=207.1
Q ss_pred CCCCeeEEEEeeccCceEEEEEEE-CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
...+|++.+.||+|+||.||++.+ +++.+|+|.+....... ..+.+|++++++++||||+++++++......++||
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCH---HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 346899999999999999999987 47889999876554432 46889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc-
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 830 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~- 830 (958)
||+++++|.+++........+.....++ +.+.+++|||..+ ++||||||+||+++.++.+||+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 9999999999987654444444444444 4489999999988 99999999999999999999999999876533221
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHH
Q 002160 831 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 909 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~ 909 (958)
......++..|+|||.+.+..++.++||||||+++|||++ |..||......+....+. ...+...+...+..+.+|+.
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~ 235 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN-AGFRLYKPRLASQSVYELMQ 235 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHh-CCCCCCCCCCCCHHHHHHHH
Confidence 1122335678999999998889999999999999999998 999998877766666553 22344446667899999999
Q ss_pred HhhhcCCCCCCCHHHHHHHH
Q 002160 910 ECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 910 ~CL~kDP~kRPSa~EIL~~L 929 (958)
+||+.+|++||++.++++.|
T Consensus 236 ~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 236 HCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHcccChhhCCCHHHHHHhh
Confidence 99999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=318.04 Aligned_cols=244 Identities=32% Similarity=0.578 Sum_probs=202.2
Q ss_pred EeeccCceEEEEEEE-CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeecCCCCHH
Q 002160 683 RIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF 761 (958)
Q Consensus 683 ~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~gGsL~ 761 (958)
.||+|+||.||+|.. .++.||+|.+.... .......+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 699999999999976 57789999876543 3444557889999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC-CCCCCCC
Q 002160 762 RILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS-KSTAGTP 839 (958)
Q Consensus 762 d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~-~s~~GT~ 839 (958)
+++........+...+.+..+ +.+|.|||.++ ++||||||+||+++.++.+||+|||++.......... ....++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI 158 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcc
Confidence 998765544555555554444 89999999988 9999999999999999999999999987643322211 1123456
Q ss_pred CccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCC
Q 002160 840 EWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSL 918 (958)
Q Consensus 840 ~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~k 918 (958)
.|+|||++.+..++.++||||||+++|+|++ |..||.+.........+. ...+...+..++..+.+|+.+||..+|++
T Consensus 159 ~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (250)
T cd05085 159 KWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYKVMQRCWDYKPEN 237 (250)
T ss_pred cccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccCccc
Confidence 7999999998889999999999999999998 999998887766655553 33445666778999999999999999999
Q ss_pred CCCHHHHHHHHH
Q 002160 919 RPSFAQLTVALK 930 (958)
Q Consensus 919 RPSa~EIL~~L~ 930 (958)
||++.++++.|.
T Consensus 238 Rp~~~~l~~~l~ 249 (250)
T cd05085 238 RPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHhc
Confidence 999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=322.17 Aligned_cols=249 Identities=30% Similarity=0.492 Sum_probs=205.4
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCH-------HHHHHHHHHHHHHHHcCCCceeEEeccccCCCc
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-------AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~-------~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~ 747 (958)
+|.+++.||+|+||.||+|.. +++.||+|.+....... .....+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 367788999999999999976 67899999886543321 233568899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
.++||||+++++|.+++...+..........+.+.+.||.|||..+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 9999999999999999977654444444444555599999999988 99999999999999999999999999886642
Q ss_pred Cc------ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCc
Q 002160 828 TF------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 901 (958)
Q Consensus 828 ~~------~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls 901 (958)
.. .......|+..|+|||.+.+..++.++|+|+|||++|+|++|+.||.+.+..+....+. ....+.++..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 237 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-ENASPEIPSNIS 237 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHh-ccCCCcCCcccC
Confidence 11 11123458889999999998888999999999999999999999998876655444432 233456677889
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 902 PLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 902 ~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
..++++|.+||+.||.+||++.+|+++
T Consensus 238 ~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 238 SEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred HHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 999999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=329.23 Aligned_cols=256 Identities=30% Similarity=0.488 Sum_probs=203.1
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEEC------------------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCc
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADWN------------------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 734 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~~------------------g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPN 734 (958)
++.++|++.+.||+|+||.||++++. ...||+|++.... .......+.+|+++|+.++|+|
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~ 80 (296)
T cd05095 2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPN 80 (296)
T ss_pred CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCC
Confidence 45678999999999999999998642 2358999876542 3444568899999999999999
Q ss_pred eeEEeccccCCCceEEEEeecCCCCHHHHHhCCCCC----------ccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCC
Q 002160 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ----------VDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKS 803 (958)
Q Consensus 735 IVkL~g~~~~~~~l~LVmEy~~gGsL~d~L~k~~~~----------~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKP 803 (958)
|+++++++...+..++||||+++++|.+++.+.... ..+..... +.+.+.||+|||.++ |+||||||
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp 158 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLAT 158 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCh
Confidence 999999999999999999999999999998754321 22233333 444489999999998 99999999
Q ss_pred CceEEcCCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCC
Q 002160 804 PNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT--LKLPWIGMN 879 (958)
Q Consensus 804 eNILId~~g~VKL~DFGLAk~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt--G~~PF~g~~ 879 (958)
+|||++.++.+||+|||+++....... ......++..|++||++.+..++.++|||||||++|||++ |..||...+
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence 999999999999999999876533211 1112334678999999988889999999999999999998 789998776
Q ss_pred hhHHHHhhhc------cccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 002160 880 PMQVVGAVGF------QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 931 (958)
Q Consensus 880 ~~ei~~~i~~------~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~k 931 (958)
..+....... .......+..+++.+.+||.+||+.||.+||++.+|++.|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 239 DEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred hHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 6655443211 111123345678999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=321.96 Aligned_cols=250 Identities=30% Similarity=0.434 Sum_probs=205.3
Q ss_pred CeeEEEEeeccCceEEEEEEE-CCcEEEEEEeecCCC----CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEE
Q 002160 677 DLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDF----SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~----~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LV 751 (958)
+|++++.||+|+||.||+|.. +++.+|||.+..... .......+.+|+++|++++|+||+++++++...+.++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999976 788899998865432 123345688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC---
Q 002160 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--- 828 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~--- 828 (958)
|||+++++|.+++.+...........++.+.+.+|+|||..+ |+|+||||+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 999999999999977554444444445555689999999988 999999999999999999999999998754211
Q ss_pred ---cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcc-ccccCCCCCCcHHH
Q 002160 829 ---FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRRLEIPKELDPLV 904 (958)
Q Consensus 829 ---~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~-~~~~~ip~~ls~eL 904 (958)
........|+..|+|||++.+..++.++||||||+++|+|++|..||...+.......+... ...+.++..++.++
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 11122356899999999999988999999999999999999999999876655443333212 23345677889999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 905 ARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 905 ~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.+||.+||..+|.+||++.+++.+
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcC
Confidence 999999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=327.92 Aligned_cols=250 Identities=30% Similarity=0.454 Sum_probs=203.7
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
.+.|++++.||.|+||.||+|+. +++.|++|.+... .......+.+|+.+++.++|+||+++++++..+..+++||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 35699999999999999999987 5788999987654 3445667889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~ 831 (958)
||+++++|..++.+......+.... .+.+++.+|.|||.++ |+||||||+|||++.++.+||+|||++.........
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 166 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR 166 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence 9999999998876544444444444 4444589999999988 999999999999999999999999998765443333
Q ss_pred CCCCCCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc-ccCCCCCCcHHHH
Q 002160 832 SKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVA 905 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~-----g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~-~~~ip~~ls~eL~ 905 (958)
.....++..|+|||++. ...++.++|||||||++|+|++|..||...+..+....+..... ....+..++.++.
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFR 246 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHH
Confidence 34456889999999985 34467899999999999999999999988776555444421111 2233557889999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 002160 906 RIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 906 dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+||.+||..+|++||++.+|+++
T Consensus 247 ~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 247 DFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred HHHHHHhcCCcccCcCHHHHhcC
Confidence 99999999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=340.43 Aligned_cols=248 Identities=23% Similarity=0.285 Sum_probs=195.8
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC------C
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------P 746 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~------~ 746 (958)
.++|++.+.||+|+||.||++.+ .++.||||++............+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 46899999999999999999976 688999999876554555566788999999999999999999987543 3
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
.+|+||||+++ +|.+.+... .........+.+.+.||.|||.++ |+||||||+||||+.++.+||+|||+++...
T Consensus 96 ~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred eeEEEhhhhcc-cHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 47999999965 666666432 223333444555599999999988 9999999999999999999999999998654
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccc---------------
Q 002160 827 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN--------------- 891 (958)
Q Consensus 827 ~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~--------------- 891 (958)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 171 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (355)
T cd07874 171 TSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_pred Ccc-ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence 332 2344678999999999999999999999999999999999999998766433322110000
Q ss_pred -----c--------------------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 892 -----R--------------------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 892 -----~--------------------~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
. ....+...+.++++||.+||+.||.+||++.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0 000112245678999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=319.95 Aligned_cols=255 Identities=31% Similarity=0.554 Sum_probs=208.8
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEE-CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceE
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~ 749 (958)
+++..++|++.+.||+|+||.||++++ .+..+|+|.+.... .....+.+|+.++++++|+||+++++++.. ..++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 357778999999999999999999986 55679999876432 234678899999999999999999999887 7789
Q ss_pred EEEeecCCCCHHHHHhCCC-CCccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 750 IITEFLPRGSLFRILHRPH-CQVDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~-~~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
++|||+++++|.+++.+.. ....+.... ++.+.+.||.|||..+ ++||||||+||+++.++.+||+|||++.....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 9999999999999987633 333444333 3445599999999987 99999999999999999999999999876543
Q ss_pred Ccc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHH
Q 002160 828 TFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 905 (958)
Q Consensus 828 ~~~-~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~ 905 (958)
... ......++..|+|||++.+..++.++|+||||+++|+|++ |+.||.+.+.......+. .......+...+.++.
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 233 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEELY 233 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-CCCCCCCcccCCHHHH
Confidence 221 1122345678999999998889999999999999999998 999999887766665543 3334445567889999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 002160 906 RIIWECWQTDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 906 dLI~~CL~kDP~kRPSa~EIL~~L~kL 932 (958)
+++.+||+.+|.+||++.++++.|+.+
T Consensus 234 ~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 234 NIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred HHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=340.37 Aligned_cols=250 Identities=26% Similarity=0.362 Sum_probs=207.3
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC-----CCce
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-----PPNL 748 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~-----~~~l 748 (958)
..|...+.||+|+||.|+.+.. +|+.||||++..........++..+|+++|+.++|+|||.+++.+.- -..+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 3455579999999999999976 78999999998666566677888999999999999999999998865 2448
Q ss_pred EEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC-
Q 002160 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN- 827 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~- 827 (958)
|+|+|+| +-+|...++.+....+...+..+.|++.||.|+|+.+ |+||||||.|+|++.++.+||||||+|+....
T Consensus 102 YiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred EEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCCEEeccccceeecccc
Confidence 9999999 6699999998776777778888888899999999998 99999999999999999999999999998743
Q ss_pred -CcccCCCCCCCCCccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcc---------------
Q 002160 828 -TFLSSKSTAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ--------------- 890 (958)
Q Consensus 828 -~~~~~~s~~GT~~Y~APEvl~-g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~--------------- 890 (958)
.....+.++.|.+|.|||++. ...|+...||||+||||.||++|++-|.|.+....+..+...
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~ 258 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSE 258 (359)
T ss_pred CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccH
Confidence 122335677899999999876 567999999999999999999999999987654333222110
Q ss_pred ---------ccccCCC-----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 891 ---------NRRLEIP-----KELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 891 ---------~~~~~ip-----~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
...+..| .+.++.+.+|+.+||..||.+|+|++|.+.|
T Consensus 259 ~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 259 KARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0011111 3678999999999999999999999999886
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=326.51 Aligned_cols=250 Identities=30% Similarity=0.447 Sum_probs=202.0
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
.++|.+.+.||+|+||.||+|++ +++.||+|.+..... .....+.+|+.+++.++||||+++++.+...+.+|+||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 35788899999999999999986 688999998865432 23456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
||+++++|.+++...+............+.+.+|.|||.++ |+|+||||+||+++.++.+||+|||++..........
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06645 86 EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR 163 (267)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcceeeeEccCccccc
Confidence 99999999999876655444444445555599999999998 9999999999999999999999999987654433333
Q ss_pred CCCCCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccccc-CC--CCCCcHHHHH
Q 002160 833 KSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL-EI--PKELDPLVAR 906 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~---g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~-~i--p~~ls~eL~d 906 (958)
....|+..|+|||++. +..++.++|||||||++|+|++|..||....+.............. .. ...++..+.+
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHH 243 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHH
Confidence 4567999999999984 4557889999999999999999999997765544333222111111 11 1246788999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 002160 907 IIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 907 LI~~CL~kDP~kRPSa~EIL~~ 928 (958)
||.+||..+|++||++++|+++
T Consensus 244 li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 244 FVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred HHHHHccCCchhCcCHHHHhcC
Confidence 9999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=323.36 Aligned_cols=256 Identities=30% Similarity=0.515 Sum_probs=209.5
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEEC-------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~~-------g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~ 745 (958)
+..++|++.+.||+|+||.||+|++. .+.|++|.+.... .......+.+|++++++++|+||+++++++.+.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 34578999999999999999999852 4568999775433 233456789999999999999999999999998
Q ss_pred CceEEEEeecCCCCHHHHHhCCCC--------CccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEE
Q 002160 746 PNLSIITEFLPRGSLFRILHRPHC--------QVDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV 816 (958)
Q Consensus 746 ~~l~LVmEy~~gGsL~d~L~k~~~--------~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL 816 (958)
...++||||+++++|.+++..... .+.+.... ++.+++.+|+|||..+ |+||||||+|||++.++.++|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCCCcEEE
Confidence 999999999999999999875441 23444444 4445599999999988 999999999999999999999
Q ss_pred EeccccccccCC-cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhcccccc
Q 002160 817 SDFGLSRLKHNT-FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRL 894 (958)
Q Consensus 817 ~DFGLAk~~~~~-~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~ 894 (958)
+|||++...... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd05046 159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL 238 (275)
T ss_pred cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence 999998754322 122233456778999999998888999999999999999998 889998877776666665444445
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 002160 895 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 931 (958)
Q Consensus 895 ~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~k 931 (958)
..+..++..+.++|.+||+.+|.+||++.++++.|.+
T Consensus 239 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 239 PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 5566789999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=367.23 Aligned_cols=258 Identities=24% Similarity=0.422 Sum_probs=210.8
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEE-CC-cEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEecc-ccC-
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADW-NG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGA-VTR- 744 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~-~g-~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~-HPNIVkL~g~-~~~- 744 (958)
..++...+++|.+.|.+|||+.||+|+. .+ ..||+|++... ++..+..+++|+++|++|. |+|||.|++. ...
T Consensus 31 ~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~ 108 (738)
T KOG1989|consen 31 TFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR 108 (738)
T ss_pred EEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence 3456667889999999999999999987 33 89999998776 5777889999999999996 9999999993 211
Q ss_pred -----CCceEEEEeecCCCCHHHHHhCC-CCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEE
Q 002160 745 -----PPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVS 817 (958)
Q Consensus 745 -----~~~l~LVmEy~~gGsL~d~L~k~-~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~ 817 (958)
.-.++|.||||.||.|-|++.++ ...+.+...+.|+.+ +.|+++||...++|||||||-|||||+.+|++|||
T Consensus 109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred cCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeC
Confidence 12478999999999999999743 233666666766666 99999999999999999999999999999999999
Q ss_pred eccccccccCCcccC---------CCCCCCCCccCcccc---cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHH
Q 002160 818 DFGLSRLKHNTFLSS---------KSTAGTPEWMAPEVL---RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVG 885 (958)
Q Consensus 818 DFGLAk~~~~~~~~~---------~s~~GT~~Y~APEvl---~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~ 885 (958)
|||.|.......... ....-|+.|.|||++ .|.+.++|+|||+|||+||-|++...||.+....
T Consensus 189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---- 264 (738)
T KOG1989|consen 189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---- 264 (738)
T ss_pred cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----
Confidence 999987543221111 112368999999997 4778899999999999999999999999775332
Q ss_pred hhhccccccCCCC--CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 886 AVGFQNRRLEIPK--ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 886 ~i~~~~~~~~ip~--~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
.+.+....||. .++..+++||..||+.||++||++.|++..+.+|...
T Consensus 265 --aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 265 --AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred --eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 22344555554 6889999999999999999999999999999988654
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=327.86 Aligned_cols=246 Identities=25% Similarity=0.444 Sum_probs=209.6
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
++|++.+.||+|+||.||++.+ +++.||||++..... .......+.+|+++|++++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4789999999999999999987 678999999876543 2234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
||+++++|.+++.+...........+..+++.||.|||..+ |+||||+|.||||+.++.+||+|||+++..... .
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---~ 155 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---T 155 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEeeCCCccccCCC---C
Confidence 99999999999987655444444445555699999999988 999999999999999999999999999876443 2
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhh
Q 002160 833 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 912 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL 912 (958)
....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+. .....+|..++..++++|.+||
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l 233 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL--EGKVRFPSFFSPDAKDLIRNLL 233 (290)
T ss_pred CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCccCCccCCHHHHHHHHHHc
Confidence 34568999999999998888999999999999999999999998877665555543 3455677888999999999999
Q ss_pred hcCCCCCC-----CHHHHHHH
Q 002160 913 QTDPSLRP-----SFAQLTVA 928 (958)
Q Consensus 913 ~kDP~kRP-----Sa~EIL~~ 928 (958)
..||.+|+ ++++++.+
T Consensus 234 ~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 234 QVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred cCCHHHccCcccCCHHHHHcC
Confidence 99999998 77777754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=327.05 Aligned_cols=248 Identities=28% Similarity=0.354 Sum_probs=191.6
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc---CCCceeEEeccccC-----CC
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL---RHPNVVLFMGAVTR-----PP 746 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L---~HPNIVkL~g~~~~-----~~ 746 (958)
+|++.+.||+|+||.||+|++ +++.||||.+............+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 488999999999999999976 678899998876433322233455677777765 69999999998754 34
Q ss_pred ceEEEEeecCCCCHHHHHhCCCC-CccHH-HHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHC-QVDEK-RRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~-~~~e~-~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
.+++||||+.+ +|..++.+... ...+. .+..+.+.+.||.|||..+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccCcccc
Confidence 58999999974 88888865332 23344 4444555599999999998 99999999999999999999999999986
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccc-------c--c--
Q 002160 825 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-------R--R-- 893 (958)
Q Consensus 825 ~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~-------~--~-- 893 (958)
..... ......||..|+|||++.+..++.++|||||||++|+|++|++||.+.........+.... . .
T Consensus 158 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07863 158 YSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT 236 (288)
T ss_pred ccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence 54332 2234568999999999999889999999999999999999999998776554433321100 0 0
Q ss_pred --------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 894 --------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 894 --------------~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
..+...++..+++||.+||+.||.+||++.+++.|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 01112467889999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=340.23 Aligned_cols=248 Identities=24% Similarity=0.272 Sum_probs=196.4
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC------C
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------P 746 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~------~ 746 (958)
.++|++.+.||+|+||.||++.+ .++.||||++............+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 47899999999999999999976 688899999876544444556788999999999999999999987543 3
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
.+|+||||+++ +|.+++... .........+.+.+.||.|||.++ |+||||||+|||++.++.+||+|||+++...
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHhc--CCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 47999999965 677766532 223333344445589999999988 9999999999999999999999999998654
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc--------------
Q 002160 827 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-------------- 892 (958)
Q Consensus 827 ~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~-------------- 892 (958)
... ......||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 178 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (364)
T cd07875 178 TSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256 (364)
T ss_pred CCC-cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence 332 23446789999999999999999999999999999999999999988766544433211000
Q ss_pred ------cc--------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 893 ------RL--------------------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 893 ------~~--------------------~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
++ ......+..+++||.+||+.||.+||++.++++|
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 0011234678999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=319.53 Aligned_cols=248 Identities=30% Similarity=0.504 Sum_probs=206.4
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
.++|++.+.||.|+||.||+|++ ++..|++|.+.... ...++.+|++++++++|+||+++++++.....+|++|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 36789999999999999999987 36889999876432 1568899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHH-HHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~ 831 (958)
||+++++|.+++........+.....++. .+.||.|||..+ |+||||+|+||+++.++.+||+|||++.........
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK 155 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence 99999999999976555555555554444 489999999988 999999999999999999999999999876544333
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcc-ccccCCCCCCcHHHHHHHHH
Q 002160 832 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRRLEIPKELDPLVARIIWE 910 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~-~~~~~ip~~ls~eL~dLI~~ 910 (958)
.....++..|+|||++.+..++.++||||||+++|+|++|+.||......+....+... ......+..++.++.+||.+
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKK 235 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHH
Confidence 34456889999999999999999999999999999999999999877665544333211 11223345678899999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 002160 911 CWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 911 CL~kDP~kRPSa~EIL~~ 928 (958)
||+.||.+||++.+|+++
T Consensus 236 ~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 236 CLVKDPEERPSAIQLLQH 253 (256)
T ss_pred HHhcChhhCcCHHHHhcC
Confidence 999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=324.32 Aligned_cols=251 Identities=24% Similarity=0.351 Sum_probs=199.3
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
++|++.+.||+|+||.||+|++ +++.||+|++............+.+|+.++++++|+||+++++++.....+++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 4689999999999999999987 58899999887554333334567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCC
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 833 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~ 833 (958)
|++++.|..++..............+.+++.+|.|||..+ |+||||||+||+++.++.+||+|||++...........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT 158 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCCCcEEECccccceecCCCccccc
Confidence 9999888887765443333334444445599999999988 99999999999999999999999999987654432333
Q ss_pred CCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccc---------------------
Q 002160 834 STAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN--------------------- 891 (958)
Q Consensus 834 s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~--------------------- 891 (958)
...++..|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+....+....
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07847 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS 238 (286)
T ss_pred CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccccc
Confidence 4568889999999876 457889999999999999999999998876544332221000
Q ss_pred -cccC-------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 892 -RRLE-------IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 892 -~~~~-------ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.... .-..++..+.+||.+||+.+|++||++.|++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000 012457889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=319.92 Aligned_cols=250 Identities=30% Similarity=0.472 Sum_probs=203.2
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC---CHHHHHHHHHHHHHHHHcCCCceeEEeccccCC--Cce
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF---SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNL 748 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~---~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~--~~l 748 (958)
.+|++++.||+|+||.||+|.+ +++.||||++..... .......+.+|++++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5799999999999999999976 678999998864321 223456788999999999999999999998764 458
Q ss_pred EEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
+++|||+++++|.+++.+..............+.+.+|.|||..+ |+|+||||+|||++.++.+||+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 899999999999999876544333333334444589999999988 999999999999999999999999998765321
Q ss_pred c---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHH
Q 002160 829 F---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 905 (958)
Q Consensus 829 ~---~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~ 905 (958)
. .......|+..|+|||++.+..++.++||||||+++|+|++|+.||..................+.+|..++..+.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCR 239 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHH
Confidence 1 1123356889999999999888999999999999999999999999887655555444434445556777888999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 002160 906 RIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 906 dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
++|.+||. +|.+||++++|+++
T Consensus 240 ~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 240 DFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HHHHHHhc-ChhhCCCHHHHhcC
Confidence 99999994 99999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=330.88 Aligned_cols=249 Identities=24% Similarity=0.347 Sum_probs=202.0
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
++|++.+.||+|+||.||++++ ++..||+|.+... .......++.+|++++++++||||+++++++..++.+++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 4689999999999999999987 5778888887643 334456678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHh-cCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~-~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
|+++++|.+++.+.+............+.+.||.|||. ++ |+||||||+|||++.++.+||+|||++....... .
T Consensus 80 y~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~ 155 (308)
T cd06615 80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--A 155 (308)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecCCcEEEccCCCcccccccc--c
Confidence 99999999999876544444444455555999999997 46 9999999999999999999999999987654332 2
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcc----------------------
Q 002160 833 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---------------------- 890 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~---------------------- 890 (958)
....|+..|+|||++.+..++.++|+||||+++|+|++|+.||...+.......+...
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
T cd06615 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR 235 (308)
T ss_pred ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccc
Confidence 3467899999999999888999999999999999999999999765543332222100
Q ss_pred -------------ccccCCCC-CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002160 891 -------------NRRLEIPK-ELDPLVARIIWECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 891 -------------~~~~~ip~-~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L 929 (958)
...+.+|. .++.++++||.+||..+|++||++.+|+.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred hhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 11112221 3678899999999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=324.46 Aligned_cols=249 Identities=27% Similarity=0.307 Sum_probs=196.6
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEee
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
+|++.+.||.|+||.||+|+. ++..||||++............+.+|+.++++++||||+++++++..+..+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 588999999999999999986 688999999876544443446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhCCC--CCccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc
Q 002160 755 LPRGSLFRILHRPH--CQVDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 755 ~~gGsL~d~L~k~~--~~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~ 831 (958)
++ ++|.+++.... ....+.... .+.+++.||+|||..+ |+||||||+|||++.++.+||+|||++.........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV 157 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence 97 58888876432 233444444 4555599999999988 999999999999999999999999998765433333
Q ss_pred CCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcc--------------------
Q 002160 832 SKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-------------------- 890 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~-------------------- 890 (958)
.....++..|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 3344678899999998764 4688999999999999999999999876543222111000
Q ss_pred -------ccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 891 -------NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 891 -------~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.........+++++++||.+||+.||.+||++.+|+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00001123478899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.38 Aligned_cols=249 Identities=34% Similarity=0.527 Sum_probs=207.5
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC---CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEE
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF---SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~---~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LV 751 (958)
+|+..+.||+|+||.||+|.. +++.|+||.+..... ..+....+.+|+.+++.++|+||+++++++.....++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 467778999999999999976 688999998865432 234566889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc
Q 002160 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~ 831 (958)
|||+++++|.+++.+...........+..+++.+|.|||..+ |+|+||+|+||+++.++.+||+|||++....... .
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-~ 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-F 157 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccceeccccc-c
Confidence 999999999999977653333333344444599999999988 9999999999999999999999999987654432 2
Q ss_pred CCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHH
Q 002160 832 SKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 910 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~g~~-~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 910 (958)
.....|+..|++||.+.... ++.++|+||||+++|+|++|+.||......+....+........++..+++.+++||.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHH
Confidence 24466899999999998766 88999999999999999999999987765555555443344556677889999999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 002160 911 CWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 911 CL~kDP~kRPSa~EIL~~ 928 (958)
||+.+|.+||++.+++.+
T Consensus 238 ~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 238 CLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HhhcCcccCcCHHHHhcC
Confidence 999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=325.38 Aligned_cols=248 Identities=22% Similarity=0.253 Sum_probs=202.3
Q ss_pred eeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEee
Q 002160 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
|++.+.||+|+||+||++.+ +++.||+|++....... .....+.+|+++|++++|+||+.+++++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 67889999999999999987 68899999987654432 2344578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhCCC-CCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 755 LPRGSLFRILHRPH-CQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 755 ~~gGsL~d~L~k~~-~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
+++++|.+++.... ....+..... +.+.+.||.|||..+ |+||||||+|||++.++.+||+|||++...... ...
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~ 158 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ESI 158 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCCCCEEEecCCcceecCCC-Ccc
Confidence 99999998876433 2344444444 444599999999988 999999999999999999999999998765322 122
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhc--cccccCCCCCCcHHHHHHHHH
Q 002160 833 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF--QNRRLEIPKELDPLVARIIWE 910 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~--~~~~~~ip~~ls~eL~dLI~~ 910 (958)
....|+..|+|||++.+..++.++|+|||||++|+|++|..||.+.........+.. ......++..++..+.+|+.+
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKM 238 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHH
Confidence 345789999999999998899999999999999999999999988765443333221 222334566789999999999
Q ss_pred hhhcCCCCCCC-----HHHHHHH
Q 002160 911 CWQTDPSLRPS-----FAQLTVA 928 (958)
Q Consensus 911 CL~kDP~kRPS-----a~EIL~~ 928 (958)
||+.||.+||+ +.+++.+
T Consensus 239 ~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 239 LLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HccCCHhHcCCCcccChHHHHcC
Confidence 99999999999 7788886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=327.86 Aligned_cols=244 Identities=22% Similarity=0.285 Sum_probs=192.6
Q ss_pred eeccCceEEEEEEE--CCcEEEEEEeecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeecCCCCH
Q 002160 684 IGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 760 (958)
Q Consensus 684 LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~gGsL 760 (958)
||+|+||.||+++. +++.||+|++....... .....+..|++++++++||||+++++++.....+++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999976 58899999986544322 1233456799999999999999999999999999999999999999
Q ss_pred HHHHhCCC-CCccHHHHHHH-HHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCCCC
Q 002160 761 FRILHRPH-CQVDEKRRIKM-ALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT 838 (958)
Q Consensus 761 ~d~L~k~~-~~~~e~~~l~i-a~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~GT 838 (958)
.+++.... ....+...+.+ .+.+.||+|||..+ |+||||||+|||++.++.+||+|||++....... ......|+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCC
Confidence 98875433 23445544444 44589999999988 9999999999999999999999999987654332 22345689
Q ss_pred CCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh----HHHHhhhccccccCCCCCCcHHHHHHHHHhhhc
Q 002160 839 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM----QVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 914 (958)
Q Consensus 839 ~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~----ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~k 914 (958)
..|+|||++.+..++.++|||||||++|+|++|+.||...... ++..... ..........++.++++||.+||++
T Consensus 158 ~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTL-EDEVKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhh-ccccccccccCCHHHHHHHHHHhcc
Confidence 9999999999988999999999999999999999999765332 2222221 1111111246789999999999999
Q ss_pred CCCCCCCHHHHHHHHHh
Q 002160 915 DPSLRPSFAQLTVALKP 931 (958)
Q Consensus 915 DP~kRPSa~EIL~~L~k 931 (958)
||.+||++.|+++.+.+
T Consensus 237 ~P~~R~~~~~~~~~~~~ 253 (277)
T cd05607 237 KPEDRLGSREKNDDPRK 253 (277)
T ss_pred CHhhCCCCccchhhhhc
Confidence 99999999776655443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=318.54 Aligned_cols=248 Identities=29% Similarity=0.501 Sum_probs=197.9
Q ss_pred EEeeccCceEEEEEEE-----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEecccc-CCCceEEEEeec
Q 002160 682 ERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT-RPPNLSIITEFL 755 (958)
Q Consensus 682 k~LG~G~fG~Vykak~-----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~-~~~~l~LVmEy~ 755 (958)
+.||+|+||.||+|.+ .+..||||.+.... .......+.+|+.+++.++||||+++++++. .++..++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 3589999999999975 23569999875432 3344567889999999999999999999765 455689999999
Q ss_pred CCCCHHHHHhCCCCCccHHHHHHH-HHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc----c
Q 002160 756 PRGSLFRILHRPHCQVDEKRRIKM-ALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF----L 830 (958)
Q Consensus 756 ~gGsL~d~L~k~~~~~~e~~~l~i-a~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~----~ 830 (958)
.+++|.+++.+......+...+.+ .+.+.||.|||..+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 999999999765444444444444 34489999999987 9999999999999999999999999987543321 1
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHH
Q 002160 831 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 909 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG-~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~ 909 (958)
......++..|+|||.+.+..++.++|||||||++|||++| .+||...+..+....+. ....+..+..++..+.+++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~ 236 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL-QGRRLLQPEYCPDPLYEVML 236 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCCCCCCCCcCCHHHHHHHH
Confidence 11233467789999999988899999999999999999995 66777766665555443 33344556678899999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHhhh
Q 002160 910 ECWQTDPSLRPSFAQLTVALKPLQ 933 (958)
Q Consensus 910 ~CL~kDP~kRPSa~EIL~~L~kL~ 933 (958)
+||..+|++||++.+|++.|+++.
T Consensus 237 ~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 237 SCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred HHcCCChhhCCCHHHHHHHHHHHh
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=321.39 Aligned_cols=258 Identities=28% Similarity=0.497 Sum_probs=213.0
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCc----EEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~----~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~ 746 (958)
+...+|++.+.||+|+||.||+|.+ +++ .||+|.+..... .....++.+|+.++++++||||+++++++.. .
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 4457899999999999999999976 232 589997765432 4456678899999999999999999999887 7
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
..++||||+++|+|.+++.+......+...+.++.+ +.||+|||.++ |+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 899999999999999999876555555555555544 99999999987 999999999999999999999999999865
Q ss_pred cCCccc--CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcH
Q 002160 826 HNTFLS--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 902 (958)
Q Consensus 826 ~~~~~~--~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~ 902 (958)
...... .....++..|+|||.+.+..++.++|+||||+++|||++ |+.||.+....++...+. .......+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-KGERLPQPPICTI 238 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-CCCCCCCCCCCCH
Confidence 432211 111223568999999988889999999999999999998 999999888777666654 3344556667889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 903 LVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 903 eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
.+.+++.+||..+|.+||++.++++.|..+.+.
T Consensus 239 ~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 239 DVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 999999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=346.62 Aligned_cols=246 Identities=22% Similarity=0.235 Sum_probs=192.5
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceE
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~ 749 (958)
.+...+|++.+.||+|+||.||+|.. +++.||||... ...+.+|+++|++|+|||||+++++|......+
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 35567899999999999999999976 68899999642 234678999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC-
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT- 828 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~- 828 (958)
+||||+. ++|..++.............++.+++.||.|||.++ ||||||||+||||+.++.+||+|||+++.....
T Consensus 160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 9999995 688888866544444444444555599999999998 999999999999999999999999999754321
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-------hHHHHhhhc------------
Q 002160 829 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP-------MQVVGAVGF------------ 889 (958)
Q Consensus 829 ~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~-------~ei~~~i~~------------ 889 (958)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+..+..
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 1222346799999999999999999999999999999999999988764321 000000000
Q ss_pred --------------c-cccc-CCC-----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 890 --------------Q-NRRL-EIP-----KELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 890 --------------~-~~~~-~ip-----~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
. ...+ ..+ ..++.++.+||.+||+.||.+||+++|++++
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0 0000 000 1346789999999999999999999999864
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.46 Aligned_cols=248 Identities=28% Similarity=0.425 Sum_probs=198.7
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccCC------C
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRP------P 746 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~------~ 746 (958)
..|++.+.||+|+||.||+|.+ .++.||||++..... ....+..|+.+++++ +|+||+++++++... .
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4578888999999999999976 678899998865432 234678899999999 799999999998653 4
Q ss_pred ceEEEEeecCCCCHHHHHhCCC-CCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~-~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
.+|++|||+++++|.+++.... ....+.....++ +.+.||+|||.++ |+||||||+||++++++.+||+|||++..
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 5899999999999999987643 334444444444 4599999999988 99999999999999999999999999986
Q ss_pred ccCCcccCCCCCCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCC
Q 002160 825 KHNTFLSSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE 899 (958)
Q Consensus 825 ~~~~~~~~~s~~GT~~Y~APEvl~-----g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ 899 (958)
............|+..|+|||++. +..++.++|||||||++|+|++|..||...........+.....+...+..
T Consensus 161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (272)
T cd06637 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 240 (272)
T ss_pred cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCC
Confidence 544333344567899999999986 335788999999999999999999999876655444433222222223446
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 900 LDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 900 ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
++..+++||.+||..+|.+||++.+|+++
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 241 WSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 78999999999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=317.19 Aligned_cols=249 Identities=31% Similarity=0.516 Sum_probs=205.7
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEee
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
+|.+.+.||+|+||.||+|.. +++.|+||.+............+.+|+.++++++|+||+++++++...+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 588899999999999999976 678999999887765555677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC--
Q 002160 755 LPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS-- 832 (958)
Q Consensus 755 ~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~-- 832 (958)
+++++|.+++.+............+.+.+.||.|||..+ |+|+||+|+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 999999999987654444444444555699999999988 9999999999999999999999999988764332211
Q ss_pred --CCCCCCCCccCcccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHhhhccccccCCCCCC--cHHH
Q 002160 833 --KSTAGTPEWMAPEVLRNEP---SNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNRRLEIPKEL--DPLV 904 (958)
Q Consensus 833 --~s~~GT~~Y~APEvl~g~~---~s~ksDIWSLGiLLyELLtG~~PF~g~~~-~ei~~~i~~~~~~~~ip~~l--s~eL 904 (958)
....++..|++||++.+.. .+.++|||+||+++|+|++|+.||..... ......+. ....+.+|... ++.+
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 237 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG-AGHKPPIPDSLQLSPEG 237 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHh-cCCCCCCCcccccCHHH
Confidence 1356788999999998766 78999999999999999999999976633 33332332 23344555544 8999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 905 ARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 905 ~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.+||.+||+.+|.+||++.+|+.+
T Consensus 238 ~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 238 KDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred HHHHHHHccCCcccCCCHHHHhcC
Confidence 999999999999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.96 Aligned_cols=247 Identities=33% Similarity=0.577 Sum_probs=205.4
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
..++|++.+.||+|+||.||+++.+++.||+|.+.... ....+.+|+.++++++||||+++++++... ..++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e 78 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME 78 (254)
T ss_pred cHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence 45789999999999999999999999999999875432 235788999999999999999999998764 5799999
Q ss_pred ecCCCCHHHHHhCCCC-CccHHHHHHHHH-HHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc
Q 002160 754 FLPRGSLFRILHRPHC-QVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~-~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~ 831 (958)
|+++++|.+++..... ...+...+.++. .+.|+.|||..+ ++||||||+|||++.++.+||+|||++.......
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-- 154 (254)
T cd05083 79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-- 154 (254)
T ss_pred CCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCcEEECCCccceeccccC--
Confidence 9999999999875432 344555554444 489999999987 9999999999999999999999999987643321
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHH
Q 002160 832 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 910 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 910 (958)
.....+..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+. ...+...+..++..+.+||.+
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ 232 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-KGYRMEPPEGCPADVYVLMTS 232 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHH
Confidence 12334568999999998889999999999999999997 999998887766665553 333445566789999999999
Q ss_pred hhhcCCCCCCCHHHHHHHHHh
Q 002160 911 CWQTDPSLRPSFAQLTVALKP 931 (958)
Q Consensus 911 CL~kDP~kRPSa~EIL~~L~k 931 (958)
||+.+|.+||++++|+..|++
T Consensus 233 ~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 233 CWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HcCCChhhCcCHHHHHHHHcc
Confidence 999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=316.16 Aligned_cols=245 Identities=31% Similarity=0.561 Sum_probs=202.0
Q ss_pred EEeeccCceEEEEEEEC-CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeecCCCCH
Q 002160 682 ERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 760 (958)
Q Consensus 682 k~LG~G~fG~Vykak~~-g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~gGsL 760 (958)
++||+|+||.||++.+. ++.||+|++...... .....+.+|++++++++|+||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 36999999999999874 889999987665433 4566889999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC--CCCCC
Q 002160 761 FRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS--KSTAG 837 (958)
Q Consensus 761 ~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~--~s~~G 837 (958)
.+++.+..........+.++ +.+.+|.|||..+ |+||||||+|||++.++.+||+|||++.......... ....+
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 99997654444454444444 4489999999988 9999999999999999999999999987654221111 11223
Q ss_pred CCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCC
Q 002160 838 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDP 916 (958)
Q Consensus 838 T~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP 916 (958)
+..|+|||.+.+..++.++||||||+++|+|++ |..||...........+. .......+..++..+.+||.+||+.+|
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-SGYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh-cCCCCCCCccCCHHHHHHHHHHhccCh
Confidence 567999999998889999999999999999998 899998877665555543 223445567889999999999999999
Q ss_pred CCCCCHHHHHHHHH
Q 002160 917 SLRPSFAQLTVALK 930 (958)
Q Consensus 917 ~kRPSa~EIL~~L~ 930 (958)
.+||++.||++.|+
T Consensus 237 ~~Rp~~~ell~~l~ 250 (251)
T cd05041 237 ENRPSFSEIYNELQ 250 (251)
T ss_pred hhCcCHHHHHHHhh
Confidence 99999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=315.95 Aligned_cols=248 Identities=26% Similarity=0.454 Sum_probs=208.5
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEee
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
+|++.+.||+|+||.||++.. ++..+|||.+............+.+|+++|++++||||+++++.+...+.+++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 588999999999999999976 688899999987666556677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhCCC-CCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEcCC-CcEEEEeccccccccCCccc
Q 002160 755 LPRGSLFRILHRPH-CQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 755 ~~gGsL~d~L~k~~-~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~-g~VKL~DFGLAk~~~~~~~~ 831 (958)
+++++|.+++.+.. ....+..... +.+.+.+|.|||.++ |+|+||||+||+++.+ +.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~- 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK- 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc-
Confidence 99999999997643 2344444444 444599999999988 9999999999999854 5689999999987654322
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHh
Q 002160 832 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 911 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~C 911 (958)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+. ......++..+++++++||.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~ 236 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM-SGTFAPISDRYSPDLRQLILSM 236 (256)
T ss_pred ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHH-hcCCCCCCCCcCHHHHHHHHHH
Confidence 233568899999999998888999999999999999999999998877666555553 2334456677899999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 002160 912 WQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 912 L~kDP~kRPSa~EIL~~ 928 (958)
|..+|.+||++.+|+.+
T Consensus 237 l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 237 LNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ccCChhhCCCHHHHhhC
Confidence 99999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=321.15 Aligned_cols=250 Identities=29% Similarity=0.472 Sum_probs=203.4
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCC---HHHHHHHHHHHHHHHHcCCCceeEEeccccC--CCce
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS---GAALLEFKREVKIMRRLRHPNVVLFMGAVTR--PPNL 748 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~---~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~--~~~l 748 (958)
.+|++.+.||+|+||.||+|.. +++.||+|++...... ......+.+|+.++++++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688899999999999999976 6889999988654322 2344578899999999999999999998865 3568
Q ss_pred EEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
+++|||+++++|.+++..............+.+.+.||.|||..+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 899999999999999876554333333334445599999999987 999999999999999999999999998765321
Q ss_pred c---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHH
Q 002160 829 F---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 905 (958)
Q Consensus 829 ~---~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~ 905 (958)
. .......++..|+|||.+.+..++.++|||||||++|+|++|+.||......+...........+.++..+++.++
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHAR 239 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHH
Confidence 1 1112345888999999999988999999999999999999999999887666555554434445667778899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 002160 906 RIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 906 dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+|| +||..+|.+||+++||+.|
T Consensus 240 ~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 240 DFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred HHH-HHhcCChhhCcCHHHHhcC
Confidence 999 6888999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.24 Aligned_cols=248 Identities=29% Similarity=0.448 Sum_probs=207.4
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
++|++.+.||.|+||.||+|++ +++.||+|.+.... .......+.+|+++++.++|+||+++++++..+..+|+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 3688889999999999999986 67899999886543 23445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCC
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 833 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~ 833 (958)
|+++++|.+++... ..........+.+.+.+|.|||..+ |+||||+|+||++++++.++|+|||+++..........
T Consensus 80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (274)
T cd06609 80 YCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRN 156 (274)
T ss_pred eeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEcccccceeecccccccc
Confidence 99999999998865 2333344444455589999999988 99999999999999999999999999987755433344
Q ss_pred CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCC-CcHHHHHHHHHhh
Q 002160 834 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE-LDPLVARIIWECW 912 (958)
Q Consensus 834 s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~-ls~eL~dLI~~CL 912 (958)
...++..|+|||.+.+..++.++|||+||+++|+|++|+.||...+..+....+. ......++.. ++..+.++|.+||
T Consensus 157 ~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~l 235 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP-KNNPPSLEGNKFSKPFKDFVSLCL 235 (274)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhh-hcCCCCCcccccCHHHHHHHHHHh
Confidence 5678899999999999889999999999999999999999998877665554443 2233444444 8899999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 002160 913 QTDPSLRPSFAQLTVA 928 (958)
Q Consensus 913 ~kDP~kRPSa~EIL~~ 928 (958)
..+|++||++++++++
T Consensus 236 ~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 236 NKDPKERPSAKELLKH 251 (274)
T ss_pred hCChhhCcCHHHHhhC
Confidence 9999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=318.64 Aligned_cols=245 Identities=32% Similarity=0.548 Sum_probs=203.9
Q ss_pred EEeeccCceEEEEEEEC---Cc--EEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeecC
Q 002160 682 ERIGLGSYGEVYHADWN---GT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 756 (958)
Q Consensus 682 k~LG~G~fG~Vykak~~---g~--~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~ 756 (958)
+.||+|+||.||+|.+. ++ .||||.+...... .....+.+|+.++++++||||+++++++.. ..+++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 35899999999999862 22 6899988776544 556788999999999999999999999988 88999999999
Q ss_pred CCCHHHHHhCCC-CCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc---c
Q 002160 757 RGSLFRILHRPH-CQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL---S 831 (958)
Q Consensus 757 gGsL~d~L~k~~-~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~---~ 831 (958)
+++|.+++.+.. ....+...+.++ +.+.||+|||..+ ++||||||+|||++.++.+||+|||+++....... .
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 999999987654 334444444444 4499999999988 99999999999999999999999999987643211 1
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHH
Q 002160 832 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 910 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 910 (958)
.....++..|+|||.+.+..++.++|||||||++|+|++ |+.||...+..+....+.........+..++..+.+++.+
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 123456788999999999889999999999999999998 9999988877776666644444555667788999999999
Q ss_pred hhhcCCCCCCCHHHHHHHHH
Q 002160 911 CWQTDPSLRPSFAQLTVALK 930 (958)
Q Consensus 911 CL~kDP~kRPSa~EIL~~L~ 930 (958)
||+.+|.+||++.+|+..|.
T Consensus 237 ~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 237 CWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HCCCCcccCCCHHHHHHHhc
Confidence 99999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=326.23 Aligned_cols=250 Identities=30% Similarity=0.466 Sum_probs=206.6
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
.++|++.+.||.|+||.||++++ ++..||+|.+... .......+.+|+.++++++||||+++++++..+..+|+||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 35789999999999999999987 5788999987643 3345567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHH-HHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKM-ALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~i-a~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~ 831 (958)
||+++++|.+++.+....+.+.....+ .+.+.+|.|||..+ |+|+||||+||+++.++.++|+|||++.........
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 999999999998765444444444444 44489999999988 999999999999999999999999998765443333
Q ss_pred CCCCCCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc-ccCCCCCCcHHHH
Q 002160 832 SKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVA 905 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~-----g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~-~~~ip~~ls~eL~ 905 (958)
.....++..|++||++. +..++.++||||||+++|+|++|+.||.+.+..+....+..... ....+..++.++.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN 239 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHH
Confidence 34456899999999985 34467799999999999999999999988877665555432211 2234567889999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 002160 906 RIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 906 dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+||.+||+.+|.+||++.+++++
T Consensus 240 ~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 240 DFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHHHhccChhhCcCHHHHhcC
Confidence 99999999999999999999886
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=322.36 Aligned_cols=251 Identities=29% Similarity=0.439 Sum_probs=197.5
Q ss_pred eeEEEEeeccCceEEEEEEE------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC--CceE
Q 002160 678 LVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNLS 749 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~--~~l~ 749 (958)
|++.+.||+|+||+||++.+ ++..||+|.+.... .......+.+|+++|++++||||+++++++... ..++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 48899999999999988753 56789999886543 233456788999999999999999999987653 3589
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
+||||+++++|.+++.... ..+...+.++ +.+.||.|||..+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 lv~e~~~~~~l~~~~~~~~--l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 85 LIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EEecCCCCCCHHHHHHHcC--CCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 9999999999999987643 4444444444 4489999999988 999999999999999999999999999865432
Q ss_pred ccc---CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh--HH------------HHhhhccc
Q 002160 829 FLS---SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM--QV------------VGAVGFQN 891 (958)
Q Consensus 829 ~~~---~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~--ei------------~~~i~~~~ 891 (958)
... .....++..|+|||.+.+..++.++||||||+++|+|++|..||...... +. ........
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence 211 12233566799999999888999999999999999999999998653211 00 00011112
Q ss_pred cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 002160 892 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 933 (958)
Q Consensus 892 ~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~ 933 (958)
.....+..++..+.+|+.+||+.+|.+||++++|+..|+.+.
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 233445678899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=324.77 Aligned_cols=249 Identities=23% Similarity=0.280 Sum_probs=194.7
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEee
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
+|++.+.||+|+||.||+|++ +++.||+|.+............+.+|+.++++++||||+++++++.+...+++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 488999999999999999987 688999999876543333345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhCCCCCccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCC
Q 002160 755 LPRGSLFRILHRPHCQVDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 833 (958)
Q Consensus 755 ~~gGsL~d~L~k~~~~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~ 833 (958)
++ ++|.+++........+.... .+.+++.||.|||..+ |+||||||+|||++.++.+||+|||+++..........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcC
Confidence 96 57887776544444455444 4444599999999988 99999999999999999999999999986544333333
Q ss_pred CCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCC-CChhHHHHhhhc------------------cccc
Q 002160 834 STAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIG-MNPMQVVGAVGF------------------QNRR 893 (958)
Q Consensus 834 s~~GT~~Y~APEvl~g~~-~s~ksDIWSLGiLLyELLtG~~PF~g-~~~~ei~~~i~~------------------~~~~ 893 (958)
...++..|+|||++.+.. ++.++|||||||++|+|++|..||.. .+..+....+.. ....
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 456789999999987754 68999999999999999999988643 332222211100 0000
Q ss_pred c---------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 894 L---------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 894 ~---------~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
. .....+++++++||.+||+.||.+||++++++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0 1112467899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=327.88 Aligned_cols=250 Identities=22% Similarity=0.314 Sum_probs=198.2
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
+++|++.+.||.|+||.||+|++ +++.||+|.+...... .....+.+|+.++++++||||+++++++...+.+++||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999976 5788999988654322 22345678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHH-HHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKR-RIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~-~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~ 831 (958)
||++ ++|..++.+......+.. +..+.+.+.||.|||..+ |+||||||+|||++.++.+||+|||++.........
T Consensus 84 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 84 EYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred eccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 9997 589888876544444443 444445599999999988 999999999999999999999999999765433333
Q ss_pred CCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcc-----------------ccc
Q 002160 832 SKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-----------------NRR 893 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~-----------------~~~ 893 (958)
.....+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+... ...
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 3345678999999998764 4788999999999999999999999887654433221100 000
Q ss_pred cCC-----------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 894 LEI-----------PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 894 ~~i-----------p~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
..+ ...+++.+++||.+||+.||.+||++.|++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 011 12468899999999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=326.47 Aligned_cols=248 Identities=23% Similarity=0.284 Sum_probs=200.0
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
.|++.+.||+|+||.||++.+ +++.||||.+....... .....+.+|+.++++++|+||+.+++.+...+.+++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 377889999999999999976 67899999987654332 234557789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCC-CCccHHHH-HHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc
Q 002160 754 FLPRGSLFRILHRPH-CQVDEKRR-IKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 754 y~~gGsL~d~L~k~~-~~~~e~~~-l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~ 831 (958)
|+++++|.+++.... ....+... .++.+.+.||.|||.++ |+||||||+|||++.++.++|+|||++....... .
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-T 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-c
Confidence 999999999885432 22344433 44445599999999988 9999999999999999999999999987654322 2
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh---HHHHhhhccccccCCCCCCcHHHHHHH
Q 002160 832 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGFQNRRLEIPKELDPLVARII 908 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~---ei~~~i~~~~~~~~ip~~ls~eL~dLI 908 (958)
.....|+..|+|||++.+..++.++||||||+++|+|++|+.||...... +...... ......++..+++++++||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh-hhhhhhcCccCCHHHHHHH
Confidence 23457899999999999999999999999999999999999999875432 1111111 1223345667899999999
Q ss_pred HHhhhcCCCCCCC-----HHHHHHH
Q 002160 909 WECWQTDPSLRPS-----FAQLTVA 928 (958)
Q Consensus 909 ~~CL~kDP~kRPS-----a~EIL~~ 928 (958)
.+||+.||.+||+ ++|++.+
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHcC
Confidence 9999999999999 8899884
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=323.81 Aligned_cols=248 Identities=29% Similarity=0.451 Sum_probs=202.2
Q ss_pred eeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeec
Q 002160 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~ 755 (958)
|++.+.||+|+||.||+|.+ ++..+++|.+... .......+.+|+++++.++||||+++++++...+..++||||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 67889999999999999987 4677888887543 2345667889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCC
Q 002160 756 PRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 834 (958)
Q Consensus 756 ~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s 834 (958)
++++|..++.+......+.....++ +.+.||.|||..+ |+||||||+|||++.++.+||+|||++............
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 162 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccCCCEEEcccccccccccccccccc
Confidence 9999998886544444544444444 4489999999988 999999999999999999999999998765443333345
Q ss_pred CCCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcc-ccccCCCCCCcHHHHHHH
Q 002160 835 TAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRRLEIPKELDPLVARII 908 (958)
Q Consensus 835 ~~GT~~Y~APEvl~-----g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~-~~~~~ip~~ls~eL~dLI 908 (958)
..++..|+|||++. +..++.++|||||||++|+|++|+.||...+..+....+... ......+..++.++++||
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFL 242 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHH
Confidence 67899999999984 445678999999999999999999999887766655444221 112234566889999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHH
Q 002160 909 WECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 909 ~~CL~kDP~kRPSa~EIL~~L 929 (958)
.+||+.||.+||++.+|+++-
T Consensus 243 ~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 243 KKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred HHHccCChhhCcCHHHHhcCC
Confidence 999999999999999987653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=335.56 Aligned_cols=251 Identities=25% Similarity=0.289 Sum_probs=207.9
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEecccc--CCCceEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT--RPPNLSI 750 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~--~~~~l~L 750 (958)
.++|+.+.+|++|.||.||+|++ +++.||+|+++......-....-.+|+.+|.+++|||||.+-.+.. +-+.+||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 46899999999999999999976 7889999999766543333445679999999999999999988764 3456999
Q ss_pred EEeecCCCCHHHHHhCCC-CCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc
Q 002160 751 ITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 751 VmEy~~gGsL~d~L~k~~-~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~ 829 (958)
|||||+. +|..++..-+ .+.....+..+.|.+.|++|||.+. |+||||||+|+|++..|.+||+|||+|+.+..+.
T Consensus 155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 9999964 8888887655 4556667777777799999999999 9999999999999999999999999999998887
Q ss_pred ccCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc----------------
Q 002160 830 LSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR---------------- 892 (958)
Q Consensus 830 ~~~~s~~GT~~Y~APEvl~g~~-~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~---------------- 892 (958)
...+..+-|.+|.|||.+.|.+ |++++|+||+|||+.||+++++-|.|......+..|.....
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~ 311 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV 311 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence 7777788999999999999855 89999999999999999999999999876655544421100
Q ss_pred -------------ccCCCCC-CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 893 -------------RLEIPKE-LDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 893 -------------~~~ip~~-ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+..|+.. ++..-.+|+..+|..||.+|.|+.+.++|
T Consensus 312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 0111111 45677899999999999999999999876
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=320.08 Aligned_cols=253 Identities=32% Similarity=0.522 Sum_probs=198.1
Q ss_pred CCeeEEEEeeccCceEEEEEEE------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC--CCc
Q 002160 676 EDLVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--PPN 747 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~--~~~ 747 (958)
.+|++.+.||+|+||.||++.+ +++.||||++.... ......+.+|+++|++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 5789999999999999999974 47789999876542 3445678999999999999999999997644 346
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
+++||||+++++|.+++.+......+.....++ +.+.||.|||..+ |+||||||+||||+.++++||+|||+++...
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 899999999999999997654444555444444 4499999999988 9999999999999999999999999998654
Q ss_pred CCccc---CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHH---------------HHhhh
Q 002160 827 NTFLS---SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV---------------VGAVG 888 (958)
Q Consensus 827 ~~~~~---~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei---------------~~~i~ 888 (958)
..... .....++..|+|||++.+..++.++||||||+++|||++|..++........ ...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 32111 1112234569999999998899999999999999999998777643321100 00011
Q ss_pred ccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 002160 889 FQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 889 ~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL 932 (958)
........+..++.++.+||.+||..+|++||++.+|++.|+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11223344567889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=338.40 Aligned_cols=246 Identities=22% Similarity=0.269 Sum_probs=193.4
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCce
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l 748 (958)
+...+|++++.||+|+||.||++.. .++.||||.+.... .+.+|+++|++++|||||++++++.....+
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 3446799999999999999999975 34679999865432 346899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
++||||+. ++|.+++.............++.+++.||.|||.++ ||||||||+||||+.++.+||+|||+++.....
T Consensus 162 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred EEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 99999995 688888855444444444444555599999999988 999999999999999999999999999765432
Q ss_pred cc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhH---HHHhhhc--c-----------
Q 002160 829 FL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ---VVGAVGF--Q----------- 890 (958)
Q Consensus 829 ~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~e---i~~~i~~--~----------- 890 (958)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..... .+..+.. +
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 21 2234679999999999999999999999999999999999999997754221 0100000 0
Q ss_pred ------------cccc--CCC-----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 891 ------------NRRL--EIP-----KELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 891 ------------~~~~--~ip-----~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
..+. .++ ..++.++++||.+||..||++||++.+++.+
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 111 2356789999999999999999999999987
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=339.24 Aligned_cols=242 Identities=27% Similarity=0.352 Sum_probs=196.5
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC-----ceE
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP-----NLS 749 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~-----~l~ 749 (958)
.|...+++|.|+||.||+|.. +++.||||+......-. .+|++||+.++|||||+|..+|.... .+.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 477789999999999999976 67899999886653211 37999999999999999998885422 356
Q ss_pred EEEeecCCCCHHHHHhC----CCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcC-CCcEEEEecccccc
Q 002160 750 IITEFLPRGSLFRILHR----PHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRL 824 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k----~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~-~g~VKL~DFGLAk~ 824 (958)
|||||++. +|.++++. +........+++.+|+..||+|||.++ |+||||||.|||||. .|.+||||||.|+.
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 89999965 88888863 445666778999999999999999988 999999999999996 59999999999998
Q ss_pred ccCCcccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc-----------
Q 002160 825 KHNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR----------- 892 (958)
Q Consensus 825 ~~~~~~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~----------- 892 (958)
+..... ..++..|+.|.|||.+.|. .|+.+.||||.||++.||+-|++-|.|.+....+..+..-.+
T Consensus 176 L~~~ep-niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 176 LVKGEP-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred eccCCC-ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 765433 3567789999999999885 489999999999999999999999999776544332211000
Q ss_pred -c------c---------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 893 -R------L---------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 893 -~------~---------~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
. + -+....++++.+|+.++|..+|.+|.++.|++.+
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 0 0 0234578999999999999999999999988865
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=325.66 Aligned_cols=249 Identities=26% Similarity=0.414 Sum_probs=204.2
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
..+|++.+.||+|+||.||+|.. +++.||||.+...... ....+.+|+.+++.++|+||++++++|......|+||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 36899999999999999999975 6889999988765433 2456889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
||+++++|.+++.+.. .........+.+.+.||+|||..+ |+||||||+|||++.++.+||+|||++..........
T Consensus 97 e~~~~~~L~~~~~~~~-~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 173 (296)
T cd06654 97 EYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (296)
T ss_pred cccCCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEECccccchhcccccccc
Confidence 9999999999986542 223333334444589999999988 9999999999999999999999999987654332223
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhc-cccccCCCCCCcHHHHHHHHHh
Q 002160 833 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-QNRRLEIPKELDPLVARIIWEC 911 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~-~~~~~~ip~~ls~eL~dLI~~C 911 (958)
....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...++......+.. .......+..++..+.+||.+|
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 253 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253 (296)
T ss_pred CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHH
Confidence 345789999999999998889999999999999999999999987766443332221 1122334567889999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 002160 912 WQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 912 L~kDP~kRPSa~EIL~~ 928 (958)
|..+|.+||++.+|+.+
T Consensus 254 l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 254 LDMDVEKRGSAKELLQH 270 (296)
T ss_pred CcCCcccCcCHHHHhhC
Confidence 99999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=319.51 Aligned_cols=246 Identities=32% Similarity=0.573 Sum_probs=197.4
Q ss_pred EeeccCceEEEEEEEC--Cc--EEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCceEEEEeecCC
Q 002160 683 RIGLGSYGEVYHADWN--GT--EVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (958)
Q Consensus 683 ~LG~G~fG~Vykak~~--g~--~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~l~LVmEy~~g 757 (958)
.||+|+||.||+|++. +. .+++|.+... ........+.+|++++.++ +||||+++++++.....+++||||+++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 5899999999999863 33 4688876532 2334456788999999999 899999999999999999999999999
Q ss_pred CCHHHHHhCCCC---------------CccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccc
Q 002160 758 GSLFRILHRPHC---------------QVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 821 (958)
Q Consensus 758 GsL~d~L~k~~~---------------~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGL 821 (958)
|+|.+++.+... ...+..... +.+.+.||+|||.++ |+||||||+|||+++++.+||+|||+
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCCCeEEECCCCC
Confidence 999999875431 223444444 444489999999987 99999999999999999999999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCC
Q 002160 822 SRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 900 (958)
Q Consensus 822 Ak~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~l 900 (958)
+...... ........+..|+|||++.+..++.++||||||+++|||++ |..||.+.+..+....+. .......+..+
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~ 236 (270)
T cd05047 159 SRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPLNC 236 (270)
T ss_pred ccccchh-hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh-CCCCCCCCCcC
Confidence 8643211 11112234567999999998889999999999999999997 999998877766665553 23344556678
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 002160 901 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 933 (958)
Q Consensus 901 s~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~ 933 (958)
+.++.+|+.+||+.+|.+||++.+++..|.++.
T Consensus 237 ~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 237 DDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 899999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=325.27 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=204.3
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
++|++.+.||+|+||.||+|.. +++.||||.+....... .....+..|+++++.++|+||+++++.+......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 4789999999999999999987 57899999998765443 34567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCC-CCccHHHHHHH-HHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc-
Q 002160 753 EFLPRGSLFRILHRPH-CQVDEKRRIKM-ALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF- 829 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~-~~~~e~~~l~i-a~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~- 829 (958)
||+.+++|.+++.+.. ..+.+.....+ .+.+.+|+|||..+ |+||||||+||||+.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 9999999999987542 33444444444 44599999999988 9999999999999999999999999986532110
Q ss_pred ----------------------------ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh
Q 002160 830 ----------------------------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM 881 (958)
Q Consensus 830 ----------------------------~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ 881 (958)
.....+.||..|+|||++.+..++.++||||||+++|+|++|+.||.+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0112346889999999999988999999999999999999999999888776
Q ss_pred HHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCC----HHHHHHH
Q 002160 882 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPS----FAQLTVA 928 (958)
Q Consensus 882 ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPS----a~EIL~~ 928 (958)
.....+............++..+++||.+||..||.+||+ +++++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 239 ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 6555543222222222237899999999999999999999 7777774
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=321.43 Aligned_cols=243 Identities=27% Similarity=0.372 Sum_probs=195.7
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
++|++.+.||+|+||.||+|.+ +++.||||.+.... ......++.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 4688899999999999999976 68889999886543 33445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCC
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 833 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~ 833 (958)
|+++++|..+.. ...........+.+.||.|||+.+ |+|+||||+|||++.++.+||+|||++....... ..
T Consensus 80 ~~~~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--~~ 151 (279)
T cd06619 80 FMDGGSLDVYRK----IPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--AK 151 (279)
T ss_pred cCCCCChHHhhc----CCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--cc
Confidence 999999975532 122233333444589999999988 9999999999999999999999999997654332 23
Q ss_pred CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh-------HHHHhhhccccccCC-CCCCcHHHH
Q 002160 834 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-------QVVGAVGFQNRRLEI-PKELDPLVA 905 (958)
Q Consensus 834 s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~-------ei~~~i~~~~~~~~i-p~~ls~eL~ 905 (958)
...|+..|+|||++.+..++.++|+||||+++|+|++|+.||...... +....+. ....... ....+++++
T Consensus 152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 230 (279)
T cd06619 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV-DEDPPVLPVGQFSEKFV 230 (279)
T ss_pred CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh-ccCCCCCCCCcCCHHHH
Confidence 467899999999999988999999999999999999999999653221 2222221 1112222 235788999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 002160 906 RIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 906 dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+||.+||+.+|.+||++++++++
T Consensus 231 ~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 231 HFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHHHhhCChhhCCCHHHHhcC
Confidence 99999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=315.45 Aligned_cols=249 Identities=31% Similarity=0.461 Sum_probs=204.0
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
++|++++.||.|+||.||+|.+ ++..+++|++....... ....+.+|+.+|+.++|+||+++++.+...+.+++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 4789999999999999999976 67889999886554433 56788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCC--CCccHH-HHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc
Q 002160 754 FLPRGSLFRILHRPH--CQVDEK-RRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 830 (958)
Q Consensus 754 y~~gGsL~d~L~k~~--~~~~e~-~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~ 830 (958)
|+++++|.+++.... ....+. ....+.+++.||.|||..+ |+||||||+||++++++.+||+|||++........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999987532 233443 3444455599999999988 99999999999999999999999999876544322
Q ss_pred c----CCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCC-----CCC
Q 002160 831 S----SKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP-----KEL 900 (958)
Q Consensus 831 ~----~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip-----~~l 900 (958)
. .....|+..|++||++... .++.++|+||||+++|+|++|+.||...+..+........ ....++ ..+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN-DPPSLETGADYKKY 236 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC-CCCCcCCccccccc
Confidence 1 2345689999999998876 6889999999999999999999999887766554444222 122222 256
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 901 DPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 901 s~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+..+++|+.+||..||.+||++.+|++|
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 237 SKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 7899999999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=324.70 Aligned_cols=258 Identities=29% Similarity=0.520 Sum_probs=208.1
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCc----EEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~----~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~ 746 (958)
+..++|++.+.||+|+||.||+|.+ ++. .||+|.+.... ......++.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 3456889999999999999999976 444 47888775433 333445788999999999999999999998754
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
..++++||+++|+|.+++........+...+.++ +.+.||.|||.++ |+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCCCceEEccccccccc
Confidence 5679999999999999988765545555555444 4489999999988 999999999999999999999999999865
Q ss_pred cCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcH
Q 002160 826 HNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 902 (958)
Q Consensus 826 ~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~ 902 (958)
..... ......++..|+|||++.+..++.++||||||+++|||++ |+.||.+....+....+. .......+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-KGERLPQPPICTI 238 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCH
Confidence 43221 1222345778999999999999999999999999999997 999998876555544443 3334445567889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 903 LVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 903 eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
.+.+++.+||..+|++||++.+|++.|+++.+.
T Consensus 239 ~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 239 DVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999999999988544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=319.75 Aligned_cols=253 Identities=29% Similarity=0.435 Sum_probs=199.1
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEecccc-----
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVT----- 743 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~----- 743 (958)
....++|++.+.||+|+||.||++++ +++.||+|++..... ....+.+|+.+++++ +||||+++++++.
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 34568899999999999999999976 678999998754321 234677899999999 7999999999873
Q ss_pred CCCceEEEEeecCCCCHHHHHhC---CCCCccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEec
Q 002160 744 RPPNLSIITEFLPRGSLFRILHR---PHCQVDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 819 (958)
Q Consensus 744 ~~~~l~LVmEy~~gGsL~d~L~k---~~~~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DF 819 (958)
..+.+++||||+++++|.+++.. ......+.... ...+.+.||.|||.++ |+||||||+||+++.++.+||+||
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECCCCCEEEccC
Confidence 44568999999999999988752 22233444334 3444589999999988 999999999999999999999999
Q ss_pred cccccccCCcccCCCCCCCCCccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccc-cc
Q 002160 820 GLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-----EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RR 893 (958)
Q Consensus 820 GLAk~~~~~~~~~~s~~GT~~Y~APEvl~g-----~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~-~~ 893 (958)
|+++.............|++.|+|||++.+ ..++.++|||||||++|+|++|+.||................ ..
T Consensus 169 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (286)
T cd06638 169 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPT 248 (286)
T ss_pred CceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCc
Confidence 998876443333344568999999999853 447889999999999999999999998776554433332111 12
Q ss_pred cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002160 894 LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 894 ~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L 929 (958)
...+..++..+.+||.+||+.||++||++.+|++++
T Consensus 249 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 249 LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 223556788999999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=324.12 Aligned_cols=249 Identities=28% Similarity=0.462 Sum_probs=206.3
Q ss_pred CCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEE
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LV 751 (958)
.+.+|++.+.||.|+||.||+|.. +++.|+||.+...... ....+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 346799999999999999999975 7889999988654332 345678999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhCCCCCccHHHHHHH-HHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc
Q 002160 752 TEFLPRGSLFRILHRPHCQVDEKRRIKM-ALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 830 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~~e~~~l~i-a~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~ 830 (958)
|||+++++|..++.+.. ..+.....+ .+.+.+++|||.++ |+||||||+||+++.++.+||+|||++........
T Consensus 95 ~e~~~~~~L~~~~~~~~--l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 95 MEYLAGGSLTDVVTETC--MDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred EEecCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 99999999999887542 344444444 44489999999998 99999999999999999999999999876544333
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhc-cccccCCCCCCcHHHHHHHH
Q 002160 831 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-QNRRLEIPKELDPLVARIIW 909 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~-~~~~~~ip~~ls~eL~dLI~ 909 (958)
......++..|+|||.+.+..++.++|||||||++|+|++|+.||.+.+.......+.. .......+..+++.+.+||.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 250 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLN 250 (296)
T ss_pred cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHH
Confidence 23345688999999999998899999999999999999999999988776554433321 12233456678999999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 002160 910 ECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 910 ~CL~kDP~kRPSa~EIL~~ 928 (958)
+||..||.+||++.+|+++
T Consensus 251 ~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 251 RCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred HHhhcChhhCCCHHHHhhC
Confidence 9999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=331.94 Aligned_cols=250 Identities=24% Similarity=0.371 Sum_probs=214.1
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
+.|++.++||+|.|+.||++.+ +|+.+|+|++....+.....+++.+|++|-+.|+|||||+|.+........|||+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 5678888999999999999965 78999999988777777778899999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEc---CCCcEEEEeccccccccCCcc
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVD---KNWNVKVSDFGLSRLKHNTFL 830 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId---~~g~VKL~DFGLAk~~~~~~~ 830 (958)
+++|++|..-+-++....+....-++.+++.+|.|+|..+ |||||+||+|+|+- ..--+||+|||+|..+... .
T Consensus 91 ~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g-~ 167 (355)
T KOG0033|consen 91 LVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG-E 167 (355)
T ss_pred cccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeCCc-c
Confidence 9999999754444333444455566777799999999998 99999999999995 3456999999999988743 3
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccC--CCCCCcHHHHHHH
Q 002160 831 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE--IPKELDPLVARII 908 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~--ip~~ls~eL~dLI 908 (958)
....++|||.|||||++...+|+..+|||+-|+|||-|+.|.+||.+.+...+++.|....-... ...+++++.++||
T Consensus 168 ~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~Lv 247 (355)
T KOG0033|consen 168 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLI 247 (355)
T ss_pred ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHH
Confidence 34568899999999999999999999999999999999999999999888888888854433222 2357899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 002160 909 WECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 909 ~~CL~kDP~kRPSa~EIL~~ 928 (958)
++||..||.+|.++.|.++|
T Consensus 248 rrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 248 RRMLTVNPKKRITADEALKH 267 (355)
T ss_pred HHHhccChhhhccHHHHhCC
Confidence 99999999999999887654
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=322.29 Aligned_cols=250 Identities=28% Similarity=0.364 Sum_probs=199.4
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
++|++.+.||+|+||.||+|.+ +++.||+|++............+.+|+++++.++||||+++++++..+..+|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 4689999999999999999987 57899999876654443445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
|++++.|..+...... ..+..... +.+++.+|.|||..+ |+|+||+|+||++++++.++|+|||++..........
T Consensus 81 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07846 81 FVDHTVLDDLEKYPNG-LDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 157 (286)
T ss_pred cCCccHHHHHHhccCC-CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence 9999999887765443 34444444 444599999999988 9999999999999999999999999988764443333
Q ss_pred CCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccc--------------------
Q 002160 833 KSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-------------------- 891 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~-------------------- 891 (958)
....++..|+|||++.+ ..++.++||||||+++|+|++|+.||......+....+....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 44568899999999876 446789999999999999999999997665433222211000
Q ss_pred ccc---------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 892 RRL---------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 892 ~~~---------~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
..+ .....++..+.+|+.+||+.+|.+||++.+|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000 0123567889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=313.80 Aligned_cols=249 Identities=31% Similarity=0.453 Sum_probs=208.8
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
++|++.+.||+|++|.||+|++ +++.|+||++...... .....+.+|+.++.+++|+||+++++++.....+++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 4688999999999999999977 5889999998765432 446788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHh-cCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~-~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
|+++++|.+++..............+.+.+.++.|||. .+ ++||||+|+||+++.++.++|+|||++..........
T Consensus 80 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 157 (264)
T cd06623 80 YMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC 157 (264)
T ss_pred ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence 99999999999865444444444445555999999999 87 9999999999999999999999999988765443333
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---hhHHHHhhhccccccCCCCC-CcHHHHHHH
Q 002160 833 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN---PMQVVGAVGFQNRRLEIPKE-LDPLVARII 908 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~---~~ei~~~i~~~~~~~~ip~~-ls~eL~dLI 908 (958)
....++..|+|||.+.+..++.++|+|+||+++|+|++|+.||.... ..+....+. ......++.. ++..+.++|
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li 236 (264)
T cd06623 158 NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPPSLPAEEFSPEFRDFI 236 (264)
T ss_pred cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCCCCCCcccCCHHHHHHH
Confidence 34568899999999999889999999999999999999999998774 334444443 3334445555 889999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 002160 909 WECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 909 ~~CL~kDP~kRPSa~EIL~~ 928 (958)
.+||..+|.+||++.+|+.+
T Consensus 237 ~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 237 SACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHccCChhhCCCHHHHHhC
Confidence 99999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=322.64 Aligned_cols=248 Identities=24% Similarity=0.398 Sum_probs=201.5
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
++|++++.||+|+||.||++++ .++.||+|.+... ........+.+|++++++++|+||+++++++...+.+|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 4688999999999999999987 5889999988654 344456788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCC--CCccHHHHH-HHHHHHHHHHHHHh-cCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc
Q 002160 754 FLPRGSLFRILHRPH--CQVDEKRRI-KMALDARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 754 y~~gGsL~d~L~k~~--~~~~e~~~l-~ia~~a~aL~yLH~-~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~ 829 (958)
|+++++|..++.... ....+.... ...+++.+|.|||. ++ |+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 999999999887631 233444444 44445899999996 46 9999999999999999999999999987653322
Q ss_pred ccCCCCCCCCCccCcccccCCC------CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhh--ccccccCCCCCCc
Q 002160 830 LSSKSTAGTPEWMAPEVLRNEP------SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG--FQNRRLEIPKELD 901 (958)
Q Consensus 830 ~~~~s~~GT~~Y~APEvl~g~~------~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~--~~~~~~~ip~~ls 901 (958)
.....++..|+|||.+.+.. ++.++|||||||++|+|++|+.||...........+. .......++..++
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd06622 158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYS 235 (286)
T ss_pred --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccC
Confidence 23346888999999986543 4789999999999999999999997655444333221 1233455667799
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 902 PLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 902 ~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.++.+||.+||+.+|.+||++.+|+.+
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 236 DDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 999999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=376.56 Aligned_cols=269 Identities=24% Similarity=0.365 Sum_probs=231.9
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~ 746 (958)
......++|+|+++||+|+||.|.++++ +++.||+|++.+... ......-|..|..||.--+.+=||+++.+|++..
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 4556778999999999999999999987 678899998876442 2344566889999999888999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
++|+||||++||+|-.++.+.....+...++|.+.++.||.-||+.| +|||||||+|||||..|||||+|||.+..+.
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 99999999999999999998876667778899999999999999998 9999999999999999999999999876654
Q ss_pred -CCcccCCCCCCCCCccCccccc----C-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCC--C
Q 002160 827 -NTFLSSKSTAGTPEWMAPEVLR----N-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--K 898 (958)
Q Consensus 827 -~~~~~~~s~~GT~~Y~APEvl~----g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip--~ 898 (958)
+....+...+|||.|++||++. + +.|++.+|||||||++|||+.|..||+.....+.+.+|......+.|| .
T Consensus 227 ~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~ 306 (1317)
T KOG0612|consen 227 ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDET 306 (1317)
T ss_pred CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCccc
Confidence 4455567788999999999985 3 558999999999999999999999999999999999997666677888 5
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCC---HHHHHHHH-------HhhhhhcCCCCC
Q 002160 899 ELDPLVARIIWECWQTDPSLRPS---FAQLTVAL-------KPLQRLVIPSHP 941 (958)
Q Consensus 899 ~ls~eL~dLI~~CL~kDP~kRPS---a~EIL~~L-------~kL~k~~~p~~P 941 (958)
.+++++++||.+++ .+|+.|.. +.+|..|- ..|.....|-.|
T Consensus 307 ~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vP 358 (1317)
T KOG0612|consen 307 DVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVP 358 (1317)
T ss_pred ccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCC
Confidence 68999999999988 67889987 99998774 244555555555
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=320.34 Aligned_cols=251 Identities=24% Similarity=0.326 Sum_probs=201.4
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
++|++.+.||+|+||.||+|.+ +++.||||++............+.+|++++++++|+||+++++++...+.+++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 3689999999999999999987 57889999887654444455678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc-cC
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL-SS 832 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~-~~ 832 (958)
|++++.|..+..+............+.+.+.||.|||..+ |+||||+|+||++++++.+||+|||++........ ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence 9998777766665444444444444555599999999988 99999999999999999999999999887654432 23
Q ss_pred CCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhc-------------------cc-
Q 002160 833 KSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-------------------QN- 891 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~-------------------~~- 891 (958)
....++..|+|||++.+. .++.++||||||+++|+|++|+.||.+.........+.. ..
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 346688999999999887 789999999999999999999999987654432211100 00
Q ss_pred c----------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 892 R----------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 892 ~----------~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
. ...++..++.++++||.+||..+|++||++++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0 001233458899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=321.19 Aligned_cols=248 Identities=29% Similarity=0.457 Sum_probs=206.5
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
..|+..+.||.|+||.||+|.+ +++.||||.+..... ......+.+|+.+++++.|+||+++++++.+...+++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 3577788899999999999976 578999998875432 3445688999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCC
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 833 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~ 833 (958)
|+++++|.+++.... .........+.+.+.+|.|||..+ ++|+||+|+||+++.++.++|+|||++...........
T Consensus 83 ~~~~~~L~~~i~~~~-l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06640 83 YLGGGSALDLLRAGP-FDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred cCCCCcHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCCCCEEEcccccceeccCCccccc
Confidence 999999999987543 233333334445589999999987 99999999999999999999999999977654333333
Q ss_pred CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhh
Q 002160 834 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 913 (958)
Q Consensus 834 s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~ 913 (958)
...++..|+|||++.+..++.++|+||||+++|+|++|..||...++......+. ....+.++..++..+.+||.+||+
T Consensus 160 ~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06640 160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP-KNNPPTLTGEFSKPFKEFIDACLN 238 (277)
T ss_pred cccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh-cCCCCCCchhhhHHHHHHHHHHcc
Confidence 4568889999999998889999999999999999999999998877665554432 333445566788999999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 002160 914 TDPSLRPSFAQLTVA 928 (958)
Q Consensus 914 kDP~kRPSa~EIL~~ 928 (958)
.+|.+||++.+++.+
T Consensus 239 ~~p~~Rp~~~~il~~ 253 (277)
T cd06640 239 KDPSFRPTAKELLKH 253 (277)
T ss_pred cCcccCcCHHHHHhC
Confidence 999999999999887
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=334.66 Aligned_cols=246 Identities=24% Similarity=0.316 Sum_probs=195.0
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC------Cc
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------PN 747 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~------~~ 747 (958)
++|++.+.||+|+||.||+|.+ +++.||||++............+.+|+++|++++||||+++++++... ..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 6799999999999999999976 678899999876543333455678999999999999999999987543 34
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
+|++||++ +++|.+++... .......+..+.+++.||.|||.++ |+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~~~~~~~~-~~~l~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 95 VYLVTNLM-GADLNNIVKCQ-KLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQADD 170 (343)
T ss_pred EEEEeecC-CCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCCCCEEEcCCccceecCC
Confidence 78999998 78998887643 2334444445555699999999998 99999999999999999999999999986543
Q ss_pred CcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccc---------------
Q 002160 828 TFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN--------------- 891 (958)
Q Consensus 828 ~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~--------------- 891 (958)
. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 171 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07878 171 E---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247 (343)
T ss_pred C---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhh
Confidence 2 234678999999999987 568899999999999999999999998766543332221000
Q ss_pred ------cccCC--------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 892 ------RRLEI--------PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 892 ------~~~~i--------p~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
..... ....++.+.+||.+||+.||.+||++.|++.|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00001 12356778999999999999999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=319.03 Aligned_cols=254 Identities=32% Similarity=0.510 Sum_probs=204.8
Q ss_pred CCCeeEEEEeeccCceEEEEEEEC------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC--CC
Q 002160 675 WEDLVLGERIGLGSYGEVYHADWN------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--PP 746 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~~------g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~--~~ 746 (958)
..+|++.+.||+|+||.||++++. ++.||||.+...... .....+.+|+++++.+.|+||+++++++.. ..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 356888899999999999999863 678999998765433 356689999999999999999999999877 55
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
..+++|||+++++|.+++.+......+.....++.+ +.||+|||..+ |+||||||+|||++.++.+||+|||++...
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 789999999999999999876655555555555444 89999999988 999999999999999999999999999876
Q ss_pred cCCccc---CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhH---------------HHHhh
Q 002160 826 HNTFLS---SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ---------------VVGAV 887 (958)
Q Consensus 826 ~~~~~~---~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~e---------------i~~~i 887 (958)
...... .....++..|++||.+.+..++.++||||||+++|||++|..||....... ....+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 532111 112335567999999998889999999999999999999999986542221 11111
Q ss_pred hccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 002160 888 GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 888 ~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL 932 (958)
....+...+..++.++.+|+.+||+.+|.+||++.+|+..|+++
T Consensus 240 -~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 240 -KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred -HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 12233344566789999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=312.08 Aligned_cols=248 Identities=38% Similarity=0.653 Sum_probs=204.9
Q ss_pred eeEEEEeeccCceEEEEEEECC------cEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEE
Q 002160 678 LVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~~g------~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LV 751 (958)
+++.+.||.|+||.||++++.. ..||+|.+.... .......+..|+.+++.++|+||+++++++...+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 3567889999999999998743 779999885543 222566889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhCCCCC-ccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc
Q 002160 752 TEFLPRGSLFRILHRPHCQ-VDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~-~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~ 829 (958)
|||+++++|.+++...... ..+.....++ +.+.+|+|||..+ ++||||||+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999998765442 4454444444 4489999999998 9999999999999999999999999998664432
Q ss_pred ccCC-CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHH
Q 002160 830 LSSK-STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 907 (958)
Q Consensus 830 ~~~~-s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dL 907 (958)
.... ...++..|+|||.+.+..++.++|||+||+++|+|++ |..||...+..+....+. .......+..++.++.++
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 236 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLK-KGYRLPKPENCPPEIYKL 236 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCCCcCCHHHHHH
Confidence 1111 2336789999999988889999999999999999998 889998877766666654 334455667789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHH
Q 002160 908 IWECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 908 I~~CL~kDP~kRPSa~EIL~~L 929 (958)
+.+||..||.+||++.++++.|
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 237 MLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHCcCChhhCcCHHHHHhhC
Confidence 9999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=315.42 Aligned_cols=251 Identities=30% Similarity=0.464 Sum_probs=199.3
Q ss_pred CCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEE
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LV 751 (958)
..+.+.....||+|+||.||+|++ ++..||+|.+.... ......+.+|+.++++++|+||+++++++..++..++|
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 334444556899999999999976 56789999876543 33456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhCCCCCc--cHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcC-CCcEEEEeccccccccC
Q 002160 752 TEFLPRGSLFRILHRPHCQV--DEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~--~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~-~g~VKL~DFGLAk~~~~ 827 (958)
|||+++++|.+++....... .+.... ...+.+.||+|||..+ |+||||||+||+++. ++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 99999999999987543222 333333 3445599999999987 999999999999986 67999999999876543
Q ss_pred CcccCCCCCCCCCccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCChhH-HHHhhhccccccCCCCCCcHHH
Q 002160 828 TFLSSKSTAGTPEWMAPEVLRNEP--SNEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGFQNRRLEIPKELDPLV 904 (958)
Q Consensus 828 ~~~~~~s~~GT~~Y~APEvl~g~~--~s~ksDIWSLGiLLyELLtG~~PF~g~~~~e-i~~~i~~~~~~~~ip~~ls~eL 904 (958)
.........|+..|+|||.+.+.. ++.++||||||+++|+|++|+.||....... .............++..+++++
T Consensus 162 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (268)
T cd06624 162 INPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEA 241 (268)
T ss_pred CCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHH
Confidence 322233456889999999987643 7889999999999999999999997654322 2222222233456777899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 905 ARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 905 ~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
++||.+||+.+|.+||++.+|+.+
T Consensus 242 ~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 242 KNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred HHHHHHHcCCCchhCCCHHHHHhC
Confidence 999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=313.60 Aligned_cols=249 Identities=28% Similarity=0.474 Sum_probs=206.4
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEee
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
+|.+.+.||+|+||.||+|.+ ++..||+|.+............+.+|++++++++|+||+++++.+.....+++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 488999999999999999987 578899999876554444556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhCCCC-CccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCC-cEEEEeccccccccCCccc
Q 002160 755 LPRGSLFRILHRPHC-QVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 755 ~~gGsL~d~L~k~~~-~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g-~VKL~DFGLAk~~~~~~~~ 831 (958)
+++++|.+++.+... ...+.....++ +.+.+|.|||..+ |+|+||||+||++++++ .+||+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL 158 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccCCccc
Confidence 999999998865432 34455444444 4489999999988 99999999999999875 4799999998776543333
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHh
Q 002160 832 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 911 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~C 911 (958)
.....|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+..+....+. ......++..++..++++|.+|
T Consensus 159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~ 237 (257)
T cd08225 159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC-QGYFAPISPNFSRDLRSLISQL 237 (257)
T ss_pred ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-cccCCCCCCCCCHHHHHHHHHH
Confidence 334568999999999998889999999999999999999999998877666555443 2233344556789999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 002160 912 WQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 912 L~kDP~kRPSa~EIL~~ 928 (958)
|..+|++||++.+|+++
T Consensus 238 l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 238 FKVSPRDRPSITSILKR 254 (257)
T ss_pred hccChhhCcCHHHHhhC
Confidence 99999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=320.96 Aligned_cols=253 Identities=31% Similarity=0.501 Sum_probs=200.2
Q ss_pred CCeeEEEEeeccCceEEEEEEE------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC--Cc
Q 002160 676 EDLVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PN 747 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~--~~ 747 (958)
.-|++.+.||+|+||.||++++ .+..||+|.+.... .......+.+|++++++++||||+++++++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 3478899999999999999974 46789999876543 334456789999999999999999999998775 56
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
.++||||+++++|.+++.+......+...+.++ +.+.||+|||..+ |+||||||+|||++.++.+||+|||++....
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCCCCEEECCCccccccc
Confidence 899999999999999987654444555545444 4489999999988 9999999999999999999999999998654
Q ss_pred CCcc---cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---------------hHHHHhhh
Q 002160 827 NTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP---------------MQVVGAVG 888 (958)
Q Consensus 827 ~~~~---~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~---------------~ei~~~i~ 888 (958)
.... ......++..|+|||++.+..++.++||||||+++|+|++++.|+..... ......+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 239 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL- 239 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH-
Confidence 3221 11234567789999999988899999999999999999998766432110 0011111
Q ss_pred ccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 002160 889 FQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 889 ~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL 932 (958)
........+..++..+.+||.+||+.+|.+||++.+|++.|+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 12233445667899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=317.76 Aligned_cols=245 Identities=24% Similarity=0.332 Sum_probs=206.0
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
+|++.+.||.|+||.||+|++ +++.||+|.+...... ......+.+|++++++++||||+++++++.....+++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 488999999999999999987 5889999998765433 2456788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCC
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 833 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~ 833 (958)
|+.+++|.+++.+...........++.+++.+|.|||.++ |+|+||||+||++++++.++|+|||++....... ...
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 157 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LTT 157 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCCCCEEEeecccccccCCCc-ccc
Confidence 9999999999987644444445555555699999999988 9999999999999999999999999987654432 223
Q ss_pred CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---hHHHHhhhccccccCCCCCCcHHHHHHHHH
Q 002160 834 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP---MQVVGAVGFQNRRLEIPKELDPLVARIIWE 910 (958)
Q Consensus 834 s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~---~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 910 (958)
...|+..|+|||++.+..++.++|+||||+++|+|++|..||...+. .+..... ......++..++..+.++|.+
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~ 235 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ--ETADVLYPATWSTEAIDAINK 235 (258)
T ss_pred ccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh--ccccccCcccCcHHHHHHHHH
Confidence 45688999999999988899999999999999999999999987763 3333322 224566777889999999999
Q ss_pred hhhcCCCCCCCH--HHHH
Q 002160 911 CWQTDPSLRPSF--AQLT 926 (958)
Q Consensus 911 CL~kDP~kRPSa--~EIL 926 (958)
||+.||.+||++ ++++
T Consensus 236 ~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 236 LLERDPQKRLGDNLKDLK 253 (258)
T ss_pred HccCChhHcCCccHHHHh
Confidence 999999999999 6554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=323.85 Aligned_cols=251 Identities=28% Similarity=0.377 Sum_probs=203.4
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEE
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~L 750 (958)
+..++|++.+.||+|+||+||++.+ +++.||+|++.... .......+.+|+++++.++||||+++++++...+.+++
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 4457899999999999999999987 48899999876543 33446688999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHh-cCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc
Q 002160 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 751 VmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~-~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~ 829 (958)
||||+++++|.+++.+.+............+.+.+|.|||. ++ |+||||||+||++++++.++|+|||++......
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 99999999999998775544334444444455899999996 56 999999999999999999999999998654322
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh-----------HHHHhhhccccccCCCC
Q 002160 830 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-----------QVVGAVGFQNRRLEIPK 898 (958)
Q Consensus 830 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~-----------ei~~~i~~~~~~~~ip~ 898 (958)
......|+..|+|||++.+..++.++|||||||++|+|++|..||...... +....+. ......++.
T Consensus 158 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 235 (284)
T cd06620 158 -IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV-QEPPPRLPS 235 (284)
T ss_pred -ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-hccCCCCCc
Confidence 123457899999999998888899999999999999999999999865442 1222221 122233333
Q ss_pred -CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002160 899 -ELDPLVARIIWECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 899 -~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L 929 (958)
.++.++.+||.+||++||.+||++.|++++.
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 3788999999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=322.46 Aligned_cols=246 Identities=27% Similarity=0.458 Sum_probs=203.2
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEee
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
.|.+.+.||+|+||.||+|.+ .++.||||.+..... ......+.+|+.++++++||||+++++++.....+|+||||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 466677899999999999976 577899998765432 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhCCCCCccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCC
Q 002160 755 LPRGSLFRILHRPHCQVDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 833 (958)
Q Consensus 755 ~~gGsL~d~L~k~~~~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~ 833 (958)
+++++|.+++... ...+.... .+.+.+.|+.|||..+ |+|+||+|+||++++++.+||+|||++...........
T Consensus 84 ~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06642 84 LGGGSALDLLKPG--PLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred cCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCCCCEEEccccccccccCcchhhh
Confidence 9999999988653 23333333 3444589999999987 99999999999999999999999999976654333333
Q ss_pred CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhh
Q 002160 834 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 913 (958)
Q Consensus 834 s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~ 913 (958)
...|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...........+. ......++..++..+.+||.+||+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP-KNSPPTLEGQYSKPFKEFVEACLN 238 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh-cCCCCCCCcccCHHHHHHHHHHcc
Confidence 4568899999999999889999999999999999999999998766555444332 233444556688999999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 002160 914 TDPSLRPSFAQLTVA 928 (958)
Q Consensus 914 kDP~kRPSa~EIL~~ 928 (958)
.+|.+||++.+|+++
T Consensus 239 ~~p~~Rp~~~~il~~ 253 (277)
T cd06642 239 KDPRFRPTAKELLKH 253 (277)
T ss_pred CCcccCcCHHHHHHh
Confidence 999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=363.84 Aligned_cols=255 Identities=24% Similarity=0.340 Sum_probs=202.7
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC--CC
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--PP 746 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~--~~ 746 (958)
.+....+|++++.||+|+||.||+|++ .+..||+|.+............|..|+.+|++|+|||||+++++|.. ..
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 455668999999999999999999987 57789999988776666667789999999999999999999998854 35
Q ss_pred ceEEEEeecCCCCHHHHHhCC---CCCccHHHHHH-HHHHHHHHHHHHhcC-----CcEeecCCCCCceEEcC-------
Q 002160 747 NLSIITEFLPRGSLFRILHRP---HCQVDEKRRIK-MALDARGMNCLHTST-----PTIVHRDLKSPNLLVDK------- 810 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~---~~~~~e~~~l~-ia~~a~aL~yLH~~g-----~gIIHRDLKPeNILId~------- 810 (958)
.+||||||+++++|.++|... ...+.+...+. +.+++.||.|||..+ .+||||||||+||||+.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 689999999999999988642 12344444444 445599999999854 35999999999999964
Q ss_pred ----------CCcEEEEeccccccccCCcccCCCCCCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 002160 811 ----------NWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIGM 878 (958)
Q Consensus 811 ----------~g~VKL~DFGLAk~~~~~~~~~~s~~GT~~Y~APEvl~g--~~~s~ksDIWSLGiLLyELLtG~~PF~g~ 878 (958)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||||||+|++|..||...
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 3459999999998654332 2234579999999999864 45789999999999999999999999876
Q ss_pred ChhHHHHhhhccccccCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 879 NPMQVVGAVGFQNRRLEIP-KELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 879 ~~~ei~~~i~~~~~~~~ip-~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+....+....... +.++ ..++.++.+||.+||..+|.+||++.|++.+
T Consensus 247 ~~~~qli~~lk~~--p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 247 NNFSQLISELKRG--PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CcHHHHHHHHhcC--CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 5443332222121 2222 3578999999999999999999999999864
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=319.47 Aligned_cols=250 Identities=28% Similarity=0.413 Sum_probs=198.5
Q ss_pred CCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccC------
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTR------ 744 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~------ 744 (958)
....|++.+.||.|+||.||+|++ .++.||+|.+.... ....++..|+.+++++ +|+||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 346789999999999999999987 67889999875432 3345688899999999 79999999999853
Q ss_pred CCceEEEEeecCCCCHHHHHhCCC-CCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccc
Q 002160 745 PPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 822 (958)
Q Consensus 745 ~~~l~LVmEy~~gGsL~d~L~k~~-~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLA 822 (958)
...+|++|||+++|+|.+++.... ....+..... +.+++.||.|||.++ |+||||||+||++++++.++|+|||++
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCcch
Confidence 456899999999999999886533 2334444333 444599999999988 999999999999999999999999998
Q ss_pred ccccCCcccCCCCCCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCC
Q 002160 823 RLKHNTFLSSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 897 (958)
Q Consensus 823 k~~~~~~~~~~s~~GT~~Y~APEvl~-----g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip 897 (958)
..............|+..|+|||++. +..++.++|||||||++|+|++|..||....+.+....+..........
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 248 (282)
T cd06636 169 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKS 248 (282)
T ss_pred hhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcc
Confidence 76543333334567899999999986 3457889999999999999999999998776554443332221122223
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 898 KELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 898 ~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
..++..+.+||.+||+.||.+||++.||+++
T Consensus 249 ~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 249 KKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred cccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 4678999999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.89 Aligned_cols=244 Identities=25% Similarity=0.382 Sum_probs=189.9
Q ss_pred EeeccCceEEEEEEEC----CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeecCCC
Q 002160 683 RIGLGSYGEVYHADWN----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758 (958)
Q Consensus 683 ~LG~G~fG~Vykak~~----g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~gG 758 (958)
.||+|+||.||+|++. +..+|+|.+..... ......+.+|+.++++++||||+++++++.+...+++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 5899999999999753 35699998765542 334457889999999999999999999999999999999999999
Q ss_pred CHHHHHhCCC----CCccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc--cc
Q 002160 759 SLFRILHRPH----CQVDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LS 831 (958)
Q Consensus 759 sL~d~L~k~~----~~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~--~~ 831 (958)
+|.+++.... ....+.... ...+.+.||.|||..+ |+||||||+||+++.++++||+|||+++...... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 9999986432 122333333 3344589999999988 9999999999999999999999999987543322 11
Q ss_pred CCCCCCCCCccCcccccCC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhcc----ccccCCCCC
Q 002160 832 SKSTAGTPEWMAPEVLRNE-------PSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQ----NRRLEIPKE 899 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~g~-------~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~----~~~~~ip~~ 899 (958)
.....++..|+|||++.+. .++.++||||||+++|||++ |..||......+........ ...+.+...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 2234578899999998643 34789999999999999996 99999877666544332111 111222335
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002160 900 LDPLVARIIWECWQTDPSLRPSFAQLTVALK 930 (958)
Q Consensus 900 ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~ 930 (958)
++..+.+++.+|| .+|++||++++|++.|+
T Consensus 239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 239 LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 6789999999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=324.38 Aligned_cols=248 Identities=26% Similarity=0.421 Sum_probs=203.6
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
.+|.+.+.||.|+||.||++.. +++.||||.+...... ....+.+|+.+++.++|+||++++++|...+.+|+|||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 6899999999999999999975 6889999998654432 24567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCC
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 833 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~ 833 (958)
|+++++|.+++.+.. .........+.+.+.+|.|||..+ |+||||||+|||++.++.+||+|||++...........
T Consensus 97 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 173 (297)
T cd06656 97 YLAGGSLTDVVTETC-MDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173 (297)
T ss_pred ccCCCCHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEECcCccceEccCCccCcC
Confidence 999999999986543 222333333444489999999988 99999999999999999999999999876544333333
Q ss_pred CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhc-cccccCCCCCCcHHHHHHHHHhh
Q 002160 834 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-QNRRLEIPKELDPLVARIIWECW 912 (958)
Q Consensus 834 s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~-~~~~~~ip~~ls~eL~dLI~~CL 912 (958)
...+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.+.......+.. .......+..++..+++||.+||
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 253 (297)
T cd06656 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCL 253 (297)
T ss_pred cccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHc
Confidence 45688999999999998899999999999999999999999987665433322221 11223345678899999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 002160 913 QTDPSLRPSFAQLTVA 928 (958)
Q Consensus 913 ~kDP~kRPSa~EIL~~ 928 (958)
+.+|.+||++.+|+++
T Consensus 254 ~~~p~~Rps~~~il~~ 269 (297)
T cd06656 254 EMDVDRRGSAKELLQH 269 (297)
T ss_pred cCChhhCcCHHHHhcC
Confidence 9999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=322.79 Aligned_cols=254 Identities=26% Similarity=0.359 Sum_probs=203.8
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
++|++.+.||+|+||.||++.+ .++.|+||.+...... ......+.+|+++++.++||||+++++.+...+.+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 4689999999999999999987 5778999988765432 234557889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC----
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT---- 828 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~---- 828 (958)
||++|++|.+++...+..........+.+++.||.|||..+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 99999999999977654444444444555689999999988 999999999999999999999999998641100
Q ss_pred -----------cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccc-cCC
Q 002160 829 -----------FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR-LEI 896 (958)
Q Consensus 829 -----------~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~-~~i 896 (958)
........++..|+|||.+.+..++.++|+|||||++|+|++|..||.+....+....+...... +..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEG 238 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCc
Confidence 00111245788999999999888999999999999999999999999988777766655322211 222
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 002160 897 PKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 931 (958)
Q Consensus 897 p~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~k 931 (958)
...++.++++||.+||+.||.+||++.++.+.|+.
T Consensus 239 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 239 DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 23578999999999999999999996555554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=315.00 Aligned_cols=250 Identities=32% Similarity=0.471 Sum_probs=199.1
Q ss_pred CCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCC----
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP---- 746 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~---- 746 (958)
..++|++.+.||+|+||.||+|++ +++.|++|.+..... ....+.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 457899999999999999999987 567899998765432 345788999999999 7999999999986544
Q ss_pred --ceEEEEeecCCCCHHHHHhCCC---CCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecc
Q 002160 747 --NLSIITEFLPRGSLFRILHRPH---CQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 820 (958)
Q Consensus 747 --~l~LVmEy~~gGsL~d~L~k~~---~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFG 820 (958)
.+++||||+++++|.+++.... ....+..... +.+.+.||.|||..+ |+|+||+|+||+++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccCCeEEECCCc
Confidence 4899999999999999886422 3344444444 444599999999988 9999999999999999999999999
Q ss_pred ccccccCCcccCCCCCCCCCccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc-cc
Q 002160 821 LSRLKHNTFLSSKSTAGTPEWMAPEVLRN-----EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RL 894 (958)
Q Consensus 821 LAk~~~~~~~~~~s~~GT~~Y~APEvl~g-----~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~-~~ 894 (958)
++..............|+..|+|||++.+ ..++.++||||||+++|+|++|+.||...........+..... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd06608 159 VSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL 238 (275)
T ss_pred cceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC
Confidence 98765443333345668999999999854 3367789999999999999999999987665544444432111 12
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 895 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 895 ~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
..+..++.++++||.+||..||.+||++.+|+++
T Consensus 239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 2233477899999999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=316.96 Aligned_cols=249 Identities=26% Similarity=0.341 Sum_probs=200.9
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEee
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
+|++.+.||.|+||.||+|++ +++.||||++............+.+|+.++++++||||+++++++..+..+++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 588999999999999999986 688999999887665455566789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc-cC
Q 002160 755 LPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL-SS 832 (958)
Q Consensus 755 ~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~-~~ 832 (958)
+ +++|.+++........+.....++ +++.+|+|||.++ |+|+||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 9 999999987654445555444444 4489999999988 99999999999999999999999999887644321 12
Q ss_pred CCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc-----------------cc
Q 002160 833 KSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-----------------RL 894 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~-----------------~~ 894 (958)
....|+..|+|||++.+. .++.++||||||+++|+|++|.+||.+.........+..... ..
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 345689999999998764 468999999999999999999888877665443322211000 00
Q ss_pred -----------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 895 -----------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 895 -----------~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.+....+..+.+||.+||+.+|.+||++++++.|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0112457889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=329.71 Aligned_cols=252 Identities=22% Similarity=0.316 Sum_probs=193.6
Q ss_pred EEEEeecc--CceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeec
Q 002160 680 LGERIGLG--SYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755 (958)
Q Consensus 680 i~k~LG~G--~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~ 755 (958)
++++||+| +||+||++++ +++.||||++............+.+|+.+++.++|||||+++++|..++.+++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45779999 7899999976 6889999998766555555667888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhCCC-CCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc---
Q 002160 756 PRGSLFRILHRPH-CQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL--- 830 (958)
Q Consensus 756 ~gGsL~d~L~k~~-~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~--- 830 (958)
++|+|.+++.... ..+.+.....++ +.+.||.|||.++ |+||||||+|||++.++.++++|||..........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 9999999986532 224444444444 4489999999988 99999999999999999999999986543321100
Q ss_pred ----cCCCCCCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc------------
Q 002160 831 ----SSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------ 892 (958)
Q Consensus 831 ----~~~s~~GT~~Y~APEvl~g--~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~------------ 892 (958)
......++..|+|||++.+ ..++.++|||||||++|+|++|+.||......+..........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 1122346778999999976 4588999999999999999999999986554332211110000
Q ss_pred --------------------------------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHhhh
Q 002160 893 --------------------------------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA--LKPLQ 933 (958)
Q Consensus 893 --------------------------------~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~--L~kL~ 933 (958)
.......+++.+++||.+||+.||.+||++++++++ ++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 000112357889999999999999999999999875 44443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=307.99 Aligned_cols=249 Identities=31% Similarity=0.543 Sum_probs=210.8
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEee
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
+|++.+.||+|++|.||++++ .++.|+||.+............+.+|++++++++|+||+++++++.....++++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 578899999999999999976 578899999987766556677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCC
Q 002160 755 LPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 834 (958)
Q Consensus 755 ~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s 834 (958)
+++++|.+++..............+.+.+.+|.|||..+ |+||||||+||+++.++.++|+|||++............
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 158 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS 158 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCCCCEEEeccccceecCCCcccccc
Confidence 999999999876644333333444445589999999988 999999999999999999999999999876554333344
Q ss_pred CCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhc
Q 002160 835 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 914 (958)
Q Consensus 835 ~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~k 914 (958)
..++..|+|||.+.+...+.++|||+||+++|+|++|+.||...+......... ......++..++..++++|.+||..
T Consensus 159 ~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~ 237 (254)
T cd06627 159 VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDFLMQCFQK 237 (254)
T ss_pred cccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-ccCCCCCCCCCCHHHHHHHHHHHhC
Confidence 678999999999988888899999999999999999999998776555444443 3445566778899999999999999
Q ss_pred CCCCCCCHHHHHHH
Q 002160 915 DPSLRPSFAQLTVA 928 (958)
Q Consensus 915 DP~kRPSa~EIL~~ 928 (958)
+|++||++.+++.+
T Consensus 238 ~p~~R~~~~~~l~~ 251 (254)
T cd06627 238 DPNLRPTAKQLLKH 251 (254)
T ss_pred ChhhCcCHHHHhcC
Confidence 99999999999854
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=336.62 Aligned_cols=246 Identities=23% Similarity=0.340 Sum_probs=219.3
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEEC--CcEEEEEEeecCCCCH-HHHHHHHHHHHHHHHc-CCCceeEEeccccCCCc
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSG-AALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~~--g~~VAVK~i~~~~~~~-~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~ 747 (958)
.|...+|.++.+||+|+||+|.++..+ .+.||||++++..+-+ .+.+--..|-++|... +-|++++++.+|+.-++
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 466689999999999999999999875 4569999887765422 2233335677788776 57899999999999999
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
+|+||||+.||+|--++++-+.+-+....++.+.++.||-+||+.+ ||+||||.+|||+|.+|+|||+|||+++.-.-
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccCCceEeeeccccccccc
Confidence 9999999999999999999888888888899999999999999998 99999999999999999999999999997666
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHH
Q 002160 828 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 907 (958)
Q Consensus 828 ~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dL 907 (958)
...+..++|||+.|+|||++..++|+..+|||++|++||||+.|++||.+.+..++...| ......+|+.++.++.++
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI--~ehnvsyPKslSkEAv~i 580 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI--MEHNVSYPKSLSKEAVAI 580 (683)
T ss_pred CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--HHccCcCcccccHHHHHH
Confidence 666778899999999999999999999999999999999999999999999999999888 455778899999999999
Q ss_pred HHHhhhcCCCCCCC
Q 002160 908 IWECWQTDPSLRPS 921 (958)
Q Consensus 908 I~~CL~kDP~kRPS 921 (958)
++..|.+.|.+|..
T Consensus 581 ckg~ltK~P~kRLG 594 (683)
T KOG0696|consen 581 CKGLLTKHPGKRLG 594 (683)
T ss_pred HHHHhhcCCccccC
Confidence 99999999999953
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=316.35 Aligned_cols=245 Identities=30% Similarity=0.504 Sum_probs=199.1
Q ss_pred EeeccCceEEEEEEECC--------cEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEee
Q 002160 683 RIGLGSYGEVYHADWNG--------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 683 ~LG~G~fG~Vykak~~g--------~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
.||+|+||.||+|++.. ..||||.+.... ......++.+|+++++.++||||+++++++......++||||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 59999999999997632 568999875432 233456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhCCC------CCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCC-----cEEEEecccc
Q 002160 755 LPRGSLFRILHRPH------CQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-----NVKVSDFGLS 822 (958)
Q Consensus 755 ~~gGsL~d~L~k~~------~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g-----~VKL~DFGLA 822 (958)
+++++|.+++.+.. ....+...+.++ +.+.||.|||..+ ++|+||||+|||++.++ .+||+|||++
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99999999986421 223444444444 4489999999987 99999999999999877 8999999998
Q ss_pred ccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCC
Q 002160 823 RLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKE 899 (958)
Q Consensus 823 k~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ 899 (958)
+....... ......++..|+|||.+.+..++.++|||||||++|+|++ |+.||...+..+....+. .......+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 237 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-AGGRLQKPEN 237 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh-cCCccCCccc
Confidence 76533211 1112345778999999999889999999999999999998 999998877766655553 3345556677
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 002160 900 LDPLVARIIWECWQTDPSLRPSFAQLTVALKP 931 (958)
Q Consensus 900 ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~k 931 (958)
++..+.+||.+||..+|.+||++.+|++.|++
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 238 CPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred chHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 89999999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=305.97 Aligned_cols=249 Identities=34% Similarity=0.542 Sum_probs=209.7
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC--CceEEEE
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNLSIIT 752 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~--~~l~LVm 752 (958)
+|.+.+.||+|++|.||+|.. +++.|++|++............+.+|+.++++++|+||+++++.+... ..++++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 477889999999999999987 488999999877665555677899999999999999999999999888 8899999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc-
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 830 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~- 830 (958)
||+++++|.+++.+.. ...+.....++ +.+.+|+|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 9999999999998765 34444444444 4489999999987 99999999999999999999999999887654432
Q ss_pred -cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hhHHHHhhhccccccCCCCCCcHHHHHHH
Q 002160 831 -SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNRRLEIPKELDPLVARII 908 (958)
Q Consensus 831 -~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~-~~ei~~~i~~~~~~~~ip~~ls~eL~dLI 908 (958)
......++..|++||.+.+...+.++|||+||+++|+|++|..||...+ .......+........++..++..+++||
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i 237 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFL 237 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHH
Confidence 1334568899999999998889999999999999999999999998765 33333333333445567778899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 002160 909 WECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 909 ~~CL~kDP~kRPSa~EIL~~ 928 (958)
.+||..+|.+||++.+++++
T Consensus 238 ~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 238 RKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HHhCcCChhhCCCHHHHhhC
Confidence 99999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.07 Aligned_cols=250 Identities=30% Similarity=0.484 Sum_probs=199.6
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCC--------HHHHHHHHHHHHHHHHcCCCceeEEeccccCCC
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS--------GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~--------~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~ 746 (958)
+|.+.+.||.|+||.||+|.. +++.||||.+...... ......+.+|+.++++++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477889999999999999965 6889999987543211 112346788999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
..++||||+++++|.+++.+.+.......+....+.+.+|.|||..+ ++||||||+||+++.++.++|+|||+++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 99999999999999999987654433444444445589999999987 9999999999999999999999999987654
Q ss_pred CCc--ccCCCCCCCCCccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCC----C
Q 002160 827 NTF--LSSKSTAGTPEWMAPEVLRNEP--SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP----K 898 (958)
Q Consensus 827 ~~~--~~~~s~~GT~~Y~APEvl~g~~--~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip----~ 898 (958)
... .......|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+..+....+........++ .
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSM 239 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccc
Confidence 321 1123346889999999987654 7889999999999999999999997665544333332222233333 3
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 899 ELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 899 ~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.++..+++||.+||..+|.+||++.+|+++
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 240 NLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 468999999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=314.53 Aligned_cols=250 Identities=27% Similarity=0.476 Sum_probs=202.9
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCC----HHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEE
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS----GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~----~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~L 750 (958)
+|+..+.||+|+||.||+++. +++.||+|++...... ......+.+|++++++++|+||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999975 7889999988654321 2245678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCC-cEEEEeccccccccCCc
Q 002160 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 751 VmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g-~VKL~DFGLAk~~~~~~ 829 (958)
||||+++++|.+++.+...........++.+.+.||.|||.++ |+|+||||+||+++.++ .+||+|||++.......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 9999999999999976554444444444555699999999998 99999999999998775 59999999987664331
Q ss_pred c----cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh---HHHHhhhccccccCCCCCCcH
Q 002160 830 L----SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGFQNRRLEIPKELDP 902 (958)
Q Consensus 830 ~----~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~---ei~~~i~~~~~~~~ip~~ls~ 902 (958)
. ......|+..|+|||++.+..++.++|+|+||+++|+|++|..||...... .....+........++..+++
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238 (268)
T ss_pred ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCH
Confidence 1 112346888999999999888999999999999999999999999754432 222222223344566777899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 903 LVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 903 eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+++++|.+||..+|.+||++.+++++
T Consensus 239 ~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 239 GLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 99999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=314.41 Aligned_cols=252 Identities=29% Similarity=0.502 Sum_probs=202.5
Q ss_pred eeEEEEeeccCceEEEEEEE-----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC------
Q 002160 678 LVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------ 746 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~-----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~------ 746 (958)
|.+.+.||+|+||.||+|.+ ++..||||++...........++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 56778999999999999975 3578999998776656666778899999999999999999999875432
Q ss_pred ceEEEEeecCCCCHHHHHhCCC-----CCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecc
Q 002160 747 NLSIITEFLPRGSLFRILHRPH-----CQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 820 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~-----~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFG 820 (958)
..++++||+.+|+|.+++.... .......... +.+.+.||+|||..+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCCCCEEECccc
Confidence 2478999999999988764221 1233343343 444489999999987 9999999999999999999999999
Q ss_pred ccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCC
Q 002160 821 LSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIP 897 (958)
Q Consensus 821 LAk~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip 897 (958)
+++...... .......++..|++||.+.+..++.++|||||||++|+|++ |+.||.+.+..+....+. .......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 237 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI-KGNRLKQP 237 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH-cCCcCCCC
Confidence 988653321 11222345678999999998889999999999999999999 899998887766655553 23334455
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 002160 898 KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 898 ~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL 932 (958)
..++..+.+++.+||+.+|++||++.++++.|+++
T Consensus 238 ~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 238 PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 67789999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=308.07 Aligned_cols=249 Identities=29% Similarity=0.489 Sum_probs=212.5
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEee
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
+|.+.+.||.|+||.||++.+ ++..|++|++............+.+|+++++.++|+|++++++.+......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 588999999999999999987 488999999887666556677889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhCCC---CCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc
Q 002160 755 LPRGSLFRILHRPH---CQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 830 (958)
Q Consensus 755 ~~gGsL~d~L~k~~---~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~ 830 (958)
+++++|.+++.+.. ..+.+.....++ +.+.||.|||..+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD 158 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence 99999999987642 344444444444 4499999999987 99999999999999999999999999987654432
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHH
Q 002160 831 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 910 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 910 (958)
......|++.|+|||.+.+..++.++|+|+||+++|+|++|+.||...+..+...... ......++..++..+.++|.+
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~ 237 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL-KGQYPPIPSQYSSELRNLVSS 237 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHH
Confidence 3344578999999999999889999999999999999999999998887766665553 333556677889999999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 002160 911 CWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 911 CL~kDP~kRPSa~EIL~~ 928 (958)
||..+|++||++.+++.+
T Consensus 238 ~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 238 LLQKDPEERPSIAQILQS 255 (258)
T ss_pred HcCCChhhCcCHHHHhcC
Confidence 999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=314.31 Aligned_cols=244 Identities=25% Similarity=0.416 Sum_probs=190.0
Q ss_pred EeeccCceEEEEEEE----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeecCCC
Q 002160 683 RIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758 (958)
Q Consensus 683 ~LG~G~fG~Vykak~----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~gG 758 (958)
.||+|+||.||+|+. ....+++|.+.... .......+.+|+.+++.++|+||+++++++.....+++||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 599999999999964 23468888765432 3444567889999999999999999999999999999999999999
Q ss_pred CHHHHHhCCCCC----ccHHHH-HHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc--cc
Q 002160 759 SLFRILHRPHCQ----VDEKRR-IKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LS 831 (958)
Q Consensus 759 sL~d~L~k~~~~----~~e~~~-l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~--~~ 831 (958)
+|.+++.+.... ..+... ....+++.||+|||+++ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999998764321 223333 34445599999999998 9999999999999999999999999986542221 11
Q ss_pred CCCCCCCCCccCcccccC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccc----cccCCCCC
Q 002160 832 SKSTAGTPEWMAPEVLRN-------EPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQN----RRLEIPKE 899 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~g-------~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~----~~~~ip~~ 899 (958)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||......+....+.... ..+.++..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 223346778999999753 346789999999999999999 788998877665544432211 12234456
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002160 900 LDPLVARIIWECWQTDPSLRPSFAQLTVALK 930 (958)
Q Consensus 900 ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~ 930 (958)
++..+.+++..|| .||++||++++|++.|.
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 8899999999999 59999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=316.31 Aligned_cols=247 Identities=29% Similarity=0.435 Sum_probs=202.4
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
++|++.+.||.|+||.||++.+ +++.||+|.+..... .....++.+|++++++++||||+++++++...+.++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 3678888999999999999987 488899998876543 3456678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHH-HHHHHHHHHHHHHh-cCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRI-KMALDARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l-~ia~~a~aL~yLH~-~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~ 831 (958)
|+++++|.+++........+.... .+.+.+.+|+|||. .+ ++|+||||+||++++++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 999999999997653344444443 44445899999999 77 99999999999999999999999999876543322
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----hhHHHHhhhccccccCCCCC-CcHHHH
Q 002160 832 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN-----PMQVVGAVGFQNRRLEIPKE-LDPLVA 905 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~-----~~ei~~~i~~~~~~~~ip~~-ls~eL~ 905 (958)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||.... ..+....+. ....+.++.. ++.+++
T Consensus 157 -~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (265)
T cd06605 157 -KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV-NEPPPRLPSGKFSPDFQ 234 (265)
T ss_pred -hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh-cCCCCCCChhhcCHHHH
Confidence 12678899999999999999999999999999999999999997642 222333332 2334444444 889999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 002160 906 RIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 906 dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+||.+||..||.+||++.+|+.+
T Consensus 235 ~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 235 DFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHHHHHcCCCchhCcCHHHHhhC
Confidence 99999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=332.24 Aligned_cols=255 Identities=27% Similarity=0.320 Sum_probs=208.2
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCc-eeEEeccccCCC-----
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN-VVLFMGAVTRPP----- 746 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPN-IVkL~g~~~~~~----- 746 (958)
...|+.+++||+|+||+||+|+. +|+.||+|+++.....+-......+|+.+|+.|+|+| ||.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 35577778899999999999975 7899999999876543334456789999999999999 999999998877
Q ss_pred -ceEEEEeecCCCCHHHHHhCCC----CCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccc
Q 002160 747 -NLSIITEFLPRGSLFRILHRPH----CQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 821 (958)
Q Consensus 747 -~l~LVmEy~~gGsL~d~L~k~~----~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGL 821 (958)
.+++|+||++ -+|.+++.... .......+.++.|++.||+|||+++ |+||||||+||||+++|.+||+|||+
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCCCcEeeeccch
Confidence 7999999995 58999997655 2333456677777799999999999 99999999999999999999999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc--------
Q 002160 822 SRLKHNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-------- 892 (958)
Q Consensus 822 Ak~~~~~~~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~-------- 892 (958)
|+...-.....+...+|.+|.|||++.|. .|+...||||+|||++||++++.-|.+....+....|.....
T Consensus 167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 99776555556677899999999999987 689999999999999999999999999887665544421110
Q ss_pred --------ccCCC------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHhh
Q 002160 893 --------RLEIP------------KELDPLVARIIWECWQTDPSLRPSFAQLTVA--LKPL 932 (958)
Q Consensus 893 --------~~~ip------------~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~--L~kL 932 (958)
...++ ...++...+++.+||+.+|.+|.|++..+.| +..+
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 00111 1223578999999999999999999999887 4443
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=313.23 Aligned_cols=241 Identities=25% Similarity=0.393 Sum_probs=203.0
Q ss_pred eeccCceEEEEEEEC--CcEEEEEEeecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeecCCCCH
Q 002160 684 IGLGSYGEVYHADWN--GTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 760 (958)
Q Consensus 684 LG~G~fG~Vykak~~--g~~VAVK~i~~~~~~-~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~gGsL 760 (958)
||.|+||.||+|+.. ++.||||++...... ......+.+|+.++++++||||+++++++.++..++++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999875 889999998765433 23456789999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCCCCCC
Q 002160 761 FRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 840 (958)
Q Consensus 761 ~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~GT~~ 840 (958)
.+++.+............+.+++.||.|||..+ ++|+||||+||+++.++.++|+|||++....... ......++..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~ 157 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTPE 157 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCcC
Confidence 999987654444444444445599999999988 9999999999999999999999999998765432 2234568999
Q ss_pred ccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--hhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCC
Q 002160 841 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN--PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSL 918 (958)
Q Consensus 841 Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~--~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~k 918 (958)
|++||.+.+..++.++|+|+||+++|+|++|..||.... ..+....+........+|...+.++++||.+||+.+|.+
T Consensus 158 ~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~ 237 (262)
T cd05572 158 YVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEE 237 (262)
T ss_pred ccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhh
Confidence 999999988889999999999999999999999998776 555555554334566777778999999999999999999
Q ss_pred CCC-----HHHHHH
Q 002160 919 RPS-----FAQLTV 927 (958)
Q Consensus 919 RPS-----a~EIL~ 927 (958)
||+ ++|+++
T Consensus 238 R~~~~~~~~~~l~~ 251 (262)
T cd05572 238 RLGNLKGGIKDIKK 251 (262)
T ss_pred CcCCcccCHHHHhc
Confidence 999 777776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=348.35 Aligned_cols=250 Identities=28% Similarity=0.443 Sum_probs=226.8
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
...|.+.+.||+|.|+.|.++++ ++..||||.+.+.......+..+.+|+++|+.|+|||||+++.+...+..+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 35789999999999999999987 7999999999998888877778999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
||+.+|.+++++.+.+...+...+.++.+...+++|||.+. |||||||.+||||+.+.++||+|||++..+... ...
T Consensus 135 eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~-~~l 211 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENMNIKIADFGFSTFFDYG-LML 211 (596)
T ss_pred EeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccccceeeeccccceeeccc-ccc
Confidence 99999999999999988877777888888899999999998 999999999999999999999999999887533 445
Q ss_pred CCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHh
Q 002160 833 KSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 911 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g~~~-s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~C 911 (958)
.++||++.|.|||++.|..| ++.+|+|+||++||.|++|.+||.+.+..+........ ...+|..++-++.+||+++
T Consensus 212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~g--k~rIp~~ms~dce~lLrk~ 289 (596)
T KOG0586|consen 212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRG--KYRIPFYMSCDCEDLLRKF 289 (596)
T ss_pred cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheee--eecccceeechhHHHHHHh
Confidence 67999999999999999887 78999999999999999999999998877776666433 5566778999999999999
Q ss_pred hhcCCCCCCCHHHHHHHH
Q 002160 912 WQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 912 L~kDP~kRPSa~EIL~~L 929 (958)
|-++|.+|+++++|.++-
T Consensus 290 lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 290 LVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred hccCccccCCHHHhhhhc
Confidence 999999999999998763
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=350.59 Aligned_cols=243 Identities=31% Similarity=0.465 Sum_probs=207.6
Q ss_pred eeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEee
Q 002160 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
|.-++.||.|+||.||.+++ +.+.||||++..... ..+.+..+..|+.+|.+++|||+|.+-|||..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 55667899999999999976 788999999876542 445677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCC
Q 002160 755 LPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 833 (958)
Q Consensus 755 ~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~ 833 (958)
| -|+-.|++.-...++.+....-+... +.||+|||+++ .||||||..|||+.+.|.|||+|||.|..... .+
T Consensus 108 C-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----An 180 (948)
T KOG0577|consen 108 C-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGSASIMAP----AN 180 (948)
T ss_pred H-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccchhhcCc----hh
Confidence 9 56778887655555555554444444 89999999999 99999999999999999999999999876543 35
Q ss_pred CCCCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCC-CCCcHHHHHHHH
Q 002160 834 STAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP-KELDPLVARIIW 909 (958)
Q Consensus 834 s~~GT~~Y~APEvl~---g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip-~~ls~eL~dLI~ 909 (958)
+|+|||+|||||++. .+.|+-++|||||||+-.||...++|++.++.+..+..|. ++..+.++ ...+..|++|+.
T Consensus 181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIA-QNesPtLqs~eWS~~F~~Fvd 259 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNESPTLQSNEWSDYFRNFVD 259 (948)
T ss_pred cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHH-hcCCCCCCCchhHHHHHHHHH
Confidence 699999999999984 4668999999999999999999999999999998888886 44455454 456888999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 002160 910 ECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 910 ~CL~kDP~kRPSa~EIL~~ 928 (958)
.||++-|.+||+.+++++|
T Consensus 260 ~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 260 SCLQKIPQERPTSEELLKH 278 (948)
T ss_pred HHHhhCcccCCcHHHHhhc
Confidence 9999999999999998876
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=311.53 Aligned_cols=250 Identities=30% Similarity=0.472 Sum_probs=205.8
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCC---CCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC--Cce
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQD---FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNL 748 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~---~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~--~~l 748 (958)
.+|++.+.||+|+||.||+|+. +++.||+|.+.... ........+.+|++++++++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 5799999999999999999976 68899999875432 2234556889999999999999999999998664 458
Q ss_pred EEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
+++|||+++++|.+++.............+..+.+.||.|||..+ |+|+||||+||+++.++.++|+|||+++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 899999999999999876544333333334445599999999988 999999999999999999999999999865321
Q ss_pred c---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHH
Q 002160 829 F---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 905 (958)
Q Consensus 829 ~---~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~ 905 (958)
. .......++..|+|||++.+..++.++|+|||||++|+|++|+.||......+....+.....+..+|..++..+.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 239 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACR 239 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHH
Confidence 1 1122356899999999999988899999999999999999999999887766655555444455677888999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 002160 906 RIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 906 dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
++|.+||+ +|.+||++.+++.|
T Consensus 240 ~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 240 DFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HHHHHHhc-CcccCccHHHHhcC
Confidence 99999998 57999999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=303.32 Aligned_cols=246 Identities=31% Similarity=0.517 Sum_probs=204.0
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEee
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
+|.+.+.||+|++|.||++.+ +++.|++|++..... .....+.+|+.++++++|+||+++++++......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 578899999999999999987 488899999876543 3456889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCC
Q 002160 755 LPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 833 (958)
Q Consensus 755 ~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~ 833 (958)
+++++|.+++........+.....++ +.+.+|.+||..+ ++||||+|+||++++++.++|+|||++........ ..
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~ 155 (253)
T cd05122 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RN 155 (253)
T ss_pred CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccCCeEEEeecccccccccccc-cc
Confidence 99999999987763344444444444 4489999999987 99999999999999999999999999877654322 34
Q ss_pred CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCC--CCcHHHHHHHHHh
Q 002160 834 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK--ELDPLVARIIWEC 911 (958)
Q Consensus 834 s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~--~ls~eL~dLI~~C 911 (958)
...++..|++||.+.+..++.++|+|+||+++|+|++|+.||...+..+....... .....++. .++..+.++|.+|
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~ 234 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKC 234 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHHH
Confidence 46788999999999988889999999999999999999999988755544443332 22223332 3489999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 002160 912 WQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 912 L~kDP~kRPSa~EIL~~ 928 (958)
|+.||.+||++.+++++
T Consensus 235 l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 235 LQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccCChhhCCCHHHHhcC
Confidence 99999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=314.21 Aligned_cols=247 Identities=26% Similarity=0.451 Sum_probs=205.1
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEee
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
-|++.+.||.|+||.||+|.+ +++.||||.+..... ......+.+|+.++++++||||+++++++.....+++||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 367888999999999999976 678999998765432 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCC
Q 002160 755 LPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 834 (958)
Q Consensus 755 ~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s 834 (958)
+++++|.+++.... .........+.+.+.++.|||..+ ++|+||||+||+++.++.++|+|||++............
T Consensus 84 ~~~~~l~~~i~~~~-~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06641 84 LGGGSALDLLEPGP-LDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred CCCCcHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCCCCEEEeecccceecccchhhhcc
Confidence 99999999987542 233333334444589999999987 999999999999999999999999998765443323334
Q ss_pred CCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhc
Q 002160 835 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 914 (958)
Q Consensus 835 ~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~k 914 (958)
..++..|+|||.+.+...+.++|+|||||++|+|++|..||...........+. ......++..++.++.++|.+||+.
T Consensus 161 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (277)
T cd06641 161 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEACLNK 239 (277)
T ss_pred ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh-cCCCCCCCcccCHHHHHHHHHHccC
Confidence 568899999999998888999999999999999999999998877665555442 3334456667899999999999999
Q ss_pred CCCCCCCHHHHHHH
Q 002160 915 DPSLRPSFAQLTVA 928 (958)
Q Consensus 915 DP~kRPSa~EIL~~ 928 (958)
+|.+||++.+++.+
T Consensus 240 ~p~~Rp~~~~~l~~ 253 (277)
T cd06641 240 EPSFRPTAKELLKH 253 (277)
T ss_pred ChhhCcCHHHHHhC
Confidence 99999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=308.08 Aligned_cols=247 Identities=29% Similarity=0.480 Sum_probs=208.2
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEee
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
+|++.+.||+|+||.||++++ +++.+|||.+...........++.+|++++++++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 588999999999999999976 678899999877655555667788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhCC---CCCccHHHHHHH-HHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc
Q 002160 755 LPRGSLFRILHRP---HCQVDEKRRIKM-ALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 830 (958)
Q Consensus 755 ~~gGsL~d~L~k~---~~~~~e~~~l~i-a~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~ 830 (958)
+++++|.+++.+. .....+.....+ .+.+.||+|||..+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 9999999988652 123344444444 44489999999988 999999999999999999999999999876554
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHH
Q 002160 831 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 910 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 910 (958)
......++..|++||.+.+..++.++|+||||+++|+|++|+.||...+..+....+. ......++..++.+++++|.+
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ 235 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-RGKYPPIPPIYSQDLQNFIRS 235 (256)
T ss_pred CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCCCCCCchhhCHHHHHHHHH
Confidence 2233568899999999999989999999999999999999999999887766555543 233344556788999999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 002160 911 CWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 911 CL~kDP~kRPSa~EIL~~ 928 (958)
||..+|.+||++.+++++
T Consensus 236 ~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 236 MLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HcCCCcccCCCHHHHhcC
Confidence 999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=316.01 Aligned_cols=249 Identities=24% Similarity=0.314 Sum_probs=196.3
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEee
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
+|++.+.||.|+||.||+|++ +++.||||++............+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 488999999999999999976 688999998865544333445788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhCCC-CCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 755 LPRGSLFRILHRPH-CQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 755 ~~gGsL~d~L~k~~-~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
+. ++|..++.... ....+..... +.+.+.||+|||..+ ++||||+|+||+++.++.+||+|||++..........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 157 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 157 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEeeccchhhcccCcccc
Confidence 95 58888876532 3334444444 444489999999988 9999999999999999999999999987654333333
Q ss_pred CCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc-------------------
Q 002160 833 KSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------------- 892 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g~~-~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~------------------- 892 (958)
....++..|+|||++.+.. ++.++||||||+++|+|++|+.||.+.+.......+.....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 3445788999999987654 58899999999999999999999987665433222110000
Q ss_pred --------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 893 --------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 893 --------~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
...+...+++++++||.+||+.||.+||++++++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 001123467899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=314.03 Aligned_cols=247 Identities=28% Similarity=0.459 Sum_probs=191.9
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHH-HHHcCCCceeEEeccccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKI-MRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~I-Lk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
++|++.+.||+|+||.||++++ +++.||||++....... ...++..|+.+ ++.++||||+++++++.....+|++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 4789999999999999999987 68999999987654333 23455556665 56668999999999999999999999
Q ss_pred eecCCCCHHHHHhC---CCCCccHHHHHHHH-HHHHHHHHHHhc-CCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 753 EFLPRGSLFRILHR---PHCQVDEKRRIKMA-LDARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 753 Ey~~gGsL~d~L~k---~~~~~~e~~~l~ia-~~a~aL~yLH~~-g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
||++ ++|.+++.. ......+.....++ +.+.||+|||.+ + ++||||||+|||++.++.+||+|||++.....
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9996 678777643 22344555544444 448999999986 6 99999999999999999999999999886543
Q ss_pred CcccCCCCCCCCCccCcccccC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hhHHHHhhhccccccCCC-CCCc
Q 002160 828 TFLSSKSTAGTPEWMAPEVLRN----EPSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNRRLEIP-KELD 901 (958)
Q Consensus 828 ~~~~~~s~~GT~~Y~APEvl~g----~~~s~ksDIWSLGiLLyELLtG~~PF~g~~-~~ei~~~i~~~~~~~~ip-~~ls 901 (958)
.. ......|+..|+|||++.+ ..++.++|+|+|||++|+|++|+.||.... ..+....+. ......++ ..++
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 234 (283)
T cd06617 157 SV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV-EEPSPQLPAEKFS 234 (283)
T ss_pred cc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH-hcCCCCCCccccC
Confidence 22 1233568899999999865 446889999999999999999999997533 222222222 22233333 3578
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 902 PLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 902 ~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.++.+||.+||..+|.+||++.+|+.+
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=311.50 Aligned_cols=251 Identities=25% Similarity=0.424 Sum_probs=202.6
Q ss_pred CeeEEEEeeccCceEEEEEEEC---CcEEEEEEeecCC--------CCHHHHHHHHHHHHHHHH-cCCCceeEEeccccC
Q 002160 677 DLVLGERIGLGSYGEVYHADWN---GTEVAVKKFLDQD--------FSGAALLEFKREVKIMRR-LRHPNVVLFMGAVTR 744 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~~---g~~VAVK~i~~~~--------~~~~~~~~f~~Ei~ILk~-L~HPNIVkL~g~~~~ 744 (958)
+|++.+.||+|+||.||+|.+. ++.+|||.+.... .......++..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4778899999999999999873 5789999876432 223345667889998876 699999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhC---CCCCccHHHHHHHH-HHHHHHHHHHh-cCCcEeecCCCCCceEEcCCCcEEEEec
Q 002160 745 PPNLSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMA-LDARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDF 819 (958)
Q Consensus 745 ~~~l~LVmEy~~gGsL~d~L~k---~~~~~~e~~~l~ia-~~a~aL~yLH~-~g~gIIHRDLKPeNILId~~g~VKL~DF 819 (958)
.+..+++|||+++++|.+++.. ....+.+...+.++ +.+.+|.|||. .+ |+|+||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999988742 33344555444444 44899999996 55 999999999999999999999999
Q ss_pred cccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCC
Q 002160 820 GLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE 899 (958)
Q Consensus 820 GLAk~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ 899 (958)
|++....... ......|+..|++||++.+..++.++|+||||+++|+|++|+.||...+.......+............
T Consensus 159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd08528 159 GLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237 (269)
T ss_pred cceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCccc
Confidence 9998754432 234456899999999999988999999999999999999999999887766655554322222222236
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002160 900 LDPLVARIIWECWQTDPSLRPSFAQLTVALK 930 (958)
Q Consensus 900 ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~ 930 (958)
+++.+.+||.+||+.||++||++.|+..+|+
T Consensus 238 ~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 238 YSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 7899999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=317.71 Aligned_cols=249 Identities=24% Similarity=0.308 Sum_probs=198.8
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCC---HHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEE
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS---GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~---~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LV 751 (958)
+|++.+.||+|+||.||+|.+ +++.||||++...... ......+..|++++++++|+||+++++++.+.+.+++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 478889999999999999986 5789999998766543 22345677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc
Q 002160 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 830 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~ 830 (958)
|||+ +++|..++........+.....++ +++.||.|||.++ |+|+||||+|||++.++.+||+|||++........
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 9999 899999997765344454444444 4499999999998 99999999999999999999999999987654433
Q ss_pred cCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc-----------------
Q 002160 831 SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR----------------- 892 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~----------------- 892 (958)
......++..|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 3334457889999999865 4578999999999999999999888877665443332210000
Q ss_pred ----cc-----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 893 ----RL-----EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 893 ----~~-----~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.. ......+..+.+||.+||+.||.+||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00 0113456889999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=319.45 Aligned_cols=250 Identities=26% Similarity=0.313 Sum_probs=200.0
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC--CceEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNLSII 751 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~--~~l~LV 751 (958)
++|++.+.||.|+||.||+|++ +++.||||.+............+.+|+.++++++||||+++++++... ..+|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 5788999999999999999987 578899999876554433345677899999999999999999998777 789999
Q ss_pred EeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc
Q 002160 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 830 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~ 830 (958)
|||++ ++|.+++......+.+.....++.+ +.||+|||..+ |+|+||||+|||++.++.+||+|||++........
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 99997 4899888765544555555555444 99999999988 99999999999999999999999999987654433
Q ss_pred cCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcc-------------------
Q 002160 831 SSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ------------------- 890 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~~-~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~------------------- 890 (958)
......++..|+|||.+.+.. ++.++||||||+++|+|++|..||......+....+...
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence 333456788999999987654 688999999999999999999999877655443322100
Q ss_pred ----------ccccCCCCC-CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 891 ----------NRRLEIPKE-LDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 891 ----------~~~~~ip~~-ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.....++.. +++.+.+||.+||+.+|++||++.|++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 001112333 58889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=335.66 Aligned_cols=256 Identities=21% Similarity=0.295 Sum_probs=212.5
Q ss_pred cccccCCCCeeEEEEeeccCceEEEEEEE-CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCC
Q 002160 669 CECEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP 746 (958)
Q Consensus 669 ~~~eI~~~dy~i~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~ 746 (958)
..+.++-..|+++++||.||.++||++.. +.+.||+|++.....+...+.-|.+|+..|.+| .|.+||+||+|-..++
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 34567778899999999999999999987 567899998877777888889999999999999 5999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCcc-HHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVD-EKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~-e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
.+||||||- ..+|..+|++...... +..+.++.+++.++.++|.++ |||.||||.|+|+- .|.+||+|||+|..+
T Consensus 434 ~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV-kG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 434 YLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV-KGRLKLIDFGIANAI 509 (677)
T ss_pred eEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE-eeeEEeeeechhccc
Confidence 999999986 5699999987765444 677888888899999999999 99999999999995 578999999999876
Q ss_pred cCC--cccCCCCCCCCCccCcccccCCC-----------CCchhhHHHHHHHHHHHHhCCCCCCCCC-hhHHHHhhhccc
Q 002160 826 HNT--FLSSKSTAGTPEWMAPEVLRNEP-----------SNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQN 891 (958)
Q Consensus 826 ~~~--~~~~~s~~GT~~Y~APEvl~g~~-----------~s~ksDIWSLGiLLyELLtG~~PF~g~~-~~ei~~~i~~~~ 891 (958)
... .....+.+||+-||+||.+.... .+.++||||||||||+|+.|+.||.... -...+..+...+
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~ 589 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPN 589 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCC
Confidence 543 23345678999999999985433 3578999999999999999999996543 223334443334
Q ss_pred cccCCCCCCcHH-HHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 892 RRLEIPKELDPL-VARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 892 ~~~~ip~~ls~e-L~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
...++|..-+.. +.++++.||..||.+||++.++|+|
T Consensus 590 ~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 590 HEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 445666554444 9999999999999999999999976
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=321.01 Aligned_cols=252 Identities=26% Similarity=0.318 Sum_probs=198.8
Q ss_pred CCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC--CceE
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNLS 749 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~--~~l~ 749 (958)
..++|++.+.||+|+||.||+|++ +++.||+|++............+.+|+.++++++|+||+++++++... +.++
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 457899999999999999999986 688999999875543333333566899999999999999999998654 4689
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
+||||+. ++|.+++........+..... +.+.+.||.|||..+ |+||||||+|||++.++.+||+|||++......
T Consensus 85 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 85 LVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9999996 478888776444444554444 444599999999998 999999999999999999999999999876543
Q ss_pred cccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc---------------
Q 002160 829 FLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--------------- 892 (958)
Q Consensus 829 ~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~--------------- 892 (958)
........++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241 (309)
T ss_pred cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence 222333446788999999876 4578999999999999999999999998877665543321000
Q ss_pred --ccCCC-----------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 893 --RLEIP-----------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 893 --~~~ip-----------~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
...++ ..+++.+.+||.+||+.||.+||++.+++.|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00010 1257889999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=349.03 Aligned_cols=249 Identities=29% Similarity=0.446 Sum_probs=214.0
Q ss_pred CCeeEEEEeeccCceEEEEEEECCc--EEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~~g~--~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
+.|+|+..||.|+||+||++....+ ..|-|+|... .++.+..+.-|+.||..++||+||+|++.|+..+++||+.|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 4478889999999999999976433 4566766443 35667889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
||.||-...++-..+..+.+....+++.+ +.||.|||..+ |||||||..|||++-+|.|+|+|||.+..........
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR 187 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR 187 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeecccccccchhHHhhh
Confidence 99999999888777777776666665555 89999999998 9999999999999999999999999876655554556
Q ss_pred CCCCCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccccc-CCCCCCcHHHHH
Q 002160 833 KSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL-EIPKELDPLVAR 906 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~-----g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~-~ip~~ls~eL~d 906 (958)
.+|.|||+|||||++. ..+|++++|||||||+|.||.-+.+|-...+++.++.++.....+. ..|...+..+.|
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~D 267 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSD 267 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHH
Confidence 7799999999999874 5679999999999999999999999999999999998886443332 236778899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 002160 907 IIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 907 LI~~CL~kDP~kRPSa~EIL~~ 928 (958)
|+.+||.+||..||++.+|++|
T Consensus 268 fLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 268 FLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred HHHHHHhcCCccCCCHHHHhhC
Confidence 9999999999999999999875
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=310.80 Aligned_cols=236 Identities=25% Similarity=0.400 Sum_probs=188.3
Q ss_pred EEeeccCceEEEEEEECCc------------EEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceE
Q 002160 682 ERIGLGSYGEVYHADWNGT------------EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 682 k~LG~G~fG~Vykak~~g~------------~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~ 749 (958)
+.||+|+||.||+|.+... .|++|.+..... ....+.+|+.+|++++||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 3699999999999987432 377776544321 15678899999999999999999999887 7789
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCC-------cEEEEeccc
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-------NVKVSDFGL 821 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g-------~VKL~DFGL 821 (958)
+||||+++|+|.+++.+..........+.++ +++.||.|||.++ |+||||||+|||++.++ .+||+|||+
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 9999999999999998766455555555555 4499999999988 99999999999999887 899999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccCC--CCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCC
Q 002160 822 SRLKHNTFLSSKSTAGTPEWMAPEVLRNE--PSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPK 898 (958)
Q Consensus 822 Ak~~~~~~~~~~s~~GT~~Y~APEvl~g~--~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~ 898 (958)
+..... .....++..|+|||++.+. .++.++||||||+++|+|++ |..||...+..+...... . ....+.
T Consensus 155 a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~--~~~~~~ 227 (259)
T cd05037 155 PITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-D--QHRLPM 227 (259)
T ss_pred cccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-c--CCCCCC
Confidence 876543 2234577889999999876 78999999999999999999 588887765443333222 1 222233
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002160 899 ELDPLVARIIWECWQTDPSLRPSFAQLTVALK 930 (958)
Q Consensus 899 ~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~ 930 (958)
.....+.+||.+||..+|.+||++.+|++.|.
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 228 PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 33489999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=313.83 Aligned_cols=237 Identities=22% Similarity=0.370 Sum_probs=188.0
Q ss_pred EEeeccCceEEEEEEEC--------------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc
Q 002160 682 ERIGLGSYGEVYHADWN--------------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 682 k~LG~G~fG~Vykak~~--------------g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~ 747 (958)
+.||+|+||.||+|++. ...|++|.+.... ......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 35899999999999752 2258888765432 2345578889999999999999999999999889
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCc-------EEEEec
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN-------VKVSDF 819 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~-------VKL~DF 819 (958)
.++||||+++++|..++.+......+...+.++.+ +.||+|||..+ |+||||||+||||+.++. +|++||
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 99999999999999988765555555555555544 99999999988 999999999999987664 999999
Q ss_pred cccccccCCcccCCCCCCCCCccCccccc-CCCCCchhhHHHHHHHHHHHH-hCCCCCCCCChhHHHHhhhccccccCCC
Q 002160 820 GLSRLKHNTFLSSKSTAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELA-TLKLPWIGMNPMQVVGAVGFQNRRLEIP 897 (958)
Q Consensus 820 GLAk~~~~~~~~~~s~~GT~~Y~APEvl~-g~~~s~ksDIWSLGiLLyELL-tG~~PF~g~~~~ei~~~i~~~~~~~~ip 897 (958)
|++..... .....++..|+|||.+. +..++.++|||||||++|+|+ .|..||......+..... .......
T Consensus 157 g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~---~~~~~~~ 229 (262)
T cd05077 157 GIPITVLS----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY---EGQCMLV 229 (262)
T ss_pred CCCccccC----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH---hcCccCC
Confidence 99865432 22356788999999987 566889999999999999998 588888776544332211 1122233
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002160 898 KELDPLVARIIWECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 898 ~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L 929 (958)
...+.++.+||.+||+.||.+||++.+|+++|
T Consensus 230 ~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 230 TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 34568899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=321.15 Aligned_cols=241 Identities=23% Similarity=0.340 Sum_probs=179.2
Q ss_pred EEEeeccCceEEEEEEE----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC--CCceEEEEee
Q 002160 681 GERIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--PPNLSIITEF 754 (958)
Q Consensus 681 ~k~LG~G~fG~Vykak~----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~--~~~l~LVmEy 754 (958)
+++||+|+||.||+|++ .++.||||.+...... ..+.+|+++|++++||||+++++++.. ...+|++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 46799999999999975 4578999988655432 346789999999999999999998854 4568999999
Q ss_pred cCCCCHHHHHhCCC--------CCccH-HHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEE----cCCCcEEEEeccc
Q 002160 755 LPRGSLFRILHRPH--------CQVDE-KRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGL 821 (958)
Q Consensus 755 ~~gGsL~d~L~k~~--------~~~~e-~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILI----d~~g~VKL~DFGL 821 (958)
+. ++|.+++.... ....+ ..+..+.+.+.||.|||..+ |+||||||+|||+ +.++.+||+|||+
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 85 58887764221 12333 34444555599999999988 9999999999999 4568999999999
Q ss_pred cccccCCc---ccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChh---------HHHHhhh
Q 002160 822 SRLKHNTF---LSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPM---------QVVGAVG 888 (958)
Q Consensus 822 Ak~~~~~~---~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~---------ei~~~i~ 888 (958)
++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.... .....+.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence 98754322 122346789999999999874 5789999999999999999999999753321 0000000
Q ss_pred c-cc-------------------------ccc----------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 889 F-QN-------------------------RRL----------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 889 ~-~~-------------------------~~~----------~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
. .+ ... ......+..+.+||.+||+.||.+|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 00 000 0001235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=312.19 Aligned_cols=249 Identities=26% Similarity=0.433 Sum_probs=208.5
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcC-CCceeEEeccccCCCceEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~-HPNIVkL~g~~~~~~~l~LV 751 (958)
++|.+.+.||+|+||.||+++. ++..||+|++..... .......+.+|+.++++++ |+||+++++++...+.+++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4789999999999999999987 688999999876433 3344567889999999998 99999999999999999999
Q ss_pred EeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc--
Q 002160 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-- 829 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~-- 829 (958)
|||+++++|.+++.+.+..........+.+.+.||.|||.++ ++|+||||+||+++.+++++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 999999999999987654444444444445599999999988 9999999999999999999999999987654322
Q ss_pred ------------------ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccc
Q 002160 830 ------------------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN 891 (958)
Q Consensus 830 ------------------~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~ 891 (958)
.......++..|+|||++.+..++.++|+|+||+++|+|++|+.||......+....+. .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~ 236 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL--K 236 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH--h
Confidence 12233457899999999998888999999999999999999999999887665555443 3
Q ss_pred cccCCCCCCcHHHHHHHHHhhhcCCCCCCCH----HHHHHH
Q 002160 892 RRLEIPKELDPLVARIIWECWQTDPSLRPSF----AQLTVA 928 (958)
Q Consensus 892 ~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa----~EIL~~ 928 (958)
....++..+++.+.+||.+||+.+|.+||++ .+|+.+
T Consensus 237 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 237 LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 4556777889999999999999999999999 777754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=316.36 Aligned_cols=236 Identities=22% Similarity=0.369 Sum_probs=191.0
Q ss_pred EeeccCceEEEEEEEC---------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 683 RIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 683 ~LG~G~fG~Vykak~~---------g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
.||.|+||.||+|.+. ...||+|.+.... ......+..|+.+++.++|||||++++++..+...++|||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 5999999999999762 2348888764332 2334578889999999999999999999999899999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCc--------EEEEecccccc
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN--------VKVSDFGLSRL 824 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~--------VKL~DFGLAk~ 824 (958)
|+++|+|..++...+....+...+.++.+ +.||+|||.++ |+||||||+|||++.++. ++|+|||++..
T Consensus 80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999999876655566666555444 89999999988 999999999999987654 69999999865
Q ss_pred ccCCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCC-CCCCCCChhHHHHhhhccccccCCCCCCcH
Q 002160 825 KHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLK-LPWIGMNPMQVVGAVGFQNRRLEIPKELDP 902 (958)
Q Consensus 825 ~~~~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~-~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~ 902 (958)
.... ....++..|+|||++.+ ..++.++||||||+++|+|++|. .||...+........ .....+|...+.
T Consensus 158 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 230 (258)
T cd05078 158 VLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY---EDRHQLPAPKWT 230 (258)
T ss_pred cCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH---HccccCCCCCcH
Confidence 4332 23568889999999986 45789999999999999999984 666665554433222 234566777789
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002160 903 LVARIIWECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 903 eL~dLI~~CL~kDP~kRPSa~EIL~~L 929 (958)
++.+||.+||+.||++||++++|++.|
T Consensus 231 ~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 231 ELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=313.44 Aligned_cols=249 Identities=31% Similarity=0.451 Sum_probs=198.0
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccCC-----C
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRP-----P 746 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~-----~ 746 (958)
.++|.+.+.||+|+||.||++.. +++.+|+|.+.... .....+.+|+.+++++ +||||+++++++... +
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 47899999999999999999976 68899999876432 2234677899999999 899999999998653 3
Q ss_pred ceEEEEeecCCCCHHHHHhC---CCCCccHHHHHHH-HHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccc
Q 002160 747 NLSIITEFLPRGSLFRILHR---PHCQVDEKRRIKM-ALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 822 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k---~~~~~~e~~~l~i-a~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLA 822 (958)
.+++||||+++++|.++++. ......+.....+ .+.+.||.|||..+ |+||||||+||+++.++.+||+|||++
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~~~~kl~dfg~~ 175 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGVS 175 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEeecccc
Confidence 58999999999999998753 2233444444444 44489999999988 999999999999999999999999998
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcc-ccccCC
Q 002160 823 RLKHNTFLSSKSTAGTPEWMAPEVLRNEP-----SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRRLEI 896 (958)
Q Consensus 823 k~~~~~~~~~~s~~GT~~Y~APEvl~g~~-----~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~-~~~~~i 896 (958)
..............|+..|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+....+... ......
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 255 (291)
T cd06639 176 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLH 255 (291)
T ss_pred hhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCc
Confidence 86544333334456899999999986433 578999999999999999999999887765544443211 112223
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 897 PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 897 p~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+...+..+.+||.+||+.+|++||++.+|++|
T Consensus 256 ~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 256 PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 45577889999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=345.20 Aligned_cols=255 Identities=23% Similarity=0.358 Sum_probs=232.0
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEECCcE--EEEEEeecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeccccCCCce
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE--VAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~~g~~--VAVK~i~~~~~~-~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l 748 (958)
++.+.+++++..||-||||.|=+++.++.. +|+|++++..+. .....-+..|.+||...+.|+||++|..|.+..++
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 345677888889999999999999887666 899988776543 33455678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
|+.||-|-||+|+..|+.++.+.+...+++.+-.+.|++|||.++ ||+|||||+|+|+|.+|.+||.|||+|+.+...
T Consensus 496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 999999999999999999999999999999999899999999999 999999999999999999999999999988665
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHH
Q 002160 829 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 908 (958)
Q Consensus 829 ~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI 908 (958)
. ...++|||++|.|||++.+...+.++|.|+|||++|||++|.+||.+.+++..+..|......+.+|..++....+||
T Consensus 574 ~-KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Li 652 (732)
T KOG0614|consen 574 R-KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLI 652 (732)
T ss_pred C-ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHH
Confidence 3 356799999999999999999999999999999999999999999999999999999888888999999999999999
Q ss_pred HHhhhcCCCCCCC-----HHHHHHHH
Q 002160 909 WECWQTDPSLRPS-----FAQLTVAL 929 (958)
Q Consensus 909 ~~CL~kDP~kRPS-----a~EIL~~L 929 (958)
+++++.+|.+|.. +.+|.+|-
T Consensus 653 k~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 653 KKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred HHHHhcCcHhhhccccCChHHHHhhh
Confidence 9999999999975 67777763
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=337.81 Aligned_cols=248 Identities=23% Similarity=0.280 Sum_probs=212.4
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHH-HHHHHHHHHHHHHcCCCceeEEeccccCCCc
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAA-LLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~-~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~ 747 (958)
..+..+.|..-++||+||||.||-++. +|+.||.|++.+..+.... ..-..+|.+||.+++.++||.+-.+|+..+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 456678899999999999999998854 8999999998776654332 2345789999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhCCC--CCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 748 LSIITEFLPRGSLFRILHRPH--CQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~--~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
+++||..|.||+|.-++...+ .+.+...+++.++++.||++||... ||+|||||+|||+|+.||++|.|+|||..+
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccCCCeEeeccceEEec
Confidence 999999999999999887766 5677778888888899999999998 999999999999999999999999999987
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh----HHHHhhhccccccCCCCCCc
Q 002160 826 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM----QVVGAVGFQNRRLEIPKELD 901 (958)
Q Consensus 826 ~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~----ei~~~i~~~~~~~~ip~~ls 901 (958)
.... .....+||.+|||||++.++.|+...|||+|||+||||+.|+-||...... ++-..+ .....+++..++
T Consensus 338 ~~g~-~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~--~~~~~ey~~kFS 414 (591)
T KOG0986|consen 338 PEGK-PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRT--LEDPEEYSDKFS 414 (591)
T ss_pred CCCC-ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHH--hcchhhcccccC
Confidence 6543 334568999999999999999999999999999999999999999765433 222222 334556788999
Q ss_pred HHHHHHHHHhhhcCCCCCCCHH
Q 002160 902 PLVARIIWECWQTDPSLRPSFA 923 (958)
Q Consensus 902 ~eL~dLI~~CL~kDP~kRPSa~ 923 (958)
+++++|.+.+|.+||.+|....
T Consensus 415 ~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 415 EEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HHHHHHHHHHHccCHHHhccCC
Confidence 9999999999999999997543
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=312.46 Aligned_cols=246 Identities=27% Similarity=0.474 Sum_probs=201.3
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC---CCceeEEeccccCCCceEEE
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~---HPNIVkL~g~~~~~~~l~LV 751 (958)
.|++.+.||.|+||.||+|.+ +++.||||.+.... ......++.+|+.++++++ ||||+++++++......++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 467788999999999999986 68899999876543 2334567889999999996 99999999999999999999
Q ss_pred EeecCCCCHHHHHhCCCCCccHHHHHHHHH-HHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc
Q 002160 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 830 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~ 830 (958)
|||+++++|.+++... ...+...+.++. .+.+|.|||..+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 81 MEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred EecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 9999999999998764 344444444444 489999999988 99999999999999999999999999987654433
Q ss_pred cCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCC-CCcHHHHHHH
Q 002160 831 SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK-ELDPLVARII 908 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~-~ls~eL~dLI 908 (958)
......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+.......+. ......++. .++.++.+||
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i 235 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP-KSKPPRLEDNGYSKLLREFV 235 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc-cCCCCCCCcccCCHHHHHHH
Confidence 3344578999999999875 446889999999999999999999998876655443332 222333443 3789999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 002160 909 WECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 909 ~~CL~kDP~kRPSa~EIL~~ 928 (958)
.+||+.||.+||++.+++.+
T Consensus 236 ~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 236 AACLDEEPKERLSAEELLKS 255 (277)
T ss_pred HHHcCCCcccCcCHHHHhhC
Confidence 99999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=316.62 Aligned_cols=254 Identities=24% Similarity=0.389 Sum_probs=208.1
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCC
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP 746 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~ 746 (958)
.+....++++++..||.|..|.|+++++ +|...|||.+...... +..++++..++++..- ..|+||+.+|+|..+.
T Consensus 86 r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nk-ee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~ 164 (391)
T KOG0983|consen 86 RYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVQCFGYFITNT 164 (391)
T ss_pred ccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCH-HHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc
Confidence 3455667888889999999999999987 5688999999887644 4466777778777666 4899999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
.++|.||.| .-.+..+|.+-.....+.....+... +.||.||..+. +|||||+||+|||+|+.|++||||||++-.+
T Consensus 165 dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlDe~GniKlCDFGIsGrl 242 (391)
T KOG0983|consen 165 DVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLDERGNIKLCDFGISGRL 242 (391)
T ss_pred hHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEccCCCEEeeccccccee
Confidence 999999998 44566677665566666666555544 89999998643 5999999999999999999999999999887
Q ss_pred cCCcccCCCCCCCCCccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHhhhccccccCCCC--C
Q 002160 826 HNTFLSSKSTAGTPEWMAPEVLRN---EPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNRRLEIPK--E 899 (958)
Q Consensus 826 ~~~~~~~~s~~GT~~Y~APEvl~g---~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~-~ei~~~i~~~~~~~~ip~--~ 899 (958)
.+... ....+|.+.|||||.+.- ..|+-++|||||||+++||.||++||.+.+. .+++..+. +..++.++. .
T Consensus 243 vdSkA-htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvl-n~ePP~L~~~~g 320 (391)
T KOG0983|consen 243 VDSKA-HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVL-NEEPPLLPGHMG 320 (391)
T ss_pred ecccc-cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHH-hcCCCCCCcccC
Confidence 66533 445679999999999964 4588899999999999999999999998654 45555554 455555553 4
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 900 LDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 900 ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+++.+++|+..||++|+.+||...++++|
T Consensus 321 FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 321 FSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred cCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 89999999999999999999999999876
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=328.37 Aligned_cols=243 Identities=20% Similarity=0.281 Sum_probs=187.8
Q ss_pred CCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEE
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LV 751 (958)
...+|++.+.||+|+||.||+|++ +++.||+|+.... ....|+.++++++|||||++++++......++|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 345799999999999999999987 4668999974332 234689999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhCCCCCccHHHHHHHHH-HHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc
Q 002160 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 830 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~ 830 (958)
|||+. ++|.+++.+......+.....++. ++.||.|||.++ ||||||||+|||++.++.+||+|||+++..... .
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~ 211 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-P 211 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEecCccccccccC-c
Confidence 99995 688888866555555555555544 499999999998 999999999999999999999999998754322 1
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh-----------HHHHhhhc-cccccCCC-
Q 002160 831 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-----------QVVGAVGF-QNRRLEIP- 897 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~-----------ei~~~i~~-~~~~~~ip- 897 (958)
......||..|+|||++.+..++.++|||||||++|||+++..++....+. .+...+.. ......++
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 223467999999999999999999999999999999999866555332111 01110000 00000111
Q ss_pred -----------------------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 898 -----------------------------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 898 -----------------------------~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
..++.++.+||.+||+.||.+||++.|++.|
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 1356677889999999999999999999876
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=350.14 Aligned_cols=261 Identities=33% Similarity=0.536 Sum_probs=230.4
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEE-----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~-----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~ 745 (958)
.+|......|.++||.|-||+||+|+. +...||||.++. ...+....+|+.|+.||.++.||||++|.|+....
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~-GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA-GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS 702 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeecc-CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence 467778899999999999999999976 345699998754 45667788999999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 746 ~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
..+.||+|||++|.|..||+++..++...+..-|... +.||.||-.++ +|||||-..||||+.+...|++|||+++.
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccceEEEeccccceee
Confidence 9999999999999999999988877776666666555 89999999999 99999999999999999999999999998
Q ss_pred ccCCcccCCCCCC---CCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCC
Q 002160 825 KHNTFLSSKSTAG---TPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 900 (958)
Q Consensus 825 ~~~~~~~~~s~~G---T~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~l 900 (958)
+.++.....+..| ..+|.|||.+...+++.++||||+||+|||.++ |..||-++.+++++..+. ++.++.-|..+
T Consensus 781 ledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe-~gyRLPpPmDC 859 (996)
T KOG0196|consen 781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-QGYRLPPPMDC 859 (996)
T ss_pred cccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH-hccCCCCCCCC
Confidence 8655432222222 358999999999999999999999999999665 999999999999998886 67788888999
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 901 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 901 s~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
|..+.+|+..||++|-.+||.|.||+..|.++.+.
T Consensus 860 P~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 860 PAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred cHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 99999999999999999999999999999999764
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=357.10 Aligned_cols=257 Identities=25% Similarity=0.344 Sum_probs=203.0
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
++|++.++||+|+||.||+|.+ +++.||||++..... ......++.+|++++++++||||+++++++.+.+..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5899999999999999999986 588999999875432 2334567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCC----------CCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccc
Q 002160 753 EFLPRGSLFRILHRPH----------CQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 821 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~----------~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGL 821 (958)
||++|++|.+++.... ........+.++ +++.||+|||..+ |+||||||+|||++.++.+||+|||+
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCCCCEEEEecCc
Confidence 9999999999886311 111122233333 4489999999988 99999999999999999999999999
Q ss_pred cccccCC------------------cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHH
Q 002160 822 SRLKHNT------------------FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV 883 (958)
Q Consensus 822 Ak~~~~~------------------~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei 883 (958)
++..... .......+||+.|+|||++.+..++.++|||||||++|||++|..||........
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 9865210 0111235699999999999999999999999999999999999999987655443
Q ss_pred HHhhhccccc-cCCCCCCcHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHhhhh
Q 002160 884 VGAVGFQNRR-LEIPKELDPLVARIIWECWQTDPSLRP-SFAQLTVALKPLQR 934 (958)
Q Consensus 884 ~~~i~~~~~~-~~ip~~ls~eL~dLI~~CL~kDP~kRP-Sa~EIL~~L~kL~k 934 (958)
.......... ......+++.+.+++.+||+.||.+|+ +++++++.|+.+..
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 3222111111 111136789999999999999999995 67888888887744
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=314.02 Aligned_cols=250 Identities=24% Similarity=0.264 Sum_probs=193.8
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeccccCCCc-----
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPN----- 747 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~-HPNIVkL~g~~~~~~~----- 747 (958)
++|++.+.||+|+||.||+|.+ +++.||||++............+.+|+.+++++. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4689999999999999999986 6889999987654333333456788999999994 6999999999877665
Q ss_pred eEEEEeecCCCCHHHHHhCCC----CCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcC-CCcEEEEeccc
Q 002160 748 LSIITEFLPRGSLFRILHRPH----CQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGL 821 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~----~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~-~g~VKL~DFGL 821 (958)
+|+||||+++ +|.+++.... ....+.....++ +++.||.|||..+ |+||||||+||+++. ++.+||+|||+
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeeccc
Confidence 8999999985 7888775432 233444444444 4489999999988 999999999999998 89999999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc--------
Q 002160 822 SRLKHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-------- 892 (958)
Q Consensus 822 Ak~~~~~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~-------- 892 (958)
++.............+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T cd07837 158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237 (295)
T ss_pred ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 8865433333333457889999999875 4578999999999999999999999988765543322210000
Q ss_pred --------------c----cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 893 --------------R----LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 893 --------------~----~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
. ......++.++.+||.+||+.||.+||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 00112478889999999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=339.00 Aligned_cols=262 Identities=28% Similarity=0.502 Sum_probs=224.2
Q ss_pred ccccccCCCCeeEEEEeeccCceEEEEEEE----CCc--EEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEecc
Q 002160 668 VCECEIPWEDLVLGERIGLGSYGEVYHADW----NGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 741 (958)
Q Consensus 668 ~~~~eI~~~dy~i~k~LG~G~fG~Vykak~----~g~--~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~ 741 (958)
...+++..+.+...+.||.|-||.||+|.+ +|+ -||||.-+.. ......+.|..|.-+|++++|||||+++|+
T Consensus 381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d-~t~d~tekflqEa~iMrnfdHphIikLIGv 459 (974)
T KOG4257|consen 381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD-CTPDDTEKFLQEASIMRNFDHPHIIKLIGV 459 (974)
T ss_pred CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC-CChhhHHHHHHHHHHHHhCCCcchhheeee
Confidence 345677778888899999999999999976 233 4888875543 445567899999999999999999999999
Q ss_pred ccCCCceEEEEeecCCCCHHHHHhCCCCCccHH-HHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecc
Q 002160 742 VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEK-RRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 820 (958)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~-~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFG 820 (958)
|.+ ...|||||+++-|.|..+|+++...+... ..++..++..+|+|||+.. +|||||-..|||+.....|||+|||
T Consensus 460 ~~e-~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~CVKLaDFG 536 (974)
T KOG4257|consen 460 CVE-QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQCVKLADFG 536 (974)
T ss_pred eec-cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCcceeeecccc
Confidence 976 46899999999999999999877655544 4455556689999999988 9999999999999999999999999
Q ss_pred ccccccCCcccCCC-CCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCC
Q 002160 821 LSRLKHNTFLSSKS-TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPK 898 (958)
Q Consensus 821 LAk~~~~~~~~~~s-~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~ 898 (958)
+++.+.+..+...+ ..-...|||||-+.-.+++.++|||.||+++||++. |..||.+..+.+++..+. ++.++..|.
T Consensus 537 LSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE-nGeRlP~P~ 615 (974)
T KOG4257|consen 537 LSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE-NGERLPCPP 615 (974)
T ss_pred hhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec-CCCCCCCCC
Confidence 99998766543332 223458999999999999999999999999999765 999999999888887775 788999999
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhh
Q 002160 899 ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934 (958)
Q Consensus 899 ~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k 934 (958)
.+|+.+..|+.+||..||.+||.|.+|...|..+..
T Consensus 616 nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 616 NCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 999999999999999999999999999999987754
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=332.32 Aligned_cols=246 Identities=27% Similarity=0.446 Sum_probs=213.7
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEee
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
-|.++++||+|+||.||++.+ .|..+|||++... .++.++..|+.||++++.|++|++||.+.....+||||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 367788999999999999966 7889999987643 3577899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCC
Q 002160 755 LPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 833 (958)
Q Consensus 755 ~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~ 833 (958)
|..|++.++++.+...+.+.....+... +.||+|||-.. =||||||..|||++.+|+.||+|||.|..+.+.....+
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRN 187 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRN 187 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccchhhhhHHhhC
Confidence 9999999999876666665555555555 89999999877 79999999999999999999999999999988888888
Q ss_pred CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCC--CCCCcHHHHHHHHHh
Q 002160 834 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI--PKELDPLVARIIWEC 911 (958)
Q Consensus 834 s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~i--p~~ls~eL~dLI~~C 911 (958)
+..||+.|||||++..-.|+.++||||||++..||..|++||.+-.++..+..+. .+.++.| |...+.++.|||+.|
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP-T~PPPTF~KPE~WS~~F~DFi~~C 266 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP-TKPPPTFKKPEEWSSEFNDFIRSC 266 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc-CCCCCCCCChHhhhhHHHHHHHHH
Confidence 8999999999999999999999999999999999999999998887776554443 2223333 456788999999999
Q ss_pred hhcCCCCCCCHHHHHHHH
Q 002160 912 WQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 912 L~kDP~kRPSa~EIL~~L 929 (958)
|-+.|++|.++.++++|-
T Consensus 267 LiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 267 LIKKPEERKTALRLCEHT 284 (502)
T ss_pred hcCCHHHHHHHHHHhhhh
Confidence 999999999999998874
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=312.84 Aligned_cols=250 Identities=23% Similarity=0.291 Sum_probs=195.8
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
++|++.+.||+|++|.||+|++ +++.||||++............+.+|++++++++||||+++++++.....+|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 6799999999999999999986 57889999886654433444578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCC-ccHHHH-HHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcC-CCcEEEEeccccccccCCcc
Q 002160 754 FLPRGSLFRILHRPHCQ-VDEKRR-IKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRLKHNTFL 830 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~-~~e~~~-l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~-~g~VKL~DFGLAk~~~~~~~ 830 (958)
|++ ++|.+++...... ..+... ..+.+++.||+|||.++ |+||||||+||+++. ++.+||+|||++........
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 996 5787777543332 333333 34445589999999988 999999999999985 56799999999976543323
Q ss_pred cCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcc--cc---------------
Q 002160 831 SSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ--NR--------------- 892 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~--~~--------------- 892 (958)
......+++.|+|||++.+. .++.++||||||+++|+|++|+.||...+..+....+... ..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 23345678899999998764 5789999999999999999999999876654433322100 00
Q ss_pred --cc--------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 893 --RL--------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 893 --~~--------~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.. .....+++.+.++|.+||+.+|++||++.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0123467889999999999999999999999874
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=312.62 Aligned_cols=250 Identities=24% Similarity=0.333 Sum_probs=193.2
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
.++|++.+.||.|+||.||+|+. +++.||||.+...... .....+.+|++++++++|+||+++++++...+..++||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 36899999999999999999976 6889999998654322 12234678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCcc-HHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc
Q 002160 753 EFLPRGSLFRILHRPHCQVD-EKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~-e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~ 831 (958)
||+.+ +|.+++.+...... ...+..+.+++.||.|||..+ |+||||||+|||++.++.+||+|||+++........
T Consensus 83 e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 83 EYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 99975 89998876544444 344444556699999999988 999999999999999999999999998765332222
Q ss_pred CCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hhHHHHhhhc-------------------c
Q 002160 832 SKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGF-------------------Q 890 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~-~~ei~~~i~~-------------------~ 890 (958)
.....++..|+|||++.+ ..++.++||||||+++|+|++|+.||.+.. ..+....+.. .
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 233457889999999876 457899999999999999999999997655 2221111100 0
Q ss_pred cccc---------CCCCCCc--HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 891 NRRL---------EIPKELD--PLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 891 ~~~~---------~ip~~ls--~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.... .....++ .++.++|.+||+.+|.+||++.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000 0001233 788999999999999999999998864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=313.30 Aligned_cols=249 Identities=30% Similarity=0.477 Sum_probs=205.3
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
.+.|++.+.||+|+||.||+|.+ .+..|++|++..... ....+.+|++++++++|+||+++++++......|+|+
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 45688889999999999999987 488999999875543 4567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~ 831 (958)
||+++++|.+++........+.....++ +.+.+|+|||..+ |+|+||||+||+++.+++++|+|||++.........
T Consensus 95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 172 (286)
T cd06614 95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK 172 (286)
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCCCCEEECccchhhhhccchhh
Confidence 9999999999998765344445444444 4489999999987 999999999999999999999999988755433222
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc-ccCCCCCCcHHHHHHHHH
Q 002160 832 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWE 910 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~-~~~ip~~ls~eL~dLI~~ 910 (958)
.....++..|++||++.+..++.++|+||||+++|+|++|+.||...+.......+..... ....+..++..+++||.+
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 252 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNK 252 (286)
T ss_pred hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHH
Confidence 3345688899999999988899999999999999999999999988776655444432211 112233478999999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 002160 911 CWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 911 CL~kDP~kRPSa~EIL~~ 928 (958)
||+.+|.+||++.+|+.+
T Consensus 253 ~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 253 CLVKDPEKRPSAEELLQH 270 (286)
T ss_pred HhccChhhCcCHHHHhhC
Confidence 999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=315.49 Aligned_cols=246 Identities=30% Similarity=0.433 Sum_probs=199.7
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
+.|.+.+.||+|+||.||+|++ +++.||+|++..... .......+.+|+.+++.++||||+++++++...+..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 5688899999999999999986 688999998865433 3344567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~ 831 (958)
||++ |+|.+++........+.....++ +++.||.|||..+ |+||||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--- 168 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--- 168 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence 9996 57777665433344555444444 4489999999988 999999999999999999999999998765322
Q ss_pred CCCCCCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCC-CCCCcHHHHHH
Q 002160 832 SKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI-PKELDPLVARI 907 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~---g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~i-p~~ls~eL~dL 907 (958)
....++..|+|||++. ...++.++||||||+++|+|++|+.||.+.+.......+... ....+ +..++..+++|
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l 246 (307)
T cd06607 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSPTLSSNDWSDYFRNF 246 (307)
T ss_pred -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC-CCCCCCchhhCHHHHHH
Confidence 2356888999999984 355788999999999999999999999887766554444322 22222 34578899999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHH
Q 002160 908 IWECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 908 I~~CL~kDP~kRPSa~EIL~~L 929 (958)
|.+||..+|.+||++.+|+.+.
T Consensus 247 i~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 247 VDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred HHHHhcCChhhCcCHHHHhcCh
Confidence 9999999999999999998864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=311.42 Aligned_cols=248 Identities=25% Similarity=0.314 Sum_probs=196.3
Q ss_pred eeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeec
Q 002160 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~ 755 (958)
|++.+.||.|++|.||+|.+ +++.||||++............+.+|++++++++||||+++++++.+.+..|++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56788999999999999976 6899999998765443333456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhCCC-CCccHHHHHHHHH-HHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCC
Q 002160 756 PRGSLFRILHRPH-CQVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 833 (958)
Q Consensus 756 ~gGsL~d~L~k~~-~~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~ 833 (958)
+ ++|.+++.... ....+.....++. .+.+|+|||.++ ++||||+|+||+++.++.++|+|||++...........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 157 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYT 157 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccC
Confidence 5 68999887654 2345555555444 489999999987 99999999999999999999999999976543322223
Q ss_pred CCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcc----------------------
Q 002160 834 STAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---------------------- 890 (958)
Q Consensus 834 s~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~---------------------- 890 (958)
...++..|+|||++.+. .++.++||||||+++|+|++|+.||...+.......+...
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF 237 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence 34568899999988764 4688999999999999999999999876654322221000
Q ss_pred -c----cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 891 -N----RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 891 -~----~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
. ........++..+.+||.+||+.||.+||++++++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 0011124567899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=318.61 Aligned_cols=247 Identities=28% Similarity=0.382 Sum_probs=199.8
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEee
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
.|.....||+|+||.||++.. ++..||||++.... ......+.+|+.+++.++|+||+++++.+...+..++||||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 344456799999999999976 68899999875432 23455688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCC
Q 002160 755 LPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 834 (958)
Q Consensus 755 ~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s 834 (958)
+++++|.+++.... .........+.+++.||.|||.++ |+||||||+||++++++.+||+|||++............
T Consensus 101 ~~~~~L~~~~~~~~-l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 177 (292)
T cd06658 101 LEGGALTDIVTHTR-MNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS 177 (292)
T ss_pred CCCCcHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCce
Confidence 99999999886532 233333444444589999999988 999999999999999999999999998765433333334
Q ss_pred CCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcc-ccccCCCCCCcHHHHHHHHHhhh
Q 002160 835 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRRLEIPKELDPLVARIIWECWQ 913 (958)
Q Consensus 835 ~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~-~~~~~ip~~ls~eL~dLI~~CL~ 913 (958)
..|+..|+|||.+.+..++.++||||||+++|||++|+.||...+..+....+... .........++..+++||.+||.
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 257 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLV 257 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHcc
Confidence 56899999999999888999999999999999999999999887766554443211 11112223578899999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 002160 914 TDPSLRPSFAQLTVA 928 (958)
Q Consensus 914 kDP~kRPSa~EIL~~ 928 (958)
.||.+||++++|+++
T Consensus 258 ~~P~~Rpt~~~il~~ 272 (292)
T cd06658 258 REPSQRATAQELLQH 272 (292)
T ss_pred CChhHCcCHHHHhhC
Confidence 999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=311.81 Aligned_cols=249 Identities=24% Similarity=0.293 Sum_probs=190.6
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
.+|.+.+.||+|+||.||+|.. +++.||||.+...... .....+.+|+++++.++|+||+++++++...+..|+|||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 6799999999999999999975 6889999998654322 223356789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCcc-HHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 754 FLPRGSLFRILHRPHCQVD-EKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~-e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
|+. ++|..++........ ...+....+.+.||.|||.++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 160 (291)
T cd07870 84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY 160 (291)
T ss_pred ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence 996 677666654333333 334444445589999999988 9999999999999999999999999987654332233
Q ss_pred CCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChh-HHHHhhhc--c--------------c---
Q 002160 833 KSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGF--Q--------------N--- 891 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~-ei~~~i~~--~--------------~--- 891 (958)
....++..|+|||++.+. .++.++||||||+++|+|++|..||.+.... +....+.. . .
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP 240 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence 445678999999998764 4788999999999999999999999765432 11111100 0 0
Q ss_pred --cccCCC---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 892 --RRLEIP---------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 892 --~~~~ip---------~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.....+ ...++.+.+|+.+||..||.+||++.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 000000 0135789999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=323.14 Aligned_cols=248 Identities=23% Similarity=0.293 Sum_probs=195.5
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC------C
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------P 746 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~------~ 746 (958)
.++|++.+.||+|+||.||+|+. +++.||||++...........++.+|+.++++++||||++++++|... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 36799999999999999999976 788999998865544444556778899999999999999999988644 3
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
..|+||||+. ++|.+.+... .........+.+++.||+|||..+ |+||||||+|||++.++.+||+|||+++...
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred cEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 4799999995 5888877653 233333444455599999999988 9999999999999999999999999998764
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccc---------------
Q 002160 827 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN--------------- 891 (958)
Q Consensus 827 ~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~--------------- 891 (958)
.... .....++..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+....
T Consensus 170 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T cd07850 170 TSFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV 248 (353)
T ss_pred CCCC-CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence 4322 334568899999999999999999999999999999999999998765433222111000
Q ss_pred -----ccc--------------CC-------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 892 -----RRL--------------EI-------PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 892 -----~~~--------------~i-------p~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.+. .+ +...+..+++||.+||+.||.+||++.|++.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 00 11346678999999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=309.26 Aligned_cols=248 Identities=24% Similarity=0.321 Sum_probs=199.6
Q ss_pred eeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeec
Q 002160 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~ 755 (958)
|++.+.||.|++|.||+|+. +++.+++|++............+.+|+++|++++|+||+++++++..+..+++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56778999999999999986 6888999998766554445567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhCCCCCccHHHHHHH-HHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCC
Q 002160 756 PRGSLFRILHRPHCQVDEKRRIKM-ALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 834 (958)
Q Consensus 756 ~gGsL~d~L~k~~~~~~e~~~l~i-a~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s 834 (958)
++ +|..++........+.....+ .+.+.+|.|||..+ |+|+||||+||+++.++.+||+|||.+............
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccC
Confidence 75 888888765444455554444 44499999999988 999999999999999999999999999876554322334
Q ss_pred CCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccc--------------------
Q 002160 835 TAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR-------------------- 893 (958)
Q Consensus 835 ~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~-------------------- 893 (958)
..++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+..+....+......
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 5688899999999876 6899999999999999999999999877654433222110000
Q ss_pred --------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 894 --------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 894 --------~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
..+...++.++++||.+||+.||.+||++.+|+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00112467899999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=309.38 Aligned_cols=248 Identities=24% Similarity=0.317 Sum_probs=195.9
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEee
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
+|++.+.||.|++|.||+|++ +++.||||++...... .....+.+|+.++++++|+||+++++++...+.+++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 588999999999999999987 6889999988765322 2234667899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhCCC--CCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc
Q 002160 755 LPRGSLFRILHRPH--CQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 755 ~~gGsL~d~L~k~~--~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~ 831 (958)
+++ +|.+++.... ....+..... +.+.+.||.|||..+ |+||||||+||++++++.+||+|||++.........
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 975 8888876543 2344444444 444489999999988 999999999999999999999999999765443333
Q ss_pred CCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccc----------------ccc
Q 002160 832 SKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN----------------RRL 894 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~----------------~~~ 894 (958)
.....++..|++||++.+. .++.++|||+||+++|+|++|+.||.+.+..+....+.... ...
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 3345678899999998764 46889999999999999999999998876554433321000 000
Q ss_pred C-----------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 895 E-----------IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 895 ~-----------ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
. +...++..++++|.+||+.||.+||++.+|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1 112457889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=316.09 Aligned_cols=241 Identities=24% Similarity=0.346 Sum_probs=178.1
Q ss_pred EEEeeccCceEEEEEEE----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEecccc--CCCceEEEEee
Q 002160 681 GERIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT--RPPNLSIITEF 754 (958)
Q Consensus 681 ~k~LG~G~fG~Vykak~----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~--~~~~l~LVmEy 754 (958)
+.+||+|+||.||+|++ ++..||+|.+...... ..+.+|+++|++++||||+++++++. ....+++||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 46799999999999986 3468999988654332 35678999999999999999999884 35668999999
Q ss_pred cCCCCHHHHHhCC--------CCCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEE----cCCCcEEEEeccc
Q 002160 755 LPRGSLFRILHRP--------HCQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGL 821 (958)
Q Consensus 755 ~~gGsL~d~L~k~--------~~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILI----d~~g~VKL~DFGL 821 (958)
+. ++|.+++... ...+.+..... +.+.+.||.|||..+ |+||||||+|||+ +.++.+||+|||+
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 86 4777776421 11234444443 444599999999988 9999999999999 5678999999999
Q ss_pred cccccCCcc---cCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChh----------HHHHhh
Q 002160 822 SRLKHNTFL---SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPM----------QVVGAV 887 (958)
Q Consensus 822 Ak~~~~~~~---~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~----------ei~~~i 887 (958)
++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... +.....
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence 986543221 2234568999999999977 45789999999999999999999999753321 000000
Q ss_pred hc-------------------------cccc----------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 888 GF-------------------------QNRR----------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 888 ~~-------------------------~~~~----------~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.. .... .......+..+.+||.+||+.||.+||++.|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 00 0000 00011235678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=310.45 Aligned_cols=261 Identities=24% Similarity=0.332 Sum_probs=210.2
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc-
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN- 747 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~- 747 (958)
.-|+-++|.+.+.||+|||.-||+++. ++..||+|++.... .+..+...+|++..++++||||++++++...+..
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 457778999999999999999999985 78899999998775 4557788999999999999999999998755544
Q ss_pred ----eEEEEeecCCCCHHHHHhC---CCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEec
Q 002160 748 ----LSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 819 (958)
Q Consensus 748 ----l~LVmEy~~gGsL~d~L~k---~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DF 819 (958)
.||++.|...|+|.+.+.. .+....+...++++.. +.||.+||...+++.||||||.|||+.+.+.++|.||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 9999999999999998753 3445667777776666 8999999999999999999999999999999999999
Q ss_pred cccccccCCccc---------CCCCCCCCCccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhh
Q 002160 820 GLSRLKHNTFLS---------SKSTAGTPEWMAPEVLRN---EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV 887 (958)
Q Consensus 820 GLAk~~~~~~~~---------~~s~~GT~~Y~APEvl~g---~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i 887 (958)
|.+....-.... ......|..|.|||.+.- ...++++|||||||+||.|++|.-||......----.+
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL 253 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL 253 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE
Confidence 998764321111 112336899999999864 34589999999999999999999999643221100112
Q ss_pred hccccccCCCC--CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 002160 888 GFQNRRLEIPK--ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 933 (958)
Q Consensus 888 ~~~~~~~~ip~--~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~ 933 (958)
...+....+|. .++..+.+||++||+.||.+||++.+++.++..+.
T Consensus 254 Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 254 AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 22344444443 38899999999999999999999999999998763
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=311.53 Aligned_cols=242 Identities=26% Similarity=0.337 Sum_probs=193.3
Q ss_pred eeccCceEEEEEEE--CCcEEEEEEeecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeecCCCCH
Q 002160 684 IGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 760 (958)
Q Consensus 684 LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~gGsL 760 (958)
||+|+||+||+|.+ +++.||+|.+....... .....+..|+++|++++||||+++++++...+.+|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999975 68899999987654322 2344567899999999999999999999999999999999999999
Q ss_pred HHHHhCCCC-CccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCCCC
Q 002160 761 FRILHRPHC-QVDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT 838 (958)
Q Consensus 761 ~d~L~k~~~-~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~GT 838 (958)
.+++.+... ...+.... +..+.+.+|.|||..+ |+||||+|+|||+++++.+||+|||++...... .......++
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccCC
Confidence 998876542 33444444 4455599999999988 999999999999999999999999998765432 222345678
Q ss_pred CCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhh--ccccccCCCCCCcHHHHHHHHHhhhcCC
Q 002160 839 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG--FQNRRLEIPKELDPLVARIIWECWQTDP 916 (958)
Q Consensus 839 ~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~--~~~~~~~ip~~ls~eL~dLI~~CL~kDP 916 (958)
..|+|||++.+..++.++||||||+++|+|++|+.||...........+. .......++..+++.+.++|.+||+.||
T Consensus 158 ~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (277)
T cd05577 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDP 237 (277)
T ss_pred CCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCCh
Confidence 89999999998889999999999999999999999997765421111111 1223445667789999999999999999
Q ss_pred CCCC-----CHHHHHHH
Q 002160 917 SLRP-----SFAQLTVA 928 (958)
Q Consensus 917 ~kRP-----Sa~EIL~~ 928 (958)
.+|| ++.+++.+
T Consensus 238 ~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 238 EKRLGCRGGSADEVREH 254 (277)
T ss_pred hHccCCCcccHHHHHhC
Confidence 9999 66666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=317.72 Aligned_cols=246 Identities=28% Similarity=0.395 Sum_probs=200.5
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEee
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
.|.....||+|+||.||++.. +++.||||.+...... ....+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc--hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 344556799999999999976 6889999998654322 245678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhCCCCCccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCC
Q 002160 755 LPRGSLFRILHRPHCQVDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 833 (958)
Q Consensus 755 ~~gGsL~d~L~k~~~~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~ 833 (958)
+++++|..++.... ..+.... .+.+.+.||.|||..+ |+||||||+|||++.++.+||+|||++...........
T Consensus 100 ~~~~~L~~~~~~~~--~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 175 (297)
T cd06659 100 LQGGALTDIVSQTR--LNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 175 (297)
T ss_pred CCCCCHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccCCcEEEeechhHhhccccccccc
Confidence 99999999876532 3334444 4444599999999988 99999999999999999999999999876544333334
Q ss_pred CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcc-ccccCCCCCCcHHHHHHHHHhh
Q 002160 834 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRRLEIPKELDPLVARIIWECW 912 (958)
Q Consensus 834 s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~-~~~~~ip~~ls~eL~dLI~~CL 912 (958)
...|+..|+|||++.+..++.++|||||||++|+|++|+.||......+....+... ......+..++..+.++|.+||
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l 255 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERML 255 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHh
Confidence 467899999999999888999999999999999999999999877765554444211 1112234467889999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 002160 913 QTDPSLRPSFAQLTVA 928 (958)
Q Consensus 913 ~kDP~kRPSa~EIL~~ 928 (958)
+.+|.+||++.+|+++
T Consensus 256 ~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 256 TREPQERATAQELLDH 271 (297)
T ss_pred cCCcccCcCHHHHhhC
Confidence 9999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=313.16 Aligned_cols=248 Identities=28% Similarity=0.396 Sum_probs=192.0
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeccccCCCceEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~-HPNIVkL~g~~~~~~~l~LV 751 (958)
.++|+..+.||+|+||.||++.+ +++.||||++...... .....+.+|+.++.++. |+||+++++++..+...+++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 35677788999999999999987 6789999998765433 44567889999999996 99999999999999999999
Q ss_pred EeecCCCCHHHHH---hC-CCCCccHHHH-HHHHHHHHHHHHHHhc-CCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 752 TEFLPRGSLFRIL---HR-PHCQVDEKRR-IKMALDARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 752 mEy~~gGsL~d~L---~k-~~~~~~e~~~-l~ia~~a~aL~yLH~~-g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
|||+.. +|.++. .. ......+... ....+.+.||+|||.. + |+||||||+|||++.++.+||+|||++...
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 999854 554432 21 1123344433 3444458999999974 6 999999999999999999999999999765
Q ss_pred cCCcccCCCCCCCCCccCcccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCChh-HHHHhhhccccccCC----C
Q 002160 826 HNTFLSSKSTAGTPEWMAPEVLRNE---PSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRLEI----P 897 (958)
Q Consensus 826 ~~~~~~~~s~~GT~~Y~APEvl~g~---~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~-ei~~~i~~~~~~~~i----p 897 (958)
..... .....|+..|+|||++.+. .++.++|||||||++|+|++|+.||...... +....+. ....+.+ +
T Consensus 159 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 236 (288)
T cd06616 159 VDSIA-KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV-KGDPPILSNSEE 236 (288)
T ss_pred ccCCc-cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhc-CCCCCcCCCcCC
Confidence 44322 2334688999999999876 6889999999999999999999999765421 2222221 1112222 2
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 898 KELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 898 ~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
..++.++.+||.+||+.+|.+||++++|+.+
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 237 REFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 3578999999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=312.11 Aligned_cols=237 Identities=22% Similarity=0.366 Sum_probs=188.7
Q ss_pred EeeccCceEEEEEEEC--------------------------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCcee
Q 002160 683 RIGLGSYGEVYHADWN--------------------------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736 (958)
Q Consensus 683 ~LG~G~fG~Vykak~~--------------------------g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIV 736 (958)
.||+|+||.||+|.+. ...|++|.+.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 5999999999999641 1348888765432 22345688899999999999999
Q ss_pred EEeccccCCCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCC---
Q 002160 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNW--- 812 (958)
Q Consensus 737 kL~g~~~~~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g--- 812 (958)
++++++......++||||+++|+|..++.+......+..++.++.+ +.||+|||..+ |+||||||+|||+++.+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCccc
Confidence 9999999999999999999999999998765555555555555554 99999999987 99999999999997643
Q ss_pred ----cEEEEeccccccccCCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHH-hCCCCCCCCChhHHHHh
Q 002160 813 ----NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELA-TLKLPWIGMNPMQVVGA 886 (958)
Q Consensus 813 ----~VKL~DFGLAk~~~~~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELL-tG~~PF~g~~~~ei~~~ 886 (958)
.+||+|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||......+....
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 233 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF 233 (274)
T ss_pred CccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 4899999987643221 22457888999999875 56789999999999999985 69999987765544332
Q ss_pred hhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002160 887 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 930 (958)
Q Consensus 887 i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~ 930 (958)
.. ....++....+.+.+||.+||+.+|.+||++.+|++.|.
T Consensus 234 ~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 234 YE---KKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HH---hccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 21 233455566789999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=372.76 Aligned_cols=249 Identities=30% Similarity=0.453 Sum_probs=218.2
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEee
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
+|.-+..||.|.||.||-|.. +|+..|+|-++.+.........+.+|..+|..|+|||+|++||+-.+.+.++|.|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 344567799999999999975 788899998887766655566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc----c
Q 002160 755 LPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF----L 830 (958)
Q Consensus 755 ~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~----~ 830 (958)
|++|+|.+++...+...+...+++..+.+.|++|||++| ||||||||+|||++.+|-+|+.|||.|+.+.+.. .
T Consensus 1316 C~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred hccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence 999999999988766777778888888899999999999 9999999999999999999999999998765543 2
Q ss_pred cCCCCCCCCCccCcccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCC-hhHHHHhhhccccccCCCCCCcHHHHH
Q 002160 831 SSKSTAGTPEWMAPEVLRNEP---SNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNRRLEIPKELDPLVAR 906 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~~---~s~ksDIWSLGiLLyELLtG~~PF~g~~-~~ei~~~i~~~~~~~~ip~~ls~eL~d 906 (958)
.-+...||+-|||||++.|.. ...++|||||||++.||+||+.||...+ ..++..++. .+..+++|..++.+-++
T Consensus 1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~-~gh~Pq~P~~ls~~g~d 1472 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVA-AGHKPQIPERLSSEGRD 1472 (1509)
T ss_pred HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHh-ccCCCCCchhhhHhHHH
Confidence 234567999999999998754 4678999999999999999999997754 456666665 67788999999999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 002160 907 IIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 907 LI~~CL~kDP~kRPSa~EIL~~ 928 (958)
||.+||..||.+|+++.||+++
T Consensus 1473 Fle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1473 FLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HHHHHHhcCchhhhHHHHHHHh
Confidence 9999999999999999988876
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=338.67 Aligned_cols=243 Identities=23% Similarity=0.309 Sum_probs=190.6
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
...|.+.+.||+|+||.||+|.+ .++.||||.... ..+.+|+++|++|+|+|||++++++...+..+|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 34799999999999999999987 567899995322 24568999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc-
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 830 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~- 830 (958)
||+. ++|..++.+....+.+...+.++.+ +.||.|||.++ ||||||||+||||+.++.+||+|||+++.......
T Consensus 240 e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 240 PKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred EccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 9994 6888888765444555555555544 89999999988 99999999999999999999999999986543211
Q ss_pred -cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------hhHHHHhhhccccc-cCCC---
Q 002160 831 -SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN--------PMQVVGAVGFQNRR-LEIP--- 897 (958)
Q Consensus 831 -~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~--------~~ei~~~i~~~~~~-~~ip--- 897 (958)
......||..|+|||++.+..++.++|||||||+||||++|..|+.... ..++...+...... ..++
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 1234579999999999999999999999999999999999887654321 12222221110000 0000
Q ss_pred ----------------------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 898 ----------------------------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 898 ----------------------------~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
..++..+.+||.+||+.||.+||++.|++++
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1345689999999999999999999999986
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=314.59 Aligned_cols=249 Identities=27% Similarity=0.424 Sum_probs=202.5
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
..+|++.+.||+|+||.||++.. ++..||+|.+..... .....+.+|+.++++++||||+++++.+...+..|+|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 46899999999999999999975 678899998754432 23456889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
||+++++|.+++.+.. .........+.+.+.||.|||..+ ++||||||+||+++.++.+||+|||++..........
T Consensus 96 e~~~~~~L~~~~~~~~-l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~ 172 (293)
T cd06647 96 EYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172 (293)
T ss_pred ecCCCCcHHHHHhhcC-CCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCCCCEEEccCcceeccccccccc
Confidence 9999999999987643 223333334444589999999988 9999999999999999999999999887654433333
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcc-ccccCCCCCCcHHHHHHHHHh
Q 002160 833 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRRLEIPKELDPLVARIIWEC 911 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~-~~~~~ip~~ls~eL~dLI~~C 911 (958)
....|++.|++||.+.+..++.++|+||||+++|+|++|+.||...+.......+... ......+..++..+++||.+|
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 252 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 252 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHH
Confidence 4456889999999999888899999999999999999999999876654433222111 111223445788999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 002160 912 WQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 912 L~kDP~kRPSa~EIL~~ 928 (958)
|..+|.+||++.+|+.+
T Consensus 253 l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 253 LEMDVEKRGSAKELLQH 269 (293)
T ss_pred ccCChhhCcCHHHHhcC
Confidence 99999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=312.27 Aligned_cols=251 Identities=25% Similarity=0.310 Sum_probs=192.3
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC------
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------ 746 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~------ 746 (958)
.++|++.+.||+|+||.||+|+. +++.||||++............+.+|++++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 36799999999999999999986 6889999988755433333345678999999999999999999876543
Q ss_pred --ceEEEEeecCCCCHHHHHhCCCCCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccc
Q 002160 747 --NLSIITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 823 (958)
Q Consensus 747 --~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk 823 (958)
..++||||+. ++|.+++.+......+..... +.+++.||.|||.++ |+|+||||+|||++.++.+||+|||++.
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 4599999996 588888766543444444444 444599999999988 9999999999999999999999999997
Q ss_pred cccCCcc----cCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc------
Q 002160 824 LKHNTFL----SSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------ 892 (958)
Q Consensus 824 ~~~~~~~----~~~s~~GT~~Y~APEvl~g~~-~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~------ 892 (958)
....... ......++..|+|||++.+.. ++.++||||||+++|+|++|+.||.+.+.......+.....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 6533221 112345788999999987654 68899999999999999999999987765443322211000
Q ss_pred -----------ccCCC-------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 893 -----------RLEIP-------------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 893 -----------~~~ip-------------~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
...++ ...+..+++||.+||+.||.+||++++++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00011 1235678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=340.07 Aligned_cols=243 Identities=27% Similarity=0.303 Sum_probs=197.4
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC-C-----CceeEEeccccCCCce
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-H-----PNVVLFMGAVTRPPNL 748 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~-H-----PNIVkL~g~~~~~~~l 748 (958)
+|+|.+.||+|+||.|.+|.+ +++.||||+++... ....+-..|+.||..|+ | -|||+++++|...+++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 899999999999999999965 78999999987643 33456678999999996 4 3799999999999999
Q ss_pred EEEEeecCCCCHHHHHhCCCCCc--cHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcC--CCcEEEEecccccc
Q 002160 749 SIITEFLPRGSLFRILHRPHCQV--DEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDK--NWNVKVSDFGLSRL 824 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~~~--~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~--~g~VKL~DFGLAk~ 824 (958)
|||+|++ .-+|+++++.+.... ....+-+..+++.||..||+.+ |||+|||||||||.. ...|||+|||.++.
T Consensus 264 ciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 264 CIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEecccccc
Confidence 9999998 569999998766433 3444444455599999999988 999999999999974 45799999999998
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcc--------------
Q 002160 825 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-------------- 890 (958)
Q Consensus 825 ~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~-------------- 890 (958)
.....+ +++-++.|.|||++.|.+|+.+.||||||||++||++|.+-|.|.+..+.+..|...
T Consensus 341 ~~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~ 417 (586)
T KOG0667|consen 341 ESQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKK 417 (586)
T ss_pred cCCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 766544 567899999999999999999999999999999999999889988776554332100
Q ss_pred ------c------------------------------cccCCC-----------CCCcHHHHHHHHHhhhcCCCCCCCHH
Q 002160 891 ------N------------------------------RRLEIP-----------KELDPLVARIIWECWQTDPSLRPSFA 923 (958)
Q Consensus 891 ------~------------------------------~~~~ip-----------~~ls~eL~dLI~~CL~kDP~kRPSa~ 923 (958)
. .....| ..-...+.+||++||..||.+|++..
T Consensus 418 ~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~ 497 (586)
T KOG0667|consen 418 AHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPA 497 (586)
T ss_pred cceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHH
Confidence 0 000011 01234689999999999999999999
Q ss_pred HHHHH
Q 002160 924 QLTVA 928 (958)
Q Consensus 924 EIL~~ 928 (958)
|.++|
T Consensus 498 qal~H 502 (586)
T KOG0667|consen 498 QALNH 502 (586)
T ss_pred HHhcC
Confidence 99887
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=315.35 Aligned_cols=251 Identities=28% Similarity=0.419 Sum_probs=204.2
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
+.|...+.||+|+||.||++++ ++..||||++..... .......+.+|++++++++||||+++++++......++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 4477889999999999999986 678999998875432 3344567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHH-HHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKM-ALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~i-a~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~ 831 (958)
||+.+ +|.+++........+.....+ .+.+.+|.|||..+ |+||||+|+||+++.++.+||+|||++.....
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---- 177 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASP---- 177 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence 99964 787777654444555554444 44489999999988 99999999999999999999999999865432
Q ss_pred CCCCCCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHH
Q 002160 832 SKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 908 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~---g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI 908 (958)
.....|+..|+|||++. +..++.++|||||||++|+|++|+.||...+.......+.........+..++..+++||
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 257 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 257 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHH
Confidence 23356889999999974 456788999999999999999999999887766655555433333333456788999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHhhh
Q 002160 909 WECWQTDPSLRPSFAQLTVALKPLQ 933 (958)
Q Consensus 909 ~~CL~kDP~kRPSa~EIL~~L~kL~ 933 (958)
.+||+.+|.+||++.+|++++-.+.
T Consensus 258 ~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 258 DSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred HHHccCCcccCcCHHHHHhChhhhc
Confidence 9999999999999999999876544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=311.28 Aligned_cols=246 Identities=28% Similarity=0.395 Sum_probs=200.8
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEee
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
+|...+.||+|++|.||++.+ +++.|+||++.... ......+.+|+.+++.++||||+++++++...+..++++||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 455567899999999999976 67889999875432 23345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCC
Q 002160 755 LPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 834 (958)
Q Consensus 755 ~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s 834 (958)
+++++|.+++... .........++.+.+.+|+|||.++ |+||||||+||+++.++.++|+|||++............
T Consensus 98 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 174 (285)
T cd06648 98 LEGGALTDIVTHT-RMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS 174 (285)
T ss_pred cCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCCCcEEEcccccchhhccCCccccc
Confidence 9999999998773 3333334444555589999999988 999999999999999999999999988765433323334
Q ss_pred CCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCC--CCCCcHHHHHHHHHhh
Q 002160 835 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI--PKELDPLVARIIWECW 912 (958)
Q Consensus 835 ~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~i--p~~ls~eL~dLI~~CL 912 (958)
..|+..|+|||.+.+..++.++||||||+++|+|++|+.||...++.+....+... ....+ +..++..+.+||.+||
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l 253 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPKLKNLHKVSPRLRSFLDRML 253 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCCCcccccCCHHHHHHHHHHc
Confidence 56899999999999988999999999999999999999999887766655544322 12222 2347899999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 002160 913 QTDPSLRPSFAQLTVA 928 (958)
Q Consensus 913 ~kDP~kRPSa~EIL~~ 928 (958)
+.+|.+||++.+|+++
T Consensus 254 ~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 254 VRDPAQRATAAELLNH 269 (285)
T ss_pred ccChhhCcCHHHHccC
Confidence 9999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=310.87 Aligned_cols=241 Identities=24% Similarity=0.328 Sum_probs=188.9
Q ss_pred EeeccCceEEEEEEE--CCcEEEEEEeecCCCCHH-HHHHHHHHHHHHHH---cCCCceeEEeccccCCCceEEEEeecC
Q 002160 683 RIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA-ALLEFKREVKIMRR---LRHPNVVLFMGAVTRPPNLSIITEFLP 756 (958)
Q Consensus 683 ~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~-~~~~f~~Ei~ILk~---L~HPNIVkL~g~~~~~~~l~LVmEy~~ 756 (958)
.||+|+||.||++.. +++.||||.+.+...... ....+.+|..+++. .+||||+.+++++...+.+++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 389999999999976 578999998876543222 12233444444433 479999999999999999999999999
Q ss_pred CCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCC
Q 002160 757 RGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 836 (958)
Q Consensus 757 gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~ 836 (958)
+++|.+++.+.+............+.+.||.|||..+ |+||||||+|||+++++.+||+|||++....... .....
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCCCCEEEccCCcceeccccC--ccCcC
Confidence 9999999876654444444444555599999999988 9999999999999999999999999987553321 22356
Q ss_pred CCCCccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh--HHHHhhhccccccCCCCCCcHHHHHHHHHhhh
Q 002160 837 GTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNPM--QVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 913 (958)
Q Consensus 837 GT~~Y~APEvl~-g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~--ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~ 913 (958)
|+..|+|||++. +..++.++|||||||++|+|++|..||...... ....... ......++..++.++++||.+||+
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~ 235 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTVNVELPDSFSPELKSLLEGLLQ 235 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh-hcCCcCCccccCHHHHHHHHHHhc
Confidence 899999999986 456789999999999999999999999764322 1111111 223455677889999999999999
Q ss_pred cCCCCCC-----CHHHHHHH
Q 002160 914 TDPSLRP-----SFAQLTVA 928 (958)
Q Consensus 914 kDP~kRP-----Sa~EIL~~ 928 (958)
.||.+|| +++++++|
T Consensus 236 ~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 236 RDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CCHHHhcCCCCCCHHHHHhC
Confidence 9999999 69999987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=306.67 Aligned_cols=245 Identities=22% Similarity=0.293 Sum_probs=190.9
Q ss_pred eeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeccccCC--CceEEEE
Q 002160 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRP--PNLSIIT 752 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~-HPNIVkL~g~~~~~--~~l~LVm 752 (958)
|++.+.||+|+||.||+|+. +++.||||++........ .....+|+.++.++. |+||+++++++.+. +.+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 67889999999999999976 688999998865432222 234457889999995 99999999999887 8899999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~ 831 (958)
||++ ++|.+++......+.+.... .+.+.+.||.|||..+ |+||||||+||+++. +.+||+|||+++.......
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 80 ELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred ecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 9996 57887776544444444444 4444599999999988 999999999999999 9999999999987644322
Q ss_pred CCCCCCCCCccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcc----------------cccc
Q 002160 832 SKSTAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ----------------NRRL 894 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~-g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~----------------~~~~ 894 (958)
.....++..|+|||++. +..++.++|||||||++|||++|..||.+.+..+.+..+... ....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07831 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234 (282)
T ss_pred cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence 23356889999999875 455688999999999999999999999887655433322100 0011
Q ss_pred CC-----------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 895 EI-----------PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 895 ~i-----------p~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.+ ...++..+.+||.+||+.+|.+||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 11 12467899999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=344.81 Aligned_cols=247 Identities=33% Similarity=0.476 Sum_probs=211.3
Q ss_pred eeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC--CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc--eEEE
Q 002160 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF--SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN--LSII 751 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~--~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~--l~LV 751 (958)
.+...+||+|+|-+||+|.+ +|..||.-.+...++ ....+.+|..|+.+|+.|+|||||++|..|.+..+ +.+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 45667899999999999976 566677654433332 44566899999999999999999999999988776 7899
Q ss_pred EeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEc-CCCcEEEEeccccccccCCcc
Q 002160 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFL 830 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId-~~g~VKL~DFGLAk~~~~~~~ 830 (958)
+|++..|+|..|+++.+.......+-|..+++.||.|||.+.++|||||||-+||+|+ ..|.|||+|+|||..+.....
T Consensus 122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a 201 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA 201 (632)
T ss_pred eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc
Confidence 9999999999999988766666666677777999999999999999999999999998 569999999999998766544
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CChhHHHHhhhccccccCCCCCCcHHHHHHHH
Q 002160 831 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG-MNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 909 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g-~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~ 909 (958)
....|||+|||||++. ..|++.+||||||++|+||+|+.+||.. .++.+++.++.-...+..+.+--+|++++||.
T Consensus 202 --ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIe 278 (632)
T KOG0584|consen 202 --KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIE 278 (632)
T ss_pred --ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHH
Confidence 3478999999999998 6789999999999999999999999975 56788888886555555666667899999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 002160 910 ECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 910 ~CL~kDP~kRPSa~EIL~~ 928 (958)
+||.. ..+||++.|||++
T Consensus 279 kCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 279 KCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HHhcC-chhccCHHHHhhC
Confidence 99999 9999999999875
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=306.04 Aligned_cols=244 Identities=21% Similarity=0.354 Sum_probs=187.9
Q ss_pred EeeccCceEEEEEEE-CC---cEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeecCCC
Q 002160 683 RIGLGSYGEVYHADW-NG---TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758 (958)
Q Consensus 683 ~LG~G~fG~Vykak~-~g---~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~gG 758 (958)
.||+|+||.||+|++ ++ ..+++|.+.... .......+.+|+.+++.++||||+++++++......|+||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 599999999999975 32 345666654432 2334568899999999999999999999999999999999999999
Q ss_pred CHHHHHhCCCC---CccHHHH-HHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc--ccC
Q 002160 759 SLFRILHRPHC---QVDEKRR-IKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSS 832 (958)
Q Consensus 759 sL~d~L~k~~~---~~~e~~~-l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~--~~~ 832 (958)
+|.+++.+... ....... ....+.+.||.|||..+ |+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999875422 2223333 33344589999999988 9999999999999999999999999986432211 122
Q ss_pred CCCCCCCCccCcccccC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccc----cccCCCCCC
Q 002160 833 KSTAGTPEWMAPEVLRN-------EPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQN----RRLEIPKEL 900 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g-------~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~----~~~~ip~~l 900 (958)
....++..|+|||++.+ ..++.++||||||+++|||++ |..||...+..+....+.... .++.++..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 34568899999999853 235778999999999999997 577888777666555442221 223444567
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002160 901 DPLVARIIWECWQTDPSLRPSFAQLTVALK 930 (958)
Q Consensus 901 s~eL~dLI~~CL~kDP~kRPSa~EIL~~L~ 930 (958)
++.+.+++..|| .+|++||++.+|++.|.
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 899999999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=341.75 Aligned_cols=243 Identities=30% Similarity=0.512 Sum_probs=207.6
Q ss_pred EEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeecCCCC
Q 002160 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGS 759 (958)
Q Consensus 682 k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~gGs 759 (958)
-+||+|.||+||.|++ +....|||.+...+ .....-+..|+.+.++|+|.|||+++|.+.+++.+-|.||-++||+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 4699999999999986 55668999876543 2334568899999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCc---cHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEc-CCCcEEEEeccccccccCCcccCCCC
Q 002160 760 LFRILHRPHCQV---DEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSKST 835 (958)
Q Consensus 760 L~d~L~k~~~~~---~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId-~~g~VKL~DFGLAk~~~~~~~~~~s~ 835 (958)
|..+|+..=.++ +....++-.+++.||.|||... |||||||-+||||+ -.|.+||.|||.++++..-.....++
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETF 736 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETF 736 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCcccccc
Confidence 999998644333 3445566667799999999998 99999999999998 57999999999999987666667789
Q ss_pred CCCCCccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCC-hhHHHHhhhccccccCCCCCCcHHHHHHHHHhh
Q 002160 836 AGTPEWMAPEVLRNEP--SNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 912 (958)
Q Consensus 836 ~GT~~Y~APEvl~g~~--~s~ksDIWSLGiLLyELLtG~~PF~g~~-~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL 912 (958)
.||..|||||++..++ |+.++|||||||++.||.||++||.... +.....++.+-...+++|..++.+++.||.+|+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcF 816 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCF 816 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence 9999999999997543 8999999999999999999999998764 334445565666788999999999999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 002160 913 QTDPSLRPSFAQLTVA 928 (958)
Q Consensus 913 ~kDP~kRPSa~EIL~~ 928 (958)
..||.+||++.+++..
T Consensus 817 epd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 817 EPDPCDRPSAKDLLQD 832 (1226)
T ss_pred CCCcccCccHHHhccC
Confidence 9999999999999863
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=319.22 Aligned_cols=255 Identities=27% Similarity=0.360 Sum_probs=200.3
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC-----Cce
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-----PNL 748 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~-----~~l 748 (958)
.+|.+.+.||+|+||.||+|+. +++.||||++............+.+|+.+++.++|+||+++++++... ..+
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 4799999999999999999986 688999999876433333455677899999999999999999988654 348
Q ss_pred EEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
|+||||+. ++|.+++.+.+............+.+.||.|||..+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred EEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 99999995 689988876654444444444555599999999988 999999999999999999999999999876443
Q ss_pred cccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhc------------------
Q 002160 829 FLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF------------------ 889 (958)
Q Consensus 829 ~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~------------------ 889 (958)
........++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07858 162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241 (337)
T ss_pred cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence 233344568899999998865 4588999999999999999999999987653322111100
Q ss_pred --------cccc---cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHhhh
Q 002160 890 --------QNRR---LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA--LKPLQ 933 (958)
Q Consensus 890 --------~~~~---~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~--L~kL~ 933 (958)
.... ......+++++++||.+||+.+|.+||++++++++ ++.+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 0000 01123578899999999999999999999999998 66653
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=302.29 Aligned_cols=241 Identities=28% Similarity=0.433 Sum_probs=197.4
Q ss_pred eeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeecCCCCH
Q 002160 684 IGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 760 (958)
Q Consensus 684 LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~gGsL 760 (958)
||.|+||.||++++ +++.|++|.+..... .......+.+|++++++++||||+++++.+.....+|++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999987 488999998866543 224456788999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc--------c
Q 002160 761 FRILHRPHCQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL--------S 831 (958)
Q Consensus 761 ~d~L~k~~~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~--------~ 831 (958)
.+++.+.+. ..+..... +.+.+.+|+|||..+ |+|+||+|+||+++.++.+||+|||++........ .
T Consensus 81 ~~~l~~~~~-~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVGS-LDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 999987553 34444444 444589999999988 99999999999999999999999999875433211 2
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCC--cHHHHHHHH
Q 002160 832 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL--DPLVARIIW 909 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~l--s~eL~dLI~ 909 (958)
.....++..|++||.+.+..++.++||||||+++|+|++|..||......+....+.. .....+... +..+.+||.
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~ 235 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--GKIEWPEDVEVSDEAIDLIS 235 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCcCCCccccCCHHHHHHHH
Confidence 2335678899999999988889999999999999999999999988887776666543 233344444 899999999
Q ss_pred HhhhcCCCCCCCHHHHHHHH
Q 002160 910 ECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 910 ~CL~kDP~kRPSa~EIL~~L 929 (958)
+||+.+|.+||++.++.+.|
T Consensus 236 ~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 236 KLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred HHhcCCHhhcCCCccHHHHh
Confidence 99999999999995554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=310.26 Aligned_cols=253 Identities=25% Similarity=0.304 Sum_probs=196.4
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC----
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP---- 746 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~---- 746 (958)
...++|++.+.||+|+||.||+|.+ +++.||||.+............+.+|++++++++||||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 3457899999999999999999987 5789999998765433334456778999999999999999999987654
Q ss_pred ------ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHH-HHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEec
Q 002160 747 ------NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKM-ALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 819 (958)
Q Consensus 747 ------~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~i-a~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DF 819 (958)
.+++||||+++ +|..++........+.....+ .+++.||+|||..+ |+||||||+||++++++.+||+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCcEEeCcc
Confidence 79999999976 777777654444444444444 44489999999988 999999999999999999999999
Q ss_pred cccccccCCcc-cCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccc----
Q 002160 820 GLSRLKHNTFL-SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR---- 893 (958)
Q Consensus 820 GLAk~~~~~~~-~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~---- 893 (958)
|++........ ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+......
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 99986543321 1122346788999998875 34688999999999999999999999876654433222110000
Q ss_pred ------------------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 894 ------------------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 894 ------------------------~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
......++..+.+||.+||+.||.+||++.+|+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00122468899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=306.56 Aligned_cols=247 Identities=27% Similarity=0.417 Sum_probs=195.3
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC--CCceEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--PPNLSII 751 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~--~~~l~LV 751 (958)
++|++.+.||.|++|.||+|.. +++.||+|.+..... .....++.+|++++++++||||++++++|.. ...+++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 4688999999999999999987 678899998875432 3445678999999999999999999998854 3468999
Q ss_pred EeecCCCCHHHHHhC---CCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 752 TEFLPRGSLFRILHR---PHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 752 mEy~~gGsL~d~L~k---~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
|||+++++|.+++.. ......+.....++ +++.+|.|||..+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999887642 22333444444444 4499999999988 99999999999999999999999999876543
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----hhHHHHhhhccccccCCC-----
Q 002160 828 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN-----PMQVVGAVGFQNRRLEIP----- 897 (958)
Q Consensus 828 ~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~-----~~ei~~~i~~~~~~~~ip----- 897 (958)
... ....++..|+|||.+.+..++.++|||+||+++|+|++|..||.... ..+....+.. .....++
T Consensus 158 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 234 (287)
T cd06621 158 SLA--GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-MPNPELKDEPGN 234 (287)
T ss_pred ccc--ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-CCchhhccCCCC
Confidence 221 23467889999999999889999999999999999999999997652 2233333221 1111111
Q ss_pred -CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 898 -KELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 898 -~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
...++.+.+||.+||..+|.+||++.||+++
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred CCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 2346789999999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=314.89 Aligned_cols=254 Identities=26% Similarity=0.352 Sum_probs=204.0
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC-----ceE
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP-----NLS 749 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~-----~l~ 749 (958)
+|++.+.||.|+||.||+|+. +++.||||++............+.+|+.+++.++|+||+++++++.... .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 588999999999999999986 5789999998765433445567889999999999999999999998775 789
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~ 829 (958)
++|||++ ++|.+++.+............+.+++.||.|||.++ |+||||||+|||++.++.++|+|||++.......
T Consensus 81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157 (330)
T ss_pred EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence 9999997 589988877654444444445555699999999988 9999999999999999999999999998765432
Q ss_pred ---ccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccc------------
Q 002160 830 ---LSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------------ 893 (958)
Q Consensus 830 ---~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~------------ 893 (958)
.......++..|+|||++.+. .++.++|+||||+++|+|++|..||.+.+..+....+......
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE 237 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence 122345688999999999887 7899999999999999999999999887765443332110000
Q ss_pred -----------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHhhh
Q 002160 894 -----------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA--LKPLQ 933 (958)
Q Consensus 894 -----------------~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~--L~kL~ 933 (958)
..+...++..+.+||.+||+++|.+||++.+++.+ ++.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 00112367889999999999999999999999986 55544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=302.99 Aligned_cols=238 Identities=25% Similarity=0.359 Sum_probs=190.7
Q ss_pred EEeeccCceEEEEEEE--CCcEEEEEEeecCCCCH-HHHHHHHHHHHHHH-HcCCCceeEEeccccCCCceEEEEeecCC
Q 002160 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMR-RLRHPNVVLFMGAVTRPPNLSIITEFLPR 757 (958)
Q Consensus 682 k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~ILk-~L~HPNIVkL~g~~~~~~~l~LVmEy~~g 757 (958)
+.||.|+||.||+|.. +++.||||.+.+..... .....+..|..++. .++|+||+++++++...+.+|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5699999999999986 67899999987654322 22334455555544 45899999999999999999999999999
Q ss_pred CCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCCC
Q 002160 758 GSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 837 (958)
Q Consensus 758 GsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~G 837 (958)
++|.+++..............+.+.+.||.|||..+ |+||||+|+|||+++++.+||+|||++..... .....+
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFVG 155 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEeecccceeccc----cccCCC
Confidence 999999976554444444444555599999999988 99999999999999999999999999875433 234568
Q ss_pred CCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc--ccCCCCCCcHHHHHHHHHhhhcC
Q 002160 838 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--RLEIPKELDPLVARIIWECWQTD 915 (958)
Q Consensus 838 T~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~--~~~ip~~ls~eL~dLI~~CL~kD 915 (958)
+..|++||.+.+..++.++||||||+++|+|++|..||...+..+....+..... .......+++++.++|.+||+.+
T Consensus 156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 235 (260)
T cd05611 156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235 (260)
T ss_pred CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence 8999999999988889999999999999999999999988877766555432211 22233467899999999999999
Q ss_pred CCCCCCHHHH
Q 002160 916 PSLRPSFAQL 925 (958)
Q Consensus 916 P~kRPSa~EI 925 (958)
|++||++.++
T Consensus 236 p~~R~~~~~~ 245 (260)
T cd05611 236 PAKRLGANGY 245 (260)
T ss_pred HHHccCCCcH
Confidence 9999966433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=327.42 Aligned_cols=261 Identities=31% Similarity=0.498 Sum_probs=218.3
Q ss_pred cccccCCCCeeEEEEeeccCceEEEEEEECC-cEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc
Q 002160 669 CECEIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 669 ~~~eI~~~dy~i~k~LG~G~fG~Vykak~~g-~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~ 747 (958)
...+++.+.+.++++||+|-||+|.+|+..+ ..||||+++.... .....+|.+|+++|.+|+|||||+++|+|..++.
T Consensus 531 al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~-~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP 609 (807)
T KOG1094|consen 531 ALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT-KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP 609 (807)
T ss_pred chhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccc-hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc
Confidence 3456778889999999999999999998866 9999999876653 3446789999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCc-cHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQV-DEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~-~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
+++||||+++|+|..++.++.... .....+.++.+ +.||+||.+.+ +|||||.+.|||+|.++++||+|||+++.+
T Consensus 610 icmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 610 LCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred hHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCccccccc
Confidence 999999999999999998875544 44444555555 99999999998 999999999999999999999999999854
Q ss_pred cCCccc--CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHH--hCCCCCCCCChhHHHHhhhc---cc---cccC
Q 002160 826 HNTFLS--SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELA--TLKLPWIGMNPMQVVGAVGF---QN---RRLE 895 (958)
Q Consensus 826 ~~~~~~--~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELL--tG~~PF~g~~~~ei~~~i~~---~~---~~~~ 895 (958)
-...+. ...++-..+|||+|.+...+++.++|+|+||+++||++ +...||....++++++.... .. .-+.
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~ 767 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLS 767 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceecc
Confidence 332221 11233457999999999999999999999999999964 58899999888887765421 11 1234
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 002160 896 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 896 ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL 932 (958)
.|..++..+.+|+.+||+.|-.+||+|++|...|+..
T Consensus 768 ~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 768 RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 4677899999999999999999999999999999865
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=313.90 Aligned_cols=251 Identities=25% Similarity=0.359 Sum_probs=208.5
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC------CHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCC
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF------SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP 746 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~------~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~ 746 (958)
+.|+-.+.||+|..+.|.++.+ ++..+|+|++..... .....+.-..|+.||+++ .||+|+++.++++.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 4566678899999999998855 788999998864322 123345667899999999 7999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
.+++|+|+|+.|.|+|+|...-...+.+.+..+.++..|+.|||..+ ||||||||+|||+|++.++||+|||+++.+.
T Consensus 97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccccceEEeccceeeccC
Confidence 99999999999999999987666666777777777799999999998 9999999999999999999999999999886
Q ss_pred CCcccCCCCCCCCCccCcccccCC------CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCC--C
Q 002160 827 NTFLSSKSTAGTPEWMAPEVLRNE------PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--K 898 (958)
Q Consensus 827 ~~~~~~~s~~GT~~Y~APEvl~g~------~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip--~ 898 (958)
.. ......||||.|+|||.+.+. .|+..+|+|++|+|||.|+.|.+||......-++..|....-...-| .
T Consensus 175 ~G-ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWa 253 (411)
T KOG0599|consen 175 PG-EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWA 253 (411)
T ss_pred Cc-hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchh
Confidence 55 334568999999999998543 36788999999999999999999997766555555553222222222 4
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002160 899 ELDPLVARIIWECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 899 ~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L 929 (958)
+++...++||.+||+.||.+|.+++|.+.|=
T Consensus 254 dis~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 254 DISATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred hccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 6788999999999999999999999999874
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=331.42 Aligned_cols=259 Identities=35% Similarity=0.602 Sum_probs=225.3
Q ss_pred cccccCCCCeeEEEEeeccCceEEEEEEEC--CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC
Q 002160 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (958)
Q Consensus 669 ~~~eI~~~dy~i~k~LG~G~fG~Vykak~~--g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~ 746 (958)
..++....++....+||-|-||.||.|.|+ .-.||||.++.. ...+.+|+.|+.+|+.++|||+|+|+|+|..+.
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 456677778889999999999999999884 557999986543 245779999999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhCCCC-CccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHC-QVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~-~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
.+|||+|||..|+|.+||++... .......++|+.+ ..||+||...+ +|||||-..|+|+.++..||++||||+++
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccccccceEEeeccchhhh
Confidence 99999999999999999987654 3345566677766 89999999988 99999999999999999999999999999
Q ss_pred ccCCcccC-CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcH
Q 002160 825 KHNTFLSS-KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 902 (958)
Q Consensus 825 ~~~~~~~~-~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~ 902 (958)
+..+.++. ....-...|.|||-+.-..++.|+|||+||++|||+.| |--||.+.+..+++..+. ++.+..-|..|++
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLE-kgyRM~~PeGCPp 493 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLE-KGYRMDGPEGCPP 493 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHh-ccccccCCCCCCH
Confidence 86654432 22234568999999999999999999999999999988 778999999988887775 6778888999999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 002160 903 LVARIIWECWQTDPSLRPSFAQLTVALKPLQ 933 (958)
Q Consensus 903 eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~ 933 (958)
.+.+|+.+||+..|.+||+|.||-+.++.+-
T Consensus 494 kVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 494 KVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred HHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 9999999999999999999999999998763
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=307.46 Aligned_cols=248 Identities=25% Similarity=0.374 Sum_probs=198.5
Q ss_pred CeeEEEEeeccCceEEEEEEE-----CCcEEEEEEeecCCCC--HHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCce
Q 002160 677 DLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFS--GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNL 748 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~-----~g~~VAVK~i~~~~~~--~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~l 748 (958)
+|++.+.||+|+||.||+++. +++.||+|++...... ......+.+|+++|+++ +|+||+++++++.....+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478899999999999999975 6788999998654321 12345678899999999 599999999999999999
Q ss_pred EEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
|+||||+++++|.+++..............+.+.+.||.|||..+ ++||||||+|||++.++++||+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 999999999999999876654444444444445699999999988 999999999999999999999999998765432
Q ss_pred c-ccCCCCCCCCCccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCh----hHHHHhhhccccccCCCCCCc
Q 002160 829 F-LSSKSTAGTPEWMAPEVLRNE--PSNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQNRRLEIPKELD 901 (958)
Q Consensus 829 ~-~~~~s~~GT~~Y~APEvl~g~--~~s~ksDIWSLGiLLyELLtG~~PF~g~~~----~ei~~~i~~~~~~~~ip~~ls 901 (958)
. .......|+..|+|||.+.+. .++.++||||||+++|+|++|..||..... .++...+ ......++..++
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 236 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSEPPYPQEMS 236 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHh--hccCCCCCccCC
Confidence 1 122245689999999998753 467899999999999999999999964332 2222222 223445677789
Q ss_pred HHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 002160 902 PLVARIIWECWQTDPSLRP-----SFAQLTVA 928 (958)
Q Consensus 902 ~eL~dLI~~CL~kDP~kRP-----Sa~EIL~~ 928 (958)
+.+.+|+.+||+.||.+|| ++++++.+
T Consensus 237 ~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 9999999999999999997 77888775
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=308.90 Aligned_cols=254 Identities=25% Similarity=0.392 Sum_probs=198.9
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEEC--CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCC
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP 746 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~~--g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~ 746 (958)
.+.+..++|++.+.||+|+||.||+|++. ++.||||.+...... ....++..|+.++.++ .||||+++++++....
T Consensus 9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 87 (296)
T cd06618 9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDS 87 (296)
T ss_pred eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence 34567789999999999999999999885 889999998765433 2345566777777777 4999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHh-cCCcEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~-~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
.+|++|||+. +.|.+++........+.....++.+ +.+|+|||. ++ |+||||+|+||++++++.+||+|||++..
T Consensus 88 ~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~~~~kL~dfg~~~~ 164 (296)
T cd06618 88 DVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGR 164 (296)
T ss_pred eEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCCCCEEECccccchh
Confidence 9999999985 5777776654445555555544444 899999997 46 99999999999999999999999999876
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHhhhccccccCCC--
Q 002160 825 KHNTFLSSKSTAGTPEWMAPEVLRNEP----SNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNRRLEIP-- 897 (958)
Q Consensus 825 ~~~~~~~~~s~~GT~~Y~APEvl~g~~----~s~ksDIWSLGiLLyELLtG~~PF~g~~~-~ei~~~i~~~~~~~~ip-- 897 (958)
...... .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||..... .+....+. ......++
T Consensus 165 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~ 242 (296)
T cd06618 165 LVDSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL-QEEPPSLPPN 242 (296)
T ss_pred ccCCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHh-cCCCCCCCCC
Confidence 543322 22345788999999997654 78899999999999999999999976433 23333332 22222222
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002160 898 KELDPLVARIIWECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 898 ~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L 929 (958)
..++.++++||.+||+.||.+||++.+|+.+-
T Consensus 243 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 243 EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 34789999999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=305.57 Aligned_cols=240 Identities=24% Similarity=0.329 Sum_probs=189.9
Q ss_pred EeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHH-HHHHHHHH---HHHHHcCCCceeEEeccccCCCceEEEEeecC
Q 002160 683 RIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAA-LLEFKREV---KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 756 (958)
Q Consensus 683 ~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~-~~~f~~Ei---~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~ 756 (958)
.||+|+||.||++++ +++.||||.+.+....... ...+..|. .+++...||||+++++++...+.+++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 389999999999976 6789999998765433211 12233343 34445579999999999999999999999999
Q ss_pred CCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCC
Q 002160 757 RGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 836 (958)
Q Consensus 757 gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~ 836 (958)
|++|.+++.+.........+.++.+.+.||.|||..+ |+||||||+|||++.++.+||+|||++....... .....
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~ 156 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASV 156 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCCCCEEEccCcCccccCccC--CcCcC
Confidence 9999998876654444444555555599999999988 9999999999999999999999999987654321 23457
Q ss_pred CCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCh---hHHHHhhhccccccCCCCCCcHHHHHHHHHhh
Q 002160 837 GTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNP---MQVVGAVGFQNRRLEIPKELDPLVARIIWECW 912 (958)
Q Consensus 837 GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~---~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL 912 (958)
|+..|+|||++.+. .++.++||||||+++|+|++|+.||.+... ....... ......++..++.++.++|.+||
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~l 234 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSFSPELRSLLEGLL 234 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh--hccCCCCCCcCCHHHHHHHHHHh
Confidence 89999999999754 578999999999999999999999987632 2222212 23345667778999999999999
Q ss_pred hcCCCCCC-----CHHHHHHH
Q 002160 913 QTDPSLRP-----SFAQLTVA 928 (958)
Q Consensus 913 ~kDP~kRP-----Sa~EIL~~ 928 (958)
..+|.+|| ++.+++++
T Consensus 235 ~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 235 QRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred hcCHHhccCCCCCCHHHHHhC
Confidence 99999999 99999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=298.08 Aligned_cols=237 Identities=28% Similarity=0.418 Sum_probs=200.9
Q ss_pred eeccCceEEEEEEE--CCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeecCCCCH
Q 002160 684 IGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL 760 (958)
Q Consensus 684 LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~gGsL 760 (958)
||+|+||.||++.+ +++.||+|.+...... ......+..|+.++++++|+||+++++.+......++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999987 4889999998766443 23566789999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCCCCCC
Q 002160 761 FRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE 840 (958)
Q Consensus 761 ~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~GT~~ 840 (958)
.+++..............+.+.+.+|.|||..+ ++|+||||+||+++.++.++|+|||++..............++..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcc
Confidence 999987654444444444555599999999987 999999999999999999999999998876543233445678899
Q ss_pred ccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCC
Q 002160 841 WMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRP 920 (958)
Q Consensus 841 Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRP 920 (958)
|++||.+.+...+.++|+|+||+++|+|++|+.||...+..+....+.. ....++..++..+.+||.+||..||++||
T Consensus 159 ~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~~R~ 236 (250)
T cd05123 159 YLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQKDPTKRL 236 (250)
T ss_pred ccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCCHhhCC
Confidence 9999999988889999999999999999999999988776665555532 45677788899999999999999999999
Q ss_pred CHHH
Q 002160 921 SFAQ 924 (958)
Q Consensus 921 Sa~E 924 (958)
++.+
T Consensus 237 ~~~~ 240 (250)
T cd05123 237 GSGG 240 (250)
T ss_pred Cccc
Confidence 9943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=308.56 Aligned_cols=254 Identities=18% Similarity=0.218 Sum_probs=182.6
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEECC-----cEEEEEEeecCCCCH--H-HH------HHHHHHHHHHHHcCCCceeE
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSG--A-AL------LEFKREVKIMRRLRHPNVVL 737 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~~g-----~~VAVK~i~~~~~~~--~-~~------~~f~~Ei~ILk~L~HPNIVk 737 (958)
++..++|++.+.||+|+||.||+|++.+ ..+|+|+........ + .. .....+...+..+.|+||++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 4556789999999999999999998743 356666543222111 0 00 11223334455668999999
Q ss_pred EeccccCCC----ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCc
Q 002160 738 FMGAVTRPP----NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN 813 (958)
Q Consensus 738 L~g~~~~~~----~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~ 813 (958)
+++++.... ..+++||++. .++.+.+................+.+.||.|||..+ |+||||||+|||++.++.
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDGNNR 164 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCc
Confidence 998765543 3467888874 467666654432333333333444599999999988 999999999999999999
Q ss_pred EEEEeccccccccCCc-------ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-hHHHH
Q 002160 814 VKVSDFGLSRLKHNTF-------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVG 885 (958)
Q Consensus 814 VKL~DFGLAk~~~~~~-------~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~-~ei~~ 885 (958)
+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+... .....
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 9999999998653211 112234699999999999999999999999999999999999999987732 22111
Q ss_pred hhh----c--cccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002160 886 AVG----F--QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 886 ~i~----~--~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L 929 (958)
... . ..... ....+++++.+++..||+.+|++||++.+|++.|
T Consensus 245 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 245 AAKCDFIKRLHEGKI-KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HhHHHHHHHhhhhhh-ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 110 0 11111 2346789999999999999999999999999876
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=317.36 Aligned_cols=250 Identities=24% Similarity=0.334 Sum_probs=196.3
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC----CCceE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR----PPNLS 749 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~----~~~l~ 749 (958)
.+|++.+.||+|+||.||+|.. +++.||+|++............+.+|+.+|++++||||+++++++.. ...++
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 6799999999999999999975 68899999987654333445677889999999999999999998753 34689
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~ 829 (958)
+||||+. ++|.+++..............+.+++.||+|||.++ |+||||||+|||++.++.+||+|||++.......
T Consensus 85 lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred EEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 9999995 689998876655444444445555699999999988 9999999999999999999999999987653322
Q ss_pred cc----CCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcc--------------
Q 002160 830 LS----SKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-------------- 890 (958)
Q Consensus 830 ~~----~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~-------------- 890 (958)
.. .....|+..|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+.......+...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~ 241 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence 11 123468899999999865 45789999999999999999999999876543322211100
Q ss_pred ----------ccccCC-----CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 891 ----------NRRLEI-----PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 891 ----------~~~~~i-----p~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
...... ...++.++++||.+||+.+|.+||++.+++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000111 13468899999999999999999999998885
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=301.11 Aligned_cols=248 Identities=27% Similarity=0.448 Sum_probs=199.3
Q ss_pred CeeEEEEeeccCceEEEEEEEC--CcEEEEEEeec---CCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEE
Q 002160 677 DLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLD---QDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~~--g~~VAVK~i~~---~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LV 751 (958)
+|.+.+.||+|+||.||++++. +..+++|.++. .........++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5889999999999999999773 34455555443 222333445677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhC---CCCCccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 752 TEFLPRGSLFRILHR---PHCQVDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 752 mEy~~gGsL~d~L~k---~~~~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
|||+++++|.+++.+ ......+.... ++.+.+.||.|||..+ ++|+||||+||+++. +.+||+|||+++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec-CCEeecccCceeecCC
Confidence 999999999988753 22334444444 4444589999999988 999999999999975 5699999999887654
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHH
Q 002160 828 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 907 (958)
Q Consensus 828 ~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dL 907 (958)
.........|+..|+|||.+.+..++.++|+||||+++|+|++|..||......+....+. ....+.++..++.++.++
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l 236 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTPSLPETYSRQLNSI 236 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-cCCCCCCcchhcHHHHHH
Confidence 4333445668899999999988888899999999999999999999998776655554443 334445567788999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 002160 908 IWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 908 I~~CL~kDP~kRPSa~EIL~~ 928 (958)
|.+||+.+|++||++.+|+++
T Consensus 237 i~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 237 MQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHHHhcCChhhCcCHHHHhhC
Confidence 999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=309.10 Aligned_cols=249 Identities=25% Similarity=0.354 Sum_probs=189.4
Q ss_pred CeeEEEEeeccCceEEEEEEE----CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCC--CceE
Q 002160 677 DLVLGERIGLGSYGEVYHADW----NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNLS 749 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~----~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~--~~l~ 749 (958)
.|++.+.||+|+||.||+|.+ .++.||||.+..... .......+.+|+.++++++||||+++++++.+. ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 478899999999999999987 568999999876431 112234567899999999999999999999888 7899
Q ss_pred EEEeecCCCCHHHHHhCC----CCCccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcC----CCcEEEEecc
Q 002160 750 IITEFLPRGSLFRILHRP----HCQVDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDK----NWNVKVSDFG 820 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~----~~~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~----~g~VKL~DFG 820 (958)
+||||+++ +|.+++... ...+.+.... .+.+++.||.|||..+ |+||||||+|||++. ++.+||+|||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 99999965 676665422 1133444444 4445599999999988 999999999999999 9999999999
Q ss_pred ccccccCCc---ccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhH---------HHHhh
Q 002160 821 LSRLKHNTF---LSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQ---------VVGAV 887 (958)
Q Consensus 821 LAk~~~~~~---~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~e---------i~~~i 887 (958)
++....... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||.+..... ....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 988654322 123345688999999998764 57899999999999999999999997654321 00000
Q ss_pred ----h--------------------ccccccCCC-----------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 888 ----G--------------------FQNRRLEIP-----------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 888 ----~--------------------~~~~~~~ip-----------~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
. .......++ ...+.++.++|.+||+.||.+||++.|++.+
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 000001111 1566789999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=301.57 Aligned_cols=248 Identities=26% Similarity=0.341 Sum_probs=195.8
Q ss_pred eeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC--CceEEEEe
Q 002160 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNLSIITE 753 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~--~~l~LVmE 753 (958)
|++.+.||.|+||.||+|++ +++.||||++............+.+|++++++++|+||+++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 67889999999999999987 468999999887643333445688999999999999999999999887 78999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHHHHH-HHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc-c
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL-S 831 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~-~ 831 (958)
|+++ +|..++.+......+...+.++. .+.||+|||..+ ++|+||||+|||+++++.+||+|||++........ .
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 9974 89888876544455555544444 489999999988 99999999999999999999999999886644321 1
Q ss_pred CCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccc-----------------
Q 002160 832 SKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR----------------- 893 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~----------------- 893 (958)
.....++..|+|||.+.+ ..++.++|||+||+++|+|++|+.||...+.......+......
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 223456889999998875 45789999999999999999999999887655443332110000
Q ss_pred ------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 894 ------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 894 ------------~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
..+...+++.+.++|.+||+.+|.+||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00111238889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=338.45 Aligned_cols=251 Identities=18% Similarity=0.243 Sum_probs=183.6
Q ss_pred CCCeeEEEEeeccCceEEEEEEEC---CcEEEEEEe--------------ec-CCCCHHHHHHHHHHHHHHHHcCCCcee
Q 002160 675 WEDLVLGERIGLGSYGEVYHADWN---GTEVAVKKF--------------LD-QDFSGAALLEFKREVKIMRRLRHPNVV 736 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~~---g~~VAVK~i--------------~~-~~~~~~~~~~f~~Ei~ILk~L~HPNIV 736 (958)
.++|++++.||+|+||+||+|.+. +..+++|.+ .+ ..........+.+|+.+|++++|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 368999999999999999998652 222222211 10 011122345688999999999999999
Q ss_pred EEeccccCCCceEEEEeecCCCCHHHHHhCCCC-----CccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCC
Q 002160 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHC-----QVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKN 811 (958)
Q Consensus 737 kL~g~~~~~~~l~LVmEy~~gGsL~d~L~k~~~-----~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~ 811 (958)
++++++...+..|+|||++. ++|..++..... ...+..+.++.+++.||.|||.++ ||||||||+||||+.+
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~~~ 303 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLNCD 303 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC
Confidence 99999999999999999984 577777643221 122333444555689999999988 9999999999999999
Q ss_pred CcEEEEeccccccccCCc-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CC--h-hHHHHh
Q 002160 812 WNVKVSDFGLSRLKHNTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG-MN--P-MQVVGA 886 (958)
Q Consensus 812 g~VKL~DFGLAk~~~~~~-~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g-~~--~-~ei~~~ 886 (958)
+.+||+|||+++.+.... .......||..|+|||++.+..++.++|||||||++|||++|..++.+ .. + .++...
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 999999999998764332 222346799999999999999999999999999999999998865432 21 1 111111
Q ss_pred hhc-ccccc-----------------------CC-----CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 887 VGF-QNRRL-----------------------EI-----PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 887 i~~-~~~~~-----------------------~i-----p~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+.. ..... .+ ...++..+.++|.+||+.||.+||++.|++.+
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 100 00000 00 01356678889999999999999999999875
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=306.60 Aligned_cols=251 Identities=25% Similarity=0.375 Sum_probs=192.0
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC-------
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------- 745 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~------- 745 (958)
.++|++.+.||.|+||.||+|++ +++.||||++............+.+|++++++++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 47899999999999999999987 578899998876543333334567899999999999999999987543
Q ss_pred -CceEEEEeecCCCCHHHHHhCCCCCccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccc
Q 002160 746 -PNLSIITEFLPRGSLFRILHRPHCQVDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 823 (958)
Q Consensus 746 -~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk 823 (958)
..+++||||+.+ +|...+........+.... .+.+++.||.|||..+ |+||||||+|||+++++.+||+|||++.
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECcCccch
Confidence 346999999965 6777766544444444444 4444599999999988 9999999999999999999999999997
Q ss_pred cccCCcc-----------cCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccc
Q 002160 824 LKHNTFL-----------SSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN 891 (958)
Q Consensus 824 ~~~~~~~-----------~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~ 891 (958)
....... ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 6433211 11223568889999988754 57899999999999999999999998877654433321000
Q ss_pred c---------------------ccCCC-------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 892 R---------------------RLEIP-------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 892 ~---------------------~~~ip-------~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
. ....+ ..+.+.+.+||.+||+.||.+||++.+++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 0 00000 2345788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=310.44 Aligned_cols=250 Identities=23% Similarity=0.303 Sum_probs=193.9
Q ss_pred eeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeecCC
Q 002160 678 LVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 757 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~g 757 (958)
+.+++.+|.|+++.|++++.+++.||||++............+.+|++++++++|+||+++++++...+.++++|||+++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 34556677777777777777899999999887655566677899999999999999999999999999999999999999
Q ss_pred CCHHHHHhCCC-CCccHHH-HHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc-----
Q 002160 758 GSLFRILHRPH-CQVDEKR-RIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL----- 830 (958)
Q Consensus 758 GsL~d~L~k~~-~~~~e~~-~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~----- 830 (958)
++|.+++.+.. ....+.. ...+.+.+.||+|||.++ |+||||||+|||++.++.+||+|||.+........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 99999987532 2233433 334444599999999998 99999999999999999999999998875432111
Q ss_pred --cCCCCCCCCCccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHH-Hhhhcc---------------
Q 002160 831 --SSKSTAGTPEWMAPEVLRNE--PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV-GAVGFQ--------------- 890 (958)
Q Consensus 831 --~~~s~~GT~~Y~APEvl~g~--~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~-~~i~~~--------------- 890 (958)
......++..|+|||++.+. .++.++|||||||++|+|++|..||......... ..+...
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence 12334577889999999763 4788999999999999999999999876544322 111000
Q ss_pred ----------------ccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002160 891 ----------------NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 891 ----------------~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L 929 (958)
.........++.++.+||.+||+.||++||++++++++-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 000011123456789999999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=302.85 Aligned_cols=240 Identities=18% Similarity=0.315 Sum_probs=187.2
Q ss_pred CCeeEEEEe--eccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCceEE
Q 002160 676 EDLVLGERI--GLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSI 750 (958)
Q Consensus 676 ~dy~i~k~L--G~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~l~L 750 (958)
++|++.+.+ |.|+||.||++.. +++.+|+|.+....... .|+.+...+ +||||++++++|...+.+|+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 345555555 9999999999975 67889999886543322 122222222 79999999999999999999
Q ss_pred EEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCC-cEEEEeccccccccCCc
Q 002160 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 751 VmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g-~VKL~DFGLAk~~~~~~ 829 (958)
||||+++++|.+++.............++.+.+.||.|||..+ |+||||||+||+++.++ .++|+|||++......
T Consensus 87 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~- 163 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP- 163 (267)
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-
Confidence 9999999999999987653333444444445599999999988 99999999999999988 9999999998765332
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHH-Hhh-hccccccCCCCCCcHHHHHH
Q 002160 830 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV-GAV-GFQNRRLEIPKELDPLVARI 907 (958)
Q Consensus 830 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~-~~i-~~~~~~~~ip~~ls~eL~dL 907 (958)
....++..|+|||++.+..++.++||||||+++|+|++|+.||......... ... .........+..+++.+++|
T Consensus 164 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (267)
T PHA03390 164 ---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDF 240 (267)
T ss_pred ---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHH
Confidence 2356899999999999988999999999999999999999999865433211 111 11123334556789999999
Q ss_pred HHHhhhcCCCCCCC-HHHHHHH
Q 002160 908 IWECWQTDPSLRPS-FAQLTVA 928 (958)
Q Consensus 908 I~~CL~kDP~kRPS-a~EIL~~ 928 (958)
|.+||+.+|.+||+ +++|++|
T Consensus 241 i~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 241 VQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred HHHHhccChhhCCchHHHHhcC
Confidence 99999999999995 6998854
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=300.50 Aligned_cols=247 Identities=27% Similarity=0.320 Sum_probs=193.4
Q ss_pred eeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc---CCCceeEEeccccCCCc-----
Q 002160 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL---RHPNVVLFMGAVTRPPN----- 747 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L---~HPNIVkL~g~~~~~~~----- 747 (958)
|++.+.||+|+||.||+|++ +++.||||.+............+.+|+.+++++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 67889999999999999987 478999999875543333344566788887776 59999999999988776
Q ss_pred eEEEEeecCCCCHHHHHhCCCC-CccHHHHHHH-HHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 748 LSIITEFLPRGSLFRILHRPHC-QVDEKRRIKM-ALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~-~~~e~~~l~i-a~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
++++|||+.+ +|.+++.+... ...+.....+ .+.+.||.|||..+ |+|+||||+|||++.++++||+|||++...
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccCCCEEEeccCcceec
Confidence 9999999974 79888865432 3444444444 44489999999988 999999999999999999999999998776
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc-------------
Q 002160 826 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------- 892 (958)
Q Consensus 826 ~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~------------- 892 (958)
.... ......++..|+|||++.+..++.++|||||||++|+|++|+.||.+....+....+.....
T Consensus 158 ~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07838 158 SFEM-ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL 236 (287)
T ss_pred cCCc-ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence 4332 12334578899999999998899999999999999999999999988776554443321000
Q ss_pred -c-----------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 893 -R-----------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 893 -~-----------~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
. ......+++.+.+||.+||+.||.+||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0 00011345788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=309.77 Aligned_cols=248 Identities=28% Similarity=0.401 Sum_probs=199.2
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
+.|...+.||+|+||.||+|++ +++.||||.+..... ......++.+|+++++.++|+||+++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 4577788899999999999986 678899998865432 3344567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~ 831 (958)
||+. |+|.+++........+.... .+.+.+.++.|||..+ ++||||||+|||++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 9996 57877765433334444444 4445589999999988 999999999999999999999999998765332
Q ss_pred CCCCCCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHH
Q 002160 832 SKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 908 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~---g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI 908 (958)
....++..|+|||.+. ...++.++|||||||++|+|++|..||...+..+....+.........+..++..+++||
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 247 (308)
T cd06634 169 -NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247 (308)
T ss_pred -ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHH
Confidence 3356889999999985 345788999999999999999999999887665554444322222223446889999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHH
Q 002160 909 WECWQTDPSLRPSFAQLTVALK 930 (958)
Q Consensus 909 ~~CL~kDP~kRPSa~EIL~~L~ 930 (958)
.+||..+|.+||++.+++.+..
T Consensus 248 ~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 248 DSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred HHHhhCCcccCCCHHHHhhCcc
Confidence 9999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=304.02 Aligned_cols=251 Identities=24% Similarity=0.341 Sum_probs=200.3
Q ss_pred CeeEEEEeeccCceEEEEEEE-----CCcEEEEEEeecCCCC--HHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCce
Q 002160 677 DLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFS--GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNL 748 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~-----~g~~VAVK~i~~~~~~--~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~l 748 (958)
+|++.+.||+|+||.||++++ +++.||||.+...... ......+.+|++++.++ +||||+++++.+.....+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478999999999999999974 4678999988754321 22345688999999999 699999999999999999
Q ss_pred EEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
++||||+++++|.+++.+.........+.++.+.+.+|.|||..+ ++||||||.|||++.++.++|+|||+++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 999999999999999876554444445555556699999999987 999999999999999999999999998765332
Q ss_pred cc-cCCCCCCCCCccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCh----hHHHHhhhccccccCCCCCCc
Q 002160 829 FL-SSKSTAGTPEWMAPEVLRNEP--SNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQNRRLEIPKELD 901 (958)
Q Consensus 829 ~~-~~~s~~GT~~Y~APEvl~g~~--~s~ksDIWSLGiLLyELLtG~~PF~g~~~----~ei~~~i~~~~~~~~ip~~ls 901 (958)
.. ......|+..|+|||.+.+.. .+.++|||+||+++|+|++|..||..... .+....+ .......+..++
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 236 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRI--LKSKPPFPKTMS 236 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHH--HccCCCCCcccC
Confidence 21 122356899999999987765 67899999999999999999999964322 2222222 123345667789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 002160 902 PLVARIIWECWQTDPSLRPSFAQLTVALKP 931 (958)
Q Consensus 902 ~eL~dLI~~CL~kDP~kRPSa~EIL~~L~k 931 (958)
..+.+||.+||+.||++||++.++.+.|..
T Consensus 237 ~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 237 AEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 999999999999999999998777666554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=329.48 Aligned_cols=268 Identities=25% Similarity=0.363 Sum_probs=218.2
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCce
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l 748 (958)
.....-|..++.||-|+||+|.+++. +...||+|.+++.+. ......-++.|.+||...+.+-||+||..|++.+.+
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL 704 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL 704 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence 44556789999999999999999975 566799999887653 444556788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc---
Q 002160 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK--- 825 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~--- 825 (958)
|+||+|++||++-.+|-+.+.+.+...+++|+.+..|+++.|..| +|||||||+|||||.+|+|||+||||+.-+
T Consensus 705 YFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred EEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCceeeeeccccccceec
Confidence 999999999999999999899999999999999999999999998 999999999999999999999999998521
Q ss_pred cCC---------------------------------------cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHH
Q 002160 826 HNT---------------------------------------FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILW 866 (958)
Q Consensus 826 ~~~---------------------------------------~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLy 866 (958)
++. ....-..+||+-|+|||++....|+..+|||+.|+|||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 110 00001345999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChhHHHHhhhccccccCC--CCCCcHHHHHHHHHhhhcCCCCCC---CHHHHHHH-------HHhhhh
Q 002160 867 ELATLKLPWIGMNPMQVVGAVGFQNRRLEI--PKELDPLVARIIWECWQTDPSLRP---SFAQLTVA-------LKPLQR 934 (958)
Q Consensus 867 ELLtG~~PF~g~~~~ei~~~i~~~~~~~~i--p~~ls~eL~dLI~~CL~kDP~kRP---Sa~EIL~~-------L~kL~k 934 (958)
||+.|+.||....+.+...++.....-+.| ...+++++.+||.+++ .+++.|. ..++|..| +..|.+
T Consensus 863 em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgIDfsslRk 941 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGIDFSSLRK 941 (1034)
T ss_pred HHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccchHhhhh
Confidence 999999999988887776666432223334 3579999999998866 4577775 24445432 233556
Q ss_pred hcCCCCCC
Q 002160 935 LVIPSHPD 942 (958)
Q Consensus 935 ~~~p~~P~ 942 (958)
+..|..|+
T Consensus 942 q~ApYIP~ 949 (1034)
T KOG0608|consen 942 QRAPYIPR 949 (1034)
T ss_pred ccCCcCcc
Confidence 66666554
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=307.27 Aligned_cols=244 Identities=30% Similarity=0.433 Sum_probs=197.6
Q ss_pred eeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEee
Q 002160 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
|...+.||+|+||+||+|++ +++.|+||++..... .......+.+|+++++.++||||+++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55667899999999999986 688999999875543 333456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhCCCCCccHHHHHHH-HHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCC
Q 002160 755 LPRGSLFRILHRPHCQVDEKRRIKM-ALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 833 (958)
Q Consensus 755 ~~gGsL~d~L~k~~~~~~e~~~l~i-a~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~ 833 (958)
+. ++|.+++........+.....+ .+++.++.|||..+ |+||||||+||+++.++.+||+|||++..... ..
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----~~ 175 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSSP----AN 175 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCCCCEEEeecCCCcccCC----CC
Confidence 95 5787777654444555544444 44589999999988 99999999999999999999999999864322 23
Q ss_pred CCCCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHH
Q 002160 834 STAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 910 (958)
Q Consensus 834 s~~GT~~Y~APEvl~---g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 910 (958)
...|+..|+|||++. +..++.++||||||+++|+|++|..||...+.......+............++..+++||.+
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 255 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDY 255 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHH
Confidence 457899999999984 35578899999999999999999999988776655554432222222234567889999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 002160 911 CWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 911 CL~kDP~kRPSa~EIL~~ 928 (958)
||+.+|.+||++.+++.+
T Consensus 256 ~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 256 CLQKIPQERPASAELLRH 273 (313)
T ss_pred HccCChhhCcCHHHHhcC
Confidence 999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=314.47 Aligned_cols=253 Identities=21% Similarity=0.302 Sum_probs=196.6
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccCC--CceE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRP--PNLS 749 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~--~~l~ 749 (958)
.++|++.+.||+|+||.||+|.+ +++.||||++............+.+|+.+++++ +||||++++++|... ..+|
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 36788999999999999999976 578999998865433334455677899999999 999999999988654 3589
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
+||||++ ++|..++... ...+..... +.+++.||.|||.++ |+||||||+|||++.++.+||+|||++......
T Consensus 86 lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred EEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 9999997 5999888765 334444443 444489999999988 999999999999999999999999999865432
Q ss_pred cc-----cCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccc-----------
Q 002160 829 FL-----SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN----------- 891 (958)
Q Consensus 829 ~~-----~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~----------- 891 (958)
.. ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+....+....+....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 21 2233568999999998865 457889999999999999999999998765443322211000
Q ss_pred ------------------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHhh
Q 002160 892 ------------------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA--LKPL 932 (958)
Q Consensus 892 ------------------~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~--L~kL 932 (958)
........++.++.+||.+||+.||.+||++.+++.+ ++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0011112368899999999999999999999999987 4444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=312.74 Aligned_cols=251 Identities=23% Similarity=0.313 Sum_probs=195.3
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC------c
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------N 747 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~------~ 747 (958)
.+|.+.+.||+|+||.||+|.+ +++.||||++............+.+|+.++++++||||+++++++.... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 5799999999999999999976 6889999998765433334456789999999999999999999886543 4
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
+++||||+. .+|..++.. ..........+.+.+.||+|||.++ |+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 95 FYLVMPYMQ-TDLQKIMGH--PLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred EEEEecccc-cCHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 689999996 477776532 2333344444455589999999988 99999999999999999999999999876532
Q ss_pred CcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccc---------------
Q 002160 828 TFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN--------------- 891 (958)
Q Consensus 828 ~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~--------------- 891 (958)
. .....++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+....
T Consensus 170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (342)
T cd07879 170 E---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246 (342)
T ss_pred C---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccc
Confidence 2 234567889999999876 457899999999999999999999998876544332221100
Q ss_pred ------cccCC--------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHhhhh
Q 002160 892 ------RRLEI--------PKELDPLVARIIWECWQTDPSLRPSFAQLTVA--LKPLQR 934 (958)
Q Consensus 892 ------~~~~i--------p~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~--L~kL~k 934 (958)
....+ ....++.+.+||.+||+.||.+||++.+++.+ ++.+.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00000 12467889999999999999999999999977 776643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=311.42 Aligned_cols=253 Identities=23% Similarity=0.377 Sum_probs=193.4
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC-----Cce
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-----PNL 748 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~-----~~l 748 (958)
++|++.+.||+|+||.||+|.+ +++.||||++.... .......+.+|+.++++++|+||+++++++... ...
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 5799999999999999999976 68899999886432 223345678899999999999999999876543 348
Q ss_pred EEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
|+||||+. ++|.+++... .......+..+.+.+.||.|||..+ |+||||||+|||++.++.+||+|||++......
T Consensus 84 ~lv~e~~~-~~l~~~~~~~-~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQ-HLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred EEEehhcc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 99999996 5888877653 2333344444455589999999998 999999999999999999999999998765332
Q ss_pred cc---cCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhc---------------
Q 002160 829 FL---SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF--------------- 889 (958)
Q Consensus 829 ~~---~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~--------------- 889 (958)
.. ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 11 1233568999999998765 5678999999999999999999999977553322111100
Q ss_pred cc---------cccC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHhhh
Q 002160 890 QN---------RRLE-----IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA--LKPLQ 933 (958)
Q Consensus 890 ~~---------~~~~-----ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~--L~kL~ 933 (958)
.. .... .....+.++.+||.+||+.+|.+||++.+++.+ ++...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 00 0000 112457889999999999999999999999998 66553
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=310.53 Aligned_cols=249 Identities=23% Similarity=0.284 Sum_probs=193.4
Q ss_pred Cee-EEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHH------------HHHHHHHHHHHHHHcCCCceeEEecc
Q 002160 677 DLV-LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA------------ALLEFKREVKIMRRLRHPNVVLFMGA 741 (958)
Q Consensus 677 dy~-i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~------------~~~~f~~Ei~ILk~L~HPNIVkL~g~ 741 (958)
+|. +.+.||.|+||.||+|.+ .++.||||++........ ....+.+|++++++++|+||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 444 567899999999999975 688999998865432210 01246789999999999999999999
Q ss_pred ccCCCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccc
Q 002160 742 VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 821 (958)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGL 821 (958)
+...+..++||||+. ++|.+++..............+.+.+.||.|||.++ |+||||||+|||++.++.+||+|||+
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCCCCEEECCccc
Confidence 999999999999996 589998876554444444445555599999999988 99999999999999999999999999
Q ss_pred cccccCC--------------cccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHh
Q 002160 822 SRLKHNT--------------FLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGA 886 (958)
Q Consensus 822 Ak~~~~~--------------~~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~ 886 (958)
+...... ........++..|+|||.+.+. .++.++|||||||++|+|++|..||.+.+..+....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~ 245 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR 245 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 8765411 1111223468889999999764 468899999999999999999999988776554433
Q ss_pred hhccccc--------------------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 887 VGFQNRR--------------------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 887 i~~~~~~--------------------------~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+...... ..+....+..+.+||.+||+.+|.+||++++++.+
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 2110000 00112457889999999999999999999999974
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=304.91 Aligned_cols=243 Identities=28% Similarity=0.397 Sum_probs=197.6
Q ss_pred EEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeecCCC
Q 002160 681 GERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758 (958)
Q Consensus 681 ~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~gG 758 (958)
...||+|+||.||++.. +++.||||++.... ......+.+|+.+++.++|+||+++++++...+..++||||++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 35699999999999976 68899999875432 234567889999999999999999999999999999999999999
Q ss_pred CHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCCCC
Q 002160 759 SLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT 838 (958)
Q Consensus 759 sL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~GT 838 (958)
+|.+++.... .........+.+.+.+++|||..+ |+||||||+||+++++++++|+|||++..............|+
T Consensus 103 ~L~~~~~~~~-~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 179 (292)
T cd06657 103 ALTDIVTHTR-MNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT 179 (292)
T ss_pred cHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEcccccceecccccccccccccC
Confidence 9999886542 233334444455589999999988 9999999999999999999999999987654333233445688
Q ss_pred CCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccc-cccCCCCCCcHHHHHHHHHhhhcCCC
Q 002160 839 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLVARIIWECWQTDPS 917 (958)
Q Consensus 839 ~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~-~~~~ip~~ls~eL~dLI~~CL~kDP~ 917 (958)
..|+|||.+.+..++.++|+||||+++|+|++|..||.+....+....+.... ........+++.+.++|.+||+.+|.
T Consensus 180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~ 259 (292)
T cd06657 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPA 259 (292)
T ss_pred ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcc
Confidence 99999999988888999999999999999999999998876655544432111 11222345789999999999999999
Q ss_pred CCCCHHHHHHH
Q 002160 918 LRPSFAQLTVA 928 (958)
Q Consensus 918 kRPSa~EIL~~ 928 (958)
+||++.+++.+
T Consensus 260 ~R~~~~~ll~~ 270 (292)
T cd06657 260 QRATAAELLKH 270 (292)
T ss_pred cCcCHHHHhcC
Confidence 99999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=299.58 Aligned_cols=248 Identities=25% Similarity=0.319 Sum_probs=196.9
Q ss_pred eeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeec
Q 002160 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~ 755 (958)
|++.+.||+|+||.||+|+. +++.||+|++............+..|+.++++++|+||+++++++.....+++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 56778899999999999987 5889999998765433334556788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhCCCCCccHHHHHHH-HHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCC
Q 002160 756 PRGSLFRILHRPHCQVDEKRRIKM-ALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 834 (958)
Q Consensus 756 ~gGsL~d~L~k~~~~~~e~~~l~i-a~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s 834 (958)
+ ++|.+++.+......+.....+ .+.+.+|.|||..+ |+||||+|+||++++++.+||+|||++............
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCCCCEEEecCCcccccCCCccccCc
Confidence 7 5899999876334444444444 44489999999998 999999999999999999999999998876443333334
Q ss_pred CCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhc-------------------ccccc
Q 002160 835 TAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-------------------QNRRL 894 (958)
Q Consensus 835 ~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~-------------------~~~~~ 894 (958)
..++..|+|||.+.+. .++.++|||+|||++|||++|+.||.+.+.......+.. .....
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 4567889999999776 788999999999999999999999987665433322210 00000
Q ss_pred --------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 895 --------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 895 --------~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.....++..+.++|.+||..||.+||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0011347789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=310.50 Aligned_cols=251 Identities=26% Similarity=0.343 Sum_probs=191.3
Q ss_pred EEeecc--CceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeecCC
Q 002160 682 ERIGLG--SYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 757 (958)
Q Consensus 682 k~LG~G--~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~g 757 (958)
..||+| +||+||++++ +++.||||++..........+.+.+|+.+++.++||||++++++|..++.+++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 9999999987 789999999876655555667889999999999999999999999999999999999999
Q ss_pred CCHHHHHhCCCC-CccHHH-HHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc----
Q 002160 758 GSLFRILHRPHC-QVDEKR-RIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS---- 831 (958)
Q Consensus 758 GsL~d~L~k~~~-~~~e~~-~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~---- 831 (958)
++|.+++.+... ...+.. ...+.+++.||+|||..+ |+||||||+|||++.++.+|++|||.+.........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 999998876432 233333 344445599999999987 999999999999999999999999865332111000
Q ss_pred ---CCCCCCCCCccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccc---------------
Q 002160 832 ---SKSTAGTPEWMAPEVLRNE--PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN--------------- 891 (958)
Q Consensus 832 ---~~s~~GT~~Y~APEvl~g~--~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~--------------- 891 (958)
.....++..|+|||++.+. .++.++|||||||++|+|++|..||......+.........
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence 1112356679999999764 46899999999999999999999998765443322111000
Q ss_pred ------------------------------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH--Hhhhh
Q 002160 892 ------------------------------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL--KPLQR 934 (958)
Q Consensus 892 ------------------------------~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L--~kL~k 934 (958)
.+...+..+++.+++||.+||+.||.+||++.+++++- +.+.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 00111234567899999999999999999999998653 44433
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=330.43 Aligned_cols=258 Identities=31% Similarity=0.523 Sum_probs=221.1
Q ss_pred cccccCCCCeeEEEEeeccCceEEEEEEEC---Cc--EEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEecccc
Q 002160 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN---GT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT 743 (958)
Q Consensus 669 ~~~eI~~~dy~i~k~LG~G~fG~Vykak~~---g~--~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~ 743 (958)
..+-|..+++.+.++||+|.||.|++|.|+ |+ .||||+++...... ....|++|+.+|.+|+|||+|+|||++.
T Consensus 103 lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl 181 (1039)
T KOG0199|consen 103 LKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVL 181 (1039)
T ss_pred cceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeec
Confidence 345577788889999999999999999994 33 59999988766543 6779999999999999999999999998
Q ss_pred CCCceEEEEeecCCCCHHHHHhC-C-CCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccc
Q 002160 744 RPPNLSIITEFLPRGSLFRILHR-P-HCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 821 (958)
Q Consensus 744 ~~~~l~LVmEy~~gGsL~d~L~k-~-~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGL 821 (958)
+ ..+.+|||++++|+|.+.|++ . ..++......|..+++.||+||..++ +|||||-..|||+-....||||||||
T Consensus 182 ~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasprtVKI~DFGL 258 (1039)
T KOG0199|consen 182 D-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASPRTVKICDFGL 258 (1039)
T ss_pred c-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecccceeeeecccc
Confidence 7 678899999999999999987 2 23444556666777799999999988 99999999999999999999999999
Q ss_pred cccccCCcccC---CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCC
Q 002160 822 SRLKHNTFLSS---KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIP 897 (958)
Q Consensus 822 Ak~~~~~~~~~---~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip 897 (958)
.+.+....... ....-...|+|||.+...+++.++|||+|||+||||++ |..||.|....++++.+. ...++.-|
T Consensus 259 mRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpRP 337 (1039)
T KOG0199|consen 259 MRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPRP 337 (1039)
T ss_pred eeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCCC
Confidence 99875432211 11123457999999999999999999999999999998 789999999999999997 77888889
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 002160 898 KELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 931 (958)
Q Consensus 898 ~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~k 931 (958)
+.++.++.+++..||..+|.+||+|..|...+-.
T Consensus 338 k~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 338 KYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred CCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 9999999999999999999999999999855543
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=307.97 Aligned_cols=246 Identities=24% Similarity=0.332 Sum_probs=193.9
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC------
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------ 746 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~------ 746 (958)
.++|++.+.||+|+||.||++.. +++.||||++............+.+|+.+|++++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 46799999999999999999976 6889999988654433444557889999999999999999999887654
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
.+++||||+ +++|.+++... . ..+.... .+.+++.||.|||.++ |+||||||+|||++.++.+||+|||++...
T Consensus 94 ~~~lv~e~~-~~~l~~~~~~~-~-l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMKHE-K-LSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred eEEEEEecC-CCCHHHHHhcC-C-CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 358999999 77998888653 2 3344444 4445589999999988 999999999999999999999999999765
Q ss_pred cCCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccc-------------
Q 002160 826 HNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN------------- 891 (958)
Q Consensus 826 ~~~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~------------- 891 (958)
... .....+++.|+|||++.+ ..++.++|+||||+++|+|++|+.||.+.+.......+....
T Consensus 169 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07880 169 DSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245 (343)
T ss_pred ccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence 432 223567899999999876 457899999999999999999999998766443322211000
Q ss_pred -------------c---ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 892 -------------R---RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 892 -------------~---~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
. ...+...+++.+.++|.+||+.||.+||++.+++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 001123578889999999999999999999999943
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=306.94 Aligned_cols=248 Identities=25% Similarity=0.330 Sum_probs=193.8
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC------C
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------P 746 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~------~ 746 (958)
.++|.+.+.||+|+||.||+|.. +++.||||++............+.+|+.++++++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 47899999999999999999975 688999999876543333455678899999999999999999987543 3
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
..|++++++ +++|.+++.... .........+.+.+.||+|||..+ |+||||||+||++++++.+||+|||++....
T Consensus 96 ~~~lv~~~~-~~~L~~~~~~~~-l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 96 DVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred cEEEEehhc-ccCHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 478888887 789988876542 333333444455589999999988 9999999999999999999999999987653
Q ss_pred CCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc-------------
Q 002160 827 NTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------- 892 (958)
Q Consensus 827 ~~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~------------- 892 (958)
.. .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+.....
T Consensus 172 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (345)
T cd07877 172 DE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 248 (345)
T ss_pred cc---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccH
Confidence 32 234568899999999876 5678899999999999999999999987655433222110000
Q ss_pred --------ccCC--------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002160 893 --------RLEI--------PKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 893 --------~~~i--------p~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L 929 (958)
...+ ....++++++||.+||+.||.+||++.+++.+=
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 249 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred hHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 0000 123578899999999999999999999999873
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=335.77 Aligned_cols=147 Identities=26% Similarity=0.392 Sum_probs=127.7
Q ss_pred CCCeeEEEEeeccCceEEEEEEEC--CcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~~--g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LV 751 (958)
+++|.+.++||+|+||.||+|.+. ++.||||++..... .......+..|+.+++.++||||+++++++.....+|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 478999999999999999999874 88999999876543 344456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccc
Q 002160 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 823 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk 823 (958)
|||+.+++|.+++...+.......+.++.+++.||.|||.++ ||||||||+||||+.++++||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999976554444444555555699999999987 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=295.86 Aligned_cols=246 Identities=26% Similarity=0.373 Sum_probs=192.0
Q ss_pred eeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeccccCCCceEEEEee
Q 002160 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~-HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
|.+.+.||.|+||.||+|+. +++.|+||++...... .......+|+..+++++ |+||+++++++..++..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 67889999999999999987 5788999988654332 22334557999999998 99999999999999999999999
Q ss_pred cCCCCHHHHHhCCC-CCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 755 LPRGSLFRILHRPH-CQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 755 ~~gGsL~d~L~k~~-~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
+ +++|.+++.... ....+...+.++ +.+.+|.|||.++ |+|+||+|+||+++.++.++|+|||++....... ..
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-~~ 155 (283)
T cd07830 80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-PY 155 (283)
T ss_pred C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCCEEEeecccceeccCCC-Cc
Confidence 9 789998887654 334445444444 4489999999988 9999999999999999999999999998664432 22
Q ss_pred CCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcc-----------------ccc-
Q 002160 833 KSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-----------------NRR- 893 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~-----------------~~~- 893 (958)
....++..|+|||++.+ ..++.++|+||||+++|+|++|+.||...........+... ...
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 34568889999998854 45789999999999999999999999776544332221100 000
Q ss_pred ----------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 894 ----------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 894 ----------~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.......+..+.+||.+||+.+|.+||+++||+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00111236789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=305.84 Aligned_cols=249 Identities=24% Similarity=0.291 Sum_probs=191.7
Q ss_pred CeeEEEEeeccCceEEEEEEEC----CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccC----CCc
Q 002160 677 DLVLGERIGLGSYGEVYHADWN----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTR----PPN 747 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~~----g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~----~~~ 747 (958)
+|++.+.||+|+||.||++++. +..||||++............+.+|+.+++++ +||||+++++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4889999999999999999874 66899998865433333455678899999999 59999999987532 245
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
+|++|||+. ++|.+++...........+..+.+++.||.|||..+ |+||||||+|||++.++++||+|||+++....
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 789999985 689988876555445555555566699999999988 99999999999999999999999999986543
Q ss_pred Ccc----cCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhc-------------
Q 002160 828 TFL----SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF------------- 889 (958)
Q Consensus 828 ~~~----~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~------------- 889 (958)
... ......|+..|+|||++.+ ..++.++||||||+++|+|++|..||.+.+.......+..
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 211 1233568999999998865 5688999999999999999999999987654322221110
Q ss_pred -------------cccccC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 890 -------------QNRRLE---IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 890 -------------~~~~~~---ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
...... ....++..+++||.+||+.||.+||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000011 112357899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=309.49 Aligned_cols=247 Identities=25% Similarity=0.350 Sum_probs=196.4
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc-----
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN----- 747 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~----- 747 (958)
.++|++.+.||+|+||.||+|++ +++.||||++............+.+|+.++++++||||+++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 46799999999999999999987 57889999886654334445667889999999999999999998876654
Q ss_pred -eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 748 -LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 748 -l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
+++|+||+ +++|.+++... ..........+.+++.||+|||..+ |+||||||+||+++.++.+||+|||++....
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~~-~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKCQ-KLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred cEEEEEecC-CCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 89999999 67999988763 2333333444445599999999988 9999999999999999999999999997654
Q ss_pred CCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc-------------
Q 002160 827 NTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------- 892 (958)
Q Consensus 827 ~~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~------------- 892 (958)
.. .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 170 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07851 170 DE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSE 246 (343)
T ss_pred cc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccch
Confidence 32 234568889999999875 3578899999999999999999999987766544433211000
Q ss_pred -------------cc---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 893 -------------RL---EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 893 -------------~~---~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+. .....++..+.+||.+||+.||.+||++.+|+.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 247 SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00 0112458899999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=303.94 Aligned_cols=247 Identities=26% Similarity=0.366 Sum_probs=193.6
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC-CCceEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-PPNLSII 751 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~-~~~l~LV 751 (958)
.++|++.+.||.|+||.||++.. +++.||||++.+..........+..|+.++++++||||++++++|.. ...+|++
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv 88 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV 88 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEE
Confidence 36799999999999999999975 68899999886544333345677899999999999999999998865 5578999
Q ss_pred EeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc
Q 002160 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~ 831 (958)
|||+ +++|..++.... .........+.+++.||.|||..+ |+||||||.|||++.++.+||+|||++......
T Consensus 89 ~e~~-~~~L~~~~~~~~-~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~--- 161 (328)
T cd07856 89 TELL-GTDLHRLLTSRP-LEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLARIQDPQ--- 161 (328)
T ss_pred eehh-ccCHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCCCCEEeCccccccccCCC---
Confidence 9998 568988886543 233333444555589999999988 999999999999999999999999998754322
Q ss_pred CCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhc---------------------
Q 002160 832 SKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF--------------------- 889 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~--------------------- 889 (958)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+..
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd07856 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241 (328)
T ss_pred cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence 233567889999999866 5688999999999999999999999987654322111100
Q ss_pred ---ccccc-----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 890 ---QNRRL-----EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 890 ---~~~~~-----~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
..... .....++..+.++|.+||+.+|.+||++.+++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 1113467899999999999999999999999776
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=306.24 Aligned_cols=247 Identities=23% Similarity=0.334 Sum_probs=191.8
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC--------
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-------- 745 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~-------- 745 (958)
.+|.+.+.||.|+||.||+|.. +++.||+|++..... .....+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 6799999999999999999976 688999999866543 3345688999999999999999999876554
Q ss_pred ------CceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEc-CCCcEEEEe
Q 002160 746 ------PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSD 818 (958)
Q Consensus 746 ------~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId-~~g~VKL~D 818 (958)
..+|+||||++ ++|.+++... .......+.++.+++.||.|||.++ |+||||||+|||++ .++.+||+|
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLEQG-PLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceEEECC
Confidence 35789999996 5898888653 2334444555556699999999988 99999999999998 456799999
Q ss_pred ccccccccCCcc---cCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcc----
Q 002160 819 FGLSRLKHNTFL---SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---- 890 (958)
Q Consensus 819 FGLAk~~~~~~~---~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~---- 890 (958)
||++........ ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.++.+....+...
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999876532211 1122357889999998754 55788999999999999999999999877654433322100
Q ss_pred -------------------cccc-----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 891 -------------------NRRL-----EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 891 -------------------~~~~-----~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.... .+...++.++++||.+||+.||.+||++.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0000 1123577899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=305.57 Aligned_cols=246 Identities=24% Similarity=0.354 Sum_probs=215.0
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCc
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~ 747 (958)
-+..++|.++++||+|+|.+|.++++ +.+.||+|+++++-.. .+++..+..|..+..+. +||++|-++.+|+.+.+
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 35568999999999999999999976 6778999998876543 34566778899998887 79999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
+++|.||++||+|--+++++....++..+++.+.+..||.|||+.| ||+||||.+|+|||..|++||+|+|+++.-..
T Consensus 326 lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccCCceeecccchhhcCCC
Confidence 9999999999999999988888888999999999999999999998 99999999999999999999999999997666
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-------CChhHHHHhhhccccccCCCCCC
Q 002160 828 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG-------MNPMQVVGAVGFQNRRLEIPKEL 900 (958)
Q Consensus 828 ~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g-------~~~~ei~~~i~~~~~~~~ip~~l 900 (958)
+.....++|||+.|+|||+++|..|+..+|||+||++++||+.|+.||.- .+.+..+..+ .......+|..+
T Consensus 404 ~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv-ilekqiriprsl 482 (593)
T KOG0695|consen 404 PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV-ILEKQIRIPRSL 482 (593)
T ss_pred CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH-Hhhhccccccee
Confidence 66667889999999999999999999999999999999999999999952 1222222222 244567789999
Q ss_pred cHHHHHHHHHhhhcCCCCCC
Q 002160 901 DPLVARIIWECWQTDPSLRP 920 (958)
Q Consensus 901 s~eL~dLI~~CL~kDP~kRP 920 (958)
+.....+++..|++||.+|.
T Consensus 483 svkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 483 SVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ehhhHHHHHHhhcCCcHHhc
Confidence 99999999999999999995
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=308.02 Aligned_cols=258 Identities=24% Similarity=0.362 Sum_probs=202.6
Q ss_pred CccccccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEecccc
Q 002160 667 DVCECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVT 743 (958)
Q Consensus 667 ~~~~~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~ 743 (958)
+...+++..++++-+..||.|+||+|++..+ .|+..|||+++.... +....+++.|.+...+- +.||||++||++.
T Consensus 55 ~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F 133 (361)
T KOG1006|consen 55 DAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALF 133 (361)
T ss_pred cccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh
Confidence 3445566777788888999999999999977 688999999988765 44567888888877766 7899999999999
Q ss_pred CCCceEEEEeecCCCCHHHHHh----CCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEe
Q 002160 744 RPPNLSIITEFLPRGSLFRILH----RPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSD 818 (958)
Q Consensus 744 ~~~~l~LVmEy~~gGsL~d~L~----k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~D 818 (958)
.++.+||.||+|+ .+|..+.. .+...+.+.....+... +.||.||...- .||||||||+|||+|..|.|||||
T Consensus 134 ~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l-kiIHRDvKPSNILldr~G~vKLCD 211 (361)
T KOG1006|consen 134 SEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL-KIIHRDVKPSNILLDRHGDVKLCD 211 (361)
T ss_pred cCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh-hhhhccCChhheEEecCCCEeeec
Confidence 9999999999995 46655432 12234455544444444 89999998642 499999999999999999999999
Q ss_pred ccccccccCCcccCCCCCCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChh-HHHHhhhccccc-c
Q 002160 819 FGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRR-L 894 (958)
Q Consensus 819 FGLAk~~~~~~~~~~s~~GT~~Y~APEvl~g--~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~-ei~~~i~~~~~~-~ 894 (958)
||++..+.+... .+..+|...|||||.+.. ..|+-++|+|||||+|||+.||++||.+++.. +.+..+.....+ +
T Consensus 212 FGIcGqLv~SiA-kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l 290 (361)
T KOG1006|consen 212 FGICGQLVDSIA-KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPIL 290 (361)
T ss_pred ccchHhHHHHHH-hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCee
Confidence 999988766543 344679999999999964 34888999999999999999999999998764 223333222211 1
Q ss_pred CCCC---CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 895 EIPK---ELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 895 ~ip~---~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
..+. +++..++.||.-||.+|-..||.+.+++++
T Consensus 291 ~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 291 LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 2233 478999999999999999999999998765
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=325.89 Aligned_cols=259 Identities=33% Similarity=0.558 Sum_probs=218.5
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEEC---------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEe
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFM 739 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~~---------g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~ 739 (958)
.+++..+++.+.+.||.|.||.|++|... ...||||.++..... .....+..|+++|+.+ +|+|||.++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 78888889999999999999999999641 446999987765544 6678899999999999 699999999
Q ss_pred ccccCCCceEEEEeecCCCCHHHHHhCCC---------------CCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCC
Q 002160 740 GAVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKS 803 (958)
Q Consensus 740 g~~~~~~~l~LVmEy~~gGsL~d~L~k~~---------------~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKP 803 (958)
|++...+.+++|+||+..|+|..+|++.+ ..+.....+.++ |++.||+||++.. +|||||-.
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAa 446 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAA 446 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhh
Confidence 99999999999999999999999998766 123333444444 4499999999988 99999999
Q ss_pred CceEEcCCCcEEEEeccccccccCCcccC-CCCCC--CCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 002160 804 PNLLVDKNWNVKVSDFGLSRLKHNTFLSS-KSTAG--TPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMN 879 (958)
Q Consensus 804 eNILId~~g~VKL~DFGLAk~~~~~~~~~-~s~~G--T~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~ 879 (958)
.||||.++..+||+|||+++......... ....| -..|||||.+....|+.++|||||||+|||+++ |..||.+..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999999999654432221 22233 235999999999999999999999999999998 889999866
Q ss_pred -hhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 002160 880 -PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 880 -~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL 932 (958)
..++.. ....+.+...|..++.++.+++..||+.+|++||+|.++.+.|..+
T Consensus 527 ~~~~l~~-~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 527 PTEELLE-FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred cHHHHHH-HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 555554 4457788899999999999999999999999999999999999885
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=336.08 Aligned_cols=243 Identities=31% Similarity=0.451 Sum_probs=190.5
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEecccc----------
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT---------- 743 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~---------- 743 (958)
.+|+.++.||+||||.||+++. +|+.||||+|.... ......++.+|+.+|.+|+|||||++|..|.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 5788889999999999999975 89999999998776 6667778999999999999999999964331
Q ss_pred --------------------------------------------------------------------C-----------
Q 002160 744 --------------------------------------------------------------------R----------- 744 (958)
Q Consensus 744 --------------------------------------------------------------------~----------- 744 (958)
+
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0
Q ss_pred ----------------------C--------CceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcC
Q 002160 745 ----------------------P--------PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTST 793 (958)
Q Consensus 745 ----------------------~--------~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g 793 (958)
. -.+||-||||+...|.++++++.........+.++ +++.||.|+|..|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 0 12688999999988889988876553333333333 4499999999998
Q ss_pred CcEeecCCCCCceEEcCCCcEEEEecccccccc------------------CCcccCCCCCCCCCccCcccccCCC---C
Q 002160 794 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH------------------NTFLSSKSTAGTPEWMAPEVLRNEP---S 852 (958)
Q Consensus 794 ~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~------------------~~~~~~~s~~GT~~Y~APEvl~g~~---~ 852 (958)
||||||||.||++|+++.|||+|||+|+... ......+..+||.-|+|||++.+.. |
T Consensus 718 --iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 718 --IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred --eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 9999999999999999999999999998611 0112345678999999999998655 9
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCC-CChhHHHHhhhccccccCCCCC------CcHHHHHHHHHhhhcCCCCCCCHHHH
Q 002160 853 NEKCDVYSFGVILWELATLKLPWIG-MNPMQVVGAVGFQNRRLEIPKE------LDPLVARIIWECWQTDPSLRPSFAQL 925 (958)
Q Consensus 853 s~ksDIWSLGiLLyELLtG~~PF~g-~~~~ei~~~i~~~~~~~~ip~~------ls~eL~dLI~~CL~kDP~kRPSa~EI 925 (958)
+.|+|+|||||||+||+. ||.. ++...++..++ ...+|.. --+.-..+|.+||+.||.+|||+.|+
T Consensus 796 n~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR----~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eL 868 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR----KGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATEL 868 (1351)
T ss_pred cchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc----cCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHH
Confidence 999999999999999984 5643 33444444443 2233322 12445789999999999999999999
Q ss_pred HHH
Q 002160 926 TVA 928 (958)
Q Consensus 926 L~~ 928 (958)
+..
T Consensus 869 L~s 871 (1351)
T KOG1035|consen 869 LNS 871 (1351)
T ss_pred hhc
Confidence 863
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=314.84 Aligned_cols=240 Identities=28% Similarity=0.409 Sum_probs=200.6
Q ss_pred EEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeecCCC
Q 002160 681 GERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRG 758 (958)
Q Consensus 681 ~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~gG 758 (958)
.++||.|-||+||-|++ +|+.||||++.+..+......++++|+.||++++||.||.|..+|+..++.++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 46799999999999975 7999999999988877666788999999999999999999999999999999999999776
Q ss_pred CHHHHHhCCCCCc-cHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCC---CcEEEEeccccccccCCcccCCC
Q 002160 759 SLFRILHRPHCQV-DEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKN---WNVKVSDFGLSRLKHNTFLSSKS 834 (958)
Q Consensus 759 sL~d~L~k~~~~~-~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~---g~VKL~DFGLAk~~~~~~~~~~s 834 (958)
-|.-+|......+ +...++.+.+++.||.|||-.+ |+|.||||+|||+... -++||||||+|+....... ..+
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-Rrs 725 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-RRS 725 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhhh-hhh
Confidence 6666665544444 4445666777799999999998 9999999999999743 4699999999998876533 456
Q ss_pred CCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccccc----CCCCCCcHHHHHHHHH
Q 002160 835 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL----EIPKELDPLVARIIWE 910 (958)
Q Consensus 835 ~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~----~ip~~ls~eL~dLI~~ 910 (958)
.+||+.|+|||+++++.|...-|+||.|+|+|--+.|.+||....+ +.+.| ++... .-.+++++++.|||..
T Consensus 726 VVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQI--QNAaFMyPp~PW~eis~~AidlIn~ 801 (888)
T KOG4236|consen 726 VVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQI--QNAAFMYPPNPWSEISPEAIDLINN 801 (888)
T ss_pred hcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--hhHHh--hccccccCCCchhhcCHHHHHHHHH
Confidence 8899999999999999999999999999999999999999976543 22222 22222 2235789999999999
Q ss_pred hhhcCCCCCCCHHHHHH
Q 002160 911 CWQTDPSLRPSFAQLTV 927 (958)
Q Consensus 911 CL~kDP~kRPSa~EIL~ 927 (958)
+|+..-.+|-+.+.-+.
T Consensus 802 LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 802 LLQVKMRKRYSVDKSLS 818 (888)
T ss_pred HHHHHHHHhcchHhhcc
Confidence 99999999999875443
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=285.23 Aligned_cols=218 Identities=21% Similarity=0.230 Sum_probs=176.6
Q ss_pred cCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeecCCCCHHHHH
Q 002160 687 GSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL 764 (958)
Q Consensus 687 G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~gGsL~d~L 764 (958)
|.||.||++++ +++.||+|++.... .+.+|...+....||||+++++++...+..++||||+++|+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 89999999976 78899999986643 2334555666667999999999999999999999999999999998
Q ss_pred hCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCCCCCCccCc
Q 002160 765 HRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 844 (958)
Q Consensus 765 ~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~GT~~Y~AP 844 (958)
.+...........++.+.+.||.|||..+ |+||||||+||+++.++.++|+|||++...... .....++..|+||
T Consensus 77 ~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~aP 151 (237)
T cd05576 77 SKFLNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCAP 151 (237)
T ss_pred HHhcCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccccCC
Confidence 76544434444445555589999999988 999999999999999999999999987655432 1234567789999
Q ss_pred ccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCH
Q 002160 845 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSF 922 (958)
Q Consensus 845 Evl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa 922 (958)
|.+.+..++.++|+||||+++|+|++|..||...... . .......+|..+++.+++||.+||+.||.+||++
T Consensus 152 E~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 152 EVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-I-----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred cccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-c-----ccccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 9998888899999999999999999999887543211 1 1122345677889999999999999999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=298.93 Aligned_cols=241 Identities=26% Similarity=0.368 Sum_probs=199.8
Q ss_pred EEEeeccCceEEEEEE--ECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCceEEEEeecCC
Q 002160 681 GERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPR 757 (958)
Q Consensus 681 ~k~LG~G~fG~Vykak--~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~l~LVmEy~~g 757 (958)
.+.||+|+|+.|--+. .++..||||++.++. .....++.+|++++.+. .|+||++|++||+++.++|||||-|.|
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 3569999999999885 489999999988763 44567889999999999 599999999999999999999999999
Q ss_pred CCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCc---EEEEeccccccccCC------
Q 002160 758 GSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRLKHNT------ 828 (958)
Q Consensus 758 GsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~---VKL~DFGLAk~~~~~------ 828 (958)
|.|..+++++..+.+.+....+..++.||.+||..| |.||||||+|||.....+ ||||||.|..-....
T Consensus 161 GplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa 238 (463)
T KOG0607|consen 161 GPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA 238 (463)
T ss_pred chHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence 999999998887777777776666799999999998 999999999999976543 999999987643211
Q ss_pred -cccCCCCCCCCCccCccccc---C--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---------------hHHHHhh
Q 002160 829 -FLSSKSTAGTPEWMAPEVLR---N--EPSNEKCDVYSFGVILWELATLKLPWIGMNP---------------MQVVGAV 887 (958)
Q Consensus 829 -~~~~~s~~GT~~Y~APEvl~---g--~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~---------------~ei~~~i 887 (958)
.....+.+|+.+|||||+.. + ..|++++|.||||+|||-||+|.+||.|.-. ..+++.|
T Consensus 239 stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesI 318 (463)
T KOG0607|consen 239 STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESI 318 (463)
T ss_pred CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHH
Confidence 11123457899999999863 3 3589999999999999999999999976321 1223333
Q ss_pred hccccccCCCC----CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002160 888 GFQNRRLEIPK----ELDPLVARIIWECWQTDPSLRPSFAQLTV 927 (958)
Q Consensus 888 ~~~~~~~~ip~----~ls~eL~dLI~~CL~kDP~kRPSa~EIL~ 927 (958)
+....+||. .++.+.++||..+|..|+.+|.++.+++.
T Consensus 319 --QEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 319 --QEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred --hccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 666777875 58899999999999999999999998877
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=319.88 Aligned_cols=249 Identities=29% Similarity=0.467 Sum_probs=209.0
Q ss_pred CCCCeeEEEEeeccCceEEEEEE--ECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccC-----C
Q 002160 674 PWEDLVLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTR-----P 745 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak--~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~-----~ 745 (958)
...-|+|.+.||.|.+|.||+++ ++++.+|||+...... ...+++.|.+||+.+ +|||++.+||+|.. +
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d---~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED---EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc---ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 34568999999999999999996 4899999998765432 234677899999998 79999999999853 5
Q ss_pred CceEEEEeecCCCCHHHHHhCC-CCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccc
Q 002160 746 PNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 823 (958)
Q Consensus 746 ~~l~LVmEy~~gGsL~d~L~k~-~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk 823 (958)
+++|||||||.||+.-|+++.. +....|....++... +.||.|||.+. +||||||-.|||++.++.|||+|||++.
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEeccCcEEEeeeeeee
Confidence 6799999999999999998754 344556666666555 89999999988 9999999999999999999999999999
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCC--
Q 002160 824 LKHNTFLSSKSTAGTPEWMAPEVLRNEP-----SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI-- 896 (958)
Q Consensus 824 ~~~~~~~~~~s~~GT~~Y~APEvl~g~~-----~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~i-- 896 (958)
.+........++.||+.|||||++.... |+.++|+|||||+..||--|.+|+.++-+...+-.|. .+.++.+
T Consensus 172 QldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip-RNPPPkLkr 250 (953)
T KOG0587|consen 172 QLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP-RNPPPKLKR 250 (953)
T ss_pred eeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC-CCCCccccc
Confidence 9888878888899999999999997543 5778999999999999999999999998887776664 2333322
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 897 PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 897 p~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
|+.-+.++-+||..||.+|-.+||+..++++|
T Consensus 251 p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 251 PKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred hhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 45667899999999999999999999988754
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=319.11 Aligned_cols=253 Identities=27% Similarity=0.451 Sum_probs=193.5
Q ss_pred eeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC------ceE
Q 002160 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------NLS 749 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~------~l~ 749 (958)
|...+.||+|+||.||+|++ +|+.||||.+.... .....+..-+|+++|++|+|+|||++++.-+... ...
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 45567899999999999985 79999999987754 2234556779999999999999999999865543 357
Q ss_pred EEEeecCCCCHHHHHhCCC--CCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEc--CCCc--EEEEecccc
Q 002160 750 IITEFLPRGSLFRILHRPH--CQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVD--KNWN--VKVSDFGLS 822 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~--~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId--~~g~--VKL~DFGLA 822 (958)
+|||||.||+|+..|++.. ..+.+...+.+... ..||.|||+++ ||||||||.||++- ++|+ .||||||.|
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999998644 34445544444444 89999999998 99999999999995 3343 899999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC----hhHHHHhhhc--------
Q 002160 823 RLKHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMN----PMQVVGAVGF-------- 889 (958)
Q Consensus 823 k~~~~~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~----~~ei~~~i~~-------- 889 (958)
+.+.+.. ...++.||..|++||++.. ++|+..+|.|||||++|+++||.+||.-.. ..++...+..
T Consensus 172 rel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i 250 (732)
T KOG4250|consen 172 RELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAI 250 (732)
T ss_pred ccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeE
Confidence 9886654 5678899999999999995 788999999999999999999999995421 1222222111
Q ss_pred -----cccc------cCCCCCCcH----HHHHHHHHhhhcCCCCCC--CHHHHHHHHHhhhh
Q 002160 890 -----QNRR------LEIPKELDP----LVARIIWECWQTDPSLRP--SFAQLTVALKPLQR 934 (958)
Q Consensus 890 -----~~~~------~~ip~~ls~----eL~dLI~~CL~kDP~kRP--Sa~EIL~~L~kL~k 934 (958)
.+.+ +++|-++++ .+...+..+|..+|.+|. .+.+....+..|..
T Consensus 251 ~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 251 GAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred eeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 1111 222333443 345667778899999999 78777777776643
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=317.39 Aligned_cols=239 Identities=23% Similarity=0.316 Sum_probs=200.5
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCceEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~l~LV 751 (958)
.+.|++...+|.|+|+.|..+.+ ++...++|++.+... +..+|+.++... +||||+++.+.+.+..+.|+|
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecCCceeeee
Confidence 45678888899999999999976 788899999876621 223566666666 799999999999999999999
Q ss_pred EeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEE-cCCCcEEEEeccccccccCCcc
Q 002160 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLV-DKNWNVKVSDFGLSRLKHNTFL 830 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILI-d~~g~VKL~DFGLAk~~~~~~~ 830 (958)
||++.|+.|.+.+....... .....++++++.++.|||.+| ||||||||+|||+ +..|+++|||||.++.....
T Consensus 395 ~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred ehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 99999999988877655444 455557777799999999988 9999999999999 69999999999999887655
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh-HHHHhhhccccccCCCCCCcHHHHHHHH
Q 002160 831 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRLEIPKELDPLVARIIW 909 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~-ei~~~i~~~~~~~~ip~~ls~eL~dLI~ 909 (958)
..+-+-|..|.|||++....|++++||||||++||+||+|+.||...... ++...+ ..+.+...++.++++||.
T Consensus 470 -~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~~s~~vS~~AKdLl~ 544 (612)
T KOG0603|consen 470 -CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPKFSECVSDEAKDLLQ 544 (612)
T ss_pred -hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCccccccCHHHHHHHH
Confidence 33456789999999999999999999999999999999999999876544 444333 244455789999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHH
Q 002160 910 ECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 910 ~CL~kDP~kRPSa~EIL~~L 929 (958)
+||+.||.+|+++.+|..+=
T Consensus 545 ~LL~~dP~~Rl~~~~i~~h~ 564 (612)
T KOG0603|consen 545 QLLQVDPALRLGADEIGAHP 564 (612)
T ss_pred HhccCChhhCcChhhhccCc
Confidence 99999999999999998764
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=300.16 Aligned_cols=252 Identities=36% Similarity=0.647 Sum_probs=199.5
Q ss_pred CCeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc--CCCceeEEeccccCCC----ceE
Q 002160 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL--RHPNVVLFMGAVTRPP----NLS 749 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L--~HPNIVkL~g~~~~~~----~l~ 749 (958)
.++.+.+.||+|.||+||+|+|.|+.||||+|...+ ...+.+|.+|++.. +|+||+.|++.-..++ ++|
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 467889999999999999999999999999986653 23567888888864 9999999998765443 489
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhc------CCcEeecCCCCCceEEcCCCcEEEEecccc
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTS------TPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 822 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~------g~gIIHRDLKPeNILId~~g~VKL~DFGLA 822 (958)
||++|.+.|+|+|||.+. .......++++.- +.||+|||.. ++.|.|||||..||||.++|...|+|+|||
T Consensus 286 LvTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred EeeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 999999999999999884 3445555555555 8999999962 356999999999999999999999999999
Q ss_pred ccccCC----cccCCCCCCCCCccCcccccCCC------CCchhhHHHHHHHHHHHHhC----------CCCCCCCCh--
Q 002160 823 RLKHNT----FLSSKSTAGTPEWMAPEVLRNEP------SNEKCDVYSFGVILWELATL----------KLPWIGMNP-- 880 (958)
Q Consensus 823 k~~~~~----~~~~~s~~GT~~Y~APEvl~g~~------~s~ksDIWSLGiLLyELLtG----------~~PF~g~~~-- 880 (958)
...... ....+..+||.+|||||++...- .-..+||||||.++||+... ++||++.-+
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D 443 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD 443 (513)
T ss_pred EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence 875433 23345678999999999985432 23578999999999998753 688876432
Q ss_pred ---hHHHHhhhccccccCCCCCC--c---HHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhh
Q 002160 881 ---MQVVGAVGFQNRRLEIPKEL--D---PLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934 (958)
Q Consensus 881 ---~ei~~~i~~~~~~~~ip~~l--s---~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k 934 (958)
+++...+-.+..++.+|... . ..+.+|++.||..+|.-|.++--|.+.|.++.+
T Consensus 444 Ps~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 444 PSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 34444444455566666432 2 346788999999999999999999999999864
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-33 Score=298.52 Aligned_cols=242 Identities=25% Similarity=0.386 Sum_probs=193.4
Q ss_pred CCeeE-EEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccCC----Cc
Q 002160 676 EDLVL-GERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRP----PN 747 (958)
Q Consensus 676 ~dy~i-~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~----~~ 747 (958)
++|.+ -++||-|-.|+|..+.+ +++++|+|++... .+.++|+++.-.. .|||||.++++|.+. ..
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 44554 35699999999999965 7899999987543 2556888876665 699999999998653 45
Q ss_pred eEEEEeecCCCCHHHHHhCCCC--CccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcC---CCcEEEEecccc
Q 002160 748 LSIITEFLPRGSLFRILHRPHC--QVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLS 822 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~--~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~---~g~VKL~DFGLA 822 (958)
+.+|||.|+||+|+..++.++. +.+.+....+.++..|+.|||..+ |.||||||+|+|... +..+||+|||+|
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEecccccc
Confidence 8899999999999998876554 334444445555589999999999 999999999999974 567999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhH----HHHhhhccccccCCCC
Q 002160 823 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ----VVGAVGFQNRRLEIPK 898 (958)
Q Consensus 823 k~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~e----i~~~i~~~~~~~~ip~ 898 (958)
+..... ....+.|-|++|.|||++..++|+..+|+||||+++|-|++|.+||+...... ....| ......||.
T Consensus 212 K~t~~~-~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI--~~gqy~FP~ 288 (400)
T KOG0604|consen 212 KETQEP-GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRI--RTGQYEFPE 288 (400)
T ss_pred cccCCC-ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHh--hccCccCCC
Confidence 976543 33456788999999999999999999999999999999999999998654322 22333 333445543
Q ss_pred ----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002160 899 ----ELDPLVARIIWECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 899 ----~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L 929 (958)
.++...+++|+.+|+.+|.+|.++.+++.+=
T Consensus 289 pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp 323 (400)
T KOG0604|consen 289 PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP 323 (400)
T ss_pred hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence 5789999999999999999999999998764
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-32 Score=300.80 Aligned_cols=255 Identities=32% Similarity=0.489 Sum_probs=203.7
Q ss_pred CCeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc--CCCceeEEeccccCCC----ceE
Q 002160 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL--RHPNVVLFMGAVTRPP----NLS 749 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L--~HPNIVkL~g~~~~~~----~l~ 749 (958)
..+++.+.||+|.||.||+|+.+++.||||+|.. +....|.+|.+|++.. +|+||++|+++-.... .++
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CchhhHHHhhcCccceeehhhccCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 4566778899999999999999999999999753 4566788999998875 7999999999877666 799
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHh-------cCCcEeecCCCCCceEEcCCCcEEEEeccc
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHT-------STPTIVHRDLKSPNLLVDKNWNVKVSDFGL 821 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~-------~g~gIIHRDLKPeNILId~~g~VKL~DFGL 821 (958)
||+||.+.|+|.++|..+- ..+.....++.- +.||+|||. ++++|+|||||..||||.++++..|+||||
T Consensus 285 LVt~fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred EEeeeccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 9999999999999998764 444445555554 899999997 345799999999999999999999999999
Q ss_pred cccccCCc--ccCCCCCCCCCccCcccccCCCC------CchhhHHHHHHHHHHHHhCC------------CCCCC----
Q 002160 822 SRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPS------NEKCDVYSFGVILWELATLK------------LPWIG---- 877 (958)
Q Consensus 822 Ak~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~------s~ksDIWSLGiLLyELLtG~------------~PF~g---- 877 (958)
|..+.... ...-..+||.+|||||++.|.-. -.+.||||+|.+||||++.- .||..
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 98865332 12223679999999999977532 24689999999999999853 34431
Q ss_pred -CChhHHHHhhhccccccCCCCC-----CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhcC
Q 002160 878 -MNPMQVVGAVGFQNRRLEIPKE-----LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVI 937 (958)
Q Consensus 878 -~~~~ei~~~i~~~~~~~~ip~~-----ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~~ 937 (958)
..-.++...+.....|+.+|.. --.-+++.|..||+.|++-|.|+.=+.+.+.++.....
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 1233555556666778888753 23568999999999999999999999999998877643
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=334.54 Aligned_cols=244 Identities=25% Similarity=0.364 Sum_probs=186.9
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEee
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
.|...+.||+|+||.||+|++ ++..||||++...... ...|++++++++|||||++++++.+....|+||||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 456677899999999999985 6889999987643321 13468899999999999999999999999999999
Q ss_pred cCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhc-CCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 755 LPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 755 ~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~-g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
+++|+|.++++. ..+..+..++.+ +.||+|||.. .++|+||||||+||+++.++..++. ||....... .
T Consensus 765 ~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----~ 835 (968)
T PLN00113 765 IEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----D 835 (968)
T ss_pred CCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----C
Confidence 999999999964 345555555554 8999999954 3459999999999999998888875 666543321 1
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--hHHHHhhh--cccc------ccCC------
Q 002160 833 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP--MQVVGAVG--FQNR------RLEI------ 896 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~--~ei~~~i~--~~~~------~~~i------ 896 (958)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+..... .... .+.+
T Consensus 836 ~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (968)
T PLN00113 836 TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV 915 (968)
T ss_pred CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCc
Confidence 234688999999999999999999999999999999999999853211 11111110 0000 0111
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 897 PKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 897 p~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
+.....++.+++.+||+.||++||++.|+++.|+++.+.
T Consensus 916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 916 NQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 111223577899999999999999999999999988654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=268.09 Aligned_cols=235 Identities=31% Similarity=0.482 Sum_probs=190.4
Q ss_pred CceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeecCCCCHHHHHh
Q 002160 688 SYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH 765 (958)
Q Consensus 688 ~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~gGsL~d~L~ 765 (958)
+||.||+|++ +++.||+|++........ ...+.+|++++++++|+||+++++++......+++|||+++++|..++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 5899999987 468999999876543322 5688999999999999999999999999899999999999999999987
Q ss_pred CCCCCccHHHHHHH-HHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCCCCCCccCc
Q 002160 766 RPHCQVDEKRRIKM-ALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 844 (958)
Q Consensus 766 k~~~~~~e~~~l~i-a~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~GT~~Y~AP 844 (958)
.... ......+.+ ...+.++.+||..+ |+|+||+|.||+++.++.++|+|||.+....... ......++..|++|
T Consensus 80 ~~~~-~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~p 155 (244)
T smart00220 80 KRGR-LSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAP 155 (244)
T ss_pred hccC-CCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCH
Confidence 6543 334444444 44489999999987 9999999999999999999999999998765432 23446688999999
Q ss_pred ccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CChhHHHHhhhccccccCCCC-CCcHHHHHHHHHhhhcCCCCCCCH
Q 002160 845 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIG-MNPMQVVGAVGFQNRRLEIPK-ELDPLVARIIWECWQTDPSLRPSF 922 (958)
Q Consensus 845 Evl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g-~~~~ei~~~i~~~~~~~~ip~-~ls~eL~dLI~~CL~kDP~kRPSa 922 (958)
|.+.+..++.++|||+||+++|+|++|..||.. .+................... .++.++.+++.+||..+|.+||++
T Consensus 156 E~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~ 235 (244)
T smart00220 156 EVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTA 235 (244)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCH
Confidence 999988889999999999999999999999987 444444443321111111111 188999999999999999999999
Q ss_pred HHHHH
Q 002160 923 AQLTV 927 (958)
Q Consensus 923 ~EIL~ 927 (958)
.++++
T Consensus 236 ~~~~~ 240 (244)
T smart00220 236 EEALQ 240 (244)
T ss_pred HHHhh
Confidence 99986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=269.94 Aligned_cols=249 Identities=24% Similarity=0.290 Sum_probs=200.0
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEee
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
+|.-.++||+|.||+||+|+. +.+.||+|.++..+.++.......+|+-+|+.++|.|||+++++...+.++-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 455567899999999999975 678899999988776665566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhCCCC-CccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCC
Q 002160 755 LPRGSLFRILHRPHC-QVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 833 (958)
Q Consensus 755 ~~gGsL~d~L~k~~~-~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~ 833 (958)
|+. +|..+...... ...+..+-.+.+.+.||.++|.++ ++||||||.|+||+.+|++||+|||+++.+.-+.....
T Consensus 83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence 954 78887765444 444556666777799999999999 99999999999999999999999999998876655555
Q ss_pred CCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhcccccc---------C-------
Q 002160 834 STAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRL---------E------- 895 (958)
Q Consensus 834 s~~GT~~Y~APEvl~g~~-~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~---------~------- 895 (958)
..+-|.+|.+|.++.|.+ |+...|+||.|||+.|+.. |++-|.+.+-...+..+-.....+ .
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 566899999999999866 7889999999999999987 666677776554444332111110 0
Q ss_pred --CCC---------CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 896 --IPK---------ELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 896 --ip~---------~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+|. .++..-++|+.++|..+|.+|.++++.+++
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 111 122345899999999999999999987764
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=298.72 Aligned_cols=253 Identities=23% Similarity=0.317 Sum_probs=202.1
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecC-CCCHHHH----HHHHHHHHHHHHcCCCceeEEeccccC-CCc
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQ-DFSGAAL----LEFKREVKIMRRLRHPNVVLFMGAVTR-PPN 747 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~-~~~~~~~----~~f~~Ei~ILk~L~HPNIVkL~g~~~~-~~~ 747 (958)
++|-++.+||+|||+.||++.+ ..+.||||+-... ++.++.. +-.-+|.+|.+.|+||-||++|++|.- .+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 5788889999999999999965 6778999964332 2222222 235689999999999999999999964 456
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEc---CCCcEEEEecccccc
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVD---KNWNVKVSDFGLSRL 824 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId---~~g~VKL~DFGLAk~ 824 (958)
++-|+|||+|.+|..+|+++....+.+.+-.+.+++.||.||.+..++|||-||||.|||+- .-|.+||+||||++.
T Consensus 543 FCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI 622 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI 622 (775)
T ss_pred ceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence 88999999999999999988877777777777788999999999999999999999999995 358899999999998
Q ss_pred ccCCcc-------cCCCCCCCCCccCccccc-C---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhH-HHHhh-hccc
Q 002160 825 KHNTFL-------SSKSTAGTPEWMAPEVLR-N---EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAV-GFQN 891 (958)
Q Consensus 825 ~~~~~~-------~~~s~~GT~~Y~APEvl~-g---~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~e-i~~~i-~~~~ 891 (958)
+.+..+ ....++||.+|++||.+. + .+.+.|+||||+|||+|.++.|+.||......+ ++... ..+.
T Consensus 623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkA 702 (775)
T KOG1151|consen 623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKA 702 (775)
T ss_pred ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcc
Confidence 754322 234567999999999875 3 235889999999999999999999997654332 22221 2233
Q ss_pred cccCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 892 RRLEIP--KELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 892 ~~~~ip--~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
....|| ..++.++++||++||...-+.|.+..++..+
T Consensus 703 tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 703 TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 344554 3589999999999999999999998887653
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=308.67 Aligned_cols=254 Identities=29% Similarity=0.494 Sum_probs=214.9
Q ss_pred CeeEEEEeeccCceEEEEEEE--C----CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEE
Q 002160 677 DLVLGERIGLGSYGEVYHADW--N----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~----g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~L 750 (958)
+++..++||.|+||+||+|.| . +.+||||++.... ......++..|+-+|.+|+|||+++|++++.... +.|
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 345578899999999999988 3 3468999876543 3445678999999999999999999999998765 889
Q ss_pred EEeecCCCCHHHHHhCCCCCccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc
Q 002160 751 ITEFLPRGSLFRILHRPHCQVDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 751 VmEy~~gGsL~d~L~k~~~~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~ 829 (958)
|++|+++|.|.++++.++..+..+..+ +..|+++||.|||.+. +|||||-..||||..-.++||+|||+++.+....
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 999999999999998776665555444 4455599999999988 9999999999999999999999999999876543
Q ss_pred ccCC--CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHH
Q 002160 830 LSSK--STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 906 (958)
Q Consensus 830 ~~~~--s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~d 906 (958)
.... ...--+.|||-|.+....|+.++|||||||++||||| |..|+.+....++...+. ...++..|..++.++..
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle-~geRLsqPpiCtiDVy~ 931 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE-KGERLSQPPICTIDVYM 931 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh-ccccCCCCCCccHHHHH
Confidence 3222 2223458999999999999999999999999999887 999999998888777665 55668889999999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 907 IIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 907 LI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
++.+||..|+..||.|+++...+.++.+.
T Consensus 932 ~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 932 VMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred HHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 99999999999999999999999887543
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=287.20 Aligned_cols=251 Identities=26% Similarity=0.353 Sum_probs=189.0
Q ss_pred CCeeEEEEeeccCceEEEEEEE----C--CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC-CCce
Q 002160 676 EDLVLGERIGLGSYGEVYHADW----N--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-PPNL 748 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~----~--g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~-~~~l 748 (958)
..|++.+.||+|.||.||+|.. . .+.+|||+|..+....-......+|+.+++.|+|||||.|..+|.. +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 5688999999999999999943 1 3369999998763222222356789999999999999999999977 7789
Q ss_pred EEEEeecCCCCHHHHHhCC-----CCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCC----CcEEEEec
Q 002160 749 SIITEFLPRGSLFRILHRP-----HCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKN----WNVKVSDF 819 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~-----~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~----g~VKL~DF 819 (958)
++++||.+. +|+.+++-. ........+-.+++++.|+.|||++. |+||||||.||||..+ |.|||+||
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeecc
Confidence 999999964 888877421 12233334455666699999999999 9999999999999766 99999999
Q ss_pred cccccccCCc---ccCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChh-------HH--HHh
Q 002160 820 GLSRLKHNTF---LSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPM-------QV--VGA 886 (958)
Q Consensus 820 GLAk~~~~~~---~~~~s~~GT~~Y~APEvl~g~~-~s~ksDIWSLGiLLyELLtG~~PF~g~~~~-------ei--~~~ 886 (958)
|+++.+.+.. ......+-|.+|.|||.+.|.+ |+++.|||++|||+.||++-.+-|.+.... +. +..
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 9999887653 2344566799999999999855 799999999999999999988888663211 10 111
Q ss_pred hhcc-----cccc----CCC--------------------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002160 887 VGFQ-----NRRL----EIP--------------------------KELDPLVARIIWECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 887 i~~~-----~~~~----~ip--------------------------~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L 929 (958)
|... ..++ .+| +.-++...+|+.++|+.||.+|.++++.+++.
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 1000 0000 001 11244578999999999999999999987764
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=280.65 Aligned_cols=253 Identities=23% Similarity=0.272 Sum_probs=195.0
Q ss_pred CCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC------
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------ 745 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~------ 745 (958)
....|+-..+||+|.||+||+|+. +++.||+|++.-+...+..-....+|+++|..|+|+|++.+++.|...
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 345677778899999999999965 678899987655433333334567899999999999999999987432
Q ss_pred --CceEEEEeecCCCCHHHHHhCCC-CCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccc
Q 002160 746 --PNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 822 (958)
Q Consensus 746 --~~l~LVmEy~~gGsL~d~L~k~~-~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLA 822 (958)
..+|+||.+|+ .+|+.+|.... .+.....+-++.....||.|+|... |+|||+||+|+||+.+|.+||+|||++
T Consensus 95 ~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 95 DRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCCceEEeeccccc
Confidence 23899999995 48888887653 3444455555666689999999998 999999999999999999999999999
Q ss_pred ccccCCc----ccCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc-----
Q 002160 823 RLKHNTF----LSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR----- 892 (958)
Q Consensus 823 k~~~~~~----~~~~s~~GT~~Y~APEvl~g~~-~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~----- 892 (958)
+.+.... ...+..+-|.+|.+||.+.|.+ |+++.|||+.|||+.||+++.+-|.+....+.+..|.....
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 7653221 1123345699999999998754 89999999999999999999999999887766655421000
Q ss_pred c---------------cCCC-------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002160 893 R---------------LEIP-------------KELDPLVARIIWECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 893 ~---------------~~ip-------------~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L 929 (958)
. ..+| ..-+++..+|+.++|..||.+|+++.+.+.|-
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 0 0011 12245788999999999999999999988763
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=300.17 Aligned_cols=247 Identities=19% Similarity=0.206 Sum_probs=165.0
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--C----CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEecc-----
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--N----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA----- 741 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~----g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~----- 741 (958)
+..++|++.+.||+|+||.||+|++ + +..||||++......+ .+..| .+....+.+++.++..
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e----~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE----IWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH----HHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 4567899999999999999999987 4 6789999875432111 11111 1122222233322222
Q ss_pred -ccCCCceEEEEeecCCCCHHHHHhCCCCCcc-------------------H-HHHHHHHHHHHHHHHHHhcCCcEeecC
Q 002160 742 -VTRPPNLSIITEFLPRGSLFRILHRPHCQVD-------------------E-KRRIKMALDARGMNCLHTSTPTIVHRD 800 (958)
Q Consensus 742 -~~~~~~l~LVmEy~~gGsL~d~L~k~~~~~~-------------------e-~~~l~ia~~a~aL~yLH~~g~gIIHRD 800 (958)
......++|||||+.+++|.+++........ . .....+.+++.||.|||.++ |||||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRD 280 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRD 280 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCc
Confidence 2455679999999999999999875432111 1 11223444589999999988 99999
Q ss_pred CCCCceEEcC-CCcEEEEeccccccccCC-cccCCCCCCCCCccCcccccCC----------------------CCCchh
Q 002160 801 LKSPNLLVDK-NWNVKVSDFGLSRLKHNT-FLSSKSTAGTPEWMAPEVLRNE----------------------PSNEKC 856 (958)
Q Consensus 801 LKPeNILId~-~g~VKL~DFGLAk~~~~~-~~~~~s~~GT~~Y~APEvl~g~----------------------~~s~ks 856 (958)
|||+|||++. ++.+||+|||+++..... ......+.+|+.|+|||.+... .+..++
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 9999999985 689999999999865322 2233457899999999976422 234567
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccc-------------ccc------CCCCCCcHHHHHHHHHhhhcCCC
Q 002160 857 DVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-------------RRL------EIPKELDPLVARIIWECWQTDPS 917 (958)
Q Consensus 857 DIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~-------------~~~------~ip~~ls~eL~dLI~~CL~kDP~ 917 (958)
|||||||+||||+++..++.... .+....+.... ... .+.........+||.+||++||.
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 99999999999999877654321 11111110000 000 00111233456899999999999
Q ss_pred CCCCHHHHHHH
Q 002160 918 LRPSFAQLTVA 928 (958)
Q Consensus 918 kRPSa~EIL~~ 928 (958)
+||++.++++|
T Consensus 440 kR~ta~e~L~H 450 (566)
T PLN03225 440 QRISAKAALAH 450 (566)
T ss_pred cCCCHHHHhCC
Confidence 99999999986
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=286.39 Aligned_cols=255 Identities=19% Similarity=0.197 Sum_probs=177.3
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE------------------CCcEEEEEEeecCCCCH--H----------HHHHHH
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW------------------NGTEVAVKKFLDQDFSG--A----------ALLEFK 721 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~------------------~g~~VAVK~i~~~~~~~--~----------~~~~f~ 721 (958)
.+..++|++.++||+|+||.||+|.+ .++.||||++....... . ......
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 35678999999999999999999953 34679999986432110 0 011234
Q ss_pred HHHHHHHHcCCCce-----eEEeccccC--------CCceEEEEeecCCCCHHHHHhCCCCC------------------
Q 002160 722 REVKIMRRLRHPNV-----VLFMGAVTR--------PPNLSIITEFLPRGSLFRILHRPHCQ------------------ 770 (958)
Q Consensus 722 ~Ei~ILk~L~HPNI-----VkL~g~~~~--------~~~l~LVmEy~~gGsL~d~L~k~~~~------------------ 770 (958)
.|+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++++.....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 57778888876654 677777643 35689999999999999998743211
Q ss_pred -----ccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc-cCCCCCCCCCccC
Q 002160 771 -----VDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL-SSKSTAGTPEWMA 843 (958)
Q Consensus 771 -----~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~-~~~s~~GT~~Y~A 843 (958)
..+.... .+.+.+.+|.|||..+ |+||||||+|||++.++.+||+|||+++....... ......+|+.|+|
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 1112222 3334488999999988 99999999999999999999999999976533211 1112335889999
Q ss_pred cccccCCCC----------------------CchhhHHHHHHHHHHHHhCCC-CCCCCChhH---------HHHhhhccc
Q 002160 844 PEVLRNEPS----------------------NEKCDVYSFGVILWELATLKL-PWIGMNPMQ---------VVGAVGFQN 891 (958)
Q Consensus 844 PEvl~g~~~----------------------s~ksDIWSLGiLLyELLtG~~-PF~g~~~~e---------i~~~i~~~~ 891 (958)
||++..... ..+.||||+||++|+|++|.. ||.+..... .........
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 999864321 134799999999999999986 775422110 000111111
Q ss_pred cccCC--CCCCcHHHHHHHHHhhhcCC---CCCCCHHHHHHH
Q 002160 892 RRLEI--PKELDPLVARIIWECWQTDP---SLRPSFAQLTVA 928 (958)
Q Consensus 892 ~~~~i--p~~ls~eL~dLI~~CL~kDP---~kRPSa~EIL~~ 928 (958)
....+ ....+...++||.+||.++| .+|+|++|+++|
T Consensus 459 ~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 459 QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 22222 34578899999999999876 689999999876
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-28 Score=239.00 Aligned_cols=210 Identities=38% Similarity=0.618 Sum_probs=178.5
Q ss_pred eeccCceEEEEEEEC--CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeecCCCCHH
Q 002160 684 IGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF 761 (958)
Q Consensus 684 LG~G~fG~Vykak~~--g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~gGsL~ 761 (958)
||+|.+|.||+++.. ++.++||++....... ....+.+|+++++.+.|++|+++++++......+++|||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999986 8999999987654322 3467899999999999999999999999989999999999999999
Q ss_pred HHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcC-CCcEEEEeccccccccCCcccCCCCCCCC
Q 002160 762 RILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRLKHNTFLSSKSTAGTP 839 (958)
Q Consensus 762 d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~-~g~VKL~DFGLAk~~~~~~~~~~s~~GT~ 839 (958)
+++..............++ ..+.++.+||..+ ++|+||+|.||+++. ++.++|+|||.+..............+..
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP 157 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCC
Confidence 9987653334444444444 4489999999997 999999999999999 89999999999987654322233456788
Q ss_pred CccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCC
Q 002160 840 EWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSL 918 (958)
Q Consensus 840 ~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~k 918 (958)
.|++||.+... ..+.+.|+|+||+++++| ..+.+++.+||+.+|.+
T Consensus 158 ~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p~~ 204 (215)
T cd00180 158 AYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDPEK 204 (215)
T ss_pred CccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCccc
Confidence 99999999887 788999999999999999 78899999999999999
Q ss_pred CCCHHHHHHHH
Q 002160 919 RPSFAQLTVAL 929 (958)
Q Consensus 919 RPSa~EIL~~L 929 (958)
||++.+++++|
T Consensus 205 R~~~~~l~~~~ 215 (215)
T cd00180 205 RPSAKEILEHL 215 (215)
T ss_pred CcCHHHHhhCC
Confidence 99999998764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=275.92 Aligned_cols=247 Identities=23% Similarity=0.294 Sum_probs=191.2
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC-C-Cc----eeEEeccccC
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-H-PN----VVLFMGAVTR 744 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~-H-PN----IVkL~g~~~~ 744 (958)
+..++|++.+.+|+|.||.|..+.. ++..||||+++.-. .-....+-|+++|++|. + |+ +|++.+||..
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 3457899999999999999999965 57789999875421 22345567999999993 2 33 8999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhCCCC--CccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcC------------
Q 002160 745 PPNLSIITEFLPRGSLFRILHRPHC--QVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDK------------ 810 (958)
Q Consensus 745 ~~~l~LVmEy~~gGsL~d~L~k~~~--~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~------------ 810 (958)
.++.+||+|.+ |-+++++|..+.. +.....+.+-.|++.++++||..+ ++|.||||+|||+-.
T Consensus 163 rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 163 RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEEeccCCc
Confidence 99999999988 7799999987553 333444555555699999999998 999999999999932
Q ss_pred --------CCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhH
Q 002160 811 --------NWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ 882 (958)
Q Consensus 811 --------~g~VKL~DFGLAk~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~e 882 (958)
+..|||+|||.|...+.. ....+.|..|.|||++.|-.|+.++||||+||||+||.+|..-|++-++.+
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~---hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEH---HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccC---cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 245999999999865443 245778999999999999999999999999999999999999998876444
Q ss_pred ---HHHhhh----------------ccccccCCCC----------------------CC---cHHHHHHHHHhhhcCCCC
Q 002160 883 ---VVGAVG----------------FQNRRLEIPK----------------------EL---DPLVARIIWECWQTDPSL 918 (958)
Q Consensus 883 ---i~~~i~----------------~~~~~~~ip~----------------------~l---s~eL~dLI~~CL~kDP~k 918 (958)
+.+.+. +...+++.+. .. -.++.|||++||..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 222111 0000111111 00 125889999999999999
Q ss_pred CCCHHHHHHH
Q 002160 919 RPSFAQLTVA 928 (958)
Q Consensus 919 RPSa~EIL~~ 928 (958)
|+++.|++.|
T Consensus 397 RiTl~EAL~H 406 (415)
T KOG0671|consen 397 RITLREALSH 406 (415)
T ss_pred cccHHHHhcC
Confidence 9999999876
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=267.51 Aligned_cols=265 Identities=26% Similarity=0.417 Sum_probs=215.7
Q ss_pred CccccccCCCCeeEEEEeeccCceEEEEEEECC-------cEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEe
Q 002160 667 DVCECEIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739 (958)
Q Consensus 667 ~~~~~eI~~~dy~i~k~LG~G~fG~Vykak~~g-------~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~ 739 (958)
...+..+...+++....+-+|.||+||.|.|.. +.|.+|.++. ...+-....+..|..+|..+.|||+..+.
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~-~AS~iQv~~~L~es~lly~~sH~nll~V~ 353 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ-HASQIQVNLLLQESMLLYGASHPNLLSVL 353 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh-cccHHHHHHHHHHHHHHhcCcCCCcccee
Confidence 344556666778888899999999999997743 3466665543 33455566788999999999999999999
Q ss_pred ccccC-CCceEEEEeecCCCCHHHHHhC-----CCC--CccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcC
Q 002160 740 GAVTR-PPNLSIITEFLPRGSLFRILHR-----PHC--QVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDK 810 (958)
Q Consensus 740 g~~~~-~~~l~LVmEy~~gGsL~d~L~k-----~~~--~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~ 810 (958)
+++.+ ....+.++.++.-|+|..+|.. ... .....+...++.+ +.|++|||.++ |||.||-..|++||+
T Consensus 354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVIDD 431 (563)
T ss_pred EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceehh
Confidence 98754 4567888999999999999972 211 1222333344444 89999999999 999999999999999
Q ss_pred CCcEEEEeccccccccCCcccCC--CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhh
Q 002160 811 NWNVKVSDFGLSRLKHNTFLSSK--STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAV 887 (958)
Q Consensus 811 ~g~VKL~DFGLAk~~~~~~~~~~--s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i 887 (958)
..+|||+|=.+++.+-...+.+- ..-....||+||.+.+..|+.++|+||||++||||++ |+.||..-++.++...+
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl 511 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL 511 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH
Confidence 99999999999987654433321 1123458999999999999999999999999999998 99999999999988877
Q ss_pred hccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 888 GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 888 ~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
. .+.++..|.++|.++..++.-||..+|++||+++|+...|.+++.+
T Consensus 512 k-dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 512 K-DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred h-ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 5 6788899999999999999999999999999999999999998754
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=257.80 Aligned_cols=242 Identities=21% Similarity=0.341 Sum_probs=193.2
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeccccCCCc--eEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPN--LSI 750 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~-HPNIVkL~g~~~~~~~--l~L 750 (958)
++|++.+++|+|.|++||.|.. ++++++||.++. ...+++.+|+.||+.|. |||||++++...++.. ..|
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 6799999999999999999974 888999998653 34568899999999996 9999999999987654 779
Q ss_pred EEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcC-CCcEEEEeccccccccCCc
Q 002160 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 751 VmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~-~g~VKL~DFGLAk~~~~~~ 829 (958)
|+||+++.+...+... ......+.++.+++.||.|+|+.| |+|||+||.|++||. ...++|+|||+|...+...
T Consensus 113 iFE~v~n~Dfk~ly~t---l~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYPT---LTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred HhhhhccccHHHHhhh---hchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 9999998777665543 345677888888899999999998 999999999999994 5679999999999887664
Q ss_pred ccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCC-CChh-HHH------------Hhhh-c----
Q 002160 830 LSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIG-MNPM-QVV------------GAVG-F---- 889 (958)
Q Consensus 830 ~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g-~~~~-ei~------------~~i~-~---- 889 (958)
. .+..+.+..|..||.+... .|++..|+|||||+|..|++.+-||.. .++. +++ ..+. +
T Consensus 188 e-YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L 266 (338)
T KOG0668|consen 188 E-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL 266 (338)
T ss_pred e-eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence 3 3345678899999999864 479999999999999999999999853 3222 221 0000 0
Q ss_pred ---------ccc--cc------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 890 ---------QNR--RL------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 890 ---------~~~--~~------~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
... ++ ......++++.||+.++|+.|-.+|++++|.+.|
T Consensus 267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 000 00 0011246899999999999999999999998765
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=254.17 Aligned_cols=222 Identities=29% Similarity=0.461 Sum_probs=177.6
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCc
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~ 747 (958)
.++.-+++..+..||+|+||.|-+.++ +|+..|+|.+.... ..+..+++.+|+++..+. .+|++|+|||.......
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 566667788889999999999988876 89999999987654 345567888999988776 79999999999999999
Q ss_pred eEEEEeecCCCCHHHHHh---CCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccc
Q 002160 748 LSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 823 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~---k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk 823 (958)
.+|.||.|+ -+|..+.. +.+....+...-.++.. +.||.|||++ ..|||||+||.||||+.+|+||+||||++-
T Consensus 120 vwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 120 VWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEEccCCcEEEcccccce
Confidence 999999995 46765543 34555666666666665 8999999985 249999999999999999999999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccC----CCCCchhhHHHHHHHHHHHHhCCCCCCCC-ChhHHHHhhhccccccCCC
Q 002160 824 LKHNTFLSSKSTAGTPEWMAPEVLRN----EPSNEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIP 897 (958)
Q Consensus 824 ~~~~~~~~~~s~~GT~~Y~APEvl~g----~~~s~ksDIWSLGiLLyELLtG~~PF~g~-~~~ei~~~i~~~~~~~~ip 897 (958)
.+.+... .+...|...|||||.+.. ..|+-++||||||++++||.++++||..+ .+.+.+..+. ....+.+|
T Consensus 198 ~L~dSiA-kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvV-eep~P~Lp 274 (282)
T KOG0984|consen 198 YLVDSIA-KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVV-EEPSPQLP 274 (282)
T ss_pred eehhhhH-HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHh-cCCCCCCc
Confidence 8766543 223568899999999853 35788999999999999999999999865 4555555543 34444444
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-29 Score=281.99 Aligned_cols=200 Identities=26% Similarity=0.390 Sum_probs=173.1
Q ss_pred CCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHH------HHHHHHHHHHHHHHcC---CCceeEEeccc
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA------ALLEFKREVKIMRRLR---HPNVVLFMGAV 742 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~------~~~~f~~Ei~ILk~L~---HPNIVkL~g~~ 742 (958)
++.+|..++.||.|+||.|++|.+ +...|+||.+.+.++=.. .+-.+-.|++||..|+ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 346799999999999999999977 566799998877654221 2234667999999997 99999999999
Q ss_pred cCCCceEEEEeec-CCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccc
Q 002160 743 TRPPNLSIITEFL-PRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 821 (958)
Q Consensus 743 ~~~~~l~LVmEy~-~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGL 821 (958)
++++++||+||-. +|.+|++++.......+.+.++.+.|.+.|+++||..+ |||||||-+|++++.+|.+||+|||.
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecCCeEEEeeccc
Confidence 9999999999975 46699999998887778888888888899999999998 99999999999999999999999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCC
Q 002160 822 SRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIG 877 (958)
Q Consensus 822 Ak~~~~~~~~~~s~~GT~~Y~APEvl~g~~~-s~ksDIWSLGiLLyELLtG~~PF~g 877 (958)
+...... ....+.||..|.|||++.|.+| ++.-|||+||++||.++....||++
T Consensus 717 aa~~ksg--pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAYTKSG--PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhhcCC--CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 8765443 2356899999999999999887 7788999999999999999999874
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-29 Score=293.23 Aligned_cols=238 Identities=29% Similarity=0.425 Sum_probs=184.2
Q ss_pred EEEeeccCceE-EEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCceEEEEeecCCC
Q 002160 681 GERIGLGSYGE-VYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRG 758 (958)
Q Consensus 681 ~k~LG~G~fG~-Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~l~LVmEy~~gG 758 (958)
.+.+|.|+-|+ ||+|.+.++.||||.+... ...-..+|+++|+.- +|||||++|+.-.+...+||..|.|. .
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~ 587 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYEGREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-C 587 (903)
T ss_pred HHHcccCCCCcEEEEEeeCCceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-h
Confidence 45689999885 8999999999999986543 233567999999998 69999999999999999999999995 5
Q ss_pred CHHHHHhCCCCCc----cHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcC---C--CcEEEEeccccccccCCc
Q 002160 759 SLFRILHRPHCQV----DEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDK---N--WNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 759 sL~d~L~k~~~~~----~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~---~--g~VKL~DFGLAk~~~~~~ 829 (958)
+|.+++....... ....+....+.+.||+|||..+ ||||||||.||||+. + ..++|.|||+++.+....
T Consensus 588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 9999998741111 1222334444589999999988 999999999999975 2 569999999999875432
Q ss_pred ---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChhHHHHhhhcccccc-CCCCCCcHHH
Q 002160 830 ---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRL-EIPKELDPLV 904 (958)
Q Consensus 830 ---~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG-~~PF~g~~~~ei~~~i~~~~~~~-~ip~~ls~eL 904 (958)
.......||-+|+|||++....-..++|||||||++|+.++| ..||......+. .|...+..+ .+....+-++
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L~~~~d~eA 743 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHLEPLPDCEA 743 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeeeccCchHHH
Confidence 223456799999999999998888999999999999998886 889976544332 221121111 1111222289
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 905 ARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 905 ~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
++||.+||+.+|..||++.+++.|
T Consensus 744 ~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 744 KDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred HHHHHHhcCCCcccCCCHHHHhCC
Confidence 999999999999999999999754
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-29 Score=279.97 Aligned_cols=250 Identities=20% Similarity=0.228 Sum_probs=198.0
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC------CCceeEEeccc
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR------HPNVVLFMGAV 742 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~------HPNIVkL~g~~ 742 (958)
.++.-.+|.+....|+|-|++|..|.. .+..||||+|..... ..+.=+.|++||++|+ --|+|+|+..|
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~---M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F 503 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV---MHKTGLKELEILKKLNDADPEDKFHCLRLFRHF 503 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH---HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence 345557899999999999999999976 577999999987643 2344568999999995 24799999999
Q ss_pred cCCCceEEEEeecCCCCHHHHHhCCCC---CccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcC-CCcEEEEe
Q 002160 743 TRPPNLSIITEFLPRGSLFRILHRPHC---QVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSD 818 (958)
Q Consensus 743 ~~~~~l~LVmEy~~gGsL~d~L~k~~~---~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~-~g~VKL~D 818 (958)
.+.+++|||+|-+ .-+|.++|.+.+. .-....+.|..++..||.+|..++ |+|.||||+||||++ ...+||||
T Consensus 504 ~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKLCD 580 (752)
T KOG0670|consen 504 KHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKLCD 580 (752)
T ss_pred hhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeeecc
Confidence 9999999999988 5689999987554 233456666667789999999999 999999999999996 46799999
Q ss_pred ccccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcc--------
Q 002160 819 FGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-------- 890 (958)
Q Consensus 819 FGLAk~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~-------- 890 (958)
||.|........ +.+..+..|.|||++.|.+|++..|+||+||+||||.||+.-|.|..+.+++......
T Consensus 581 fGSA~~~~enei--tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km 658 (752)
T KOG0670|consen 581 FGSASFASENEI--TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM 658 (752)
T ss_pred Cccccccccccc--cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH
Confidence 999987655433 3455678999999999999999999999999999999999999987766554221100
Q ss_pred -------cccc-------------------------CCC-----------CCCc-------HHHHHHHHHhhhcCCCCCC
Q 002160 891 -------NRRL-------------------------EIP-----------KELD-------PLVARIIWECWQTDPSLRP 920 (958)
Q Consensus 891 -------~~~~-------------------------~ip-----------~~ls-------~eL~dLI~~CL~kDP~kRP 920 (958)
.... ..| ..++ ..|++|+.+||..||.+|.
T Consensus 659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi 738 (752)
T KOG0670|consen 659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI 738 (752)
T ss_pred hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence 0000 001 0011 2588999999999999999
Q ss_pred CHHHHHHH
Q 002160 921 SFAQLTVA 928 (958)
Q Consensus 921 Sa~EIL~~ 928 (958)
+..+.|+|
T Consensus 739 t~nqAL~H 746 (752)
T KOG0670|consen 739 TVNQALKH 746 (752)
T ss_pred CHHHHhcC
Confidence 99998876
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-29 Score=266.48 Aligned_cols=245 Identities=26% Similarity=0.384 Sum_probs=196.5
Q ss_pred EEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC-----ceEEEEee
Q 002160 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP-----NLSIITEF 754 (958)
Q Consensus 682 k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~-----~l~LVmEy 754 (958)
+.||-|+||.||-+++ +|+.||+|++..-...-...+.+.+|+++|.-++|.|++..++..+-.. .+|+++|+
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 5699999999999976 7999999998654433345678899999999999999999888765432 37889999
Q ss_pred cCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc-ccCC
Q 002160 755 LPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-LSSK 833 (958)
Q Consensus 755 ~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~-~~~~ 833 (958)
| ..+|.+++-..........+.+..+++.||.|||..+ |+||||||.|+|++.+..+||||||+++...... ...+
T Consensus 139 m-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMT 215 (449)
T KOG0664|consen 139 M-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMT 215 (449)
T ss_pred H-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEecccccccccchhhhhhhH
Confidence 9 4589998887777777788888888899999999998 9999999999999999999999999998754322 2233
Q ss_pred CCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccc---------------------
Q 002160 834 STAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN--------------------- 891 (958)
Q Consensus 834 s~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~--------------------- 891 (958)
..+-|.+|.|||++.|. .|+.+.||||.|||+.||+-.+.-|...++.+.++.|....
T Consensus 216 qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR 295 (449)
T KOG0664|consen 216 HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLR 295 (449)
T ss_pred HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhc
Confidence 34568899999999985 48999999999999999999999999888776554432100
Q ss_pred ---cccCCC--------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002160 892 ---RRLEIP--------KELDPLVARIIWECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 892 ---~~~~ip--------~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L 929 (958)
..+.++ .....+..+++.++|..||++|.+.++.+.++
T Consensus 296 ~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 296 AGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred cCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 011111 12345678899999999999999999888765
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-29 Score=284.38 Aligned_cols=251 Identities=31% Similarity=0.498 Sum_probs=209.8
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEE
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~L 750 (958)
-+.++|+++.++|.|.||.||++++ .++..|||.++.... ....-+..|+-+++..+|||||-+++.+...+++||
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 3457899999999999999999976 788999998876532 234556789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc
Q 002160 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 751 VmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~ 829 (958)
+||||.||+|.+..+-.+ .+.+.+..+.... ..+|+|||..+ =+|||||-.|||+++.|.+||+|||.+..+....
T Consensus 90 cMEycgggslQdiy~~Tg-plselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred EEEecCCCcccceeeecc-cchhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccCchhhhhhhh
Confidence 999999999999887654 3445555555544 89999999998 7999999999999999999999999998887777
Q ss_pred ccCCCCCCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhh---ccccccCCCCCCcHH
Q 002160 830 LSSKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG---FQNRRLEIPKELDPL 903 (958)
Q Consensus 830 ~~~~s~~GT~~Y~APEvl~---g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~---~~~~~~~ip~~ls~e 903 (958)
.....+.||++|||||+-. ...|...+|||++|++..||-.-+.|.+..-+++.....- ++-....-+..-++.
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~ 246 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEF 246 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHH
Confidence 7788899999999999863 4558899999999999999999999988887777655442 222223334456788
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 904 VARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 904 L~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+-+|++.||.++|.+||+++.++.|
T Consensus 247 fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheec
Confidence 9999999999999999999877653
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.2e-28 Score=258.92 Aligned_cols=246 Identities=24% Similarity=0.292 Sum_probs=192.9
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC------c
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------N 747 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~------~ 747 (958)
.+|.-++.+|.|.- .|..+.+ .+++||||++...........+..+|..++..++|+|||+++.+|.-.. .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 57888899999998 6666643 7999999998776545555667889999999999999999999986543 4
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
+|+|||||. ++|...+.. ....+..+....+...|+.|||+.+ |+||||||+||++..++.+||.|||+++....
T Consensus 96 ~y~v~e~m~-~nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~ 170 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVILM--ELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSDCTLKILDFGLARTEDT 170 (369)
T ss_pred HHHHHHhhh-hHHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecchhheeeccchhhcccCc
Confidence 899999995 588877662 1233444455555599999999998 99999999999999999999999999987655
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc---------------
Q 002160 828 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--------------- 892 (958)
Q Consensus 828 ~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~--------------- 892 (958)
. ...+.+..|..|.|||++.|..+.+.+||||+||++.||++|..-|.|.+......++....+
T Consensus 171 ~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r 249 (369)
T KOG0665|consen 171 D-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR 249 (369)
T ss_pred c-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence 4 345667889999999999998899999999999999999999999988655433322211000
Q ss_pred -----c-----cC----CCC-----------CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 893 -----R-----LE----IPK-----------ELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 893 -----~-----~~----ip~-----------~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+ .. +|. .-...+++|+.+||-.||++|.+++++++|
T Consensus 250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0 00 111 112357999999999999999999999887
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-26 Score=233.99 Aligned_cols=208 Identities=34% Similarity=0.545 Sum_probs=170.4
Q ss_pred eeEEEEeeccCceEEEEEEEC--CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeec
Q 002160 678 LVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~~--g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~ 755 (958)
|.+.+.||.|++|.||++... ++.++||.+...... .....+.+|++.+++++|+||+++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 567889999999999999874 689999998765433 24668889999999999999999999999889999999999
Q ss_pred CCCCHHHHHhCCCCCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc-ccCC
Q 002160 756 PRGSLFRILHRPHCQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-LSSK 833 (958)
Q Consensus 756 ~gGsL~d~L~k~~~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~-~~~~ 833 (958)
++++|.+++........+..... +.+.+.++.+||.++ ++|+||+|.||+++.++.++|+|||++....... ....
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 99999999876544234444444 344489999999997 9999999999999999999999999988765432 1223
Q ss_pred CCCCCCCccCcccc-cCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CChh-HHHHhhh
Q 002160 834 STAGTPEWMAPEVL-RNEPSNEKCDVYSFGVILWELATLKLPWIG-MNPM-QVVGAVG 888 (958)
Q Consensus 834 s~~GT~~Y~APEvl-~g~~~s~ksDIWSLGiLLyELLtG~~PF~g-~~~~-ei~~~i~ 888 (958)
...++..|++||++ ....++.++|+|+||+++|+|++|+.||.. .+.. ++.+.+.
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~ 215 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS 215 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence 45688899999999 667778899999999999999999999977 4444 4555553
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-23 Score=217.20 Aligned_cols=248 Identities=28% Similarity=0.392 Sum_probs=198.1
Q ss_pred eeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHH-HHHHHHHHHHHHHHcCCC-ceeEEeccccCCCceEEEEeec
Q 002160 678 LVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGA-ALLEFKREVKIMRRLRHP-NVVLFMGAVTRPPNLSIITEFL 755 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~-~~~~f~~Ei~ILk~L~HP-NIVkL~g~~~~~~~l~LVmEy~ 755 (958)
|.+.+.||.|+||.||++.+. ..+++|.+........ ....+.+|+.++..+.|+ +|+++++++......++++||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 778899999999999999888 8899998877654443 567899999999999887 7999999997777789999999
Q ss_pred CCCCHHHHHhCCC---CCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCC-cEEEEeccccccccCCcc-
Q 002160 756 PRGSLFRILHRPH---CQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRLKHNTFL- 830 (958)
Q Consensus 756 ~gGsL~d~L~k~~---~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g-~VKL~DFGLAk~~~~~~~- 830 (958)
.+++|.+++.... .........++.+.+.++.|+|..+ ++||||||+|||++..+ .++++|||+++.......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999998777654 3444445555555588899999998 99999999999999988 799999999986543321
Q ss_pred -----cCCCCCCCCCccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh----hHHHHhhhccccc-c--C
Q 002160 831 -----SSKSTAGTPEWMAPEVLRN---EPSNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQNRR-L--E 895 (958)
Q Consensus 831 -----~~~s~~GT~~Y~APEvl~g---~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~----~ei~~~i~~~~~~-~--~ 895 (958)
......||..|++||.+.+ ..+....|+|++|++++++++|..||..... .+....+...... . .
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 2356789999999999988 5788999999999999999999999877663 3444433322211 1 1
Q ss_pred CCCCC----cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 896 IPKEL----DPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 896 ip~~l----s~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
..... ...+.+++..|+..+|..|.+..+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11111 2578999999999999999998887775
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=234.10 Aligned_cols=251 Identities=17% Similarity=0.254 Sum_probs=210.3
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~l~LVm 752 (958)
-.|+|+++||+|.||.+|.|+. +++.||||.-...... -+++.|.+..+.| ..++|.+.|.+...+.+-.|||
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCCc----chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 4799999999999999999975 8999999965443322 3677889999988 4699999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCC-----CcEEEEecccccccc
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKN-----WNVKVSDFGLSRLKH 826 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~-----g~VKL~DFGLAk~~~ 826 (958)
|++ |-+|.|++.-.+..+......+++.+ +.-++|+|.+. +|+|||||+|+||... ..|.|+|||+|+...
T Consensus 104 dLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred hhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 988 88999999888888888888877776 78899999999 9999999999999753 459999999999764
Q ss_pred C-------CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---hhHHHHhhhcccccc--
Q 002160 827 N-------TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN---PMQVVGAVGFQNRRL-- 894 (958)
Q Consensus 827 ~-------~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~---~~ei~~~i~~~~~~~-- 894 (958)
+ ++....+..||.+||+-....|...+.+.|+-+||-+++++|.|.+||.|.. ..+.+++|.......
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i 260 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPI 260 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCH
Confidence 3 2344567789999999999999999999999999999999999999999864 445566664332222
Q ss_pred -CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 002160 895 -EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 933 (958)
Q Consensus 895 -~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~ 933 (958)
.++..+|.++..-+.-.-+.+-.+-|+.+-+...+..+.
T Consensus 261 ~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvl 300 (449)
T KOG1165|consen 261 EVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVL 300 (449)
T ss_pred HHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 345788999999999999999999999988877776653
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-23 Score=235.33 Aligned_cols=130 Identities=20% Similarity=0.269 Sum_probs=100.5
Q ss_pred CCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC-----C---CceeEEecccc
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-----H---PNVVLFMGAVT 743 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~-----H---PNIVkL~g~~~ 743 (958)
.-.+|.+.++||-|.|++||+|.+ ..+.||+|+.+... .-.+....|+++|++++ | .+||+|++.|.
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 336899999999999999999965 68889999876532 23346678999999983 3 35999999996
Q ss_pred C----CCceEEEEeecCCCCHHHHHhCCCC--CccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEE
Q 002160 744 R----PPNLSIITEFLPRGSLFRILHRPHC--QVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLV 808 (958)
Q Consensus 744 ~----~~~l~LVmEy~~gGsL~d~L~k~~~--~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILI 808 (958)
. +.+++||+|++ |.+|..++.+... ......+-...+.+.||.|||..- +|||.||||+|||+
T Consensus 153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec-gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC-GIIHTDLKPENVLL 221 (590)
T ss_pred ecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc-CccccCCCcceeee
Confidence 5 45699999999 7888888865433 222333334444489999999743 59999999999999
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.1e-25 Score=270.05 Aligned_cols=194 Identities=21% Similarity=0.189 Sum_probs=136.5
Q ss_pred HcCC-CceeEEeccc-------cCCCceEEEEeecCCCCHHHHHhCCCCCccHHHHH-HHHHHHHHHHHHHhcCCcEeec
Q 002160 729 RLRH-PNVVLFMGAV-------TRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI-KMALDARGMNCLHTSTPTIVHR 799 (958)
Q Consensus 729 ~L~H-PNIVkL~g~~-------~~~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHR 799 (958)
.++| +||++++++| .....++++|||+ +++|+++|......+.+.... ++.+++.||.|||.++ ||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvHr 104 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVVH 104 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eeec
Confidence 4445 5788888877 3334678889987 669999997654444444444 4445599999999988 9999
Q ss_pred CCCCCceEEcCC-------------------CcEEEEeccccccccCCc----------------ccCCCCCCCCCccCc
Q 002160 800 DLKSPNLLVDKN-------------------WNVKVSDFGLSRLKHNTF----------------LSSKSTAGTPEWMAP 844 (958)
Q Consensus 800 DLKPeNILId~~-------------------g~VKL~DFGLAk~~~~~~----------------~~~~s~~GT~~Y~AP 844 (958)
||||+||||+.. +.+||+|||+++...... ......+||+.||||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 999999999654 445566666655321100 001124589999999
Q ss_pred ccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHH
Q 002160 845 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQ 924 (958)
Q Consensus 845 Evl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~E 924 (958)
|++.+..++.++|||||||+||||++|..||..... ....+......... ....+...+++.+||+++|.+||++.|
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~~L~~~P~~Rps~~e 261 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQI-LLNWPKEASFCLWLLHPEPSCRPSMSE 261 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhh-hhcCHHHHHHHHHhCCCChhhCcChHH
Confidence 999999999999999999999999999888754321 11112111111111 112456778999999999999999999
Q ss_pred HHHH
Q 002160 925 LTVA 928 (958)
Q Consensus 925 IL~~ 928 (958)
|+++
T Consensus 262 il~h 265 (793)
T PLN00181 262 LLQS 265 (793)
T ss_pred Hhhc
Confidence 9875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-24 Score=211.79 Aligned_cols=163 Identities=23% Similarity=0.281 Sum_probs=125.7
Q ss_pred CCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCC
Q 002160 758 GSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 836 (958)
Q Consensus 758 GsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~ 836 (958)
|+|.+++...+..+.+...+.++.+ +.||.|||.++ ||+|||++.++.+|+ ||+++..... ...
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeeccc-----cCC
Confidence 6899999875555666666655554 99999999986 999999999999999 9998765432 236
Q ss_pred CCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh-HHHHhhhcccccc-----CCCCCCcH--HHHHHH
Q 002160 837 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRL-----EIPKELDP--LVARII 908 (958)
Q Consensus 837 GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~-ei~~~i~~~~~~~-----~ip~~ls~--eL~dLI 908 (958)
||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+....... ..+..++. ++++||
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 899999999999999999999999999999999999999765432 2222221111111 11122333 699999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 909 WECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 909 ~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
.+||..+|.+||++.+++.++..+...
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHHHHH
Confidence 999999999999999999999877543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=239.85 Aligned_cols=246 Identities=23% Similarity=0.339 Sum_probs=189.6
Q ss_pred CCCCeeEEEEeeccCceEEEEEEE-----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCc
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~-----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~ 747 (958)
..+.|.++++||.|.|+.||++.. ..+.||+|.+..... ...+.+|+++|..+ .+.||+++.+++...++
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 346788999999999999999964 467899999876543 23678999999999 58999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEc-CCCcEEEEecccccccc
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId-~~g~VKL~DFGLAk~~~ 826 (958)
..+||||++.....+++.... ....++++.....||.++|..| ||||||||.|+|.+ ..+.-.|+|||+|....
T Consensus 110 v~ivlp~~~H~~f~~l~~~l~---~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRSLS---LAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred eEEEecccCccCHHHHHhcCC---HHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHHHHH
Confidence 999999999988888887543 4556677777789999999998 99999999999998 46889999999987210
Q ss_pred ---------------CC-------------------cc----------cCCCCCCCCCccCcccccCCC-CCchhhHHHH
Q 002160 827 ---------------NT-------------------FL----------SSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSF 861 (958)
Q Consensus 827 ---------------~~-------------------~~----------~~~s~~GT~~Y~APEvl~g~~-~s~ksDIWSL 861 (958)
.. .+ .....+||++|.|||++...+ .+.++||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 00 00 011245999999999997644 5889999999
Q ss_pred HHHHHHHHhCCCCCCCCChh-----HHH---------------Hh--hh--------------cccc-------------
Q 002160 862 GVILWELATLKLPWIGMNPM-----QVV---------------GA--VG--------------FQNR------------- 892 (958)
Q Consensus 862 GiLLyELLtG~~PF~g~~~~-----ei~---------------~~--i~--------------~~~~------------- 892 (958)
|+|+..++++++||...... ++. .. +. +...
T Consensus 265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~ 344 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT 344 (418)
T ss_pred cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence 99999999999999653211 110 00 00 0000
Q ss_pred -ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 893 -RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 893 -~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+......++..+.+|+.+||..||.+|.++++.|+|
T Consensus 345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred eeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 000012245578999999999999999999998876
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-24 Score=227.96 Aligned_cols=248 Identities=22% Similarity=0.325 Sum_probs=182.8
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEec-cccCCCceEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMG-AVTRPPNLSII 751 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g-~~~~~~~l~LV 751 (958)
+.|.|.+.||+|.||.+.++++ .++.+++|.+..... .+.+|.+|..---.| .|.|||.-|+ +|+..+.+.++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t---t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT---TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh---hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 4588999999999999999988 567899998876543 356788887655555 5899998776 47778888899
Q ss_pred EeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEc--CCCcEEEEeccccccccCCc
Q 002160 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVD--KNWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId--~~g~VKL~DFGLAk~~~~~~ 829 (958)
+||++.|+|..-+...+. .+...+....+.+.|+.|+|+.+ +||||||.+||||- +..+|||||||+.+......
T Consensus 101 qE~aP~gdL~snv~~~Gi-gE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV 177 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAAGI-GEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV 177 (378)
T ss_pred eccCccchhhhhcCcccc-cHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence 999999999988876443 33444555556699999999998 99999999999995 33579999999987654332
Q ss_pred ccCCCCCCCCCccCcccccCC---C--CCchhhHHHHHHHHHHHHhCCCCCCCCChh--HHHHhhhc-cccccCCCC---
Q 002160 830 LSSKSTAGTPEWMAPEVLRNE---P--SNEKCDVYSFGVILWELATLKLPWIGMNPM--QVVGAVGF-QNRRLEIPK--- 898 (958)
Q Consensus 830 ~~~~s~~GT~~Y~APEvl~g~---~--~s~ksDIWSLGiLLyELLtG~~PF~g~~~~--ei~~~i~~-~~~~~~ip~--- 898 (958)
.. ..-+..|.+||.+... . ..+..|+|.|||++|.+|+|++||+..... .......+ +...+..|.
T Consensus 178 ~~---~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~ 254 (378)
T KOG1345|consen 178 KY---LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFN 254 (378)
T ss_pred hh---hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhc
Confidence 21 2245679999987432 2 367889999999999999999999853211 11111111 222334443
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 002160 899 ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 899 ~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL 932 (958)
.+++.+..+.++-|..++.+|--..+..+.-..+
T Consensus 255 ~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~ 288 (378)
T KOG1345|consen 255 PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCL 288 (378)
T ss_pred ccCHHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence 4678899999999999999996665555554433
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-22 Score=225.66 Aligned_cols=254 Identities=22% Similarity=0.258 Sum_probs=196.5
Q ss_pred CeeEEEEeeccCceEEEEEEECC---cEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCC----CceeEEeccc-cCCCce
Q 002160 677 DLVLGERIGLGSYGEVYHADWNG---TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH----PNVVLFMGAV-TRPPNL 748 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~~g---~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~H----PNIVkL~g~~-~~~~~l 748 (958)
.|.+.+.||+|+||.||+|.... +.+|+|.......... ..+..|..+|..+.. .++.++++.+ ......
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 89999999999999999998743 4688887655432211 157788999999863 6899999998 577789
Q ss_pred EEEEeecCCCCHHHHHhCCC-CCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCC-----CcEEEEeccc
Q 002160 749 SIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKN-----WNVKVSDFGL 821 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~-~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~-----g~VKL~DFGL 821 (958)
||||+.+ |.+|.++..... ..+.....+.++.+ +.+|.++|+.| +|||||||.|+++... ..+.|.|||+
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 9999987 889999886544 55666667776666 89999999998 9999999999999854 4699999999
Q ss_pred cc--cccCCcc-------c-CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccc
Q 002160 822 SR--LKHNTFL-------S-SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN 891 (958)
Q Consensus 822 Ak--~~~~~~~-------~-~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~ 891 (958)
++ ....... . ...+.||.+|+++.+..+...+.+.|+||++.++.+|+.|..||.+..............
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 98 3211111 1 234569999999999999999999999999999999999999998766432222221111
Q ss_pred cccC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 892 RRLE---IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 892 ~~~~---ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
.... .....+.++.++...+-..+...+|....+...|+.+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 1111 2344567888888888889999999999999999887554
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-23 Score=215.45 Aligned_cols=253 Identities=20% Similarity=0.258 Sum_probs=206.0
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCC-CceeEEeccccCCCceE
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH-PNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~H-PNIVkL~g~~~~~~~l~ 749 (958)
|....|.++++||.|+||.+|+|.. .|+.||||.-....... ++..|.++...|++ ..|..+..++.+...-.
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp----qL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv 87 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP----QLLYESKVYRILQGGVGIPHIRHYGTEKDYNV 87 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc----chhHHHHHHHHhccCCCCchhhhhccccccce
Confidence 4557899999999999999999975 89999999754433222 56789999999975 78888888888888899
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcC---CCcEEEEeccccccc
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLSRLK 825 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~---~g~VKL~DFGLAk~~ 825 (958)
+||+++ |-+|.+++.-....+.....++.+.+ +.-++|+|.++ +|||||||+|+|..- -..+.|+|||+++.+
T Consensus 88 lVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 88 LVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccchhhh
Confidence 999988 88999988766666777777777776 78899999998 999999999999974 356999999999864
Q ss_pred cC-------CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh---HHHHhhhcc---cc
Q 002160 826 HN-------TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGFQ---NR 892 (958)
Q Consensus 826 ~~-------~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~---ei~~~i~~~---~~ 892 (958)
-+ +........||.+|.+-....|...+.+.|+-|+|.+|.++..|.+||++.... +.++.|... ..
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ 244 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP 244 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence 32 233445677999999999998888899999999999999999999999987544 444444322 12
Q ss_pred ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 002160 893 RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 893 ~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL 932 (958)
...+++.+|.++.-.+.-|-...-++-|+..-|.+.++-|
T Consensus 245 ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL 284 (341)
T KOG1163|consen 245 IEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL 284 (341)
T ss_pred HHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence 2245688999999999999999999999988777766644
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-24 Score=248.27 Aligned_cols=225 Identities=28% Similarity=0.389 Sum_probs=193.8
Q ss_pred eeccCceEEEEEEE-----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeccccCCCceEEEEeecCC
Q 002160 684 IGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEFLPR 757 (958)
Q Consensus 684 LG~G~fG~Vykak~-----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~-HPNIVkL~g~~~~~~~l~LVmEy~~g 757 (958)
+|+|+||.|++++. .+.-+|+|...+.............|..++...+ ||++|++..+|+.+..++++++|..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 79999999998843 5667899987765543333335567889999996 99999999999999999999999999
Q ss_pred CCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCCC
Q 002160 758 GSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG 837 (958)
Q Consensus 758 GsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~G 837 (958)
|+|+..+.+...+.....+++.+..+.++.++|..+ |+|||+|++||+++.+|++|+.|||+++....... .||
T Consensus 82 g~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----~cg 155 (612)
T KOG0603|consen 82 GDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----ACG 155 (612)
T ss_pred chhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhHhHhhhh----ccc
Confidence 999999988888888889999999999999999998 99999999999999999999999999987654332 289
Q ss_pred CCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCC
Q 002160 838 TPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPS 917 (958)
Q Consensus 838 T~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~ 917 (958)
|..|||||++.| ....+|+|+||+++|||++|..||.+ ++...| ....+.+|..++..+++++.+++..+|.
T Consensus 156 t~eymApEI~~g--h~~a~D~ws~gvl~felltg~~pf~~----~~~~~I--l~~~~~~p~~l~~~a~~~~~~l~~r~p~ 227 (612)
T KOG0603|consen 156 TYEYRAPEIING--HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRI--LKAELEMPRELSAEARSLFRQLFKRNPE 227 (612)
T ss_pred chhhhhhHhhhc--cCCcccchhhhhhHHHHhhCCCCCch----HHHHHH--hhhccCCchhhhHHHHHHHHHHHhhCHH
Confidence 999999999993 57899999999999999999999988 444444 3346778899999999999999999999
Q ss_pred CCCCH
Q 002160 918 LRPSF 922 (958)
Q Consensus 918 kRPSa 922 (958)
+|...
T Consensus 228 nrLg~ 232 (612)
T KOG0603|consen 228 NRLGA 232 (612)
T ss_pred HHhcc
Confidence 99644
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-23 Score=218.67 Aligned_cols=256 Identities=29% Similarity=0.608 Sum_probs=216.1
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
|...++.+..+|.+...|+.|+|+|.|..+++|++...+........|..|.-.|+-+.||||+.+++.|..+.++.++.
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence 55667777888999999999999999999999998887777666678999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCC-CccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc
Q 002160 753 EFLPRGSLFRILHRPHC-QVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 830 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~-~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~ 830 (958)
.||+.|+|+..|+.... ..+..+...++++ +.|++|||+..+-|-.--|....++||++.+.+|. .+-++.. .
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfs----f 341 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFS----F 341 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceee----e
Confidence 99999999999987554 3455566777776 99999999988555555789999999999876663 1111110 1
Q ss_pred cCCCCCCCCCccCcccccCCCC---CchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHH
Q 002160 831 SSKSTAGTPEWMAPEVLRNEPS---NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 907 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~~~---s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dL 907 (958)
......-.+.||+||.+...+. -.++|+|||++++|||.|...||....+.+.--++...+.+..+|..+++.+.+|
T Consensus 342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~kl 421 (448)
T KOG0195|consen 342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKL 421 (448)
T ss_pred eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHH
Confidence 1122345788999999987764 3578999999999999999999999999999888888899999999999999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHhhh
Q 002160 908 IWECWQTDPSLRPSFAQLTVALKPLQ 933 (958)
Q Consensus 908 I~~CL~kDP~kRPSa~EIL~~L~kL~ 933 (958)
+.-|++.||.+||.|+.|+--|+++.
T Consensus 422 m~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 422 MNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred HHHHhcCCCCcCCCcceehhhHHHhc
Confidence 99999999999999999999998864
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.1e-22 Score=223.79 Aligned_cols=166 Identities=18% Similarity=0.178 Sum_probs=126.2
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE---CCcEEEEEEeecCCC---CHHHHHHHHHHHHHHHHcCCCceeE-EeccccCC
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW---NGTEVAVKKFLDQDF---SGAALLEFKREVKIMRRLRHPNVVL-FMGAVTRP 745 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~---~g~~VAVK~i~~~~~---~~~~~~~f~~Ei~ILk~L~HPNIVk-L~g~~~~~ 745 (958)
....+|.+.+.||+|+||+||+|.+ +++.||||++..... .......|.+|+++|++++|+||+. ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 4457899999999999999999976 467789998753311 2334567899999999999999984 5543
Q ss_pred CceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCC-CCCceEEcCCCcEEEEecccccc
Q 002160 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDL-KSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 746 ~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDL-KPeNILId~~g~VKL~DFGLAk~ 824 (958)
+..||||||++|++|... .... . ..++.+.+.+|.|||.++ |+|||| ||+|||++.++.+||+|||+++.
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~~~----~--~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RPHG----D--PAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Cccc----h--HHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 457999999999999732 2111 1 223344489999999988 999999 99999999999999999999986
Q ss_pred ccCCcc--------cCCCCCCCCCccCcccccCCC
Q 002160 825 KHNTFL--------SSKSTAGTPEWMAPEVLRNEP 851 (958)
Q Consensus 825 ~~~~~~--------~~~s~~GT~~Y~APEvl~g~~ 851 (958)
...... .-....++..|+|||.+....
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence 543211 112456888999999986543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.3e-23 Score=246.40 Aligned_cols=246 Identities=25% Similarity=0.325 Sum_probs=189.4
Q ss_pred eEEEEeeccCceEEEEEEE--CCcEEEEEEeec---CCCCHHH-HHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 679 VLGERIGLGSYGEVYHADW--NGTEVAVKKFLD---QDFSGAA-LLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 679 ~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~---~~~~~~~-~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
.-.+.+|.|++|.|+.+.. ..+.++.|.+.. ....+.. ...+..|+.+-..|.||||+..+..+++....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3467899999998887754 344455554431 2222222 223778888888999999999998888877777779
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc--
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL-- 830 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~-- 830 (958)
|||++ +|+.++.............++.++..|+.|+|.+| |.||||||+|+++..+|.+||+|||.+........
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 99999 99999987655566666777777799999999999 99999999999999999999999999887544322
Q ss_pred --cCCCCCCCCCccCcccccCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCChhHHH-Hhhhcc------ccccCCCCCC
Q 002160 831 --SSKSTAGTPEWMAPEVLRNEPSNE-KCDVYSFGVILWELATLKLPWIGMNPMQVV-GAVGFQ------NRRLEIPKEL 900 (958)
Q Consensus 831 --~~~s~~GT~~Y~APEvl~g~~~s~-ksDIWSLGiLLyELLtG~~PF~g~~~~ei~-~~i~~~------~~~~~ip~~l 900 (958)
....++|+..|+|||++.+..|++ ..||||.|++++.|++|+.||......+.. ...... .....+-..+
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 557 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLL 557 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhc
Confidence 345678999999999999999865 579999999999999999999765433221 111111 1111223457
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002160 901 DPLVARIIWECWQTDPSLRPSFAQLTV 927 (958)
Q Consensus 901 s~eL~dLI~~CL~kDP~kRPSa~EIL~ 927 (958)
+.+.+.+|.+||+.||.+|.++++|++
T Consensus 558 p~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 558 PRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred hhhHHHHHHHHccCChhheecHHHHhh
Confidence 888999999999999999999999986
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.6e-21 Score=228.91 Aligned_cols=204 Identities=29% Similarity=0.434 Sum_probs=155.6
Q ss_pred CCeeEEEEeeccCceEEEEEEEC--CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~~--g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
.+|+.++.|-.|+||.||+++++ .+++|+| +.++.+. +++ ||.....|++|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li------lRn---ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI------LRN---ILTFAGNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccchh------hhc---cccccCCccee-----------------
Confidence 67899999999999999999874 7789995 4433211 011 33333445554
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccccc-------
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH------- 826 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~------- 826 (958)
|+-...++..+...... +.+++|||..+ |+|||+||+|+||+.-|++|++|||+++.-.
T Consensus 136 ----gDc~tllk~~g~lPvdm--------vla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 136 ----GDCATLLKNIGPLPVDM--------VLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred ----chhhhhcccCCCCcchh--------hHHhHhhccCC--eecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence 45555555433322111 67899999988 9999999999999999999999999987411
Q ss_pred --------CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccccc-CCC
Q 002160 827 --------NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL-EIP 897 (958)
Q Consensus 827 --------~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~-~ip 897 (958)
......+..+||++|+|||++..+.|++.+|||++|+|+||++-|..||.+..+++++..+.-....+ +-.
T Consensus 202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~d 281 (1205)
T KOG0606|consen 202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEED 281 (1205)
T ss_pred hhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccC
Confidence 00122345689999999999999999999999999999999999999999999999988774322222 223
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCC
Q 002160 898 KELDPLVARIIWECWQTDPSLRP 920 (958)
Q Consensus 898 ~~ls~eL~dLI~~CL~kDP~kRP 920 (958)
..++++++++|.++|+.+|..|-
T Consensus 282 ea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 282 EALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred cCCCHHHHHHHHHHHHhChHhhc
Confidence 46789999999999999999994
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.7e-20 Score=224.12 Aligned_cols=247 Identities=19% Similarity=0.197 Sum_probs=183.5
Q ss_pred CeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCC--CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEee
Q 002160 677 DLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDF--SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~--~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
+|...+.||.+.|=+|.+|++++..|+||++.+++- .-....+...|++ ...++|||++.+.-+-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 678889999999999999998777799999987652 3333445555666 5666999999999988888889999999
Q ss_pred cCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc--cCCc-cc
Q 002160 755 LPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK--HNTF-LS 831 (958)
Q Consensus 755 ~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~--~~~~-~~ 831 (958)
+ ..+|+|.+..+......+.++.+++++.|+.-+|..| |+|||||.+||||+.-+-+.|+||..-+.. ..+. ..
T Consensus 103 v-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 103 V-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred H-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 9 5699999988766666667777777799999999998 999999999999999999999999876532 1111 11
Q ss_pred ----CCCCCCCCCccCcccccCC----------C-CCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhcccccc-
Q 002160 832 ----SKSTAGTPEWMAPEVLRNE----------P-SNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRL- 894 (958)
Q Consensus 832 ----~~s~~GT~~Y~APEvl~g~----------~-~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~- 894 (958)
..+......|+|||.+... . .+++-||||+||+++||++ |+++|.- .++.....-....+
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L---SQL~aYr~~~~~~~e 256 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL---SQLLAYRSGNADDPE 256 (1431)
T ss_pred ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH---HHHHhHhccCccCHH
Confidence 1112234579999987531 1 4678899999999999987 6777742 11211111000000
Q ss_pred -CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002160 895 -EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 930 (958)
Q Consensus 895 -~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~ 930 (958)
-+-+--++.++.||..|++.||.+|.++++.++.-+
T Consensus 257 ~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 257 QLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred HHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 001122457899999999999999999999998744
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.3e-20 Score=194.09 Aligned_cols=174 Identities=14% Similarity=0.072 Sum_probs=133.0
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHH-HHHH------HHHHHHHHHHcCCCceeEEeccccCC
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGA-ALLE------FKREVKIMRRLRHPNVVLFMGAVTRP 745 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~-~~~~------f~~Ei~ILk~L~HPNIVkL~g~~~~~ 745 (958)
+...+|++.+.||.|+||.||+...++..+|||.+.......+ .... +.+|++.+.++.|++|..+.+++...
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 3457899999999999999999877888999999876543322 2223 68999999999999999988875533
Q ss_pred --------CceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEE
Q 002160 746 --------PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVS 817 (958)
Q Consensus 746 --------~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~ 817 (958)
+..+|+|||++|.+|.++... .+. ...+.+.++..+|..+ |+||||||.||+++.+| ++|+
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~~-----~~~---~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~~g-i~li 176 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPEI-----SED---VKAKIKASIESLHQHG--MVSGDPHKGNFIVSKNG-LRII 176 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhhc-----cHH---HHHHHHHHHHHHHHcC--CccCCCChHHEEEeCCC-EEEE
Confidence 358899999999999887421 122 1224477899999998 99999999999999988 9999
Q ss_pred eccccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHH
Q 002160 818 DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELA 869 (958)
Q Consensus 818 DFGLAk~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELL 869 (958)
|||..+........ ...+....+..++|+|+||+++..+.
T Consensus 177 Dfg~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 177 DLSGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ECCCcccccchhhH------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99987654221110 01334445667999999999988664
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.6e-19 Score=214.84 Aligned_cols=245 Identities=21% Similarity=0.246 Sum_probs=184.1
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEE-CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC---CCceeEEeccccCC
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVVLFMGAVTRP 745 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~---HPNIVkL~g~~~~~ 745 (958)
.+++..+.|.|.+.||+|+||.||+|.. +++.||+|+-.... .. +|.--.+++.+|+ -+-|..+..+....
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~-~W----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPN-PW----EFYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCC-ce----eeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 4456667899999999999999999976 78999999765443 22 2222234445554 34566777777778
Q ss_pred CceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcC-------CCcEEEEe
Q 002160 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDK-------NWNVKVSD 818 (958)
Q Consensus 746 ~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~-------~g~VKL~D 818 (958)
+..+||+||.+.|+|.++++..+...........++++..+.+||.++ |||+||||+|+||.. .--++|+|
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEEEe
Confidence 889999999999999999997666666666667777799999999999 999999999999953 34499999
Q ss_pred cccccccc--CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCC
Q 002160 819 FGLSRLKH--NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI 896 (958)
Q Consensus 819 FGLAk~~~--~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~i 896 (958)
||.+..+. .........++|-.+-.+|+..|.+|++.+|.|+|+.++|.||+|++- + ...+..+..
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~-------q-----~~~g~~~~~ 912 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM-------E-----VKNGSSWMV 912 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH-------H-----hcCCcceec
Confidence 99886532 222344567789999999999999999999999999999999999742 1 112222222
Q ss_pred CCCCc-----HHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 002160 897 PKELD-----PLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 933 (958)
Q Consensus 897 p~~ls-----~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~ 933 (958)
...++ .-+-+|+..+|+.|...=|...+|...|++.-
T Consensus 913 ~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~ 954 (974)
T KOG1166|consen 913 KTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVL 954 (974)
T ss_pred cccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHH
Confidence 22222 23567888899866666688888888887663
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.5e-19 Score=194.57 Aligned_cols=189 Identities=24% Similarity=0.391 Sum_probs=141.2
Q ss_pred CCCceeEEeccccCC---------------------------CceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHH
Q 002160 731 RHPNVVLFMGAVTRP---------------------------PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDA 783 (958)
Q Consensus 731 ~HPNIVkL~g~~~~~---------------------------~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a 783 (958)
+|||||+++++|.+. ..+|+||...+ .+|..++-.+. ......++.+++.+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~-~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH-RSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC-CchHHHHHHHHHHH
Confidence 599999999887532 23789999884 48999887653 33455666777779
Q ss_pred HHHHHHHhcCCcEeecCCCCCceEEc--CC--CcEEEEeccccccccC-----Cc-ccCCCCCCCCCccCcccccCCC--
Q 002160 784 RGMNCLHTSTPTIVHRDLKSPNLLVD--KN--WNVKVSDFGLSRLKHN-----TF-LSSKSTAGTPEWMAPEVLRNEP-- 851 (958)
Q Consensus 784 ~aL~yLH~~g~gIIHRDLKPeNILId--~~--g~VKL~DFGLAk~~~~-----~~-~~~~s~~GT~~Y~APEvl~g~~-- 851 (958)
.|..|||.|| |.|||+|.+||||. ++ -.+.|+|||++--... ++ ......-|...-||||+....+
T Consensus 352 Eav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 352 EAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred HHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 9999999999 99999999999994 33 3489999997643211 11 1122344778899999986543
Q ss_pred ----CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHH
Q 002160 852 ----SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFA 923 (958)
Q Consensus 852 ----~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~ 923 (958)
...|+|.|+.|.+.||++....||++...+.+-...-.+...+.+|..+++.+++|+..+|+.||.+|++..
T Consensus 430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred ceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 246899999999999999999999985433221111112335677899999999999999999999998754
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=191.05 Aligned_cols=231 Identities=22% Similarity=0.267 Sum_probs=148.7
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCC----------CceeEEecccc
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRH----------PNVVLFMGAVT 743 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~H----------PNIVkL~g~~~ 743 (958)
.+..++.||.|+++.||.+++ +++.+|||++..... .....+++++|.-....+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 466789999999999999998 679999999876553 23356777777755555432 11222222111
Q ss_pred ---------CC---C-----ceEEEEeecCCCCHHHHHh---CCCC---CccHHHHHHHHH-HHHHHHHHHhcCCcEeec
Q 002160 744 ---------RP---P-----NLSIITEFLPRGSLFRILH---RPHC---QVDEKRRIKMAL-DARGMNCLHTSTPTIVHR 799 (958)
Q Consensus 744 ---------~~---~-----~l~LVmEy~~gGsL~d~L~---k~~~---~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHR 799 (958)
.. . +.+++|.-+ .++|.+++. .... ......++.+.. .+..+++||..| |||+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVHg 169 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LVHG 169 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEES
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eEec
Confidence 11 1 236677777 568877753 2111 222334444433 378899999999 9999
Q ss_pred CCCCCceEEcCCCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCC--------CCCchhhHHHHHHHHHHHHhC
Q 002160 800 DLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE--------PSNEKCDVYSFGVILWELATL 871 (958)
Q Consensus 800 DLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~GT~~Y~APEvl~g~--------~~s~ksDIWSLGiLLyELLtG 871 (958)
||||+|+|++++|.++|+||+........... ...+..|.+||..... .++.+.|.|+||+++|.|+|+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 99999999999999999999987665443221 2345789999987442 468899999999999999999
Q ss_pred CCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCC
Q 002160 872 KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLR 919 (958)
Q Consensus 872 ~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kR 919 (958)
..||........... ....+..++..+++||.++|+.+|.+|
T Consensus 247 ~lPf~~~~~~~~~~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 999986644322111 233444789999999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=183.39 Aligned_cols=188 Identities=17% Similarity=0.199 Sum_probs=139.7
Q ss_pred eEEEEeeccCceEEEEEEECCcEEEEEEeecCCC--CHHHHHHHHHHHHHHHHcC-CCceeEEeccccCCCceEEEEeec
Q 002160 679 VLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDF--SGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEFL 755 (958)
Q Consensus 679 ~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~--~~~~~~~f~~Ei~ILk~L~-HPNIVkL~g~~~~~~~l~LVmEy~ 755 (958)
.+...|++|+||+||++...+.+++.+.+..... ..-....+.+|+++|++|. |++|++++++ +..+++|||+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 3567899999999999988888988877654332 1112225789999999995 5889999886 3469999999
Q ss_pred CCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCC-CCCceEEcCCCcEEEEeccccccccCCccc---
Q 002160 756 PRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDL-KSPNLLVDKNWNVKVSDFGLSRLKHNTFLS--- 831 (958)
Q Consensus 756 ~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDL-KPeNILId~~g~VKL~DFGLAk~~~~~~~~--- 831 (958)
.|.+|...+... . ...+.+.+.+|.++|.+| |+|||| ||+|||++.+|.++|+|||++.........
T Consensus 81 ~G~~L~~~~~~~-----~--~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~ 151 (218)
T PRK12274 81 AGAAMYQRPPRG-----D--LAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL 151 (218)
T ss_pred cCccHHhhhhhh-----h--HHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence 999997654221 1 112334478999999998 999999 799999999999999999999854432210
Q ss_pred ----------CCCCCCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 002160 832 ----------SKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIGMN 879 (958)
Q Consensus 832 ----------~~s~~GT~~Y~APEvl~g--~~~s~ksDIWSLGiLLyELLtG~~PF~g~~ 879 (958)
..-...++.|+.|+...- .+.-...+|++.|+-+|.++|+..++.+.+
T Consensus 152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 001125788888886543 222367899999999999999999876543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.8e-19 Score=185.01 Aligned_cols=140 Identities=21% Similarity=0.176 Sum_probs=99.7
Q ss_pred EEEeeccCceEEEEEEE-CCcEEEEEEeecCCCCHHH------------------------HHHHHHHHHHHHHcCCCce
Q 002160 681 GERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAA------------------------LLEFKREVKIMRRLRHPNV 735 (958)
Q Consensus 681 ~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~~~------------------------~~~f~~Ei~ILk~L~HPNI 735 (958)
...||+|+||.||+|.. +|+.||||+++........ ......|+++|.++.+++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35699999999999986 6999999998754321110 1123459999999987766
Q ss_pred eEEeccccCCCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHH-HhcCCcEeecCCCCCceEEcCCCcE
Q 002160 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCL-HTSTPTIVHRDLKSPNLLVDKNWNV 814 (958)
Q Consensus 736 VkL~g~~~~~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yL-H~~g~gIIHRDLKPeNILId~~g~V 814 (958)
.....+.. ...+|||||++|++|.....+............+.+.+.+|.++ |..+ |+||||||+|||++ ++.+
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-~~~v 156 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-DGKL 156 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE-CCcE
Confidence 43332221 22389999999887765533333333333344444458999999 6877 99999999999998 5789
Q ss_pred EEEeccccccc
Q 002160 815 KVSDFGLSRLK 825 (958)
Q Consensus 815 KL~DFGLAk~~ 825 (958)
+|+|||++...
T Consensus 157 ~LiDFG~a~~~ 167 (190)
T cd05147 157 YIIDVSQSVEH 167 (190)
T ss_pred EEEEccccccC
Confidence 99999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.9e-18 Score=177.85 Aligned_cols=141 Identities=21% Similarity=0.197 Sum_probs=102.6
Q ss_pred EEEeeccCceEEEEEEE-CCcEEEEEEeecCCCCH------------------------HHHHHHHHHHHHHHHcCCCce
Q 002160 681 GERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSG------------------------AALLEFKREVKIMRRLRHPNV 735 (958)
Q Consensus 681 ~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~------------------------~~~~~f~~Ei~ILk~L~HPNI 735 (958)
.+.||+|+||.||+|++ +|+.||||++....... .....+..|.+.+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999987 69999999987653110 011234689999999999887
Q ss_pred eEEeccccCCCceEEEEeecCCCCHHHH-HhCCCCCccHHHHHHHHHHHHHHHHHHh-cCCcEeecCCCCCceEEcCCCc
Q 002160 736 VLFMGAVTRPPNLSIITEFLPRGSLFRI-LHRPHCQVDEKRRIKMALDARGMNCLHT-STPTIVHRDLKSPNLLVDKNWN 813 (958)
Q Consensus 736 VkL~g~~~~~~~l~LVmEy~~gGsL~d~-L~k~~~~~~e~~~l~ia~~a~aL~yLH~-~g~gIIHRDLKPeNILId~~g~ 813 (958)
.....+... ..+|||||++|+++... +.. .............+.+.++.++|. .+ |+||||||+|||++ ++.
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-~~~ 155 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-VPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh-ccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE-CCC
Confidence 544333322 24899999998855433 433 222223333344445899999999 87 99999999999999 899
Q ss_pred EEEEeccccccccC
Q 002160 814 VKVSDFGLSRLKHN 827 (958)
Q Consensus 814 VKL~DFGLAk~~~~ 827 (958)
++|+|||+++....
T Consensus 156 ~~liDFG~a~~~~~ 169 (190)
T cd05145 156 PYIIDVSQAVELDH 169 (190)
T ss_pred EEEEEcccceecCC
Confidence 99999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.3e-17 Score=169.18 Aligned_cols=136 Identities=23% Similarity=0.348 Sum_probs=109.5
Q ss_pred EEeeccCceEEEEEEECCcEEEEEEeecCCCCHH------HHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeec
Q 002160 682 ERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGA------ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755 (958)
Q Consensus 682 k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~------~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~ 755 (958)
+.||+|++|.||+|.+.+..|+||+......... ....+.+|+.++..+.|++|+....++......+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 5699999999999999999999998765433211 2245788999999999999877666666777889999999
Q ss_pred CCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 756 PRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 756 ~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
+|++|.+++..... .........+.+|.++|..+ ++|||++|.|||++ ++.++|+|||++..
T Consensus 82 ~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNGM----EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999998865322 22223333478999999998 99999999999999 78999999998754
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.3e-17 Score=171.06 Aligned_cols=134 Identities=19% Similarity=0.229 Sum_probs=101.0
Q ss_pred EEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-----CCCceeEEeccccCCC---c-eEEE
Q 002160 681 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-----RHPNVVLFMGAVTRPP---N-LSII 751 (958)
Q Consensus 681 ~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-----~HPNIVkL~g~~~~~~---~-l~LV 751 (958)
.+.||+|+||.||.-..++.. +||++...... ....+.+|+++++.+ .||||+++++++++.. . +.+|
T Consensus 7 ~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYAHPEDAQR-CIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEECCCCcCe-EEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 367999999999963334444 68987654322 345789999999999 5799999999998874 3 3378
Q ss_pred Eee--cCCCCHHHHHhCCCCCccHHHHHHHHHHHHHH-HHHHhcCCcEeecCCCCCceEEcC----CCcEEEEecccc
Q 002160 752 TEF--LPRGSLFRILHRPHCQVDEKRRIKMALDARGM-NCLHTSTPTIVHRDLKSPNLLVDK----NWNVKVSDFGLS 822 (958)
Q Consensus 752 mEy--~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL-~yLH~~g~gIIHRDLKPeNILId~----~g~VKL~DFGLA 822 (958)
||| +.+++|.+++.+.. +.+. ...+.+++.++ .|||.++ ||||||||+|||++. ++.++|+||+.+
T Consensus 84 ~e~~G~~~~tL~~~l~~~~--~~e~-~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQCR--YEED-VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred ecCCCCcchhHHHHHHccc--ccHh-HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 999 55799999997642 3333 23344555566 9999998 999999999999974 347999995433
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.8e-17 Score=190.35 Aligned_cols=208 Identities=33% Similarity=0.528 Sum_probs=164.8
Q ss_pred HHHcCCCceeEEeccccCCCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCc
Q 002160 727 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPN 805 (958)
Q Consensus 727 Lk~L~HPNIVkL~g~~~~~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeN 805 (958)
|+.+.|.|+.+|+|.+.++...++|.+||..|+|.|.+.......++.....+... +.||+|||..... .|+.|+..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~-~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIG-YHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcce-eeeeecccc
Confidence 45688999999999999999999999999999999999987777888877777766 8999999997633 999999999
Q ss_pred eEEcCCCcEEEEeccccccccCC--cccCCCCCCCCCccCcccccCCC-------CCchhhHHHHHHHHHHHHhCCCCCC
Q 002160 806 LLVDKNWNVKVSDFGLSRLKHNT--FLSSKSTAGTPEWMAPEVLRNEP-------SNEKCDVYSFGVILWELATLKLPWI 876 (958)
Q Consensus 806 ILId~~g~VKL~DFGLAk~~~~~--~~~~~s~~GT~~Y~APEvl~g~~-------~s~ksDIWSLGiLLyELLtG~~PF~ 876 (958)
+++|..+.+||+|||+....... ........-..-|.|||.+.+.. .+.+.||||||++++|+++.+-||.
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~ 159 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD 159 (484)
T ss_pred ceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence 99999999999999998766321 11111122345799999998742 3567999999999999999999997
Q ss_pred CC----ChhHHHHhhhccc---cccCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 877 GM----NPMQVVGAVGFQN---RRLEIP--KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 877 g~----~~~ei~~~i~~~~---~~~~ip--~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
.. ++.+++..+.... .++.+. ..+++++..++..||..+|.+||++++|...++.+.+.
T Consensus 160 ~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 160 LRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred cccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 53 2334555543311 122222 14566899999999999999999999999999988664
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=8e-17 Score=165.07 Aligned_cols=132 Identities=22% Similarity=0.334 Sum_probs=105.0
Q ss_pred eeccCceEEEEEEECCcEEEEEEeecCCCCH------HHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeecCC
Q 002160 684 IGLGSYGEVYHADWNGTEVAVKKFLDQDFSG------AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 757 (958)
Q Consensus 684 LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~------~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~g 757 (958)
||+|+||.||+|.+.+..|+||+........ ....++.+|++++..++|+++.....++......++||||++|
T Consensus 2 ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g 81 (199)
T TIGR03724 2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEG 81 (199)
T ss_pred CCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECC
Confidence 8999999999999999999999866543211 1235678999999999887755444444556677999999999
Q ss_pred CCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 758 GSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 758 GsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
++|.+++..... ..+.+.+.+|.+||..+ ++|||++|.|||++ ++.++|+|||++...
T Consensus 82 ~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 82 KPLKDVIEEGND-------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred ccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999998765321 23334488999999988 99999999999999 889999999998653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=4e-16 Score=184.93 Aligned_cols=136 Identities=19% Similarity=0.305 Sum_probs=110.1
Q ss_pred eeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCH------HHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEE
Q 002160 678 LVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSG------AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~------~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LV 751 (958)
|...+.||+|+||.||+|.+.+..+++|+........ .....+.+|+++++.++|++|+..+.++......++|
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 414 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV 414 (535)
T ss_pred cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence 4557889999999999999988887777654332211 1235688999999999999998887777777788999
Q ss_pred EeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
|||++|++|.+++.. ......+.+.+|.+||..+ |+||||||+|||+ .++.++|+|||+++.
T Consensus 415 ~E~~~g~~L~~~l~~--------~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 415 MEYIGGKDLKDVLEG--------NPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEecCCCcHHHHHHH--------HHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 999999999998851 2233344489999999998 9999999999999 678999999999864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.3e-16 Score=166.78 Aligned_cols=143 Identities=23% Similarity=0.169 Sum_probs=105.4
Q ss_pred CeeEEEEeeccCceEEEEEE---ECCcEEEEEEeecCCCC--------------------H--HHHHHHHHHHHHHHHcC
Q 002160 677 DLVLGERIGLGSYGEVYHAD---WNGTEVAVKKFLDQDFS--------------------G--AALLEFKREVKIMRRLR 731 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak---~~g~~VAVK~i~~~~~~--------------------~--~~~~~f~~Ei~ILk~L~ 731 (958)
-|.+.+.||+|+||.||+|. .+++.||||++...... . .....+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 37899999998754311 0 01234678999999997
Q ss_pred CC--ceeEEeccccCCCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEc
Q 002160 732 HP--NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVD 809 (958)
Q Consensus 732 HP--NIVkL~g~~~~~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId 809 (958)
+. .+.+++++ ...+|||||++|++|...+................+.+.++.+||.++ +|+||||||+|||++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~NIli~ 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYNILVH 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhhEEEE
Confidence 53 34455543 235899999999888765533332222333344445589999999875 499999999999999
Q ss_pred CCCcEEEEeccccccc
Q 002160 810 KNWNVKVSDFGLSRLK 825 (958)
Q Consensus 810 ~~g~VKL~DFGLAk~~ 825 (958)
++.++|+|||.+...
T Consensus 184 -~~~i~LiDFg~a~~~ 198 (237)
T smart00090 184 -DGKVVIIDVSQSVEL 198 (237)
T ss_pred -CCCEEEEEChhhhcc
Confidence 889999999998654
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.1e-15 Score=157.66 Aligned_cols=136 Identities=22% Similarity=0.214 Sum_probs=102.6
Q ss_pred eeEEEEeeccCceEEEEEEE-CCcEEEEEEeecCCCCH--------------------HHHHHHHHHHHHHHHcCCC--c
Q 002160 678 LVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSG--------------------AALLEFKREVKIMRRLRHP--N 734 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~--------------------~~~~~f~~Ei~ILk~L~HP--N 734 (958)
|.+.+.||+|+||.||++.+ +++.||||++....... .....+.+|+.++..+.|+ .
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 66778899999999999987 68999999876532110 0112367899999999877 4
Q ss_pred eeEEeccccCCCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcE
Q 002160 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNV 814 (958)
Q Consensus 735 IVkL~g~~~~~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~V 814 (958)
++.+++. ...++||||++|++|..+... ..........+.++.++|..+ |+||||||+||+|++++.+
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~~~~~~ 164 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVDDDEKI 164 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEcCCCcE
Confidence 4555542 345899999999998776431 111222333477899999987 9999999999999999999
Q ss_pred EEEeccccccc
Q 002160 815 KVSDFGLSRLK 825 (958)
Q Consensus 815 KL~DFGLAk~~ 825 (958)
+|+|||++...
T Consensus 165 ~liDfg~~~~~ 175 (198)
T cd05144 165 YIIDWPQMVST 175 (198)
T ss_pred EEEECCccccC
Confidence 99999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=7.7e-17 Score=193.01 Aligned_cols=250 Identities=24% Similarity=0.314 Sum_probs=193.5
Q ss_pred CCeeEEEEeeccCceEEEEEEE---CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeccccCCCceEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW---NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~---~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~-HPNIVkL~g~~~~~~~l~LV 751 (958)
..|.+.+.||+|+|+.|-+... ....+|+|.+...............|..+-+.+. |.|++++++...+....+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 4566777899999999988754 3445677765544333334455667888888886 99999999999999999999
Q ss_pred EeecCCCCHHHHH-hCCC-CCccHHHHHHHHHHHHHHHHHH-hcCCcEeecCCCCCceEEcCCC-cEEEEeccccccccC
Q 002160 752 TEFLPRGSLFRIL-HRPH-CQVDEKRRIKMALDARGMNCLH-TSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRLKHN 827 (958)
Q Consensus 752 mEy~~gGsL~d~L-~k~~-~~~~e~~~l~ia~~a~aL~yLH-~~g~gIIHRDLKPeNILId~~g-~VKL~DFGLAk~~~~ 827 (958)
++|..|+++++.+ .... .........+..+...++.|+| ..+ +.||||||+|.+++..+ .+|+.|||+|..+..
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 9999999999988 5443 4555666677777789999999 777 99999999999999999 999999999987644
Q ss_pred ---CcccCCCCCC-CCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHH--hhhcccc-ccCCCCC
Q 002160 828 ---TFLSSKSTAG-TPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVG--AVGFQNR-RLEIPKE 899 (958)
Q Consensus 828 ---~~~~~~s~~G-T~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~--~i~~~~~-~~~ip~~ 899 (958)
........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..||.......... ....... .......
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 2233445678 9999999999985 45788999999999999999999997654433211 1111111 1233456
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002160 900 LDPLVARIIWECWQTDPSLRPSFAQLTV 927 (958)
Q Consensus 900 ls~eL~dLI~~CL~kDP~kRPSa~EIL~ 927 (958)
++....+++.+++..+|..|.+.+++..
T Consensus 258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred CChhhhhcccccccCCchhccccccccc
Confidence 7888999999999999999999887754
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=8.5e-15 Score=139.34 Aligned_cols=134 Identities=18% Similarity=0.152 Sum_probs=107.8
Q ss_pred EEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCC--CceeEEeccccCCCceEEEEeecCC
Q 002160 680 LGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH--PNVVLFMGAVTRPPNLSIITEFLPR 757 (958)
Q Consensus 680 i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~H--PNIVkL~g~~~~~~~l~LVmEy~~g 757 (958)
+.+.||.|.++.||+++..+..++||.+..... ...+.+|+.+++.++| .++++++.++...+..+++|||+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 357799999999999999889999998765432 4578899999999976 5899999998888889999999998
Q ss_pred CCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcC-CcEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 758 GSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTST-PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 758 GsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g-~gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
+.+..+ ............+.+++.+|... .+++|+||+|+|||+++.+.++|+|||++..
T Consensus 78 ~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 877654 11222222333478899999853 3599999999999999999999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.6e-15 Score=173.80 Aligned_cols=169 Identities=23% Similarity=0.321 Sum_probs=120.1
Q ss_pred CceEEEEeecCCCCHHHHHhCCCC--CccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccc
Q 002160 746 PNLSIITEFLPRGSLFRILHRPHC--QVDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 822 (958)
Q Consensus 746 ~~l~LVmEy~~gGsL~d~L~k~~~--~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLA 822 (958)
.++||.|++|...+|.+++.++.. ........ ++.+.+.++.| ++ .+|||+||.||+...+..+||.|||+.
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccchhhhhhhhhhe
Confidence 358899999999999999964432 22222222 33333778888 44 999999999999999999999999998
Q ss_pred ccccCCc------ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccC
Q 002160 823 RLKHNTF------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLE 895 (958)
Q Consensus 823 k~~~~~~------~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ 895 (958)
....... ...+...||..||+||.+.|+.|+.++|||+||+||+||+. =...|.... ....+.....++.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~---t~~d~r~g~ip~~ 480 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA---TLTDIRDGIIPPE 480 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH---hhhhhhcCCCChH
Confidence 7654332 23455679999999999999999999999999999999997 333332211 1111211111112
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHH
Q 002160 896 IPKELDPLVARIIWECWQTDPSLRPSFA 923 (958)
Q Consensus 896 ip~~ls~eL~dLI~~CL~kDP~kRPSa~ 923 (958)
+...+ |+-..|+.++|...|.+||++.
T Consensus 481 ~~~d~-p~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 481 FLQDY-PEEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred HhhcC-cHHHHHHHHhcCCCcccCchHH
Confidence 22233 4445899999999999999443
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.2e-14 Score=147.47 Aligned_cols=137 Identities=24% Similarity=0.197 Sum_probs=93.9
Q ss_pred EEEeeccCceEEEEEEEC-CcEEEEEEeecCCCCHHHHHH----------------------HHHHHHHHHHcCCC--ce
Q 002160 681 GERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLE----------------------FKREVKIMRRLRHP--NV 735 (958)
Q Consensus 681 ~k~LG~G~fG~Vykak~~-g~~VAVK~i~~~~~~~~~~~~----------------------f~~Ei~ILk~L~HP--NI 735 (958)
++.||+|+||.||+|.+. ++.||||++............ ...|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999874 999999988754322111111 14567777777543 34
Q ss_pred eEEeccccCCCceEEEEeecCCCCHHH-HHhCCCCCccHHHHHHHHHHHHHHHHHHh-cCCcEeecCCCCCceEEcCCCc
Q 002160 736 VLFMGAVTRPPNLSIITEFLPRGSLFR-ILHRPHCQVDEKRRIKMALDARGMNCLHT-STPTIVHRDLKSPNLLVDKNWN 813 (958)
Q Consensus 736 VkL~g~~~~~~~l~LVmEy~~gGsL~d-~L~k~~~~~~e~~~l~ia~~a~aL~yLH~-~g~gIIHRDLKPeNILId~~g~ 813 (958)
.+++++. ..++||||++++.+.. .+.... .....+......+.++.++|. ++ |+||||||+||+++ ++.
T Consensus 82 ~~~~~~~----~~~lv~e~~~g~~~~~~~l~~~~--~~~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 82 PKPIDLN----RHVLVMEFIGGDGIPAPRLKDVR--LLEDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CceEecC----CCEEEEEEeCCCCccChhhhhhh--hcccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE-CCc
Confidence 5555432 3589999999854321 111111 112233334445889999998 77 99999999999999 899
Q ss_pred EEEEecccccccc
Q 002160 814 VKVSDFGLSRLKH 826 (958)
Q Consensus 814 VKL~DFGLAk~~~ 826 (958)
++|+|||.+....
T Consensus 153 ~~liDfg~a~~~~ 165 (187)
T cd05119 153 VYIIDVPQAVEID 165 (187)
T ss_pred EEEEECccccccc
Confidence 9999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=3e-14 Score=152.72 Aligned_cols=136 Identities=16% Similarity=0.252 Sum_probs=103.7
Q ss_pred EEee-ccCceEEEEEEECCcEEEEEEeecCCC-----------CHHHHHHHHHHHHHHHHcCCCce--eEEeccccCCCc
Q 002160 682 ERIG-LGSYGEVYHADWNGTEVAVKKFLDQDF-----------SGAALLEFKREVKIMRRLRHPNV--VLFMGAVTRPPN 747 (958)
Q Consensus 682 k~LG-~G~fG~Vykak~~g~~VAVK~i~~~~~-----------~~~~~~~f~~Ei~ILk~L~HPNI--VkL~g~~~~~~~ 747 (958)
..|| .||.|+||+++..+..++||.+..... .......+.+|+.++.+|.|++| ++.+++......
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4577 889999999988899999998854321 11233567899999999988775 677776433222
Q ss_pred ----eEEEEeecCC-CCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccc
Q 002160 748 ----LSIITEFLPR-GSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 822 (958)
Q Consensus 748 ----l~LVmEy~~g-GsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLA 822 (958)
.++||||++| .+|.+++.... ..+.. +.+.+.++.+||..| |+||||||+|||++.++.++|+|||.+
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~~~--l~~~~---~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQEAP--LSEEQ---WQAIGQLIARFHDAG--VYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhcCC--CCHHH---HHHHHHHHHHHHHCC--CCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 3599999997 69998886532 22222 234478999999998 999999999999999999999999987
Q ss_pred cc
Q 002160 823 RL 824 (958)
Q Consensus 823 k~ 824 (958)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 54
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.45 E-value=3.8e-14 Score=171.88 Aligned_cols=251 Identities=22% Similarity=0.257 Sum_probs=198.2
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCC-CCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQD-FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~-~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~ 747 (958)
+....+.+.+.+.+-.|.++.++.++- .+...++|...... +..........+-.++-..++|.++....-+.....
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence 567788999999999999999998865 33334444332221 111123334455555555567888887777777788
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
.+|+++|+.+++|...|+..+....+..+.++.....++++||... ++|||++|.|+|+..+|+.++.|||......-
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred cchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccch--hhcccccccchhhcccCCcccCcccccccccc
Confidence 9999999999999999998887888888899998899999999987 89999999999999999999999984332100
Q ss_pred --------------------------C-----cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 002160 828 --------------------------T-----FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI 876 (958)
Q Consensus 828 --------------------------~-----~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~ 876 (958)
. ........||+.|.+||.+.+......+|||++|++++|.++|..||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 011223568999999999999999999999999999999999999999
Q ss_pred CCChhHHHHhhhccccccC-CCCCCcHHHHHHHHHhhhcCCCCCCCHH
Q 002160 877 GMNPMQVVGAVGFQNRRLE-IPKELDPLVARIIWECWQTDPSLRPSFA 923 (958)
Q Consensus 877 g~~~~ei~~~i~~~~~~~~-ip~~ls~eL~dLI~~CL~kDP~kRPSa~ 923 (958)
...+.++++.+......+. -+...+.+.++++...|..+|.+|..+.
T Consensus 1037 a~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999999988864444443 3567899999999999999999997765
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.36 E-value=5.9e-13 Score=155.08 Aligned_cols=247 Identities=23% Similarity=0.192 Sum_probs=178.3
Q ss_pred CeeEEEEeec--cCceEEEEEEE----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCceE
Q 002160 677 DLVLGERIGL--GSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 677 dy~i~k~LG~--G~fG~Vykak~----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~l~ 749 (958)
.+.+.+.+|. |.+|.||.++. ....+|+|+=+...-.......=.+|+.-.+++ .|+|.++.+..|...+.++
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3455677999 99999999865 566789886332221112222224566666666 4999999999999999999
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HH----HHHHHHhcCCcEeecCCCCCceEEcCC-CcEEEEeccccc
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-AR----GMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSR 823 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~----aL~yLH~~g~gIIHRDLKPeNILId~~-g~VKL~DFGLAk 823 (958)
+-+|+| +.+|..+.+...........+..... .. |+.++|... |+|-|+||+||++..+ ...+++|||+..
T Consensus 195 iqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred eeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCcceeE
Confidence 999998 57888888766554444444433333 44 999999988 9999999999999998 889999999998
Q ss_pred cccCCcccCC-----CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCC
Q 002160 824 LKHNTFLSSK-----STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK 898 (958)
Q Consensus 824 ~~~~~~~~~~-----s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~ 898 (958)
.+.+...... ...|...|++||.+.+. ++...|+|+||.++.+-.++..++........ ..+.......++..
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W-~~~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSW-SQLRQGYIPLEFCE 349 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCc-cccccccCchhhhc
Confidence 8765543222 22688899999999876 67899999999999999887665533211111 01111112344555
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 899 ELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 899 ~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
..+..+...+.+|++.+|..|+++..+..+
T Consensus 350 ~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 350 GGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred CcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 667778889999999999999988776553
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.33 E-value=6.7e-12 Score=145.88 Aligned_cols=142 Identities=22% Similarity=0.221 Sum_probs=94.8
Q ss_pred EEeeccCceEEEEEEE-CCcEEEEEEeecCCCCHH--H------------------------------------HHHHHH
Q 002160 682 ERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGA--A------------------------------------LLEFKR 722 (958)
Q Consensus 682 k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~~--~------------------------------------~~~f~~ 722 (958)
+.||.|++|.||+|+. +|+.||||+.+......- + ...|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999987 799999998754321100 0 012556
Q ss_pred HHHHHHHcC-----CCceeEEeccccCCCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEe
Q 002160 723 EVKIMRRLR-----HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIV 797 (958)
Q Consensus 723 Ei~ILk~L~-----HPNIVkL~g~~~~~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gII 797 (958)
|++.+.++. +++|.-..-++......+|||||++|++|.++.......... ..+........+..+|..| ++
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~~-~~ia~~~~~~~l~ql~~~g--~~ 279 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLDR-KALAENLARSFLNQVLRDG--FF 279 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCCH-HHHHHHHHHHHHHHHHhCC--ce
Confidence 777666662 344332222223344578999999999998876432111111 1111111123467788887 99
Q ss_pred ecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 798 HRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 798 HRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
|+|++|.||+++.++.++|+|||++..+.
T Consensus 280 H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 280 HADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.29 E-value=1e-11 Score=123.50 Aligned_cols=129 Identities=16% Similarity=0.112 Sum_probs=94.5
Q ss_pred EEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCce-eEEeccccCCCceEEEEeecCCCC
Q 002160 681 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV-VLFMGAVTRPPNLSIITEFLPRGS 759 (958)
Q Consensus 681 ~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNI-VkL~g~~~~~~~l~LVmEy~~gGs 759 (958)
.+.|+.|.++.||+++..+..|++|....... ....+..|+.+++.+.+.++ .+++.+.. ...++||||++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence 46789999999999999999999998654321 12346789999999865443 45555433 34589999999988
Q ss_pred HHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCC---cEeecCCCCCceEEcCCCcEEEEeccccc
Q 002160 760 LFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTP---TIVHRDLKSPNLLVDKNWNVKVSDFGLSR 823 (958)
Q Consensus 760 L~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~---gIIHRDLKPeNILId~~g~VKL~DFGLAk 823 (958)
+.... .. ......+.+.+|+.||..+. +++|+|++|.||+++ ++.++|+|||.+.
T Consensus 78 l~~~~-----~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 78 LLTED-----FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccccc-----cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 76430 00 11223344788999998762 369999999999999 6789999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.7e-10 Score=136.14 Aligned_cols=222 Identities=19% Similarity=0.227 Sum_probs=145.6
Q ss_pred CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeecCCCCHHHHHhCCCCCccHHHHH
Q 002160 698 NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI 777 (958)
Q Consensus 698 ~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l 777 (958)
++.+|.|+.+....- ......++-++.|+.|+||||+++++.+...+.+|||+|.+. -|..++.+.+ .+...+
T Consensus 36 ~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~---~~~v~~ 108 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG---KEEVCL 108 (690)
T ss_pred cCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH---HHHHHH
Confidence 677888877655432 334556788899999999999999999999999999999985 4666666544 556667
Q ss_pred HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhh
Q 002160 778 KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCD 857 (958)
Q Consensus 778 ~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksD 857 (958)
-+.+++.||.+||..+ .++|++|.-..|+|++.|+.||++|-++..............---.|..|+.+.... ...|
T Consensus 109 Gl~qIl~AL~FL~~d~-~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D 185 (690)
T KOG1243|consen 109 GLFQILAALSFLNDDC-NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSID 185 (690)
T ss_pred HHHHHHHHHHHHhccC-CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cchh
Confidence 7777799999998543 399999999999999999999999998765432221111111122455666554332 4679
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChhHHHHhhh-----cc-ccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHh
Q 002160 858 VYSFGVILWELATLKLPWIGMNPMQVVGAVG-----FQ-NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKP 931 (958)
Q Consensus 858 IWSLGiLLyELLtG~~PF~g~~~~ei~~~i~-----~~-~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~k 931 (958)
.|.|||++++++.|..+ ..........+. .. .....-+...+. ..+++..|+....--|=.+-+++..|+.
T Consensus 186 ~~~Lg~li~el~ng~~~--~~~~~~~~~~ipk~~~~~~~k~~~~~~~~r~n-~~~~~~~~~~~~gff~n~fvd~~~fLee 262 (690)
T KOG1243|consen 186 SWGLGCLIEELFNGSLL--TKTDLSNTGKIPKALIELYCKKLGATELKRPN-KLRFILECRLLGGFFRNDFVDTLLFLEE 262 (690)
T ss_pred hhhHHHHHHHHhCcccC--cchhhhccCccchhHHHHHHHHhccccccccc-hhhHHHHHHhccccccchHHHHHHHHHh
Confidence 99999999999999322 111111111110 00 000000111122 5566666766666666666666666665
Q ss_pred h
Q 002160 932 L 932 (958)
Q Consensus 932 L 932 (958)
+
T Consensus 263 l 263 (690)
T KOG1243|consen 263 L 263 (690)
T ss_pred c
Confidence 5
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.8e-11 Score=144.98 Aligned_cols=146 Identities=16% Similarity=0.165 Sum_probs=90.2
Q ss_pred CCCeeEEEEeeccCceEEEEEEE-C-CcEEEEEEeecCCC---------------------------CH-----HHHH--
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW-N-GTEVAVKKFLDQDF---------------------------SG-----AALL-- 718 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~-~-g~~VAVK~i~~~~~---------------------------~~-----~~~~-- 718 (958)
+.+|+. +.||.|++|.||+|+. + |+.||||+.++... .. +...
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345665 7899999999999987 4 89999999875421 00 0011
Q ss_pred ----HHHHHHHHHHHcC----CCceeEEeccc-cCCCceEEEEeecCCCCHHHH--HhCCCCCccHHHHHHHHHHHHHHH
Q 002160 719 ----EFKREVKIMRRLR----HPNVVLFMGAV-TRPPNLSIITEFLPRGSLFRI--LHRPHCQVDEKRRIKMALDARGMN 787 (958)
Q Consensus 719 ----~f~~Ei~ILk~L~----HPNIVkL~g~~-~~~~~l~LVmEy~~gGsL~d~--L~k~~~~~~e~~~l~ia~~a~aL~ 787 (958)
++.+|+..+.+++ +.+.|.+-.++ ......+|||||++|+.|.++ +.+.+... .. +--.....-+.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~--~~-la~~~v~~~~~ 274 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDM--KL-LAERGVEVFFT 274 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCH--HH-HHHHHHHHHHH
Confidence 2344555555542 33223222222 223456799999999999874 33322111 11 10000111223
Q ss_pred HHHhcCCcEeecCCCCCceEEcCCC----cEEEEecccccccc
Q 002160 788 CLHTSTPTIVHRDLKSPNLLVDKNW----NVKVSDFGLSRLKH 826 (958)
Q Consensus 788 yLH~~g~gIIHRDLKPeNILId~~g----~VKL~DFGLAk~~~ 826 (958)
.+...| ++|+|+||.||+++.+| .++++|||++..+.
T Consensus 275 Qif~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 275 QVFRDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHHhCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 344566 99999999999999888 99999999987654
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.5e-11 Score=130.92 Aligned_cols=201 Identities=22% Similarity=0.304 Sum_probs=136.5
Q ss_pred HHHHHHcCCCceeEEeccccCCC-----ceEEEEeecCCCCHHHHHhCC---CC-CccHHHHHHHHHHHHHHHHHHhcCC
Q 002160 724 VKIMRRLRHPNVVLFMGAVTRPP-----NLSIITEFLPRGSLFRILHRP---HC-QVDEKRRIKMALDARGMNCLHTSTP 794 (958)
Q Consensus 724 i~ILk~L~HPNIVkL~g~~~~~~-----~l~LVmEy~~gGsL~d~L~k~---~~-~~~e~~~l~ia~~a~aL~yLH~~g~ 794 (958)
..-|-++.|.|||+++.||.+.. +..+++||+..|+|..+|++. +. .+...++.|.-++..||.|||.+.+
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 34455667999999999996543 478999999999999999742 22 2333334444445899999999999
Q ss_pred cEeecCCCCCceEEcCCCcEEEEeccccccccCCccc-----CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHH
Q 002160 795 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS-----SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELA 869 (958)
Q Consensus 795 gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~-----~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELL 869 (958)
+|+|+++.-+.|++..+|-||+.- +--...+..... .....+-++|.+||.=.....+.++|||+||+...+|.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 999999999999999888888742 111111111111 11123567899999877666778999999999999998
Q ss_pred hCCCC-CCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002160 870 TLKLP-WIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 930 (958)
Q Consensus 870 tG~~P-F~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~ 930 (958)
-+..- -......+.-..+. +... ..-...-+++|.+||+-.|..||++.+++.|.-
T Consensus 277 ilEiq~tnseS~~~~ee~ia--~~i~---~len~lqr~~i~kcl~~eP~~rp~ar~llfHpl 333 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIA--NVII---GLENGLQRGSITKCLEGEPNGRPDARLLLFHPL 333 (458)
T ss_pred HheeccCCCcceeehhhhhh--hhee---eccCccccCcCcccccCCCCCCcchhhhhcCce
Confidence 87643 22222211111111 0011 111233467899999999999999999887643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.13 E-value=4.5e-11 Score=139.55 Aligned_cols=250 Identities=20% Similarity=0.159 Sum_probs=178.4
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE---CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCce
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW---NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNL 748 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~---~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~l 748 (958)
....+|..+..||.|.|+.|+.+.. .+..|++|.+............-..|+.+...+ .|.+++.++..|..-.+.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 4456888999999999999999854 577899987665544332222334677676666 599999999989888889
Q ss_pred EEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCC-CcEEEEeccccccccC
Q 002160 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHN 827 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~-g~VKL~DFGLAk~~~~ 827 (958)
||-.|||+++++.....-.....+...+....+.+.++.++|+.. ++|+|+||+||++..+ +..++.|||+...+..
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhccccccccccce
Confidence 999999999988766532222333333444455589999999888 9999999999999875 8899999999865321
Q ss_pred CcccCCCCCCCCCcc--CcccccCCCCCchhhHHHHHHHHHHHHhCCC-CCCCCChhHHHHhhhccccccCCCCCCcHHH
Q 002160 828 TFLSSKSTAGTPEWM--APEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 904 (958)
Q Consensus 828 ~~~~~~s~~GT~~Y~--APEvl~g~~~s~ksDIWSLGiLLyELLtG~~-PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL 904 (958)
. ...+.+.-+++ +++.+....+-.+.|+++||..+++.+++.. ++.+.... .+ .............++
T Consensus 420 ~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~----~i--~~~~~p~~~~~~~~~ 490 (524)
T KOG0601|consen 420 S---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL----TI--RSGDTPNLPGLKLQL 490 (524)
T ss_pred e---cccccccccccccchhhccccccccccccccccccccccccCcccCcccccce----ee--ecccccCCCchHHhh
Confidence 1 11233334444 5556667778899999999999999999864 33332211 11 222222223344788
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 002160 905 ARIIWECWQTDPSLRPSFAQLTVALKPLQ 933 (958)
Q Consensus 905 ~dLI~~CL~kDP~kRPSa~EIL~~L~kL~ 933 (958)
..+.+.++..++..||.+.++..+.+...
T Consensus 491 q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 491 QVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred hhhhhhhcCCccccchhhhhhcccchhhh
Confidence 89999999999999999999887776554
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.10 E-value=5.5e-10 Score=117.00 Aligned_cols=137 Identities=20% Similarity=0.121 Sum_probs=91.1
Q ss_pred EEeeccCceEEEEEEEC--------CcEEEEEEeecCCC--C------------------HHHHH----HHHHHHHHHHH
Q 002160 682 ERIGLGSYGEVYHADWN--------GTEVAVKKFLDQDF--S------------------GAALL----EFKREVKIMRR 729 (958)
Q Consensus 682 k~LG~G~fG~Vykak~~--------g~~VAVK~i~~~~~--~------------------~~~~~----~f~~Ei~ILk~ 729 (958)
..||.|--+.||.|... +..+|||+++.... . ..... ..++|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 45899999999999653 37899997742110 0 00111 23489999999
Q ss_pred cCC--CceeEEeccccCCCceEEEEeecCCCCHHH-HHhCCCCCccHHHHHHHHHHHHHHHHH-HhcCCcEeecCCCCCc
Q 002160 730 LRH--PNVVLFMGAVTRPPNLSIITEFLPRGSLFR-ILHRPHCQVDEKRRIKMALDARGMNCL-HTSTPTIVHRDLKSPN 805 (958)
Q Consensus 730 L~H--PNIVkL~g~~~~~~~l~LVmEy~~gGsL~d-~L~k~~~~~~e~~~l~ia~~a~aL~yL-H~~g~gIIHRDLKPeN 805 (958)
+.. -++.+++++ ..-+|||||+.++.+.. .+... ..........+.+.+.+|..+ |..+ |||+||++.|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~-~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA-KLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc-ccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHH
Confidence 953 566677764 45689999997654432 22221 111122222233446778777 8887 9999999999
Q ss_pred eEEcCCCcEEEEecccccccc
Q 002160 806 LLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 806 ILId~~g~VKL~DFGLAk~~~ 826 (958)
||++ ++.++|+|||.+....
T Consensus 156 IL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 156 MLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEEE-CCcEEEEECCCceeCC
Confidence 9997 4689999999887653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.2e-09 Score=112.70 Aligned_cols=132 Identities=23% Similarity=0.331 Sum_probs=98.2
Q ss_pred EeeccCceEEEEEEECCcEEEEEEeecCCCCHHH------HHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeecC
Q 002160 683 RIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAA------LLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLP 756 (958)
Q Consensus 683 ~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~------~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~ 756 (958)
.|++|+-..+|.+.|.+..+++|.-.++.+.... ..+-.+|+++|.+++--.|.-.+=++.+++...|+|||++
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~ 82 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE 82 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence 5889999999999998888888865554443322 2346789999999965555444444456777889999999
Q ss_pred CCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 757 RGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 757 gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
|..|.+++.... . . .+-..-.-+.-||..+ |||+||.+.||++..++ +.++||||+..
T Consensus 83 G~~lkd~l~~~~--~--~---~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 83 GELLKDALEEAR--P--D---LLREVGRLVGKLHKAG--IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred ChhHHHHHHhcc--h--H---HHHHHHHHHHHHHhcC--eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999998887651 1 0 1111134567789988 99999999999998765 99999999863
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.98 E-value=3.8e-09 Score=108.91 Aligned_cols=140 Identities=21% Similarity=0.241 Sum_probs=92.3
Q ss_pred EEeeccCceEEEEEEECC-cEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCC--CceeEEeccccCC---CceEEEEeec
Q 002160 682 ERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH--PNVVLFMGAVTRP---PNLSIITEFL 755 (958)
Q Consensus 682 k~LG~G~fG~Vykak~~g-~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~H--PNIVkL~g~~~~~---~~l~LVmEy~ 755 (958)
+.|+.|.++.||+++..+ +.+++|........ .....+..|+++++.+.+ .++.+++.+.... +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999998765 89999986544321 124467899999999965 3456777776553 3678999999
Q ss_pred CCCCHHHHHhCCCCCccHHHHH-HHHHHHHHHHHHHh-------------------------------------------
Q 002160 756 PRGSLFRILHRPHCQVDEKRRI-KMALDARGMNCLHT------------------------------------------- 791 (958)
Q Consensus 756 ~gGsL~d~L~k~~~~~~e~~~l-~ia~~a~aL~yLH~------------------------------------------- 791 (958)
+|.+|.+.+.. ......... ...+.+..|..||.
T Consensus 83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 98877654321 001111110 11111222222221
Q ss_pred -----------cCCcEeecCCCCCceEEcC--CCcEEEEecccccc
Q 002160 792 -----------STPTIVHRDLKSPNLLVDK--NWNVKVSDFGLSRL 824 (958)
Q Consensus 792 -----------~g~gIIHRDLKPeNILId~--~g~VKL~DFGLAk~ 824 (958)
....++|+|+.|.|||++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1234899999999999998 67789999997753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=7.6e-09 Score=106.69 Aligned_cols=143 Identities=17% Similarity=0.209 Sum_probs=100.9
Q ss_pred EEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHH------HHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 680 LGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGA------ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 680 i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~------~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
....|-+|+-+.|+++.+.|+.+.||.-....+... ...+.++|+++|.+++--.|.-..-+|.+...-.|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 457799999999999999999999986544444322 23456889999999865454433334455556678999
Q ss_pred ecCC-CCHHHHHhCCCCCc-cHHH-HHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCC---cEEEEecccccc
Q 002160 754 FLPR-GSLFRILHRPHCQV-DEKR-RIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNW---NVKVSDFGLSRL 824 (958)
Q Consensus 754 y~~g-GsL~d~L~k~~~~~-~e~~-~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g---~VKL~DFGLAk~ 824 (958)
|++| .++.+++....... .... .-.....-..+.-||..+ |||+||..+||++..++ .+.|+|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhc
Confidence 9987 47777775433222 2222 222223367788999998 99999999999997543 368999999754
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.75 E-value=3.1e-07 Score=104.13 Aligned_cols=251 Identities=17% Similarity=0.241 Sum_probs=157.8
Q ss_pred EEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEecc------ccC-CCceEEE
Q 002160 680 LGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA------VTR-PPNLSII 751 (958)
Q Consensus 680 i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~------~~~-~~~l~LV 751 (958)
.++.||+|+-+.+|-.-.-+.. +-|+++........ + -+..|... .||-+-.-+.| .-+ +....++
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d~-VAKIYh~Pppa~~a--q---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRDQ-VAKIYHAPPPAAQA--Q---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecchhhch-hheeecCCCchHHH--H---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 4577999999999865332333 34666554332211 1 12233333 56543321111 112 2226678
Q ss_pred EeecCCCC-HHHHHh-----CCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 752 TEFLPRGS-LFRILH-----RPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 752 mEy~~gGs-L~d~L~-----k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
|..+.|.. ..+++. +.-....+...++.+.. +.+.+-||.+| .+-+|+.++|+|+.+++.|.|.|=..-..
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceEEEEcccceee
Confidence 88877642 233332 12224456666666665 88899999998 89999999999999999999998553322
Q ss_pred ccCCcccCCCCCCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhC-CCCCCCC-------ChhH--HHHhh--
Q 002160 825 KHNTFLSSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATL-KLPWIGM-------NPMQ--VVGAV-- 887 (958)
Q Consensus 825 ~~~~~~~~~s~~GT~~Y~APEvl~-----g~~~s~ksDIWSLGiLLyELLtG-~~PF~g~-------~~~e--i~~~i-- 887 (958)
..+ .......+|..+|.+||... |..-+...|.|.||+++|+|+.| +.||.|. ++.+ +....
T Consensus 167 ~~n-g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ 245 (637)
T COG4248 167 NAN-GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA 245 (637)
T ss_pred ccC-CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence 212 12233456899999999865 44457788999999999999887 8999763 2222 11100
Q ss_pred -------hccccccCCC-CCCcHHHHHHHHHhhhc--CCCCCCCHHHHHHHHHhhhhhcCCC
Q 002160 888 -------GFQNRRLEIP-KELDPLVARIIWECWQT--DPSLRPSFAQLTVALKPLQRLVIPS 939 (958)
Q Consensus 888 -------~~~~~~~~ip-~~ls~eL~dLI~~CL~k--DP~kRPSa~EIL~~L~kL~k~~~p~ 939 (958)
........+| .-+++.++.|..+|+.. .+.-||+++..+..|..+.++..++
T Consensus 246 ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C 307 (637)
T COG4248 246 YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKC 307 (637)
T ss_pred echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhh
Confidence 0011112233 24789999999999964 3678999999998888887765543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.4e-07 Score=103.43 Aligned_cols=135 Identities=19% Similarity=0.127 Sum_probs=90.1
Q ss_pred cCceEEEEEEECCcEEEEEEeecCCCCHH---------HHHHHHHHHHHHHHcCCCc--eeEEeccccC-----CCceEE
Q 002160 687 GSYGEVYHADWNGTEVAVKKFLDQDFSGA---------ALLEFKREVKIMRRLRHPN--VVLFMGAVTR-----PPNLSI 750 (958)
Q Consensus 687 G~fG~Vykak~~g~~VAVK~i~~~~~~~~---------~~~~f~~Ei~ILk~L~HPN--IVkL~g~~~~-----~~~l~L 750 (958)
.....|+++.+.|+.|.||........+- ....+.+|...+.+|..-+ .+.+++++.. ....+|
T Consensus 33 ~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L 112 (268)
T PRK15123 33 LEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI 112 (268)
T ss_pred CCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence 33344777888999999997644331110 0114778999998884333 2344444432 234789
Q ss_pred EEeecCCC-CHHHHHhCC-CCCccHHHH-HHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcC-------CCcEEEEecc
Q 002160 751 ITEFLPRG-SLFRILHRP-HCQVDEKRR-IKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDK-------NWNVKVSDFG 820 (958)
Q Consensus 751 VmEy~~gG-sL~d~L~k~-~~~~~e~~~-l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~-------~g~VKL~DFG 820 (958)
|||++++. +|.+++... ........+ ..+...+..+.-||..| |+|+|+++.||||+. ++.+.|+||+
T Consensus 113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~ 190 (268)
T PRK15123 113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLH 190 (268)
T ss_pred EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence 99999876 898887531 112222222 23333478899999998 999999999999975 4689999999
Q ss_pred ccc
Q 002160 821 LSR 823 (958)
Q Consensus 821 LAk 823 (958)
.+.
T Consensus 191 r~~ 193 (268)
T PRK15123 191 RAQ 193 (268)
T ss_pred ccc
Confidence 774
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.67 E-value=2.1e-07 Score=97.08 Aligned_cols=127 Identities=28% Similarity=0.289 Sum_probs=75.6
Q ss_pred EEEEEEE-CCcEEEEEEeecCC--CC----------------------HHHHHHHHHHHHHHHHcCCC--ceeEEecccc
Q 002160 691 EVYHADW-NGTEVAVKKFLDQD--FS----------------------GAALLEFKREVKIMRRLRHP--NVVLFMGAVT 743 (958)
Q Consensus 691 ~Vykak~-~g~~VAVK~i~~~~--~~----------------------~~~~~~f~~Ei~ILk~L~HP--NIVkL~g~~~ 743 (958)
.||.|.. ++..+|||..+... +. ........+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899976 78899999774321 11 11223567899999999755 566777553
Q ss_pred CCCceEEEEeecC--CCCHHHHHhCCCCCccHHHHHHHHHHHH-HHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecc
Q 002160 744 RPPNLSIITEFLP--RGSLFRILHRPHCQVDEKRRIKMALDAR-GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 820 (958)
Q Consensus 744 ~~~~l~LVmEy~~--gGsL~d~L~k~~~~~~e~~~l~ia~~a~-aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFG 820 (958)
.-.|||||++ |..+..+...... ......+.. ..+. ....+|..| |||+||.+.|||++++ .+.|+|||
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~~~-~~~~~~~~~-~il~~~~~~~~~~g--ivHGDLs~~NIlv~~~-~~~iIDf~ 151 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVDLS-PEEPKELLE-EILEEIIKMLHKAG--IVHGDLSEYNILVDDG-KVYIIDFG 151 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCGGG-GSTHHHHHH-HHHHHHHHHHHCTT--EEESS-STTSEEEETT-CEEE--GT
T ss_pred ---CCEEEEEecCCCccchhhHHhcccc-chhHHHHHH-HHHHHHHHHHHhcC--ceecCCChhhEEeecc-eEEEEecC
Confidence 3479999998 6555544432211 111111111 1122 334457877 9999999999999987 99999999
Q ss_pred cccccc
Q 002160 821 LSRLKH 826 (958)
Q Consensus 821 LAk~~~ 826 (958)
.+....
T Consensus 152 qav~~~ 157 (188)
T PF01163_consen 152 QAVDSS 157 (188)
T ss_dssp TEEETT
T ss_pred cceecC
Confidence 886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.8e-06 Score=100.26 Aligned_cols=211 Identities=16% Similarity=0.177 Sum_probs=146.7
Q ss_pred CceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC----CCceEEEEeecCC-CCH
Q 002160 688 SYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR----PPNLSIITEFLPR-GSL 760 (958)
Q Consensus 688 ~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~----~~~l~LVmEy~~g-GsL 760 (958)
.-.+.|++.. +|..|++|+++...... ...-..-+++++++.|.|||+|.++|.. +..+++|++|.++ ++|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~--~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQS--TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccC--cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 3456788854 78999999984332211 1112234678999999999999999873 3458899999985 578
Q ss_pred HHHHhCCC---------------CCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 761 FRILHRPH---------------CQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 761 ~d~L~k~~---------------~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
.++..... ...++..+.++.++..||.++|+.| +..+=|.|.+||++.+.+++|...|+...+
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEecccceeee
Confidence 77653221 1223455666667799999999998 788999999999998889999877776554
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCChhHH-HHhhhccccccCCCCCCcHH
Q 002160 826 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP-WIGMNPMQV-VGAVGFQNRRLEIPKELDPL 903 (958)
Q Consensus 826 ~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~P-F~g~~~~ei-~~~i~~~~~~~~ip~~ls~e 903 (958)
.... -|-+.+ ..+-|.-.||.+++.|.+|..- |.....++. .. .+-..++.+
T Consensus 444 ~~d~--------------~~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~---------~I~~~yS~D 497 (655)
T KOG3741|consen 444 QEDP--------------TEPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLT---------RITTTYSTD 497 (655)
T ss_pred cCCC--------------CcchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHH---------HhhhhhhHH
Confidence 3321 022222 2567899999999999998532 333333322 11 223568899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002160 904 VARIIWECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 904 L~dLI~~CL~kDP~kRPSa~EIL~~L 929 (958)
++++|.-+...++++ -++.+++.++
T Consensus 498 ~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 498 LRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred HHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 999999999988887 5666666554
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=5.7e-08 Score=115.58 Aligned_cols=143 Identities=18% Similarity=0.263 Sum_probs=105.2
Q ss_pred HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC---------CCCCCCCCccCcccccCCCCC
Q 002160 783 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS---------KSTAGTPEWMAPEVLRNEPSN 853 (958)
Q Consensus 783 a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~---------~s~~GT~~Y~APEvl~g~~~s 853 (958)
+.||.|+|.+- ++||++|.|++|.+++++.+||+.|+++.-........ .-..-...|.|||++.+...+
T Consensus 109 ~dgl~flh~sA-k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~~ 187 (700)
T KOG2137|consen 109 ADGLAFLHRSA-KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTNT 187 (700)
T ss_pred cchhhhhccCc-ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccccc
Confidence 47999999863 69999999999999999999999999876543311110 011235689999999998889
Q ss_pred chhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHh--hhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q 002160 854 EKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGA--VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLT 926 (958)
Q Consensus 854 ~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~--i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL 926 (958)
.++|+||||+++|.+.. |+.-+...+....... ........-++..++.++++-+.++|..++..||++.++.
T Consensus 188 ~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 188 PASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 99999999999999985 4444444322222111 1112223344578999999999999999999999776654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=8e-07 Score=96.85 Aligned_cols=136 Identities=24% Similarity=0.264 Sum_probs=94.0
Q ss_pred eeEEEEeeccCceEEEEEEE-CCcEEEEEEeecCC------------------CC--HHHHHHHHHHHHHHHHcCCC--c
Q 002160 678 LVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQD------------------FS--GAALLEFKREVKIMRRLRHP--N 734 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~------------------~~--~~~~~~f~~Ei~ILk~L~HP--N 734 (958)
..++..||-|--+.||.|.. .+.++|||.-+.-. .+ ........+|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 35678899999999999987 69999999432110 01 11223567899999999644 6
Q ss_pred eeEEeccccCCCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcE
Q 002160 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNV 814 (958)
Q Consensus 735 IVkL~g~~~~~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~V 814 (958)
|.+.+++ ++-.+||||++|-.|...-- ...+....+..++......| ..| |||+|+.+-|||++++|.+
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~---~~en~~~il~~il~~~~~~~--~~G--iVHGDlSefNIlV~~dg~~ 241 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL---DVENPDEILDKILEEVRKAY--RRG--IVHGDLSEFNILVTEDGDI 241 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC---cccCHHHHHHHHHHHHHHHH--HcC--ccccCCchheEEEecCCCE
Confidence 7777765 45679999999987765431 11122222333332222333 455 9999999999999999999
Q ss_pred EEEecccccc
Q 002160 815 KVSDFGLSRL 824 (958)
Q Consensus 815 KL~DFGLAk~ 824 (958)
.++||-.+..
T Consensus 242 ~vIDwPQ~v~ 251 (304)
T COG0478 242 VVIDWPQAVP 251 (304)
T ss_pred EEEeCccccc
Confidence 9999986654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.48 E-value=6.5e-07 Score=94.05 Aligned_cols=127 Identities=26% Similarity=0.231 Sum_probs=84.5
Q ss_pred EECCcEEEEEEeecCCCCH-----HHHHHHHHHHHHHHHcCCC--ceeEEeccccCC----CceEEEEeecCCC-CHHHH
Q 002160 696 DWNGTEVAVKKFLDQDFSG-----AALLEFKREVKIMRRLRHP--NVVLFMGAVTRP----PNLSIITEFLPRG-SLFRI 763 (958)
Q Consensus 696 k~~g~~VAVK~i~~~~~~~-----~~~~~f~~Ei~ILk~L~HP--NIVkL~g~~~~~----~~l~LVmEy~~gG-sL~d~ 763 (958)
....+.+.+|......... ....+..+|...+..|..- .+.+.+++.... ...+||||++++. +|.++
T Consensus 29 ~~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~ 108 (206)
T PF06293_consen 29 DLVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDL 108 (206)
T ss_pred cccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHH
Confidence 3455666666433221111 1233677888888888432 234555554432 2358999999884 79998
Q ss_pred HhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCC---cEEEEecccccc
Q 002160 764 LHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNW---NVKVSDFGLSRL 824 (958)
Q Consensus 764 L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g---~VKL~DFGLAk~ 824 (958)
+..............+...+..+.-||..| |+|+|+++.|||++.++ .+.|+||+-++.
T Consensus 109 ~~~~~~~~~~~~~~ll~~l~~~i~~lH~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 109 LQQWEQLDPSQRRELLRALARLIAKLHDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHhhcccchhhHHHHHHHHHHHHHHHHHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 876333223333333444478899999998 99999999999999887 899999997754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.26 E-value=3.5e-06 Score=100.05 Aligned_cols=142 Identities=22% Similarity=0.219 Sum_probs=92.5
Q ss_pred EEeeccCceEEEEEEE-CCcEEEEEEeecCCCC---------------------------HH-HH----------HHHHH
Q 002160 682 ERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFS---------------------------GA-AL----------LEFKR 722 (958)
Q Consensus 682 k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~---------------------------~~-~~----------~~f~~ 722 (958)
+.|+.++-|.||+|++ +|+.||||+.++.-.. .. .. ..+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5699999999999998 4999999976532111 00 00 12456
Q ss_pred HHHHHHHcC-----CCceeEEeccccCCCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEe
Q 002160 723 EVKIMRRLR-----HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIV 797 (958)
Q Consensus 723 Ei~ILk~L~-----HPNIVkL~g~~~~~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gII 797 (958)
|...+.+++ .++|.-..=+++....-.|+|||++|-.+.++........+......... -..+..+-..| ++
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~-~~f~~q~~~dg--ff 287 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLV-RAFLRQLLRDG--FF 287 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHH-HHHHHHHHhcC--cc
Confidence 666666662 35554333444555667899999999988887422222222111111111 12233333456 99
Q ss_pred ecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 798 HRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 798 HRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
|.|..|.||+++.+|++.+.|||+...+.
T Consensus 288 HaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 288 HADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred ccCCCccceEEecCCcEEEEcCcceecCC
Confidence 99999999999999999999999987654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.15 E-value=3.5e-05 Score=79.49 Aligned_cols=139 Identities=19% Similarity=0.242 Sum_probs=83.3
Q ss_pred EEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCC--ceeEEeccc---cCCCceEEEEeec
Q 002160 681 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP--NVVLFMGAV---TRPPNLSIITEFL 755 (958)
Q Consensus 681 ~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HP--NIVkL~g~~---~~~~~l~LVmEy~ 755 (958)
++.|+.|..+.||++...+..+++|..... .....+.+|..+++.|... .+.+++.+. ......+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 467999999999999988889999985443 3456778899999888422 345666533 2233478999999
Q ss_pred CCCCHHH----------------HH---hCC---CCCccHHH--------HH-HH-----H--------HHHH-HHHHHH
Q 002160 756 PRGSLFR----------------IL---HRP---HCQVDEKR--------RI-KM-----A--------LDAR-GMNCLH 790 (958)
Q Consensus 756 ~gGsL~d----------------~L---~k~---~~~~~e~~--------~l-~i-----a--------~~a~-aL~yLH 790 (958)
+|..+.. .+ ++. ........ .. .. . .... .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9988877 11 111 01111000 00 00 0 0001 233333
Q ss_pred h-----cCCcEeecCCCCCceEEc-CCCcEEEEeccccc
Q 002160 791 T-----STPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSR 823 (958)
Q Consensus 791 ~-----~g~gIIHRDLKPeNILId-~~g~VKL~DFGLAk 823 (958)
. ....++|+|+.|.|||++ +++.+.|+||+.+.
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2 233599999999999999 67777899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.12 E-value=3.5e-05 Score=82.01 Aligned_cols=139 Identities=17% Similarity=0.103 Sum_probs=95.4
Q ss_pred eeccCceEEEEEEECCcEEEEEEeecCCC---C-HHHHHHHHHHHHHHHHcCC--CceeEEeccc--cCC--CceEEEEe
Q 002160 684 IGLGSYGEVYHADWNGTEVAVKKFLDQDF---S-GAALLEFKREVKIMRRLRH--PNVVLFMGAV--TRP--PNLSIITE 753 (958)
Q Consensus 684 LG~G~fG~Vykak~~g~~VAVK~i~~~~~---~-~~~~~~f~~Ei~ILk~L~H--PNIVkL~g~~--~~~--~~l~LVmE 753 (958)
-|+||-+.|+.....|..+-+|.-..... . ..-...|.+|...|.+|.. -.+.++..+. ..+ .+.+||+|
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE 105 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence 46699999999998888899986431110 0 1134578999999999953 2244444221 111 23679999
Q ss_pred ecCC-CCHHHHHhCCCC-CccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCc--EEEEecccccc
Q 002160 754 FLPR-GSLFRILHRPHC-QVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN--VKVSDFGLSRL 824 (958)
Q Consensus 754 y~~g-GsL~d~L~k~~~-~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~--VKL~DFGLAk~ 824 (958)
-++| -+|.+++..... ......+..++.. +..+.-||..+ +.|+|+-+.|||++.+|. ++++||--++.
T Consensus 106 ~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 106 DMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred eCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 7754 588888865322 2333333333333 88999999998 999999999999986667 99999986543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.11 E-value=2.8e-05 Score=83.23 Aligned_cols=135 Identities=19% Similarity=0.221 Sum_probs=85.0
Q ss_pred EEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCc--eeEEeccccCCCceEEEEeecCCCC
Q 002160 682 ERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN--VVLFMGAVTRPPNLSIITEFLPRGS 759 (958)
Q Consensus 682 k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPN--IVkL~g~~~~~~~l~LVmEy~~gGs 759 (958)
..||+|..+.||+. .+..+++|...... . ...+.+|.++++.+..-. +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~-~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF-D---KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC-C---HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 56899999999984 35678888765432 1 234688999999985433 4677777777777889999999863
Q ss_pred -HH--------------HH-------HhCC---CCCccHH-HHHHHHH----------HHHHHHHHH--hcCCcEeecCC
Q 002160 760 -LF--------------RI-------LHRP---HCQVDEK-RRIKMAL----------DARGMNCLH--TSTPTIVHRDL 801 (958)
Q Consensus 760 -L~--------------d~-------L~k~---~~~~~e~-~~l~ia~----------~a~aL~yLH--~~g~gIIHRDL 801 (958)
+. .. ++.. ....... .++...+ ......+|. .....++|+|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 11 11 1221 1111110 0110000 011122332 22335899999
Q ss_pred CCCceEEcCCCcEEEEeccccc
Q 002160 802 KSPNLLVDKNWNVKVSDFGLSR 823 (958)
Q Consensus 802 KPeNILId~~g~VKL~DFGLAk 823 (958)
.|.||++++++ +.|+||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999888 9999999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.09 E-value=3e-05 Score=82.67 Aligned_cols=136 Identities=21% Similarity=0.229 Sum_probs=84.6
Q ss_pred EeeccCc-eEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeccccCCCceEEEEeecCCCCH
Q 002160 683 RIGLGSY-GEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEFLPRGSL 760 (958)
Q Consensus 683 ~LG~G~f-G~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~-HPNIVkL~g~~~~~~~l~LVmEy~~gGsL 760 (958)
.|-.|.. ..||+....+..++||...... ...+.+|+++++.+. +--+.++++++...+..++|||+++|..|
T Consensus 5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred ecCCCCCcCeEEEEcCCCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 3555665 7889997777788888754432 235678999998883 44466788877766778999999998776
Q ss_pred HHHH-------------------hCCC---CCccHH--HHHHHHH---------------------HHHHHHHHHh----
Q 002160 761 FRIL-------------------HRPH---CQVDEK--RRIKMAL---------------------DARGMNCLHT---- 791 (958)
Q Consensus 761 ~d~L-------------------~k~~---~~~~e~--~~l~ia~---------------------~a~aL~yLH~---- 791 (958)
.... +... ...... ..+.... ....+..|-.
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 5331 1110 011100 0000000 0011112211
Q ss_pred -cCCcEeecCCCCCceEEcCCCcEEEEeccccc
Q 002160 792 -STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 823 (958)
Q Consensus 792 -~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk 823 (958)
..+.++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 12359999999999999998888999999763
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.07 E-value=4.5e-05 Score=81.61 Aligned_cols=140 Identities=16% Similarity=0.125 Sum_probs=92.8
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHH-HHH------HHHHHHHHHHcCCC---ceeEEecc-
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAA-LLE------FKREVKIMRRLRHP---NVVLFMGA- 741 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~-~~~------f~~Ei~ILk~L~HP---NIVkL~g~- 741 (958)
+.-.+|.+.+++-.....-|.+...+++.+++|..+......+. ... ..+++..+.+++.. .+..++.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 44568899999988888888888899999999987655432221 111 23445555555322 22222222
Q ss_pred ----ccCCCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEE
Q 002160 742 ----VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVS 817 (958)
Q Consensus 742 ----~~~~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~ 817 (958)
+......+|+|||++|..|.++..- .+...- ..+.++.-||.+| +.|+|..|.|+++.+++ ++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~i-----~e~~~~---ki~~~ikqlH~~G--~~HGD~hpgNFlv~~~~-i~iI 176 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIEDI-----DEDLAE---KIVEAIKQLHKHG--FYHGDPHPGNFLVSNNG-IRII 176 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchhc-----CHHHHH---HHHHHHHHHHHcC--CccCCCCcCcEEEECCc-EEEE
Confidence 2222346689999999988776431 111111 1245688999998 99999999999998655 9999
Q ss_pred eccccc
Q 002160 818 DFGLSR 823 (958)
Q Consensus 818 DFGLAk 823 (958)
||+..+
T Consensus 177 D~~~k~ 182 (229)
T PF06176_consen 177 DTQGKR 182 (229)
T ss_pred ECcccc
Confidence 998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.02 E-value=6.5e-05 Score=81.47 Aligned_cols=138 Identities=20% Similarity=0.120 Sum_probs=86.6
Q ss_pred EEEeeccCceEEEEEEE-CCcEEEEEEeecCCCCHHH----------------------HHHHHHHHHHHHHcC--CCce
Q 002160 681 GERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAA----------------------LLEFKREVKIMRRLR--HPNV 735 (958)
Q Consensus 681 ~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~~~----------------------~~~f~~Ei~ILk~L~--HPNI 735 (958)
...|..|--..||+|.. ++..||||+++........ .....+|+.-|+++. +-.+
T Consensus 53 ~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 53 VGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred EeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 34677888889999964 7999999988643221111 112457888888884 4445
Q ss_pred eEEeccccCCCceEEEEeecCCCCHH-HHHhCCCCCccHHHHHHHHHHHHHHHHHHh-cCCcEeecCCCCCceEEcCCCc
Q 002160 736 VLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDARGMNCLHT-STPTIVHRDLKSPNLLVDKNWN 813 (958)
Q Consensus 736 VkL~g~~~~~~~l~LVmEy~~gGsL~-d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~-~g~gIIHRDLKPeNILId~~g~ 813 (958)
.+.+.+.. -.|||||+....+- -.|..-. ...+.......+.+..+.-|-. .+ +||+||..-|||+. ++.
T Consensus 133 P~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~-~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 133 PEPIAFRN----NVLVMEFIGDDGLPAPRLKDVP-LELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH-DGE 204 (268)
T ss_pred CCceeecC----CeEEEEeccCCCCCCCCcccCC-cCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE-CCe
Confidence 56666543 36999999543111 1122111 1111222222222445554444 55 99999999999999 889
Q ss_pred EEEEecccccccc
Q 002160 814 VKVSDFGLSRLKH 826 (958)
Q Consensus 814 VKL~DFGLAk~~~ 826 (958)
+.|||||.|....
T Consensus 205 p~iID~~QaV~~~ 217 (268)
T COG1718 205 PYIIDVSQAVTID 217 (268)
T ss_pred EEEEECccccccC
Confidence 9999999887554
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.00 E-value=1.3e-06 Score=103.25 Aligned_cols=181 Identities=21% Similarity=0.219 Sum_probs=127.5
Q ss_pred EEEeeccCceEEEEEEECCcE-EEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCc-eeEEeccccCCCceEEEEeecCCC
Q 002160 681 GERIGLGSYGEVYHADWNGTE-VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN-VVLFMGAVTRPPNLSIITEFLPRG 758 (958)
Q Consensus 681 ~k~LG~G~fG~Vykak~~g~~-VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPN-IVkL~g~~~~~~~l~LVmEy~~gG 758 (958)
-..+++|++++++|.+-..+. ...+.+... ....-++++|.+++||| .+..++-++.+...+++|+|+.++
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~ 319 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTG 319 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCC
Confidence 344789999999998764433 223433222 34567889999999999 777777778888899999999877
Q ss_pred -CHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCC
Q 002160 759 -SLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 836 (958)
Q Consensus 759 -sL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~ 836 (958)
+-..........+.+....+.... ..++++||+.. =+||| |||..+ +..|+.||+....+.... ..+.+.
T Consensus 320 rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~~t~~ 391 (829)
T KOG0576|consen 320 RSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KPRTAI 391 (829)
T ss_pred ccccccCChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccCCcccCccc-ccccCC
Confidence 222111111111111111222222 67899999864 48998 777755 679999999988776554 556788
Q ss_pred CCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 002160 837 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI 876 (958)
Q Consensus 837 GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~ 876 (958)
+|+.|+|||+.....+....|.|++|.--.+|--|-+|-.
T Consensus 392 ~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 392 GTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 9999999999999999999999999987777777766643
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.89 E-value=6e-05 Score=78.07 Aligned_cols=131 Identities=21% Similarity=0.244 Sum_probs=87.6
Q ss_pred CeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCce-eEEeccccCCCceEEEEeec
Q 002160 677 DLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV-VLFMGAVTRPPNLSIITEFL 755 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNI-VkL~g~~~~~~~l~LVmEy~ 755 (958)
...+.+.|++|.+|.||+|.|.+..+|+|+-+... ....+..|+++|..+.-.++ .++|.|..+ ++.|||+
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds----~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i 94 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDS----PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYI 94 (201)
T ss_pred hhhhhhhhhcccccEEEEeeccCceEEEEEecCCc----chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhh
Confidence 34556789999999999999999999999754433 34578899999999986665 466665443 3559999
Q ss_pred CCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCC-CCceEEcCCCcEEEEecccccc
Q 002160 756 PRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLK-SPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 756 ~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLK-PeNILId~~g~VKL~DFGLAk~ 824 (958)
+|-.|.+.-... +....+.++.. -.-|...| |-|..|. |..++|-.++.+.|+||.-|..
T Consensus 95 ~G~~L~~~~~~~----~rk~l~~vlE~---a~~LD~~G--I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 95 DGRPLGKLEIGG----DRKHLLRVLEK---AYKLDRLG--IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cCcchhhhhhcc----cHHHHHHHHHH---HHHHHHhc--cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 998887765431 12222222222 12223334 6666654 4444454555999999998864
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00028 Score=74.72 Aligned_cols=127 Identities=29% Similarity=0.409 Sum_probs=89.1
Q ss_pred CCeeEEEEeeccCc-eEEEEEEECCcEEEEEEeecCC----------CCH---------HHHHHHHHHHHHHHHcC---C
Q 002160 676 EDLVLGERIGLGSY-GEVYHADWNGTEVAVKKFLDQD----------FSG---------AALLEFKREVKIMRRLR---H 732 (958)
Q Consensus 676 ~dy~i~k~LG~G~f-G~Vykak~~g~~VAVK~i~~~~----------~~~---------~~~~~f~~Ei~ILk~L~---H 732 (958)
.+++.++.||.|.- |.||+++.+|..||+|.+..-. ... ....-|..|.+...+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 67899999999999 9999999999999999842211 000 11224778988888884 4
Q ss_pred Cce--eEEeccccCC------------------CceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhc
Q 002160 733 PNV--VLFMGAVTRP------------------PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTS 792 (958)
Q Consensus 733 PNI--VkL~g~~~~~------------------~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~ 792 (958)
.++ |+++||..-. ....||.||++... .. ....+-.+..-|..+|..
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~---~~~~~~~~~~dl~~~~k~ 183 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PL---QIRDIPQMLRDLKILHKL 183 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------cc---chhHHHHHHHHHHHHHHC
Confidence 566 9999987211 12468899887653 00 011112224557778998
Q ss_pred CCcEeecCCCCCceEEcCCCcEEEEecccc
Q 002160 793 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 822 (958)
Q Consensus 793 g~gIIHRDLKPeNILId~~g~VKL~DFGLA 822 (958)
+ |+=+|+|+.|.. .=||+|||.+
T Consensus 184 g--I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 184 G--IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred C--eeeccCcccccc-----CCEEEecccC
Confidence 8 999999999987 3489999854
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00039 Score=87.62 Aligned_cols=235 Identities=16% Similarity=0.115 Sum_probs=159.0
Q ss_pred eeccCceEEEEEEECC------cEEEEEEeec-CCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc----eEEEE
Q 002160 684 IGLGSYGEVYHADWNG------TEVAVKKFLD-QDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN----LSIIT 752 (958)
Q Consensus 684 LG~G~fG~Vykak~~g------~~VAVK~i~~-~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~----l~LVm 752 (958)
|..-.+|++++.+|.. .++-++.-.. .......+.....|...+.++.|+|++.++.|...... ..+..
T Consensus 186 ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~~~~k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~ 265 (1351)
T KOG1035|consen 186 LSHLTQGTLLLVKWVEQAQSLSEPIEISHDYESTPCGKKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQ 265 (1351)
T ss_pred eccccCceEEEEehhhhHHhhcCcccccCcccCccchHHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHH
Confidence 6667778888887621 1222221000 11112334456678888888999999999988655433 33556
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCC---ceEEcCCCcEEEE--eccccccccC
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSP---NLLVDKNWNVKVS--DFGLSRLKHN 827 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPe---NILId~~g~VKL~--DFGLAk~~~~ 827 (958)
|||...++...+..-+....+..+++.+....||.|+|... ..|.-|... +-.++..+.+.+. ||+..+...+
T Consensus 266 ~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~--l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d 343 (1351)
T KOG1035|consen 266 EICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS--LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPD 343 (1351)
T ss_pred hhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc--cceeEEecccccccccCccceeecchhhhcccccCCC
Confidence 88999999999988777777778888888899999999986 445444444 4445566777777 9998887765
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCch--hhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHH
Q 002160 828 TFLSSKSTAGTPEWMAPEVLRNEPSNEK--CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 905 (958)
Q Consensus 828 ~~~~~~s~~GT~~Y~APEvl~g~~~s~k--sDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~ 905 (958)
.... ....-...|.++|......+..+ .|+|.+|.++..+..|..+-..... . ...++........
T Consensus 344 ~~~~-~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~--~---------~~~l~~~~~~~~~ 411 (1351)
T KOG1035|consen 344 NEKS-FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAV--P---------VSLLDVLSTSELL 411 (1351)
T ss_pred cccc-hhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccc--h---------hhhhccccchhhh
Confidence 5332 22344567888888876665444 6999999999999987654211100 0 0111122222778
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 002160 906 RIIWECWQTDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 906 dLI~~CL~kDP~kRPSa~EIL~~L~kL 932 (958)
++..+|+.-++++|++..+++.+.-.-
T Consensus 412 d~~~~~~~~~~~~Rl~~~~ll~~~f~~ 438 (1351)
T KOG1035|consen 412 DALPKCLDEDSEERLSALELLTHPFLR 438 (1351)
T ss_pred hhhhhhcchhhhhccchhhhhhchhcc
Confidence 999999999999999999999887654
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00057 Score=86.09 Aligned_cols=78 Identities=17% Similarity=0.198 Sum_probs=56.8
Q ss_pred EEEeeccCceEEEEEEECC----cEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC-CCce--eEEeccccCC---CceEE
Q 002160 681 GERIGLGSYGEVYHADWNG----TEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNV--VLFMGAVTRP---PNLSI 750 (958)
Q Consensus 681 ~k~LG~G~fG~Vykak~~g----~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~-HPNI--VkL~g~~~~~---~~l~L 750 (958)
.+.|+.|.++.+|+.+..+ ..+++|+....... .....+.+|+++|+.|. |.+| .+++.++.+. +..|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 5778999999999987754 46777865432211 12346789999999995 6665 7888877664 46789
Q ss_pred EEeecCCCC
Q 002160 751 ITEFLPRGS 759 (958)
Q Consensus 751 VmEy~~gGs 759 (958)
||||++|..
T Consensus 122 VME~v~G~~ 130 (822)
T PLN02876 122 IMEYLEGRI 130 (822)
T ss_pred EEEecCCcc
Confidence 999998764
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00026 Score=84.52 Aligned_cols=139 Identities=20% Similarity=0.199 Sum_probs=85.3
Q ss_pred EEeeccCceEEEEEEE-CCcEEEEEEeecCCCCH--HHH---------------------------------HHHHHHHH
Q 002160 682 ERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSG--AAL---------------------------------LEFKREVK 725 (958)
Q Consensus 682 k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~--~~~---------------------------------~~f~~Ei~ 725 (958)
+.||.-+.|.||+|+. +|+.||||+-++.-... .++ ..|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5699999999999986 78999999654321110 000 02445555
Q ss_pred HHHHc----CCCc------eeEEeccccCCCceEEEEeecCCCCHHHH--HhCCCCCccHHHHHHHHHHHHHHHHHHhcC
Q 002160 726 IMRRL----RHPN------VVLFMGAVTRPPNLSIITEFLPRGSLFRI--LHRPHCQVDEKRRIKMALDARGMNCLHTST 793 (958)
Q Consensus 726 ILk~L----~HPN------IVkL~g~~~~~~~l~LVmEy~~gGsL~d~--L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g 793 (958)
-..++ .|-+ |.++|- .......|+||||+|.-+.|. +.+.+.... ........+-+- -+-.+|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~--~i~~~l~~~~~~-qIf~~G 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRGISPH--DILNKLVEAYLE-QIFKTG 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcCCCHH--HHHHHHHHHHHH-HHHhcC
Confidence 44444 3444 333332 233457899999999877654 444433222 122111112222 222345
Q ss_pred CcEeecCCCCCceEEcC----CCcEEEEeccccccccC
Q 002160 794 PTIVHRDLKSPNLLVDK----NWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 794 ~gIIHRDLKPeNILId~----~g~VKL~DFGLAk~~~~ 827 (958)
++|.|=.|.||||.. ++.+.+.|||+......
T Consensus 322 --ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 --FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred --CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 999999999999983 67899999999876543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00041 Score=73.96 Aligned_cols=72 Identities=15% Similarity=0.161 Sum_probs=45.9
Q ss_pred EEeeccCce-EEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCC---ceeEEeccccCC---CceEEEEee
Q 002160 682 ERIGLGSYG-EVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP---NVVLFMGAVTRP---PNLSIITEF 754 (958)
Q Consensus 682 k~LG~G~fG-~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HP---NIVkL~g~~~~~---~~l~LVmEy 754 (958)
+.|+.|+.. .||+. +..+++|...... ....+.+|.++|..|... -+.++++..... ...+++||+
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAAG----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCccc----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 467777776 48876 3467778643321 234688999999888531 344555544332 235889999
Q ss_pred cCCCCH
Q 002160 755 LPRGSL 760 (958)
Q Consensus 755 ~~gGsL 760 (958)
++|.++
T Consensus 76 i~G~~l 81 (235)
T cd05155 76 LEGETA 81 (235)
T ss_pred ecCCCC
Confidence 998765
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.58 E-value=1.4e-05 Score=101.50 Aligned_cols=199 Identities=16% Similarity=0.095 Sum_probs=133.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECC---cEEEEEEeecCCC---CHHHHHHHHHHHHHHHHcCCCceeEEeccccC--CCc
Q 002160 676 EDLVLGERIGLGSYGEVYHADWNG---TEVAVKKFLDQDF---SGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--PPN 747 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~~g---~~VAVK~i~~~~~---~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~--~~~ 747 (958)
+++++.=-||.|.++ +++|-+ ..+-+|+.+.-++ .+....-...|.+.++...|++++..+.-... ...
T Consensus 1229 e~~EV~l~i~~~~~~---R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~e 1305 (2724)
T KOG1826|consen 1229 EHSEVNLGISNHFHF---RNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTE 1305 (2724)
T ss_pred hhhheeeecccceee---ccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChH
Confidence 455555556666554 566522 2344554433222 23333344556666777789998877665432 334
Q ss_pred eEEEEeecCCCCHHHHHhCCCC---CccHHHHHHHHHH-HHHHHHHHhc---CCcEeecCCCCCceEEcCCCcEEEEecc
Q 002160 748 LSIITEFLPRGSLFRILHRPHC---QVDEKRRIKMALD-ARGMNCLHTS---TPTIVHRDLKSPNLLVDKNWNVKVSDFG 820 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~---~~~e~~~l~ia~~-a~aL~yLH~~---g~gIIHRDLKPeNILId~~g~VKL~DFG 820 (958)
.|.+++|+.+|.++..+-+... ............+ +....-+|.. +.-.+|++||+-|.+|..+..+|+.++|
T Consensus 1306 e~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~g 1385 (2724)
T KOG1826|consen 1306 EYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGG 1385 (2724)
T ss_pred HHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccc
Confidence 7899999999999998854322 2222222222222 4444444432 3348999999999999999999999999
Q ss_pred ccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 002160 821 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIG 877 (958)
Q Consensus 821 LAk~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g 877 (958)
+.+.............+++.|+.|++...-.++.++|+|.+|+.+|++-.|..+|..
T Consensus 1386 LdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~ 1442 (2724)
T KOG1826|consen 1386 LDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIF 1442 (2724)
T ss_pred cccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHH
Confidence 999544443334456788899999999988888889999999999999998888754
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0013 Score=73.26 Aligned_cols=79 Identities=15% Similarity=-0.009 Sum_probs=57.0
Q ss_pred eeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCC---CceeEEeccccC---CCceEEE
Q 002160 678 LVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH---PNVVLFMGAVTR---PPNLSII 751 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~H---PNIVkL~g~~~~---~~~l~LV 751 (958)
..-.+.||.|..+.||.....+..+++|..+. ... ...+..|...|+.|.. -.+.++++++.. .+..+||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~-~~~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQGNPMPLMARS-FST---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred hheeeecCCccceeEEEEEcCCCCEEEEEecc-ccc---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 34457799999999999977555677776432 111 2367899999998842 357788877654 3668999
Q ss_pred EeecCCCCH
Q 002160 752 TEFLPRGSL 760 (958)
Q Consensus 752 mEy~~gGsL 760 (958)
||+++|+++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998754
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0011 Score=70.23 Aligned_cols=73 Identities=19% Similarity=0.282 Sum_probs=49.0
Q ss_pred EEEeeccCceEEEEEEEC---CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeccccCCCceEEEEeecC
Q 002160 681 GERIGLGSYGEVYHADWN---GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEFLP 756 (958)
Q Consensus 681 ~k~LG~G~fG~Vykak~~---g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~-HPNIVkL~g~~~~~~~l~LVmEy~~ 756 (958)
++.|..|-...+|++... ++.|++|....... ......+|+.+++.+. +.-.+++++.+.. .++|||++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~ 75 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIP 75 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeC
Confidence 466888999999999765 57899997543211 1123457899999884 3334555554432 37999999
Q ss_pred CCCH
Q 002160 757 RGSL 760 (958)
Q Consensus 757 gGsL 760 (958)
|..+
T Consensus 76 G~~l 79 (235)
T cd05157 76 GRTL 79 (235)
T ss_pred CCcC
Confidence 8765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0014 Score=69.39 Aligned_cols=133 Identities=20% Similarity=0.306 Sum_probs=89.6
Q ss_pred EEeeccCceEEEEEEECCcEEEEEEeecCC--------------CCHHHHHHHHHHHHHHHHcC------CCceeEEecc
Q 002160 682 ERIGLGSYGEVYHADWNGTEVAVKKFLDQD--------------FSGAALLEFKREVKIMRRLR------HPNVVLFMGA 741 (958)
Q Consensus 682 k~LG~G~fG~Vykak~~g~~VAVK~i~~~~--------------~~~~~~~~f~~Ei~ILk~L~------HPNIVkL~g~ 741 (958)
..||+|+.=.||.-- .+....||+..... .......+..+|+.-...+. +.+|.+++|+
T Consensus 7 ~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 459999998888543 33445667766554 11112345666776666665 7889999999
Q ss_pred ccCCCceEEEEeecCC------CCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCC--C-
Q 002160 742 VTRPPNLSIITEFLPR------GSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKN--W- 812 (958)
Q Consensus 742 ~~~~~~l~LVmEy~~g------GsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~--g- 812 (958)
.++.....+|+|.+.. -+|.+++..... .. .+..++ -.-..||-.++ |+.+||+|.||++... +
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~--~~--~~~~~L-~~f~~~l~~~~--Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLKEGGL--TE--ELRQAL-DEFKRYLLDHH--IVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHHcCCc--cH--HHHHHH-HHHHHHHHHcC--CeecCCCcccEEEEecCCCc
Confidence 9999999999999742 378888865432 22 111111 23456777777 9999999999999632 2
Q ss_pred -cEEEEe-cccc
Q 002160 813 -NVKVSD-FGLS 822 (958)
Q Consensus 813 -~VKL~D-FGLA 822 (958)
.+.|+| ||-.
T Consensus 159 ~~lvlIDG~G~~ 170 (199)
T PF10707_consen 159 FRLVLIDGLGEK 170 (199)
T ss_pred eEEEEEeCCCCc
Confidence 588888 5543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.00059 Score=74.83 Aligned_cols=138 Identities=21% Similarity=0.160 Sum_probs=83.9
Q ss_pred EEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCC--ceeEEecc------ccCCCceEEEE
Q 002160 681 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP--NVVLFMGA------VTRPPNLSIIT 752 (958)
Q Consensus 681 ~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HP--NIVkL~g~------~~~~~~l~LVm 752 (958)
.+.|..|....+|+....+..+++|+.... . ...+..|++++..|.+- .+.+++.. ....+..++|+
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~--~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEKV--S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCCC--C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 566888888999999887778999986541 1 23566788888888432 24555442 12345678999
Q ss_pred eecCCCCHHH-----------HH---hCC--C--------CCccHHHHHHH-----------HHHHHHHHHHHh-----c
Q 002160 753 EFLPRGSLFR-----------IL---HRP--H--------CQVDEKRRIKM-----------ALDARGMNCLHT-----S 792 (958)
Q Consensus 753 Ey~~gGsL~d-----------~L---~k~--~--------~~~~e~~~l~i-----------a~~a~aL~yLH~-----~ 792 (958)
+|++|..+.. .+ +.. . ....+...... .....++.++.. .
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9998876421 11 110 0 00011110000 000223333332 1
Q ss_pred CCcEeecCCCCCceEEcCCCcEEEEeccccc
Q 002160 793 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 823 (958)
Q Consensus 793 g~gIIHRDLKPeNILId~~g~VKL~DFGLAk 823 (958)
..++||+|+.|.|||+++++.+.|+||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 2359999999999999998778999999764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0035 Score=65.58 Aligned_cols=100 Identities=20% Similarity=0.247 Sum_probs=74.9
Q ss_pred HHHHHHHHHcCC-CceeEEeccccCCCceEEEEeecCCCCHHHHHh--CCCCCccHHHHHHHHHH-HHHHHHHHhcCC-c
Q 002160 721 KREVKIMRRLRH-PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH--RPHCQVDEKRRIKMALD-ARGMNCLHTSTP-T 795 (958)
Q Consensus 721 ~~Ei~ILk~L~H-PNIVkL~g~~~~~~~l~LVmEy~~gGsL~d~L~--k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~-g 795 (958)
..|.-+|+.+++ +++++++|+|-+ ++++||+..+++..... .+-....|..+..++.. +..+.+|+.... .
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357888999976 699999999843 67999998776643210 01124567888888776 677777776322 3
Q ss_pred EeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 796 IVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 796 IIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
+.-.|++|+|+-|+++|++|++|...+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 88899999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >smart00460 TGc Transglutaminase/protease-like homologues | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.00051 Score=58.94 Aligned_cols=54 Identities=30% Similarity=0.248 Sum_probs=44.3
Q ss_pred cccccchhhHHHHHHhhhcCCCCceeecccCCC---------CccCcceEEEEeCCcceeeeec
Q 002160 262 INIGLSRHRALLFKVLADSIRLPCRLVKGSHYT---------GVEDDAVNIIKLEEEREFLVDL 316 (958)
Q Consensus 262 i~~G~~rhRAlLFKvLaD~i~l~c~lv~G~~~~---------g~~~~a~~~v~~~~~~~~~vDl 316 (958)
-+.|.|.+.|.||+.|+-.+|||||+|.|.... .....+|++|.++ ++=+.+|-
T Consensus 4 ~~~G~C~~~a~l~~~llr~~GIpar~v~g~~~~~~~~~~~~~~~~~H~W~ev~~~-~~W~~~D~ 66 (68)
T smart00460 4 TKYGTCGEFAALFVALLRSLGIPARVVSGYLKAPDTIGGLRSIWEAHAWAEVYLE-GGWVPVDP 66 (68)
T ss_pred ccceeeHHHHHHHHHHHHHCCCCeEEEeeeecCCCCCcccccCCCcEEEEEEEEC-CCeEEEeC
Confidence 367999999999999999999999999995432 2456889999987 55677763
|
Transglutaminases are enzymes that establish covalent links between proteins. A subset of transglutaminase homologues appear to catalyse the reverse reaction, the hydrolysis of peptide bonds. Proteins with this domain are both extracellular and intracellular, and it is likely that the eukaryotic intracellular proteins are involved in signalling events. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0015 Score=70.46 Aligned_cols=134 Identities=15% Similarity=0.104 Sum_probs=77.2
Q ss_pred eeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCce-eEEeccccCCCceEEEEeecCCCCHHH
Q 002160 684 IGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV-VLFMGAVTRPPNLSIITEFLPRGSLFR 762 (958)
Q Consensus 684 LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNI-VkL~g~~~~~~~l~LVmEy~~gGsL~d 762 (958)
+..|-.+.+|+....+..+++|...... ........+|..+++.+..-.+ .++++.+. -++||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~--~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVC--KALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCccc--ccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 5668888999998888889998644321 1100235678899998853222 34444332 368999999876531
Q ss_pred --------------H---HhCCCC---CccHHH--HHHHHHH---------HHHHHHHHhc------CCcEeecCCCCCc
Q 002160 763 --------------I---LHRPHC---QVDEKR--RIKMALD---------ARGMNCLHTS------TPTIVHRDLKSPN 805 (958)
Q Consensus 763 --------------~---L~k~~~---~~~e~~--~l~ia~~---------a~aL~yLH~~------g~gIIHRDLKPeN 805 (958)
. ++.... ...... ..+..+. ...+..+-.. ...++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 122111 111111 1111000 0111111111 2248999999999
Q ss_pred eEEcCCCcEEEEecccccc
Q 002160 806 LLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 806 ILId~~g~VKL~DFGLAk~ 824 (958)
||+++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999997753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0046 Score=68.68 Aligned_cols=143 Identities=17% Similarity=0.107 Sum_probs=83.7
Q ss_pred CeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCC--ceeEEeccc------cCCCce
Q 002160 677 DLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP--NVVLFMGAV------TRPPNL 748 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HP--NIVkL~g~~------~~~~~l 748 (958)
.....+.|+.|....+|+.+.++..+++|+..... . ...+..|.+++..|... .+.+++... ...+..
T Consensus 23 ~~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~-~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~ 98 (307)
T TIGR00938 23 ELLSLKGIAEGVENSNYLLTTDVGRYILTLYEKRV-K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP 98 (307)
T ss_pred CceeccccCCccccceEEEEeCCCcEEEEEecCCC-C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence 34456778888888999998767788899765422 1 22445677777777422 244444421 224567
Q ss_pred EEEEeecCCCCHH-----------HH---HhC--CCC---------CccHHHHHHH-------------HHHHHHHHHHH
Q 002160 749 SIITEFLPRGSLF-----------RI---LHR--PHC---------QVDEKRRIKM-------------ALDARGMNCLH 790 (958)
Q Consensus 749 ~LVmEy~~gGsL~-----------d~---L~k--~~~---------~~~e~~~l~i-------------a~~a~aL~yLH 790 (958)
+++|||++|..+. .. +++ .+. ...+...... ......++++.
T Consensus 99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~ 178 (307)
T TIGR00938 99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD 178 (307)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence 8999999885431 11 111 000 0000000000 00012344443
Q ss_pred h-----cCCcEeecCCCCCceEEcCCCcEEEEeccccc
Q 002160 791 T-----STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 823 (958)
Q Consensus 791 ~-----~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk 823 (958)
. ...++||+|+.+.||+++.++.+.|+||+.+.
T Consensus 179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 179 KFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 2 23469999999999999988877999999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0068 Score=67.37 Aligned_cols=138 Identities=15% Similarity=0.113 Sum_probs=76.8
Q ss_pred EEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCc--eeEEecc------ccCCCceEEEE
Q 002160 681 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN--VVLFMGA------VTRPPNLSIIT 752 (958)
Q Consensus 681 ~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPN--IVkL~g~------~~~~~~l~LVm 752 (958)
.+.|+.|....+|+.+..+..+++|++. .... ..+..|+.++..|...+ +.+++.. ....+..++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g~~vLK~~~--~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~ 101 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQGEYVLTLFE--RLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIV 101 (319)
T ss_pred cchhccccccceEEEEeCCCcEEEEEec--cCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEE
Confidence 4567788888999998777789999875 2222 23344566666663211 3333321 12345678999
Q ss_pred eecCCCCHH-----------HHH---hCCCC----------CccH-HHHHH-HH------------HH-HHHHHHHHh--
Q 002160 753 EFLPRGSLF-----------RIL---HRPHC----------QVDE-KRRIK-MA------------LD-ARGMNCLHT-- 791 (958)
Q Consensus 753 Ey~~gGsL~-----------d~L---~k~~~----------~~~e-~~~l~-ia------------~~-a~aL~yLH~-- 791 (958)
||++|..+. ..| +.... ...+ ...+. .. .. ...+..+..
T Consensus 102 ~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 181 (319)
T PRK05231 102 TFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAA 181 (319)
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccc
Confidence 999887431 111 11000 0001 00000 00 00 111222221
Q ss_pred ---cCCcEeecCCCCCceEEcCCCcEEEEeccccc
Q 002160 792 ---STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 823 (958)
Q Consensus 792 ---~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk 823 (958)
...++||+|+.|.|||++.+...-|+||+.+.
T Consensus 182 ~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 182 WPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 22369999999999999966556899999875
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0047 Score=68.09 Aligned_cols=74 Identities=23% Similarity=0.331 Sum_probs=48.6
Q ss_pred EEEeeccCceEEEEEEEC--------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCc-eeEEeccccCCCceEEE
Q 002160 681 GERIGLGSYGEVYHADWN--------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN-VVLFMGAVTRPPNLSII 751 (958)
Q Consensus 681 ~k~LG~G~fG~Vykak~~--------g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPN-IVkL~g~~~~~~~l~LV 751 (958)
++.|..|-...||+.+.. ++.|++|+..... .......+|.+++..+...+ ..++++++.. .+|
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v 75 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRI 75 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cch
Confidence 356777888899998764 4789999865432 12235678888888884322 3455555542 368
Q ss_pred EeecCCCCHH
Q 002160 752 TEFLPRGSLF 761 (958)
Q Consensus 752 mEy~~gGsL~ 761 (958)
+||++|..+.
T Consensus 76 ~e~i~G~~l~ 85 (302)
T cd05156 76 EEFIPSRTLT 85 (302)
T ss_pred hheeCCCcCC
Confidence 9999887653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.021 Score=66.61 Aligned_cols=77 Identities=17% Similarity=0.050 Sum_probs=54.0
Q ss_pred EEEeeccCceEEEEEEECC--cEEEEEEeecCCC---C--HHHHHHHHHHHHHHHHcC---CCceeEEeccccCCCceEE
Q 002160 681 GERIGLGSYGEVYHADWNG--TEVAVKKFLDQDF---S--GAALLEFKREVKIMRRLR---HPNVVLFMGAVTRPPNLSI 750 (958)
Q Consensus 681 ~k~LG~G~fG~Vykak~~g--~~VAVK~i~~~~~---~--~~~~~~f~~Ei~ILk~L~---HPNIVkL~g~~~~~~~l~L 750 (958)
.+.||.|.+..||++...+ +.|+||.-..... . .....++..|.+.|+.+. ..++.+++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4679999999999998754 4899997542211 0 123456777888888873 2467778876 3456789
Q ss_pred EEeecCCCC
Q 002160 751 ITEFLPRGS 759 (958)
Q Consensus 751 VmEy~~gGs 759 (958)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.0019 Score=72.63 Aligned_cols=135 Identities=19% Similarity=0.198 Sum_probs=89.2
Q ss_pred eeEEEEeeccCceEEEEEEE-CCcEEEEEEeecCCC------------------CHH--HHHHHHHHHHHHHHcC-CC-c
Q 002160 678 LVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDF------------------SGA--ALLEFKREVKIMRRLR-HP-N 734 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~------------------~~~--~~~~f~~Ei~ILk~L~-HP-N 734 (958)
+.+++.||-|--+.||++-. .|++.++|.-+.-.. .+. ......+|...|+.|. |- -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 56789999999999999976 688888883221110 111 1123467999999984 32 2
Q ss_pred eeEEeccccCCCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcE
Q 002160 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNV 814 (958)
Q Consensus 735 IVkL~g~~~~~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~V 814 (958)
|.+.+++ ++-++|||++.|-.|...-+-.. . ..++-.+ ..-+--|-.+| +||+|..--||+|++++.+
T Consensus 174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~d----~-~~ly~~l-m~~Iv~la~~G--lIHgDFNEFNimv~dd~~i 241 (465)
T KOG2268|consen 174 VPKPIDH----NRHCVVMELVDGYPLRQVRHVED----P-PTLYDDL-MGLIVRLANHG--LIHGDFNEFNIMVKDDDKI 241 (465)
T ss_pred CCCcccc----cceeeHHHhhcccceeeeeecCC----h-HHHHHHH-HHHHHHHHHcC--ceecccchheeEEecCCCE
Confidence 4555554 45689999999877765432211 1 1111111 12233455667 9999999999999999999
Q ss_pred EEEecccccc
Q 002160 815 KVSDFGLSRL 824 (958)
Q Consensus 815 KL~DFGLAk~ 824 (958)
+++||-....
T Consensus 242 ~vIDFPQmvS 251 (465)
T KOG2268|consen 242 VVIDFPQMVS 251 (465)
T ss_pred EEeechHhhc
Confidence 9999986543
|
|
| >PF01841 Transglut_core: Transglutaminase-like superfamily; InterPro: IPR002931 This domain is found in many proteins known to have transglutaminase activity, i | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.002 Score=60.32 Aligned_cols=53 Identities=25% Similarity=0.270 Sum_probs=42.0
Q ss_pred ccccchhhHHHHHHhhhcCCCCceeecccCCC----------CccCcceEEEEeCCcceeeee
Q 002160 263 NIGLSRHRALLFKVLADSIRLPCRLVKGSHYT----------GVEDDAVNIIKLEEEREFLVD 315 (958)
Q Consensus 263 ~~G~~rhRAlLFKvLaD~i~l~c~lv~G~~~~----------g~~~~a~~~v~~~~~~~~~vD 315 (958)
+.|.|+.-|.||..|+-.+|||||+|.|.... +....+||+|.+.+++=+.+|
T Consensus 50 ~~G~C~~~a~l~~allr~~Gipar~v~g~~~~~~~~~~~~~~~~~~H~w~ev~~~~~~W~~~D 112 (113)
T PF01841_consen 50 GRGDCEDYASLFVALLRALGIPARVVSGYVKGPDPDGDYSVDGNDNHAWVEVYLPGGGWIPLD 112 (113)
T ss_dssp EEESHHHHHHHHHHHHHHHT--EEEEEEEEEECSSTTCTSTSSEEEEEEEEEEETTTEEEEEE
T ss_pred CCCccHHHHHHHHHHHhhCCCceEEEEEEcCCccccccccCCCCCCEEEEEEEEcCCcEEEcC
Confidence 35999999999999999999999999997642 344489999999766666665
|
e. which cross-link proteins through an acyl-transfer reaction between the gamma-carboxamide group of peptide-bound glutamine and the epsilon-amino group of peptide-bound lysine, resulting in a epsilon-(gamma-glutamyl)lysine isopeptide bond. Tranglutaminases have been found in a diverse range of species, from bacteria through to mammals. The enzymes require calcium binding and their activity leads to post-translational modification of proteins through acyl-transfer reactions, involving peptidyl glutamine residues as acyl donors and a variety of primary amines as acyl acceptors, with the generation of proteinase resistant isopeptide bonds []. Sequence conservation in this superfamily primarily involves three motifs that centre around conserved cysteine, histidine, and aspartate residues that form the catalytic triad in the structurally characterised transglutaminase, the human blood clotting factor XIIIa' []. On the basis of the experimentally demonstrated activity of the Methanobacterium phage psiM2 pseudomurein endoisopeptidase [], it is proposed that many, if not all, microbial homologs of the transglutaminases are proteases and that the eukaryotic transglutaminases have evolved from an ancestral protease []. A subunit of plasma Factor XIII revealed that each Factor XIIIA subunit is composed of four domains (termed N-terminal beta-sandwich, core domain (containing the catalytic and the regulatory sites), and C-terminal beta-barrels 1 and 2) and that two monomers assemble into the native dimer through the surfaces in domains 1 and 2, in opposite orientation. This organisation in four domains is highly conserved during evolution among transglutaminase isoforms [].; PDB: 2F4M_A 2F4O_A 1GGY_B 1FIE_B 1GGU_B 1GGT_B 1F13_A 1QRK_B 1EVU_A 1EX0_B .... |
| >COG5279 CYK3 Uncharacterized protein involved in cytokinesis, contains TGc (transglutaminase/protease-like) domain [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.0041 Score=72.65 Aligned_cols=55 Identities=27% Similarity=0.454 Sum_probs=46.6
Q ss_pred cccchhhHHHHHHhhhcCCCCceeecccCCCC-------ccCcceEEEEeCCcceeeeecccC
Q 002160 264 IGLSRHRALLFKVLADSIRLPCRLVKGSHYTG-------VEDDAVNIIKLEEEREFLVDLMAA 319 (958)
Q Consensus 264 ~G~~rhRAlLFKvLaD~i~l~c~lv~G~~~~g-------~~~~a~~~v~~~~~~~~~vDlm~~ 319 (958)
-++|--=|.|||.||-.+||||.+|+|.--.+ ..++|||+|++.| +=|+||.--.
T Consensus 209 eavCtgYa~lfK~lcn~lgIp~~iIegf~k~~~~~~~~~~iNHaWN~VkiD~-~yy~VDtTwg 270 (521)
T COG5279 209 EAVCTGYAELFKELCNALGIPCEIIEGFLKSPIYYTRDININHAWNIVKIDN-EYYLVDTTWG 270 (521)
T ss_pred ccccchHHHHHHHHHHhcCCceEEEeecccccccccCCccccceeeEEEECC-eEEEEeeecC
Confidence 47788889999999999999999999994333 4459999999999 7899997643
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.048 Score=62.15 Aligned_cols=137 Identities=15% Similarity=0.250 Sum_probs=78.6
Q ss_pred EEEeeccCceEEEEEEEC------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCce-eEEeccccCCCceEEEEe
Q 002160 681 GERIGLGSYGEVYHADWN------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV-VLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 681 ~k~LG~G~fG~Vykak~~------g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNI-VkL~g~~~~~~~l~LVmE 753 (958)
.+.|-.|-...+|++.+. ++.|++|...... . ......+|..+++.+..-++ .++++.+..+ .|+|
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~e 113 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--E-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEE 113 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--C-eeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEE
Confidence 445666888899999752 3678888765432 1 22234678999998854333 3556665432 5899
Q ss_pred ecCCCCHHHH-----------------HhCCCC-----CccHHHHHHHHHH------------------HHHHHH----H
Q 002160 754 FLPRGSLFRI-----------------LHRPHC-----QVDEKRRIKMALD------------------ARGMNC----L 789 (958)
Q Consensus 754 y~~gGsL~d~-----------------L~k~~~-----~~~e~~~l~ia~~------------------a~aL~y----L 789 (958)
|+++.+|... +++... .........+... ...+.. +
T Consensus 114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~ 193 (344)
T PLN02236 114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL 193 (344)
T ss_pred eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence 9987665311 122111 1111111011100 001111 1
Q ss_pred Hh--cCCcEeecCCCCCceEEcC-CCcEEEEecccccc
Q 002160 790 HT--STPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRL 824 (958)
Q Consensus 790 H~--~g~gIIHRDLKPeNILId~-~g~VKL~DFGLAk~ 824 (958)
.. ....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 194 ~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 194 SGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred cccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 11 1235999999999999986 57899999988753
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.074 Score=58.58 Aligned_cols=29 Identities=28% Similarity=0.382 Sum_probs=25.4
Q ss_pred CcEeecCCCCCceEEcCCCcEEEEeccccc
Q 002160 794 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 823 (958)
Q Consensus 794 ~gIIHRDLKPeNILId~~g~VKL~DFGLAk 823 (958)
.++||+|+.+.|||++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 46999999999999987 678999999664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.087 Score=59.74 Aligned_cols=147 Identities=20% Similarity=0.252 Sum_probs=86.0
Q ss_pred CeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCC--CceeEEeccccCCC--ceEEEE
Q 002160 677 DLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH--PNVVLFMGAVTRPP--NLSIIT 752 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~H--PNIVkL~g~~~~~~--~l~LVm 752 (958)
...+.+.+-.|.--.+|....+++.+++. ............+..+|+.+|+.+.- --+...+++|..+. ..|.||
T Consensus 26 ~~~~v~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 26 GLLIVEEISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred CCceeeeccCCcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 34455556555555566666667888887 33222233345567789999998843 23445566665554 579999
Q ss_pred eecCCCC------------------HHHHHh---C-----------CC----CCcc-HHHHHH---HHH------HHHHH
Q 002160 753 EFLPRGS------------------LFRILH---R-----------PH----CQVD-EKRRIK---MAL------DARGM 786 (958)
Q Consensus 753 Ey~~gGs------------------L~d~L~---k-----------~~----~~~~-e~~~l~---ia~------~a~aL 786 (958)
+|++|.. |.++|. + .. .+.. +..... ... .....
T Consensus 105 ~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~ 184 (321)
T COG3173 105 EWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI 184 (321)
T ss_pred EEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence 9998732 222221 0 00 0000 001110 000 02234
Q ss_pred HHHHhcCC------cEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 787 NCLHTSTP------TIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 787 ~yLH~~g~------gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
.+|+.+.+ .++|+|+.+.||+|+.++-+=|+||+++..
T Consensus 185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 185 KWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 45544332 499999999999999888899999998864
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.081 Score=59.91 Aligned_cols=76 Identities=20% Similarity=0.332 Sum_probs=47.4
Q ss_pred CeeEEEEeeccCceEEEEEEECC-----cEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCce-eEEeccccCCCceEE
Q 002160 677 DLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV-VLFMGAVTRPPNLSI 750 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~~g-----~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNI-VkL~g~~~~~~~l~L 750 (958)
++++ +.|..|=...+|+....+ ..|++|+..... . ......+|..+++.+..-++ .++++++..+ +
T Consensus 16 ~i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t--~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~ 87 (330)
T PLN02421 16 DFSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT--D-YVIDRERELQAIKYLSAAGFGAKLLGVFGNG----M 87 (330)
T ss_pred ceEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCc--C-eEechHHHHHHHHHHHhcCCCCceeEEeCCc----E
Confidence 4444 445558888899987543 378888764421 1 22344678899998854444 4566655322 5
Q ss_pred EEeecCCCCH
Q 002160 751 ITEFLPRGSL 760 (958)
Q Consensus 751 VmEy~~gGsL 760 (958)
|.+|++|..|
T Consensus 88 i~~fi~g~~l 97 (330)
T PLN02421 88 IQSFINARTL 97 (330)
T ss_pred eehhhcCCCC
Confidence 8999987654
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.096 Score=58.40 Aligned_cols=30 Identities=20% Similarity=0.307 Sum_probs=27.3
Q ss_pred cEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 795 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 795 gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
++||+|+.+.|||++.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 599999999999999999999999987753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.059 Score=61.92 Aligned_cols=139 Identities=24% Similarity=0.247 Sum_probs=82.0
Q ss_pred EEEeeccCceEEEEEEE-CCcEEEEEEeecCCCC----------------------H--HHHHHHHHHHHHHHHcCCCce
Q 002160 681 GERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFS----------------------G--AALLEFKREVKIMRRLRHPNV 735 (958)
Q Consensus 681 ~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~----------------------~--~~~~~f~~Ei~ILk~L~HPNI 735 (958)
-..|..|--..||.+.. +|..+|||+++...+. . ........|++-|++|+...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 34588999999999975 7889999976432110 1 111234678888999875554
Q ss_pred eEEeccccCCCceEEEEeecCCCCHHH-HHhCCCCCccHHHHHHHHHHHHHHHHH-HhcCCcEeecCCCCCceEEcCCCc
Q 002160 736 VLFMGAVTRPPNLSIITEFLPRGSLFR-ILHRPHCQVDEKRRIKMALDARGMNCL-HTSTPTIVHRDLKSPNLLVDKNWN 813 (958)
Q Consensus 736 VkL~g~~~~~~~l~LVmEy~~gGsL~d-~L~k~~~~~~e~~~l~ia~~a~aL~yL-H~~g~gIIHRDLKPeNILId~~g~ 813 (958)
.-.--... ..-.|||+|+.+..... .|+.-. ......+-...+.+.-|.-| |.++ +||.||.--|+|+. +|.
T Consensus 229 P~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~-ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Lyh-dG~ 302 (520)
T KOG2270|consen 229 PCPEPILL--KNHVLVMEFLGRDGWAAPKLKDAS-LSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYH-DGK 302 (520)
T ss_pred CCCCceee--ecceEeeeeccCCCCcCccccccc-CChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEE-CCE
Confidence 32211111 12368999995321111 122111 11112222222223334333 4566 99999999999995 578
Q ss_pred EEEEeccccccc
Q 002160 814 VKVSDFGLSRLK 825 (958)
Q Consensus 814 VKL~DFGLAk~~ 825 (958)
+.|+|.+.+...
T Consensus 303 lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 303 LYIIDVSQSVEH 314 (520)
T ss_pred EEEEEccccccC
Confidence 999999987653
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.68 E-value=0.049 Score=58.83 Aligned_cols=117 Identities=11% Similarity=0.077 Sum_probs=76.1
Q ss_pred cCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeecCCCCHHHHHhC
Q 002160 687 GSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR 766 (958)
Q Consensus 687 G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~gGsL~d~L~k 766 (958)
|+-.+.-+++.+-.+..+|+++.-.+.- ...-|..+.+++.+++ .|+++..- +...+.++.|+|-....
T Consensus 73 ~gNsTl~~~kt~iG~L~lKKi~slp~~~-~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------ 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKIGPLFLKKIRSLPCCI-NDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------ 141 (308)
T ss_pred CCceEEEEeccccchhhhhhccCCCccc-chhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence 3334444444333456677766544331 1234578889998875 47887742 44557899999943111
Q ss_pred CCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccc
Q 002160 767 PHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 821 (958)
Q Consensus 767 ~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGL 821 (958)
...-.+...+..|...|+...+.+|+|-.|+||+-|+.|.+||.|=+.
T Consensus 142 -------~~~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 142 -------NFSNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred -------chhHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 011112222567888897766899999999999999999999999664
|
The function of this family is unknown. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.13 Score=57.02 Aligned_cols=29 Identities=24% Similarity=0.487 Sum_probs=24.7
Q ss_pred cEeecCCCCCceEEcCCCc-EEEEeccccc
Q 002160 795 TIVHRDLKSPNLLVDKNWN-VKVSDFGLSR 823 (958)
Q Consensus 795 gIIHRDLKPeNILId~~g~-VKL~DFGLAk 823 (958)
.+||+|+.|.|||++.++. .-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 4999999999999997555 5699999774
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.055 Score=60.45 Aligned_cols=76 Identities=21% Similarity=0.187 Sum_probs=49.4
Q ss_pred eeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC---CCceeEEeccccCCCceEEEEee
Q 002160 678 LVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~---HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
.+-.+.|+.|....+|+.+..++.+.||+-.... ...|..|..-|+.|. .-.+.+++++....+..+|||||
T Consensus 19 i~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~-----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~ 93 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLDTDGGSYFVKVNSESG-----RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEF 93 (288)
T ss_dssp --EEEEE--SSSSEEEEEETTS-EEEEEEEEGGG-----CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-
T ss_pred eeeeEecCCCChhheEEEECCCccEEEEecChhh-----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEe
Confidence 3446779999999999999889999999865221 235778888888883 34577888888777778999999
Q ss_pred cCCC
Q 002160 755 LPRG 758 (958)
Q Consensus 755 ~~gG 758 (958)
++.+
T Consensus 94 l~~~ 97 (288)
T PF03881_consen 94 LEMG 97 (288)
T ss_dssp ----
T ss_pred ecCC
Confidence 9766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.34 E-value=0.029 Score=66.50 Aligned_cols=153 Identities=16% Similarity=0.192 Sum_probs=92.2
Q ss_pred HHHHHHHHHHHHcCCCceeEEeccccC-CCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcE
Q 002160 718 LEFKREVKIMRRLRHPNVVLFMGAVTR-PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTI 796 (958)
Q Consensus 718 ~~f~~Ei~ILk~L~HPNIVkL~g~~~~-~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gI 796 (958)
.++....++++.+.|+|..+++++-.. ..+..+|||++ +-+|.+++..+.... ..++ .++ +
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~~-----------~s~~----~~~--~ 88 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLKD-----------ESLL----AHG--V 88 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccch-----------hhhc----ccc--c
Confidence 356677889999999999999887643 34478899998 679999886543110 1111 112 3
Q ss_pred eecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 002160 797 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI 876 (958)
Q Consensus 797 IHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~ 876 (958)
.|-. .++.+| .+.... ... ..+|+|||++|.++.++.-|..-|.
T Consensus 89 ~~~~------------~~~~td-----~~~t~~---~~~----------------~~pKsdVwsl~~i~~el~L~~~l~~ 132 (725)
T KOG1093|consen 89 LHLN------------IIYITD-----HFLTKY---PSP----------------IGPKSDVWSLGFIILELYLGISLEA 132 (725)
T ss_pred ceeh------------hhhccc-----cccccC---CCC----------------CCcchhhhhHHHHHHHHHHhhHHHH
Confidence 3322 133333 000000 001 1149999999999999999887776
Q ss_pred CCChhHHHHhhhcc-cccc---------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHH
Q 002160 877 GMNPMQVVGAVGFQ-NRRL---------EIPKELDPLVARIIWECWQTDPSLRPSFAQ 924 (958)
Q Consensus 877 g~~~~ei~~~i~~~-~~~~---------~ip~~ls~eL~dLI~~CL~kDP~kRPSa~E 924 (958)
.....+....+..- .... .+...++..+.++...|+-..|..||...+
T Consensus 133 ~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~ 190 (725)
T KOG1093|consen 133 ELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPME 190 (725)
T ss_pred HHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhH
Confidence 55444333222110 0000 122356778889999999999988875443
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.17 E-value=0.19 Score=58.86 Aligned_cols=76 Identities=14% Similarity=-0.022 Sum_probs=52.4
Q ss_pred EEEEeeccCceEEEEEEECCcEEEEEEeecCCC-C-H---HHHHHHHHHHHHHHHcC---CCceeEEeccccCCCceEEE
Q 002160 680 LGERIGLGSYGEVYHADWNGTEVAVKKFLDQDF-S-G---AALLEFKREVKIMRRLR---HPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 680 i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~-~-~---~~~~~f~~Ei~ILk~L~---HPNIVkL~g~~~~~~~l~LV 751 (958)
..+.||.|....||+....+..|+||+-..... . . ....+-..|...|+.+. ..++.+++.++. +..+++
T Consensus 36 ~~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred eEEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 357799999999999987777899997552111 1 0 12334445677776663 247888888876 446789
Q ss_pred EeecCC
Q 002160 752 TEFLPR 757 (958)
Q Consensus 752 mEy~~g 757 (958)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.07 E-value=0.11 Score=59.67 Aligned_cols=105 Identities=18% Similarity=0.184 Sum_probs=62.6
Q ss_pred CCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 745 ~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
....|++|++. |+.|.-.-. ......+.++..+..+-+.-+.+.+.=|||+.-.||||+ +|+|.|+||-+++.
T Consensus 298 ~~y~yl~~kdh-gt~is~ik~-----~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 298 TLYLYLHFKDH-GTPISIIKA-----DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ceEEEEEEecC-Cceeeeeec-----ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 34577888875 655543211 123333333333444445555556789999999999999 99999999999985
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHH
Q 002160 825 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFG 862 (958)
Q Consensus 825 ~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLG 862 (958)
-....... -.+.--|-.+.|.. +..-+||-+-
T Consensus 371 ~~~q~~is-----y~rldhp~lF~G~d-d~QFeIYrlM 402 (488)
T COG5072 371 SYSQGIIS-----YNRLDHPDLFNGVD-DYQFEIYRLM 402 (488)
T ss_pred ccCCceee-----ccccCchhhhcCcc-ceeeeHHHHH
Confidence 43332111 11222344445433 5666776643
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.04 E-value=0.11 Score=60.02 Aligned_cols=74 Identities=20% Similarity=0.098 Sum_probs=48.4
Q ss_pred EeeccCceEEEEEEECC--cEEEEEEeecCCC----C-HHHHHHHHHHHHHHHHcC--CC-ceeEEeccccCCCceEEEE
Q 002160 683 RIGLGSYGEVYHADWNG--TEVAVKKFLDQDF----S-GAALLEFKREVKIMRRLR--HP-NVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 683 ~LG~G~fG~Vykak~~g--~~VAVK~i~~~~~----~-~~~~~~f~~Ei~ILk~L~--HP-NIVkL~g~~~~~~~l~LVm 752 (958)
.||.|...-||++...+ +.|+||.-..... . .-...+...|...|+... -| .+.++|.+ +++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 48999999999998754 5799996542111 0 122345567788887763 24 45666653 455667999
Q ss_pred eecCCC
Q 002160 753 EFLPRG 758 (958)
Q Consensus 753 Ey~~gG 758 (958)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 999543
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.60 E-value=0.19 Score=54.65 Aligned_cols=78 Identities=19% Similarity=0.153 Sum_probs=57.8
Q ss_pred eEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC---CCceeEEeccccCCCceEEEEeec
Q 002160 679 VLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVVLFMGAVTRPPNLSIITEFL 755 (958)
Q Consensus 679 ~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~---HPNIVkL~g~~~~~~~l~LVmEy~ 755 (958)
+..+.+-.|.--..|...+...+|.||+-. ......|..|+.-|..|. .-.+.+++.+....+..|+||||+
T Consensus 19 ~er~~v~gG~inea~~v~dg~~~~FvK~n~-----~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L 93 (286)
T COG3001 19 KEREEVSGGDINEAWRLRDGTDPFFVKCNQ-----REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYL 93 (286)
T ss_pred hcccccCCccccceeEeecCCcceEEEecc-----hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeec
Confidence 344556677777778888888899999732 233456778887777773 456788999999999999999999
Q ss_pred CCCCHH
Q 002160 756 PRGSLF 761 (958)
Q Consensus 756 ~gGsL~ 761 (958)
+-+.+.
T Consensus 94 ~~~~~d 99 (286)
T COG3001 94 PTGPLD 99 (286)
T ss_pred cCCCCC
Confidence 875443
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.62 E-value=0.48 Score=54.12 Aligned_cols=135 Identities=18% Similarity=0.237 Sum_probs=77.1
Q ss_pred eeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCc------eeEE----eccccCCCceEEEEe
Q 002160 684 IGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN------VVLF----MGAVTRPPNLSIITE 753 (958)
Q Consensus 684 LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPN------IVkL----~g~~~~~~~l~LVmE 753 (958)
|.. .-..||+.+..+..+++|+.... ... .++..|...|..|.-.+ |..+ +..+..+.+.+-+++
T Consensus 34 l~s-~eN~~f~~~~~~g~~iLki~~~~-~~~---~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRYILKIYRPG-WTR---AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred ccc-ccCceEEEEecCCCeEEEEecCC-CCH---HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 444 55678999887777788987665 332 35567778888873211 2222 222222236788999
Q ss_pred ecCCCCHHH-H-----------H---h----C----CCC---CccHHH-----HH---------HHHHHHHHHHHHHh--
Q 002160 754 FLPRGSLFR-I-----------L---H----R----PHC---QVDEKR-----RI---------KMALDARGMNCLHT-- 791 (958)
Q Consensus 754 y~~gGsL~d-~-----------L---~----k----~~~---~~~e~~-----~l---------~ia~~a~aL~yLH~-- 791 (958)
|++|..+.. . | + . +.. ...+.. .. ..+.....+..+..
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999887762 1 1 1 0 000 111110 00 00011122222222
Q ss_pred ----cCCc--EeecCCCCCceEEcCCCc-EEEEeccccc
Q 002160 792 ----STPT--IVHRDLKSPNLLVDKNWN-VKVSDFGLSR 823 (958)
Q Consensus 792 ----~g~g--IIHRDLKPeNILId~~g~-VKL~DFGLAk 823 (958)
...+ +||+|+-|.|||++.+.. +.++|||-+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1213 999999999999998875 9999999764
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=93.24 E-value=0.28 Score=57.29 Aligned_cols=75 Identities=17% Similarity=0.060 Sum_probs=51.0
Q ss_pred EEEeeccCceEEEEEEEC--CcEEEEEEeecCCC---C-HHHHHHHHHHHHHHHHcC--CC-ceeEEeccccCCCceEEE
Q 002160 681 GERIGLGSYGEVYHADWN--GTEVAVKKFLDQDF---S-GAALLEFKREVKIMRRLR--HP-NVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 681 ~k~LG~G~fG~Vykak~~--g~~VAVK~i~~~~~---~-~~~~~~f~~Ei~ILk~L~--HP-NIVkL~g~~~~~~~l~LV 751 (958)
.+.||.|.-.-||++... ++.|+||.-...-. . .-...+...|..+|+.+. -| ++.++|.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 577999999999999874 67899996542211 1 123456667888888773 34 46666654 45566789
Q ss_pred EeecCC
Q 002160 752 TEFLPR 757 (958)
Q Consensus 752 mEy~~g 757 (958)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999853
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.93 E-value=1.9 Score=56.19 Aligned_cols=31 Identities=29% Similarity=0.483 Sum_probs=26.1
Q ss_pred CcEeecCCCCCceEEcCCC--cEE-EEecccccc
Q 002160 794 PTIVHRDLKSPNLLVDKNW--NVK-VSDFGLSRL 824 (958)
Q Consensus 794 ~gIIHRDLKPeNILId~~g--~VK-L~DFGLAk~ 824 (958)
.++||+|+.+.|||++.++ ++. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 3599999999999999775 566 999998754
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 958 | ||||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-99 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-98 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-40 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-39 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-39 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-38 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-37 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-37 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-37 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-37 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-37 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-37 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-36 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-36 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-36 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-36 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-36 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-35 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-35 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-35 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-35 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-35 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-35 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-35 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-35 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-35 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-35 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-35 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-35 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-35 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-35 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-35 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-35 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-35 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-35 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-35 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-35 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-34 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-34 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-34 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-34 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-34 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-32 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-31 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-31 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-31 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-30 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-30 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-30 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-30 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-30 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-30 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-30 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-30 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-30 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-30 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-30 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-30 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-30 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-30 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-30 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-30 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-30 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-30 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-29 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-29 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-29 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-29 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-29 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-29 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-29 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-29 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-29 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-29 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-29 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-29 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-29 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-29 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-28 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-28 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-28 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-28 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-28 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-28 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-28 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-28 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-28 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-28 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-28 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-28 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-28 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-28 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-28 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-28 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-28 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-28 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-28 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-28 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-28 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-28 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-28 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-27 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-27 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-27 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-27 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-27 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-27 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-27 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-27 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-27 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-27 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-27 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-27 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-27 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-27 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-27 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-27 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-27 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-27 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-27 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-27 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-27 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-27 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 9e-27 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-26 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-26 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-26 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-26 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-26 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-26 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-26 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-26 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-26 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-26 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-26 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-26 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-26 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-26 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-26 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-26 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-26 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-26 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-26 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-26 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-26 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-26 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-26 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-26 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-26 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-26 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-26 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-26 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-26 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-26 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-26 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-26 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-26 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-26 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-26 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-26 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-26 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-26 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-26 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-26 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-25 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-25 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-25 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-25 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-25 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-25 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-25 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-25 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-25 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-25 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-25 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-25 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-25 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-25 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-25 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-25 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-25 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-25 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-25 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-25 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-25 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-25 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-25 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-25 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-25 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-24 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-24 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-24 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-24 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-24 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-24 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-24 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-24 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-24 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-24 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-24 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-24 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-24 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-24 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-24 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-24 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-24 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-24 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-24 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-24 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-24 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-24 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-24 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-24 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-24 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-24 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-24 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-24 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-24 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-24 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-24 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-24 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-24 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 9e-24 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-23 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-23 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-23 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-23 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-23 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-23 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-23 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-23 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-23 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-23 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-23 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-23 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-23 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-23 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-23 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-23 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-23 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-23 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-23 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-23 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-23 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-23 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-23 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-23 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-23 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-23 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-23 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-23 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 8e-23 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-22 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-22 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-22 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-22 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-22 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-22 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-22 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-22 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-22 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-22 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-22 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-22 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-22 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-22 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-22 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-22 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-22 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-22 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-22 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-22 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-22 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-21 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-21 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-21 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-21 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-21 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-21 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-21 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-21 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-21 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-21 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-21 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-21 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-21 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-21 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-21 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-21 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-21 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-21 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-21 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-21 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-21 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-21 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-21 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-21 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-20 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-20 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-20 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-20 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-20 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-20 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-20 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-20 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-20 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-20 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-20 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-20 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-20 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-20 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-20 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-20 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-20 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-20 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-20 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-20 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-20 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-20 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-20 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-20 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-20 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-20 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-20 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-20 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-20 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-20 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-20 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-19 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-19 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-19 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-19 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-19 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-19 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-19 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-19 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-19 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-19 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-19 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-19 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-19 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-19 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-19 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-19 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-19 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-19 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-19 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-19 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-19 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-19 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-19 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-19 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-19 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-19 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-19 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-19 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-19 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-19 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-19 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-19 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-19 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-19 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-19 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-19 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-19 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-19 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-19 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-19 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-19 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-19 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-19 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-19 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-19 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-19 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-19 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-19 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 8e-19 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-19 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-19 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-19 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-19 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-18 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-18 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-18 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-18 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-18 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-18 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-18 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-18 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-18 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-18 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-18 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-18 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-18 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-18 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-18 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-18 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-18 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-18 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-18 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-18 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-18 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-18 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-18 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-18 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-18 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-18 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-18 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-18 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-18 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-18 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-18 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-18 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-18 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-18 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-18 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-18 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-18 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-18 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-18 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-18 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-18 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-18 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-18 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-18 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-18 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-18 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-18 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-18 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-18 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-18 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-18 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-18 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-18 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 9e-18 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-17 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-17 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-17 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-17 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-17 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-17 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-17 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-17 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-17 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-17 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-17 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-17 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-17 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-17 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-17 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-17 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-17 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-17 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-17 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-17 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-16 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-16 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-16 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-16 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-16 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-16 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-16 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-16 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-16 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-16 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-16 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-16 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-16 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-16 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-16 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-16 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-16 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-16 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-16 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-16 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-16 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-16 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-16 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-15 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-15 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-15 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-15 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-15 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-15 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-15 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-15 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-15 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-15 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-15 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-15 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-15 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-15 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-15 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-15 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-15 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-15 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-15 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-15 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-15 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-15 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-15 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-15 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-15 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-15 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-15 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-15 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-15 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-15 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-15 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-15 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-15 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-15 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-15 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-15 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-15 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-15 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-15 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-15 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-15 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-15 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-15 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-15 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-15 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-15 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-15 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-15 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-15 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-15 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-15 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-15 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-15 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-15 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-15 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-15 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-15 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-15 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-15 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-15 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-15 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-15 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-15 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-15 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-15 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-15 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-15 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-15 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-15 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-15 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-15 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-15 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-15 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-15 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-15 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-15 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-15 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-14 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-14 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-14 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-14 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-14 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-14 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-14 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-14 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-14 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-14 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-14 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-14 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-14 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-13 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-13 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-13 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-13 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-13 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-13 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-13 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-13 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-13 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-13 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 8e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-12 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-12 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-12 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-12 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-12 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-12 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-12 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-12 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-11 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-11 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-11 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-11 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-11 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-11 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-11 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-11 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-11 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 8e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-11 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-09 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-09 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-09 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-09 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-09 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-09 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-09 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-09 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-09 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-09 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-09 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-09 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-07 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 8e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 8e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 9e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-06 |
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 478 bits (1232), Expect = e-163
Identities = 180/302 (59%), Positives = 223/302 (73%), Gaps = 4/302 (1%)
Query: 641 LKLRDLESPSSSVDSSTSKVDQIFD-DDVCECEIPWEDLVLGERIGLGSYGEVYHADWNG 699
+K P S D T++ D + +IPW DL + E+IG GS+G V+ A+W+G
Sbjct: 1 MKHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHG 60
Query: 700 TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGS 759
++VAVK ++QDF + EF REV IM+RLRHPN+VLFMGAVT+PPNLSI+TE+L RGS
Sbjct: 61 SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 760 LFRILHRPHC--QVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV 816
L+R+LH+ Q+DE+RR+ MA D A+GMN LH P IVHR+LKSPNLLVDK + VKV
Sbjct: 121 LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKV 180
Query: 817 SDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI 876
DFGLSRLK +TFLSSKS AGTPEWMAPEVLR+EPSNEK DVYSFGVILWELATL+ PW
Sbjct: 181 CDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG 240
Query: 877 GMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 936
+NP QVV AVGF+ +RLEIP+ L+P VA II CW +P RPSFA + L+PL +
Sbjct: 241 NLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300
Query: 937 IP 938
+P
Sbjct: 301 VP 302
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 428 bits (1102), Expect = e-144
Identities = 81/270 (30%), Positives = 138/270 (51%), Gaps = 12/270 (4%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
I ++ L ++ GE++ W G ++ VK +D+S +F E +R
Sbjct: 6 GIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS 65
Query: 732 HPNVVLFMGAVTRPP--NLSIITEFLPRGSLFRILHRPHC-QVDEKRRIKMALD-ARGMN 787
HPNV+ +GA PP + ++IT ++P GSL+ +LH VD+ + +K ALD ARGM
Sbjct: 66 HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125
Query: 788 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL 847
LHT P I L S ++++D++ ++S + S P W+APE L
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF-----SFQSPGRMYAPAWVAPEAL 180
Query: 848 RNEPSN---EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 904
+ +P + D++SF V+LWEL T ++P+ ++ M++ V + R IP + P V
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHV 240
Query: 905 ARIIWECWQTDPSLRPSFAQLTVALKPLQR 934
++++ C DP+ RP F + L+ +Q
Sbjct: 241 SKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 423 bits (1089), Expect = e-142
Identities = 98/273 (35%), Positives = 146/273 (53%), Gaps = 16/273 (5%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFL--DQDFSGAALLEFKREVKIMRR 729
EI + +L L E IG+G +G+VY A W G EVAVK + + ++E K+
Sbjct: 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNC 788
L+HPN++ G + PNL ++ EF G L R+L ++ + A+ ARGMN
Sbjct: 63 LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNY 120
Query: 789 LHTSTP-TIVHRDLKSPNLLVDK--------NWNVKVSDFGLSRLKHNTFLSSKSTAGTP 839
LH I+HRDLKS N+L+ + N +K++DFGL+R H T + S AG
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT--TKMSAAGAY 178
Query: 840 EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE 899
WMAPEV+R ++ DV+S+GV+LWEL T ++P+ G++ + V V L IP
Sbjct: 179 AWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST 238
Query: 900 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932
A+++ +CW DP RPSF + L +
Sbjct: 239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 420 bits (1083), Expect = e-140
Identities = 93/314 (29%), Positives = 149/314 (47%), Gaps = 23/314 (7%)
Query: 644 RDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVA 703
+L S+ + IF E +IP+E L +GE IG G +G+VYH W+G EVA
Sbjct: 4 MNLSLLSARSFPRKASQTSIFLQ---EWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVA 59
Query: 704 VKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRI 763
++ + + L FKREV R+ RH NVVLFMGA PP+L+IIT +L+ +
Sbjct: 60 IRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSV 119
Query: 764 LHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 822
+ +D + ++A + +GM LH I+H+DLKS N+ D N V ++DFGL
Sbjct: 120 VRDAKIVLDVNKTRQIAQEIVKGMGYLH--AKGILHKDLKSKNVFYD-NGKVVITDFGLF 176
Query: 823 RLKHNTFLSSKST-----AGTPEWMAPEVLRN---------EPSNEKCDVYSFGVILWEL 868
+ + G +APE++R P ++ DV++ G I +EL
Sbjct: 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236
Query: 869 ATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928
+ P+ ++ +G + + ++ I+ CW + RP+F +L
Sbjct: 237 HAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296
Query: 929 LKPLQRLVI-PSHP 941
L+ L + SHP
Sbjct: 297 LEKLPKRNRRLSHP 310
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 419 bits (1079), Expect = e-140
Identities = 100/279 (35%), Positives = 156/279 (55%), Gaps = 14/279 (5%)
Query: 666 DDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVK 725
D + EIP + +G+RIG GS+G VY W+G +VAVK + L FK EV
Sbjct: 14 DAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVG 72
Query: 726 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-AR 784
++R+ RH N++LFMG T P L+I+T++ SL+ LH + + K+ I +A AR
Sbjct: 73 VLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTAR 131
Query: 785 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWM 842
GM+ LH +I+HRDLKS N+ + ++ VK+ DFGL+ K S + G+ WM
Sbjct: 132 GMDYLH--AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189
Query: 843 APEVLRNEPSN---EKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRR---LE 895
APEV+R + SN + DVY+FG++L+EL T +LP+ +N Q++ VG + +
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 249
Query: 896 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934
+ + R++ EC + RPSF ++ ++ L R
Sbjct: 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 406 bits (1046), Expect = e-135
Identities = 83/278 (29%), Positives = 135/278 (48%), Gaps = 22/278 (7%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALL-----EFKREV 724
+ ++ ++IG G +G V+ + + VA+K + D G + EF+REV
Sbjct: 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-A 783
IM L HPN+V G + PP ++ EF+P G L+ L + ++++ LD A
Sbjct: 75 FIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIA 132
Query: 784 RGMNCLHTSTPTIVHRDLKSPNLLVDK-----NWNVKVSDFGLSRLKHNTFLSSKSTAGT 838
G+ + P IVHRDL+SPN+ + KV+DFGLS+ ++ G
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS---VSGLLGN 189
Query: 839 PEWMAPEVL--RNEPSNEKCDVYSFGVILWELATLKLPWIGMNP--MQVVGAVGFQNRRL 894
+WMAPE + E EK D YSF +IL+ + T + P+ + ++ + + + R
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249
Query: 895 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932
IP++ P + +I CW DP RP F+ + L L
Sbjct: 250 TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 405 bits (1044), Expect = e-135
Identities = 90/292 (30%), Positives = 127/292 (43%), Gaps = 18/292 (6%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRR 729
DL+ GE +G G +G+ T + F F +EVK+MR
Sbjct: 4 HRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRC 63
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNC 788
L HPNV+ F+G + + L+ ITE++ G+L I+ Q +R+ A D A GM
Sbjct: 64 LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAY 123
Query: 789 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--------------KHNTFLSSKS 834
LH+ I+HRDL S N LV +N NV V+DFGL+RL K +
Sbjct: 124 LHSM--NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 835 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-QNRR 893
G P WMAPE++ +EK DV+SFG++L E+ P + +
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241
Query: 894 LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPS 945
P P I C DP RPSF +L L+ L+ + P P
Sbjct: 242 RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQ 293
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 395 bits (1018), Expect = e-131
Identities = 82/281 (29%), Positives = 135/281 (48%), Gaps = 15/281 (5%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
I ++++ + E +G G++G V A W +VA+K+ + F E++ + R+
Sbjct: 4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERK----AFIVELRQLSRVN 59
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH--RPHCQVDEKRRIKMALD-ARGMNC 788
HPN+V GA P + ++ E+ GSL+ +LH P + L ++G+
Sbjct: 60 HPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 789 LHTSTPT-IVHRDLKSPNLLVDKNWNV-KVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 846
LH+ P ++HRDLK PNLL+ V K+ DFG + ++K G+ WMAPEV
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAPEV 174
Query: 847 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNRRLEIPKELDPLVA 905
+EKCDV+S+G+ILWE+ T + P+ + P + R + K L +
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE 234
Query: 906 RIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSS 946
++ CW DPS RPS ++ + L R +
Sbjct: 235 SLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYP 275
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 359 bits (924), Expect = e-116
Identities = 91/341 (26%), Positives = 146/341 (42%), Gaps = 59/341 (17%)
Query: 637 MGTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHAD 696
G +L+ +S SS S + Q + + + ++IG G YGEV+
Sbjct: 7 PGESLRDLIEQSQSSGSGSGLPLLVQ---------RTIAKQIQMVKQIGKGRYGEVWMGK 57
Query: 697 WNGTEVAVKKFLDQDFSGAALLEFKREVKI--MRRLRHPNVVLFMGAVTRP----PNLSI 750
W G +VAVK F + + + RE +I +RH N++ F+ A + L +
Sbjct: 58 WRGEKVAVKVFFTTEEA-----SWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL 112
Query: 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTST------PTIVHRDLKS 803
IT++ GSL+ L +D K +K+A G+ LHT P I HRDLKS
Sbjct: 113 ITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKS 170
Query: 804 PNLLVDKNWNVKVSDFGLSRL----KHNTFLSSKSTAGTPEWMAPEVL------RNEPSN 853
N+LV KN ++D GL+ + + + GT +M PEVL + S
Sbjct: 171 KNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSY 230
Query: 854 EKCDVYSFGVILWELAT----------LKLPWIGMNPMQ-----VVGAVGFQNRRLEIPK 898
D+YSFG+ILWE+A +LP+ + P + V + R P
Sbjct: 231 IMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPN 290
Query: 899 -----ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934
E + +++ ECW +P+ R + ++ L +
Sbjct: 291 RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 355 bits (913), Expect = e-115
Identities = 84/300 (28%), Positives = 133/300 (44%), Gaps = 50/300 (16%)
Query: 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKI--MRRLRHP 733
D+ L E +G G YGEV+ W G VAVK F +D + RE ++ LRH
Sbjct: 8 RDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEK-----SWFRETELYNTVMLRHE 62
Query: 734 NVVLFMGAVTR----PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNC 788
N++ F+ + L +IT + GSL+ L +D +++ L A G+
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAH 120
Query: 789 LHT------STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF----LSSKSTAGT 838
LH P I HRDLKS N+LV KN ++D GL+ + + + + GT
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
Query: 839 PEWMAPEVLRNEP------SNEKCDVYSFGVILWELAT----------LKLPWIGMNP-- 880
+MAPEVL S ++ D+++FG++LWE+A K P+ + P
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240
Query: 881 ---MQVVGAVGFQNRRLEIPKELD-----PLVARIIWECWQTDPSLRPSFAQLTVALKPL 932
+ V +R IP +A+++ ECW +PS R + ++ L +
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 342 bits (880), Expect = e-110
Identities = 97/340 (28%), Positives = 151/340 (44%), Gaps = 59/340 (17%)
Query: 638 GTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADW 697
GT LK + +S S + Q +VL E IG G +GEV+ W
Sbjct: 13 GTTLKDLIYDMTTSGSGSGLPLLVQ---------RTIARTIVLQESIGKGRFGEVWRGKW 63
Query: 698 NGTEVAVKKFLDQDFSGAALLEFKREVKI--MRRLRHPNVVLFMGAVTR----PPNLSII 751
G EVAVK F ++ + RE +I LRH N++ F+ A + L ++
Sbjct: 64 RGEEVAVKIFSSREER-----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 118
Query: 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTST------PTIVHRDLKSP 804
+++ GSLF L+R V + IK+AL A G+ LH P I HRDLKS
Sbjct: 119 SDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 176
Query: 805 NLLVDKNWNVKVSDFGLSRLKHNT----FLSSKSTAGTPEWMAPEVLRNE------PSNE 854
N+LV KN ++D GL+ + ++ GT +MAPEVL + S +
Sbjct: 177 NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFK 236
Query: 855 KCDVYSFGVILWELATL----------KLPWIGMNPM-----QVVGAVGFQNRRLEIPK- 898
+ D+Y+ G++ WE+A +LP+ + P ++ V Q R IP
Sbjct: 237 RADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNR 296
Query: 899 ----ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934
E ++A+I+ ECW + + R + ++ L L +
Sbjct: 297 WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 334 bits (858), Expect = e-107
Identities = 85/330 (25%), Positives = 125/330 (37%), Gaps = 57/330 (17%)
Query: 647 ESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKK 706
SS VD T L L E G +G V+ A VAVK
Sbjct: 6 HHHSSGVDLGTE-----------NLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKI 54
Query: 707 FLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN----LSIITEFLPRGSLFR 762
F QD + + EV + ++H N++ F+GA R + L +IT F +GSL
Sbjct: 55 FPIQDKQS---WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSD 111
Query: 763 ILHRPHCQVDEKRRIKMALD-ARGMNCLHT--------STPTIVHRDLKSPNLLVDKNWN 813
L V +A ARG+ LH P I HRD+KS N+L+ N
Sbjct: 112 FLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT 169
Query: 814 VKVSDFGLSRLKH--NTFLSSKSTAGTPEWMAPEVLRNEP-----SNEKCDVYSFGVILW 866
++DFGL+ + + GT +MAPEVL + + D+Y+ G++LW
Sbjct: 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLW 229
Query: 867 ELATLKLPWIGMNP----------------MQVVGAVGFQNRRLEIPKELDP-----LVA 905
ELA+ G + V + +R + ++
Sbjct: 230 ELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLC 289
Query: 906 RIIWECWQTDPSLRPSFAQLTVALKPLQRL 935
I ECW D R S + + +QRL
Sbjct: 290 ETIEECWDHDAEARLSAGCVGERITQMQRL 319
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 317 bits (815), Expect = e-101
Identities = 83/331 (25%), Positives = 125/331 (37%), Gaps = 61/331 (18%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMR- 728
E + ++L L E IG G YG VY + VAVK F + F E I R
Sbjct: 7 EPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQ-----NFINEKNIYRV 61
Query: 729 -RLRHPNVVLFMGAVTRPP-----NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 782
+ H N+ F+ R ++ E+ P GSL + L D ++A
Sbjct: 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHS 119
Query: 783 -ARGMNCLHTST-------PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL---- 830
RG+ LHT P I HRDL S N+LV + +SDFGLS L
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 831 ----SSKSTAGTPEWMAPEVLRN-------EPSNEKCDVYSFGVILWELA---TLKLPWI 876
++ S GT +MAPEVL E + ++ D+Y+ G+I WE+ T P
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239
Query: 877 GMNPMQV---------------VGAVGFQNRRLEIPKELDP------LVARIIWECWQTD 915
+ Q+ V + +R + P+ + I +CW D
Sbjct: 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQD 299
Query: 916 PSLRPSFAQLTVALKPLQRLVIPSHPDQPSS 946
R + + L + + P++
Sbjct: 300 AEARLTAQXAEERMAELMMIWERNKSVSPTA 330
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 1e-70
Identities = 78/255 (30%), Positives = 121/255 (47%), Gaps = 13/255 (5%)
Query: 680 LGERIGLGSYGEVYHA-DW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
IG GS+ VY D EVA + D+ + + FK E ++++ L+HPN+V
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 738 FMGA----VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTS 792
F + V + ++TE + G+L L R + K +G+ LHT
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTR 148
Query: 793 TPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 851
TP I+HRDLK N+ + +VK+ D GL+ LK +F +K+ GTPE+MAPE+ +
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMAPEMYEEK- 205
Query: 852 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVV-GAVGFQNRRLEIPKELDPLVARIIWE 910
+E DVY+FG+ + E+AT + P+ + V + K P V II
Sbjct: 206 YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG 265
Query: 911 CWQTDPSLRPSFAQL 925
C + + R S L
Sbjct: 266 CIRQNKDERYSIKDL 280
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 2e-67
Identities = 83/271 (30%), Positives = 139/271 (51%), Gaps = 10/271 (3%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG--TEVAVKKFLDQDFSGAALLEFKREVKIM 727
+ + EDLVLGE+IG G++GEV+ T VAVK + +F +E +I+
Sbjct: 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKS-CRETLPPDLKAKFLQEARIL 166
Query: 728 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGM 786
++ HPN+V +G T+ + I+ E + G L ++ K ++M D A GM
Sbjct: 167 KQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGM 226
Query: 787 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT-P-EWMAP 844
L + +HRDL + N LV + +K+SDFG+SR + + ++ P +W AP
Sbjct: 227 EYLESK--CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAP 284
Query: 845 EVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 903
E L + + DV+SFG++LWE +L P+ ++ Q V + RL P+
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPELCPDA 343
Query: 904 VARIIWECWQTDPSLRPSFAQLTVALKPLQR 934
V R++ +CW +P RPSF+ + L+ +++
Sbjct: 344 VFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 2e-65
Identities = 89/285 (31%), Positives = 144/285 (50%), Gaps = 19/285 (6%)
Query: 655 SSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSG 714
S + D+ + + ++L L + IG G +G+V D+ G +VAVK +
Sbjct: 3 GSVAAQDEFYRS---GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN----D 55
Query: 715 AALLEFKREVKIMRRLRHPNVVLFMGAVTR-PPNLSIITEFLPRGSLFRILH-RPHCQVD 772
A F E +M +LRH N+V +G + L I+TE++ +GSL L R +
Sbjct: 56 ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLG 115
Query: 773 EKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 831
+K +LD M L VHRDL + N+LV ++ KVSDFGL++ +T +
Sbjct: 116 GDCLLKFSLDVCEAMEYL--EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 173
Query: 832 SKSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGF 889
K P +W APE LR + + K DV+SFG++LWE+ + ++P+ + VV V
Sbjct: 174 GK----LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE- 228
Query: 890 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934
+ +++ P P V ++ CW D ++RPSF QL L+ ++
Sbjct: 229 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 3e-65
Identities = 83/312 (26%), Positives = 138/312 (44%), Gaps = 26/312 (8%)
Query: 650 SSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAV 704
+ + + + + I L+LG+ +G G +G V + +VAV
Sbjct: 8 HHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAV 67
Query: 705 KKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-----PPNLSIITEFLPRGS 759
K + S + EF E M+ HPNV+ +G P +I F+ G
Sbjct: 68 KTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGD 127
Query: 760 LFRIL--HRPHCQVDE---KRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN 813
L L R + +K +D A GM L S +HRDL + N ++ +
Sbjct: 128 LHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL--SNRNFLHRDLAARNCMLRDDMT 185
Query: 814 VKVSDFGLSRLKHNTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL 871
V V+DFGLS+ ++ + P +W+A E L + K DV++FGV +WE+AT
Sbjct: 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 245
Query: 872 -KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 930
P+ G+ ++ + RL+ P++ + I++ CW+TDP RP+F+ L + L+
Sbjct: 246 GMTPYPGVQNHEMYDYLL-HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLE 304
Query: 931 PLQRLVIPSHPD 942
L + S PD
Sbjct: 305 KL----LESLPD 312
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 3e-65
Identities = 78/267 (29%), Positives = 128/267 (47%), Gaps = 10/267 (3%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
I +L + IG G +G V+ W +VA+K + + +F E ++M +L
Sbjct: 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSEE--DFIEEAEVMMKL 60
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCL 789
HP +V G + ++TEF+ G L L + + M LD GM L
Sbjct: 61 SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120
Query: 790 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVLR 848
++HRDL + N LV +N +KVSDFG++R + +S + P +W +PEV
Sbjct: 121 --EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 178
Query: 849 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 907
+ K DV+SFGV++WE+ + K+P+ + +VV + RL P+ V +I
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQI 237
Query: 908 IWECWQTDPSLRPSFAQLTVALKPLQR 934
+ CW+ P RP+F++L L +
Sbjct: 238 MNHCWRERPEDRPAFSRLLRQLAEIAE 264
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 4e-65
Identities = 81/294 (27%), Positives = 132/294 (44%), Gaps = 23/294 (7%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREV 724
+ IP + LG +G G +G V A +VAVK + + + EF RE
Sbjct: 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREA 76
Query: 725 KIMRRLRHPNVVLFMGAVTR------PPNLSIITEFLPRGSLFRIL--HRPH---CQVDE 773
M+ HP+V +G R P +I F+ G L L R +
Sbjct: 77 ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136
Query: 774 KRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832
+ ++ +D A GM L S+ +HRDL + N ++ ++ V V+DFGLSR ++
Sbjct: 137 QTLVRFMVDIACGMEYL--SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR 194
Query: 833 KSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGF 889
+ A P +W+A E L + DV++FGV +WE+ T + P+ G+ ++ +
Sbjct: 195 QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI- 253
Query: 890 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQ 943
RL+ P E V ++++CW DP RPSF L + L+ + + Q
Sbjct: 254 GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ 307
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 6e-65
Identities = 85/267 (31%), Positives = 138/267 (51%), Gaps = 10/267 (3%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
E+ E++ L + +G G +G V W G +VAVK + + EF +E + M +L
Sbjct: 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKM-IKEGSMSED--EFFQEAQTMMKL 60
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCL 789
HP +V F G ++ + I+TE++ G L L ++ + ++M D GM L
Sbjct: 61 SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 790 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVLR 848
+ +HRDL + N LVD++ VKVSDFG++R + S P +W APEV
Sbjct: 121 --ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFH 178
Query: 849 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 907
+ K DV++FG+++WE+ +L K+P+ +VV V Q RL P + +I
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLASDTIYQI 237
Query: 908 IWECWQTDPSLRPSFAQLTVALKPLQR 934
++ CW P RP+F QL +++PL+
Sbjct: 238 MYSCWHELPEKRPTFQQLLSSIEPLRE 264
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 1e-64
Identities = 82/273 (30%), Positives = 124/273 (45%), Gaps = 13/273 (4%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREV 724
+ I ED+VL +G G +GEVY + VAVK +D + +F E
Sbjct: 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKT-CKKDCTLDNKEKFMSEA 64
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-A 783
IM+ L HP++V +G + P II E P G L L R + + +L
Sbjct: 65 VIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQIC 123
Query: 784 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWM 842
+ M L + VHRD+ N+LV VK+ DFGLSR + S P +WM
Sbjct: 124 KAMAYL--ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 181
Query: 843 APEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELD 901
+PE + DV+ F V +WE+ + K P+ + V+G + + RL P
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLPKPDLCP 240
Query: 902 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934
P++ ++ CW DPS RP F +L +L + +
Sbjct: 241 PVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 2e-64
Identities = 90/287 (31%), Positives = 145/287 (50%), Gaps = 15/287 (5%)
Query: 663 IFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFK 721
++D E E+P E L L ER+G G +GEV+ +NG T+VAVK L Q F
Sbjct: 3 WWED---EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPD--AFL 56
Query: 722 REVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL-HRPHCQVDEKRRIKMA 780
E +M++L+H +V VT+ P IITE++ GSL L ++ + + MA
Sbjct: 57 AEANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMA 115
Query: 781 LD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP 839
A GM + +HRDL++ N+LV + K++DFGL+RL + +++ A P
Sbjct: 116 AQIAEGMAFI--EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 840 -EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIP 897
+W APE + K DV+SFG++L E+ T ++P+ GM +V+ + + R+ P
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRP 232
Query: 898 KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQP 944
+ +++ CW+ P RP+F L L+ + QP
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP 279
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 2e-64
Identities = 80/267 (29%), Positives = 124/267 (46%), Gaps = 10/267 (3%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
EI +DL + +G G +G V + W G +VA+K + + EF E K+M L
Sbjct: 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKM-IKEGSMSED--EFIEEAKVMMNL 76
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCL 789
H +V G T+ + IITE++ G L L + ++ ++M D M L
Sbjct: 77 SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 790 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAPEVLR 848
+ +HRDL + N LV+ VKVSDFGLSR + +S + P W PEVL
Sbjct: 137 --ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 194
Query: 849 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 907
+ K D+++FGV++WE+ +L K+P+ + + Q RL P V I
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTI 253
Query: 908 IWECWQTDPSLRPSFAQLTVALKPLQR 934
++ CW RP+F L + +
Sbjct: 254 MYSCWHEKADERPTFKILLSNILDVMD 280
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 2e-64
Identities = 90/304 (29%), Positives = 149/304 (49%), Gaps = 28/304 (9%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
E+ E + + +G GS+G VY G T VA+K +++ S +EF E
Sbjct: 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT-VNEAASMRERIEFLNEA 79
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSL--FRILHRPHCQVDEKRR------ 776
+M+ +VV +G V++ +I E + RG L + RP +
Sbjct: 80 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139
Query: 777 -IKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 834
I+MA + A GM L + VHRDL + N +V +++ VK+ DFG++R + T K
Sbjct: 140 MIQMAGEIADGMAYL--NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 197
Query: 835 TAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 891
G P WM+PE L++ DV+SFGV+LWE+ATL + P+ G++ QV+ V +
Sbjct: 198 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-MEG 256
Query: 892 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ----RLVIPSHPDQPSSA 947
L+ P ++ ++ CWQ +P +RPSF ++ ++K R V + ++
Sbjct: 257 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEENKLP 316
Query: 948 LPQE 951
P+E
Sbjct: 317 EPEE 320
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 4e-64
Identities = 72/274 (26%), Positives = 122/274 (44%), Gaps = 15/274 (5%)
Query: 671 CEIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREV 724
+ + + +G G++G VY W VA+K+ L + S A E E
Sbjct: 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE-LREATSPKANKEILDEA 68
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-A 783
+M + +P+V +G + +IT+ +P G L + + + + + A
Sbjct: 69 YVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 784 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTP-EW 841
+GMN L +VHRDL + N+LV +VK++DFGL++ L P +W
Sbjct: 128 KGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 842 MAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKEL 900
MA E + + + DV+S+GV +WEL T P+ G+ ++ + + RL P
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPIC 244
Query: 901 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934
V I+ +CW D RP F +L + + R
Sbjct: 245 TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 5e-64
Identities = 85/293 (29%), Positives = 140/293 (47%), Gaps = 19/293 (6%)
Query: 667 DVCECEIP--WEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLE 719
+V + IP IG G +G VYH ++ + A+K L + +
Sbjct: 10 EVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKS-LSRITEMQQVEA 68
Query: 720 FKREVKIMRRLRHPNVVLFMGAVTRP-PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK 778
F RE +MR L HPNV+ +G + P ++ ++ G L + + P K I
Sbjct: 69 FLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLIS 128
Query: 779 MALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--FLSSKST 835
L ARGM L + VHRDL + N ++D+++ VKV+DFGL+R + + +
Sbjct: 129 FGLQVARGMEYL--AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHR 186
Query: 836 AGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNR 892
P +W A E L+ K DV+SFGV+LWEL T P+ ++P + + Q R
Sbjct: 187 HARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-QGR 245
Query: 893 RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSH-PDQP 944
RL P+ + +++ +CW+ DP++RP+F L ++ + ++ H P
Sbjct: 246 RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHYVQLP 298
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 7e-64
Identities = 86/295 (29%), Positives = 137/295 (46%), Gaps = 31/295 (10%)
Query: 666 DDVCECEIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALL 718
+ I D+VL +G G++G+V+ A+ VAVK +D + AA
Sbjct: 5 SGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL--KDPTLAARK 62
Query: 719 EFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRR 776
+F+RE +++ L+H ++V F G L ++ E++ G L + L H P + +
Sbjct: 63 DFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQ 122
Query: 777 -------------IKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 822
+ +A A GM L ++ VHRDL + N LV N VK+ DFG+S
Sbjct: 123 PRQAKGELGLSQMLHIASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
Query: 823 RLKHNTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMN 879
R ++T P WM PE + + DV+SFGVILWE+ T K PW ++
Sbjct: 181 RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 240
Query: 880 PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934
+V+ + Q R LE P+ V ++ CWQ +P R + ++ L L +
Sbjct: 241 NTEVIECIT-QGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGK 294
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 5e-63
Identities = 85/300 (28%), Positives = 134/300 (44%), Gaps = 29/300 (9%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
E+P +++ L +G G++GEVY +G +VAVK L + S L+F E
Sbjct: 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-LPEVCSEQDELDFLMEA 84
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDE----KRRIK 778
I+ + H N+V +G + I+ E + G L L RP +
Sbjct: 85 LIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144
Query: 779 MALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRLKHNTFLSSKS 834
+A D A G L +HRD+ + N L+ K+ DFG++R + K
Sbjct: 145 VARDIACGCQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 202
Query: 835 TAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 891
P +WM PE K D +SFGV+LWE+ +L +P+ + +V+ V
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SG 261
Query: 892 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQE 951
R++ PK V RI+ +CWQ P RP+FA + ++ + PD ++ALP E
Sbjct: 262 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ-----DPDVINTALPIE 316
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 7e-63
Identities = 86/271 (31%), Positives = 124/271 (45%), Gaps = 14/271 (5%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALL-EFKRE 723
C I +DL L E++G GS+G V +W+ VAVK S + +F RE
Sbjct: 12 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 71
Query: 724 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD- 782
V M L H N++ G V PP + ++TE P GSL L + + A+
Sbjct: 72 VNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 130
Query: 783 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P- 839
A GM L + +HRDL + NLL+ VK+ DFGL R P
Sbjct: 131 AEGMGYL--ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 188
Query: 840 EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPK 898
W APE L+ + D + FGV LWE+ T + PWIG+N Q++ + + RL P+
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE 248
Query: 899 ELDPLVARIIWECWQTDPSLRPSFAQLTVAL 929
+ + ++ +CW P RP+F L L
Sbjct: 249 DCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 2e-62
Identities = 83/300 (27%), Positives = 133/300 (44%), Gaps = 16/300 (5%)
Query: 653 VDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKF 707
+D S + + + E IG G +G VYH AVK
Sbjct: 2 IDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS- 60
Query: 708 LDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-PNLSIITEFLPRGSLFRILHR 766
L++ + +F E IM+ HPNV+ +G R + ++ ++ G L +
Sbjct: 61 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 120
Query: 767 PHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825
K I L A+GM L ++ VHRDL + N ++D+ + VKV+DFGL+R
Sbjct: 121 ETHNPTVKDLIGFGLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178
Query: 826 HNT--FLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNP 880
++ + T P +WMA E L+ + K DV+SFGV+LWEL T P+ +N
Sbjct: 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 238
Query: 881 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSH 940
+ + Q RRL P+ + ++ +CW +RPSF++L + + I H
Sbjct: 239 FDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 297
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 2e-62
Identities = 96/324 (29%), Positives = 149/324 (45%), Gaps = 31/324 (9%)
Query: 636 FMGTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHA 695
MG+ L E S + + Q F D C I D+VL +G G++G+V+ A
Sbjct: 2 AMGSGSSLSPTEGKGSGLQGHIIENPQYFSDA-CVHHIKRRDIVLKWELGEGAFGKVFLA 60
Query: 696 DWNG-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748
+ + VAVK ++ S +A +F+RE +++ L+H ++V F G T L
Sbjct: 61 ECHNLLPEQDKMLVAVKAL--KEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118
Query: 749 SIITEFLPRGSLFRIL--HRPHCQVDEKRR------------IKMALD-ARGMNCLHTST 793
++ E++ G L R L H P ++ + +A A GM L +
Sbjct: 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL--AG 176
Query: 794 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT-P-EWMAPEVLRNEP 851
VHRDL + N LV + VK+ DFG+SR ++T P WM PE +
Sbjct: 177 LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK 236
Query: 852 SNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 910
+ DV+SFGV+LWE+ T K PW ++ + + + Q R LE P+ P V I+
Sbjct: 237 FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT-QGRELERPRACPPEVYAIMRG 295
Query: 911 CWQTDPSLRPSFAQLTVALKPLQR 934
CWQ +P R S + L+ L +
Sbjct: 296 CWQREPQQRHSIKDVHARLQALAQ 319
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 2e-62
Identities = 96/270 (35%), Positives = 143/270 (52%), Gaps = 14/270 (5%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG--TEVAVKKFLDQDFSGAALLEFKREVKIM 727
+ E+ D+ + ++G G YGEVY W VAVK L +D EF +E +M
Sbjct: 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKEDTMEVE--EFLKEAAVM 63
Query: 728 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALD-AR 784
+ ++HPN+V +G TR P IITEF+ G+L L +V + MA +
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISS 122
Query: 785 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMA 843
M L +HRDL + N LV +N VKV+DFGLSRL ++ + A P +W A
Sbjct: 123 AMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 180
Query: 844 PEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 902
PE L + K DV++FGV+LWE+AT P+ G++ QV + ++ R+E P+
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPE 239
Query: 903 LVARIIWECWQTDPSLRPSFAQLTVALKPL 932
V ++ CWQ +PS RPSFA++ A + +
Sbjct: 240 KVYELMRACWQWNPSDRPSFAEIHQAFETM 269
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 3e-62
Identities = 84/288 (29%), Positives = 122/288 (42%), Gaps = 30/288 (10%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
EI + E +G +G+VY G VA+K L G EF+ E
Sbjct: 5 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKT-LKDKAEGPLREEFRHEA 63
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRR------ 776
+ RL+HPNVV +G VT+ LS+I + G L L PH V
Sbjct: 64 MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 777 -------IKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828
+ + A GM L S+ +VH+DL + N+LV NVK+SD GL R +
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181
Query: 829 FLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVG 885
P WMAPE + + D++S+GV+LWE+ + P+ G + VV
Sbjct: 182 DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 241
Query: 886 AVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 933
+ + L P + V ++ ECW PS RP F + L+
Sbjct: 242 MIR-NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 288
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 3e-62
Identities = 82/273 (30%), Positives = 123/273 (45%), Gaps = 13/273 (4%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREV 724
+ EI E + LG IG G +G+V+ + VA+K S + +F +E
Sbjct: 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKT-CKNCTSDSVREKFLQEA 67
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-A 783
MR+ HP++V +G +T P II E G L L +D I A +
Sbjct: 68 LTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 126
Query: 784 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWM 842
+ L + VHRD+ + N+LV N VK+ DFGLSR ++ S P +WM
Sbjct: 127 TALAYL--ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 184
Query: 843 APEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELD 901
APE + DV+ FGV +WE+ P+ G+ V+G + RL +P
Sbjct: 185 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCP 243
Query: 902 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934
P + ++ +CW DPS RP F +L L +
Sbjct: 244 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 5e-62
Identities = 85/302 (28%), Positives = 134/302 (44%), Gaps = 29/302 (9%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
E+P +++ L +G G++GEVY +G +VAVK L + S L+F E
Sbjct: 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-LPEVCSEQDELDFLMEA 125
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDE----KRRIK 778
I+ + H N+V +G + I+ E + G L L RP +
Sbjct: 126 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185
Query: 779 MALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRLKHNTFLSSKS 834
+A D A G L +HRD+ + N L+ K+ DFG++R + K
Sbjct: 186 VARDIACGCQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKG 243
Query: 835 TAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 891
P +WM PE K D +SFGV+LWE+ +L +P+ + +V+ V
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SG 302
Query: 892 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQE 951
R++ PK V RI+ +CWQ P RP+FA + ++ + PD ++ALP E
Sbjct: 303 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ-----DPDVINTALPIE 357
Query: 952 IS 953
Sbjct: 358 YG 359
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 5e-62
Identities = 69/295 (23%), Positives = 126/295 (42%), Gaps = 20/295 (6%)
Query: 671 CEIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREV 724
+L + +G G +G V+ W V +K ++ + +
Sbjct: 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKV-IEDKSGRQSFQAVTDHM 66
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-A 783
+ L H ++V +G L ++T++LP GSL + + + + + + A
Sbjct: 67 LAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125
Query: 784 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAG-TP-EW 841
+GM L +VHR+L + N+L+ V+V+DFG++ L + TP +W
Sbjct: 126 KGMYYL--EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 183
Query: 842 MAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKEL 900
MA E + + DV+S+GV +WEL T P+ G+ +V + + RL P+
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGERLAQPQIC 242
Query: 901 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR-----LVIPSHPDQPSSALPQ 950
V ++ +CW D ++RP+F +L + R LVI + P+
Sbjct: 243 TIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLVIKRESGPGIAPGPE 297
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 2e-61
Identities = 84/294 (28%), Positives = 140/294 (47%), Gaps = 20/294 (6%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREVK 725
EI + + IG G +GEVY VA+K L ++ ++F E
Sbjct: 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT-LKAGYTEKQRVDFLGEAG 98
Query: 726 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-AR 784
IM + H N++ G +++ + IITE++ G+L + L + + + M A
Sbjct: 99 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 158
Query: 785 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P-EW 841
GM L + VHRDL + N+LV+ N KVSDFGLSR+ + ++ +T+G P W
Sbjct: 159 GMKYL--ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 216
Query: 842 MAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKEL 900
APE + DV+SFG+++WE+ T + P+ ++ +V+ A+ RL P +
Sbjct: 217 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMDC 275
Query: 901 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR-----LVIPSHPDQPSSALP 949
+ +++ +CWQ + + RP FA + L L R + + S LP
Sbjct: 276 PSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIRLP 329
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 2e-61
Identities = 74/295 (25%), Positives = 129/295 (43%), Gaps = 19/295 (6%)
Query: 671 CEIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREV 724
+ + + +G G++G VY W VA+K+ L + S A E E
Sbjct: 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE-LREATSPKANKEILDEA 68
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-A 783
+M + +P+V +G + +IT+ +P G L + + + + + A
Sbjct: 69 YVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 784 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTP-EW 841
+GMN L +VHRDL + N+LV +VK++DFGL++ L P +W
Sbjct: 128 KGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 842 MAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKEL 900
MA E + + + DV+S+GV +WEL T P+ G+ ++ + + RL P
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPIC 244
Query: 901 DPLVARIIWECWQTDPSLRPSFAQLTVALKPL----QRLVIPSHPDQPSSALPQE 951
V I+ +CW D RP F +L + + QR ++ ++ P +
Sbjct: 245 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTD 299
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 2e-61
Identities = 83/305 (27%), Positives = 134/305 (43%), Gaps = 16/305 (5%)
Query: 648 SPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNG-----TEV 702
+ + +D S + + + E IG G +G VYH
Sbjct: 61 ANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHC 120
Query: 703 AVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-PNLSIITEFLPRGSLF 761
AVK L++ + +F E IM+ HPNV+ +G R + ++ ++ G L
Sbjct: 121 AVKS-LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 179
Query: 762 RILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 820
+ K I L A+GM L ++ VHRDL + N ++D+ + VKV+DFG
Sbjct: 180 NFIRNETHNPTVKDLIGFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFG 237
Query: 821 LSRLKHNT--FLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPW 875
L+R ++ T P +WMA E L+ + K DV+SFGV+LWEL T P+
Sbjct: 238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 297
Query: 876 IGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935
+N + + Q RRL P+ + ++ +CW +RPSF++L + +
Sbjct: 298 PDVNTFDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356
Query: 936 VIPSH 940
I H
Sbjct: 357 FIGEH 361
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 3e-61
Identities = 80/310 (25%), Positives = 130/310 (41%), Gaps = 38/310 (12%)
Query: 659 KVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQD 711
++ + + + E P ++ IG G++G V+ A G T VAVK L ++
Sbjct: 30 RMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM-LKEE 88
Query: 712 FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHC 769
S +F+RE +M +PN+V +G + ++ E++ G L L PH
Sbjct: 89 ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHT 148
Query: 770 QVDEKRR---------------------IKMALD-ARGMNCLHTSTPTIVHRDLKSPNLL 807
+ +A A GM L S VHRDL + N L
Sbjct: 149 VCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL--SERKFVHRDLATRNCL 206
Query: 808 VDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVIL 865
V +N VK++DFGLSR ++ P WM PE + + DV+++GV+L
Sbjct: 207 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 266
Query: 866 WELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQ 924
WE+ + P+ GM +V+ V L P+ + ++ CW P+ RPSF
Sbjct: 267 WEIFSYGLQPYYGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCS 325
Query: 925 LTVALKPLQR 934
+ L+ +
Sbjct: 326 IHRILQRMCE 335
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 3e-61
Identities = 87/272 (31%), Positives = 139/272 (51%), Gaps = 20/272 (7%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVK--KFLDQDFSGAALLEFKREVKIM 727
+ ++L L + IG G +G+V D+ G +VAVK K + A F E +M
Sbjct: 187 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK------NDATAQAFLAEASVM 240
Query: 728 RRLRHPNVVLFMGAVTR-PPNLSIITEFLPRGSLFRIL-HRPHCQVDEKRRIKMALD-AR 784
+LRH N+V +G + L I+TE++ +GSL L R + +K +LD
Sbjct: 241 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 300
Query: 785 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMA 843
M L VHRDL + N+LV ++ KVSDFGL++ +T + K P +W A
Sbjct: 301 AMEYL--EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKWTA 354
Query: 844 PEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 902
PE LR + + K DV+SFG++LWE+ + ++P+ + VV V + +++ P P
Sbjct: 355 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPP 413
Query: 903 LVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934
V ++ CW D + RP+F QL L+ ++
Sbjct: 414 AVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 3e-61
Identities = 87/294 (29%), Positives = 147/294 (50%), Gaps = 14/294 (4%)
Query: 656 STSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSG 714
+SK + ++ D EIP E L L +++G G +GEV+ A +N T+VAVK
Sbjct: 170 MSSKPQKPWEKD--AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP---GS 224
Query: 715 AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL-HRPHCQVDE 773
++ F E +M+ L+H +V VT+ P IITEF+ +GSL L +
Sbjct: 225 MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPL 283
Query: 774 KRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832
+ I + A GM + +HRDL++ N+LV + K++DFGL+R+ + ++
Sbjct: 284 PKLIDFSAQIAEGMAFI--EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341
Query: 833 KSTAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQ 890
+ A P +W APE + K DV+SFG++L E+ T ++P+ GM+ +V+ A+ +
Sbjct: 342 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-R 400
Query: 891 NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQP 944
R+ P+ + I+ CW+ P RP+F + L + + P
Sbjct: 401 GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEEIP 454
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 4e-61
Identities = 94/316 (29%), Positives = 159/316 (50%), Gaps = 36/316 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG---------TEVAVKKFLDQDFSGAALLEFKR 722
E+P + LVLG+ +G G++G+V A+ G T+VAVK L D + L +
Sbjct: 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM-LKSDATEKDLSDLIS 123
Query: 723 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSL---------------FRILHR 766
E+++M+ + +H N++ +GA T+ L +I E+ +G+L + H
Sbjct: 124 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183
Query: 767 PHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825
P Q+ K + A ARGM L ++ +HRDL + N+LV ++ +K++DFGL+R
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 241
Query: 826 HNTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQ 882
H+ K+T G P +WMAPE L + + DV+SFGV+LWE+ TL P+ G+ +
Sbjct: 242 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301
Query: 883 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPD 942
+ + + R++ P + ++ +CW PS RP+F QL ++ L R+V +
Sbjct: 302 LFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL---VEDLDRIVALTSNQ 357
Query: 943 QPSSALPQEISVNSTP 958
+ P
Sbjct: 358 EMGYYHHHHHHDYDIP 373
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 6e-61
Identities = 89/290 (30%), Positives = 147/290 (50%), Gaps = 33/290 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG---------TEVAVKKFLDQDFSGAALLEFKR 722
E P + L LG+ +G G++G+V A+ G VAVK L D + L +
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM-LKDDATEKDLSDLVS 89
Query: 723 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHC---------- 769
E+++M+ + +H N++ +GA T+ L +I E+ +G+L L RP
Sbjct: 90 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 770 ---QVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825
Q+ K + ARGM L ++ +HRDL + N+LV +N +K++DFGL+R
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 826 HNTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQ 882
+N K+T G P +WMAPE L + + DV+SFGV++WE+ TL P+ G+ +
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267
Query: 883 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932
+ + + R++ P + ++ +CW PS RP+F QL L +
Sbjct: 268 LFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 213 bits (543), Expect = 1e-60
Identities = 92/285 (32%), Positives = 142/285 (49%), Gaps = 16/285 (5%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMR 728
EIP E L L ++G G +GEV+ WNG T VA+K L + F +E ++M+
Sbjct: 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKT-LKPGTM--SPEAFLQEAQVMK 234
Query: 729 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALD-ARG 785
+LRH +V V+ P I+TE++ +GSL L + + + MA A G
Sbjct: 235 KLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASG 292
Query: 786 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAP 844
M + VHRDL++ N+LV +N KV+DFGL+RL + +++ A P +W AP
Sbjct: 293 MAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 350
Query: 845 EVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 903
E K DV+SFG++L EL T ++P+ GM +V+ V + R+ P E
Sbjct: 351 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPES 409
Query: 904 VARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSAL 948
+ ++ +CW+ +P RP+F L L+ QP L
Sbjct: 410 LHDLMCQCWRKEPEERPTFEYLQAFLEDY--FTSTEPQYQPGENL 452
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 3e-60
Identities = 72/271 (26%), Positives = 123/271 (45%), Gaps = 15/271 (5%)
Query: 670 ECEIPWEDLVLGER-IGLGSYGEVYHADWNG----TEVAVKKFLDQDFSGAALLEFKREV 724
E + + L L ++ +G G++G V + VAVK ++ A E E
Sbjct: 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEA 69
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-A 783
+M++L +P +V +G + ++ E G L + L + + V +K I++ +
Sbjct: 70 NVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVS 127
Query: 784 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P-E 840
GM L VHRDL + N+L+ K+SDFGLS+ K+ P +
Sbjct: 128 MGMKYL--EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 185
Query: 841 WMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKE 899
W APE + + K DV+SFGV++WE + + P+ GM +V + + R+ P
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAG 244
Query: 900 LDPLVARIIWECWQTDPSLRPSFAQLTVALK 930
+ ++ CW D RP FA + + L+
Sbjct: 245 CPREMYDLMNLCWTYDVENRPGFAAVELRLR 275
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 3e-60
Identities = 87/273 (31%), Positives = 129/273 (47%), Gaps = 14/273 (5%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKI 726
EI + + + IG G GEV + VA+K L ++ +F E I
Sbjct: 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKA-LKAGYTERQRRDFLSEASI 103
Query: 727 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARG 785
M + HPN++ G VTR I+TE++ GSL L Q + + M G
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAG 163
Query: 786 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P-EWM 842
M L S VHRDL + N+LVD N KVSDFGLSR+ + ++ +T G P W
Sbjct: 164 MRYL--SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT 221
Query: 843 APEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELD 901
APE + + DV+SFGV++WE+ + P+ M V+ +V + RL P
Sbjct: 222 APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGYRLPAPMGCP 280
Query: 902 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934
+ +++ +CW D + RP F+Q+ L L R
Sbjct: 281 HALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 3e-60
Identities = 88/295 (29%), Positives = 142/295 (48%), Gaps = 38/295 (12%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
E P ++LVLG+ +G G +G+V A T VAVK L ++ S + L + E
Sbjct: 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM-LKENASPSELRDLLSEF 77
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRR------ 776
+++++ HP+V+ GA ++ L +I E+ GSL L R
Sbjct: 78 NVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137
Query: 777 ---------------IKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 820
I A ++GM L + +VHRDL + N+LV + +K+SDFG
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFG 195
Query: 821 LSRLKHNTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIG 877
LSR + K + G P +WMA E L + + DV+SFGV+LWE+ TL P+ G
Sbjct: 196 LSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255
Query: 878 MNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932
+ P ++ + R+E P + R++ +CW+ +P RP FA ++ L+ +
Sbjct: 256 IPPERLFNLLK-TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 3e-60
Identities = 79/293 (26%), Positives = 131/293 (44%), Gaps = 33/293 (11%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKRE 723
+ L +++G G++G V ++ VAVKK L + L +F+RE
Sbjct: 4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHS-TEEHLRDFERE 61
Query: 724 VKIMRRLRHPNVVLFMGAVTRPPNLS--IITEFLPRGSLFRILHRPHCQVDEKRRIKMAL 781
++I++ L+H N+V + G + +I E+LP GSL L + ++D + ++
Sbjct: 62 IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 121
Query: 782 D-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAG-T 838
+GM L T +HRDL + N+LV+ VK+ DFGL++ L + G +
Sbjct: 122 QICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES 179
Query: 839 P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL----------------KLPWIGMNPM 881
P W APE L + DV+SFGV+L+EL T M
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239
Query: 882 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934
++ + N RL P + I+ ECW + + RPSF L + + ++
Sbjct: 240 HLIELLK-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 7e-60
Identities = 95/330 (28%), Positives = 158/330 (47%), Gaps = 41/330 (12%)
Query: 637 MGTNLKLRDLESPSSSVDS-----STSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGE 691
M +N L + + SS S+ + D E P + L LG+ +G G +G+
Sbjct: 40 MNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKW---EFPRDKLTLGKPLGEGCFGQ 96
Query: 692 VYHADWNG---------TEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA 741
V A+ G VAVK L D + L + E+++M+ + +H N++ +GA
Sbjct: 97 VVMAEAVGIDKDKPKEAVTVAVKM-LKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155
Query: 742 VTRPPNLSIITEFLPRGSL--FRILHRPHC-------------QVDEKRRIKMALD-ARG 785
T+ L +I E+ +G+L + RP Q+ K + ARG
Sbjct: 156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARG 215
Query: 786 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT-P-EWMA 843
M L ++ +HRDL + N+LV +N +K++DFGL+R +N K+T G P +WMA
Sbjct: 216 MEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMA 273
Query: 844 PEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 902
PE L + + DV+SFGV++WE+ TL P+ G+ ++ + + R++ P
Sbjct: 274 PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK-EGHRMDKPANCTN 332
Query: 903 LVARIIWECWQTDPSLRPSFAQLTVALKPL 932
+ ++ +CW PS RP+F QL L +
Sbjct: 333 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 7e-60
Identities = 89/302 (29%), Positives = 147/302 (48%), Gaps = 19/302 (6%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREVKI 726
E+ ++ + + +G G +GEV VA+K L ++ +F E I
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT-LKVGYTEKQRRDFLGEASI 99
Query: 727 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARG 785
M + HPN++ G VT+ + I+TE++ GSL L + Q + + M A G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 786 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P-EWM 842
M L S VHRDL + N+L++ N KVSDFGL R+ + ++ +T G P W
Sbjct: 160 MKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 843 APEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELD 901
+PE + DV+S+G++LWE+ + + P+ M+ V+ AV + RL P +
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMDCP 276
Query: 902 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQR-----LVIPSHPDQPSSALPQEISVNS 956
+ +++ +CWQ D + RP F Q+ L L R +I S +PS+ L + +V+
Sbjct: 277 AALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDI 336
Query: 957 TP 958
T
Sbjct: 337 TT 338
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 9e-60
Identities = 82/290 (28%), Positives = 128/290 (44%), Gaps = 31/290 (10%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVK 725
L +G G +G+V + G +VAVK L + G + + K+E++
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS-LKPESGGNHIADLKKEIE 75
Query: 726 IMRRLRHPNVVLFMGAVTRPPN--LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD- 782
I+R L H N+V + G T + +I EFLP GSL L + +++ K+++K A+
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 135
Query: 783 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P- 839
+GM+ L + VHRDL + N+LV+ VK+ DFGL++ P
Sbjct: 136 CKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPV 193
Query: 840 EWMAPEVLRNEPSNEKCDVYSFGVILWELATL---------------KLPWIGMNPMQVV 884
W APE L DV+SFGV L EL T M ++V
Sbjct: 194 FWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253
Query: 885 GAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934
+ + +RL P V +++ +CW+ PS R SF L + L +
Sbjct: 254 NTLK-EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 1e-59
Identities = 93/272 (34%), Positives = 143/272 (52%), Gaps = 14/272 (5%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG--TEVAVKKFLDQDFSGAALLEFKREVKIM 727
+ E+ D+ + ++G G YGEVY W VAVK L +D EF +E +M
Sbjct: 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKEDTMEVE--EFLKEAAVM 270
Query: 728 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALD-AR 784
+ ++HPN+V +G TR P IITEF+ G+L L +V + MA +
Sbjct: 271 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISS 329
Query: 785 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMA 843
M L +HR+L + N LV +N VKV+DFGLSR + +T+ + +W A
Sbjct: 330 AMEYLEKK--NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 387
Query: 844 PEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 902
PE L + K DV++FGV+LWE+AT P+ G++ QV + ++ R+E P+
Sbjct: 388 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPE 446
Query: 903 LVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934
V ++ CWQ +PS RPSFA++ A + + +
Sbjct: 447 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 1e-59
Identities = 88/285 (30%), Positives = 137/285 (48%), Gaps = 31/285 (10%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG----TEVAVKKFLDQDFSGAALLEFKREVKIM 727
+ W D+ + IG G++G+V A + A+K+ + + S +F E++++
Sbjct: 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR-MKEYASKDDHRDFAGELEVL 79
Query: 728 RRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRR-------- 776
+L HPN++ +GA L + E+ P G+L L R
Sbjct: 80 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 139
Query: 777 -----IKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 830
+ A D ARGM+ L S +HRDL + N+LV +N+ K++DFGLSR +
Sbjct: 140 SSQQLLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-- 195
Query: 831 SSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAV 887
K T G P WMA E L DV+S+GV+LWE+ +L P+ GM ++ +
Sbjct: 196 -VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254
Query: 888 GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932
Q RLE P D V ++ +CW+ P RPSFAQ+ V+L +
Sbjct: 255 P-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 1e-59
Identities = 80/291 (27%), Positives = 131/291 (45%), Gaps = 33/291 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREVK 725
+ L +++G G++G V ++ VAVKK Q + L +F+RE++
Sbjct: 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIE 94
Query: 726 IMRRLRHPNVVLFMGAVTRPPN--LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD- 782
I++ L+H N+V + G L +I E+LP GSL L + ++D + ++
Sbjct: 95 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 154
Query: 783 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAG-TP- 839
+GM L T +HRDL + N+LV+ VK+ DFGL++ L + G +P
Sbjct: 155 CKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI 212
Query: 840 EWMAPEVLRNEPSNEKCDVYSFGVILWELATL----------------KLPWIGMNPMQV 883
W APE L + DV+SFGV+L+EL T M +
Sbjct: 213 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272
Query: 884 VGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934
+ + N RL P + I+ ECW + + RPSF L + + ++
Sbjct: 273 IELLK-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 3e-59
Identities = 67/269 (24%), Positives = 122/269 (45%), Gaps = 15/269 (5%)
Query: 672 EIPWEDLVLGE-RIGLGSYGEVYHADWNG----TEVAVKKFLDQDFSGAALLEFKREVKI 726
+ ++L++ + +G G++G V + +VA+K L Q A E RE +I
Sbjct: 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMREAQI 63
Query: 727 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARG 785
M +L +P +V +G + ++ E G L + L ++ ++ + G
Sbjct: 64 MHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 122
Query: 786 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P-EWM 842
M L VHRDL + N+L+ K+SDFGLS+ + + P +W
Sbjct: 123 MKYL--EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 180
Query: 843 APEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELD 901
APE + + + DV+S+GV +WE + + P+ M +V+ + Q +R+E P E
Sbjct: 181 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPECP 239
Query: 902 PLVARIIWECWQTDPSLRPSFAQLTVALK 930
P + ++ +CW RP F + ++
Sbjct: 240 PELYALMSDCWIYKWEDRPDFLTVEQRMR 268
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 4e-59
Identities = 88/325 (27%), Positives = 139/325 (42%), Gaps = 38/325 (11%)
Query: 642 KLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNG-- 699
+L+ ++ SS + + ++ D+ + E P E+L G+ +G G++G+V +A G
Sbjct: 12 QLQMVQVTGSSDNEYFYVDFREYEYDL-KWEFPRENLEFGKVLGSGAFGKVMNATAYGIS 70
Query: 700 -----TEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITE 753
+VAVK L + + E+K+M +L H N+V +GA T + +I E
Sbjct: 71 KTGVSIQVAVKM-LKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 129
Query: 754 FLPRGSLFRIL--HRPHCQVDEKRR--------------------IKMALD-ARGMNCLH 790
+ G L L R DE + A A+GM L
Sbjct: 130 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL- 188
Query: 791 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT-P-EWMAPEVLR 848
+ VHRDL + N+LV VK+ DFGL+R + P +WMAPE L
Sbjct: 189 -EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF 247
Query: 849 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 907
K DV+S+G++LWE+ +L P+ G+ + +++ P + I
Sbjct: 248 EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYII 307
Query: 908 IWECWQTDPSLRPSFAQLTVALKPL 932
+ CW D RPSF LT L
Sbjct: 308 MQSCWAFDSRKRPSFPNLTSFLGCQ 332
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 6e-59
Identities = 85/290 (29%), Positives = 138/290 (47%), Gaps = 33/290 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
E P + L LG+ +G G++G+V AD G VAVK L + + + E+
Sbjct: 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM-LKEGATHSEHRALMSEL 81
Query: 725 KIMRRL-RHPNVVLFMGAVTRPPN-LSIITEFLPRGSLFRIL--HRPHC----------- 769
KI+ + H NVV +GA T+P L +I EF G+L L R
Sbjct: 82 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 141
Query: 770 --QVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826
+ + I + A+GM L ++ +HRDL + N+L+ + VK+ DFGL+R +
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 827 NTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGM-NPMQ 882
+ P +WMAPE + + + DV+SFGV+LWE+ +L P+ G+ +
Sbjct: 200 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259
Query: 883 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932
+ + R+ P P + + + +CW +PS RP+F++L L L
Sbjct: 260 FCRRLK-EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 8e-59
Identities = 79/290 (27%), Positives = 122/290 (42%), Gaps = 32/290 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
E P L G+ +G G++G+V A G VAVK L E+
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM-LKPSAHLTEREALMSEL 77
Query: 725 KIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPH------------- 768
K++ L H N+V +GA T +ITE+ G L L R
Sbjct: 78 KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 769 --CQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825
+D + + + A+GM L ++ +HRDL + N+L+ K+ DFGL+R
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 826 HNTFLSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQ 882
N P +WMAPE + N + DV+S+G+ LWEL +L P+ GM
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 883 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932
+ + R+ P+ + I+ CW DP RP+F Q+ ++
Sbjct: 256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 1e-58
Identities = 82/271 (30%), Positives = 122/271 (45%), Gaps = 13/271 (4%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREVKI 726
EI E + LG IG G +G+V+ + VA+K S + +F +E
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKT-CKNCTSDSVREKFLQEALT 444
Query: 727 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARG 785
MR+ HP++V +G +T P II E G L L +D I A +
Sbjct: 445 MRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA 503
Query: 786 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAP 844
+ L + VHRD+ + N+LV N VK+ DFGLSR ++ S P +WMAP
Sbjct: 504 LAYL--ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 561
Query: 845 EVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 903
E + DV+ FGV +WE+ P+ G+ V+G + RL +P P
Sbjct: 562 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPPT 620
Query: 904 VARIIWECWQTDPSLRPSFAQLTVALKPLQR 934
+ ++ +CW DPS RP F +L L +
Sbjct: 621 LYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 1e-58
Identities = 66/283 (23%), Positives = 119/283 (42%), Gaps = 33/283 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG---------TEVAVKKFLDQDFSGAALLEFKR 722
+I EDL+ E +G G++ +++ TEV +K LD+ F
Sbjct: 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKV-LDKA-HRNYSESFFE 61
Query: 723 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD 782
+M +L H ++VL G ++ EF+ GSL L + ++ ++++A
Sbjct: 62 AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQ 121
Query: 783 -ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN--------VKVSDFGLSRLKHNTFLSSK 833
A M+ L T++H ++ + N+L+ + + +K+SD G+S + K
Sbjct: 122 LAAAMHFL--EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-----VLPK 174
Query: 834 STAGTP-EWMAPEVLRNEPS-NEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQ 890
W+ PE + N + N D +SFG LWE+ + P ++ + +
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE-D 233
Query: 891 NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 933
+L PK +A +I C +P RPSF + L L
Sbjct: 234 RHQLPAPK--AAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 2e-58
Identities = 76/292 (26%), Positives = 123/292 (42%), Gaps = 33/292 (11%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKRE 723
L +G G +G+V ++ VAVK L D +K+E
Sbjct: 25 PTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA-LKADAGPQHRSGWKQE 83
Query: 724 VKIMRRLRHPNVVLFMGAVTRP--PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL 781
+ I+R L H +++ + G +L ++ E++P GSL L R + + + A
Sbjct: 84 IDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQ 141
Query: 782 D-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAG-T 838
GM LH +HRDL + N+L+D + VK+ DFGL++ + G +
Sbjct: 142 QICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 199
Query: 839 P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL---------------KLPWIGMNPMQ 882
P W APE L+ DV+SFGV L+EL T + M ++
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259
Query: 883 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934
+ + + RL P + V ++ CW+T+ S RP+F L LK +
Sbjct: 260 LTELLE-RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 208 bits (530), Expect = 4e-58
Identities = 92/285 (32%), Positives = 142/285 (49%), Gaps = 16/285 (5%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMR 728
EIP E L L ++G G +GEV+ WNG T VA+K L + F +E ++M+
Sbjct: 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKT-LKPGTM--SPEAFLQEAQVMK 317
Query: 729 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALD-ARG 785
+LRH +V V+ P I+TE++ +GSL L + + + MA A G
Sbjct: 318 KLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASG 375
Query: 786 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTP-EWMAP 844
M + VHRDL++ N+LV +N KV+DFGL+RL + +++ A P +W AP
Sbjct: 376 MAYV--ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 433
Query: 845 EVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 903
E K DV+SFG++L EL T ++P+ GM +V+ V + R+ P E
Sbjct: 434 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPES 492
Query: 904 VARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSAL 948
+ ++ +CW+ +P RP+F L L+ QP L
Sbjct: 493 LHDLMCQCWRKEPEERPTFEYLQAFLEDY--FTSTEPQYQPGENL 535
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 5e-58
Identities = 76/287 (26%), Positives = 125/287 (43%), Gaps = 30/287 (10%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREV 724
E P +L G+ +G G++G+V A G +VAVK L E+
Sbjct: 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKM-LKSTAHADEKEALMSEL 100
Query: 725 KIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRR----- 776
KIM L +H N+V +GA T + +ITE+ G L L + D
Sbjct: 101 KIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160
Query: 777 ------IKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 829
+ + A+GM L ++ +HRD+ + N+L+ K+ DFGL+R N
Sbjct: 161 ASTRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
Query: 830 LSSKSTAGT-P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIG-MNPMQVVG 885
P +WMAPE + + + DV+S+G++LWE+ +L P+ G + +
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278
Query: 886 AVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932
V ++ P + I+ CW +P+ RP+F Q+ L+
Sbjct: 279 LVK-DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 6e-57
Identities = 78/313 (24%), Positives = 131/313 (41%), Gaps = 37/313 (11%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKRE 723
L ++G G++G V ++ VAVK+ Q +F+RE
Sbjct: 17 PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQRE 74
Query: 724 VKIMRRLRHPNVVLFMGAVTRP--PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL 781
++I++ L +V + G P +L ++ E+LP G L L R ++D R + +
Sbjct: 75 IQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS 134
Query: 782 D-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGT 838
+GM L + VHRDL + N+LV+ +VK++DFGL++L + + +
Sbjct: 135 QICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 192
Query: 839 P-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGF------- 889
P W APE L + + + DV+SFGV+L+EL T +
Sbjct: 193 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252
Query: 890 ------QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL-------KPLQRLV 936
+ +RL P V ++ CW P RPSF+ L L + +
Sbjct: 253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHA 312
Query: 937 IPSHPDQPSSALP 949
+HP+ +L
Sbjct: 313 FTAHPEGKHHSLS 325
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 4e-52
Identities = 66/271 (24%), Positives = 123/271 (45%), Gaps = 15/271 (5%)
Query: 670 ECEIPWEDLVLGE-RIGLGSYGEVYHADWNG----TEVAVKKFLDQDFSGAALLEFKREV 724
+ + ++L++ + +G G++G V + +VA+K L Q A E RE
Sbjct: 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMREA 387
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-A 783
+IM +L +P +V +G + ++ E G L + L ++ ++ +
Sbjct: 388 QIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 446
Query: 784 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGT--P-E 840
GM L VHR+L + N+L+ K+SDFGLS+ + + P +
Sbjct: 447 MGMKYL--EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 504
Query: 841 WMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKE 899
W APE + + + DV+S+GV +WE + + P+ M +V+ + Q +R+E P E
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPE 563
Query: 900 LDPLVARIIWECWQTDPSLRPSFAQLTVALK 930
P + ++ +CW RP F + ++
Sbjct: 564 CPPELYALMSDCWIYKWEDRPDFLTVEQRMR 594
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 5e-52
Identities = 72/292 (24%), Positives = 119/292 (40%), Gaps = 20/292 (6%)
Query: 644 RDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHA-DW-NGTE 701
+ + D+ + + E + R+G GS+GEV+ D G +
Sbjct: 26 KLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQ 85
Query: 702 VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF 761
AVKK + F E+ L P +V GAV P ++I E L GSL
Sbjct: 86 CAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLG 138
Query: 762 RILHRPHCQVDEKRRIKMALDA-RGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDF 819
+++ + + E R + A G+ LHT I+H D+K+ N+L+ + + DF
Sbjct: 139 QLI-KQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDF 195
Query: 820 GLSR-----LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLP 874
G + + L+ GT MAPEV+ +P + K D++S ++ + P
Sbjct: 196 GHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
Query: 875 WIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 925
W + + + EIP PL A+ I E + +P R S +L
Sbjct: 256 WTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMEL 307
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 6e-52
Identities = 61/254 (24%), Positives = 127/254 (50%), Gaps = 7/254 (2%)
Query: 676 EDLVLGERIGLGSYGEVYHA-DW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
E V ++IG GS+G+ +G + +K+ S E +REV ++ ++HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRIL-HRPHCQVDEKRRIKMALD-ARGMNCLHT 791
N+V + + +L I+ ++ G LF+ + + E + + + + +H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 792 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 851
I+HRD+KS N+ + K+ V++ DFG++R+ ++T +++ GTP +++PE+ N+P
Sbjct: 144 RK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201
Query: 852 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 911
N K D+++ G +L+EL TLK + + +V + + + ++ +
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII-SGSFPPVSLHYSYDLRSLVSQL 260
Query: 912 WQTDPSLRPSFAQL 925
++ +P RPS +
Sbjct: 261 FKRNPRDRPSVNSI 274
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 7e-52
Identities = 70/261 (26%), Positives = 120/261 (45%), Gaps = 12/261 (4%)
Query: 676 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
ED + IG GSYG +G + K+ + A EV ++R L+HP
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 734 NVVLFMGAVTRPPN--LSIITEFLPRGSLFRIL---HRPHCQVDEKRRIKMALD-ARGMN 787
N+V + + N L I+ E+ G L ++ + +DE+ +++ +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 788 CLH---TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 844
H T++HRDLK N+ +D NVK+ DFGL+R+ ++ +K+ GTP +M+P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSP 185
Query: 845 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 904
E + NEK D++S G +L+EL L P+ + ++ G + + + IP +
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIPYRYSDEL 244
Query: 905 ARIIWECWQTDPSLRPSFAQL 925
II RPS ++
Sbjct: 245 NEIITRMLNLKDYHRPSVEEI 265
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 3e-51
Identities = 77/283 (27%), Positives = 136/283 (48%), Gaps = 19/283 (6%)
Query: 655 SSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHA-DW-NGTEVAVKKFLDQDF 712
S S + + D+ E + +++ +G G+YG VY D N +A+K+ ++D
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60
Query: 713 SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH--CQ 770
+ L E+ + + L+H N+V ++G+ + + I E +P GSL +L +
Sbjct: 61 RYSQPLH--EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLK 118
Query: 771 VDE---KRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKH 826
+E K L G+ LH + IVHRD+K N+L++ + +K+SDFG S+
Sbjct: 119 DNEQTIGFYTKQIL--EGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174
Query: 827 NTFLSSKSTAGTPEWMAPEVLRNEPS--NEKCDVYSFG-VILWELATLKLPWIGM-NPMQ 882
+++ GT ++MAPE++ P + D++S G I+ E+AT K P+ + P
Sbjct: 175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTII-EMATGKPPFYELGEPQA 233
Query: 883 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 925
+ VG EIP+ + I +C++ DP R L
Sbjct: 234 AMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDL 276
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 5e-51
Identities = 66/260 (25%), Positives = 123/260 (47%), Gaps = 13/260 (5%)
Query: 676 EDLVLGERIGLGSYGEVYHA-DW-NGTEVAVKK-FLDQDFSGAALLEFKREVKIMRRLRH 732
+ + ++IG G + EVY A +G VA+KK + A + +E+ ++++L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRIL---HRPHCQVDEKRRIKMALD-ARGMNC 788
PNV+ + + L+I+ E G L R++ + + E+ K + +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 789 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 848
+H+ ++HRD+K N+ + VK+ D GL R + ++ S GTP +M+PE +
Sbjct: 152 MHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209
Query: 849 NEPSNEKCDVYSFGVILWELATLKLPWIG--MNPMQVVGAVGFQNRRLEIPKE-LDPLVA 905
N K D++S G +L+E+A L+ P+ G MN + + Q +P + +
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI-EQCDYPPLPSDHYSEELR 268
Query: 906 RIIWECWQTDPSLRPSFAQL 925
+++ C DP RP +
Sbjct: 269 QLVNMCINPDPEKRPDVTYV 288
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-48
Identities = 72/290 (24%), Positives = 119/290 (41%), Gaps = 54/290 (18%)
Query: 676 EDLVLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
D +G G++G+V A + A+KK + L EV ++ L H
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVMLLASLNHQ 62
Query: 734 NVVLFMGAVTRPPNLS-------------IITEFLPRGSLFRILHRPHCQVDEK------ 774
VV + A N I E+ G+L+ ++H +
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 775 RRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 834
R+I AL +H+ I+HRDLK N+ +D++ NVK+ DFGL++ H + K
Sbjct: 123 RQILEALS-----YIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 835 TA--------------GTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMN 879
+ GT ++A EVL NEK D+YS G+I +E+ + GM
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM--IYPFSTGME 233
Query: 880 PMQVVGAVGFQNRRLEIPKELD----PLVARIIWECWQTDPSLRPSFAQL 925
+ ++ + ++ +E P + D + +II DP+ RP L
Sbjct: 234 RVNILKKL--RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL 281
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 4e-48
Identities = 55/264 (20%), Positives = 108/264 (40%), Gaps = 23/264 (8%)
Query: 680 LGERIGLGSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN--VV 736
+ ++IG G +V+ + A+K ++ L ++ E+ + +L+ + ++
Sbjct: 13 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 72
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPT 795
+ ++ E L L + +D R + ++ +H
Sbjct: 73 RLYDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQH--G 128
Query: 796 IVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVLRNEPS- 852
IVH DLK N L+ +K+ DFG++ T + S GT +M PE +++ S
Sbjct: 129 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187
Query: 853 ----------NEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKELD 901
+ K DV+S G IL+ + K P+ + N + + A+ N +E P +
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 247
Query: 902 PLVARIIWECWQTDPSLRPSFAQL 925
+ ++ C + DP R S +L
Sbjct: 248 KDLQDVLKCCLKRDPKQRISIPEL 271
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 5e-48
Identities = 55/264 (20%), Positives = 108/264 (40%), Gaps = 23/264 (8%)
Query: 680 LGERIGLGSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN--VV 736
+ ++IG G +V+ + A+K ++ L ++ E+ + +L+ + ++
Sbjct: 32 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 91
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPT 795
+ ++ E L L + +D R + ++ +H
Sbjct: 92 RLYDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQH--G 147
Query: 796 IVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVLRNEPS- 852
IVH DLK N L+ +K+ DFG++ T + S GT +M PE +++ S
Sbjct: 148 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206
Query: 853 ----------NEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKELD 901
+ K DV+S G IL+ + K P+ + N + + A+ N +E P +
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 266
Query: 902 PLVARIIWECWQTDPSLRPSFAQL 925
+ ++ C + DP R S +L
Sbjct: 267 KDLQDVLKCCLKRDPKQRISIPEL 290
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 5e-47
Identities = 60/272 (22%), Positives = 119/272 (43%), Gaps = 39/272 (14%)
Query: 676 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKK-FLDQDFSGAALLEFKREVKIMRRLRH 732
D E IG G +G+V+ A +G +K+ + + + +REVK + +L H
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE-------KAEREVKALAKLDH 63
Query: 733 PNVVLFMGA----------------VTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKR 775
N+V + G ++ L I EF +G+L + + R ++D+
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 776 RIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSK 833
+++ +G++ +H+ +++RDLK N+ + VK+ DFGL LK++
Sbjct: 124 ALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--T 179
Query: 834 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR 893
+ GT +M+PE + ++ ++ D+Y+ G+IL EL + + R
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AFETSKFF-TDLRD 233
Query: 894 LEIPKELDPLVARIIWECWQTDPSLRPSFAQL 925
I D ++ + P RP+ +++
Sbjct: 234 GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEI 265
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 7e-47
Identities = 54/264 (20%), Positives = 107/264 (40%), Gaps = 23/264 (8%)
Query: 680 LGERIGLGSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN--VV 736
+ ++IG G +V+ + A+K ++ L ++ E+ + +L+ + ++
Sbjct: 60 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 119
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEK-RRIKMALDARGMNCLHTSTPT 795
+ ++ E L L + +D R+ ++ +H
Sbjct: 120 RLYDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQH--G 175
Query: 796 IVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVLRNEPSN 853
IVH DLK N L+ +K+ DFG++ T + S G +M PE +++ S+
Sbjct: 176 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 854 -----------EKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKELD 901
K DV+S G IL+ + K P+ + N + + A+ N +E P +
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 294
Query: 902 PLVARIIWECWQTDPSLRPSFAQL 925
+ ++ C + DP R S +L
Sbjct: 295 KDLQDVLKCCLKRDPKQRISIPEL 318
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 166 bits (424), Expect = 6e-46
Identities = 73/288 (25%), Positives = 131/288 (45%), Gaps = 42/288 (14%)
Query: 676 EDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 734
++G G +G+VY +G +VA+K+ + S + EF+ E++ + RHP+
Sbjct: 43 HKFLIGH----GVFGKVYKGVLRDGAKVALKR-RTPE-SSQGIEEFETEIETLSFCRHPH 96
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALD-ARGMNCLH 790
+V +G + +I +++ G+L R L+ P + ++R+++ + ARG++ LH
Sbjct: 97 LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156
Query: 791 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST--AGTPEWMAPEVLR 848
T I+HRD+KS N+L+D+N+ K++DFG+S+ + ST GT ++ PE
Sbjct: 157 T--RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFI 214
Query: 849 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---------RRLEIPKE 899
EK DVYSFGV+L+E+ + + N ++ +
Sbjct: 215 KGRLTEKSDVYSFGVVLFEVLC------ARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268
Query: 900 LDPL------------VARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935
+DP +C RPS + L+ RL
Sbjct: 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-45
Identities = 69/324 (21%), Positives = 110/324 (33%), Gaps = 30/324 (9%)
Query: 609 NSKDENPKNVE--DHEIGYHDRRKCTHDRFMGTNLKLRDLESPSSSVDSSTSKVDQIFDD 666
+ + V+ + + + R L+SP S Q F
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQ- 60
Query: 667 DVCECEIPWEDLVLGERIGLGSYGEVYHA-DW-NGTEVAVKKFLDQDFSGAALLEFKREV 724
R+G GSYGEV+ +G AVK+ + EV
Sbjct: 61 -------------RLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEV 107
Query: 725 KIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD- 782
++ +HP V A L + TE SL + + E + D
Sbjct: 108 GSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDT 166
Query: 783 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM 842
+ LH+ +VH D+K N+ + K+ DFGL + T + + G P +M
Sbjct: 167 LLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLV-ELGTAGAGEVQEGDPRYM 223
Query: 843 APEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELD 901
APE+L DV+S G+ + E+A G Q + Q E L
Sbjct: 224 APELL-QGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQL----RQGYLPPEFTAGLS 278
Query: 902 PLVARIIWECWQTDPSLRPSFAQL 925
+ ++ + DP LR + L
Sbjct: 279 SELRSVLVMMLEPDPKLRATAEAL 302
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 6e-45
Identities = 78/281 (27%), Positives = 132/281 (46%), Gaps = 45/281 (16%)
Query: 684 IGLGSYGEVYHAD-WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 742
+G G +G+VY +GT VAVK+ L ++ + L+F+ EV+++ H N++ G
Sbjct: 38 LGRGGFGKVYKGRLADGTLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96
Query: 743 TRPPNLSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALD-ARGMNCLH-TSTPTIV 797
P ++ ++ GS+ L +D +R ++AL ARG+ LH P I+
Sbjct: 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKII 156
Query: 798 HRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK 855
HRD+K+ N+L+D+ + V DFGL++L +T +++ GT +APE L S+EK
Sbjct: 157 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-VRGTIGHIAPEYLSTGKSSEK 215
Query: 856 CDVYSFGVILWELATLKLPWIGMNPMQVVGAVG-------------FQNRRLEIPKEL-D 901
DV+ +GV+L EL T G + + ++LE L D
Sbjct: 216 TDVFGYGVMLLELIT------GQRAFDLARLANDDDVMLLDWVKGLLKEKKLE---ALVD 266
Query: 902 PL---------VARIIW---ECWQTDPSLRPSFAQLTVALK 930
V ++I C Q+ P RP +++ L+
Sbjct: 267 VDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 6e-44
Identities = 67/287 (23%), Positives = 112/287 (39%), Gaps = 24/287 (8%)
Query: 655 SSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHAD-WNGTEVAVKKFLDQDFS 713
SS S D++ + + +G G+ G + + ++ +VAVK+ L + FS
Sbjct: 3 SSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS 62
Query: 714 GAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVD 772
A REV+++R HPNV+ + I E +L + +
Sbjct: 63 FA-----DREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHL 116
Query: 773 EKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLV-----DKNWNVKVSDFGLSRL-- 824
I + G+ LH+ IVHRDLK N+L+ +SDFGL +
Sbjct: 117 GLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174
Query: 825 -KHNTFLSSKSTAGTPEWMAPEVLRNEPS---NEKCDVYSFGVILWELATL-KLPWIGMN 879
++F GT W+APE+L + D++S G + + + + P+
Sbjct: 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234
Query: 880 PMQVVGAVG-FQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 925
Q +G L K D + +I + DP RPS +
Sbjct: 235 QRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 7e-44
Identities = 73/276 (26%), Positives = 127/276 (46%), Gaps = 34/276 (12%)
Query: 666 DDVCECEIPWEDLVLGERIGLGSYGEVYHAD--WNGTEVAVKKF-LDQDFSGAALLEFKR 722
D+ + P E + E++G GSYG VY A G VA+K+ ++ D E +
Sbjct: 19 DEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ-----EIIK 73
Query: 723 EVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEK------RR 776
E+ IM++ P+VV + G+ + +L I+ E+ GS+ I+ + + E +
Sbjct: 74 EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQS 133
Query: 777 IKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNTFL 830
L+ LH +HRD+K+ N+L++ + K++DFG++ K NT +
Sbjct: 134 TLKGLEY-----LHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI 186
Query: 831 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ 890
GTP WMAPEV++ N D++S G+ E+A K P+ ++PM+ + +
Sbjct: 187 ------GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN 240
Query: 891 NR-RLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 925
P+ + +C P R + QL
Sbjct: 241 PPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQL 276
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 169 bits (428), Expect = 7e-44
Identities = 61/280 (21%), Positives = 112/280 (40%), Gaps = 23/280 (8%)
Query: 679 VLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+ ER+G G +G V G +VA+K+ Q+ S + E++IM++L HPNVV
Sbjct: 17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQC-RQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 737 -LF-----MGAVTRPPNLSIITEFLPRGSLFRILHRP--HCQVDEKR-RIKMALDARGMN 787
+ + + E+ G L + L++ C + E R ++ + +
Sbjct: 76 SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 788 CLHTSTPTIVHRDLKSPNLLVDKN---WNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMA 843
LH + I+HRDLK N+++ K+ D G ++ L GT +++A
Sbjct: 136 YLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC--TEFVGTLQYLA 191
Query: 844 PEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 903
PE+L + D +SFG + +E T P++ + + E D L
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK-VREKSNEHIVVYDDL 250
Query: 904 VARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQ 943
+ + P+ L+ + ++ H Q
Sbjct: 251 TGAVKFSSVLPTPNHLSGILA--GKLERWLQCMLMWHQRQ 288
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 9e-44
Identities = 61/294 (20%), Positives = 109/294 (37%), Gaps = 33/294 (11%)
Query: 676 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
+ + +++G G + V +G A+K+ L + E +RE + R HP
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQ--DREEAQREADMHRLFNHP 86
Query: 734 NVVLFMGAVTRPPN----LSIITEFLPRGSLFRIL---HRPHCQVDEKRRIKMALD-ARG 785
N++ + R ++ F RG+L+ + + E + + + L RG
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 786 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--------- 836
+ +H HRDLK N+L+ + D G S+
Sbjct: 147 LEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 837 GTPEWMAPEVL---RNEPSNEKCDVYSFGVILWELATLKLP--WIGMNPMQVVGAVGFQN 891
T + APE+ + +E+ DV+S G +L+ + + P + V AV
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV---Q 261
Query: 892 RRLEIPK--ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQ 943
+L IP+ + +++ DP RP L L+ LQ H Q
Sbjct: 262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQHTTQ 315
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 9e-44
Identities = 80/278 (28%), Positives = 130/278 (46%), Gaps = 55/278 (19%)
Query: 674 PWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
P E E+IG GS+GEV+ + VA+K +D + + + + ++E+ ++ +
Sbjct: 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKI-IDLEEAEDEIEDIQQEITVLSQCD 78
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEK------RRIKMALDARG 785
P V + G+ + L II E+L GS +L +DE R I LD
Sbjct: 79 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDY-- 134
Query: 786 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNTFLSSKSTAGTP 839
LH+ +HRD+K+ N+L+ ++ VK++DFG++ ++K NTF GTP
Sbjct: 135 ---LHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF------VGTP 183
Query: 840 EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE 899
WMAPEV++ + K D++S G+ ELA + P ++PM+V+ IPK
Sbjct: 184 FWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL---------FLIPKN 234
Query: 900 LDP------------LVARIIWECWQTDPSLRPSFAQL 925
P V C +PS RP+ +L
Sbjct: 235 NPPTLEGNYSKPLKEFVEA----CLNKEPSFRPTAKEL 268
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 5e-43
Identities = 66/296 (22%), Positives = 118/296 (39%), Gaps = 56/296 (18%)
Query: 679 VLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+L + +G G+ V+ G A+K F + + RE +++++L H N+V
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 737 -LFMGAV---TRPPNLSIITEFLPRGSLFRILHRP--HCQVDEKRRIKMALD-ARGMNCL 789
LF A+ T + +I EF P GSL+ +L P + E + + D GMN L
Sbjct: 71 KLF--AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 790 HTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAP 844
+ IVHR++K N++ D K++DFG +R L+ + S GT E++ P
Sbjct: 129 REN--GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VSLYGTEEYLHP 184
Query: 845 EVLR--------NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ-------------- 882
++ + D++S GV + AT LP+ +
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 883 ---VVGAVGFQNRRLE----------IPKELDPLVARIIWECWQTDPSLRPSFAQL 925
+ G +N ++ + + L L+ ++ + D F Q
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 6e-43
Identities = 56/273 (20%), Positives = 97/273 (35%), Gaps = 39/273 (14%)
Query: 681 GERIGLGSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVV 736
E+IG G +G V+ +G A+K+ REV L +H +VV
Sbjct: 16 LEKIGSGEFGSVFKCVKRL-DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV 74
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRIL---HRPHCQVDEKRRIKMALD-ARGMNCLHTS 792
+ A ++ I E+ GSL + +R E + L RG+ +H+
Sbjct: 75 RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM 134
Query: 793 TPTIVHRDLKSPNLLVDKN-------------------WNVKVSDFGLSRLKHNTFLSSK 833
+ +VH D+K N+ + + K+ D G + +
Sbjct: 135 S--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP----Q 188
Query: 834 STAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR 892
G ++A EVL+ N K D+++ + + A + + + Q R
Sbjct: 189 VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI----RQGR 244
Query: 893 RLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 925
IP+ L ++ DP RPS L
Sbjct: 245 LPRIPQVLSQEFTELLKVMIHPDPERRPSAMAL 277
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 156 bits (398), Expect = 6e-43
Identities = 62/252 (24%), Positives = 112/252 (44%), Gaps = 9/252 (3%)
Query: 676 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRH 732
ED +G +G G +G VY A + +A+K A + +REV+I LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTS 792
PN++ G + +I E+ P G+++R L + +++ + A ++ H+
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 793 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 852
++HRD+K NLL+ +K++DFG S H GT +++ PE++
Sbjct: 129 R--VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIEGRMH 184
Query: 853 NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 912
+EK D++S GV+ +E K P+ + + P + +I
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLL 242
Query: 913 QTDPSLRPSFAQ 924
+ +PS RP +
Sbjct: 243 KHNPSQRPMLRE 254
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 156 bits (398), Expect = 1e-42
Identities = 76/275 (27%), Positives = 122/275 (44%), Gaps = 27/275 (9%)
Query: 679 VLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDF--SGAALLEFKREVKIMRRLRHPNVV 736
+GE G +G VY N T VAVKK + +F +E+K+M + +H N+V
Sbjct: 38 KMGE----GGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV--DEKRRIKMALD-ARGMNCLHTST 793
+G + +L ++ ++P GSL L R K+A A G+N LH
Sbjct: 94 ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE-- 151
Query: 794 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST--AGTPEWMAPEVLRNEP 851
+HRD+KS N+L+D+ + K+SDFGL+R + ++ GT +MAPE LR E
Sbjct: 152 NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE- 210
Query: 852 SNEKCDVYSFGVILWELATLKLPWIGMNPMQ--VVGAVGFQNRRLEIPKELDPL------ 903
K D+YSFGV+L E+ T Q + ++ I +D
Sbjct: 211 ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADS 270
Query: 904 -----VARIIWECWQTDPSLRPSFAQLTVALKPLQ 933
+ + +C + RP ++ L+ +
Sbjct: 271 TSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 2e-42
Identities = 67/327 (20%), Positives = 129/327 (39%), Gaps = 51/327 (15%)
Query: 644 RDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHA--DWNGTE 701
+ LE + +++ E+ +D +G G+ G V+ +G
Sbjct: 2 KKLEELELD-EQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLV 60
Query: 702 VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF 761
+A K + + A + RE++++ P +V F GA +SI E + GSL
Sbjct: 61 MARKL-IHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 119
Query: 762 RILHRPHCQVDEKRRIKMALDA-RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 820
++L + ++ E+ K+++ +G+ L I+HRD+K N+LV+ +K+ DFG
Sbjct: 120 QVLKKAG-RIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFG 177
Query: 821 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP 880
+S ++ + S GT +M+PE L+ + + D++S G+ L E+A + P +
Sbjct: 178 VSGQLIDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235
Query: 881 MQVVGAVGFQNRRLE---------------------------------IPKELDPLVARI 907
++ G Q I E P +
Sbjct: 236 KELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSG 295
Query: 908 IW---------ECWQTDPSLRPSFAQL 925
++ +C +P+ R QL
Sbjct: 296 VFSLEFQDFVNKCLIKNPAERADLKQL 322
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-42
Identities = 72/298 (24%), Positives = 129/298 (43%), Gaps = 32/298 (10%)
Query: 645 DLESPSSSVDSSTSKV--DQIFD--DDVCECEIPWEDLVLGERIGLGSYGEVYHA--DWN 698
++ + ++ + V +Q V + P L +IG GS G V A +
Sbjct: 10 GVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHS 69
Query: 699 GTEVAVKKF---LDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755
G +VAVK Q EV IMR +H NVV + L ++ EFL
Sbjct: 70 GRQVAVKMMDLRKQQRRE-----LLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL 124
Query: 756 PRGSLFRILHRPHCQVDEKRRIKMALDA-RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNV 814
G+L I+ +++E++ + + + LH ++HRD+KS ++L+ + V
Sbjct: 125 QGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGRV 180
Query: 815 KVSDFGLS------RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWEL 868
K+SDFG K + GTP WMAPEV+ + D++S G+++ E+
Sbjct: 181 KLSDFGFCAQISKDVPKRKSL------VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEM 234
Query: 869 ATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 925
+ P+ +P+Q + + +L+ ++ P++ + DP R + +L
Sbjct: 235 VDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQEL 292
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-42
Identities = 64/298 (21%), Positives = 109/298 (36%), Gaps = 46/298 (15%)
Query: 676 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
D + +G G +G V+ A + A+K+ + A + REVK + +L HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKR-IRLPNRELAREKVMREVKALAKLEHP 63
Query: 734 NVVLFMGA------------VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL 781
+V + A + L I + + +L ++ E+R + L
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG--RCTIEERERSVCL 121
Query: 782 D-----ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 836
A + LH+ ++HRDLK N+ + VKV DFGL
Sbjct: 122 HIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 837 ------------GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV 884
GT +M+PE + + K D++S G+IL+EL M ++ +
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQMERVRTL 237
Query: 885 GAVGFQNRRLEIPKELD---PLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPS 939
V R L+ P P ++ + P RP + + + L P
Sbjct: 238 TDV----RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI-IENAVFEDLDFPG 290
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-42
Identities = 59/252 (23%), Positives = 111/252 (44%), Gaps = 9/252 (3%)
Query: 676 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRH 732
+D +G +G G +G VY A N +A+K + +RE++I LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTS 792
PN++ + ++ EF PRG L++ L + +++ M A ++ H
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 133
Query: 793 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 852
++HRD+K NLL+ +K++DFG S + ++ GT +++ PE++ +
Sbjct: 134 K--VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR--RTMCGTLDYLPPEMIEGKTH 189
Query: 853 NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 912
+EK D++ GV+ +E P+ + + + N L+ P L +I +
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI--VNVDLKFPPFLSDGSKDLISKLL 247
Query: 913 QTDPSLRPSFAQ 924
+ P R
Sbjct: 248 RYHPPQRLPLKG 259
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-42
Identities = 69/270 (25%), Positives = 128/270 (47%), Gaps = 24/270 (8%)
Query: 667 DVCECEIPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSGAALLEFKRE 723
+ P + E+IG G+ G VY A G EVA+++ L Q E
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINE 67
Query: 724 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI-KMALD 782
+ +MR ++PN+V ++ + L ++ E+L GSL ++ + + + L
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL- 126
Query: 783 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNTFLSSKSTA 836
+ + LH++ ++HRD+KS N+L+ + +VK++DFG + K +T
Sbjct: 127 -QALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM------V 177
Query: 837 GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLE 895
GTP WMAPEV+ + K D++S G++ E+ + P++ NP++ + + L+
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ 237
Query: 896 IPKELDPLVARIIWECWQTDPSLRPSFAQL 925
P++L + + C + D R S +L
Sbjct: 238 NPEKLSAIFRDFLNRCLEMDVEKRGSAKEL 267
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-42
Identities = 77/289 (26%), Positives = 133/289 (46%), Gaps = 51/289 (17%)
Query: 673 IPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
I +D L E IG G+ V A +VA+K+ ++ + ++ E +E++ M +
Sbjct: 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKR-INLEKCQTSMDELLKEIQAMSQC 70
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI----------KMA 780
HPN+V + + L ++ + L GS+ I+ + + K + +
Sbjct: 71 HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 781 LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-----------RLKHNTF 829
L G+ LH + +HRD+K+ N+L+ ++ +V+++DFG+S TF
Sbjct: 131 L--EGLEYLHKN--GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 830 LSSKSTAGTPEWMAPEVL-RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG 888
GTP WMAPEV+ + + K D++SFG+ ELAT P+ PM+V+
Sbjct: 187 ------VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL---- 236
Query: 889 F---QNR--RLEIPKELDPLVAR-------IIWECWQTDPSLRPSFAQL 925
QN LE + ++ + +I C Q DP RP+ A+L
Sbjct: 237 MLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAEL 285
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-41
Identities = 71/309 (22%), Positives = 119/309 (38%), Gaps = 38/309 (12%)
Query: 680 LGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVV 736
+ + G + VY A +G E A+K+ L + +EV M++L HPN+V
Sbjct: 32 VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEE--KNRAIIQEVCFMKKLSGHPNIV 89
Query: 737 LFMGAVTRPPNLS-------IITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALD-ARGM 786
F A + S ++ L +G L L + +K+ R +
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 787 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA---------- 836
+H P I+HRDLK NLL+ +K+ DFG + + S S
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209
Query: 837 --GTPEWMAPEVL---RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN 891
TP + PE++ N P EK D+++ G IL+ L + P+ +++V N
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV------N 263
Query: 892 RRLEIPKELD--PLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALP 949
+ IP + +I Q +P R S A++ L+ + + + L
Sbjct: 264 GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLE 323
Query: 950 QEISVNSTP 958
Q S
Sbjct: 324 QNGGYGSAT 332
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 79/282 (28%), Positives = 132/282 (46%), Gaps = 39/282 (13%)
Query: 666 DDVCECEIPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKRE 723
+ V P E + +G G++G+VY A G A K ++ S L ++ E
Sbjct: 9 EHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKV-IETK-SEEELEDYIVE 66
Query: 724 VKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI----KM 779
++I+ HP +V +GA L I+ EF P G++ I+ + E + I +
Sbjct: 67 IEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ-IQVVCRQ 125
Query: 780 ALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKHNTFLSSK 833
L +N LH+ I+HRDLK+ N+L+ +++++DFG+S K ++F+
Sbjct: 126 ML--EALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI--- 178
Query: 834 STAGTPEWMAPEVLRNEPS-----NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG 888
GTP WMAPEV+ E + K D++S G+ L E+A ++ P +NPM+V+
Sbjct: 179 ---GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL---- 231
Query: 889 F---QNR--RLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 925
++ L P + + +P RPS AQL
Sbjct: 232 LKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQL 273
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-41
Identities = 53/297 (17%), Positives = 115/297 (38%), Gaps = 42/297 (14%)
Query: 680 LGERIGLGSYGEVYHADWNGTEVAVK---------------KFLDQDFSGAALLEFKREV 724
+ + G + ++ + + A+K D+ + +FK E+
Sbjct: 35 IIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDAR 784
+I+ +++ + G +T + II E++ S+ + +
Sbjct: 95 QIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154
Query: 785 --------GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 836
+ +H + I HRD+K N+L+DKN VK+SDFG S + + K +
Sbjct: 155 CIIKSVLNSFSYIH-NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI--KGSR 211
Query: 837 GTPEWMAPEVLRNEP--SNEKCDVYSFGVILWELATLKLP-WIGMNPMQVVGAVGFQNRR 893
GT E+M PE NE + K D++S G+ L+ + +P + ++ +++ + + +
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI--RTKN 269
Query: 894 LEIPKELDPLVARIIWECWQTDPSLRPSFAQ------LTVALKPLQRLVIP---SHP 941
+E P + + + + + + + L P +R+ H
Sbjct: 270 IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRK--NPAERITSEDALKHE 324
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 155 bits (392), Expect = 4e-41
Identities = 66/307 (21%), Positives = 120/307 (39%), Gaps = 56/307 (18%)
Query: 680 LGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV- 736
L + +G G+ V+ G A+K F + + RE +++++L H N+V
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 737 LFMGAV---TRPPNLSIITEFLPRGSLFRILHRP--HCQVDEKRRIKMALD-ARGMNCLH 790
LF A+ T + +I EF P GSL+ +L P + E + + D GMN L
Sbjct: 72 LF--AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 791 TSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPE 845
+ IVHR++K N++ D K++DFG +R L+ + S GT E++ P+
Sbjct: 130 EN--GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VSLYGTEEYLHPD 185
Query: 846 VLR--------NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ--------------- 882
+ + D++S GV + AT LP+ +
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 883 --VVGAVGFQNRRLE----------IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 930
+ G +N ++ + + L L+ ++ + D F Q
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305
Query: 931 PLQRLVI 937
+ ++
Sbjct: 306 DILHRMV 312
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-40
Identities = 78/299 (26%), Positives = 119/299 (39%), Gaps = 40/299 (13%)
Query: 647 ESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAV 704
+ ++ + P + IG GS+G VY A N VA+
Sbjct: 25 AMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAI 84
Query: 705 KKF-LDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRI 763
KK S + +EV+ +++LRHPN + + G R ++ E+ GS +
Sbjct: 85 KKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDL 143
Query: 764 LHRPHCQVDEKR---RIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 820
L + E AL +G+ LH+ ++HRD+K+ N+L+ + VK+ DFG
Sbjct: 144 LEVHKKPLQEVEIAAVTHGAL--QGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFG 199
Query: 821 LS--RLKHNTFLSSKSTAGTPEWMAPEVLRNEPS---NEKCDVYSFGVILWELATLKLPW 875
+ N+F GTP WMAPEV+ + K DV+S G+ ELA K P
Sbjct: 200 SASIMAPANSF------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253
Query: 876 IGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW---------ECWQTDPSLRPSFAQL 925
MN M + I + P + W C Q P RP+ L
Sbjct: 254 FNMNAMSAL---------YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 303
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 67/251 (26%), Positives = 109/251 (43%), Gaps = 11/251 (4%)
Query: 680 LGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE--FKREVKIMRRLRHPNV 735
G +G G + + + A K + + E+ I R L H +V
Sbjct: 19 RGRFLGKGGFAKCFEISDADTKEVFAGK-IVPKSLLLKPHQREKMSMEISIHRSLAHQHV 77
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRIL-HRPHCQVDEKRRIKMALDARGMNCLHTSTP 794
V F G + ++ E R SL + R E R + G LH +
Sbjct: 78 VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI-VLGCQYLHRNR- 135
Query: 795 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNE 854
++HRDLK NL ++++ VK+ DFGL+ K GTP ++APEVL + +
Sbjct: 136 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 194
Query: 855 KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 914
+ DV+S G I++ L K P+ + + + IPK ++P+ A +I + QT
Sbjct: 195 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--KKNEYSIPKHINPVAASLIQKMLQT 252
Query: 915 DPSLRPSFAQL 925
DP+ RP+ +L
Sbjct: 253 DPTARPTINEL 263
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-40
Identities = 67/287 (23%), Positives = 120/287 (41%), Gaps = 52/287 (18%)
Query: 679 VLGERIGLGSYGEVYHA--DWNGTEVAVK-----KFLDQDFSGAALLEF----------- 720
L + IG GSYG V A + + T A+K K + Q
Sbjct: 16 TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQ 75
Query: 721 --------KREVKIMRRLRHPNVV-LF--MGAVTRPPNLSIITEFLPRGSLFRILHRPHC 769
+E+ I+++L HPNVV L + +L ++ E + +G + +
Sbjct: 76 PRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNED-HLYMVFELVNQGPVMEVPTLKPL 134
Query: 770 QVDEKRR----IKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL- 824
D+ R + ++ LH I+HRD+K NLLV ++ ++K++DFG+S
Sbjct: 135 SEDQARFYFQDLIKGIE-----YLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 825 -KHNTFLSSKSTAGTPEWMAPEVLRNEPSN---EKCDVYSFGVILWELATLKLPWIGMNP 880
+ L +T GTP +MAPE L + DV++ GV L+ + P++
Sbjct: 188 KGSDALL--SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245
Query: 881 MQVVGAVGFQNRRLEIPK--ELDPLVARIIWECWQTDPSLRPSFAQL 925
M + + +++ LE P ++ + +I +P R ++
Sbjct: 246 MCLHSKI--KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEI 290
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-40
Identities = 81/304 (26%), Positives = 132/304 (43%), Gaps = 55/304 (18%)
Query: 655 SSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDF 712
+S S + + D+ P L E +G G+YG+VY G A+K D
Sbjct: 3 ASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKV---MDV 59
Query: 713 SGAALLEFKREVKIMRRL-RHPNVVLFMGA------VTRPPNLSIITEFLPRGSLFRILH 765
+G E K+E+ ++++ H N+ + GA L ++ EF GS+ ++
Sbjct: 60 TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119
Query: 766 RPHCQVDEKRRI----KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 821
++ I + L RG++ LH ++HRD+K N+L+ +N VK+ DFG+
Sbjct: 120 NTKGNTLKEEWIAYICREIL--RGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGV 175
Query: 822 S------RLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-----NEKCDVYSFGVILWELAT 870
S + NTF GTP WMAPEV+ + + + K D++S G+ E+A
Sbjct: 176 SAQLDRTVGRRNTF------IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE 229
Query: 871 LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW---------ECWQTDPSLRPS 921
P M+PM+ + F IP+ P + W C + S RP+
Sbjct: 230 GAPPLCDMHPMRAL----FL-----IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPA 280
Query: 922 FAQL 925
QL
Sbjct: 281 TEQL 284
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 4e-39
Identities = 76/265 (28%), Positives = 115/265 (43%), Gaps = 26/265 (9%)
Query: 674 PWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
W+ L + +G G+YGEV A VAVK +D + K+E+ I + L
Sbjct: 8 DWD---LVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLN 63
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDARGMNCLH 790
H NVV F G + E+ G LF RI + +R L A G+ LH
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-GVVYLH 122
Query: 791 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL----KHNTFLSSKSTAGTPEWMAPEV 846
I HRD+K NLL+D+ N+K+SDFGL+ + L GT ++APE+
Sbjct: 123 GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKMCGTLPYVAPEL 178
Query: 847 LRNEP-SNEKCDVYSFGVILWELATLKLPW-IGMNPMQ----VVGAVGFQNRRLEIPKEL 900
L+ E DV+S G++L + +LPW + Q + N +I
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238
Query: 901 DPLVARIIWECWQTDPSLRPSFAQL 925
L+ +I+ +PS R + +
Sbjct: 239 LALLHKIL----VENPSARITIPDI 259
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-39
Identities = 71/251 (28%), Positives = 117/251 (46%), Gaps = 12/251 (4%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
L + IG G++ +V A G EVA+K + +L + REV+IM+ L HPN+V
Sbjct: 19 LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 78
Query: 738 FMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTI 796
+ L +I E+ G +F ++ + E R + + H I
Sbjct: 79 LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI-VSAVQYCHQKR--I 135
Query: 797 VHRDLKSPNLLVDKNWNVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPEVLRNEPSN-E 854
VHRDLK+ NLL+D + N+K++DFG S L + G P + APE+ + + +
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL--DAFCGAPPYAAPELFQGKKYDGP 193
Query: 855 KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 914
+ DV+S GVIL+ L + LP+ G N ++ V + IP + ++
Sbjct: 194 EVDVWSLGVILYTLVSGSLPFDGQNLKELRERV--LRGKYRIPFYMSTDCENLLKRFLVL 251
Query: 915 DPSLRPSFAQL 925
+P R + Q+
Sbjct: 252 NPIKRGTLEQI 262
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 5e-39
Identities = 73/256 (28%), Positives = 127/256 (49%), Gaps = 21/256 (8%)
Query: 680 LGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRHPNVV 736
LG+ +G+G++G+V G +VAVK Q ++ KRE++ ++ RHP+++
Sbjct: 15 LGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHII 74
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRR----IKMALDARGMNCLHT 791
++ P + ++ E++ G LF I + E RR I A+D H
Sbjct: 75 KLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD-----YCHR 129
Query: 792 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPEVLRNE 850
+VHRDLK N+L+D + N K++DFGLS + FL +++ G+P + APEV+
Sbjct: 130 HM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--RTSCGSPNYAAPEVISGR 185
Query: 851 P-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 909
+ + D++S GVIL+ L LP+ + + + + IP+ L+ VA ++
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI--RGGVFYIPEYLNRSVATLLM 243
Query: 910 ECWQTDPSLRPSFAQL 925
Q DP R + +
Sbjct: 244 HMLQVDPLKRATIKDI 259
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-39
Identities = 65/250 (26%), Positives = 111/250 (44%), Gaps = 8/250 (3%)
Query: 680 LGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRHPNVV 736
+G +G GS+ VY A G EVA+K + A +++ + EVKI +L+HP+++
Sbjct: 15 VGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSIL 74
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDARGMNCLHTSTPT 795
+ ++ E G + R L E R M GM LH+
Sbjct: 75 ELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG-- 132
Query: 796 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK 855
I+HRDL NLL+ +N N+K++DFGL+ + GTP +++PE+ +
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLE 192
Query: 856 CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTD 915
DV+S G + + L + P+ + V E+P L +I + + +
Sbjct: 193 SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV--VLADYEMPSFLSIEAKDLIHQLLRRN 250
Query: 916 PSLRPSFAQL 925
P+ R S + +
Sbjct: 251 PADRLSLSSV 260
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 7e-39
Identities = 67/251 (26%), Positives = 109/251 (43%), Gaps = 11/251 (4%)
Query: 680 LGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE--FKREVKIMRRLRHPNV 735
G +G G + + + A K + + E+ I R L H +V
Sbjct: 45 RGRFLGKGGFAKCFEISDADTKEVFAGK-IVPKSLLLKPHQREKMSMEISIHRSLAHQHV 103
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRIL-HRPHCQVDEKRRIKMALDARGMNCLHTSTP 794
V F G + ++ E R SL + R E R + G LH +
Sbjct: 104 VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI-VLGCQYLHRNR- 161
Query: 795 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNE 854
++HRDLK NL ++++ VK+ DFGL+ K GTP ++APEVL + +
Sbjct: 162 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 220
Query: 855 KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT 914
+ DV+S G I++ L K P+ + + + IPK ++P+ A +I + QT
Sbjct: 221 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--KKNEYSIPKHINPVAASLIQKMLQT 278
Query: 915 DPSLRPSFAQL 925
DP+ RP+ +L
Sbjct: 279 DPTARPTINEL 289
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 67/280 (23%), Positives = 123/280 (43%), Gaps = 44/280 (15%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKI-MR 728
E+ +DL +G G+YG V +G +AVK+ + + ++ I MR
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKR-IRATVNSQEQKRLLMDLDISMR 61
Query: 729 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ---VDEKRRIKMALDA-R 784
+ P V F GA+ R ++ I E + SL + + + + E K+A+ +
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 785 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-----LKHNTFLSSKSTAGTP 839
+ LH S +++HRD+K N+L++ VK+ DFG+S + + AG
Sbjct: 121 ALEHLH-SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID------AGCK 173
Query: 840 EWMAPEVLRNEPS----NEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRL 894
+MAPE + E + + K D++S G+ + ELA L+ P+ P Q +
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ-------- 225
Query: 895 EIPKELDPLVARIIW---------ECWQTDPSLRPSFAQL 925
+ +E P + + +C + + RP++ +L
Sbjct: 226 -VVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPEL 264
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-38
Identities = 60/311 (19%), Positives = 111/311 (35%), Gaps = 31/311 (9%)
Query: 661 DQIFDDDVCECEIPWEDLVLGERIGLG--SYGEVYHA--DWNGTEVAVKKFLDQDFSGAA 716
+ ++ + L IG G V A G V V++ + S
Sbjct: 10 ENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEM 69
Query: 717 LLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRR 776
+ + E+ + + HPN+V + L ++T F+ GS ++ +
Sbjct: 70 VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA 129
Query: 777 I----KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS------RLKH 826
I + L + ++ +H VHR +K+ ++L+ + V +S + +
Sbjct: 130 IAYILQGVL--KALDYIHHM--GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQ 185
Query: 827 NT-FLSSKSTAGTPEWMAPEVLRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQV 883
K + W++PEVL+ + K D+YS G+ ELA +P+ M Q+
Sbjct: 186 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM 245
Query: 884 VGAVGFQNRRLEIPKELDP-LVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPD 942
+ LE P L+ + S S A ++ PS+ D
Sbjct: 246 L---------LEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGD 296
Query: 943 QPSSALPQEIS 953
PS + S
Sbjct: 297 SPSHPYHRTFS 307
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 7e-38
Identities = 72/272 (26%), Positives = 112/272 (41%), Gaps = 40/272 (14%)
Query: 674 PWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
W+ L + +G G+YGEV A VAVK +D + K+E+ I + L
Sbjct: 8 DWD---LVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLN 63
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRR----IKMALD---A 783
H NVV F G + E+ G LF RI + +R + +
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 784 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL----KHNTFLSSKSTAGTP 839
G I HRD+K NLL+D+ N+K+SDFGL+ + L GT
Sbjct: 124 IG----------ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL--NKMCGTL 171
Query: 840 EWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPW-IGMNPMQ----VVGAVGFQNRR 893
++APE+L+ E DV+S G++L + +LPW + Q + N
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231
Query: 894 LEIPKELDPLVARIIWECWQTDPSLRPSFAQL 925
+I L+ +I+ +PS R + +
Sbjct: 232 KKIDSAPLALLHKIL----VENPSARITIPDI 259
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 8e-38
Identities = 81/341 (23%), Positives = 135/341 (39%), Gaps = 75/341 (21%)
Query: 667 DVCECEIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEF 720
D + E P + L LG+ +G G++G+V AD G K L + + +
Sbjct: 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 72
Query: 721 KREVKIMRRL-RHPNVVLFMGAVTRPPN-LSIITEFLPRGSLFRILHRP----------- 767
E+KI+ + H NVV +GA T+P L +I EF G+L L
Sbjct: 73 MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKG 132
Query: 768 -----------HCQVDEKRRIKMALDARG------------MNCLHTSTPTIVHRDLKSP 804
VD KRR+ ++ + P +++D +
Sbjct: 133 ARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTL 192
Query: 805 NLLVDKNW----------------------NVKVS--------DFGLSR-LKHNTFLSSK 833
L+ ++ N+ +S DFGL+R + + K
Sbjct: 193 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252
Query: 834 STAGTP-EWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 891
A P +WMAPE + + + DV+SFGV+LWE+ +L P+ G+ + +
Sbjct: 253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 312
Query: 892 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932
R+ P P + + + +CW +PS RP+F++L L L
Sbjct: 313 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 58/193 (30%), Positives = 97/193 (50%), Gaps = 15/193 (7%)
Query: 680 LGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
E +G G++ EV+ T A+K + LE E+ ++++++H N+V
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE--NEIAVLKKIKHENIVT 70
Query: 738 FMGAVTRPPNLSIITEFLPRGSLF-RILHRPH-CQVDEKRRIKMALDARGMNCLHTSTPT 795
+ ++ + + G LF RIL R + D I+ L A + LH +
Sbjct: 71 LEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSA--VKYLHENG-- 126
Query: 796 IVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 852
IVHRDLK NLL ++N + ++DFGLS+++ N + + GTP ++APEVL +P
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM--STACGTPGYVAPEVLAQKPY 184
Query: 853 NEKCDVYSFGVIL 865
++ D +S GVI
Sbjct: 185 SKAVDCWSIGVIT 197
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 1e-37
Identities = 56/194 (28%), Positives = 98/194 (50%), Gaps = 14/194 (7%)
Query: 680 LGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ E +G G++ V T E A K + S + +RE +I R+L+HPN+V
Sbjct: 10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 69
Query: 738 FMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRR-IKMALDARGMNCLHTSTPT 795
++ ++ + + G LF I+ R + I+ L++ + H++
Sbjct: 70 LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES--IAYCHSN--G 125
Query: 796 IVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEP 851
IVHR+LK NLL+ K VK++DFGL+ + + AGTP +++PEVL+ +P
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVLKKDP 183
Query: 852 SNEKCDVYSFGVIL 865
++ D+++ GVIL
Sbjct: 184 YSKPVDIWACGVIL 197
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 59/270 (21%), Positives = 114/270 (42%), Gaps = 39/270 (14%)
Query: 679 VLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQD---FSGAALLEFKREVKIMRRLRHP 733
++G+ +G GSYG+V AVK L + K+E++++RRLRH
Sbjct: 8 LMGDLLGEGSYGKVKEVLDSETLCRRAVK-ILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 734 NVV-LF--MGAVTRPPNLSIITEFLPRGS--LFRILHRPHCQVDEKRR----IKMALD-- 782
NV+ L + + ++ E+ G + + V + + L+
Sbjct: 67 NVIQLVDVLYNEE-KQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYL 125
Query: 783 -ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL----KHNTFLSSKSTAG 837
++G IVH+D+K NLL+ +K+S G++ + +++ G
Sbjct: 126 HSQG----------IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC--RTSQG 173
Query: 838 TPEWMAPEVLRNEP--SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE 895
+P + PE+ S K D++S GV L+ + T P+ G N ++ +
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI--GKGSYA 231
Query: 896 IPKELDPLVARIIWECWQTDPSLRPSFAQL 925
IP + P ++ ++ + +P+ R S Q+
Sbjct: 232 IPGDCGPPLSDLLKGMLEYEPAKRFSIRQI 261
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 66/194 (34%), Positives = 97/194 (50%), Gaps = 15/194 (7%)
Query: 680 LGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ +G GS+GEV T E AVK REV+++++L HPN++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 738 FMGAVTRPPNLSIITEFLPRGSLF-RILHRPH-CQVDEKRRIKMALDARGMNCLHTSTPT 795
+ + I+ E G LF I+ R + D R IK + +H
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG--ITYMHKH--N 141
Query: 796 IVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEP 851
IVHRDLK N+L+ +K+ ++K+ DFGLS + NT + + GT ++APEVLR
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR--IGTAYYIAPEVLR-GT 198
Query: 852 SNEKCDVYSFGVIL 865
+EKCDV+S GVIL
Sbjct: 199 YDEKCDVWSAGVIL 212
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-37
Identities = 71/278 (25%), Positives = 122/278 (43%), Gaps = 36/278 (12%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKI-MR 728
+ EDL IG G+YG V +G +AVK+ + + ++ + MR
Sbjct: 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKR-IRSTVDEKEQKQLLMDLDVVMR 76
Query: 729 RLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ----VDEKRRIKMALDA- 783
P +V F GA+ R + I E + S + + + E+ K+ L
Sbjct: 77 SSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATV 135
Query: 784 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 843
+ +N L I+HRD+K N+L+D++ N+K+ DFG+S ++ ++ AG +MA
Sbjct: 136 KALNHLK-ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS-IAKTRDAGCRPYMA 193
Query: 844 PEVLRNEPSNE----KCDVYSFGVILWELATLKLPWIGMNPM-----QVVGAVGFQNRRL 894
PE + S + + DV+S G+ L+ELAT + P+ N + QVV +
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV--------KG 245
Query: 895 EIPKELDPLVAR-------IIWECWQTDPSLRPSFAQL 925
+ P+ + + C D S RP + +L
Sbjct: 246 DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKEL 283
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 7e-37
Identities = 59/259 (22%), Positives = 103/259 (39%), Gaps = 25/259 (9%)
Query: 679 VLGERIGLGSYGEVYHA--DWNGTEVAVK-----KFL-DQDFSGAALLEFKREVKIMRRL 730
+G G++G V+ A EV VK K L D L + E+ I+ R+
Sbjct: 27 STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGS-LF-RILHRPHCQVDEKRRIKMALDARGMNC 788
H N++ + ++ E G LF I P I L +
Sbjct: 87 EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL-VSAVGY 145
Query: 789 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPEVL 847
L I+HRD+K N+++ +++ +K+ DFG + + + GT E+ APEVL
Sbjct: 146 LRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF--YTFCGTIEYCAPEVL 201
Query: 848 RNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 906
P + +++S GV L+ L + P+ + + V A + P + +
Sbjct: 202 MGNPYRGPELEMWSLGVTLYTLVFEENPFCELE--ETVEA------AIHPPYLVSKELMS 253
Query: 907 IIWECWQTDPSLRPSFAQL 925
++ Q P R + +L
Sbjct: 254 LVSGLLQPVPERRTTLEKL 272
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-37
Identities = 57/285 (20%), Positives = 112/285 (39%), Gaps = 16/285 (5%)
Query: 652 SVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLD 709
S SS + + + DL +G G+ G+V+ G +AVK+ +
Sbjct: 2 SSGSSGKQTGYLTIGGQ-RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQ-MR 59
Query: 710 QDFSGAALLEFKREVKI-MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH 768
+ + ++ + ++ P +V G ++ I E + +
Sbjct: 60 RSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG 119
Query: 769 CQVDEKRRIKMALDA-RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827
+ E+ KM + + + L ++HRD+K N+L+D+ +K+ DFG+S +
Sbjct: 120 P-IPERILGKMTVAIVKALYYLK-EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177
Query: 828 TFLSSKSTAGTPEWMAPEVLRNEPSNE-----KCDVYSFGVILWELATLKLPWIGMNP-M 881
+ +AG +MAPE + + + DV+S G+ L ELAT + P+
Sbjct: 178 D-KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF 236
Query: 882 QVVGA-VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 925
+V+ + + L + +C D RP + +L
Sbjct: 237 EVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKL 281
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 8e-37
Identities = 58/193 (30%), Positives = 95/193 (49%), Gaps = 11/193 (5%)
Query: 680 LGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
L E +G G++ V E A + S + +RE +I R L+HPN+V
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 738 FMGAVTRPPNLSIITEFLPRGSLF-RILHRPH-CQVDEKRRIKMALDARGMNCLHTSTPT 795
+++ + +I + + G LF I+ R + + D I+ L+A + H
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEA--VLHCHQM--G 130
Query: 796 IVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 852
+VHR+LK NLL+ K VK++DFGL+ + AGTP +++PEVLR +P
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY 190
Query: 853 NEKCDVYSFGVIL 865
+ D+++ GVIL
Sbjct: 191 GKPVDLWACGVIL 203
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 9e-37
Identities = 57/194 (29%), Positives = 99/194 (51%), Gaps = 14/194 (7%)
Query: 680 LGERIGLGSYGEVYHADWNGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ E +G G++ V T E A K + S + +RE +I R+L+HPN+V
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92
Query: 738 FMGAVTRPPNLSIITEFLPRGSLF-RILHRPH-CQVDEKRRIKMALDARGMNCLHTSTPT 795
++ ++ + + G LF I+ R + D I+ L++ + H++
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES--IAYCHSN--G 148
Query: 796 IVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEP 851
IVHR+LK NLL+ K VK++DFGL+ + + AGTP +++PEVL+ +P
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVLKKDP 206
Query: 852 SNEKCDVYSFGVIL 865
++ D+++ GVIL
Sbjct: 207 YSKPVDIWACGVIL 220
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-36
Identities = 63/284 (22%), Positives = 110/284 (38%), Gaps = 47/284 (16%)
Query: 679 VLGERIGLGSYGEVYHAD-WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVV 736
V + +G GS G V + G VAVK+ L A E+K++ HPNV+
Sbjct: 18 VSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA-----LMEIKLLTESDDHPNVI 72
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDAR--------GMNC 788
+ + T L I E +L ++ + DE +++ + G+
Sbjct: 73 RYYCSETTDRFLYIALELCN-LNLQDLVESKN-VSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 789 LHTSTPTIVHRDLKSPNLLVD-------------KNWNVKVSDFGLSRL----KHNTFLS 831
LH+ I+HRDLK N+LV +N + +SDFGL + + + +
Sbjct: 131 LHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 832 SKSTAGTPEWMAPEVLRN-------EPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQ- 882
+ +GT W APE+L D++S G + + + + K P+ +
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248
Query: 883 --VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQ 924
+ G + + L +I + DP RP+ +
Sbjct: 249 NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMK 292
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 19/199 (9%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVK----KFLDQDFSGAALLEFKREVKIMRRLRHP 733
+GE +G G + V G E A K + L G + E +REV I+R +RHP
Sbjct: 9 MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHP 68
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPH-CQVDEKRRIKMALDARGMNCLHT 791
N++ ++ +I E + G LF + + + + + +K LD G++ LH+
Sbjct: 69 NIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD--GVHYLHS 126
Query: 792 STPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEV 846
I H DLK N+++ N +K+ DFG++ ++ K+ GTPE++APE+
Sbjct: 127 KR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAPEI 182
Query: 847 LRNEPSNEKCDVYSFGVIL 865
+ EP + D++S GVI
Sbjct: 183 VNYEPLGLEADMWSIGVIT 201
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVK----KFLDQDFSGAALLEFKREVKIMRRLRHP 733
+GE +G G + V G E A K + G + E +REV I+R++ H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPH-CQVDEKRRIKMALDARGMNCLHT 791
NV+ ++ +I E + G LF + + + + IK LD G+N LHT
Sbjct: 76 NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD--GVNYLHT 133
Query: 792 STPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEV 846
I H DLK N+++ ++K+ DFGL+ ++ K+ GTPE++APE+
Sbjct: 134 KK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAPEI 189
Query: 847 LRNEPSNEKCDVYSFGVIL 865
+ EP + D++S GVI
Sbjct: 190 VNYEPLGLEADMWSIGVIT 208
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-36
Identities = 52/199 (26%), Positives = 91/199 (45%), Gaps = 19/199 (9%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVK----KFLDQDFSGAALLEFKREVKIMRRLRHP 733
GE +G G + V G + A K + G + + +REV I++ ++HP
Sbjct: 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPH-CQVDEKRRIKMALDARGMNCLHT 791
NV+ ++ +I E + G LF + + + + +K L+ + LH+
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG--VYYLHS 132
Query: 792 STPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEV 846
I H DLK N+++ +K+ DFGL+ + K+ GTPE++APE+
Sbjct: 133 LQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEI 188
Query: 847 LRNEPSNEKCDVYSFGVIL 865
+ EP + D++S GVI
Sbjct: 189 VNYEPLGLEADMWSIGVIT 207
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 9e-36
Identities = 67/252 (26%), Positives = 117/252 (46%), Gaps = 24/252 (9%)
Query: 625 YHDRRKCTHDRFMGTNLKLRDLESPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERI 684
+H + NL + + S ++S T+ + + D + + + +
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESEL 61
Query: 685 GLGSYGEVYHADWNGT--EVAVK---KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
G G+ VY GT A+K K +D+ + E+ ++ RL HPN++
Sbjct: 62 GRGATSIVYRCKQKGTQKPYALKVLKKTVDKK-------IVRTEIGVLLRLSHPNIIKLK 114
Query: 740 GAVTRPPNLSIITEFLPRGSLF-RILHRPH-CQVDEKRRIKMALDARGMNCLHTSTPTIV 797
P +S++ E + G LF RI+ + + + D +K L+A + LH + IV
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEA--VAYLHENG--IV 170
Query: 798 HRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEPSN 853
HRDLK NLL + +K++DFGLS+ ++H + K+ GTP + APE+LR
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCGTPGYCAPEILRGCAYG 228
Query: 854 EKCDVYSFGVIL 865
+ D++S G+I
Sbjct: 229 PEVDMWSVGIIT 240
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-35
Identities = 75/260 (28%), Positives = 124/260 (47%), Gaps = 30/260 (11%)
Query: 680 LGERIGLGSYGEVYHA--DWNGTEVAVK-----KFLDQDFSGAALLEFKREVKIMRRLRH 732
+ E +G GS+G+V A +VA+K D +RE+ ++ LRH
Sbjct: 13 IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHM----RVEREISYLKLLRH 68
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRR----IKMALDARGMN 787
P+++ +T P ++ ++ E+ G LF I+ + DE RR I A++
Sbjct: 69 PHIIKLYDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQIICAIE----- 122
Query: 788 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPEV 846
H IVHRDLK NLL+D N NVK++DFGLS + FL K++ G+P + APEV
Sbjct: 123 YCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL--KTSCGSPNYAAPEV 178
Query: 847 LRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 905
+ + + + DV+S G++L+ + +LP+ + V + +P L P
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGAQ 236
Query: 906 RIIWECWQTDPSLRPSFAQL 925
+I DP R + ++
Sbjct: 237 SLIRRMIVADPMQRITIQEI 256
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-35
Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVK----KFLDQDFSGAALLEFKREVKIMRRLRHP 733
+GE +G G + V G E A K + G E +REV I+R++ HP
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPH-CQVDEKRRIKMALDARGMNCLHT 791
N++ ++ +I E + G LF + + + + IK LD G+N LHT
Sbjct: 76 NIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD--GVNYLHT 133
Query: 792 STPTIVHRDLKSPNLLV----DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEV 846
I H DLK N+++ ++K+ DFGL+ ++ K+ GTPE++APE+
Sbjct: 134 KK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAPEI 189
Query: 847 LRNEPSNEKCDVYSFGVIL 865
+ EP + D++S GVI
Sbjct: 190 VNYEPLGLEADMWSIGVIT 208
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-35
Identities = 76/287 (26%), Positives = 139/287 (48%), Gaps = 26/287 (9%)
Query: 680 LGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQD--FSGAALLEFKREVKIMRRLRHPNV 735
LG+ +G+G++G+V + G +VAVK L++ S + + +RE++ ++ RHP++
Sbjct: 20 LGDTLGVGTFGKVKVGKHELTGHKVAVK-ILNRQKIRSLDVVGKIRREIQNLKLFRHPHI 78
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRR----IKMALDARGMNCLH 790
+ ++ P ++ ++ E++ G LF I E RR I +D H
Sbjct: 79 IKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD-----YCH 133
Query: 791 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPEVLRN 849
+VHRDLK N+L+D + N K++DFGLS + FL +++ G+P + APEV+
Sbjct: 134 RHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--RTSCGSPNYAAPEVISG 189
Query: 850 EP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 908
+ + D++S GVIL+ L LP+ + + + + P+ L+P V ++
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI--CDGIFYTPQYLNPSVISLL 247
Query: 909 WECWQTDPSLRPSFAQLTV---ALKPLQRLVIPSHPDQPSSALPQEI 952
Q DP R + + + L + + P P S+ + E
Sbjct: 248 KHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEA 294
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 61/294 (20%), Positives = 110/294 (37%), Gaps = 45/294 (15%)
Query: 679 VLGERIGLGSYGEVYHA--DWNGTEVAVK----KFLDQDFSGAALLEFKREVKIMRRLRH 732
+G +G G +G VY + VA+K + EV +++++
Sbjct: 46 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 105
Query: 733 --PNVVLFMGAVTRPPNLSIITEF-LPRGSLF-RILHRPHCQVDEKRR----IKMALD-- 782
V+ + RP + +I E P LF I R Q + R + A+
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 165
Query: 783 -ARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHNTFLSSKSTAGTPE 840
G ++HRD+K N+L+D N +K+ DFG L +T GT
Sbjct: 166 HNCG----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRV 213
Query: 841 WMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE 899
+ PE +R V+S G++L+++ +P+ +++ ++ +
Sbjct: 214 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--EIIRG------QVFFRQR 265
Query: 900 LDPLVARIIWECWQTDPSLRPSFAQ------LTVALKPLQRLVIPSHPDQPSSA 947
+ +I C PS RP+F + + L P + I H P +
Sbjct: 266 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPS 319
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-35
Identities = 56/194 (28%), Positives = 89/194 (45%), Gaps = 17/194 (8%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
L IG GS+GEV A A KK K+E++IM+ L HPN++
Sbjct: 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRF--KQEIEIMKSLDHPNIIR 70
Query: 738 FMGAVTRPPNLSIITEFLPRGSLF-RILHRPH-CQVDEKRRIKMALDARGMNCLHTSTPT 795
++ ++ E G LF R++H+ + D R +K L A + H
Sbjct: 71 LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA--VAYCHKL--N 126
Query: 796 IVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEP 851
+ HRDLK N L + +K+ DFGL+ K + ++ GTP +++P+VL
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVSPQVLEG-L 183
Query: 852 SNEKCDVYSFGVIL 865
+CD +S GV++
Sbjct: 184 YGPECDEWSAGVMM 197
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-34
Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 18/200 (9%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVK---KFLDQDFSGAALLEFKREVKIMRRLRHPN 734
L E IG G + V G + AVK G + + KRE I L+HP+
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQV-----DEKRRIKMALDARGMNC 788
+V + + L ++ EF+ L I+ R ++ L+A +
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA--LRY 145
Query: 789 LHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 845
H + I+HRD+K +L+ + + VK+ FG++ + L + GTP +MAPE
Sbjct: 146 CHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE 203
Query: 846 VLRNEPSNEKCDVYSFGVIL 865
V++ EP + DV+ GVIL
Sbjct: 204 VVKREPYGKPVDVWGCGVIL 223
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 25/205 (12%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVK-------KFLDQDFSGAALLEFKREVKIMRRL 730
E +G G V E AVK + +EV I+R++
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 731 -RHPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRI-KMALDARGMN 787
HPN++ ++ + + +G LF + + E R+I + L+ +
Sbjct: 81 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV--IC 138
Query: 788 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEV 846
LH IVHRDLK N+L+D + N+K++DFG S L L + GTP ++APE+
Sbjct: 139 ALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSYLAPEI 194
Query: 847 LRNEPS------NEKCDVYSFGVIL 865
+ + ++ D++S GVI+
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 65/300 (21%), Positives = 108/300 (36%), Gaps = 57/300 (19%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVK---KFLDQDFSGAALLEFKREVKIMRRLRHPN 734
L IG GSYG V A A+K K + + + K EV++M++L HPN
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDARGMNCLHTST 793
+ + ++ E G L ++ + + +
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 794 PT-------------------------------------IVHRDLKSPNLLV--DKNWNV 814
I HRD+K N L +K++ +
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEI 209
Query: 815 KVSDFGLSRL----KHNTFLSSKSTAGTPEWMAPEVLR--NEPSNEKCDVYSFGVILWEL 868
K+ DFGLS+ + + + AGTP ++APEVL NE KCD +S GV+L L
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 869 ATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV---AR-IIWECWQTDPSLRPSFAQ 924
+P+ G+N + V N++L ++ AR ++ + R +
Sbjct: 270 LMGAVPFPGVNDADTISQV--LNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMR 327
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 54/203 (26%), Positives = 100/203 (49%), Gaps = 24/203 (11%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLE------FKREVKIMRRLR 731
+ + +G G+ GEV A +VA+K + F+ + E + E++I+++L
Sbjct: 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRI-KMALDARGMNCL 789
HP ++ + I+ E + G LF +++ + + L A + L
Sbjct: 74 HPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA--VQYL 130
Query: 790 HTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPE 845
H + I+HRDLK N+L+ +++ +K++DFG S+ L + + ++ GTP ++APE
Sbjct: 131 HEN--GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLCGTPTYLAPE 186
Query: 846 VLRNEPS---NEKCDVYSFGVIL 865
VL + + N D +S GVIL
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-34
Identities = 74/269 (27%), Positives = 119/269 (44%), Gaps = 45/269 (16%)
Query: 680 LGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE--FKREVKIMRRLRHPNV 735
+ IG G++G VAVK ++++ A ++ +RE+ R LRHPN+
Sbjct: 24 FVKDIGSGNFGVARLMRDKLTKELVAVK-YIERG----AAIDENVQREIINHRSLRHPNI 78
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRR----IKMALD---ARGMN 787
V F + P +L+II E+ G L+ RI + DE R + + +
Sbjct: 79 VRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ-- 136
Query: 788 CLHTSTPTIVHRDLKSPNLLVDKNW--NVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAP 844
I HRDLK N L+D + +K+ DFG S+ ++ KST GTP ++AP
Sbjct: 137 --------ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAYIAP 186
Query: 845 EVLRNEPSN-EKCDVYSFGVILWELATLKLPWIGMNPM-------QVVGAVGFQN-RRLE 895
EVL + + + DV+S GV L+ + P+ Q + +V + +
Sbjct: 187 EVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR 246
Query: 896 IPKELDPLVARIIWECWQTDPSLRPSFAQ 924
I E L++RI DP+ R S +
Sbjct: 247 ISPECCHLISRIF----VADPATRISIPE 271
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-34
Identities = 81/301 (26%), Positives = 133/301 (44%), Gaps = 50/301 (16%)
Query: 648 SPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGT--EVAVK 705
+P + S + +++ +++G G+YGEV T E A+K
Sbjct: 23 TPGMFITSKKGHLSEMYQ--------------RVKKLGSGAYGEVLLCRDKVTHVERAIK 68
Query: 706 KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RIL 764
S ++ + EV +++ L HPN++ N ++ E G LF I+
Sbjct: 69 IIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII 128
Query: 765 HRPH-CQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFG 820
HR +VD IK L + LH IVHRDLK NLL+ +K+ +K+ DFG
Sbjct: 129 HRMKFNEVDAAVIIKQVLSG--VTYLHKH--NIVHRDLKPENLLLESKEKDALIKIVDFG 184
Query: 821 LSRL-KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN 879
LS + ++ + + GT ++APEVLR + +EKCDV+S GVIL+ L P+ G
Sbjct: 185 LSAVFENQKKMKER--LGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT 241
Query: 880 PMQVVGAVGFQNRRLEIPKELDP----------LVARIIWECWQTDPSLRPSFAQLTVAL 929
+++ V + + + L+ +++ Q D R S Q AL
Sbjct: 242 DQEILRKV----EKGKYTFDSPEWKNVSEGAKDLIKQML----QFDSQRRISAQQ---AL 290
Query: 930 K 930
+
Sbjct: 291 E 291
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 53/198 (26%), Positives = 86/198 (43%), Gaps = 17/198 (8%)
Query: 679 VLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH-PNV 735
+ + +G G + V G E A K + E E+ ++ + P V
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEK---RRIKMALDARGMNCLHT 791
+ + +I E+ G +F L V E R IK L+ G+ LH
Sbjct: 92 INLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE--GVYYLHQ 149
Query: 792 STPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVL 847
+ IVH DLK N+L+ ++K+ DFG+SR + H L + GTPE++APE+L
Sbjct: 150 NN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL--REIMGTPEYLAPEIL 205
Query: 848 RNEPSNEKCDVYSFGVIL 865
+P D+++ G+I
Sbjct: 206 NYDPITTATDMWNIGIIA 223
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 65/301 (21%), Positives = 112/301 (37%), Gaps = 43/301 (14%)
Query: 679 VLGERIGLGSYGEVYHA--DWNGTEVAVK----KFLDQDFSGAALLEFKREVKIMRRLR- 731
LG +G G +G V+ + +VA+K + + + EV ++ ++
Sbjct: 34 RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGA 93
Query: 732 ---HPNVVLFMGAVTRPPNLSIITEF-LPRGSLF-RILHRPHCQVDEKRRI-KMALDARG 785
HP V+ + ++ E LP LF I + R + A
Sbjct: 94 GGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA-- 151
Query: 786 MNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 844
+ H+ +VHRD+K N+L+D + K+ DFG L H+ GT + P
Sbjct: 152 IQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY--TDFDGTRVYSPP 207
Query: 845 EVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------LEIP 897
E + V+S G++L+++ V G + F+ + L P
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDM--------------VCGDIPFERDQEILEAELHFP 253
Query: 898 KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQEISVNST 957
+ P +I C PS RPS + + L P + P PS P ++ +
Sbjct: 254 AHVSPDCCALIRRCLAPKPSSRPSLEE--ILLDPWMQTPAEDVPLNPSKGGPAPLAWSLL 311
Query: 958 P 958
P
Sbjct: 312 P 312
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-34
Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 26/199 (13%)
Query: 680 LGERIGLGSYGEVYHADWNGT--EVAVK-----KFLDQDFSGAALLEFKREVKIMRRLRH 732
+ E +G G++G V+ T K LD+ K E+ IM +L H
Sbjct: 55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY-------TVKNEISIMNQLHH 107
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHC--QVDEKRRIKMALDARGMNCL 789
P ++ A + +I EFL G LF RI + + + ++ A + G+ +
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE--GLKHM 165
Query: 790 HTSTPTIVHRDLKSPNLLV--DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEV 846
H + IVH D+K N++ K +VK+ DFGL+ L + + K T T E+ APE+
Sbjct: 166 HEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV--KVTTATAEFAAPEI 221
Query: 847 LRNEPSNEKCDVYSFGVIL 865
+ EP D+++ GV+
Sbjct: 222 VDREPVGFYTDMWAIGVLG 240
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 67/265 (25%), Positives = 122/265 (46%), Gaps = 33/265 (12%)
Query: 679 VLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+ ++G G++G+V+ + +G E +K +++D S + + + E+++++ L HPN++
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIK-TINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQ-----VDEKRRIKMALDARGMNCLH 790
N+ I+ E G L RI+ +K ++A + H
Sbjct: 84 KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA--LAYFH 141
Query: 791 TSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEV 846
+ +VH+DLK N+L + +K+ DFGL+ K + + AGT +MAPEV
Sbjct: 142 SQ--HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGTALYMAPEV 197
Query: 847 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP---- 902
+ KCD++S GV+++ L T LP+ G + +V + E P
Sbjct: 198 FK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA--TYKEPNYAVECRPLTPQ 254
Query: 903 ---LVARIIWECWQTDPSLRPSFAQ 924
L+ +++ DP RPS AQ
Sbjct: 255 AVDLLKQML----TKDPERRPSAAQ 275
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-34
Identities = 43/198 (21%), Positives = 83/198 (41%), Gaps = 25/198 (12%)
Query: 680 LGERIGLGSYGEVYHADWNGT--EVAVK----KFLDQDFSGAALLEFKREVKIMRRLRHP 733
+ E +G G +G V+ + K K DQ K+E+ I+ RH
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-------LVKKEISILNIARHR 61
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHR--PHCQVDEKRRIKMALDARGMNCLH 790
N++ + L +I EF+ +F RI + + + + + LH
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE--ALQFLH 119
Query: 791 TSTPTIVHRDLKSPNLLV--DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVL 847
+ I H D++ N++ ++ +K+ +FG +R LK + PE+ APEV
Sbjct: 120 SHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVH 175
Query: 848 RNEPSNEKCDVYSFGVIL 865
+++ + D++S G ++
Sbjct: 176 QHDVVSTATDMWSLGTLV 193
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-34
Identities = 51/202 (25%), Positives = 99/202 (49%), Gaps = 22/202 (10%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLE------FKREVKIMRRLR 731
+ + +G G+ GEV A +VA++ + F+ + E + E++I+++L
Sbjct: 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 198
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRIKMALDARGMNCLH 790
HP ++ + I+ E + G LF +++ + + + + LH
Sbjct: 199 HPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM-LLAVQYLH 256
Query: 791 TSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEV 846
+ I+HRDLK N+L+ +++ +K++DFG S+ L + + ++ GTP ++APEV
Sbjct: 257 EN--GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLCGTPTYLAPEV 312
Query: 847 LRNEPS---NEKCDVYSFGVIL 865
L + + N D +S GVIL
Sbjct: 313 LVSVGTAGYNRAVDCWSLGVIL 334
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-33
Identities = 57/202 (28%), Positives = 101/202 (50%), Gaps = 26/202 (12%)
Query: 677 DLVLGERIGLGSYGEVYHADWNGT--EVAVK-----KFLDQDFSGAALLEFKREVKIMRR 729
+ E +G G +G+V+ + T ++A K D++ E K E+ +M +
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE-------EVKNEISVMNQ 142
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHC--QVDEKRRIKMALDARGM 786
L H N++ A ++ ++ E++ G LF RI+ + ++D +K + G+
Sbjct: 143 LDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE--GI 200
Query: 787 NCLHTSTPTIVHRDLKSPNLL-VDKNWN-VKVSDFGLSR-LKHNTFLSSKSTAGTPEWMA 843
+H I+H DLK N+L V+++ +K+ DFGL+R K L K GTPE++A
Sbjct: 201 RHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL--KVNFGTPEFLA 256
Query: 844 PEVLRNEPSNEKCDVYSFGVIL 865
PEV+ + + D++S GVI
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVIA 278
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-33
Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 24/204 (11%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVK------KFLDQDFSGAALLEFKREVKIMRRLR 731
+ IG G V G E AVK + L + +RE I+R++
Sbjct: 98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157
Query: 732 -HPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEKRRI-KMALDARGMNC 788
HP+++ + + + ++ + + +G LF + + E R I + L+A ++
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEA--VSF 215
Query: 789 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVL 847
LH + IVHRDLK N+L+D N +++SDFG S L+ L + GTP ++APE+L
Sbjct: 216 LHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL--RELCGTPGYLAPEIL 271
Query: 848 RNEPS------NEKCDVYSFGVIL 865
+ ++ D+++ GVIL
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVIL 295
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-33
Identities = 48/320 (15%), Positives = 100/320 (31%), Gaps = 52/320 (16%)
Query: 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRL 730
LV G +G A G V + A+ + K EV +R L
Sbjct: 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 135
Query: 731 R----------------------HPNVVLFMGAVTRPPNLSIITEFLPR-------GSLF 761
R P + ++ +++ F +
Sbjct: 136 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 195
Query: 762 RILH---RPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVS 817
+L H + R+++ L R + LH +VH L+ ++++D+ V ++
Sbjct: 196 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLT 253
Query: 818 DFGLSRLKHNTFLSSKSTA-GTPEWMAPEVLRNEPSNEK-----CDVYSFGVILWELATL 871
F + +S PE A +L + D ++ G+ ++ +
Sbjct: 254 GFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313
Query: 872 KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL--TVAL 929
LP + + F++ + IP+ + L+ + + R Q T
Sbjct: 314 DLPNTDDAALGGSEWI-FRSCK-NIPQPVRALLEGFL----RYPKEDRLLPLQAMETPEY 367
Query: 930 KPLQRLVIPSHPDQPSSALP 949
+ L+ + + P + P
Sbjct: 368 EQLRTELSAALPLYQTDGEP 387
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-33
Identities = 79/265 (29%), Positives = 123/265 (46%), Gaps = 28/265 (10%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ +G GS+GEV E AVK REV+++++L HPN++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 738 FMGAVTRPPNLSIITEFLPRGSLF-RILHRPH-CQVDEKRRIKMALDARGMNCLHTSTPT 795
+ + I+ E G LF I+ R + D R IK + +H
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG--ITYMHKH--N 141
Query: 796 IVHRDLKSPNLLV---DKNWNVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPEVLRNEP 851
IVHRDLK N+L+ +K+ ++K+ DFGLS + NT + + GT ++APEVLR
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR--IGTAYYIAPEVLR-GT 198
Query: 852 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVV-----GAVGFQNRR-LEIPKELDPLVA 905
+EKCDV+S GVIL+ L + P+ G N ++ G F + I + L+
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR 258
Query: 906 RIIWECWQTDPSLRPSFAQLTVALK 930
+++ PSLR + Q L+
Sbjct: 259 KML----TFHPSLRITATQ---CLE 276
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-33
Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 33/204 (16%)
Query: 679 VLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNV 735
+ + +GLG G+V G + A+K D + ++EV + P++
Sbjct: 32 LSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHI 84
Query: 736 VLFMGA----VTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEK------RRIKMALDAR 784
V + L II E + G LF RI R E+ R I A+
Sbjct: 85 VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQF- 143
Query: 785 GMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEW 841
LH+ I HRD+K NLL +K+ +K++DFG ++ L ++ TP +
Sbjct: 144 ----LHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL--QTPCYTPYY 195
Query: 842 MAPEVLRNEPSNEKCDVYSFGVIL 865
+APEVL E ++ CD++S GVI+
Sbjct: 196 VAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-33
Identities = 83/298 (27%), Positives = 131/298 (43%), Gaps = 43/298 (14%)
Query: 648 SPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHAD--WNGTEVAVK 705
+P V ST+ + +G GS+GEV G E AVK
Sbjct: 12 TPGMFVQHSTAIFSDRYK--------------GQRVLGKGSFGEVILCKDKITGQECAVK 57
Query: 706 KFLDQDFSGAALLE-FKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RI 763
+ E REV+++++L HPN++ ++ E G LF I
Sbjct: 58 VISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI 117
Query: 764 LHRPH-CQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDF 819
+ R +VD R I+ L + +H + IVHRDLK NLL+ K+ N+++ DF
Sbjct: 118 ISRKRFSEVDAARIIRQVLSG--ITYMHKN--KIVHRDLKPENLLLESKSKDANIRIIDF 173
Query: 820 GLSRL-KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM 878
GLS + + + K GT ++APEVL +EKCDV+S GVIL+ L + P+ G
Sbjct: 174 GLSTHFEASKKMKDK--IGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGA 230
Query: 879 NPMQVV-----GAVGFQNRR-LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 930
N ++ G F+ + ++ + L+ +++ PS+R S AL
Sbjct: 231 NEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKML----TYVPSMRISARD---ALD 281
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-33
Identities = 43/321 (13%), Positives = 83/321 (25%), Gaps = 61/321 (19%)
Query: 677 DLVLGERIGLGSYGEVYHA-DWN-GTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRHP 733
L L E + +G V+ D + A+K F + + S + L RL
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 734 NVVLFMG--------AVTRPPNLSIITEFLPRGSLFRILHR----PHCQVDEKRRIKMAL 781
+ + + P + + + P VD +
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 782 D--------------------ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 821
R L + +VH NL + + + + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPDGRLMLGDVSA 240
Query: 822 SRLKHNTFLSSKSTAGTPEWMAPEVL---RNEPSNEKCDVYSFGVILWELATLKLPWIGM 878
+ P AP + + G+ ++ + L LP+ +
Sbjct: 241 LWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296
Query: 879 NP-------MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK- 930
P + G + L V +I D R + A++
Sbjct: 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLE---AMET 353
Query: 931 -PLQRLVIPSHPDQPSSALPQ 950
+L ++ SS+L
Sbjct: 354 PEFLQL-----QNEISSSLST 369
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-33
Identities = 60/285 (21%), Positives = 121/285 (42%), Gaps = 23/285 (8%)
Query: 680 LGERIGLGSYGEVYHA-DWN-GTEVAVKKFLDQDFSG--AALLEFKREVKIMRRLRHPNV 735
+ +++G G VY A D +VA+K + L F+REV +L H N+
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEETLKRFEREVHNSSQLSHQNI 73
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTP 794
V + ++ E++ +L + H + I G+ H
Sbjct: 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMR- 131
Query: 795 TIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEPSN 853
IVHRD+K N+L+D N +K+ DFG+++ L + + GT ++ +PE + E ++
Sbjct: 132 -IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 854 EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK-------ELDPLVAR 906
E D+YS G++L+E+ + P+ G + + ++ + +P ++ ++
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPPFNGETAVSIA----IKHIQDSVPNVTTDVRKDIPQSLSN 246
Query: 907 IIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQE 951
+I + D + R Q L ++ + ++ L +
Sbjct: 247 VILRATEKDKANRYKTIQ--EMKDDLSSVLHENRANEDVYELDKM 289
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 7e-33
Identities = 75/312 (24%), Positives = 125/312 (40%), Gaps = 61/312 (19%)
Query: 648 SPSSSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGT--EVAVK 705
+P V K+ + + ++G G+YGEV E A+K
Sbjct: 22 NPGMYVRKKEGKIGESYF--------------KVRKLGSGAYGEVLLCKEKNGHSEKAIK 67
Query: 706 -----------KFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754
D E E+ +++ L HPN++ ++TEF
Sbjct: 68 VIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEF 127
Query: 755 LPRGSLF-RILHRPH-CQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLV---D 809
G LF +I++R + D +K L + LH IVHRD+K N+L+ +
Sbjct: 128 YEGGELFEQIINRHKFDECDAANIMKQILSG--ICYLHKH--NIVHRDIKPENILLENKN 183
Query: 810 KNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWEL 868
N+K+ DFGLS + L + GT ++APEVL+ + NEKCDV+S GVI++ L
Sbjct: 184 SLLNIKIVDFGLSSFFSKDYKLRDR--LGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYIL 240
Query: 869 ATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP----------LVARIIWECWQTDPSL 918
P+ G N ++ V + + + + L+ ++ D +
Sbjct: 241 LCGYPPFGGQNDQDIIKKV----EKGKYYFDFNDWKNISDEAKELIKLML----TYDYNK 292
Query: 919 RPSFAQLTVALK 930
R + + AL
Sbjct: 293 RCTAEE---ALN 301
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 8e-33
Identities = 49/253 (19%), Positives = 91/253 (35%), Gaps = 30/253 (11%)
Query: 693 YHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752
+ + + + + S + + +++ M N V + + L I
Sbjct: 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQM 140
Query: 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALD-----ARGMNCLHTSTPTIVHRDLKSPNLL 807
+ + +L ++R E R + L A + LH+ ++HRDLK N+
Sbjct: 141 QLCRKENLKDWMNR--RCSLEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIF 196
Query: 808 VDKNWNVKVSDFGLSRLKHNTFLSSKSTA------------GTPEWMAPEVLRNEPSNEK 855
+ VKV DFGL GT +M+PE + + K
Sbjct: 197 FTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK 256
Query: 856 CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD---PLVARIIWECW 912
D++S G+IL+EL M ++++ V R L+ P P ++ +
Sbjct: 257 VDIFSLGLILFELLYSFST--QMERVRIITDV----RNLKFPLLFTQKYPQEHMMVQDML 310
Query: 913 QTDPSLRPSFAQL 925
P+ RP +
Sbjct: 311 SPSPTERPEATDI 323
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 17/63 (26%), Positives = 29/63 (46%), Gaps = 3/63 (4%)
Query: 676 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
D + +G G +G V+ A + A+K+ + A + REVK + +L HP
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKR-IRLPNRELAREKVMREVKALAKLEHP 64
Query: 734 NVV 736
+V
Sbjct: 65 GIV 67
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 4e-32
Identities = 41/240 (17%), Positives = 84/240 (35%), Gaps = 39/240 (16%)
Query: 670 ECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKR 722
E ++ + + + +G G++ +VY A N + +K A EF
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ-----KPANPWEFYI 113
Query: 723 EVKIMRRLR---HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR----PHCQVDEKR 775
++M RL+ + F A ++ E G+L ++ P + +
Sbjct: 114 GTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGL 173
Query: 776 RIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLV-----------DKNWNVKVSDFGLSR 823
I A+ + +H I+H D+K N ++ D + + + D G S
Sbjct: 174 VISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 824 ----LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN 879
T ++K T + E+L N+P N + D + ++ + +
Sbjct: 232 DMKLFPKGTIFTAK--CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 52/195 (26%), Positives = 88/195 (45%), Gaps = 17/195 (8%)
Query: 679 VLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNV 735
+ + +G GS+ + AVK + + ++E+ ++ HPN+
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT-----QKEITALKLCEGHPNI 68
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPH-CQVDEKRRIKMALDARGMNCLHTST 793
V + ++ E L G LF RI + H + + ++ + A ++ +H
Sbjct: 69 VKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSA--VSHMHDVG 126
Query: 794 PTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 850
+VHRDLK NLL + N +K+ DFG +RLK K+ T + APE+L
Sbjct: 127 --VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184
Query: 851 PSNEKCDVYSFGVIL 865
+E CD++S GVIL
Sbjct: 185 GYDESCDLWSLGVIL 199
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-31
Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 34/205 (16%)
Query: 679 VLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNV 735
V + +GLG G+V + A+K D + +REV++ R + P++
Sbjct: 65 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELHWRASQCPHI 117
Query: 736 VLFMGA----VTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEK------RRIKMALDAR 784
V + L I+ E L G LF RI R E+ + I A+
Sbjct: 118 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY- 176
Query: 785 GMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPE 840
LH+ I HRD+K NLL N +K++DFG ++ + L + TP
Sbjct: 177 ----LHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--TTPCYTPY 228
Query: 841 WMAPEVLRNEPSNEKCDVYSFGVIL 865
++APEVL E ++ CD++S GVI+
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-31
Identities = 65/281 (23%), Positives = 108/281 (38%), Gaps = 42/281 (14%)
Query: 599 GPPLVEDLSSNSKDENPKNVEDHEIGYHDRRKCTHDRFMGTNLKLRDLESPSSSVDSSTS 658
P L + + + + E G R K T + + V+
Sbjct: 94 CEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHD 153
Query: 659 KVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGT--EVAVK-----KFLDQD 711
V +D + E +G G++G V+ T A K D++
Sbjct: 154 HVLDHYD--------------IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE 199
Query: 712 FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRPHCQ 770
++E++ M LRHP +V A + +I EF+ G LF ++ H +
Sbjct: 200 -------TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE-HNK 251
Query: 771 VDEK---RRIKMALDARGMNCLHTSTPTIVHRDLKSPNLL-VDKNWN-VKVSDFGLSR-L 824
+ E ++ G+ +H + VH DLK N++ K N +K+ DFGL+ L
Sbjct: 252 MSEDEAVEYMRQVCK--GLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307
Query: 825 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVIL 865
+ K T GT E+ APEV +P D++S GV+
Sbjct: 308 DPKQSV--KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-31
Identities = 47/327 (14%), Positives = 95/327 (29%), Gaps = 77/327 (23%)
Query: 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLR-- 731
LV G +G A G V + A+ + K EV +R LR
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 732 -----------------------HPNVVLFMGAVTRPPNLSI-ITEFLPRGSLFRILH-- 765
++ LS + +L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 766 ----RPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 820
H + R+++ L R + LH +VH L+ ++++D+ V ++ F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFE 251
Query: 821 LSRLKHNTFLSSKSTAGTPEWMAPEVL-----------RNEPSNEKCDVYSFGVILWELA 869
+ ++ + + PE+ R D ++ G++++ +
Sbjct: 252 HLV-RDGAR---VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307
Query: 870 TLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 929
LP + + F++ + IP+ + L+ + + R Q
Sbjct: 308 CADLPITKDAALGGSEWI-FRSCK-NIPQPVRALLEGFL----RYPKEDRLLPLQ----- 356
Query: 930 KPLQRLVIPSHP------DQPSSALPQ 950
P + S+ALP
Sbjct: 357 -------AMETPEYEQLRTELSAALPL 376
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-31
Identities = 49/197 (24%), Positives = 85/197 (43%), Gaps = 23/197 (11%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVV 736
+ E IG+GSY E AVK + + E++I+ R +HPN++
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK------SKRDPTEEIEILLRYGQHPNII 79
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLF-RILHRPH-CQVDEKRRIKMALDARGMNCLHTSTP 794
+ ++TE + G L +IL + + + + + LH
Sbjct: 80 TLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKT--VEYLHAQG- 136
Query: 795 TIVHRDLKSPNLLV----DKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVLR 848
+VHRDLK N+L ++++ DFG ++ N L + T ++APEVL
Sbjct: 137 -VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL--MTPCYTANFVAPEVLE 193
Query: 849 NEPSNEKCDVYSFGVIL 865
+ + CD++S GV+L
Sbjct: 194 RQGYDAACDIWSLGVLL 210
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 79/308 (25%), Positives = 132/308 (42%), Gaps = 43/308 (13%)
Query: 680 LGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSG--AALLEFKREVKIMRRLRHPNV 735
LGE +G G EV+ A +VAVK L D + + L F+RE + L HP +
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALNHPAI 74
Query: 736 VLFMGAV--------TRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGM 786
V AV P I+ E++ +L I+H + KR I++ D + +
Sbjct: 75 V----AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQAL 129
Query: 787 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA---GTPEWMA 843
N H + I+HRD+K N+++ VKV DFG++R ++ S TA GT ++++
Sbjct: 130 NFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 844 PEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV--------VGAVGFQNRRLE 895
PE R + + + DVYS G +L+E+ T + P+ G +P+ V ++
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE--G 245
Query: 896 IPKELDPLVARIIWECWQTDPSLRPSFAQ-----LTVALKPLQRLVIPSHPDQPSSALPQ 950
+ +LD +V + +P R A L D ++L
Sbjct: 246 LSADLDAVVLK----ALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLTDAERTSLLS 301
Query: 951 EISVNSTP 958
+ N +
Sbjct: 302 SAAGNLSG 309
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 61/239 (25%), Positives = 99/239 (41%), Gaps = 49/239 (20%)
Query: 652 SVDSSTSKVDQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHAD--WNGTEVAVKKFLD 709
S DS + + + ++ + + +G G++ V E AVK
Sbjct: 2 STDSFSGRFEDVYQ-------------LQEDVLGEGAHARVQTCINLITSQEYAVKIIEK 48
Query: 710 QDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEFLPRGSLF-RILHRP 767
Q + REV+++ + + H NV+ + ++ E + GS+ I R
Sbjct: 49 QPGHIRS--RVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR 106
Query: 768 HCQVDEK------RRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSD 818
H +E + + ALD LH I HRDLK N+L ++ VK+ D
Sbjct: 107 H--FNELEASVVVQDVASALDF-----LHN--KGIAHRDLKPENILCEHPNQVSPVKICD 157
Query: 819 FGLSR-LKHNTFLSSKST------AGTPEWMAPEVLRNEPS-----NEKCDVYSFGVIL 865
F L +K N S ST G+ E+MAPEV+ +++CD++S GVIL
Sbjct: 158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 55/263 (20%), Positives = 110/263 (41%), Gaps = 37/263 (14%)
Query: 676 EDLVLGERIGLGSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFK------REVKI 726
ED G+ +G GS+ V E A+K +++ RE +
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELA-TSREYAIKIL-----EKRHIIKENKVPYVTRERDV 83
Query: 727 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRR-----IKMAL 781
M RL HP V L + G L + + + + R I AL
Sbjct: 84 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 143
Query: 782 DARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTP 839
+ LH I+HRDLK N+L++++ +++++DFG +++ +++ + GT
Sbjct: 144 E-----YLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 196
Query: 840 EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---RRLEI 896
++++PE+L + + + D+++ G I+++L P+ N + FQ +
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-----FQKIIKLEYDF 251
Query: 897 PKELDPLVARIIWECWQTDPSLR 919
P++ P ++ + D + R
Sbjct: 252 PEKFFPKARDLVEKLLVLDATKR 274
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 71/298 (23%), Positives = 115/298 (38%), Gaps = 53/298 (17%)
Query: 680 LGERIGLGSYGEVYHA-----DWNGTEVAVKKFLDQDFSG--AALLEFKREVKIMRRLRH 732
L +G G G+VY A + VA+K + + S +RE + RL+
Sbjct: 38 LRRLVGRGGMGDVYEAEDTVRER---IVALK-LMSETLSSDPVFRTRMQREARTAGRLQE 93
Query: 733 PNVVLFMGAV----TRPPNLSIITEFLPRGSLFRILHR-----PHCQVDEKRRIKMALDA 783
P+VV + L + + L +L R P V R+I ALDA
Sbjct: 94 PHVV----PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDA 149
Query: 784 ---RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA-GTP 839
G HRD+K N+LV + + DFG++ + L+ GT
Sbjct: 150 AHAAG----------ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTL 199
Query: 840 EWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ------NRR 893
+MAPE + + D+Y+ +L+E T P+ G + + V+GA Q R
Sbjct: 200 YYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG-DQLSVMGAHINQAIPRPSTVR 258
Query: 894 LEIPKELDPLVARIIWECWQTDPSLR-PSFAQLTVALKPLQRLVIPSHPDQPSSALPQ 950
IP D ++AR +P R + L+ A + + D+ + L +
Sbjct: 259 PGIPVAFDAVIAR----GMAKNPEDRYVTCGDLSAA---AHAALATADQDRATDILRR 309
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 9e-29
Identities = 60/283 (21%), Positives = 104/283 (36%), Gaps = 36/283 (12%)
Query: 680 LGERIGLGSYGEVYHA-DW--NGTEVAVKKFL---DQDFSGAALLEFKREVKIMRRLRHP 733
+ I G G +Y A D NG V +K + D + E + + + HP
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAM----AMAERQFLAEVVHP 139
Query: 734 NVVL-----FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMN 787
++V P I+ E++ SL R + + I L+ ++
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALS 196
Query: 788 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL 847
LH+ +V+ DLK N+++ + +K+ D G S GTP + APE++
Sbjct: 197 YLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGAVS----RINSFGYLYGTPGFQAPEIV 249
Query: 848 RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 907
R P+ D+Y+ G L L G + V + + L+ L+ R
Sbjct: 250 RTGPT-VATDIYTVGRTLAALTLDLPTRNG----RYVDGLPEDDPVLKTYDSYGRLLRR- 303
Query: 908 IWECWQTDPSLRP-SFAQLTVALKPLQRLVIPSHPDQPSSALP 949
DP R + +++ L + R V+ P L
Sbjct: 304 ---AIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGLS 343
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 52/201 (25%), Positives = 80/201 (39%), Gaps = 47/201 (23%)
Query: 679 VLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNV 735
V + +GLG G+V + A+K D + +REV++ R + P++
Sbjct: 21 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELHWRASQCPHI 73
Query: 736 VLFMGA----VTRPPNLSIITEFLPRGSLF-RILHRPHCQVDEK---RRIKMALDARGMN 787
V + L I+ E L G LF RI R E+ +K +A +
Sbjct: 74 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA--IQ 131
Query: 788 CLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 844
LH+ I HRD+K NLL N +K++DFG A
Sbjct: 132 YLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF---------------------AK 168
Query: 845 EVLRNEPSNEKCDVYSFGVIL 865
E E ++ CD++S GVI+
Sbjct: 169 ETTG-EKYDKSCDMWSLGVIM 188
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-26
Identities = 51/240 (21%), Positives = 107/240 (44%), Gaps = 32/240 (13%)
Query: 684 IGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLE------FKREVKIMRRLRHPNV 735
IG G++GEV + A+K + +L+ F+ E ++ +
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKIL-----NKWEMLKRAETACFREERDVLVNGDSKWI 136
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR------RIKMALDARGMNCL 789
A NL ++ ++ G L +L + ++ E+ + +A+D +
Sbjct: 137 TTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAID-----SV 191
Query: 790 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLR 848
H VHRD+K N+L+D N +++++DFG +L + + S GTP++++PE+L+
Sbjct: 192 HQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 849 NEPSNEK-----CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 903
+ CD +S GV ++E+ + P+ + ++ G + R + P ++ +
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV 309
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 61/299 (20%), Positives = 126/299 (42%), Gaps = 48/299 (16%)
Query: 648 SPSSSVDSSTSKVDQIFDDDVCECEIPW----------EDLVLGERIGLGSYGEVYHADW 697
+ ++ S V + + W + + +G GS+G V
Sbjct: 3 AAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKH 62
Query: 698 NGTE--VAVKKFLDQDFSGAALLEFKR------EVKIMRRLRHPNVVLFMGAVTRPPNLS 749
+ A+K +++ K+ E +I++ + P +V + NL
Sbjct: 63 KESGNHYAMKIL-----DKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117
Query: 750 IITEFLPRGSLFRILHRPHCQVDEKRR-----IKMALDARGMNCLHTSTPTIVHRDLKSP 804
++ E++ G +F L R + R I + + LH+ +++RDLK
Sbjct: 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE-----YLHSLD--LIYRDLKPE 170
Query: 805 NLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGV 863
NLL+D+ ++V+DFG + R+K T+ + GTPE +APE++ ++ N+ D ++ GV
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTW----TLCGTPEALAPEIILSKGYNKAVDWWALGV 226
Query: 864 ILWELATLKLPWIGMNPMQVVGAVGFQN---RRLEIPKELDPLVARIIWECWQTDPSLR 919
+++E+A P+ P+Q+ ++ ++ P + ++ Q D + R
Sbjct: 227 LIYEMAAGYPPFFADQPIQI-----YEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKR 280
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 29/206 (14%)
Query: 682 ERIGLGSYGEVYHAD--WNGTEVAVKKF-LDQDFSGA---ALLEFKREVKIMRRLRHPNV 735
+IG GSYG V+ G VA+KKF +D AL RE++++++L+HPN+
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL----REIRMLKQLKHPNL 64
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDARGMNCLHTS 792
V + R L ++ E+ ++ L R V E K L + +N H
Sbjct: 65 VNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTL--QAVNFCHKH 121
Query: 793 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEVL 847
+HRD+K N+L+ K+ +K+ DFG +RL L+ S E W +PE+L
Sbjct: 122 N--CIHRDVKPENILITKHSVIKLCDFGFARL-----LTGPSDYYDDEVATRWYRSPELL 174
Query: 848 RNEPS-NEKCDVYSFGVILWELATLK 872
+ DV++ G + EL +
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 29/208 (13%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSGA---ALLEFKREVKIMRRLRHPNV 735
E+IG G+YG V+ A VA+K+ LD D G AL RE+ +++ L+H N+
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL----REICLLKELKHKNI 63
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDARGMNCLHTS 792
V + L+++ EF + L + + +D K + L +G+ H+
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL--KGLGFCHSR 120
Query: 793 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEVL 847
++HRDLK NLL+++N +K+++FGL+R + E W P+VL
Sbjct: 121 N--VLHRDLKPQNLLINRNGELKLANFGLARAF-----GIPVRCYSAEVVTLWYRPPDVL 173
Query: 848 RNEPS-NEKCDVYSFGVILWELATLKLP 874
+ D++S G I ELA P
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 28/205 (13%)
Query: 682 ERIGLGSYGEVYHA-DWNGTEVAVKKF-LDQDFSGA---ALLEFKREVKIMRRLRHPNVV 736
E++G G+YG VY A D G VA+K+ LD + G A+ RE+ +++ L HPN+V
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAI----REISLLKELHHPNIV 82
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDARGMNCLHTST 793
+ + L+++ EF+ + L ++L + + K + L RG+ H
Sbjct: 83 SLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL--RGVAHCHQHR 139
Query: 794 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEVLR 848
I+HRDLK NLL++ + +K++DFGL+R + T E W AP+VL
Sbjct: 140 --ILHRDLKPQNLLINSDGALKLADFGLARAF-----GIPVRSYTHEVVTLWYRAPDVLM 192
Query: 849 NEPS-NEKCDVYSFGVILWELATLK 872
+ D++S G I E+ T K
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-25
Identities = 50/242 (20%), Positives = 101/242 (41%), Gaps = 34/242 (14%)
Query: 684 IGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLE------FKREVKIMRRLRHPNV 735
IG G++ EV T A+K + +L+ F+ E ++ +
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIM-----NKWDMLKRGEVSCFREERDVLVNGDRRWI 123
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR------RIKMALDARGMNCL 789
A L ++ E+ G L +L + ++ + I MA+D +
Sbjct: 124 TQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAID-----SV 178
Query: 790 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLR 848
H VHRD+K N+L+D+ +++++DFG +L+ + + S GTP++++PE+L+
Sbjct: 179 HRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236
Query: 849 NEPSNEK-------CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 901
CD ++ GV +E+ + P+ + + G + L +P +
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDE 296
Query: 902 PL 903
+
Sbjct: 297 GV 298
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 28/205 (13%)
Query: 682 ERIGLGSYGEVYHA-DWNGTEVAVKKF-LDQDFSGA---ALLEFKREVKIMRRLRHPNVV 736
E+IG G+YG VY A + G A+KK L+++ G + RE+ I++ L+H N+V
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTI----REISILKELKHSNIV 63
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDARGMNCLHTST 793
+ L ++ E L + L ++L ++ K + L G+ H
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL--NGIAYCHDRR 120
Query: 794 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEVLR 848
++HRDLK NLL+++ +K++DFGL+R T E W AP+VL
Sbjct: 121 --VLHRDLKPQNLLINREGELKIADFGLARAF-----GIPVRKYTHEIVTLWYRAPDVLM 173
Query: 849 NEPS-NEKCDVYSFGVILWELATLK 872
+ D++S G I E+
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-25
Identities = 59/232 (25%), Positives = 103/232 (44%), Gaps = 23/232 (9%)
Query: 684 IGLGSYGEVYHADWNGTE--VAVKKFLDQDFSGAALLE-FKREVKIMRRLRHPNVVLFMG 740
IG G++GEV T A+K + + F E IM P VV
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR------RIKMALDARGMNCLHTSTP 794
A L ++ E++P G L ++ V EK + +ALD +H+
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALD-----AIHSMG- 188
Query: 795 TIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN 853
+HRD+K N+L+DK+ ++K++DFG ++ + + GTP++++PEVL+++ +
Sbjct: 189 -FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 247
Query: 854 EK----CDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 901
CD +S GV L+E+ P+ + + + L P + D
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 299
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-25
Identities = 71/315 (22%), Positives = 118/315 (37%), Gaps = 69/315 (21%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSGA---ALLEFKREVKIMRRLRHPNV 735
+G GSYG V G VA+KKF D A+ RE+K++++LRH N+
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAM----REIKLLKQLRHENL 86
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDARGMNCLHTS 792
V + + ++ EF+ ++ L +D ++ + + G+ H+
Sbjct: 87 VNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQII--NGIGFCHSH 143
Query: 793 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEVL 847
I+HRD+K N+LV ++ VK+ DFG +R L++ E W APE+L
Sbjct: 144 N--IIHRDIKPENILVSQSGVVKLCDFGFART-----LAAPGEVYDDEVATRWYRAPELL 196
Query: 848 RNEPS-NEKCDVYSFGVILWELATLK--LP----------------------WIGMNPMQ 882
+ + DV++ G ++ E+ + P N
Sbjct: 197 VGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256
Query: 883 VVGAVGF------QNRRLEIPKELDPLVARIIWECWQTDPSLRPS---------FAQLTV 927
V V + PK L +V + +C DP RP F
Sbjct: 257 VFAGVRLPEIKEREPLERRYPK-LSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGF 315
Query: 928 ALKPLQRLVIPSHPD 942
A + Q L + D
Sbjct: 316 AERFSQELQLKVQKD 330
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 61/264 (23%), Positives = 119/264 (45%), Gaps = 44/264 (16%)
Query: 676 EDLVLGERIGLGSYGEVYHADWNGTE--VAVK---KFLDQDFSGAALLEFKR------EV 724
+D + +G GS+G V+ A+K K ++ K+ E
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKK--------EIVVRLKQVEHTNDER 57
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRR-----IKM 779
++ + HP ++ G + +I +++ G LF +L + + + + +
Sbjct: 58 LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL 117
Query: 780 ALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGT 838
AL+ LH+ I++RDLK N+L+DKN ++K++DFG + + T+ + GT
Sbjct: 118 ALE-----YLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY----TLCGT 166
Query: 839 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---RRLE 895
P+++APEV+ +P N+ D +SFG++++E+ P+ N M+ ++ L
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-----YEKILNAELR 221
Query: 896 IPKELDPLVARIIWECWQTDPSLR 919
P + V ++ D S R
Sbjct: 222 FPPFFNEDVKDLLSRLITRDLSQR 245
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 54/205 (26%), Positives = 100/205 (48%), Gaps = 28/205 (13%)
Query: 682 ERIGLGSYGEVYHADWNGTE--VAVKKF-LDQD--FSGAALLEFKREVKIMRRLRHPNVV 736
+++G G+Y VY T+ VA+K+ L+ + A+ REV +++ L+H N+V
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI----REVSLLKDLKHANIV 63
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDARGMNCLHTST 793
+ +L+++ E+L + L + L ++ K + L RG+ H
Sbjct: 64 TLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL--RGLAYCHR-- 118
Query: 794 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEVLR 848
++HRDLK NLL+++ +K++DFGL+R K S + E W P++L
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLARAK-----SIPTKTYDNEVVTLWYRPPDILL 173
Query: 849 NEPS-NEKCDVYSFGVILWELATLK 872
+ + D++ G I +E+AT +
Sbjct: 174 GSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 31/209 (14%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQD--FSGAALLEFKREVKIMRRLRHPNVV 736
E++G G+Y VY G VA+K+ LD + A+ RE+ +M+ L+H N+V
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI----REISLMKELKHENIV 66
Query: 737 LFMGAVTRPPNLSIITEFLP-------RGSLFRILHRPHCQVDEKRRIKMALDARGMNCL 789
+ L+++ EF+ R K L +G+
Sbjct: 67 RLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL--QGLAFC 124
Query: 790 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-AP 844
H + I+HRDLK NLL++K +K+ DFGL+R + E W AP
Sbjct: 125 HENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAF-----GIPVNTFSSEVVTLWYRAP 177
Query: 845 EVLRNEPS-NEKCDVYSFGVILWELATLK 872
+VL + + D++S G IL E+ T K
Sbjct: 178 DVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 32/209 (15%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKK----FLDQDFSGA---ALLEFKREVKIMRRLRH 732
+ +G G + VY A VA+KK + G AL RE+K+++ L H
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL----REIKLLQELSH 71
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDARGMNCL 789
PN++ + A N+S++ +F+ L I+ + K + M L +G+ L
Sbjct: 72 PNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTL--QGLEYL 128
Query: 790 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-AP 844
H I+HRDLK NLL+D+N +K++DFGL++ S + A T + W AP
Sbjct: 129 HQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSF-----GSPNRAYTHQVVTRWYRAP 181
Query: 845 EVLRNEPS-NEKCDVYSFGVILWELATLK 872
E+L D+++ G IL EL
Sbjct: 182 ELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-23
Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 33/214 (15%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSGA---ALLEFKREVKIMRRLRHPNV 735
+IG G++GEV+ A G +VA+KK ++ + G AL RE+KI++ L+H NV
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL----REIKILQLLKHENV 78
Query: 736 VLFMGAVT--------RPPNLSIITEFLPRGSLFRILHRPHCQVDE---KRRIKMALDAR 784
V + ++ ++ +F L +L + KR ++M L
Sbjct: 79 VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLL--N 135
Query: 785 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE---- 840
G+ +H + I+HRD+K+ N+L+ ++ +K++DFGL+R + +S+ T
Sbjct: 136 GLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARA-FSLAKNSQPNRYTNRVVTL 192
Query: 841 WM-APEVLRNEPS-NEKCDVYSFGVILWELATLK 872
W PE+L E D++ G I+ E+ T
Sbjct: 193 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-22
Identities = 60/245 (24%), Positives = 111/245 (45%), Gaps = 18/245 (7%)
Query: 684 IGLGSYGEVYHADWNGTE------VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+G G++G+V T + K+ + A E ++++ RHP +
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT---LTENRVLQNSRHPFLTA 212
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIV 797
+ L + E+ G LF L R +++ R A ++ LH S +V
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH-SEKNVV 271
Query: 798 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCD 857
+RDLK NL++DK+ ++K++DFGL + + K+ GTPE++APEVL + D
Sbjct: 272 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 331
Query: 858 VYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELDPLVARIIWECWQT 914
+ GV+++E+ +LP+ + ++ F+ + P+ L P ++ +
Sbjct: 332 WWGLGVVMYEMMCGRLPFYNQDHEKL-----FELILMEEIRFPRTLGPEAKSLLSGLLKK 386
Query: 915 DPSLR 919
DP R
Sbjct: 387 DPKQR 391
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-22
Identities = 45/211 (21%), Positives = 85/211 (40%), Gaps = 27/211 (12%)
Query: 682 ERIGLGSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFK---------REVKIMRRLR 731
I GSYG V D G VA+K+ + G + RE++++
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 732 HPNVVLFMGAVTRPPNLS------IITEFLPRGSLFRILHRPHCQVDEKRR---IKMALD 782
HPN++ + ++TE + L +++H + + + L
Sbjct: 88 HPNILGLR-DIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHIL- 144
Query: 783 ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM 842
G++ LH + +VHRDL N+L+ N ++ + DF L+R + +
Sbjct: 145 -LGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT-HRWYR 200
Query: 843 APEVLRNEPS-NEKCDVYSFGVILWELATLK 872
APE++ + D++S G ++ E+ K
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-22
Identities = 59/255 (23%), Positives = 117/255 (45%), Gaps = 34/255 (13%)
Query: 684 IGLGSYGEVYHADWNGTEV--AVK-----KFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
IG GS+G+V N T+ A+K K ++++ + +E++IM+ L HP +V
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERN----EVRNVFKELQIMQGLEHPFLV 78
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRR-----IKMALDARGMNCLHT 791
+ ++ ++ + L G L L + +E + + MALD L
Sbjct: 79 NLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALD-----YLQN 133
Query: 792 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEVLRNE 850
I+HRD+K N+L+D++ +V ++DF ++ L T +++ + GT +MAPE+ +
Sbjct: 134 QR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--GTKPYMAPEMFSSR 189
Query: 851 PS---NEKCDVYSFGVILWELATLKLPWIGM---NPMQVVGAVGFQNRRLEIPKELDPLV 904
+ D +S GV +EL + P+ + ++V F+ + P +
Sbjct: 190 KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT--FETTVVTYPSAWSQEM 247
Query: 905 ARIIWECWQTDPSLR 919
++ + + +P R
Sbjct: 248 VSLLKKLLEPNPDQR 262
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-22
Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 45/215 (20%)
Query: 682 ERIGLGSYGEVYHADWNGT-EVAVKK-FLDQDFSGAALLEFKREVKIMRRLRHPNVVLFM 739
+ IG GS+G V+ A + EVA+KK D+ F RE++IMR ++HPNVV
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN-------RELQIMRIVKHPNVVDLK 98
Query: 740 GAVTRPPN------LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD---------AR 784
+ L+++ E++P +++R K + M + R
Sbjct: 99 AFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHY-----AKLKQTMPMLLIKLYMYQLLR 152
Query: 785 GMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHNTFLSSKSTAGTPE--- 840
+ +H+ I HRD+K NLL+D +K+ DFG ++ +
Sbjct: 153 SLAYIHSI--GICHRDIKPQNLLLDPPSGVLKLIDFGSAK------ILIAGEPNVSYICS 204
Query: 841 -WM-APEVLRNEPS-NEKCDVYSFGVILWELATLK 872
+ APE++ + D++S G ++ EL +
Sbjct: 205 RYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 3e-22
Identities = 60/249 (24%), Positives = 98/249 (39%), Gaps = 22/249 (8%)
Query: 684 IGLGSYGEVYHADWNGTEV--AVKKF-----LDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+G G +GEV T A KK + AL E K+ I+ ++ VV
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE-KQ---ILEKVNSRFVV 247
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV-DEKR-RIKMALDARGMNCLHTSTP 794
A L ++ + G L ++ E R A G+ LH
Sbjct: 248 SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER- 306
Query: 795 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST-AGTPEWMAPEVLRNEPSN 853
IV+RDLK N+L+D + ++++SD GL+ H + GT +MAPEV++NE
Sbjct: 307 -IVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNERYT 363
Query: 854 EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELDPLVARIIWE 910
D ++ G +L+E+ + P+ V + E + P + +
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV-ERLVKEVPEEYSERFSPQARSLCSQ 422
Query: 911 CWQTDPSLR 919
DP+ R
Sbjct: 423 LLCKDPAER 431
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 4e-22
Identities = 52/210 (24%), Positives = 87/210 (41%), Gaps = 33/210 (15%)
Query: 682 ERIGLGSYGEVYHAD--WNGTEVAVKKF-LDQDFSGA---ALLEFKREVKIMRRLRHPNV 735
++G G+YGEVY A VA+K+ L+ + G A+ REV +++ L+H N+
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI----REVSLLKELQHRNI 95
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRIL--HRPHCQVDEKRRIKMALDARGMNCLHTST 793
+ + L +I E+ L + + + K + + G+N H +
Sbjct: 96 IELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLI--NGVNFCH--S 150
Query: 794 PTIVHRDLKSPNLLVDKNW-----NVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-A 843
+HRDLK NLL+ + +K+ DFGL+R T E W
Sbjct: 151 RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-----GIPIRQFTHEIITLWYRP 205
Query: 844 PEVLRNEPS-NEKCDVYSFGVILWELATLK 872
PE+L + D++S I E+
Sbjct: 206 PEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 4e-22
Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 30/207 (14%)
Query: 682 ERIGLGSYGEVYHAD--WNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNV 735
+ IG G+ G V A VA+KK F +Q + A RE+ +M+ + H N+
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY----RELVLMKCVNHKNI 86
Query: 736 VLFMGAVTRPPNLS------IITEFLPRGSLFRILHRP----HCQVDEKRRIKMALDARG 785
+ + T +L I+ E + +L +++ + L G
Sbjct: 87 IGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSY----LLYQML--CG 139
Query: 786 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPE 845
+ LH++ I+HRDLK N++V + +K+ DFGL+R +F+ + T + APE
Sbjct: 140 IKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPE 196
Query: 846 VLRNEPSNEKCDVYSFGVILWELATLK 872
V+ E D++S G I+ E+
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 7e-22
Identities = 65/214 (30%), Positives = 94/214 (43%), Gaps = 41/214 (19%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKK---FLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+G G+YG V A G VA+KK F F+ L RE+KI++ +H N++
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKILKHFKHENII 72
Query: 737 LFMGAVTRPPNLS------IITEFLPRGSLFRILHRP-----HCQVDEKRRIKMALDARG 785
+ RP + II E + L R++ H Q I L R
Sbjct: 73 TIF-NIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQY----FIYQTL--RA 124
Query: 786 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM--- 842
+ LH S ++HRDLK NLL++ N ++KV DFGL+R+ + + G M
Sbjct: 125 VKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 843 -------APEVLRNEPS-NEKCDVYSFGVILWEL 868
APEV+ + DV+S G IL EL
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 9e-22
Identities = 52/219 (23%), Positives = 93/219 (42%), Gaps = 34/219 (15%)
Query: 679 VLGERIGLGSYGEVYHA----DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 734
G ++G G+YG VY A + + A+K+ S +A RE+ ++R L+HPN
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC----REIALLRELKHPN 79
Query: 735 VVLFMGAVTRPPNLSI--ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDA--------- 783
V+ + + + ++ L+ I+ K+ +++
Sbjct: 80 VISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 784 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWN----VKVSDFGLSRLKHNTFLSSKSTAGTP 839
G++ LH + ++HRDLK N+LV VK++D G +RL ++ P
Sbjct: 139 DGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP--LKPLADLDP 194
Query: 840 E----WM-APEVLRNEPS-NEKCDVYSFGVILWELATLK 872
W APE+L + D+++ G I EL T +
Sbjct: 195 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 1e-21
Identities = 61/250 (24%), Positives = 102/250 (40%), Gaps = 21/250 (8%)
Query: 684 IGLGSYGEVYHADWNGTEV--AVKKF-----LDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+G G +GEV+ T A KK + A++E K+ I+ ++ +V
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVE-KK---ILAKVHSRFIV 248
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV---DEKR-RIKMALDARGMNCLHTS 792
A +L ++ + G + ++ E R A G+ LH
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 793 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 852
I++RDLK N+L+D + NV++SD GL+ +K AGTP +MAPE+L E
Sbjct: 309 N--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 853 NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELDPLVARIIW 909
+ D ++ GV L+E+ + P+ + Q + + P + P
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL-KQRVLEQAVTYPDKFSPASKDFCE 425
Query: 910 ECWQTDPSLR 919
Q DP R
Sbjct: 426 ALLQKDPEKR 435
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 2e-21
Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 41/216 (18%)
Query: 682 ERIGLGSYGEVYHA-DWNGTE--VAVKKF-LDQDFSGA---ALLEFKREVKIMRRLR--- 731
IG G+YG+V+ A D VA+K+ + G + REV ++R L
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI----REVAVLRHLETFE 72
Query: 732 HPNVV-----LFMGAVTRPPNLSIITEFLPR--GSLFRILHRPHCQVDE-KRRIKMALDA 783
HPNVV + R L+++ E + + + + P + K + L
Sbjct: 73 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL-- 130
Query: 784 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN--TFLSSKSTAGTPE- 840
RG++ LH+ +VHRDLK N+LV + +K++DFGL+R+ T
Sbjct: 131 RGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--------TSVV 180
Query: 841 ---WM-APEVLRNEPSNEKCDVYSFGVILWELATLK 872
W APEVL D++S G I E+ K
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-21
Identities = 53/220 (24%), Positives = 88/220 (40%), Gaps = 48/220 (21%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKK-FLDQDFSGAALLEFKREVKIMRRLR---HPNV 735
G G++G V G VA+KK D F RE++IM+ L HPN+
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-------NRELQIMQDLAVLHHPNI 81
Query: 736 V----LFMGAVTRPPN---LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD------ 782
V F R L+++ E++P +L R + +R++
Sbjct: 82 VQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYY-----RRQVAPPPILIKVFL 135
Query: 783 ---ARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRLKHNTFLSSKSTAGT 838
R + CLH + + HRD+K N+LV++ + +K+ DFG ++ S S
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK------KLSPSEPNV 189
Query: 839 PEWM-----APEVLRNEPS-NEKCDVYSFGVILWELATLK 872
APE++ D++S G I E+ +
Sbjct: 190 AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 2e-21
Identities = 67/249 (26%), Positives = 117/249 (46%), Gaps = 25/249 (10%)
Query: 684 IGLGSYGEVY---HADWNGTE------VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 734
+G GS+G+V+ + V K L + K E I+ + HP
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR----DRVRTKMERDILVEVNHPF 87
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDARGMNCLHTST 793
+V A L +I +FL G LF L + E+ + +A A ++ LH+
Sbjct: 88 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM-FTEEDVKFYLAELALALDHLHSLG 146
Query: 794 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSN 853
I++RDLK N+L+D+ ++K++DFGLS+ + + S GT E+MAPEV+
Sbjct: 147 --IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 204
Query: 854 EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELDPLVARIIWE 910
+ D +SFGV+++E+ T LP+ G + + +L +P+ L P ++
Sbjct: 205 QSADWWSFGVLMFEMLTGTLPFQGKDRKET-----MTMILKAKLGMPQFLSPEAQSLLRM 259
Query: 911 CWQTDPSLR 919
++ +P+ R
Sbjct: 260 LFKRNPANR 268
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-21
Identities = 62/252 (24%), Positives = 109/252 (43%), Gaps = 33/252 (13%)
Query: 684 IGLGSYGEVYHADWNGTE------VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+G G++G+V T + K+ + A E ++++ RHP +
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT---VTESRVLQNTRHPFLTA 69
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDARGMNCLHTSTPTI 796
A L + E+ G LF L R E+R R A + LH+ +
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLHSRD--V 126
Query: 797 VHRDLKSPNLLVDKNWNVKVSDFGLSRL------KHNTFLSSKSTAGTPEWMAPEVLRNE 850
V+RD+K NL++DK+ ++K++DFGL + TF GTPE++APEVL +
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF------CGTPEYLAPEVLEDN 180
Query: 851 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELDPLVARI 907
D + GV+++E+ +LP+ + ++ F+ + P+ L P +
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-----FELILMEEIRFPRTLSPEAKSL 235
Query: 908 IWECWQTDPSLR 919
+ + DP R
Sbjct: 236 LAGLLKKDPKQR 247
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 6e-21
Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNV 735
+ IG G+ G V A VA+KK F +Q + A RE+ +M+ + H N+
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY----RELVLMKCVNHKNI 123
Query: 736 VLFMGAVTRPPNLS------IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCL 789
+ + T L ++ E + +L +++ E+ + G+ L
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQME--LDHERMSYLLYQMLCGIKHL 180
Query: 790 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 849
H++ I+HRDLK N++V + +K+ DFGL+R +F+ + T + APEV+
Sbjct: 181 HSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILG 237
Query: 850 EPSNEKCDVYSFGVILWELATLK 872
E D++S G I+ E+ K
Sbjct: 238 MGYKENVDIWSVGCIMGEMVRHK 260
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 7e-21
Identities = 65/214 (30%), Positives = 93/214 (43%), Gaps = 35/214 (16%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSGAALLEFK--REVKIMRRLR---HP 733
IG+G+YG VY A +G VA+K + G L REV ++RRL HP
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 734 NVV-----LFMGAVTRPPNLSIITEFLPR--GSLFRILHRPHCQVDE-KRRIKMALDARG 785
NVV R ++++ E + + + P + K ++ L RG
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL--RG 132
Query: 786 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH--NTFLSSKSTAGTPE--- 840
++ LH + IVHRDLK N+LV VK++DFGL+R+ TP
Sbjct: 133 LDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--------TPVVVT 182
Query: 841 -WM-APEVLRNEPSNEKCDVYSFGVILWELATLK 872
W APEVL D++S G I E+ K
Sbjct: 183 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 9e-21
Identities = 54/214 (25%), Positives = 94/214 (43%), Gaps = 42/214 (19%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKK-FLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
+ IG GS+G VY A +G VA+KK D+ F RE++IMR+L H N+V
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRL 112
Query: 739 MGAVTRPPN------LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD---------A 783
L+++ +++P +++R+ + + + +
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHY-----SRAKQTLPVIYVKLYMYQLF 166
Query: 784 RGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSR-LKHNTFLSSK-STAGTPE 840
R + +H+ I HRD+K NLL+D + +K+ DFG ++ L S +
Sbjct: 167 RSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS----R 220
Query: 841 WM-APEVLRNEPS-NEKCDVYSFGVILWELATLK 872
+ APE++ DV+S G +L EL +
Sbjct: 221 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 44/294 (14%), Positives = 85/294 (28%), Gaps = 65/294 (22%)
Query: 680 LGERIGLGSYGEVYHA-DWN-GTEVAVKKFLDQDFSGAA--LLEFKREVKIMRRLRHPNV 735
L G + + A D +VA+ F+D L E + R+ P V
Sbjct: 35 LLIFHGGVPPLQFWQALDTALDRQVALT-FVDPQGVLPDDVLQETLSRTLRLSRIDKPGV 93
Query: 736 VLFMGAVTRPPNLSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMALDA---RGMNCL 789
+ V ++ E++ GSL + P + + + A DA G
Sbjct: 94 ARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAG---- 149
Query: 790 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 849
+ + V + +V ++
Sbjct: 150 ------VALSIDHPSRVRVSIDGDVVLAYPATMP-------------------------- 177
Query: 850 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---------NRRLEIPKEL 900
+N + D+ G L+ L + P + + +IP ++
Sbjct: 178 -DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI 236
Query: 901 DPLVARIIWECWQTDPSLRPSFAQLTVALK----PLQRLVIPSHPDQPSSALPQ 950
+ AR Q D +R + L + + + V+ + P SA P+
Sbjct: 237 SAVAAR----SVQGDGGIRSASTLLNLMQQATAVADRTEVLGPIDEAPVSAAPR 286
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 43/213 (20%)
Query: 682 ERIGLGSYGEVYHAD--WNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNV 735
+G G+YG V A +G +VA+KK F + F+ A RE+ +++ ++H NV
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY----RELLLLKHMQHENV 85
Query: 736 VLFMGAVTRPPNLS------IITEFLPRGSLFRILHRP----HCQVDEKRRIKMALDARG 785
+ + T +L ++ F+ L +I+ Q + L +G
Sbjct: 86 IGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQY----LVYQML--KG 138
Query: 786 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM--- 842
+ +H++ +VHRDLK NL V+++ +K+ DFGL+R T +
Sbjct: 139 LKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLAR--------HADAEMTGYVVTRW 188
Query: 843 --APEVLRNEPS-NEKCDVYSFGVILWELATLK 872
APEV+ + N+ D++S G I+ E+ T K
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 2e-20
Identities = 61/258 (23%), Positives = 108/258 (41%), Gaps = 41/258 (15%)
Query: 684 IGLGSYGEVY---HADWNGTEV--AVKKFLDQDFSGAALLEFKREV-------KIMRRLR 731
+G G YG+V+ T A+K A ++ ++ I+ ++
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVL-----KKAMIVRNAKDTAHTKAERNILEEVK 79
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDARGMNCLH 790
HP +V + A L +I E+L G LF L R E +A + + LH
Sbjct: 80 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLH 138
Query: 791 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL------KHNTFLSSKSTAGTPEWMAP 844
I++RDLK N++++ +VK++DFGL + +TF GT E+MAP
Sbjct: 139 QKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC------GTIEYMAP 190
Query: 845 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELD 901
E+L N D +S G +++++ T P+ G N + +L +P L
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT-----IDKILKCKLNLPPYLT 245
Query: 902 PLVARIIWECWQTDPSLR 919
++ + + + + R
Sbjct: 246 QEARDLLKKLLKRNAASR 263
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 2e-20
Identities = 62/248 (25%), Positives = 104/248 (41%), Gaps = 20/248 (8%)
Query: 684 IGLGSYGEVYHADWNGTEV--AVKKF-----LDQDFSGAALLEFKREVKIMRRLRHPNVV 736
IG G +GEVY T A+K + AL E + + ++ P +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVSTGDCPFIV 255
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDARGMNCLHTSTPT 795
A P LS I + + G L L + H E R A G+ +H
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRF-- 312
Query: 796 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL-RNEPSNE 854
+V+RDLK N+L+D++ +V++SD GL+ + ++ GT +MAPEVL + +
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGTHGYMAPEVLQKGVAYDS 370
Query: 855 KCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGFQNRRLEIPKELDPLVARIIWEC 911
D +S G +L++L P+ ++ +E+P P + ++
Sbjct: 371 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSFSPELRSLLEGL 428
Query: 912 WQTDPSLR 919
Q D + R
Sbjct: 429 LQRDVNRR 436
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 7e-20
Identities = 70/249 (28%), Positives = 116/249 (46%), Gaps = 26/249 (10%)
Query: 684 IGLGSYGEVYHADWNGTEV--AVK-----KFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
IG GS+G+V A EV AVK L + + E R V +++ ++HP +V
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSE--RNV-LLKNVKHPFLV 102
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDARGMNCLHTSTPT 795
+ L + +++ G LF L R C E R R A A + LH+
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHLQRERC-FLEPRARFYAAEIASALGYLHSLN-- 159
Query: 796 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAPEVLRNEPSN 853
IV+RDLK N+L+D ++ ++DFGL K N +S ++ GTPE++APEVL +P +
Sbjct: 160 IVYRDLKPENILLDSQGHIVLTDFGLC--KENIEHNSTTSTFCGTPEYLAPEVLHKQPYD 217
Query: 854 EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---RRLEIPKELDPLVARIIWE 910
D + G +L+E+ P+ N ++ + N + L++ + ++
Sbjct: 218 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEM-----YDNILNKPLQLKPNITNSARHLLEG 272
Query: 911 CWQTDPSLR 919
Q D + R
Sbjct: 273 LLQKDRTKR 281
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 1e-19
Identities = 67/254 (26%), Positives = 114/254 (44%), Gaps = 36/254 (14%)
Query: 684 IGLGSYGEVYHADWNGTEV-----AVKKFLDQDFSGAALLEFKREVKIM--RR-----LR 731
+G GS+G+V+ A++ T A+KK +L M +R
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKK--------DVVLMDDDVECTMVEKRVLSLAWE 76
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDARGMNCLH 790
HP + NL + E+L G L + H D R A G+ LH
Sbjct: 77 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH 135
Query: 791 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAPEVLR 848
+ IV+RDLK N+L+DK+ ++K++DFG+ K N +K+ GTP+++APE+L
Sbjct: 136 SKG--IVYRDLKLDNILLDKDGHIKIADFGMC--KENMLGDAKTNTFCGTPDYIAPEILL 191
Query: 849 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELDPLVA 905
+ N D +SFGV+L+E+ + P+ G + ++ F P+ L+
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-----FHSIRMDNPFYPRWLEKEAK 246
Query: 906 RIIWECWQTDPSLR 919
++ + + +P R
Sbjct: 247 DLLVKLFVREPEKR 260
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 1e-19
Identities = 58/228 (25%), Positives = 88/228 (38%), Gaps = 55/228 (24%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNV 735
IG GSYG VY A VA+KK F D L RE+ I+ RL+ +
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL----REITILNRLKSDYI 87
Query: 736 VLFMGAVTRPPNLS------IITEFLPRGSLFRILHRP------HCQVDEKRRIKMALDA 783
+ + P +L I+ E L ++ P H + + L
Sbjct: 88 IRLY-DLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKT----ILYNLL-- 139
Query: 784 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR------------LKHNTFLS 831
G N +H S I+HRDLK N L++++ +VKV DFGL+R
Sbjct: 140 LGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 832 SKSTAGTPEWM----------APEVLRNEPS-NEKCDVYSFGVILWEL 868
+ + APE++ + + + D++S G I EL
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-19
Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 34/209 (16%)
Query: 682 ERIGLGSYGEVYHAD--WNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNV 735
+ +G G+YG V A G +VA+KK F + F+ A RE+++++ +RH NV
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY----RELRLLKHMRHENV 86
Query: 736 VLFMGAVTRPPNLS------IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCL 789
+ + T L ++ F+ L +++ D + + + +G+ +
Sbjct: 87 IGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQM-LKGLRYI 144
Query: 790 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-AP 844
H + I+HRDLK NL V+++ +K+ DFGL+R + T W AP
Sbjct: 145 HAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR--------QADSEMTGYVVTRWYRAP 194
Query: 845 EVLRNEPS-NEKCDVYSFGVILWELATLK 872
EV+ N + D++S G I+ E+ T K
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 47/216 (21%), Positives = 93/216 (43%), Gaps = 29/216 (13%)
Query: 673 IPWE---DLVLGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIM 727
+ W D L ++G G Y EV+ A N +V VK + KRE+KI+
Sbjct: 30 VEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK-----KIKREIKIL 84
Query: 728 RRLR-HPNVVLFMGAVTRPP---NLSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMA 780
LR PN++ + + P +++ E + ++ + +
Sbjct: 85 ENLRGGPNIITLA-DIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR----FYMYEI 139
Query: 781 LDARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSKSTAGTP 839
L + ++ H+ I+HRD+K N+++D ++ +++ D+GL+ H + A +
Sbjct: 140 L--KALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA-SR 194
Query: 840 EWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLP 874
+ PE+L + + D++S G +L + K P
Sbjct: 195 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 30/207 (14%)
Query: 682 ERIGLGSYGEVYHAD--WNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNV 735
+G G+YG V A G VAVKK F + RE+++++ ++H NV
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENV 90
Query: 736 VLFMGAVTRPPNLS------IITEFLPRGSLFRILHRPHCQVDEKRRIKMAL--DARGMN 787
+ + T +L ++T + L I+ CQ ++ + RG+
Sbjct: 91 IGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVK---CQKLTDDHVQFLIYQILRGLK 146
Query: 788 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEW-MAPEV 846
+H++ I+HRDLK NL V+++ +K+ DFGL+R + +T W APE+
Sbjct: 147 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVAT----RWYRAPEI 200
Query: 847 LRNEPS-NEKCDVYSFGVILWELATLK 872
+ N N+ D++S G I+ EL T +
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 5e-19
Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 38/211 (18%)
Query: 684 IGLGSYGEVYHA--DWNGTEVAVKK---FLDQDFSGAALLEFKREVKIMRRLRHPNVVLF 738
IG G+YG V A + N VA+KK F Q + L RE+KI+ R RH N++
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 90
Query: 739 MGAVTRPPNLS------IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTS 792
+ R P + I+ + + L+++L H D + RG+ +H++
Sbjct: 91 N-DIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQI-LRGLKYIHSA 147
Query: 793 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM---------- 842
++HRDLK NLL++ ++K+ DFGL+R + ++
Sbjct: 148 N--VLHRDLKPSNLLLNTTCDLKICDFGLAR-------VADPDHDHTGFLTEYVATRWYR 198
Query: 843 APEVLRNEPS-NEKCDVYSFGVILWELATLK 872
APE++ N + D++S G IL E+ + +
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 90.5 bits (224), Expect = 8e-19
Identities = 79/452 (17%), Positives = 162/452 (35%), Gaps = 32/452 (7%)
Query: 480 KTSLHKNPTESKVEEFQSHRINPVSGRPPIPMMRKNQHPYNEVPRKKEYSYMEGILPKIN 539
T + ++ + V R ++ + + ++ K + K
Sbjct: 153 GTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQK 212
Query: 540 REPNNNLSTSASTSSTSENFNPHSFKPSNDANISSKDSESRSALSGSGPSLASSTSQ--L 597
+ + + I D SR+ GS S + +
Sbjct: 213 TKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGV 272
Query: 598 NGPPLVEDLSSNSKDENPKNVEDHEIGYHDRRKCTHDRFMGTNLKLRDLESPSSSVDSST 657
+G + P E E R+K + + + + S +
Sbjct: 273 DGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNN 332
Query: 658 SKVDQIFDDDVCECEIPWEDL-VLGERIGLGSYGEVYHADWNGTE------VAVKKFLDQ 710
D++ D + L VLG+ GS+G+V ++ GT+ + K + Q
Sbjct: 333 GNRDRMKLTD-------FNFLMVLGK----GSFGKVMLSERKGTDELYAVKILKKDVVIQ 381
Query: 711 DFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ 770
D + KR + + + P + L + E++ G L + +
Sbjct: 382 DDDVECTMVEKRVLALPGK--PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRF 439
Query: 771 VDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 830
+ A A G+ L + I++RDLK N+++D ++K++DFG+ + +
Sbjct: 440 KEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 497
Query: 831 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ 890
++K+ GTP+++APE++ +P + D ++FGV+L+E+ + P+ G + ++ FQ
Sbjct: 498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-----FQ 552
Query: 891 ---NRRLEIPKELDPLVARIIWECWQTDPSLR 919
+ PK + I P R
Sbjct: 553 SIMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 584
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 1e-18
Identities = 59/233 (25%), Positives = 91/233 (39%), Gaps = 60/233 (25%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLRHPNV 735
IG GSYG V A VA+KK F D L RE+ I+ RL H +V
Sbjct: 59 HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL----REIAILNRLNHDHV 114
Query: 736 VLFMGAVTRPPNLS------IITEFLPRGSLFRILHRP------HCQVDEKRRIKMALDA 783
V + + P ++ ++ E ++ P H + + L
Sbjct: 115 VKVL-DIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT----LLYNLL-- 166
Query: 784 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-----------------LKH 826
G+ +H++ I+HRDLK N LV+++ +VKV DFGL+R
Sbjct: 167 VGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 827 NTFLSSKSTAGTPEWM----------APEVLRNEPS-NEKCDVYSFGVILWEL 868
++ T + APE++ + + E DV+S G I EL
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 49/220 (22%), Positives = 88/220 (40%), Gaps = 43/220 (19%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKK--FLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ +G G G V+ A + VA+KK D AL RE+KI+RRL H N+V
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL----REIKIIRRLDHDNIVK 72
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRI----------LHRP-HCQVDEKRRIKMAL--DAR 784
+ P + + L + L + ++ + R
Sbjct: 73 VF-EILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLR 131
Query: 785 GMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWM- 842
G+ +H++ ++HRDLK NL ++ ++ +K+ DFGL+R +
Sbjct: 132 GLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLAR-------IMDPHYSHKGHLS 182
Query: 843 ---------APEVLRNEPS-NEKCDVYSFGVILWELATLK 872
+P +L + + + D+++ G I E+ T K
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 3e-18
Identities = 62/249 (24%), Positives = 102/249 (40%), Gaps = 26/249 (10%)
Query: 684 IGLGSYGEVYHADWNGTE--VAVK-----KFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+G GS+G+V A T AVK L D + E + + + HP +
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTE--KRI-LSLARNHPFLT 87
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDARGMNCLHTSTPT 795
P L + EF+ G L + + DE R R A + LH
Sbjct: 88 QLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR-FDEARARFYAAEIISALMFLHDKG-- 144
Query: 796 IVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA--GTPEWMAPEVLRNEPSN 853
I++RDLK N+L+D + K++DFG+ K + GTP+++APE+L+
Sbjct: 145 IIYRDLKLDNVLLDHEGHCKLADFGMC--KEGICNGVTTATFCGTPDYIAPEILQEMLYG 202
Query: 854 EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELDPLVARIIWE 910
D ++ GV+L+E+ P+ N + F+ N + P L I+
Sbjct: 203 PAVDWWAMGVLLYEMLCGHAPFEAENEDDL-----FEAILNDEVVYPTWLHEDATGILKS 257
Query: 911 CWQTDPSLR 919
+P++R
Sbjct: 258 FMTKNPTMR 266
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 3e-18
Identities = 53/228 (23%), Positives = 97/228 (42%), Gaps = 51/228 (22%)
Query: 682 ERIGLGSYGEVYHA--DWNGTEVAVKK----FLDQDFSGAALLEFKREVKIMRRLR-HPN 734
+++G G+YG V+ + G VAVKK F + + RE+ I+ L H N
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF----REIMILTELSGHEN 70
Query: 735 VVLFMGAVTRPPNLS---IITEFLPRGSLFRILHRP-----HCQVDEKRRIKMALDARGM 786
+V + V R N ++ +++ L ++ H Q + + + +
Sbjct: 71 IVNLL-NVLRADNDRDVYLVFDYME-TDLHAVIRANILEPVHKQY----VVYQLI--KVI 122
Query: 787 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-----------LKHNTFLSSKST 835
LH+ ++HRD+K N+L++ +VKV+DFGLSR + + ++++
Sbjct: 123 KYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 836 AGTPEWM----------APEVLRNEPS-NEKCDVYSFGVILWELATLK 872
+ APE+L + D++S G IL E+ K
Sbjct: 181 DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 5e-18
Identities = 62/257 (24%), Positives = 107/257 (41%), Gaps = 33/257 (12%)
Query: 684 IGLGSYGEVYHADWNGTEV--AVK-----KFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
IG GSY +V T+ A+K D + E + V + HP +V
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTE--KHV-FEQASNHPFLV 73
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDARGMNCLHTSTPT 795
L + E++ G L + R + E+ R A + +N LH
Sbjct: 74 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEISLALNYLHERG-- 130
Query: 796 IVHRDLKSPNLLVDKNWNVKVSDFGLSRL------KHNTFLSSKSTAGTPEWMAPEVLRN 849
I++RDLK N+L+D ++K++D+G+ + +TF GTP ++APE+LR
Sbjct: 131 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF------CGTPNYIAPEILRG 184
Query: 850 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG----FQ---NRRLEIPKELDP 902
E D ++ GV+++E+ + P+ + FQ +++ IP+ L
Sbjct: 185 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV 244
Query: 903 LVARIIWECWQTDPSLR 919
A ++ DP R
Sbjct: 245 KAASVLKSFLNKDPKER 261
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-17
Identities = 63/263 (23%), Positives = 112/263 (42%), Gaps = 43/263 (16%)
Query: 684 IGLGSYGEVY---HADWNGTEV--AVKKFLDQDFSGAALLEFKREV-------KIMRRLR 731
+G G+YG+V+ + T A+K A +++ + +++ +R
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVL-----KKATIVQKAKTTEHTRTERQVLEHIR 116
Query: 732 H-PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR------RIKMALDAR 784
P +V A L +I +++ G LF L + + E I +AL+
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALE-- 173
Query: 785 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA---GTPEW 841
LH I++RD+K N+L+D N +V ++DFGLS K ++ GT E+
Sbjct: 174 ---HLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLS--KEFVADETERAYDFCGTIEY 226
Query: 842 MAPEVLRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---RRLEI 896
MAP+++R S ++ D +S GV+++EL T P+ + +
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-SRRILKSEPPY 285
Query: 897 PKELDPLVARIIWECWQTDPSLR 919
P+E+ L +I DP R
Sbjct: 286 PQEMSALAKDLIQRLLMKDPKKR 308
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 56/253 (22%), Positives = 107/253 (42%), Gaps = 34/253 (13%)
Query: 684 IGLGSYGEVYHADWNGTE------VAVKKFLDQDFSGAALLEFKREVKIMRR-LRHPNVV 736
+G GS+G+V ++ GT+ + K + QD E +++ + P +
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT---MVEKRVLALPGKPPFLT 84
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDARGMNCLHTSTPT 795
L + E++ G L + + + E A A G+ L +
Sbjct: 85 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKG-- 141
Query: 796 IVHRDLKSPNLLVDKNWNVKVSDFGLSRL------KHNTFLSSKSTAGTPEWMAPEVLRN 849
I++RDLK N+++D ++K++DFG+ + TF GTP+++APE++
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF------CGTPDYIAPEIIAY 195
Query: 850 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---NRRLEIPKELDPLVAR 906
+P + D ++FGV+L+E+ + P+ G + ++ FQ + PK +
Sbjct: 196 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-----FQSIMEHNVAYPKSMSKEAVA 250
Query: 907 IIWECWQTDPSLR 919
I P R
Sbjct: 251 ICKGLMTKHPGKR 263
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 53/248 (21%), Positives = 91/248 (36%), Gaps = 78/248 (31%)
Query: 682 ERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFK-REVKIMRRLRHPNVV-- 736
+ +G GS+G V G A+KK L QD +K RE+ IM+ L H N++
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALKKVL-QDPR------YKNRELDIMKVLDHVNIIKL 65
Query: 737 ------------------------------LFMGAVTRPPN------LSIITEFLPRGSL 760
+ + N L++I E++P +L
Sbjct: 66 VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTL 124
Query: 761 FRILHRPHCQVDEKRRIKMALD---------ARGMNCLHTSTPTIVHRDLKSPNLLVD-K 810
++L + + ++ R + +H+ I HRD+K NLLV+ K
Sbjct: 125 HKVLKSFI-----RSGRSIPMNLISIYIYQLFRAVGFIHSL--GICHRDIKPQNLLVNSK 177
Query: 811 NWNVKVSDFGLSRLKHNTFLSSKSTAGTPE----WM-APEVLRNEPS-NEKCDVYSFGVI 864
+ +K+ DFG ++ S + APE++ D++S G +
Sbjct: 178 DNTLKLCDFGSAK------KLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231
Query: 865 LWELATLK 872
EL K
Sbjct: 232 FGELILGK 239
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-17
Identities = 63/257 (24%), Positives = 107/257 (41%), Gaps = 33/257 (12%)
Query: 684 IGLGSYGEVYHADWNGTEV-----AVKK--FLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
IG GSY +V T+ VKK D + E + V + HP +V
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTE--KHV-FEQASNHPFLV 116
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKR-RIKMALDARGMNCLHTSTPT 795
L + E++ G L + R + E+ R A + +N LH
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEISLALNYLHERG-- 173
Query: 796 IVHRDLKSPNLLVDKNWNVKVSDFGLSRL------KHNTFLSSKSTAGTPEWMAPEVLRN 849
I++RDLK N+L+D ++K++D+G+ + +TF GTP ++APE+LR
Sbjct: 174 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF------CGTPNYIAPEILRG 227
Query: 850 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG----FQ---NRRLEIPKELDP 902
E D ++ GV+++E+ + P+ + FQ +++ IP+ L
Sbjct: 228 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV 287
Query: 903 LVARIIWECWQTDPSLR 919
A ++ DP R
Sbjct: 288 KAASVLKSFLNKDPKER 304
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.5 bits (169), Expect = 1e-12
Identities = 35/196 (17%), Positives = 55/196 (28%), Gaps = 47/196 (23%)
Query: 673 IPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKK------FLDQDFSGAALLEFKREVKI 726
+P E L E+IG G +GEV+ + T VA+K L E E+ I
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 727 MRRL---------RHPNVVLFMGA------------------------------VTRPPN 747
+ L R + +
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLL 807
L I+ EF G + + + I + + S HRDL N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSI-LHQLTASLAVAEAS-LRFEHRDLHWGNVL 194
Query: 808 VDKNWNVKVSDFGLSR 823
+ K K+ +
Sbjct: 195 LKKTSLKKLHYTLNGK 210
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 45/225 (20%), Positives = 93/225 (41%), Gaps = 55/225 (24%)
Query: 682 ERIGLGSYGEVYHA-D-WNGTEVAVK------KFLDQDFSGAALLEFKREVKIMRRLR-- 731
++G G + V+ A D N T VA+K + + + E+K+++R+
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA---------EDEIKLLQRVNDA 75
Query: 732 ---------HPNVVLFMGAVT-RPPNLS---IITEFLPRGSLFRILHR------PHCQVD 772
+++ + + PN ++ E L +L ++ + P V
Sbjct: 76 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVK 134
Query: 773 EK-RRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVD------KNWNVKVSDFGLSRLK 825
+ +++ + LD +H I+H D+K N+L++ +K++D G +
Sbjct: 135 QISKQLLLGLD-----YMHRRC-GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 188
Query: 826 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT 870
+ +S T E+ +PEVL P D++S +++EL T
Sbjct: 189 DEHYTNSIQT---REYRSPEVLLGAPWGCGADIWSTACLIFELIT 230
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 39/211 (18%)
Query: 682 ERIGLGSYGEVYHADW--NGTEVAVK------KFLDQDFSGAALLEFKREVKIMRRLRHP 733
IG GS+G+V A VA+K FL+Q A +E V+++ +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQ-----AQIE----VRLLELMNKH 110
Query: 734 ------NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ---VDEKRRIKMALDAR 784
+V +L ++ E L +L+ +L + + ++ R+ +
Sbjct: 111 DTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQM-CT 168
Query: 785 GMNCLHTSTPTIVHRDLKSPNLLV--DKNWNVKVSDFGLSRLKHN---TFLSSKSTAGTP 839
+ L T +I+H DLK N+L+ K +K+ DFG S ++ S+
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF----- 223
Query: 840 EWMAPEVLRNEPSNEKCDVYSFGVILWELAT 870
+ +PEVL P + D++S G IL E+ T
Sbjct: 224 -YRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 61.8 bits (149), Expect = 9e-10
Identities = 72/441 (16%), Positives = 124/441 (28%), Gaps = 168/441 (38%)
Query: 596 QLNGPPLVEDLSSNSKDENPKNV----E-DHEIGYHDRRKCTHDRFMGTNLKLRDLESPS 650
+ V++ + PK++ E DH I D T R T L
Sbjct: 23 SVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGT-LRLFWT---LLS--KQE 76
Query: 651 SSVDSSTSKVDQIFDDDVCECEIPWEDLVLGERI---------GLGSYGEVYHADWNGTE 701
V Q F ++V + L I Y E +N +
Sbjct: 77 EMV--------QKFVEEVLRINYKF----LMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQ 124
Query: 702 VAVKKFLDQDFSGAALLEFKREVKIMR------RLR-HPNVVLF-MG---------AVTR 744
V K + R ++ LR NV++ + V
Sbjct: 125 VFAKYNV------------SRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCL 172
Query: 745 PPNLSIITEFLPRGSLFRI--LHRPHCQVDEK---------RRIKMALDARGMNCLHTST 793
+ + + F+I L+ +C E +I +R H+S
Sbjct: 173 --SYKVQCKM-D----FKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSR---SDHSSN 222
Query: 794 PTIVHRDLKS-----------PN-LLV-DKNWNVKVSD-FGL-------SRLKHNT-FLS 831
+ +++ N LLV N K + F L +R K T FLS
Sbjct: 223 IKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLS 282
Query: 832 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN 891
+ +T + + + E+ +L L ++ P
Sbjct: 283 AATT------------THISLDHHSMTLTPD----EVKSLLLKYLDCRPQ---------- 316
Query: 892 RRLEIPKE---LDPLVARII----------WECWQT-----------------DPS-LRP 920
++P+E +P II W+ W+ +P+ R
Sbjct: 317 ---DLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRK 373
Query: 921 SFAQLTV----ALKPLQRLVI 937
F +L+V A P L +
Sbjct: 374 MFDRLSVFPPSAHIPTILLSL 394
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 53.7 bits (128), Expect = 2e-07
Identities = 49/334 (14%), Positives = 93/334 (27%), Gaps = 63/334 (18%)
Query: 16 SNRTNETLASTTSCATDHNRTSSSSSNAAP-----PSPSASAATAASS--PAPVVS---- 64
+ T +R + + A P A PA V
Sbjct: 99 KTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGV 158
Query: 65 --SGSRTDYMTSE--EEFQVQLAMA-----ISASSSN-PEDFSEKDQIRAATLLSLNNRR 114
SG + + ++VQ M ++ + N PE E Q + R
Sbjct: 159 LGSGKTW--VALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSR 216
Query: 115 SDLG---RDKADVAAEVLSR--QYWEYN----VLD--YEERVVDGFYDIYG---LST--D 158
SD + + L R + Y VL + + F ++ L T
Sbjct: 217 SDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAF-NL-SCKILLTTRF 274
Query: 159 PSTQGKLPSLA--HLESNLGNSGFEVVIVNRTIDHALEELVQVAQCIALDLPATDVGILV 216
L + H+ + + T D L++ C DLP +
Sbjct: 275 KQVTDFLSAATTTHISLDHHSMTL-------TPDEVKSLLLKYLDCRPQDLPREVLTTNP 327
Query: 217 QQLADLVNGHMGGPVKDANIMLARWMERSTE-LRRSLQTSVLPIGSINIGLSRHRALLFK 275
++L+ ++ ++D W + + L +++S + + R
Sbjct: 328 RRLS-II----AESIRDGLATWDNWKHVNCDKLTTIIESS---LNVLEPAEYRKMFDRLS 379
Query: 276 VLADSIRLP----CRLVKGSHYTGVEDDAVNIIK 305
V S +P + + V + K
Sbjct: 380 VFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHK 413
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.2 bits (124), Expect = 8e-07
Identities = 90/650 (13%), Positives = 165/650 (25%), Gaps = 220/650 (33%)
Query: 296 VEDDAVNIIKLEEEREFLVDLMAAPGTLIPADILSAKDTAFKPYNPLISKIPILRTSNDS 355
V+D +I+ EE +D I+ +KD + L + +
Sbjct: 38 VQDMPKSILSKEE-----ID-----------HIIMSKDAVSGTL--RL--FWTLLSKQEE 77
Query: 356 GAVYSKPKPLHAEGSSQNSTVDGSLPLNGG--STSEKAESL-PSFPSPSYEPGAASSGIS 412
V+ L +N + K E PS + Y I
Sbjct: 78 MV---------------QKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMY--------IE 114
Query: 413 SR-VTPNQSDYLSS---------STIGTSLYKGGRGPNAVGDGARMNVNVVPYGQTGQED 462
R N + + + +L + R NV+ G
Sbjct: 115 QRDRLYNDNQVFAKYNVSRLQPYLKLRQALLE-----------LRPAKNVLIDGV----- 158
Query: 463 SKSLFADLNPFQIKGAGKTSL------------------------HKNPTESKVEEFQS- 497
G+GKT + + N E+ +E Q
Sbjct: 159 -------------LGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKL 205
Query: 498 -HRINPVSGRPPIPMMRKNQHPYNEVPRKKEY----SYMEGIL-------PKINREPNNN 545
++I+P ++ + Y +L K N +
Sbjct: 206 LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLS 265
Query: 546 ---LSTSASTSSTSENFNPHSFKPS-NDANISSKDSESRSALSGSGPSLASSTSQLNGPP 601
L T+ T + S + +++ E +S L L+ P
Sbjct: 266 CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL----------KYLDCRP 315
Query: 602 LVEDLSSNSKDENP-------KNVEDHEIGYHDRRKCTHDRFMGTNL-KLRDLESPSSSV 653
+DL NP +++ D T D + N KL SS+
Sbjct: 316 --QDLPREVLTTNPRRLSIIAESIRDG--------LATWDNWKHVNCDKLT--TIIESSL 363
Query: 654 DSSTSKVDQ-------IFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKK 706
+ + +F IP +L + W +
Sbjct: 364 NVLEPAEYRKMFDRLSVFPPSA---HIPTI--LL----------SLI---WFDVIKSDVM 405
Query: 707 FLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR 766
+ +L+E K+ + + SI E + LHR
Sbjct: 406 VVVNKLHKYSLVE-KQPKESTISI-P----------------SIYLELKVKLENEYALHR 447
Query: 767 PHCQVDEKRRIKMALDARGM--NCL----------HTSTPTIVHRDLKSPNLLVDKNW-N 813
+ + I D+ + L H R + +D +
Sbjct: 448 ---SIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLE 504
Query: 814 VKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEK--CDVYSF 861
K+ + N S +T ++ P + N+P E+ + F
Sbjct: 505 QKIRHDSTAW---NASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDF 551
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 53/233 (22%), Positives = 87/233 (37%), Gaps = 61/233 (26%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH----P 733
LG +IG GS+G++Y G EVA+K + + L E KI + ++ P
Sbjct: 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKL--ECVKTKHPQL--HIESKIYKMMQGGVGIP 68
Query: 734 NV----------VLFM---GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA 780
+ V+ M G P+L LF R K +K
Sbjct: 69 TIRWCGAEGDYNVMVMELLG-----PSLE---------DLFNFCSR-------KFSLKTV 107
Query: 781 LDA-----RGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRL-------K 825
L + +H+ +HRD+K N L+ V + DFGL++ +
Sbjct: 108 LLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165
Query: 826 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM 878
H + +K+ GT + + + + D+ S G +L LPW G+
Sbjct: 166 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 8e-09
Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 41/211 (19%)
Query: 682 ERIGLGSYGEVYHA-D-WNGTEVAVK------KFLDQDFSGAALLEFKREVKIMRRLRH- 732
+ IG GS+G+V A D VA+K +F Q A E ++I+ LR
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQ-----AAEE----IRILEHLRKQ 153
Query: 733 -----PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ---VDEKRRIKMALDAR 784
NV+ + T ++ + E L +L+ ++ + Q + R+ ++ +
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSI-LQ 211
Query: 785 GMNCLHTSTPTIVHRDLKSPNLLV--DKNWNVKVSDFGLSRLKHN---TFLSSKSTAGTP 839
++ LH + I+H DLK N+L+ +KV DFG S +H T++ S+
Sbjct: 212 CLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF----- 264
Query: 840 EWMAPEVLRNEPSNEKCDVYSFGVILWELAT 870
+ APEV+ D++S G IL EL T
Sbjct: 265 -YRAPEVILGARYGMPIDMWSLGCILAELLT 294
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 46/236 (19%), Positives = 85/236 (36%), Gaps = 63/236 (26%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH----P 733
+G++IG G++GE+ + VA+K L E + ++L P
Sbjct: 13 VGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQL---HLEYRFYKQLGSGDGIP 68
Query: 734 NV----------VLFM---GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA 780
V + + G P+L LF + R +K
Sbjct: 69 QVYYFGPCGKYNAMVLELLG-----PSLE---------DLFDLCDR-------TFSLKTV 107
Query: 781 LD-ARGM----NCLHTSTPTIVHRDLKSPNLLVDKNWN-----VKVSDFGLSRL------ 824
L A + +H+ +++RD+K N L+ + N + + DF L++
Sbjct: 108 LMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET 165
Query: 825 -KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN 879
KH + KS GT +M+ + + + D+ + G + LPW G+
Sbjct: 166 KKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK 221
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 55/236 (23%), Positives = 91/236 (38%), Gaps = 63/236 (26%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH----P 733
+G RIG GS+G ++ N +VA+K + S A L + E + + L P
Sbjct: 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKF--EPRRSDAPQL--RDEYRTYKLLAGCTGIP 69
Query: 734 NV----------VLFM---GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA 780
NV VL + G P+L L + R K +K
Sbjct: 70 NVYYFGQEGLHNVLVIDLLG-----PSLE---------DLLDLCGR-------KFSVKTV 108
Query: 781 LD-ARGM----NCLHTSTPTIVHRDLKSPNLLV----DKNWN-VKVSDFGLSRL------ 824
A+ M +H + +V+RD+K N L+ KN N + V DFG+ +
Sbjct: 109 AMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 166
Query: 825 -KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN 879
+H + K+ +GT +M+ + + D+ + G + LPW G+
Sbjct: 167 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 222
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 58/234 (24%), Positives = 88/234 (37%), Gaps = 61/234 (26%)
Query: 680 LGERIGLGSYGEVYHAD--WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH----P 733
LG +IG GS+GE+Y EVA+K + + L E KI R L+ P
Sbjct: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQL--LYESKIYRILQGGTGIP 66
Query: 734 NV----------VLFM---GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA 780
NV VL M G P+L LF R K +K
Sbjct: 67 NVRWFGVEGDYNVLVMDLLG-----PSLE---------DLFNFCSR-------KLSLKTV 105
Query: 781 LDA-----RGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRL-------K 825
L + +H+ + +HRD+K N L+ V + DFGL++ +
Sbjct: 106 LMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163
Query: 826 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN 879
H + +K+ GT + + + + D+ S G +L LPW G+
Sbjct: 164 HIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 49/239 (20%), Positives = 82/239 (34%), Gaps = 53/239 (22%)
Query: 680 LGERIGLGSYGEVYHAD-WNGTEVAVKK--FLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+G IG G +G +Y AD + V + + S L E+K +R P +
Sbjct: 39 VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFT--ELKFYQRAAKPEQI 96
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMN-------CL 789
+ L + P+ H + + R M +D G +
Sbjct: 97 QKWIRTRKLKYLGV-----PK----YWGSGLHDKNGKSYRF-MIMDRFGSDLQKIYEANA 146
Query: 790 HT-STPTI-------------------VHRDLKSPNLLVD-KNWN-VKVSDFGLSRL--- 824
S T+ VH D+K+ NLL++ KN + V + D+GL+
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP 206
Query: 825 ----KHNTFLSSKSTAGTPEWMAPEV-LRNEPSNEKCDVYSFGVILWELATLKLPWIGM 878
K + GT E+ + + PS + D+ G + + T LPW
Sbjct: 207 EGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPS-RRGDLEILGYCMIQWLTGHLPWEDN 264
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 46/253 (18%), Positives = 88/253 (34%), Gaps = 75/253 (29%)
Query: 684 IGLGSYGEVYHA--DWNGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLR-----HPN- 734
+G G + V+ + VA+K + ++ A E+++++ +R PN
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA----LDEIRLLKSVRNSDPNDPNR 100
Query: 735 --VVLFMGAVT-RPPN---LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD--ARGM 786
VV + N + ++ E L L + + + + Q +K + +G+
Sbjct: 101 EMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGL 159
Query: 787 NCLHTSTPTIVHRDLKSPNLLV-------------------------------------- 808
+ LHT I+H D+K N+L+
Sbjct: 160 DYLHTKC-RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 809 -----------DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCD 857
+ VK++D G + H F T ++ + EVL N D
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQT---RQYRSLEVLIGSGYNTPAD 275
Query: 858 VYSFGVILWELAT 870
++S + +ELAT
Sbjct: 276 IWSTACMAFELAT 288
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 47/236 (19%), Positives = 79/236 (33%), Gaps = 48/236 (20%)
Query: 679 VLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
VLG++IG G +G +Y A + A + ++ L E+K +R+ + +
Sbjct: 40 VLGKKIGSGGFGLIYLAFPTNKPEKDARH-VVKVEYQENGPLF--SELKFYQRVAKKDCI 96
Query: 737 LFMGAVTRPPNLSIIT-----EFLPRGSLFRILHRPHCQV------------DEKRR--I 777
+ L I +G +R + V +
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFM------VMERLGIDLQKISGQNGTFKK 150
Query: 778 KMALD-ARGM----NCLHTSTPTIVHRDLKSPNLLVDKNWNVKV--SDFGLSRL------ 824
L M +H + VH D+K+ NLL+ +V +D+GLS
Sbjct: 151 STVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGN 208
Query: 825 -KHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGM 878
K K GT E+ + + + S + DV G + KLPW
Sbjct: 209 HKQYQENPRKGHNGTIEFTSLDAHKGVALS-RRSDVEILGYCMLRWLCGKLPWEQN 263
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 49/232 (21%), Positives = 86/232 (37%), Gaps = 65/232 (28%)
Query: 682 ERIGLGSYGEVYHA---DWNGTEVAVK------KFLDQDFSGAALLEFKREVKIMRRLRH 732
+ +G G++G+V G VAVK ++ + A E ++++ L
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEA-----ARSE----IQVLEHLNT 70
Query: 733 P------NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR------PHCQVDEKRRIKMA 780
V + ++ I+ E L S + + + R++
Sbjct: 71 TDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHI---RKMAYQ 126
Query: 781 LDARGMNCLHTSTPTIVHRDLKSPN-LLVD------------------KNWNVKVSDFG- 820
+ + +N LH++ + H DLK N L V N ++KV DFG
Sbjct: 127 I-CKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183
Query: 821 --LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT 870
H+T +S++ APEV+ ++ CDV+S G IL E
Sbjct: 184 ATYDDEHHSTLVSTRHYR------APEVILALGWSQPCDVWSIGCILIEYYL 229
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 50/232 (21%), Positives = 86/232 (37%), Gaps = 65/232 (28%)
Query: 682 ERIGLGSYGEVYHA---DWNGTEVAVK------KFLDQDFSGAALLEFKREVKIMRRLRH 732
+G G++G+V ++VA+K K+ + A LE + ++++++
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA-----ARLE----INVLKKIKE 75
Query: 733 P------NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR------PHCQVDEKRRIKMA 780
VL ++ I E L + F L P V R +
Sbjct: 76 KDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHV---RHMAYQ 131
Query: 781 LDARGMNCLHTSTPTIVHRDLKSPN-LLVD------------------KNWNVKVSDFG- 820
L + LH + + H DLK N L V+ KN +++V+DFG
Sbjct: 132 L-CHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188
Query: 821 --LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT 870
H T ++++ PEV+ + CDV+S G IL+E
Sbjct: 189 ATFDHEHHTTIVATRHY------RPPEVILELGWAQPCDVWSIGCILFEYYR 234
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 5e-05
Identities = 51/237 (21%), Positives = 92/237 (38%), Gaps = 71/237 (29%)
Query: 682 ERIGLGSYGEVYHADW---NGTEVAVK------KFLDQDFSGAALLEFKREVKIMRRLRH 732
++G G++G V N AVK K+ A +E I++++++
Sbjct: 41 RKMGDGTFGRVLLC-QHIDNKKYYAVKVVRNIKKYTRS-----AKIE----ADILKKIQN 90
Query: 733 -----PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR------PHCQVDEKRRIKMAL 781
N+V + G ++ +I E L SL+ I+ R + + + +
Sbjct: 91 DDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDI---KLYCIEI 146
Query: 782 DARGMNCLHTSTPTIVHRDLKSPN-LLVD------------------------KNWNVKV 816
+ +N L + + H DLK N LL D K+ +K+
Sbjct: 147 -LKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 817 SDFG---LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT 870
DFG H + ++++ + APEV+ N + D++SFG +L EL T
Sbjct: 204 IDFGCATFKSDYHGSIINTRQ------YRAPEVILNLGWDVSSDMWSFGCVLAELYT 254
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 27/167 (16%), Positives = 51/167 (30%), Gaps = 49/167 (29%)
Query: 680 LGERIGLGSYGEVYHA-DWNGTEVAVKKF----------------LDQDFSGAALLEFKR 722
+G+ +G G V++ E VK D FS A+ +
Sbjct: 94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 153
Query: 723 EVKIMRRLRHPNV---------VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDE 773
E + +++L+ V + M + L+R + +
Sbjct: 154 EFRALQKLQGLAVPKVYAWEGNAVLMELIDAKE-----------------LYRVRVENPD 196
Query: 774 KRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 820
+ + + IVH DL N+LV + + + DF
Sbjct: 197 EVLDMILEEVAKFYHRG-----IVHGDLSQYNVLVSEE-GIWIIDFP 237
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 958 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.74 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.59 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.19 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.02 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.97 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.7 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.49 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.24 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.19 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.14 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.13 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.03 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.98 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.89 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.64 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.53 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.31 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.27 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.08 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.02 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.8 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.78 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.61 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.59 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.44 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.27 | |
| 3isr_A | 293 | Transglutaminase-like enzymes, putative cysteine; | 96.0 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.83 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.94 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.75 | |
| 2f4m_A | 295 | Peptide N-glycanase; glycoproteins, ubiquitin-depe | 94.33 | |
| 3kd4_A | 506 | Putative protease; structural genomics, joint cent | 94.23 | |
| 1x3z_A | 335 | Peptide: N-glycanase; hydrolase-hydrolase inhibito | 91.3 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.39 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-54 Score=479.02 Aligned_cols=251 Identities=24% Similarity=0.417 Sum_probs=216.6
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
.++|++++.||+|+||+||+|++ +++.||||++.+..........+.+|+++|++|+|||||+++++|.+++.+||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 47899999999999999999987 6899999999888777777889999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCC-CCccH-HHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc
Q 002160 753 EFLPRGSLFRILHRPH-CQVDE-KRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 830 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~-~~~~e-~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~ 830 (958)
|||+||+|.+++...+ ....+ ..+.++.+++.||.|||+++ ||||||||+||||+.+|++||+|||+|+.......
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence 9999999999996443 33344 44555666699999999998 99999999999999999999999999987754433
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHH
Q 002160 831 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 910 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 910 (958)
.....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+++..+.. ...+.++..+++++++||.+
T Consensus 181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~-~~~~~~~~~~s~~~~~li~~ 259 (350)
T 4b9d_A 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS-GSFPPVSLHYSYDLRSLVSQ 259 (350)
T ss_dssp HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-TCCCCCCTTSCHHHHHHHHH
T ss_pred cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc-CCCCCCCccCCHHHHHHHHH
Confidence 33457899999999999999999999999999999999999999999998888877753 33445677899999999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 002160 911 CWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 911 CL~kDP~kRPSa~EIL~~ 928 (958)
||++||.+||++.||++|
T Consensus 260 ~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 260 LFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp HTCSSGGGSCCHHHHHTS
T ss_pred HccCChhHCcCHHHHhcC
Confidence 999999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=461.82 Aligned_cols=263 Identities=34% Similarity=0.577 Sum_probs=219.4
Q ss_pred cccccCCCCeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCce
Q 002160 669 CECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (958)
Q Consensus 669 ~~~eI~~~dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l 748 (958)
..++|+.++|+++++||+|+||+||+|++.+ .||||+++...........|.+|+.+|++++|||||++++++.+ +.+
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~ 106 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL 106 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence 3467899999999999999999999998765 59999988776677778899999999999999999999998865 578
Q ss_pred EEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
|||||||++|+|.++|+.....+.+...+.++.+ +.||+|||+++ ||||||||+||||++++++||+|||+|+....
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 9999999999999999876666677766666655 99999999988 99999999999999999999999999987543
Q ss_pred C--cccCCCCCCCCCccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccc-cc---cCCCC
Q 002160 828 T--FLSSKSTAGTPEWMAPEVLRN---EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RR---LEIPK 898 (958)
Q Consensus 828 ~--~~~~~s~~GT~~Y~APEvl~g---~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~-~~---~~ip~ 898 (958)
. .......+||+.|||||++.+ .+|+.++|||||||+||||++|+.||.+.+.......+.... .. ..++.
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 264 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYK 264 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCT
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Confidence 2 222345789999999999974 358999999999999999999999999876654443332222 22 23566
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 899 ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 899 ~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
.+++++.+||.+||++||.+||++.||+++|+.|+..
T Consensus 265 ~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 265 NCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp TSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 7899999999999999999999999999999988654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-52 Score=461.69 Aligned_cols=260 Identities=33% Similarity=0.529 Sum_probs=220.5
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEEC-------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEecccc
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT 743 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~~-------g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~ 743 (958)
.+|..++|.+.++||+|+||+||+|++. ++.||||++... ......+|.+|+++|++|+|||||+++++|.
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 113 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCT 113 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 3566789999999999999999999863 678999998653 4556778999999999999999999999999
Q ss_pred CCCceEEEEeecCCCCHHHHHhCCC--------------CCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEE
Q 002160 744 RPPNLSIITEFLPRGSLFRILHRPH--------------CQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLV 808 (958)
Q Consensus 744 ~~~~l~LVmEy~~gGsL~d~L~k~~--------------~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILI 808 (958)
+.+.+|||||||++|+|.+++++.. ..+.+..++.++.+ +.||+|||.++ ||||||||+||||
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl 191 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLV 191 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEE
Confidence 9999999999999999999997643 23556666666655 99999999988 9999999999999
Q ss_pred cCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHH
Q 002160 809 DKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVG 885 (958)
Q Consensus 809 d~~g~VKL~DFGLAk~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~ 885 (958)
++++++||+|||+++...... ......+||+.|||||++.+..++.++|||||||+||||++ |+.||.+.+..++..
T Consensus 192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 271 (329)
T 4aoj_A 192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271 (329)
T ss_dssp ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999999998764332 22345679999999999999999999999999999999998 899999999888887
Q ss_pred hhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 886 AVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 886 ~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
.+. ...++.+|..+++++.+||.+||++||++||++.||+++|+.+.+.
T Consensus 272 ~i~-~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 272 CIT-QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHH-HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHH-cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 775 4557788999999999999999999999999999999999998754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=459.82 Aligned_cols=259 Identities=31% Similarity=0.542 Sum_probs=224.8
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE-------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~ 744 (958)
+|..++|.+.+.||+|+||+||+|++ +++.||||++... ......+|.+|+++|++|+|||||+++++|.+
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE 86 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 56778999999999999999999986 3678999998653 45566789999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhCCC------------CCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCC
Q 002160 745 PPNLSIITEFLPRGSLFRILHRPH------------CQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKN 811 (958)
Q Consensus 745 ~~~l~LVmEy~~gGsL~d~L~k~~------------~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~ 811 (958)
++.+|||||||++|+|.++|++.+ ..+.+..++.++.+ +.||+|||+++ ||||||||+||||+++
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECCC
Confidence 999999999999999999997542 34566666666655 99999999988 9999999999999999
Q ss_pred CcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhh
Q 002160 812 WNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVG 888 (958)
Q Consensus 812 g~VKL~DFGLAk~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~ 888 (958)
+++||+|||+|+....... ......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..++...+.
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 244 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999987543322 2233568999999999999999999999999999999998 899999999988887775
Q ss_pred ccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 889 FQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 889 ~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
...++..|..+++++.+||.+||+.||.+||++.+|...|+++.+.
T Consensus 245 -~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 245 -QGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp -HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 4556778899999999999999999999999999999999998764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=468.17 Aligned_cols=249 Identities=21% Similarity=0.349 Sum_probs=222.1
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
++|++++.||+|+||+||+|++ +++.||||++.+.... ......+.+|+++|++|+|||||+++++|++++.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 6799999999999999999987 6889999999765332 223567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC--cc
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--FL 830 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~--~~ 830 (958)
|||+||+|.+++.+.+...+...+.++.+++.||+|||+++ ||||||||+||||+.+|++||+|||+|+.+... ..
T Consensus 112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence 99999999999988777777777788888899999999998 999999999999999999999999999976432 23
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHH
Q 002160 831 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 910 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 910 (958)
...+++||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..++...+. .....+|..+++++++||.+
T Consensus 190 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~--~~~~~~p~~~s~~~~dli~~ 267 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII--KLEYDFPEKFFPKARDLVEK 267 (311)
T ss_dssp CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HTCCCCCTTCCHHHHHHHHH
T ss_pred cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCcccCHHHHHHHHH
Confidence 3456899999999999999999999999999999999999999999999888888774 34567888999999999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 002160 911 CWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 911 CL~kDP~kRPSa~EIL~~ 928 (958)
||++||.+||+++|++.+
T Consensus 268 lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 268 LLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp HSCSSGGGSTTSGGGTCH
T ss_pred HccCCHhHCcChHHHcCC
Confidence 999999999999987543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-52 Score=457.48 Aligned_cols=259 Identities=30% Similarity=0.507 Sum_probs=223.3
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEE-------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEecccc
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT 743 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~ 743 (958)
.+|...++++.++||+|+||+||+|++ +++.||||++.... ......+|.+|+.+|++|+|||||+++|+|.
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence 356778899999999999999999986 35789999986543 3334568999999999999999999999999
Q ss_pred CCCceEEEEeecCCCCHHHHHhCCC---------------CCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceE
Q 002160 744 RPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLL 807 (958)
Q Consensus 744 ~~~~l~LVmEy~~gGsL~d~L~k~~---------------~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNIL 807 (958)
+++.++||||||++|+|.++|.... ..+.+..++.++.+ +.||+|||+++ ||||||||+|||
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NIL 177 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVL 177 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEE
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceE
Confidence 9999999999999999999996532 23555666665555 99999999998 999999999999
Q ss_pred EcCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 002160 808 VDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVV 884 (958)
Q Consensus 808 Id~~g~VKL~DFGLAk~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~ 884 (958)
|++++++||+|||+++...... ......+||+.|||||++.+..|+.++|||||||+||||++ |..||.+.+..++.
T Consensus 178 l~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~ 257 (308)
T 4gt4_A 178 VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 257 (308)
T ss_dssp ECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH
T ss_pred ECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999998764322 22345679999999999999999999999999999999998 89999999998888
Q ss_pred HhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 002160 885 GAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 933 (958)
Q Consensus 885 ~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~ 933 (958)
..+. ...++..|..+++++.+||.+||+.||.+||+|.||+++|+.+.
T Consensus 258 ~~i~-~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 258 EMIR-NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHH-cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 8775 45567788999999999999999999999999999999998753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=466.13 Aligned_cols=248 Identities=28% Similarity=0.378 Sum_probs=216.8
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
+.|+++++||+|+||+||+|++ +|+.||||++....... ...+.+|+++|++++|||||+++++|.+.+.+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5799999999999999999987 68999999997654322 3457899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCC
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 833 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~ 833 (958)
||+||+|.+++.+. ...+...+.++.+++.||+|||.++ ||||||||+||||+.+|++||+|||+|+..........
T Consensus 152 y~~gg~L~~~l~~~-~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 228 (346)
T 4fih_A 152 FLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 228 (346)
T ss_dssp CCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred CCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence 99999999999764 3455556666666699999999998 99999999999999999999999999998766555566
Q ss_pred CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccc-cccCCCCCCcHHHHHHHHHhh
Q 002160 834 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLVARIIWECW 912 (958)
Q Consensus 834 s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~-~~~~ip~~ls~eL~dLI~~CL 912 (958)
+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++...+.... .....+..+++++++||.+||
T Consensus 229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L 308 (346)
T 4fih_A 229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLL 308 (346)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHS
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHc
Confidence 7899999999999999999999999999999999999999999998888877764321 123344578999999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 002160 913 QTDPSLRPSFAQLTVA 928 (958)
Q Consensus 913 ~kDP~kRPSa~EIL~~ 928 (958)
++||.+||++.||++|
T Consensus 309 ~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 309 VRDPAQRATAAELLKH 324 (346)
T ss_dssp CSSTTTSCCHHHHTTC
T ss_pred CCChhHCcCHHHHhcC
Confidence 9999999999999875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-53 Score=465.60 Aligned_cols=252 Identities=27% Similarity=0.401 Sum_probs=215.0
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE-----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~-----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~ 747 (958)
+..++|++++.||+|+||+||+|++ +++.||||++.+..........+.+|+++|++++|||||+++++|.+++.
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 100 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK 100 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 4457899999999999999999976 46789999997654433334468899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
+|||||||+||+|.+++.+.+...+...+.++.+++.||+|||+++ ||||||||+|||++.+|++||+|||+|+....
T Consensus 101 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 9999999999999999988776677777777777799999999998 99999999999999999999999999987655
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHH
Q 002160 828 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 907 (958)
Q Consensus 828 ~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dL 907 (958)
......+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++...+. ...+.+|..+++++++|
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~l 256 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL--KAKLGMPQFLSPEAQSL 256 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHH
T ss_pred CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHH--cCCCCCCCcCCHHHHHH
Confidence 4445567899999999999999999999999999999999999999999999888888774 34567888999999999
Q ss_pred HHHhhhcCCCCCCC-----HHHHHHH
Q 002160 908 IWECWQTDPSLRPS-----FAQLTVA 928 (958)
Q Consensus 908 I~~CL~kDP~kRPS-----a~EIL~~ 928 (958)
|.+||++||.+||+ ++||++|
T Consensus 257 i~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 257 LRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp HHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred HHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 99999999999998 4677764
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-52 Score=461.89 Aligned_cols=253 Identities=26% Similarity=0.370 Sum_probs=217.4
Q ss_pred CCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEE
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LV 751 (958)
..++|++.++||+|+||+||+|++ +++.||||++...... .+|+.+|++|+|||||+++++|.+++.+|||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 446799999999999999999987 5889999999865433 3699999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCC-cEEEEeccccccccCCc-
Q 002160 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRLKHNTF- 829 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g-~VKL~DFGLAk~~~~~~- 829 (958)
||||+||+|.+++++.+...+...+.++.+++.||+|||.++ ||||||||+||||+.+| ++||+|||+|+.+....
T Consensus 129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 999999999999987766666666666777799999999998 99999999999999887 69999999998764321
Q ss_pred ----ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccc-cCCCCCCcHHH
Q 002160 830 ----LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR-LEIPKELDPLV 904 (958)
Q Consensus 830 ----~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~-~~ip~~ls~eL 904 (958)
.....++||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..++...+...... ..++..+++++
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~ 286 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLT 286 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHH
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHH
Confidence 1233468999999999999999999999999999999999999999988777766666433322 35678899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 905 ARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 905 ~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
++||.+||++||.+||++.||+++|.+....
T Consensus 287 ~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 287 AQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 9999999999999999999999999876543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-52 Score=451.12 Aligned_cols=248 Identities=31% Similarity=0.455 Sum_probs=211.3
Q ss_pred eeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC----CCceEEE
Q 002160 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR----PPNLSII 751 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~----~~~l~LV 751 (958)
|++.++||+|+||+||+|.+ ++..||||++............|.+|+++|++|+|||||+++++|.. ...+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 57888999999999999987 57889999998877777777889999999999999999999999865 3458999
Q ss_pred EeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEc-CCCcEEEEeccccccccCCcc
Q 002160 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFL 830 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId-~~g~VKL~DFGLAk~~~~~~~ 830 (958)
||||+||+|.+++.+.+.......+.++.+++.||+|||.++++||||||||+||||+ .+|++||+|||+|+.....
T Consensus 108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~-- 185 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-- 185 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT--
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC--
Confidence 9999999999999876655555555666667999999999888899999999999998 5899999999999865433
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHhhhccccccCCCCCCcHHHHHHHH
Q 002160 831 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNRRLEIPKELDPLVARIIW 909 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~-~ei~~~i~~~~~~~~ip~~ls~eL~dLI~ 909 (958)
...+.+||+.|||||++.+ +|+.++|||||||+||||++|+.||.+.+. .++...+.....+..++..+++++++||.
T Consensus 186 ~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~ 264 (290)
T 3fpq_A 186 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE 264 (290)
T ss_dssp SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHH
T ss_pred ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHH
Confidence 2346789999999999876 599999999999999999999999987554 44445454333344566778999999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 002160 910 ECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 910 ~CL~kDP~kRPSa~EIL~~ 928 (958)
+||++||.+|||+.||++|
T Consensus 265 ~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 265 GCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHSCSSGGGSCCHHHHHTS
T ss_pred HHccCChhHCcCHHHHhcC
Confidence 9999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=446.78 Aligned_cols=247 Identities=27% Similarity=0.427 Sum_probs=204.0
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
++|++++.||+|+||+||+|++ +++.||||++.+..... .....+.+|+++|++++|||||+++++|.+.+.+||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999986 68999999998765433 33567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
||| +|+|.+++.+.+...+...+.++.+++.||+|||+++ ||||||||+||||+.++++||+|||+|+..... ...
T Consensus 93 Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~~ 168 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFL 168 (275)
T ss_dssp ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCCCCEEEeecCCCeecCCC-Ccc
Confidence 999 6899999987776666677777777799999999998 999999999999999999999999999876543 233
Q ss_pred CCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHh
Q 002160 833 KSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 911 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g~~~-s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~C 911 (958)
.+.+||+.|||||++.+..+ +.++|||||||++|+|++|+.||.+.+..++...+. .....+|..+++++++||.+|
T Consensus 169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~~~ 246 (275)
T 3hyh_A 169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNIS--NGVYTLPKFLSPGAAGLIKRM 246 (275)
T ss_dssp ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HTCCCCCTTSCHHHHHHHHHH
T ss_pred CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHH
Confidence 46789999999999999876 579999999999999999999999988888777764 345678889999999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 002160 912 WQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 912 L~kDP~kRPSa~EIL~~ 928 (958)
|++||.+|||++|+++|
T Consensus 247 L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 247 LIVNPLNRISIHEIMQD 263 (275)
T ss_dssp SCSSGGGSCCHHHHHHC
T ss_pred ccCChhHCcCHHHHHcC
Confidence 99999999999999885
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=468.41 Aligned_cols=249 Identities=28% Similarity=0.374 Sum_probs=217.9
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
.+.|+++++||+|+||.||+|++ +|+.||||++....... ...+.+|+.+|++|+|||||+++++|.+.+.+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 36799999999999999999987 68999999997654332 346789999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
|||+||+|.+++... ...+...+.++.+++.||+|||.++ ||||||||+||||+.+|++||+|||+|+.+.......
T Consensus 228 Ey~~gG~L~~~i~~~-~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 304 (423)
T 4fie_A 228 EFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 304 (423)
T ss_dssp ECCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCB
T ss_pred eCCCCCcHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEecCccceECCCCCccc
Confidence 999999999999754 3445555566666699999999998 9999999999999999999999999999876655556
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccc-cccCCCCCCcHHHHHHHHHh
Q 002160 833 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLVARIIWEC 911 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~-~~~~ip~~ls~eL~dLI~~C 911 (958)
.+++||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++...+.... .....+..+++++++||.+|
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~ 384 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 384 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHH
Confidence 67899999999999999999999999999999999999999999999888877764322 23344567999999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 002160 912 WQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 912 L~kDP~kRPSa~EIL~~ 928 (958)
|.+||.+||++.||++|
T Consensus 385 L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 385 LVRDPAQRATAAELLKH 401 (423)
T ss_dssp SCSSTTTSCCHHHHTTC
T ss_pred cCCChhHCcCHHHHhcC
Confidence 99999999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=459.02 Aligned_cols=269 Identities=30% Similarity=0.486 Sum_probs=225.7
Q ss_pred CccccccCCCCeeEEEEeeccCceEEEEEEECC-------cEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCC-CceeEE
Q 002160 667 DVCECEIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH-PNVVLF 738 (958)
Q Consensus 667 ~~~~~eI~~~dy~i~k~LG~G~fG~Vykak~~g-------~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~H-PNIVkL 738 (958)
+...++|+.++|++++.||+|+||+||+|++.+ +.||||++.... .......|.+|+++|.++.| ||||++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 345678999999999999999999999998743 579999986543 34456789999999999965 999999
Q ss_pred eccccCC-CceEEEEeecCCCCHHHHHhCCC---------------CCccHHHHHHHHH-HHHHHHHHHhcCCcEeecCC
Q 002160 739 MGAVTRP-PNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDL 801 (958)
Q Consensus 739 ~g~~~~~-~~l~LVmEy~~gGsL~d~L~k~~---------------~~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDL 801 (958)
+++|.+. +.+|||||||++|+|.++|++.. ..+.+...+.++. .+.||+|||+++ ||||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDL 211 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDL 211 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCcc
Confidence 9998664 56899999999999999996432 2345555555554 499999999998 999999
Q ss_pred CCCceEEcCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 002160 802 KSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGM 878 (958)
Q Consensus 802 KPeNILId~~g~VKL~DFGLAk~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~ 878 (958)
||+||||++++++||+|||+|+...... ......+||+.|||||++.+..|+.++|||||||+||||++ |+.||.+.
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998764322 22345679999999999999999999999999999999998 99999987
Q ss_pred ChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhcCC
Q 002160 879 NPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 938 (958)
Q Consensus 879 ~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~~p 938 (958)
+..+.+........++.+|..+++++.+||.+||+.||.+||++.||+++|+++.+....
T Consensus 292 ~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~~ 351 (353)
T 4ase_A 292 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 351 (353)
T ss_dssp CCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC-
T ss_pred CHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhhC
Confidence 755554444446667888999999999999999999999999999999999998766443
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-49 Score=428.14 Aligned_cols=255 Identities=33% Similarity=0.516 Sum_probs=198.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC----ceEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP----NLSII 751 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~----~l~LV 751 (958)
.+|.+.++||+|+||+||+|+++|+.||||++.... .....++.|+.++.+++|||||++++++.+++ .+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 468899999999999999999999999999986542 22223445677777889999999999997654 58999
Q ss_pred EeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhc------CCcEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTS------TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~------g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
||||++|+|.+++++.. ..+..++.++.+ +.||+|||.+ .++||||||||+||||+.++++||+|||+++.
T Consensus 80 ~Ey~~~gsL~~~l~~~~--l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ecCCCCCcHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 99999999999998653 444555555544 9999999986 33599999999999999999999999999987
Q ss_pred ccCCcc----cCCCCCCCCCccCcccccCC------CCCchhhHHHHHHHHHHHHhCCCCCCCCC---------------
Q 002160 825 KHNTFL----SSKSTAGTPEWMAPEVLRNE------PSNEKCDVYSFGVILWELATLKLPWIGMN--------------- 879 (958)
Q Consensus 825 ~~~~~~----~~~s~~GT~~Y~APEvl~g~------~~s~ksDIWSLGiLLyELLtG~~PF~g~~--------------- 879 (958)
...... .....+||+.|||||++.+. .++.++|||||||+||||++|..||....
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 643321 22346799999999999765 35679999999999999999976653221
Q ss_pred hhHHHHhhhccccccCCCCC-----CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 880 PMQVVGAVGFQNRRLEIPKE-----LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 880 ~~ei~~~i~~~~~~~~ip~~-----ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
..++...+.....++.+|.. .+..+.+||.+||+.||.+|||+.||++.|++|.+.
T Consensus 238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 12333333334445556543 235789999999999999999999999999998754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-49 Score=429.00 Aligned_cols=246 Identities=23% Similarity=0.314 Sum_probs=188.4
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC-------
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------- 746 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~------- 746 (958)
++|++++.||+|+||+||+|++ +++.||||++.... .+.....+.+|+++|++|+|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 4799999999999999999987 58899999987654 3445678999999999999999999999986544
Q ss_pred -----ceEEEEeecCCCCHHHHHhCCCCCc--cHH-HHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEe
Q 002160 747 -----NLSIITEFLPRGSLFRILHRPHCQV--DEK-RRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSD 818 (958)
Q Consensus 747 -----~l~LVmEy~~gGsL~d~L~k~~~~~--~e~-~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~D 818 (958)
.+|||||||++|+|.+++.+..... .+. .+.++.+++.||+|||+++ ||||||||+||||+.+|++||+|
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCCCcEEEcc
Confidence 3799999999999999998765432 223 3334455599999999998 99999999999999999999999
Q ss_pred ccccccccCCcc------------cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh-HHHH
Q 002160 819 FGLSRLKHNTFL------------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVG 885 (958)
Q Consensus 819 FGLAk~~~~~~~------------~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~-ei~~ 885 (958)
||+|+....... .....+||+.|||||++.+..|+.++|||||||++|||++ ||.+.... ....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~ 238 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence 999987643211 1234679999999999999999999999999999999996 88653221 2222
Q ss_pred hhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 886 AVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 886 ~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.+. ....+..+...++.+.+||.+||++||.+||++.||++|
T Consensus 239 ~~~-~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 239 DVR-NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHH-TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHh-cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 221 111111223456778999999999999999999999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=437.18 Aligned_cols=250 Identities=24% Similarity=0.325 Sum_probs=211.5
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC------CCc
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR------PPN 747 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~------~~~ 747 (958)
++|++++.||+|+||+||+|++ +|+.||||++............+.+|+++|++|+|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5799999999999999999987 68999999998776666667788999999999999999999998653 467
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
+|||||||+ |+|.+++.+.+.......+.++.+++.||.|||+++ ||||||||+|||++.+|++||+|||+|+.+..
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 999999995 689999988777777777777778899999999998 99999999999999999999999999987543
Q ss_pred C----cccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccC-------
Q 002160 828 T----FLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE------- 895 (958)
Q Consensus 828 ~----~~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~------- 895 (958)
. .....+++||+.|||||++.+. .++.++|||||||++|||++|++||.+.+..+.+..+......+.
T Consensus 211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~ 290 (398)
T 4b99_A 211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAV 290 (398)
T ss_dssp -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC--
T ss_pred CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhh
Confidence 2 2234567899999999999875 469999999999999999999999999888776655532111100
Q ss_pred ----------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 896 ----------------------IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 896 ----------------------ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+...+++++++||.+||.+||.+|||+.|+++|
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp ---CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 112468999999999999999999999999876
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=409.51 Aligned_cols=272 Identities=64% Similarity=1.077 Sum_probs=226.2
Q ss_pred ccccccCCCCeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc
Q 002160 668 VCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 668 ~~~~eI~~~dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~ 747 (958)
....++.+.+|++.+.||+|+||.||+|+++++.||||++...........++.+|+++|++++||||+++++++.....
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 34567888999999999999999999999999999999998877777777889999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhCCCC--CccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 748 LSIITEFLPRGSLFRILHRPHC--QVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~--~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
+++||||+++|+|.+++.+... .+.+...+.++ +.+.||+|||.++++|+||||||+||||+.++.+||+|||+++.
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 9999999999999999987543 14444444444 44999999999877799999999999999999999999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHH
Q 002160 825 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 904 (958)
Q Consensus 825 ~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL 904 (958)
............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+........++..+++.+
T Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 268 (309)
T 3p86_A 189 KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQV 268 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHH
T ss_pred ccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHH
Confidence 65544444567899999999999999999999999999999999999999999998888877766677788889999999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhcCCC
Q 002160 905 ARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPS 939 (958)
Q Consensus 905 ~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~~p~ 939 (958)
.+||.+||+.||.+||++.+|++.|+.+.+...|+
T Consensus 269 ~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 269 AAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999999998765543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=449.00 Aligned_cols=252 Identities=23% Similarity=0.345 Sum_probs=213.8
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCC----HHHHHHHHHHHHHHHHcCCCceeEEeccccC
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS----GAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~----~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~ 744 (958)
..+..++|++++.||+|+||+||+|++ +++.||||++.+.... .........++.+++.++|||||+++++|++
T Consensus 184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263 (689)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence 356778999999999999999999987 6889999999754321 1222233445666677799999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 745 ~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
.+.+|||||||+||+|.++|.+.+...+...+.++++++.||+|||.++ ||||||||+||||+.+|++||+|||+|+.
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCCCCEEecccceeee
Confidence 9999999999999999999988777778888888888899999999998 99999999999999999999999999987
Q ss_pred ccCCcccCCCCCCCCCccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---hHHHHhhhccccccCCCCCC
Q 002160 825 KHNTFLSSKSTAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNP---MQVVGAVGFQNRRLEIPKEL 900 (958)
Q Consensus 825 ~~~~~~~~~s~~GT~~Y~APEvl~-g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~---~ei~~~i~~~~~~~~ip~~l 900 (958)
.... ...+.+||+.|||||++. +..|+.++|||||||+||||++|++||.+.+. .++...+ ......+|..+
T Consensus 342 ~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i--~~~~~~~p~~~ 417 (689)
T 3v5w_A 342 FSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDSF 417 (689)
T ss_dssp CSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH--HHCCCCCCTTS
T ss_pred cCCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh--cCCCCCCCccC
Confidence 6543 235679999999999996 56799999999999999999999999986432 2333333 23456788899
Q ss_pred cHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 002160 901 DPLVARIIWECWQTDPSLRPS-----FAQLTVA 928 (958)
Q Consensus 901 s~eL~dLI~~CL~kDP~kRPS-----a~EIL~~ 928 (958)
++++++||.+||++||.+|++ ++||++|
T Consensus 418 S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 418 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 999999999999999999997 7888775
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=438.51 Aligned_cols=249 Identities=25% Similarity=0.361 Sum_probs=214.9
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
.++|++++.||+|+||.||+|++ +|+.||||++.... ......+.+|+++|+.|+|||||+++++|.+...+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 36899999999999999999987 68899999987653 334567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCc-cHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcC--CCcEEEEeccccccccCCc
Q 002160 753 EFLPRGSLFRILHRPHCQV-DEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDK--NWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~-~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~--~g~VKL~DFGLAk~~~~~~ 829 (958)
|||+||+|++++.+....+ +...+.++.+++.||.|||.++ ||||||||+|||++. .+++||+|||+++.+....
T Consensus 234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 9999999999997554444 4455556666699999999998 999999999999985 4899999999999875432
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccccc--CCCCCCcHHHHHH
Q 002160 830 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVARI 907 (958)
Q Consensus 830 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~--~ip~~ls~eL~dL 907 (958)
.....+||+.|||||++.+..|+.++|||||||+||+|++|+.||.+.+..+++..+....... ..+..+++++++|
T Consensus 312 -~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dl 390 (573)
T 3uto_A 312 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 390 (573)
T ss_dssp -EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHH
T ss_pred -ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 2345689999999999999999999999999999999999999999999988887775433222 2235689999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 002160 908 IWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 908 I~~CL~kDP~kRPSa~EIL~~ 928 (958)
|.+||++||.+||++.|+++|
T Consensus 391 i~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 391 IRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp HHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=412.99 Aligned_cols=244 Identities=22% Similarity=0.316 Sum_probs=195.6
Q ss_pred CCeeEEEEeeccCceEEEEEEE-----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCceE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~-----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~l~ 749 (958)
++|++++.||+|+||+||+|++ +++.||||++..... ..++.+|+++|+.+ +|||||+++++|.+.+++|
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 5799999999999999999975 367899999865432 34678999999999 6999999999999999999
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCC-CcEEEEeccccccccCC
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~-g~VKL~DFGLAk~~~~~ 828 (958)
||||||+||+|.+++.. ......+.++.+++.||+|||+++ ||||||||+||||+.+ +++||+|||+|+.....
T Consensus 97 lvmE~~~g~~L~~~~~~---l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 97 IAMPYLEHESFLDILNS---LSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp EEEECCCCCCHHHHHTT---CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred EEEeCCCcccHHHHHcC---CCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 99999999999999853 445566667777799999999998 9999999999999876 89999999999864322
Q ss_pred c----------------------------ccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 002160 829 F----------------------------LSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMN 879 (958)
Q Consensus 829 ~----------------------------~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~ 879 (958)
. ......+||+.|+|||++.+. .|+.++||||+||++|||++|+.||...+
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 1 112345799999999999876 48999999999999999999999996543
Q ss_pred -hhHHHHhhhc------------------------------------c----------------ccccCCCCCCcHHHHH
Q 002160 880 -PMQVVGAVGF------------------------------------Q----------------NRRLEIPKELDPLVAR 906 (958)
Q Consensus 880 -~~ei~~~i~~------------------------------------~----------------~~~~~ip~~ls~eL~d 906 (958)
..+.+..+.. . .........++++++|
T Consensus 252 ~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~D 331 (361)
T 4f9c_A 252 DDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYD 331 (361)
T ss_dssp SHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHH
T ss_pred CHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHH
Confidence 2222221100 0 0001112357899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 002160 907 IIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 907 LI~~CL~kDP~kRPSa~EIL~~ 928 (958)
||.+||+.||.+|+|++|+++|
T Consensus 332 Ll~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 332 LLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp HHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHCcCChhHCcCHHHHhcC
Confidence 9999999999999999999875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=395.63 Aligned_cols=251 Identities=28% Similarity=0.425 Sum_probs=221.5
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEE
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~L 750 (958)
....+|++++.||+|+||.||+|++ +++.||||++...........++.+|+++|+.++||||+++++++...+.+|+
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 3457899999999999999999987 78999999998877777777889999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc
Q 002160 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 830 (958)
Q Consensus 751 VmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~ 830 (958)
||||+++|+|.+++.+.+.......+..+.+.+.||.|||.++ |+||||||+|||++.++++||+|||++...... .
T Consensus 92 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~ 168 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-G 168 (328)
T ss_dssp EECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-C
T ss_pred EEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCCCCEEEeeccCceecCCC-C
Confidence 9999999999999976655555555555666699999999998 999999999999999999999999999866443 2
Q ss_pred cCCCCCCCCCccCcccccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHH
Q 002160 831 SSKSTAGTPEWMAPEVLRNEPSN-EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 909 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~~~s-~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~ 909 (958)
.....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+..++...+. .....+|..+++++.+||.
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~ 246 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL--RGKYRIPFYMSTDCENLLK 246 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHHHH
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHHHH
Confidence 33557899999999999988875 79999999999999999999999998888777664 3355677889999999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 002160 910 ECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 910 ~CL~kDP~kRPSa~EIL~~ 928 (958)
+||..||.+||++.||++|
T Consensus 247 ~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 247 RFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHCCSSTTTSCCHHHHTTC
T ss_pred HHCCCChhHCcCHHHHhcC
Confidence 9999999999999999886
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=398.94 Aligned_cols=252 Identities=24% Similarity=0.402 Sum_probs=220.4
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceE
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~ 749 (958)
+..++|++++.||+|+||+||+|++ +++.||||++.+... .......+.+|+++|+.++||||+++++++...+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 4567999999999999999999987 688999999875422 1123456889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~ 829 (958)
+||||++||+|..++.+.+.......+.++.+++.||.|||.++ |+||||||+||||+.+|++||+|||+++......
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 99999999999999987665666666666777799999999998 9999999999999999999999999998654443
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHH
Q 002160 830 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 909 (958)
Q Consensus 830 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~ 909 (958)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+.. ....+|..+++++++||.
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~ 237 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--EEIRFPRTLSPEAKSLLA 237 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHHH
T ss_pred CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHH
Confidence 445567899999999999999999999999999999999999999999888877776643 356678899999999999
Q ss_pred HhhhcCCCCCC-----CHHHHHHH
Q 002160 910 ECWQTDPSLRP-----SFAQLTVA 928 (958)
Q Consensus 910 ~CL~kDP~kRP-----Sa~EIL~~ 928 (958)
+||++||.+|| ++.+|++|
T Consensus 238 ~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 238 GLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHhhcCHHHhcCCCCCCHHHHHcC
Confidence 99999999999 89999886
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=373.99 Aligned_cols=259 Identities=30% Similarity=0.583 Sum_probs=226.4
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC--Cce
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--PNL 748 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~--~~l 748 (958)
..+..++|++.+.||+|+||.||+|+++++.||||++............+.+|+.++++++||||+++++++... ..+
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 456778999999999999999999999999999999988777777778899999999999999999999999887 778
Q ss_pred EEEEeecCCCCHHHHHhCCCC-CccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 749 SIITEFLPRGSLFRILHRPHC-QVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~-~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
++||||+++|+|.+++.+... ...+...+.++ +.+.||.|||.++.+|+||||||+|||++.++.++|+|||++....
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999999999987653 34555555444 4499999999987779999999999999999999999999875432
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCc---hhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHH
Q 002160 827 NTFLSSKSTAGTPEWMAPEVLRNEPSNE---KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 903 (958)
Q Consensus 827 ~~~~~~~s~~GT~~Y~APEvl~g~~~s~---ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~e 903 (958)
. ....||+.|+|||++.+..+.. ++|||||||++|+|++|+.||.+.+..+....+......+.++..+++.
T Consensus 165 ~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (271)
T 3kmu_A 165 S-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPH 239 (271)
T ss_dssp C-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHH
T ss_pred c-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHH
Confidence 2 3356899999999998766544 7999999999999999999999988887777766666677888899999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhhhh
Q 002160 904 VARIIWECWQTDPSLRPSFAQLTVALKPLQR 934 (958)
Q Consensus 904 L~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k 934 (958)
+.+||.+||+.||.+||++.+|++.|+++.+
T Consensus 240 ~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 240 VSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 9999999999999999999999999999864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=371.91 Aligned_cols=259 Identities=31% Similarity=0.528 Sum_probs=224.3
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEE-CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceE
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~ 749 (958)
+.+..++|++.+.||+|+||.||+|++ +++.||||++....... .++.+|++++++++||||+++++++.+...++
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 81 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred EEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCCceE
Confidence 456778999999999999999999988 77889999987665443 46889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
+||||+++++|.+++........+...+.++.+ +.||.|||.++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCCCCEEecccccccccccc
Confidence 999999999999999876655666655555444 89999999998 999999999999999999999999999865433
Q ss_pred c-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHH
Q 002160 829 F-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 906 (958)
Q Consensus 829 ~-~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~d 906 (958)
. .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+....+....+. .......+..+++.+.+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 238 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQ 238 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTSCHHHHH
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-cCccCCCCCcCCHHHHH
Confidence 2 22334557889999999999999999999999999999999 999999988887776664 33455667788999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 907 IIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 907 LI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
||.+||+.||.+||++.+++++|+++.+.
T Consensus 239 li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 239 IMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 99999999999999999999999998764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=392.06 Aligned_cols=261 Identities=31% Similarity=0.528 Sum_probs=221.0
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEEC---------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEec
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMG 740 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~~---------g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g 740 (958)
+++..++|++++.||+|+||.||+|++. +..||||++... ........+.+|+.+|+++ +|||||++++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 4566689999999999999999999862 346999988654 3455677899999999999 8999999999
Q ss_pred cccCCCceEEEEeecCCCCHHHHHhCCCC---------------CccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCC
Q 002160 741 AVTRPPNLSIITEFLPRGSLFRILHRPHC---------------QVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSP 804 (958)
Q Consensus 741 ~~~~~~~l~LVmEy~~gGsL~d~L~k~~~---------------~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPe 804 (958)
+|...+.+|+||||+++|+|.+++..... ...+...+. +.+++.||.|||.++ ||||||||+
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~ 232 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAAR 232 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGG
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchh
Confidence 99999999999999999999999975432 234444444 444599999999998 999999999
Q ss_pred ceEEcCCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChh
Q 002160 805 NLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPM 881 (958)
Q Consensus 805 NILId~~g~VKL~DFGLAk~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ 881 (958)
||||+.++++||+|||+++....... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999999999999986544321 2233457889999999999999999999999999999999 99999998877
Q ss_pred HHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 882 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 882 ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
++...+. ...+...+..++.++.+||.+||+.||.+||++.||+++|+++...
T Consensus 313 ~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 313 ELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp GHHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 7766554 4456677888999999999999999999999999999999998754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=400.05 Aligned_cols=253 Identities=23% Similarity=0.333 Sum_probs=213.6
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCc
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~ 747 (958)
.+..++|++++.||+|+||.||+|++ +++.||||++.+... .......+.+|..+|+.+ +||||++++++|.+.+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 45678999999999999999999987 588999999876432 222345678999999998 79999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
+||||||++||+|.+++.+.........+.++.+++.||.|||.++ ||||||||+||||+.+|++||+|||+++....
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 9999999999999999987666666666677777799999999998 99999999999999999999999999986544
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHH
Q 002160 828 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 907 (958)
Q Consensus 828 ~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dL 907 (958)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+. .....+|..+++++++|
T Consensus 177 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~l 254 (353)
T 3txo_A 177 NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL--NDEVVYPTWLHEDATGI 254 (353)
T ss_dssp ---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHH
T ss_pred CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHH
Confidence 4444556789999999999999999999999999999999999999999999888887774 34566788899999999
Q ss_pred HHHhhhcCCCCCCCH------HHHHHH
Q 002160 908 IWECWQTDPSLRPSF------AQLTVA 928 (958)
Q Consensus 908 I~~CL~kDP~kRPSa------~EIL~~ 928 (958)
|.+||++||.+||++ .+|++|
T Consensus 255 i~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 255 LKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp HHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred HHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 999999999999998 777764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=384.84 Aligned_cols=263 Identities=31% Similarity=0.483 Sum_probs=222.2
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEE-----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~-----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~ 745 (958)
.++...+|++.+.||+|+||.||+|++ .+..||||++... ........+.+|+.+|++++||||+++++++.+.
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 356678999999999999999999987 3446999998654 3455667899999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 746 ~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
..+||||||+++++|.+++......+.+...+.++.+ +.||.|||..+ |+||||||+||||+.++.+||+|||+++.
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 9999999999999999999766555555555555544 89999999998 99999999999999999999999999987
Q ss_pred ccCCcc---cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCC
Q 002160 825 KHNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 900 (958)
Q Consensus 825 ~~~~~~---~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~l 900 (958)
...... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....++...+. .......+..+
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 279 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGYRLPAPMGC 279 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCCTTC
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCCCCCCCCc
Confidence 643321 2223446778999999999999999999999999999999 999999988887777664 34456677889
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhcC
Q 002160 901 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVI 937 (958)
Q Consensus 901 s~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~~ 937 (958)
++.+.+||.+||..||.+||++.+|++.|+.+.+...
T Consensus 280 ~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 280 PHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 9999999999999999999999999999999977633
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=387.59 Aligned_cols=267 Identities=30% Similarity=0.491 Sum_probs=221.7
Q ss_pred CccccccCCCCeeEEEEeeccCceEEEEEEE-------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEE
Q 002160 667 DVCECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLF 738 (958)
Q Consensus 667 ~~~~~eI~~~dy~i~k~LG~G~fG~Vykak~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL 738 (958)
....+++..++|++++.||+|+||.||+|++ +++.||||++.... .......+.+|+++|+++ +|||||++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 4456678889999999999999999999985 34789999986543 444567899999999999 79999999
Q ss_pred eccccCCCc-eEEEEeecCCCCHHHHHhCCCCC-----------------------------------------------
Q 002160 739 MGAVTRPPN-LSIITEFLPRGSLFRILHRPHCQ----------------------------------------------- 770 (958)
Q Consensus 739 ~g~~~~~~~-l~LVmEy~~gGsL~d~L~k~~~~----------------------------------------------- 770 (958)
++++...+. +++||||+++|+|.+++......
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999887654 89999999999999999765321
Q ss_pred ------------------ccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc--
Q 002160 771 ------------------VDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF-- 829 (958)
Q Consensus 771 ------------------~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~-- 829 (958)
+.+...+.++ +.+.||.|||.++ |+||||||+||||+.++.+||+|||+++......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 4444444444 4499999999998 9999999999999999999999999998653321
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHH
Q 002160 830 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 908 (958)
Q Consensus 830 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI 908 (958)
.......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+..............+..+++++.+||
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 329 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTM 329 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHH
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 22334568889999999999999999999999999999998 99999887755554444445556677888999999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHhhhhhc
Q 002160 909 WECWQTDPSLRPSFAQLTVALKPLQRLV 936 (958)
Q Consensus 909 ~~CL~kDP~kRPSa~EIL~~L~kL~k~~ 936 (958)
.+||+.||.+||++.||+++|+.+....
T Consensus 330 ~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 330 LDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 9999999999999999999999987653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=368.70 Aligned_cols=257 Identities=38% Similarity=0.659 Sum_probs=208.7
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCC--HHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceE
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFS--GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~--~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~ 749 (958)
++.+++|++.+.||+|+||.||+|++.++.||||++...... ......+.+|+++++.++||||+++++++.+.+.++
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 567789999999999999999999999999999998654322 223467889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHH-HHHHHHHHHHHHhcCC-cEeecCCCCCceEEcC--------CCcEEEEec
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDARGMNCLHTSTP-TIVHRDLKSPNLLVDK--------NWNVKVSDF 819 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~-ia~~a~aL~yLH~~g~-gIIHRDLKPeNILId~--------~g~VKL~DF 819 (958)
+||||+++++|.+++... ...+..... +.+.+.||.|||.++. +|+||||||+|||++. ++.+||+||
T Consensus 83 lv~e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 999999999999998654 334444444 4445999999999874 3899999999999986 788999999
Q ss_pred cccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCC
Q 002160 820 GLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE 899 (958)
Q Consensus 820 GLAk~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ 899 (958)
|+++...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+........++..
T Consensus 161 g~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (271)
T 3dtc_A 161 GLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST 238 (271)
T ss_dssp CC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTT
T ss_pred Cccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcc
Confidence 9998654432 23457999999999999999999999999999999999999999998887777766656666777889
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 002160 900 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 900 ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL 932 (958)
+++.+.+||.+||+.||.+||++.|++++|++|
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 999999999999999999999999999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=381.39 Aligned_cols=265 Identities=33% Similarity=0.499 Sum_probs=217.3
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEE
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~L 750 (958)
+..++|++++.||+|+||.||+|++ +++.||||++... .......+.+|+++|++++||||+++++++.+...+++
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF 84 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEE
Confidence 4567899999999999999999987 5889999987543 45667789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc
Q 002160 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 751 VmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~ 829 (958)
||||+++++|.+++........+...+.++.+ +.||.|||.++ |+||||||+||||+.++.+||+|||+++......
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 99999999999999875555565555555544 99999999998 9999999999999999999999999998654322
Q ss_pred cc--------------CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhh-hcccccc
Q 002160 830 LS--------------SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV-GFQNRRL 894 (958)
Q Consensus 830 ~~--------------~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i-~~~~~~~ 894 (958)
.. .....||+.|+|||++.+..++.++||||||+++|+|++|..||............ .......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence 11 11467999999999999999999999999999999999999998764332111000 0011123
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhcCCCCC
Q 002160 895 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHP 941 (958)
Q Consensus 895 ~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~~p~~P 941 (958)
..+..+++.+.+||.+||+.||.+||++.+|++.|+.+........|
T Consensus 243 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~~~ 289 (310)
T 3s95_A 243 YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLP 289 (310)
T ss_dssp TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHCCC
T ss_pred cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCccc
Confidence 35678899999999999999999999999999999999776544433
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=379.42 Aligned_cols=249 Identities=26% Similarity=0.414 Sum_probs=212.5
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
.++|++.+.||+|+||.||+|++ +++.||||++....... ...+.+|+.++++++||||+++++++...+.+|+||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 46799999999999999999975 78899999987654332 356789999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
||+++|+|.+++.+.. .........+.+.+.||.|||.++ |+||||||+|||++.++.+||+|||++..........
T Consensus 97 e~~~~~~L~~~~~~~~-~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 173 (297)
T 3fxz_A 97 EYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (297)
T ss_dssp ECCTTCBHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred ECCCCCCHHHHHhhcC-CCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccccc
Confidence 9999999999997653 333344444445599999999998 9999999999999999999999999998776554445
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhc-cccccCCCCCCcHHHHHHHHHh
Q 002160 833 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF-QNRRLEIPKELDPLVARIIWEC 911 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~-~~~~~~ip~~ls~eL~dLI~~C 911 (958)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.. .......+..++..+++||.+|
T Consensus 174 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 253 (297)
T 3fxz_A 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253 (297)
T ss_dssp CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHH
T ss_pred CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHH
Confidence 567899999999999999999999999999999999999999998887665554432 2223455678999999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 002160 912 WQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 912 L~kDP~kRPSa~EIL~~ 928 (958)
|+.||.+||++.|++++
T Consensus 254 l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 254 LEMDVEKRGSAKELLQH 270 (297)
T ss_dssp SCSSTTTSCCHHHHTTC
T ss_pred ccCChhHCcCHHHHhhC
Confidence 99999999999999875
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=384.37 Aligned_cols=253 Identities=25% Similarity=0.375 Sum_probs=207.4
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE-----CCcEEEEEEeecCCCC--HHHHHHHHHHHHHHHHcCCCceeEEeccccC
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFS--GAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~-----~g~~VAVK~i~~~~~~--~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~ 744 (958)
.+..++|++.+.||+|+||.||+|++ +++.||||++.+.... ......+.+|+.+|++++||||+++++++..
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 45668999999999999999999986 6889999998765432 2334567899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 745 ~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
.+.+|+||||+++++|.+++.+.+.........++.+++.||.|||.++ |+||||||+||||+.++++||+|||+++.
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 9999999999999999999987655555555566666699999999998 99999999999999999999999999986
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHH
Q 002160 825 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 904 (958)
Q Consensus 825 ~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL 904 (958)
...........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+. .....+|..++.++
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~ 248 (327)
T 3a62_A 171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL--KCKLNLPPYLTQEA 248 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--HTCCCCCTTSCHHH
T ss_pred cccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHH
Confidence 5433333455789999999999999999999999999999999999999999988877776664 23556778899999
Q ss_pred HHHHHHhhhcCCCCCC-----CHHHHHHH
Q 002160 905 ARIIWECWQTDPSLRP-----SFAQLTVA 928 (958)
Q Consensus 905 ~dLI~~CL~kDP~kRP-----Sa~EIL~~ 928 (958)
++||.+||+.||.+|| ++.++++|
T Consensus 249 ~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 249 RDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred HHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 9999999999999999 78888875
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=394.97 Aligned_cols=255 Identities=20% Similarity=0.305 Sum_probs=217.2
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeccccCC
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRP 745 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~ 745 (958)
...+..++|++++.||+|+||.||+|++ +++.||||++.+... .......+..|..+|..+ +||||+++++++.+.
T Consensus 14 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 93 (353)
T 2i0e_A 14 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 93 (353)
T ss_dssp -----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS
T ss_pred cCCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC
Confidence 3456778999999999999999999988 467899999876432 112345678899999988 899999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 746 ~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
+.+||||||++||+|.+++.+.+.......+.++.+++.||.|||.++ |+||||||+||||+.+|++||+|||+++..
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 999999999999999999987655556666666677799999999998 999999999999999999999999999865
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHH
Q 002160 826 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 905 (958)
Q Consensus 826 ~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~ 905 (958)
..........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+.. ....+|..++++++
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~ 249 (353)
T 2i0e_A 172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPKSMSKEAV 249 (353)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHH
T ss_pred ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHH
Confidence 4433445567899999999999999999999999999999999999999999988888777743 35667889999999
Q ss_pred HHHHHhhhcCCCCCCC-----HHHHHHH
Q 002160 906 RIIWECWQTDPSLRPS-----FAQLTVA 928 (958)
Q Consensus 906 dLI~~CL~kDP~kRPS-----a~EIL~~ 928 (958)
+||.+||++||.+||+ +.+|++|
T Consensus 250 ~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 250 AICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred HHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 9999999999999995 5788765
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=387.75 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=214.7
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCce
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNL 748 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~l 748 (958)
+..++|++++.||+|+||.||+|++ +++.||||++.+... .......+.+|+.+|+++ +|||||+++++|.+...+
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 4567899999999999999999987 588999999987654 344566788999999998 899999999999999999
Q ss_pred EEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
|+||||+++|+|.+++.+.+.......+.++.+++.||.|||.++ |+||||||+||||+.+|++||+|||+++.....
T Consensus 86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 999999999999999987655556666666677799999999998 999999999999999999999999999865443
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---------ChhHHHHhhhccccccCCCCC
Q 002160 829 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM---------NPMQVVGAVGFQNRRLEIPKE 899 (958)
Q Consensus 829 ~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~---------~~~ei~~~i~~~~~~~~ip~~ 899 (958)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||... ....+...+ ......+|..
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~~p~~ 241 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIPRS 241 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH--HHCCCCCCTT
T ss_pred CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH--HcCCCCCCCC
Confidence 34455678999999999999999999999999999999999999999752 222233333 2345667889
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 002160 900 LDPLVARIIWECWQTDPSLRPSF------AQLTVA 928 (958)
Q Consensus 900 ls~eL~dLI~~CL~kDP~kRPSa------~EIL~~ 928 (958)
+++++++||.+||+.||.+||++ .+|+.|
T Consensus 242 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 99999999999999999999985 677665
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=367.49 Aligned_cols=259 Identities=33% Similarity=0.576 Sum_probs=220.0
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEEC-CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceE
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~~-g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~ 749 (958)
.++..++|++.+.||+|+||.||+|++. +..||||++....... .++.+|++++++++||||+++++++.+...++
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY 79 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred eEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence 3566789999999999999999999884 5579999987655443 46889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
+||||+++++|.+++......+.+...+.++.+ +.||.|||..+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 999999999999999765544555555554444 89999999998 999999999999999999999999999865443
Q ss_pred c-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHH
Q 002160 829 F-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 906 (958)
Q Consensus 829 ~-~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~d 906 (958)
. .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+. .......+..+++.+.+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~ 236 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLASDTIYQ 236 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTSCHHHHH
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH-cCCCCCCCCcChHHHHH
Confidence 2 22233456778999999999889999999999999999999 999999888877766654 34455567778999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 907 IIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 907 LI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
||.+||+.||.+||++.+|+++|+.+.+.
T Consensus 237 li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 237 IMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 99999999999999999999999998653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=369.66 Aligned_cols=261 Identities=30% Similarity=0.489 Sum_probs=219.6
Q ss_pred cccccCCCCeeEEEEeeccCceEEEEEEEC-CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc
Q 002160 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 669 ~~~eI~~~dy~i~k~LG~G~fG~Vykak~~-g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~ 747 (958)
..+++..++|++++.||+|+||.||+|++. +..||||++....... .++.+|++++++++||||+++++++.+...
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 93 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 93 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecCCC
Confidence 345677889999999999999999999884 5589999987665443 468899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHH-HHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
+++||||+++++|.+++......+.+...+.++. .+.||.|||.++ |+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 9999999999999999987444455555555444 489999999998 9999999999999999999999999998654
Q ss_pred CCc-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHH
Q 002160 827 NTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 904 (958)
Q Consensus 827 ~~~-~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL 904 (958)
... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+. .......+..+++.+
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 250 (283)
T 3gen_A 172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKV 250 (283)
T ss_dssp CHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHH
T ss_pred ccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh-cccCCCCCCcCCHHH
Confidence 322 22233457788999999999999999999999999999998 999999988877776664 344555677889999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 905 ARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 905 ~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
.+||.+||+.||.+||++.+|+++|+++.+.
T Consensus 251 ~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 251 YTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 9999999999999999999999999998754
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=394.33 Aligned_cols=253 Identities=24% Similarity=0.388 Sum_probs=216.7
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCc
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~ 747 (958)
.+..++|++.+.||+|+||.||+|++ +++.||||++.+... .......+..|..+|..+ +||||+++++++.+...
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 45678999999999999999999987 588999999876421 112245677899999987 89999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
+|+||||++||+|.+++.+.+.......+.++.+++.||.|||.++ |+||||||+||||+.+|++||+|||+++....
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 9999999999999999987655555666666667799999999998 99999999999999999999999999986543
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHH
Q 002160 828 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 907 (958)
Q Consensus 828 ~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dL 907 (958)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+.. ....+|..+++++++|
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~l 248 (345)
T 1xjd_A 171 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--DNPFYPRWLEKEAKDL 248 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHH
T ss_pred CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh--CCCCCCcccCHHHHHH
Confidence 33345567899999999999999999999999999999999999999999988888777743 3556788899999999
Q ss_pred HHHhhhcCCCCCCCHH-HHHHH
Q 002160 908 IWECWQTDPSLRPSFA-QLTVA 928 (958)
Q Consensus 908 I~~CL~kDP~kRPSa~-EIL~~ 928 (958)
|.+||..||.+||++. +|++|
T Consensus 249 i~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 249 LVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGS
T ss_pred HHHHhcCCHhHcCCChHHHHcC
Confidence 9999999999999997 77643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=380.22 Aligned_cols=262 Identities=29% Similarity=0.474 Sum_probs=220.8
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEECC-------cEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccc
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 742 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~~g-------~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~ 742 (958)
..++..++|++++.||+|+||.||+|++.+ +.||||++.... .......+.+|+.+|++++||||+++++++
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 345677899999999999999999998753 789999987543 445567899999999999999999999999
Q ss_pred cCCCceEEEEeecCCCCHHHHHhCCC-----------------------CCccHHHHHHHH-HHHHHHHHHHhcCCcEee
Q 002160 743 TRPPNLSIITEFLPRGSLFRILHRPH-----------------------CQVDEKRRIKMA-LDARGMNCLHTSTPTIVH 798 (958)
Q Consensus 743 ~~~~~l~LVmEy~~gGsL~d~L~k~~-----------------------~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIH 798 (958)
.+.+.+++||||+++|+|.+++.+.. ..+.+...+.++ +.+.||.|||.++ |+|
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH 197 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVH 197 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eec
Confidence 99999999999999999999997532 234444444444 4499999999998 999
Q ss_pred cCCCCCceEEcCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 002160 799 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPW 875 (958)
Q Consensus 799 RDLKPeNILId~~g~VKL~DFGLAk~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF 875 (958)
|||||+||||+.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 9999999999999999999999998654322 12234567889999999999999999999999999999999 99999
Q ss_pred CCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 876 IGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 876 ~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
.+.+..++...+. ......++..+++.+.+||.+||+.||.+||++.+|++.|+++...
T Consensus 278 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 278 YGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp TTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CCCChHHHHHHHh-CCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 9988877776664 3445567788999999999999999999999999999999998654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=384.33 Aligned_cols=249 Identities=24% Similarity=0.399 Sum_probs=217.1
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceE
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~ 749 (958)
+..++|++++.||+|+||.||+|+. +++.||||++.+.... ......+.+|+.+|+.++||||+++++++.+...+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 3457899999999999999999987 6889999998754321 122456788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~ 829 (958)
+||||++||+|.+++.+.........+.++.+++.||.|||.++ |+||||||+||||+.+|++||+|||+++.....
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 99999999999999987665555666666667799999999998 999999999999999999999999999876433
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHH
Q 002160 830 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 909 (958)
Q Consensus 830 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~ 909 (958)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.. ....+|..+++++++||.
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li~ 235 (318)
T 1fot_A 160 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--AELRFPPFFNEDVKDLLS 235 (318)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHHH
T ss_pred --cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHHHHH
Confidence 2356899999999999999999999999999999999999999999888877776643 356678889999999999
Q ss_pred HhhhcCCCCCC-----CHHHHHHH
Q 002160 910 ECWQTDPSLRP-----SFAQLTVA 928 (958)
Q Consensus 910 ~CL~kDP~kRP-----Sa~EIL~~ 928 (958)
+||+.||.+|| ++++|++|
T Consensus 236 ~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 236 RLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHhccCHHHcCCCcCCCHHHHhcC
Confidence 99999999999 88999865
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=372.61 Aligned_cols=263 Identities=31% Similarity=0.516 Sum_probs=222.4
Q ss_pred cccccCCCCeeEEEEeeccCceEEEEEEE-------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEecc
Q 002160 669 CECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 741 (958)
Q Consensus 669 ~~~eI~~~dy~i~k~LG~G~fG~Vykak~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~ 741 (958)
..+++..++|.+++.||+|+||.||+|++ .++.||||++... ........+.+|+++|++++||||++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 94 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGA 94 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence 45667788999999999999999999976 2378999988654 345566789999999999999999999999
Q ss_pred ccCCCceEEEEeecCCCCHHHHHhCCCC-----------------------CccHHHHHHH-HHHHHHHHHHHhcCCcEe
Q 002160 742 VTRPPNLSIITEFLPRGSLFRILHRPHC-----------------------QVDEKRRIKM-ALDARGMNCLHTSTPTIV 797 (958)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~d~L~k~~~-----------------------~~~e~~~l~i-a~~a~aL~yLH~~g~gII 797 (958)
+.+.+.+++||||+++++|.+++..... ...+...+.+ .+.+.||.|||.++ |+
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iv 172 (314)
T 2ivs_A 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LV 172 (314)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Cc
Confidence 9999999999999999999999975432 2344444444 44499999999998 99
Q ss_pred ecCCCCCceEEcCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 002160 798 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLP 874 (958)
Q Consensus 798 HRDLKPeNILId~~g~VKL~DFGLAk~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~P 874 (958)
||||||+||||+.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999998654322 22234457889999999999989999999999999999999 9999
Q ss_pred CCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 875 WIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 875 F~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
|.+....++...+. .......+..+++.+.+||.+||+.||.+||++.+|+++|+++...
T Consensus 253 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 253 YPGIPPERLFNLLK-TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp STTCCGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCHHHHHHHhh-cCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 99988777766554 3445667788999999999999999999999999999999998654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=392.35 Aligned_cols=262 Identities=31% Similarity=0.541 Sum_probs=223.4
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~ 747 (958)
.+.+..++|++++.||+|+||.||+|++ +++.||||.+... .......+|.+|+++|++++|||||++++++...+.
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP 186 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence 4567778999999999999999999998 5889999988644 344555678999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHH-HHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
+|+||||+++|+|.+++...+....+...+.++. .+.||+|||.++ |+||||||+||||+.++.+||+|||+++...
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 9999999999999999986554455555555444 499999999998 9999999999999999999999999998654
Q ss_pred CCcccCC--CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHH
Q 002160 827 NTFLSSK--STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 903 (958)
Q Consensus 827 ~~~~~~~--s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~e 903 (958)
....... ...++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+. ...+...|..++..
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 343 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPELCPDA 343 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH-TTCCCCCCTTCCHH
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 3322111 1234678999999998889999999999999999998 999999988877766554 44566778889999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 904 VARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 904 L~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
+.+||.+||+.||.+||++.+|++.|+.+.+.
T Consensus 344 l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 344 VFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 99999999999999999999999999998764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=396.22 Aligned_cols=253 Identities=23% Similarity=0.349 Sum_probs=213.9
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCH-HHHHHHHHHHHHHHHc-CCCceeEEeccccCCCc
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~ 747 (958)
.+..++|++++.||+|+||+||+|++ +++.||||++.+..... .....+.+|..+|.++ +|||||+++++|.+...
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 45678999999999999999999987 57889999998764432 3345678899999987 89999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
+||||||++||+|..++.+.+.......+.++.+++.||.|||.++ ||||||||+||||+.+|++||+|||+++....
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 9999999999999999987666666667777777799999999998 99999999999999999999999999986444
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---------hhHHHHhhhccccccCCCC
Q 002160 828 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN---------PMQVVGAVGFQNRRLEIPK 898 (958)
Q Consensus 828 ~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~---------~~ei~~~i~~~~~~~~ip~ 898 (958)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+ ......+|.
T Consensus 206 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~~p~ 283 (396)
T 4dc2_A 206 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIPR 283 (396)
T ss_dssp TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH--HHCCCCCCT
T ss_pred CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH--hccccCCCC
Confidence 4444567889999999999999999999999999999999999999996432 12223333 344667888
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 002160 899 ELDPLVARIIWECWQTDPSLRPSF------AQLTVA 928 (958)
Q Consensus 899 ~ls~eL~dLI~~CL~kDP~kRPSa------~EIL~~ 928 (958)
.+++++++||.+||++||.+||++ .||++|
T Consensus 284 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 999999999999999999999985 677664
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=384.28 Aligned_cols=266 Identities=31% Similarity=0.524 Sum_probs=225.9
Q ss_pred cccccCCCCeeEEEEeeccCceEEEEEEEC---------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEE
Q 002160 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLF 738 (958)
Q Consensus 669 ~~~eI~~~dy~i~k~LG~G~fG~Vykak~~---------g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL 738 (958)
..+++..++|++++.||+|+||.||+|++. +..||||++... .......++.+|+++++++ +|||||++
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~ 140 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINL 140 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence 345778899999999999999999999863 257999998655 3455667899999999999 99999999
Q ss_pred eccccCCCceEEEEeecCCCCHHHHHhCCC---------------CCccHHHHHHHHH-HHHHHHHHHhcCCcEeecCCC
Q 002160 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDLK 802 (958)
Q Consensus 739 ~g~~~~~~~l~LVmEy~~gGsL~d~L~k~~---------------~~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDLK 802 (958)
++++...+.+++||||+++|+|.+++.... ..+.+...+.++. ++.||.|||..+ |+|||||
T Consensus 141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlk 218 (382)
T 3tt0_A 141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLA 218 (382)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCC
T ss_pred eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCC
Confidence 999999999999999999999999997543 2345555555444 499999999998 9999999
Q ss_pred CCceEEcCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 002160 803 SPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMN 879 (958)
Q Consensus 803 PeNILId~~g~VKL~DFGLAk~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~ 879 (958)
|+||||+.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+
T Consensus 219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp GGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999998764332 22334457889999999999999999999999999999999 999999988
Q ss_pred hhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhcCC
Q 002160 880 PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 938 (958)
Q Consensus 880 ~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~~p 938 (958)
..++...+. .......+..+++++.+||.+||+.||.+||++.+|+++|+++......
T Consensus 299 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 299 VEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp HHHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred HHHHHHHHH-cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 877776664 4456667788999999999999999999999999999999999766433
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=363.01 Aligned_cols=259 Identities=31% Similarity=0.524 Sum_probs=222.2
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEE-CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceE
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~ 749 (958)
+.+..++|++.+.||+|+||.||+|++ +++.||||++....... ..+.+|++++++++||||+++++++.+.+.++
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred eEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence 456778999999999999999999988 67789999987665443 46889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHHH-HHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
+||||+++++|.+++........+...+.++. .+.||.|||.++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCCCCEEEcccccccccccc
Confidence 99999999999999987655555555555444 489999999998 999999999999999999999999999865432
Q ss_pred c-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHH
Q 002160 829 F-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 906 (958)
Q Consensus 829 ~-~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~d 906 (958)
. .......++..|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..+....+. .......+..++..+.+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~ 236 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQ 236 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTSCHHHHH
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHh-cCCcCCCCccCcHHHHH
Confidence 1 22234557889999999999899999999999999999999 899999988877776664 33345567788999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 907 IIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 907 LI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
||.+||+.||.+||++.+++++|+++.+.
T Consensus 237 li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 237 IMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999998764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=385.90 Aligned_cols=250 Identities=24% Similarity=0.383 Sum_probs=215.0
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
++|++++.||+|+||.||+|.+ +++.||||++............+.+|+.+|++++|||||++++++.+.+.+|+|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 5799999999999999999987 58899999998877777777889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCC---CcEEEEeccccccccCCcc
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKN---WNVKVSDFGLSRLKHNTFL 830 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~---g~VKL~DFGLAk~~~~~~~ 830 (958)
|+++|+|.+++..............+.+++.||.|||.++ |+||||||+||||+.+ +.+||+|||+++......
T Consensus 109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~- 185 (362)
T 2bdw_A 109 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE- 185 (362)
T ss_dssp CCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC-
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc-
Confidence 9999999999987655555555555556699999999998 9999999999999864 459999999998765432
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCC--CCCcHHHHHHH
Q 002160 831 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARII 908 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip--~~ls~eL~dLI 908 (958)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..++...+.........+ ..+++++++||
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 265 (362)
T 2bdw_A 186 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 265 (362)
T ss_dssp SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHH
T ss_pred ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 2345689999999999999999999999999999999999999999988877776664332222221 36799999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 002160 909 WECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 909 ~~CL~kDP~kRPSa~EIL~~ 928 (958)
.+||+.||.+||++.+++++
T Consensus 266 ~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 266 DSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHSCSSGGGSCCHHHHTTS
T ss_pred HHHcCCChhhCcCHHHHhcC
Confidence 99999999999999998865
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=397.82 Aligned_cols=251 Identities=25% Similarity=0.339 Sum_probs=217.4
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
++|++++.||+|+||.||+|.+ +++.||+|++............+.+|+.+|++++|||||++++++.+.+.+|+|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 5799999999999999999986 78899999998877766677789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEc---CCCcEEEEeccccccccCCcc
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVD---KNWNVKVSDFGLSRLKHNTFL 830 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId---~~g~VKL~DFGLAk~~~~~~~ 830 (958)
|++||+|.+++..............+.+++.||.|||.++ |+||||||+|||++ .++.+||+|||+++.......
T Consensus 91 ~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~ 168 (444)
T 3soa_A 91 LVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168 (444)
T ss_dssp CCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence 9999999999887665555555555666699999999998 99999999999998 568899999999987765544
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCC--CCCCcHHHHHHH
Q 002160 831 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI--PKELDPLVARII 908 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~i--p~~ls~eL~dLI 908 (958)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......... ...+++++++||
T Consensus 169 ~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 248 (444)
T 3soa_A 169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLI 248 (444)
T ss_dssp BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHH
T ss_pred eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHH
Confidence 445678999999999999999999999999999999999999999999888877776543322222 246899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 002160 909 WECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 909 ~~CL~kDP~kRPSa~EIL~~ 928 (958)
.+||+.||.+||++.|+++|
T Consensus 249 ~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 249 NKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHSCSSTTTSCCHHHHHHS
T ss_pred HHHcCCChhHCCCHHHHhcC
Confidence 99999999999999999875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=386.01 Aligned_cols=250 Identities=25% Similarity=0.391 Sum_probs=213.4
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCH----HHHHHHHHHHHHHHHcCCCceeEEeccccCCCceE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~----~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~ 749 (958)
++|++++.||+|+||.||+|++ +++.||||++....... .....+.+|+.+|++++|||||+++++|.+...+|
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 5799999999999999999987 58899999998754322 13467899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCC----cEEEEeccccccc
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNW----NVKVSDFGLSRLK 825 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g----~VKL~DFGLAk~~ 825 (958)
+||||++||+|.+++.+...........++.+++.||.|||.++ |+||||||+|||++.++ ++||+|||+++..
T Consensus 92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 99999999999999987665555555555666699999999998 99999999999998776 7999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccccc--CCCCCCcHH
Q 002160 826 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPL 903 (958)
Q Consensus 826 ~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~--~ip~~ls~e 903 (958)
... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+....... .++..++.+
T Consensus 170 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 248 (361)
T 2yab_A 170 EDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248 (361)
T ss_dssp CTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHH
T ss_pred CCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHH
Confidence 543 22345789999999999999999999999999999999999999999988888777664322111 122568999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 904 VARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 904 L~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+++||.+||..||.+||++.|+++|
T Consensus 249 ~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 249 AKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcC
Confidence 9999999999999999999999863
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=372.39 Aligned_cols=253 Identities=25% Similarity=0.393 Sum_probs=203.4
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCH------------------------HHHHHHHHHHHH
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG------------------------AALLEFKREVKI 726 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~------------------------~~~~~f~~Ei~I 726 (958)
+..++|++.+.||+|+||.||+|++ +++.||||++....... .....+.+|+++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 3457899999999999999999986 68899999987654321 123568899999
Q ss_pred HHHcCCCceeEEeccccC--CCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCC
Q 002160 727 MRRLRHPNVVLFMGAVTR--PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSP 804 (958)
Q Consensus 727 Lk~L~HPNIVkL~g~~~~--~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPe 804 (958)
|++++||||+++++++.+ ...+|+||||+++++|.+++... ..........+.+.+.||.|||.++ |+||||||+
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~ 166 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK-PLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPS 166 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHH
Confidence 999999999999999876 56799999999999998876543 2333333444445599999999998 999999999
Q ss_pred ceEEcCCCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCChh
Q 002160 805 NLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP---SNEKCDVYSFGVILWELATLKLPWIGMNPM 881 (958)
Q Consensus 805 NILId~~g~VKL~DFGLAk~~~~~~~~~~s~~GT~~Y~APEvl~g~~---~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ 881 (958)
||||+.++++||+|||+++.............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 99999999999999999987655433344567999999999998765 378899999999999999999999988877
Q ss_pred HHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 882 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 882 ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.....+............+++++++||.+||+.||.+||++.||++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 247 CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 66665543333333335789999999999999999999999999865
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=368.17 Aligned_cols=261 Identities=30% Similarity=0.506 Sum_probs=209.8
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEEC-----CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~~-----g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~ 744 (958)
.+++..++|++++.||+|+||.||+|++. +..||||++.... .......+.+|+.++++++||||+++++++.
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 86 (281)
T 1mp8_A 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 86 (281)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence 45677789999999999999999999873 3469999876532 4455678999999999999999999999985
Q ss_pred CCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccc
Q 002160 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 823 (958)
Q Consensus 745 ~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk 823 (958)
.+..|+||||+++++|.+++........+...+.++ +.+.||.|||.++ |+||||||+|||++.++++||+|||+++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCCCCEEECcccccc
Confidence 467899999999999999998665455555555544 4499999999998 9999999999999999999999999998
Q ss_pred cccCCcc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCc
Q 002160 824 LKHNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 901 (958)
Q Consensus 824 ~~~~~~~-~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls 901 (958)
....... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+. ......++..++
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~~~ 243 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCP 243 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTCC
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH-cCCCCCCCCCCC
Confidence 7643321 2233456789999999999999999999999999999996 999999888777766664 334556778899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 902 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 902 ~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
+.+.+||.+||+.||.+||++.+|++.|+++.+.
T Consensus 244 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 244 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999998654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=366.57 Aligned_cols=256 Identities=32% Similarity=0.584 Sum_probs=213.1
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHH-----HHHHHHHHHHHHcCCCceeEEeccccC
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAAL-----LEFKREVKIMRRLRHPNVVLFMGAVTR 744 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~-----~~f~~Ei~ILk~L~HPNIVkL~g~~~~ 744 (958)
.+..++|++.+.||+|+||.||+|++ +++.||||++.......... ..+.+|+.++++++||||+++++++.+
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 35568899999999999999999987 68899999987654332211 678999999999999999999999876
Q ss_pred CCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCc-----EEEEe
Q 002160 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN-----VKVSD 818 (958)
Q Consensus 745 ~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~-----VKL~D 818 (958)
.. ++||||+++++|.+++.+......+...+.++.+ +.||.|||.++.+|+||||||+|||++.++. +||+|
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 55 7999999999999988776655666655555544 9999999998777999999999999988776 99999
Q ss_pred ccccccccCCcccCCCCCCCCCccCccccc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHH--HHhhhcccccc
Q 002160 819 FGLSRLKHNTFLSSKSTAGTPEWMAPEVLR--NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV--VGAVGFQNRRL 894 (958)
Q Consensus 819 FGLAk~~~~~~~~~~s~~GT~~Y~APEvl~--g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei--~~~i~~~~~~~ 894 (958)
||+++..... .....||+.|+|||++. +..++.++|||||||++|+|++|+.||........ ...+.......
T Consensus 173 fg~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 249 (287)
T 4f0f_A 173 FGLSQQSVHS---VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249 (287)
T ss_dssp CTTCBCCSSC---EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCC
T ss_pred CCcccccccc---ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCC
Confidence 9999754432 33467999999999994 45578999999999999999999999987654433 34444445566
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 002160 895 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 895 ~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL 932 (958)
.++..+++.+.+||.+||+.||.+||++.+|++.|++|
T Consensus 250 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 250 TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 77889999999999999999999999999999999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=375.59 Aligned_cols=268 Identities=30% Similarity=0.519 Sum_probs=223.2
Q ss_pred cccccCCCCeeEEEEeeccCceEEEEEEE---------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEE
Q 002160 669 CECEIPWEDLVLGERIGLGSYGEVYHADW---------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLF 738 (958)
Q Consensus 669 ~~~eI~~~dy~i~k~LG~G~fG~Vykak~---------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL 738 (958)
..+++..++|++++.||+|+||.||+|++ ++..||||++.... .......+.+|+.+++++ +||||+++
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~ 106 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL 106 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence 44567788999999999999999999986 35679999986543 455667899999999999 89999999
Q ss_pred eccccCCCceEEEEeecCCCCHHHHHhCCCC---------------CccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCC
Q 002160 739 MGAVTRPPNLSIITEFLPRGSLFRILHRPHC---------------QVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLK 802 (958)
Q Consensus 739 ~g~~~~~~~l~LVmEy~~gGsL~d~L~k~~~---------------~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLK 802 (958)
++++...+.+++||||+++|+|.+++..... ...+...+.++ +++.||.|||.++ |+|||||
T Consensus 107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlk 184 (334)
T 2pvf_A 107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLA 184 (334)
T ss_dssp EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCS
T ss_pred EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCc
Confidence 9999999999999999999999999976542 23444444444 4499999999998 9999999
Q ss_pred CCceEEcCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 002160 803 SPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMN 879 (958)
Q Consensus 803 PeNILId~~g~VKL~DFGLAk~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~ 879 (958)
|+||||+.++.+||+|||+++...... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+..
T Consensus 185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp GGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 999999999999999999998764432 12233457889999999999889999999999999999999 999999988
Q ss_pred hhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhcCCCC
Q 002160 880 PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSH 940 (958)
Q Consensus 880 ~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~~p~~ 940 (958)
..++...+. .......+..++..+.+||.+||+.||.+||++.+|+++|+++.......+
T Consensus 265 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~~ 324 (334)
T 2pvf_A 265 VEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE 324 (334)
T ss_dssp HHHHHHHHH-HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred HHHHHHHHh-cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccCc
Confidence 777666554 334556778899999999999999999999999999999999977654443
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=376.51 Aligned_cols=267 Identities=28% Similarity=0.475 Sum_probs=206.1
Q ss_pred cccccCCCCeeEEEEeeccCceEEEEEEECC-----cEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEecccc
Q 002160 669 CECEIPWEDLVLGERIGLGSYGEVYHADWNG-----TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT 743 (958)
Q Consensus 669 ~~~eI~~~dy~i~k~LG~G~fG~Vykak~~g-----~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~ 743 (958)
....+..++|++++.||+|+||.||+|++.. ..||||++............+.+|++++++++||||+++++++.
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 3456777899999999999999999998632 27999998776555566788999999999999999999999998
Q ss_pred CCCce------EEEEeecCCCCHHHHHhCCC-----CCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCC
Q 002160 744 RPPNL------SIITEFLPRGSLFRILHRPH-----CQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKN 811 (958)
Q Consensus 744 ~~~~l------~LVmEy~~gGsL~d~L~k~~-----~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~ 811 (958)
..... ++||||+++|+|.+++.... ..+.+...+.++ +.+.||.|||..+ |+||||||+||||+.+
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAED 173 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEcCC
Confidence 77655 99999999999999885322 134444444444 4499999999998 9999999999999999
Q ss_pred CcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhh
Q 002160 812 WNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVG 888 (958)
Q Consensus 812 g~VKL~DFGLAk~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~ 888 (958)
+.+||+|||+++....... ......+++.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..+....+.
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~ 253 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI 253 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh
Confidence 9999999999986543221 1223456789999999999999999999999999999999 999999988877776664
Q ss_pred ccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhcCC
Q 002160 889 FQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 938 (958)
Q Consensus 889 ~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~~p 938 (958)
.......+..++.++.+||.+||+.||.+||++.++++.|+++....+.
T Consensus 254 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~ 302 (323)
T 3qup_A 254 -GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV 302 (323)
T ss_dssp -TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred -cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhh
Confidence 3445666778999999999999999999999999999999999776554
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=373.55 Aligned_cols=254 Identities=24% Similarity=0.299 Sum_probs=204.1
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE-CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEE
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~L 750 (958)
+-..++|++++.||+|+||.||+|++ +++.||||++............+.+|+++|++++||||+++++++.+...+++
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 34457899999999999999999987 68899999987665444456778899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhCCCCCccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc
Q 002160 751 ITEFLPRGSLFRILHRPHCQVDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 751 VmEy~~gGsL~d~L~k~~~~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~ 829 (958)
||||+++ +|.+++......+.+.... .+.+.+.||.|||.++ |+||||||+|||++.++.+||+|||+++......
T Consensus 97 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 97 VFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp EEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred EEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9999975 8888887665545544444 4445599999999998 9999999999999999999999999998765444
Q ss_pred ccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccc---------------
Q 002160 830 LSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--------------- 893 (958)
Q Consensus 830 ~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~--------------- 893 (958)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+......
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence 44455679999999999987 56899999999999999999999999887665544333110000
Q ss_pred -------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 894 -------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 894 -------------~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
..+...+++++++||.+||+.||.+||++.|+++|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00123467899999999999999999999999874
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=368.68 Aligned_cols=250 Identities=22% Similarity=0.279 Sum_probs=202.9
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
++|++++.||+|+||.||+|++ +++.||||++............+.+|+.++++++||||+++++++.+...+++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 6899999999999999999987 68899999998776666666788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhC-CCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 754 FLPRGSLFRILHR-PHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 754 y~~gGsL~d~L~k-~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
|+++ +|.+++.. .+.......+..+.+.+.||.|||.++ |+||||||+|||++.++++||+|||+++.........
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence 9976 55555544 333334444444555599999999998 9999999999999999999999999998775554445
Q ss_pred CCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCC-CCCChhHHHHhhhccc-------------------
Q 002160 833 KSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPW-IGMNPMQVVGAVGFQN------------------- 891 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g~~-~s~ksDIWSLGiLLyELLtG~~PF-~g~~~~ei~~~i~~~~------------------- 891 (958)
....||+.|+|||++.+.. ++.++|||||||++|+|++|..|| .+.+..+....+....
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence 5677999999999998766 799999999999999999988885 4444444333321100
Q ss_pred --------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 892 --------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 892 --------~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
........++..+++||.+||+.||.+||+++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0011223578999999999999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=376.37 Aligned_cols=264 Identities=29% Similarity=0.411 Sum_probs=217.2
Q ss_pred cccccCCCCeeEEEEeeccCceEEEEEEE-------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEec
Q 002160 669 CECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMG 740 (958)
Q Consensus 669 ~~~eI~~~dy~i~k~LG~G~fG~Vykak~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g 740 (958)
..+++..++|++++.||+|+||.||+|++ .+..||||++.... .......+.+|+.+|+++ +||||+++++
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 35678889999999999999999999986 34579999987543 233456789999999999 8999999999
Q ss_pred cccCCCceEEEEeecCCCCHHHHHhCCCCC----------------------ccHHHHHHHH-HHHHHHHHHHhcCCcEe
Q 002160 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQ----------------------VDEKRRIKMA-LDARGMNCLHTSTPTIV 797 (958)
Q Consensus 741 ~~~~~~~l~LVmEy~~gGsL~d~L~k~~~~----------------------~~e~~~l~ia-~~a~aL~yLH~~g~gII 797 (958)
++...+.+++||||+++|+|.+++...... +.+...+.++ +++.||.|||.++ |+
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iv 194 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CV 194 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cc
Confidence 999999999999999999999999765432 3444444444 4499999999998 99
Q ss_pred ecCCCCCceEEcCCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 002160 798 HRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLP 874 (958)
Q Consensus 798 HRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~P 874 (958)
||||||+||||+.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999999986543221 1223457889999999999999999999999999999998 9999
Q ss_pred CCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 875 WIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 875 F~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
|.+...................+..+++++.+||.+||..||.+||++.+|+++|+.+...
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 275 YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp STTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 9887655554444444556667788999999999999999999999999999999988553
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=370.10 Aligned_cols=264 Identities=22% Similarity=0.315 Sum_probs=215.4
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceE
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~ 749 (958)
+..++|++++.||+|+||.||+|++ +++.||||++..... .......+.+|+.++++++||||+++++++...+.+|
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 3447899999999999999999986 688999999866543 4456678999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~ 829 (958)
+||||+++++|.+++.+.+..........+.+.+.||.|||.++ |+||||||+|||++.++++||+|||+++......
T Consensus 88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 99999999999999987654444444445555599999999998 9999999999999999999999999998764332
Q ss_pred -ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc---ccCCCCCCcHHHH
Q 002160 830 -LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR---RLEIPKELDPLVA 905 (958)
Q Consensus 830 -~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~---~~~ip~~ls~eL~ 905 (958)
.......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+............. ...++..+++.+.
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 245 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS 245 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHH
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHH
Confidence 223346799999999999999999999999999999999999999999887665444322211 1234567899999
Q ss_pred HHHHHhhhcCCCCCC-CHHHHHHHHHhhhhhcCC
Q 002160 906 RIIWECWQTDPSLRP-SFAQLTVALKPLQRLVIP 938 (958)
Q Consensus 906 dLI~~CL~kDP~kRP-Sa~EIL~~L~kL~k~~~p 938 (958)
++|.+||.+||.+|| ++.++.+.|+.+......
T Consensus 246 ~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~ 279 (294)
T 4eqm_A 246 NVILRATEKDKANRYKTIQEMKDDLSSVLHENRA 279 (294)
T ss_dssp HHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred HHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence 999999999999998 899999999988655433
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=392.61 Aligned_cols=248 Identities=24% Similarity=0.380 Sum_probs=208.0
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCC-HHHHHHHHHHHHH-HHHcCCCceeEEeccccCCCce
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKI-MRRLRHPNVVLFMGAVTRPPNL 748 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~I-Lk~L~HPNIVkL~g~~~~~~~l 748 (958)
+..++|++++.||+|+||.||+|++ +++.||||++.+.... ......+.+|..+ ++.++|||||+++++|.+.+.+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 4457899999999999999999987 5788999999876543 2334556777776 4678999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
||||||++||+|.+++.+.........+.++.+++.||.|||.++ |+||||||+||||+.+|++||+|||+++.....
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 999999999999999987666666666777777799999999998 999999999999999999999999999875444
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHH
Q 002160 829 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 908 (958)
Q Consensus 829 ~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI 908 (958)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..++...+.. ....++..++..+++||
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li 270 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN--KPLQLKPNITNSARHLL 270 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHH--SCCCCCSSSCHHHHHHH
T ss_pred CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--cccCCCCCCCHHHHHHH
Confidence 4445667899999999999999999999999999999999999999999888888777743 35567788999999999
Q ss_pred HHhhhcCCCCCCCHHH
Q 002160 909 WECWQTDPSLRPSFAQ 924 (958)
Q Consensus 909 ~~CL~kDP~kRPSa~E 924 (958)
.+||++||.+||++.+
T Consensus 271 ~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 271 EGLLQKDRTKRLGAKD 286 (373)
T ss_dssp HHHTCSSGGGSTTTTT
T ss_pred HHHcccCHHhCCCCCC
Confidence 9999999999998753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=387.73 Aligned_cols=249 Identities=22% Similarity=0.363 Sum_probs=218.0
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceE
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~ 749 (958)
...++|++++.||+|+||.||+|++ +++.||||++.+.... ......+.+|+++|+.++||||+++++++.+...+|
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 4567899999999999999999987 5889999998654321 123457889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~ 829 (958)
|||||++||+|.+++.+.+.......+.++.+++.||.|||.++ |+||||||+||||+.+|++||+|||+++.....
T Consensus 118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 99999999999999987655556666666667799999999998 999999999999999999999999999876443
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHH
Q 002160 830 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 909 (958)
Q Consensus 830 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~ 909 (958)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...+.. ....+|..+++++++||.
T Consensus 195 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li~ 270 (350)
T 1rdq_E 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS--GKVRFPSHFSSDLKDLLR 270 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTCCHHHHHHHH
T ss_pred --cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHH
Confidence 2356899999999999999999999999999999999999999999988888777743 356778899999999999
Q ss_pred HhhhcCCCCCCC-----HHHHHHH
Q 002160 910 ECWQTDPSLRPS-----FAQLTVA 928 (958)
Q Consensus 910 ~CL~kDP~kRPS-----a~EIL~~ 928 (958)
+||+.||.+||+ +++|++|
T Consensus 271 ~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 271 NLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHhhcCHHhccCCccCCHHHHHhC
Confidence 999999999998 8888775
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=369.45 Aligned_cols=264 Identities=28% Similarity=0.427 Sum_probs=220.5
Q ss_pred cccccCCCCeeEEEEeeccCceEEEEEEE-------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEec
Q 002160 669 CECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMG 740 (958)
Q Consensus 669 ~~~eI~~~dy~i~k~LG~G~fG~Vykak~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g 740 (958)
..+++..++|++++.||+|+||.||+|++ +++.||||++.... .......+.+|+.+|+++ +||||+++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 94 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLG 94 (313)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence 34567788999999999999999999985 45789999987543 344567899999999999 9999999999
Q ss_pred cccCCCceEEEEeecCCCCHHHHHhCCCC-----------------CccHHHHHHHHH-HHHHHHHHHhcCCcEeecCCC
Q 002160 741 AVTRPPNLSIITEFLPRGSLFRILHRPHC-----------------QVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDLK 802 (958)
Q Consensus 741 ~~~~~~~l~LVmEy~~gGsL~d~L~k~~~-----------------~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDLK 802 (958)
++...+..++||||+++|+|.+++..... ...+...+.++. .+.||.|||.++ |+|||||
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlk 172 (313)
T 1t46_A 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLA 172 (313)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCc
Confidence 99999999999999999999999975432 244554554444 499999999998 9999999
Q ss_pred CCceEEcCCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 002160 803 SPNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMN 879 (958)
Q Consensus 803 PeNILId~~g~VKL~DFGLAk~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~ 879 (958)
|+|||++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+..
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 9999999999999999999987644321 1233457789999999999999999999999999999998 999998876
Q ss_pred hhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 880 PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 880 ~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
.................+..++..+.+||.+||+.||.+||++.+|+++|+++...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp SSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 55444444334445556778999999999999999999999999999999998664
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=393.17 Aligned_cols=257 Identities=31% Similarity=0.552 Sum_probs=219.9
Q ss_pred cccccCCCCeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC-c
Q 002160 669 CECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP-N 747 (958)
Q Consensus 669 ~~~eI~~~dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~-~ 747 (958)
..+++..++|++.+.||+|+||.||+|+++++.||||++.... ....|.+|+.+|++++|||||++++++.... .
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 261 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 261 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence 3467888999999999999999999999999999999987653 2357889999999999999999999976655 7
Q ss_pred eEEEEeecCCCCHHHHHhCCCC-CccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 748 LSIITEFLPRGSLFRILHRPHC-QVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~-~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
+||||||+++|+|.+++.+.+. ...+...+.++ +.+.||+|||.++ |+||||||+||||+.++.+||+|||+++..
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 9999999999999999976543 23445444444 4499999999998 999999999999999999999999999864
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHH
Q 002160 826 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 904 (958)
Q Consensus 826 ~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL 904 (958)
... .....++..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+. ...+...|..+++.+
T Consensus 340 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l 415 (450)
T 1k9a_A 340 SST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAV 415 (450)
T ss_dssp C---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-TTCCCCCCTTCCHHH
T ss_pred ccc---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHH
Confidence 332 123467889999999999999999999999999999998 999999888777776664 445677888999999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 905 ARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 905 ~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
.+||.+||+.||.+||++.+|++.|+.+...
T Consensus 416 ~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 416 YDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999999999998764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=380.00 Aligned_cols=265 Identities=30% Similarity=0.395 Sum_probs=208.8
Q ss_pred CCccccccCCCCeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC
Q 002160 666 DDVCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (958)
Q Consensus 666 ~~~~~~eI~~~dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~ 745 (958)
....+..+..++|++++.||+|+||.||+|++.++.||||++.... .....+.+|+.+|++++|||||++++++...
T Consensus 14 ~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (322)
T 3soc_A 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRG 90 (322)
T ss_dssp CCCCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred cCccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence 3445566778899999999999999999999999999999986542 3344567799999999999999999999875
Q ss_pred Cc----eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhc--------CCcEeecCCCCCceEEcCCC
Q 002160 746 PN----LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTS--------TPTIVHRDLKSPNLLVDKNW 812 (958)
Q Consensus 746 ~~----l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~--------g~gIIHRDLKPeNILId~~g 812 (958)
.. +++||||+++|+|.+++.... ..+.....++ +.+.||.|||.. ..+|+||||||+||||+.++
T Consensus 91 ~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~ 168 (322)
T 3soc_A 91 TSVDVDLWLITAFHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL 168 (322)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC
T ss_pred CCCCceEEEEEecCCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC
Confidence 43 799999999999999997643 4444444444 449999999998 11399999999999999999
Q ss_pred cEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCh-----
Q 002160 813 NVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNE-----PSNEKCDVYSFGVILWELATLKLPWIGMNP----- 880 (958)
Q Consensus 813 ~VKL~DFGLAk~~~~~~~--~~~s~~GT~~Y~APEvl~g~-----~~s~ksDIWSLGiLLyELLtG~~PF~g~~~----- 880 (958)
++||+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+...
T Consensus 169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~ 248 (322)
T 3soc_A 169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248 (322)
T ss_dssp CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence 999999999987643322 23346799999999999873 346688999999999999999999976432
Q ss_pred -----------hHHHHhhhccccccCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 881 -----------MQVVGAVGFQNRRLEIPK-----ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 881 -----------~ei~~~i~~~~~~~~ip~-----~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
......+.....++.++. ..+.++.+||.+||+.||.+||++.+|++.|++|.+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp THHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 122222222222333322 2345699999999999999999999999999999765
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=370.05 Aligned_cols=250 Identities=24% Similarity=0.290 Sum_probs=201.0
Q ss_pred CCeeEEEEeeccCceEEEEEEE-CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEee
Q 002160 676 EDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
++|++++.||+|+||.||+|++ +++.||||++............+.+|++++++++||||+++++++...+.+++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 6899999999999999999987 588999999876554333345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhCCCCCccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCC
Q 002160 755 LPRGSLFRILHRPHCQVDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 833 (958)
Q Consensus 755 ~~gGsL~d~L~k~~~~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~ 833 (958)
+++ +|.+++........+.... .+.+.+.||.|||.++ |+||||||+|||++.++.+||+|||+++..........
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEeECccccccCccccccc
Confidence 975 8999887654444444444 4445599999999998 99999999999999999999999999987654333334
Q ss_pred CCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc----------------c---
Q 002160 834 STAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR----------------R--- 893 (958)
Q Consensus 834 s~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~----------------~--- 893 (958)
...||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+..... .
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccc
Confidence 56789999999999764 589999999999999999999999998876655443311000 0
Q ss_pred --------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 894 --------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 894 --------~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
..+...+++++++||.+||+.||.+||++.|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 01224578999999999999999999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=367.33 Aligned_cols=262 Identities=36% Similarity=0.634 Sum_probs=206.6
Q ss_pred cccccCCCCeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCce
Q 002160 669 CECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (958)
Q Consensus 669 ~~~eI~~~dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l 748 (958)
...+|...+|++.+.||+|+||.||+|++.+ .||||++............+.+|+.+|++++||||+++++++ ....+
T Consensus 17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~ 94 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL 94 (289)
T ss_dssp -CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred CCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence 3457888999999999999999999998765 599999987766777778899999999999999999999965 45678
Q ss_pred EEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
++||||+++++|.+++......+.+...+.++.+ +.||.|||.++ |+||||||+||||+.++.+||+|||+++....
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEEccceecccccc
Confidence 9999999999999999766666666655555554 89999999998 99999999999999999999999999976532
Q ss_pred C--cccCCCCCCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHh-hhccccc---cCCCC
Q 002160 828 T--FLSSKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGA-VGFQNRR---LEIPK 898 (958)
Q Consensus 828 ~--~~~~~s~~GT~~Y~APEvl~---g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~-i~~~~~~---~~ip~ 898 (958)
. ........||+.|+|||++. +..++.++||||||+++|+|++|+.||.+....+.... +...... ..++.
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRS 252 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCT
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccc
Confidence 1 12223456999999999997 66688899999999999999999999988655443332 2211111 22345
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhh
Q 002160 899 ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934 (958)
Q Consensus 899 ~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k 934 (958)
.+++.+.+||.+||+.||.+||++.+|++.|+++.+
T Consensus 253 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 253 NCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 789999999999999999999999999999998864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=386.42 Aligned_cols=261 Identities=27% Similarity=0.442 Sum_probs=218.9
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEE-------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEecccc
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT 743 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~ 743 (958)
.++..++|++++.||+|+||.||+|++ +++.||||++... .......++.+|+.+|++++|||||++++++.
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSL 144 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 356678999999999999999999985 3567999998643 34555668899999999999999999999999
Q ss_pred CCCceEEEEeecCCCCHHHHHhCCC------CCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCC---c
Q 002160 744 RPPNLSIITEFLPRGSLFRILHRPH------CQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNW---N 813 (958)
Q Consensus 744 ~~~~l~LVmEy~~gGsL~d~L~k~~------~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g---~ 813 (958)
.....++||||+++|+|.+++.... ..+.+...+.++ +.+.||.|||.++ |+||||||+||||+.++ .
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCC
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCce
Confidence 9999999999999999999996532 234444444444 4499999999998 99999999999999555 5
Q ss_pred EEEEeccccccccCC--cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhcc
Q 002160 814 VKVSDFGLSRLKHNT--FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQ 890 (958)
Q Consensus 814 VKL~DFGLAk~~~~~--~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~ 890 (958)
+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+. .
T Consensus 223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~-~ 301 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-S 301 (367)
T ss_dssp EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-T
T ss_pred EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-c
Confidence 999999999864322 122233567999999999999999999999999999999998 999999988887777664 3
Q ss_pred ccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 891 NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 891 ~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
......+..++..+.+||.+||+.||.+||++.+|+++|+.+...
T Consensus 302 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 302 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 445667788999999999999999999999999999999988653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=399.23 Aligned_cols=252 Identities=23% Similarity=0.401 Sum_probs=208.2
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceE
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~ 749 (958)
+..++|++++.||+|+||.||+|++ +++.||||++..... .......+.+|+.+|+.++||||++++++|...+.+|
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 4557899999999999999999987 688999999876432 2334456788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHh-cCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~-~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
|||||+++|+|.+++.+.........+.++.+++.||+|||. ++ ||||||||+||||+.++++||+|||+++.....
T Consensus 225 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp EEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 999999999999999776555555555566666999999998 77 999999999999999999999999999875444
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHH
Q 002160 829 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 908 (958)
Q Consensus 829 ~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI 908 (958)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.. ....+|..+++++++||
T Consensus 303 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li 380 (446)
T 4ejn_A 303 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EEIRFPRTLGPEAKSLL 380 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHH
T ss_pred CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHHHHHH
Confidence 4445567899999999999999999999999999999999999999999888877777643 35567888999999999
Q ss_pred HHhhhcCCCCCC-----CHHHHHHH
Q 002160 909 WECWQTDPSLRP-----SFAQLTVA 928 (958)
Q Consensus 909 ~~CL~kDP~kRP-----Sa~EIL~~ 928 (958)
.+||+.||.+|| ++.||++|
T Consensus 381 ~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 381 SGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHcccCHHHhCCCCCCCHHHHHhC
Confidence 999999999999 99999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=368.88 Aligned_cols=259 Identities=30% Similarity=0.495 Sum_probs=209.9
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC-
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR- 744 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~- 744 (958)
++..++|++++.||+|+||.||+|++ +++.||||++... .......+.+|+++|++++||||+++++++..
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 45668899999999999999999984 5788999998654 34556789999999999999999999998854
Q ss_pred -CCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccc
Q 002160 745 -PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 822 (958)
Q Consensus 745 -~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLA 822 (958)
...+++||||+++++|.+++.+......+...+.++.+ +.||.|||.++ |+||||||+|||++.++++||+|||++
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCCCeEEEccCccc
Confidence 35589999999999999999876554555555555444 99999999988 999999999999999999999999999
Q ss_pred ccccCCc---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh----------------HH
Q 002160 823 RLKHNTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM----------------QV 883 (958)
Q Consensus 823 k~~~~~~---~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~----------------ei 883 (958)
+...... .......++..|+|||++.+..++.++||||||+++|+|++|..||...... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence 8764322 1122345777899999999999999999999999999999999998653211 11
Q ss_pred HHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 884 VGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 884 ~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
... .....+...+..+++++.+||.+||+.||.+||++.+|++.|+++.+.
T Consensus 242 ~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 242 IEL-LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHH-HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHH-HhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 111 123445667788999999999999999999999999999999999764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=386.99 Aligned_cols=260 Identities=30% Similarity=0.515 Sum_probs=210.6
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEEC-----CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~~-----g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~ 746 (958)
++...+|.+.+.||+|+||.||+|++. +..||||++.... .......|.+|+.+|++++|||||++++++.+..
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 456678999999999999999999763 6679999986543 4556678999999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
.++|||||+++|+|.+++.+......+...+.++.+ +.||.|||.++ |+||||||+||||+.++.+||+|||+++..
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 999999999999999999877655666655555554 99999999998 999999999999999999999999999876
Q ss_pred cCCcc---cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCc
Q 002160 826 HNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 901 (958)
Q Consensus 826 ~~~~~---~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls 901 (958)
..... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+. ...+...+..++
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~ 276 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMDCP 276 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH-TTEECCCCTTCB
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccc
Confidence 43321 1122345778999999999999999999999999999998 999999988877776664 333455667899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 902 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 902 ~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
..+.+||.+||+.||.+||++.+|++.|+++.+.
T Consensus 277 ~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 277 AALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999998654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=394.00 Aligned_cols=268 Identities=30% Similarity=0.512 Sum_probs=224.6
Q ss_pred cccccCCCCeeEEEEeeccCceEEEEEEE-CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc
Q 002160 669 CECEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 669 ~~~eI~~~dy~i~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~ 747 (958)
..+++..++|++.+.||+|+||.||+|++ .+..||||++...... ...|.+|+++|++++|||||++++++. ...
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~ 256 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVT-KEP 256 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc
Confidence 34678889999999999999999999998 4778999998765432 467899999999999999999999987 567
Q ss_pred eEEEEeecCCCCHHHHHhCCCC-CccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 748 LSIITEFLPRGSLFRILHRPHC-QVDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~-~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
+||||||+++|+|.+++.+... .......+ ++.+++.||.|||.++ ||||||||+||||+.++.+||+|||+++..
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 8999999999999999975431 23344444 4445599999999998 999999999999999999999999999876
Q ss_pred cCCcc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHH
Q 002160 826 HNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 903 (958)
Q Consensus 826 ~~~~~-~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~e 903 (958)
..... ......++..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+. ...+...|..++++
T Consensus 335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~ 413 (454)
T 1qcf_A 335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEE 413 (454)
T ss_dssp CCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-HTCCCCCCTTSCHH
T ss_pred CCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 43321 1233456789999999998899999999999999999999 999999998888777664 34456677889999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhcCCCCCCC
Q 002160 904 VARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQ 943 (958)
Q Consensus 904 L~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~~p~~P~~ 943 (958)
+.+||.+||+.||.+||++.+|++.|+.+.....++-.++
T Consensus 414 l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~~~~~~ 453 (454)
T 1qcf_A 414 LYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEEI 453 (454)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCCSSBCC
T ss_pred HHHHHHHHccCChhHCcCHHHHHHHHHHHHhccccccccC
Confidence 9999999999999999999999999999876655444333
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=360.76 Aligned_cols=251 Identities=23% Similarity=0.362 Sum_probs=215.2
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
.++|++.+.||+|+||.||+|.+ +++.||||++............+.+|+.++++++||||+++++++......++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 46899999999999999999987 5889999999887777777788999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCc---EEEEeccccccccCCc
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRLKHNTF 829 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~---VKL~DFGLAk~~~~~~ 829 (958)
||+++++|.+++..............+.+.+.||.|||..+ |+||||||+|||++.++. +||+|||++.......
T Consensus 85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (284)
T 3kk8_A 85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162 (284)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence 99999999988876554444444555555599999999998 999999999999986655 9999999997765432
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCC--CCCCcHHHHHH
Q 002160 830 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI--PKELDPLVARI 907 (958)
Q Consensus 830 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~i--p~~ls~eL~dL 907 (958)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+....+......... ...+++++.+|
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (284)
T 3kk8_A 163 -AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 241 (284)
T ss_dssp -BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHH
T ss_pred -cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHH
Confidence 234567999999999999999999999999999999999999999998887777666433322222 24689999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 002160 908 IWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 908 I~~CL~kDP~kRPSa~EIL~~ 928 (958)
|.+||+.||.+||++.|++++
T Consensus 242 i~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 242 IDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp HHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHcccChhhCCCHHHHhcC
Confidence 999999999999999999985
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=383.22 Aligned_cols=260 Identities=21% Similarity=0.283 Sum_probs=208.9
Q ss_pred ccCCCCeeEEEEeecc--CceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc
Q 002160 672 EIPWEDLVLGERIGLG--SYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G--~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~ 747 (958)
.....+|++++.||+| +||.||+|++ +++.||||++............+.+|+.+|++++|||||+++++|.+.+.
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence 3455789999999999 9999999987 58899999998877667777889999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhCC--CCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 748 LSIITEFLPRGSLFRILHRP--HCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~--~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
+|+||||+++|+|.+++... ........+.++.+++.||.|||.++ |+||||||+||||+.++.+||+|||++...
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999999999999998754 33333344444445599999999998 999999999999999999999999988654
Q ss_pred cCC-------cccCCCCCCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc----
Q 002160 826 HNT-------FLSSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR---- 892 (958)
Q Consensus 826 ~~~-------~~~~~s~~GT~~Y~APEvl~g--~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~---- 892 (958)
... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 221 111233478999999999987 6789999999999999999999999988665544433211100
Q ss_pred ----------------------------------------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HH
Q 002160 893 ----------------------------------------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA--LK 930 (958)
Q Consensus 893 ----------------------------------------~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~--L~ 930 (958)
...++..+++++++||.+||+.||.+||++.|+++| ++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~ 338 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 338 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGG
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHH
Confidence 112345678999999999999999999999999977 55
Q ss_pred hhh
Q 002160 931 PLQ 933 (958)
Q Consensus 931 kL~ 933 (958)
.+.
T Consensus 339 ~~~ 341 (389)
T 3gni_B 339 QIK 341 (389)
T ss_dssp GC-
T ss_pred HHh
Confidence 443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=359.18 Aligned_cols=262 Identities=32% Similarity=0.543 Sum_probs=218.6
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEEC-CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCce
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~~-g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l 748 (958)
.+++..++|++++.||+|+||.||+|++. +..||||++...... ...+.+|+++|++++||||+++++++.. +..
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 82 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPI 82 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCc
Confidence 46777889999999999999999999884 568999998765433 3578899999999999999999999874 568
Q ss_pred EEEEeecCCCCHHHHHhCCCC-CccHHHHHHH-HHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 749 SIITEFLPRGSLFRILHRPHC-QVDEKRRIKM-ALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~-~~~e~~~l~i-a~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
++||||+++++|.+++..... ...+...+.+ .+.+.||.|||.++ |+||||||+|||++.++.+||+|||++....
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 999999999999999975431 3444444444 44499999999998 9999999999999999999999999998765
Q ss_pred CCcc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHH
Q 002160 827 NTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 904 (958)
Q Consensus 827 ~~~~-~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL 904 (958)
.... ......++..|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..+....+. .......+..++..+
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 239 (279)
T 1qpc_A 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEEL 239 (279)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHH
T ss_pred CcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHh-cccCCCCcccccHHH
Confidence 4322 2233457889999999998889999999999999999999 999999988877766654 334455677899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhcCC
Q 002160 905 ARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 938 (958)
Q Consensus 905 ~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~~p 938 (958)
.+||.+||..||.+||++.+|++.|+.+......
T Consensus 240 ~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 273 (279)
T 1qpc_A 240 YQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273 (279)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred HHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence 9999999999999999999999999999766433
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=373.49 Aligned_cols=250 Identities=25% Similarity=0.377 Sum_probs=211.0
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCH----HHHHHHHHHHHHHHHcCCCceeEEeccccCCCceE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~----~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~ 749 (958)
++|++.+.||+|+||.||+|++ +++.||||++....... .....+.+|+.+|++++||||+++++++.....++
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 5699999999999999999987 58899999987654321 13567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCC----cEEEEeccccccc
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNW----NVKVSDFGLSRLK 825 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g----~VKL~DFGLAk~~ 825 (958)
+||||+++++|.+++..............+.+.+.||.|||.++ |+||||||+|||++.++ .+||+|||+++..
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 99999999999999987655444555555555599999999998 99999999999999877 8999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccccc--CCCCCCcHH
Q 002160 826 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPL 903 (958)
Q Consensus 826 ~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~--~ip~~ls~e 903 (958)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+....... ..+..++..
T Consensus 169 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (326)
T 2y0a_A 169 DFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247 (326)
T ss_dssp CTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred CCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHH
Confidence 4332 2345679999999999999999999999999999999999999999988777666553222111 122468899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 904 VARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 904 L~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+++||.+||..||.+||++.++++|
T Consensus 248 ~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 248 AKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHccCChhhCCCHHHHhcC
Confidence 9999999999999999999999975
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=368.81 Aligned_cols=267 Identities=30% Similarity=0.482 Sum_probs=220.1
Q ss_pred ccccccCCCCeeEEEEeeccCceEEEEEEE-------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEe
Q 002160 668 VCECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFM 739 (958)
Q Consensus 668 ~~~~eI~~~dy~i~k~LG~G~fG~Vykak~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~ 739 (958)
...+++..++|++++.||+|+||.||+|++ +++.||||++.... .......+.+|+.+|+++ +||||++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 345567778999999999999999999975 35789999987543 444566889999999999 799999999
Q ss_pred ccccCCC-ceEEEEeecCCCCHHHHHhCCCCC---------------ccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCC
Q 002160 740 GAVTRPP-NLSIITEFLPRGSLFRILHRPHCQ---------------VDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLK 802 (958)
Q Consensus 740 g~~~~~~-~l~LVmEy~~gGsL~d~L~k~~~~---------------~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLK 802 (958)
+++...+ .+++||||+++++|.+++...... ..+...+.++ +.+.||.|||.++ |+|||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dik 175 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLA 175 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccCc
Confidence 9987755 499999999999999999865431 4444444444 4499999999998 9999999
Q ss_pred CCceEEcCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 002160 803 SPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMN 879 (958)
Q Consensus 803 PeNILId~~g~VKL~DFGLAk~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~ 879 (958)
|+||||+.++++||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|+|++ |..||.+..
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 999999999999999999998654321 12233457889999999999999999999999999999998 999998876
Q ss_pred hhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhcC
Q 002160 880 PMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVI 937 (958)
Q Consensus 880 ~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~~ 937 (958)
..+..............+..+++.+.+||.+||+.||.+||++.+|+++|+.+.+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 256 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred hhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 5444433333445566778899999999999999999999999999999999876543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=366.11 Aligned_cols=255 Identities=30% Similarity=0.592 Sum_probs=204.8
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEE
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LV 751 (958)
.+..++|++.+.||+|+||.||+|++.++.||||++... .....+.+|+++|++++||||+++++++.+ ..++|
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv 77 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLV 77 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEE
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEE
Confidence 356689999999999999999999999999999997543 345678999999999999999999999874 48999
Q ss_pred EeecCCCCHHHHHhCCCC--CccHHHHHHHH-HHHHHHHHHHhcC-CcEeecCCCCCceEEcCCCc-EEEEecccccccc
Q 002160 752 TEFLPRGSLFRILHRPHC--QVDEKRRIKMA-LDARGMNCLHTST-PTIVHRDLKSPNLLVDKNWN-VKVSDFGLSRLKH 826 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~--~~~e~~~l~ia-~~a~aL~yLH~~g-~gIIHRDLKPeNILId~~g~-VKL~DFGLAk~~~ 826 (958)
|||+++++|.+++..... .......+.++ +.+.||.|||..+ .+|+||||||+||||+.++. +||+|||++....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 999999999999986543 23444444444 4489999999933 24999999999999998886 7999999997654
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh--HHHHhhhccccccCCCCCCcHHH
Q 002160 827 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM--QVVGAVGFQNRRLEIPKELDPLV 904 (958)
Q Consensus 827 ~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~--ei~~~i~~~~~~~~ip~~ls~eL 904 (958)
.. .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...... +....+ .......++..++..+
T Consensus 158 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l 233 (307)
T 2eva_A 158 TH---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAV-HNGTRPPLIKNLPKPI 233 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHH-HTTCCCCCBTTCCHHH
T ss_pred cc---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHH-hcCCCCCcccccCHHH
Confidence 32 22356999999999999999999999999999999999999999764332 222222 2344556667899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhc
Q 002160 905 ARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 936 (958)
Q Consensus 905 ~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~ 936 (958)
.+||.+||+.||.+||++.+|++.|+.+.+..
T Consensus 234 ~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 234 ESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred HHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 99999999999999999999999999997653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=375.01 Aligned_cols=249 Identities=18% Similarity=0.291 Sum_probs=211.0
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
.++|++++.||+|+||.||+|++ +++.||+|.+... ......+.+|+.+|+.++||||+++++++.+.+.+++||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 46899999999999999999987 5789999988643 234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcC--CCcEEEEeccccccccCCc
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDK--NWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~--~g~VKL~DFGLAk~~~~~~ 829 (958)
||+++++|.+++......+.+.....++ +.+.||.|||.++ |+||||||+|||++. ++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 9999999999998765455555555444 4499999999998 999999999999987 7899999999998764432
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccC--CCCCCcHHHHHH
Q 002160 830 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE--IPKELDPLVARI 907 (958)
Q Consensus 830 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~--ip~~ls~eL~dL 907 (958)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+........ ....++.++++|
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 237 (321)
T 1tki_A 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred -ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHH
Confidence 22345689999999999998899999999999999999999999999888877776643322211 124689999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHH
Q 002160 908 IWECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 908 I~~CL~kDP~kRPSa~EIL~~L 929 (958)
|.+||..||.+||++.|+++|-
T Consensus 238 i~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 238 VDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp HHTTSCSSGGGSCCHHHHHHSH
T ss_pred HHHHcCCChhHCcCHHHHhcCh
Confidence 9999999999999999999863
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=375.71 Aligned_cols=257 Identities=28% Similarity=0.500 Sum_probs=209.2
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCc----EEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~----~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~ 746 (958)
+..++|++.+.||+|+||.||+|++ +++ +||+|.+.... ......++.+|+.++++++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-
Confidence 4457899999999999999999987 344 35777765432 233456789999999999999999999999875
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
..++||||+.+|+|.+++.+....+.+...+.++.+ +.||.|||.++ |+||||||+||||+.++++||+|||+++..
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 478999999999999999876555565555555544 99999999998 999999999999999999999999999876
Q ss_pred cCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcH
Q 002160 826 HNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 902 (958)
Q Consensus 826 ~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~ 902 (958)
..... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....++...+. .......+..++.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 246 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTI 246 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTBCH
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH-cCCCCCCCccCCH
Confidence 43322 2233456889999999999999999999999999999999 999999888776665554 3445566778999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhh
Q 002160 903 LVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934 (958)
Q Consensus 903 eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k 934 (958)
.+.+||.+||+.||.+||++.+|+++|+++.+
T Consensus 247 ~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 247 DVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 99999999999999999999999999998865
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=360.63 Aligned_cols=260 Identities=25% Similarity=0.446 Sum_probs=219.5
Q ss_pred cccCCCCeeEEE-EeeccCceEEEEEEE----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC
Q 002160 671 CEIPWEDLVLGE-RIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (958)
Q Consensus 671 ~eI~~~dy~i~k-~LG~G~fG~Vykak~----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~ 745 (958)
+.+..++|.+.+ .||+|+||.||+|.+ ++..||||++.... .......+.+|++++++++||||+++++++ ..
T Consensus 4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~ 81 (287)
T 1u59_A 4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA 81 (287)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES
T ss_pred ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC
Confidence 345667888877 999999999999975 57789999987643 455677899999999999999999999999 45
Q ss_pred CceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 746 ~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
+.+++||||+++++|.+++........+...+.++.+ +.||.|||.++ |+||||||+|||++.++.+||+|||+++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCCCCEEECcccceee
Confidence 6799999999999999999766555555555555544 99999999998 99999999999999999999999999987
Q ss_pred ccCCcc---cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCC
Q 002160 825 KHNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 900 (958)
Q Consensus 825 ~~~~~~---~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~l 900 (958)
...... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..+....+. ...+..++..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~ 238 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPEC 238 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCCCCTTC
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh-cCCcCCCCCCc
Confidence 643221 1223456889999999998889999999999999999998 999999888777666554 34456778899
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 901 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 901 s~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
++.+.+||.+||+.||.+||++.+|+++|+.+...
T Consensus 239 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 239 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 99999999999999999999999999999998654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=366.60 Aligned_cols=267 Identities=28% Similarity=0.458 Sum_probs=212.9
Q ss_pred CCccccccCCCCeeEEEEeeccCceEEEEEEEC-----CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEec
Q 002160 666 DDVCECEIPWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMG 740 (958)
Q Consensus 666 ~~~~~~eI~~~dy~i~k~LG~G~fG~Vykak~~-----g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g 740 (958)
.......+..++|.+++.||+|+||.||+|++. +..||||++............+.+|+.++++++||||+++++
T Consensus 24 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 103 (313)
T 3brb_A 24 NKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLG 103 (313)
T ss_dssp CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred hhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeE
Confidence 344556677889999999999999999999762 347999998877666667788999999999999999999999
Q ss_pred cccCCC-----ceEEEEeecCCCCHHHHHhC-----CCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEc
Q 002160 741 AVTRPP-----NLSIITEFLPRGSLFRILHR-----PHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVD 809 (958)
Q Consensus 741 ~~~~~~-----~l~LVmEy~~gGsL~d~L~k-----~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId 809 (958)
++.... ..++||||+++++|.+++.. ....+.+...+.++ +.+.||.|||.++ |+||||||+||||+
T Consensus 104 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~ 181 (313)
T 3brb_A 104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLR 181 (313)
T ss_dssp EEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEEC
T ss_pred EEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc
Confidence 987655 35999999999999999842 22334444444444 4499999999998 99999999999999
Q ss_pred CCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHh
Q 002160 810 KNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGA 886 (958)
Q Consensus 810 ~~g~VKL~DFGLAk~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~ 886 (958)
.++.+||+|||+++...... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+....+....
T Consensus 182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 261 (313)
T 3brb_A 182 DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY 261 (313)
T ss_dssp TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH
Confidence 99999999999998654322 11233457889999999999999999999999999999999 8999998887776665
Q ss_pred hhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 887 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 887 i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
+. .......+..+++.+.+||.+||..||.+||++.+|+++|+++.+.
T Consensus 262 ~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 262 LL-HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp HH-TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH-cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 54 3445667788999999999999999999999999999999998765
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=363.92 Aligned_cols=262 Identities=26% Similarity=0.401 Sum_probs=216.4
Q ss_pred ccccCCCCeeEEE-EeeccCceEEEEEEE----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC
Q 002160 670 ECEIPWEDLVLGE-RIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (958)
Q Consensus 670 ~~eI~~~dy~i~k-~LG~G~fG~Vykak~----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~ 744 (958)
...+...+|++.+ .||+|+||.||+|.+ .++.||||++...........++.+|++++++++||||+++++++ .
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E 88 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence 3456668899988 999999999999965 367899999876655555577899999999999999999999998 5
Q ss_pred CCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 745 ~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
.+.+++||||+++++|.+++.+............+.+.+.||.|||.++ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 6778999999999999999987654444444445555599999999998 99999999999999999999999999987
Q ss_pred ccCCcc---cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCC
Q 002160 825 KHNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 900 (958)
Q Consensus 825 ~~~~~~---~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~l 900 (958)
...... ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..++...+. ...+..++..+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 245 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGC 245 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTC
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCCC
Confidence 543221 1222346788999999999889999999999999999999 999999988877766654 34456677889
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 901 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 901 s~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
++.+.+||.+||+.||.+||++.+|++.|+++...
T Consensus 246 ~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 246 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999998543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=358.43 Aligned_cols=261 Identities=31% Similarity=0.546 Sum_probs=215.5
Q ss_pred CeeEEEEeeccCceEEEEEEE--CC---cEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCce-EE
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NG---TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL-SI 750 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g---~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l-~L 750 (958)
.|.+.+.||+|+||.||+|++ ++ ..||||++... ........+.+|+.++++++||||+++++++...+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 467789999999999999986 22 26999987653 3445567899999999999999999999999876665 99
Q ss_pred EEeecCCCCHHHHHhCCCCCccHHHHHHHHH-HHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc
Q 002160 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 751 VmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~ 829 (958)
||||+.+++|.+++........+...+.++. .+.||.|||.++ |+||||||+|||++.++.+||+|||+++......
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 9999999999999987666566665555554 499999999998 9999999999999999999999999998654321
Q ss_pred ----ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChhHHHHhhhccccccCCCCCCcHHH
Q 002160 830 ----LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 904 (958)
Q Consensus 830 ----~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG-~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL 904 (958)
.......+|+.|+|||.+.+..++.++||||||+++|+|++| .+||...+..+....+. .......+..++..+
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 257 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-QGRRLPQPEYCPDSL 257 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH-TTCCCCCCTTCCHHH
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh-cCCCCCCCccchHHH
Confidence 223345678899999999999999999999999999999995 45566666655555443 444566677899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhcCCCCC
Q 002160 905 ARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHP 941 (958)
Q Consensus 905 ~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~~p~~P 941 (958)
.+||.+||+.||.+||++.++++.|+++.........
T Consensus 258 ~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~~ 294 (298)
T 3pls_A 258 YQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHY 294 (298)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCCB
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccch
Confidence 9999999999999999999999999999887655443
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=387.58 Aligned_cols=252 Identities=21% Similarity=0.334 Sum_probs=213.3
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~ 747 (958)
.++..++|++++.||+|+||.||+|++ +++.||||++.+... .......+.+|+++|+.++|||||+++++|.+...
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED 89 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 456778999999999999999999987 578899999875432 11234578899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
+|+||||+.||+|.+++.+.........+.++.+++.||.|||.++ ||||||||+||||+.+|++||+|||+++....
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 9999999999999999988766666666677777799999999998 99999999999999999999999999987644
Q ss_pred CcccCCCCCCCCCccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---hHHHHhhhccccccCCCCCCc
Q 002160 828 TFLSSKSTAGTPEWMAPEVLRN---EPSNEKCDVYSFGVILWELATLKLPWIGMNP---MQVVGAVGFQNRRLEIPKELD 901 (958)
Q Consensus 828 ~~~~~~s~~GT~~Y~APEvl~g---~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~---~ei~~~i~~~~~~~~ip~~ls 901 (958)
. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... .+....+ ......+|..++
T Consensus 168 ~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--~~~~~~~p~~~s 244 (384)
T 4fr4_A 168 E-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF--ETTVVTYPSAWS 244 (384)
T ss_dssp T-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH--HHCCCCCCTTSC
T ss_pred C-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH--hhcccCCCCcCC
Confidence 3 23456789999999999974 4588999999999999999999999975433 3333333 334566788899
Q ss_pred HHHHHHHHHhhhcCCCCCCC-HHHHHH
Q 002160 902 PLVARIIWECWQTDPSLRPS-FAQLTV 927 (958)
Q Consensus 902 ~eL~dLI~~CL~kDP~kRPS-a~EIL~ 927 (958)
+.+.+||.+||+.||.+||+ +.+|+.
T Consensus 245 ~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 245 QEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 99999999999999999998 777765
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=374.68 Aligned_cols=257 Identities=26% Similarity=0.443 Sum_probs=210.4
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcE----EEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTE----VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~----VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~ 746 (958)
+..++|++.+.||+|+||.||+|++ +++. ||+|.+..... ......+.+|+.++++++||||+++++++. ..
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS 87 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence 4567899999999999999999987 3443 78887654321 122345678999999999999999999986 46
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
..++||||+++|+|.+++.+....+.+...+ ++.+.+.||.|||.++ |+||||||+||||+.++++||+|||+++..
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCCCeEEECCCCccccc
Confidence 7899999999999999998754444444444 4445599999999998 999999999999999999999999999876
Q ss_pred cCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcH
Q 002160 826 HNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 902 (958)
Q Consensus 826 ~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~ 902 (958)
.... .......||..|+|||++.+..++.++|||||||++|+|++ |+.||.+....++...+. .......+..++.
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 244 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGERLAQPQICTI 244 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH-TTCBCCCCTTBCT
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCCCcCcH
Confidence 4332 12234567889999999999999999999999999999999 999999887777666554 4446667778899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhh
Q 002160 903 LVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934 (958)
Q Consensus 903 eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k 934 (958)
++.+||.+||..||.+||++.+|+++|+++.+
T Consensus 245 ~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 245 DVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp TTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999999999854
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=359.56 Aligned_cols=258 Identities=17% Similarity=0.237 Sum_probs=212.4
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCceE
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~l~ 749 (958)
+..++|++++.||+|+||.||+|++ +++.||||++...... ..+.+|+.+++++ +|+||+++++++......+
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 82 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 82 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeE
Confidence 4457899999999999999999985 7899999998655432 2577899999999 7999999999999999999
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCc-----EEEEeccccc
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN-----VKVSDFGLSR 823 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~-----VKL~DFGLAk 823 (958)
+||||+ +++|.+++......+.+.....++.+ +.||.|||.++ |+||||||+||||+.++. +||+|||+++
T Consensus 83 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 83 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 999999 99999999866554555555555544 99999999988 999999999999987776 9999999998
Q ss_pred cccCCcc-------cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---hhHHHHhhhcc---
Q 002160 824 LKHNTFL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN---PMQVVGAVGFQ--- 890 (958)
Q Consensus 824 ~~~~~~~-------~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~---~~ei~~~i~~~--- 890 (958)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+ ..+....+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 7644321 2345679999999999999999999999999999999999999998753 33333332211
Q ss_pred ccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhcC
Q 002160 891 NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVI 937 (958)
Q Consensus 891 ~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~~ 937 (958)
.....+...+++++.+||.+||+.||.+||++.+|++.|+++.+..-
T Consensus 240 ~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 240 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 11222345789999999999999999999999999999999977643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=365.62 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=203.0
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
.++|++++.||+|+||.||+|++ +++.||||++............+.+|+.++++++||||+++++++...+.+++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 36899999999999999999987 5889999998877666666778899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
||+++++|.+++..............+.+.+.||.|||.++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY 159 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCCCCEEEeeCCCchhccCccccc
Confidence 99999999998876655444444455555599999999998 9999999999999999999999999998765444444
Q ss_pred CCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcc-------------------cc
Q 002160 833 KSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-------------------NR 892 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~-------------------~~ 892 (958)
....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+... ..
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
T 4agu_A 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV 239 (311)
T ss_dssp ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTC
T ss_pred CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccC
Confidence 55679999999999986 66799999999999999999999999988766544332110 00
Q ss_pred ccCC----------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 893 RLEI----------PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 893 ~~~i----------p~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.... ...++..+.+||.+||+.||.+||+++|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 13578899999999999999999999999976
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=369.51 Aligned_cols=261 Identities=30% Similarity=0.493 Sum_probs=214.8
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEECC------cEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~~g------~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~ 744 (958)
.++...+|.+.+.||+|+||.||+|++.. ..||||.+.... .......+.+|+.++++++||||+++++++..
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 35677899999999999999999997632 359999986543 44556689999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHH-HHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccc
Q 002160 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 823 (958)
Q Consensus 745 ~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk 823 (958)
.+.++|||||+++++|.+++........+...+.++. ++.||.|||.++ |+||||||+||||+.++.+||+|||+++
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCCCcEEECCCCcch
Confidence 9999999999999999999976555555555555444 489999999998 9999999999999999999999999998
Q ss_pred cccCCcc---cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCC
Q 002160 824 LKHNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKE 899 (958)
Q Consensus 824 ~~~~~~~---~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ 899 (958)
....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..++...+. ...+...+..
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~ 274 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMD 274 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTT
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-CCCcCCCccc
Confidence 7543221 1222346788999999999999999999999999999998 999999888877766664 3345556778
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 900 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 900 ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
++..+.+||.+||+.||.+||++.+|++.|+++...
T Consensus 275 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 275 CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999999999999988553
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=361.54 Aligned_cols=261 Identities=35% Similarity=0.585 Sum_probs=221.7
Q ss_pred cccccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC
Q 002160 669 CECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (958)
Q Consensus 669 ~~~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~ 746 (958)
..+++..++|++.+.||+|+||.||+|.+ ++..||||++.... .....+.+|++++++++||||+++++++.+..
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 82 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 35667788999999999999999999988 48899999986543 24567889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhCCC-CCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~-~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
.+++||||+++++|.+++.+.. ....+...+.++ +.+.||.|||.++ |+||||||+|||++.++.+||+|||++..
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 9999999999999999997533 334455554444 4499999999998 99999999999999999999999999987
Q ss_pred ccCCc-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcH
Q 002160 825 KHNTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 902 (958)
Q Consensus 825 ~~~~~-~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~ 902 (958)
..... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+. .......+..+++
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 239 (288)
T 3kfa_A 161 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPE 239 (288)
T ss_dssp SCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCCH
T ss_pred ccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-ccCCCCCCCCCCH
Confidence 64332 22233456789999999999999999999999999999999 999999888777666554 3445667788999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 903 LVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 903 eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
.+.+||.+||..||.+||++.+|++.|+.+...
T Consensus 240 ~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 240 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 999999999999999999999999999988543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=361.91 Aligned_cols=257 Identities=32% Similarity=0.544 Sum_probs=210.7
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC-Cce
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-PNL 748 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~-~~l 748 (958)
.+.+..++|++.+.||+|+||.||+|+++++.||||++.... ....+.+|++++++++||||+++++++... +.+
T Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (278)
T 1byg_A 15 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 90 (278)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred cccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCce
Confidence 356777899999999999999999999999999999986543 345788999999999999999999986544 579
Q ss_pred EEEEeecCCCCHHHHHhCCCC-CccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 749 SIITEFLPRGSLFRILHRPHC-QVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~-~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
++||||+++++|.+++.+... ...+...+. +.+.+.||.|||.++ |+||||||+|||++.++.+||+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 999999999999999875432 133443444 444499999999998 9999999999999999999999999987654
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHH
Q 002160 827 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 905 (958)
Q Consensus 827 ~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~ 905 (958)
... ....+++.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+. .......+..+++.+.
T Consensus 169 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~ 244 (278)
T 1byg_A 169 STQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVY 244 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCCHHHH
T ss_pred ccc---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCcccCCHHHH
Confidence 332 23467889999999999999999999999999999998 999999887777666554 3345667788999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHhhhhhc
Q 002160 906 RIIWECWQTDPSLRPSFAQLTVALKPLQRLV 936 (958)
Q Consensus 906 dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~ 936 (958)
+||.+||+.||.+||++.+|++.|+.+....
T Consensus 245 ~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 245 EVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 9999999999999999999999999997653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=360.13 Aligned_cols=260 Identities=30% Similarity=0.489 Sum_probs=214.6
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEEC-----CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~~-----g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~ 745 (958)
+.+..++|++.+.||+|+||.||+|++. +..||||.+.... .......+.+|+.++++++||||+++++++.+
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 84 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE- 84 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-
Confidence 4566789999999999999999999863 2359999886543 44556789999999999999999999999875
Q ss_pred CceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 746 ~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
+..++||||+++++|.+++.+......+...+.++ +.+.||.|||.++ |+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 85 EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCCCcEEeCccCCCcc
Confidence 45789999999999999997655545555555444 4499999999998 99999999999999999999999999987
Q ss_pred ccCCcc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcH
Q 002160 825 KHNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 902 (958)
Q Consensus 825 ~~~~~~-~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~ 902 (958)
...... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+. .......+..+++
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 241 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLPKPDLCPP 241 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH-HTCCCCCCTTCCH
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh-cCCCCCCCCCCCH
Confidence 543321 2233457889999999999999999999999999999998 999998877776665553 3345566778999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 903 LVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 903 eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
.+.+||.+||..||.+||++.+|+++|+.+...
T Consensus 242 ~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 242 VLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 999999999999999999999999999988653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=362.73 Aligned_cols=252 Identities=24% Similarity=0.423 Sum_probs=211.6
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeccccCCCce
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l 748 (958)
++..++|++++.||+|+||.||+|++ +++.||||++....... .....+.+|+.++++++||||+++++++.+....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 45668999999999999999999987 56789999986543221 1245688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
++||||+++++|.+++.+............+.+.+.||.|||..+ |+||||||+||||+.++.+||+|||++......
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 999999999999999876554444444455555599999999988 999999999999999999999999998654432
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHH
Q 002160 829 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 908 (958)
Q Consensus 829 ~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI 908 (958)
. .....||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+. .....++..++..+++||
T Consensus 163 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li 238 (279)
T 3fdn_A 163 R--RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFPDFVTEGARDLI 238 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HTCCCCCTTSCHHHHHHH
T ss_pred c--ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH--hCCCCCCCcCCHHHHHHH
Confidence 2 234679999999999999999999999999999999999999999888777766653 335567788999999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHH
Q 002160 909 WECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 909 ~~CL~kDP~kRPSa~EIL~~L 929 (958)
.+||+.||.+||++.||++|-
T Consensus 239 ~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 239 SRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp HHHCCSSGGGSCCHHHHHHCH
T ss_pred HHHhccChhhCCCHHHHhhCc
Confidence 999999999999999999874
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=373.86 Aligned_cols=251 Identities=27% Similarity=0.321 Sum_probs=204.2
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
.++|++++.||+|+||.||+|++ +++.||||++...... .....+.+|+.+++.++|||||++++++.+.+..|+||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 47899999999999999999987 6889999998655432 23456889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC--cc
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--FL 830 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~--~~ 830 (958)
||+++++|.+++...........+.++.+.+.||.|||.++ |+||||||+||||+.++.+||+|||+++..... ..
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 99999999999987655555555555555699999999998 999999999999999999999999999865322 12
Q ss_pred cCCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhH-HHHhhhccccccCCCCCCcHHHHHHH
Q 002160 831 SSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGFQNRRLEIPKELDPLVARII 908 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~~~-s~ksDIWSLGiLLyELLtG~~PF~g~~~~e-i~~~i~~~~~~~~ip~~ls~eL~dLI 908 (958)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+..... .................++..+.+||
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHH
Confidence 2345689999999999988775 778999999999999999999998765432 22222212222222356899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 002160 909 WECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 909 ~~CL~kDP~kRPSa~EIL~~ 928 (958)
.+||+.||.+||++.||+++
T Consensus 243 ~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 243 HKILVENPSARITIPDIKKD 262 (323)
T ss_dssp HHHSCSSTTTSCCHHHHTTC
T ss_pred HHHccCChhhCcCHHHHhhC
Confidence 99999999999999999876
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=393.62 Aligned_cols=256 Identities=22% Similarity=0.352 Sum_probs=215.5
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeccccCCC
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~ 746 (958)
...+..++|++++.||+|+||.||+|++ +++.||||++.+.... ......+.+|+.+|+.++|||||+++++|.+..
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 3456778999999999999999999987 5789999998653211 111234778999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
.+||||||++||+|.+++.+. .......+.++.+++.||.|||.++ ||||||||+||||+.+|++||+|||+++...
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence 999999999999999999764 3444555556666699999999998 9999999999999999999999999998764
Q ss_pred CCc-ccCCCCCCCCCccCcccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCC--CC
Q 002160 827 NTF-LSSKSTAGTPEWMAPEVLRNEP----SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KE 899 (958)
Q Consensus 827 ~~~-~~~~s~~GT~~Y~APEvl~g~~----~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip--~~ 899 (958)
... ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+..+....+........+| ..
T Consensus 220 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 299 (410)
T 3v8s_A 220 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 299 (410)
T ss_dssp TTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCC
T ss_pred cCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccc
Confidence 432 2344678999999999998765 7889999999999999999999999999888877775433334454 36
Q ss_pred CcHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 002160 900 LDPLVARIIWECWQTDPSL--RPSFAQLTVA 928 (958)
Q Consensus 900 ls~eL~dLI~~CL~kDP~k--RPSa~EIL~~ 928 (958)
+++++++||.+||+.+|.+ ||+++||++|
T Consensus 300 ~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 300 ISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 8999999999999999988 9999999987
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=395.58 Aligned_cols=257 Identities=21% Similarity=0.338 Sum_probs=215.1
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeccccCCC
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~ 746 (958)
...+..++|++++.||+|+||+||+|++ +++.||||++.+..... .....+.+|+.+|..++|||||+++++|.+.+
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 147 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN 147 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 3456678999999999999999999987 47889999986532111 11224789999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhCCC-CCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~-~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
.+||||||++||+|.+++.+.. .......+.++.+++.||.|||.++ ||||||||+||||+.+|++||+|||+++..
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 225 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKL 225 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCCCCEEEcchhhhhhc
Confidence 9999999999999999998743 4444555556666699999999998 999999999999999999999999999765
Q ss_pred cCCc-ccCCCCCCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCC-
Q 002160 826 HNTF-LSSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK- 898 (958)
Q Consensus 826 ~~~~-~~~~s~~GT~~Y~APEvl~-----g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~- 898 (958)
.... ......+||+.|+|||++. +..++.++|||||||++|||++|+.||.+.+..+....+........+|.
T Consensus 226 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 305 (437)
T 4aw2_A 226 MEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQ 305 (437)
T ss_dssp CTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSS
T ss_pred ccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcc
Confidence 4332 2334568999999999997 45689999999999999999999999999998888877754433445554
Q ss_pred --CCcHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 002160 899 --ELDPLVARIIWECWQTDPSL--RPSFAQLTVA 928 (958)
Q Consensus 899 --~ls~eL~dLI~~CL~kDP~k--RPSa~EIL~~ 928 (958)
.+++++++||.+||..+|++ ||+++||++|
T Consensus 306 ~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 306 VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 48999999999999888888 9999999886
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=363.37 Aligned_cols=260 Identities=30% Similarity=0.466 Sum_probs=209.7
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEE------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~ 744 (958)
..+...+|++++.||+|+||.||+|++ +++.||||++.... .......+.+|+++|++++||||+++++++..
T Consensus 16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTE 94 (302)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 345567799999999999999999984 68899999987543 22335678999999999999999999999987
Q ss_pred C--CceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHH-HHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccc
Q 002160 745 P--PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 821 (958)
Q Consensus 745 ~--~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGL 821 (958)
. ..+++||||+++++|.+++.+......+...+.++. .+.||.|||.++ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTT
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCCCCEEECcccc
Confidence 6 668999999999999999965544455555554444 499999999998 99999999999999999999999999
Q ss_pred cccccCCc---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------------ChhHHH
Q 002160 822 SRLKHNTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM--------------NPMQVV 884 (958)
Q Consensus 822 Ak~~~~~~---~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~--------------~~~ei~ 884 (958)
++...... .......||..|+|||++.+..++.++||||||+++|+|++|..||... ......
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 98764432 2233456888999999999998999999999999999999999886432 111111
Q ss_pred HhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 002160 885 GAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 933 (958)
Q Consensus 885 ~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~ 933 (958)
............+..+++.+.+||.+||+.||.+||++.++++.|+.+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 2222234456677889999999999999999999999999999999875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=359.73 Aligned_cols=260 Identities=29% Similarity=0.460 Sum_probs=213.2
Q ss_pred CCCeeEEEEeeccCceEEEEEEEC-----CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccc-cCCCce
Q 002160 675 WEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV-TRPPNL 748 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~~-----g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~-~~~~~l 748 (958)
..+|++.+.||+|+||.||+|++. ...||||.+... ........+.+|+.++++++||||+++++++ ...+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 356999999999999999999862 225889987653 3445567899999999999999999999985 556678
Q ss_pred EEEEeecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
++||||+++|+|.+++.+......+...+.++ +.+.||.|||.++ |+||||||+|||++.++.+||+|||+++....
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCCCCEEECcccccccccc
Confidence 99999999999999998766555555555554 4499999999998 99999999999999999999999999986543
Q ss_pred Cc----ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcH
Q 002160 828 TF----LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 902 (958)
Q Consensus 828 ~~----~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~ 902 (958)
.. .......+|+.|+|||++.+..++.++||||||+++|+|++ |.+||.+.+..+....+. .......+..++.
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 259 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPD 259 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH-TTCCCCCCTTCCH
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-cCCCCCCCccCCH
Confidence 22 12234457889999999999999999999999999999999 667777776666555543 3445556778899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhcCC
Q 002160 903 LVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 938 (958)
Q Consensus 903 eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~~p 938 (958)
.+.+||.+||+.||.+||++.+|++.|+++......
T Consensus 260 ~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 260 PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 999999999999999999999999999999876543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=369.48 Aligned_cols=253 Identities=18% Similarity=0.239 Sum_probs=206.3
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCceEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~l~LV 751 (958)
.++|++++.||+|+||.||+|++ +++.||||++...... ..+.+|+.+++++ +||||+++++++......++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 46899999999999999999985 7889999998755432 2578999999999 999999999999999999999
Q ss_pred EeecCCCCHHHHHhCCCCCccHHHHHHHHH-HHHHHHHHHhcCCcEeecCCCCCceEEcCCCc-----EEEEeccccccc
Q 002160 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN-----VKVSDFGLSRLK 825 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~-----VKL~DFGLAk~~ 825 (958)
|||+ +++|.+++......+.+...+.++. .+.||.|||.++ |+||||||+||||+.++. +||+|||+++..
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 84 LELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 9999 9999999986544455555555444 499999999998 999999999999998887 999999999875
Q ss_pred cCCcc-------cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh---HHHHhhhccccc--
Q 002160 826 HNTFL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGFQNRR-- 893 (958)
Q Consensus 826 ~~~~~-------~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~---ei~~~i~~~~~~-- 893 (958)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.. +....+......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 43321 124578999999999999999999999999999999999999999885433 223332111111
Q ss_pred -cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 894 -LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 894 -~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
..+...++ ++.+||.+||+.||.+||++.+|++.|+.+.+.
T Consensus 241 ~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 241 IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 11123355 999999999999999999999999999988653
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=366.83 Aligned_cols=261 Identities=31% Similarity=0.514 Sum_probs=218.5
Q ss_pred cccccCCCCeeEEEEeeccCceEEEEEEEC-------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEecc
Q 002160 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 741 (958)
Q Consensus 669 ~~~eI~~~dy~i~k~LG~G~fG~Vykak~~-------g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~ 741 (958)
..+++..++|++.+.||+|+||.||+|++. ++.||||++.... .......+.+|+.++++++||||++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 345677789999999999999999999753 5789999986543 34456678999999999999999999999
Q ss_pred ccCCCceEEEEeecCCCCHHHHHhCCC---------CCccHHHHHHH-HHHHHHHHHHHhcCCcEeecCCCCCceEEcCC
Q 002160 742 VTRPPNLSIITEFLPRGSLFRILHRPH---------CQVDEKRRIKM-ALDARGMNCLHTSTPTIVHRDLKSPNLLVDKN 811 (958)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~d~L~k~~---------~~~~e~~~l~i-a~~a~aL~yLH~~g~gIIHRDLKPeNILId~~ 811 (958)
+.+....++||||+++|+|.+++.... ....+...+.+ .+.+.||.|||.++ |+||||||+||||+.+
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAED 174 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTT
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEcCC
Confidence 999999999999999999999986421 22344444444 44499999999998 9999999999999999
Q ss_pred CcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhh
Q 002160 812 WNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVG 888 (958)
Q Consensus 812 g~VKL~DFGLAk~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~ 888 (958)
+.+||+|||+++...... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+.
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 999999999998654322 11233457889999999999999999999999999999999 899999988877766654
Q ss_pred ccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 002160 889 FQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 933 (958)
Q Consensus 889 ~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~ 933 (958)
.......+..++..+.+||.+||+.||.+||++.+++++|+++.
T Consensus 255 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 255 -EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp -TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred -cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 33445567789999999999999999999999999999998873
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=359.11 Aligned_cols=252 Identities=27% Similarity=0.387 Sum_probs=216.8
Q ss_pred CCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEE
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~L 750 (958)
...+|.+++.||+|+||.||+|++ +++.||+|++..... .......+.+|+.++++++||||+++++++.+.+.+++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 446899999999999999999987 478899999876543 34556788999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc
Q 002160 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 830 (958)
Q Consensus 751 VmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~ 830 (958)
||||+++++|.+++..............+.+.+.||.|||.++ |+||||||+|||++.++.+||+|||++........
T Consensus 93 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp EEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 9999999999998876544444444444555599999999998 99999999999999999999999999987654433
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHH
Q 002160 831 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 910 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 910 (958)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+. .....++..+++.+.+||.+
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~ 248 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--KNEYSIPKHINPVAASLIQK 248 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHHHHHH
T ss_pred ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--hccCCCccccCHHHHHHHHH
Confidence 4455679999999999999989999999999999999999999999888776665553 33456778899999999999
Q ss_pred hhhcCCCCCCCHHHHHHHH
Q 002160 911 CWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 911 CL~kDP~kRPSa~EIL~~L 929 (958)
||+.||.+||++.+++++-
T Consensus 249 ~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 249 MLQTDPTARPTINELLNDE 267 (294)
T ss_dssp HTCSSGGGSCCGGGGGGSH
T ss_pred HcccChhhCcCHHHHhhCh
Confidence 9999999999999999863
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=361.43 Aligned_cols=250 Identities=32% Similarity=0.569 Sum_probs=197.5
Q ss_pred CCCCeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHH--cCCCceeEEeccccC----CCc
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRR--LRHPNVVLFMGAVTR----PPN 747 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~--L~HPNIVkL~g~~~~----~~~ 747 (958)
..++|++++.||+|+||.||+|+++++.||||++... ....+.+|.+++.. ++||||+++++++.. ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 3468999999999999999999999999999998643 23455667777777 799999999998643 345
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHH--------hcCCcEeecCCCCCceEEcCCCcEEEEe
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLH--------TSTPTIVHRDLKSPNLLVDKNWNVKVSD 818 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH--------~~g~gIIHRDLKPeNILId~~g~VKL~D 818 (958)
+++||||+++|+|.++++.. ...+...+.++ +.+.||.||| .++ |+||||||+||||+.++++||+|
T Consensus 81 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEEEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEECTTSCEEECC
T ss_pred eEEehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEcCCCCEEEee
Confidence 89999999999999999654 34444444444 4499999999 666 99999999999999999999999
Q ss_pred ccccccccCCcc----cCCCCCCCCCccCcccccCC------CCCchhhHHHHHHHHHHHHhC----------CCCCCCC
Q 002160 819 FGLSRLKHNTFL----SSKSTAGTPEWMAPEVLRNE------PSNEKCDVYSFGVILWELATL----------KLPWIGM 878 (958)
Q Consensus 819 FGLAk~~~~~~~----~~~s~~GT~~Y~APEvl~g~------~~s~ksDIWSLGiLLyELLtG----------~~PF~g~ 878 (958)
||+++....... ......||+.|+|||++.+. .++.++|||||||++|||++| +.||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 999976543321 12345799999999999877 345799999999999999999 8898654
Q ss_pred Ch-----hHHHHhhhccccccCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 002160 879 NP-----MQVVGAVGFQNRRLEIPK-----ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 879 ~~-----~ei~~~i~~~~~~~~ip~-----~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL 932 (958)
.. ......+.....+..++. .+++.+.+||.+||+.||.+||++.+|++.|++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 237 VPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 22 222222222233333432 3567899999999999999999999999999986
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=379.43 Aligned_cols=250 Identities=25% Similarity=0.343 Sum_probs=203.0
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC---CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF---SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~---~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~L 750 (958)
++|++.+.||+|+||.||+|++ +++.||||++..... .......+.+|+.+|+.++|||||++++++...+.+|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 5799999999999999999987 688999999864321 11134678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhCC---CCCccHHHH-HHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCc---EEEEeccccc
Q 002160 751 ITEFLPRGSLFRILHRP---HCQVDEKRR-IKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSR 823 (958)
Q Consensus 751 VmEy~~gGsL~d~L~k~---~~~~~e~~~-l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~---VKL~DFGLAk 823 (958)
||||+++++|.+++.+. +..+.+... ..+.+++.||.|||.++ |+||||||+|||++.++. +||+|||+++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 99999999998877532 223444444 44455599999999998 999999999999986554 9999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccccc--CCCCCCc
Q 002160 824 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELD 901 (958)
Q Consensus 824 ~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~--~ip~~ls 901 (958)
............+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.. .+....+....... .....++
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s 260 (351)
T 3c0i_A 182 QLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHIS 260 (351)
T ss_dssp ECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSC
T ss_pred EecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCC
Confidence 77654444456789999999999999999999999999999999999999998754 33444332221111 1124689
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 902 PLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 902 ~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.++++||.+||..||.+||++.++++|
T Consensus 261 ~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 261 ESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 999999999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=363.08 Aligned_cols=255 Identities=27% Similarity=0.435 Sum_probs=211.6
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccc--cCCCceEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV--TRPPNLSI 750 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~--~~~~~l~L 750 (958)
.++|++.+.||+|+||.||+|++ +++.||||++............+.+|+.++++++||||+++++++ .....+++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 36899999999999999999987 688999999988776777778899999999999999999999987 44667999
Q ss_pred EEeecCCCCHHHHHhCC---CCCccHHHHHHHHH-HHHHHHHHHhcC---CcEeecCCCCCceEEcCCCcEEEEeccccc
Q 002160 751 ITEFLPRGSLFRILHRP---HCQVDEKRRIKMAL-DARGMNCLHTST---PTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 823 (958)
Q Consensus 751 VmEy~~gGsL~d~L~k~---~~~~~e~~~l~ia~-~a~aL~yLH~~g---~gIIHRDLKPeNILId~~g~VKL~DFGLAk 823 (958)
||||+++++|.+++... .....+...+.++. .+.||.|||..+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999998642 22244554554444 499999999976 349999999999999999999999999997
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHH
Q 002160 824 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 903 (958)
Q Consensus 824 ~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~e 903 (958)
.............||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..++...+. ......++..++.+
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~ 243 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIPYRYSDE 243 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-HTCCCCCCTTSCHH
T ss_pred eeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHh-hcccccCCcccCHH
Confidence 65433222233568999999999999999999999999999999999999999988777666654 33344677789999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002160 904 VARIIWECWQTDPSLRPSFAQLTVALK 930 (958)
Q Consensus 904 L~dLI~~CL~kDP~kRPSa~EIL~~L~ 930 (958)
+.+||.+||+.||.+||++.||++++.
T Consensus 244 l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 244 LNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred HHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 999999999999999999999998764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=368.57 Aligned_cols=265 Identities=25% Similarity=0.357 Sum_probs=207.6
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc----
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN---- 747 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~---- 747 (958)
.++|++++.||+|+||.||+|++ +++.||||++..... .......+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999986 688999999877543 34456788999999999999999999999876554
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
+|+||||+++++|.+++...+..........+.+.+.||.|||.++ |+||||||+||||+.++.+||+|||+++....
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 4999999999999999976554444444445555599999999998 99999999999999999999999999986543
Q ss_pred Cc---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccccc--CCCCCCcH
Q 002160 828 TF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDP 902 (958)
Q Consensus 828 ~~---~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~--~ip~~ls~ 902 (958)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+............ .....++.
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 248 (311)
T ss_dssp -------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCH
T ss_pred cccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCH
Confidence 21 12234569999999999999999999999999999999999999999988776655443222111 12356899
Q ss_pred HHHHHHHHhhhcCCCCCCC-HHHHHHHHHhhhhhcCCCCC
Q 002160 903 LVARIIWECWQTDPSLRPS-FAQLTVALKPLQRLVIPSHP 941 (958)
Q Consensus 903 eL~dLI~~CL~kDP~kRPS-a~EIL~~L~kL~k~~~p~~P 941 (958)
++.+||.+||+.||.+||+ ++++...|.++.....|..|
T Consensus 249 ~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~~ 288 (311)
T 3ork_A 249 DLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAP 288 (311)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSSC
T ss_pred HHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCCC
Confidence 9999999999999999985 55566677777655444444
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=364.30 Aligned_cols=252 Identities=25% Similarity=0.411 Sum_probs=208.1
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEEC--C-------cEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccc
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADWN--G-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 742 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~~--g-------~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~ 742 (958)
++..++|++.+.||+|+||.||+|++. + ..||+|++.... ......+.+|+.+|++++||||+++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 456689999999999999999999763 3 569999986543 23456789999999999999999999999
Q ss_pred cCCCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCc--------
Q 002160 743 TRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN-------- 813 (958)
Q Consensus 743 ~~~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~-------- 813 (958)
...+..++||||+++++|.+++.+......+...+.++.+ +.||.|||.++ |+||||||+||||+.++.
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecCCcccccccce
Confidence 9999999999999999999999876654555555555444 99999999998 999999999999998877
Q ss_pred EEEEeccccccccCCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhC-CCCCCCCChhHHHHhhhccc
Q 002160 814 VKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 891 (958)
Q Consensus 814 VKL~DFGLAk~~~~~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG-~~PF~g~~~~ei~~~i~~~~ 891 (958)
+||+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++| ..||...+........ .
T Consensus 160 ~kl~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~---~ 232 (289)
T 4fvq_A 160 IKLSDPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY---E 232 (289)
T ss_dssp EEECCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH---H
T ss_pred eeeccCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh---h
Confidence 999999998765332 22457889999999987 6789999999999999999995 4555555544433322 2
Q ss_pred cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhh
Q 002160 892 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934 (958)
Q Consensus 892 ~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k 934 (958)
....++...++++.+||.+||+.||.+||++.+|+++|+++..
T Consensus 233 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 233 DRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp TTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred ccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 3455667778999999999999999999999999999998854
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=381.78 Aligned_cols=250 Identities=27% Similarity=0.438 Sum_probs=210.7
Q ss_pred CCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEE
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~L 750 (958)
...+|.+.+.||+|+||.||+|++ +++.||||++....... .....+.+|+.+|+.++||||+++++++.....+++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 347899999999999999999987 78899999986542211 123468899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc
Q 002160 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 830 (958)
Q Consensus 751 VmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~ 830 (958)
||||+ +|+|.+++.+.+.......+..+.+.+.||.|||.++ |+||||||+|||++.++.+||+|||++.......
T Consensus 87 v~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~- 162 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN- 162 (336)
T ss_dssp EECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB-
T ss_pred EEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCCCCEEEEEeccceeccCCc-
Confidence 99999 7899998876555555555555556699999999998 9999999999999999999999999998765432
Q ss_pred cCCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHH
Q 002160 831 SSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 909 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~~~-s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~ 909 (958)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+....+....+ ......+|..+++++++||.
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~~~~~li~ 240 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGAQSLIR 240 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--CSSCCCCCTTSCHHHHHHHH
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--HcCCCCCcccCCHHHHHHHH
Confidence 2345689999999999998876 78999999999999999999999887655544433 33345677889999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHH
Q 002160 910 ECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 910 ~CL~kDP~kRPSa~EIL~~L 929 (958)
+||+.||.+||++.||+++-
T Consensus 241 ~~L~~dP~~Rpt~~eil~hp 260 (336)
T 3h4j_B 241 RMIVADPMQRITIQEIRRDP 260 (336)
T ss_dssp TTSCSSGGGSCCHHHHTTCH
T ss_pred HHcCCChhHCcCHHHHHhCh
Confidence 99999999999999998863
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=391.80 Aligned_cols=256 Identities=21% Similarity=0.320 Sum_probs=213.6
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeccccCCC
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~ 746 (958)
...+..++|++++.||+|+||+||+|++ +++.||||++.+.... ......+.+|+.+|..++||||++++++|.+.+
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN 134 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 3456778999999999999999999987 6899999998753221 112335789999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhCCC-CCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~-~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
.+||||||++||+|.+++.+.+ .......+.++.+++.||.|||.++ ||||||||+||||+.+|++||+|||+++..
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~g~vkL~DFGla~~~ 212 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKL 212 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCCCCEEEeechhheec
Confidence 9999999999999999997654 3444555566666799999999998 999999999999999999999999999876
Q ss_pred cCCcc-cCCCCCCCCCccCccccc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCC
Q 002160 826 HNTFL-SSKSTAGTPEWMAPEVLR-------NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 897 (958)
Q Consensus 826 ~~~~~-~~~s~~GT~~Y~APEvl~-------g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip 897 (958)
..... .....+||+.|+|||++. +..++.++|||||||++|||++|+.||.+.+..+....+........+|
T Consensus 213 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p 292 (412)
T 2vd5_A 213 RADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLP 292 (412)
T ss_dssp CTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred cCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCC
Confidence 44322 234568999999999997 3568999999999999999999999999998888777765333333333
Q ss_pred ---CCCcHHHHHHHHHhhhcCCCCC---CCHHHHHHH
Q 002160 898 ---KELDPLVARIIWECWQTDPSLR---PSFAQLTVA 928 (958)
Q Consensus 898 ---~~ls~eL~dLI~~CL~kDP~kR---PSa~EIL~~ 928 (958)
..+++++++||.+||. +|.+| |+++||++|
T Consensus 293 ~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 293 LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp ----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 5799999999999998 99998 589999876
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=393.21 Aligned_cols=259 Identities=35% Similarity=0.595 Sum_probs=222.2
Q ss_pred cccccCCCCeeEEEEeeccCceEEEEEEEC--CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC
Q 002160 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (958)
Q Consensus 669 ~~~eI~~~dy~i~k~LG~G~fG~Vykak~~--g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~ 746 (958)
..+++...+|++.+.||+|+||.||+|++. +..||||++...... ..+|.+|+.+|++++|||||++++++....
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREP 289 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 446778889999999999999999999984 789999998765432 467899999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhCCC-CCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~-~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
.+||||||+++|+|.+++.+.. ....+...+.++ +++.||.|||.++ ||||||||+||||+.++.+||+|||+++.
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 367 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSRL 367 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCCCcEEEeeccccee
Confidence 9999999999999999997533 334555555544 4499999999998 99999999999999999999999999987
Q ss_pred ccCCcc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcH
Q 002160 825 KHNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 902 (958)
Q Consensus 825 ~~~~~~-~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~ 902 (958)
...... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+. ...+...|..+++
T Consensus 368 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 446 (495)
T 1opk_A 368 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPE 446 (495)
T ss_dssp CTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCCH
T ss_pred ccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCH
Confidence 643322 2233456789999999999889999999999999999999 999999988777766554 4456677888999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 002160 903 LVARIIWECWQTDPSLRPSFAQLTVALKPLQ 933 (958)
Q Consensus 903 eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~ 933 (958)
.+.+||.+||+.||.+||++.+|++.|+.+.
T Consensus 447 ~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 447 KVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 9999999999999999999999999999874
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=367.49 Aligned_cols=263 Identities=27% Similarity=0.450 Sum_probs=218.1
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEECC-------cEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEecc
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA 741 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~~g-------~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~ 741 (958)
.+++..++|++.+.||+|+||.||+|++.+ ..||||.+.... .......+.+|+.+|+++ +||||++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 467888999999999999999999998732 479999886543 344567899999999999 89999999999
Q ss_pred ccCCCceEEEEeecCCCCHHHHHhCCC-------------CCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceE
Q 002160 742 VTRPPNLSIITEFLPRGSLFRILHRPH-------------CQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLL 807 (958)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~d~L~k~~-------------~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNIL 807 (958)
+...+.+++||||+++|+|.+++.... ....+...+.++ +.+.||.|||.++ |+||||||+|||
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl 196 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVL 196 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEE
Confidence 999999999999999999999986421 123444444444 4499999999998 999999999999
Q ss_pred EcCCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHH
Q 002160 808 VDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVV 884 (958)
Q Consensus 808 Id~~g~VKL~DFGLAk~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~ 884 (958)
|+.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.......
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence 99999999999999986543221 1233456789999999999999999999999999999998 99999887655544
Q ss_pred HhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 885 GAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 885 ~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
..+.........+..++..+.+||.+||+.||.+||++.+|++.|+.+...
T Consensus 277 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 277 YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 444434445566778899999999999999999999999999999987543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=371.12 Aligned_cols=254 Identities=20% Similarity=0.285 Sum_probs=209.2
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE-CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCC--CceeEEeccccCCCce
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH--PNVVLFMGAVTRPPNL 748 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~H--PNIVkL~g~~~~~~~l 748 (958)
.+..++|++++.||+|+||.||++.+ +++.||||++............+.+|+.+|++++| |||+++++++.....+
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 45667899999999999999999976 67889999998777777777889999999999976 9999999999999999
Q ss_pred EEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
|||||| .+++|.+++.+...........++.+++.||.|||.++ |+||||||+||||+ ++.+||+|||+++.....
T Consensus 85 ~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 85 YMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 999995 58899999987665555555556666699999999998 99999999999997 678999999999876433
Q ss_pred cc--cCCCCCCCCCccCcccccC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHhhhcccccc
Q 002160 829 FL--SSKSTAGTPEWMAPEVLRN-----------EPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNRRL 894 (958)
Q Consensus 829 ~~--~~~s~~GT~~Y~APEvl~g-----------~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~-~ei~~~i~~~~~~~ 894 (958)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ......+.......
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 240 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 240 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCccc
Confidence 21 2335679999999999975 6688999999999999999999999987543 23334443344566
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002160 895 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 895 ~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L 929 (958)
.++...+.++.+||.+||+.||.+||++.|+++|-
T Consensus 241 ~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 77788899999999999999999999999999874
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=359.23 Aligned_cols=252 Identities=23% Similarity=0.402 Sum_probs=213.7
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeccccCCCc
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~ 747 (958)
..+..++|++.+.||+|+||.||+|++ +++.||||++....... .....+.+|+.++++++||||+++++++.+.+.
T Consensus 9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 88 (284)
T 2vgo_A 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR 88 (284)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred cchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCE
Confidence 345668999999999999999999987 57789999986543211 123578899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
+++||||+++++|.+++.+............+.+.+.||.|||.++ |+||||||+|||++.++.+||+|||++.....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999999999999976554444444444555599999999988 99999999999999999999999999876543
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHH
Q 002160 828 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 907 (958)
Q Consensus 828 ~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dL 907 (958)
. ......|++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+. .....++..++..+++|
T Consensus 167 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l 242 (284)
T 2vgo_A 167 L--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV--NVDLKFPPFLSDGSKDL 242 (284)
T ss_dssp S--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHHH
T ss_pred c--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh--ccccCCCCcCCHHHHHH
Confidence 2 2345679999999999999999999999999999999999999999888776665553 33556778899999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 002160 908 IWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 908 I~~CL~kDP~kRPSa~EIL~~ 928 (958)
|.+||+.||.+||++.+|+++
T Consensus 243 i~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 243 ISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp HHHHSCSSGGGSCCHHHHHTC
T ss_pred HHHHhhcCHhhCCCHHHHhhC
Confidence 999999999999999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=368.26 Aligned_cols=250 Identities=27% Similarity=0.393 Sum_probs=215.9
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LV 751 (958)
..+|.+++.||+|+||.||++++ +++.||+|++..... .......+.+|+.++++++||||+++++++.+.+.+|+|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 46799999999999999999987 578899999876543 445567889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc
Q 002160 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~ 831 (958)
|||+++++|.+++..............+.+.+.||.|||.++ |+||||||+|||++.++.+||+|||+++........
T Consensus 120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 197 (335)
T 2owb_A 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 197 (335)
T ss_dssp ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCCCCEEEeeccCceecccCccc
Confidence 999999999999876544444444444555599999999998 999999999999999999999999999876544344
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHh
Q 002160 832 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 911 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~C 911 (958)
.....||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+. .....++..+++.+.+||.+|
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~ 275 (335)
T 2owb_A 198 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--KNEYSIPKHINPVAASLIQKM 275 (335)
T ss_dssp BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HTCCCCCTTSCHHHHHHHHHH
T ss_pred ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh--cCCCCCCccCCHHHHHHHHHH
Confidence 455679999999999999999999999999999999999999999887776665553 234567788999999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 002160 912 WQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 912 L~kDP~kRPSa~EIL~~ 928 (958)
|+.||.+||++.||+++
T Consensus 276 l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 276 LQTDPTARPTINELLND 292 (335)
T ss_dssp TCSSGGGSCCGGGGGGS
T ss_pred ccCChhHCcCHHHHhcC
Confidence 99999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=411.12 Aligned_cols=255 Identities=20% Similarity=0.315 Sum_probs=219.4
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHc-CCCceeEEeccccCC
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRP 745 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~ 745 (958)
...+..++|++++.||+|+||.||+|++ +++.||||++.+... .......+..|..+|..+ +||||++++++|.+.
T Consensus 335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~ 414 (674)
T 3pfq_A 335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 414 (674)
T ss_dssp -----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS
T ss_pred cccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC
Confidence 3456778999999999999999999987 577899999875422 112345678899999988 799999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 746 ~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
+.+||||||++||+|.+++.+.+.......+.++.+++.||.|||.++ ||||||||+||||+.+|++||+|||+++..
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred CEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999999999987666666666667777799999999998 999999999999999999999999999875
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHH
Q 002160 826 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 905 (958)
Q Consensus 826 ~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~ 905 (958)
..........+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..++...+. .....+|..++++++
T Consensus 493 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~ 570 (674)
T 3pfq_A 493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM--EHNVAYPKSMSKEAV 570 (674)
T ss_dssp CCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--SSCCCCCTTSCHHHH
T ss_pred ccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHH--hCCCCCCccCCHHHH
Confidence 444444567889999999999999999999999999999999999999999999888888875 345678889999999
Q ss_pred HHHHHhhhcCCCCCCCH-----HHHHHH
Q 002160 906 RIIWECWQTDPSLRPSF-----AQLTVA 928 (958)
Q Consensus 906 dLI~~CL~kDP~kRPSa-----~EIL~~ 928 (958)
+||.+||++||.+||++ +||++|
T Consensus 571 ~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 571 AICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp HHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred HHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 99999999999999997 777764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=359.50 Aligned_cols=263 Identities=24% Similarity=0.436 Sum_probs=202.3
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceE
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~ 749 (958)
....+|++.+.||+|+||.||+|++ +++.||||++..... .......+.+|+.++++++||||+++++++...+.++
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 3456899999999999999999986 688999999876443 4456678899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhC---CCCCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 750 IITEFLPRGSLFRILHR---PHCQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k---~~~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
+||||+++++|.+++.. ......+...+. +.+.+.||.|||..+ |+||||||+||||+.++.+||+|||++...
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 99999999999998863 223344444444 444499999999998 999999999999999999999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--hhHHHHhhhccccccCCCCCCcHH
Q 002160 826 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN--PMQVVGAVGFQNRRLEIPKELDPL 903 (958)
Q Consensus 826 ~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~--~~ei~~~i~~~~~~~~ip~~ls~e 903 (958)
...........|++.|+|||++.+..++.++||||||+++|+|++|+.||.+.. .......+.........+..++.+
T Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (310)
T 2wqm_A 187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 266 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHH
T ss_pred cCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHH
Confidence 544333345679999999999999999999999999999999999999997653 233333333222222223578999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhcC
Q 002160 904 VARIIWECWQTDPSLRPSFAQLTVALKPLQRLVI 937 (958)
Q Consensus 904 L~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~~ 937 (958)
+.+||.+||..||.+||++.+|++.|+++....-
T Consensus 267 l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 267 LRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 9999999999999999999999999999976643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=361.68 Aligned_cols=250 Identities=26% Similarity=0.397 Sum_probs=186.9
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LV 751 (958)
.++|++.+.||+|+||.||+|++ +++.||||++....... .....+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 36899999999999999999986 78899999986542211 1245788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhCCCCCccHHHHHHHHH-HHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc
Q 002160 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 830 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~ 830 (958)
|||+++++|.+++......+.+.....++. .+.||.|||.++ |+||||||+|||++.++.+||+|||++........
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 999999999999987655555555554444 499999999998 99999999999999999999999999987654333
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHH
Q 002160 831 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 910 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 910 (958)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+. .....++..++.++++||.+
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~ 245 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV--LADYEMPSFLSIEAKDLIHQ 245 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC--SSCCCCCTTSCHHHHHHHHH
T ss_pred cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh--hcccCCccccCHHHHHHHHH
Confidence 3345679999999999999989999999999999999999999998776555544442 22445677899999999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 002160 911 CWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 911 CL~kDP~kRPSa~EIL~~ 928 (958)
||+.||.+||++.+++++
T Consensus 246 ~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 246 LLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp HSCSSGGGSCCHHHHTTS
T ss_pred HcccCHhhCCCHHHHhcC
Confidence 999999999999999874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=369.03 Aligned_cols=262 Identities=28% Similarity=0.431 Sum_probs=211.0
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEecccc--C
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT--R 744 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~--~ 744 (958)
+..++|++++.||+|+||.||+|++ +++.||||++... .......+.+|+++|++++||||+++++++. +
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 4557899999999999999999984 5788999998754 3445667899999999999999999999876 4
Q ss_pred CCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccc
Q 002160 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 823 (958)
Q Consensus 745 ~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk 823 (958)
...+++||||+++++|.+++......+.+...+.++ +.+.||.|||..+ |+||||||+||||+.++.+||+|||+++
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCCCCEEEcccccce
Confidence 556899999999999999997644444555555444 4499999999988 9999999999999999999999999998
Q ss_pred cccCCc---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh--------------HHHHh
Q 002160 824 LKHNTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM--------------QVVGA 886 (958)
Q Consensus 824 ~~~~~~---~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~--------------ei~~~ 886 (958)
...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||...... .....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence 754322 1233456888999999999998999999999999999999999998654322 11111
Q ss_pred hhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhcCC
Q 002160 887 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 938 (958)
Q Consensus 887 i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~~p 938 (958)
..........+..+++.+.+||.+||+.||.+||++.+|+++|+.+......
T Consensus 256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 307 (327)
T 3lxl_A 256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307 (327)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence 2223445566788999999999999999999999999999999998654433
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=370.86 Aligned_cols=257 Identities=28% Similarity=0.500 Sum_probs=208.3
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcE----EEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTE----VAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~----VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~ 746 (958)
+..++|++++.||+|+||.||+|++ +++. ||+|.+.... .......+.+|+.+|++++||||+++++++....
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence 4567899999999999999999987 4444 5777665432 2234567889999999999999999999998754
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHH-HHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
.++||||+.+|+|.+++......+.+...+.++. .+.||.|||.++ |+||||||+||||+.++++||+|||+++..
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 8899999999999999987555555555554444 499999999998 999999999999999999999999999875
Q ss_pred cCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcH
Q 002160 826 HNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 902 (958)
Q Consensus 826 ~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~ 902 (958)
.... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+. .......+..++.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 246 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTI 246 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTBCH
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCH
Confidence 4322 12233456789999999999999999999999999999999 999999988777666554 4445666788999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhh
Q 002160 903 LVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934 (958)
Q Consensus 903 eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k 934 (958)
++.+||.+||+.||.+||++.||++.|+++..
T Consensus 247 ~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 247 DVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=358.28 Aligned_cols=253 Identities=31% Similarity=0.446 Sum_probs=209.6
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC----CC
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR----PP 746 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~----~~ 746 (958)
.....|++.+.||+|+||.||+|.+ ++..||+|++............+.+|+.+|++++||||+++++++.. ..
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence 3445699999999999999999987 57789999998877777778889999999999999999999998764 45
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEc-CCCcEEEEeccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLK 825 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId-~~g~VKL~DFGLAk~~ 825 (958)
.+++||||+++++|.+++.+...........++.+.+.||.|||..+.+|+||||||+|||++ .++.+||+|||++...
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 589999999999999999865444444444455555999999999877799999999999998 7899999999999765
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHhhhccccccCCCCCCcHHH
Q 002160 826 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNRRLEIPKELDPLV 904 (958)
Q Consensus 826 ~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~-~ei~~~i~~~~~~~~ip~~ls~eL 904 (958)
.... .....||+.|+|||++.+. ++.++|||||||++|+|++|+.||..... .+....+........++...++++
T Consensus 183 ~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 259 (290)
T 1t4h_A 183 RASF--AKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 259 (290)
T ss_dssp CTTS--BEESCSSCCCCCGGGGGTC-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred cccc--cccccCCcCcCCHHHHhcc-CCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHH
Confidence 4332 2345799999999998754 88999999999999999999999987544 344444433333444566788999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 905 ARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 905 ~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.+||.+||+.||.+||++.+|+++
T Consensus 260 ~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 260 KEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHccCChhhCCCHHHHhhC
Confidence 999999999999999999999875
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=365.59 Aligned_cols=246 Identities=28% Similarity=0.383 Sum_probs=208.4
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEee
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
.|...+.||+|+||.||+|++ +++.||||++...... ....+.+|+.++++++||||+++++++...+.+++||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 478888999999999999987 6899999998765432 245688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCC
Q 002160 755 LPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 833 (958)
Q Consensus 755 ~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~ 833 (958)
+++++|.+++.+.. ..+.....++ +.+.||.|||.++ |+||||||+||||+.++.+||+|||+++..........
T Consensus 124 ~~~~~L~~~l~~~~--l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 199 (321)
T 2c30_A 124 LQGGALTDIVSQVR--LNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 199 (321)
T ss_dssp CCSCBHHHHHTTCC--CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred CCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccc
Confidence 99999999987642 3444444444 4489999999988 99999999999999999999999999987655444445
Q ss_pred CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc-ccCCCCCCcHHHHHHHHHhh
Q 002160 834 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARIIWECW 912 (958)
Q Consensus 834 s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~-~~~ip~~ls~eL~dLI~~CL 912 (958)
...||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+....+..... ....+..+++.+++||.+||
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 279 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML 279 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHS
T ss_pred cccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHc
Confidence 67899999999999999999999999999999999999999998887776665532211 12233468899999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 002160 913 QTDPSLRPSFAQLTVA 928 (958)
Q Consensus 913 ~kDP~kRPSa~EIL~~ 928 (958)
+.||.+||++.+++++
T Consensus 280 ~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 280 VRDPQERATAQELLDH 295 (321)
T ss_dssp CSSTTTSCCHHHHHTS
T ss_pred cCChhhCcCHHHHhcC
Confidence 9999999999999886
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=366.97 Aligned_cols=260 Identities=31% Similarity=0.569 Sum_probs=214.3
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcE--EEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCc
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTE--VAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~--VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~ 747 (958)
+.+++|++.+.||+|+||.||+|++ ++.. ||||.+.... .......+.+|+.+|+++ +||||+++++++.+.+.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 100 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 100 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence 5678999999999999999999976 5554 4999876432 333456788999999999 89999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhCCC---------------CCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEcCC
Q 002160 748 LSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVDKN 811 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~---------------~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~ 811 (958)
+|+||||+++++|.+++.+.. ....+...+. +.+++.||.|||.++ |+||||||+||||+.+
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN 178 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGG
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEEcCC
Confidence 999999999999999997654 2344444444 444599999999998 9999999999999999
Q ss_pred CcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhcc
Q 002160 812 WNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQ 890 (958)
Q Consensus 812 g~VKL~DFGLAk~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~ 890 (958)
+.+||+|||+++..... .......+++.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..+....+. .
T Consensus 179 ~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~-~ 256 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-Q 256 (327)
T ss_dssp GCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG-G
T ss_pred CeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh-c
Confidence 99999999998754322 22233457889999999999889999999999999999998 999999988877776664 3
Q ss_pred ccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhcC
Q 002160 891 NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVI 937 (958)
Q Consensus 891 ~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~~ 937 (958)
......+..+++.+.+||.+||..||.+||++.+++++|.++.....
T Consensus 257 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 257 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 34556677899999999999999999999999999999999876543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=369.77 Aligned_cols=250 Identities=25% Similarity=0.290 Sum_probs=190.0
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
.++|++++.||+|+||.||+|++ +++.||||++..... ......+.+|+.+|++++|||||++++++...+.+++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 36799999999999999999976 588999999875542 222356789999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCC-----CCccHHHH-HHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 753 EFLPRGSLFRILHRPH-----CQVDEKRR-IKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~-----~~~~e~~~-l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
||++ ++|.+++.... ....+... ..+.+.+.||.|||.++ |+||||||+|||++.++.+||+|||+++...
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 9997 59998885421 22344444 44445599999999998 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc-------------
Q 002160 827 NTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------- 892 (958)
Q Consensus 827 ~~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~------------- 892 (958)
..........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239 (317)
T ss_dssp SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence 44344455679999999999987 4689999999999999999999999998877665544321000
Q ss_pred -------------------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 893 -------------------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 893 -------------------~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
....+..++.++++||.+||+.||.+||++.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 011223578899999999999999999999999875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=385.81 Aligned_cols=263 Identities=33% Similarity=0.557 Sum_probs=216.5
Q ss_pred cccccCCCCeeEEEEeeccCceEEEEEEECC-cEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc
Q 002160 669 CECEIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 669 ~~~eI~~~dy~i~k~LG~G~fG~Vykak~~g-~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~ 747 (958)
..+++..++|++.+.||+|+||.||+|++.+ ..||||++...... ...|.+|+++|++++|||||++++++.+ +.
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~ 252 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 252 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence 3466788899999999999999999999854 67999998765433 3578999999999999999999999876 67
Q ss_pred eEEEEeecCCCCHHHHHhCC-CCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 748 LSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~-~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
++|||||+++|+|.+++... .....+...+.++ +.+.||.|||.++ |+||||||+||||+.++.+||+|||+++..
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCCCCEEECCCccceec
Confidence 89999999999999999742 2234444444444 4499999999998 999999999999999999999999999876
Q ss_pred cCCcc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHH
Q 002160 826 HNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 903 (958)
Q Consensus 826 ~~~~~-~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~e 903 (958)
..... ......++..|+|||++.+..++.++|||||||++|||++ |+.||.+....++...+. ...+...|..++..
T Consensus 331 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~ 409 (452)
T 1fmk_A 331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPES 409 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTSCHH
T ss_pred CCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 43322 1223456789999999999999999999999999999999 999999998888777664 44566778889999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhcCC
Q 002160 904 VARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 938 (958)
Q Consensus 904 L~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~~p 938 (958)
+.+||.+||+.||.+||++.+|++.|+.+.....|
T Consensus 410 l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 410 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 99999999999999999999999999998655433
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=377.44 Aligned_cols=256 Identities=22% Similarity=0.282 Sum_probs=197.7
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeccccCCC--ceE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPP--NLS 749 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~-HPNIVkL~g~~~~~~--~l~ 749 (958)
.++|++++.||+|+||.||+|.+ +++.||||++............+.+|+.+|+++. |||||++++++...+ .+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 36899999999999999999986 6889999998766556666778899999999997 999999999987544 689
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC-
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT- 828 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~- 828 (958)
+||||++ ++|..++... .......+..+.+++.||.|||+.+ |+||||||+||||+.++++||+|||+++.....
T Consensus 88 lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRAN-ILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEEECCS-EEHHHHHHHT-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EEecccC-cCHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 9999997 5899988763 2333344444555699999999998 999999999999999999999999999865321
Q ss_pred --------------------cccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhh
Q 002160 829 --------------------FLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV 887 (958)
Q Consensus 829 --------------------~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i 887 (958)
.......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 243 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 112234679999999999987 67899999999999999999999999998876655444
Q ss_pred hcccccc---------------------------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCH
Q 002160 888 GFQNRRL---------------------------------------------EIPKELDPLVARIIWECWQTDPSLRPSF 922 (958)
Q Consensus 888 ~~~~~~~---------------------------------------------~ip~~ls~eL~dLI~~CL~kDP~kRPSa 922 (958)
......+ ..+..+++++.+||.+||+.||.+||++
T Consensus 244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~ 323 (388)
T 3oz6_A 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323 (388)
T ss_dssp HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence 2110000 0112678999999999999999999999
Q ss_pred HHHHHH--HHhhhh
Q 002160 923 AQLTVA--LKPLQR 934 (958)
Q Consensus 923 ~EIL~~--L~kL~k 934 (958)
.|+++| ++.+..
T Consensus 324 ~e~l~Hp~~~~~~~ 337 (388)
T 3oz6_A 324 NDALKHPFVSIFHN 337 (388)
T ss_dssp HHHTTSTTTTTTCC
T ss_pred HHHhCCHHHHHhcC
Confidence 999988 555543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=374.07 Aligned_cols=250 Identities=27% Similarity=0.368 Sum_probs=195.4
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEE
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~L 750 (958)
...++|++++.||+|+||.||++++ +++.||||++....... ..+.+|+.++++++|||||++++++.....+++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 4457899999999999999999987 68899999987654322 457899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCc--EEEEeccccccccCC
Q 002160 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN--VKVSDFGLSRLKHNT 828 (958)
Q Consensus 751 VmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~--VKL~DFGLAk~~~~~ 828 (958)
||||+++|+|.+++...+.......+.++.+.+.||.|||.++ |+||||||+||||+.++. +||+|||+++.....
T Consensus 94 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 94 IMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 9999999999999876555555555556666699999999998 999999999999987665 999999999754322
Q ss_pred cccCCCCCCCCCccCcccccCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCChh----HHHHhhhccccccCCCCCCcHH
Q 002160 829 FLSSKSTAGTPEWMAPEVLRNEPSNEK-CDVYSFGVILWELATLKLPWIGMNPM----QVVGAVGFQNRRLEIPKELDPL 903 (958)
Q Consensus 829 ~~~~~s~~GT~~Y~APEvl~g~~~s~k-sDIWSLGiLLyELLtG~~PF~g~~~~----ei~~~i~~~~~~~~ip~~ls~e 903 (958)
.......||+.|+|||++.+..+..+ +|||||||++|+|++|+.||.+.... .....+............++++
T Consensus 172 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 250 (361)
T 3uc3_A 172 -SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPE 250 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHH
T ss_pred -CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHH
Confidence 22344679999999999998887655 89999999999999999999875442 2233332222222223368999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 904 VARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 904 L~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+++||.+||+.||.+||++.||++|
T Consensus 251 ~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 251 CCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHccCChhHCcCHHHHHhC
Confidence 9999999999999999999999987
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=362.85 Aligned_cols=250 Identities=25% Similarity=0.370 Sum_probs=210.5
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCH----HHHHHHHHHHHHHHHcCCCceeEEeccccCCCceE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~----~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~ 749 (958)
++|++++.||+|+||.||+|++ +++.||||++....... .....+.+|+.+|++++||||+++++++.+...++
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 5699999999999999999987 58899999987654322 13567899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCC----cEEEEeccccccc
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNW----NVKVSDFGLSRLK 825 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g----~VKL~DFGLAk~~ 825 (958)
+||||+++++|.+++.+............+.+.+.||.|||.++ |+||||||+|||++.++ ++||+|||+++..
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 99999999999999987654444444444555599999999998 99999999999999887 8999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccc--cCCCCCCcHH
Q 002160 826 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--LEIPKELDPL 903 (958)
Q Consensus 826 ~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~--~~ip~~ls~e 903 (958)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+...... ..++..++..
T Consensus 170 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 248 (321)
T 2a2a_A 170 EDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248 (321)
T ss_dssp CTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred Cccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHH
Confidence 5432 234567999999999999999999999999999999999999999998877776665322111 1122568899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 904 VARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 904 L~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+++||.+||..||.+||++.|++++
T Consensus 249 ~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 249 AKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcC
Confidence 9999999999999999999999875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=367.22 Aligned_cols=268 Identities=28% Similarity=0.398 Sum_probs=198.0
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHH--HHHcCCCceeEEeccc-----c
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKI--MRRLRHPNVVLFMGAV-----T 743 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~I--Lk~L~HPNIVkL~g~~-----~ 743 (958)
..+..++|++++.||+|+||.||+|+++++.||||++.... ...+..|..+ +..++||||+++++++ .
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD 82 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred CCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence 45677899999999999999999999999999999986542 2233344444 4558999999999743 3
Q ss_pred CCCceEEEEeecCCCCHHHHHhCCCCCccHHHHHH-HHHHHHHHHHHHhc---------CCcEeecCCCCCceEEcCCCc
Q 002160 744 RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDARGMNCLHTS---------TPTIVHRDLKSPNLLVDKNWN 813 (958)
Q Consensus 744 ~~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~-ia~~a~aL~yLH~~---------g~gIIHRDLKPeNILId~~g~ 813 (958)
....+++||||+++|+|.+++..... .+...+. +.+.+.||.|||.. + |+||||||+||||+.++.
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLHTS--DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHCCB--CHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEECTTSC
T ss_pred CCceEEEEEecCCCCcHHHHHhhccc--chhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEcCCCc
Confidence 34467899999999999999976543 3333333 44449999999998 6 999999999999999999
Q ss_pred EEEEeccccccccCCc--------ccCCCCCCCCCccCcccccC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 002160 814 VKVSDFGLSRLKHNTF--------LSSKSTAGTPEWMAPEVLRN-------EPSNEKCDVYSFGVILWELATLKLPWIGM 878 (958)
Q Consensus 814 VKL~DFGLAk~~~~~~--------~~~~s~~GT~~Y~APEvl~g-------~~~s~ksDIWSLGiLLyELLtG~~PF~g~ 878 (958)
+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 9999999998654321 12234579999999999987 34567899999999999999998776432
Q ss_pred Ch------------------hHHHHhhhccccccCCCCC------CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhh
Q 002160 879 NP------------------MQVVGAVGFQNRRLEIPKE------LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934 (958)
Q Consensus 879 ~~------------------~ei~~~i~~~~~~~~ip~~------ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k 934 (958)
.. ......+.....+..++.. +++.+.+||.+||+.||.+||++.|+++.|+++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 21 1111112222333444433 44589999999999999999999999999999988
Q ss_pred hcCCCCCCCCCCC
Q 002160 935 LVIPSHPDQPSSA 947 (958)
Q Consensus 935 ~~~p~~P~~p~~~ 947 (958)
.+.-.....|+++
T Consensus 319 ~~~~~~~~~~~~~ 331 (336)
T 3g2f_A 319 IWERNKSVSPTAH 331 (336)
T ss_dssp CCCC---------
T ss_pred HHHhcccCCCccc
Confidence 7766655555443
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=359.71 Aligned_cols=261 Identities=33% Similarity=0.525 Sum_probs=208.1
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEEC---Cc--EEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCC
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADWN---GT--EVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~~---g~--~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~ 745 (958)
.+..++|++++.||+|+||.||+|++. ++ .||||++..... .......+.+|++++++++||||+++++++...
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 455678999999999999999999862 23 589998876543 234567899999999999999999999999876
Q ss_pred CceEEEEeecCCCCHHHHHhCCCCCccHHHHHHH-HHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKM-ALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 746 ~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~i-a~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
. .++||||+++++|.+++.+......+.....+ .+.+.||.|||.++ |+||||||+|||++.++.+||+|||++..
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCCCCEEEcccccccc
Confidence 4 89999999999999998765444444444444 44499999999998 99999999999999999999999999987
Q ss_pred ccCCcc---cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCC
Q 002160 825 KHNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 900 (958)
Q Consensus 825 ~~~~~~---~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~l 900 (958)
...... ......+|..|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..+....+.........+..+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 250 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCc
Confidence 643321 1233457889999999999889999999999999999999 999999998888877776555566677789
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 901 DPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 901 s~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
+..+.+||.+||..||.+||++.+|++.|+++...
T Consensus 251 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 251 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 99999999999999999999999999999988643
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=364.50 Aligned_cols=262 Identities=27% Similarity=0.409 Sum_probs=211.9
Q ss_pred CCCeeEEEEeeccCceEEEEEEE------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC--C
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP--P 746 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~--~ 746 (958)
...|++++.||+|+||.||++.+ +++.||||++... ........+.+|+++|++++||||+++++++.+. .
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence 34469999999999999999865 6788999998755 3445667899999999999999999999999774 5
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
.+++||||+++++|.+++.+.. ..+...+. +.+.+.||.|||..+ |+||||||+|||++.++.+||+|||+++..
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred eEEEEEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCCCCEEECCccccccc
Confidence 6899999999999999997754 33444444 444499999999998 999999999999999999999999999876
Q ss_pred cCCc---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhH--------------HHHhhh
Q 002160 826 HNTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ--------------VVGAVG 888 (958)
Q Consensus 826 ~~~~---~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~e--------------i~~~i~ 888 (958)
.... .......+|..|+|||++.+..++.++||||||+++|+|++|..||....... ......
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 4432 12234568889999999999889999999999999999999999997532210 011112
Q ss_pred ccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhcCCCCC
Q 002160 889 FQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHP 941 (958)
Q Consensus 889 ~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~~p~~P 941 (958)
........+..+++++.+||.+||+.||.+||++.+|++.|+.+.+....+.|
T Consensus 265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~p 317 (318)
T 3lxp_A 265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP 317 (318)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC---
T ss_pred hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCCC
Confidence 23445566788999999999999999999999999999999999887665554
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=370.98 Aligned_cols=252 Identities=21% Similarity=0.213 Sum_probs=196.4
Q ss_pred CCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEE
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LV 751 (958)
..++|++++.||+|+||.||+|++ +++.||||++............+.+|+.+|++++||||+++++++.+...++||
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 346899999999999999999976 688999999876655555566788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEc-----CCCcEEEEecccccccc
Q 002160 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVD-----KNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId-----~~g~VKL~DFGLAk~~~ 826 (958)
|||++ |+|.+++.+.........+..+.+++.||.|||.++ |+||||||+||||+ .++.+||+|||+++...
T Consensus 112 ~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 99997 599999987665555555555556699999999998 99999999999994 55669999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccccc-----------
Q 002160 827 NTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL----------- 894 (958)
Q Consensus 827 ~~~~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~----------- 894 (958)
..........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+......+
T Consensus 189 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (329)
T 3gbz_A 189 IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL 268 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred CcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhh
Confidence 444444556789999999999874 48999999999999999999999999887766554432110000
Q ss_pred -----CC------------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 895 -----EI------------PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 895 -----~i------------p~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.+ +..++.++++||.+||+.||.+||++.|+++|
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 00 11267899999999999999999999999874
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=391.46 Aligned_cols=252 Identities=25% Similarity=0.479 Sum_probs=216.9
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeccccCCCce
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l 748 (958)
.+...+|.+++.||+|+||.||+|++ +++.||||++....... .....+.+|+.+|+.++||||+++++++.....+
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 91 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI 91 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 45567899999999999999999987 68999999987543211 2345788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
|+||||+++|+|.+++.+.+.......+..+.+++.||.|||.++ |+||||||+|||++.++++||+|||+++.....
T Consensus 92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 999999999999999987665555555555666699999999998 999999999999999999999999999876543
Q ss_pred cccCCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHH
Q 002160 829 FLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 907 (958)
Q Consensus 829 ~~~~~s~~GT~~Y~APEvl~g~~~-s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dL 907 (958)
. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+....+. ......|..+++++++|
T Consensus 170 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~L 246 (476)
T 2y94_A 170 E-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC--DGIFYTPQYLNPSVISL 246 (476)
T ss_dssp C-CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHH--TTCCCCCTTCCHHHHHH
T ss_pred c-cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHh--cCCcCCCccCCHHHHHH
Confidence 2 2345689999999999998775 689999999999999999999999888777776663 33456678899999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 002160 908 IWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 908 I~~CL~kDP~kRPSa~EIL~~ 928 (958)
|.+||+.||.+||++.+|++|
T Consensus 247 i~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 247 LKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp HHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHcCCCchhCcCHHHHHhC
Confidence 999999999999999999985
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=367.32 Aligned_cols=259 Identities=29% Similarity=0.433 Sum_probs=208.9
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE-CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEE
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LV 751 (958)
...++|++.+.||+|+||.||+|++ +++.||||++..... .....+.+|+.+|++++||||+++++++...+.+++|
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 113 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILI 113 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS--SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEE
T ss_pred HHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 3457899999999999999999987 588999998766533 3456789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhCCCC---CccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 752 TEFLPRGSLFRILHRPHC---QVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~---~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
|||+++|+|.+++..... ...+...+.++.+ +.||.|||.++ |+||||||+|||++.++.+||+|||+++....
T Consensus 114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKITDFGISKKGTE 191 (321)
T ss_dssp EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 999999999999875432 3455555555444 89999999988 99999999999999999999999999986433
Q ss_pred Cc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhh------c-----c----
Q 002160 828 TF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG------F-----Q---- 890 (958)
Q Consensus 828 ~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~------~-----~---- 890 (958)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..+.+...... . .
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP 271 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSS
T ss_pred ccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcCh
Confidence 21 12234568999999999999899999999999999999999999997654432211100 0 0
Q ss_pred ccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 891 NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 891 ~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
.....++..++..+.+||.+||+.||.+||++.+++++|+.+.+.
T Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 272 NLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred hhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 001112233567799999999999999999999999999988764
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=367.11 Aligned_cols=251 Identities=28% Similarity=0.366 Sum_probs=202.1
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCC---CCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQD---FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~---~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~L 750 (958)
++|++++.||+|+||.||+|++ +++.||||++.... ........+.+|+++|++++|||||++++++.+.+.+++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 5799999999999999999987 67789999986542 233456789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhCC---------------------------------------CCCccHHHHH-HHHHHHHHHHHHH
Q 002160 751 ITEFLPRGSLFRILHRP---------------------------------------HCQVDEKRRI-KMALDARGMNCLH 790 (958)
Q Consensus 751 VmEy~~gGsL~d~L~k~---------------------------------------~~~~~e~~~l-~ia~~a~aL~yLH 790 (958)
||||+++|+|.+++... .....+.... .+.+.+.||.|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 99999999999988521 0011233333 3444489999999
Q ss_pred hcCCcEeecCCCCCceEEcCCC--cEEEEeccccccccCCc----ccCCCCCCCCCccCcccccC--CCCCchhhHHHHH
Q 002160 791 TSTPTIVHRDLKSPNLLVDKNW--NVKVSDFGLSRLKHNTF----LSSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFG 862 (958)
Q Consensus 791 ~~g~gIIHRDLKPeNILId~~g--~VKL~DFGLAk~~~~~~----~~~~s~~GT~~Y~APEvl~g--~~~s~ksDIWSLG 862 (958)
..+ |+||||||+||||+.++ .+||+|||+++...... .......||+.|+|||++.+ ..++.++||||||
T Consensus 186 ~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG 263 (345)
T 3hko_A 186 NQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263 (345)
T ss_dssp HTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred HCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence 998 99999999999998766 89999999998653211 12345679999999999975 6788999999999
Q ss_pred HHHHHHHhCCCCCCCCChhHHHHhhhccccccCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 863 VILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 863 iLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip--~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
|++|+|++|+.||.+.+..+....+.........+ ..+++++++||.+||+.||.+||++.+++++
T Consensus 264 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 264 VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred HHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 99999999999999988877776664333333222 2478999999999999999999999999885
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=352.71 Aligned_cols=245 Identities=24% Similarity=0.347 Sum_probs=207.4
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
++|++.+.||+|+||.||+|++ ++..||+|++....... ...+.+|++++++++||||+++++++.+...+++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 5699999999999999999987 46689999987654332 4578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEE---cCCCcEEEEeccccccccCCcc
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFL 830 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILI---d~~g~VKL~DFGLAk~~~~~~~ 830 (958)
|+++++|.+++..............+.+.+.||.|||.++ |+||||||+|||+ +.++.+||+|||++.......
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~- 163 (277)
T 3f3z_A 87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK- 163 (277)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS-
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc-
Confidence 9999999998876554444444445555599999999998 9999999999999 788999999999998765432
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCC----CCcHHHHH
Q 002160 831 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPK----ELDPLVAR 906 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~----~ls~eL~d 906 (958)
......||+.|+|||++.+. ++.++||||||+++|+|++|+.||...+..+....+... ...++. .+++.+.+
T Consensus 164 ~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 240 (277)
T 3f3z_A 164 MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG--TFTFPEKDWLNVSPQAES 240 (277)
T ss_dssp CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCHHHHTTSCHHHHH
T ss_pred chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--CCCCCchhhhcCCHHHHH
Confidence 23456799999999998775 889999999999999999999999998887776666432 233332 68999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 002160 907 IIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 907 LI~~CL~kDP~kRPSa~EIL~~ 928 (958)
||.+||+.||.+||++.+++++
T Consensus 241 li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 241 LIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999875
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=375.46 Aligned_cols=253 Identities=20% Similarity=0.285 Sum_probs=208.2
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE-CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC--CCceeEEeccccCCCceE
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR--HPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~--HPNIVkL~g~~~~~~~l~ 749 (958)
+...+|++++.||+|+||.||+|.+ .++.||||++............+.+|+.+|++++ |||||++++++...+.+|
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 4446799999999999999999986 5888999999877767777888999999999996 599999999999999999
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~ 829 (958)
|||| +.+++|.+++.+...........++.+++.||.|||.++ |+||||||+||||+ ++.+||+|||+++......
T Consensus 133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9999 568899999987665444455555556699999999998 99999999999995 5899999999998764322
Q ss_pred --ccCCCCCCCCCccCcccccC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHhhhccccccC
Q 002160 830 --LSSKSTAGTPEWMAPEVLRN-----------EPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNRRLE 895 (958)
Q Consensus 830 --~~~~s~~GT~~Y~APEvl~g-----------~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~-~ei~~~i~~~~~~~~ 895 (958)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+... ......+........
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~ 288 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 288 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCC
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCC
Confidence 12345679999999999976 3688999999999999999999999987543 334444443444556
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002160 896 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 896 ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L 929 (958)
++...+.++++||.+||+.||.+||++.|++++-
T Consensus 289 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 289 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred CCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 7777899999999999999999999999999763
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=364.91 Aligned_cols=247 Identities=23% Similarity=0.338 Sum_probs=194.4
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC-------
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------- 746 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~------- 746 (958)
++|++++.||+|+||.||+|++ +++.||||++.... .......+.+|+++|++++|||||+++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 5799999999999999999987 68899999987654 3345678899999999999999999999885543
Q ss_pred --------------------------------------------------ceEEEEeecCCCCHHHHHhCCCCCc--cHH
Q 002160 747 --------------------------------------------------NLSIITEFLPRGSLFRILHRPHCQV--DEK 774 (958)
Q Consensus 747 --------------------------------------------------~l~LVmEy~~gGsL~d~L~k~~~~~--~e~ 774 (958)
.+++||||+++++|.+++.+..... .+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 3899999999999999998755432 222
Q ss_pred HHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc------------ccCCCCCCCCCc
Q 002160 775 RRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF------------LSSKSTAGTPEW 841 (958)
Q Consensus 775 ~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~------------~~~~s~~GT~~Y 841 (958)
..+ .+.+.+.||.|||.++ |+||||||+||||+.++.+||+|||+++...... .......||+.|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 233 3444599999999998 9999999999999999999999999998765431 223446799999
Q ss_pred cCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCC
Q 002160 842 MAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPS 921 (958)
Q Consensus 842 ~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPS 921 (958)
+|||++.+..++.++|||||||++|+|++|..|+... .+....+. ...........++.+.+||.+||+.||.+||+
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 319 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVR-NLKFPLLFTQKYPQEHMMVQDMLSPSPTERPE 319 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHH-TTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCC
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhh-ccCCCcccccCChhHHHHHHHHccCCCCcCCC
Confidence 9999999999999999999999999999987765221 11222221 11111112345688899999999999999999
Q ss_pred HHHHHHH
Q 002160 922 FAQLTVA 928 (958)
Q Consensus 922 a~EIL~~ 928 (958)
+.|++++
T Consensus 320 ~~~~l~~ 326 (332)
T 3qd2_B 320 ATDIIEN 326 (332)
T ss_dssp HHHHHHS
T ss_pred HHHHhhc
Confidence 9999875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=362.41 Aligned_cols=255 Identities=24% Similarity=0.364 Sum_probs=202.6
Q ss_pred CCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC--ceE
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP--NLS 749 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~--~l~ 749 (958)
..++|++++.||+|+||.||+|++ +++.||||++...... .....+.+|+++|++++||||+++++++.... .++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 346799999999999999999988 4889999998754322 22456789999999999999999999987655 789
Q ss_pred EEEeecCCCCHHHHHhCCCC--CccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEE----cCCCcEEEEecccc
Q 002160 750 IITEFLPRGSLFRILHRPHC--QVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLS 822 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~--~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILI----d~~g~VKL~DFGLA 822 (958)
+||||+++++|.+++..... .+.+...+. +.+.+.||.|||..+ |+||||||+|||| +.++.+||+|||++
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 99999999999999976433 144444444 444499999999998 9999999999999 78888999999999
Q ss_pred ccccCCcccCCCCCCCCCccCccccc--------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh----hHHHHhhhcc
Q 002160 823 RLKHNTFLSSKSTAGTPEWMAPEVLR--------NEPSNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQ 890 (958)
Q Consensus 823 k~~~~~~~~~~s~~GT~~Y~APEvl~--------g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~----~ei~~~i~~~ 890 (958)
+...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||..... .+....+...
T Consensus 164 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 164 RELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp EECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred eecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 8765432 234567999999999986 57789999999999999999999999975432 2222222111
Q ss_pred cc-------------------c----cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 002160 891 NR-------------------R----LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 891 ~~-------------------~----~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL 932 (958)
.. . ..++..++..+.+||.+||+.||.+||+++|++++...-
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 10 0 012234567899999999999999999999999998754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=364.90 Aligned_cols=260 Identities=27% Similarity=0.443 Sum_probs=213.9
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE-------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~ 744 (958)
++..++|++++.||+|+||.||+|++ +++.||||++... .......++.+|+.++++++||||+++++++..
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 46678999999999999999999984 4668999998643 345556788999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhCCC------CCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcC---CCcE
Q 002160 745 PPNLSIITEFLPRGSLFRILHRPH------CQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNV 814 (958)
Q Consensus 745 ~~~l~LVmEy~~gGsL~d~L~k~~------~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~---~g~V 814 (958)
....|+||||+++++|.+++.... ....+...+.++ +.+.||.|||.++ |+||||||+||||+. ++.+
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceE
Confidence 999999999999999999997543 224444444444 4499999999998 999999999999994 4569
Q ss_pred EEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccc
Q 002160 815 KVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQN 891 (958)
Q Consensus 815 KL~DFGLAk~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~ 891 (958)
||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+. ..
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~ 261 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SG 261 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-TT
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh-cC
Confidence 999999987543322 11223457899999999999999999999999999999998 999999888777666554 34
Q ss_pred cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 892 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 892 ~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
.....+..++..+.+||.+||+.||.+||++.+|+++|..+...
T Consensus 262 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 262 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 45566788999999999999999999999999999999988653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=369.35 Aligned_cols=246 Identities=22% Similarity=0.356 Sum_probs=205.1
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~l~LVm 752 (958)
++|++++.||+|+||.||+|++ +++.||||++...... +.+|+++|.++ +||||+++++++.+...+|+||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 5799999999999999999987 5889999998765432 34688888888 7999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcC-C---CcEEEEeccccccccCC
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDK-N---WNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~-~---g~VKL~DFGLAk~~~~~ 828 (958)
||++||+|.+++.+.+.........++.+++.||.|||.++ |+||||||+|||+.. + +.+||+|||+++.....
T Consensus 96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 99999999999987765555555566666699999999998 999999999999853 2 35999999999876554
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---ChhHHHHhhhcccccc--CCCCCCcHH
Q 002160 829 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM---NPMQVVGAVGFQNRRL--EIPKELDPL 903 (958)
Q Consensus 829 ~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~---~~~ei~~~i~~~~~~~--~ip~~ls~e 903 (958)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+. ...++...+....... ..+..++.+
T Consensus 174 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 253 (342)
T 2qr7_A 174 NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDT 253 (342)
T ss_dssp TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHH
T ss_pred CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHH
Confidence 44445678999999999999888899999999999999999999999863 4445555553222211 223568999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002160 904 VARIIWECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 904 L~dLI~~CL~kDP~kRPSa~EIL~~L 929 (958)
+++||.+||..||.+||++.++++|-
T Consensus 254 ~~~li~~~L~~dP~~R~t~~~il~hp 279 (342)
T 2qr7_A 254 AKDLVSKMLHVDPHQRLTAALVLRHP 279 (342)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcCC
Confidence 99999999999999999999999863
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=369.51 Aligned_cols=249 Identities=23% Similarity=0.301 Sum_probs=191.6
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEE
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~L 750 (958)
...++|++.+.||+|+||.||+|++ +++.||||++.... ....+.+|+.+|++++||||+++++++.....+++
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 125 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence 3446799999999999999999988 57789999987543 23467899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcC---CCcEEEEeccccccccC
Q 002160 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 751 VmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~---~g~VKL~DFGLAk~~~~ 827 (958)
||||+++++|.+++...+..........+.+.+.||.|||.++ |+||||||+||||+. ++.+||+|||+++....
T Consensus 126 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp EECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 9999999999999987655444445555555599999999998 999999999999975 89999999999987644
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhH-HHHhhhccccc--cCCCCCCcHHH
Q 002160 828 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGFQNRR--LEIPKELDPLV 904 (958)
Q Consensus 828 ~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~e-i~~~i~~~~~~--~~ip~~ls~eL 904 (958)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+ ....+...... ......++.++
T Consensus 204 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 282 (349)
T 2w4o_A 204 QV-LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNA 282 (349)
T ss_dssp ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred cc-ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHH
Confidence 32 2345679999999999999999999999999999999999999998766544 33333222111 12235689999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 905 ARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 905 ~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
++||.+||+.||.+||++.+++++
T Consensus 283 ~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 283 KDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999999874
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=362.00 Aligned_cols=245 Identities=24% Similarity=0.267 Sum_probs=199.2
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~l~LVm 752 (958)
++|++.++||+|+||+||+|++ +++.||||++...........++..|+..+.++ +|||||+++++|.+.+.+++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 6799999999999999999987 588999999877655555566666777777666 8999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~ 831 (958)
||+ +++|.+++......+.+.....++.+ +.||.|||..+ |+||||||+||||+.++++||+|||+++...... .
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-~ 212 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-A 212 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEccceeeeecccCC-C
Confidence 999 67999888765555555555555544 99999999998 9999999999999999999999999998764432 2
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHh
Q 002160 832 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 911 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~C 911 (958)
.....||+.|+|||++.+ .++.++|||||||++|||++|..||.+....+ .+........++..+++++.+||.+|
T Consensus 213 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~~ 288 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQGYLPPEFTAGLSSELRSVLVMM 288 (311)
T ss_dssp --CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTTTCCCHHHHTTSCHHHHHHHHHH
T ss_pred CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhccCCCcccccCCCHHHHHHHHHH
Confidence 344679999999999987 68999999999999999999977766543322 22222223344567899999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 002160 912 WQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 912 L~kDP~kRPSa~EIL~~ 928 (958)
|+.||.+||++.||+++
T Consensus 289 L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 289 LEPDPKLRATAEALLAL 305 (311)
T ss_dssp SCSSTTTSCCHHHHHTS
T ss_pred cCCChhhCcCHHHHHhC
Confidence 99999999999999864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=350.33 Aligned_cols=243 Identities=21% Similarity=0.296 Sum_probs=202.2
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~l~LVm 752 (958)
++|++.+.||+|+||.||+|++ +++.||||++...........++.+|+.++.++ +||||+++++++.+.+.+++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5799999999999999999987 689999999987665556677889999999999 9999999999999999999999
Q ss_pred eecCCCCHHHHHhCC----CCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCC-----------------
Q 002160 753 EFLPRGSLFRILHRP----HCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKN----------------- 811 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~----~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~----------------- 811 (958)
||+++++|.+++.+. ...........+.+.+.||.|||.++ |+||||||+|||++.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-------------------
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 999999999998753 22333444444445599999999998 9999999999999844
Q ss_pred --CcEEEEeccccccccCCcccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhh
Q 002160 812 --WNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG 888 (958)
Q Consensus 812 --g~VKL~DFGLAk~~~~~~~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~ 888 (958)
..+||+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|..++....... .+.
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~~ 241 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH---EIR 241 (289)
T ss_dssp -CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH---HHH
T ss_pred CceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH---HHH
Confidence 47999999999876443 234699999999999876 56689999999999999999998776543322 221
Q ss_pred ccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 889 FQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 889 ~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
......++..+++++.+||.+||+.||.+||++.+++++
T Consensus 242 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 242 -QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -TTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -cCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 334456778899999999999999999999999999875
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=367.05 Aligned_cols=253 Identities=25% Similarity=0.316 Sum_probs=204.8
Q ss_pred CCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEE
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LV 751 (958)
..++|++++.||+|+||.||+|++ +++.||||++............+.+|+.++++++||||+++++++.....+++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 457899999999999999999987 488999999987766666677789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc
Q 002160 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~ 831 (958)
|||+++++|.+++..............+.+.+.||.|||..+ |+||||||+||||+.++.+||+|||+++........
T Consensus 103 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 180 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 180 (331)
T ss_dssp EECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred EecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence 999999999988776555444444555555599999999998 999999999999999999999999999876544444
Q ss_pred CCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccc-------------------
Q 002160 832 SKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN------------------- 891 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~------------------- 891 (958)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence 4556799999999999875 68999999999999999999999999887665443331100
Q ss_pred cc-cC---------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 892 RR-LE---------IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 892 ~~-~~---------ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.. .. ....+++.+.+||.+||+.||.+||++.||+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 00 012578999999999999999999999999875
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=375.48 Aligned_cols=248 Identities=24% Similarity=0.350 Sum_probs=209.9
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
++|++.+.||+|+||.||+|.+ +++.||+|++.... ......+.+|+.+|++++|||||++++++.+...+++|||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 6799999999999999999987 68899999986543 3345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHHH-HHHHHHHHHHHhcCCcEeecCCCCCceEEcC--CCcEEEEeccccccccCCcc
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIKM-ALDARGMNCLHTSTPTIVHRDLKSPNLLVDK--NWNVKVSDFGLSRLKHNTFL 830 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~i-a~~a~aL~yLH~~g~gIIHRDLKPeNILId~--~g~VKL~DFGLAk~~~~~~~ 830 (958)
|+++|+|.+++......+.+.....+ .+++.||.|||.++ |+||||||+|||++. ++.+||+|||+++......
T Consensus 129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 205 (387)
T 1kob_A 129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 205 (387)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence 99999999999876545555555444 44499999999998 999999999999974 5789999999998764432
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccc--cCCCCCCcHHHHHHH
Q 002160 831 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--LEIPKELDPLVARII 908 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~--~~ip~~ls~eL~dLI 908 (958)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+...... ......+++++++||
T Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 285 (387)
T 1kob_A 206 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 285 (387)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHH
Confidence 223457999999999999999999999999999999999999999998877776665432222 223356899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 002160 909 WECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 909 ~~CL~kDP~kRPSa~EIL~~ 928 (958)
.+||+.||.+||++.|++++
T Consensus 286 ~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 286 KNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HTTSCSSGGGSCCHHHHHTS
T ss_pred HHHcCCChhHCcCHHHHhhC
Confidence 99999999999999999875
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=355.06 Aligned_cols=249 Identities=27% Similarity=0.464 Sum_probs=213.8
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
+.|++++.||+|+||.||+|++ +++.||||++...... .....+.+|+.++++++||||+++++++.....+++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 5699999999999999999986 6889999998765432 335678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
|+++++|.+++... ...+.... .+.+.+.||.|||..+ |+||||||+|||++.++.+||+|||++..........
T Consensus 101 ~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 176 (303)
T 3a7i_A 101 YLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176 (303)
T ss_dssp CCTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred eCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence 99999999999753 23344444 4444599999999998 9999999999999999999999999998765544444
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhh
Q 002160 833 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 912 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL 912 (958)
....||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+. ......++..++..+.+||.+||
T Consensus 177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l 255 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEACL 255 (303)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-HSCCCCCCSSCCHHHHHHHHHHC
T ss_pred CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhh-cCCCCCCccccCHHHHHHHHHHc
Confidence 56779999999999999999999999999999999999999999888776665553 33445667789999999999999
Q ss_pred hcCCCCCCCHHHHHHHHH
Q 002160 913 QTDPSLRPSFAQLTVALK 930 (958)
Q Consensus 913 ~kDP~kRPSa~EIL~~L~ 930 (958)
+.||.+||++.+|+++.-
T Consensus 256 ~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 256 NKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp CSSGGGSCCHHHHTTCHH
T ss_pred CCChhhCcCHHHHhhChh
Confidence 999999999999998753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=369.27 Aligned_cols=247 Identities=28% Similarity=0.413 Sum_probs=207.4
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
+.|++.+.||+|+||.||+|++ +++.||||++...... ......+.+|+++|++++|||||++++++...+..+|||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4599999999999999999986 7889999998765433 344567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~ 831 (958)
||+. |+|.+++......+.+.....++ +.+.||.|||.++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence 9997 68888775443444555444444 4489999999998 999999999999999999999999999765432
Q ss_pred CCCCCCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHH
Q 002160 832 SKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 908 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~---g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI 908 (958)
....||+.|+|||++. +..++.++|||||||++|||++|+.||.+.+.......+.........+..++..+++||
T Consensus 208 -~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 286 (348)
T 1u5q_A 208 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 286 (348)
T ss_dssp -CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHH
T ss_pred -CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 3467999999999985 567899999999999999999999999988877666555433333334567899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHH
Q 002160 909 WECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 909 ~~CL~kDP~kRPSa~EIL~~L 929 (958)
.+||+.||.+||++.+|+++.
T Consensus 287 ~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 287 DSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp HHHTCSSGGGSCCHHHHTTCH
T ss_pred HHHcccChhhCcCHHHHhhCh
Confidence 999999999999999998764
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=380.13 Aligned_cols=250 Identities=24% Similarity=0.277 Sum_probs=187.6
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC-----CCce
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-----PPNL 748 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~-----~~~l 748 (958)
++|++++.||+|+||.||+|++ +++.||||++............+.+|+++|++++|||||++++++.. ...+
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 6799999999999999999976 68899999997766666677889999999999999999999999843 3569
Q ss_pred EEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
|+||||+ +++|.+++...........+.++.+++.||.|||.++ ||||||||+||||+.++++||+|||+++.....
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp EEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred EEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 9999998 5799999987765666666666667799999999998 999999999999999999999999999875422
Q ss_pred c---------------------------ccCCCCCCCCCccCcccc-cCCCCCchhhHHHHHHHHHHHHh----------
Q 002160 829 F---------------------------LSSKSTAGTPEWMAPEVL-RNEPSNEKCDVYSFGVILWELAT---------- 870 (958)
Q Consensus 829 ~---------------------------~~~~s~~GT~~Y~APEvl-~g~~~s~ksDIWSLGiLLyELLt---------- 870 (958)
. ......+||+.|+|||++ .+..++.++||||||||||||++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~ 289 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA 289 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence 1 122446789999999986 46679999999999999999998
Q ss_pred -CCCCCCCCChh--------------------HHHHhhhc--------------------------cc---cccCCCCCC
Q 002160 871 -LKLPWIGMNPM--------------------QVVGAVGF--------------------------QN---RRLEIPKEL 900 (958)
Q Consensus 871 -G~~PF~g~~~~--------------------ei~~~i~~--------------------------~~---~~~~ip~~l 900 (958)
|+++|.+.+.. ..+..+.. .. ........+
T Consensus 290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (458)
T 3rp9_A 290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS 369 (458)
T ss_dssp GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence 67777664310 00000000 00 000112346
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 901 DPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 901 s~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
++++.+||.+||..||.+||+++|+++|
T Consensus 370 s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 370 SADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 8999999999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=353.38 Aligned_cols=253 Identities=26% Similarity=0.463 Sum_probs=205.2
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~ 747 (958)
..+..++|++++.||+|+||.||+|++ +++.||||++...... ......+.+|+.+++.++||||+++++++.....
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD 85 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence 345568999999999999999999987 5889999998654321 1224578899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
+++||||+++++|.+++.+............+.+.+.||.|||.++ |+||||||+|||++.++.+||+|||++.....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 9999999999999999976554444444444555599999999998 99999999999999999999999999987644
Q ss_pred CcccCCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHH
Q 002160 828 TFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 906 (958)
Q Consensus 828 ~~~~~~s~~GT~~Y~APEvl~g~~~-s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~d 906 (958)
.. ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||......+....+. .....++..++..+.+
T Consensus 164 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~ 240 (276)
T 2h6d_A 164 GE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIR--GGVFYIPEYLNRSVAT 240 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHH
T ss_pred Cc-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh--cCcccCchhcCHHHHH
Confidence 32 2234578999999999998765 689999999999999999999999887777666653 2345567889999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 002160 907 IIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 907 LI~~CL~kDP~kRPSa~EIL~~ 928 (958)
||.+||+.||.+||++.+|+++
T Consensus 241 li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 241 LLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCChhhCCCHHHHHhC
Confidence 9999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=359.77 Aligned_cols=255 Identities=32% Similarity=0.565 Sum_probs=199.0
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc--CCCceeEEeccccCC----Cce
Q 002160 675 WEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL--RHPNVVLFMGAVTRP----PNL 748 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L--~HPNIVkL~g~~~~~----~~l 748 (958)
.++|++++.||+|+||.||+|+++++.||||++.... ...+.+|.+++..+ +||||+++++++... ..+
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred ccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 3689999999999999999999999999999986432 23444555666554 899999999998877 679
Q ss_pred EEEEeecCCCCHHHHHhCCCCCccHHHHHH-HHHHHHHHHHHHhc------CCcEeecCCCCCceEEcCCCcEEEEeccc
Q 002160 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDARGMNCLHTS------TPTIVHRDLKSPNLLVDKNWNVKVSDFGL 821 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~-ia~~a~aL~yLH~~------g~gIIHRDLKPeNILId~~g~VKL~DFGL 821 (958)
++||||+++|+|.+++.... ..+...+. +.+.+.||.|||.+ ..+|+||||||+||||+.++++||+|||+
T Consensus 111 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 188 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 188 (337)
T ss_dssp EEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEeccCCCcHHHHhhccC--CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCC
Confidence 99999999999999997642 44444444 44449999999988 22399999999999999999999999999
Q ss_pred cccccCCccc----CCCCCCCCCccCcccccCCCCCch------hhHHHHHHHHHHHHhC----------CCCCCCCCh-
Q 002160 822 SRLKHNTFLS----SKSTAGTPEWMAPEVLRNEPSNEK------CDVYSFGVILWELATL----------KLPWIGMNP- 880 (958)
Q Consensus 822 Ak~~~~~~~~----~~s~~GT~~Y~APEvl~g~~~s~k------sDIWSLGiLLyELLtG----------~~PF~g~~~- 880 (958)
++........ .....||+.|+|||++.+..+... +|||||||++|||++| +.||.....
T Consensus 189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 268 (337)
T 3mdy_A 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS 268 (337)
T ss_dssp CEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCC
Confidence 9765433211 234679999999999988776554 9999999999999999 777765322
Q ss_pred ----hHHHHhhhccccccCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhc
Q 002160 881 ----MQVVGAVGFQNRRLEIPK-----ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 936 (958)
Q Consensus 881 ----~ei~~~i~~~~~~~~ip~-----~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~ 936 (958)
......+.....+..++. .++.++.+||.+||+.||.+||++.+|+++|+++.+..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 222222322333444443 45678999999999999999999999999999997653
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=353.60 Aligned_cols=253 Identities=25% Similarity=0.353 Sum_probs=189.8
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceE
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~ 749 (958)
++..++|++++.||+|+||.||+|++ +++.||||++............+.++..+++.++||||+++++++.+.+..+
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 56678999999999999999999987 7899999998766444444444555666678889999999999999999999
Q ss_pred EEEeecCCCCHHHHHhC---CCCCccHHHHHH-HHHHHHHHHHHHhc-CCcEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 750 IITEFLPRGSLFRILHR---PHCQVDEKRRIK-MALDARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k---~~~~~~e~~~l~-ia~~a~aL~yLH~~-g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
+||||++ |+|.+++.. ......+..... +.+.+.||.|||.+ + |+||||||+|||++.++.+||+|||+++.
T Consensus 83 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 83 ICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 9999997 488776643 233444444444 44459999999997 8 99999999999999999999999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccc----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hhHHHHhhhccccccCCCCC
Q 002160 825 KHNTFLSSKSTAGTPEWMAPEVL----RNEPSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNRRLEIPKE 899 (958)
Q Consensus 825 ~~~~~~~~~s~~GT~~Y~APEvl----~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~-~~ei~~~i~~~~~~~~ip~~ 899 (958)
..... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||.... .................+..
T Consensus 160 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (290)
T 3fme_A 160 LVDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADK 238 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTT
T ss_pred ccccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCccccc
Confidence 64432 22345799999999996 56678999999999999999999999998643 33333333222222223457
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 900 LDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 900 ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+++++.+||.+||+.||.+||++.|+++|
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 239 FSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 89999999999999999999999999884
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=373.40 Aligned_cols=260 Identities=29% Similarity=0.470 Sum_probs=206.9
Q ss_pred CCeeEEEEeeccCceEEEEEEEC-----CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEecccc-CCCceE
Q 002160 676 EDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT-RPPNLS 749 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~~-----g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~-~~~~l~ 749 (958)
..|++.+.||+|+||.||+|++. +..||||.+.... ......++.+|+.+|++++|||||++++++. ..+..+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 45888999999999999999862 2358999876432 3445678999999999999999999999864 456789
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
+||||+++|+|.+++.+......+...+.++ +.+.||.|||.++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCCCCEEEeecccccccccc
Confidence 9999999999999998766656665555554 4499999999998 999999999999999999999999999865332
Q ss_pred cc----cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHH
Q 002160 829 FL----SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 903 (958)
Q Consensus 829 ~~----~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~e 903 (958)
.. ......+|+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+....+. ...+...|..++..
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~-~~~~~~~p~~~~~~ 324 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDP 324 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH-TTCCCCCCTTCCHH
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 11 1233457789999999999999999999999999999999 788888777666555543 34455667889999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhcCCC
Q 002160 904 VARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPS 939 (958)
Q Consensus 904 L~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~~p~ 939 (958)
+.+||.+||+.||.+||++.+|++.|+.+.......
T Consensus 325 l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 325 LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 999999999999999999999999999998765543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=393.59 Aligned_cols=253 Identities=24% Similarity=0.333 Sum_probs=211.9
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeccccCCCce
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l 748 (958)
.+..++|++.+.||+|+||.||+|++ +++.||||++.+..... .....+.+|+++|++++|||||+++++|.+...+
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence 35568899999999999999999987 68999999987543221 2245688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhCCC----CCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 749 SIITEFLPRGSLFRILHRPH----CQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~----~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
||||||++||+|.+++.+.. .......+.++.+++.||.|||.++ |+||||||+||||+.+|++||+|||+++.
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCCCCEEEeecceeee
Confidence 99999999999999987543 2334444555566699999999998 99999999999999999999999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----hhHHHHhhhccccccCCCCCC
Q 002160 825 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMN----PMQVVGAVGFQNRRLEIPKEL 900 (958)
Q Consensus 825 ~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~----~~ei~~~i~~~~~~~~ip~~l 900 (958)
...........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+ ..++...+. .....+|..+
T Consensus 339 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~--~~~~~~p~~~ 416 (543)
T 3c4z_A 339 LKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL--EQAVTYPDKF 416 (543)
T ss_dssp CCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHH--HCCCCCCTTS
T ss_pred ccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHh--hcccCCCccc
Confidence 6554443455689999999999999999999999999999999999999998753 334444442 3355677889
Q ss_pred cHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 002160 901 DPLVARIIWECWQTDPSLRPSF-----AQLTVA 928 (958)
Q Consensus 901 s~eL~dLI~~CL~kDP~kRPSa-----~EIL~~ 928 (958)
++.+++||.+||++||.+||++ .+|+.|
T Consensus 417 s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred CHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 9999999999999999999965 677653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=390.93 Aligned_cols=263 Identities=33% Similarity=0.557 Sum_probs=221.7
Q ss_pred cccccCCCCeeEEEEeeccCceEEEEEEECC-cEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc
Q 002160 669 CECEIPWEDLVLGERIGLGSYGEVYHADWNG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 669 ~~~eI~~~dy~i~k~LG~G~fG~Vykak~~g-~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~ 747 (958)
..+++..++|++.+.||+|+||.||+|++.+ ..||||++...... ..+|.+|+++|++|+|||||++++++.+ +.
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~ 335 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 335 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-cc
Confidence 4567888999999999999999999999854 67999998765433 3578999999999999999999999876 67
Q ss_pred eEEEEeecCCCCHHHHHhCC-CCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 748 LSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~-~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
+||||||+++|+|.+++... ...+.+...+.++ +++.||.|||.++ ||||||||+||||+.++.+||+|||+++..
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 89999999999999999742 2234444444444 4499999999998 999999999999999999999999999876
Q ss_pred cCCcc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHH
Q 002160 826 HNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 903 (958)
Q Consensus 826 ~~~~~-~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~e 903 (958)
..... ......++..|+|||++.+..++.++|||||||+||||++ |+.||.+....++...+. ...+...+..++..
T Consensus 414 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~ 492 (535)
T 2h8h_A 414 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPES 492 (535)
T ss_dssp CCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHH
T ss_pred CCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 43221 1233456789999999999999999999999999999999 999999998888777664 44566677889999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhcCC
Q 002160 904 VARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 938 (958)
Q Consensus 904 L~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~~p 938 (958)
+.+||.+||+.||.+||++.+|++.|+.+.....|
T Consensus 493 l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 493 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 99999999999999999999999999998655433
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=385.84 Aligned_cols=249 Identities=29% Similarity=0.449 Sum_probs=209.5
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
++|++++.||+|+||.||+|++ +++.||||++............+.+|+.+|++++|||||++++++.+...+|+|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 5799999999999999999987 58899999986543333335678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEc---CCCcEEEEeccccccccCCcc
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVD---KNWNVKVSDFGLSRLKHNTFL 830 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId---~~g~VKL~DFGLAk~~~~~~~ 830 (958)
|+.+|+|.+++.+............+.+++.||.|||.++ |+||||||+||||+ .++.+||+|||+++......
T Consensus 102 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~- 178 (486)
T 3mwu_A 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT- 178 (486)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC-
Confidence 9999999998876555555555555556699999999998 99999999999995 46789999999998664432
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCC--CCCcHHHHHHH
Q 002160 831 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARII 908 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip--~~ls~eL~dLI 908 (958)
.....+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..++...+.........+ ..+++++++||
T Consensus 179 ~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 257 (486)
T 3mwu_A 179 KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLI 257 (486)
T ss_dssp ---CCTTGGGGCCGGGGGSC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHH
T ss_pred ccCCCcCCCCCCCHHHhCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHH
Confidence 23456799999999999874 8999999999999999999999999998888777765443333332 46899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 002160 909 WECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 909 ~~CL~kDP~kRPSa~EIL~~ 928 (958)
.+||+.||.+||++.++++|
T Consensus 258 ~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 258 RKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHTCSSTTTSCCHHHHHHC
T ss_pred HHHcCCChhhCcCHHHHhcC
Confidence 99999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=394.19 Aligned_cols=262 Identities=24% Similarity=0.440 Sum_probs=216.6
Q ss_pred ccCCCCeeEEE-EeeccCceEEEEEEE----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC
Q 002160 672 EIPWEDLVLGE-RIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (958)
Q Consensus 672 eI~~~dy~i~k-~LG~G~fG~Vykak~----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~ 746 (958)
.+..+++.+.+ .||+|+||.||+|.+ ++..||||++.... ......+|.+|+++|++++|||||++++++.. +
T Consensus 331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~ 408 (613)
T 2ozo_A 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 408 (613)
T ss_dssp BCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred eccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence 34556777766 899999999999976 34569999987643 23345689999999999999999999999976 5
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
.++|||||+++|+|.+++......+.+...+.++.+ +.||.|||.++ ||||||||+||||+.++.+||+|||+++..
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 699999999999999999766555555555555544 99999999998 999999999999999999999999999876
Q ss_pred cCCcc---cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCc
Q 002160 826 HNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 901 (958)
Q Consensus 826 ~~~~~---~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls 901 (958)
..... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+. ...+..+|..++
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~ 565 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPECP 565 (613)
T ss_dssp C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH-TTCCCCCCTTCC
T ss_pred cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCC
Confidence 43211 1122345689999999999999999999999999999998 999999988888777665 455677888999
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhcCC
Q 002160 902 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 938 (958)
Q Consensus 902 ~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~~p 938 (958)
+++.+||.+||+.||.+||++.+|++.|+.+......
T Consensus 566 ~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 566 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp HHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 9999999999999999999999999999998766443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=365.25 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=205.2
Q ss_pred CCeeEE-EEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCceEEE
Q 002160 676 EDLVLG-ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 676 ~dy~i~-k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~l~LV 751 (958)
++|.+. +.||+|+||.||+|++ +++.||||++............+.+|+.+++++ +||||+++++++.+...+++|
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv 107 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence 457776 8999999999999987 588999999887655544567889999999999 569999999999999999999
Q ss_pred EeecCCCCHHHHHhCC-CCCccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcC---CCcEEEEecccccccc
Q 002160 752 TEFLPRGSLFRILHRP-HCQVDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLSRLKH 826 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~-~~~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~---~g~VKL~DFGLAk~~~ 826 (958)
|||+++|+|.+++... ...+.+.... .+.+++.||.|||.++ |+||||||+||||+. ++.+||+|||+++...
T Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 185 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185 (327)
T ss_dssp EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence 9999999999998653 2334444444 4445599999999998 999999999999997 7899999999998764
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc--ccCCCCCCcHHH
Q 002160 827 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--RLEIPKELDPLV 904 (958)
Q Consensus 827 ~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~--~~~ip~~ls~eL 904 (958)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..... .......+++.+
T Consensus 186 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 264 (327)
T 3lm5_A 186 HAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLA 264 (327)
T ss_dssp ---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred Ccc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHH
Confidence 432 23446799999999999999999999999999999999999999999887776655532222 223345789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 905 ARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 905 ~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
++||.+||+.||.+||++++++++
T Consensus 265 ~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 265 TDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHHHHHHcCCChhhCcCHHHHhCC
Confidence 999999999999999999999876
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=373.35 Aligned_cols=246 Identities=25% Similarity=0.356 Sum_probs=201.4
Q ss_pred eeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeec
Q 002160 678 LVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~ 755 (958)
|...+.||+|+||.||+|++ +++.||||++.... ......+.+|+++|++++|||||++++++...+.++|||||+
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 168 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV 168 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence 34477899999999999987 68899999987653 244568899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhCCCCCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEE--cCCCcEEEEeccccccccCCcccC
Q 002160 756 PRGSLFRILHRPHCQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLV--DKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 756 ~gGsL~d~L~k~~~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILI--d~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
++++|.+++......+.+...+. +.+++.||.|||.++ |+||||||+|||+ +.++.+||+|||+++...... ..
T Consensus 169 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-~~ 245 (373)
T 2x4f_A 169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KL 245 (373)
T ss_dssp TTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-BC
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-cc
Confidence 99999998876544445544444 445599999999998 9999999999999 567899999999998765432 23
Q ss_pred CCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccccc--CCCCCCcHHHHHHHHH
Q 002160 833 KSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVARIIWE 910 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~--~ip~~ls~eL~dLI~~ 910 (958)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....... .....+++++++||.+
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 325 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISK 325 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHT
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHH
Confidence 34579999999999999999999999999999999999999999988877766664332221 1124689999999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 002160 911 CWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 911 CL~kDP~kRPSa~EIL~~ 928 (958)
||+.||.+||++.|++++
T Consensus 326 ~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 326 LLIKEKSWRISASEALKH 343 (373)
T ss_dssp TSCSSGGGSCCHHHHHHS
T ss_pred HcCCChhhCCCHHHHhcC
Confidence 999999999999999984
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=385.13 Aligned_cols=253 Identities=29% Similarity=0.396 Sum_probs=207.6
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
++|++++.||+|+||.||+|++ ++..||||++............+.+|+.+|+.++|||||+++++|.+...+|+|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 4699999999999999999987 68899999998765444445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcC---CCcEEEEeccccccccCCcc
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLSRLKHNTFL 830 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~---~g~VKL~DFGLAk~~~~~~~ 830 (958)
||++|+|.+++.+............+.+++.||.|||.++ |+||||||+||||+. ++.+||+|||+++......
T Consensus 117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~- 193 (494)
T 3lij_A 117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK- 193 (494)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB-
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc-
Confidence 9999999998876555445555555556699999999998 999999999999976 4559999999998765432
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCC--CCCcHHHHHHH
Q 002160 831 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARII 908 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip--~~ls~eL~dLI 908 (958)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..++...+.........+ ..+++.+++||
T Consensus 194 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 272 (494)
T 3lij_A 194 KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLI 272 (494)
T ss_dssp CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHH
T ss_pred cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHH
Confidence 2345679999999999875 58999999999999999999999999999888877775433332222 46899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH--HHhh
Q 002160 909 WECWQTDPSLRPSFAQLTVA--LKPL 932 (958)
Q Consensus 909 ~~CL~kDP~kRPSa~EIL~~--L~kL 932 (958)
.+||+.||.+||++.++++| +++.
T Consensus 273 ~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 273 KQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHCCCChhhCccHHHHhcCcccccC
Confidence 99999999999999999976 4444
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=358.66 Aligned_cols=252 Identities=28% Similarity=0.350 Sum_probs=198.8
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCC---HHHHHHHHHHHHHHHHc---CCCceeEEeccccC
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS---GAALLEFKREVKIMRRL---RHPNVVLFMGAVTR 744 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~---~~~~~~f~~Ei~ILk~L---~HPNIVkL~g~~~~ 744 (958)
+..++|++++.||+|+||.||+|++ +++.||||++...... ......+.+|+.+++++ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3457899999999999999999985 7889999998754321 11123556777777766 49999999999876
Q ss_pred CC-----ceEEEEeecCCCCHHHHHhCCCC-CccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEE
Q 002160 745 PP-----NLSIITEFLPRGSLFRILHRPHC-QVDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVS 817 (958)
Q Consensus 745 ~~-----~l~LVmEy~~gGsL~d~L~k~~~-~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~ 817 (958)
.. .+++||||+. ++|.+++.+... .+.+.... .+.+.+.||+|||.++ |+||||||+|||++.++++||+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTTSCEEEC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEEe
Confidence 55 4899999996 599999987554 24444444 4445599999999998 9999999999999999999999
Q ss_pred eccccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccccc---
Q 002160 818 DFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--- 894 (958)
Q Consensus 818 DFGLAk~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~--- 894 (958)
|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.......
T Consensus 163 Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 163 DFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp SCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eCccccccCCC-cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 99999866433 22345679999999999999999999999999999999999999999988776655442110000
Q ss_pred ----------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 895 ----------------------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 895 ----------------------~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.+...++..+.+||.+||+.||.+||++.|+++|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 0113578999999999999999999999999875
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=366.63 Aligned_cols=255 Identities=24% Similarity=0.328 Sum_probs=209.0
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~ 747 (958)
..++..++|++.+.||+|+||.||+|++ +++.||+|++.... .......+.+|+.+|++++||||+++++++...+.
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 105 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 105 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE
T ss_pred ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE
Confidence 3456678999999999999999999988 48899999987653 45566789999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhc-CCcEeecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~-g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
+++||||+++++|.+++.+............+.+.+.||.|||.. + |+||||||+||||+.++++||+|||+++...
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 999999999999999997755444444444555559999999985 7 9999999999999999999999999997653
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhh------------------
Q 002160 827 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG------------------ 888 (958)
Q Consensus 827 ~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~------------------ 888 (958)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.
T Consensus 184 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 184 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp HH--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred cc--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 32 2234679999999999999999999999999999999999999998766544322110
Q ss_pred -----------------------ccccccCC-CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002160 889 -----------------------FQNRRLEI-PKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 889 -----------------------~~~~~~~i-p~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L 929 (958)
........ ...++.++++||.+||+.||.+||++.|+++|-
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 326 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 01111222 235789999999999999999999999999863
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=350.43 Aligned_cols=257 Identities=26% Similarity=0.421 Sum_probs=209.9
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCH----HHHHHHHHHHHHHHHcCCCceeEEeccccCCCceE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~----~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~ 749 (958)
++|++++.||+|+||.||+|++ +++.||||++....... .....+.+|+.+|++++||||+++++++.+...++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 4699999999999999999987 58899999987654322 13567899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCC----cEEEEeccccccc
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNW----NVKVSDFGLSRLK 825 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g----~VKL~DFGLAk~~ 825 (958)
+||||+++++|.+++.+............+.+.+.||.|||.++ |+||||||+|||++.++ .+||+|||++...
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 99999999999999976544444444444555599999999998 99999999999999877 8999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccc--cCCCCCCcHH
Q 002160 826 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--LEIPKELDPL 903 (958)
Q Consensus 826 ~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~--~~ip~~ls~e 903 (958)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+...... ...+..++..
T Consensus 163 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T 3bhy_A 163 EAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241 (283)
T ss_dssp C---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred cCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHH
Confidence 4432 223457999999999999999999999999999999999999999998877766655322111 1122567899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH--HHhhhhh
Q 002160 904 VARIIWECWQTDPSLRPSFAQLTVA--LKPLQRL 935 (958)
Q Consensus 904 L~dLI~~CL~kDP~kRPSa~EIL~~--L~kL~k~ 935 (958)
+.+||.+||..||.+||++.+++++ ++.+...
T Consensus 242 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred HHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 9999999999999999999999984 5555444
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=370.70 Aligned_cols=262 Identities=18% Similarity=0.202 Sum_probs=202.1
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEEC-------CcEEEEEEeecCCCCHHHH---------HHHHHHHHHHHHcCCCce
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAAL---------LEFKREVKIMRRLRHPNV 735 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~~-------g~~VAVK~i~~~~~~~~~~---------~~f~~Ei~ILk~L~HPNI 735 (958)
++..++|++++.||+|+||.||+|++. ++.||||++.......... ..+..|+..+..++||||
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 355678999999999999999999873 4689999987653211100 123455666777789999
Q ss_pred eEEeccccCC----CceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEc-
Q 002160 736 VLFMGAVTRP----PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVD- 809 (958)
Q Consensus 736 VkL~g~~~~~----~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId- 809 (958)
+++++++... ..+||||||+ +++|.+++......+.+...+.++.+ +.||.|||.++ |+||||||+||||+
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNY 187 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEES
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEec
Confidence 9999998765 4489999999 99999999876555566555555554 99999999998 99999999999999
Q ss_pred -CCCcEEEEeccccccccCCcc-------cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh
Q 002160 810 -KNWNVKVSDFGLSRLKHNTFL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM 881 (958)
Q Consensus 810 -~~g~VKL~DFGLAk~~~~~~~-------~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ 881 (958)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 889999999999986543211 113455999999999999999999999999999999999999999864322
Q ss_pred H-HHHhhh--ccccc-----cC-CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhc
Q 002160 882 Q-VVGAVG--FQNRR-----LE-IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 936 (958)
Q Consensus 882 e-i~~~i~--~~~~~-----~~-ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~ 936 (958)
. ...... ..... .. ....++.++.+||.+||..||.+||++.+|++.|+.+.+..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 268 PKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp HHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 1 111110 00000 01 12567999999999999999999999999999999986643
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=366.25 Aligned_cols=264 Identities=32% Similarity=0.538 Sum_probs=213.1
Q ss_pred ccccccCCCCeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc
Q 002160 668 VCECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 668 ~~~~eI~~~dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~ 747 (958)
...+++..++|++++.||+|+||.||+|++.+ .||||++............+.+|+.++++++||||+++++++.....
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 45677889999999999999999999999866 49999987654443334567789999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
+++||||+++++|.+++........+...+. +.+.+.||.|||.++ |+||||||+|||++ ++.+||+|||+++...
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 9999999999999999987664444444444 444599999999998 99999999999998 6899999999987542
Q ss_pred CC-----cccCCCCCCCCCccCcccccC---------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc
Q 002160 827 NT-----FLSSKSTAGTPEWMAPEVLRN---------EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR 892 (958)
Q Consensus 827 ~~-----~~~~~s~~GT~~Y~APEvl~g---------~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~ 892 (958)
.. ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+....+....+.....
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 260 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK 260 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCC
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCC
Confidence 11 112233458999999999975 4578899999999999999999999999888777666543333
Q ss_pred ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 893 RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 893 ~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
....+..++.++.+||.+||..||.+||++.+|++.|+.+.+.
T Consensus 261 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 261 PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp CCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred CCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 3333446889999999999999999999999999999998655
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=356.95 Aligned_cols=258 Identities=26% Similarity=0.397 Sum_probs=189.9
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeccc-----
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAV----- 742 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~-HPNIVkL~g~~----- 742 (958)
.++...+|++.+.||+|+||.||+|++ +++.||||++... .......+.+|+.+++++. ||||+++++++
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 100 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE 100 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence 445567899999999999999999998 7889999988654 3445667899999999995 99999999988
Q ss_pred ---cCCCceEEEEeecCCCCHHHHHhC--CCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEE
Q 002160 743 ---TRPPNLSIITEFLPRGSLFRILHR--PHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV 816 (958)
Q Consensus 743 ---~~~~~l~LVmEy~~gGsL~d~L~k--~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL 816 (958)
.....+++||||+. |+|.+++.+ ....+.+...+.++ +++.||.|||.++++|+||||||+||||+.++++||
T Consensus 101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 101 ESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp TSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred ccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEE
Confidence 34445899999995 789888754 22334454444444 449999999998777999999999999999999999
Q ss_pred EeccccccccCCcc------------cCCCCCCCCCccCcccc---cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh
Q 002160 817 SDFGLSRLKHNTFL------------SSKSTAGTPEWMAPEVL---RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM 881 (958)
Q Consensus 817 ~DFGLAk~~~~~~~------------~~~s~~GT~~Y~APEvl---~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ 881 (958)
+|||+++....... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||.+....
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 99999987543211 11145689999999998 5667889999999999999999999999876554
Q ss_pred HHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 882 QVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 882 ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
..... ......+...+..+.+||.+||+.||.+||++.|++++|+.+...
T Consensus 260 ~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 260 RIVNG----KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp ----------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhhcC----cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 43322 222333456778899999999999999999999999999999765
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=368.59 Aligned_cols=249 Identities=23% Similarity=0.293 Sum_probs=195.5
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
++|++++.||+|+||.||+|++ +++.||||++..... ......+.+|+.+|++++||||+++++++.....+++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 6899999999999999999987 588999999865432 1122245579999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
|++ |+|.+++........+..... +.+.+.||.|||.++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence 997 589988876655555544444 445599999999998 9999999999999999999999999998765444444
Q ss_pred CCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccc------------------
Q 002160 833 KSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------------------ 893 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~------------------ 893 (958)
....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence 45678999999999987 56899999999999999999999999998876655444211000
Q ss_pred ----------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 894 ----------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 894 ----------~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
......+++++++||.+||+.||.+||++.|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 01123578899999999999999999999999985
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=368.69 Aligned_cols=262 Identities=27% Similarity=0.436 Sum_probs=205.6
Q ss_pred ccccccCCCCeeEEEEeeccCceEEEEEEE-CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC
Q 002160 668 VCECEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (958)
Q Consensus 668 ~~~~eI~~~dy~i~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~ 746 (958)
....++..++|++.+.||+|+||.||+|++ +++.||||++...... .....+.+|++++++++||||+++++++....
T Consensus 22 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 100 (326)
T 3uim_A 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 100 (326)
T ss_dssp THHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS
T ss_pred HHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecCC
Confidence 345566778999999999999999999986 6889999998754322 11236889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhCCCC---CccHHHHHHHHHH-HHHHHHHHhc---CCcEeecCCCCCceEEcCCCcEEEEec
Q 002160 747 NLSIITEFLPRGSLFRILHRPHC---QVDEKRRIKMALD-ARGMNCLHTS---TPTIVHRDLKSPNLLVDKNWNVKVSDF 819 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~---~~~e~~~l~ia~~-a~aL~yLH~~---g~gIIHRDLKPeNILId~~g~VKL~DF 819 (958)
..++||||+++|+|.+++..... ...+.....++.+ +.||.|||.+ + |+||||||+|||++.++.+||+||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~~~~~~kl~Df 178 (326)
T 3uim_A 101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLDEEFEAVVGDF 178 (326)
T ss_dssp CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEECTTCCEEECCC
T ss_pred ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEECCCCCEEeccC
Confidence 99999999999999999976432 2455555554444 8999999998 6 999999999999999999999999
Q ss_pred cccccccCCc-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----ChhHHHHhhh---cc
Q 002160 820 GLSRLKHNTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM-----NPMQVVGAVG---FQ 890 (958)
Q Consensus 820 GLAk~~~~~~-~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~-----~~~ei~~~i~---~~ 890 (958)
|+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||... ........+. ..
T Consensus 179 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 258 (326)
T 3uim_A 179 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258 (326)
T ss_dssp SSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSS
T ss_pred ccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhc
Confidence 9998764322 2233456999999999999988999999999999999999999999521 1111111110 00
Q ss_pred ---------ccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 002160 891 ---------NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 891 ---------~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL 932 (958)
.....++...+..+.+||.+||+.||.+||++.+|+++|+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 001112223447899999999999999999999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=359.47 Aligned_cols=261 Identities=20% Similarity=0.231 Sum_probs=204.5
Q ss_pred CCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEE
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~L 750 (958)
..++|++.+.||+|+||.||+|++ +++.||||++..... .......+.+|+.++++++||||+++++++...+.+|+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 357899999999999999999986 688999999876543 33445788999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc-
Q 002160 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF- 829 (958)
Q Consensus 751 VmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~- 829 (958)
||||+++++|.+++.+............+.+.+.||.|||.++ |+||||||+|||++.++.+||+|||++.......
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 9999999999999986544444444444455599999999998 9999999999999999999999999987654332
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc-ccCCCCCCcHHHHHHH
Q 002160 830 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVARII 908 (958)
Q Consensus 830 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~-~~~ip~~ls~eL~dLI 908 (958)
.......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+..... ...++..+++++.+||
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 269 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVI 269 (309)
T ss_dssp -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHH
T ss_pred ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHH
Confidence 222345789999999999999999999999999999999999999988766544443322211 2244567899999999
Q ss_pred HHhhhcCCCCCC-CHHHHHHHHHhhhhhc
Q 002160 909 WECWQTDPSLRP-SFAQLTVALKPLQRLV 936 (958)
Q Consensus 909 ~~CL~kDP~kRP-Sa~EIL~~L~kL~k~~ 936 (958)
.+||+.||.+|| +++++++.|+++....
T Consensus 270 ~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 270 ARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp HHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred HHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 999999999999 9999999999875443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=348.41 Aligned_cols=256 Identities=21% Similarity=0.249 Sum_probs=205.0
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEecc-ccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA-VTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~-~~~~~~l~LVm 752 (958)
++|++.+.||+|+||.||+|++ +++.||||++....... ++.+|+.+++.++|++++..+.+ +......++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCC----HHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchh----HHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 6899999999999999999985 78999999987654332 57899999999988776555544 46667789999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEE---cCCCcEEEEeccccccccCC
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILI---d~~g~VKL~DFGLAk~~~~~ 828 (958)
||+ +++|.+++........+...+.++.+ +.||.|||.++ |+||||||+|||| +.++.+||+|||+++.....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 999 99999999754444555555555444 99999999998 9999999999999 48899999999999876443
Q ss_pred cc-------cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh---HHHHhhhc---cccccC
Q 002160 829 FL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGF---QNRRLE 895 (958)
Q Consensus 829 ~~-------~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~---ei~~~i~~---~~~~~~ 895 (958)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.... +....+.. ......
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHH
Confidence 22 124567999999999999999999999999999999999999999874322 22222211 111122
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhcCC
Q 002160 896 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIP 938 (958)
Q Consensus 896 ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~~p 938 (958)
++..+++++.+||.+||+.||.+||++.+|++.|+++....-.
T Consensus 242 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 3467899999999999999999999999999999998766433
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=383.60 Aligned_cols=248 Identities=23% Similarity=0.288 Sum_probs=196.9
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC------
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------ 746 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~------ 746 (958)
.++|++++.||+|+||.||+|.+ +++.||||++...........++.+|+.+|+.++|||||++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 47899999999999999999986 6889999999876556666778999999999999999999999986553
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
.+||||||+++ +|.+.+... ......+.++.+++.||.|||.++ |+||||||+||||+.++++||+|||+++...
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~~--l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTSC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred eEEEEEeCCCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 57999999976 576666543 333444445555699999999998 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccc-------------
Q 002160 827 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------------- 893 (958)
Q Consensus 827 ~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~------------- 893 (958)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......
T Consensus 216 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~ 294 (464)
T 3ttj_A 216 TS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294 (464)
T ss_dssp -C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred CC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence 43 2234578999999999999999999999999999999999999999998766554443211000
Q ss_pred -------cC---------CCCC-----------CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 894 -------LE---------IPKE-----------LDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 894 -------~~---------ip~~-----------ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+. ++.. .++++++||.+||+.||.+||+++|+++|
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 0110 15679999999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=354.53 Aligned_cols=251 Identities=28% Similarity=0.452 Sum_probs=204.1
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceE
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~ 749 (958)
....++|++.+.||+|+||.||+|++ +++.||||++..... ...+.+|+.++++++||||+++++++...+.++
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 34557899999999999999999987 488999999876542 346789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
+||||+++++|.+++......+.+.....++ +.+.||.|||.++ |+||||||+|||++.++++||+|||++......
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 9999999999999987433444444444444 4499999999998 999999999999999999999999999876554
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcc-ccccCCCCCCcHHHHHH
Q 002160 829 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRRLEIPKELDPLVARI 907 (958)
Q Consensus 829 ~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~-~~~~~ip~~ls~eL~dL 907 (958)
........||+.|+|||++.+..++.++||||||+++|+|++|+.||...+.......+... ......+..++..+.+|
T Consensus 179 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 258 (314)
T 3com_A 179 MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDF 258 (314)
T ss_dssp BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHH
Confidence 44445567999999999999999999999999999999999999999988766554443211 11223355689999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 002160 908 IWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 908 I~~CL~kDP~kRPSa~EIL~~ 928 (958)
|.+||..||.+||++.+++++
T Consensus 259 i~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 259 VKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp HHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHHccCChhhCcCHHHHHhC
Confidence 999999999999999999874
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=364.06 Aligned_cols=252 Identities=23% Similarity=0.306 Sum_probs=201.2
Q ss_pred CCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC-------
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR------- 744 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~------- 744 (958)
...+|++++.||+|+||.||+|++ +++.||||++............+.+|+.+|++++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 347899999999999999999987 68899999987665544445577899999999999999999999876
Q ss_pred -CCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccc
Q 002160 745 -PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 822 (958)
Q Consensus 745 -~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLA 822 (958)
.+.+|+||||+++ +|.+.+........+.....++ +.+.||.|||.++ |+||||||+||||+.++.+||+|||++
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 3468999999975 7777776654445555444444 4499999999998 999999999999999999999999999
Q ss_pred ccccCC----cccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccc--cC
Q 002160 823 RLKHNT----FLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--LE 895 (958)
Q Consensus 823 k~~~~~----~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~--~~ 895 (958)
+..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...... ..
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 865421 122344678999999999987 45799999999999999999999999998776655444211111 11
Q ss_pred C-CC---------------------------CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 896 I-PK---------------------------ELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 896 i-p~---------------------------~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
. +. ..++.+++||.+||+.||.+||++.|+++|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0 00 026789999999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=384.86 Aligned_cols=250 Identities=29% Similarity=0.408 Sum_probs=213.1
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LV 751 (958)
.++|++.+.||+|+||.||+|++ +++.||||++...... ......+.+|+.+|++++|||||++++++.+...+|+|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 36799999999999999999987 6889999998765432 23456789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEE---cCCCcEEEEeccccccccCC
Q 002160 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILI---d~~g~VKL~DFGLAk~~~~~ 828 (958)
|||+.+|+|.+++..............+.+.+.||.|||.++ |+||||||+|||+ +.++.+||+|||+++.....
T Consensus 105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 999999999999987665555555555555699999999998 9999999999999 46789999999999876443
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCC--CCCcHHHHH
Q 002160 829 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVAR 906 (958)
Q Consensus 829 ~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip--~~ls~eL~d 906 (958)
. .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..++...+.........+ ..+++++++
T Consensus 183 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 260 (484)
T 3nyv_A 183 K-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD 260 (484)
T ss_dssp C-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHH
T ss_pred c-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHH
Confidence 2 2234579999999999987 58999999999999999999999999999888877775443333333 468999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 002160 907 IIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 907 LI~~CL~kDP~kRPSa~EIL~~ 928 (958)
||.+||+.||.+||++.|+++|
T Consensus 261 li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 261 LIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHCCCChhHCcCHHHHhhC
Confidence 9999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=363.85 Aligned_cols=251 Identities=24% Similarity=0.263 Sum_probs=199.0
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCH---HHHHHHHHHHHHHHHcCCCceeEEeccccCCCceE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG---AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~---~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~ 749 (958)
.++|++++.||+|+||.||+|++ +++.||||++....... .....+.+|++++++++||||+++++++.+...++
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 46899999999999999999987 58899999987543221 12246789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhCCCCCccH-HHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDE-KRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e-~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
+||||+++ +|.+++......+.+ .....+.+.+.||.|||.++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 99999976 898888765543433 34444445589999999998 999999999999999999999999999877554
Q ss_pred cccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccccc-------------
Q 002160 829 FLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL------------- 894 (958)
Q Consensus 829 ~~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~------------- 894 (958)
........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 245 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245 (346)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence 4444567899999999999764 47899999999999999999999999888766554442111000
Q ss_pred --------C-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 895 --------E-----IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 895 --------~-----ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
. +...++.++++||.+||..||.+||++.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 114567899999999999999999999999886
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=367.68 Aligned_cols=246 Identities=23% Similarity=0.328 Sum_probs=199.1
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC------c
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------N 747 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~------~ 747 (958)
++|++.+.||+|+||.||+|.+ +++.||||++...........++.+|+++|+.++||||+++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 6799999999999999999987 6889999998766556666778999999999999999999999987653 4
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
+|+||||+ +++|.+++... .......+..+.+++.||.|||.++ |+||||||+||||+.++.+||+|||+++....
T Consensus 105 ~~lv~e~~-~~~L~~~~~~~-~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 105 FYLVMPFM-GTDLGKLMKHE-KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp CEEEEECC-SEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEEecC-CCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 69999999 88999998763 2334444445555699999999998 99999999999999999999999999987543
Q ss_pred CcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc--------------
Q 002160 828 TFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-------------- 892 (958)
Q Consensus 828 ~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~-------------- 892 (958)
. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 181 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~ 257 (367)
T 1cm8_A 181 E---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 257 (367)
T ss_dssp S---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred c---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHH
Confidence 2 345678999999999987 6789999999999999999999999998876655443321000
Q ss_pred ---------------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 893 ---------------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 893 ---------------~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
...+...+++.+.+||.+||..||.+||++.++++|
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 258 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 012234678999999999999999999999999985
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=353.56 Aligned_cols=248 Identities=25% Similarity=0.438 Sum_probs=199.8
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
++|.+.+.||+|+||.||+|++ ++..||||++..... ......+.+|+++|++++||||+++++++.+...+++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 5799999999999999999987 588999999876542 2235678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCC---CCCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEE---cCCCcEEEEecccccccc
Q 002160 754 FLPRGSLFRILHRP---HCQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 754 y~~gGsL~d~L~k~---~~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILI---d~~g~VKL~DFGLAk~~~ 826 (958)
|+++++|.+++... ...+.+..... +.+.+.||.|||..+ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 99999999988532 23344444444 444599999999998 9999999999999 456889999999998654
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCC-CCCCcHHHH
Q 002160 827 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI-PKELDPLVA 905 (958)
Q Consensus 827 ~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~i-p~~ls~eL~ 905 (958)
.. .......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.+.+..+....+......... ...+++.+.
T Consensus 179 ~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (285)
T 3is5_A 179 SD-EHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAV 256 (285)
T ss_dssp ---------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHH
T ss_pred Cc-ccCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHH
Confidence 43 22345679999999999864 5789999999999999999999999998877776665433322222 234789999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 002160 906 RIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 906 dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+||.+||+.||.+||++.||+++
T Consensus 257 ~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 257 DLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=356.18 Aligned_cols=253 Identities=28% Similarity=0.409 Sum_probs=200.5
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccC---
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTR--- 744 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~--- 744 (958)
.....++|++++.||+|+||.||+|++ +++.||||++...... ...+.+|+.+++++ +||||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 344567899999999999999999998 7889999998755432 35688999999999 89999999999876
Q ss_pred ---CCceEEEEeecCCCCHHHHHhCCC-CCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEec
Q 002160 745 ---PPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 819 (958)
Q Consensus 745 ---~~~l~LVmEy~~gGsL~d~L~k~~-~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DF 819 (958)
...+++||||+++++|.+++.... ....+..... +.+++.||.|||.++ |+||||||+||||+.++.+||+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECCC
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCCCCEEEeeC
Confidence 467999999999999999987542 2344444444 444599999999998 999999999999999999999999
Q ss_pred cccccccCCcccCCCCCCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccccc
Q 002160 820 GLSRLKHNTFLSSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL 894 (958)
Q Consensus 820 GLAk~~~~~~~~~~s~~GT~~Y~APEvl~-----g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~ 894 (958)
|++..............||+.|+|||++. +..++.++|||||||++|+|++|..||.+.+.......+.......
T Consensus 174 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 253 (326)
T 2x7f_A 174 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR 253 (326)
T ss_dssp TTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred cCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccc
Confidence 99987654433344567999999999997 5668899999999999999999999999888766655543332223
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 895 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 895 ~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
..+..++..+++||.+||..||.+||++.+|+++
T Consensus 254 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 254 LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 3356789999999999999999999999999885
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=348.22 Aligned_cols=250 Identities=27% Similarity=0.327 Sum_probs=204.3
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
++|++++.||+|+||.||+|++ +++.||||++...... .....+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 5799999999999999999987 5889999998755432 345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc--cc
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LS 831 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~--~~ 831 (958)
|+++++|.+++..............+.+.+.||.|||.++ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence 9999999999976544444444445555599999999998 9999999999999999999999999997653221 22
Q ss_pred CCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhH-HHHhhhccccccCCCCCCcHHHHHHHH
Q 002160 832 SKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGFQNRRLEIPKELDPLVARIIW 909 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~g~~~-s~ksDIWSLGiLLyELLtG~~PF~g~~~~e-i~~~i~~~~~~~~ip~~ls~eL~dLI~ 909 (958)
.....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||....... .................+++.+++||.
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 243 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHH
Confidence 345679999999999988765 778999999999999999999998765432 222222122222223568999999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 002160 910 ECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 910 ~CL~kDP~kRPSa~EIL~~ 928 (958)
+||..||.+||++.+|+++
T Consensus 244 ~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 244 KILVENPSARITIPDIKKD 262 (276)
T ss_dssp HHSCSSTTTSCCHHHHTTC
T ss_pred HHCCCCchhCCCHHHHhcC
Confidence 9999999999999999874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=354.95 Aligned_cols=247 Identities=22% Similarity=0.375 Sum_probs=206.7
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
++|.+.+.||+|+||.||+|++ +++.||||++..... .....+.+|+.++++++||||+++++++.+...+++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 5799999999999999999987 688999999875432 223568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEE---cCCCcEEEEeccccccccCCcc
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFL 830 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILI---d~~g~VKL~DFGLAk~~~~~~~ 830 (958)
|+++++|.+++...+..........+.+.+.||.|||.++ |+||||||+|||+ +.++.+||+|||+++.....
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-- 162 (304)
T 2jam_A 87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-- 162 (304)
T ss_dssp CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--
T ss_pred cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--
Confidence 9999999999876554444444555555599999999998 9999999999999 78899999999998765432
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccc--cCCCCCCcHHHHHHH
Q 002160 831 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--LEIPKELDPLVARII 908 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~--~~ip~~ls~eL~dLI 908 (958)
......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+...... ..++..+++.+.+||
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 242 (304)
T 2jam_A 163 IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFI 242 (304)
T ss_dssp TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHH
T ss_pred ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHH
Confidence 122346899999999999999999999999999999999999999998877776665433222 233457899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 002160 909 WECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 909 ~~CL~kDP~kRPSa~EIL~~ 928 (958)
.+||..||.+||++.+++++
T Consensus 243 ~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 243 CHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp HHHHCSSTTTSCCHHHHHTS
T ss_pred HHHcCCChhHCcCHHHHhcC
Confidence 99999999999999999875
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=365.62 Aligned_cols=243 Identities=23% Similarity=0.374 Sum_probs=181.2
Q ss_pred CeeEE---EEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeccccCCCceEE
Q 002160 677 DLVLG---ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSI 750 (958)
Q Consensus 677 dy~i~---k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~-HPNIVkL~g~~~~~~~l~L 750 (958)
+|++. +.||+|+||.||+|++ +++.||||++... ....+.+|+.+|+.+. ||||+++++++.+....|+
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l 83 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL 83 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence 45553 7799999999999987 5889999998653 2356778999999996 9999999999999999999
Q ss_pred EEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCC---cEEEEeccccccccC
Q 002160 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNW---NVKVSDFGLSRLKHN 827 (958)
Q Consensus 751 VmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g---~VKL~DFGLAk~~~~ 827 (958)
||||+++|+|.+++.+............+.+.+.||.|||.++ |+||||||+|||++.++ .+||+|||+++....
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 161 (325)
T 3kn6_A 84 VMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP 161 (325)
T ss_dssp EECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred EEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence 9999999999999987655555555555556699999999998 99999999999998765 899999999987655
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-------hHHHHhhhccccccCCC---
Q 002160 828 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP-------MQVVGAVGFQNRRLEIP--- 897 (958)
Q Consensus 828 ~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~-------~ei~~~i~~~~~~~~ip--- 897 (958)
........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+. .++...+.. ....++
T Consensus 162 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~--~~~~~~~~~ 239 (325)
T 3kn6_A 162 DNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK--GDFSFEGEA 239 (325)
T ss_dssp ----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT--TCCCCCSHH
T ss_pred CCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc--CCCCCCccc
Confidence 44444566789999999999999999999999999999999999999986543 334444422 222222
Q ss_pred -CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 898 -KELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 898 -~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
..+++++++||.+||+.||.+||++.+++++
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 3589999999999999999999999998754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=361.99 Aligned_cols=252 Identities=26% Similarity=0.352 Sum_probs=203.9
Q ss_pred ccccccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC-----CCceeEEec
Q 002160 668 VCECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-----HPNVVLFMG 740 (958)
Q Consensus 668 ~~~~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~-----HPNIVkL~g 740 (958)
.....+..++|++++.||+|+||.||+|++ +++.||||++... ......+..|+.+++.+. |||||++++
T Consensus 27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 344455668999999999999999999988 7889999998642 344556788999999996 999999999
Q ss_pred cccCCCceEEEEeecCCCCHHHHHhCCCC-Ccc-HHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcC--------
Q 002160 741 AVTRPPNLSIITEFLPRGSLFRILHRPHC-QVD-EKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDK-------- 810 (958)
Q Consensus 741 ~~~~~~~l~LVmEy~~gGsL~d~L~k~~~-~~~-e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~-------- 810 (958)
++...+.+++||||+ +++|.+++.+... ... ...+.++.+++.||.|||.++ ||||||||+||||+.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~ 180 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLI 180 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEcccccccccc
Confidence 999999999999999 9999999876442 233 444444555599999999998 999999999999975
Q ss_pred -----------------CCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 002160 811 -----------------NWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL 873 (958)
Q Consensus 811 -----------------~g~VKL~DFGLAk~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~ 873 (958)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 257 (360)
T 3llt_A 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257 (360)
T ss_dssp EEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred chhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCC
Confidence 789999999999865432 235679999999999999999999999999999999999999
Q ss_pred CCCCCChhHHHHhhhcccc------------------------ccCCCC--------------------CCcHHHHHHHH
Q 002160 874 PWIGMNPMQVVGAVGFQNR------------------------RLEIPK--------------------ELDPLVARIIW 909 (958)
Q Consensus 874 PF~g~~~~ei~~~i~~~~~------------------------~~~ip~--------------------~ls~eL~dLI~ 909 (958)
||.+.+..+....+..... ...+|. ..++.+.+||.
T Consensus 258 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 337 (360)
T 3llt_A 258 LFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLY 337 (360)
T ss_dssp SCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHH
T ss_pred CCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHH
Confidence 9998776655443321100 000111 12377889999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 002160 910 ECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 910 ~CL~kDP~kRPSa~EIL~~ 928 (958)
+||+.||.+||++.|+++|
T Consensus 338 ~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 338 SILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHCCSSGGGSCCHHHHTTS
T ss_pred HHhcCChhhCCCHHHHhcC
Confidence 9999999999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=368.86 Aligned_cols=242 Identities=21% Similarity=0.324 Sum_probs=204.4
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHH------HHHHHHHHHHHHHHcCCCceeEEeccccCCCc
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA------ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~------~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~ 747 (958)
++|++.+.||+|+||.||+|++ +++.||||++........ ....+.+|+.+|++++||||++++++|.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 5799999999999999999976 788999999987643221 23457789999999999999999999999999
Q ss_pred eEEEEeecCCC-CHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 748 LSIITEFLPRG-SLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 748 l~LVmEy~~gG-sL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
+++||||+.+| +|.+++.+............+.+++.||.|||.++ |+||||||+||||+.++.+||+|||+++...
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 99999999776 99999987765555555555555699999999998 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHH
Q 002160 827 NTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVA 905 (958)
Q Consensus 827 ~~~~~~~s~~GT~~Y~APEvl~g~~~-s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~ 905 (958)
... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...... .......+..+++++.
T Consensus 182 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~~~~~~~~~~l~ 252 (335)
T 3dls_A 182 RGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------VEAAIHPPYLVSKELM 252 (335)
T ss_dssp TTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------TTTCCCCSSCCCHHHH
T ss_pred CCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------HhhccCCCcccCHHHH
Confidence 432 2334679999999999998876 78999999999999999999999763221 1223445667899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 002160 906 RIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 906 dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+||.+||+.||.+||++.+|+++
T Consensus 253 ~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 253 SLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHC
T ss_pred HHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999987
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=395.20 Aligned_cols=260 Identities=27% Similarity=0.405 Sum_probs=215.0
Q ss_pred cCCCCeeEE-EEeeccCceEEEEEEE----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc
Q 002160 673 IPWEDLVLG-ERIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 673 I~~~dy~i~-k~LG~G~fG~Vykak~----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~ 747 (958)
+....+.+. +.||+|+||.||+|.+ .++.||||++...........++.+|+++|++++|||||++++++.. +.
T Consensus 365 ~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~ 443 (635)
T 4fl3_A 365 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ES 443 (635)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred ccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CC
Confidence 344455553 5899999999999965 35789999987765555556789999999999999999999999865 56
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
++|||||+++|+|.+++.............++.+++.||.|||.++ ||||||||+||||+.++.+||+|||+++....
T Consensus 444 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 444 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRA 521 (635)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred EEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence 8999999999999999987654444444455555599999999998 99999999999999999999999999987643
Q ss_pred Cc---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHH
Q 002160 828 TF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 903 (958)
Q Consensus 828 ~~---~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~e 903 (958)
.. .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+. ...+..++..++.+
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~ 600 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPRE 600 (635)
T ss_dssp -------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHH
T ss_pred CccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHH
Confidence 22 11223456789999999999999999999999999999998 999999998888777665 44566778899999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhc
Q 002160 904 VARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 936 (958)
Q Consensus 904 L~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~ 936 (958)
+.+||.+||+.||.+||++.+|++.|+.+....
T Consensus 601 l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 601 MYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 999999999999999999999999999986543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=371.01 Aligned_cols=250 Identities=24% Similarity=0.291 Sum_probs=196.9
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC-----Cce
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-----PNL 748 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~-----~~l 748 (958)
++|++++.||+|+||.||+|++ +++.||||++............+.+|+++|++++|||||++++++... ..+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 6899999999999999999987 678899999987655666677899999999999999999999998766 569
Q ss_pred EEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
|+||||++ ++|.+++...........+.++.+++.||.|||+++ |+||||||+||||+.++++||+|||+++.....
T Consensus 106 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 106 YIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred EEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 99999996 599999987665555666666666699999999998 999999999999999999999999999875432
Q ss_pred cc----------------------cCCCCCCCCCccCcccc-cCCCCCchhhHHHHHHHHHHHHhCC-----------CC
Q 002160 829 FL----------------------SSKSTAGTPEWMAPEVL-RNEPSNEKCDVYSFGVILWELATLK-----------LP 874 (958)
Q Consensus 829 ~~----------------------~~~s~~GT~~Y~APEvl-~g~~~s~ksDIWSLGiLLyELLtG~-----------~P 874 (958)
.. .....+||+.|+|||++ .+..++.++|||||||++|||++|. ++
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~ 262 (432)
T 3n9x_A 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262 (432)
T ss_dssp ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCS
T ss_pred ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccccc
Confidence 11 12557899999999986 5666899999999999999999843 34
Q ss_pred CCCCCh-----------------hHHH------------------------HhhhccccccC-----CCCCCcHHHHHHH
Q 002160 875 WIGMNP-----------------MQVV------------------------GAVGFQNRRLE-----IPKELDPLVARII 908 (958)
Q Consensus 875 F~g~~~-----------------~ei~------------------------~~i~~~~~~~~-----ip~~ls~eL~dLI 908 (958)
|.+.+. ...+ ..+........ ....+++++.+||
T Consensus 263 f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl 342 (432)
T 3n9x_A 263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLL 342 (432)
T ss_dssp CCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHH
T ss_pred CCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHH
Confidence 433321 0000 00000000000 0135789999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 002160 909 WECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 909 ~~CL~kDP~kRPSa~EIL~~ 928 (958)
.+||+.||.+||+++|+++|
T Consensus 343 ~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 343 ESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp HHHSCSSTTTSCCHHHHHTC
T ss_pred HHHhcCCcccCCCHHHHhcC
Confidence 99999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=348.23 Aligned_cols=255 Identities=21% Similarity=0.254 Sum_probs=201.2
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEecc-ccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA-VTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~-~~~~~~l~LVm 752 (958)
++|++++.||+|+||.||+|++ +++.||||++...... ..+.+|+.+++.++|++++..+++ +......++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 6799999999999999999985 7889999987654332 257789999999988776655554 46677789999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEE---cCCCcEEEEeccccccccCC
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILI---d~~g~VKL~DFGLAk~~~~~ 828 (958)
||+ +++|.+++......+.+.....++.+ +.||.|||.++ |+||||||+|||| +.++.+||+|||+++.....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 999 99999999854444555555555544 99999999998 9999999999999 78899999999999875443
Q ss_pred cc-------cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh---HHHHhhhc---cccccC
Q 002160 829 FL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGF---QNRRLE 895 (958)
Q Consensus 829 ~~-------~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~---ei~~~i~~---~~~~~~ 895 (958)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.. +....+.. ......
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh
Confidence 21 223567999999999999999999999999999999999999999875432 22222111 111112
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhcC
Q 002160 896 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVI 937 (958)
Q Consensus 896 ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~~ 937 (958)
+...+++++.+||.+||+.||.+||++.+|++.|+++....-
T Consensus 242 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 236789999999999999999999999999999999876543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=381.82 Aligned_cols=250 Identities=28% Similarity=0.406 Sum_probs=206.9
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCH-----------HHHHHHHHHHHHHHHcCCCceeEEecc
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-----------AALLEFKREVKIMRRLRHPNVVLFMGA 741 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~-----------~~~~~f~~Ei~ILk~L~HPNIVkL~g~ 741 (958)
.++|++++.||+|+||.||+|++ +++.||||++....... .....+.+|+.+|++++|||||+++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 36799999999999999999987 57899999987654321 234578899999999999999999999
Q ss_pred ccCCCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCC---cEEEEe
Q 002160 742 VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNW---NVKVSD 818 (958)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g---~VKL~D 818 (958)
+.+...+|||||||++|+|.+++..............+.+++.||.|||.++ |+||||||+|||++.++ .+||+|
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccEEEEE
Confidence 9999999999999999999998876555444455555555599999999998 99999999999999765 699999
Q ss_pred ccccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCC--
Q 002160 819 FGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI-- 896 (958)
Q Consensus 819 FGLAk~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~i-- 896 (958)
||+++...... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..++...+.........
T Consensus 193 fg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 270 (504)
T 3q5i_A 193 FGLSSFFSKDY-KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFND 270 (504)
T ss_dssp CTTCEECCTTS-CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH
T ss_pred CCCCEEcCCCC-ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence 99998765432 3345679999999999875 5899999999999999999999999999988887777533222221
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 897 PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 897 p~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
...+++++++||.+||+.||.+||++.|+++|
T Consensus 271 ~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 271 WKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 25789999999999999999999999999876
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=358.38 Aligned_cols=258 Identities=21% Similarity=0.297 Sum_probs=202.8
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEecccc----C
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT----R 744 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~----~ 744 (958)
..+..++|++++.||+|+||.||+++. +++.||||++... .......+.+|+.++++++||||+++++++. .
T Consensus 24 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA 101 (317)
T ss_dssp EEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred EEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence 345667899999999999999999986 7899999988654 3455678899999999999999999999986 3
Q ss_pred CCceEEEEeecCCCCHHHHHhC---CCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecc
Q 002160 745 PPNLSIITEFLPRGSLFRILHR---PHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 820 (958)
Q Consensus 745 ~~~l~LVmEy~~gGsL~d~L~k---~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFG 820 (958)
...+++||||+++|+|.+++.. ....+.+...+.++ +.+.||.|||.++ |+||||||+||||+.++.+||+|||
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~dfg 179 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDEGQPVLMDLG 179 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCS
T ss_pred CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCCEEEEecC
Confidence 4578999999999999998864 23344455444444 4499999999998 9999999999999999999999999
Q ss_pred ccccccCCccc---------CCCCCCCCCccCcccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCh--hHHHHh
Q 002160 821 LSRLKHNTFLS---------SKSTAGTPEWMAPEVLRNEP---SNEKCDVYSFGVILWELATLKLPWIGMNP--MQVVGA 886 (958)
Q Consensus 821 LAk~~~~~~~~---------~~s~~GT~~Y~APEvl~g~~---~s~ksDIWSLGiLLyELLtG~~PF~g~~~--~ei~~~ 886 (958)
++......... .....||+.|+|||++.+.. ++.++||||||+++|+|++|+.||..... ......
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 259 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH
Confidence 98764321110 11234799999999998664 68899999999999999999999954211 111111
Q ss_pred hhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 002160 887 VGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 933 (958)
Q Consensus 887 i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~ 933 (958)
+. .......+..++..+.+||.+||+.||.+||++.+|+++|+.+.
T Consensus 260 ~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 260 VQ-NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HH-CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred hh-ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 11 22233344578999999999999999999999999999999875
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=393.82 Aligned_cols=252 Identities=23% Similarity=0.276 Sum_probs=211.9
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeccccCCCce
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l 748 (958)
.+..++|++.+.||+|+||.||+|++ +++.||||++.+.... ......+.+|+++|++++|||||++++++.+.+.+
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 259 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence 46678899999999999999999987 6889999998754321 12245678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhCCCC--CccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 749 SIITEFLPRGSLFRILHRPHC--QVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~--~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
||||||++||+|.+++...+. ......+.++.+++.||.|||.++ ||||||||+||||+.+|++||+|||+++...
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999999999876543 344444555556699999999998 9999999999999999999999999998764
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh----hHHHHhhhccccccCCCCCCcH
Q 002160 827 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQNRRLEIPKELDP 902 (958)
Q Consensus 827 ~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~----~ei~~~i~~~~~~~~ip~~ls~ 902 (958)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+... .++...+ ......++..+++
T Consensus 338 ~~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i--~~~~~~~p~~~s~ 414 (576)
T 2acx_A 338 EGQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV--KEVPEEYSERFSP 414 (576)
T ss_dssp TTC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH--HHCCCCCCTTSCH
T ss_pred cCc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh--hcccccCCccCCH
Confidence 432 23446899999999999999999999999999999999999999987642 3333333 2335567788999
Q ss_pred HHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 002160 903 LVARIIWECWQTDPSLRP-----SFAQLTVA 928 (958)
Q Consensus 903 eL~dLI~~CL~kDP~kRP-----Sa~EIL~~ 928 (958)
++++||.+||+.||.+|| ++.||++|
T Consensus 415 ~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 415 QARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred HHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 999999999999999999 78999876
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=354.32 Aligned_cols=254 Identities=30% Similarity=0.452 Sum_probs=203.3
Q ss_pred eeEEEEeeccCceEEEEEEECCcEEEEEEeecCC--CCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeec
Q 002160 678 LVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQD--FSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFL 755 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~--~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~ 755 (958)
|..++.||+|+||.||+|+++++.||||++.... ........+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 112 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence 4446889999999999999999999999987543 23345678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhCC--CCCccHHHHHHHHH-HHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc--c
Q 002160 756 PRGSLFRILHRP--HCQVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--L 830 (958)
Q Consensus 756 ~gGsL~d~L~k~--~~~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~--~ 830 (958)
++++|.+++... .....+...+.++. .+.||.|||.++ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 999999998642 22345555555444 489999999998 9999999999999999999999999998654321 1
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhh----hc---------cccccCCC
Q 002160 831 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV----GF---------QNRRLEIP 897 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i----~~---------~~~~~~ip 897 (958)
......||+.|+|||++.+. ++.++||||||+++|+|++|..||.+....+....+ .. .......+
T Consensus 191 ~~~~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDAD 269 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCC
T ss_pred cccccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccc
Confidence 23345799999999998764 789999999999999999999999875443221111 10 00111223
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhh
Q 002160 898 KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934 (958)
Q Consensus 898 ~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k 934 (958)
...+..+.+||.+||+.||.+||++.+|+++|+++..
T Consensus 270 ~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 270 STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred hHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 3456789999999999999999999999999998853
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=366.55 Aligned_cols=257 Identities=21% Similarity=0.211 Sum_probs=197.5
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE-----CCcEEEEEEeecCCCCHHH---------HHHHHHHHHHHHHcCCCceeE
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAA---------LLEFKREVKIMRRLRHPNVVL 737 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~-----~g~~VAVK~i~~~~~~~~~---------~~~f~~Ei~ILk~L~HPNIVk 737 (958)
++..++|++++.||+|+||.||+|++ .+..||||++......... ...+.+|+.+++.++||||++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~ 112 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence 34557899999999999999999987 4678999998765421111 123667889999999999999
Q ss_pred EeccccC----CCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCC-
Q 002160 738 FMGAVTR----PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNW- 812 (958)
Q Consensus 738 L~g~~~~----~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g- 812 (958)
+++++.. ...+|+||||+ +++|.+++.+.+..........+.+.+.||.|||.++ |+||||||+||||+.++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESSST
T ss_pred eecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccCCC
Confidence 9999877 67899999999 9999999987653333444444445599999999998 99999999999999877
Q ss_pred -cEEEEeccccccccCCc-------ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--ChhH
Q 002160 813 -NVKVSDFGLSRLKHNTF-------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM--NPMQ 882 (958)
Q Consensus 813 -~VKL~DFGLAk~~~~~~-------~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~--~~~e 882 (958)
.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+. +...
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 99999999998653321 1113457999999999999999999999999999999999999999653 2222
Q ss_pred HHHhhhccccccCCC---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 002160 883 VVGAVGFQNRRLEIP---------KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 933 (958)
Q Consensus 883 i~~~i~~~~~~~~ip---------~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~ 933 (958)
..... ......++ ..++.++++||.+||..||.+||++.+|++.|+.+.
T Consensus 270 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 270 VQTAK--TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHH--HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHH--HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 21111 11112222 278899999999999999999999999999998864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=354.48 Aligned_cols=250 Identities=30% Similarity=0.462 Sum_probs=201.9
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
.++|++++.||+|+||.||+|++ +++.||+|++..... .....+.+|+.++++++||||+++++++...+.+++||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH--HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 36799999999999999999988 488999998865432 23567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~ 831 (958)
||+++++|.+++.+......+.....++ +.+.||.|||.++ |+||||||+|||++.++.+||+|||++.........
T Consensus 96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK 173 (302)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC
T ss_pred EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCCCCEEEEECCCCccccccccc
Confidence 9999999999887544444455444444 4499999999998 999999999999999999999999997654332222
Q ss_pred CCCCCCCCCccCcccc-----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc-ccCCCCCCcHHHH
Q 002160 832 SKSTAGTPEWMAPEVL-----RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLVA 905 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl-----~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~-~~~ip~~ls~eL~ 905 (958)
.....||+.|+|||++ .+..++.++||||||+++|+|++|..||...+.......+..... ....+..++..+.
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFR 253 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHH
Confidence 3446799999999998 466788999999999999999999999998887766555432222 2233567899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 002160 906 RIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 906 dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+||.+||+.||.+||++.+|+++
T Consensus 254 ~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 254 DFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HHHHHHSCSCTTTSCCHHHHTTS
T ss_pred HHHHHHcccChhhCCCHHHHhcC
Confidence 99999999999999999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=372.20 Aligned_cols=244 Identities=25% Similarity=0.366 Sum_probs=189.9
Q ss_pred CCeeEE-EEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccC----CCc
Q 002160 676 EDLVLG-ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTR----PPN 747 (958)
Q Consensus 676 ~dy~i~-k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~----~~~ 747 (958)
++|.+. +.||+|+||.||+|.+ +++.||||++... ..+.+|+.++.++ +||||++++++|.. ...
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 567776 7899999999999987 5889999998632 2567888887554 89999999998865 567
Q ss_pred eEEEEeecCCCCHHHHHhCCCC-CccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcC---CCcEEEEecccc
Q 002160 748 LSIITEFLPRGSLFRILHRPHC-QVDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLS 822 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~-~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~---~g~VKL~DFGLA 822 (958)
+||||||++||+|.+++..... .+.+.... ++.+++.||.|||.++ ||||||||+||||+. ++.+||+|||++
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 8999999999999999987542 34444444 4445599999999998 999999999999997 789999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhH----HHHhhhccccccC--C
Q 002160 823 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ----VVGAVGFQNRRLE--I 896 (958)
Q Consensus 823 k~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~e----i~~~i~~~~~~~~--i 896 (958)
+..... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..... ....+........ .
T Consensus 212 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 290 (400)
T 1nxk_A 212 KETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 290 (400)
T ss_dssp EECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTT
T ss_pred cccCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcc
Confidence 865433 22345789999999999999999999999999999999999999998765432 2222321211111 1
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002160 897 PKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 897 p~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L 929 (958)
...++.++++||.+||+.||.+||++.+|++|-
T Consensus 291 ~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 291 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 246899999999999999999999999999874
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=350.40 Aligned_cols=249 Identities=24% Similarity=0.410 Sum_probs=202.5
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCC--HHHHHHHHHHHHHHHHcCCCceeEEeccc--cCCCce
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS--GAALLEFKREVKIMRRLRHPNVVLFMGAV--TRPPNL 748 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~--~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~--~~~~~l 748 (958)
.++|++++.||+|+||.||+|.+ +++.||||++...... ......+.+|++++++++||||+++++++ .+...+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 36799999999999999999987 6789999998754321 23456789999999999999999999998 445679
Q ss_pred EEEEeecCCCCHHHHHhC-CCCCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 749 SIITEFLPRGSLFRILHR-PHCQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k-~~~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
++||||++++ |.+++.. ....+.+..... +.+.+.||.|||.++ |+||||||+|||++.++.+||+|||++....
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 9999999876 6666653 223344444444 444599999999998 9999999999999999999999999998754
Q ss_pred CC--cccCCCCCCCCCccCcccccCCCC--CchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcH
Q 002160 827 NT--FLSSKSTAGTPEWMAPEVLRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 902 (958)
Q Consensus 827 ~~--~~~~~s~~GT~~Y~APEvl~g~~~--s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~ 902 (958)
.. ........||+.|+|||++.+... +.++||||||+++|+|++|+.||.+.+..+....+. .....++..+++
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~--~~~~~~~~~~~~ 238 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG--KGSYAIPGDCGP 238 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--HCCCCCCSSSCH
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHh--cCCCCCCCccCH
Confidence 22 122334569999999999987543 779999999999999999999999988777766663 335567788999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 903 LVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 903 eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.+.+||.+||+.||.+||++.+++++
T Consensus 239 ~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 239 PLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 99999999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=348.55 Aligned_cols=251 Identities=24% Similarity=0.342 Sum_probs=208.4
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC---C----HHHHHHHHHHHHHHHHcC-CCceeEEeccccC
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF---S----GAALLEFKREVKIMRRLR-HPNVVLFMGAVTR 744 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~---~----~~~~~~f~~Ei~ILk~L~-HPNIVkL~g~~~~ 744 (958)
.++|++.+.||+|+||.||+|++ +++.||||++..... . ......+.+|+++|+++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 47899999999999999999987 678999999876531 1 123456889999999995 9999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 745 ~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
...+++||||+++++|.+++..............+.+.+.||.|||.++ |+||||||+|||++.++.+||+|||++..
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCCCcEEEecccchhh
Confidence 9999999999999999999976544444444444555599999999998 99999999999999999999999999987
Q ss_pred ccCCcccCCCCCCCCCccCccccc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCC-
Q 002160 825 KHNTFLSSKSTAGTPEWMAPEVLR------NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP- 897 (958)
Q Consensus 825 ~~~~~~~~~s~~GT~~Y~APEvl~------g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip- 897 (958)
..... ......||+.|+|||++. ...++.++||||||+++|+|++|..||.+.+..+....+.........+
T Consensus 174 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
T 1phk_A 174 LDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 252 (298)
T ss_dssp CCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred cCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCccc
Confidence 64332 234567999999999985 4567899999999999999999999999888777666554332222222
Q ss_pred -CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 898 -KELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 898 -~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
..++..+.+||.+||+.||.+||++.+++++
T Consensus 253 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 253 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 4688999999999999999999999999864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=356.76 Aligned_cols=253 Identities=34% Similarity=0.571 Sum_probs=203.8
Q ss_pred CCCeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHH--cCCCceeEEeccccCCC----ce
Q 002160 675 WEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRR--LRHPNVVLFMGAVTRPP----NL 748 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~--L~HPNIVkL~g~~~~~~----~l 748 (958)
.++|++.+.||+|+||.||+|+++++.||||++... ....+.+|++++.. ++||||+++++++.... .+
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~ 115 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred cccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence 367999999999999999999999999999998543 23567789999988 68999999999998776 79
Q ss_pred EEEEeecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHH--------hcCCcEeecCCCCCceEEcCCCcEEEEec
Q 002160 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLH--------TSTPTIVHRDLKSPNLLVDKNWNVKVSDF 819 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH--------~~g~gIIHRDLKPeNILId~~g~VKL~DF 819 (958)
++||||+++|+|.+++.+.. ..+...+.++ +.+.||.||| ..+ |+||||||+||||+.++++||+||
T Consensus 116 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 116 WLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp EEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEECTTSCEEECCC
T ss_pred EEEEeecCCCcHHHHHhccC--ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEECCCCCEEEEEC
Confidence 99999999999999997643 3444444444 4499999999 555 999999999999999999999999
Q ss_pred cccccccCCcc----cCCCCCCCCCccCcccccCCC------CCchhhHHHHHHHHHHHHhC----------CCCCCCCC
Q 002160 820 GLSRLKHNTFL----SSKSTAGTPEWMAPEVLRNEP------SNEKCDVYSFGVILWELATL----------KLPWIGMN 879 (958)
Q Consensus 820 GLAk~~~~~~~----~~~s~~GT~~Y~APEvl~g~~------~s~ksDIWSLGiLLyELLtG----------~~PF~g~~ 879 (958)
|+++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++| +.||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 99987544321 234567999999999998763 23689999999999999999 88997653
Q ss_pred -----hhHHHHhhhccccccCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhc
Q 002160 880 -----PMQVVGAVGFQNRRLEIPK-----ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 936 (958)
Q Consensus 880 -----~~ei~~~i~~~~~~~~ip~-----~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~ 936 (958)
.......+.....++.++. .++..+.+||.+||+.||.+||++.+|+++|+++.+..
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 2233333333333444443 34568999999999999999999999999999997653
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=350.92 Aligned_cols=254 Identities=27% Similarity=0.449 Sum_probs=203.5
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCce
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l 748 (958)
..+..++|.....||+|+||.||+|++ +++.||||.+.... ......+.+|+.+++.++||||+++++++...+.+
T Consensus 17 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 94 (295)
T 2clq_A 17 YDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFI 94 (295)
T ss_dssp EEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred ccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcE
Confidence 344455666667899999999999987 67899999987653 23356788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhCCCC--CccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEcC-CCcEEEEecccccc
Q 002160 749 SIITEFLPRGSLFRILHRPHC--QVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRL 824 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~--~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~-~g~VKL~DFGLAk~ 824 (958)
++||||+++++|.+++..... ...+..... +.+.+.||.|||.++ |+||||||+|||++. ++.+||+|||+++.
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~ 172 (295)
T 2clq_A 95 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKR 172 (295)
T ss_dssp EEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEE
T ss_pred EEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccccc
Confidence 999999999999999875432 233444443 445599999999998 999999999999997 89999999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCChhH-HHHhhhccccccCCCCCCc
Q 002160 825 KHNTFLSSKSTAGTPEWMAPEVLRNEP--SNEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGFQNRRLEIPKELD 901 (958)
Q Consensus 825 ~~~~~~~~~s~~GT~~Y~APEvl~g~~--~s~ksDIWSLGiLLyELLtG~~PF~g~~~~e-i~~~i~~~~~~~~ip~~ls 901 (958)
............||+.|+|||++.+.. ++.++||||||+++|+|++|+.||....... .............++..++
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (295)
T 2clq_A 173 LAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMS 252 (295)
T ss_dssp SCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSC
T ss_pred cCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCC
Confidence 654333344567999999999997654 7899999999999999999999997654332 2222222334556778899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 902 PLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 902 ~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+++.+||.+||+.||.+||++.+++.+
T Consensus 253 ~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 253 AEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp HHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 999999999999999999999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=369.50 Aligned_cols=253 Identities=24% Similarity=0.368 Sum_probs=206.0
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE-----CCcEEEEEEeecCCC--CHHHHHHHHHHHHHHHHc-CCCceeEEeccccC
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDF--SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTR 744 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~-----~g~~VAVK~i~~~~~--~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~ 744 (958)
+..++|++++.||+|+||.||+|++ +++.||||++..... .......+.+|+++|+++ +||||+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 4457899999999999999999987 688999999865322 111233567899999999 69999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 745 ~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
...++|||||+++++|.+++.+............+.+++.||.|||.++ |+||||||+||||+.++++||+|||+++.
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 9999999999999999999976555445555555556699999999998 99999999999999999999999999986
Q ss_pred ccCC-cccCCCCCCCCCccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCh----hHHHHhhhccccccCCC
Q 002160 825 KHNT-FLSSKSTAGTPEWMAPEVLRNE--PSNEKCDVYSFGVILWELATLKLPWIGMNP----MQVVGAVGFQNRRLEIP 897 (958)
Q Consensus 825 ~~~~-~~~~~s~~GT~~Y~APEvl~g~--~~s~ksDIWSLGiLLyELLtG~~PF~g~~~----~ei~~~i~~~~~~~~ip 897 (958)
.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||..... .++...+ ......++
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~ 286 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSEPPYP 286 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--HHCCCCCC
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH--hccCCCCC
Confidence 5332 2223346799999999999863 468999999999999999999999975432 2232222 22355677
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHHH
Q 002160 898 KELDPLVARIIWECWQTDPSLRP-----SFAQLTVAL 929 (958)
Q Consensus 898 ~~ls~eL~dLI~~CL~kDP~kRP-----Sa~EIL~~L 929 (958)
..++..+++||.+||..||.+|| ++.+++++.
T Consensus 287 ~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 88999999999999999999999 999999875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=356.58 Aligned_cols=259 Identities=30% Similarity=0.494 Sum_probs=211.7
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~ 745 (958)
.+...+|++++.||+|+||.||+|++ +++.||||++... .......+.+|+++|++++||||+++++++...
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 45567899999999999999999984 5788999998754 334567899999999999999999999988765
Q ss_pred C--ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHH-HHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccc
Q 002160 746 P--NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 822 (958)
Q Consensus 746 ~--~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLA 822 (958)
+ .+++||||+++++|.+++.+......+...+.++. .+.||.|||..+ |+||||||+||||+.++.+||+|||++
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCCCcEEEecCcch
Confidence 4 68999999999999999987655555555555444 499999999988 999999999999999999999999999
Q ss_pred ccccCCcc---cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh----------------HH
Q 002160 823 RLKHNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM----------------QV 883 (958)
Q Consensus 823 k~~~~~~~---~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~----------------ei 883 (958)
+....... ......++..|+|||++.+..++.++||||||+++|+|++|..||...... .+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 87643321 123345778899999999988999999999999999999999998642110 11
Q ss_pred HHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 884 VGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 884 ~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
.. ......+...+..++.++.+||.+||+.||.+||++.+|++.|+.+.+.
T Consensus 273 ~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 273 IE-LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HH-HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH-HhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11 1123334566778999999999999999999999999999999999765
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=354.49 Aligned_cols=247 Identities=24% Similarity=0.319 Sum_probs=195.8
Q ss_pred CCeeEE-EEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCceEEE
Q 002160 676 EDLVLG-ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 676 ~dy~i~-k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~l~LV 751 (958)
+.|++. +.||+|+||.||+|++ +++.||||++..... .....+.+|+++|.++ +||||+++++++.+.+.+|+|
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 568884 7899999999999986 688999999876532 2345788999999995 799999999999999999999
Q ss_pred EeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCc---EEEEeccccccccCC
Q 002160 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRLKHNT 828 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~---VKL~DFGLAk~~~~~ 828 (958)
|||+++++|.+++.+............+.+.+.||.|||.++ |+||||||+|||++.++. +||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred EEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 999999999999976554444555555555699999999998 999999999999998766 999999998765321
Q ss_pred c-------ccCCCCCCCCCccCcccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---------------h
Q 002160 829 F-------LSSKSTAGTPEWMAPEVLRN-----EPSNEKCDVYSFGVILWELATLKLPWIGMNP---------------M 881 (958)
Q Consensus 829 ~-------~~~~s~~GT~~Y~APEvl~g-----~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~---------------~ 881 (958)
. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+... .
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 247 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence 1 11223569999999999975 4578899999999999999999999987542 1
Q ss_pred HHHHhhhccccccCCC----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 882 QVVGAVGFQNRRLEIP----KELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 882 ei~~~i~~~~~~~~ip----~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.+...+. .....++ ..+++.+++||.+||+.||.+||++.|+++|
T Consensus 248 ~~~~~i~--~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 248 MLFESIQ--EGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHH--HCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHh--ccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 2233332 2223333 3588999999999999999999999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=362.68 Aligned_cols=251 Identities=22% Similarity=0.349 Sum_probs=207.6
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCH---------------HHHHHHHHHHHHHHHcCCCcee
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSG---------------AALLEFKREVKIMRRLRHPNVV 736 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~---------------~~~~~f~~Ei~ILk~L~HPNIV 736 (958)
.+..++|++++.||+|+||.||+|+++++.||||++....... .....+.+|+.++++++||||+
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 4456899999999999999999999999999999987543211 1126789999999999999999
Q ss_pred EEeccccCCCceEEEEeecCCCCHHHH------HhCC-CCCccHHHHHHH-HHHHHHHHHHHh-cCCcEeecCCCCCceE
Q 002160 737 LFMGAVTRPPNLSIITEFLPRGSLFRI------LHRP-HCQVDEKRRIKM-ALDARGMNCLHT-STPTIVHRDLKSPNLL 807 (958)
Q Consensus 737 kL~g~~~~~~~l~LVmEy~~gGsL~d~------L~k~-~~~~~e~~~l~i-a~~a~aL~yLH~-~g~gIIHRDLKPeNIL 807 (958)
++++++.+.+.+++||||+++++|.++ +.+. .....+.....+ .+.+.||.|||. ++ |+||||||+|||
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Nil 184 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNIL 184 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGEE
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhEE
Confidence 999999999999999999999999998 6552 234444444444 445999999998 87 999999999999
Q ss_pred EcCCCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCCCh-hHHH
Q 002160 808 VDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE-PSNE-KCDVYSFGVILWELATLKLPWIGMNP-MQVV 884 (958)
Q Consensus 808 Id~~g~VKL~DFGLAk~~~~~~~~~~s~~GT~~Y~APEvl~g~-~~s~-ksDIWSLGiLLyELLtG~~PF~g~~~-~ei~ 884 (958)
++.++++||+|||++...... ......||+.|+|||++.+. .++. ++||||||+++|+|++|+.||..... .+..
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 999999999999999876443 23456799999999999987 5655 99999999999999999999988766 5555
Q ss_pred HhhhccccccCCC-------------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 885 GAVGFQNRRLEIP-------------------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 885 ~~i~~~~~~~~ip-------------------~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
..+... ...++ ..++.++.+||.+||+.||.+||++.|++++
T Consensus 263 ~~i~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 263 NNIRTK--NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHTSC--CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHhcc--CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 555322 33333 5689999999999999999999999999874
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=345.77 Aligned_cols=245 Identities=24% Similarity=0.376 Sum_probs=202.9
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC---------
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--------- 744 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~--------- 744 (958)
.+|++.+.||+|+||.||+|++ +++.||||++.... ..+.+|++++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 5799999999999999999988 58999999987643 246789999999999999999998754
Q ss_pred -------CCceEEEEeecCCCCHHHHHhCC-CCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEE
Q 002160 745 -------PPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVK 815 (958)
Q Consensus 745 -------~~~l~LVmEy~~gGsL~d~L~k~-~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VK 815 (958)
...+++||||+++++|.+++.+. .....+...+.++ +.+.||.|||.++ |+||||||+|||++.++.+|
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEcCCCCEE
Confidence 34589999999999999999643 2334454444444 4499999999998 99999999999999999999
Q ss_pred EEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccC
Q 002160 816 VSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE 895 (958)
Q Consensus 816 L~DFGLAk~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ 895 (958)
|+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||... ......+. ...
T Consensus 163 l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~----~~~ 235 (284)
T 2a19_B 163 IGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLR----DGI 235 (284)
T ss_dssp ECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHH----TTC
T ss_pred ECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhh----ccc
Confidence 99999998765432 234467999999999999999999999999999999999999987532 12222221 233
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 896 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 896 ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
++..++..+++||.+||+.||.+||++.|++++|..+.+.
T Consensus 236 ~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 236 ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 5667899999999999999999999999999999998765
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=360.93 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=207.5
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC--CH----HHHHHHHHHHHHHHHc-CCCceeEEeccccCCC
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF--SG----AALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP 746 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~--~~----~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~ 746 (958)
++|++.+.||+|+||.||+|++ +|+.||||++..... .. .....+.+|+.+++++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 5799999999999999999987 588999999876532 21 2245678999999999 7999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
..|+||||+++++|.+++.............++.+.+.||.|||.++ |+||||||+||||+.+|.+||+|||++....
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 99999999999999999976544444445555555699999999998 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCC--CC
Q 002160 827 NTFLSSKSTAGTPEWMAPEVLRN------EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI--PK 898 (958)
Q Consensus 827 ~~~~~~~s~~GT~~Y~APEvl~g------~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~i--p~ 898 (958)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+......... ..
T Consensus 252 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 330 (365)
T 2y7j_A 252 PGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD 330 (365)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHS
T ss_pred CCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccc
Confidence 432 2345689999999999864 35788999999999999999999999988777666655432222211 14
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 899 ELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 899 ~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.++..+.+||.+||+.||.+||++.+++++
T Consensus 331 ~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 331 DRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp SSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 678999999999999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=362.01 Aligned_cols=249 Identities=23% Similarity=0.268 Sum_probs=194.2
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC------
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------ 746 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~------ 746 (958)
.++|++++.||+|+||.||+|.+ +++.||||++............+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 36899999999999999999986 6889999999876656666778899999999999999999999987665
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
.+|+||||+++ +|.+++... .........+.+++.||.|||.++ |+||||||+||||+.++.+||+|||+++...
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred ceEEEEEcCCC-CHHHHHhhc--cCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 68999999975 788888642 333334444555599999999998 9999999999999999999999999998664
Q ss_pred CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccc-------------
Q 002160 827 NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------------- 893 (958)
Q Consensus 827 ~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~------------- 893 (958)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 179 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 257 (371)
T 2xrw_A 179 TSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257 (371)
T ss_dssp ------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred ccc-ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 332 234467999999999999999999999999999999999999999988776555444221100
Q ss_pred -------cC--------------CCC------CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002160 894 -------LE--------------IPK------ELDPLVARIIWECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 894 -------~~--------------ip~------~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L 929 (958)
+. +|. ..+..+++||.+||..||.+||+++|+++|=
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 00 011 1256899999999999999999999999863
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=372.92 Aligned_cols=242 Identities=15% Similarity=0.122 Sum_probs=190.9
Q ss_pred CCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHH---HHHHcCCCceeEEe-------c
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVK---IMRRLRHPNVVLFM-------G 740 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~---ILk~L~HPNIVkL~-------g 740 (958)
..++|++.+.||+|+||.||+|++ +++.||||++..... .......+.+|+. +|++++|||||+++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 357899999999999999999985 689999999976532 3345678899994 55555899999998 4
Q ss_pred cccCCC-----------------ceEEEEeecCCCCHHHHHhCCCCCcc------HHHHH-HHHHHHHHHHHHHhcCCcE
Q 002160 741 AVTRPP-----------------NLSIITEFLPRGSLFRILHRPHCQVD------EKRRI-KMALDARGMNCLHTSTPTI 796 (958)
Q Consensus 741 ~~~~~~-----------------~l~LVmEy~~gGsL~d~L~k~~~~~~------e~~~l-~ia~~a~aL~yLH~~g~gI 796 (958)
++...+ ..||||||+ +|+|.+++.+.+.... +..++ ++.+++.||+|||.++ |
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i 227 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--L 227 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--e
Confidence 444332 378999999 6899999975433333 34444 4445599999999998 9
Q ss_pred eecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCC-----------CCCchhhHHHHHHHH
Q 002160 797 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE-----------PSNEKCDVYSFGVIL 865 (958)
Q Consensus 797 IHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~GT~~Y~APEvl~g~-----------~~s~ksDIWSLGiLL 865 (958)
+||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++.+. .++.++|||||||++
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR---VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTCE---EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCCc---ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 99999999999999999999999999864332 234567 999999999987 899999999999999
Q ss_pred HHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 866 WELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 866 yELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
|||++|+.||.+.+..+....+ ...+..+++++++||.+||+.||.+||++.+++++
T Consensus 304 ~elltg~~Pf~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHSSCCC------CCSGGG------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHCCCCCcccccccchhhh------hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 9999999999876654433332 12235789999999999999999999999999863
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=368.19 Aligned_cols=248 Identities=14% Similarity=0.058 Sum_probs=185.2
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHHc--CCCceeEEecccc------
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRL--RHPNVVLFMGAVT------ 743 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~ILk~L--~HPNIVkL~g~~~------ 743 (958)
..+|++++.||+|+||.||+|++ +++.||||++...... ......+.+|+.+++.| +||||++++..+.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 34699999999999999999986 6889999999887653 34556778886666655 5999888664332
Q ss_pred -CC-----------------CceEEEEeecCCCCHHHHHhCCCCCccHHHH------HHH-HHHHHHHHHHHhcCCcEee
Q 002160 744 -RP-----------------PNLSIITEFLPRGSLFRILHRPHCQVDEKRR------IKM-ALDARGMNCLHTSTPTIVH 798 (958)
Q Consensus 744 -~~-----------------~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~------l~i-a~~a~aL~yLH~~g~gIIH 798 (958)
.. ..+||||||++ |+|.+++...+....+..+ +++ .+++.||+|||.++ |||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--ivH 217 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVH 217 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--Ccc
Confidence 21 33899999998 8999999764333343444 555 55599999999998 999
Q ss_pred cCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCCCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 002160 799 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWI 876 (958)
Q Consensus 799 RDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~GT~~Y~APEvl~g--~~~s~ksDIWSLGiLLyELLtG~~PF~ 876 (958)
|||||+||||+.++++||+|||+++....... ...+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP---ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCEEE---GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCCcc---CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987643321 3456799999999987 678999999999999999999999998
Q ss_pred CCChhHHHHh-----hhccccccCC--CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 877 GMNPMQVVGA-----VGFQNRRLEI--PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 877 g~~~~ei~~~-----i~~~~~~~~i--p~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+......... .........+ +..+++.+++||.+||+.||.+||++.++++|
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 7644321100 1111112222 35789999999999999999999999999763
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=359.56 Aligned_cols=257 Identities=17% Similarity=0.171 Sum_probs=206.1
Q ss_pred cccccCCCCeeEEEEeeccCceEEEEEE-------ECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC---CCceeEE
Q 002160 669 CECEIPWEDLVLGERIGLGSYGEVYHAD-------WNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVVLF 738 (958)
Q Consensus 669 ~~~eI~~~dy~i~k~LG~G~fG~Vykak-------~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~---HPNIVkL 738 (958)
...++..++|.+.+.||+|+||.||+|. ..++.||||++.... ..++.+|+++++.++ |+||+++
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~ 132 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKF 132 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhh
Confidence 3455677889999999999999999993 268899999986542 346778888999886 8999999
Q ss_pred eccccCCCceEEEEeecCCCCHHHHHhC----CCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcC---
Q 002160 739 MGAVTRPPNLSIITEFLPRGSLFRILHR----PHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDK--- 810 (958)
Q Consensus 739 ~g~~~~~~~l~LVmEy~~gGsL~d~L~k----~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~--- 810 (958)
++++...+..||||||+++|+|.+++.. ....+.+...+.++ +++.||+|||.++ ||||||||+||||+.
T Consensus 133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~~ 210 (365)
T 3e7e_A 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFL 210 (365)
T ss_dssp EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGGT
T ss_pred heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEeccccc
Confidence 9999999999999999999999999963 23344555455444 4499999999988 999999999999998
Q ss_pred --------CCcEEEEecccccccc--CCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q 002160 811 --------NWNVKVSDFGLSRLKH--NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP 880 (958)
Q Consensus 811 --------~g~VKL~DFGLAk~~~--~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~ 880 (958)
++.+||+|||+++... .........+||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 8999999999997643 222234557899999999999999999999999999999999999999965432
Q ss_pred hHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCC-CCHHHHHHHHHhhhhhcCC
Q 002160 881 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLR-PSFAQLTVALKPLQRLVIP 938 (958)
Q Consensus 881 ~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kR-PSa~EIL~~L~kL~k~~~p 938 (958)
.... + . ...-....+..+.+++..||+.+|.+| |++.++.+.|+++.....+
T Consensus 291 ~~~~--~--~--~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~~ 343 (365)
T 3e7e_A 291 GECK--P--E--GLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343 (365)
T ss_dssp TEEE--E--C--SCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHTT
T ss_pred Ccee--e--c--hhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhhh
Confidence 2110 0 0 010112347889999999999999999 6899999999888665443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=363.30 Aligned_cols=251 Identities=24% Similarity=0.326 Sum_probs=197.8
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC------
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR------ 744 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~------ 744 (958)
...++|++++.||+|+||.||+|++ +++.||||++...... ..+|+++|+.++|||||+++++|..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 4457899999999999999999987 7899999998754322 2379999999999999999999843
Q ss_pred --------------------------------CCceEEEEeecCCCCHHHHHh----CCCCCccHHHHHHHHHHHHHHHH
Q 002160 745 --------------------------------PPNLSIITEFLPRGSLFRILH----RPHCQVDEKRRIKMALDARGMNC 788 (958)
Q Consensus 745 --------------------------------~~~l~LVmEy~~gGsL~d~L~----k~~~~~~e~~~l~ia~~a~aL~y 788 (958)
...+++||||++ ++|.+.+. ..........+.++.+++.||.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 334889999997 47776654 33334444445555566999999
Q ss_pred HHhcCCcEeecCCCCCceEEc-CCCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHH
Q 002160 789 LHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILW 866 (958)
Q Consensus 789 LH~~g~gIIHRDLKPeNILId-~~g~VKL~DFGLAk~~~~~~~~~~s~~GT~~Y~APEvl~g~~-~s~ksDIWSLGiLLy 866 (958)
||.++ |+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|
T Consensus 157 LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 157 IHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp HHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred HHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 99988 99999999999998 68999999999998764432 334567899999999998754 899999999999999
Q ss_pred HHHhCCCCCCCCChhHHHHhhhcc---------------------------ccccCCCCCCcHHHHHHHHHhhhcCCCCC
Q 002160 867 ELATLKLPWIGMNPMQVVGAVGFQ---------------------------NRRLEIPKELDPLVARIIWECWQTDPSLR 919 (958)
Q Consensus 867 ELLtG~~PF~g~~~~ei~~~i~~~---------------------------~~~~~ip~~ls~eL~dLI~~CL~kDP~kR 919 (958)
+|++|+.||.+.+..+....+... .....++..+++++++||.+||+.||.+|
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 999999999988776555443210 00112455688999999999999999999
Q ss_pred CCHHHHHHH--HHhhh
Q 002160 920 PSFAQLTVA--LKPLQ 933 (958)
Q Consensus 920 PSa~EIL~~--L~kL~ 933 (958)
|++.|+++| ++.+.
T Consensus 314 ~t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 314 INPYEAMAHPFFDHLR 329 (383)
T ss_dssp CCHHHHHTSGGGHHHH
T ss_pred CCHHHHhcCHHHHHHH
Confidence 999999865 44443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=370.53 Aligned_cols=249 Identities=23% Similarity=0.366 Sum_probs=192.8
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCC------HHHHHHHHHHHHHHHHcCCCceeEEeccccCCC
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS------GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~------~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~ 746 (958)
.++|.+.+.||+|+||.||+|.+ +++.||||++...... ......+.+|+.+|++++|||||++++++.. .
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 36899999999999999999987 6789999998765321 1123357899999999999999999999864 5
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCC---CcEEEEeccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKN---WNVKVSDFGLSR 823 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~---g~VKL~DFGLAk 823 (958)
.+|+||||+++|+|.+++...........+..+.+.+.||.|||.++ |+||||||+||||+.+ +.+||+|||+++
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeecccce
Confidence 58999999999999999887665555555555666699999999998 9999999999999754 459999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhH-HHHhhhccccc---cCC
Q 002160 824 LKHNTFLSSKSTAGTPEWMAPEVLRN---EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVGFQNRR---LEI 896 (958)
Q Consensus 824 ~~~~~~~~~~s~~GT~~Y~APEvl~g---~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~e-i~~~i~~~~~~---~~i 896 (958)
..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+..... ....+. .... ...
T Consensus 291 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~-~~~~~~~~~~ 368 (419)
T 3i6u_A 291 ILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SGKYNFIPEV 368 (419)
T ss_dssp SCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHH-TTCCCCCHHH
T ss_pred ecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHh-cCCCCCCchh
Confidence 76543 22345779999999999864 567889999999999999999999998754432 222221 1111 112
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 897 PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 897 p~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
...+++.+.+||.+||+.||.+||++.|+++|
T Consensus 369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 24689999999999999999999999999875
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=351.33 Aligned_cols=256 Identities=29% Similarity=0.431 Sum_probs=187.3
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~ 747 (958)
.+.+..++|++.+.||+|+||.||+|++ +++.||||++..... .....++.+|+.++++++||||+++++++...+.
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 3567788999999999999999999976 788999998765432 2335678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhC-------CCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEec
Q 002160 748 LSIITEFLPRGSLFRILHR-------PHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 819 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k-------~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DF 819 (958)
.++||||+++++|.+++.. ......+.....++ +.+.||.|||.++ |+||||||+|||++.++.+||+||
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~df 165 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADF 165 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECCC
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCCCCEEEEec
Confidence 9999999999999999863 22334444444444 4499999999998 999999999999999999999999
Q ss_pred cccccccCCc-----ccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc-
Q 002160 820 GLSRLKHNTF-----LSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR- 892 (958)
Q Consensus 820 GLAk~~~~~~-----~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~- 892 (958)
|++....... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+..........
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 245 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP 245 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC
Confidence 9987653221 11234579999999999976 5688999999999999999999999988776655433321111
Q ss_pred -------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 893 -------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 893 -------~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.......++.++.+||.+||+.||.+||++.+|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 112335678999999999999999999999999874
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=348.14 Aligned_cols=249 Identities=29% Similarity=0.443 Sum_probs=207.6
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
++|++.+.||+|+||.||+|++ +++.||||++............+.+|++++++++||||+++++++.....+++|||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 5799999999999999999987 68899999987655444456678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCC---CcEEEEeccccccccCCcc
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKN---WNVKVSDFGLSRLKHNTFL 830 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~---g~VKL~DFGLAk~~~~~~~ 830 (958)
|+++++|.+++.+............+.+.+.||.|||.++ |+||||||+||||+.+ +.+||+|||++.......
T Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~- 178 (287)
T 2wei_A 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT- 178 (287)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS-
T ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcceeecCCC-
Confidence 9999999998876544444444444455599999999998 9999999999999754 479999999998654332
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCC--CCCcHHHHHHH
Q 002160 831 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARII 908 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip--~~ls~eL~dLI 908 (958)
......||+.|+|||++.+. ++.++||||||+++|+|++|..||.+.+..+....+.........+ ..++.++.+||
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 257 (287)
T 2wei_A 179 KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLI 257 (287)
T ss_dssp SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHH
T ss_pred ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHH
Confidence 22334588899999999875 8899999999999999999999999988877766664333222222 46899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 002160 909 WECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 909 ~~CL~kDP~kRPSa~EIL~~ 928 (958)
.+||+.||.+||++.+++++
T Consensus 258 ~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 258 RKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHHTCSSGGGSCCHHHHHHS
T ss_pred HHHcccChhhCcCHHHHhcC
Confidence 99999999999999999985
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=352.21 Aligned_cols=249 Identities=23% Similarity=0.353 Sum_probs=195.4
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCC------HHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS------GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~------~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~ 747 (958)
++|++.+.||+|+||.||+|++ +++.||||++...... ......+.+|+++|++++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 5799999999999999999987 5789999998765321 122345889999999999999999999987654
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCc---EEEEecccccc
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRL 824 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~---VKL~DFGLAk~ 824 (958)
+|+||||+++++|.+++..............+.+++.||.|||.++ |+||||||+||||+.++. +||+|||+++.
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 8999999999999999987655555555555556699999999998 999999999999987654 99999999987
Q ss_pred ccCCcccCCCCCCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh-HHHHhhhccc--cccCCCC
Q 002160 825 KHNTFLSSKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQN--RRLEIPK 898 (958)
Q Consensus 825 ~~~~~~~~~s~~GT~~Y~APEvl~---g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~-ei~~~i~~~~--~~~~ip~ 898 (958)
..... ......||+.|+|||++. +..++.++|||||||++|+|++|..||...... .+...+.... .....+.
T Consensus 167 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (322)
T 2ycf_A 167 LGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245 (322)
T ss_dssp CCCCH-HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHT
T ss_pred ccccc-ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhh
Confidence 64331 122356899999999974 466889999999999999999999999765433 2222221111 1112234
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 899 ELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 899 ~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.++..+.+||.+||..||.+||++.+++++
T Consensus 246 ~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 246 EVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 688999999999999999999999999853
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=348.53 Aligned_cols=255 Identities=20% Similarity=0.278 Sum_probs=206.6
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEE-CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC--CCceeEEeccccCCCc
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR--HPNVVLFMGAVTRPPN 747 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~--HPNIVkL~g~~~~~~~ 747 (958)
..+..++|++++.||+|+||.||++++ +++.||||++............+.+|+.++++++ ||||+++++++.....
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 455667899999999999999999987 5788999999877767777788999999999996 5999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
+++||| +.+++|.+++.+............+.+.+.||.|||.++ |+||||||+|||+++ +.+||+|||+++....
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD-GMLKLIDFGIANQMQP 178 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred EEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence 999999 558899999987655444455555555699999999998 999999999999964 8999999999987543
Q ss_pred Ccc--cCCCCCCCCCccCcccccC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHhhhccccc
Q 002160 828 TFL--SSKSTAGTPEWMAPEVLRN-----------EPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNRR 893 (958)
Q Consensus 828 ~~~--~~~s~~GT~~Y~APEvl~g-----------~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~-~ei~~~i~~~~~~ 893 (958)
... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||..... ......+......
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 258 (313)
T 3cek_A 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 258 (313)
T ss_dssp -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccc
Confidence 221 1234569999999999976 4678899999999999999999999987543 2333333334445
Q ss_pred cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002160 894 LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 894 ~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L 929 (958)
..++...+.++.+||.+||+.||.+||++.+++++-
T Consensus 259 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 259 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 567778899999999999999999999999999864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=358.48 Aligned_cols=254 Identities=16% Similarity=0.163 Sum_probs=200.9
Q ss_pred CCCCeeEEEEeeccCceEEEEEEEC----------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeE------
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADWN----------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL------ 737 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~~----------g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVk------ 737 (958)
..++|++.+.||+|+||.||+|++. ++.||||++... ..+.+|++++++++|||||+
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 4578999999999999999999873 678999998754 25779999999999999998
Q ss_pred ---------EeccccC-CCceEEEEeecCCCCHHHHHhCC-CCCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCc
Q 002160 738 ---------FMGAVTR-PPNLSIITEFLPRGSLFRILHRP-HCQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPN 805 (958)
Q Consensus 738 ---------L~g~~~~-~~~l~LVmEy~~gGsL~d~L~k~-~~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeN 805 (958)
+++++.. ...+||||||+ +++|.+++... ...+.+...+. +.+.+.||.|||.++ |+||||||+|
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~N 189 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAEN 189 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGGG
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHH
Confidence 4555544 67789999999 99999999865 22344444444 444599999999998 9999999999
Q ss_pred eEEcCCC--cEEEEeccccccccCCcc-------cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 002160 806 LLVDKNW--NVKVSDFGLSRLKHNTFL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI 876 (958)
Q Consensus 806 ILId~~g--~VKL~DFGLAk~~~~~~~-------~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~ 876 (958)
||++.++ .+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 999999999986543211 1234579999999999999999999999999999999999999998
Q ss_pred CCC--hhHHHHhhh-ccccccCCC------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhcC
Q 002160 877 GMN--PMQVVGAVG-FQNRRLEIP------KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVI 937 (958)
Q Consensus 877 g~~--~~ei~~~i~-~~~~~~~ip------~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~~ 937 (958)
+.. ...+..... +......++ ..+++++.+||.+||..||.+||++.+|++.|+++.+..-
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 270 NCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp GGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 764 222222211 111111111 2568999999999999999999999999999999976643
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=349.32 Aligned_cols=249 Identities=29% Similarity=0.370 Sum_probs=199.9
Q ss_pred CCeeEEEEeeccCceEEEEEEE---CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc---CCCceeEEecccc-----C
Q 002160 676 EDLVLGERIGLGSYGEVYHADW---NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL---RHPNVVLFMGAVT-----R 744 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~---~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L---~HPNIVkL~g~~~-----~ 744 (958)
++|++.+.||+|+||.||+|++ +++.||||++............+.+|+.+++.+ +||||+++++++. .
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 90 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 90 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence 6799999999999999999987 477899999875543322223456777777766 8999999999986 5
Q ss_pred CCceEEEEeecCCCCHHHHHhCCCC-CccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccc
Q 002160 745 PPNLSIITEFLPRGSLFRILHRPHC-QVDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 822 (958)
Q Consensus 745 ~~~l~LVmEy~~gGsL~d~L~k~~~-~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLA 822 (958)
...+++||||++ |+|.+++..... ...+.... .+.+.+.||.|||.++ |+||||||+|||++.++.+||+|||++
T Consensus 91 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 91 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp EEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCCCCEEEecCccc
Confidence 667999999997 699998875432 24444444 4444599999999998 999999999999999999999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccc-----------
Q 002160 823 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN----------- 891 (958)
Q Consensus 823 k~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~----------- 891 (958)
+...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 168 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (326)
T 1blx_A 168 RIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246 (326)
T ss_dssp CCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred ccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccc
Confidence 8664332 2345679999999999999999999999999999999999999999887765554432100
Q ss_pred --------------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 892 --------------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 892 --------------~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
....+...++..+++||.+||..||.+||++.++++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 247 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0112335688999999999999999999999999965
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=363.67 Aligned_cols=246 Identities=25% Similarity=0.339 Sum_probs=185.2
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC------Cc
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP------PN 747 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~------~~ 747 (958)
++|++++.||+|+||.||+|.+ +++.||||++............+.+|+.+|+.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 6899999999999999999976 688999999876655566677889999999999999999999998654 56
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
+|+||||+ +++|.+++... .......+..+.+++.||.|||..+ |+||||||+||||+.++.+||+|||+++....
T Consensus 109 ~~lv~e~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp CEEEEECC-CEECC-----C-CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC---------
T ss_pred EEEEeccc-CCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 89999999 78999988753 3333444444555599999999998 99999999999999999999999999986543
Q ss_pred CcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccc-------------
Q 002160 828 TFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------------- 893 (958)
Q Consensus 828 ~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~------------- 893 (958)
. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 185 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 261 (367)
T 2fst_X 185 E---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261 (367)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHH
T ss_pred c---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 2 234679999999999987 67899999999999999999999999988766554433210000
Q ss_pred --------cC--------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 894 --------LE--------IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 894 --------~~--------ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.. +...+++.+++||.+||..||.+||++.|++.|
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00 112468899999999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=357.48 Aligned_cols=245 Identities=25% Similarity=0.334 Sum_probs=199.6
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCce-----
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL----- 748 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l----- 748 (958)
++|.+.+.||+|+||.||+|.+ +++.||||++............+.+|+.+++.++||||+++++++......
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 6899999999999999999986 688999999987666666678899999999999999999999999877665
Q ss_pred -EEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 749 -SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 749 -~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
|+||||+. ++|.+++... .........+.+.+.||.|||.++ |+||||||+||||+.++.+||+|||+++....
T Consensus 122 ~~lv~e~~~-~~l~~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMGME--FSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp CEEEEECCC-EEHHHHTTSC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred EEEEEcccc-ccHHHHhhcC--CCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 99999996 6888887543 333344444445599999999998 99999999999999999999999999986543
Q ss_pred CcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccc-------------
Q 002160 828 TFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR------------- 893 (958)
Q Consensus 828 ~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~------------- 893 (958)
. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 197 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 273 (371)
T 4exu_A 197 E---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 273 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHH
T ss_pred C---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhh
Confidence 3 234678999999999987 67899999999999999999999999988766554443211000
Q ss_pred ----------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 894 ----------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 894 ----------------~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
..++..+++.+++||.+||+.||.+||++.|++++
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 274 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 01123578999999999999999999999999876
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=368.90 Aligned_cols=258 Identities=23% Similarity=0.356 Sum_probs=204.0
Q ss_pred CCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC--ceE
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP--NLS 749 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~--~l~ 749 (958)
..++|++.+.||+|+||.||+|++ +++.||||++...... .....+.+|+++|++++||||+++++++.... .++
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 346899999999999999999987 4889999998754322 22456789999999999999999999987655 689
Q ss_pred EEEeecCCCCHHHHHhCCCC--CccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEE----cCCCcEEEEecccc
Q 002160 750 IITEFLPRGSLFRILHRPHC--QVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLV----DKNWNVKVSDFGLS 822 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~--~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILI----d~~g~VKL~DFGLA 822 (958)
+||||+++|+|.+++.+... .+.+...+. +.+.+.||.|||.++ |+||||||+|||| +.++.+||+|||++
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 99999999999999976432 144444444 444599999999998 9999999999999 77888999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC----hhHHHHhhhcc
Q 002160 823 RLKHNTFLSSKSTAGTPEWMAPEVLRN--------EPSNEKCDVYSFGVILWELATLKLPWIGMN----PMQVVGAVGFQ 890 (958)
Q Consensus 823 k~~~~~~~~~~s~~GT~~Y~APEvl~g--------~~~s~ksDIWSLGiLLyELLtG~~PF~g~~----~~ei~~~i~~~ 890 (958)
+...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+....+...
T Consensus 164 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 164 RELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp EECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred eEccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 8765432 2345679999999999875 456789999999999999999999997532 22333222211
Q ss_pred cc-------------------c----cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 891 NR-------------------R----LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 891 ~~-------------------~----~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
.. . ..++..++..+.+||.+||+.||.+||++.++++.|..+...
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 10 0 011233567899999999999999999999999999988654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=346.49 Aligned_cols=242 Identities=21% Similarity=0.315 Sum_probs=194.8
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeccccC--CCceEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTR--PPNLSI 750 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~-HPNIVkL~g~~~~--~~~l~L 750 (958)
++|++++.||+|+||.||+|++ +++.||||++.... ...+.+|+.+|++++ ||||+++++++.. ....++
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 6899999999999999999976 78899999986432 356889999999997 9999999999987 567899
Q ss_pred EEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCC-cEEEEeccccccccCCc
Q 002160 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 751 VmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g-~VKL~DFGLAk~~~~~~ 829 (958)
||||+++++|.+++.. ......+..+.+.+.||.|||.++ |+||||||+||||+.++ .+||+|||+++......
T Consensus 111 v~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp EEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred EEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 9999999999998864 333444445555599999999998 99999999999999766 89999999998764432
Q ss_pred ccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hhHHHHhhhc-------------cc---
Q 002160 830 LSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGF-------------QN--- 891 (958)
Q Consensus 830 ~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~-~~ei~~~i~~-------------~~--- 891 (958)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ..+....+.. ..
T Consensus 186 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 264 (330)
T 3nsz_A 186 -EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264 (330)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred -ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence 2345678999999999987 668999999999999999999999995432 2211111100 00
Q ss_pred -------------------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 892 -------------------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 892 -------------------~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.....+..+++++++||.+||+.||.+||+++|+++|
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0011122378999999999999999999999999875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=346.94 Aligned_cols=255 Identities=22% Similarity=0.345 Sum_probs=188.0
Q ss_pred cccccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC
Q 002160 669 CECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (958)
Q Consensus 669 ~~~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~ 746 (958)
..+.+..++|++++.||+|+||.||+|++ +++.||||++............+..+..+++.++||||+++++++...+
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 97 (318)
T 2dyl_A 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT 97 (318)
T ss_dssp SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence 45667778999999999999999999987 5889999999876544444444555666788889999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhc-CCcEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~-g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
.+++||||+ ++.+..+.......+.+.....++ +.+.||.|||.. + |+||||||+|||++.++++||+|||++..
T Consensus 98 ~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp EEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred cEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 999999999 566666655433344444444444 449999999984 7 99999999999999999999999999976
Q ss_pred ccCCcccCCCCCCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hhHHHHhhhccccccCCC-
Q 002160 825 KHNTFLSSKSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMN-PMQVVGAVGFQNRRLEIP- 897 (958)
Q Consensus 825 ~~~~~~~~~s~~GT~~Y~APEvl~-----g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~-~~ei~~~i~~~~~~~~ip- 897 (958)
..... ......||+.|+|||++. +..++.++|||||||++|+|++|+.||.... ..+....+. ......++
T Consensus 175 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~ 252 (318)
T 2dyl_A 175 LVDDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL-QEEPPLLPG 252 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH-HSCCCCCCS
T ss_pred ccCCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHh-ccCCCCCCc
Confidence 54332 223457999999999994 5567899999999999999999999998743 334443332 22233333
Q ss_pred -CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 898 -KELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 898 -~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
..+++++.+||.+||+.||.+||++.+|+++
T Consensus 253 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 253 HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 4589999999999999999999999999875
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=354.50 Aligned_cols=248 Identities=23% Similarity=0.330 Sum_probs=200.3
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC-----Cce
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-----PNL 748 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~-----~~l 748 (958)
.+|++++.||+|+||.||+|++ +++.||||++.... .......+.+|+++|++++||||+++++++... ..+
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 5799999999999999999986 68889999987533 344567889999999999999999999998655 368
Q ss_pred EEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
|+||||++ ++|.+++.... .........+.+.+.||.|||.++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 106 ~iv~e~~~-~~L~~~l~~~~-~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQH-LSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp EEEEECCS-EEHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEcccC-cCHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 99999996 59999887643 333444444555599999999998 999999999999999999999999999875432
Q ss_pred cc---cCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccc-----------
Q 002160 829 FL---SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR----------- 893 (958)
Q Consensus 829 ~~---~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~----------- 893 (958)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 261 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 21 1244679999999998764 55899999999999999999999999988766554443210000
Q ss_pred ------------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 894 ------------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 894 ------------------~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
..+...+++++.+||.+||+.||.+||++.|+++|
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 01124578999999999999999999999999975
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=384.90 Aligned_cols=261 Identities=30% Similarity=0.504 Sum_probs=217.1
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEEC-----CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~~-----g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~ 744 (958)
.+++..++|++++.||+|+||.||+|++. +..||||++... ........+.+|+.+|++++|||||++++++.
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 34566788999999999999999999873 356999987643 24455678999999999999999999999985
Q ss_pred CCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccc
Q 002160 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 823 (958)
Q Consensus 745 ~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk 823 (958)
.+.+|+||||+++|+|.+++........+...+.++ +.+.||.|||.++ |+||||||+|||++.++++||+|||+++
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCCCCEEEEecCCCe
Confidence 457899999999999999998665555555555544 4499999999998 9999999999999999999999999998
Q ss_pred cccCCcc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCc
Q 002160 824 LKHNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 901 (958)
Q Consensus 824 ~~~~~~~-~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls 901 (958)
....... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+. ...+..++..++
T Consensus 540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~~ 618 (656)
T 2j0j_A 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCP 618 (656)
T ss_dssp SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-HTCCCCCCTTCC
T ss_pred ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCCCCCCcccc
Confidence 7644321 2223457789999999999999999999999999999997 999999988887776664 344566788899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 902 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 902 ~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
+.+.+||.+||..||.+||++.+|++.|+.+.+.
T Consensus 619 ~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 619 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999998543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=365.04 Aligned_cols=243 Identities=23% Similarity=0.287 Sum_probs=191.1
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC------CCc
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR------PPN 747 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~------~~~ 747 (958)
.+|++++.||+|+||.||+|++ +++.||||++..... .+.+|+++|++++|||||+++++|.. ...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 4699999999999999999988 588999999865432 23479999999999999999998843 223
Q ss_pred eEEEEeecCCCCHHHHHh----CCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCC-CcEEEEecccc
Q 002160 748 LSIITEFLPRGSLFRILH----RPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLS 822 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~----k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~-g~VKL~DFGLA 822 (958)
+++||||+++ +|.+++. ..........+.++.+++.||.|||.++ |+||||||+||||+.+ +.+||+|||++
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 6799999975 5665543 2233333444455556699999999988 9999999999999954 67899999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccc----------
Q 002160 823 RLKHNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN---------- 891 (958)
Q Consensus 823 k~~~~~~~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~---------- 891 (958)
+...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+....
T Consensus 205 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 205 KQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp EECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred hhcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 8764332 23456799999999999775 68999999999999999999999999887655443332100
Q ss_pred -----cccC------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 892 -----RRLE------------IPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 892 -----~~~~------------ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.... ++..+++++++||.+||..||.+||++.|+++|
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0111 234578999999999999999999999999875
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=351.02 Aligned_cols=245 Identities=25% Similarity=0.340 Sum_probs=198.4
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc------
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN------ 747 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~------ 747 (958)
++|.+.+.||+|+||.||+|++ +++.||||++............+.+|+.+|++++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 6799999999999999999987 68899999997766566667789999999999999999999999987654
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
+|+||||++ ++|.+++... .........+.+++.||.|||.++ |+||||||+|||++.++.+||+|||+++....
T Consensus 104 ~~lv~e~~~-~~l~~~~~~~--~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGLK--FSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CEEEEECCS-EEGGGTTTSC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred EEEEecccc-CCHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 499999997 5888877542 333334444445599999999998 99999999999999999999999999986543
Q ss_pred CcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcc----------------
Q 002160 828 TFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ---------------- 890 (958)
Q Consensus 828 ~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~---------------- 890 (958)
. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 179 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 255 (353)
T 3coi_A 179 E---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred C---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence 2 234678999999999987 67899999999999999999999999987765544332110
Q ss_pred ----------ccc---cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 891 ----------NRR---LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 891 ----------~~~---~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
... ..+...+++++++||.+||+.||.+||++.++++|
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 001 12234678999999999999999999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=350.77 Aligned_cols=254 Identities=27% Similarity=0.421 Sum_probs=180.3
Q ss_pred cccccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHH-HHHHcCCCceeEEeccccCC
Q 002160 669 CECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVK-IMRRLRHPNVVLFMGAVTRP 745 (958)
Q Consensus 669 ~~~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~-ILk~L~HPNIVkL~g~~~~~ 745 (958)
..+.+..++|++++.||+|+||.||+|++ +++.||||++.... ......++..|+. +++.++||||+++++++...
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~ 93 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE 93 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC
Confidence 45667889999999999999999999987 48899999987654 3334455666666 66677999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhC----CCCCccHHHHHH-HHHHHHHHHHHHhc-CCcEeecCCCCCceEEcCCCcEEEEec
Q 002160 746 PNLSIITEFLPRGSLFRILHR----PHCQVDEKRRIK-MALDARGMNCLHTS-TPTIVHRDLKSPNLLVDKNWNVKVSDF 819 (958)
Q Consensus 746 ~~l~LVmEy~~gGsL~d~L~k----~~~~~~e~~~l~-ia~~a~aL~yLH~~-g~gIIHRDLKPeNILId~~g~VKL~DF 819 (958)
+..++||||+++ +|.+++.. ......+..... +.+.+.||.|||.. + |+||||||+||||+.++.+||+||
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~~~~kl~Df 170 (327)
T 3aln_A 94 GDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDF 170 (327)
T ss_dssp SEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETTTEEEECCC
T ss_pred CceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCCCCEEEccC
Confidence 999999999975 78777652 223344444444 44449999999998 8 999999999999999999999999
Q ss_pred cccccccCCcccCCCCCCCCCccCcccc----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh-HHHHhhhcccccc
Q 002160 820 GLSRLKHNTFLSSKSTAGTPEWMAPEVL----RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRL 894 (958)
Q Consensus 820 GLAk~~~~~~~~~~s~~GT~~Y~APEvl----~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~-ei~~~i~~~~~~~ 894 (958)
|+++...... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||.+.... +....+ ......
T Consensus 171 g~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~ 248 (327)
T 3aln_A 171 GISGQLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-VKGDPP 248 (327)
T ss_dssp SSSCC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCC-CCSCCC
T ss_pred CCceeccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH-hcCCCC
Confidence 9998764432 22334799999999999 4666899999999999999999999999875432 222222 122222
Q ss_pred CCC----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 895 EIP----KELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 895 ~ip----~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.++ ..+++.+.+||.+||+.||.+||++.+|+++
T Consensus 249 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 249 QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 222 3589999999999999999999999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=353.63 Aligned_cols=252 Identities=20% Similarity=0.278 Sum_probs=194.9
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE-CCcEEEEEEeecCCC---------CHHHHHHHHHHHHHHHHcCCCceeEEeccc
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDF---------SGAALLEFKREVKIMRRLRHPNVVLFMGAV 742 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~---------~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~ 742 (958)
...++|++++.||+|+||.||+|.+ +++.||||++..... .......+.+|+++|++++||||+++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 3457899999999999999999976 688999998865332 223346889999999999999999999998
Q ss_pred c-----CCCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEE
Q 002160 743 T-----RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKV 816 (958)
Q Consensus 743 ~-----~~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL 816 (958)
. ....+|+||||++ |+|.+++........+.....++ +.+.||.|||.++ |+||||||+||||+.++.+||
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp EECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEE
T ss_pred EeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEcCCCCEEE
Confidence 3 3446899999997 68888887665555555555444 4599999999998 999999999999999999999
Q ss_pred EeccccccccCCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc---
Q 002160 817 SDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--- 892 (958)
Q Consensus 817 ~DFGLAk~~~~~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~--- 892 (958)
+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 176 ~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 254 (362)
T 3pg1_A 176 CDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254 (362)
T ss_dssp CCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred EecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 999999764433 22344678999999999987 6789999999999999999999999998876655444321100
Q ss_pred -------------------c--------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 893 -------------------R--------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 893 -------------------~--------~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
. ..++..+++.+.+||.+||+.||.+||++.|+++|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 0 01123568899999999999999999999999875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=348.62 Aligned_cols=249 Identities=26% Similarity=0.339 Sum_probs=197.6
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC-----Cc
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-----PN 747 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~-----~~ 747 (958)
.++|++.+.||+|+||.||+|++ +++.||||++.... .......+.+|+++|++++||||+++++++... ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 36899999999999999999987 48899999986432 344566788999999999999999999987654 67
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
.++||||+. ++|.+++... ..........+.+.+.||.|||.++ |+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQ-MLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EEEEEeccC-ccHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 999999996 6899988763 2333334444445599999999998 99999999999999999999999999987543
Q ss_pred Ccc----------cCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc----
Q 002160 828 TFL----------SSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR---- 892 (958)
Q Consensus 828 ~~~----------~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~---- 892 (958)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCS
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCch
Confidence 211 1223578999999998765 6789999999999999999999999998775544332210000
Q ss_pred ------------------c--------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 893 ------------------R--------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 893 ------------------~--------~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
. ......+++++++||.+||+.||.+||++.|+++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 01123678999999999999999999999999875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=343.68 Aligned_cols=248 Identities=22% Similarity=0.306 Sum_probs=193.3
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEecccc---------
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVT--------- 743 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~--------- 743 (958)
.++|++++.||+|+||.||+|++ +++.||||++... ......++.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 36899999999999999999987 4889999998754 3455678899999999999999999998863
Q ss_pred -----CCCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEc-CCCcEEEE
Q 002160 744 -----RPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVS 817 (958)
Q Consensus 744 -----~~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId-~~g~VKL~ 817 (958)
....+|+||||++ |+|.+++.+. .......+..+.+.+.||.|||.++ |+||||||+|||++ +++.+||+
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQG-PLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccccCceeEEeeccC-CCHHHHhhcC-CccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeEEEc
Confidence 4467899999997 6999998753 3333444444455599999999998 99999999999997 57799999
Q ss_pred eccccccccCCc---ccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc-
Q 002160 818 DFGLSRLKHNTF---LSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR- 892 (958)
Q Consensus 818 DFGLAk~~~~~~---~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~- 892 (958)
|||+++...... .......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 243 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999998754321 12233457999999999875 6789999999999999999999999998876655444321100
Q ss_pred ---------------------------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 893 ---------------------------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 893 ---------------------------~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
...++..++.++++||.+||+.||.+||++.++++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 001224689999999999999999999999999885
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=356.05 Aligned_cols=246 Identities=18% Similarity=0.203 Sum_probs=192.5
Q ss_pred CCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC--------CCceeEEecccc
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR--------HPNVVLFMGAVT 743 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~--------HPNIVkL~g~~~ 743 (958)
..++|++.+.||+|+||.||+|++ +++.||||++... ......+.+|+.+|++++ |+||+++++++.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 347899999999999999999986 6889999998643 344567889999999995 788999999987
Q ss_pred ----CCCceEEEEeecCCCCHHHHHh-CCCCCccHH-HHHHHHHHHHHHHHHHhc-CCcEeecCCCCCceEEcCCC----
Q 002160 744 ----RPPNLSIITEFLPRGSLFRILH-RPHCQVDEK-RRIKMALDARGMNCLHTS-TPTIVHRDLKSPNLLVDKNW---- 812 (958)
Q Consensus 744 ----~~~~l~LVmEy~~gGsL~d~L~-k~~~~~~e~-~~l~ia~~a~aL~yLH~~-g~gIIHRDLKPeNILId~~g---- 812 (958)
....++|||||+ +++|.+++. .....+.+. .+.++.+++.||.|||.+ + |+||||||+||||+.++
T Consensus 112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 112 ISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp EEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECCCHHHHH
T ss_pred ecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEeccchhhh
Confidence 566799999999 556665554 332334444 444445559999999997 7 99999999999999775
Q ss_pred ---------------------------------------------cEEEEeccccccccCCcccCCCCCCCCCccCcccc
Q 002160 813 ---------------------------------------------NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL 847 (958)
Q Consensus 813 ---------------------------------------------~VKL~DFGLAk~~~~~~~~~~s~~GT~~Y~APEvl 847 (958)
.+||+|||+++..... .....||+.|+|||++
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhh
Confidence 7999999999876443 2346799999999999
Q ss_pred cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh------HHHHhhhc-cc-----------------------------
Q 002160 848 RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM------QVVGAVGF-QN----------------------------- 891 (958)
Q Consensus 848 ~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~------ei~~~i~~-~~----------------------------- 891 (958)
.+..++.++|||||||++|+|++|+.||.+.+.. .....+.. ..
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 9999999999999999999999999999865421 11111100 00
Q ss_pred ----------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 892 ----------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 892 ----------~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
....++...+..+++||.+||+.||.+||++.||++|
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0011223345778999999999999999999999875
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=372.15 Aligned_cols=253 Identities=21% Similarity=0.267 Sum_probs=205.9
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCC-CceeEEeccccCCCceEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH-PNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~H-PNIVkL~g~~~~~~~l~LV 751 (958)
.++|+++++||+|+||.||+|++ +++.||||++....... ++.+|+++++.|+| ++|+.+..++...+..+||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC----CHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH----HHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 46899999999999999999986 58999999877654332 47789999999976 6677777777788889999
Q ss_pred EeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEE---cCCCcEEEEeccccccccC
Q 002160 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLV---DKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILI---d~~g~VKL~DFGLAk~~~~ 827 (958)
|||+ +++|.+++......+.+...+.++.+ +.||.|||.++ ||||||||+|||| +.++.+||+|||+++....
T Consensus 82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 9999 99999999854445555555555544 99999999998 9999999999999 5889999999999987644
Q ss_pred Ccc-------cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh---HHHHhhhc---ccccc
Q 002160 828 TFL-------SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGF---QNRRL 894 (958)
Q Consensus 828 ~~~-------~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~---ei~~~i~~---~~~~~ 894 (958)
... ......||+.|+|||++.+..++.++|||||||+||||++|+.||.+.... +.+..+.. .....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 321 223567999999999999999999999999999999999999999875542 22222211 11122
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhh
Q 002160 895 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934 (958)
Q Consensus 895 ~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k 934 (958)
.++..++.++.+||.+||+.||.+||++.+|++.|+.+..
T Consensus 239 ~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 3346789999999999999999999999999999998844
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=344.67 Aligned_cols=247 Identities=19% Similarity=0.235 Sum_probs=199.5
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE---CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCC------ceeEEecccc
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW---NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP------NVVLFMGAVT 743 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~---~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HP------NIVkL~g~~~ 743 (958)
+..++|++.+.||+|+||.||+|.+ +++.||||++... ......+.+|+++++.++|+ +|+++++++.
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 4457899999999999999999976 5788999998643 34456788999999999765 4999999999
Q ss_pred CCCceEEEEeecCCCCHHHHHhCCCC-CccHHHH-HHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcC-----------
Q 002160 744 RPPNLSIITEFLPRGSLFRILHRPHC-QVDEKRR-IKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDK----------- 810 (958)
Q Consensus 744 ~~~~l~LVmEy~~gGsL~d~L~k~~~-~~~e~~~-l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~----------- 810 (958)
..+.+++||||+ +++|.+++..... .+.+... ..+.+.+.||.|||.++ |+||||||+||||+.
T Consensus 88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC---
T ss_pred cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCCcc
Confidence 999999999999 8899999876542 3344444 44445599999999998 999999999999987
Q ss_pred --------CCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhH
Q 002160 811 --------NWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ 882 (958)
Q Consensus 811 --------~g~VKL~DFGLAk~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~e 882 (958)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||...+..+
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 678999999999865432 234679999999999999999999999999999999999999999877655
Q ss_pred HHHhhhcccc------------------------------------------ccCCCCCCcHHHHHHHHHhhhcCCCCCC
Q 002160 883 VVGAVGFQNR------------------------------------------RLEIPKELDPLVARIIWECWQTDPSLRP 920 (958)
Q Consensus 883 i~~~i~~~~~------------------------------------------~~~ip~~ls~eL~dLI~~CL~kDP~kRP 920 (958)
....+..... ....+...++.+.+||.+||+.||.+||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 4333211000 0011123467899999999999999999
Q ss_pred CHHHHHHH
Q 002160 921 SFAQLTVA 928 (958)
Q Consensus 921 Sa~EIL~~ 928 (958)
++.|++++
T Consensus 322 t~~ell~h 329 (339)
T 1z57_A 322 TLREALKH 329 (339)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999876
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=361.34 Aligned_cols=245 Identities=23% Similarity=0.244 Sum_probs=198.9
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc------CCCceeEEeccccCCC
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL------RHPNVVLFMGAVTRPP 746 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L------~HPNIVkL~g~~~~~~ 746 (958)
..+|++++.||+|+||.||+|++ +++.||||++... ......+.+|+++++.+ +|+||+++++++....
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 35799999999999999999987 5789999998653 33456778899999888 4679999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhCCCC-CccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCc--EEEEecccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHC-QVDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN--VKVSDFGLS 822 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~-~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~--VKL~DFGLA 822 (958)
.+++||||+. ++|.+++..... .+.+.... ++.+++.||.|||.++ ||||||||+||||+.++. +||+|||++
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 9999999995 689988875442 24444444 4444599999999998 999999999999999887 999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccc---------
Q 002160 823 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--------- 893 (958)
Q Consensus 823 k~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~--------- 893 (958)
+..... ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+......
T Consensus 250 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~ 326 (429)
T 3kvw_A 250 CYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDAS 326 (429)
T ss_dssp EETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTB
T ss_pred eecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 765433 23467999999999999999999999999999999999999999988766554333210000
Q ss_pred ------------------------------------------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHH
Q 002160 894 ------------------------------------------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQL 925 (958)
Q Consensus 894 ------------------------------------------------~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EI 925 (958)
..++...++++++||.+||+.||.+||++.|+
T Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~ 406 (429)
T 3kvw_A 327 KRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQA 406 (429)
T ss_dssp TTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred hhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHH
Confidence 00112347889999999999999999999999
Q ss_pred HHH
Q 002160 926 TVA 928 (958)
Q Consensus 926 L~~ 928 (958)
++|
T Consensus 407 L~H 409 (429)
T 3kvw_A 407 LRH 409 (429)
T ss_dssp HTS
T ss_pred hCC
Confidence 875
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=352.19 Aligned_cols=251 Identities=19% Similarity=0.229 Sum_probs=184.0
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc---
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN--- 747 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~--- 747 (958)
...++|++.+.||+|+||.||+|++ +++.||||++....... ..+.+|++.+..++||||++++++|.....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR---NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC---CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc---HHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 3457899999999999999999987 58899999886543222 245677888899999999999999865333
Q ss_pred ----eEEEEeecCCCCHHHHH----hCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcC-CCcEEEEe
Q 002160 748 ----LSIITEFLPRGSLFRIL----HRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSD 818 (958)
Q Consensus 748 ----l~LVmEy~~gGsL~d~L----~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~-~g~VKL~D 818 (958)
+++||||+++ +|.+.+ ..............+.+.+.||.|||.+..+|+||||||+||||+. ++.+||+|
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~D 175 (360)
T 3e3p_A 97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD 175 (360)
T ss_dssp TCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred cceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEee
Confidence 8899999976 444333 2333333344444455558999999943334999999999999996 89999999
Q ss_pred ccccccccCCcccCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc-----
Q 002160 819 FGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR----- 892 (958)
Q Consensus 819 FGLAk~~~~~~~~~~s~~GT~~Y~APEvl~g~~-~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~----- 892 (958)
||+++...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 176 fg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (360)
T 3e3p_A 176 FGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE 254 (360)
T ss_dssp CTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred CCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHH
Confidence 99998765432 234567899999999997654 89999999999999999999999999877655544421100
Q ss_pred -------------------------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 893 -------------------------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 893 -------------------------~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
....+...++++++||.+||+.||.+||++.|+++|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 011223367899999999999999999999999976
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=341.20 Aligned_cols=245 Identities=26% Similarity=0.396 Sum_probs=191.1
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC---------
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--------- 744 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~--------- 744 (958)
++|++++.||+|+||.||+|++ +++.||||++... ......+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 4799999999999999999986 6889999998643 3456788999999999999999999998754
Q ss_pred ----CCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEec
Q 002160 745 ----PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 819 (958)
Q Consensus 745 ----~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DF 819 (958)
...+|+||||+++++|.+++........+...+.++ +.+.||.|||.++ |+||||||+|||++.++.+||+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCCCCEEEeeC
Confidence 356899999999999999998655444444444444 4499999999998 999999999999999999999999
Q ss_pred cccccccCC--------------cccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC-ChhHH
Q 002160 820 GLSRLKHNT--------------FLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGM-NPMQV 883 (958)
Q Consensus 820 GLAk~~~~~--------------~~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~-~~~ei 883 (958)
|+++..... ........||+.|+|||++.+. .++.++|||||||++|+|++ ||... +..+.
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~ 237 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI 237 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence 999865422 1122345689999999999865 68999999999999999998 66432 22333
Q ss_pred HHhhhcc--ccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 884 VGAVGFQ--NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 884 ~~~i~~~--~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
...+... .....++...+..+++||.+||+.||.+||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 3333211 11233455677889999999999999999999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=359.35 Aligned_cols=249 Identities=23% Similarity=0.257 Sum_probs=194.7
Q ss_pred CCCeeEEEEeeccCceEEEEEEE-CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC------c
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------N 747 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~------~ 747 (958)
..+|++++.||+|+||.||+|++ .+..||||++...... ..+|+++|+.++|||||+++++|.... .
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 35799999999999999999988 5566999988654321 237999999999999999999985433 3
Q ss_pred eEEEEeecCCCCHHHHH---hCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEc-CCCcEEEEeccccc
Q 002160 748 LSIITEFLPRGSLFRIL---HRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSR 823 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L---~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId-~~g~VKL~DFGLAk 823 (958)
+++||||++++.+..+. ...........+.++.+++.||.|||.++ |+||||||+||||+ .++.+||+|||+++
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 88999999875443322 22333444445555666699999999998 99999999999999 79999999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccc-----------
Q 002160 824 LKHNTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN----------- 891 (958)
Q Consensus 824 ~~~~~~~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~----------- 891 (958)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....+....
T Consensus 191 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 191 ILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp ECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 764432 23456789999999999775 48999999999999999999999999887665443332100
Q ss_pred ----cc------------cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHhh
Q 002160 892 ----RR------------LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA--LKPL 932 (958)
Q Consensus 892 ----~~------------~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~--L~kL 932 (958)
.. ..++..+++++++||.+||+.||.+||++.|+++| ++.+
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 00 01234578999999999999999999999999986 4444
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=345.14 Aligned_cols=244 Identities=23% Similarity=0.402 Sum_probs=193.9
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCH----HHHHHHHHHHHHHHHc----CCCceeEEeccc
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRL----RHPNVVLFMGAV 742 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~----~~~~~f~~Ei~ILk~L----~HPNIVkL~g~~ 742 (958)
...++|++++.||+|+||.||+|++ +++.||||++....... .....+.+|+.++.++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 3457899999999999999999987 68899999987654322 1233466899999999 899999999999
Q ss_pred cCCCceEEEEee-cCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEc-CCCcEEEEecc
Q 002160 743 TRPPNLSIITEF-LPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFG 820 (958)
Q Consensus 743 ~~~~~l~LVmEy-~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId-~~g~VKL~DFG 820 (958)
...+..++|||| +.+++|.+++.+............+.+.+.||.|||.++ |+||||||+|||++ .++.+||+|||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEECCCS
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEEEEcc
Confidence 999999999999 789999999976554444444444555599999999998 99999999999999 89999999999
Q ss_pred ccccccCCcccCCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCC
Q 002160 821 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKE 899 (958)
Q Consensus 821 LAk~~~~~~~~~~s~~GT~~Y~APEvl~g~~~-s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ 899 (958)
+++...... .....||..|+|||++.+..+ +.++||||||+++|+|++|+.||.... +. ......++..
T Consensus 186 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~------~~~~~~~~~~ 255 (312)
T 2iwi_A 186 SGALLHDEP--YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--EI------LEAELHFPAH 255 (312)
T ss_dssp SCEECCSSC--BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--HH------HHTCCCCCTT
T ss_pred hhhhcccCc--ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--HH------hhhccCCccc
Confidence 998765432 245679999999999987666 458999999999999999999997532 11 1224456778
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 900 LDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 900 ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
++..+++||.+||+.||.+||++.|++++
T Consensus 256 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 256 VSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999999999875
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=350.92 Aligned_cols=249 Identities=22% Similarity=0.221 Sum_probs=197.6
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC-CC-----ceeEEeccccC
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HP-----NVVLFMGAVTR 744 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~-HP-----NIVkL~g~~~~ 744 (958)
...++|++.+.||+|+||.||+|++ +++.||||++... .....++.+|+.+++.++ |+ +|+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 3457899999999999999999987 5788999998643 344567788999999884 55 49999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhCCC-CCccHHHHH-HHHHHHHHHHHHHhcCCcEeecCCCCCceEEc--CCCcEEEEecc
Q 002160 745 PPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRI-KMALDARGMNCLHTSTPTIVHRDLKSPNLLVD--KNWNVKVSDFG 820 (958)
Q Consensus 745 ~~~l~LVmEy~~gGsL~d~L~k~~-~~~~e~~~l-~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId--~~g~VKL~DFG 820 (958)
.+.++|||||++ ++|.+++.... ....+.... .+.+.+.||.|||.+..+||||||||+||||+ .++.+||+|||
T Consensus 128 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 128 RNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred CCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 999999999996 59999887543 234444444 44445999999997655699999999999995 57889999999
Q ss_pred ccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccccc------
Q 002160 821 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL------ 894 (958)
Q Consensus 821 LAk~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~------ 894 (958)
+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+......+
T Consensus 207 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 283 (382)
T 2vx3_A 207 SSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD 283 (382)
T ss_dssp TCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred Cceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 99876433 235679999999999999999999999999999999999999999887766554432110000
Q ss_pred ----------CCCC----------------------------------------------CCcHHHHHHHHHhhhcCCCC
Q 002160 895 ----------EIPK----------------------------------------------ELDPLVARIIWECWQTDPSL 918 (958)
Q Consensus 895 ----------~ip~----------------------------------------------~ls~eL~dLI~~CL~kDP~k 918 (958)
.++. ...+++++||.+||+.||.+
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 363 (382)
T 2vx3_A 284 QAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKT 363 (382)
T ss_dssp TCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTT
T ss_pred hhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhh
Confidence 0000 00147899999999999999
Q ss_pred CCCHHHHHHH
Q 002160 919 RPSFAQLTVA 928 (958)
Q Consensus 919 RPSa~EIL~~ 928 (958)
|||+.|+++|
T Consensus 364 Rpta~e~L~h 373 (382)
T 2vx3_A 364 RIQPYYALQH 373 (382)
T ss_dssp SCCHHHHTTS
T ss_pred CCCHHHHhcC
Confidence 9999999875
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=349.52 Aligned_cols=245 Identities=22% Similarity=0.363 Sum_probs=201.7
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCH----HHHHHHHHHHHHHHHcC--CCceeEEecccc
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRLR--HPNVVLFMGAVT 743 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~----~~~~~f~~Ei~ILk~L~--HPNIVkL~g~~~ 743 (958)
+...++|++++.||+|+||.||+|++ +++.||||++....... .....+.+|+.++++++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34457899999999999999999987 68899999987654322 12235678999999996 599999999999
Q ss_pred CCCceEEEEeecCC-CCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEc-CCCcEEEEeccc
Q 002160 744 RPPNLSIITEFLPR-GSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGL 821 (958)
Q Consensus 744 ~~~~l~LVmEy~~g-GsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId-~~g~VKL~DFGL 821 (958)
..+.+++||||+.+ ++|.+++.+............+.+.+.||.|||..+ |+||||||+||||+ +++.+||+|||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 99999999999976 899999876554444444445555599999999998 99999999999999 789999999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCC
Q 002160 822 SRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKEL 900 (958)
Q Consensus 822 Ak~~~~~~~~~~s~~GT~~Y~APEvl~g~~~-s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~l 900 (958)
++...... .....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||..... .. .....++..+
T Consensus 197 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~------~~~~~~~~~~ 266 (320)
T 3a99_A 197 GALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--II------RGQVFFRQRV 266 (320)
T ss_dssp CEECCSSC--BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--HH------HCCCCCSSCC
T ss_pred cccccccc--ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--hh------cccccccccC
Confidence 98765432 234679999999999987765 6889999999999999999999976421 11 1233456788
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 901 DPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 901 s~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
++++.+||.+||+.||.+||++.+|+++
T Consensus 267 ~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 267 SSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999999999875
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=340.81 Aligned_cols=247 Identities=20% Similarity=0.261 Sum_probs=195.3
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CC-cEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCc------eeEEecccc
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NG-TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN------VVLFMGAVT 743 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g-~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPN------IVkL~g~~~ 743 (958)
+..++|++.+.||+|+||.||+|.+ ++ +.||||++... ......+.+|+.++++++|++ |+.+++++.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 3357899999999999999999987 33 68999998643 344567889999999997655 999999999
Q ss_pred CCCceEEEEeecCCCCHHHHHhCCC-CCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEE-------------
Q 002160 744 RPPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLV------------- 808 (958)
Q Consensus 744 ~~~~l~LVmEy~~gGsL~d~L~k~~-~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILI------------- 808 (958)
..+.++|||||+ +++|.+++.... ..+.+..... +.+++.||.|||.++ |+||||||+||||
T Consensus 93 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 93 FHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecccccccccccc
Confidence 999999999999 566776665433 3344444444 444599999999998 9999999999999
Q ss_pred ------cCCCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhH
Q 002160 809 ------DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ 882 (958)
Q Consensus 809 ------d~~g~VKL~DFGLAk~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~e 882 (958)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 56789999999999865432 234679999999999999999999999999999999999999999877655
Q ss_pred HHHhhhccccc------------------------------------------cCCCCCCcHHHHHHHHHhhhcCCCCCC
Q 002160 883 VVGAVGFQNRR------------------------------------------LEIPKELDPLVARIIWECWQTDPSLRP 920 (958)
Q Consensus 883 i~~~i~~~~~~------------------------------------------~~ip~~ls~eL~dLI~~CL~kDP~kRP 920 (958)
....+...... .......+.++.+||.+||+.||.+||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 43322110000 000112356899999999999999999
Q ss_pred CHHHHHHH
Q 002160 921 SFAQLTVA 928 (958)
Q Consensus 921 Sa~EIL~~ 928 (958)
++.|+++|
T Consensus 327 t~~e~l~h 334 (355)
T 2eu9_A 327 TLAEALLH 334 (355)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999865
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=345.06 Aligned_cols=248 Identities=18% Similarity=0.266 Sum_probs=193.3
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC-----------CCceeEE
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-----------HPNVVLF 738 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~-----------HPNIVkL 738 (958)
.+...+|++++.||+|+||.||+|++ +++.||||++... ......+.+|+.++++++ ||||+++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 34557899999999999999999986 6889999998643 334567889999999886 8999999
Q ss_pred eccccCCC----ceEEEEeecCCCCHHHHHhCCC-CCccHHHHHH-HHHHHHHHHHHHhc-CCcEeecCCCCCceEEc--
Q 002160 739 MGAVTRPP----NLSIITEFLPRGSLFRILHRPH-CQVDEKRRIK-MALDARGMNCLHTS-TPTIVHRDLKSPNLLVD-- 809 (958)
Q Consensus 739 ~g~~~~~~----~l~LVmEy~~gGsL~d~L~k~~-~~~~e~~~l~-ia~~a~aL~yLH~~-g~gIIHRDLKPeNILId-- 809 (958)
++++...+ .+++||||+ +++|.+++.+.. ....+..... +.+++.||.|||.+ + |+||||||+||||+
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIV 168 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEE
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEecc
Confidence 99987654 689999999 899999987532 2344444444 44459999999997 8 99999999999994
Q ss_pred ----CCCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh----
Q 002160 810 ----KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---- 881 (958)
Q Consensus 810 ----~~g~VKL~DFGLAk~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~---- 881 (958)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred CCCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 4458999999999876443 23457999999999999999999999999999999999999999865421
Q ss_pred --HHHHhhhc----------------------------------------cccccCCCCCCcHHHHHHHHHhhhcCCCCC
Q 002160 882 --QVVGAVGF----------------------------------------QNRRLEIPKELDPLVARIIWECWQTDPSLR 919 (958)
Q Consensus 882 --ei~~~i~~----------------------------------------~~~~~~ip~~ls~eL~dLI~~CL~kDP~kR 919 (958)
.....+.. ......++..++.++++||.+||+.||.+|
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 11111100 001122344567889999999999999999
Q ss_pred CCHHHHHHH
Q 002160 920 PSFAQLTVA 928 (958)
Q Consensus 920 PSa~EIL~~ 928 (958)
|++.||++|
T Consensus 326 pt~~ell~h 334 (373)
T 1q8y_A 326 ADAGGLVNH 334 (373)
T ss_dssp BCHHHHHTC
T ss_pred CCHHHHhhC
Confidence 999999885
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=353.91 Aligned_cols=245 Identities=22% Similarity=0.307 Sum_probs=175.6
Q ss_pred CeeE-EEEeeccCceEEEEEEE----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccc--cCCCceE
Q 002160 677 DLVL-GERIGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV--TRPPNLS 749 (958)
Q Consensus 677 dy~i-~k~LG~G~fG~Vykak~----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~--~~~~~l~ 749 (958)
.|++ +++||+|+||.||+|++ +++.||||++....... .+.+|+.+|++++|||||+++++| .....+|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM----SACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCH----HHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCH----HHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 3555 56799999999999986 36789999987655433 577899999999999999999999 4567899
Q ss_pred EEEeecCCCCHHHHHhCC--------CCCccHHH-HHHHHHHHHHHHHHHhcCCcEeecCCCCCceEE----cCCCcEEE
Q 002160 750 IITEFLPRGSLFRILHRP--------HCQVDEKR-RIKMALDARGMNCLHTSTPTIVHRDLKSPNLLV----DKNWNVKV 816 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~--------~~~~~e~~-~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILI----d~~g~VKL 816 (958)
|||||++ ++|.+++... ...+.+.. +.++.+++.||.|||.++ |+||||||+|||| +.++.+||
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999996 5788776421 11234443 444445599999999998 9999999999999 67899999
Q ss_pred EeccccccccCCc---ccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChh---------HH
Q 002160 817 SDFGLSRLKHNTF---LSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPM---------QV 883 (958)
Q Consensus 817 ~DFGLAk~~~~~~---~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~---------ei 883 (958)
+|||+++...... ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.... +.
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 9999998764321 223456799999999999874 5899999999999999999999999765431 11
Q ss_pred HHhhhcccccc------------------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002160 884 VGAVGFQNRRL------------------------------------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTV 927 (958)
Q Consensus 884 ~~~i~~~~~~~------------------------------------~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~ 927 (958)
+..+......+ ......++.+.+||.+||+.||.+||+++|+++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11110000000 001123678999999999999999999999988
Q ss_pred H
Q 002160 928 A 928 (958)
Q Consensus 928 ~ 928 (958)
|
T Consensus 334 h 334 (405)
T 3rgf_A 334 D 334 (405)
T ss_dssp S
T ss_pred C
Confidence 6
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=340.25 Aligned_cols=244 Identities=24% Similarity=0.339 Sum_probs=167.6
Q ss_pred CCeeEEE-EeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC----CCce
Q 002160 676 EDLVLGE-RIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR----PPNL 748 (958)
Q Consensus 676 ~dy~i~k-~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~----~~~l 748 (958)
++|.+.+ .||+|+||.||+|++ +++.||||++... ... .......++.+.||||+++++++.. ...+
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKA---RQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHH---HHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 6788854 699999999999987 5889999998653 111 1222334566799999999999875 4458
Q ss_pred EEEEeecCCCCHHHHHhCCCC-CccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcC---CCcEEEEeccccc
Q 002160 749 SIITEFLPRGSLFRILHRPHC-QVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLSR 823 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~-~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~---~g~VKL~DFGLAk 823 (958)
++||||+++|+|.+++.+... .+.+.....++ +.+.||.|||.++ |+||||||+||||+. ++.+||+|||+++
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 999999999999999986542 34455444444 4499999999998 999999999999986 4569999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhc--ccccc----CCC
Q 002160 824 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF--QNRRL----EIP 897 (958)
Q Consensus 824 ~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~--~~~~~----~ip 897 (958)
...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.............. ..... ...
T Consensus 180 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (336)
T 3fhr_A 180 ETTQNA--LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEW 257 (336)
T ss_dssp EC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTS
T ss_pred eccccc--cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhh
Confidence 654332 2346789999999999988899999999999999999999999987655433211110 11111 122
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002160 898 KELDPLVARIIWECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 898 ~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L 929 (958)
..+++++++||.+||+.||.+||++.|++++-
T Consensus 258 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 258 SEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 46899999999999999999999999999854
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=329.56 Aligned_cols=232 Identities=15% Similarity=0.091 Sum_probs=188.4
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEEC--CcEEEEEEeecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceE
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADWN--GTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~~--g~~VAVK~i~~~~~~-~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~ 749 (958)
+...+|++.+.||+|+||.||+|++. ++.||||++...... ......+.+|+.++.+++||||+++++++.+.+.+|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 33467999999999999999999884 899999999876543 455678999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~ 829 (958)
+||||++|++|.+++.+. .........+.+.+.||.|||.++ |+||||||+||||+.+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCCCCEEEEecc---------
Confidence 999999999999999653 233343344455599999999998 9999999999999999999998544
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhh-hcccccc----CCCCCCcHHH
Q 002160 830 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV-GFQNRRL----EIPKELDPLV 904 (958)
Q Consensus 830 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i-~~~~~~~----~ip~~ls~eL 904 (958)
|++ +++.++|||||||++|+|++|+.||.+.+..+..... ....... .+...+++++
T Consensus 175 -----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (286)
T 3uqc_A 175 -----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI 236 (286)
T ss_dssp -----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHH
T ss_pred -----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHH
Confidence 232 3689999999999999999999999887654322110 0001111 2335789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhc
Q 002160 905 ARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 936 (958)
Q Consensus 905 ~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~ 936 (958)
.+||.+||++||.+| ++.|+++.|+++....
T Consensus 237 ~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 237 SAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp HHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred HHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 999999999999999 9999999999986543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=355.28 Aligned_cols=251 Identities=25% Similarity=0.346 Sum_probs=190.3
Q ss_pred ccccCCCCeeEEEEeeccCceE-EEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCc
Q 002160 670 ECEIPWEDLVLGERIGLGSYGE-VYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~-Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~ 747 (958)
...+...+|.+.+.||+|+||+ ||++.++++.||||++...... .+.+|+++|+++ +|||||++++++.+...
T Consensus 18 ~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 92 (432)
T 3p23_A 18 VVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKDRQF 92 (432)
T ss_dssp CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEETTE
T ss_pred cEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEecCCE
Confidence 3445667899999999999998 5555679999999998654322 346899999999 79999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccH-HHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcC-----CCcEEEEeccc
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDE-KRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDK-----NWNVKVSDFGL 821 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e-~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~-----~g~VKL~DFGL 821 (958)
+|||||||. |+|.+++........+ .....+.+++.||.|||.++ ||||||||+||||+. ...+||+|||+
T Consensus 93 ~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~ 169 (432)
T 3p23_A 93 QYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGL 169 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred EEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence 999999996 5999999766543332 23344455599999999998 999999999999953 33588999999
Q ss_pred cccccCCc---ccCCCCCCCCCccCccccc---CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccc-
Q 002160 822 SRLKHNTF---LSSKSTAGTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRR- 893 (958)
Q Consensus 822 Ak~~~~~~---~~~~s~~GT~~Y~APEvl~---g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~- 893 (958)
++...... .......||+.|+|||++. +..++.++|||||||++|||++ |..||......+...........
T Consensus 170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~ 249 (432)
T 3p23_A 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC 249 (432)
T ss_dssp EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTT
T ss_pred eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccc
Confidence 98764321 2234567999999999998 4557789999999999999999 89999765544433222111111
Q ss_pred cCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 894 LEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 894 ~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
...+...+..+++||.+||+.||.+||++.+|++|
T Consensus 250 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 250 LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 11123356778999999999999999999999954
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=346.08 Aligned_cols=243 Identities=25% Similarity=0.335 Sum_probs=182.8
Q ss_pred CCeeEEEEeeccCceEEEEE-EECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vyka-k~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
+.|.+.+.||+|+||+||.+ ..+++.||||++.... ...+.+|+.+|+++ +|||||++++++.+...+|||||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 34666889999999999655 5589999999986532 34577899999987 89999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHH-------HHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCC-------------Cc
Q 002160 754 FLPRGSLFRILHRPHCQVDEK-------RRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKN-------------WN 813 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~-------~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~-------------g~ 813 (958)
||. |+|.+++.......... ....+.+++.||.|||.++ ||||||||+||||+.+ ++
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccccCCCceE
Confidence 995 69999998654322211 1224445589999999998 9999999999999754 48
Q ss_pred EEEEeccccccccCCcc----cCCCCCCCCCccCcccccC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCChh
Q 002160 814 VKVSDFGLSRLKHNTFL----SSKSTAGTPEWMAPEVLRN-------EPSNEKCDVYSFGVILWELAT-LKLPWIGMNPM 881 (958)
Q Consensus 814 VKL~DFGLAk~~~~~~~----~~~s~~GT~~Y~APEvl~g-------~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ 881 (958)
+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+....
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 99999999987654321 1234579999999999976 668999999999999999999 99999765443
Q ss_pred HHHHhhhcccccc-CC----CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 882 QVVGAVGFQNRRL-EI----PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 882 ei~~~i~~~~~~~-~i----p~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+.. +....... .. ...+++++++||.+||+.||.+||++.+|++|
T Consensus 247 ~~~--i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 247 ESN--IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HHH--HHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHH--HhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 321 11111111 11 12356889999999999999999999999863
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=341.27 Aligned_cols=242 Identities=16% Similarity=0.113 Sum_probs=183.4
Q ss_pred CCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCC-CceeE------------
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRH-PNVVL------------ 737 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~H-PNIVk------------ 737 (958)
....|.+++.||+|+||.||+|++ +++.||||++..... .......+.+|+.+++.++| .|+..
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 445688999999999999999997 499999998874332 22335678999999999977 32211
Q ss_pred ---------EeccccC-----CCceEEEEeecCCCCHHHHHh------CCCCCccHHHHHHH-HHHHHHHHHHHhcCCcE
Q 002160 738 ---------FMGAVTR-----PPNLSIITEFLPRGSLFRILH------RPHCQVDEKRRIKM-ALDARGMNCLHTSTPTI 796 (958)
Q Consensus 738 ---------L~g~~~~-----~~~l~LVmEy~~gGsL~d~L~------k~~~~~~e~~~l~i-a~~a~aL~yLH~~g~gI 796 (958)
++.++.. ...++++|+++ +++|.+++. .....+.+..++.+ .+.+.||.|||.++ |
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i 232 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--L 232 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--c
Confidence 1111111 22467778866 689999884 22334455566666 44599999999998 9
Q ss_pred eecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCCCCCCCccCcccc----------cCCCCCchhhHHHHHHHHH
Q 002160 797 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL----------RNEPSNEKCDVYSFGVILW 866 (958)
Q Consensus 797 IHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~~GT~~Y~APEvl----------~g~~~s~ksDIWSLGiLLy 866 (958)
|||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||++|
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 99999999999999999999999999875443 344678 999999999 5556788999999999999
Q ss_pred HHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 867 ELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 867 ELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
||++|+.||.+.+..+....+. .....+++.+++||.+||+.||.+||++.+++++
T Consensus 309 elltg~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGGSEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHSSCCCCTTGGGSCSGGGG------SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHCCCCCCCcchhhhHHHHH------hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 9999999998876554433331 2224678999999999999999999997776543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=318.79 Aligned_cols=223 Identities=25% Similarity=0.389 Sum_probs=175.1
Q ss_pred CCeeEE-EEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHH-HHcCCCceeEEeccccC----CCc
Q 002160 676 EDLVLG-ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIM-RRLRHPNVVLFMGAVTR----PPN 747 (958)
Q Consensus 676 ~dy~i~-k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~IL-k~L~HPNIVkL~g~~~~----~~~ 747 (958)
++|.+. +.||+|+||.||+|.+ +++.||||++... ..+.+|+.++ +.++||||+++++++.. ...
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 567776 8899999999999987 6889999998642 2566888888 55589999999999876 667
Q ss_pred eEEEEeecCCCCHHHHHhCCC-CCccHHHHHHH-HHHHHHHHHHHhcCCcEeecCCCCCceEEcC---CCcEEEEecccc
Q 002160 748 LSIITEFLPRGSLFRILHRPH-CQVDEKRRIKM-ALDARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLS 822 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~-~~~~e~~~l~i-a~~a~aL~yLH~~g~gIIHRDLKPeNILId~---~g~VKL~DFGLA 822 (958)
+++||||+++|+|.+++.... ..+.+.....+ .+.+.||.|||.++ |+||||||+||||+. ++.+||+|||++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 999999999999999997654 23444444444 44499999999998 999999999999997 789999999998
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhc--cccccCCC---
Q 002160 823 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF--QNRRLEIP--- 897 (958)
Q Consensus 823 k~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~--~~~~~~ip--- 897 (958)
.... +..++.++|||||||++|+|++|+.||.+............ ......++
T Consensus 168 ~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (299)
T 3m2w_A 168 KETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 225 (299)
T ss_dssp EECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHH
T ss_pred cccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchh
Confidence 6432 23467899999999999999999999987665443322211 11122233
Q ss_pred -CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002160 898 -KELDPLVARIIWECWQTDPSLRPSFAQLTVAL 929 (958)
Q Consensus 898 -~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L 929 (958)
..+++++++||.+||+.||.+||++.|+++|-
T Consensus 226 ~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp 258 (299)
T 3m2w_A 226 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 258 (299)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred cccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 46899999999999999999999999999863
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=341.12 Aligned_cols=242 Identities=19% Similarity=0.182 Sum_probs=183.8
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCC------CHHHHHHHHHHHHHHHHcC---------------
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDF------SGAALLEFKREVKIMRRLR--------------- 731 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~------~~~~~~~f~~Ei~ILk~L~--------------- 731 (958)
+..++|++++.||+|+||.||+|+++++.||||++..... .......+.+|+.+|+.++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 4457899999999999999999999999999999986542 2223467889999999986
Q ss_pred -----------CCceeEEeccccC-------------CCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHH
Q 002160 732 -----------HPNVVLFMGAVTR-------------PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMN 787 (958)
Q Consensus 732 -----------HPNIVkL~g~~~~-------------~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~ 787 (958)
|||||+++++|.. ...+||||||+++|++.+.+.+ ........+.++.+++.||.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence 5555555555554 7789999999999977776654 23344445555556699999
Q ss_pred HHH-hcCCcEeecCCCCCceEEcCCC--------------------cEEEEeccccccccCCcccCCCCCCCCCccCccc
Q 002160 788 CLH-TSTPTIVHRDLKSPNLLVDKNW--------------------NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 846 (958)
Q Consensus 788 yLH-~~g~gIIHRDLKPeNILId~~g--------------------~VKL~DFGLAk~~~~~~~~~~s~~GT~~Y~APEv 846 (958)
||| .++ ||||||||+||||+.++ .+||+|||+++..... ..+||+.|+|||+
T Consensus 176 ~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 176 VAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSGG
T ss_pred HHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChhh
Confidence 999 888 99999999999999887 9999999999876543 3479999999999
Q ss_pred ccCCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCh-hHHHHhhh----cccc-ccCCCCCCcHHHHHHHHHhhhcCCCCC
Q 002160 847 LRNEPSNEKCDVYSFGVI-LWELATLKLPWIGMNP-MQVVGAVG----FQNR-RLEIPKELDPLVARIIWECWQTDPSLR 919 (958)
Q Consensus 847 l~g~~~s~ksDIWSLGiL-LyELLtG~~PF~g~~~-~ei~~~i~----~~~~-~~~ip~~ls~eL~dLI~~CL~kDP~kR 919 (958)
+.+.. +.++||||||++ .++++.|..||.+... ......+. .... ...++..+++++++||.+||+.|
T Consensus 249 ~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d---- 323 (336)
T 2vuw_A 249 FTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS---- 323 (336)
T ss_dssp GCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----
T ss_pred hcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----
Confidence 99877 899999998777 6778899999854221 11111111 1100 11112357889999999999976
Q ss_pred CCHHHHH-HH
Q 002160 920 PSFAQLT-VA 928 (958)
Q Consensus 920 PSa~EIL-~~ 928 (958)
+++|++ +|
T Consensus 324 -sa~e~l~~H 332 (336)
T 2vuw_A 324 -SATDLLCQH 332 (336)
T ss_dssp -SHHHHHHHC
T ss_pred -CHHHHHhcC
Confidence 899988 54
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=360.21 Aligned_cols=243 Identities=21% Similarity=0.261 Sum_probs=192.1
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE---CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc-
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW---NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN- 747 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~---~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~- 747 (958)
++..++|++++.||+|+||.||+|.+ +++.||||++.... .......+.+|+++|++++|||||+++++|...+.
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 34457899999999999999999987 47899999886543 34556678999999999999999999999987665
Q ss_pred ----eEEEEeecCCCCHHHHHhCCCCCccHHHHHH-HHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccc
Q 002160 748 ----LSIITEFLPRGSLFRILHRPHCQVDEKRRIK-MALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS 822 (958)
Q Consensus 748 ----l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~-ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLA 822 (958)
+||||||++|++|.+++.. .+.+...+. +.+++.||.|||.++ ||||||||+||||+.+ .+||+|||++
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred CCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC-cEEEEecccc
Confidence 7999999999999988765 344444444 444499999999998 9999999999999985 8999999999
Q ss_pred ccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcH
Q 002160 823 RLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 902 (958)
Q Consensus 823 k~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~ 902 (958)
+..... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||.+.....+ .........++
T Consensus 229 ~~~~~~----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~--------~~~~~~~~~~~ 295 (681)
T 2pzi_A 229 SRINSF----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL--------PEDDPVLKTYD 295 (681)
T ss_dssp EETTCC----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC--------CTTCHHHHHCH
T ss_pred hhcccC----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc--------cccccccccCH
Confidence 876443 3467999999999998765 8899999999999999999988865321100 00000012457
Q ss_pred HHHHHHHHhhhcCCCCCC-CHHHHHHHHHhhhh
Q 002160 903 LVARIIWECWQTDPSLRP-SFAQLTVALKPLQR 934 (958)
Q Consensus 903 eL~dLI~~CL~kDP~kRP-Sa~EIL~~L~kL~k 934 (958)
.+.+||.+||+.||.+|| +++++...|..+.+
T Consensus 296 ~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 296 SYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred HHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 899999999999999999 57777777776643
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=352.27 Aligned_cols=256 Identities=22% Similarity=0.258 Sum_probs=196.9
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC------CC
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR------PP 746 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~------~~ 746 (958)
..+|++.+.||+|+||.||+|.+ +++.||||++... ........+.+|+++|++++||||+++++++.. .+
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 36899999999999999999976 6889999987654 345567789999999999999999999998765 66
Q ss_pred ceEEEEeecCCCCHHHHHhCCC---CCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCc---EEEEecc
Q 002160 747 NLSIITEFLPRGSLFRILHRPH---CQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFG 820 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~---~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~---VKL~DFG 820 (958)
..++||||+++|+|.+++.... ..........+.+.+.||.|||..+ |+||||||+|||++.++. +||+|||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 7899999999999999998644 2333344444455599999999988 999999999999997665 9999999
Q ss_pred ccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHh---------h-hc-
Q 002160 821 LSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGA---------V-GF- 889 (958)
Q Consensus 821 LAk~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~---------i-~~- 889 (958)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+......... + ..
T Consensus 170 ~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 248 (676)
T 3qa8_A 170 YAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248 (676)
T ss_dssp CCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred ccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence 998765432 23456899999999999999999999999999999999999999976432211000 0 00
Q ss_pred -ccc----------ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHH-----HHHHHHhhhh
Q 002160 890 -QNR----------RLEIPKELDPLVARIIWECWQTDPSLRPSFAQ-----LTVALKPLQR 934 (958)
Q Consensus 890 -~~~----------~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~E-----IL~~L~kL~k 934 (958)
... ...+...+++.+.+||.+||..||.+||++.+ .++.+..+..
T Consensus 249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 000 01122346789999999999999999999988 5566666544
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.2e-30 Score=300.87 Aligned_cols=185 Identities=15% Similarity=0.068 Sum_probs=130.8
Q ss_pred EeeccCceEEEEEE--ECCcEEEEEEeecCCC--------CHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCCceEEE
Q 002160 683 RIGLGSYGEVYHAD--WNGTEVAVKKFLDQDF--------SGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 683 ~LG~G~fG~Vykak--~~g~~VAVK~i~~~~~--------~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~~l~LV 751 (958)
.++.|++|.+..++ +.|+.||||.+.+... .+....+|.+|+++|+++ .|+||++++++++++..+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 46778888777664 3799999999976532 123456799999999999 799999999999999999999
Q ss_pred EeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc
Q 002160 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~ 831 (958)
|||++|++|.+++.+.+... ... .+.+++.||+|+|.+| ||||||||+||||+.+|++||+|||+|+........
T Consensus 321 MEyv~G~~L~d~i~~~~~l~-~~~--I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~ 395 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEID-REK--ILGSLLRSLAALEKQG--FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW 395 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCC-HHH--HHHHHHHHHHHHHHTT--CEESCCCGGGEEECTTSCEEECCCTTEESCC---CC
T ss_pred EecCCCCcHHHHHHhCCCCC-HHH--HHHHHHHHHHHHHHCC--ceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc
Confidence 99999999999998866543 332 3456699999999998 999999999999999999999999999877655444
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 002160 832 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL 873 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~ 873 (958)
..+.+||+.|||||++.+. +..++|+|++|+++++|.++..
T Consensus 396 ~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp SHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred ccCceechhhccHHHhCCC-CCCcccccccccchhhhccccc
Confidence 5567899999999999875 5678999999999887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.5e-26 Score=268.64 Aligned_cols=186 Identities=15% Similarity=0.169 Sum_probs=145.1
Q ss_pred eEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHH------HHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 679 VLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGA------ALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 679 ~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~------~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
...+.||+|+||.||+|++.++.+++|++........ ...++.+|+++|++++||||+++..++...+..||||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 3367899999999999999999999998766543322 2345899999999999999995555555677789999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc--
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL-- 830 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~-- 830 (958)
||+++++|.+++.+ ...++.+.+.+|.|||+++ |+||||||+|||++. ++||+|||+++.......
T Consensus 419 E~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 419 SYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp ECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred ECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence 99999999999976 2234455589999999998 999999999999999 999999999987654321
Q ss_pred -----cCCCCCCCCCccCcccccC--CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 002160 831 -----SSKSTAGTPEWMAPEVLRN--EPSNEKCDVYSFGVILWELATLKLPWI 876 (958)
Q Consensus 831 -----~~~s~~GT~~Y~APEvl~g--~~~s~ksDIWSLGiLLyELLtG~~PF~ 876 (958)
....++||+.|||||++.+ ..|+...|+|+..+-..+.+.++-+|.
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 1235679999999999987 557778899999999998888776663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=5.6e-22 Score=214.25 Aligned_cols=145 Identities=19% Similarity=0.166 Sum_probs=113.0
Q ss_pred CeeEEEEeeccCceEEEEEEE-CCcEEEEEEeecCCCCH----------------HHHHHHHHHHHHHHHcCCCceeEEe
Q 002160 677 DLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSG----------------AALLEFKREVKIMRRLRHPNVVLFM 739 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~----------------~~~~~f~~Ei~ILk~L~HPNIVkL~ 739 (958)
.|.+++.||+|+||.||+|++ +++.||||++....... .....+.+|+.+|++++ | ++++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 456779999999999999998 58899999986432211 23567899999999999 4 6666
Q ss_pred ccccCCCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEec
Q 002160 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDF 819 (958)
Q Consensus 740 g~~~~~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DF 819 (958)
+++. .+..|+||||++|++|.+ +... .....+.+.+.||.|||.++ ||||||||+||||+ ++++||+||
T Consensus 168 ~~~~-~~~~~lvmE~~~g~~L~~-l~~~------~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~-~~~vkl~DF 236 (282)
T 1zar_A 168 KVYA-WEGNAVLMELIDAKELYR-VRVE------NPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-EEGIWIIDF 236 (282)
T ss_dssp CEEE-EETTEEEEECCCCEEGGG-CCCS------CHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-TTEEEECCC
T ss_pred eEEe-ccceEEEEEecCCCcHHH-cchh------hHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE-CCcEEEEEC
Confidence 6543 356799999999999998 4321 12234445589999999998 99999999999999 999999999
Q ss_pred cccccccCCcccCCCCCCCCCccCccccc
Q 002160 820 GLSRLKHNTFLSSKSTAGTPEWMAPEVLR 848 (958)
Q Consensus 820 GLAk~~~~~~~~~~s~~GT~~Y~APEvl~ 848 (958)
|+++. +..|+|||.+.
T Consensus 237 G~a~~-------------~~~~~a~e~l~ 252 (282)
T 1zar_A 237 PQSVE-------------VGEEGWREILE 252 (282)
T ss_dssp TTCEE-------------TTSTTHHHHHH
T ss_pred CCCeE-------------CCCCCHHHHHH
Confidence 99863 34578899874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=5.6e-18 Score=179.96 Aligned_cols=137 Identities=18% Similarity=0.194 Sum_probs=102.1
Q ss_pred eeEEEEeeccCceEEEEEEE--CCcE--EEEEEeecCCCC----------------------HHHHHHHHHHHHHHHHcC
Q 002160 678 LVLGERIGLGSYGEVYHADW--NGTE--VAVKKFLDQDFS----------------------GAALLEFKREVKIMRRLR 731 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~--~g~~--VAVK~i~~~~~~----------------------~~~~~~f~~Ei~ILk~L~ 731 (958)
|++.+.||+|+||.||+|.+ +|+. ||||++...... ......+.+|+.+|.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78899999999999999987 8889 999987543211 011236789999999998
Q ss_pred CCce--eEEeccccCCCceEEEEeecCC-C----CHHHHHhCCCCCccHHHHHHHHHHHHHHHHHH-hcCCcEeecCCCC
Q 002160 732 HPNV--VLFMGAVTRPPNLSIITEFLPR-G----SLFRILHRPHCQVDEKRRIKMALDARGMNCLH-TSTPTIVHRDLKS 803 (958)
Q Consensus 732 HPNI--VkL~g~~~~~~~l~LVmEy~~g-G----sL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH-~~g~gIIHRDLKP 803 (958)
|++| +.++++ ...+|||||+.+ | .|.++.... ........+.+.+.+|.||| .++ ||||||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~~---~~~~~~~i~~qi~~~l~~lH~~~g--ivHrDlkp 199 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGREL---KELDVEGIFNDVVENVKRLYQEAE--LVHADLSE 199 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGGG---GGSCHHHHHHHHHHHHHHHHHTSC--EECSSCST
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhcc---ChHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCH
Confidence 7754 444442 356899999942 3 777765321 11223334445589999999 887 99999999
Q ss_pred CceEEcCCCcEEEEeccccccc
Q 002160 804 PNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 804 eNILId~~g~VKL~DFGLAk~~ 825 (958)
+|||++. .++|+|||++...
T Consensus 200 ~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS--SEEECCCTTCEET
T ss_pred HHEEEcC--cEEEEECcccccC
Confidence 9999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.59 E-value=7.8e-16 Score=174.46 Aligned_cols=136 Identities=16% Similarity=0.158 Sum_probs=96.3
Q ss_pred eeEEEEeeccCceEEEEEEE-CCcEEEEEEeecCCC---------------CHH-----HHHHHHHHHHHHHHcCCCce-
Q 002160 678 LVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDF---------------SGA-----ALLEFKREVKIMRRLRHPNV- 735 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~---------------~~~-----~~~~f~~Ei~ILk~L~HPNI- 735 (958)
|.+++.||+|+||.||+|.. +|+.||||+++.... ... ......+|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 89999999999999999986 789999998753211 000 01123456777777754443
Q ss_pred -eEEeccccCCCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCC--
Q 002160 736 -VLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-- 812 (958)
Q Consensus 736 -VkL~g~~~~~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g-- 812 (958)
...+++ ...+|||||++|+.|.++.... . ....+.+++.+|.+||.++ ||||||||.||||+++|
T Consensus 177 vp~p~~~----~~~~LVME~i~G~~L~~l~~~~----~--~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 177 VPEPIAQ----SRHTIVMSLVDALPMRQVSSVP----D--PASLYADLIALILRLAKHG--LIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CCCEEEE----ETTEEEEECCSCEEGGGCCCCS----C--HHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEEEEECS
T ss_pred CCeeeec----cCceEEEEecCCccHhhhcccH----H--HHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeCCCCc
Confidence 222322 1237999999999887654321 1 1223445588999999988 99999999999998776
Q ss_pred --------cEEEEeccccccc
Q 002160 813 --------NVKVSDFGLSRLK 825 (958)
Q Consensus 813 --------~VKL~DFGLAk~~ 825 (958)
.+.|+||+.+...
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEET
T ss_pred ccccccccceEEEEeCCcccC
Confidence 3899999987643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=4e-11 Score=125.77 Aligned_cols=141 Identities=15% Similarity=0.038 Sum_probs=106.4
Q ss_pred CCeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeccccCCCceEEEEee
Q 002160 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~-HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
..|++...++.|+++.||++...++.+++|........ ....+.+|+.+|+.+. +..+.++++++...+..|+||||
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 46888888999999999999888899999987642111 1235789999999994 67788999998888889999999
Q ss_pred cCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 002160 755 LPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTS------------------------------------------ 792 (958)
Q Consensus 755 ~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~------------------------------------------ 792 (958)
++|.+|.+.+... .. ......+.+.+|..||..
T Consensus 92 i~G~~l~~~~~~~---~~--~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 92 ADGVLCSEEYEDE---QS--PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp CSSEEHHHHCCTT---TC--HHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred cCCeehhhccCCc---cc--HHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 9999998764211 11 112223336778888871
Q ss_pred ---------------CCcEeecCCCCCceEEcCCCcEEEEeccccc
Q 002160 793 ---------------TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 823 (958)
Q Consensus 793 ---------------g~gIIHRDLKPeNILId~~g~VKL~DFGLAk 823 (958)
...++|+|++|.|||++.++.+.|+||+.+.
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 0349999999999999876666799999763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.02 E-value=4.7e-10 Score=115.95 Aligned_cols=135 Identities=19% Similarity=0.144 Sum_probs=92.7
Q ss_pred CCeeEEEEeeccCceEEEEEEE-CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCc--eeEEeccccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN--VVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPN--IVkL~g~~~~~~~l~LVm 752 (958)
..+.+....+.|..+.||++.. +++.++||...... ...+.+|+.+|+.+.+.+ +.++++++...+..++||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 3455544444666799999976 46789999865431 135778999999995434 567888888888899999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTST--------------------------------------- 793 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g--------------------------------------- 793 (958)
||++|.+|. .... ... ....+.+..|..||...
T Consensus 95 e~i~G~~l~--~~~~----~~~--~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 95 GEVPGQDLL--SSHL----APA--EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp ECCSSEETT--TSCC----CHH--HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred EecCCcccC--cCcC----CHh--HHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 999998884 2110 111 11122244555555432
Q ss_pred -----------------CcEeecCCCCCceEEcCCCcEEEEeccccc
Q 002160 794 -----------------PTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 823 (958)
Q Consensus 794 -----------------~gIIHRDLKPeNILId~~g~VKL~DFGLAk 823 (958)
..++|+|++|.|||++.++.+.|+|||.+.
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 139999999999999877667799999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.97 E-value=1.6e-09 Score=119.43 Aligned_cols=142 Identities=19% Similarity=0.180 Sum_probs=98.7
Q ss_pred EEEEeeccCceEEEEEEECCcEEEEEEee--cCCCCHHHHHHHHHHHHHHHHcC--CCceeEEeccccCC---CceEEEE
Q 002160 680 LGERIGLGSYGEVYHADWNGTEVAVKKFL--DQDFSGAALLEFKREVKIMRRLR--HPNVVLFMGAVTRP---PNLSIIT 752 (958)
Q Consensus 680 i~k~LG~G~fG~Vykak~~g~~VAVK~i~--~~~~~~~~~~~f~~Ei~ILk~L~--HPNIVkL~g~~~~~---~~l~LVm 752 (958)
..+.|+.|.++.||+++..+..+++|+.. .... ......+.+|+.+|+.|. +..+++++.++.+. +..|+||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 46779999999999999888899999765 2221 112346789999999996 45578888888766 4589999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTS---------------------------------------- 792 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~---------------------------------------- 792 (958)
||++|..+.+.... ..............+..|+.||..
T Consensus 121 e~v~G~~l~~~~~~--~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 121 EFVSGRVLWDQSLP--GMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp ECCCCBCCCCTTCT--TCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred EecCCeecCCCccc--cCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 99999877542111 111222222333347788888862
Q ss_pred ----------------CCcEeecCCCCCceEEcCCCc--EEEEecccccc
Q 002160 793 ----------------TPTIVHRDLKSPNLLVDKNWN--VKVSDFGLSRL 824 (958)
Q Consensus 793 ----------------g~gIIHRDLKPeNILId~~g~--VKL~DFGLAk~ 824 (958)
...+||+|++|.|||++.++. +.|+||+.+..
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997653 69999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.70 E-value=1.3e-08 Score=109.82 Aligned_cols=185 Identities=18% Similarity=0.130 Sum_probs=107.4
Q ss_pred EEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCc--eeEEeccccCCC---ceEEEEeec
Q 002160 682 ERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPN--VVLFMGAVTRPP---NLSIITEFL 755 (958)
Q Consensus 682 k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPN--IVkL~g~~~~~~---~l~LVmEy~ 755 (958)
+.++.|....||++. ..+++|+... ......+.+|..+|+.+ .+.. +.+++....... ..|+||||+
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred EecCCCCcceEEEEC---CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 458999999999874 6788887432 23456788999999988 3332 445555544333 358899999
Q ss_pred CCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 002160 756 PRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHT-------------------------------------------- 791 (958)
Q Consensus 756 ~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~-------------------------------------------- 791 (958)
+|..|....... ...+.......+.+..|..||.
T Consensus 99 ~G~~l~~~~~~~--l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 99 KGVPLTPLLLNN--LPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CCEECCHHHHHT--SCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred CCeECCcccccc--CCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 998776422100 0000111111111222222221
Q ss_pred ------------cCCcEeecCCCCCceEEcC--CCcEEEEeccccccccCCcccCCCCCCCCCccCcccc----cCCCC-
Q 002160 792 ------------STPTIVHRDLKSPNLLVDK--NWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL----RNEPS- 852 (958)
Q Consensus 792 ------------~g~gIIHRDLKPeNILId~--~g~VKL~DFGLAk~~~~~~~~~~s~~GT~~Y~APEvl----~g~~~- 852 (958)
....++|+|++|.|||++. .+.+.|+||+.+..-...... ........-..|+.. .....
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl-~~~~~~~~~~~~~~~~~~l~~Y~~~ 255 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF-ISLMEDDEEYGMEFVSKILNHYKHK 255 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH-HTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH-HHHHhhccccCHHHHHHHHHHcCCC
Confidence 1135999999999999998 556899999988653221100 000000000223321 11111
Q ss_pred ---------CchhhHHHHHHHHHHHHhCCCCCC
Q 002160 853 ---------NEKCDVYSFGVILWELATLKLPWI 876 (958)
Q Consensus 853 ---------s~ksDIWSLGiLLyELLtG~~PF~ 876 (958)
....+.|+++.++|.+.+|..+|.
T Consensus 256 ~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 256 DIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 123689999999999999988763
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=1.4e-05 Score=86.66 Aligned_cols=75 Identities=13% Similarity=0.002 Sum_probs=55.5
Q ss_pred EEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCC---ceeEEecccc-CCCceEEEEeecC
Q 002160 681 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP---NVVLFMGAVT-RPPNLSIITEFLP 756 (958)
Q Consensus 681 ~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HP---NIVkL~g~~~-~~~~l~LVmEy~~ 756 (958)
.+.++.|....||+. +..++||+-. .......+.+|..+|+.|.+. .|.+++.++. ..+..++||||++
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE---CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 456899999999988 6888898732 223456789999999999642 2556666653 4456789999999
Q ss_pred CCCHHH
Q 002160 757 RGSLFR 762 (958)
Q Consensus 757 gGsL~d 762 (958)
|..|..
T Consensus 97 G~~l~~ 102 (306)
T 3tdw_A 97 GQILGE 102 (306)
T ss_dssp SEECHH
T ss_pred CeECch
Confidence 987765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=1.2e-05 Score=84.17 Aligned_cols=77 Identities=18% Similarity=0.254 Sum_probs=56.1
Q ss_pred EeeccCce-EEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeccccCCCceEEEEeecCCC
Q 002160 683 RIGLGSYG-EVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEFLPRG 758 (958)
Q Consensus 683 ~LG~G~fG-~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~-HPNIVkL~g~~~~~~~l~LVmEy~~gG 758 (958)
.+..|..| .||+... .+..+++|.-.. .....+.+|..+|+.|. +--+.++++++.+.+..++|||+++|.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 35556555 6888764 456789997543 23456789999999884 333678888888888999999999998
Q ss_pred CHHHHH
Q 002160 759 SLFRIL 764 (958)
Q Consensus 759 sL~d~L 764 (958)
++.+..
T Consensus 106 ~~~~~~ 111 (272)
T 4gkh_A 106 TAFQVL 111 (272)
T ss_dssp EHHHHH
T ss_pred cccccc
Confidence 776543
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.03 E-value=1.7e-05 Score=85.39 Aligned_cols=74 Identities=11% Similarity=0.042 Sum_probs=44.6
Q ss_pred EEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC--CCceeEEecc------ccCCCceEEEE
Q 002160 681 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR--HPNVVLFMGA------VTRPPNLSIIT 752 (958)
Q Consensus 681 ~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~--HPNIVkL~g~------~~~~~~l~LVm 752 (958)
.+.|+.|..+.||++...+..+++|+.... . .++..|..+++.|. .-.+.+++.. ....+..+++|
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSGAVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EEECC----CEEEEEEETTEEEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeeccccccCcEEEEEeCCCCEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 456777789999999887777999987652 2 23345566666553 1123444431 12456689999
Q ss_pred eecCCCCH
Q 002160 753 EFLPRGSL 760 (958)
Q Consensus 753 Ey~~gGsL 760 (958)
||++|..+
T Consensus 111 ~~i~G~~~ 118 (346)
T 2q83_A 111 DWIEGRPF 118 (346)
T ss_dssp ECCCCBCC
T ss_pred EeecCccC
Confidence 99998643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.98 E-value=1.8e-05 Score=86.77 Aligned_cols=84 Identities=6% Similarity=-0.031 Sum_probs=56.5
Q ss_pred eeEEEEe-eccCceEEEEEEEC--------CcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcC-C--CceeEEeccccC
Q 002160 678 LVLGERI-GLGSYGEVYHADWN--------GTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLR-H--PNVVLFMGAVTR 744 (958)
Q Consensus 678 y~i~k~L-G~G~fG~Vykak~~--------g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~-H--PNIVkL~g~~~~ 744 (958)
....+.| +.|....+|+.... ++.+++|....... .......+.+|+.+|+.|. + -.+.+++.++.+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3445778 89999999998765 67899987543220 0000135678888888884 3 346777777665
Q ss_pred C---CceEEEEeecCCCCHH
Q 002160 745 P---PNLSIITEFLPRGSLF 761 (958)
Q Consensus 745 ~---~~l~LVmEy~~gGsL~ 761 (958)
. +..++||||++|..|.
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp STTTSSCEEEEECCCCBCCC
T ss_pred CCccCCceEEEEecCCCChh
Confidence 4 3578999999886543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.89 E-value=4.3e-05 Score=85.23 Aligned_cols=77 Identities=17% Similarity=0.115 Sum_probs=50.1
Q ss_pred EEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CH----HHHHHHHHHHHHHHHcCC--C-ceeEEeccccCCCceE
Q 002160 680 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SG----AALLEFKREVKIMRRLRH--P-NVVLFMGAVTRPPNLS 749 (958)
Q Consensus 680 i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~----~~~~~f~~Ei~ILk~L~H--P-NIVkL~g~~~~~~~l~ 749 (958)
..+.||.|.++.||+++. .++.|+||....... .. .....+..|.++|+.+.. + .+.+++.+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 356799999999999954 568899997653211 00 112356778999988832 3 34456654 344568
Q ss_pred EEEeecCCC
Q 002160 750 IITEFLPRG 758 (958)
Q Consensus 750 LVmEy~~gG 758 (958)
+||||+++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.0002 Score=78.62 Aligned_cols=77 Identities=19% Similarity=0.117 Sum_probs=62.1
Q ss_pred eEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC---CCceeEEeccccCCCceEEEEeec
Q 002160 679 VLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVVLFMGAVTRPPNLSIITEFL 755 (958)
Q Consensus 679 ~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~---HPNIVkL~g~~~~~~~l~LVmEy~ 755 (958)
.-.+.|+.|....+|+....+..+++|+.... ....+..|...|+.|. ...+.+++.++...+..++||||+
T Consensus 39 ~~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLINDEVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp CEEEEECCSSSSEEEEEESSSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eeeEEeCCccceeeeEEEECCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 34577999999999999888889999986542 2456789999999883 356788888887778899999999
Q ss_pred CCCCH
Q 002160 756 PRGSL 760 (958)
Q Consensus 756 ~gGsL 760 (958)
+|..+
T Consensus 114 ~G~~~ 118 (312)
T 3jr1_A 114 NKSKN 118 (312)
T ss_dssp CCCCC
T ss_pred cCCCC
Confidence 98754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00035 Score=78.84 Aligned_cols=76 Identities=14% Similarity=0.048 Sum_probs=47.1
Q ss_pred EEEEeeccCceEEEEEEECCcEEEEEEeecCCC--CHH-----HHHHHHHHHHHHHH-cCCCceeEEeccccCCCceEEE
Q 002160 680 LGERIGLGSYGEVYHADWNGTEVAVKKFLDQDF--SGA-----ALLEFKREVKIMRR-LRHPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 680 i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~--~~~-----~~~~f~~Ei~ILk~-L~HPNIVkL~g~~~~~~~l~LV 751 (958)
-.+.||.|..+.||++...++.++||....... ... ....++.|+..+.. .....+.+++.+. .+..++|
T Consensus 38 ~i~~l~~G~~n~vyrv~~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVGSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEEECCCSSSCEEEEEECSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEEccCCCcEEEEEEEcCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 357799999999999987788999995432110 000 12233334333322 2234566777665 4667999
Q ss_pred Eeec-CC
Q 002160 752 TEFL-PR 757 (958)
Q Consensus 752 mEy~-~g 757 (958)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.31 E-value=0.002 Score=69.19 Aligned_cols=143 Identities=13% Similarity=0.061 Sum_probs=80.2
Q ss_pred CeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCc--eeEEeccc------cCCCce
Q 002160 677 DLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN--VVLFMGAV------TRPPNL 748 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPN--IVkL~g~~------~~~~~l 748 (958)
+..-.+.|+.|....+|+....+..+++|...... ....+..|+.++..|...+ +.+++... ...+..
T Consensus 23 ~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~ 98 (322)
T 2ppq_A 23 SLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 98 (322)
T ss_dssp CEEEEEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred cceEeeccCCCcccceEEEEeCCccEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence 34456778889999999998876689999876521 1124556788887773212 33444321 123567
Q ss_pred EEEEeecCCCCHHH-----------H---HhC---C-CCC----c---cHHHHHHHH-------------HHHHHHHHHH
Q 002160 749 SIITEFLPRGSLFR-----------I---LHR---P-HCQ----V---DEKRRIKMA-------------LDARGMNCLH 790 (958)
Q Consensus 749 ~LVmEy~~gGsL~d-----------~---L~k---~-~~~----~---~e~~~l~ia-------------~~a~aL~yLH 790 (958)
+++|+|++|..+.. . ++. . ... . .+...+... .....+..++
T Consensus 99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~ 178 (322)
T 2ppq_A 99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 178 (322)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence 89999998864310 0 111 0 000 0 011100000 0122334443
Q ss_pred hc-----CCcEeecCCCCCceEEcCCCcEEEEeccccc
Q 002160 791 TS-----TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 823 (958)
Q Consensus 791 ~~-----g~gIIHRDLKPeNILId~~g~VKL~DFGLAk 823 (958)
.. ..++||+|+.+.|||++.++.+.|+||+.+.
T Consensus 179 ~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 179 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 21 2359999999999999987666899999775
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.27 E-value=0.0023 Score=68.16 Aligned_cols=78 Identities=17% Similarity=0.158 Sum_probs=55.6
Q ss_pred CCeeEEEEeeccCceEEEEEEE-CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC-C--CceeEEeccccCCCceEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-H--PNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~-H--PNIVkL~g~~~~~~~l~LV 751 (958)
.++.-.+.+|.|..+.||+.+. +|+.|++|+....... ....|..|+..|+.|. . --+.+++++. .-++|
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv 88 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPA--LDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLA 88 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCC--CTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcc--hhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEE
Confidence 4566678899999999999987 6899999975433221 1235778999999984 2 2345566543 24789
Q ss_pred EeecCCCC
Q 002160 752 TEFLPRGS 759 (958)
Q Consensus 752 mEy~~gGs 759 (958)
|||++++.
T Consensus 89 ~e~l~~~~ 96 (288)
T 3f7w_A 89 MEWVDERP 96 (288)
T ss_dssp EECCCCCC
T ss_pred EEeecccC
Confidence 99998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0012 Score=71.72 Aligned_cols=136 Identities=14% Similarity=0.100 Sum_probs=70.7
Q ss_pred EEeeccCceE-EEEEEEC-CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC-C-CceeEEeccccCCCceEEEEeecCC
Q 002160 682 ERIGLGSYGE-VYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-H-PNVVLFMGAVTRPPNLSIITEFLPR 757 (958)
Q Consensus 682 k~LG~G~fG~-Vykak~~-g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~-H-PNIVkL~g~~~~~~~l~LVmEy~~g 757 (958)
+.|+.|+... +|+.... +..+++|....... ..+..|+.+++.|. + -.+.+++.+....+ +++||++.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~-----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~ 96 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG-----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGD 96 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT-----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCS
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC-----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCC
Confidence 3466665554 6677664 77787876443210 23446677777763 2 23456666543333 789999977
Q ss_pred CCHHHHHh---------------------CCC----CCccHHHH---------HHH------------HHHHHHHHHH--
Q 002160 758 GSLFRILH---------------------RPH----CQVDEKRR---------IKM------------ALDARGMNCL-- 789 (958)
Q Consensus 758 GsL~d~L~---------------------k~~----~~~~e~~~---------l~i------------a~~a~aL~yL-- 789 (958)
..+.+.+. ... ........ .+. ......+..+
T Consensus 97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~ 176 (333)
T 3csv_A 97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS 176 (333)
T ss_dssp CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence 66654332 100 00111100 000 0001112222
Q ss_pred --HhcCCcEeecCCCCCceEEcCC----CcEEEEecccccc
Q 002160 790 --HTSTPTIVHRDLKSPNLLVDKN----WNVKVSDFGLSRL 824 (958)
Q Consensus 790 --H~~g~gIIHRDLKPeNILId~~----g~VKL~DFGLAk~ 824 (958)
......+||+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1123359999999999999874 6899999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0035 Score=67.52 Aligned_cols=74 Identities=9% Similarity=0.037 Sum_probs=47.8
Q ss_pred EEeeccCceEEEEEEE-CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCC--CceeEEecc-----ccCCCceEEEEe
Q 002160 682 ERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH--PNVVLFMGA-----VTRPPNLSIITE 753 (958)
Q Consensus 682 k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~H--PNIVkL~g~-----~~~~~~l~LVmE 753 (958)
+.|+ |....||++.. +|+.+++|......... ..+..|..+++.|.. -.+++++.. ....+..+++||
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 4466 88889999876 46689999876443322 355678888888742 124455443 112345678999
Q ss_pred ecCCCC
Q 002160 754 FLPRGS 759 (958)
Q Consensus 754 y~~gGs 759 (958)
|++|..
T Consensus 108 ~i~G~~ 113 (328)
T 1zyl_A 108 SVGGRQ 113 (328)
T ss_dssp CCCCEE
T ss_pred ecCCCC
Confidence 998754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0039 Score=71.12 Aligned_cols=72 Identities=14% Similarity=0.195 Sum_probs=49.6
Q ss_pred EEEEeeccCceEEEEEEEC---------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeccccCCCceE
Q 002160 680 LGERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 680 i~k~LG~G~fG~Vykak~~---------g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~-HPNIVkL~g~~~~~~~l~ 749 (958)
-.+.|+.|....||++... ++.+++|+..... . ...+.+|..+++.|. +.-..++++.+.+ .
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 3567899999999999864 4789999874321 1 134457999998884 3223567776543 3
Q ss_pred EEEeecCCCC
Q 002160 750 IITEFLPRGS 759 (958)
Q Consensus 750 LVmEy~~gGs 759 (958)
+||||++|..
T Consensus 149 ~v~e~l~G~~ 158 (429)
T 1nw1_A 149 RLEEYIPSRP 158 (429)
T ss_dssp EEECCCCEEE
T ss_pred EEEEEeCCcc
Confidence 8999998643
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.78 E-value=0.00083 Score=72.05 Aligned_cols=134 Identities=14% Similarity=0.082 Sum_probs=75.3
Q ss_pred EEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCce-eEEeccccCCCceEEEEeec-CCC
Q 002160 681 GERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV-VLFMGAVTRPPNLSIITEFL-PRG 758 (958)
Q Consensus 681 ~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNI-VkL~g~~~~~~~l~LVmEy~-~gG 758 (958)
.+.|+.|....+|++ ..+++|+..... .......+|+.+++.+..-++ .++++++. +.-++++||+ +|.
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGT---EEYINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee----eeEEEECCCCCc---cceeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCCCc
Confidence 577999999999999 678888765421 111123568888877742222 45665443 3347899999 665
Q ss_pred CHHH------------------HHhCCCCCc----cHHHHH--HHHH--------------H---H-HHHHHHH--hcCC
Q 002160 759 SLFR------------------ILHRPHCQV----DEKRRI--KMAL--------------D---A-RGMNCLH--TSTP 794 (958)
Q Consensus 759 sL~d------------------~L~k~~~~~----~e~~~l--~ia~--------------~---a-~aL~yLH--~~g~ 794 (958)
.|.. .++...... .....+ +... . + .....+. ....
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~ 173 (301)
T 3dxq_A 94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL 173 (301)
T ss_dssp ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence 4421 112211100 000000 0000 0 0 0111111 1233
Q ss_pred cEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 795 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 795 gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
.++|+|+.+.||| ..++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 5999999999999 5667899999998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.61 E-value=0.0039 Score=68.77 Aligned_cols=72 Identities=13% Similarity=0.156 Sum_probs=43.9
Q ss_pred EEEeeccCceEEEEEEECC----------cEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCc-eeEEeccccCCCceE
Q 002160 681 GERIGLGSYGEVYHADWNG----------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN-VVLFMGAVTRPPNLS 749 (958)
Q Consensus 681 ~k~LG~G~fG~Vykak~~g----------~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPN-IVkL~g~~~~~~~l~ 749 (958)
.+.|+.|....+|++...+ +.+++|+..... ........|..+++.|...+ +.++++.+. -+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTFN----GG 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEecC----Cc
Confidence 4678889999999998754 688888754321 11112467888888884223 446665542 26
Q ss_pred EEEeecCCCC
Q 002160 750 IITEFLPRGS 759 (958)
Q Consensus 750 LVmEy~~gGs 759 (958)
+||||++|..
T Consensus 111 ~v~e~i~G~~ 120 (369)
T 3c5i_A 111 RIEEWLYGDP 120 (369)
T ss_dssp EEEECCCSEE
T ss_pred EEEEEecCCc
Confidence 8999998754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0078 Score=69.47 Aligned_cols=74 Identities=18% Similarity=0.104 Sum_probs=48.8
Q ss_pred EEEEeeccCceEEEEEEECC--cEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCce-eEEeccccCCCceEEEEeecC
Q 002160 680 LGERIGLGSYGEVYHADWNG--TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV-VLFMGAVTRPPNLSIITEFLP 756 (958)
Q Consensus 680 i~k~LG~G~fG~Vykak~~g--~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNI-VkL~g~~~~~~~l~LVmEy~~ 756 (958)
-.+.|+.|-...+|++...+ ..+++|+..... .. .....+|..+|+.|...++ .++++++.. .+||||++
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~--~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~ 184 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DE--IINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMD 184 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CS--CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hh--hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeC
Confidence 35678999999999998866 789999764321 10 1112589999999964444 577777632 35999998
Q ss_pred CCCH
Q 002160 757 RGSL 760 (958)
Q Consensus 757 gGsL 760 (958)
|..|
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 7543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.44 E-value=0.0068 Score=68.30 Aligned_cols=136 Identities=13% Similarity=0.152 Sum_probs=77.4
Q ss_pred EEeeccCceEEEEEEEC---------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeccccCCCceEEE
Q 002160 682 ERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 682 k~LG~G~fG~Vykak~~---------g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~-HPNIVkL~g~~~~~~~l~LV 751 (958)
+.|..|-...+|++... ++.|++|+.... . .....+.+|..+++.|. +.-..++++++.+ .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~--~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-L--QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-c--chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 56777888899999763 468999875321 1 12345668999999884 3333667776654 289
Q ss_pred EeecCCCCHHH--------------H---HhCCC----CCcc--HHHHHHHHHHH--------------------HHHHH
Q 002160 752 TEFLPRGSLFR--------------I---LHRPH----CQVD--EKRRIKMALDA--------------------RGMNC 788 (958)
Q Consensus 752 mEy~~gGsL~d--------------~---L~k~~----~~~~--e~~~l~ia~~a--------------------~aL~y 788 (958)
|||++|..|.. . |+... .... +.....+..++ ..+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 99998765431 1 12211 1111 11111111111 11222
Q ss_pred ----HHhc--CCcEeecCCCCCceEEcCC----CcEEEEecccccc
Q 002160 789 ----LHTS--TPTIVHRDLKSPNLLVDKN----WNVKVSDFGLSRL 824 (958)
Q Consensus 789 ----LH~~--g~gIIHRDLKPeNILId~~----g~VKL~DFGLAk~ 824 (958)
|... ...++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2222 2359999999999999876 7899999998753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.27 E-value=0.024 Score=62.19 Aligned_cols=71 Identities=14% Similarity=0.069 Sum_probs=45.5
Q ss_pred EEee--ccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC---CCceeEEecc------ccCCCceEE
Q 002160 682 ERIG--LGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR---HPNVVLFMGA------VTRPPNLSI 750 (958)
Q Consensus 682 k~LG--~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~---HPNIVkL~g~------~~~~~~l~L 750 (958)
+.|. .|....||+....+..+++|+...... ..|+.+++.|. -|++++++.. ....+..++
T Consensus 27 ~~l~~G~g~~N~vy~v~~~~g~~vLK~~~~~~~--------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~ 98 (339)
T 3i1a_A 27 QFIQGGADTNAFAYQADSESKSYFIKLKYGYHD--------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKII 98 (339)
T ss_dssp EEETTTSCSSCEEEEEECSSCEEEEEEEECSSC--------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEE
T ss_pred EEeeccCccccceEEEEeCCCCEEEEEecCccc--------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEE
Confidence 4453 333689999987555999998765442 34666666662 2335555543 123466889
Q ss_pred EEeecCCCCH
Q 002160 751 ITEFLPRGSL 760 (958)
Q Consensus 751 VmEy~~gGsL 760 (958)
+|+|++|..+
T Consensus 99 l~~~i~G~~~ 108 (339)
T 3i1a_A 99 AYPFIHAPNG 108 (339)
T ss_dssp EEECCCCCBT
T ss_pred EEeccCCCcC
Confidence 9999998765
|
| >3isr_A Transglutaminase-like enzymes, putative cysteine; protease, hutchinsoni MCSG, structural genomics; 1.90A {Cytophaga hutchinsonii} | Back alignment and structure |
|---|
Probab=96.00 E-value=0.0069 Score=66.12 Aligned_cols=102 Identities=15% Similarity=0.122 Sum_probs=67.4
Q ss_pred HHHHHHHHHHhcCCCCchHHHHHHHHHHHHhhcCCCCCChhHHHHhHHHHHHHHHHHhCCceeEeeecccccchhhHHHH
Q 002160 195 ELVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPVKDANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLF 274 (958)
Q Consensus 195 ~L~~~a~~l~~~l~~~~~~~~~~~lA~~V~~~mgg~~~~~~~~~~~~~~~~~~l~~~~~s~v~pig~i~~G~~rhRAlLF 274 (958)
++.+.|..+..+.. +..+.++.|...|.+.+. ........... ...-|+ -+.|+|++-|.||
T Consensus 127 ~i~~~A~~~~~~~~--~~~~~~~ai~~~v~~~~~-Y~~~~~~~~~~---a~~~l~------------~~~G~C~d~A~l~ 188 (293)
T 3isr_A 127 KLQKLAYKEFGKIE--NVYSKVLAITDWIYNNVE-YISGSTNSQTS---AFDTIT------------ERAGVCRDFAHLG 188 (293)
T ss_dssp GSHHHHHHHHTTCC--SHHHHHHHHHHHHHHHSE-ECTTSCCTTCC---HHHHHH------------HCEECHHHHHHHH
T ss_pred HHHHHHHHHhccCC--CHHHHHHHHHHHHHhhcE-EeccCCCCCCC---HHHhhc------------CCcEehHHHHHHH
Confidence 35666777765543 336778999999988654 21111100001 111222 3589999999999
Q ss_pred HHhhhcCCCCceeecccCCC--CccCcceEEEEeCCcceeeee
Q 002160 275 KVLADSIRLPCRLVKGSHYT--GVEDDAVNIIKLEEEREFLVD 315 (958)
Q Consensus 275 KvLaD~i~l~c~lv~G~~~~--g~~~~a~~~v~~~~~~~~~vD 315 (958)
..||-.+|||||+|-|.... ..+.+||++|.+.+ .=+.+|
T Consensus 189 val~Ra~GIPAR~VsGy~~~~~~~~~HAW~Evyl~g-gWv~~D 230 (293)
T 3isr_A 189 IALCRALSIPARYFTGYAFKLNPPDFHACFEAYIGG-NWIIFD 230 (293)
T ss_dssp HHHHHHTTCCEEEEEEEETTCSSCCEEEEEEEEETT-EEEEEC
T ss_pred HHHHHHCCCCEEEEEEECCCCCCCCeEEEEEEEECC-cEEEEE
Confidence 99999999999999997543 23458999999976 344444
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.83 E-value=0.059 Score=56.67 Aligned_cols=141 Identities=18% Similarity=0.158 Sum_probs=90.6
Q ss_pred CCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHH-HhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCCC
Q 002160 758 GSLFRILHRPHCQVDEKRRIKMALD-ARGMNCL-HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST 835 (958)
Q Consensus 758 GsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yL-H~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s~ 835 (958)
-+|.++|...+.++.+...+-++.+ +.+|.-+ +... -..+=+-|..|+|..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc------------
Confidence 4899999887778877777766655 4444332 1111 12334557999999999998763 2110
Q ss_pred CCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhc-
Q 002160 836 AGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQT- 914 (958)
Q Consensus 836 ~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~k- 914 (958)
.....+.+||... ...+.+.=|||||+++|.-+--..| ...+..+++.+.+||..|...
T Consensus 98 ~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~-------------------e~eE~eLS~~LE~LL~~Mt~~~ 157 (229)
T 2yle_A 98 AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK-------------------ENEERELSPPLEQLIDHMANTV 157 (229)
T ss_dssp ---------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC-------------------TTEEECCCHHHHHHHHHHTTCC
T ss_pred ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC-------------------cccchhhCHHHHHHHHHHHhcc
Confidence 1233567888864 3346889999999999998753332 112346899999999999865
Q ss_pred ------------------------CCCCCCCHHHHHHHHHhhh
Q 002160 915 ------------------------DPSLRPSFAQLTVALKPLQ 933 (958)
Q Consensus 915 ------------------------DP~kRPSa~EIL~~L~kL~ 933 (958)
.+..|+++++|++..+...
T Consensus 158 ~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~hl 200 (229)
T 2yle_A 158 EADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAHL 200 (229)
T ss_dssp C--------------------CCSCCCCCCSHHHHHHHHHTTS
T ss_pred cccccccccccccccccccccccccccCcCCHHHHHHHHHhhc
Confidence 2468899999998887653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.94 E-value=0.056 Score=61.79 Aligned_cols=74 Identities=14% Similarity=0.132 Sum_probs=49.2
Q ss_pred EEEEeeccCceEEEEEEEC---------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeccccCCCceE
Q 002160 680 LGERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 680 i~k~LG~G~fG~Vykak~~---------g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~-HPNIVkL~g~~~~~~~l~ 749 (958)
-.+.|..|-...+|++... ++.|++++..... .......+|..+++.|. +.-..++++.+. -+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~ 146 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP----EG 146 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CC
Confidence 3566888889999999875 6889999754321 11123457888888884 333455665443 27
Q ss_pred EEEeecCCCCH
Q 002160 750 IITEFLPRGSL 760 (958)
Q Consensus 750 LVmEy~~gGsL 760 (958)
+||||++|..|
T Consensus 147 ~I~efI~G~~l 157 (424)
T 3mes_A 147 RIEEFIDGEPL 157 (424)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEeCCccC
Confidence 89999998653
|
| >2f4m_A Peptide N-glycanase; glycoproteins, ubiquitin-dependent protein degradation, NUCL excision repair, peptide:N-glycanase; 1.85A {Mus musculus} SCOP: d.3.1.4 PDB: 2f4o_A* | Back alignment and structure |
|---|
Probab=94.33 E-value=0.031 Score=60.97 Aligned_cols=48 Identities=17% Similarity=0.145 Sum_probs=41.2
Q ss_pred ccccchhhHHHHHHhhhcCCCCceeecccCCCCccCcceEEEEeCC-cceeeee
Q 002160 263 NIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDDAVNIIKLEE-EREFLVD 315 (958)
Q Consensus 263 ~~G~~rhRAlLFKvLaD~i~l~c~lv~G~~~~g~~~~a~~~v~~~~-~~~~~vD 315 (958)
+.|.|++-|.||-.|+-.+|||||+|-|. ++.||++|.+.. .+=.-||
T Consensus 139 r~G~C~d~A~lf~al~Ra~GIpAR~V~Gy-----~~HaW~Evy~~g~~gWv~~D 187 (295)
T 2f4m_A 139 RCGRCGEWANCFTLCCRALGFEARYVWDY-----TDHVWTEVYSPSQQRWLHCD 187 (295)
T ss_dssp CEESHHHHHHHHHHHHHHTTCCEEEEEET-----TTEEEEEEEETTTTEEEEEE
T ss_pred CCEeeHHHHHHHHHHHHHCCCCEEEEcCC-----CCEEEEEEEECCCCeEEEEe
Confidence 68999999999999999999999999996 578999999976 3333444
|
| >3kd4_A Putative protease; structural genomics, joint center for STR genomics, JCSG, protein structure initiative, PSI-2, hydrol; HET: MSE; 2.00A {Parabacteroides distasonis atcc 8503} | Back alignment and structure |
|---|
Probab=94.23 E-value=0.12 Score=60.45 Aligned_cols=106 Identities=11% Similarity=0.036 Sum_probs=65.3
Q ss_pred HHHHHHHHHhcCCCCchHHHHHHHHHHHHhhcCCCCCChhHHHHhHHHHHHHHHHHhCCceeEeeecccccchhhHHHHH
Q 002160 196 LVQVAQCIALDLPATDVGILVQQLADLVNGHMGGPVKDANIMLARWMERSTELRRSLQTSVLPIGSINIGLSRHRALLFK 275 (958)
Q Consensus 196 L~~~a~~l~~~l~~~~~~~~~~~lA~~V~~~mgg~~~~~~~~~~~~~~~~~~l~~~~~s~v~pig~i~~G~~rhRAlLFK 275 (958)
+++.|..+..+... ..+.++.|-.+|.+.+.=.....+..-..-.....-|+.. .|.|+--|+||.
T Consensus 230 i~~~a~~l~~~~~~--~~ek~~~iy~~V~~~i~y~~~~~~~~g~~~~~a~~vl~~~------------~G~C~d~a~Ll~ 295 (506)
T 3kd4_A 230 SKTFAQFLTDKSGN--EQEKVNIIRDHILNNLSTCPIPMAMTGYTVRDIDTVLRSA------------YGTPLEIAQLLN 295 (506)
T ss_dssp HHHHHHHHHSSCSS--HHHHHHHHHHHHHHHCEECCCCGGGGTTCCCCHHHHHHHT------------EECHHHHHHHHH
T ss_pred HHHHHHHHHhcCCC--HHHHHHHHHHHHHhccEecceecccCCCCCCCHHHHHHhC------------CcchHHHHHHHH
Confidence 44555666655432 2566677777777666311000000000000122333333 699999999999
Q ss_pred HhhhcCCCCceeecccCC--------CCccCcceEEEEeCCcceeeeec
Q 002160 276 VLADSIRLPCRLVKGSHY--------TGVEDDAVNIIKLEEEREFLVDL 316 (958)
Q Consensus 276 vLaD~i~l~c~lv~G~~~--------~g~~~~a~~~v~~~~~~~~~vDl 316 (958)
.|+-..|||||+|-+.-. -...+.+|..|.+ +++.|++|-
T Consensus 296 AllRa~GIpA~~v~~~t~~~~~~~~~lp~~nh~i~~v~~-~g~~y~lDa 343 (506)
T 3kd4_A 296 VMLNAAGIPSEVLAVYPGHLDTDACGLAAIQTLAVKATV-DGKDQYLSA 343 (506)
T ss_dssp HHHHHTTCCEEEEEEEETTSCGGGCCSTTCCEEEEEEEE-TTEEEEESS
T ss_pred HHHHHCCCCcEEEEEEcCCCCCccCCCCCCCEEEEEEEE-CCEEEEEec
Confidence 999999999999987732 1122678888886 577999997
|
| >1x3z_A Peptide: N-glycanase; hydrolase-hydrolase inhibitor complex; HET: SUC; 2.80A {Saccharomyces cerevisiae} SCOP: d.3.1.4 PDB: 1x3w_A* 3esw_A* | Back alignment and structure |
|---|
Probab=91.30 E-value=0.15 Score=56.44 Aligned_cols=48 Identities=23% Similarity=0.179 Sum_probs=40.5
Q ss_pred ccccchhhHHHHHHhhhcCCCCceeecccCCCCccCcceEEEEeCCcceee-ee
Q 002160 263 NIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDDAVNIIKLEEEREFL-VD 315 (958)
Q Consensus 263 ~~G~~rhRAlLFKvLaD~i~l~c~lv~G~~~~g~~~~a~~~v~~~~~~~~~-vD 315 (958)
+.|.|.|=|.||=.|+=.+|||||+|-| ..+.+|++|.+.....+| ||
T Consensus 180 r~G~C~e~A~lF~~llRalGi~aR~V~~-----~~~H~W~EV~~~~~~rWv~vD 228 (335)
T 1x3z_A 180 RKGRCGEWCNLFTLILKSFGLDVRYVWN-----REDHVWCEYFSNFLNRWVHVD 228 (335)
T ss_dssp CEECHHHHHHHHHHHHHTTTCCEEEEEE-----TTTEEEEEEEETTTTEEEEEE
T ss_pred CCcChHHHHHHHHHHHHHCCCCeEEEec-----CCCcEEEEEEECCCCCEEEEC
Confidence 3799999999999999999999999987 468899999997754333 44
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.39 E-value=1 Score=50.36 Aligned_cols=29 Identities=24% Similarity=0.425 Sum_probs=25.2
Q ss_pred EeecCCCCCceEE------cCCCcEEEEecccccc
Q 002160 796 IVHRDLKSPNLLV------DKNWNVKVSDFGLSRL 824 (958)
Q Consensus 796 IIHRDLKPeNILI------d~~g~VKL~DFGLAk~ 824 (958)
++|+|+.+.|||+ ++++.++|+||-+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567899999998864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 958 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-80 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-74 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-70 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-70 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-70 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-70 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-69 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-69 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-68 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-68 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-68 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-68 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-67 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-67 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-66 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-66 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-65 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-65 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-65 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-64 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-64 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-63 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-63 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-63 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-62 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-62 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-61 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-60 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-60 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-59 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-58 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-57 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-56 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-55 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-55 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-55 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-55 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-54 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-54 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-53 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-51 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-50 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-49 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-48 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-47 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-47 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-46 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-46 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-46 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-45 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-45 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-44 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-43 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-42 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-37 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-36 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-35 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-33 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-20 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 259 bits (663), Expect = 3e-80
Identities = 93/273 (34%), Positives = 151/273 (55%), Gaps = 14/273 (5%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
EIP + +G+RIG GS+G VY W+G VAVK + L FK EV ++R+ R
Sbjct: 4 EIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLH 790
H N++LFMG T P L+I+T++ SL+ LH + + + I +A A+GM+ LH
Sbjct: 63 HVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 791 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKST--AGTPEWMAPEVLR 848
+I+HRDLKS N+ + ++ VK+ DFGL+ +K S + +G+ WMAPEV+R
Sbjct: 122 A--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 849 NE---PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL----EIPKELD 901
+ P + + DVY+FG++L+EL T +LP+ +N + + + ++
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239
Query: 902 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934
+ R++ EC + RP F Q+ +++ L R
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (618), Expect = 5e-74
Identities = 85/267 (31%), Positives = 137/267 (51%), Gaps = 14/267 (5%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
+ ++L L + IG G +G+V D+ G +VAVK + A F E +M +LR
Sbjct: 3 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND----ATAQAFLAEASVMTQLR 58
Query: 732 HPNVVLFMGAVTRPPN-LSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALD-ARGMNC 788
H N+V +G + L I+TE++ +GSL L R + +K +LD M
Sbjct: 59 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 118
Query: 789 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 848
L VHRDL + N+LV ++ KVSDFGL++ +T + +W APE LR
Sbjct: 119 LEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALR 173
Query: 849 NEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARI 907
+ + K DV+SFG++LWE+ + ++P+ + VV V + +++ P P V +
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVYEV 232
Query: 908 IWECWQTDPSLRPSFAQLTVALKPLQR 934
+ CW D ++RPSF QL L+ ++
Sbjct: 233 MKNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (592), Expect = 2e-70
Identities = 79/257 (30%), Positives = 121/257 (47%), Gaps = 10/257 (3%)
Query: 673 IPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
I +DL + +G G +G V + W +VA+K + S EF E K+M L
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLS 57
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLH 790
H +V G T+ + IITE++ G L L + ++ ++M D M L
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 791 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRN 849
+ +HRDL + N LV+ VKVSDFGLSR + + + SS + W PEVL
Sbjct: 118 --SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 850 EPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 908
+ K D+++FGV++WE+ +L K+P+ + + Q RL P V I+
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTIM 234
Query: 909 WECWQTDPSLRPSFAQL 925
+ CW RP+F L
Sbjct: 235 YSCWHEKADERPTFKIL 251
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 233 bits (594), Expect = 4e-70
Identities = 87/287 (30%), Positives = 134/287 (46%), Gaps = 21/287 (7%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDFSGAALLEFKREVKI 726
EI + + + IG G +GEV VA+K L ++ +F E I
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKT-LKSGYTEKQRRDFLSEASI 80
Query: 727 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARG 785
M + HPNV+ G VT+ + IITEF+ GSL L + Q + + M A G
Sbjct: 81 MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140
Query: 786 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-----KHNTFLSSKSTAGTPE 840
M L VHRDL + N+LV+ N KVSDFGLSR T+ S+
Sbjct: 141 MKYLAD--MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR 198
Query: 841 WMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKE 899
W APE ++ DV+S+G+++WE+ + + P+ M V+ A+ Q+ RL P +
Sbjct: 199 WTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPPMD 257
Query: 900 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSS 946
+ +++ +CWQ D + RP F Q+ L + R +P+ +
Sbjct: 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR-----NPNSLKA 299
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (590), Expect = 5e-70
Identities = 80/265 (30%), Positives = 129/265 (48%), Gaps = 10/265 (3%)
Query: 673 IPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
I +L + IG G +G V+ W N +VA+K + S +F E ++M +L
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLS 58
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLH 790
HP +V G + ++ EF+ G L L + + M LD GM L
Sbjct: 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 791 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEVLRN 849
++HRDL + N LV +N +KVSDFG++R + + + SS T +W +PEV
Sbjct: 119 E--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 850 EPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 908
+ K DV+SFGV++WE+ + K+P+ + +VV + RL P+ V +I+
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQIM 235
Query: 909 WECWQTDPSLRPSFAQLTVALKPLQ 933
CW+ P RP+F++L L +
Sbjct: 236 NHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (590), Expect = 5e-70
Identities = 70/261 (26%), Positives = 120/261 (45%), Gaps = 12/261 (4%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
ED + IG GSYG +G + K+ + A EV ++R L+HP
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 734 NVVLFMGAVTRPPN--LSIITEFLPRGSLFRILH---RPHCQVDEKRRIKMALD-ARGMN 787
N+V + + N L I+ E+ G L ++ + +DE+ +++ +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 788 CLH---TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 844
H T++HRDLK N+ +D NVK+ DFGL+R+ ++ +K+ GTP +M+P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 845 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 904
E + NEK D++S G +L+EL L P+ + ++ G + + + IP +
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-REGKFRRIPYRYSDEL 242
Query: 905 ARIIWECWQTDPSLRPSFAQL 925
II RPS ++
Sbjct: 243 NEIITRMLNLKDYHRPSVEEI 263
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (586), Expect = 2e-69
Identities = 86/274 (31%), Positives = 128/274 (46%), Gaps = 14/274 (5%)
Query: 671 CEIPWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLE-FKREV 724
C I +DL L E++G GS+G V +W+ VAVK S ++ F REV
Sbjct: 3 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREV 62
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-A 783
M L H N++ G V PP + ++TE P GSL L + + A+ A
Sbjct: 63 NAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121
Query: 784 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL---KHNTFLSSKSTAGTPE 840
GM L + +HRDL + NLL+ VK+ DFGL R + ++ +
Sbjct: 122 EGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 841 WMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKE 899
W APE L+ + D + FGV LWE+ T + PWIG+N Q++ + + RL P++
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239
Query: 900 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 933
+ ++ +CW P RP+F L L Q
Sbjct: 240 CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (586), Expect = 2e-69
Identities = 84/275 (30%), Positives = 141/275 (51%), Gaps = 15/275 (5%)
Query: 663 IFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFK 721
++D+ E+P E L L ER+G G +GEV+ +N T+VAVK S F
Sbjct: 3 WWEDEW---EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFL 56
Query: 722 REVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPH-CQVDEKRRIKMA 780
E +M++L+H +V VT+ P + IITE++ GSL L P ++ + + MA
Sbjct: 57 AEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMA 115
Query: 781 LD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGT 838
A GM + +HRDL++ N+LV + K++DFGL+R ++ N + + +
Sbjct: 116 AQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 839 PEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIP 897
+W APE + K DV+SFG++L E+ T ++P+ GM +V+ + + R+ P
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRP 232
Query: 898 KELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932
+ +++ CW+ P RP+F L L+
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 1e-68
Identities = 91/282 (32%), Positives = 141/282 (50%), Gaps = 14/282 (4%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGT-EVAVKKFLDQDFSGAALLEFKREVKIMRRL 730
EIP E L L ++G G +GEV+ WNGT VA+K S F +E ++M++L
Sbjct: 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKL 69
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALD-ARGMNC 788
RH +V V+ P + I+TE++ +GSL L + + + MA A GM
Sbjct: 70 RHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 128
Query: 789 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL-KHNTFLSSKSTAGTPEWMAPEVL 847
+ VHRDL++ N+LV +N KV+DFGL+RL + N + + + +W APE
Sbjct: 129 VER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186
Query: 848 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 906
K DV+SFG++L EL T ++P+ GM +V+ V + R+ P E +
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHD 245
Query: 907 IIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSAL 948
++ +CW+ +P RP+F L L+ QP L
Sbjct: 246 LMCQCWRKEPEERPTFEYLQAFLEDY--FTSTEPQYQPGENL 285
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (577), Expect = 5e-68
Identities = 68/271 (25%), Positives = 126/271 (46%), Gaps = 15/271 (5%)
Query: 670 ECEIPWEDLVLGER-IGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREV 724
+ + ++L++ + +G G++G V + +VA+K L Q A E RE
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMREA 60
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-A 783
+IM +L +P +V +G V + L ++ E G L + L ++ ++ +
Sbjct: 61 QIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119
Query: 784 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL---KHNTFLSSKSTAGTPE 840
GM L VHRDL + N+L+ K+SDFGLS+ + + + + +
Sbjct: 120 MGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177
Query: 841 WMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKE 899
W APE + + + DV+S+GV +WE + + P+ M +V+ + Q +R+E P E
Sbjct: 178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPE 236
Query: 900 LDPLVARIIWECWQTDPSLRPSFAQLTVALK 930
P + ++ +CW RP F + ++
Sbjct: 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (576), Expect = 6e-68
Identities = 79/254 (31%), Positives = 120/254 (47%), Gaps = 11/254 (4%)
Query: 680 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
IG GS+ VY EVA + D+ + + FK E ++++ L+HPN+V
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 738 FMGA----VTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTST 793
F + V + ++TE + G+L L R + R +G+ LHT T
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 794 PTIVHRDLKSPN-LLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 852
P I+HRDLK N + +VK+ D GL+ LK +F +K+ GTPE+MAPE+ +
Sbjct: 133 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMAPEMYEEKYD 190
Query: 853 NEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 911
E DVY+FG+ + E+AT + P+ N Q+ V + K P V II C
Sbjct: 191 -ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGC 249
Query: 912 WQTDPSLRPSFAQL 925
+ + R S L
Sbjct: 250 IRQNKDERYSIKDL 263
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (575), Expect = 8e-68
Identities = 81/269 (30%), Positives = 125/269 (46%), Gaps = 13/269 (4%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGTE-----VAVKKFLDQDFSGAALLEFKREVKI 726
EI E + LG IG G +G+V+ + E VA+K S + +F +E
Sbjct: 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKT-CKNCTSDSVREKFLQEALT 61
Query: 727 MRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARG 785
MR+ HP++V +G +T + II E G L L +D I A +
Sbjct: 62 MRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120
Query: 786 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAP 844
+ L + VHRD+ + N+LV N VK+ DFGLSR ++ +T+ + +WMAP
Sbjct: 121 LAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 845 EVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 903
E + DV+ FGV +WE+ P+ G+ V+G + RL +P P
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPPNCPPT 237
Query: 904 VARIIWECWQTDPSLRPSFAQLTVALKPL 932
+ ++ +CW DPS RP F +L L +
Sbjct: 238 LYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 4e-67
Identities = 71/269 (26%), Positives = 124/269 (46%), Gaps = 15/269 (5%)
Query: 673 IPWEDLVLGER-IGLGSYGEVYHADWN----GTEVAVKKFLDQDFSGAALLEFKREVKIM 727
+ + L L ++ +G G++G V + VAVK ++ A E E +M
Sbjct: 3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62
Query: 728 RRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGM 786
++L +P +V +G + + ++ E G L + L + + V +K I++ + GM
Sbjct: 63 QQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGM 120
Query: 787 NCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL---KHNTFLSSKSTAGTPEWMA 843
L S VHRDL + N+L+ K+SDFGLS+ N + + +W A
Sbjct: 121 KYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178
Query: 844 PEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 902
PE + + K DV+SFGV++WE + + P+ GM +V + + R+ P
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPR 237
Query: 903 LVARIIWECWQTDPSLRPSFAQLTVALKP 931
+ ++ CW D RP FA + + L+
Sbjct: 238 EMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 223 bits (570), Expect = 5e-67
Identities = 89/268 (33%), Positives = 136/268 (50%), Gaps = 10/268 (3%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRR 729
E+ D+ + ++G G YGEVY W VAVK + EF +E +M+
Sbjct: 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKE 69
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALD-ARGMN 787
++HPN+V +G TR P IITEF+ G+L L +V + MA + M
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129
Query: 788 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR-LKHNTFLSSKSTAGTPEWMAPEV 846
L +HRDL + N LV +N VKV+DFGLSR + +T+ + +W APE
Sbjct: 130 YLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 187
Query: 847 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 906
L + K DV++FGV+LWE+AT + + V + ++ R+E P+ V
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 247
Query: 907 IIWECWQTDPSLRPSFAQLTVALKPLQR 934
++ CWQ +PS RPSFA++ A + + +
Sbjct: 248 LMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (568), Expect = 2e-66
Identities = 82/285 (28%), Positives = 136/285 (47%), Gaps = 27/285 (9%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGT----EVAVKKFLDQDFSGAALLEFKREVKIM 727
+ W D+ + IG G++G+V A + A+K+ + + S +F E++++
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR-MKEYASKDDHRDFAGELEVL 64
Query: 728 RRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ---------------V 771
+L HPN++ +GA L + E+ P G+L L + +
Sbjct: 65 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 772 DEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 830
++ + A D ARGM+ L +HRDL + N+LV +N+ K++DFGLSR ++
Sbjct: 125 SSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRG-QEVYV 181
Query: 831 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGF 889
WMA E L DV+S+GV+LWE+ +L P+ GM ++ +
Sbjct: 182 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP- 240
Query: 890 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934
Q RLE P D V ++ +CW+ P RPSFAQ+ V+L +
Sbjct: 241 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 5e-66
Identities = 80/293 (27%), Positives = 127/293 (43%), Gaps = 37/293 (12%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGT-------EVAVKKFLDQDFSGAALLEFKREV 724
E P E+L G+ +G G++G+V +A G +VAVK L + + E+
Sbjct: 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKM-LKEKADSSEREALMSEL 91
Query: 725 KIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ------------- 770
K+M +L H N+V +GA T + +I E+ G L L +
Sbjct: 92 KMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 151
Query: 771 ---------VDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 820
+ + + A A+GM L + VHRDL + N+LV VK+ DFG
Sbjct: 152 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCVHRDLAARNVLVTHGKVVKICDFG 209
Query: 821 LSRL--KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIG 877
L+R + ++ + +WMAPE L K DV+S+G++LWE+ +L P+ G
Sbjct: 210 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269
Query: 878 MNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 930
+ + +++ P + I+ CW D RPSF LT L
Sbjct: 270 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 2e-65
Identities = 76/285 (26%), Positives = 131/285 (45%), Gaps = 18/285 (6%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADWNGT------EVAVKKFLDQDFSGAALLEFKREVK 725
EI + + IG G +GEVY + VA+K L ++ ++F E
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT-LKAGYTEKQRVDFLGEAG 61
Query: 726 IMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARG 785
IM + H N++ G +++ + IITE++ G+L + L + + + M
Sbjct: 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGI-A 120
Query: 786 MNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA---GTPEWM 842
+ + VHRDL + N+LV+ N KVSDFGLSR+ + ++ +T+ W
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 843 APEVLRNEPSNEKCDVYSFGVILWELATLKLPWI-GMNPMQVVGAVGFQNRRLEIPKELD 901
APE + DV+SFG+++WE+ T ++ +V+ A+ RL P +
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMDCP 239
Query: 902 PLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSS 946
+ +++ +CWQ + + RP FA + L L R PD +
Sbjct: 240 SAIYQLMMQCWQQERARRPKFADIVSILDKLIR-----APDSLKT 279
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 2e-65
Identities = 73/279 (26%), Positives = 128/279 (45%), Gaps = 20/279 (7%)
Query: 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731
P + + +G G++G+VY A A K + ++ E+ I+
Sbjct: 10 PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE--DYMVEIDILASCD 67
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLH 790
HPN+V + A NL I+ EF G++ ++ + E + + +N LH
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127
Query: 791 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL--- 847
+ I+HRDLK+ N+L + ++K++DFG+S T S GTP WMAPEV+
Sbjct: 128 DNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 185
Query: 848 --RNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPLV 904
++ P + K DV+S G+ L E+A ++ P +NPM+V+ + L P
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF 245
Query: 905 ARIIWECWQTDPSLRPSFAQL-------TVALKPLQRLV 936
+ +C + + R + +QL + KP++ L+
Sbjct: 246 KDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELI 284
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 6e-65
Identities = 83/288 (28%), Positives = 130/288 (45%), Gaps = 18/288 (6%)
Query: 667 DVCECEIPWEDLVL--GERIGLGSYGEVYHA-----DWNGTEVAVKKFLDQDFSGAALLE 719
V I L++ E IG G +G VYH D AVK L++ + +
Sbjct: 16 AVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVSQ 74
Query: 720 FKREVKIMRRLRHPNVVLFMGAVTRPPN-LSIITEFLPRGSLFRILHRPHCQVDEKRRIK 778
F E IM+ HPNV+ +G R ++ ++ G L + K I
Sbjct: 75 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 134
Query: 779 MALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH----NTFLSSK 833
L A+GM L + VHRDL + N ++D+ + VKV+DFGL+R + ++ +
Sbjct: 135 FGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 192
Query: 834 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNR 892
+WMA E L+ + K DV+SFGV+LWEL T P+ +N + + Q R
Sbjct: 193 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGR 251
Query: 893 RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSH 940
RL P+ + ++ +CW +RPSF++L + + I H
Sbjct: 252 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 1e-64
Identities = 64/254 (25%), Positives = 116/254 (45%), Gaps = 11/254 (4%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRH 732
ED +G +G G +G VY A + +A+K A + +REV+I LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHT 791
PN++ G + +I E+ P G+++R L + DE+R + A ++ H+
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHS 124
Query: 792 STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 851
++HRD+K NLL+ +K++DFG S ++ + GT +++ PE++
Sbjct: 125 KR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRM 180
Query: 852 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 911
+EK D++S GV+ +E K P+ + + P + +I
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRL 238
Query: 912 WQTDPSLRPSFAQL 925
+ +PS RP ++
Sbjct: 239 LKHNPSQRPMLREV 252
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 217 bits (553), Expect = 2e-64
Identities = 77/295 (26%), Positives = 127/295 (43%), Gaps = 38/295 (12%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREV 724
E P ++ IG G++G V+ A T VAVK L ++ S +F+RE
Sbjct: 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM-LKEEASADMQADFQREA 67
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQ-------------- 770
+M +PN+V +G + ++ E++ G L L
Sbjct: 68 ALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 127
Query: 771 ---------VDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 820
+ ++ +A A GM L VHRDL + N LV +N VK++DFG
Sbjct: 128 RVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVHRDLATRNCLVGENMVVKIADFG 185
Query: 821 LSRLKH--NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKL-PWIG 877
LSR + + + + + A WM PE + + DV+++GV+LWE+ + L P+ G
Sbjct: 186 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245
Query: 878 MNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932
M +V+ V L P+ + ++ CW P+ RPSF + L+ +
Sbjct: 246 MAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 1e-63
Identities = 83/279 (29%), Positives = 139/279 (49%), Gaps = 24/279 (8%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHA-------DWNGTEVAVKKFLDQDFSGAALLEFKREV 724
E+ E + + +G GS+G VY D T VA+K +++ S +EF E
Sbjct: 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT-VNEAASMRERIEFLNEA 74
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQV---------DEKR 775
+M+ +VV +G V++ +I E + RG L L + +
Sbjct: 75 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 776 RIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 834
I+MA + A GM L+ + VHRDL + N +V +++ VK+ DFG++R + T K
Sbjct: 135 MIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192
Query: 835 TA--GTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQN 891
WM+PE L++ DV+SFGV+LWE+ATL + P+ G++ QV+ V +
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-MEG 251
Query: 892 RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 930
L+ P ++ ++ CWQ +P +RPSF ++ ++K
Sbjct: 252 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 5e-63
Identities = 65/262 (24%), Positives = 121/262 (46%), Gaps = 8/262 (3%)
Query: 667 DVCECEIPWEDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREV 724
+ P + E+IG G+ G VY A G EVA+++ Q E+
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE--LIINEI 68
Query: 725 KIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDAR 784
+MR ++PN+V ++ + L ++ E+L GSL ++ + + +
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQ 127
Query: 785 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 844
+ LH++ ++HRD+KS N+L+ + +VK++DFG + GTP WMAP
Sbjct: 128 ALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
Query: 845 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR-RLEIPKELDPL 903
EV+ + K D++S G++ E+ + P++ NP++ + + L+ P++L +
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245
Query: 904 VARIIWECWQTDPSLRPSFAQL 925
+ C D R S +L
Sbjct: 246 FRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 8e-63
Identities = 86/300 (28%), Positives = 132/300 (44%), Gaps = 46/300 (15%)
Query: 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNV 735
+VL E IG G +GEV+ W G EVAVK F ++ + E+ LRH N+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERS---WFREAEIYQTVMLRHENI 59
Query: 736 VLFMGAVTRP----PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLH 790
+ F+ A + L +++++ GSLF L+R V + IK+AL A G+ LH
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLH 117
Query: 791 T------STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL----KHNTFLSSKSTAGTPE 840
P I HRDLKS N+LV KN ++D GL+ ++ GT
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 841 WMAPEVLRNE------PSNEKCDVYSFGVILWELATLKLPWIGMNPMQ------------ 882
+MAPEVL + S ++ D+Y+ G++ WE+A Q
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237
Query: 883 ---VVGAVGFQNRRLEIPK-----ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934
+ V Q R IP E ++A+I+ ECW + + R + ++ L L +
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 211 bits (538), Expect = 4e-62
Identities = 72/272 (26%), Positives = 112/272 (41%), Gaps = 20/272 (7%)
Query: 661 DQIFDDDVCECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKF-LDQDFSGAAL 717
+ F DD P + IG GS+G VY A N VA+KK S
Sbjct: 6 ELFFKDD------PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59
Query: 718 LEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRI 777
+ +EV+ +++LRHPN + + G R ++ E+ + + + E
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIA 118
Query: 778 KMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTA 836
+ +G+ LH+ ++HRD+K+ N+L+ + VK+ DFG + + S
Sbjct: 119 AVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFV 172
Query: 837 GTPEWMAPEVLR---NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR 893
GTP WMAPEV+ + K DV+S G+ ELA K P MN M + +
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 232
Query: 894 LEIPKELDPLVARIIWECWQTDPSLRPSFAQL 925
+ C Q P RP+ L
Sbjct: 233 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 7e-62
Identities = 76/297 (25%), Positives = 125/297 (42%), Gaps = 35/297 (11%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREV 724
E P L G+ +G G++G+V A VAVK L E+
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM-LKPSAHLTEREALMSEL 77
Query: 725 KIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHR----------------- 766
K++ L H N+V +GA T +ITE+ G L L R
Sbjct: 78 KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 767 PHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL- 824
+D + + + A+GM L + +HRDL + N+L+ K+ DFGL+R
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 825 -KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWI-GMNPMQ 882
+ ++ + +WMAPE + N + DV+S+G+ LWEL +L GM
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 883 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPS 939
+ + R+ P+ + I+ CW DP RP+F Q+ ++ +++ + S
Sbjct: 256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI---VQLIEKQISES 309
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 1e-61
Identities = 73/291 (25%), Positives = 126/291 (43%), Gaps = 13/291 (4%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVK---KFLDQDFSGAALLEFKREVKIMRRL 730
+ + +G G++G VY W G +V + K L + S A E E +M +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 731 RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCL 789
+P+V +G + +IT+ +P G L + + + + + A+GMN L
Sbjct: 69 DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 790 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVL 847
+VHRDL + N+LV +VK++DFGL++L ++ +WMA E +
Sbjct: 128 ED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 848 RNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 906
+ + DV+S+GV +WEL T P+ G+ ++ + + RL P V
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTIDVYM 244
Query: 907 IIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQEISVNST 957
I+ +CW D RP F +L + + R Q + +S
Sbjct: 245 IMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSN 295
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 2e-61
Identities = 67/283 (23%), Positives = 122/283 (43%), Gaps = 14/283 (4%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRR 729
E+ +D +G G+ G V+ +G +A K + + A + RE++++
Sbjct: 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKL-IHLEIKPAIRNQIIRELQVLHE 60
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNC 788
P +V F GA +SI E + GSL ++L + ++ E+ K+++ +G+
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTY 119
Query: 789 LHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 848
L I+HRD+K N+LV+ +K+ DFG+S ++ + S GT +M+PE L+
Sbjct: 120 LREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQ 176
Query: 849 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 908
+ + D++S G+ L E+A + P + ++ + F + E P
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL--ELMFGCQVEGDAAETPPRPRTPG 234
Query: 909 WECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPDQPSSALPQE 951
RP A + L +V P PS E
Sbjct: 235 RPLSSYGMDSRPPMA----IFELLDYIVNEPPPKLPSGVFSLE 273
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 2e-60
Identities = 55/271 (20%), Positives = 111/271 (40%), Gaps = 15/271 (5%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRH 732
ED G+ +G GS+ V A E A+K + RE +M RL H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTS 792
P V L + G L + + + + R A + LH
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG- 126
Query: 793 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH--NTFLSSKSTAGTPEWMAPEVLRNE 850
I+HRDLK N+L++++ +++++DFG +++ + + S GT ++++PE+L +
Sbjct: 127 -KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 851 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 910
+ + D+++ G I+++L P+ N + + + P++ P ++ +
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI--IKLEYDFPEKFFPKARDLVEK 243
Query: 911 CWQTDPSLRPSFAQLTVALKPLQRLVIPSHP 941
D + R ++ + +HP
Sbjct: 244 LLVLDATKRLGCEEM------EGYGPLKAHP 268
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 2e-60
Identities = 88/294 (29%), Positives = 151/294 (51%), Gaps = 36/294 (12%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADW---------NGTEVAVKKFLDQDFSGAALLEFKR 722
E+P + LVLG+ +G G++G+V A+ T+VAVK L D + L +
Sbjct: 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM-LKSDATEKDLSDLIS 67
Query: 723 EVKIMRRL-RHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILH---------------R 766
E+++M+ + +H N++ +GA T+ L +I E+ +G+L L
Sbjct: 68 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127
Query: 767 PHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825
P Q+ K + A ARGM L + +HRDL + N+LV ++ +K++DFGL+R
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 826 H--NTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQ 882
H + + + + +WMAPE L + + DV+SFGV+LWE+ TL P+ G+ +
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245
Query: 883 VVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLV 936
+ + + R++ P + ++ +CW PS RP+F QL ++ L R+V
Sbjct: 246 LFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL---VEDLDRIV 295
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 2e-59
Identities = 72/257 (28%), Positives = 113/257 (43%), Gaps = 11/257 (4%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
ED L + +G G+YGEV A VAVK +D + K+E+ I + L H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHE 63
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTS 792
NVV F G + E+ G LF + + E + G+ LH
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH-- 120
Query: 793 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL--KHNTFLSSKSTAGTPEWMAPEVLRNE 850
I HRD+K NLL+D+ N+K+SDFGL+ + +N GT ++APE+L+
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 851 P-SNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRLEIPKELDPLVARII 908
E DV+S G++L + +LPW + Q + L K++D ++
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240
Query: 909 WECWQTDPSLRPSFAQL 925
+ +PS R + +
Sbjct: 241 HKILVENPSARITIPDI 257
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 5e-58
Identities = 84/294 (28%), Positives = 136/294 (46%), Gaps = 31/294 (10%)
Query: 667 DVCECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLE 719
D + E P + L LG+ +G G++G+V AD VAVK L + + +
Sbjct: 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM-LKEGATHSEHRA 62
Query: 720 FKREVKIMRR-LRHPNVVLFMGAVTRPPN-LSIITEFLPRGSLFRILHRPHCQ------- 770
E+KI+ H NVV +GA T+P L +I EF G+L L +
Sbjct: 63 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122
Query: 771 --------VDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGL 821
+ + I + A+GM L + +HRDL + N+L+ + VK+ DFGL
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGL 180
Query: 822 SRL--KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGM 878
+R K ++ +WMAPE + + + DV+SFGV+LWE+ +L P+ G+
Sbjct: 181 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240
Query: 879 NPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932
+ + R+ P P + + + +CW +PS RP+F++L L L
Sbjct: 241 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 198 bits (505), Expect = 3e-57
Identities = 69/283 (24%), Positives = 115/283 (40%), Gaps = 18/283 (6%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
+ + E +G G++G V+ G A K + S ++E++ M LRHP
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE--TVRKEIQTMSVLRHP 83
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTS 792
+V A + +I EF+ G LF + H ++ E ++ +G+ +H
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH-- 141
Query: 793 TPTIVHRDLKSPNLLV--DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 850
VH DLK N++ ++ +K+ DFGL+ + S K T GT E+ APEV +
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA-HLDPKQSVKVTTGTAEFAAPEVAEGK 200
Query: 851 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV--GFQNRRLEIPKELDPLVARII 908
P D++S GV+ + L + P+ G N + + V N + I
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 260
Query: 909 WECWQTDPSLRPSFAQL------TVALKPLQRLVIPSHPDQPS 945
+ DP+ R + Q T P + IPS
Sbjct: 261 RKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKI 303
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 9e-56
Identities = 46/258 (17%), Positives = 106/258 (41%), Gaps = 13/258 (5%)
Query: 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH 732
+E ++ E +G G +G V+ + K G + K+E+ I+ RH
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV---KVKGTDQVLVKKEISILNIARH 60
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHT 791
N++ + L +I EF+ +F ++ +++E+ + + LH
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH- 119
Query: 792 STPTIVHRDLKSPNLLVD--KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 849
+ I H D++ N++ ++ +K+ +FG +R + + PE+ APEV ++
Sbjct: 120 -SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYAPEVHQH 177
Query: 850 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVARI 907
+ + D++S G +++ L + P++ Q++ + E KE+
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 908 IWECWQTDPSLRPSFAQL 925
+ + R + ++
Sbjct: 238 VDRLLVKERKSRMTASEA 255
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 193 bits (490), Expect = 2e-55
Identities = 62/256 (24%), Positives = 116/256 (45%), Gaps = 10/256 (3%)
Query: 676 EDLVLGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRH 732
+D + +G GS+G V+ NG A+K + +E E ++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTS 792
P ++ G + +I +++ G LF +L + + + A + LH+
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS- 122
Query: 793 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 852
I++RDLK N+L+DKN ++K++DFG ++ + + GTP+++APEV+ +P
Sbjct: 123 -KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---YTLCGTPDYIAPEVVSTKPY 178
Query: 853 NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 912
N+ D +SFG++++E+ P+ N M+ + N L P + V ++
Sbjct: 179 NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI--LNAELRFPPFFNEDVKDLLSRLI 236
Query: 913 QTDPSLRPSFAQLTVA 928
D S R Q
Sbjct: 237 TRDLSQRLGNLQNGTE 252
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 192 bits (489), Expect = 5e-55
Identities = 59/257 (22%), Positives = 106/257 (41%), Gaps = 12/257 (4%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
+ + E +G G++G V+ G K K E+ IM +L HP
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY--TVKNEISIMNQLHHP 86
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTS 792
++ A + +I EFL G LF + ++ E I G+ +H
Sbjct: 87 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 793 TPTIVHRDLKSPNLLVD--KNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 850
+IVH D+K N++ + K +VK+ DFGL+ + + +T T E+ APE++ E
Sbjct: 147 --SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT-ATAEFAAPEIVDRE 203
Query: 851 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVARII 908
P D+++ GV+ + L + P+ G + ++ + V + + + P I
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 263
Query: 909 WECWQTDPSLRPSFAQL 925
Q +P R +
Sbjct: 264 KNLLQKEPRKRLTVHDA 280
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 191 bits (485), Expect = 6e-55
Identities = 61/253 (24%), Positives = 110/253 (43%), Gaps = 11/253 (4%)
Query: 680 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ +G G++ EV A+ VA+K + + + E+ ++ +++HPN+V
Sbjct: 13 FRDVLGTGAFSEVILAEDKRTQKLVAIKC-IAKKALEGKEGSMENEIAVLHKIKHPNIVA 71
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIV 797
+L +I + + G LF + + + + LH IV
Sbjct: 72 LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH--DLGIV 129
Query: 798 HRDLKSPNLLV---DKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNE 854
HRDLK NLL D++ + +SDFGLS+++ + S + GTP ++APEVL +P ++
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS-TACGTPGYVAPEVLAQKPYSK 188
Query: 855 KCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP--KELDPLVARIIWECW 912
D +S GVI + L P+ N ++ + + P ++ I
Sbjct: 189 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLM 248
Query: 913 QTDPSLRPSFAQL 925
+ DP R + Q
Sbjct: 249 EKDPEKRFTCEQA 261
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 7e-55
Identities = 63/254 (24%), Positives = 120/254 (47%), Gaps = 10/254 (3%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLE-FKREVKIMRR-LR 731
ED +L + +G GS+G+V+ A++ A+K +E E +++
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLH 790
HP + NL + E+L G L + H + D R A + G+ LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH 120
Query: 791 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 850
+ IV+RDLK N+L+DK+ ++K++DFG+ + + + GTP+++APE+L +
Sbjct: 121 S--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 178
Query: 851 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 910
N D +SFGV+L+E+ + P+ G + ++ ++ + P+ L+ ++ +
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI--RMDNPFYPRWLEKEAKDLLVK 236
Query: 911 CWQTDPSLRPSFAQ 924
+ +P R
Sbjct: 237 LFVREPEKRLGVRG 250
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 8e-54
Identities = 64/258 (24%), Positives = 105/258 (40%), Gaps = 15/258 (5%)
Query: 680 LGERIGLGSYGEVYHADW--NGTEVAVKKF----LDQDFSGAALLEFKREVKIMRRLRHP 733
GE +G G + V G + A K G + + +REV I++ ++HP
Sbjct: 14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTST 793
NV+ ++ +I E + G LF L +E+ + G+ LH +
Sbjct: 74 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH--S 131
Query: 794 PTIVHRDLKSPNLLVDKNW----NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 849
I H DLK N+++ +K+ DFGL+ K+ GTPE++APE++
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEFVAPEIVNY 190
Query: 850 EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVARI 907
EP + D++S GVI + L + P++G + + V N E L
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDF 250
Query: 908 IWECWQTDPSLRPSFAQL 925
I DP R +
Sbjct: 251 IRRLLVKDPKKRMTIQDS 268
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 8e-54
Identities = 60/256 (23%), Positives = 113/256 (44%), Gaps = 7/256 (2%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRH 732
D + +G G++G+V G A+K + + + E ++++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTS 792
P + A L + E+ G LF L R +E+ R A + LH+
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS- 123
Query: 793 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 852
+V+RD+K NL++DK+ ++K++DFGL + + + K+ GTPE++APEVL +
Sbjct: 124 -RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 853 NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 912
D + GV+++E+ +LP+ + ++ + + P+ L P ++
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--LMEEIRFPRTLSPEAKSLLAGLL 240
Query: 913 QTDPSLRPSFAQLTVA 928
+ DP R
Sbjct: 241 KKDPKQRLGGGPSDAK 256
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 184 bits (468), Expect = 5e-53
Identities = 61/270 (22%), Positives = 107/270 (39%), Gaps = 23/270 (8%)
Query: 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLE-------FKREVK 725
+E+ E +G G V E AVK + E +EV
Sbjct: 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 726 IMRRLR-HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-A 783
I+R++ HPN++ ++ + + +G LF L + EK K+
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALL 120
Query: 784 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 843
+ LH IVHRDLK N+L+D + N+K++DFG S + GTP ++A
Sbjct: 121 EVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLREVCGTPSYLA 177
Query: 844 PEVLRNEPS------NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP 897
PE++ + ++ D++S GVI++ L P+ M ++ + N + P
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237
Query: 898 --KELDPLVARIIWECWQTDPSLRPSFAQL 925
+ V ++ P R + +
Sbjct: 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 179 bits (456), Expect = 2e-51
Identities = 69/273 (25%), Positives = 120/273 (43%), Gaps = 18/273 (6%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKF-LDQDFSGAALLEFKREVKIMRRLRH 732
+ LGE +G G EV+ A +VAVK D + L F+RE + L H
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 733 PNVVLFMGAVTRPPNLS----IITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMN 787
P +V I+ E++ +L I+H + KR I++ D + +N
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALN 125
Query: 788 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL---KHNTFLSSKSTAGTPEWMAP 844
H I+HRD+K N+++ VKV DFG++R N+ + + GT ++++P
Sbjct: 126 FSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 845 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--LEIPKELDP 902
E R + + + DVYS G +L+E+ T + P+ G +P+ V ++ + L
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 243
Query: 903 LVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935
+ ++ + +P R A L R+
Sbjct: 244 DLDAVVLKALAKNPENRYQTAAE--MRADLVRV 274
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 179 bits (454), Expect = 5e-50
Identities = 59/261 (22%), Positives = 101/261 (38%), Gaps = 12/261 (4%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRR 729
D + IG G +GEVY G A+K + L + + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 730 LRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCL 789
P +V A P LS I + + G L L + + R A G+ +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 790 HTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVL-R 848
H +V+RDLK N+L+D++ +V++SD GL+ ++ GT +MAPEVL +
Sbjct: 124 H--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQK 179
Query: 849 NEPSNEKCDVYSFGVILWELATLKLPWIGMNPM-QVVGAVGFQNRRLEIPKELDPLVARI 907
+ D +S G +L++L P+ + +E+P P + +
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 239
Query: 908 IWECWQTDPSLRPSFAQLTVA 928
+ Q D + R
Sbjct: 240 LEGLLQRDVNRRLGCLGRGAQ 260
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 3e-49
Identities = 51/257 (19%), Positives = 96/257 (37%), Gaps = 23/257 (8%)
Query: 680 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLE----FKREVKIMRRLR-- 731
+G +G G +G VY + VA+K S L EV +++++
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 732 HPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLH 790
V+ + RP + +I E + E+ + H
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 791 TSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN 849
++HRD+K N+L+D N +K+ DFG L +T + GT + PE +R
Sbjct: 128 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD--FDGTRVYSPPEWIRY 183
Query: 850 EP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 908
V+S G++L+++ +P+ + ++ + + +I
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------IRGQVFFRQRVSSECQHLI 235
Query: 909 WECWQTDPSLRPSFAQL 925
C PS RP+F ++
Sbjct: 236 RWCLALRPSDRPTFEEI 252
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 4e-48
Identities = 62/265 (23%), Positives = 113/265 (42%), Gaps = 28/265 (10%)
Query: 679 VLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNV 735
V + +GLG G+V + A+K D + +REV++ R + P++
Sbjct: 15 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELHWRASQCPHI 67
Query: 736 V----LFMGAVTRPPNLSIITEFLPRGSLFRILH-RPHCQVDEKRRIKMALD-ARGMNCL 789
V ++ L I+ E L G LF + R E+ ++ + L
Sbjct: 68 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 127
Query: 790 HTSTPTIVHRDLKSPNLLVDKNWN---VKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 846
H+ I HRD+K NLL +K++DFG ++ + S + TP ++APEV
Sbjct: 128 HSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPCYTPYYVAPEV 184
Query: 847 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEI------PKEL 900
L E ++ CD++S GVI++ L P+ + + + + + R + E+
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244
Query: 901 DPLVARIIWECWQTDPSLRPSFAQL 925
V +I +T+P+ R + +
Sbjct: 245 SEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 2e-47
Identities = 63/281 (22%), Positives = 109/281 (38%), Gaps = 33/281 (11%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
E+ E+IG G+YG VY A G VA+KK + RE+ +++ L HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTS 792
N+V + + L ++ EFL + + + +G+ H+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 120
Query: 793 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP- 851
++HRDLK NLL++ +K++DFGL+R + T + APE+L
Sbjct: 121 -HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 852 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVV----------------GAVGFQNRRLE 895
+ D++S G I E+ T + + G + + + G + +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 896 IPK-----------ELDPLVARIIWECWQTDPSLRPSFAQL 925
PK LD ++ + DP+ R S
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (426), Expect = 4e-47
Identities = 52/276 (18%), Positives = 99/276 (35%), Gaps = 26/276 (9%)
Query: 680 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
LG +IG GS+G++Y G EVA+K + + E KI + ++ +
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----QLHIESKIYKMMQGGVGIP 66
Query: 738 FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTI 796
+ + +++ L SL + + + K + +A + +H+
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--F 124
Query: 797 VHRDLKSPNLLV---DKNWNVKVSDFGLSRL-------KHNTFLSSKSTAGTPEWMAPEV 846
+HRD+K N L+ K V + DFGL++ +H + +K+ GT + +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 847 LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV------GFQNRRLEIPKEL 900
+ + D+ S G +L LPW G+ + K
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 244
Query: 901 DPLVARIIWECWQTDPSLRPSFAQLTVALK-PLQRL 935
A + C +P ++ L + R
Sbjct: 245 PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 166 bits (421), Expect = 2e-46
Identities = 40/274 (14%), Positives = 89/274 (32%), Gaps = 27/274 (9%)
Query: 680 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH-PNVV 736
+G RIG GS+G ++ N +VA+K + + + + E + + L +
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP----QLRDEYRTYKLLAGCTGIP 64
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTI 796
+ ++ + L + + + + +H + +
Sbjct: 65 NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--L 122
Query: 797 VHRDLKSPNLLVDK-----NWNVKVSDFGLSRL-------KHNTFLSSKSTAGTPEWMAP 844
V+RD+K N L+ + + V DFG+ + +H + K+ +GT +M+
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 845 EVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQV------VGAVGFQNRRLEIPK 898
+ + D+ + G + LPW G+ +G E+
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 242
Query: 899 ELDPLVARIIWECWQTDPSLRPSFAQLTVALKPL 932
+ + P + L +
Sbjct: 243 GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 165 bits (417), Expect = 4e-46
Identities = 58/279 (20%), Positives = 102/279 (36%), Gaps = 31/279 (11%)
Query: 676 EDLVLGERIGLGSYGEVYHA-DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN 734
E E+IG G+YG VY A + G A+KK + RE+ I++ L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 735 VVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTP 794
+V + L ++ E L + + + + G+ H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--DR 119
Query: 795 TIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-N 853
++HRDLK NLL+++ +K++DFGL+R T + AP+VL +
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179
Query: 854 EKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV-------------------------- 887
D++S G I E+ + G++ + +
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239
Query: 888 -GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 925
K LD ++ + + DP+ R + Q
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 166 bits (422), Expect = 4e-46
Identities = 58/256 (22%), Positives = 113/256 (44%), Gaps = 10/256 (3%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLE-FKREVKIMRRLRH 732
+ + +G GS+G V +G A+K Q +E E +I++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 733 PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTS 792
P +V + NL ++ E++ G +F L R + R A LH+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 793 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS 852
+++RDLK NLL+D+ ++V+DFG ++ + GTPE +APE++ ++
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WTLCGTPEALAPEIILSKGY 215
Query: 853 NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECW 912
N+ D ++ GV+++E+A P+ P+Q+ + + ++ P + ++
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI--VSGKVRFPSHFSSDLKDLLRNLL 273
Query: 913 QTDPSLRPSFAQLTVA 928
Q D + R + V
Sbjct: 274 QVDLTKRFGNLKNGVN 289
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 1e-45
Identities = 68/287 (23%), Positives = 115/287 (40%), Gaps = 40/287 (13%)
Query: 676 EDLVLGERIGLGSYGEVY---HADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-- 730
+ IG G+YG+V+ G VA+K+ Q L REV ++R L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 731 -RHPNVVLFMGAVTRPPN-----LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-A 783
HPNVV T L+++ E + + + P V + M
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 784 RGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMA 843
RG++ LH+ +VHRDLK N+LV + +K++DFGL+R+ ++ ++ S T + A
Sbjct: 127 RGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI-YSFQMALTSVVVTLWYRA 183
Query: 844 PEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV---------------- 887
PEVL D++S G I E+ K + G + + +G +
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 888 ---------GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 925
+ ++D L ++ +C +P+ R S
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 2e-45
Identities = 67/302 (22%), Positives = 114/302 (37%), Gaps = 41/302 (13%)
Query: 682 ERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGA---ALLEFKREVKIMRRLRHPNVV 736
+ +G G + VY A VA+KK S A RE+K+++ L HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 737 LFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTI 796
+ A N+S++ +F+ I + M + +G+ LH I
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ--HWI 121
Query: 797 VHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEK 855
+HRDLK NLL+D+N +K++DFGL++ + + T + APE+L
Sbjct: 122 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVG 181
Query: 856 CDVYSFGVILWELATLKLPWIGMNPMQVVGAV-------------------------GFQ 890
D+++ G IL EL G + + + + F
Sbjct: 182 VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 241
Query: 891 NRRL-EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHPD-QPSSAL 948
L I + +I + +P R + Q L+ + P P L
Sbjct: 242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA------LKMKYFSNRPGPTPGCQL 295
Query: 949 PQ 950
P+
Sbjct: 296 PR 297
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 8e-45
Identities = 62/266 (23%), Positives = 110/266 (41%), Gaps = 15/266 (5%)
Query: 676 EDLVLGERIGLGSYGEVYHA-----DWNGTEVAVKKFLDQDFSGAA--LLEFKREVKIMR 728
E+ L + +G G+YG+V+ G A+K A + E +++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 729 RLRH-PNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMN 787
+R P +V A L +I +++ G LF L + + + +I + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 788 CLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLS-RLKHNTFLSSKSTAGTPEWMAPEV 846
LH I++RD+K N+L+D N +V ++DFGLS + + GT E+MAP++
Sbjct: 144 HLHK--LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 201
Query: 847 LRNEPS--NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV--GFQNRRLEIPKELDP 902
+R S ++ D +S GV+++EL T P+ + P+E+
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 261
Query: 903 LVARIIWECWQTDPSLRPSFAQLTVA 928
L +I DP R
Sbjct: 262 LAKDLIQRLLMKDPKKRLGCGPRDAD 287
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 2e-44
Identities = 71/317 (22%), Positives = 126/317 (39%), Gaps = 50/317 (15%)
Query: 680 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
IG G+YG V A N VA+KK + RE+KI+ R RH N++
Sbjct: 12 NLSYIGEGAYGMVCSAYDNVNKVRVAIKK-ISPFEHQTYCQRTLREIKILLRFRHENIIG 70
Query: 738 FMGAVTRPP----NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTST 793
+ P + L L+++L H D + RG+ +H++
Sbjct: 71 INDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYF-LYQILRGLKYIHSAN 129
Query: 794 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL---KHNTFLSSKSTAGTPEWMAPEVLRNE 850
++HRDLK NLL++ ++K+ DFGL+R+ H+ T + APE++ N
Sbjct: 130 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 187
Query: 851 -PSNEKCDVYSFGVILWELATLKLPWIGMNPM----QVVGAVGFQNRRL----------- 894
+ D++S G IL E+ + + + G + + ++G +G ++
Sbjct: 188 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 247
Query: 895 --------------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK-P-LQRLVIP 938
+ D ++ + +P R Q AL P L++ P
Sbjct: 248 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ---ALAHPYLEQYYDP 304
Query: 939 SHPDQPSSALPQEISVN 955
S D+P + P + +
Sbjct: 305 S--DEPIAEAPFKFDME 319
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 3e-43
Identities = 61/303 (20%), Positives = 115/303 (37%), Gaps = 51/303 (16%)
Query: 672 EIPWEDLV----LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVK 725
E P+ D V +IG G++GEV+ A G +VA+KK L ++ + RE+K
Sbjct: 2 ECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK 61
Query: 726 IMRRLRHPNVVLFMGAVTRPP--------NLSIITEFLPRGSLFRILHRPHCQVDEKRRI 777
I++ L+H NVV + ++ ++ +F + + + +
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 121
Query: 778 KMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL----KHNTFLSSK 833
M + G+ +H I+HRD+K+ N+L+ ++ +K++DFGL+R K++
Sbjct: 122 VMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 179
Query: 834 STAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV----- 887
+ T + PE+L E D++ G I+ E+ T G + +
Sbjct: 180 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 239
Query: 888 -------------------------GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSF 922
+ + DP +I + DP+ R
Sbjct: 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299
Query: 923 AQL 925
Sbjct: 300 DDA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 3e-42
Identities = 55/281 (19%), Positives = 105/281 (37%), Gaps = 33/281 (11%)
Query: 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHP 733
+ E+IG G+YG V+ A VA+K+ D RE+ +++ L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 734 NVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTST 793
N+V + L+++ EF + E + + +G+ H +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH--S 119
Query: 794 PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPS- 852
++HRDLK NLL+++N +K+++FGL+R + T + P+VL
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 853 NEKCDVYSFGVILWELATLKLPW-IGMNPMQVVGAV------------------------ 887
+ D++S G I ELA P G + + +
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 888 ---GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 925
+ + +L+ ++ + +P R S +
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 4e-37
Identities = 60/283 (21%), Positives = 108/283 (38%), Gaps = 43/283 (15%)
Query: 680 LGERIGLGSYGEVYHA--DWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ +G G+YG V A G +VA+KK S RE+++++ +RH NV+
Sbjct: 22 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIG 81
Query: 738 FMGAVTRPPNLSIITEF-----LPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTS 792
+ T L T+F L +++ D + + + +G+ +H
Sbjct: 82 LLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFL-VYQMLKGLRYIH-- 138
Query: 793 TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRN-EP 851
I+HRDLK NL V+++ +K+ DFGL+R + T + APEV+ N
Sbjct: 139 AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGYVVTRWYRAPEVILNWMR 195
Query: 852 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL----------------- 894
+ D++S G I+ E+ T K + G + + + +
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255
Query: 895 ------------EIPKELDPLVARIIWECWQTDPSLRPSFAQL 925
I PL ++ + D R + +
Sbjct: 256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 3e-36
Identities = 68/291 (23%), Positives = 116/291 (39%), Gaps = 44/291 (15%)
Query: 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRR 729
E+P E +G G+YG V A G VAVKK S RE+++++
Sbjct: 15 EVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKH 73
Query: 730 LRHPNVVLFMGAVTRPPNLS-----IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDAR 784
++H NV+ + T +L + L L I+ D + + + R
Sbjct: 74 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-LR 132
Query: 785 GMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAP 844
G+ +H + I+HRDLK NL V+++ +K+ DFGL+R + T + AP
Sbjct: 133 GLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAP 187
Query: 845 EV-LRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVV------------------- 884
E+ L N+ D++S G I+ EL T + + G + + +
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 885 --GAVGFQNRRLEIPK--------ELDPLVARIIWECWQTDPSLRPSFAQL 925
A + ++PK +PL ++ + D R + AQ
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 2e-35
Identities = 59/256 (23%), Positives = 105/256 (41%), Gaps = 22/256 (8%)
Query: 680 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVL 737
+ IG G+ G V A VA+KK + RE+ +M+ + H N++
Sbjct: 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80
Query: 738 FMGAVTRPP------NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLH 790
+ T ++ ++ E + I D +R + G+ LH
Sbjct: 81 LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGIKHLH 136
Query: 791 TSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 850
+ I+HRDLK N++V + +K+ DFGL+R +F+ + T + APEV+
Sbjct: 137 S--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP-YVVTRYYRAPEVILGM 193
Query: 851 PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 910
E D++S G I+ E+ K+ + G + + N+ +E P + +
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW------NKVIEQLGTPCPEFMKKLQP 247
Query: 911 CWQTDPSLRPSFAQLT 926
+ RP +A LT
Sbjct: 248 TVRNYVENRPKYAGLT 263
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 3e-35
Identities = 51/281 (18%), Positives = 88/281 (31%), Gaps = 47/281 (16%)
Query: 684 IGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGA 741
IG GS+G VY A +G VA+KK L RE++IMR+L H N+V
Sbjct: 28 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYF 81
Query: 742 VTRP------PNLSIITEFLPRGSLFRILH--RPHCQVDEKRRIKMALD-ARGMNCLHTS 792
L+++ +++P H R + R + +H+
Sbjct: 82 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS- 140
Query: 793 TPTIVHRDLK-SPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEP 851
I HRD+K LL +K+ DFG ++ + +
Sbjct: 141 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD 199
Query: 852 SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV------------------------ 887
DV+S G +L EL + + G + + + +
Sbjct: 200 YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 259
Query: 888 ---GFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQL 925
P + + P+ R + +
Sbjct: 260 PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 128 bits (322), Expect = 4e-33
Identities = 61/318 (19%), Positives = 120/318 (37%), Gaps = 59/318 (18%)
Query: 654 DSSTSKVDQIFDDDVCECEIPW---EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFL 708
D +T + + +D + + W +D L ++G G Y EV+ A N +V VK
Sbjct: 12 DVNTHRPREYWDYE--SHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK 69
Query: 709 DQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPN--LSIITEFLPRGSLFRILH 765
+ KRE+KI+ LR PN++ V P + +++ E + ++
Sbjct: 70 PVKKK-----KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ 124
Query: 766 RPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRL 824
D R M + ++ H+ I+HRD+K N+++D ++ +++ D+GL+
Sbjct: 125 TLT---DYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179
Query: 825 KHNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNP--- 880
H + + PE+L + + D++S G +L + K P+ +
Sbjct: 180 YHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 238
Query: 881 -----MQVVGAVGFQNRRLEIPKELDPLVARI---------------------------- 907
+V+G + + ELDP I
Sbjct: 239 QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF 298
Query: 908 IWECWQTDPSLRPSFAQL 925
+ + + D R + +
Sbjct: 299 LDKLLRYDHQSRLTAREA 316
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 108 bits (271), Expect = 4e-26
Identities = 49/287 (17%), Positives = 102/287 (35%), Gaps = 31/287 (10%)
Query: 679 VLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVV 736
+L ++G G + V+ A N T VA+K + E+K+++R+ +
Sbjct: 16 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV---RGDKVYTEAAEDEIKLLQRVNDADNT 72
Query: 737 L---------------FMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL 781
F ++ ++ E L L I H + +++
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 782 D-ARGMNCLHTSTPTIVHRDLKSPNLLVDKN------WNVKVSDFGLSRLKHNTFLSSKS 834
G++ +H I+H D+K N+L++ +K++D G + + +
Sbjct: 133 QLLLGLDYMHRR-CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY---TN 188
Query: 835 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL 894
+ T E+ +PEVL P D++S +++EL T + + +
Sbjct: 189 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248
Query: 895 EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRLVIPSHP 941
E+ EL + R S + PL+ ++ +
Sbjct: 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYK 295
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.5 bits (216), Expect = 3e-20
Identities = 31/192 (16%), Positives = 59/192 (30%), Gaps = 44/192 (22%)
Query: 679 VLGERIGLGSYGEVYHA-DWNGTEVAVKKF----------------LDQDFSGAALLEFK 721
+G+ +G G V++ E VK D FS A+ +
Sbjct: 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 722 REVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMAL 781
E + +++L+ V +++ E + +V+ + + +
Sbjct: 63 NEFRALQKLQGLAVPKVYAWEGN----AVLMELIDAK------ELYRVRVENPDEV-LDM 111
Query: 782 DARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKSTAGTPEW 841
+ + IVH DL N+LV + + DF S E
Sbjct: 112 ILEEVAKFY--HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV-------------EVGEE 155
Query: 842 MAPEVLRNEPSN 853
E+L + N
Sbjct: 156 GWREILERDVRN 167
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 958 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.17 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.42 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.4 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.5 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.12 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.03 | |
| d2f4ma1 | 287 | Peptide:N-glycanase 1, PNG1 {Mouse (Mus musculus) | 90.1 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=441.01 Aligned_cols=249 Identities=24% Similarity=0.433 Sum_probs=218.8
Q ss_pred CCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCH-HHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEE
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSI 750 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~-~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~L 750 (958)
..++|++++.||+|+||+||+|++ +++.||||++.+..... .....+.+|+++|++++|||||++++++.+++.+||
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence 357899999999999999999987 58899999987543222 234578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc
Q 002160 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 830 (958)
Q Consensus 751 VmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~ 830 (958)
|||||++|+|.+++.+.........+.++.+++.||+|||+++ ||||||||+||||+.++++||+|||+++......
T Consensus 84 vmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 160 (263)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred EEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence 9999999999999987665555666666667799999999998 9999999999999999999999999998765432
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHH
Q 002160 831 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 910 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 910 (958)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...+. .....+|..+++++++||.+
T Consensus 161 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~~ 237 (263)
T d2j4za1 161 -RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFPDFVTEGARDLISR 237 (263)
T ss_dssp -CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHHHHHH
T ss_pred -ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCccCCHHHHHHHHH
Confidence 345679999999999999999999999999999999999999999998888877764 34567788999999999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 002160 911 CWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 911 CL~kDP~kRPSa~EIL~~ 928 (958)
||+.||.+|||++|+++|
T Consensus 238 ~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 238 LLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp HTCSSGGGSCCHHHHHTC
T ss_pred HccCCHhHCcCHHHHHcC
Confidence 999999999999999874
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=440.96 Aligned_cols=262 Identities=35% Similarity=0.604 Sum_probs=217.0
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceE
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~ 749 (958)
.++|+.++|++++.||+|+||+||+|++++ .||||++............|.+|+.+|++++|||||++++++.. +.++
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~ 79 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLA 79 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEE
Confidence 357888999999999999999999998765 59999998776666677899999999999999999999998754 5689
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
||||||++|+|.+++......+.+...+.++.+ +.||+|||+++ ||||||||+||||+.++++||+|||+++.....
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 999999999999999876666666666655554 99999999988 999999999999999999999999999876432
Q ss_pred --cccCCCCCCCCCccCcccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc----ccCCCCC
Q 002160 829 --FLSSKSTAGTPEWMAPEVLRNE---PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR----RLEIPKE 899 (958)
Q Consensus 829 --~~~~~s~~GT~~Y~APEvl~g~---~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~----~~~ip~~ 899 (958)
........||+.|||||++.+. .++.++|||||||+||||++|+.||.+.+............. ...++..
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 237 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTT
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcccc
Confidence 2233456799999999999753 478999999999999999999999998776544433322221 1245677
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 900 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 900 ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
+++++++||.+||+.||.+|||++||+++|+.|.+.
T Consensus 238 ~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 238 CPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 899999999999999999999999999999999764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-51 Score=431.76 Aligned_cols=256 Identities=31% Similarity=0.542 Sum_probs=212.9
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE-CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEE
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LV 751 (958)
|+.++|++++.||+|+||.||+|++ +++.||||++....... .+|.+|+++|++++|||||++++++..++.++||
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence 4567899999999999999999998 56789999987654443 5789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc
Q 002160 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL 830 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~ 830 (958)
|||+++|+|.+++........+..++.++.+ +.||.|||.++ |+||||||+||||++++++||+|||+++.......
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 9999999999999877666666666655555 99999999998 99999999999999999999999999987654322
Q ss_pred -cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHH
Q 002160 831 -SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARII 908 (958)
Q Consensus 831 -~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI 908 (958)
......||+.|+|||++.+..++.++|||||||++|||++ |.+||...+..++...+. ...+...|..+++++.+||
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li 235 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQIM 235 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHH-HTCCCCCCTTSCHHHHHHH
T ss_pred eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHH-hcCCCCCccccCHHHHHHH
Confidence 2334578999999999999999999999999999999999 566677777777776664 4456677889999999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHhhhh
Q 002160 909 WECWQTDPSLRPSFAQLTVALKPLQR 934 (958)
Q Consensus 909 ~~CL~kDP~kRPSa~EIL~~L~kL~k 934 (958)
.+||+.||.+||+++||+++|++|.+
T Consensus 236 ~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 236 NHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999865
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=439.28 Aligned_cols=252 Identities=28% Similarity=0.443 Sum_probs=204.8
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC--CCceEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR--PPNLSII 751 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~--~~~l~LV 751 (958)
++|++++.||+|+||+||+|++ +++.||||++......+.....+.+|+++|++++|||||++++++.+ .+.+|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 6899999999999999999987 58899999998887777777889999999999999999999999864 4568999
Q ss_pred EeecCCCCHHHHHhC---CCCCccHHHH-HHHHHHHHHHHHHHhcC---CcEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 752 TEFLPRGSLFRILHR---PHCQVDEKRR-IKMALDARGMNCLHTST---PTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 752 mEy~~gGsL~d~L~k---~~~~~~e~~~-l~ia~~a~aL~yLH~~g---~gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
||||++|+|.+++.+ ....+.+... .++.+.+.||.|||+.+ .+||||||||+||||+.++++||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999998853 2233444444 44555599999999865 3599999999999999999999999999988
Q ss_pred ccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHH
Q 002160 825 KHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 904 (958)
Q Consensus 825 ~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL 904 (958)
...........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+. ......+|..+++++
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~s~~l 242 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIPYRYSDEL 242 (269)
T ss_dssp C-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-HTCCCCCCTTSCHHH
T ss_pred cccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHH
Confidence 7654444556789999999999999999999999999999999999999999998888877764 333446778899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 905 ARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 905 ~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
++||.+||+.||.+||++.||++|
T Consensus 243 ~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 243 NEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHcCCChhHCcCHHHHHhC
Confidence 999999999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-51 Score=442.10 Aligned_cols=250 Identities=21% Similarity=0.346 Sum_probs=216.4
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LV 751 (958)
.++|++++.||+|+||+||+|++ +++.||||++.+... .......+.+|+++|++++|||||+++++|.+.+.+|||
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 46899999999999999999987 588999999875432 122346789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC--c
Q 002160 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--F 829 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~--~ 829 (958)
||||+||+|.+++...+.......+.++.+.+.||+|||+++ ||||||||+||||+++|++||+|||+++..... .
T Consensus 87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 999999999999887766666666666777799999999998 999999999999999999999999999876432 2
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHH
Q 002160 830 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 909 (958)
Q Consensus 830 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~ 909 (958)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...+. .....+|..+++++++||.
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~ 242 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII--KLEYDFPEKFFPKARDLVE 242 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--TTCCCCCTTCCHHHHHHHH
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHH--cCCCCCCccCCHHHHHHHH
Confidence 23345689999999999999999999999999999999999999999998888877774 3456788899999999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 002160 910 ECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 910 ~CL~kDP~kRPSa~EIL~~ 928 (958)
+||++||.+|||++|++.+
T Consensus 243 ~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 243 KLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp TTSCSSGGGSTTSGGGTCH
T ss_pred HHccCCHhHCcCHHHHcCC
Confidence 9999999999999997654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=437.00 Aligned_cols=248 Identities=26% Similarity=0.438 Sum_probs=215.2
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
++|++.+.||+|+||+||+|++ +|+.||||++....... ...+.+|+++|++++|||||+++++|.+.+.+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 5799999999999999999986 68999999987654332 4568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCC
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 833 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~ 833 (958)
||+||+|.+++.+. .......+.++.+++.||.|||+++ ||||||||+||||+.+|++||+|||+++..........
T Consensus 98 y~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 174 (293)
T d1yhwa1 98 YLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (293)
T ss_dssp CCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred ecCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCCCcEeeccchhheeecccccccc
Confidence 99999999988764 3444455555666699999999998 99999999999999999999999999998765545556
Q ss_pred CCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcc-ccccCCCCCCcHHHHHHHHHhh
Q 002160 834 STAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ-NRRLEIPKELDPLVARIIWECW 912 (958)
Q Consensus 834 s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~-~~~~~ip~~ls~eL~dLI~~CL 912 (958)
..+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+... ......+..+++++++||.+||
T Consensus 175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L 254 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254 (293)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHT
T ss_pred ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHc
Confidence 678999999999999999999999999999999999999999998877666555322 2234556789999999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q 002160 913 QTDPSLRPSFAQLTVA 928 (958)
Q Consensus 913 ~kDP~kRPSa~EIL~~ 928 (958)
++||.+||++.|+++|
T Consensus 255 ~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 255 DMDVEKRGSAKELLQH 270 (293)
T ss_dssp CSSTTTSCCHHHHTTC
T ss_pred cCChhHCcCHHHHhcC
Confidence 9999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.3e-50 Score=434.02 Aligned_cols=260 Identities=33% Similarity=0.543 Sum_probs=214.0
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEEC--C---cEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADWN--G---TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~~--g---~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~ 746 (958)
++..++|++.+.||+|+||+||+|++. + ..||||++... ........|.+|+++|++++|||||++++++.+.+
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 456678999999999999999999873 2 25888887544 34556678999999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
.+|+|||||++|+|.+++.+....+.+..++.++.+ +.||.|||.++ ||||||||+||||+.++++||+|||+++..
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCCCcEEECCcccceEc
Confidence 999999999999999999876666666666655554 99999999988 999999999999999999999999999876
Q ss_pred cCCcc-----cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCC
Q 002160 826 HNTFL-----SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKE 899 (958)
Q Consensus 826 ~~~~~-----~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ 899 (958)
..... ......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+. ...++..|..
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~~~~ 257 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPPMD 257 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTT
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcc
Confidence 43221 1122457899999999999999999999999999999998 899999999888877775 4556677888
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 900 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 900 ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
++..+.+||.+||+.||.+||++.||++.|+++.+.
T Consensus 258 ~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 999999999999999999999999999999988653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=446.29 Aligned_cols=252 Identities=24% Similarity=0.393 Sum_probs=225.9
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceE
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~ 749 (958)
|..++|++++.||+|+||.||+|++ +++.||||++.+.... ......+.+|+.+|++++|||||+++++|.+.+.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 5668999999999999999999986 6899999998765321 223567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~ 829 (958)
+|||||+||+|.+++.+.+...+...+.++++++.||+|||+++ ||||||||+||||+.+|++||+|||+|+......
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 99999999999999988777777778888888899999999998 9999999999999999999999999999765544
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHH
Q 002160 830 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 909 (958)
Q Consensus 830 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~ 909 (958)
......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..++...+. .....+|..+++++++||.
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~dli~ 237 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL--MEEIRFPRTLSPEAKSLLA 237 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHHHH
T ss_pred cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHh--cCCCCCCccCCHHHHHHHH
Confidence 55567889999999999999999999999999999999999999999999888887774 3457788999999999999
Q ss_pred HhhhcCCCCCCC-----HHHHHHH
Q 002160 910 ECWQTDPSLRPS-----FAQLTVA 928 (958)
Q Consensus 910 ~CL~kDP~kRPS-----a~EIL~~ 928 (958)
+||++||.+|++ +.||++|
T Consensus 238 ~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 238 GLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred hhccCCchhhcccccccHHHHHcC
Confidence 999999999995 8888875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.3e-50 Score=432.95 Aligned_cols=259 Identities=35% Similarity=0.589 Sum_probs=220.0
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~ 747 (958)
.++|+.++|++.+.||+|+||+||+|++ +++.||||++...... ..+|.+|+++|++++|||||+++++|.+.+.
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 4678889999999999999999999987 5889999998765433 4578999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhCC-CCCccHHHHHHHHH-HHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 748 LSIITEFLPRGSLFRILHRP-HCQVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~-~~~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
+|||||||++|+|.+++.+. .....+..++.++. .+.||+|||+++ ||||||||+||||++++++||+|||+++..
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCCCcEEEccccceeec
Confidence 99999999999999998643 34556666655554 499999999988 999999999999999999999999999876
Q ss_pred cCCcc-cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCC-CCCChhHHHHhhhccccccCCCCCCcHH
Q 002160 826 HNTFL-SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPW-IGMNPMQVVGAVGFQNRRLEIPKELDPL 903 (958)
Q Consensus 826 ~~~~~-~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF-~g~~~~ei~~~i~~~~~~~~ip~~ls~e 903 (958)
..... ......||+.|+|||++.+..++.++|||||||++|||++|..|| .+.+..++...+ ....++.+|..++++
T Consensus 166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i-~~~~~~~~~~~~~~~ 244 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRMERPEGCPEK 244 (287)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-HTTCCCCCCTTCCHH
T ss_pred CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH-hcCCCCCCCccchHH
Confidence 54322 223345889999999999999999999999999999999976665 455555554444 345677888899999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhhhh
Q 002160 904 VARIIWECWQTDPSLRPSFAQLTVALKPLQR 934 (958)
Q Consensus 904 L~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k 934 (958)
+++||.+||+.||.+||++.||++.|+.+.+
T Consensus 245 l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 245 VYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 9999999999999999999999999988743
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-50 Score=431.81 Aligned_cols=250 Identities=27% Similarity=0.327 Sum_probs=206.2
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
++|++++.||+|+||+||+|++ +++.||||++...... .....+.+|+++|++++|||||++++++.+++.+|||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 6799999999999999999987 5889999998765432 234578999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC--ccc
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT--FLS 831 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~--~~~ 831 (958)
||++|+|.+++.+.........+.++.+.+.||.|||+++ ||||||||+||||+.++++||+|||+|+..... ...
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence 9999999999987665555666666667799999999998 999999999999999999999999999876432 223
Q ss_pred CCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhHH-HHhhhccccccCCCCCCcHHHHHHHH
Q 002160 832 SKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQV-VGAVGFQNRRLEIPKELDPLVARIIW 909 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~g~~~-s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei-~~~i~~~~~~~~ip~~ls~eL~dLI~ 909 (958)
....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ ................+++++++||.
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 241 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHH
Confidence 456789999999999998876 5789999999999999999999987654322 22222222222333578999999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 002160 910 ECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 910 ~CL~kDP~kRPSa~EIL~~ 928 (958)
+||+.||.+||+++||++|
T Consensus 242 ~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 242 KILVENPSARITIPDIKKD 260 (271)
T ss_dssp HHSCSSTTTSCCHHHHTTC
T ss_pred HHcCCChhHCcCHHHHhcC
Confidence 9999999999999998764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=426.86 Aligned_cols=249 Identities=31% Similarity=0.461 Sum_probs=210.4
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC----CCceEE
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR----PPNLSI 750 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~----~~~l~L 750 (958)
.|++.++||+|+||+||+|++ +++.||||++............|.+|+++|++++|||||+++++|.. ...+||
T Consensus 10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 357888999999999999987 57789999998877777777889999999999999999999999864 345899
Q ss_pred EEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEc-CCCcEEEEeccccccccCCc
Q 002160 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVD-KNWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 751 VmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId-~~g~VKL~DFGLAk~~~~~~ 829 (958)
|||||++|+|.+++.+.........+.++.+++.||+|||+++.+||||||||+||||+ +++.+||+|||+++......
T Consensus 90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~ 169 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 169 (270)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCc
Confidence 99999999999999876555555555566666999999999887899999999999996 58999999999998654332
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-hHHHHhhhccccccCCCCCCcHHHHHHH
Q 002160 830 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNP-MQVVGAVGFQNRRLEIPKELDPLVARII 908 (958)
Q Consensus 830 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~-~ei~~~i~~~~~~~~ip~~ls~eL~dLI 908 (958)
....+||+.|+|||++.+ +++.++|||||||++|||++|+.||.+... .++...+........++..+++++++||
T Consensus 170 --~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li 246 (270)
T d1t4ha_ 170 --AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 246 (270)
T ss_dssp --BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHH
T ss_pred --cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHH
Confidence 345789999999999976 489999999999999999999999987654 4444555433344456677899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 002160 909 WECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 909 ~~CL~kDP~kRPSa~EIL~~ 928 (958)
.+||++||++|||++||++|
T Consensus 247 ~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 247 EGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp HHHSCSSGGGSCCHHHHHTS
T ss_pred HHHccCCHhHCcCHHHHhCC
Confidence 99999999999999999874
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-50 Score=433.89 Aligned_cols=249 Identities=28% Similarity=0.438 Sum_probs=212.3
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
+.|++++.||+|+||+||+|++ +++.||||++..... .....+.+|+++|++++|||||++++++.+++.+|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS--GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 4689999999999999999987 688999999876532 335678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCcc-HHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 754 FLPRGSLFRILHRPHCQVD-EKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~-e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
||++|+|.+++.+....+. ...+.++.+++.||.|||+++ ||||||||+||||+.+|++||+|||+++.........
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~ 167 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 167 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHH
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCCCCEEEEechhhhccCCCcccc
Confidence 9999999998765444444 445555566699999999998 9999999999999999999999999998765443334
Q ss_pred CCCCCCCCccCccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccc-cccCCCCCCcHHHHH
Q 002160 833 KSTAGTPEWMAPEVLR-----NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN-RRLEIPKELDPLVAR 906 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~-----g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~-~~~~ip~~ls~eL~d 906 (958)
...+||+.|+|||++. +..|+.++|||||||++|||++|+.||.+.+..++...+.... .....+..+++++++
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~ 247 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHH
Confidence 5678999999999984 4557899999999999999999999999998888777665332 233446689999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 002160 907 IIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 907 LI~~CL~kDP~kRPSa~EIL~~ 928 (958)
||.+||+.||.+|||+.||++|
T Consensus 248 li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 248 FLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=422.70 Aligned_cols=253 Identities=30% Similarity=0.516 Sum_probs=222.7
Q ss_pred CCCCeeEEEEeeccCceEEEEEEE-CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
+.++|++++.||+|+||+||+|++ +++.||||++....... .+|.+|+.++++++|||||+++++|.+++.+++||
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 457899999999999999999998 46689999998765543 47899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc-
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 830 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~- 830 (958)
||+++|+|..++........+..++.++.+ +.||+|||.++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 999999999998776666666666666655 99999999988 99999999999999999999999999986544322
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHH
Q 002160 831 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIW 909 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~ 909 (958)
......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+. ...++..|..+++++++||.
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~ 235 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTIMY 235 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHH
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH-hCCCCCCcccccHHHHHHHH
Confidence 3334678999999999999999999999999999999998 899999999888887775 45577788999999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHhh
Q 002160 910 ECWQTDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 910 ~CL~kDP~kRPSa~EIL~~L~kL 932 (958)
+||+.||++||++.+|+++|.+|
T Consensus 236 ~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 236 SCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHccCCHhHCcCHHHHHHHhhCC
Confidence 99999999999999999999754
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-50 Score=439.28 Aligned_cols=256 Identities=24% Similarity=0.350 Sum_probs=211.0
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceE
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~ 749 (958)
++..++|++++.||+|+||+||+|++ +++.||||++.... ......++.+|+++|++++|||||+++++|.+++++|
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 45567899999999999999999987 68899999987653 3444578899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHh-cCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHT-STPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~-~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
||||||+||+|.+++.+.+.......+.++.+++.||.|||+ ++ ||||||||+||||+.+|++||+|||+|+.....
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 999999999999999876665556666666677999999996 57 999999999999999999999999999876443
Q ss_pred cccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhh--------------------
Q 002160 829 FLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG-------------------- 888 (958)
Q Consensus 829 ~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~-------------------- 888 (958)
. ..+.+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+......
T Consensus 159 ~--~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 159 M--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp T--C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred c--cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 2 345789999999999999999999999999999999999999998765432211000
Q ss_pred ---------------------ccccccCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHhh
Q 002160 889 ---------------------FQNRRLEIP-KELDPLVARIIWECWQTDPSLRPSFAQLTVA--LKPL 932 (958)
Q Consensus 889 ---------------------~~~~~~~ip-~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~--L~kL 932 (958)
.....+.++ ..+++++++||.+||+.||.+|||++|+++| +++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 001111222 2468899999999999999999999999986 5554
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-49 Score=422.75 Aligned_cols=259 Identities=32% Similarity=0.561 Sum_probs=218.9
Q ss_pred cccccCCCCeeEEEEeeccCceEEEEEEEC-CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc
Q 002160 669 CECEIPWEDLVLGERIGLGSYGEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 669 ~~~eI~~~dy~i~k~LG~G~fG~Vykak~~-g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~ 747 (958)
..++|+.++|++++.||+|+||.||+|+++ ++.||||++...... ...|.+|+++|++++|||||++++++.+ +.
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~ 81 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP 81 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc-CC
Confidence 456788899999999999999999999985 578999998765443 3578999999999999999999998765 56
Q ss_pred eEEEEeecCCCCHHHHHhCCCC-CccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 748 LSIITEFLPRGSLFRILHRPHC-QVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~-~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
+||||||+++|+|.+++..... .+.+..++.++.+ +.||.|||.++ ||||||||+||||++++++||+|||+++..
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecccceeeccccceEEc
Confidence 8999999999999998765432 3455555555554 99999999988 999999999999999999999999999876
Q ss_pred cCCc-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChhHHHHhhhccccccCCCCCCcHH
Q 002160 826 HNTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGFQNRRLEIPKELDPL 903 (958)
Q Consensus 826 ~~~~-~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG-~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~e 903 (958)
.... .......||+.|+|||++.+..++.++|||||||++|||++| .+||...+..++...+. ...++..|..++++
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~~~ 238 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEE 238 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHH
T ss_pred cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCcccChHH
Confidence 5432 233456789999999999998999999999999999999995 55566666666666664 45567778899999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHhhhh
Q 002160 904 VARIIWECWQTDPSLRPSFAQLTVALKPLQR 934 (958)
Q Consensus 904 L~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k 934 (958)
+.+||.+||+.||.+|||+++|++.|+.+-.
T Consensus 239 l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 9999999999999999999999999988643
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=435.81 Aligned_cols=258 Identities=30% Similarity=0.436 Sum_probs=216.3
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEECC-------cEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEecc
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADWNG-------TEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA 741 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~~g-------~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~ 741 (958)
.++|+.++|++++.||+|+||+||+|++.+ ..||||++.... .......+.+|+.+|.++ +|||||+++++
T Consensus 31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~ 109 (325)
T d1rjba_ 31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGA 109 (325)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence 457888999999999999999999998732 269999876543 233456789999999998 89999999999
Q ss_pred ccCCCceEEEEeecCCCCHHHHHhCCCC----------------------CccHHHHHHH-HHHHHHHHHHHhcCCcEee
Q 002160 742 VTRPPNLSIITEFLPRGSLFRILHRPHC----------------------QVDEKRRIKM-ALDARGMNCLHTSTPTIVH 798 (958)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~d~L~k~~~----------------------~~~e~~~l~i-a~~a~aL~yLH~~g~gIIH 798 (958)
|.+.+.+|||||||++|+|.++++.... .+.+...+.+ .+.+.||.|||+++ |||
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiH 187 (325)
T d1rjba_ 110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVH 187 (325)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred EeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eee
Confidence 9999999999999999999999976432 2344444444 44499999999998 999
Q ss_pred cCCCCCceEEcCCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 002160 799 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPW 875 (958)
Q Consensus 799 RDLKPeNILId~~g~VKL~DFGLAk~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF 875 (958)
|||||+|||++.++++||+|||+|+....... ......||+.|||||++.+..++.++|||||||++|||++ |+.||
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence 99999999999999999999999987544322 2234568999999999999999999999999999999997 89999
Q ss_pred CCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002160 876 IGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALK 930 (958)
Q Consensus 876 ~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~ 930 (958)
.+.+..+.+..+.....++..|..+++++++||.+||+.||++|||++||+++|.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 268 PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 9877666666665566678888999999999999999999999999999999995
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-49 Score=422.42 Aligned_cols=261 Identities=30% Similarity=0.515 Sum_probs=215.5
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEECC------cEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADWNG------TEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR 744 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~~g------~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~ 744 (958)
.+|..++|++.++||+|+||.||+|++.+ ..||||++... .......+|.+|+++|++++|||||++++++.+
T Consensus 2 ~ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~ 80 (283)
T d1mqba_ 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 80 (283)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CcCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec
Confidence 35777899999999999999999998732 36999998654 344556689999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccc
Q 002160 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 823 (958)
Q Consensus 745 ~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk 823 (958)
.+.+++||||+.+++|.+++........+..++.++.+ +.||+|||+++ ||||||||+||||+.++++||+|||+++
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred CCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCCCeEEEcccchhh
Confidence 99999999999999999988766666666666665555 99999999998 9999999999999999999999999998
Q ss_pred cccCCc---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCChhHHHHhhhccccccCCCCC
Q 002160 824 LKHNTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLK-LPWIGMNPMQVVGAVGFQNRRLEIPKE 899 (958)
Q Consensus 824 ~~~~~~---~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~-~PF~g~~~~ei~~~i~~~~~~~~ip~~ 899 (958)
...... .......||+.|+|||++.+..++.++|||||||++|||++|. +||.+.+..++...+. ...++..|..
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~-~~~~~~~~~~ 237 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMD 237 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTT
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHh-ccCCCCCchh
Confidence 764322 1223456899999999999999999999999999999999965 4555666666666654 4566778889
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 900 LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 900 ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
++.++.+||.+||+.||++||++.||++.|+++.+.
T Consensus 238 ~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 238 CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred hHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 999999999999999999999999999999988753
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-49 Score=424.60 Aligned_cols=257 Identities=25% Similarity=0.452 Sum_probs=219.8
Q ss_pred cCCCCeeEEEE-eeccCceEEEEEEE----CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc
Q 002160 673 IPWEDLVLGER-IGLGSYGEVYHADW----NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 673 I~~~dy~i~k~-LG~G~fG~Vykak~----~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~ 747 (958)
+..++|.+.+. ||+|+||.||+|.+ ++..||||++... .......+|.+|+++|++++|||||++++++.. +.
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~ 82 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 82 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence 45577888885 99999999999976 3447999998654 345567789999999999999999999999875 56
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
+|||||||++|+|.+++......+.+.....++.+ +.||+|||+++ ||||||||+||||+.++++||+|||+++...
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccCCceeeccchhhhccc
Confidence 89999999999999998766555565555555554 99999999988 9999999999999999999999999998764
Q ss_pred CCc---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcH
Q 002160 827 NTF---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 902 (958)
Q Consensus 827 ~~~---~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~ 902 (958)
... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+. ...++.+|..+++
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~ 239 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPECPP 239 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCCCCTTCCH
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCH
Confidence 322 22334568999999999999999999999999999999998 899999988888777665 4567788899999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhh
Q 002160 903 LVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934 (958)
Q Consensus 903 eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k 934 (958)
++.+||.+||+.||++||++.+|++.|+.+..
T Consensus 240 ~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 99999999999999999999999999987754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-49 Score=420.46 Aligned_cols=259 Identities=31% Similarity=0.507 Sum_probs=212.0
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEEC-----CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP 745 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~~-----g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~ 745 (958)
++|+.++|++++.||+|+||.||+|++. +..||||.+... ........|.+|+++|++++|||||++++++. .
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 79 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 79 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 5788899999999999999999999873 245888887543 34555678999999999999999999999986 4
Q ss_pred CceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 746 PNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 746 ~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
+.+|+||||+++|+|.+++......+.+...+.++ +.+.||.|||+++ ||||||||+|||++.++++||+|||+++.
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC------
T ss_pred CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCCCcEEEccchhhee
Confidence 67899999999999999887665555655555554 4499999999998 99999999999999999999999999987
Q ss_pred ccCCc-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcH
Q 002160 825 KHNTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDP 902 (958)
Q Consensus 825 ~~~~~-~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~ 902 (958)
..... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..++...+. ...++.+|..+++
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~ 236 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPP 236 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTCCH
T ss_pred ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCH
Confidence 64332 22344568999999999999999999999999999999998 899999999888887775 4556778889999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhh
Q 002160 903 LVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934 (958)
Q Consensus 903 eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k 934 (958)
++++||.+||..||.+||++.||+++|+++.+
T Consensus 237 ~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 237 TLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 99999999999999999999999999998854
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-49 Score=432.06 Aligned_cols=249 Identities=24% Similarity=0.354 Sum_probs=200.0
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
+.|++++.||+|+||+||+|++ +++.||||++....... ....+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5699999999999999999987 58899999997665432 34568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEc---CCCcEEEEeccccccccCCcc
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVD---KNWNVKVSDFGLSRLKHNTFL 830 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId---~~g~VKL~DFGLAk~~~~~~~ 830 (958)
||+||+|.+++.+.+.......+.++.+++.||.|||+++ ||||||||+|||+. +++.+||+|||+++......
T Consensus 88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~- 164 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS- 164 (307)
T ss_dssp CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEccCCC-
Confidence 9999999999988766666666667777799999999998 99999999999995 57899999999998764432
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccccc--CCCCCCcHHHHHHH
Q 002160 831 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPLVARII 908 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~--~ip~~ls~eL~dLI 908 (958)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...+....... ..+..+++++++||
T Consensus 165 ~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 244 (307)
T d1a06a_ 165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFI 244 (307)
T ss_dssp --------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHH
T ss_pred eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHH
Confidence 2345789999999999999999999999999999999999999999988888777765443333 23467899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 002160 909 WECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 909 ~~CL~kDP~kRPSa~EIL~~ 928 (958)
.+||++||.+|||+.|+++|
T Consensus 245 ~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 245 RHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHSCSSGGGSCCHHHHHHS
T ss_pred HHHccCCHhHCcCHHHHhcC
Confidence 99999999999999999885
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-49 Score=422.02 Aligned_cols=248 Identities=27% Similarity=0.425 Sum_probs=207.6
Q ss_pred EEeeccCceEEEEEEEC----CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEeecCC
Q 002160 682 ERIGLGSYGEVYHADWN----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEFLPR 757 (958)
Q Consensus 682 k~LG~G~fG~Vykak~~----g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy~~g 757 (958)
++||+|+||+||+|.+. ++.||||++...........+|.+|+++|++++|||||+++++|.. +.++||||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999762 4579999987665555566789999999999999999999999865 467899999999
Q ss_pred CCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc---ccCCC
Q 002160 758 GSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF---LSSKS 834 (958)
Q Consensus 758 GsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~---~~~~s 834 (958)
|+|.+++.+...........++.+.+.||+|||+++ ||||||||+||||+.++.+||+|||+++...... .....
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 169 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC---
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcccccCcccccchhhhhhccccccccccccc
Confidence 999999987654444444444445599999999988 9999999999999999999999999998754322 12234
Q ss_pred CCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhh
Q 002160 835 TAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQ 913 (958)
Q Consensus 835 ~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~ 913 (958)
..||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+. ...++.+|..+++++++||.+||+
T Consensus 170 ~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~~~~li~~cl~ 248 (277)
T d1xbba_ 170 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPREMYDLMNLCWT 248 (277)
T ss_dssp -CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred cCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHHHHHHHHcC
Confidence 568999999999999999999999999999999997 899999998888777664 456778889999999999999999
Q ss_pred cCCCCCCCHHHHHHHHHhhh
Q 002160 914 TDPSLRPSFAQLTVALKPLQ 933 (958)
Q Consensus 914 kDP~kRPSa~EIL~~L~kL~ 933 (958)
.||.+||++++|++.|+.+.
T Consensus 249 ~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 249 YDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp SSTTTSCCHHHHHHHHHHHH
T ss_pred CCHhHCcCHHHHHHHhhCHH
Confidence 99999999999999988764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-49 Score=431.00 Aligned_cols=246 Identities=27% Similarity=0.373 Sum_probs=211.6
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
.|++++.||+|+||+||+|++ +++.||||++...... ......+.+|+++|++++|||||++++++.+++.+|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 499999999999999999986 6888999999876543 3456779999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCC
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 833 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~ 833 (958)
||++|+|..++...........+.++.+++.||.|||.++ ||||||||+||||+.++++||+|||+++..... .
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~----~ 169 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----N 169 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----C
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCCCCEEEeecccccccCCC----C
Confidence 9999999877665555555555556666699999999998 999999999999999999999999999865432 3
Q ss_pred CCCCCCCccCcccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHH
Q 002160 834 STAGTPEWMAPEVLRN---EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWE 910 (958)
Q Consensus 834 s~~GT~~Y~APEvl~g---~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~ 910 (958)
...||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+....+.........+..+++++++||.+
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~ 249 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHH
T ss_pred ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 5689999999999964 3578999999999999999999999999888877766654433334456789999999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 002160 911 CWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 911 CL~kDP~kRPSa~EIL~~ 928 (958)
||+.||.+|||++||++|
T Consensus 250 ~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 250 CLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HTCSSGGGSCCHHHHTTC
T ss_pred HCcCChhHCcCHHHHHhC
Confidence 999999999999999874
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.8e-49 Score=430.09 Aligned_cols=247 Identities=24% Similarity=0.402 Sum_probs=219.1
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LV 751 (958)
.++|++++.||+|+||+||+|++ +|+.||||++.+.... ......+.+|+.+|++++|||||++++++.+.+.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 47899999999999999999987 5889999998754321 12356788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc
Q 002160 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~ 831 (958)
||||+||+|..++...........+.++.+++.||.|||+++ ||||||||+||||+.+|++||+|||+++.....
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--- 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 157 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCCCCEEEecCccceEeccc---
Confidence 999999999999987766666666667777799999999998 999999999999999999999999999876543
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHh
Q 002160 832 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 911 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~C 911 (958)
....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..++...+.. ....+|..+++++++||.+|
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~~~ 235 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--AELRFPPFFNEDVKDLLSRL 235 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHH
Confidence 2357899999999999999999999999999999999999999999998888877743 35667888999999999999
Q ss_pred hhcCCCCCC-----CHHHHHHH
Q 002160 912 WQTDPSLRP-----SFAQLTVA 928 (958)
Q Consensus 912 L~kDP~kRP-----Sa~EIL~~ 928 (958)
|.+||.+|+ ++++|++|
T Consensus 236 L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 236 ITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp TCSCTTTCTTSSTTTTHHHHTS
T ss_pred hhhCHHhccccchhhHHHHHcC
Confidence 999999996 89999876
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=421.55 Aligned_cols=250 Identities=25% Similarity=0.377 Sum_probs=215.2
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCH----HHHHHHHHHHHHHHHcCCCceeEEeccccCCCceE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLS 749 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~----~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~ 749 (958)
++|++++.||+|+||+||+|++ +|+.||||++.+..... .....+.+|+++|++++|||||+++++|.+.+.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5699999999999999999987 58899999997654322 23567899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCC----cEEEEeccccccc
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNW----NVKVSDFGLSRLK 825 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g----~VKL~DFGLAk~~ 825 (958)
||||||++|+|.+++.+.+.......+.++.+.+.||+|||+++ ||||||||+|||++.++ ++||+|||+++..
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 99999999999999987665555666666666799999999998 99999999999998766 5999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccccc--CCCCCCcHH
Q 002160 826 HNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPL 903 (958)
Q Consensus 826 ~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~--~ip~~ls~e 903 (958)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+....... .++..++++
T Consensus 168 ~~~~-~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 246 (293)
T d1jksa_ 168 DFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246 (293)
T ss_dssp TTSC-BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHH
T ss_pred CCCc-cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHH
Confidence 5432 2345689999999999999999999999999999999999999999998888877764332221 233578999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 904 VARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 904 L~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+++||.+||+.||.+||+++||++|
T Consensus 247 ~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 247 AKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999999874
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.5e-48 Score=431.15 Aligned_cols=249 Identities=25% Similarity=0.367 Sum_probs=213.2
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
.++|++++.||+|+||.||+|++ +|+.||||++.... ......+.+|+++|++|+|||||+++++|.+.+.+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 36899999999999999999987 58899999987653 344567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccH-HHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEc--CCCcEEEEeccccccccCCc
Q 002160 753 EFLPRGSLFRILHRPHCQVDE-KRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVD--KNWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e-~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId--~~g~VKL~DFGLAk~~~~~~ 829 (958)
|||+||+|.+++.+....+.+ ..+.++.+++.||.|||+++ ||||||||+||||+ .++.+||+|||+++......
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 999999999999655444444 44455555699999999998 99999999999996 46899999999998765432
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccC--CCCCCcHHHHHH
Q 002160 830 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE--IPKELDPLVARI 907 (958)
Q Consensus 830 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~--ip~~ls~eL~dL 907 (958)
......||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+..++...+........ ....+++++++|
T Consensus 181 -~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 259 (350)
T d1koaa2 181 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 259 (350)
T ss_dssp -CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHH
T ss_pred -ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 23456899999999999999999999999999999999999999999988888777753332222 234689999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 002160 908 IWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 908 I~~CL~kDP~kRPSa~EIL~~ 928 (958)
|.+||+.||.+|||++||++|
T Consensus 260 i~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 260 IRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999886
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=418.25 Aligned_cols=266 Identities=31% Similarity=0.493 Sum_probs=211.7
Q ss_pred CccccccCCCCeeEEEEeeccCceEEEEEEEC-------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEE
Q 002160 667 DVCECEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLF 738 (958)
Q Consensus 667 ~~~~~eI~~~dy~i~k~LG~G~fG~Vykak~~-------g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL 738 (958)
+...++|++++|+++++||+|+||.||+|++. ++.||||++.... .......+.+|..++.++ +|+|||++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 44567888999999999999999999999862 3579999986543 344556788888888887 68999999
Q ss_pred eccccCC-CceEEEEeecCCCCHHHHHhCCC---------------CCccHHHHHHHH-HHHHHHHHHHhcCCcEeecCC
Q 002160 739 MGAVTRP-PNLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMA-LDARGMNCLHTSTPTIVHRDL 801 (958)
Q Consensus 739 ~g~~~~~-~~l~LVmEy~~gGsL~d~L~k~~---------------~~~~e~~~l~ia-~~a~aL~yLH~~g~gIIHRDL 801 (958)
++++... ..+++|||||++|+|.++++... ..+.+.....++ +.+.||.|||+++ ||||||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDl 160 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDL 160 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcC
Confidence 9987654 46899999999999999986432 124444455444 4499999999998 999999
Q ss_pred CCCceEEcCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCC
Q 002160 802 KSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGM 878 (958)
Q Consensus 802 KPeNILId~~g~VKL~DFGLAk~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG-~~PF~g~ 878 (958)
||+||||+.++++||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++| ..||.+.
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998654322 223456799999999999999999999999999999999986 5678877
Q ss_pred ChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 879 NPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 879 ~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
+..+.+........++.+|..+++++++||.+||+.||.+||++.||+++|+++.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 241 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp CCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 655555444445667788889999999999999999999999999999999998654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=415.17 Aligned_cols=255 Identities=33% Similarity=0.586 Sum_probs=214.1
Q ss_pred cccCCCCeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC-CCceE
Q 002160 671 CEIPWEDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-PPNLS 749 (958)
Q Consensus 671 ~eI~~~dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~-~~~l~ 749 (958)
++|..++|++++.||+|+||.||+|+++++.||||++.... ..+.|.+|+++|++++|||||++++++.+ .+.+|
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence 57888999999999999999999999999999999986543 23578899999999999999999998854 56789
Q ss_pred EEEeecCCCCHHHHHhCCC-CCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 750 IITEFLPRGSLFRILHRPH-CQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~-~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
+||||+++|+|.+++.+.. ..+.+...+.++.+ +.||.|||..+ ||||||||+|||++.++++||+|||+++....
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCCCCEeecccccceecCC
Confidence 9999999999999997543 23455555555555 99999999988 99999999999999999999999999987544
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHH
Q 002160 828 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVAR 906 (958)
Q Consensus 828 ~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~d 906 (958)
. .....+|..|+|||++.+..++.++|||||||++|||++ |++||.+.+..++...+. ...++++|..+++++++
T Consensus 156 ~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~ 231 (262)
T d1byga_ 156 T---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVYE 231 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCCHHHHH
T ss_pred C---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCHHHHH
Confidence 3 234568999999999999999999999999999999998 799999888888777764 45678888999999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 907 IIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 907 LI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
||.+||+.||.+||++.+|+++|+++...
T Consensus 232 li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 232 VMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 99999999999999999999999998653
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.7e-48 Score=429.16 Aligned_cols=248 Identities=24% Similarity=0.344 Sum_probs=213.5
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
++|++++.||+|+||.||+|++ +++.||||++.... ......+.+|+.+|++|+|||||+++++|.+++.+|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 5799999999999999999987 68999999987653 3345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHH-HHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEc--CCCcEEEEeccccccccCCcc
Q 002160 754 FLPRGSLFRILHRPHCQVDEK-RRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVD--KNWNVKVSDFGLSRLKHNTFL 830 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~-~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId--~~g~VKL~DFGLAk~~~~~~~ 830 (958)
||+||+|.+++.+....+.+. .+.++.+++.||.|||+++ ||||||||+||||+ .++++||+|||+|+......
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~- 183 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 183 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence 999999999887766545544 4445555599999999998 99999999999998 67899999999998775432
Q ss_pred cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccc--cCCCCCCcHHHHHHH
Q 002160 831 SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR--LEIPKELDPLVARII 908 (958)
Q Consensus 831 ~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~--~~ip~~ls~eL~dLI 908 (958)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...+...... ...+..+++++++||
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 263 (352)
T d1koba_ 184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 263 (352)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 234467999999999999999999999999999999999999999999888887776433322 223457899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 002160 909 WECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 909 ~~CL~kDP~kRPSa~EIL~~ 928 (958)
.+||++||.+||++.|+++|
T Consensus 264 ~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 264 KNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HTTSCSSGGGSCCHHHHHTS
T ss_pred HHHccCChhHCcCHHHHhcC
Confidence 99999999999999999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.1e-48 Score=417.42 Aligned_cols=260 Identities=29% Similarity=0.473 Sum_probs=221.8
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEEC-------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccc
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 742 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~~-------g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~ 742 (958)
..+++.++|++++.||+|+||+||+|++. ++.||||++... .......+|.+|+++|++++||||++++++|
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 35677889999999999999999999874 368999998654 3455567899999999999999999999999
Q ss_pred cCCCceEEEEeecCCCCHHHHHhCCC-----------------------CCccHHHHHHHHHH-HHHHHHHHhcCCcEee
Q 002160 743 TRPPNLSIITEFLPRGSLFRILHRPH-----------------------CQVDEKRRIKMALD-ARGMNCLHTSTPTIVH 798 (958)
Q Consensus 743 ~~~~~l~LVmEy~~gGsL~d~L~k~~-----------------------~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIH 798 (958)
...+.+++||||+++|+|.+++.... ..+.+...+.++.+ +.||+|||.++ |||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivH 163 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVH 163 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEe
Confidence 99999999999999999999986432 12445555555555 99999999998 999
Q ss_pred cCCCCCceEEcCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCC-CCC
Q 002160 799 RDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLK-LPW 875 (958)
Q Consensus 799 RDLKPeNILId~~g~VKL~DFGLAk~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~-~PF 875 (958)
|||||+|||||.++++||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|. .||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999999999999999999998654322 2233467899999999999999999999999999999999985 688
Q ss_pred CCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 002160 876 IGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 933 (958)
Q Consensus 876 ~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~ 933 (958)
.+.+..++...+. ...++.+|..+++++.+||.+||+.||.+||+|.||++.|++|.
T Consensus 244 ~~~~~~e~~~~v~-~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 244 YGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCHHHHHHHHH-cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 8888888887775 44567788899999999999999999999999999999999874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-48 Score=420.32 Aligned_cols=255 Identities=28% Similarity=0.497 Sum_probs=212.4
Q ss_pred CCCeeEEEEeeccCceEEEEEEEC--Cc----EEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCce
Q 002160 675 WEDLVLGERIGLGSYGEVYHADWN--GT----EVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~~--g~----~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l 748 (958)
..+|++++.||+|+||+||+|++. ++ .||||++.... ......+|.+|+.+|++++|||||+++++|.++ ..
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 357999999999999999999873 33 58888876432 233456899999999999999999999999864 57
Q ss_pred EEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
+++|||+.+|+|.+++........+...+.++.+ +.||.|||.++ ||||||||+||||+.++++||+|||+++....
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 8889999999999988776666666666655544 99999999998 99999999999999999999999999987643
Q ss_pred Ccc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCcHHH
Q 002160 828 TFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 904 (958)
Q Consensus 828 ~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL 904 (958)
... ......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+. ...++..|..+++++
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~p~~~~~~~ 242 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTIDV 242 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH-HTCCCCCCTTBCHHH
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHH
Confidence 322 2234568999999999999999999999999999999998 899999888777766554 456677888999999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHhhhh
Q 002160 905 ARIIWECWQTDPSLRPSFAQLTVALKPLQR 934 (958)
Q Consensus 905 ~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k 934 (958)
.+||.+||+.||.+||++.||+.+|.++.+
T Consensus 243 ~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 243 YMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999998854
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=426.52 Aligned_cols=248 Identities=24% Similarity=0.392 Sum_probs=217.1
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHH-HcCCCceeEEeccccCCCceEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMR-RLRHPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk-~L~HPNIVkL~g~~~~~~~l~LV 751 (958)
++|++++.||+|+||+||+|++ +++.||||++.+... .......+..|..++. .++|||||++++++.+++.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 6899999999999999999987 789999999875432 1122445667777765 68999999999999999999999
Q ss_pred EeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc
Q 002160 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~ 831 (958)
||||++|+|.+++...........+.++.+++.||+|||+++ ||||||||+|||+++++++||+|||+++........
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~ 159 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK 159 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCCCceeccccchhhhccccccc
Confidence 999999999999987666666666677777799999999998 999999999999999999999999999876655555
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHh
Q 002160 832 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 911 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~C 911 (958)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...+. ...+.+|..+++++++||.+|
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~--~~~~~~p~~~s~~~~dli~~~ 237 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR--MDNPFYPRWLEKEAKDLLVKL 237 (320)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCccCCHHHHHHHHHh
Confidence 566789999999999999999999999999999999999999999999988888774 346678889999999999999
Q ss_pred hhcCCCCCCCHH-HHHH
Q 002160 912 WQTDPSLRPSFA-QLTV 927 (958)
Q Consensus 912 L~kDP~kRPSa~-EIL~ 927 (958)
|.+||.+||++. +|++
T Consensus 238 L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 238 FVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp SCSSGGGSBTTBSCGGG
T ss_pred cccCCCCCcCHHHHHHh
Confidence 999999999995 7765
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.5e-47 Score=408.85 Aligned_cols=256 Identities=25% Similarity=0.361 Sum_probs=211.6
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCc----e
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN----L 748 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~----l 748 (958)
++|++.+.||+|+||+||+|++ +++.||||++..... .......|.+|+++|++++|||||++++++...+. +
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 6799999999999999999986 689999999987654 34556789999999999999999999999876543 8
Q ss_pred EEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
||||||++|++|.+++...+.......+.++.+++.||.|||+++ ||||||||+||||+.++.++|+|||+++.....
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCccccceeehhhhhhhhccc
Confidence 999999999999999877665555556666666699999999998 999999999999999999999999998765332
Q ss_pred c---ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccccc--CCCCCCcHH
Q 002160 829 F---LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EIPKELDPL 903 (958)
Q Consensus 829 ~---~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~--~ip~~ls~e 903 (958)
. ......+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+....+......+ .....++++
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 244 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 244 (277)
T ss_dssp --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHH
T ss_pred cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHH
Confidence 1 23445679999999999999999999999999999999999999999988887766654333222 334678999
Q ss_pred HHHHHHHhhhcCCCCCC-CHHHHHHHHHhhh
Q 002160 904 VARIIWECWQTDPSLRP-SFAQLTVALKPLQ 933 (958)
Q Consensus 904 L~dLI~~CL~kDP~kRP-Sa~EIL~~L~kL~ 933 (958)
+++||.+||.+||.+|| +++++++.|.++.
T Consensus 245 l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 245 LDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 99999999999999998 8999999998875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.8e-48 Score=429.42 Aligned_cols=247 Identities=23% Similarity=0.373 Sum_probs=217.9
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCC-HHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFS-GAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~-~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LV 751 (958)
.++|++++.||+|+||.||+|++ +|+.||||++.+.... ......+.+|+++|++++|||||++++++.+...+++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 47899999999999999999987 6899999998754321 12345788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCccc
Q 002160 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLS 831 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~ 831 (958)
|||+.+|+|..++.+.+.......+.++.+++.||.|||+++ ||||||||+||||+.+|++||+|||+++.....
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--- 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCCCCEEeeeceeeeecccc---
Confidence 999999999999987666666666667777799999999998 999999999999999999999999999877543
Q ss_pred CCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHHHHHHHHh
Q 002160 832 SKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLVARIIWEC 911 (958)
Q Consensus 832 ~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~C 911 (958)
....+||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+..++...+. ...+.+|..+++++.+||.+|
T Consensus 195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~~~ 272 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV--SGKVRFPSHFSSDLKDLLRNL 272 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTCCHHHHHHHHHH
T ss_pred cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHh--cCCCCCCccCCHHHHHHHHHH
Confidence 235789999999999999999999999999999999999999999998888877774 335667889999999999999
Q ss_pred hhcCCCCCC-----CHHHHHHH
Q 002160 912 WQTDPSLRP-----SFAQLTVA 928 (958)
Q Consensus 912 L~kDP~kRP-----Sa~EIL~~ 928 (958)
|++||.+|+ ++++|++|
T Consensus 273 L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 273 LQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp SCSCTTTCTTSSTTTTHHHHTS
T ss_pred hhhCHHhccccccccHHHHHcC
Confidence 999999994 89999874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=413.51 Aligned_cols=261 Identities=32% Similarity=0.544 Sum_probs=212.8
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEE-CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCce
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNL 748 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l 748 (958)
.++|+.++|++++.||+|+||+||+|++ +++.||||++...... ...|.+|+.+|++++|||||++++++.+ +.+
T Consensus 11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~ 86 (285)
T d1fmka3 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 86 (285)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEec-CCe
Confidence 4567789999999999999999999988 4567999998765443 3578999999999999999999999865 568
Q ss_pred EEEEeecCCCCHHHHHhCC-CCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 749 SIITEFLPRGSLFRILHRP-HCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~-~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
++||||+++|+|..++... ...+.+..++.++.+ +.||+|||.++ |+||||||+||||+.++++||+|||+++...
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIE 164 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCCCcEEEcccchhhhcc
Confidence 9999999999999887643 234556556655555 99999999998 9999999999999999999999999998764
Q ss_pred CCc-ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCChhHHHHhhhccccccCCCCCCcHHH
Q 002160 827 NTF-LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLK-LPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 904 (958)
Q Consensus 827 ~~~-~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~-~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL 904 (958)
... .......||+.|+|||++.+..++.++|||||||++|||++|. +||.+....++...+. ...+..++..+++++
T Consensus 165 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l 243 (285)
T d1fmka3 165 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESL 243 (285)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTSCHHH
T ss_pred CCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCCcccCHHH
Confidence 332 2233456899999999999999999999999999999999965 5556666666766664 445667888999999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHhhhhhcC
Q 002160 905 ARIIWECWQTDPSLRPSFAQLTVALKPLQRLVI 937 (958)
Q Consensus 905 ~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~~~ 937 (958)
++||.+||+.||++||++++|++.|+++.....
T Consensus 244 ~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 244 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred HHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 999999999999999999999999988765443
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-48 Score=414.03 Aligned_cols=257 Identities=32% Similarity=0.527 Sum_probs=210.4
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEEC-----CcEEEEEEeecCCC-CHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDF-SGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP 746 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~~-----g~~VAVK~i~~~~~-~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~ 746 (958)
|..++|++.+.||+|+||.||+|++. ...||||++.+... ......+|.+|+.+|++++|||||++++++.+ .
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 56688999999999999999999863 23689998876544 33456789999999999999999999999976 4
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLK 825 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~ 825 (958)
.+++||||+++|+|.+++......+.+...+.++.+ +.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccccceeeccchhhhhc
Confidence 688999999999999988765555555555555544 99999999988 999999999999999999999999999876
Q ss_pred cCCcc---cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhHHHHhhhccccccCCCCCCc
Q 002160 826 HNTFL---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNPMQVVGAVGFQNRRLEIPKELD 901 (958)
Q Consensus 826 ~~~~~---~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls 901 (958)
..... ......|+..|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+.....+++.+..++
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCccccc
Confidence 43321 2233457889999999999999999999999999999998 8999999999998888876777778888999
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHhh
Q 002160 902 PLVARIIWECWQTDPSLRPSFAQLTVALKPL 932 (958)
Q Consensus 902 ~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL 932 (958)
+.+++||.+||+.||.+|||+.+|++.|++.
T Consensus 242 ~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 242 QDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 9999999999999999999999999999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=414.38 Aligned_cols=259 Identities=32% Similarity=0.604 Sum_probs=217.2
Q ss_pred ccCCCCeeEEEEeeccCceEEEEEEE--CCc--EEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccCCC
Q 002160 672 EIPWEDLVLGERIGLGSYGEVYHADW--NGT--EVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTRPP 746 (958)
Q Consensus 672 eI~~~dy~i~k~LG~G~fG~Vykak~--~g~--~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~~~ 746 (958)
.|++++|++.++||+|+||.||+|++ ++. .||||++.... .......|.+|+++|+++ +|||||++++++.+.+
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 47889999999999999999999987 344 47788765433 233456799999999999 7999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhCCC---------------CCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcC
Q 002160 747 NLSIITEFLPRGSLFRILHRPH---------------CQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDK 810 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~---------------~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~ 810 (958)
.+|+||||+++|+|.+++++.. ..+.+..++.++.+ +.||.|||.++ ||||||||+|||++.
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~~ 162 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGE 162 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEcC
Confidence 9999999999999999997542 34555555555555 99999999998 999999999999999
Q ss_pred CCcEEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCChhHHHHhhhc
Q 002160 811 NWNVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLK-LPWIGMNPMQVVGAVGF 889 (958)
Q Consensus 811 ~g~VKL~DFGLAk~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~-~PF~g~~~~ei~~~i~~ 889 (958)
++.+||+|||+++..... .......||..|+|||.+.+..++.++|||||||++|||++|. +||.+.+..++...+.
T Consensus 163 ~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~- 240 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP- 240 (309)
T ss_dssp GGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG-
T ss_pred CCceEEcccccccccccc-ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH-
Confidence 999999999999865433 2234467899999999999999999999999999999999965 6788888888877764
Q ss_pred cccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 890 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 890 ~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
...++.+|..+++++++||.+||+.||++||++.||+++|+++.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 241 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 4567788889999999999999999999999999999999998764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.5e-47 Score=424.96 Aligned_cols=251 Identities=24% Similarity=0.322 Sum_probs=208.0
Q ss_pred CCCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCH----HHHHHHHHHHHHHHHcCCCceeEEeccccCCCc
Q 002160 674 PWEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPN 747 (958)
Q Consensus 674 ~~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~----~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~ 747 (958)
..++|++++.||+|+||.||+|++ +|+.||||++.+..... ........|+.+++.++|||||+++++|.+.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 468999999999999999999987 68899999986543221 112223345667777789999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
+|||||||+||+|.+++.+.....+...+.++.+++.||.|||.++ ||||||||+||||+.+|++||+|||+|+....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 9999999999999999987666666666666777799999999998 99999999999999999999999999987654
Q ss_pred CcccCCCCCCCCCccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhh-hccccccCCCCCCcHHHH
Q 002160 828 TFLSSKSTAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAV-GFQNRRLEIPKELDPLVA 905 (958)
Q Consensus 828 ~~~~~~s~~GT~~Y~APEvl~-g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i-~~~~~~~~ip~~ls~eL~ 905 (958)
. .....+||+.|+|||++. +..|+.++|||||||++|||++|+.||.+.+........ ........+|..++++++
T Consensus 160 ~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 237 (364)
T d1omwa3 160 K--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 237 (364)
T ss_dssp S--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHH
T ss_pred C--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHH
Confidence 3 234568999999999997 466899999999999999999999999876543322221 113445667788999999
Q ss_pred HHHHHhhhcCCCCCCC-----HHHHHHH
Q 002160 906 RIIWECWQTDPSLRPS-----FAQLTVA 928 (958)
Q Consensus 906 dLI~~CL~kDP~kRPS-----a~EIL~~ 928 (958)
+||.+||++||.+||+ ++||++|
T Consensus 238 ~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 238 SLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp HHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred HHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 9999999999999999 6888875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-47 Score=408.48 Aligned_cols=262 Identities=32% Similarity=0.549 Sum_probs=220.4
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEEC---------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEe
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFM 739 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~~---------g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~ 739 (958)
.++|+.++|++++.||+|+||.||+|++. +..||||++.... ......++.+|..++.++ +|||||+++
T Consensus 7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 47788999999999999999999999752 2469999886543 455567889999999998 899999999
Q ss_pred ccccCCCceEEEEeecCCCCHHHHHhCCCC---------------CccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCC
Q 002160 740 GAVTRPPNLSIITEFLPRGSLFRILHRPHC---------------QVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKS 803 (958)
Q Consensus 740 g~~~~~~~l~LVmEy~~gGsL~d~L~k~~~---------------~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKP 803 (958)
++|.+++.+++||||+++|+|.+++..... .+.+...+.++.+ +.||+|||+++ ||||||||
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp 163 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAA 163 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeecc
Confidence 999999999999999999999999975532 2455555555544 99999999998 99999999
Q ss_pred CceEEcCCCcEEEEeccccccccCCcc--cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 002160 804 PNLLVDKNWNVKVSDFGLSRLKHNTFL--SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNP 880 (958)
Q Consensus 804 eNILId~~g~VKL~DFGLAk~~~~~~~--~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~ 880 (958)
+|||++.++.+||+|||+++....... ......||+.|+|||++.+..|+.++|||||||++|||++ |++||.+.+.
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 999999999999999999987654322 2344568999999999999999999999999999999998 7999998888
Q ss_pred hHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 881 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 881 ~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
.++...+. ...++.+|..+++++++||.+||+.||.+|||+.||++.|++|...
T Consensus 244 ~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 244 EELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHH-cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 87776664 4567788899999999999999999999999999999999998653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.3e-47 Score=405.78 Aligned_cols=251 Identities=23% Similarity=0.319 Sum_probs=214.9
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCH-------HHHHHHHHHHHHHHHcC-CCceeEEeccccC
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG-------AALLEFKREVKIMRRLR-HPNVVLFMGAVTR 744 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~-------~~~~~f~~Ei~ILk~L~-HPNIVkL~g~~~~ 744 (958)
.++|++.+.||+|+||+||+|++ +++.||||++.+..... .....+.+|+.+|++++ |||||+++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 46899999999999999999987 78999999997764321 23346889999999996 9999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 745 ~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
++.+|||||||++|+|.+++...+.......+.++.+++.||+|||.++ ||||||||+||||+.++.+||+|||+++.
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCCCCeEEccchheeE
Confidence 9999999999999999999987766666666667777799999999998 99999999999999999999999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccC--C
Q 002160 825 KHNTFLSSKSTAGTPEWMAPEVLRN------EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLE--I 896 (958)
Q Consensus 825 ~~~~~~~~~s~~GT~~Y~APEvl~g------~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~--i 896 (958)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+........ .
T Consensus 160 ~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (277)
T d1phka_ 160 LDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238 (277)
T ss_dssp CCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred ccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 75432 3355789999999999863 3468899999999999999999999999988877766643333322 2
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 897 PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 897 p~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
...+++++++||.+||+.||.+||+++||++|
T Consensus 239 ~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 34789999999999999999999999999875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-47 Score=408.27 Aligned_cols=247 Identities=24% Similarity=0.260 Sum_probs=201.9
Q ss_pred EEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCH---HHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEee
Q 002160 680 LGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG---AALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 680 i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~---~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
.+++||+|+||+||+|++ +++.||||++....... .....+.+|+++|++++|||||+++++|.+.+.+||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 468899999999999986 68899999986544322 1234688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCCC
Q 002160 755 LPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSKS 834 (958)
Q Consensus 755 ~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~s 834 (958)
+.++.+..+............+.++.+++.||.|||.++ ||||||||+|||++.++.+||+|||+++...........
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~ 159 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH 159 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCCCccccccCccccccCCCcccccc
Confidence 998887777665555556666667777799999999998 999999999999999999999999999887665555566
Q ss_pred CCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccc--------------------
Q 002160 835 TAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR-------------------- 893 (958)
Q Consensus 835 ~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~-------------------- 893 (958)
.+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+......
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhcc
Confidence 789999999999875 45799999999999999999999999998877665544211000
Q ss_pred -c-----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 894 -L-----EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 894 -~-----~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
. .+...+++++++||.+||+.||.+|||++|+++|
T Consensus 240 ~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0 0113568899999999999999999999999875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-47 Score=414.59 Aligned_cols=246 Identities=18% Similarity=0.278 Sum_probs=211.2
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVm 752 (958)
+++|++++.||+|+||+||+|.+ +++.||||++.... .....+.+|+++|++++|||||+++++|.+++.+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 47899999999999999999987 68899999987653 23456889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhCCCCCccH-HHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcC--CCcEEEEeccccccccCCc
Q 002160 753 EFLPRGSLFRILHRPHCQVDE-KRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDK--NWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e-~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~--~g~VKL~DFGLAk~~~~~~ 829 (958)
|||+||+|.+++.+.+..+.+ ..+.++.+++.||.|||+++ ||||||||+|||++. .+.+||+|||+++......
T Consensus 81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 999999999999876644444 44455556699999999998 999999999999985 4589999999998764432
Q ss_pred ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCC----CCCcHHHH
Q 002160 830 LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIP----KELDPLVA 905 (958)
Q Consensus 830 ~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip----~~ls~eL~ 905 (958)
......||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+..++...+... ...++ ..++++++
T Consensus 159 -~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~ 235 (321)
T d1tkia_ 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA--EYTFDEEAFKEISIEAM 235 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--CCCCCHHHHTTSCHHHH
T ss_pred -cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCChhhccCCCHHHH
Confidence 233457899999999999999999999999999999999999999999988887777433 22232 46899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 002160 906 RIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 906 dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+||.+||.+||.+||++.|+++|
T Consensus 236 ~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 236 DFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999985
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=407.78 Aligned_cols=262 Identities=29% Similarity=0.442 Sum_probs=221.9
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEE-------CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEecc
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADW-------NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGA 741 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~-------~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~ 741 (958)
.++|+.++|+++++||+|+||.||+|++ .++.||||++.... .......|.+|+.+++++ +|||||+++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 5678889999999999999999999986 34579999987654 344566899999999999 69999999999
Q ss_pred ccCCCceEEEEeecCCCCHHHHHhCCCC-----------------CccHHHHHHHHH-HHHHHHHHHhcCCcEeecCCCC
Q 002160 742 VTRPPNLSIITEFLPRGSLFRILHRPHC-----------------QVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDLKS 803 (958)
Q Consensus 742 ~~~~~~l~LVmEy~~gGsL~d~L~k~~~-----------------~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDLKP 803 (958)
+.+...++||||||++|+|.+++++... ...+.....++. ++.||+|||.++ ||||||||
T Consensus 96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp 173 (311)
T d1t46a_ 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAA 173 (311)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccccc
Confidence 9999999999999999999999875431 344445544444 499999999998 99999999
Q ss_pred CceEEcCCCcEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 002160 804 PNLLVDKNWNVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELAT-LKLPWIGMNP 880 (958)
Q Consensus 804 eNILId~~g~VKL~DFGLAk~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLt-G~~PF~g~~~ 880 (958)
+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+.
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999998765432 23344678999999999999999999999999999999998 6666777666
Q ss_pred hHHHHhhhccccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhh
Q 002160 881 MQVVGAVGFQNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934 (958)
Q Consensus 881 ~ei~~~i~~~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k 934 (958)
.+.+..+.....++..+..++.++.+||.+||+.||.+||++.||++.|+++..
T Consensus 254 ~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 565555555666777888999999999999999999999999999999987654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=408.93 Aligned_cols=260 Identities=32% Similarity=0.536 Sum_probs=223.4
Q ss_pred ccccCCCCeeEEEEeeccCceEEEEEEEC-------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccc
Q 002160 670 ECEIPWEDLVLGERIGLGSYGEVYHADWN-------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAV 742 (958)
Q Consensus 670 ~~eI~~~dy~i~k~LG~G~fG~Vykak~~-------g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~ 742 (958)
.++|++++|++++.||+|+||.||+|.+. ++.||||++.... .......|.+|++++++++|||||++++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 46888999999999999999999999763 4689999987543 445567899999999999999999999999
Q ss_pred cCCCceEEEEeecCCCCHHHHHhCCC---------CCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCC
Q 002160 743 TRPPNLSIITEFLPRGSLFRILHRPH---------CQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNW 812 (958)
Q Consensus 743 ~~~~~l~LVmEy~~gGsL~d~L~k~~---------~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g 812 (958)
...+.+++||||+++|+|.+++.... ....+..++.++.+ +.||.|||.++ ||||||||+||||+.++
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDF 170 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTC
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeecCCc
Confidence 99999999999999999999885321 23345555555555 89999999988 99999999999999999
Q ss_pred cEEEEeccccccccCCc--ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChhHHHHhhhc
Q 002160 813 NVKVSDFGLSRLKHNTF--LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATL-KLPWIGMNPMQVVGAVGF 889 (958)
Q Consensus 813 ~VKL~DFGLAk~~~~~~--~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG-~~PF~g~~~~ei~~~i~~ 889 (958)
++||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++| ..||.+.+..++...+.
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~- 249 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM- 249 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH-
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-
Confidence 99999999998664332 223345689999999999999999999999999999999998 58899998888887765
Q ss_pred cccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhh
Q 002160 890 QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQ 933 (958)
Q Consensus 890 ~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~ 933 (958)
...++..|..+++.+.+||.+||+.||.+||++.+|+++|++..
T Consensus 250 ~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 250 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred hCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 45567788899999999999999999999999999999998763
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=404.71 Aligned_cols=251 Identities=24% Similarity=0.295 Sum_probs=201.7
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
++|++++.||+|+||+||+|++ +++.||||++......+.....+.+|+++|++++|||||+++++|.+.+.+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999987 58899999997655444445688999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccH-HHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccC
Q 002160 754 FLPRGSLFRILHRPHCQVDE-KRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSS 832 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e-~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~ 832 (958)
|+.++.+..........+.+ ..+.++.+.+.||.|||+++ ||||||||+|||++.++++||+|||+++.........
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~ 159 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCT
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeecccCcceeccCCcceeccCCcccc
Confidence 99765444443443444444 44455555599999999998 9999999999999999999999999998876655555
Q ss_pred CCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccc----------------cccC
Q 002160 833 KSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN----------------RRLE 895 (958)
Q Consensus 833 ~s~~GT~~Y~APEvl~g~~-~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~----------------~~~~ 895 (958)
....||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+..+....+.... ....
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc
Confidence 6678999999999987665 5789999999999999999999999887665544331100 0000
Q ss_pred C-----------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 896 I-----------PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 896 i-----------p~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+ ...+++++++||.+||+.||.+|||+.||++|
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 1 12467899999999999999999999999987
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-46 Score=403.31 Aligned_cols=257 Identities=30% Similarity=0.483 Sum_probs=212.8
Q ss_pred eEEEEeeccCceEEEEEEEC-----CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC-CCceEEEE
Q 002160 679 VLGERIGLGSYGEVYHADWN-----GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-PPNLSIIT 752 (958)
Q Consensus 679 ~i~k~LG~G~fG~Vykak~~-----g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~-~~~l~LVm 752 (958)
.+.++||+|+||+||+|++. ...||||++... .......+|.+|+++|++++|||||++++++.. ++.+++||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 34788999999999999872 235899988643 355667889999999999999999999999765 56799999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcc-
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFL- 830 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~- 830 (958)
|||++|+|.+++........+..++.++.+ +.||.|||..+ |+||||||+||||++++.+||+|||+++.......
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 999999999999877766766666665555 99999999998 99999999999999999999999999987643321
Q ss_pred ---cCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-ChhHHHHhhhccccccCCCCCCcHHHHH
Q 002160 831 ---SSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGFQNRRLEIPKELDPLVAR 906 (958)
Q Consensus 831 ---~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~-~~~ei~~~i~~~~~~~~ip~~ls~eL~d 906 (958)
......||+.|+|||.+.+..++.++|||||||++|||++|..||... +..++...+. .+.++..|..+++++.+
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~-~g~~~~~p~~~~~~l~~ 265 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPLYE 265 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH-TTCCCCCCTTCCHHHHH
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCcccCcHHHHH
Confidence 223356899999999999999999999999999999999987777654 3334444443 45677788899999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHhhhhhcCCC
Q 002160 907 IIWECWQTDPSLRPSFAQLTVALKPLQRLVIPS 939 (958)
Q Consensus 907 LI~~CL~kDP~kRPSa~EIL~~L~kL~k~~~p~ 939 (958)
||.+||+.||.+||++.||+++|+++...+..+
T Consensus 266 li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 266 VMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred HHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 999999999999999999999999998765543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.8e-46 Score=399.86 Aligned_cols=252 Identities=23% Similarity=0.250 Sum_probs=205.7
Q ss_pred CCCeeEEEEeeccCceEEEEEEE-CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
.++|+++++||+|+||+||+|++ +++.||||++......+.....+.+|+.+|++++|||||+++++|...+..+++||
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 36899999999999999999987 67899999997765544445788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCC
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 833 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~ 833 (958)
|+.++.+..+....+.......+..+.+.+.||+|||.++ ||||||||+||||+.++.+||+|||++...........
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (286)
T ss_dssp CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence 9988777777666655555666666666699999999988 99999999999999999999999999988765544455
Q ss_pred CCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccc---------------------
Q 002160 834 STAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQN--------------------- 891 (958)
Q Consensus 834 s~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~--------------------- 891 (958)
...|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..+....+....
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence 56799999999999764 56899999999999999999999999887665544321100
Q ss_pred ------cccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 892 ------RRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 892 ------~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
....+...+++++++||.+||+.||++|||+.||++|
T Consensus 239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0012234678999999999999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=397.99 Aligned_cols=250 Identities=28% Similarity=0.372 Sum_probs=201.2
Q ss_pred CCeeEEEEeeccCceEEEEEEE--C-CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc---CCCceeEEecccc-----C
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--N-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRL---RHPNVVLFMGAVT-----R 744 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~-g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L---~HPNIVkL~g~~~-----~ 744 (958)
++|++++.||+|+||+||+|++ + ++.||||++............+.+|+.+|+.| +|||||+++++|. .
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 6899999999999999999987 2 56799999876544333333456777777766 7999999999884 3
Q ss_pred CCceEEEEeecCCCCHHHHHhCCCCCccH-HHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccc
Q 002160 745 PPNLSIITEFLPRGSLFRILHRPHCQVDE-KRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSR 823 (958)
Q Consensus 745 ~~~l~LVmEy~~gGsL~d~L~k~~~~~~e-~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk 823 (958)
...++++|||++++.+............+ ..+.++.+.+.||+|||+++ ||||||||+|||++.++.+||+|||+++
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCCCCeeecchhhhh
Confidence 45689999999988776555554444444 44455556699999999998 9999999999999999999999999998
Q ss_pred cccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcc-------------
Q 002160 824 LKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ------------- 890 (958)
Q Consensus 824 ~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~------------- 890 (958)
..... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+...
T Consensus 165 ~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (305)
T d1blxa_ 165 IYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243 (305)
T ss_dssp CCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred hhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence 65443 2345678999999999999999999999999999999999999999998877655443210
Q ss_pred ------------ccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 891 ------------NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 891 ------------~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.....++..+++.+++||.+||+.||.+|||+.|+++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00112345678999999999999999999999999886
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=401.04 Aligned_cols=241 Identities=22% Similarity=0.369 Sum_probs=202.3
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCH----HHHHHHHHHHHHHHHcC--CCceeEEeccccCCCc
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSG----AALLEFKREVKIMRRLR--HPNVVLFMGAVTRPPN 747 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~----~~~~~f~~Ei~ILk~L~--HPNIVkL~g~~~~~~~ 747 (958)
++|++++.||+|+||+||+|++ +++.||||++.+..... ....++.+|+.+|++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5799999999999999999987 68899999987654321 11234678999999996 8999999999999999
Q ss_pred eEEEEeecCC-CCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcC-CCcEEEEeccccccc
Q 002160 748 LSIITEFLPR-GSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDK-NWNVKVSDFGLSRLK 825 (958)
Q Consensus 748 l~LVmEy~~g-GsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~-~g~VKL~DFGLAk~~ 825 (958)
+|+||||+.+ +++.+++.+.....+...+.++.+++.||.|||+++ ||||||||+|||++. ++.+||+|||+++..
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECccccceec
Confidence 9999999976 688888876665556666666777799999999998 999999999999985 579999999999876
Q ss_pred cCCcccCCCCCCCCCccCcccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccccCCCCCCcHHH
Q 002160 826 HNTFLSSKSTAGTPEWMAPEVLRNEPS-NEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRLEIPKELDPLV 904 (958)
Q Consensus 826 ~~~~~~~~s~~GT~~Y~APEvl~g~~~-s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~~ip~~ls~eL 904 (958)
.... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+.+ ++ ......++..+++++
T Consensus 162 ~~~~--~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~i------~~~~~~~~~~~s~~~ 231 (273)
T d1xwsa_ 162 KDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--EI------IRGQVFFRQRVSSEC 231 (273)
T ss_dssp CSSC--BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--HH------HHCCCCCSSCCCHHH
T ss_pred cccc--ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--HH------hhcccCCCCCCCHHH
Confidence 4432 345789999999999987765 577899999999999999999997632 11 122455677899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 905 ARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 905 ~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
++||.+||+.||.+|||++||++|
T Consensus 232 ~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 232 QHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHccCCHhHCcCHHHHhcC
Confidence 999999999999999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=407.22 Aligned_cols=244 Identities=26% Similarity=0.382 Sum_probs=197.2
Q ss_pred CCCeeEEE-EeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHc-CCCceeEEeccccC----CC
Q 002160 675 WEDLVLGE-RIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRL-RHPNVVLFMGAVTR----PP 746 (958)
Q Consensus 675 ~~dy~i~k-~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L-~HPNIVkL~g~~~~----~~ 746 (958)
.++|++.+ .||+|+||.||+|++ +++.||||++... ..+.+|+.++.++ +|||||+++++|++ ..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 36798865 699999999999986 6889999998643 3567899987665 89999999999865 45
Q ss_pred ceEEEEeecCCCCHHHHHhCCC-CCcc-HHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcC---CCcEEEEeccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPH-CQVD-EKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGL 821 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~-~~~~-e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~---~g~VKL~DFGL 821 (958)
.+|||||||+||+|.+++.+.+ ..+. ...+.++.+++.||+|||.++ |+||||||+|||++. .+.+||+|||+
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccccccccccccccccce
Confidence 6899999999999999998653 2344 445555666699999999998 999999999999985 56799999999
Q ss_pred cccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhc--cccccCCCC-
Q 002160 822 SRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF--QNRRLEIPK- 898 (958)
Q Consensus 822 Ak~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~--~~~~~~ip~- 898 (958)
++...... .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+.. ......+|.
T Consensus 161 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (335)
T d2ozaa1 161 AKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239 (335)
T ss_dssp CEECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTT
T ss_pred eeeccCCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCc
Confidence 98765432 34557899999999999999999999999999999999999999988765544333211 222333332
Q ss_pred ---CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 899 ---ELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 899 ---~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.+++++++||.+||+.||.+||++.||++|
T Consensus 240 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 578999999999999999999999999886
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-44 Score=381.64 Aligned_cols=251 Identities=22% Similarity=0.250 Sum_probs=211.8
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCCceEEEEe
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPPNLSIITE 753 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~~l~LVmE 753 (958)
++|++++.||+|+||+||+|++ +++.||||++...........++.+|+.+|+.++|||||+++++|.+...+++|||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 6899999999999999999987 68889999998776666677889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCcccCC
Q 002160 754 FLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTFLSSK 833 (958)
Q Consensus 754 y~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~~~~~ 833 (958)
|+.+++|..++...+.......+.++.+.+.||+|||.++ ||||||||+||||+.++++||+|||+++..........
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~ 159 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCC
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccCCceeeeecchhhcccCCCccce
Confidence 9999999988887766666666777777799999999998 99999999999999999999999999998766555555
Q ss_pred CCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCC-ChhHHHHhhhc----------------------
Q 002160 834 STAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGM-NPMQVVGAVGF---------------------- 889 (958)
Q Consensus 834 s~~GT~~Y~APEvl~g~~-~s~ksDIWSLGiLLyELLtG~~PF~g~-~~~ei~~~i~~---------------------- 889 (958)
...+++.|+|||++.+.. ++.++|||||||++|||++|+.||... +..+....+..
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T d1unla_ 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccc
Confidence 566888999999988765 689999999999999999999996543 43333332210
Q ss_pred -----cccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 890 -----QNRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 890 -----~~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
..........+++.+++||.+||+.||.+|||++|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001112334578899999999999999999999999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=391.78 Aligned_cols=255 Identities=33% Similarity=0.522 Sum_probs=197.0
Q ss_pred CCeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC----ceEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP----NLSII 751 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~----~l~LV 751 (958)
.+|.+.+.||+|+||.||+|+++|+.||||++.... .....++.|+..+.+++|||||++++++.+.+ .+|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 468899999999999999999999999999986432 22222345566666789999999999987654 58999
Q ss_pred EeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhc------CCcEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTS------TPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~------g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
||||++|+|.+++++.. ..+..++.++.+ +.||+|||.. .++||||||||+||||+.++++||+|||+++.
T Consensus 80 ~Ey~~~g~L~~~l~~~~--l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EecccCCCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 99999999999998753 445555555555 8999999974 34699999999999999999999999999987
Q ss_pred ccCCc----ccCCCCCCCCCccCcccccCCC------CCchhhHHHHHHHHHHHHhCCCCCCCCC---------------
Q 002160 825 KHNTF----LSSKSTAGTPEWMAPEVLRNEP------SNEKCDVYSFGVILWELATLKLPWIGMN--------------- 879 (958)
Q Consensus 825 ~~~~~----~~~~s~~GT~~Y~APEvl~g~~------~s~ksDIWSLGiLLyELLtG~~PF~g~~--------------- 879 (958)
..... .......||+.|+|||++.+.. ++.++|||||||+||||++|..||....
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 64332 1233567999999999997653 4678999999999999999988774321
Q ss_pred hhHHHHhhhccccccCCCCC-----CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 880 PMQVVGAVGFQNRRLEIPKE-----LDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 880 ~~ei~~~i~~~~~~~~ip~~-----ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
.......+.....++.++.. ....+.+|+.+||+.||.+||++.||++.|++|.++
T Consensus 238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 12222223223334444433 234689999999999999999999999999999765
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-44 Score=386.14 Aligned_cols=252 Identities=23% Similarity=0.269 Sum_probs=198.6
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC--------
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR-------- 744 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~-------- 744 (958)
.++|++++.||+|+||+||+|++ +++.||||++......+....++.+|+++|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 37899999999999999999987 68899999987665555556678899999999999999999998754
Q ss_pred CCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 745 ~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
.+.+|+||||+.++.+..+............+..+.+.+.||.|||+++ ||||||||+||||+.++.+||+|||+++.
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCCCcEEeeecceeee
Confidence 3468999999987766655555444555555556666699999999998 99999999999999999999999999976
Q ss_pred ccCC----cccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccccc--CC-
Q 002160 825 KHNT----FLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRRL--EI- 896 (958)
Q Consensus 825 ~~~~----~~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~~--~i- 896 (958)
.... .......+||+.|+|||++.+. .+++++|||||||++|||++|+.||.+.+..+....+....... ..
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 5432 1223446799999999999865 68999999999999999999999999887766554432111000 00
Q ss_pred ------------------C---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 897 ------------------P---------KELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 897 ------------------p---------~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
+ ...++++++||.+||+.||++|||++|+++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0 0136778999999999999999999999976
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-43 Score=387.21 Aligned_cols=252 Identities=23% Similarity=0.328 Sum_probs=202.0
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC------
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP------ 746 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~------ 746 (958)
.++|++++.||+|+||+||+|++ +++.||||++............+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 36899999999999999999987 5899999999877666677788999999999999999999999987654
Q ss_pred ceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccccc
Q 002160 747 NLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKH 826 (958)
Q Consensus 747 ~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~ 826 (958)
.+||||||+ +.+|..+++.. .......+.++.+++.||.|||+++ ||||||||+|||++.++.+||+|||+++...
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE-KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEEecc-cccHHHHHHhc-cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcccccccccccccceeccC
Confidence 479999999 66788777653 3445555556666699999999998 9999999999999999999999999998765
Q ss_pred CCcccCCCCCCCCCccCcccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcc---------------
Q 002160 827 NTFLSSKSTAGTPEWMAPEVLRNE-PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ--------------- 890 (958)
Q Consensus 827 ~~~~~~~s~~GT~~Y~APEvl~g~-~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~--------------- 890 (958)
.. .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 173 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (346)
T d1cm8a_ 173 SE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249 (346)
T ss_dssp SS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred Cc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence 43 3456799999999999864 5689999999999999999999999987765443222100
Q ss_pred --------------ccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHhhh
Q 002160 891 --------------NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA--LKPLQ 933 (958)
Q Consensus 891 --------------~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~--L~kL~ 933 (958)
.....+...+++++++||.+||..||.+|||++||++| |+.+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 00112335678999999999999999999999999987 55543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-43 Score=384.21 Aligned_cols=248 Identities=23% Similarity=0.259 Sum_probs=195.5
Q ss_pred CeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC------CCce
Q 002160 677 DLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR------PPNL 748 (958)
Q Consensus 677 dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~------~~~l 748 (958)
+|..+++||+|+||+||+|++ +++.||||++...... +.+|+++|++++|||||+++++|.. ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 689999999999999999987 6889999998765422 2479999999999999999999843 3347
Q ss_pred EEEEeecCCCCHHHHH---hCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCC-cEEEEecccccc
Q 002160 749 SIITEFLPRGSLFRIL---HRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNW-NVKVSDFGLSRL 824 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L---~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g-~VKL~DFGLAk~ 824 (958)
|||||||+++.+..+. ...........+.++.+++.||+|||+++ ||||||||+||||+.++ .+||+|||+++.
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccchhh
Confidence 8999999876443332 23333444555566666699999999988 99999999999999765 899999999987
Q ss_pred ccCCcccCCCCCCCCCccCcccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcc-------------
Q 002160 825 KHNTFLSSKSTAGTPEWMAPEVLRN-EPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQ------------- 890 (958)
Q Consensus 825 ~~~~~~~~~s~~GT~~Y~APEvl~g-~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~------------- 890 (958)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+...
T Consensus 173 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 173 LVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp CCTTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred ccCCc-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 65432 2345789999999999875 46899999999999999999999999887766544333110
Q ss_pred --cccc------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHhhh
Q 002160 891 --NRRL------------EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA--LKPLQ 933 (958)
Q Consensus 891 --~~~~------------~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~--L~kL~ 933 (958)
.... .....+++++++||.+||+.||.+|||+.|+++| ++.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 0000 1123578999999999999999999999999976 55554
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-44 Score=391.81 Aligned_cols=254 Identities=24% Similarity=0.359 Sum_probs=210.6
Q ss_pred cCCCCeeEEEEeeccCceEEEEEEE-----CCcEEEEEEeecCCC--CHHHHHHHHHHHHHHHHcCC-CceeEEeccccC
Q 002160 673 IPWEDLVLGERIGLGSYGEVYHADW-----NGTEVAVKKFLDQDF--SGAALLEFKREVKIMRRLRH-PNVVLFMGAVTR 744 (958)
Q Consensus 673 I~~~dy~i~k~LG~G~fG~Vykak~-----~g~~VAVK~i~~~~~--~~~~~~~f~~Ei~ILk~L~H-PNIVkL~g~~~~ 744 (958)
+..++|++++.||+|+||+||+|++ +|+.||||++.+... .......+.+|+++|++++| |||+++++++.+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 3458899999999999999999975 478899999865432 11224467899999999966 899999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecccccc
Q 002160 745 PPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRL 824 (958)
Q Consensus 745 ~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~ 824 (958)
...++++|||+.+|+|.+++...+...+...+.++.+++.||.|||..+ ||||||||+||||+.+|.+||+|||+++.
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCCCCEEEeeccchhh
Confidence 9999999999999999999987766666777777777799999999998 99999999999999999999999999987
Q ss_pred ccCC-cccCCCCCCCCCccCcccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhc--cccccCCCCC
Q 002160 825 KHNT-FLSSKSTAGTPEWMAPEVLRNE--PSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGF--QNRRLEIPKE 899 (958)
Q Consensus 825 ~~~~-~~~~~s~~GT~~Y~APEvl~g~--~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~--~~~~~~ip~~ 899 (958)
.... ........|++.|++||.+.+. .++.++|||||||+||+|++|+.||.+.+..+....+.. ....+.+|..
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 258 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCccc
Confidence 5432 2234456799999999999765 367899999999999999999999988765544333321 2335567788
Q ss_pred CcHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 002160 900 LDPLVARIIWECWQTDPSLRP-----SFAQLTVA 928 (958)
Q Consensus 900 ls~eL~dLI~~CL~kDP~kRP-----Sa~EIL~~ 928 (958)
+++++++||.+||+.||.+|| +++|+++|
T Consensus 259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 999999999999999999999 48899875
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-43 Score=383.40 Aligned_cols=253 Identities=23% Similarity=0.316 Sum_probs=197.5
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCCC----ceE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRPP----NLS 749 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~~----~l~ 749 (958)
.+|++++.||+|+||+||+|++ +++.||||++.+.. .......+.+|+.+|++++|||||++++++.... ..+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 4699999999999999999986 69999999987644 3445668899999999999999999999986543 234
Q ss_pred EEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCCc
Q 002160 750 IITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 750 LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~~ 829 (958)
++++|+.+|+|.+++.... ......+..+.+++.||+|||+++ ||||||||+||||+.++.+||+|||+++......
T Consensus 87 ~l~~~~~~g~L~~~l~~~~-l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp EEEEECCCEEHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEeecCCchhhhhhcCC-CCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 5556677999999997643 344445555666699999999998 9999999999999999999999999998654322
Q ss_pred ---ccCCCCCCCCCccCccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc-------------
Q 002160 830 ---LSSKSTAGTPEWMAPEVLR-NEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR------------- 892 (958)
Q Consensus 830 ---~~~~s~~GT~~Y~APEvl~-g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~------------- 892 (958)
......+||+.|+|||++. +..++.++||||+||++|+|++|+.||.+.+.............
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence 2234567999999999985 55678999999999999999999999988765443322210000
Q ss_pred -------------cc---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHhh
Q 002160 893 -------------RL---EIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA--LKPL 932 (958)
Q Consensus 893 -------------~~---~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~--L~kL 932 (958)
.. .....+++++++||.+||+.||.+||++.|+++| |+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 00 1123578899999999999999999999999987 5443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-42 Score=371.52 Aligned_cols=252 Identities=20% Similarity=0.252 Sum_probs=197.2
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCc-eeEEeccccCCCceEEEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN-VVLFMGAVTRPPNLSIIT 752 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPN-IVkL~g~~~~~~~l~LVm 752 (958)
++|++++.||+|+||.||+|++ +++.||||++...... .++..|++++++++|+| |+.+.+++.+.+..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 4699999999999999999987 5889999987765432 25778999999997665 566666777888899999
Q ss_pred eecCCCCHHHHHhCCCCCccHHHHHHHHH-HHHHHHHHHhcCCcEeecCCCCCceEEcC---CCcEEEEeccccccccCC
Q 002160 753 EFLPRGSLFRILHRPHCQVDEKRRIKMAL-DARGMNCLHTSTPTIVHRDLKSPNLLVDK---NWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 753 Ey~~gGsL~d~L~k~~~~~~e~~~l~ia~-~a~aL~yLH~~g~gIIHRDLKPeNILId~---~g~VKL~DFGLAk~~~~~ 828 (958)
||+ +++|.+.+......+.+...+.++. .+.||+|||+++ ||||||||+|||++. +..+||+|||+++.....
T Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 999 5667666654444455555555554 499999999998 999999999999864 567999999999876432
Q ss_pred c-------ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhh------ccccccC
Q 002160 829 F-------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVG------FQNRRLE 895 (958)
Q Consensus 829 ~-------~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~------~~~~~~~ 895 (958)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+. .......
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH
Confidence 1 22345679999999999999999999999999999999999999998765543322211 0111223
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhh
Q 002160 896 IPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQR 934 (958)
Q Consensus 896 ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k 934 (958)
++..+++++.+||.+||+.||.+||++.+|.+.|+.+..
T Consensus 240 ~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 456789999999999999999999999999998887743
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3e-42 Score=371.56 Aligned_cols=254 Identities=18% Similarity=0.238 Sum_probs=207.6
Q ss_pred CCCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCC-CceeEEeccccCCCceEEE
Q 002160 675 WEDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH-PNVVLFMGAVTRPPNLSII 751 (958)
Q Consensus 675 ~~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~H-PNIVkL~g~~~~~~~l~LV 751 (958)
-++|++++.||+|+||+||+|++ +++.||||++...... ..+.+|+++++.|.| +||+.+++++......++|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 36899999999999999999986 6889999987654322 246789999999965 8999999999999999999
Q ss_pred EeecCCCCHHHHHhCCCCCccHHHHHHHHHH-HHHHHHHHhcCCcEeecCCCCCceEEcC-----CCcEEEEeccccccc
Q 002160 752 TEFLPRGSLFRILHRPHCQVDEKRRIKMALD-ARGMNCLHTSTPTIVHRDLKSPNLLVDK-----NWNVKVSDFGLSRLK 825 (958)
Q Consensus 752 mEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~-a~aL~yLH~~g~gIIHRDLKPeNILId~-----~g~VKL~DFGLAk~~ 825 (958)
|||+ +++|.+++...+..+.......++.+ +.||+|||+++ ||||||||+||||+. ++.+||+|||+++..
T Consensus 80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 9999 78999998776655666666655555 89999999998 999999999999974 578999999999875
Q ss_pred cCCc-------ccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh---HHHHhhhc---ccc
Q 002160 826 HNTF-------LSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPM---QVVGAVGF---QNR 892 (958)
Q Consensus 826 ~~~~-------~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~---ei~~~i~~---~~~ 892 (958)
.... ......+||+.|||||++.+..++.++|||||||++|||++|+.||.+.... +....+.. ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 4321 2234567999999999999999999999999999999999999999865433 22222211 111
Q ss_pred ccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHhhhhh
Q 002160 893 RLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVALKPLQRL 935 (958)
Q Consensus 893 ~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~L~kL~k~ 935 (958)
...++..+|+++.+|+..||..+|++||+++.|.+.|+++.+.
T Consensus 237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence 2234567899999999999999999999999999999887544
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-42 Score=378.60 Aligned_cols=247 Identities=26% Similarity=0.312 Sum_probs=199.7
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccCC-----Cce
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTRP-----PNL 748 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~~-----~~l 748 (958)
++|++++.||+|+||+||+|++ +++.||||++.+.........++.+|+++|++++|||||++++++... ...
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 6799999999999999999986 689999999987766666777899999999999999999999998543 334
Q ss_pred EEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccCC
Q 002160 749 SIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHNT 828 (958)
Q Consensus 749 ~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~~ 828 (958)
+++|||+.+|+|.+++... .......+.++.+++.||+|||+++ ||||||||+|||++.+|.+|++|||++......
T Consensus 98 ~~i~~~~~gg~L~~~~~~~-~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~ 174 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174 (348)
T ss_dssp CEEEEECCSEEHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCC----CCTGG
T ss_pred EEEEEeecCCchhhhcccc-cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCccccccccccccccccchhcccCcc
Confidence 6667778899999999654 3444555555666699999999998 999999999999999999999999999765433
Q ss_pred cccCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhccccc--------------
Q 002160 829 FLSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNRR-------------- 893 (958)
Q Consensus 829 ~~~~~s~~GT~~Y~APEvl~g~~-~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~~-------------- 893 (958)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 175 ---~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 251 (348)
T d2gfsa1 175 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251 (348)
T ss_dssp ---GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred ---cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence 34567999999999987754 688999999999999999999999988766554443211000
Q ss_pred -------cCC--------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 894 -------LEI--------PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 894 -------~~i--------p~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
... ...+++++++||.+||+.||.+|||++|+++|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 001 13578999999999999999999999999985
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.7e-42 Score=372.65 Aligned_cols=242 Identities=21% Similarity=0.307 Sum_probs=193.2
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeccccC--CCceEE
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTR--PPNLSI 750 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~-HPNIVkL~g~~~~--~~~l~L 750 (958)
++|+++++||+|+||+||+|++ +++.||||++.... ..++.+|+++|+++. ||||++++++|.. ...+++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 6799999999999999999987 68899999986532 356889999999995 9999999999864 456999
Q ss_pred EEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCC-CcEEEEeccccccccCCc
Q 002160 751 ITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKN-WNVKVSDFGLSRLKHNTF 829 (958)
Q Consensus 751 VmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~-g~VKL~DFGLAk~~~~~~ 829 (958)
|||||.+++|..+.+ .......+..+.+++.||.|||+++ ||||||||+||||+.+ +.+||+|||+++.....
T Consensus 110 v~e~~~~~~L~~~~~---~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~- 183 (328)
T d3bqca1 110 VFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG- 183 (328)
T ss_dssp EEECCCSCBGGGTTT---SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-
T ss_pred EEeecCCCcHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceeccCC-
Confidence 999999999987643 3445555666666699999999998 9999999999999865 46999999999876543
Q ss_pred ccCCCCCCCCCccCcccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhH-HHHhhh----------------cc-
Q 002160 830 LSSKSTAGTPEWMAPEVLRNEP-SNEKCDVYSFGVILWELATLKLPWIGMNPMQ-VVGAVG----------------FQ- 890 (958)
Q Consensus 830 ~~~~s~~GT~~Y~APEvl~g~~-~s~ksDIWSLGiLLyELLtG~~PF~g~~~~e-i~~~i~----------------~~- 890 (958)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||....... ....+. ..
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence 2345567999999999988754 7999999999999999999999997654321 110000 00
Q ss_pred ------------------ccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 891 ------------------NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 891 ------------------~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.........+++++++||.+||+.||.+|||++|+++|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00001123478999999999999999999999999874
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-42 Score=380.26 Aligned_cols=247 Identities=23% Similarity=0.271 Sum_probs=191.8
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCceeEEeccccC------CCc
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPNVVLFMGAVTR------PPN 747 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPNIVkL~g~~~~------~~~ 747 (958)
++|+++++||+|+||+||+|.+ +++.||||++...........++.+|+.+|++++|||||+++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 6799999999999999999987 58999999998877777777789999999999999999999999854 367
Q ss_pred eEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEeccccccccC
Q 002160 748 LSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFGLSRLKHN 827 (958)
Q Consensus 748 l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFGLAk~~~~ 827 (958)
+|+|||||.++ |.+.+.. .......+..+.+.+.||.|||..+ |+||||||+|||++.++.+|++|||+++....
T Consensus 97 ~~iv~Ey~~~~-l~~~~~~--~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp EEEEEECCSEE-HHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred eEEEEeccchH-HHHhhhc--CCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccccceeeechhhhhcccc
Confidence 89999999765 4444543 3445556666666799999999998 99999999999999999999999999887644
Q ss_pred CcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhHHHHhhhcccc---------------
Q 002160 828 TFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQVVGAVGFQNR--------------- 892 (958)
Q Consensus 828 ~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~ei~~~i~~~~~--------------- 892 (958)
. ......+||+.|+|||++.+..+++++||||+||++|+|++|+.||.+.+.......+.....
T Consensus 172 ~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (355)
T d2b1pa1 172 S-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_dssp ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred c-cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence 3 233456799999999999999999999999999999999999999988775544332210000
Q ss_pred -----cc--------------CC------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002160 893 -----RL--------------EI------PKELDPLVARIIWECWQTDPSLRPSFAQLTVA 928 (958)
Q Consensus 893 -----~~--------------~i------p~~ls~eL~dLI~~CL~kDP~kRPSa~EIL~~ 928 (958)
.. .. +...++++++||.+||..||++|||++||++|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 00 01235689999999999999999999999977
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.2e-37 Score=336.93 Aligned_cols=245 Identities=18% Similarity=0.260 Sum_probs=181.1
Q ss_pred CCeeEEEEeeccCceEEEEEEE--CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC-----------CCceeEEeccc
Q 002160 676 EDLVLGERIGLGSYGEVYHADW--NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-----------HPNVVLFMGAV 742 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~-----------HPNIVkL~g~~ 742 (958)
.+|+++++||+|+||+||+|++ +++.||||++.+.. .....+.+|+++|+.++ |+|||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 4699999999999999999987 68999999987542 33456788999998885 47899999887
Q ss_pred cCC--CceEEEEeecCCCCHHHH-H-h-CCCCCccHHHHHHHHHHHHHHHHHHh-cCCcEeecCCCCCceEEcCCC----
Q 002160 743 TRP--PNLSIITEFLPRGSLFRI-L-H-RPHCQVDEKRRIKMALDARGMNCLHT-STPTIVHRDLKSPNLLVDKNW---- 812 (958)
Q Consensus 743 ~~~--~~l~LVmEy~~gGsL~d~-L-~-k~~~~~~e~~~l~ia~~a~aL~yLH~-~g~gIIHRDLKPeNILId~~g---- 812 (958)
... ...+++|+++..+..... . . ..........+..+.+++.||.|||. ++ |+||||||+||||+.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTT
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccCcccc
Confidence 543 456677777655443322 2 2 22334444455555666999999997 66 99999999999998655
Q ss_pred --cEEEEeccccccccCCcccCCCCCCCCCccCcccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhH------HH
Q 002160 813 --NVKVSDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLKLPWIGMNPMQ------VV 884 (958)
Q Consensus 813 --~VKL~DFGLAk~~~~~~~~~~s~~GT~~Y~APEvl~g~~~s~ksDIWSLGiLLyELLtG~~PF~g~~~~e------i~ 884 (958)
.+||+|||.+...... ....+||+.|+|||++.+..++.++|||||||++++|++|+.||...+... ..
T Consensus 168 ~~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred cceeeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 3999999999865433 245679999999999999999999999999999999999999997543210 00
Q ss_pred -Hhhhc--------------------------c-------------ccccCCCCCCcHHHHHHHHHhhhcCCCCCCCHHH
Q 002160 885 -GAVGF--------------------------Q-------------NRRLEIPKELDPLVARIIWECWQTDPSLRPSFAQ 924 (958)
Q Consensus 885 -~~i~~--------------------------~-------------~~~~~ip~~ls~eL~dLI~~CL~kDP~kRPSa~E 924 (958)
..+.. . .....++...++++++||.+||..||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 00000 0 0011122335678999999999999999999999
Q ss_pred HHHH
Q 002160 925 LTVA 928 (958)
Q Consensus 925 IL~~ 928 (958)
+++|
T Consensus 325 ~L~H 328 (362)
T d1q8ya_ 325 LVNH 328 (362)
T ss_dssp HHTC
T ss_pred HhcC
Confidence 9876
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=6.3e-22 Score=198.63 Aligned_cols=166 Identities=18% Similarity=0.142 Sum_probs=116.6
Q ss_pred eeEEEEeeccCceEEEEEEE-CCcEEEEEEeecCCCC----------------HHHHHHHHHHHHHHHHcCCCceeEEec
Q 002160 678 LVLGERIGLGSYGEVYHADW-NGTEVAVKKFLDQDFS----------------GAALLEFKREVKIMRRLRHPNVVLFMG 740 (958)
Q Consensus 678 y~i~k~LG~G~fG~Vykak~-~g~~VAVK~i~~~~~~----------------~~~~~~f~~Ei~ILk~L~HPNIVkL~g 740 (958)
+.++++||+|+||.||+|+. +|+.||||+++..... ......+.+|..++.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 35789999999999999986 7899999987532110 112234567899999999999999887
Q ss_pred cccCCCceEEEEeecCCCCHHHHHhCCCCCccHHHHHHHHHHHHHHHHHHhcCCcEeecCCCCCceEEcCCCcEEEEecc
Q 002160 741 AVTRPPNLSIITEFLPRGSLFRILHRPHCQVDEKRRIKMALDARGMNCLHTSTPTIVHRDLKSPNLLVDKNWNVKVSDFG 820 (958)
Q Consensus 741 ~~~~~~~l~LVmEy~~gGsL~d~L~k~~~~~~e~~~l~ia~~a~aL~yLH~~g~gIIHRDLKPeNILId~~g~VKL~DFG 820 (958)
+.. .+++|||+++..+.++.. ......+.+.+.++.|||.++ |+||||||+|||++++ .++|+|||
T Consensus 82 ~~~----~~lvme~~~~~~~~~l~~-------~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~-~~~liDFG 147 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYRVRV-------ENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEE-GIWIIDFP 147 (191)
T ss_dssp EET----TEEEEECCCCEEGGGCCC-------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETT-EEEECCCT
T ss_pred ecC----CEEEEEeeccccccchhh-------HHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCC-CEEEEECC
Confidence 642 379999998876544211 112233445589999999998 9999999999999965 49999999
Q ss_pred ccccccCCcccCCCCCCCCCccCc--c---cccCCCCCchhhHHHHHHHH
Q 002160 821 LSRLKHNTFLSSKSTAGTPEWMAP--E---VLRNEPSNEKCDVYSFGVIL 865 (958)
Q Consensus 821 LAk~~~~~~~~~~s~~GT~~Y~AP--E---vl~g~~~s~ksDIWSLGiLL 865 (958)
+|+....... ..|... + .+..+.|..++|+||+.--+
T Consensus 148 ~a~~~~~~~~--------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 148 QSVEVGEEGW--------REILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TCEETTSTTH--------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred CcccCCCCCc--------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 9976532211 112211 0 01235577889999975443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.17 E-value=5e-06 Score=84.25 Aligned_cols=86 Identities=12% Similarity=-0.073 Sum_probs=61.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeccccCCCceEEEEee
Q 002160 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRPPNLSIITEF 754 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~-HPNIVkL~g~~~~~~~l~LVmEy 754 (958)
+.|+..+..+.++...||+....+..++||+....... ....+.+|..+|..|. +--+.+++.++..++..++||++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 45666665555556789999888888999986543221 1234678888888884 33356777777788889999999
Q ss_pred cCCCCHHHH
Q 002160 755 LPRGSLFRI 763 (958)
Q Consensus 755 ~~gGsL~d~ 763 (958)
++|..+...
T Consensus 92 l~G~~~~~~ 100 (263)
T d1j7la_ 92 ADGVLCSEE 100 (263)
T ss_dssp CSSEEHHHH
T ss_pred ccccccccc
Confidence 998877543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.42 E-value=0.00019 Score=71.82 Aligned_cols=73 Identities=16% Similarity=0.156 Sum_probs=51.0
Q ss_pred EeeccCc-eEEEEEEEC-CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCC--CceeEEeccccCCCceEEEEeecCCC
Q 002160 683 RIGLGSY-GEVYHADWN-GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRH--PNVVLFMGAVTRPPNLSIITEFLPRG 758 (958)
Q Consensus 683 ~LG~G~f-G~Vykak~~-g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~H--PNIVkL~g~~~~~~~l~LVmEy~~gG 758 (958)
.+..|.. ..||+.... +..+++|....... ..+..|...|+.|.. -.+.+++.+..+++..++||||++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 4555554 678999875 44577886544332 246678888887742 33667888888888899999999876
Q ss_pred CH
Q 002160 759 SL 760 (958)
Q Consensus 759 sL 760 (958)
.+
T Consensus 92 ~~ 93 (255)
T d1nd4a_ 92 DL 93 (255)
T ss_dssp ET
T ss_pred cc
Confidence 55
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.40 E-value=0.00016 Score=78.81 Aligned_cols=77 Identities=16% Similarity=0.093 Sum_probs=49.2
Q ss_pred EEEeeccCceEEEEEEE--CCcEEEEEEeecCC-CC----HHHHHHHHHHHHHHHHc-CC--CceeEEeccccCCCceEE
Q 002160 681 GERIGLGSYGEVYHADW--NGTEVAVKKFLDQD-FS----GAALLEFKREVKIMRRL-RH--PNVVLFMGAVTRPPNLSI 750 (958)
Q Consensus 681 ~k~LG~G~fG~Vykak~--~g~~VAVK~i~~~~-~~----~~~~~~f~~Ei~ILk~L-~H--PNIVkL~g~~~~~~~l~L 750 (958)
.+.||.|....||+++. .++.|+||.-.... .. .....+...|...|+.+ .+ ..+.+++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 45699999999999975 46789999654311 10 11123455688888877 33 345666654 3455689
Q ss_pred EEeecCCCC
Q 002160 751 ITEFLPRGS 759 (958)
Q Consensus 751 VmEy~~gGs 759 (958)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.50 E-value=0.0045 Score=63.98 Aligned_cols=52 Identities=10% Similarity=0.041 Sum_probs=33.6
Q ss_pred CCeeEEEEeeccCceEEEEEEECCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC
Q 002160 676 EDLVLGERIGLGSYGEVYHADWNGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR 731 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~ 731 (958)
..+.-.+.|..|---+.|+.+.++..+++|++.... ...++..|+++|..|.
T Consensus 18 g~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~----~~~~l~~~~~~l~~L~ 69 (316)
T d2ppqa1 18 GSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV----EKNDLPFFLGLMQHLA 69 (316)
T ss_dssp CCEEEEEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHH
T ss_pred CCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCC----CHHHHHHHHHHHHhhh
Confidence 445556678888889999999888889999875432 1234556777777774
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.12 E-value=0.0067 Score=63.60 Aligned_cols=69 Identities=10% Similarity=0.047 Sum_probs=44.4
Q ss_pred cCceEEEEEEE-CCcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcCCCc--eeEEec-----cccCCCceEEEEeecCCC
Q 002160 687 GSYGEVYHADW-NGTEVAVKKFLDQDFSGAALLEFKREVKIMRRLRHPN--VVLFMG-----AVTRPPNLSIITEFLPRG 758 (958)
Q Consensus 687 G~fG~Vykak~-~g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~HPN--IVkL~g-----~~~~~~~l~LVmEy~~gG 758 (958)
+.--.||+++. +|+.|++|+.+....+. .++..|...|..|...+ ++..+. .+...+..+.++++++|.
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cccceeEEEEcCCCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 33468999976 78889999876654333 45677888888884222 222221 123445678899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.03 E-value=0.0088 Score=64.30 Aligned_cols=76 Identities=17% Similarity=0.270 Sum_probs=51.4
Q ss_pred CCeeEEEEeeccCceEEEEEEEC---------CcEEEEEEeecCCCCHHHHHHHHHHHHHHHHcC-CCceeEEeccccCC
Q 002160 676 EDLVLGERIGLGSYGEVYHADWN---------GTEVAVKKFLDQDFSGAALLEFKREVKIMRRLR-HPNVVLFMGAVTRP 745 (958)
Q Consensus 676 ~dy~i~k~LG~G~fG~Vykak~~---------g~~VAVK~i~~~~~~~~~~~~f~~Ei~ILk~L~-HPNIVkL~g~~~~~ 745 (958)
+++++ +.|+.|-.-.+|+++.. .+.|.+++.-... . .....+|..+++.+. +.-..++++++.+
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~- 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG- 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-h---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence 44554 57888999999999763 2457777654221 1 234568999999884 4334578887754
Q ss_pred CceEEEEeecCCCCH
Q 002160 746 PNLSIITEFLPRGSL 760 (958)
Q Consensus 746 ~~l~LVmEy~~gGsL 760 (958)
.+||||++|..|
T Consensus 117 ---g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ---GRLEEYIPSRPL 128 (395)
T ss_dssp ---EEEECCCCEEEC
T ss_pred ---ceEEEEeccccC
Confidence 689999987543
|
| >d2f4ma1 d.3.1.4 (A:164-450) Peptide:N-glycanase 1, PNG1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Cysteine proteinases superfamily: Cysteine proteinases family: Transglutaminase core domain: Peptide:N-glycanase 1, PNG1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=90.10 E-value=0.1 Score=54.28 Aligned_cols=51 Identities=16% Similarity=0.183 Sum_probs=43.0
Q ss_pred ecccccchhhHHHHHHhhhcCCCCceeecccCCCCccCcceEEEEeCCcceee-eec
Q 002160 261 SINIGLSRHRALLFKVLADSIRLPCRLVKGSHYTGVEDDAVNIIKLEEEREFL-VDL 316 (958)
Q Consensus 261 ~i~~G~~rhRAlLFKvLaD~i~l~c~lv~G~~~~g~~~~a~~~v~~~~~~~~~-vDl 316 (958)
.-+.|.|.|=|.||-.|+=.+|+|||.|.|.. |++|++|.+.+...+| ||-
T Consensus 137 ~tr~G~C~e~a~~~~~~~Ra~g~~aR~v~~~~-----~H~W~Ev~~~~~~rWv~vDp 188 (287)
T d2f4ma1 137 ETRCGRCGEWANCFTLCCRALGFEARYVWDYT-----DHVWTEVYSPSQQRWLHCDA 188 (287)
T ss_dssp HHCEESHHHHHHHHHHHHHHTTCCEEEEEETT-----TEEEEEEEETTTTEEEEEET
T ss_pred HhcCccHHHHHHHHHHHHHHcCCCeEEEecCC-----cceeEEEEecCCCcEEEecC
Confidence 34689999999999999999999999999853 7899999998865443 453
|